Psyllid ID: psy622
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 473 | 2.2.26 [Sep-21-2011] | |||||||
| Q6DBX4 | 860 | Serine/threonine-protein | yes | N/A | 0.408 | 0.224 | 0.562 | 5e-52 | |
| Q6NTJ3 | 887 | Serine/threonine-protein | N/A | N/A | 0.439 | 0.234 | 0.507 | 7e-50 | |
| E1C2I2 | 881 | Serine/threonine-protein | yes | N/A | 0.391 | 0.209 | 0.565 | 2e-49 | |
| B1WAR9 | 890 | Serine/threonine-protein | yes | N/A | 0.391 | 0.207 | 0.539 | 9e-49 | |
| E2RJI4 | 883 | Serine/threonine-protein | yes | N/A | 0.391 | 0.209 | 0.533 | 1e-48 | |
| E1BFR5 | 883 | Serine/threonine-protein | yes | N/A | 0.391 | 0.209 | 0.528 | 1e-48 | |
| Q96GX5 | 879 | Serine/threonine-protein | yes | N/A | 0.391 | 0.210 | 0.554 | 2e-48 | |
| D2HXI8 | 882 | Serine/threonine-protein | yes | N/A | 0.391 | 0.209 | 0.549 | 4e-48 | |
| Q8C0P0 | 865 | Serine/threonine-protein | yes | N/A | 0.391 | 0.213 | 0.544 | 4e-48 | |
| Q559T8 | 2102 | Probable serine/threonine | yes | N/A | 0.289 | 0.065 | 0.579 | 1e-40 |
| >sp|Q6DBX4|GWL_DANRE Serine/threonine-protein kinase greatwall OS=Danio rerio GN=mastl PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 206 bits (523), Expect = 5e-52, Method: Compositional matrix adjust.
Identities = 113/201 (56%), Positives = 140/201 (69%), Gaps = 8/201 (3%)
Query: 28 CDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVS 87
C+ S S +KAP I DF +VK ISRGAFGKV+L KK N +LYAIKV+KK EM++KNM
Sbjct: 8 CESSNSAVKAPSIEDFVLVKPISRGAFGKVYLARKKCN-SKLYAIKVVKKAEMVDKNMTE 66
Query: 88 QVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFY 147
Q+ ER+ALAL+ SPF V LFYSLQT++ V+LVMEY+IGGDVKSL+ G EDM+ Y
Sbjct: 67 QMRAERDALALSKSPFIVHLFYSLQTATKVYLVMEYLIGGDVKSLLHIYGYFDEDMSLKY 126
Query: 148 AAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVN-TLFLAILQQPIVYLEI---S 203
+EV LAL YLH H IIHRDLKPDNMLIS + H + + L L + + ++I
Sbjct: 127 ISEVALALDYLHRHSIIHRDLKPDNMLISNEG-HIKLTDFGLSKVKLDRELNLMDILTTP 185
Query: 204 DLVNGTPNAFNIRTPGQLLSL 224
LV T + F RTPGQ+LSL
Sbjct: 186 SLVKPTKDYF--RTPGQVLSL 204
|
Serine/threonine kinase that plays a key role in M phase by acting as a regulator of mitosis entry and maintenance. Acts by promoting the inactivation of protein phosphatase 2A (PP2A) during M phase: does not directly inhibit PP2A but acts by mediating phosphorylation and subsequent activation of arpp19 and ensa at 'Ser-62' and 'Ser-74', respectively. ARPP19 and ENSA are phosphatase inhibitors that specifically inhibit the ppp2r2d (PR55-delta) subunit of PP2A. Inactivation of PP2A during M phase is essential to keep cyclin-B1-CDK1 activity high. Following DNA damage, it is also involved in checkpoint recovery by being inhibited (By similarity). May be involved in megakaryocyte differentiation. Danio rerio (taxid: 7955) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6NTJ3|GWL_XENLA Serine/threonine-protein kinase greatwall OS=Xenopus laevis GN=mastl PE=1 SV=1 | Back alignment and function description |
|---|
Score = 198 bits (504), Expect = 7e-50, Method: Compositional matrix adjust.
Identities = 108/213 (50%), Positives = 145/213 (68%), Gaps = 5/213 (2%)
Query: 15 ILEITNKASENSLCDVSKSCL-KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIK 73
I+ T++ + SLC K + + P I +F IVK ISRGAFGKV+L +K N +L+A+K
Sbjct: 3 IVAETSQNGDTSLCSEKKFTVPQPPSIEEFGIVKPISRGAFGKVYLARRKNN-SKLFAVK 61
Query: 74 VMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI 133
V+KK +MINKNMV QV ER+ALAL+ SPF V L+YSLQ+++ ++LVMEY+IGGDVKSL+
Sbjct: 62 VVKKADMINKNMVQQVQAERDALALSKSPFIVHLYYSLQSANNIYLVMEYLIGGDVKSLL 121
Query: 134 AANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVN-TLFLAI 192
G E+MA Y +EV +AL YLH HGIIHRDLKPDNMLIS + H + + L
Sbjct: 122 HIYGYFDEEMAVKYISEVAMALDYLHRHGIIHRDLKPDNMLISNKG-HIKLTDFGLSKVT 180
Query: 193 LQQPIVYLEI-SDLVNGTPNAFNIRTPGQLLSL 224
L++ + ++I + P RTPGQ+LSL
Sbjct: 181 LKRELCMMDILTTPSMAKPKRDYSRTPGQVLSL 213
|
Serine/threonine kinase that plays a key role in M phase by acting as a regulator of mitosis entry and maintenance. Acts by promoting the inactivation of protein phosphatase 2A (PP2A) during M phase: does not directly inhibit PP2A but acts by mediating phosphorylation and subsequent activation of arpp19 and ensa at 'Ser-67', 2 phosphatase inhibitors that specifically inhibit the ppp2r2d (PR55-delta) subunit of PP2A. Inactivation of PP2A during M phase is essential to keep cyclin-B1-CDK1 activity high. Following DNA damage, it is also involved in checkpoint recovery by being inhibited. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|E1C2I2|GWL_CHICK Serine/threonine-protein kinase greatwall OS=Gallus gallus GN=MASTL PE=3 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 108/191 (56%), Positives = 131/191 (68%), Gaps = 6/191 (3%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+ P I +F IVK ISRGAFGKV+LG K +LYA+KVMKK +MINKNMV QV ER+A
Sbjct: 23 RPPSIEEFTIVKPISRGAFGKVYLGRKA---GRLYAVKVMKKADMINKNMVHQVQAERDA 79
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
LAL+ SPF V L+YSLQ+++ V+LVMEY+IGGDVKSL+ G E+MA Y +E LAL
Sbjct: 80 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEAALAL 139
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVN-TLFLAILQQPIVYLEI-SDLVNGTPNAF 213
YLH HGIIHRDLKPDNMLIS Q H + + L L + I ++I + P
Sbjct: 140 DYLHRHGIIHRDLKPDNMLISNQG-HIKLTDFGLSRVTLNREINMIDILTTPSMAKPKHD 198
Query: 214 NIRTPGQLLSL 224
RTPGQLLSL
Sbjct: 199 YSRTPGQLLSL 209
|
Serine/threonine kinase that plays a key role in M phase by acting as a regulator of mitosis entry and maintenance. Acts by promoting the inactivation of protein phosphatase 2A (PP2A) during M phase: does not directly inhibit PP2A but acts by mediating phosphorylation and subsequent activation of ARPP19 and ENSA at 'Ser-62' and 'Ser-67', respectively. ARPP19 and ENSA are phosphatase inhibitors that specifically inhibit the PPP2R2D (PR55-delta) subunit of PP2A. Inactivation of PP2A during M phase is essential to keep cyclin-B1-CDK1 activity high. Following DNA damage, it is also involved in checkpoint recovery by being inhibited. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|B1WAR9|GWL_XENTR Serine/threonine-protein kinase greatwall OS=Xenopus tropicalis GN=mastl PE=2 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (494), Expect = 9e-49, Method: Compositional matrix adjust.
Identities = 102/189 (53%), Positives = 134/189 (70%), Gaps = 4/189 (2%)
Query: 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
P I +F IVK ISRGAFGKV+L +K N ++L+A+KV+KK +MINKNMV QV ER+ALA
Sbjct: 28 PSIEEFSIVKPISRGAFGKVYLARRKNN-NKLFAVKVVKKADMINKNMVQQVQAERDALA 86
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
L+ SPF V L+YSLQ+++ ++L+MEY+IGGDVKSL+ G E+MA Y +EV LAL Y
Sbjct: 87 LSKSPFIVHLYYSLQSANNIYLIMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDY 146
Query: 158 LHSHGIIHRDLKPDNMLISAQAPHCPIVN-TLFLAILQQPIVYLEI-SDLVNGTPNAFNI 215
LH HGIIHRDLKPDNMLIS + H + + L L++ + ++I + P
Sbjct: 147 LHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSKVTLKRELSMMDILTTPSMAKPKRDYS 205
Query: 216 RTPGQLLSL 224
RTPGQ+LSL
Sbjct: 206 RTPGQVLSL 214
|
Serine/threonine kinase that plays a key role in M phase by acting as a regulator of mitosis entry and maintenance. Acts by promoting the inactivation of protein phosphatase 2A (PP2A) during M phase: does not directly inhibit PP2A but acts by mediating phosphorylation and subsequent activation of arpp19 and ensa at 'Ser-67', 2 phosphatase inhibitors that specifically inhibit the ppp2r2d (PR55-delta) subunit of PP2A. Inactivation of PP2A during M phase is essential to keep cyclin-B1-CDK1 activity high. Following DNA damage, it is also involved in checkpoint recovery by being inhibited. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|E2RJI4|GWL_CANFA Serine/threonine-protein kinase greatwall OS=Canis familiaris GN=MASTL PE=3 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (493), Expect = 1e-48, Method: Compositional matrix adjust.
Identities = 103/193 (53%), Positives = 130/193 (67%), Gaps = 8/193 (4%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+ P I +F IVK ISRGAFGKV+LG K +LYA+KV+KK +MINKNM QV ER+A
Sbjct: 28 RPPSIEEFTIVKPISRGAFGKVYLGQKG---GKLYAVKVVKKADMINKNMTHQVQAERDA 84
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
LAL+ SPF V L+YSLQ+++ V+LVMEY+IGGDVKSL+ G E+MA Y +EV LAL
Sbjct: 85 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALAL 144
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVN----GTPN 211
YLH HGIIHRDLKPDNMLIS + H + + I + + + D++ P
Sbjct: 145 DYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSKITLNRDIDINMMDILTTPSMAKPR 203
Query: 212 AFNIRTPGQLLSL 224
RTPGQ+LSL
Sbjct: 204 QDYSRTPGQVLSL 216
|
Serine/threonine kinase that plays a key role in M phase by acting as a regulator of mitosis entry and maintenance. Acts by promoting the inactivation of protein phosphatase 2A (PP2A) during M phase: does not directly inhibit PP2A but acts by mediating phosphorylation and subsequent activation of ARPP19 and ENSA at 'Ser-62' and 'Ser-67', respectively. ARPP19 and ENSA are phosphatase inhibitors that specifically inhibit the PPP2R2D (PR55-delta) subunit of PP2A. Inactivation of PP2A during M phase is essential to keep cyclin-B1-CDK1 activity high. Following DNA damage, it is also involved in checkpoint recovery by being inhibited. Canis familiaris (taxid: 9615) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|E1BFR5|GWL_BOVIN Serine/threonine-protein kinase greatwall OS=Bos taurus GN=MASTL PE=3 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (493), Expect = 1e-48, Method: Compositional matrix adjust.
Identities = 102/193 (52%), Positives = 131/193 (67%), Gaps = 8/193 (4%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+ P I +F IVK ISRGAFGKV+LG K ++LYA+KV+KK +MINKNM QV ER+A
Sbjct: 28 RPPSIEEFTIVKPISRGAFGKVYLGQKG---NRLYAVKVVKKADMINKNMTHQVQAERDA 84
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
LAL+ SPF V L+YSLQ+++ V+LVMEY+IGGDVKSL+ G E+MA Y +EV LAL
Sbjct: 85 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALAL 144
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVN----GTPN 211
YLH HGIIHRDLKPDNMLIS + H + + + + + + D++ P
Sbjct: 145 DYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSKVTLNRDIDINMMDILTTPSMAKPR 203
Query: 212 AFNIRTPGQLLSL 224
RTPGQ+LSL
Sbjct: 204 QDYSRTPGQVLSL 216
|
Serine/threonine kinase that plays a key role in M phase by acting as a regulator of mitosis entry and maintenance. Acts by promoting the inactivation of protein phosphatase 2A (PP2A) during M phase: does not directly inhibit PP2A but acts by mediating phosphorylation and subsequent activation of ARPP19 and ENSA at 'Ser-62' and 'Ser-67', respectively. ARPP19 and ENSA are phosphatase inhibitors that specifically inhibit the PPP2R2D (PR55-delta) subunit of PP2A. Inactivation of PP2A during M phase is essential to keep cyclin-B1-CDK1 activity high. Following DNA damage, it is also involved in checkpoint recovery by being inhibited. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96GX5|GWL_HUMAN Serine/threonine-protein kinase greatwall OS=Homo sapiens GN=MASTL PE=1 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (492), Expect = 2e-48, Method: Compositional matrix adjust.
Identities = 106/191 (55%), Positives = 131/191 (68%), Gaps = 6/191 (3%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
K P I +F IVK ISRGAFGKV+LG K +LYA+KV+KK +MINKNM QV ER+A
Sbjct: 28 KPPSIEEFSIVKPISRGAFGKVYLGQKG---GKLYAVKVVKKADMINKNMTHQVQAERDA 84
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
LAL+ SPF V L+YSLQ+++ V+LVMEY+IGGDVKSL+ G E+MA Y +EV LAL
Sbjct: 85 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALAL 144
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVN-TLFLAILQQPIVYLEI-SDLVNGTPNAF 213
YLH HGIIHRDLKPDNMLIS + H + + L L + I ++I + P
Sbjct: 145 DYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSKVTLNRDINMMDILTTPSMAKPRQD 203
Query: 214 NIRTPGQLLSL 224
RTPGQ+LSL
Sbjct: 204 YSRTPGQVLSL 214
|
Serine/threonine kinase that plays a key role in M phase by acting as a regulator of mitosis entry and maintenance. Acts by promoting the inactivation of protein phosphatase 2A (PP2A) during M phase: does not directly inhibit PP2A but acts by mediating phosphorylation and subsequent activation of ARPP19 and ENSA at 'Ser-62' and 'Ser-67', respectively. ARPP19 and ENSA are phosphatase inhibitors that specifically inhibit the PPP2R2D (PR55-delta) subunit of PP2A. Inactivation of PP2A during M phase is essential to keep cyclin-B1-CDK1 activity high. Following DNA damage, it is also involved in checkpoint recovery by being inhibited. Phosphorylates histone protein in vitro; however such activity is unsure in vivo. May be involved in megakaryocyte differentiation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|D2HXI8|GWL_AILME Serine/threonine-protein kinase greatwall OS=Ailuropoda melanoleuca GN=MASTL PE=3 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (489), Expect = 4e-48, Method: Compositional matrix adjust.
Identities = 105/191 (54%), Positives = 131/191 (68%), Gaps = 6/191 (3%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+ P I +F IVK ISRGAFGKV+LG K +LYA+KV+KK +MINKNM QV ER+A
Sbjct: 28 RPPSIEEFTIVKPISRGAFGKVYLGQKG---GKLYAVKVVKKADMINKNMTHQVQAERDA 84
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
LAL+ SPF V L+YSLQ+++ V+LVMEY+IGGDVKSL+ G E+MA Y +EV LAL
Sbjct: 85 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALAL 144
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVN-TLFLAILQQPIVYLEI-SDLVNGTPNAF 213
YLH HGIIHRDLKPDNMLIS + H + + L L + I ++I + P
Sbjct: 145 DYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSKVTLNRDINMMDILTTPSMAKPRQD 203
Query: 214 NIRTPGQLLSL 224
RTPGQ+LSL
Sbjct: 204 YSRTPGQVLSL 214
|
Serine/threonine kinase that plays a key role in M phase by acting as a regulator of mitosis entry and maintenance. Acts by promoting the inactivation of protein phosphatase 2A (PP2A) during M phase: does not directly inhibit PP2A but acts by mediating phosphorylation and subsequent activation of ARPP19 and ENSA at 'Ser-62' and 'Ser-67', respectively. ARPP19 and ENSA are phosphatase inhibitors that specifically inhibit the PPP2R2D (PR55-delta) subunit of PP2A. Inactivation of PP2A during M phase is essential to keep cyclin-B1-CDK1 activity high. Following DNA damage, it is also involved in checkpoint recovery by being inhibited. Ailuropoda melanoleuca (taxid: 9646) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8C0P0|GWL_MOUSE Serine/threonine-protein kinase greatwall OS=Mus musculus GN=Mastl PE=2 SV=2 | Back alignment and function description |
|---|
Score = 192 bits (488), Expect = 4e-48, Method: Compositional matrix adjust.
Identities = 104/191 (54%), Positives = 131/191 (68%), Gaps = 6/191 (3%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+ P I +F IVK ISRGAFGKV+LG K +LYA+KV+KK +MINKNM QV ER+A
Sbjct: 27 RPPSIEEFTIVKPISRGAFGKVYLGQKG---GKLYAVKVVKKADMINKNMTHQVQAERDA 83
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
LAL+ SPF V L+YSLQ++S ++L+MEY+IGGDVKSL+ G E+MA Y +EV LAL
Sbjct: 84 LALSKSPFVVHLYYSLQSASNIYLIMEYLIGGDVKSLLHIYGYFDEEMAIKYISEVALAL 143
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVN-TLFLAILQQPIVYLEI-SDLVNGTPNAF 213
YLH HGIIHRDLKPDNMLIS + H + + L L + I ++I + P
Sbjct: 144 DYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSKVTLNRDINMMDILTTPSMSKPKQD 202
Query: 214 NIRTPGQLLSL 224
RTPGQ+LSL
Sbjct: 203 YSRTPGQVLSL 213
|
Serine/threonine kinase that plays a key role in M phase by acting as a regulator of mitosis entry and maintenance. Acts by promoting the inactivation of protein phosphatase 2A (PP2A) during M phase: does not directly inhibit PP2A but acts by mediating phosphorylation and subsequent activation of ARPP19 and ENSA at 'Ser-62' and 'Ser-67', respectively. ARPP19 and ENSA are phosphatase inhibitors that specifically inhibit the PPP2R2D (PR55-delta) subunit of PP2A. Inactivation of PP2A during M phase is essential to keep cyclin-B1-CDK1 activity high. Following DNA damage, it is also involved in checkpoint recovery by being inhibited. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q559T8|Y0701_DICDI Probable serine/threonine-protein kinase DDB_G0272282 OS=Dictyostelium discoideum GN=DDB_G0272282 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 168 bits (425), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 80/138 (57%), Positives = 100/138 (72%), Gaps = 1/138 (0%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
I+DFEI+K ISRGAFG+V+L KK D LYAIKV+KK + I KNMV+ V+ ERN LA+
Sbjct: 1524 IADFEIIKPISRGAFGRVYLAQKKKTGD-LYAIKVLKKLDTIRKNMVNHVIVERNILAMV 1582
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
+ F V+LFY+ Q++ ++LVMEY+IGGD SL+ A G E MA Y AE VL L+YLH
Sbjct: 1583 QNEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETVLCLEYLH 1642
Query: 160 SHGIIHRDLKPDNMLISA 177
I+HRDLKPDNMLI
Sbjct: 1643 KSAIVHRDLKPDNMLIDG 1660
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 473 | ||||||
| 322784870 | 750 | hypothetical protein SINV_03845 [Solenop | 0.458 | 0.289 | 0.594 | 6e-67 | |
| 340713652 | 709 | PREDICTED: serine/threonine-protein kina | 0.412 | 0.275 | 0.646 | 2e-66 | |
| 350409521 | 709 | PREDICTED: serine/threonine-protein kina | 0.412 | 0.275 | 0.646 | 2e-66 | |
| 307209073 | 723 | Microtubule-associated serine/threonine- | 0.416 | 0.272 | 0.65 | 3e-66 | |
| 332016221 | 735 | Microtubule-associated serine/threonine- | 0.458 | 0.295 | 0.590 | 5e-66 | |
| 156543463 | 728 | PREDICTED: serine/threonine-protein kina | 0.416 | 0.270 | 0.628 | 1e-65 | |
| 307172643 | 743 | Microtubule-associated serine/threonine- | 0.418 | 0.266 | 0.635 | 1e-65 | |
| 383852744 | 708 | PREDICTED: serine/threonine-protein kina | 0.416 | 0.278 | 0.635 | 6e-65 | |
| 48095908 | 715 | PREDICTED: microtubule-associated serine | 0.412 | 0.272 | 0.641 | 6e-65 | |
| 380024998 | 715 | PREDICTED: serine/threonine-protein kina | 0.412 | 0.272 | 0.636 | 9e-65 |
| >gi|322784870|gb|EFZ11650.1| hypothetical protein SINV_03845 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 261 bits (667), Expect = 6e-67, Method: Compositional matrix adjust.
Identities = 135/227 (59%), Positives = 164/227 (72%), Gaps = 10/227 (4%)
Query: 6 LFSGADKENILEITNKASE--------NSLCDVSKSCLKAPEISDFEIVKAISRGAFGKV 57
+++G D E E T + SE N++ + K P+I DF+IVK ISRGAFGKV
Sbjct: 27 IYNGNDTERHGECTPQQSERCINNSIFNTISKIVNPTTKVPDIQDFKIVKPISRGAFGKV 86
Query: 58 FLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117
FLGYKKTN +Q+YAIKVMKK+EMINKNM SQV+ ERNALALT SP+CVQLFYSLQ+ S V
Sbjct: 87 FLGYKKTNSEQVYAIKVMKKNEMINKNMASQVVIERNALALTRSPYCVQLFYSLQSISSV 146
Query: 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177
+LVMEYM+GGD+KSL+ G + E MAAFY AEV LAL+YLHSHGI+HRDLKPDNML+S
Sbjct: 147 YLVMEYMVGGDLKSLLGVCGFMEESMAAFYTAEVCLALEYLHSHGIVHRDLKPDNMLLSR 206
Query: 178 QAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLSL 224
+ H + + L+ + LEISDLVN + RTPGQLLSL
Sbjct: 207 EG-HVKLTD-FGLSKISSLHRDLEISDLVNPMTPSLCTRTPGQLLSL 251
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340713652|ref|XP_003395354.1| PREDICTED: serine/threonine-protein kinase greatwall-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 259 bits (662), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 130/201 (64%), Positives = 156/201 (77%), Gaps = 6/201 (2%)
Query: 25 NSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN 84
N++ + K PEI DF+IVK ISRGAFGKVFLGYKK+N +++YAIKVMKK+EMINKN
Sbjct: 62 NTISKIVNPTAKVPEIQDFKIVKPISRGAFGKVFLGYKKSNSEKVYAIKVMKKNEMINKN 121
Query: 85 MVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMA 144
M SQV+ ERNALALTHSP+CVQLFYSLQ+ S ++LVMEYM+GGD+KSL+ G + E MA
Sbjct: 122 MASQVIIERNALALTHSPYCVQLFYSLQSVSSIYLVMEYMVGGDLKSLLGVYGYMEESMA 181
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI-LQQPIVYLEIS 203
AFY AEV LAL+YLHSHGI+HRDLKPDNML+S + H + + I L + LEIS
Sbjct: 182 AFYTAEVCLALEYLHSHGIVHRDLKPDNMLLSKEG-HVKLTDFGLSKISLHRD---LEIS 237
Query: 204 DLVNGTPNAFNIRTPGQLLSL 224
DLVN TP + RTPGQLLSL
Sbjct: 238 DLVNCTP-SLCTRTPGQLLSL 257
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350409521|ref|XP_003488767.1| PREDICTED: serine/threonine-protein kinase greatwall-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 259 bits (662), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 130/201 (64%), Positives = 156/201 (77%), Gaps = 6/201 (2%)
Query: 25 NSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN 84
N++ + K PEI DF+IVK ISRGAFGKVFLGYKK+N +++YAIKVMKK+EMINKN
Sbjct: 62 NTISKIVNPTAKVPEIQDFKIVKPISRGAFGKVFLGYKKSNSEKVYAIKVMKKNEMINKN 121
Query: 85 MVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMA 144
M SQV+ ERNALALTHSP+CVQLFYSLQ+ S ++LVMEYM+GGD+KSL+ G + E MA
Sbjct: 122 MASQVIIERNALALTHSPYCVQLFYSLQSVSSIYLVMEYMVGGDLKSLLGVYGYMEESMA 181
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI-LQQPIVYLEIS 203
AFY AEV LAL+YLHSHGI+HRDLKPDNML+S + H + + I L + LEIS
Sbjct: 182 AFYTAEVCLALEYLHSHGIVHRDLKPDNMLLSKEG-HVKLTDFGLSKISLHRD---LEIS 237
Query: 204 DLVNGTPNAFNIRTPGQLLSL 224
DLVN TP + RTPGQLLSL
Sbjct: 238 DLVNCTP-SLCTRTPGQLLSL 257
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307209073|gb|EFN86240.1| Microtubule-associated serine/threonine-protein kinase-like [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 259 bits (661), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 130/200 (65%), Positives = 156/200 (78%), Gaps = 3/200 (1%)
Query: 25 NSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN 84
N++ + K PEI DF+IVK ISRGAFGKVFLGYKK+N +Q+YAIKVMKK+EMI+KN
Sbjct: 57 NTISKIVNPNTKVPEIEDFKIVKPISRGAFGKVFLGYKKSNHEQVYAIKVMKKNEMIHKN 116
Query: 85 MVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMA 144
M SQV+ ERNALALT SP+CVQLFYSLQT S V+LVMEYM+GGD+KSL+ G + E MA
Sbjct: 117 MASQVVIERNALALTRSPYCVQLFYSLQTVSSVYLVMEYMVGGDLKSLLGFYGYMEESMA 176
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISD 204
AFY AEV LAL+YLHSHGI+HRDLKPDNML+S++ H + + L+ + LEISD
Sbjct: 177 AFYTAEVCLALEYLHSHGIVHRDLKPDNMLLSSEG-HVKLTD-FGLSKISSLHRDLEISD 234
Query: 205 LVNGTPNAFNIRTPGQLLSL 224
LVN TP + RTPGQLLSL
Sbjct: 235 LVNCTP-SLCARTPGQLLSL 253
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332016221|gb|EGI57134.1| Microtubule-associated serine/threonine-protein kinase-like protein [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 258 bits (659), Expect = 5e-66, Method: Compositional matrix adjust.
Identities = 134/227 (59%), Positives = 163/227 (71%), Gaps = 10/227 (4%)
Query: 6 LFSGADKENILEITNKASE--------NSLCDVSKSCLKAPEISDFEIVKAISRGAFGKV 57
++S D E E T + SE N++ + K P+I DF+IVK ISRGAFGKV
Sbjct: 27 IYSENDTERHGECTPQQSEKCINNSIFNTISKIVNPTTKVPDIQDFKIVKPISRGAFGKV 86
Query: 58 FLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117
FLGYKKTN +Q+YA+KVMKK+EMINKNM SQV+ ERNALALT SP+CVQLFYSLQ+ S V
Sbjct: 87 FLGYKKTNPEQVYAVKVMKKNEMINKNMASQVVIERNALALTRSPYCVQLFYSLQSISSV 146
Query: 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177
+LVMEYM+GGD+KSL+ G + E MAAFY AEV LAL+YLHSHGI+HRDLKPDNML+S
Sbjct: 147 YLVMEYMVGGDLKSLLGVYGFMEESMAAFYTAEVCLALEYLHSHGIVHRDLKPDNMLLSR 206
Query: 178 QAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLSL 224
+ H + + L+ + LEISDLVN + RTPGQLLSL
Sbjct: 207 EG-HVKLTD-FGLSKISSLHRDLEISDLVNPMTPSLCTRTPGQLLSL 251
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|156543463|ref|XP_001601387.1| PREDICTED: serine/threonine-protein kinase greatwall-like [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 256 bits (655), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 127/202 (62%), Positives = 157/202 (77%), Gaps = 5/202 (2%)
Query: 25 NSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN 84
N++ + K PEI DF+IVK ISRGAFGKVFLGYK+TN DQ+YAIKVMKK+EMI+KN
Sbjct: 60 NTISKIVNRTAKVPEIQDFKIVKPISRGAFGKVFLGYKRTNPDQVYAIKVMKKNEMIHKN 119
Query: 85 MVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMA 144
M SQV+ ERNALA+ SP+CVQLFYSLQ+++ V+LVMEYM+GGD+KSL+ G + E MA
Sbjct: 120 MASQVVIERNALAIVRSPYCVQLFYSLQSATSVYLVMEYMVGGDLKSLVGMYGYMEESMA 179
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY--LEI 202
AFY AEV LAL+YLHSHGI+HRDLKPDNML+S + H + + L+ + ++ LEI
Sbjct: 180 AFYTAEVCLALEYLHSHGIVHRDLKPDNMLLSKEG-HVKLTD-FGLSKISTSTLHRDLEI 237
Query: 203 SDLVNGTPNAFNIRTPGQLLSL 224
SDLVN TP + RTPGQLLSL
Sbjct: 238 SDLVNCTP-SLCTRTPGQLLSL 258
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307172643|gb|EFN63999.1| Microtubule-associated serine/threonine-protein kinase-like [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 256 bits (655), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 127/200 (63%), Positives = 153/200 (76%), Gaps = 2/200 (1%)
Query: 25 NSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN 84
N++ + K P++ DF+IVK ISRGAFGKVFLGYKK+N +Q+YAIKVMKK+EMINKN
Sbjct: 56 NTISKIVNPTTKVPDVQDFKIVKPISRGAFGKVFLGYKKSNSEQVYAIKVMKKNEMINKN 115
Query: 85 MVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMA 144
M SQV+ ERNALA+ HSP+CVQLFYSLQ+ S V+LVMEYM+GGD+KSLI G E MA
Sbjct: 116 MASQVVIERNALAVIHSPYCVQLFYSLQSVSSVYLVMEYMVGGDLKSLIGVYGFFEEPMA 175
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISD 204
AFY AEV LAL+YLHSHGI+HRDLKPDNML+S + H + + L+ + LEISD
Sbjct: 176 AFYIAEVCLALEYLHSHGIVHRDLKPDNMLLSREG-HVKLTD-FGLSKISSLHRDLEISD 233
Query: 205 LVNGTPNAFNIRTPGQLLSL 224
LVN T + RTPGQLLSL
Sbjct: 234 LVNPTTPSLCTRTPGQLLSL 253
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383852744|ref|XP_003701885.1| PREDICTED: serine/threonine-protein kinase greatwall-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 254 bits (650), Expect = 6e-65, Method: Compositional matrix adjust.
Identities = 129/203 (63%), Positives = 156/203 (76%), Gaps = 6/203 (2%)
Query: 25 NSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN 84
N++ + K PEI DF+IVK ISRGAFGKVFLGYKK+N +++YAIKVMKK+EMINKN
Sbjct: 62 NTISKIVNPAAKVPEIQDFKIVKPISRGAFGKVFLGYKKSNPEKVYAIKVMKKNEMINKN 121
Query: 85 MVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMA 144
M SQV+ ERNALALTHS +CVQLFYSLQ+ S ++LVMEYM+GGD+KSL+ G + E MA
Sbjct: 122 MASQVIIERNALALTHSAYCVQLFYSLQSVSSIYLVMEYMVGGDLKSLVGVYGYMEESMA 181
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI-LQQPIVYLEIS 203
AFY AEV LAL+YLHSHGI+HRDLKPDNML+S + H + + I L + LEIS
Sbjct: 182 AFYTAEVCLALEYLHSHGIVHRDLKPDNMLLSKEG-HVKLTDFGLSKISLHRD---LEIS 237
Query: 204 DLVNGTPNAFNIRTPGQLLSLKT 226
DLVN TP + RTPGQLLSL +
Sbjct: 238 DLVNCTP-SLCARTPGQLLSLTS 259
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|48095908|ref|XP_394554.1| PREDICTED: microtubule-associated serine/threonine-protein kinase-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 254 bits (649), Expect = 6e-65, Method: Compositional matrix adjust.
Identities = 129/201 (64%), Positives = 156/201 (77%), Gaps = 6/201 (2%)
Query: 25 NSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN 84
N++ + K PEI DF+IVK ISRGAFGKVFLG+KK+N +++YAIKVMKK+EMINKN
Sbjct: 62 NTISKIVNPAAKVPEIQDFKIVKPISRGAFGKVFLGHKKSNPEKVYAIKVMKKNEMINKN 121
Query: 85 MVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMA 144
M SQV+ ERNALALT SP+CVQLFYSLQ++S V+LVMEYM+GGD+KSL+ G + E MA
Sbjct: 122 MASQVIIERNALALTRSPYCVQLFYSLQSASSVYLVMEYMVGGDLKSLLGVYGYMEESMA 181
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI-LQQPIVYLEIS 203
AFY AEV LAL+YLHSHGI+HRDLKPDNML+S + H + + I L + LEIS
Sbjct: 182 AFYTAEVCLALEYLHSHGIVHRDLKPDNMLLSKEG-HVKLTDFGLSNISLHRD---LEIS 237
Query: 204 DLVNGTPNAFNIRTPGQLLSL 224
DLVN TP + RTPGQLLSL
Sbjct: 238 DLVNCTP-SLCTRTPGQLLSL 257
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380024998|ref|XP_003696270.1| PREDICTED: serine/threonine-protein kinase greatwall-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 254 bits (648), Expect = 9e-65, Method: Compositional matrix adjust.
Identities = 128/201 (63%), Positives = 156/201 (77%), Gaps = 6/201 (2%)
Query: 25 NSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN 84
N++ + K PEI DF+IVK ISRGAFGKVFLG+KK+N +++YAIKVMKK+EMINKN
Sbjct: 62 NTISKIVNPTAKVPEIQDFKIVKPISRGAFGKVFLGHKKSNPEKVYAIKVMKKNEMINKN 121
Query: 85 MVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMA 144
M SQV+ ERNALALT SP+CVQLFYSLQ++S V+LVMEYM+GGD+KSL+ G + E MA
Sbjct: 122 MASQVIIERNALALTRSPYCVQLFYSLQSASSVYLVMEYMVGGDLKSLLGVYGYMEESMA 181
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI-LQQPIVYLEIS 203
AFY AE+ LAL+YLHSHGI+HRDLKPDNML+S + H + + I L + LEIS
Sbjct: 182 AFYTAEICLALEYLHSHGIVHRDLKPDNMLLSKEG-HVKLTDFGLSNISLHRD---LEIS 237
Query: 204 DLVNGTPNAFNIRTPGQLLSL 224
DLVN TP + RTPGQLLSL
Sbjct: 238 DLVNCTP-SLCTRTPGQLLSL 257
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 473 | ||||||
| FB|FBgn0260399 | 846 | gwl "greatwall" [Drosophila me | 0.427 | 0.238 | 0.602 | 4.7e-65 | |
| UNIPROTKB|E1C2I2 | 881 | MASTL "Serine/threonine-protei | 0.391 | 0.209 | 0.565 | 1.3e-54 | |
| ZFIN|ZDB-GENE-040801-128 | 860 | mastl "microtubule associated | 0.408 | 0.224 | 0.562 | 4.4e-54 | |
| UNIPROTKB|Q96GX5 | 879 | MASTL "Serine/threonine-protei | 0.524 | 0.282 | 0.455 | 1e-53 | |
| UNIPROTKB|F1RVK2 | 878 | MASTL "Uncharacterized protein | 0.391 | 0.210 | 0.533 | 5.6e-53 | |
| UNIPROTKB|D4A355 | 866 | Mastl "Protein Mastl" [Rattus | 0.501 | 0.273 | 0.472 | 9.4e-53 | |
| UNIPROTKB|Q6NTJ3 | 887 | mastl "Serine/threonine-protei | 0.439 | 0.234 | 0.507 | 1.3e-52 | |
| MGI|MGI:1914371 | 865 | Mastl "microtubule associated | 0.429 | 0.234 | 0.518 | 1.5e-51 | |
| UNIPROTKB|G5E5K2 | 880 | MASTL "Serine/threonine-protei | 0.391 | 0.210 | 0.554 | 1.7e-51 | |
| UNIPROTKB|D2HXI8 | 882 | MASTL "Serine/threonine-protei | 0.391 | 0.209 | 0.549 | 2.9e-51 |
| FB|FBgn0260399 gwl "greatwall" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 576 (207.8 bits), Expect = 4.7e-65, Sum P(2) = 4.7e-65
Identities = 129/214 (60%), Positives = 154/214 (71%)
Query: 11 DKENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLY 70
DK NIL T K EN S++ K P I DF I+K ISRGAFGKVFLGYK + +L+
Sbjct: 33 DKINIL--TTKP-ENH----SQNA-KLPTIKDFVIIKPISRGAFGKVFLGYKNNDSKRLF 84
Query: 71 AIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVK 130
AIKVM+K EMINKNMVSQV+ ERNALAL+ S FCV LFYSLQ+ S V+LVMEYM+GGD+K
Sbjct: 85 AIKVMRKSEMINKNMVSQVITERNALALSRSQFCVSLFYSLQSLSYVYLVMEYMVGGDLK 144
Query: 131 SLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190
SL+A G E A FY AE+V+ALQYLH HGI+HRD+KPDNML+S+ H + +
Sbjct: 145 SLLAMFGYFDEPTARFYVAEMVMALQYLHQHGIVHRDIKPDNMLLSSSG-HVKLTDFGLS 203
Query: 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLLSL 224
I + LEISDL+N +PN N RTPGQLLSL
Sbjct: 204 KIDMRRD--LEISDLINCSPN-LNARTPGQLLSL 234
|
|
| UNIPROTKB|E1C2I2 MASTL "Serine/threonine-protein kinase greatwall" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 477 (173.0 bits), Expect = 1.3e-54, Sum P(3) = 1.3e-54
Identities = 108/191 (56%), Positives = 131/191 (68%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+ P I +F IVK ISRGAFGKV+LG K +LYA+KVMKK +MINKNMV QV ER+A
Sbjct: 23 RPPSIEEFTIVKPISRGAFGKVYLGRKA---GRLYAVKVMKKADMINKNMVHQVQAERDA 79
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
LAL+ SPF V L+YSLQ+++ V+LVMEY+IGGDVKSL+ G E+MA Y +E LAL
Sbjct: 80 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEAALAL 139
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNT-LFLAILQQPIVYLEISDLVN-GTPNAF 213
YLH HGIIHRDLKPDNMLIS Q H + + L L + I ++I + P
Sbjct: 140 DYLHRHGIIHRDLKPDNMLISNQG-HIKLTDFGLSRVTLNREINMIDILTTPSMAKPKHD 198
Query: 214 NIRTPGQLLSL 224
RTPGQLLSL
Sbjct: 199 YSRTPGQLLSL 209
|
|
| ZFIN|ZDB-GENE-040801-128 mastl "microtubule associated serine/threonine kinase-like" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 504 (182.5 bits), Expect = 4.4e-54, Sum P(2) = 4.4e-54
Identities = 113/201 (56%), Positives = 140/201 (69%)
Query: 28 CDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVS 87
C+ S S +KAP I DF +VK ISRGAFGKV+L KK N +LYAIKV+KK EM++KNM
Sbjct: 8 CESSNSAVKAPSIEDFVLVKPISRGAFGKVYLARKKCNS-KLYAIKVVKKAEMVDKNMTE 66
Query: 88 QVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFY 147
Q+ ER+ALAL+ SPF V LFYSLQT++ V+LVMEY+IGGDVKSL+ G EDM+ Y
Sbjct: 67 QMRAERDALALSKSPFIVHLFYSLQTATKVYLVMEYLIGGDVKSLLHIYGYFDEDMSLKY 126
Query: 148 AAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNT-LFLAILQQPIVYLEI---S 203
+EV LAL YLH H IIHRDLKPDNMLIS + H + + L L + + ++I
Sbjct: 127 ISEVALALDYLHRHSIIHRDLKPDNMLISNEG-HIKLTDFGLSKVKLDRELNLMDILTTP 185
Query: 204 DLVNGTPNAFNIRTPGQLLSL 224
LV T + F RTPGQ+LSL
Sbjct: 186 SLVKPTKDYF--RTPGQVLSL 204
|
|
| UNIPROTKB|Q96GX5 MASTL "Serine/threonine-protein kinase greatwall" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 473 (171.6 bits), Expect = 1.0e-53, Sum P(2) = 1.0e-53
Identities = 117/257 (45%), Positives = 154/257 (59%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
K P I +F IVK ISRGAFGKV+LG K +LYA+KV+KK +MINKNM QV ER+A
Sbjct: 28 KPPSIEEFSIVKPISRGAFGKVYLGQKG---GKLYAVKVVKKADMINKNMTHQVQAERDA 84
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
LAL+ SPF V L+YSLQ+++ V+LVMEY+IGGDVKSL+ G E+MA Y +EV LAL
Sbjct: 85 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALAL 144
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNT-LFLAILQQPIVYLEISDLVN-GTPNAF 213
YLH HGIIHRDLKPDNMLIS + H + + L L + I ++I + P
Sbjct: 145 DYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSKVTLNRDINMMDILTTPSMAKPRQD 203
Query: 214 NIRTPGQLLSLKTGT-FPT-FQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271
RTPGQ+LSL + F T + A SA SQ+ + ++ +D
Sbjct: 204 YSRTPGQVLSLISSLGFNTPIAEKNQDPANILSACLSETSQLSQGLVCPMSVD-QKDTTP 262
Query: 272 LNPSTEETILALLKSDP 288
+ ++ L + S+P
Sbjct: 263 YSSKLLKSCLETVASNP 279
|
|
| UNIPROTKB|F1RVK2 MASTL "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 471 (170.9 bits), Expect = 5.6e-53, Sum P(2) = 5.6e-53
Identities = 103/193 (53%), Positives = 131/193 (67%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+ P I +F IVK ISRGAFGKV+LG K D+LYA+KV+KK +MINKNM QV ER+A
Sbjct: 28 RPPSIEEFTIVKPISRGAFGKVYLGQKG---DRLYAVKVVKKADMINKNMTHQVQAERDA 84
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
LAL+ SPF V L+YSLQ+++ V+LVMEY+IGGDVKSL+ G E+MA Y +EV LAL
Sbjct: 85 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALAL 144
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVN----GTPN 211
YLH HGIIHRDLKPDNMLIS + H + + + + + + D++ P
Sbjct: 145 DYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSKVTLNRDIDINMMDILTTPSMAKPR 203
Query: 212 AFNIRTPGQLLSL 224
RTPGQ+LSL
Sbjct: 204 QDYSRTPGQVLSL 216
|
|
| UNIPROTKB|D4A355 Mastl "Protein Mastl" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 479 (173.7 bits), Expect = 9.4e-53, Sum P(2) = 9.4e-53
Identities = 121/256 (47%), Positives = 156/256 (60%)
Query: 16 LEITNKASENSLCDVSKSCL------KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQL 69
+E + + EN ++ C+ + P I +F IVK ISRGAFGKV+LG K + +L
Sbjct: 1 MESASGSEENEEGAATEKCVNRIPVPRPPSIEEFTIVKPISRGAFGKVYLGQKGS---KL 57
Query: 70 YAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDV 129
YA+KV+KK +MINKNM QV ER+ALAL+ SPF V L+YSLQ++S V+L+MEY+IGGDV
Sbjct: 58 YAVKVVKKADMINKNMTHQVQAERDALALSKSPFVVHLYYSLQSASNVYLIMEYLIGGDV 117
Query: 130 KSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNT-L 188
KSL+ G E+MA Y +EV LAL YLH HGIIHRDLKPDNMLIS + H + + L
Sbjct: 118 KSLLHIYGYFDEEMAIKYTSEVALALDYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGL 176
Query: 189 FLAILQQPIVYLEISDLVN-GTPNAFNIRTPGQLLSL--KTGTF-PTFQDVQNS----QA 240
L + I ++I + P RTPGQ+LSL G F P + Q+S A
Sbjct: 177 SKVTLNRDINMMDILTTPSMSKPKQDYSRTPGQVLSLISSLGFFTPVGEKDQDSANVFSA 236
Query: 241 PFPSALRVAGSQIPTS 256
P A GS P S
Sbjct: 237 PKSEAQLSQGSICPMS 252
|
|
| UNIPROTKB|Q6NTJ3 mastl "Serine/threonine-protein kinase greatwall" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 489 (177.2 bits), Expect = 1.3e-52, Sum P(2) = 1.3e-52
Identities = 108/213 (50%), Positives = 145/213 (68%)
Query: 15 ILEITNKASENSLCDVSKSCL-KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIK 73
I+ T++ + SLC K + + P I +F IVK ISRGAFGKV+L +K N +L+A+K
Sbjct: 3 IVAETSQNGDTSLCSEKKFTVPQPPSIEEFGIVKPISRGAFGKVYLARRKNNS-KLFAVK 61
Query: 74 VMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI 133
V+KK +MINKNMV QV ER+ALAL+ SPF V L+YSLQ+++ ++LVMEY+IGGDVKSL+
Sbjct: 62 VVKKADMINKNMVQQVQAERDALALSKSPFIVHLYYSLQSANNIYLVMEYLIGGDVKSLL 121
Query: 134 AANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNT-LFLAI 192
G E+MA Y +EV +AL YLH HGIIHRDLKPDNMLIS + H + + L
Sbjct: 122 HIYGYFDEEMAVKYISEVAMALDYLHRHGIIHRDLKPDNMLISNKG-HIKLTDFGLSKVT 180
Query: 193 LQQPIVYLEISDLVN-GTPNAFNIRTPGQLLSL 224
L++ + ++I + P RTPGQ+LSL
Sbjct: 181 LKRELCMMDILTTPSMAKPKRDYSRTPGQVLSL 213
|
|
| MGI|MGI:1914371 Mastl "microtubule associated serine/threonine kinase-like" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 470 (170.5 bits), Expect = 1.5e-51, Sum P(2) = 1.5e-51
Identities = 110/212 (51%), Positives = 139/212 (65%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+ P I +F IVK ISRGAFGKV+LG K +LYA+KV+KK +MINKNM QV ER+A
Sbjct: 27 RPPSIEEFTIVKPISRGAFGKVYLGQKG---GKLYAVKVVKKADMINKNMTHQVQAERDA 83
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
LAL+ SPF V L+YSLQ++S ++L+MEY+IGGDVKSL+ G E+MA Y +EV LAL
Sbjct: 84 LALSKSPFVVHLYYSLQSASNIYLIMEYLIGGDVKSLLHIYGYFDEEMAIKYISEVALAL 143
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNT-LFLAILQQPIVYLEISDLVN-GTPNAF 213
YLH HGIIHRDLKPDNMLIS + H + + L L + I ++I + P
Sbjct: 144 DYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSKVTLNRDINMMDILTTPSMSKPKQD 202
Query: 214 NIRTPGQLLSL--KTGTF-PTFQDVQNSQAPF 242
RTPGQ+LSL G F P + Q+S F
Sbjct: 203 YSRTPGQVLSLISSLGFFTPVGEKDQDSANMF 234
|
|
| UNIPROTKB|G5E5K2 MASTL "Serine/threonine-protein kinase greatwall" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 471 (170.9 bits), Expect = 1.7e-51, Sum P(2) = 1.7e-51
Identities = 106/191 (55%), Positives = 133/191 (69%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+ P I +F IVK ISRGAFGKV+LG +K N+ LYA+KV+KK +MINKNM QV ER+A
Sbjct: 28 RPPSIEEFTIVKPISRGAFGKVYLG-QKGNR--LYAVKVVKKADMINKNMTHQVQAERDA 84
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
LAL+ SPF V L+YSLQ+++ V+LVMEY+IGGDVKSL+ G E+MA Y +EV LAL
Sbjct: 85 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALAL 144
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNT-LFLAILQQPIVYLEISDLVN-GTPNAF 213
YLH HGIIHRDLKPDNMLIS + H + + L L + I ++I + P
Sbjct: 145 DYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSKVTLNRDINMMDILTTPSMAKPRQD 203
Query: 214 NIRTPGQLLSL 224
RTPGQ+LSL
Sbjct: 204 YSRTPGQVLSL 214
|
|
| UNIPROTKB|D2HXI8 MASTL "Serine/threonine-protein kinase greatwall" [Ailuropoda melanoleuca (taxid:9646)] | Back alignment and assigned GO terms |
|---|
Score = 468 (169.8 bits), Expect = 2.9e-51, Sum P(2) = 2.9e-51
Identities = 105/191 (54%), Positives = 131/191 (68%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+ P I +F IVK ISRGAFGKV+LG K +LYA+KV+KK +MINKNM QV ER+A
Sbjct: 28 RPPSIEEFTIVKPISRGAFGKVYLGQKG---GKLYAVKVVKKADMINKNMTHQVQAERDA 84
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
LAL+ SPF V L+YSLQ+++ V+LVMEY+IGGDVKSL+ G E+MA Y +EV LAL
Sbjct: 85 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALAL 144
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNT-LFLAILQQPIVYLEISDLVN-GTPNAF 213
YLH HGIIHRDLKPDNMLIS + H + + L L + I ++I + P
Sbjct: 145 DYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSKVTLNRDINMMDILTTPSMAKPRQD 203
Query: 214 NIRTPGQLLSL 224
RTPGQ+LSL
Sbjct: 204 YSRTPGQVLSL 214
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6DBX4 | GWL_DANRE | 2, ., 7, ., 1, 1, ., 1 | 0.5621 | 0.4080 | 0.2244 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 473 | |||
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-74 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-64 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-56 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-50 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-49 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-46 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-45 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-44 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-42 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-42 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-42 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-39 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-39 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-38 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-37 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-37 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-37 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-35 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-35 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-35 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-35 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-34 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-34 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-34 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-33 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-33 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-33 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-33 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-33 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-32 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-32 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-31 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-31 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-30 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-30 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-30 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-30 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-29 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-29 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-29 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-29 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-29 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-28 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-27 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-27 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-27 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-27 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-26 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-26 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-25 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-25 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-25 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-25 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-25 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-24 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-24 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-24 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-24 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-23 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-21 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-20 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-17 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-17 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-17 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-16 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-14 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-06 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-05 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-04 | |
| smart00133 | 64 | smart00133, S_TK_X, Extension to Ser/Thr-type prot | 4e-04 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 5e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 8e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 0.001 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.001 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.001 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.002 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.002 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.003 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.003 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 0.003 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.004 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.004 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.004 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 246 bits (629), Expect = 2e-74
Identities = 108/192 (56%), Positives = 133/192 (69%), Gaps = 10/192 (5%)
Query: 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
P I +F IVK ISRGAFGKV+LG KK N +LYA+KV+KK +MINKNMV QV ER+ALA
Sbjct: 1 PSIEEFVIVKPISRGAFGKVYLGRKKNNS-KLYAVKVVKKADMINKNMVHQVQAERDALA 59
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
L+ SPF V L+YSLQ+++ V+LVMEY+IGGDVKSL+ G E+MA Y +EV LAL Y
Sbjct: 60 LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDY 119
Query: 158 LHSHGIIHRDLKPDNMLISAQAPHCPIVN-TLFLAILQQPIVYLEISDLVNGTPNAF--- 213
LH HGIIHRDLKPDNMLIS + H + + L L + L + D++ A
Sbjct: 120 LHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSKVTLNRE---LNMMDILTTPSMAKPKN 175
Query: 214 -NIRTPGQLLSL 224
RTPGQ+LSL
Sbjct: 176 DYSRTPGQVLSL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 8e-64
Identities = 75/130 (57%), Positives = 99/130 (76%), Gaps = 1/130 (0%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108
IS+GA+G+VFL KK+ D +YAIKV+KK +MI KN V QVL ER+ L+ SP+ V+L+
Sbjct: 1 ISKGAYGRVFLAKKKSTGD-IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 109 YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168
YS Q ++LVMEY+ GGD+ SL+ G+L ED+A Y AE+VLAL+YLHS+GIIHRDL
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 169 KPDNMLISAQ 178
KPDN+LI +
Sbjct: 120 KPDNILIDSN 129
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 1e-56
Identities = 62/130 (47%), Positives = 91/130 (70%), Gaps = 1/130 (0%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108
+ +G+FGKV L +K + +LYA+KV+KK ++I + V L ERN L+ + PF V+L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 109 YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168
Y+ QT ++LV+EY GG++ S ++ G E+ A FYAAE+VLAL+YLHS GII+RDL
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 169 KPDNMLISAQ 178
KP+N+L+ A
Sbjct: 120 KPENILLDAD 129
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 7e-50
Identities = 55/134 (41%), Positives = 82/134 (61%), Gaps = 3/134 (2%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+EI++ + G+FGKV+L K +L AIKV+KK ++ ++LRE L P
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTG-KLVAIKVIKKKKIKKD--RERILREIKILKKLKHP 57
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
V+L+ + ++LVMEY GGD+ L+ G L ED A FY +++ AL+YLHS G
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 163 IIHRDLKPDNMLIS 176
I+HRDLKP+N+L+
Sbjct: 118 IVHRDLKPENILLD 131
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 3e-49
Identities = 68/137 (49%), Positives = 94/137 (68%), Gaps = 1/137 (0%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
DFE++K I RGAFG+V+L K Q+YA+KV++K +MI +N ++ V ER+ LA
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTG-QVYAMKVLRKSDMIKRNQIAHVRAERDILADAD 59
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
SP+ V+L+YS Q ++LVMEYM GGD+ +L+ PE+ A FY AE+VLAL +H
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119
Query: 161 HGIIHRDLKPDNMLISA 177
G IHRD+KPDN+LI A
Sbjct: 120 LGFIHRDIKPDNILIDA 136
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 5e-46
Identities = 59/138 (42%), Positives = 89/138 (64%), Gaps = 1/138 (0%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
DFE +K + G+FG+V L K + + YA+K++ K +++ V VL E+ L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSG-KYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
PF V L+ S Q S ++LVMEY+ GG++ S + +G PE +A FYAA+VVLAL+YLHS
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 161 HGIIHRDLKPDNMLISAQ 178
I++RDLKP+N+L+ +
Sbjct: 120 LDIVYRDLKPENLLLDSD 137
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 6e-45
Identities = 55/137 (40%), Positives = 81/137 (59%), Gaps = 2/137 (1%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LT 99
DF+ K I G+F V L +K + YAIK++ K ++I + V V E+ L L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETN-KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN 59
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
P ++L+Y+ Q ++ V+EY G++ I G+L E FYAAE++LAL+YLH
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 160 SHGIIHRDLKPDNMLIS 176
S GIIHRDLKP+N+L+
Sbjct: 120 SKGIIHRDLKPENILLD 136
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 102/284 (35%), Positives = 142/284 (50%), Gaps = 44/284 (15%)
Query: 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRER-NALALTHSPFC 104
+K IS+GAFG V+L K++ D +AIKV+KK +MI KN V+ V ER + SP+
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGD-YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGII 164
+L+YS Q+ ++LVMEY+ GGD SLI G LPED A Y AEVVL ++ LH GII
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGII 119
Query: 165 HRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAF---NIRTPGQ- 220
HRD+KP+N+LI Q H L L LE V GTP+ I G
Sbjct: 120 HRDIKPENLLID-QTGH------LKLTDFGLSRNGLENKKFV-GTPDYLAPETILGVGDD 171
Query: 221 -----------LLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED- 268
+ G +P F +++ P + +I WPE+
Sbjct: 172 KMSDWWSLGCVIFEFLFG-YPPF----HAETPDAVFDNILSRRI----------NWPEEV 216
Query: 269 EEALNPSTEETILALLKSDPTQR--PSGHQ-VRRLPMFKDYDWD 309
+E +P + I LL DP +R +G+Q ++ P FK +WD
Sbjct: 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 2e-42
Identities = 60/137 (43%), Positives = 88/137 (64%), Gaps = 1/137 (0%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
DFE +K I RGAFG+V L KK +YA+K ++K EM+ K V+ V ER+ LA
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGH-IYAMKKLRKSEMLEKEQVAHVRAERDILAEAD 59
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
+P+ V+L+YS Q + ++L+MEY+ GGD+ +L+ E+ FY AE +LA+ +H
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK 119
Query: 161 HGIIHRDLKPDNMLISA 177
G IHRD+KPDN+L+ A
Sbjct: 120 LGYIHRDIKPDNLLLDA 136
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-42
Identities = 66/137 (48%), Positives = 92/137 (67%), Gaps = 1/137 (0%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
DFE +K IS GA+G V+L K + Q +A+K + K +I +N + QV ER+ L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETR-QRFAMKKINKQNLILRNQIQQVFVERDILTFAE 59
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
+PF V +F S +T + +VMEY+ GGD +L+ GALP DMA Y AE VLAL+YLH+
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN 119
Query: 161 HGIIHRDLKPDNMLISA 177
+GI+HRDLKPDN+LI++
Sbjct: 120 YGIVHRDLKPDNLLITS 136
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 7e-42
Identities = 100/323 (30%), Positives = 147/323 (45%), Gaps = 64/323 (19%)
Query: 47 KAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS-PFC 104
K + +G+FGKV L K T D+LYA+KV+KKD ++ + V + E+ LAL PF
Sbjct: 1 KVLGKGSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGII 164
QL QT +F VMEY+ GGD+ I +G E A FYAAE+VL LQ+LH GII
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 165 HRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPN--AFNIRTP---- 218
+RDLK DN+L+ ++ H I + + ++ I+ + GTP+ A I +
Sbjct: 119 YRDLKLDNVLLDSEG-HIKIAD---FGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 219 --------GQLL-SLKTGTFP--------TFQDVQNSQAPFPSALRVAGSQIPTSTAAQL 261
G LL + G P FQ + + +P L I
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSI-------- 226
Query: 262 QLEWPEDEEALNPSTEETILALLKSDPTQR----PSG-HQVRRLPMFKDYDWDSILDQE- 315
+ + L +P +R P+G ++ P F++ DWD + +E
Sbjct: 227 ------------------LKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEI 268
Query: 316 -PPFVPQPDDVFDTSYFHADKTN 337
PPF P+ FD S F + T
Sbjct: 269 KPPFKPKIKGRFDVSNFDDEFTK 291
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 62/138 (44%), Positives = 89/138 (64%), Gaps = 5/138 (3%)
Query: 41 SDFEIVKAISRGAFGKVFL-GYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
F+ +K + +G G+VFL K T K L+A+KV+ K EMI +N V +VL E+ LA
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGK--LFALKVLDKKEMIKRNKVKRVLTEQEILATL 58
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI--AANGALPEDMAAFYAAEVVLALQY 157
PF L+ S QT + + LVM+Y GG++ L+ L E++A FYAAEV+LAL+Y
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 158 LHSHGIIHRDLKPDNMLI 175
LH GI++RDLKP+N+L+
Sbjct: 119 LHLLGIVYRDLKPENILL 136
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 1e-39
Identities = 69/153 (45%), Positives = 102/153 (66%), Gaps = 5/153 (3%)
Query: 24 ENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK 83
E + ++K +KA DF+++K I RGAFG+V L K++K Q+YA+K++ K EMI +
Sbjct: 29 EKAAEKITKLRMKA---EDFDVIKVIGRGAFGEVQLVRHKSSK-QVYAMKLLSKFEMIKR 84
Query: 84 NMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDM 143
+ + ER+ +A +S + VQL Y+ Q +++VMEYM GGD+ +L++ N +PE
Sbjct: 85 SDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS-NYDIPEKW 143
Query: 144 AAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
A FY AEVVLAL +HS G IHRD+KPDNML+
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 61/143 (42%), Positives = 91/143 (63%), Gaps = 4/143 (2%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHS 101
FE+++ I +GAFGKV + K+ K +++A+K M K + + K V VL ER L L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTK-KMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH- 59
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
PF V L+YS Q ++LV++ ++GGD++ ++ E+ F+ E+VLAL+YLHS
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 162 GIIHRDLKPDNMLISAQAPHCPI 184
GIIHRD+KPDN+L+ Q H I
Sbjct: 120 GIIHRDIKPDNILLDEQG-HVHI 141
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 1e-38
Identities = 46/134 (34%), Positives = 74/134 (55%), Gaps = 2/134 (1%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+E+++ + G+FG V+ K ++ A+K++KK RE L P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHK-GTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHP 58
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
V+L + + ++LVMEY GGD+ ++ G L ED A A +++ L+YLHS+G
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 163 IIHRDLKPDNMLIS 176
IIHRDLKP+N+L+
Sbjct: 119 IIHRDLKPENILLD 132
|
Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 5e-38
Identities = 60/137 (43%), Positives = 84/137 (61%), Gaps = 1/137 (0%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
DF+I+ + +G +G+VFL KK + ++ A+K MKK + N V VL ER+ L T
Sbjct: 1 KDFQILTQVGQGGYGQVFLA-KKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK 59
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
S + V+L Y+ Q ++L MEY+ GGD ++L+ G L ED A FY AE+ A+ LH
Sbjct: 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE 119
Query: 161 HGIIHRDLKPDNMLISA 177
G IHRDLKP+N LI A
Sbjct: 120 LGYIHRDLKPENFLIDA 136
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-37
Identities = 56/135 (41%), Positives = 87/135 (64%), Gaps = 1/135 (0%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
S F +K I GAFG+V L +K + + LYA+K ++K +++ +N + V ER+ LA
Sbjct: 1 SMFVKIKTIGIGAFGEVCLV-RKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD 59
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
+ + V+L+YS Q ++ VM+Y+ GGD+ SL+ G ED+A FY AE+ A++ +H
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK 119
Query: 161 HGIIHRDLKPDNMLI 175
G IHRD+KPDN+LI
Sbjct: 120 MGFIHRDIKPDNILI 134
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 47/135 (34%), Positives = 78/135 (57%), Gaps = 4/135 (2%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108
+ G FG V+L K + AIK++KK++ + +++ ++LRE L + P V+L+
Sbjct: 1 LGEGGFGTVYLARDKKTG-KKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 109 YSLQTSSCVFLVMEYMIGGDVKSLIAANGA-LPEDMAAFYAAEVVLALQYLHSHGIIHRD 167
+ + ++LVMEY GG +K L+ N L ED +++ L+YLHS+GIIHRD
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 168 LKPDNMLISAQAPHC 182
LKP+N+L+ +
Sbjct: 118 LKPENILLDSDNGKV 132
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 6e-37
Identities = 103/326 (31%), Positives = 155/326 (47%), Gaps = 37/326 (11%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
DF++ + RG FG+V + +K D +YA+KVMKK ++ + VS ER+ L++++S
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGD-IYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHS 160
P+ QL Y+ Q ++LVMEY GGD+ SL+ EDMA FY AE+VLA+ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 161 HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQ 220
G +HRD+KP+N+LI + H + + A L + S L GTP+ P
Sbjct: 121 MGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVN--SKLPVGTPDYI---APEV 174
Query: 221 LLSLKTGTFPTFQ-------------DVQNSQAPFPSALRVAGSQIPTSTAA---QLQLE 264
L ++ T+ ++ ++PF G+ T Q L+
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH-----EGTSAKTYNNIMNFQRFLK 229
Query: 265 WPEDEEALNPSTEETILALLKS---DPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVPQ 321
+PED P L L++S +R + P F DW++I + PPFVP
Sbjct: 230 FPED-----PKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPT 284
Query: 322 PDDVFDTSYFHADKTNSYMDSTLSTT 347
DTS F + NS S STT
Sbjct: 285 LKSDDDTSNFDEPEKNSTRRSQSSTT 310
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 92/307 (29%), Positives = 151/307 (49%), Gaps = 47/307 (15%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQ--LYAIKVMKKDEMINKNMVSQVLR-ERNAL-A 97
+FE+++ + GA+GKVFL K D LYA+KV+KK ++ K ++ R ER L A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
+ PF V L Y+ QT + + L+++Y+ GG++ + + E Y AE+VLAL +
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 158 LHSHGIIHRDLKPDNMLISAQAPHCPIVNT------LFLAILQQ-------PIVYLEISD 204
LH GII+RD+K +N+L+ ++ H +V T FLA ++ I Y+ +
Sbjct: 121 LHQLGIIYRDIKLENILLDSEG-H--VVLTDFGLSKEFLAEEEERAYSFCGTIEYMA-PE 176
Query: 205 LVNGTP----NAFNIRTPGQLL-SLKTGTFP-TFQDVQNSQAPFPSALRVAGSQIPTSTA 258
++ G A + + G L L TG P T QNSQ+ + R+ S+ P
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SRRILKSKPP---- 230
Query: 259 AQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSG---HQVRRLPMFKDYDWDSILDQE 315
+P+ ++ + I LL+ DP +R +++ P F+ DWD + +
Sbjct: 231 ------FPKT---MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKR 281
Query: 316 --PPFVP 320
PF P
Sbjct: 282 IPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 2e-35
Identities = 100/307 (32%), Positives = 161/307 (52%), Gaps = 30/307 (9%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
D+++VK I RGAFG+V L K+++ ++YA+K++ K EMI ++ + ER+ +A +S
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQ-KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
P+ VQLF + Q +++VMEYM GGD+ +L++ N +PE A FY AEVVLAL +HS
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS-NYDVPEKWAKFYTAEVVLALDAIHSM 161
Query: 162 GIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQL 221
G+IHRD+KPDNML+ H + + F ++ + D GTP+ +P L
Sbjct: 162 GLIHRDVKPDNMLLDKHG-HLKLAD--FGTCMKMDETGMVRCDTAVGTPDYI---SPEVL 215
Query: 222 LS-------------LKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268
S G F F+ + + +L S+I + L +PED
Sbjct: 216 KSQGGDGYYGRECDWWSVGVF-LFEMLVGDTPFYADSLVGTYSKIMDHKNS---LNFPED 271
Query: 269 EEALNPSTEETILALLKSDPTQ--RPSGHQVRRLPMFKD--YDWDSILDQEPPFVPQPDD 324
E ++ + I A L + R ++++ P FK+ ++WD+I + P VP+
Sbjct: 272 VE-ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSS 330
Query: 325 VFDTSYF 331
D+S F
Sbjct: 331 DIDSSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-35
Identities = 45/130 (34%), Positives = 79/130 (60%), Gaps = 1/130 (0%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108
+ G FG+V L K +K++ +A+K +KK ++ + E+ L + PF V+L+
Sbjct: 1 LGVGGFGRVEL-VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 109 YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168
+ + ++++MEY +GG++ +++ G E A FY A VVLA +YLH+ GII+RDL
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 169 KPDNMLISAQ 178
KP+N+L+ +
Sbjct: 120 KPENLLLDSN 129
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 101/308 (32%), Positives = 159/308 (51%), Gaps = 32/308 (10%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
D+E+VK I RGAFG+V L K+ + ++YA+K++ K EMI ++ + ER+ +A +S
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTR-KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
P+ VQLFY+ Q +++VMEYM GGD+ +L+ +N +PE A FY AEVVLAL +HS
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSM 161
Query: 162 GIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQL 221
G IHRD+KPDNML+ ++ H + + F ++ + D GTP+ +P L
Sbjct: 162 GFIHRDVKPDNMLLD-KSGHLKLAD--FGTCMKMNKEGMVRCDTAVGTPDYI---SPEVL 215
Query: 222 LS-------------LKTGTFPTFQDVQNSQAPF-PSALRVAGSQIPTSTAAQLQLEWPE 267
S G F ++ PF +L S+I + L +P+
Sbjct: 216 KSQGGDGYYGRECDWWSVGVF--LYEMLVGDTPFYADSLVGTYSKIMNHKNS---LTFPD 270
Query: 268 DEEALNPSTEETILALLKSDPTQ--RPSGHQVRRLPMFKD--YDWDSILDQEPPFVPQPD 323
D + ++ + I A L + R +++R FK+ + W+++ D P VP
Sbjct: 271 DND-ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLS 329
Query: 324 DVFDTSYF 331
DTS F
Sbjct: 330 SDIDTSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 61/141 (43%), Positives = 85/141 (60%), Gaps = 3/141 (2%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS-PFCV 105
K + +G+FGKV L K D++YAIKV+KKD ++ + V + E+ LAL PF
Sbjct: 1 KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIH 165
L QT +F VMEY+ GGD+ I + E + FYAAEV LAL +LH HG+I+
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 166 RDLKPDNMLISAQAPHCPIVN 186
RDLK DN+L+ A+ HC + +
Sbjct: 120 RDLKLDNILLDAEG-HCKLAD 139
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 95/315 (30%), Positives = 148/315 (46%), Gaps = 33/315 (10%)
Query: 47 KAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL-THSPFC 104
K + +G+FGKV L K TN + +AIK +KKD ++ + V + ER LAL PF
Sbjct: 1 KVLGKGSFGKVMLAELKGTN--EFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGII 164
LF + QT +F VMEY+ GGD+ I ++G E A FYAAE++ LQ+LH GII
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 165 HRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLSL 224
+RDLK DN+L+ H I + + ++ + + GTP+ P L
Sbjct: 119 YRDLKLDNVLLDKDG-HIKIAD---FGMCKENMNGEGKASTFCGTPDYI---APEILKGQ 171
Query: 225 KTGT---FPTF----QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTE 277
K + +F ++ Q+PF + + + P ++ +
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPF-------HGEDEDELFDSILNDRPHFPRWISKEAK 224
Query: 278 ETILALLKSDPTQR-PSGHQVRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYFHAD 334
+ + L + DPT+R +R+ P F+ DW+ + +E PPF P+ D S F +
Sbjct: 225 DCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDRE 284
Query: 335 KTN-----SYMDSTL 344
TN S +D L
Sbjct: 285 FTNEKVRLSPVDKKL 299
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 8e-34
Identities = 61/140 (43%), Positives = 81/140 (57%), Gaps = 7/140 (5%)
Query: 43 FEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
F + + RG FGKV L YKKT + LYAIK +KK ++I ++ V ++ E+ +S
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGE--LYAIKALKKGDIIARDEVESLMCEKRIFETANS 58
Query: 102 ---PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
PF V LF QT V VMEY GGD+ I + E A FYAA VVL LQYL
Sbjct: 59 ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD-VFSEPRAVFYAACVVLGLQYL 117
Query: 159 HSHGIIHRDLKPDNMLISAQ 178
H + I++RDLK DN+L+ +
Sbjct: 118 HENKIVYRDLKLDNLLLDTE 137
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 97/317 (30%), Positives = 156/317 (49%), Gaps = 51/317 (16%)
Query: 46 VKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPF 103
+K + +G+FGKVFL K T D QLYA+KV+KK + ++ V + ER+ LA + PF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPF 59
Query: 104 CVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGI 163
V+L Y+ QT ++L+++++ GGD+ + ++ E+ FY AE+ LAL +LHS GI
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 164 IHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGT-----PNAFNIRTP 218
I+RDLKP+N+L+ + H + + + ++ I + + + GT P N R
Sbjct: 120 IYRDLKPENILLDEEG-HIKLTD---FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 175
Query: 219 GQ----------LLSLKTGTFPTFQ--DVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266
Q + + TG+ P FQ D + + A +L P
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLP-FQGKDRKETMTMILKA----------------KLGMP 218
Query: 267 EDEEALNPSTEETILALLKSDPTQR----PSG-HQVRRLPMFKDYDWDSILDQE--PPFV 319
+ L+P + + AL K +P R P G +++R P F DW+ + +E PPF
Sbjct: 219 ---QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFK 275
Query: 320 PQPDDVFDTSYFHADKT 336
P DT YF + T
Sbjct: 276 PAVGRPDDTFYFDPEFT 292
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 5e-33
Identities = 86/315 (27%), Positives = 140/315 (44%), Gaps = 52/315 (16%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
D E +K + G FG+V L + ++ YA+KVM E+I V E+ L
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISE-HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
PF ++LF++ ++++MEY+ GG++ S + +G FYA+E+V AL+YLHS
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 161 HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISD---LVNGTPN------ 211
I++RDLKP+N+L+ + H + + F ++ D + GTP
Sbjct: 120 KEIVYRDLKPENILLDKEG-HIKLTDFGFAK---------KLRDRTWTLCGTPEYLAPEV 169
Query: 212 --------AFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQL 263
A + G L+ +P F D PF ++ ++
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN----PFGIYEKILAGKL---------- 215
Query: 264 EWPEDEEALNPSTEETILALLKSDPTQR----PSGHQ-VRRLPMFKDYDWDSILDQ--EP 316
E+P L+ ++ I LL D T+R +G V+ FK DWD + + +P
Sbjct: 216 EFP---RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKP 272
Query: 317 PFVPQPDDVFDTSYF 331
P VP+ DTS F
Sbjct: 273 PIVPKVSHDGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 6e-33
Identities = 94/328 (28%), Positives = 148/328 (45%), Gaps = 57/328 (17%)
Query: 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL 98
++SDFE+ + + G+FG+V + K + YAIK +KK E++ V V +E++ L
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGT-GEYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
PF V + S Q + V+ ++E+++GG++ + + G P D+A FY AE+VLA +YL
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 159 HSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTP-------- 210
HS II+RDLKP+N+L+ + H + + F + L GTP
Sbjct: 135 HSKDIIYRDLKPENLLLDNKG-HVKVTDFGFAKKVPDRTFTL------CGTPEYLAPEVI 187
Query: 211 ------NAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264
A + T G LL +P F D PF ++ A +L+
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPPFFD----DTPFRIYEKI--------LAGRLKFP 235
Query: 265 WPEDEEALNPSTEETILALLKSDPTQR----PSGHQ-VRRLPMFKDYDWDSILDQEPPFV 319
D A + + LL++D T+R G V+ P F +WD + + +
Sbjct: 236 NWFDGRA-----RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYAR---YY 287
Query: 320 PQPDDVF-----DTSYFHADKTNSYMDS 342
P P V DTS F Y DS
Sbjct: 288 PAPIPVRVKSPGDTSNF-----EKYPDS 310
|
Length = 329 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 7e-33
Identities = 58/136 (42%), Positives = 89/136 (65%), Gaps = 1/136 (0%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
DF VK I +GAFG+V L +K + ++YA+K + K EM K+ ++ V ER+ LA + S
Sbjct: 2 DFHTVKVIGKGAFGEVRL-VQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
P+ V L+YS Q + ++L+ME++ GGD+ +++ ED+ FY AE VLA++ +H
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 162 GIIHRDLKPDNMLISA 177
G IHRD+KPDN+LI
Sbjct: 121 GFIHRDIKPDNILIDR 136
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 7e-33
Identities = 43/138 (31%), Positives = 73/138 (52%), Gaps = 6/138 (4%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTH 100
++ + + RG+FG V+L K +L A+K ++ + + + RE L +L H
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTG-ELMAVKSVELSGDSEEEL-EALEREIRILSSLQH 58
Query: 101 SPFCVQLFYSLQTSSCVFL--VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
P V+ + S + L +EY+ GG + SL+ G LPE + Y +++ L YL
Sbjct: 59 -PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 159 HSHGIIHRDLKPDNMLIS 176
HS+GI+HRD+K N+L+
Sbjct: 118 HSNGIVHRDIKGANILVD 135
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 7e-33
Identities = 89/309 (28%), Positives = 143/309 (46%), Gaps = 41/309 (13%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS-PFCV 105
+ + +G+FGKV L K + +LYA+KV+KKD ++ + V + E+ L+L + PF
Sbjct: 1 RVLGKGSFGKVMLARLKES-GRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIH 165
QL+ QT +F VME++ GGD+ I + E A FYAAE+ AL +LH GII+
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 166 RDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLSLK 225
RDLK DN+L+ + HC + + + ++ I + + GTP+ P L +
Sbjct: 120 RDLKLDNVLLDHEG-HCKLAD---FGMCKEGIFNGKTTSTFCGTPDYI---APEILQEML 172
Query: 226 TGTFPTF-------QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPS--- 275
G + ++ APF + L E ++E + P+
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEA-----------ENEDDL-FEAILNDEVVYPTWLS 220
Query: 276 --TEETILALLKSDPTQRPSG------HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDV 325
+ + A + +PT R + R P FK+ DW+ + + EPPF P+
Sbjct: 221 QDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSR 280
Query: 326 FDTSYFHAD 334
D S F D
Sbjct: 281 EDVSNFDPD 289
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 60/138 (43%), Positives = 84/138 (60%), Gaps = 2/138 (1%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
DF + + +G+FGKV L +K D+LYAIK++KKD +I + V + E+ LAL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGT-DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 102 P-FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
P F QL QT ++ VMEY+ GGD+ I G E A FYAAE+ + L +LHS
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 161 HGIIHRDLKPDNMLISAQ 178
GII+RDLK DN+++ A+
Sbjct: 120 KGIIYRDLKLDNVMLDAE 137
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-32
Identities = 82/294 (27%), Positives = 132/294 (44%), Gaps = 40/294 (13%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108
+ +G FG+V + ++YA K + K + + L E+ L S F V L
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 109 YSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHR 166
Y+ +T + LVM M GGD+K I G PE A FYAA+++ L++LH I++R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 167 DLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPG----QLL 222
DLKP+N+L+ + I + L LA+ +L G TPG ++L
Sbjct: 120 DLKPENVLLDDHG-NVRISD-LGLAV-----------ELKGGKKIKGRAGTPGYMAPEVL 166
Query: 223 SLKTGTFP--------TFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED-EEALN 273
+ F T ++ ++PF R ++ + LE + + +
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGRSPF----RQRKEKVEKEELKRRTLEMAVEYPDKFS 222
Query: 274 PSTEETILALLKSDPTQR-----PSGHQVRRLPMFKDYDWDSILDQ--EPPFVP 320
P ++ ALL+ DP +R S +VR P+FKD +W + EPPF+P
Sbjct: 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 94/322 (29%), Positives = 162/322 (50%), Gaps = 42/322 (13%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINKNMVSQVLR-ERNALAL 98
+FE++K + GA+GKVFL K T D +LYA+KV++K ++ K + R ERN L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 99 T-HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
SPF V L Y+ QT + + L+++Y+ GG++ + + ED FY+ E++LAL++
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 158 LHSHGIIHRDLKPDNMLISAQAPHCPI----VNTLFLAILQQ-------PIVYL--EISD 204
LH GI++RD+K +N+L+ ++ H + ++ FL+ ++ I Y+ EI
Sbjct: 121 LHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179
Query: 205 LVNGTPNAFNIRTPGQLL-SLKTGTFP-TFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQ 262
G A + + G L+ L TG P T + +N+Q+ + P+
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS------- 232
Query: 263 LEWPEDEEALNPSTEETILALLKSDPTQR----PSG-HQVRRLPMFKDYDWDSILDQE-- 315
+ P ++ + LL+ DP +R P G +++ P FK DW+++ ++
Sbjct: 233 --------FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVN 284
Query: 316 PPFVPQPDDVFDTSYFHADKTN 337
PPF P + D F + TN
Sbjct: 285 PPFRPSIRNELDVGNFAEEFTN 306
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 58/135 (42%), Positives = 87/135 (64%), Gaps = 2/135 (1%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
DFEI+K I RGAFG+V + K N Q+YA+K++ K EM+ + + ER+ L
Sbjct: 2 DFEILKVIGRGAFGEVAV-VKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHS 160
+ L Y+ Q + ++LVM+Y +GGD+ +L++ LPEDMA FY AE+VLA+ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 161 HGIIHRDLKPDNMLI 175
G +HRD+KPDN+L+
Sbjct: 121 LGYVHRDIKPDNVLL 135
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 49/140 (35%), Positives = 81/140 (57%), Gaps = 6/140 (4%)
Query: 41 SDFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
SD E VK + +G+ G V+ +K T K +YA+K + D ++ Q+LRE L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGK--IYALKKIHVDG--DEEFRKQLLRELKTLRSC 56
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
SP+ V+ + + + +V+EYM GG + L+ G +PE + A+ A +++ L YLH
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 160 S-HGIIHRDLKPDNMLISAQ 178
+ IIHRD+KP N+LI+++
Sbjct: 117 TKRHIIHRDIKPSNLLINSK 136
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 8e-31
Identities = 57/132 (43%), Positives = 86/132 (65%), Gaps = 4/132 (3%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL---ALTHSPFCV 105
I +G FG+V+ +K + ++YA+KV+ K E++ K V+ + ERN L L SPF V
Sbjct: 1 IGKGTFGQVYQ-VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIH 165
L +S QT S ++LV +YM GG++ + G ED A FY AE+VLAL++LH + I++
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVY 119
Query: 166 RDLKPDNMLISA 177
RDLKP+N+L+ A
Sbjct: 120 RDLKPENILLDA 131
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 46/136 (33%), Positives = 75/136 (55%), Gaps = 5/136 (3%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
FEI++ I +G FG+V+ K + AIKV+K + K +++ E L
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTG-KEVAIKVIKLESKEKKE---KIINEIQILKKCKH 56
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHS 160
P V+ + S +++VME+ GG +K L+ + N L E A+ E++ L+YLHS
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 161 HGIIHRDLKPDNMLIS 176
+GIIHRD+K N+L++
Sbjct: 117 NGIIHRDIKAANILLT 132
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 88/303 (29%), Positives = 144/303 (47%), Gaps = 28/303 (9%)
Query: 47 KAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFC 104
K + +G+FGKVFL K TN Q +AIK +KKD ++ + V + E+ L+L PF
Sbjct: 1 KMLGKGSFGKVFLAELKGTN--QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 58
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGII 164
L+ + QT +F VMEY+ GGD+ I + A FYAAE++ LQ+LHS GI+
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 165 HRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLSL 224
+RDLK DN+L+ H I + + ++ ++ + GTP+ P LL
Sbjct: 119 YRDLKLDNILLDTDG-HIKIAD---FGMCKENMLGDAKTCTFCGTPDYI---APEILLGQ 171
Query: 225 KTGTFPTF-------QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTE 277
K T + ++ Q+PF ++++ P L +
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPF-------HGHDEEELFQSIRMDNPCYPRWLTREAK 224
Query: 278 ETILALLKSDPTQRPSGH-QVRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYFHAD 334
+ ++ L +P +R +R+ P F++ DW ++ ++E PPF P+ D S F +
Sbjct: 225 DILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKE 284
Query: 335 KTN 337
N
Sbjct: 285 FLN 287
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 55/136 (40%), Positives = 85/136 (62%), Gaps = 3/136 (2%)
Query: 46 VKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMI-NKNMVSQVLRERNALALTHSP 102
+K + +G +GKVF K T D +++A+KV+KK ++ N+ + ERN L P
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
F V L Y+ QT ++L++EY+ GG++ + G ED A FY +E+ LAL++LH G
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 163 IIHRDLKPDNMLISAQ 178
II+RDLKP+N+L+ AQ
Sbjct: 121 IIYRDLKPENILLDAQ 136
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-30
Identities = 87/384 (22%), Positives = 143/384 (37%), Gaps = 30/384 (7%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LTH 100
+ I++ + G+FG+V+L + +L A+KV+ K V + LRE LA L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNH 56
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG---ALPEDMAAFYAAEVVLALQY 157
P V+L+ Q ++LVMEY+ GG ++ L+ G L E A F A+++ AL+Y
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 158 LHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRT 217
LHS GIIHRD+KP+N+L+ +++ +L P I L + +
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 218 PGQLLSLKTGTFPTFQDV----------QNSQAPFP-----SALRVAGSQIPTSTAAQLQ 262
P LL L + D+ PF SA I L
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 263 LEWPED-EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVPQ 321
E ++ + + + LL DP R S + +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDD 296
Query: 322 PDDVFDTSYFHADKTNSYMDSTLSTTHG------NGSFVCCSNLNSHTASGMDVDSPSAL 375
+ + + S ++S + N S N S + S
Sbjct: 297 SAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTA 356
Query: 376 YSKLSTMDCMSPPNAHNLSGVSPF 399
SK S++ +S ++ + S
Sbjct: 357 SSKRSSLPKISARSSPSSLSSSSR 380
|
Length = 384 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 57/138 (41%), Positives = 88/138 (63%), Gaps = 1/138 (0%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
DFE +K I RGAFG+V L KK + +YA+K+++K +M+ K V+ + ER+ L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKK-DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
+ V++FYS Q ++L+ME++ GGD+ +L+ L E+ FY AE VLA+ +H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 162 GIIHRDLKPDNMLISAQA 179
G IHRD+KPDN+L+ A+
Sbjct: 121 GFIHRDIKPDNLLLDAKG 138
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 57/135 (42%), Positives = 88/135 (65%), Gaps = 1/135 (0%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
S F +K + GAFG+V L +K + LYA+K ++K +++ +N V+ V ER+ LA
Sbjct: 1 SMFVKIKTLGIGAFGEVCLA-RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD 59
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
+ + V+L+YS Q ++ VM+Y+ GGD+ SL+ G PED+A FY AE+ A++ +H
Sbjct: 60 NEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK 119
Query: 161 HGIIHRDLKPDNMLI 175
G IHRD+KPDN+LI
Sbjct: 120 MGFIHRDIKPDNILI 134
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 57/138 (41%), Positives = 88/138 (63%), Gaps = 1/138 (0%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
DFE +K I RGAFG+V L KK + +YA+K+++K +M+ K V + ER+ L S
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKK-DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
+ V++FYS Q ++L+ME++ GGD+ +L+ L E+ FY AE VLA+ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 162 GIIHRDLKPDNMLISAQA 179
G IHRD+KPDN+L+ ++
Sbjct: 121 GFIHRDIKPDNLLLDSKG 138
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 87/322 (27%), Positives = 151/322 (46%), Gaps = 46/322 (14%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108
I +G+FGKV + +K + ++YA+K ++K +++++ V+ L ER LA + PF V L
Sbjct: 1 IGKGSFGKV-MQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 109 YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168
+S Q+ ++LV+ ++ GG++ + G A FY AE++ AL+ LH +I+RDL
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119
Query: 169 KPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTP--------------NAFN 214
KP+N+L+ Q H + + + + + + ++ GTP A +
Sbjct: 120 KPENILLDYQG-HIALCD---FGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175
Query: 215 IRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE--DEEAL 272
T G LL P F D +N + L Q L +P+ D +A
Sbjct: 176 WWTLGVLLYEMLTGLPPFYD-ENVNEMYRKIL-------------QEPLRFPDGFDRDA- 220
Query: 273 NPSTEETILALLKSDPTQR---PSGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFD 327
++ ++ LL DPT+R +++ P F W +L + +PPF P D
Sbjct: 221 ----KDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAID 276
Query: 328 TSYFHADKTNSY-MDSTLSTTH 348
TS F + T +DS + +H
Sbjct: 277 TSNFDEEFTREKPIDSVVDDSH 298
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 57/135 (42%), Positives = 87/135 (64%), Gaps = 1/135 (0%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
S F +K + GAFG+V L K + LYA+K ++K +++N+N V+ V ER+ LA
Sbjct: 1 SMFVKIKTLGIGAFGEVCLA-CKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD 59
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
+ + V+L+YS Q ++ VM+Y+ GGD+ SL+ PE +A FY AE+ LA++ +H
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK 119
Query: 161 HGIIHRDLKPDNMLI 175
G IHRD+KPDN+LI
Sbjct: 120 MGFIHRDIKPDNILI 134
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 56/134 (41%), Positives = 84/134 (62%), Gaps = 4/134 (2%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA--LTHSPFC 104
K I +G+FGKV L K + + YA+KV++K ++ K ++ ERN L + H PF
Sbjct: 1 KVIGKGSFGKVLLAKHKAD-GKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH-PFL 58
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGII 164
V L YS QT+ ++ V++Y+ GG++ + + PE A FYAAE+ AL YLHS II
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 165 HRDLKPDNMLISAQ 178
+RDLKP+N+L+ +Q
Sbjct: 119 YRDLKPENILLDSQ 132
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 5e-28
Identities = 59/139 (42%), Positives = 85/139 (61%), Gaps = 2/139 (1%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-H 100
DF + + +G+FGKV L +K D+LYAIK++KKD +I + V + E+ LAL+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
PF QL QT ++ VMEY+ GGD+ I G E A FYAAE+ + L +LHS
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 161 HGIIHRDLKPDNMLISAQA 179
GII+RDLK DN+++ ++
Sbjct: 120 KGIIYRDLKLDNVMLDSEG 138
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 93/307 (30%), Positives = 156/307 (50%), Gaps = 45/307 (14%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINKNMVSQVLR-ERNALA- 97
+FE++K + GA+GKVFL K + D +LYA+KV+KK ++ K ++ R ER L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
+ SPF V L Y+ QT + + L+++Y+ GG++ + ++ E Y+ E+VLAL++
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 158 LHSHGIIHRDLKPDNMLISAQAPHCPI----VNTLFLAILQQ-------PIVYLEISDLV 206
LH GII+RD+K +N+L+ + H + ++ F + I Y+ D+V
Sbjct: 121 LHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA-PDIV 178
Query: 207 ----NGTPNAFNIRTPGQLL-SLKTGTFP-TFQDVQNSQAPFPSALRVAGSQIPTSTAAQ 260
G A + + G L+ L TG P T +NSQA + R+ S+ P
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSEPP------ 230
Query: 261 LQLEWPEDEEALNPSTEETILALLKSDPTQR----PSGHQ-VRRLPMFKDYDWDSILDQE 315
+P++ AL ++ I LL DP +R PS +++ P F+ +WD + ++
Sbjct: 231 ----YPQEMSAL---AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKK 283
Query: 316 --PPFVP 320
PF P
Sbjct: 284 VPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 56/135 (41%), Positives = 87/135 (64%), Gaps = 2/135 (1%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
DFEI+K I RGAFG+V + K + +++YA+K++ K EM+ + + ERN L
Sbjct: 2 DFEIIKVIGRGAFGEVAV-VKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHS 160
+ L Y+ Q + ++LVM+Y +GGD+ +L++ LPEDMA FY AE+VLA+ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 161 HGIIHRDLKPDNMLI 175
+HRD+KPDN+L+
Sbjct: 121 LHYVHRDIKPDNVLL 135
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 52/129 (40%), Positives = 76/129 (58%), Gaps = 1/129 (0%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQ 106
K + +G FGKV L +K + YA+K++KK+ +I K+ V+ L E L T PF
Sbjct: 1 KLLGKGTFGKVILVREKATG-KYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 107 LFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHR 166
L YS QT + VMEY GG++ ++ ED A FY AE+V AL YLHS +++R
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 167 DLKPDNMLI 175
DLK +N+++
Sbjct: 120 DLKLENLML 128
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 51/134 (38%), Positives = 80/134 (59%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
DF ++ + G+FG+V L K AIK +K ++I + V V ER L +
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
PFCV L+ S + S ++LV+E++IGG+ + + N P D+ FYAA++VL +YL S
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL 150
Query: 162 GIIHRDLKPDNMLI 175
I++RDLKP+N+L+
Sbjct: 151 NIVYRDLKPENLLL 164
|
Length = 340 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 95/331 (28%), Positives = 151/331 (45%), Gaps = 33/331 (9%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCV 105
K + +G+FGKV L K K + +A+K +KKD ++ + V + E+ LAL +PF
Sbjct: 1 KVLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIH 165
L+ + QT +F VME++ GGD+ I G A FYAAE+V LQ+LHS GII+
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIY 119
Query: 166 RDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLSLK 225
RDLK DN+++ H I + + ++ + + GTP+ P L LK
Sbjct: 120 RDLKLDNVMLDRDG-HIKIAD---FGMCKENVFGDNRASTFCGTPDYI---APEILQGLK 172
Query: 226 TGTFPT--------FQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTE 277
TF ++ Q+PF ++++ P + ++
Sbjct: 173 Y-TFSVDWWSFGVLLYEMLIGQSPF-------HGDDEDELFESIRVDTPHYPRWITKESK 224
Query: 278 ETILALLKSDPTQRPS-GHQVRRLPMFKDYDWDSILDQE--PPFVPQ---PDDV--FDTS 329
+ + L + DPT+R +R P FK +W ++ +E PPF P+ P D FD
Sbjct: 225 DILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDRE 284
Query: 330 YFHADKTNSYMDSTLSTTHGNGSFVCCSNLN 360
+ SY D L + +F S +N
Sbjct: 285 FLSEKPRLSYSDKNLIDSMDQSAFAGFSFIN 315
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 44/140 (31%), Positives = 74/140 (52%), Gaps = 6/140 (4%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
+EI+K I +G+FGKV+L ++ + +LY +K + M K L E L +
Sbjct: 1 KYEIIKQIGKGSFGKVYL-VRRKSDGKLYVLKEIDLSNMSEKE-REDALNEVKILKKLNH 58
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGD----VKSLIAANGALPEDMAAFYAAEVVLALQY 157
P ++ + S + + +VMEY GGD +K PE+ + ++ LAL+Y
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 158 LHSHGIIHRDLKPDNMLISA 177
LHS I+HRD+KP N+ +++
Sbjct: 119 LHSRKILHRDIKPQNIFLTS 138
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 55/135 (40%), Positives = 88/135 (65%), Gaps = 2/135 (1%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
DFEI+K I RGAFG+V + K N D+++A+K++ K EM+ + + ER+ L +
Sbjct: 2 DFEILKVIGRGAFGEVAV-VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHS 160
+ L Y+ Q + ++LVM+Y +GGD+ +L++ LPEDMA FY AE+V+A+ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 161 HGIIHRDLKPDNMLI 175
+HRD+KPDN+L+
Sbjct: 121 LHYVHRDIKPDNILM 135
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 56/134 (41%), Positives = 84/134 (62%), Gaps = 4/134 (2%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL--ALTHSPFC 104
K I +G+FGKV L +K++ YA+KV++K ++ K + ++ ERN L L H PF
Sbjct: 1 KVIGKGSFGKVLLAKRKSD-GSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH-PFL 58
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGII 164
V L YS QT+ ++ V++Y+ GG++ + E A FYAAEV A+ YLHS II
Sbjct: 59 VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 165 HRDLKPDNMLISAQ 178
+RDLKP+N+L+ +Q
Sbjct: 119 YRDLKPENILLDSQ 132
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 52/133 (39%), Positives = 81/133 (60%), Gaps = 2/133 (1%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHSPFCV 105
+ I RG++ KV L K ++YA+KV+KK+ + + + V E++ ++ PF V
Sbjct: 1 RVIGRGSYAKVLLVELKKT-RRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIH 165
L QT S +F V+E++ GGD+ + LPE+ A FY+AE+ LAL +LH GII+
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY 119
Query: 166 RDLKPDNMLISAQ 178
RDLK DN+L+ A+
Sbjct: 120 RDLKLDNVLLDAE 132
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 32/298 (10%)
Query: 43 FEIVKAISRGAFGKV-FLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
F + + +G FG+V + T K +YA K ++K + + + L E+ L +S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGK--MYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 59
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI--AANGALPEDMAAFYAAEVVLALQYLH 159
F V L Y+ +T + LV+ M GGD+K I N E+ A FYAAE+ L+ LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 160 SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPG 219
I++RDLKP+N+L+ H I + L LA V + + + G P
Sbjct: 120 RERIVYRDLKPENILLDDYG-HIRISD-LGLA------VEIPEGETIRGRVGTVGYMAPE 171
Query: 220 QLLSLKTGTFPTF-------QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED-EEA 271
+ + + P + ++ ++PF R ++ + E E+ E
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPF----RQRKEKVKREEVERRVKEDQEEYSEK 227
Query: 272 LNPSTEETILALLKSDPTQR-----PSGHQVRRLPMFKDYDWDSILDQ--EPPFVPQP 322
+ + LL DP R +V+ P F+ ++ + EPPF P P
Sbjct: 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 58/139 (41%), Positives = 83/139 (59%), Gaps = 2/139 (1%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
DF + + +G+FGKV L +K D+LYAIK++KKD +I + V + E+ LAL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGT-DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK 59
Query: 102 P-FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
P F QL QT ++ VMEY+ GGD+ I G E A FYAAE+ + L +LH
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 161 HGIIHRDLKPDNMLISAQA 179
GII+RDLK DN+++ ++
Sbjct: 120 RGIIYRDLKLDNVMLDSEG 138
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 87/312 (27%), Positives = 137/312 (43%), Gaps = 45/312 (14%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQ 106
K + +G FGKV L +K + + YA+K++KK+ +I K+ V+ L E L T PF
Sbjct: 1 KLLGKGTFGKVILVREKAS-GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 107 LFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHR 166
L YS QT + VMEY+ GG++ ++ ED FY AE+V AL YLHS I++R
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 167 DLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPN--------------A 212
DLK +N+++ H I + + ++ I GTP A
Sbjct: 120 DLKLENLMLDKDG-HIKITD---FGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 213 FNIRTPGQLL-SLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271
+ G ++ + G P + Q+ + F L +++P
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYN--QDHEKLFELIL-------------MEDIKFP---RT 217
Query: 272 LNPSTEETILALLKSDPTQRPSG-----HQVRRLPMFKDYDWDSILDQE--PPFVPQPDD 324
L+ + + LL DP +R G ++ R F +W + D++ PPF PQ
Sbjct: 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTS 277
Query: 325 VFDTSYFHADKT 336
DT YF + T
Sbjct: 278 ETDTRYFDEEFT 289
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 75/301 (24%), Positives = 134/301 (44%), Gaps = 54/301 (17%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS---PFCV 105
I RG FG+V+ G +K + ++YA+K + K + K + L ER L+L + PF V
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIH 165
+ Y+ T + +++ M GGD+ ++ +G E FYAAE++L L+++H+ +++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 166 RDLKPDNMLI-----------------SAQAPHCPIVNTLFLA--ILQQPIVYLEISDLV 206
RDLKP N+L+ S + PH + ++A +LQ+ + Y
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY------- 173
Query: 207 NGTPNAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266
+ + + F++ L L G P Q + +I T +E P
Sbjct: 174 DSSADWFSLGC--MLFKLLRGHSPFRQHKTKDK-----------HEIDRMTLTM-AVELP 219
Query: 267 EDEEALNPSTEETILALLKSDPTQRPSGH-----QVRRLPMFKDYDWDSILDQE--PPFV 319
+ +P + LL+ D +R +V+ P F+ DW + Q+ PP +
Sbjct: 220 DS---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLI 276
Query: 320 P 320
P
Sbjct: 277 P 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 89/306 (29%), Positives = 142/306 (46%), Gaps = 22/306 (7%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS-PFCV 105
+ I RG++ KV L K N DQ+YA+KV+KK+ + + + V E++ S PF V
Sbjct: 1 RVIGRGSYAKVLLVRLKKN-DQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIH 165
L QT+S +FLV+EY+ GGD+ + LPE+ A FYAAE+ +AL +LH GII+
Sbjct: 60 GLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIY 119
Query: 166 RDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFN---IRTPGQLL 222
RDLK DN+L+ A H + + + ++ + + + GTPN +R
Sbjct: 120 RDLKLDNVLLDADG-HIKLTD---YGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 223 SLKTGTFPTFQ-DVQNSQAPFPSALRVAGSQIPTSTAA-QLQLEWP-EDEEALNPSTEET 279
S+ ++ ++PF + + T Q+ LE P L+
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD--IITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHV 233
Query: 280 ILALLKSDPTQRPSGH------QVRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYF 331
+ L DP +R ++ F+ DWD + ++ PPF PQ D + F
Sbjct: 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENF 293
Query: 332 HADKTN 337
T+
Sbjct: 294 DTQFTS 299
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 54/135 (40%), Positives = 86/135 (63%), Gaps = 4/135 (2%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA--LTHSPFC 104
K I +G+FGKV L +K + + YA+KV++K ++N+ ++ ERN L + H PF
Sbjct: 1 KVIGKGSFGKVLLAKRKLD-GKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH-PFL 58
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGII 164
V L YS QT+ ++ V++++ GG++ + + PE A FYAAE+ AL YLHS I+
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 165 HRDLKPDNMLISAQA 179
+RDLKP+N+L+ +Q
Sbjct: 119 YRDLKPENILLDSQG 133
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-24
Identities = 89/313 (28%), Positives = 147/313 (46%), Gaps = 34/313 (10%)
Query: 47 KAISRGAFGKVFL-GYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHSPFC 104
+ I RG++ KV L KKT +++YA+KV+KK+ + + + V E++ ++ PF
Sbjct: 1 RVIGRGSYAKVLLVRLKKT--ERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 58
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGII 164
V L QT S +F V+EY+ GGD+ + LPE+ A FY+AE+ LAL YLH GII
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII 118
Query: 165 HRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFN---IRTPGQL 221
+RDLK DN+L+ ++ H + + + ++ + + + GTPN +R
Sbjct: 119 YRDLKLDNVLLDSEG-HIKLTD---YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 222 LSLKTGTFPTFQ-DVQNSQAPFPSALRVAGSQIPTSTAA--------QLQLEWPEDEEAL 272
S+ ++ ++PF V S P + Q+ P +L
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDI---VGSSDNPDQNTEDYLFQVILEKQIRIP---RSL 228
Query: 273 NPSTEETILALLKSDPTQR-----PSGH-QVRRLPMFKDYDWDSILDQE--PPFVPQPDD 324
+ + + L DP +R +G ++ P F++ DWD + ++ PPF P
Sbjct: 229 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISG 288
Query: 325 VFDTSYFHADKTN 337
F F A TN
Sbjct: 289 EFGLDNFDAQFTN 301
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-23
Identities = 84/296 (28%), Positives = 133/296 (44%), Gaps = 41/296 (13%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108
+ +G FG+V + +LYA K + K + + + E+ LA HS F V L
Sbjct: 1 LGKGGFGEVSACQMRAT-GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 109 YSLQTSSCVFLVMEYMIGGDVKSLI----AANGALPEDMAAFYAAEVVLALQYLHSHGII 164
Y+ QT + + LVM M GGD++ I N PE A FY A+++ L++LH II
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 165 HRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPG----Q 220
+RDLKP+N+L+ + I + L LA+ E+ D + T TPG +
Sbjct: 120 YRDLKPENVLLD-NDGNVRISD-LGLAV--------ELKDGQSKTKGYAG--TPGFMAPE 167
Query: 221 LLSLKTGTFP--------TFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED-EEA 271
LL + F T ++ ++ PF R G ++ Q L +
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAARGPF----RARGEKVENKELKQRILNDSVTYPDK 223
Query: 272 LNPSTEETILALLKSDPTQR-----PSGHQVRRLPMFKDYDWDSILDQ--EPPFVP 320
+P+++ ALL DP +R + +R P+F+D +W + PPFVP
Sbjct: 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 52/134 (38%), Positives = 80/134 (59%), Gaps = 2/134 (1%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCV 105
K I +G+FGKV L K ++ YA+KV++K ++ K ++ ERN L PF V
Sbjct: 1 KVIGKGSFGKVLLARHKAE-EKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIH 165
L +S QT+ ++ V++Y+ GG++ + E A FYAAE+ AL YLHS I++
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 166 RDLKPDNMLISAQA 179
RDLKP+N+L+ +Q
Sbjct: 120 RDLKPENILLDSQG 133
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 6e-23
Identities = 48/139 (34%), Positives = 79/139 (56%), Gaps = 6/139 (4%)
Query: 41 SDFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
F +++ I +G+FG+V+ K+TN Q+ AIKV+ +E ++ + + +E L+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTN--QVVAIKVIDLEEAEDE--IEDIQQEIQFLSQC 56
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
SP+ + + S S ++++MEY GG L+ G L E AF EV+L L+YLH
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLH 115
Query: 160 SHGIIHRDLKPDNMLISAQ 178
G IHRD+K N+L+S +
Sbjct: 116 EEGKIHRDIKAANILLSEE 134
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-22
Identities = 47/129 (36%), Positives = 77/129 (59%), Gaps = 1/129 (0%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQ 106
K + +G FGKV L +K + YA+K+++K+ +I K+ V+ + E L T PF
Sbjct: 1 KLLGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 107 LFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHR 166
L Y+ QT + VMEY GG++ ++ E+ A FY AE+V AL+YLHS +++R
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 167 DLKPDNMLI 175
D+K +N+++
Sbjct: 120 DIKLENLML 128
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 6e-22
Identities = 83/303 (27%), Positives = 132/303 (43%), Gaps = 42/303 (13%)
Query: 43 FEIVKAISRGAFGKV-FLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
F + + +G FG+V + T K +YA K ++K + + S L E+ L +S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGK--MYACKRLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI--AANGALPEDMAAFYAAEVVLALQYLH 159
F V L Y+ +T + LV+ M GGD+K I N E+ A FYAAE++ L+ LH
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 160 SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPG 219
++RDLKP+N+L+ H I + L LA+ + + + G P
Sbjct: 120 RENTVYRDLKPENILLDDYG-HIRISD-LGLAV------KIPEGESIRGRVGTVGYMAPE 171
Query: 220 QLLSLKTGTFPTF-------QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272
L + + P + ++ Q+PF R ++ + L E EE
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPF----RGRKEKVKREEVDRRVL---ETEEVY 224
Query: 273 NPSTEETILA----LLKSDPTQR-----PSGHQVRRLPMFKDYDWD----SILDQEPPFV 319
+ E + LL DP QR +V+R P F++ ++ +LD PPFV
Sbjct: 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLD--PPFV 282
Query: 320 PQP 322
P P
Sbjct: 283 PDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 82/311 (26%), Positives = 127/311 (40%), Gaps = 58/311 (18%)
Query: 43 FEIVKAISRGAFGKV-FLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
F + + +G FG+V + T K +YA K ++K + + S L E+ L +S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGK--MYACKKLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLH 159
F V L Y+ +T + LV+ M GGD+K I G E A FYAAE+ L+ LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 160 SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTP- 218
I++RDLKP+N+L+ ++ ISDL + P
Sbjct: 120 QERIVYRDLKPENILLDDHG-------------------HIRISDL------GLAVHVPE 154
Query: 219 GQLLSLKTGT--FPTFQDVQNSQAPFP-----------------SALRVAGSQIPTSTAA 259
GQ + + GT + + V+N + F S + +I
Sbjct: 155 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 214
Query: 260 QLQLEWPED-EEALNPSTEETILALLKSDPTQR-----PSGHQVRRLPMFKDYDWDSILD 313
+L E E+ E +P LL DP +R +V+ P+FK ++ +
Sbjct: 215 RLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEA 274
Query: 314 Q--EPPFVPQP 322
EPPF P P
Sbjct: 275 GMLEPPFKPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 8e-21
Identities = 74/301 (24%), Positives = 131/301 (43%), Gaps = 54/301 (17%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS---PFCV 105
I RG FG+V+ G +K + ++YA+K + K + K + L ER L+L + PF V
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIH 165
+ Y+ T + +++ M GGD+ ++ +G E FYA E++L L+++H+ +++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 166 RDLKPDNMLI-----------------SAQAPHCPIVNTLFLA--ILQQPIVYLEISDLV 206
RDLKP N+L+ S + PH + ++A +LQ+ Y +D
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSAD-- 178
Query: 207 NGTPNAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266
SL F + +PF +I T + +E P
Sbjct: 179 --------------WFSLGCMLFKLLR----GHSPFRQHKTKDKHEIDRMTLT-VNVELP 219
Query: 267 EDEEALNPSTEETILALLKSDPTQRPSGH-----QVRRLPMFKDYDWDSILDQ--EPPFV 319
++ +P + + LL+ D ++R +V+ FK DW + Q PP +
Sbjct: 220 ---DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLI 276
Query: 320 P 320
P
Sbjct: 277 P 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 43/133 (32%), Positives = 70/133 (52%), Gaps = 14/133 (10%)
Query: 49 ISRGAFGKVFLGY-KKTNKDQLYAIKVM---KKDEMINKNMVSQVLRERNALALTHSPFC 104
I GA G+V+ + T K+ AIK M K+++ + N + ++++ P
Sbjct: 27 IGEGASGEVYKATDRATGKE--VAIKKMRLRKQNKELIINEIL-IMKD------CKHPNI 77
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGI 163
V + S +++VMEYM GG + +I N + E A+ EV+ L+YLHS +
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137
Query: 164 IHRDLKPDNMLIS 176
IHRD+K DN+L+S
Sbjct: 138 IHRDIKSDNILLS 150
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 44/142 (30%), Positives = 80/142 (56%), Gaps = 12/142 (8%)
Query: 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINKNMVSQVLRERNA 95
PE F+I++ + G++G V YK +K+ Q+ AIKV+ +E + ++++E +
Sbjct: 1 PE-EVFDILEKLGEGSYGSV---YKAIHKETGQVVAIKVVPVEEDL-----QEIIKEISI 51
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLA 154
L SP+ V+ + S ++ +++VMEY G V ++ N L E+ A + +
Sbjct: 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 155 LQYLHSHGIIHRDLKPDNMLIS 176
L+YLHS+ IHRD+K N+L++
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLN 133
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 42/137 (30%), Positives = 75/137 (54%), Gaps = 4/137 (2%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LTH 100
++++ I RGAFG V+ G AIK + +++ + + +++E + L L H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKIKEEAL-KSIMQEIDLLKNLKH 58
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
P V+ S++TS +++++EY G ++ +I G PE + A Y +V+ L YLH
Sbjct: 59 -PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 161 HGIIHRDLKPDNMLISA 177
G+IHRD+K N+L +
Sbjct: 118 QGVIHRDIKAANILTTK 134
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 45/141 (31%), Positives = 75/141 (53%), Gaps = 7/141 (4%)
Query: 41 SDFEIVKAISRGAFGKVFLGY-KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
D E + + G G V + T ++ A+K ++ + IN+ + Q+LRE + L
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTG--KIMAVKTIRLE--INEAIQKQILRELDILHKC 56
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDV-KSLIAANGALPEDMAAFYAAEVVLALQYL 158
+SP+ V + + + + + MEYM GG + K L G +PE + A V+ L YL
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL 116
Query: 159 HS-HGIIHRDLKPDNMLISAQ 178
H H IIHRD+KP N+L++++
Sbjct: 117 HEKHKIIHRDVKPSNILVNSR 137
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 50/130 (38%), Positives = 76/130 (58%), Gaps = 2/130 (1%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQ 106
K + +G FGKV L K+ + YA+K++KK+ ++ K+ V+ L E L + PF
Sbjct: 1 KLLGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 107 LFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH-GIIH 165
L YS QT + VMEY GG++ ++ ED A FY AE+V AL YLHS +++
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 166 RDLKPDNMLI 175
RDLK +N+++
Sbjct: 120 RDLKLENLML 129
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 43/142 (30%), Positives = 71/142 (50%), Gaps = 17/142 (11%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKK-----DEMINKNMVSQVLRERNAL- 96
++++K + G FG V+L + +L AIK MKK +E +N LRE +L
Sbjct: 1 YKVIKQLGDGTFGSVYLA-RNKETGELVAIKKMKKKFYSWEECMN-------LREVKSLR 52
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI--AANGALPEDMAAFYAAEVVLA 154
L P V+L + + ++ V EYM G++ L+ E + +++
Sbjct: 53 KLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 155 LQYLHSHGIIHRDLKPDNMLIS 176
L ++H HG HRDLKP+N+L+S
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVS 133
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 3e-19
Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 6/136 (4%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHS 101
+E ++ + G +G V+ K ++ A+K ++ D + S LRE + L L H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDK-KTGEIVALKKIRLDNEEE-GIPSTALREISLLKELKH- 57
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIA-ANGALPEDMAAFYAAEVVLALQYLHS 160
P V+L + T ++LV EY D+K + G L ++ +++ L Y HS
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 161 HGIIHRDLKPDNMLIS 176
H I+HRDLKP N+LI+
Sbjct: 117 HRILHRDLKPQNILIN 132
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 5e-19
Identities = 41/140 (29%), Positives = 73/140 (52%), Gaps = 6/140 (4%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
D+E+++ I GA V+ N +++ AIK + ++ ++ ++ +E A++ +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKV-AIKRIDLEKC-QTSV-DELRKEVQAMSQCN 57
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGG---DVKSLIAANGALPEDMAAFYAAEVVLALQY 157
P V+ + S ++LVM Y+ GG D+ G L E + A EV+ L+Y
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 158 LHSHGIIHRDLKPDNMLISA 177
LHS+G IHRD+K N+L+
Sbjct: 118 LHSNGQIHRDIKAGNILLGE 137
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 46/150 (30%), Positives = 71/150 (47%), Gaps = 18/150 (12%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LTH 100
FE+V+ I G +GKV+ + QL AIK+M I ++ ++ E N L ++
Sbjct: 7 IFELVEVIGEGTYGKVYKA-RHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSN 61
Query: 101 SPFCVQLFYS--LQTSSCV-----FLVMEYMIGGD----VKSLIAANGALPEDMAAFYAA 149
P FY ++ + +LVME GG VK L L E+ A+
Sbjct: 62 HPNIAT-FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLISAQA 179
E + L YLH + +IHRD+K N+L++ A
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNA 150
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 76/311 (24%), Positives = 127/311 (40%), Gaps = 58/311 (18%)
Query: 43 FEIVKAISRGAFGKV-FLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
F + + +G FG+V + T K +YA K ++K + + + L E+ L +S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGK--MYACKKLEKKRIKKRKGEAMALNEKRILEKVNS 59
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI--AANGALPEDMAAFYAAEVVLALQYLH 159
F V L Y+ +T + LV+ M GGD+K I N E A FYAAE+ L+ L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 160 SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTP- 218
I++RDLKP+N+L+ + ++ ISDL ++ P
Sbjct: 120 RERIVYRDLKPENILLDDRG-------------------HIRISDL------GLAVQIPE 154
Query: 219 GQLLSLKTGT--FPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQL-------QLEWPEDE 269
G+ + + GT + + + N + F G I Q +++ E +
Sbjct: 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD 214
Query: 270 EALNPSTEE-----------TILALLKSDPTQR-----PSGHQVRRLPMFKDYDWDSILD 313
+ EE LL +P +R V++ P+FK+ ++ +
Sbjct: 215 RRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEA 274
Query: 314 Q--EPPFVPQP 322
EPPF P P
Sbjct: 275 NMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 7e-18
Identities = 45/138 (32%), Positives = 75/138 (54%), Gaps = 4/138 (2%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
DFEI+ I +G+FG VF +K +K ++YA+K + +M N+ + + E LA S
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADK-RVYAMKQIDLSKM-NRREREEAIDEARVLAKLDS 58
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGA--LPEDMAAFYAAEVVLALQYLH 159
+ ++ + S + +VMEY GD+ L+ LPED + +++L L +LH
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 160 SHGIIHRDLKPDNMLISA 177
S I+HRD+K N+ + A
Sbjct: 119 SKKILHRDIKSLNLFLDA 136
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 41/136 (30%), Positives = 69/136 (50%), Gaps = 4/136 (2%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
++ + I G +G V+ K ++ AIK +K ++ + LRE L + P
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLT-GEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHP 58
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLALQYLHSH 161
++L + ++LV E+M D+ LI LPE + Y +++ L + HSH
Sbjct: 59 NIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 162 GIIHRDLKPDNMLISA 177
GI+HRDLKP+N+LI+
Sbjct: 118 GILHRDLKPENLLINT 133
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 44/130 (33%), Positives = 68/130 (52%), Gaps = 3/130 (2%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMK--KDEMINKNMVSQVLRERNALALTHSPFC 104
K + +GAFG+V+L Y +L A+K + D K V+ + E L
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGREL-AVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGII 164
VQ + L+ + + MEYM GG VK + A GAL E + Y +++ ++YLHS+ I+
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 165 HRDLKPDNML 174
HRD+K N+L
Sbjct: 127 HRDIKGANIL 136
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 43/132 (32%), Positives = 72/132 (54%), Gaps = 3/132 (2%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108
+ +G FG+V + N ++YA K + K + K+ L E+ L +SPF V L
Sbjct: 1 LGKGGFGEV-CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 109 YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMA--AFYAAEVVLALQYLHSHGIIHR 166
Y+ ++ + + LVM M GGD+K I G +M Y+A++ + +LHS I++R
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 167 DLKPDNMLISAQ 178
D+KP+N+L+ Q
Sbjct: 120 DMKPENVLLDDQ 131
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 5/137 (3%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
D+E+++ I G +G V+ + +L AIKV+K + + + +E + L
Sbjct: 3 EDYELIQRIGSGTYGDVYKA-RDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECR 58
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLALQYLH 159
P V F S +++VMEY GG ++ + G L E A+ E + L YLH
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 160 SHGIIHRDLKPDNMLIS 176
G IHRD+K N+L++
Sbjct: 119 ETGKIHRDIKGANILLT 135
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 4e-17
Identities = 39/135 (28%), Positives = 60/135 (44%), Gaps = 7/135 (5%)
Query: 49 ISRGAFGKVFLGY---KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCV 105
+ GAFG+V+ G K K+ A+K +K+D + + LRE + P V
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNIV 64
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGI 163
+L + +VMEYM GGD+ + N L +A ++ ++YL S
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF 124
Query: 164 IHRDLKPDNMLISAQ 178
IHRDL N L+
Sbjct: 125 IHRDLAARNCLVGEN 139
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIK---VMKKDEMINKNMVSQVLRERNALAL 98
++I+ I GA G VF + + A+K + + + I Q LRE AL
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRET-GETVALKKVALRRLEGGIPN----QALREIKALQA 55
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIA-ANGALPEDMAAFYAAEVVLALQY 157
P+ V+L S LVMEYM D+ ++ LPE Y ++ + Y
Sbjct: 56 CQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 158 LHSHGIIHRDLKPDNMLISA 177
+H++GI+HRDLKP N+LISA
Sbjct: 115 MHANGIMHRDLKPANLLISA 134
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 5e-17
Identities = 31/71 (43%), Positives = 46/71 (64%)
Query: 263 LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVPQP 322
+ WPE EE L+ + + I LL DPT+R ++++ P+F DW+++ +Q PF+PQP
Sbjct: 597 IPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFIPQP 656
Query: 323 DDVFDTSYFHA 333
DD DTSYF A
Sbjct: 657 DDETDTSYFEA 667
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 6e-17
Identities = 45/142 (31%), Positives = 70/142 (49%), Gaps = 22/142 (15%)
Query: 41 SDFEIVKAI--SRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN------MVSQVLRE 92
+ EIVK + G FGKV + K +L+ K++K KN MV Q+++
Sbjct: 14 KNCEIVKKLKLIDGKFGKVSV-LKHKPTQKLFVQKIIK-----AKNFNAIEPMVHQLMK- 66
Query: 93 RNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVV 152
+P ++L+YS+ T L+M+Y+ GD+ L+ G L E ++V
Sbjct: 67 -------DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLV 119
Query: 153 LALQYLHSHGIIHRDLKPDNML 174
AL LH H IIH D+K +N+L
Sbjct: 120 EALNDLHKHNIIHNDIKLENVL 141
|
Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 43/141 (30%), Positives = 78/141 (55%), Gaps = 9/141 (6%)
Query: 41 SDFEIVKAISRGAFGKVFLGYK-KTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-- 97
S ++ ++ I RGA+G V+ G T + + A+K++ D + VS + RE L+
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGR--VVALKIINLDT--PDDDVSDIQREVALLSQL 56
Query: 98 -LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQ 156
+ P + + S ++++MEY GG V++L+ A G + E + EV++AL+
Sbjct: 57 RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALK 115
Query: 157 YLHSHGIIHRDLKPDNMLISA 177
Y+H G+IHRD+K N+L++
Sbjct: 116 YIHKVGVIHRDIKAANILVTN 136
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 38/140 (27%), Positives = 69/140 (49%), Gaps = 6/140 (4%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
DF+++K + +G++G V+ K+ + +Q YA+K + M ++ + E LA +
Sbjct: 1 DFKVLKKLGKGSYGSVYK-VKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNH 58
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGA----LPEDMAAFYAAEVVLALQY 157
P + + + + +VMEY GD+ I+ +PE +++ LQ
Sbjct: 59 PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 158 LHSHGIIHRDLKPDNMLISA 177
LH I+HRDLK N+L+ A
Sbjct: 119 LHEQKILHRDLKSANILLVA 138
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 40/135 (29%), Positives = 70/135 (51%), Gaps = 4/135 (2%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+E ++ + RGAFG V L +K ++ +L IK + ++M ++ E L L P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQ-KLVIIKQIPVEQMTKDERLA-AQNECQVLKLLSHP 59
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIA--ANGALPEDMAAFYAAEVVLALQYLHS 160
++ + + + +VMEY GG + I N L ED + +++LAL ++H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 161 HGIIHRDLKPDNMLI 175
I+HRDLK N+L+
Sbjct: 120 KLILHRDLKTQNILL 134
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 2e-16
Identities = 40/132 (30%), Positives = 61/132 (46%), Gaps = 6/132 (4%)
Query: 49 ISRGAFGKVFLGY---KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCV 105
+ GAFG+V+ G K K A+K +K+D + + + LRE + P V
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKLDHPNVV 64
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLALQYLHSHGII 164
+L +++VMEYM GGD+ S L L +A ++ ++YL S I
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFI 124
Query: 165 HRDLKPDNMLIS 176
HRDL N L+
Sbjct: 125 HRDLAARNCLVG 136
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 23/153 (15%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN--KNM-VSQV--LRERNAL 96
D+E+++ I +G+FG V +K++ ++ K + M K VS+V LRE
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDG-KILVWKEIDYGNMTEKEKQQLVSEVNILRE---- 55
Query: 97 ALTHSPFCVQLFYSL--QTSSCVFLVMEYMIGGDVKSLI----AANGALPEDMAAFYAAE 150
L H P V+ + + +++ +++VMEY GGD+ LI + E+ +
Sbjct: 56 -LKH-PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113
Query: 151 VVLALQYLH-----SHGIIHRDLKPDNMLISAQ 178
++LAL H + ++HRDLKP N+ + A
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDAN 146
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 7e-16
Identities = 39/128 (30%), Positives = 66/128 (51%), Gaps = 4/128 (3%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108
I G FGKV+ + L A+K ++ + + + ++ E L L P V+ +
Sbjct: 8 IGGGTFGKVYTAVNLDTGE-LMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVK-Y 64
Query: 109 YSLQT-SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRD 167
Y ++ V++ MEY GG ++ L+ L E + Y +++ L YLHSHGI+HRD
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRD 124
Query: 168 LKPDNMLI 175
+KP N+ +
Sbjct: 125 IKPANIFL 132
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 9e-16
Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 10/145 (6%)
Query: 43 FEIVKA--ISRGAFGKVFLGYKKTNKDQLYAIK-------VMKKDEMINKNMVSQVLRER 93
F+ VK I +G +G+V+L T + + A+K + + + K+MV + E
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMM-AVKQVELPATIAGRHDSRQKDMVKALRSEI 59
Query: 94 NALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
L VQ T + + +EY+ GG + S + G E + F+ +V+
Sbjct: 60 ETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE 119
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQ 178
L YLHS GI+HRDLK DN+L+ A
Sbjct: 120 GLAYLHSKGILHRDLKADNLLVDAD 144
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 59/274 (21%), Positives = 109/274 (39%), Gaps = 46/274 (16%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMK--KDEMINKNMVSQVLRERNAL-ALTHSPFCV 105
+ G+FG V+ G + D +A+K + D + V Q+ +E L L H P V
Sbjct: 8 LGSGSFGSVYEGLNLDDGD-FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIV 65
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIH 165
Q + + +++ +E + GG + L+ G+ PE + Y +++L L+YLH +H
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 166 RDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLSLK 225
RD+K N+L+ ++++D G A + S K
Sbjct: 126 RDIKGANILVDTNG-------------------VVKLADF--GM--AKQVVEFSFAKSFK 162
Query: 226 TGTFPTFQDVQNSQAPFPSA----------LRVAGSQIPTSTAAQLQLEW--------PE 267
+ +V Q + A L +A + P S + + P
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPP 222
Query: 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLP 301
+ L+ ++ IL L+ DP+ RP+ ++ P
Sbjct: 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 47/140 (33%), Positives = 71/140 (50%), Gaps = 14/140 (10%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMK---KDEMINKNMVSQVLRERNALA 97
+E++ + GA+G V K NK ++ AIK K DE + K LRE L
Sbjct: 3 YEVLGVVGEGAYGVVL---KCRNKATGEIVAIKKFKESEDDEDVKKT----ALREVKVLR 55
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQ 156
V L + + ++LV EY + + L+ A+ G LP D Y +++ A+
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEY-VERTLLELLEASPGGLPPDAVRSYIWQLLQAIA 114
Query: 157 YLHSHGIIHRDLKPDNMLIS 176
Y HSH IIHRD+KP+N+L+S
Sbjct: 115 YCHSHNIIHRDIKPENILVS 134
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 47/142 (33%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 39 EISDFEIVKAISRGAFGKVF-LGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
+++D E + I G G+V+ + +KKT + A+K M++ NK ++L + + +
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGH--VMAVKQMRRTG--NKEENKRILMDLDVVL 68
Query: 98 LTH-SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQ 156
+H P+ V+ + T S VF+ ME M K L G +PED+ +V AL
Sbjct: 69 KSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALH 128
Query: 157 YL-HSHGIIHRDLKPDNMLISA 177
YL HG+IHRD+KP N+L+ A
Sbjct: 129 YLKEKHGVIHRDVKPSNILLDA 150
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 5e-15
Identities = 35/140 (25%), Positives = 58/140 (41%), Gaps = 10/140 (7%)
Query: 43 FEIVKAISRGAFGKVFLGY---KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
E+ K + GAFG+V+ G + A+K +K+ + + L E + +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS--EEEREEFLEEASIMKKL 58
Query: 100 HSPFCVQL--FYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLALQ 156
P V+L + + V EYM GGD+ L L A ++ ++
Sbjct: 59 SHPNIVRLLGVCTQGEPLYI--VTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 157 YLHSHGIIHRDLKPDNMLIS 176
YL S +HRDL N L++
Sbjct: 117 YLESKNFVHRDLAARNCLVT 136
|
Length = 258 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 14/153 (9%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHS 101
+E ++ I G +GKV+ K +L A+K + EM + + LRE + L L+ S
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNT-GKLVALK-KTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 102 PFCVQLFYSLQTSS-----CVFLVMEYMIGGDVKSLIAANG-----ALPEDMAAFYAAEV 151
+ V+L ++LV EY+ D+K + +NG LP + ++
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 152 VLALQYLHSHGIIHRDLKPDNMLISAQAPHCPI 184
+ + + H HG++HRDLKP N+L+ Q I
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKI 152
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 7e-15
Identities = 44/136 (32%), Positives = 70/136 (51%), Gaps = 4/136 (2%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+ VK I G+FGK L K + Q Y IK + +M K + +E L+ P
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQ-YVIKEINISKMSPKER-EESRKEVAVLSNMKHP 59
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGAL-PEDMAAFYAAEVVLALQYLHS 160
VQ S + + +++VM+Y GGD+ I A G L PED + ++ LAL+++H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 161 HGIIHRDLKPDNMLIS 176
I+HRD+K N+ ++
Sbjct: 120 RKILHRDIKSQNIFLT 135
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 24/148 (16%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVS--QVLRE-------- 92
+E++K I GA+G V K ++ AIK K + +++ ++LRE
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKV-AIK---KISNVFDDLIDAKRILREIKLLRHLR 57
Query: 93 -RNALALTHSPFCVQLFYSLQTSSC--VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAA 149
N + L + V++V E M D+ +I + L +D ++
Sbjct: 58 HENIIGLLD------ILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLY 110
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLISA 177
+++ L+YLHS +IHRDLKP N+L+++
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNS 138
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 42/136 (30%), Positives = 71/136 (52%), Gaps = 4/136 (2%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+EI+K I G+FGK++L K++ + ++ + + S+ +E LA P
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAKMKHP 59
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDV-KSLIAANGAL-PEDMAAFYAAEVVLALQYLHS 160
V F S Q + +F+VMEY GGD+ K + G L ED + ++ L L+++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 161 HGIIHRDLKPDNMLIS 176
I+HRD+K N+ +S
Sbjct: 120 RKILHRDIKSQNIFLS 135
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 42/141 (29%), Positives = 70/141 (49%), Gaps = 10/141 (7%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHS 101
+E + I G +G+V+ K + L A+K ++ + + +RE L L H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGE-LVALKKIRMENE-KEGFPITAIREIKLLQKLRH- 57
Query: 102 PFCVQLFYSLQTSSC---VFLVMEYMIGGDVKSLIAANGA-LPEDMAAFYAAEVVLALQY 157
P V+L + TS +++V EYM D+ L+ + E Y +++ LQY
Sbjct: 58 PNIVRL-KEIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 158 LHSHGIIHRDLKPDNMLISAQ 178
LHS+GI+HRD+K N+LI+
Sbjct: 116 LHSNGILHRDIKGSNILINND 136
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 39/144 (27%), Positives = 73/144 (50%), Gaps = 11/144 (7%)
Query: 41 SDFEIVKAISRGAFGKVF-LGYKKTNKDQLYAIKVMKKDEM-INKNMVSQVLRERNALAL 98
+ E++ + +G +G V+ + ++ T MK+ + ++++ +Q++ E + L
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGV-----TMAMKEIRLELDESKFNQIIMELDILHK 55
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIA---ANGALPEDMAAFYAAEVVLAL 155
SP+ V + + V++ MEYM G + L A A +PED+ VV L
Sbjct: 56 AVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 156 QYL-HSHGIIHRDLKPDNMLISAQ 178
++L H IIHRD+KP N+L++
Sbjct: 116 KFLKEEHNIIHRDVKPTNVLVNGN 139
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 6e-14
Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK----NMVSQVLRERNALAL 98
+E K + G + V+ K ++ AIK +K E N LRE L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDK-ETGRIVAIKKIKLGERKEAKDGINFT--ALREIKLLQE 58
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGAL--PEDMAAFYAAEVVLALQ 156
P + L S + LV E+M D++ +I + P D+ + Y + L+
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKS-YMLMTLRGLE 116
Query: 157 YLHSHGIIHRDLKPDNMLISAQ 178
YLHS+ I+HRDLKP+N+LI++
Sbjct: 117 YLHSNWILHRDLKPNNLLIASD 138
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 9/142 (6%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+ + GA G V K ++A+K + D N ++ Q+LRE SP
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTG-MIFALKTITTDP--NPDLQKQILRELEINKSCKSP 59
Query: 103 FCVQLF--YSLQTSSCVFLVMEYMIGGDVKSL---IAANGALPEDMAAFYAAEVVL-ALQ 156
+ V+ + + ++SS + + MEY GG + S+ + G + AE VL L
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 157 YLHSHGIIHRDLKPDNMLISAQ 178
YLHS IIHRD+KP N+L++ +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRK 141
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 37/140 (26%), Positives = 61/140 (43%), Gaps = 15/140 (10%)
Query: 51 RGAFGKVFLG--YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108
GAFG+V+ G K K A+K +K+D ++ L+E + P V+L
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 109 -YSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAF--------YAAEVVLALQYL 158
+ ++LV+EYM GGD+ L + P + +A ++ ++YL
Sbjct: 63 GVCTEEEP-LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 159 HSHGIIHRDLKPDNMLISAQ 178
S +HRDL N L+
Sbjct: 122 ASKKFVHRDLAARNCLVGED 141
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 42/137 (30%), Positives = 74/137 (54%), Gaps = 4/137 (2%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
F ++ I +G+FG+V+ G K ++ AIK++ +E ++ + + +E L+ SP
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTK-EVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSP 62
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
+ + + S + ++++MEY+ GG L+ G L E A E++ L YLHS
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER 121
Query: 163 IIHRDLKPDNMLISAQA 179
IHRD+K N+L+S Q
Sbjct: 122 KIHRDIKAANVLLSEQG 138
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 53/162 (32%), Positives = 83/162 (51%), Gaps = 13/162 (8%)
Query: 26 SLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVM----KKDEMI 81
SL D+ S L+ P FE+V+ + G +G+V+ G + QL AIKVM ++E I
Sbjct: 2 SLDDIDLSALRDPA-GIFELVEVVGNGTYGQVYKG-RHVKTGQLAAIKVMDVTEDEEEEI 59
Query: 82 NK--NMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI--AANG 137
NM+ + RN +A + F + ++LVME+ G V L+
Sbjct: 60 KLEINMLKKYSHHRN-IATYYGAFIKK--SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN 116
Query: 138 ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA 179
AL ED A+ E++ L +LH+H +IHRD+K N+L++ A
Sbjct: 117 ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA 158
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIK------VMKKDEMINKNMVSQVLRERNALALTHSP 102
I G+FG V+LG ++ +L A+K V + ++M+ + RE L
Sbjct: 8 IGSGSFGSVYLGMNASS-GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
VQ S + + + +EY+ GG V +L+ GA E + + +++ L YLH+ G
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 163 IIHRDLKPDNMLI 175
IIHRD+K N+L+
Sbjct: 127 IIHRDIKGANILV 139
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-13
Identities = 36/108 (33%), Positives = 59/108 (54%), Gaps = 1/108 (0%)
Query: 71 AIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS-SCVFLVMEYMIGGDV 129
AIK+++ D ++ ++ RE A + P V L S + +F V EY+ G +
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66
Query: 130 KSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177
+ ++AA+GALP +V+ AL H+ GI+HRDLKP N+++S
Sbjct: 67 REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 36/148 (24%), Positives = 73/148 (49%), Gaps = 17/148 (11%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK---KDEMINKNMVSQV--LRERNALA 97
+E + I GA+G V+ + N + A+K ++ +E I + + ++ L++ +
Sbjct: 1 YEELAEIGEGAYGTVYKA-RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 98 LTHSPFCVQL---FYSLQTSSC--VFLVMEYMIGGDVKSLI--AANGALPEDMAAFYAAE 150
H P V+L + +T + LV E+ + D+ + + LP + +
Sbjct: 60 --H-PNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 151 VVLALQYLHSHGIIHRDLKPDNMLISAQ 178
++ + +LHSH I+HRDLKP N+L+++
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSD 143
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 28/151 (18%)
Query: 40 ISDFEIVKAISRGAFGKVFLGY-KKTNKDQLYAIKVMKKD-EMINKNMVSQVLRERNALA 97
+ ++E + I G +G V+ KKT + + A+K +K + E + S LRE N L
Sbjct: 4 VDEYEKLNRIEEGTYGVVYRARDKKTGE--IVALKKLKMEKEKEGFPITS--LREINILL 59
Query: 98 LTHSPFCVQL----FYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMA-AFYAAEV- 151
P V + S +++VMEY+ D+KSL+ E M F +EV
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDK--IYMVMEYV-EHDLKSLM-------ETMKQPFLQSEVK 109
Query: 152 ------VLALQYLHSHGIIHRDLKPDNMLIS 176
+ + +LH + I+HRDLK N+L++
Sbjct: 110 CLMLQLLSGVAHLHDNWILHRDLKTSNLLLN 140
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 47/146 (32%), Positives = 71/146 (48%), Gaps = 26/146 (17%)
Query: 43 FEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQV--LRERNAL-AL 98
++I+ I G F +V +KT + YAIK MKK + QV LRE AL L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTG--KYYAIKCMKKH----FKSLEQVNNLREIQALRRL 54
Query: 99 THSPFCVQLFYSL--QTSSCVFLVMEYM-------IGGDVKSLIAANGALPEDMAAFYAA 149
+ P ++L L + + + LV E M I G + L PE Y
Sbjct: 55 SPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPL-------PEKRVKSYMY 107
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLI 175
+++ +L ++H +GI HRD+KP+N+LI
Sbjct: 108 QLLKSLDHMHRNGIFHRDIKPENILI 133
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 26/73 (35%), Positives = 41/73 (56%), Gaps = 3/73 (4%)
Query: 262 QLEWPEDEEALNPSTEETILALLKSDPTQR---PSGHQVRRLPMFKDYDWDSILDQEPPF 318
+EWPE +EAL ++ I LL+ +P +R +V++ F DW+ +L Q+ F
Sbjct: 232 DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEF 291
Query: 319 VPQPDDVFDTSYF 331
+PQ + DTSYF
Sbjct: 292 IPQLESEDDTSYF 304
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 43/137 (31%), Positives = 74/137 (54%), Gaps = 4/137 (2%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
F ++ I +G+FG+VF G + Q+ AIK++ +E ++ + + +E L+ SP
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQ-QVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSP 62
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
+ + + S + ++++MEY+ GG L+ A G E A E++ L YLHS
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 163 IIHRDLKPDNMLISAQA 179
IHRD+K N+L+S Q
Sbjct: 122 KIHRDIKAANVLLSEQG 138
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 43/168 (25%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKD-QLYAIKVMKKD-------------------EMIN 82
+EI I RG +G+V+ +K KD + YAIK K D E+ +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 83 KNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-----AANG 137
+N+VS L E + L H V+L+ +Y D+ +I A
Sbjct: 62 ENVVS--LVE---VFLEH------------ADKSVYLLFDYA-EHDLWQIIKFHRQAKRV 103
Query: 138 ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185
++P M +++ + YLHS+ ++HRDLKP N+L+ + P +V
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVV 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 5e-12
Identities = 41/134 (30%), Positives = 73/134 (54%), Gaps = 4/134 (2%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
F ++ I +G+FG+VF G + ++ AIK++ +E ++ + + +E L+ SP
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQ-KVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSP 62
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
+ + + S + ++++MEY+ GG L+ G L E A E++ L YLHS
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK 121
Query: 163 IIHRDLKPDNMLIS 176
IHRD+K N+L+S
Sbjct: 122 KIHRDIKAANVLLS 135
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-12
Identities = 43/145 (29%), Positives = 80/145 (55%), Gaps = 14/145 (9%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRE-RNALALTHS 101
++I++ I +G G+V+L Y ++ A+K +++D N + + LRE + A L H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRV-ALKKIREDLSENPLLKKRFLREAKIAADLIH- 61
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAA---NGALPEDMA------AFYAA--E 150
P V ++ V+ M Y+ G +KSL+ + +L +++A AF + +
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 151 VVLALQYLHSHGIIHRDLKPDNMLI 175
+ ++Y+HS G++HRDLKPDN+L+
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILL 146
|
Length = 932 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 35/150 (23%), Positives = 66/150 (44%), Gaps = 16/150 (10%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
+++ + +G+FG V+ G K + AIK + ++ + + + + L E + +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVM 63
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI--------AANGALPEDMAAFY- 147
+ V+L + T +VME M GD+KS + G P + F
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 148 -AAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
AAE+ + YL + +HRDL N +++
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVA 153
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 41/135 (30%), Positives = 68/135 (50%), Gaps = 4/135 (2%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
DFE+++ I G +G V+ + N +L AIKV+K + + +V Q E +
Sbjct: 10 DFELIQRIGSGTYGDVYKA-RNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKH 65
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
V F S +++ ME+ GG ++ + G L E A+ + E + L YLHS
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 162 GIIHRDLKPDNMLIS 176
G +HRD+K N+L++
Sbjct: 126 GKMHRDIKGANILLT 140
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 37/137 (27%), Positives = 73/137 (53%), Gaps = 9/137 (6%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNK--DQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
++ V+ I G +G V YK +K ++ A+K ++ + ++ + S +RE + L +
Sbjct: 1 YQKVEKIGEGTYGVV---YKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELN 56
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI--AANGALPEDMAAFYAAEVVLALQYL 158
P V+L + + + ++LV E++ D+K + + L + Y +++ + Y
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 159 HSHGIIHRDLKPDNMLI 175
HSH ++HRDLKP N+LI
Sbjct: 116 HSHRVLHRDLKPQNLLI 132
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 42/141 (29%), Positives = 75/141 (53%), Gaps = 11/141 (7%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKD-EMINKNMVSQVLRERNALALT 99
F+ V+ I G +G V YK NK ++ A+K ++ D E + + S +RE + L
Sbjct: 2 FQKVEKIGEGTYGVV---YKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKEL 56
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSL--IAANGALPEDMAAFYAAEVVLALQY 157
+ P V+L + T + ++LV E++ D+K + +P + Y +++ L +
Sbjct: 57 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 158 LHSHGIIHRDLKPDNMLISAQ 178
HSH ++HRDLKP N+LI+ +
Sbjct: 116 CHSHRVLHRDLKPQNLLINTE 136
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 33/92 (35%), Positives = 52/92 (56%)
Query: 87 SQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAF 146
S+ RER + P V L + + VFLV+++ GG + S I+ +PE+
Sbjct: 30 SEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKR 89
Query: 147 YAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
+AAE+V+AL LH GI+ RDL P+N+L+ +
Sbjct: 90 WAAEMVVALDALHREGIVCRDLNPNNILLDDR 121
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 37/139 (26%), Positives = 70/139 (50%), Gaps = 7/139 (5%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK-KDEMINKNMVSQVLRERNALAL 98
+EI+ + GAFGKV+ K A K+++ + E + + E + L+
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETG-LFAAAKIIQIESE----EELEDFMVEIDILSE 58
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGA-LPEDMAAFYAAEVVLALQY 157
P V L+ + + +++++E+ GG + S++ L E + +++ AL +
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 158 LHSHGIIHRDLKPDNMLIS 176
LHSH +IHRDLK N+L++
Sbjct: 119 LHSHKVIHRDLKAGNILLT 137
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-11
Identities = 46/145 (31%), Positives = 75/145 (51%), Gaps = 12/145 (8%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK----KDEMINK--NMVSQVLRERNAL 96
FE+V+ + G +G+V+ G + QL AIKVM ++E I + NM+ + RN +
Sbjct: 8 FELVELVGNGTYGQVYKG-RHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN-I 65
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI--AANGALPEDMAAFYAAEVVLA 154
A + F + + ++LVME+ G V LI L E+ A+ E++
Sbjct: 66 ATYYGAFIKKNPPGMDDQ--LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 155 LQYLHSHGIIHRDLKPDNMLISAQA 179
L +LH H +IHRD+K N+L++ A
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENA 148
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 38/143 (26%), Positives = 71/143 (49%), Gaps = 5/143 (3%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
+ +F+I K I +G F V+ + ++ A+K ++ EM++ L+E + L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLD-GRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL 59
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI---AANGAL-PEDMAAFYAAEVVLAL 155
P ++ S ++ + +V+E GD+ +I L PE Y ++ AL
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 156 QYLHSHGIIHRDLKPDNMLISAQ 178
+++HS I+HRD+KP N+ I+A
Sbjct: 120 EHMHSKRIMHRDIKPANVFITAT 142
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 41/131 (31%), Positives = 65/131 (49%), Gaps = 3/131 (2%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKV-MKKDEMINKNMVSQVLRERNALALTHSPFCV 105
K + RGAFG+V+L Y +L +V D V+ + E L V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 106 QLFYSLQ--TSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGI 163
Q + L+ + + +EYM GG +K + A GAL E++ Y +++ + YLHS+ I
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127
Query: 164 IHRDLKPDNML 174
+HRD+K N+L
Sbjct: 128 VHRDIKGANIL 138
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 37/142 (26%), Positives = 70/142 (49%), Gaps = 15/142 (10%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRER--NALAL 98
S + I G+ G V + K+ Q+ A+K M ++ Q RE N + +
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQV-AVKKM--------DLRKQQRRELLFNEVVI 69
Query: 99 T---HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
P V+++ S +++VME++ GG + ++ + E+ A V+ AL
Sbjct: 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKAL 128
Query: 156 QYLHSHGIIHRDLKPDNMLISA 177
+LH+ G+IHRD+K D++L+++
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTS 150
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 36/136 (26%), Positives = 64/136 (47%), Gaps = 4/136 (2%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+ ++ + +GAFG+ L Y++T D L K + + K L E L+L P
Sbjct: 2 YIPIRVLGKGAFGEATL-YRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQHP 59
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGA--LPEDMAAFYAAEVVLALQYLHS 160
+ + + + + MEY GG + I E+M +Y ++V A+ Y+H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 161 HGIIHRDLKPDNMLIS 176
GI+HRD+K N+ ++
Sbjct: 120 AGILHRDIKTLNIFLT 135
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 41/136 (30%), Positives = 70/136 (51%), Gaps = 4/136 (2%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
FE++ + GA+G V L + ++ AIK K E N+ + LRE L
Sbjct: 3 FEVLGVVGEGAYG-VVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQE 60
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIA-ANGALPEDMAAFYAAEVVLALQYLHSH 161
V+L + + ++LV EY+ ++ L NG PE + + Y +++ A+ + H +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRS-YIYQLIKAIHWCHKN 119
Query: 162 GIIHRDLKPDNMLISA 177
I+HRD+KP+N+LIS
Sbjct: 120 DIVHRDIKPENLLISH 135
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 54/279 (19%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNM-VSQVLRERNALALTHSPFC--- 104
+ +G +G V+ + + ++ AIK E+ ++ Q L E AL HS
Sbjct: 16 LGKGTYGIVYAARDLSTQVRI-AIK-----EIPERDSRYVQPLHEEIAL---HSYLKHRN 66
Query: 105 -VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-GALP--EDMAAFYAAEVVLALQYLHS 160
VQ S + + ME + GG + +L+ + G L E FY +++ L+YLH
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 161 HGIIHRDLKPDNMLISAQAPHCPI--------------VNTLFLAILQQPIVYL--EISD 204
+ I+HRD+K DN+L++ + I F LQ Y+ E+ D
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQ----YMAPEVID 182
Query: 205 L-VNGTPNAFNIRTPG-QLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQ 262
G +I + G ++ + TG P F ++ QA + +V +I
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGK-PPFIELGEPQA---AMFKVGMFKIH-------- 230
Query: 263 LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLP 301
PE E+L+ + IL + DP +R S H + + P
Sbjct: 231 ---PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 43/131 (32%), Positives = 65/131 (49%), Gaps = 3/131 (2%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKV-MKKDEMINKNMVSQVLRERNALALTHSPFCV 105
K + +GAFG+V+L Y +L A +V + VS + E L V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 106 QLFYSLQ--TSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGI 163
Q + L+ + + MEYM GG VK + A GAL E + Y +++ + YLHS+ I
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 164 IHRDLKPDNML 174
+HRD+K N+L
Sbjct: 128 VHRDIKGANIL 138
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 49/150 (32%), Positives = 82/150 (54%), Gaps = 21/150 (14%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINKNMVSQVLRERNAL-ALT 99
+EI++ I +G +GKV YK TNK L A+K++ D + ++ ++ E N L +L
Sbjct: 24 WEIIETIGKGTYGKV---YKVTNKKDGSLAAVKIL--DPI--SDVDEEIEAEYNILQSLP 76
Query: 100 HSPFCVQLFYSL--QTSSCV----FLVMEYMIGGDV----KSLIAANGALPEDMAAFYAA 149
+ P V+ FY + + V +LV+E GG V K L+ L E M ++
Sbjct: 77 NHPNVVK-FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLISAQA 179
+L LQ+LH++ IIHRD+K +N+L++ +
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEG 165
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 37/139 (26%), Positives = 66/139 (47%), Gaps = 4/139 (2%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
D E + + G G V K + A KV+ ++ Q+LRE +
Sbjct: 5 EDLETISDLGAGNGGSVSK-VKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR 61
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
SP+ V + + + + + ME+M G + + G +P ++ A VV L YL++
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 161 -HGIIHRDLKPDNMLISAQ 178
H I+HRD+KP N+L++++
Sbjct: 122 VHRIMHRDIKPSNILVNSR 140
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 48/139 (34%), Positives = 75/139 (53%), Gaps = 13/139 (9%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQ--LYAIKVM--KKDEMINKNMVSQVLRERNALAL 98
+EI+ + GAFGKV YK NK+ L A KV+ K +E + MV E LA
Sbjct: 14 WEIIGELGDGAFGKV---YKAKNKETGALAAAKVIETKSEEELEDYMV-----EIEILAT 65
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLALQY 157
+ P+ V+L + +++++E+ GG V + ++ + L E +++ ALQY
Sbjct: 66 CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY 125
Query: 158 LHSHGIIHRDLKPDNMLIS 176
LHS IIHRDLK N+L++
Sbjct: 126 LHSMKIIHRDLKAGNVLLT 144
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 38/137 (27%), Positives = 70/137 (51%), Gaps = 5/137 (3%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
+ +++ + G+FG+ L + N DQ YA+K ++ + + S+ +E LA
Sbjct: 1 QYNVLRVVGEGSFGRALL-VQHVNSDQKYAMKEIRLPKSSSAVEDSR--KEAVLLAKMKH 57
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIA-ANGAL-PEDMAAFYAAEVVLALQYLH 159
P V S + +++VMEY GGD+ I G L PED + ++ L +Q++H
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117
Query: 160 SHGIIHRDLKPDNMLIS 176
++HRD+K N+ ++
Sbjct: 118 EKRVLHRDIKSKNIFLT 134
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 36/131 (27%), Positives = 71/131 (54%), Gaps = 7/131 (5%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIK--VMKKDEMINKNMVSQVLRERNAL--ALTHSPFC 104
+ +GA+G V+ G TN+ QL A+K + ++ + L+E L +L H
Sbjct: 8 LGKGAYGTVYCGL--TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGII 164
L L ++ + + ME++ GG + S++ G LPE + Y +++ + YLH++ ++
Sbjct: 66 QYLGTCLDDNT-ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 165 HRDLKPDNMLI 175
HRD+K +N+++
Sbjct: 125 HRDIKGNNVML 135
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 37/138 (26%), Positives = 72/138 (52%), Gaps = 10/138 (7%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ---VLRERNALAL 98
D+E+++ + G +G V+ + + +L A+K++K + + +++ Q +++E
Sbjct: 10 DYELIQRVGSGTYGDVYKA-RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE-----C 63
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
H V F S + +++ MEY GG ++ + G L E A+ E + L YL
Sbjct: 64 KHCNI-VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYL 122
Query: 159 HSHGIIHRDLKPDNMLIS 176
HS G +HRD+K N+L++
Sbjct: 123 HSKGKMHRDIKGANILLT 140
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 37/139 (26%), Positives = 72/139 (51%), Gaps = 6/139 (4%)
Query: 41 SDFEIVKAISRGAFGKVFL-GYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
DFE + + G G V ++ + + A K++ + I + +Q++RE L
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSG--LIMARKLIHLE--IKPAIRNQIIRELKVLHEC 56
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
+SP+ V + + + + + ME+M GG + ++ G +PE++ + V+ L YL
Sbjct: 57 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLR 116
Query: 160 S-HGIIHRDLKPDNMLISA 177
H I+HRD+KP N+L+++
Sbjct: 117 EKHKIMHRDVKPSNILVNS 135
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-10
Identities = 44/153 (28%), Positives = 80/153 (52%), Gaps = 16/153 (10%)
Query: 38 PEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
P+ SD +EI++ I +G +GKVF K N + A+K++ I++ ++ E N L
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKA-AVKILDPIHDIDE----EIEAEYNIL 68
Query: 97 -ALTHSPFCVQLF-----YSLQTSSCVFLVMEYMIGGDV----KSLIAANGALPEDMAAF 146
AL+ P V+ + ++ ++LV+E GG V K + + E + A+
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 147 YAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA 179
E ++ LQ+LH + IHRD+K +N+L++ +
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG 161
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 36/134 (26%), Positives = 56/134 (41%), Gaps = 1/134 (0%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
F ++ I G+FG V+ +++ AIK M + +++E L P
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRT-NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
++ +LVMEY +G L L E A + L YLHSH
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE 135
Query: 163 IIHRDLKPDNMLIS 176
IHRD+K N+L++
Sbjct: 136 RIHRDIKAGNILLT 149
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 36/141 (25%), Positives = 67/141 (47%), Gaps = 11/141 (7%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKK--DEMINKNMVSQVLRERNALAL 98
S ++ ++ I GA+G V + ++ AIK + D + LRE L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKV-AIKKIPHAFDVPTL---AKRTLRELKILRH 60
Query: 99 THSPFCVQLFYSLQTSSC----VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLA 154
+ + L+ V++VM+ M D+ +I ++ L E+ ++ +++
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 155 LQYLHSHGIIHRDLKPDNMLI 175
L+Y+HS +IHRDLKP N+L+
Sbjct: 120 LKYIHSANVIHRDLKPSNLLV 140
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 42/144 (29%), Positives = 72/144 (50%), Gaps = 17/144 (11%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA--- 97
+++ + K + +GAFG+V+L Y +L +V E + +E NAL
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES------PETSKEVNALECEI 55
Query: 98 -----LTHSPFCVQLFYSLQTS--SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAE 150
L H VQ + L+ + + ME+M GG +K + + GAL E++ Y +
Sbjct: 56 QLLKNLLHERI-VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ 114
Query: 151 VVLALQYLHSHGIIHRDLKPDNML 174
++ + YLHS+ I+HRD+K N+L
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANIL 138
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 39/140 (27%), Positives = 74/140 (52%), Gaps = 6/140 (4%)
Query: 42 DFEIVKAISRGAFGKVF-LGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
DFE + + G G VF + +K + + A K++ + I + +Q++RE L +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSG--LIMARKLIHLE--IKPAIRNQIIRELQVLHECN 61
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL-H 159
SP+ V + + + + + ME+M GG + ++ G +PE + + V+ L YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 160 SHGIIHRDLKPDNMLISAQA 179
H I+HRD+KP N+L++++
Sbjct: 122 KHKIMHRDVKPSNILVNSRG 141
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 7/139 (5%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
S+ +K + G FG V LG + K + AIK++++ M + + + + + L+H
Sbjct: 4 SELTFLKELGSGQFGVVHLGKWR-GKIDV-AIKMIREGAMSEDDFIEEA---KVMMKLSH 58
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLH 159
P VQL+ +F+V EYM G + + + G L + ++V A++YL
Sbjct: 59 -PNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 160 SHGIIHRDLKPDNMLISAQ 178
S+G IHRDL N L+
Sbjct: 118 SNGFIHRDLAARNCLVGED 136
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 35/142 (24%), Positives = 73/142 (51%), Gaps = 5/142 (3%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
+++F+I K I RG F +V+ ++ + A+K ++ EM++ ++E + L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDR-KPVALKKVQIFEMMDAKARQDCVKEIDLLKQL 59
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI----AANGALPEDMAAFYAAEVVLAL 155
+ P ++ S + + +V+E GD+ +I +PE Y ++ A+
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 156 QYLHSHGIIHRDLKPDNMLISA 177
+++HS ++HRD+KP N+ I+A
Sbjct: 120 EHMHSRRVMHRDIKPANVFITA 141
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 38/139 (27%), Positives = 66/139 (47%), Gaps = 12/139 (8%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVM---KKDEMINKNMVSQVLRERNALA 97
+E + + G++G V K +K+ Q+ AIK + D+M+ K +RE L
Sbjct: 3 YENLGLVGEGSYGMVM---KCKHKETGQIVAIKKFLESEDDKMVKK----IAMREIRMLK 55
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
V L + ++LV E++ + L L E Y +++ +++
Sbjct: 56 QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEF 115
Query: 158 LHSHGIIHRDLKPDNMLIS 176
HSH IIHRD+KP+N+L+S
Sbjct: 116 CHSHNIIHRDIKPENILVS 134
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 13/139 (9%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQ--LYAIKVM--KKDEMINKNMVSQVLRERNALAL 98
+EI+ + GAFGKV YK NK+ L A KV+ K +E + MV E + LA
Sbjct: 7 WEIIGELGDGAFGKV---YKAQNKETGVLAAAKVIDTKSEEELEDYMV-----EIDILAS 58
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLALQY 157
P V+L + + +++++E+ GG V + ++ L E + + AL Y
Sbjct: 59 CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNY 118
Query: 158 LHSHGIIHRDLKPDNMLIS 176
LH + IIHRDLK N+L +
Sbjct: 119 LHENKIIHRDLKAGNILFT 137
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 41/136 (30%), Positives = 67/136 (49%), Gaps = 17/136 (12%)
Query: 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVM------KKDEMINKNMVSQVLRERNALALT 99
+ I +GA G V+ ++ AIK M KK+ +IN+ +V +RE
Sbjct: 24 FEKIGQGASGTVYTAIDVATGQEV-AIKQMNLQQQPKKELIINEILV---MRENK----- 74
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
P V S +++VMEY+ GG + ++ + E A E + AL++LH
Sbjct: 75 -HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLH 132
Query: 160 SHGIIHRDLKPDNMLI 175
S+ +IHRD+K DN+L+
Sbjct: 133 SNQVIHRDIKSDNILL 148
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 39/144 (27%), Positives = 67/144 (46%), Gaps = 6/144 (4%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMK--KDEMINKNMVSQVLRERNAL--ALTHSP 102
+ + GAF + + L A+K + ++ + V + LR+ L L H P
Sbjct: 6 QQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH-P 63
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
+++ + S L +E+M GG V L++ GA E + Y +++ L YLH +
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 163 IIHRDLKPDNMLISAQAPHCPIVN 186
IIHRD+K N+LI + I +
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIAD 147
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 10/145 (6%)
Query: 44 EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPF 103
++VK + G FG+V++GY + AIK +K+ M L E N + P
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGH--TKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPR 62
Query: 104 CVQLFYSLQTSSCVFLVMEYMIGGD-VKSLIAANGA-LPEDMAAFYAAEVVLALQYLHSH 161
V+L Y++ T ++++ EYM G V L G L + AA++ + ++
Sbjct: 63 LVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK 121
Query: 162 GIIHRDLKPDNMLISAQAPHCPIVN 186
IHRDL+ N+L+S + C I +
Sbjct: 122 NYIHRDLRAANILVS-ETLCCKIAD 145
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 38/140 (27%), Positives = 68/140 (48%), Gaps = 12/140 (8%)
Query: 42 DFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKN--MVSQVLRERNALAL 98
D+ ++ I G +G V+ G KKT + I MKK + ++ + S +RE + L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQ-----IVAMKKIRLESEEEGVPSTAIREISLLKE 55
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSL---IAANGALPEDMAAFYAAEVVLAL 155
P V L L S ++L+ E++ D+K + + ++ Y +++ +
Sbjct: 56 LQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 156 QYLHSHGIIHRDLKPDNMLI 175
+ HS ++HRDLKP N+LI
Sbjct: 115 LFCHSRRVLHRDLKPQNLLI 134
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 66/276 (23%), Positives = 113/276 (40%), Gaps = 45/276 (16%)
Query: 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA-------LAL 98
V+ + +G++G+V L +T+ Q Y IK + N+ + RER A L+
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQ-YVIKKL--------NLRNASRRERKAAEQEAQLLSQ 55
Query: 99 THSPFCVQLFYSLQTSSC-VFLVMEYMIGGDV-KSLIAANGAL-PEDMAAFYAAEVVLAL 155
P V S + +++VM + GGD+ L G L PE+ + ++ +AL
Sbjct: 56 LKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTP----- 210
QYLH I+HRDLK N+ ++ I+ L I + +++ + GTP
Sbjct: 116 QYLHEKHILHRDLKTQNVFLT----RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSP 171
Query: 211 -----NAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265
+N ++ L T + N++ R+ ++P
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP---------PM 222
Query: 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLP 301
P+D +P E I +L P +RPS + R P
Sbjct: 223 PKD---YSPELGELIATMLSKRPEKRPSVKSILRQP 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 37/142 (26%), Positives = 61/142 (42%), Gaps = 11/142 (7%)
Query: 39 EISDFEIVKA--ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
I+ E+ I +G FG V LG + K A+K +K D L E + +
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDYRGQK---VAVKCLKDDS----TAAQAFLAEASVM 54
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLA 154
P VQL + + +++V EYM G + + + G + +A +V
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 155 LQYLHSHGIIHRDLKPDNMLIS 176
++YL +HRDL N+L+S
Sbjct: 115 MEYLEEKNFVHRDLAARNVLVS 136
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 44/147 (29%), Positives = 72/147 (48%), Gaps = 20/147 (13%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
+++FE + I G +G V+ T+ + + A+K ++ D + +S LRE L
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIV-ALKKVRMDNERDGIPISS-LREITLLLNL 63
Query: 100 HSPFCVQLFYSLQTSS--CVFLVMEYMIGGDVKSLIAANGALPEDMAA-FYAAEV----- 151
P V+L + +FLVMEY D+ SL+ ++M F ++V
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEY-CEQDLASLL-------DNMPTPFSESQVKCLML 115
Query: 152 --VLALQYLHSHGIIHRDLKPDNMLIS 176
+ LQYLH + IIHRDLK N+L++
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLT 142
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 33/137 (24%), Positives = 60/137 (43%), Gaps = 7/137 (5%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
+F + + + G FG+V+ G K AIK++K D+++ + +E AL
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVR--VAIKILKSDDLLKQQDFQ---KEVQALKRLR 60
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAF--YAAEVVLALQYL 158
+ LF V+++ E M G + + + + +A+ A +V + YL
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 159 HSHGIIHRDLKPDNMLI 175
IHRDL N+L+
Sbjct: 121 EEQNSIHRDLAARNILV 137
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 37/143 (25%), Positives = 62/143 (43%), Gaps = 12/143 (8%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ-VLRERNALALT 99
++ + I GA+G V K ++ AIK K Q LRE L
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKV-AIK---KISPFEHQTFCQRTLREIKILRRF 60
Query: 100 H-----SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLA 154
+ S ++ + V++V E M D+ LI L D ++ +++
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQ-HLSNDHIQYFLYQILRG 118
Query: 155 LQYLHSHGIIHRDLKPDNMLISA 177
L+Y+HS ++HRDLKP N+L++
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNT 141
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 8e-09
Identities = 42/140 (30%), Positives = 73/140 (52%), Gaps = 11/140 (7%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKK--DEMINKNMVSQVLRERNAL-ALT 99
+EI++ + +GA+G V+ + K+ + +KK D N + RE L L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKE----VVALKKIFDAFRNATDAQRTFREIMFLQELG 64
Query: 100 HSPFCVQLF--YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
P V+L + ++LV EYM D+ ++I AN L + + +++ AL+Y
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVIRAN-ILEDVHKRYIMYQLLKALKY 122
Query: 158 LHSHGIIHRDLKPDNMLISA 177
+HS +IHRDLKP N+L+++
Sbjct: 123 IHSGNVIHRDLKPSNILLNS 142
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 39/136 (28%), Positives = 71/136 (52%), Gaps = 6/136 (4%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
+E ++ I G +G VF K N++ ++ A+K ++ D+ ++ + S LRE L
Sbjct: 2 YEKLEKIGEGTYGTVF---KAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK 57
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
V+L+ L + + LV EY K + NG + ++ + +++ L + HS
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 161 HGIIHRDLKPDNMLIS 176
H ++HRDLKP N+LI+
Sbjct: 118 HNVLHRDLKPQNLLIN 133
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 36/137 (26%), Positives = 69/137 (50%), Gaps = 9/137 (6%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LTHS 101
F+ ++ + G + V+ G +T ++ A+K + D + S +RE + + L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTT-GEIVALKEIHLDA--EEGTPSTAIREISLMKELKH- 57
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG---ALPEDMAAFYAAEVVLALQYL 158
V+L + T + + LV EYM D+K + +G AL + + +++ + +
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 159 HSHGIIHRDLKPDNMLI 175
H + ++HRDLKP N+LI
Sbjct: 117 HENRVLHRDLKPQNLLI 133
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 38/137 (27%), Positives = 71/137 (51%), Gaps = 9/137 (6%)
Query: 43 FEIVKAISRGAFGKVFLGYKK-TNKD-QLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
+E V+ I G +G V+ + TN+ L I++ ++DE + S +RE + L
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE----GVPSTAIREISLLKEMQ 59
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPED--MAAFYAAEVVLALQYL 158
V+L + + ++LV EY+ D+K + ++ ++ + Y +++ + Y
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 159 HSHGIIHRDLKPDNMLI 175
HSH ++HRDLKP N+LI
Sbjct: 119 HSHRVLHRDLKPQNLLI 135
|
Length = 294 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 40/140 (28%), Positives = 74/140 (52%), Gaps = 8/140 (5%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
++I + I +G++G V T+ + AIK + D + + +++LRE L L P
Sbjct: 2 YKIQEVIGKGSYG-VVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 59
Query: 103 FCVQLFYSLQTSSC-----VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
V++ + + S +++V E M D+ +I AN L + F+ +++ AL+Y
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118
Query: 158 LHSHGIIHRDLKPDNMLISA 177
+H+ + HRDLKP N+L +A
Sbjct: 119 IHTANVFHRDLKPKNILANA 138
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 36/126 (28%), Positives = 67/126 (53%), Gaps = 9/126 (7%)
Query: 51 RGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYS 110
R A K+ L ++ K L IK++++ + + N+V + L + S + S
Sbjct: 32 RVAVKKIVLTDPQSVKHALREIKIIRR--LDHDNIV----KVYEVLGPSGSDLTEDV-GS 84
Query: 111 LQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKP 170
L + V++V EYM D+ +++ G L E+ A + +++ L+Y+HS ++HRDLKP
Sbjct: 85 LTELNSVYIVQEYM-ETDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKP 142
Query: 171 DNMLIS 176
N+ I+
Sbjct: 143 ANVFIN 148
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 17/146 (11%)
Query: 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDE----MINKNMVSQVLRE 92
A + + ++++ I +G FG V LG + NK A+K +K D + + V LR
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNK---VAVKCIKNDATAQAFLAEASVMTQLRH 58
Query: 93 RNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAE 150
N + L L ++ +++V EYM G + + + G L D ++ +
Sbjct: 59 SNLVQL--------LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 110
Query: 151 VVLALQYLHSHGIIHRDLKPDNMLIS 176
V A++YL ++ +HRDL N+L+S
Sbjct: 111 VCEAMEYLEANNFVHRDLAARNVLVS 136
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 27/94 (28%), Positives = 53/94 (56%), Gaps = 1/94 (1%)
Query: 87 SQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAF 146
+Q++RE L +SP+ V + + + + + ME+M GG + ++ +PE++
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 107
Query: 147 YAAEVVLALQYL-HSHGIIHRDLKPDNMLISAQA 179
+ V+ L YL H I+HRD+KP N+L++++
Sbjct: 108 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG 141
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 7/137 (5%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
D + + + G G V+ Y + ++ A+KV+ D I + Q++ E L S
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTR-RILAVKVIPLD--ITVELQKQIMSELEILYKCDS 58
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
P+ + + + + + + E+M GG + +PE + A VV L YL S
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSLD----VYRKIPEHVLGRIAVAVVKGLTYLWSL 114
Query: 162 GIIHRDLKPDNMLISAQ 178
I+HRD+KP NML++ +
Sbjct: 115 KILHRDVKPSNMLVNTR 131
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 35/133 (26%), Positives = 61/133 (45%), Gaps = 3/133 (2%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQ-LYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCV 105
+ G FG V G K K + A+K++K D + + ++LRE N + +P+ V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIV 59
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIH 165
++ + S + LVME G + + N + E +V + ++YL +H
Sbjct: 60 RMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118
Query: 166 RDLKPDNMLISAQ 178
RDL N+L+ Q
Sbjct: 119 RDLAARNVLLVTQ 131
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKD--QLYAIK--VMKKDEMINKNMVSQVLRERNALAL 98
+E + I G++G VF K N++ Q+ AIK V +D+ + K + LRE L
Sbjct: 3 YEKLSKIGEGSYGVVF---KCRNRETGQIVAIKKFVESEDDPVIKKIA---LREIRMLKQ 56
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
P V L + + LV EY + L +PE + + + A+ +
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 159 HSHGIIHRDLKPDNMLISAQ 178
H H IHRD+KP+N+LI+ Q
Sbjct: 117 HKHNCIHRDVKPENILITKQ 136
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 5e-08
Identities = 41/139 (29%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 47 KAISRGAFGKVF------LGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
+ I +GA G VF G + K Q+ K KK+ +IN+ +V + L+
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIK-QINLQKQPKKELIINEILVMKELK--------- 74
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
+P V S +F+VMEY+ GG + ++ + E A E + AL++LH+
Sbjct: 75 NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHA 133
Query: 161 HGIIHRDLKPDNMLISAQA 179
+ +IHRD+K DN+L+
Sbjct: 134 NQVIHRDIKSDNVLLGMDG 152
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 37/134 (27%), Positives = 64/134 (47%), Gaps = 3/134 (2%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+E ++ + G++ V+ G K N +L A+KV++ E + +RE + L
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVN-GKLVALKVIRLQE--EEGTPFTAIREASLLKGLKHA 63
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
V L + T + LV EY+ + + G L + + +++ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 163 IIHRDLKPDNMLIS 176
I+HRDLKP N+LIS
Sbjct: 124 ILHRDLKPQNLLIS 137
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 70/327 (21%), Positives = 113/327 (34%), Gaps = 62/327 (18%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
I K + +K TN L A+K + D +K + + +E
Sbjct: 1 ELLTLIGKCFEDLMIVHLAK-HKPTNT--LVAVKKINLDSC-SKEDLKLLQQEIITSRQL 56
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQY 157
P + S S +++V M G + L+ + LPE AF +V+ AL Y
Sbjct: 57 QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDY 116
Query: 158 LHSHGIIHRDLKPDNMLISA----------------------QAPHCP----IVNTLFLA 191
+HS G IHR +K ++L+S + H + N +L+
Sbjct: 117 IHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 192 --ILQQPIV-YLEISD----------LVNGTPNAFNIRTPGQLLSLKTGTFP------TF 232
+LQQ + Y E SD L NG ++ LL GT P T+
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236
Query: 233 QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRP 292
++S + S+ ++ + + + L+ DP RP
Sbjct: 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYT---------RTFSEHFHQFVELCLQRDPESRP 287
Query: 293 SGHQVRRLPMFKDYDW--DSILDQEPP 317
S Q+ FK S+LD P
Sbjct: 288 SASQLLNHSFFKQCKRRNTSLLDLLKP 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 34/147 (23%), Positives = 64/147 (43%), Gaps = 17/147 (11%)
Query: 46 VKAISRGAFGKVFLGYKK----TNKDQLYAIKVM-KKDEMINKNMVSQVLRERNALALTH 100
+ + RG FG+VFL K + L +K + K + +N+ S+ RE +
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD---ENLQSEFRRELDMFRKLS 66
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAA---------FYAAEV 151
V+L + + ++++EY GD+K + A + E + ++
Sbjct: 67 HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 152 VLALQYLHSHGIIHRDLKPDNMLISAQ 178
L + +L + +HRDL N L+S+Q
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQ 153
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 36/134 (26%), Positives = 72/134 (53%), Gaps = 17/134 (12%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVM------KKDEMINKNMVSQVLRERNALALTHSP 102
I G+ G V + +K + Q+ A+K+M +++ + N+ ++ + + +N
Sbjct: 29 IGEGSTGIVCIAREKHSGRQV-AVKMMDLRKQQRRELLFNEVVIMRDYQHQNV------- 80
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
V+++ S ++++ME++ GG + I + L E+ A V+ AL YLHS G
Sbjct: 81 --VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQG 137
Query: 163 IIHRDLKPDNMLIS 176
+IHRD+K D++L++
Sbjct: 138 VIHRDIKSDSILLT 151
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 34/142 (23%), Positives = 72/142 (50%), Gaps = 5/142 (3%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
+++F I K I RG F +V+ + A+K ++ ++++ + ++E + L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDG-VPVALKKVQIFDLMDAKARADCIKEIDLLKQL 59
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI----AANGALPEDMAAFYAAEVVLAL 155
+ P ++ + S + + +V+E GD+ +I +PE Y ++ AL
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 156 QYLHSHGIIHRDLKPDNMLISA 177
+++HS ++HRD+KP N+ I+A
Sbjct: 120 EHMHSRRVMHRDIKPANVFITA 141
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 38 PEIS--DFEIVKAISRGAFGKVFLG-YKKTNKD-QLYAIKVMKKDEMINKNMVSQVLRER 93
PE+ +++A+ GAFG+V+ G Y+ + D + V E ++ S L E
Sbjct: 1 PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60
Query: 94 NALALTHSPFCVQLF-YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAA------- 145
++ + V+L S + F+++E M GGD+KS + N PE ++
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLP-RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 146 FYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP 180
F A +V +YL + IHRD+ N L++ + P
Sbjct: 120 FCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGP 154
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 21/61 (34%), Positives = 40/61 (65%), Gaps = 1/61 (1%)
Query: 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
V++V E M D+ +I ++ L +D ++ +++ L+Y+HS ++HRDLKP N+L++
Sbjct: 84 VYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN 142
Query: 177 A 177
A
Sbjct: 143 A 143
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 41/155 (26%), Positives = 63/155 (40%), Gaps = 11/155 (7%)
Query: 32 KSCLKAPEISD----------FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI 81
K +K PEI+D F + I G+FG V+ +++ A+K M
Sbjct: 2 KGVVKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHT-NEVVAVKKMSYSGKQ 60
Query: 82 NKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPE 141
+++E L P ++ +LVMEY +G L L E
Sbjct: 61 TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE 120
Query: 142 DMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
A + L YLHSH +IHRD+K N+L++
Sbjct: 121 VEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT 155
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 41/152 (26%), Positives = 65/152 (42%), Gaps = 11/152 (7%)
Query: 35 LKAPEISD----------FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN 84
LK PEI++ F ++ I G+FG V+ + +++ AIK M +
Sbjct: 9 LKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFA-RDVRTNEVVAIKKMSYSGKQSNE 67
Query: 85 MVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMA 144
+++E L P ++ +LVMEY +G L L E
Sbjct: 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI 127
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
A + L YLHSH +IHRD+K N+L++
Sbjct: 128 AAITHGALQGLAYLHSHNMIHRDIKAGNILLT 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 35/137 (25%), Positives = 66/137 (48%), Gaps = 17/137 (12%)
Query: 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMK--KDEMINKNMVSQV-----LRERNALAL 98
++ + GAFG V + + K+MK ++ K ++ LR N ++L
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
+ +F S ++ V E + G D+ L+ + L + ++ +++ L+Y+
Sbjct: 75 S------DIFISPLED--IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYV 124
Query: 159 HSHGIIHRDLKPDNMLI 175
HS G++HRDLKP N+LI
Sbjct: 125 HSAGVVHRDLKPSNILI 141
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 18/147 (12%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNK--DQLYAIKVMKKDEMINKNMVSQVLRERN-ALAL 98
D E+++ + RGA+G V K + + A+K ++ +N ++L + + ++
Sbjct: 2 DLEVIEELGRGAYGVV---DKMRHVPTGTIMAVKRIRAT--VNSQEQKRLLMDLDISMRS 56
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDV------KSLIAANGALPEDMAAFYAAEVV 152
P+ V + +L V++ ME M D K + +PED+ A +V
Sbjct: 57 VDCPYTVTFYGALFREGDVWICMEVM---DTSLDKFYKKVYDKGLTIPEDILGKIAVSIV 113
Query: 153 LALQYLHSH-GIIHRDLKPDNMLISAQ 178
AL+YLHS +IHRD+KP N+LI+
Sbjct: 114 KALEYLHSKLSVIHRDVKPSNVLINRN 140
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 42/145 (28%), Positives = 75/145 (51%), Gaps = 15/145 (10%)
Query: 37 APEISDFEIVKAISRGAFGKVF-LGYKKTNKDQLYAIKVM--KKDEMINKNMVSQVLRER 93
A +S+ E V I GA G V+ + ++ T + LYA+KV+ ++ + + Q+ RE
Sbjct: 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGR--LYALKVIYGNHEDTVRR----QICREI 123
Query: 94 NALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSL-IAANGALPEDMAAFYAAEVV 152
L + P V+ + + +++E+M GG ++ IA L A A +++
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFL-----ADVARQIL 178
Query: 153 LALQYLHSHGIIHRDLKPDNMLISA 177
+ YLH I+HRD+KP N+LI++
Sbjct: 179 SGIAYLHRRHIVHRDIKPSNLLINS 203
|
Length = 353 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 34/145 (23%), Positives = 67/145 (46%), Gaps = 7/145 (4%)
Query: 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQL---YAIKVMKKDEMINKNMVSQVLR 91
L+ + ++ E +K + GAFG V+ G +++ AIKV++++ N ++L
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN--KEILD 58
Query: 92 ERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAE 150
E +A P V+L + SS V L+ + M G + + + + + +
Sbjct: 59 EAYVMASVDHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ 117
Query: 151 VVLALQYLHSHGIIHRDLKPDNMLI 175
+ + YL ++HRDL N+L+
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLV 142
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 41/152 (26%), Positives = 76/152 (50%), Gaps = 25/152 (16%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIK------------VMKKDEMINKNMVSQV- 89
+ +++ + GAFG V+ KK N L A+K ++D+ I ++VS+V
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSI-GDIVSEVT 60
Query: 90 -LRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYM----IGGDVKSLIAANGALPEDMA 144
++E+ L H P V+ + + + +++VM+ + +G SL E+
Sbjct: 61 IIKEQ----LRH-PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI 115
Query: 145 AFYAAEVVLALQYLHSHG-IIHRDLKPDNMLI 175
++VLAL+YLH I+HRDL P+N+++
Sbjct: 116 WNIFVQMVLALRYLHKEKRIVHRDLTPNNIML 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 5/129 (3%)
Query: 52 GAFGKVFLGYKKTNKDQL-YAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYS 110
G FG V G K K Q+ AIKV+K + K++ +++RE + +P+ V++
Sbjct: 6 GNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGV 63
Query: 111 LQTSSCVFLVMEYMIGGDV-KSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLK 169
+ + + LVME GG + K L + +V + ++YL +HRDL
Sbjct: 64 CEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLA 122
Query: 170 PDNMLISAQ 178
N+L+ Q
Sbjct: 123 ARNVLLVNQ 131
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 12/137 (8%)
Query: 44 EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPF 103
++VK + G FG+V++GY N A+K +K M V L E N +
Sbjct: 9 KLVKKLGAGQFGEVWMGY--YNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDK 62
Query: 104 CVQLFYSLQTSSCVFLVMEYMIGGDV----KSLIAANGALPEDMAAFYAAEVVLALQYLH 159
V+L+ + ++++ EYM G + KS LP+ + ++A++ + Y+
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID--FSAQIAEGMAYIE 120
Query: 160 SHGIIHRDLKPDNMLIS 176
IHRDL+ N+L+S
Sbjct: 121 RKNYIHRDLRAANVLVS 137
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 33/129 (25%), Positives = 68/129 (52%), Gaps = 5/129 (3%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108
I G+ G V + +K Q+ K+ + + + + ++V+ R+ H V ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRD----YHHENVVDMY 85
Query: 109 YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168
S +++VME++ GG + ++ + + E+ A V+ AL YLH+ G+IHRD+
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDI 144
Query: 169 KPDNMLISA 177
K D++L+++
Sbjct: 145 KSDSILLTS 153
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 40/148 (27%), Positives = 62/148 (41%), Gaps = 18/148 (12%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
EI ++ + + G FG+V++G N A+K +K M L+E +
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGT--WNGTTKVAVKTLKPGTM----SPEAFLQEAQIM 55
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDV----KSLIAANGALPE--DMAAFYAAE 150
VQL+ +++V EYM G + KS LP+ DMAA +
Sbjct: 56 KKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA----Q 111
Query: 151 VVLALQYLHSHGIIHRDLKPDNMLISAQ 178
+ + YL S IHRDL N+L+
Sbjct: 112 IAEGMAYLESRNYIHRDLAARNILVGEN 139
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 5e-07
Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 17/135 (12%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVM------KKDEMINKNMVSQVLRERNALALTH 100
+ I +GA G V+ ++ AI+ M KK+ +IN+ +V +RE
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEV-AIRQMNLQQQPKKELIINEILV---MRENK------ 75
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
+P V S +++VMEY+ GG + ++ + E A E + AL++LHS
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS 134
Query: 161 HGIIHRDLKPDNMLI 175
+ +IHRD+K DN+L+
Sbjct: 135 NQVIHRDIKSDNILL 149
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 6e-07
Identities = 41/135 (30%), Positives = 67/135 (49%), Gaps = 17/135 (12%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVM------KKDEMINKNMVSQVLRERNALALTH 100
+ I +GA G V+ ++ AIK M KK+ +IN+ +V +RE
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEV-AIKQMNLQQQPKKELIINEILV---MRENK------ 74
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
+P V S +++VMEY+ GG + ++ + E A E + AL +LHS
Sbjct: 75 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHS 133
Query: 161 HGIIHRDLKPDNMLI 175
+ +IHRD+K DN+L+
Sbjct: 134 NQVIHRDIKSDNILL 148
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 39/149 (26%), Positives = 62/149 (41%), Gaps = 11/149 (7%)
Query: 38 PEISD----------FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVS 87
P++++ F ++ I G+FG V+ + ++ AIK M +
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 88 QVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFY 147
+++E L P +Q +LVMEY +G L L E A
Sbjct: 61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120
Query: 148 AAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
+ L YLHSH +IHRD+K N+L+S
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLS 149
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 31/127 (24%), Positives = 55/127 (43%), Gaps = 7/127 (5%)
Query: 52 GAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSL 111
G +G+V+ G K A+K +K+D M V + L+E + P VQL
Sbjct: 17 GQYGEVYEGVWKKY-SLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 112 QTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLK 169
+++ E+M G++ + + + + A ++ A++YL IHRDL
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 131
Query: 170 PDNMLIS 176
N L+
Sbjct: 132 ARNCLVG 138
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 10/147 (6%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
+ D+EI+ + G FG+V+ + + K++ +E LRE L
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKL 64
Query: 100 HSPFCVQL---FY-----SLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEV 151
P V L S + V++V YM L + L E Y ++
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 152 VLALQYLHSHGIIHRDLKPDNMLISAQ 178
+ + YLH + I+HRD+K N+LI Q
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDNQ 151
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 38/142 (26%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 41 SDFEIVKAISRGAFGKVF-LGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-AL 98
D + + I RGAFG V + +K + + A+K ++ + K ++L + + +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGT--IMAVKRIRS-TVDEKEQ-KRLLMDLDVVMRS 59
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYM-IGGDVKSLIA---ANGALPEDMAAFYAAEVVLA 154
+ P+ V+ + +L ++ ME M I D +PE++ A V A
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 155 LQYL-HSHGIIHRDLKPDNMLI 175
L YL IIHRD+KP N+L+
Sbjct: 120 LNYLKEELKIIHRDVKPSNILL 141
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 25/64 (39%), Positives = 38/64 (59%), Gaps = 2/64 (3%)
Query: 110 SLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLK 169
SL+ V+LV M G D+ +++ L +D F +++ L+Y+HS GIIHRDLK
Sbjct: 88 SLEDFQDVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLK 145
Query: 170 PDNM 173
P N+
Sbjct: 146 PSNI 149
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 12/145 (8%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIK---VMKKDEMINKNMVSQVLRERNALALT 99
+E V I GA+GKVF N + A+K V +E + + + +V R+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 100 HSPFCVQLFYSLQTSSC-----VFLVMEYMIGGDVKSLI--AANGALPEDMAAFYAAEVV 152
H P V+LF S + LV E+ + D+ + + +P + +++
Sbjct: 63 H-PNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 153 LALQYLHSHGIIHRDLKPDNMLISA 177
L +LHSH ++HRDLKP N+L+++
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTS 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 41/134 (30%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKV--MKKDEMINKNMVSQVLRERNAL-ALTHSP 102
++ + G++ V+ G + N QL A+KV MK +E + + RE + L L H+
Sbjct: 10 LEKLGEGSYATVYKGISRIN-GQLVALKVISMKTEEGVPFTAI----REASLLKGLKHAN 64
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
V L + T + V EYM + +I G L + +++ L Y+H
Sbjct: 65 I-VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 163 IIHRDLKPDNMLIS 176
I+HRDLKP N+LIS
Sbjct: 124 ILHRDLKPQNLLIS 137
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 5/134 (3%)
Query: 47 KAISRGAFGKVFLGY--KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFC 104
K + G FG V G K+ K+ A+K +K++ + + LRE + +A P
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--AAGKKEFLREASVMAQLDHPCI 58
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGII 164
V+L + + LVME G + + +P A +V + + YL S +
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 165 HRDLKPDNMLISAQ 178
HRDL N+L+ +
Sbjct: 118 HRDLAARNVLLVNR 131
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 43/139 (30%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMV--SQVLRERNALAL 98
S+ +V+ I G FG V+LGY K ++ AIK +++ M ++ + +QV+ + L
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKV-AIKTIREGAMSEEDFIEEAQVM-----MKL 56
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLALQY 157
+H P VQL+ S + LV E+M G + L A G ++ +V + Y
Sbjct: 57 SH-PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAY 115
Query: 158 LHSHGIIHRDLKPDNMLIS 176
L S +IHRDL N L+
Sbjct: 116 LESSNVIHRDLAARNCLVG 134
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 37/138 (26%), Positives = 65/138 (47%), Gaps = 7/138 (5%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
S+ +K + G FG V LG + AIK + + M ++ + + + + L+H
Sbjct: 4 SELTFMKELGSGQFGVVHLGKWRAQIK--VAIKAINEGAMSEEDFIEEA---KVMMKLSH 58
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLH 159
P VQL+ +++V E+M G + + + G L +DM +V ++YL
Sbjct: 59 -PKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 160 SHGIIHRDLKPDNMLISA 177
+ IHRDL N L+S+
Sbjct: 118 RNSFIHRDLAARNCLVSS 135
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 20/72 (27%), Positives = 36/72 (50%), Gaps = 3/72 (4%)
Query: 263 LEWPEDEEALNPSTEET---ILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFV 319
L+ P ++ ++E I L+ + S ++ P FK+ DW+ + + +PPFV
Sbjct: 217 LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFV 276
Query: 320 PQPDDVFDTSYF 331
P+ + DT YF
Sbjct: 277 PELESEIDTGYF 288
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 23/58 (39%), Positives = 33/58 (56%), Gaps = 4/58 (6%)
Query: 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
+VMEY+ G +K LI +NG + + E+ + LHS GIIH DL NM++S
Sbjct: 76 IVMEYIEGEPLKDLINSNGMEELE----LSREIGRLVGKLHSAGIIHGDLTTSNMILS 129
|
Length = 211 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 32/129 (24%), Positives = 55/129 (42%), Gaps = 5/129 (3%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108
I +G FG V+ G K N + A+K + + ++ + L+E L P V+L
Sbjct: 3 IGKGNFGDVYKGVLKGNTE--VAVKTCRST--LPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 109 YSLQTSSCVFLVMEYMIGGDVKSLIAANGA-LPEDMAAFYAAEVVLALQYLHSHGIIHRD 167
+++VME + GG + + + L + + ++YL S IHRD
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 168 LKPDNMLIS 176
L N L+
Sbjct: 119 LAARNCLVG 127
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 263 LEWPEDEEALNPSTEETILALLKSDPTQR---PSGHQVRRLPMFKDYDWDSILDQEPPFV 319
L +P+D L+ E+ I L+ ++ R H+++ P F+ DWD+I PF+
Sbjct: 267 LYFPDDIH-LSVEAEDLIRRLI-TNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPFI 324
Query: 320 PQPDDVFDTSYFHADKTNSYMDSTL 344
PQ + DTSYF D+ ++
Sbjct: 325 PQLKSITDTSYFPTDELEQVPEAPA 349
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 24/59 (40%), Positives = 37/59 (62%), Gaps = 2/59 (3%)
Query: 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
+LVM +M G D+ L+ L ED F +++ L+Y+H+ GIIHRDLKP N+ ++
Sbjct: 96 YLVMPFM-GTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN 152
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 34/143 (23%), Positives = 57/143 (39%), Gaps = 13/143 (9%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMK-----KDEMINKNMVSQV------LRERNA 95
+ G +GKV Y T ++ AIK +K D ++ +V LRE
Sbjct: 15 AHLGEGTYGKVEKAYD-TLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
+ + L + LVM+ M D+K ++ L E +++ L
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 156 QYLHSHGIIHRDLKPDNMLISAQ 178
LH +HRDL P N+ I+++
Sbjct: 133 NVLHKWYFMHRDLSPANIFINSK 155
|
Length = 335 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 41 SDFEIVKAISRGAFGKVFLG-YKKTNKDQL-YAIKVMKKD--EMINKNMVSQVLRERNAL 96
D + + I G FG V+ G Y +++ A+K K + + + + R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ-- 63
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLAL 155
H P V+L + T + V++VME G+++S + N +L Y+ ++ AL
Sbjct: 64 -FDH-PHIVKLI-GVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHC 182
YL S +HRD+ N+L+S +P C
Sbjct: 121 AYLESKRFVHRDIAARNVLVS--SPDC 145
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 37/139 (26%), Positives = 63/139 (45%), Gaps = 20/139 (14%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108
I RG FG+VF G + + + A+K + E + ++ ++ L+E L P V+L
Sbjct: 3 IGRGNFGEVFSGRLRAD-NTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 109 YSLQTSSCVFLVMEYMIGGDVKSLIAANGA---------LPEDMAAFYAAEVVLALQYLH 159
+++VME + GGD + + G + E+ AA ++YL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAA--------GMEYLE 111
Query: 160 SHGIIHRDLKPDNMLISAQ 178
S IHRDL N L++ +
Sbjct: 112 SKHCIHRDLAARNCLVTEK 130
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 36/137 (26%), Positives = 68/137 (49%), Gaps = 5/137 (3%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN-MVSQVLRERNALALTHS 101
+++ I G+FG V+ +++ KV++ + N+ ++ + L N + L
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 102 PFCVQLFYSLQTSSCVFLVMEYM---IGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
+ + F + + + +VME++ + +K N ALP + Y+ ++ AL Y+
Sbjct: 128 -YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 159 HSHGIIHRDLKPDNMLI 175
HS I HRDLKP N+LI
Sbjct: 187 HSKFICHRDLKPQNLLI 203
|
Length = 440 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 39/153 (25%), Positives = 77/153 (50%), Gaps = 10/153 (6%)
Query: 29 DVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKK--DEMINKNMV 86
+++K+ + PE ++ + + GA+G V Y T Q A+K + + +I+
Sbjct: 5 ELNKTVWEVPE--RYQNLTPVGSGAYGSVCSAYD-TRLRQKVAVKKLSRPFQSLIHARRT 61
Query: 87 SQVLRERNALALTHSPFCVQLFY---SLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDM 143
+ LR + + + +F S++ + V+LV M G D+ +++ L ++
Sbjct: 62 YRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ-KLSDEH 119
Query: 144 AAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
F +++ L+Y+HS GIIHRDLKP N+ ++
Sbjct: 120 VQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN 152
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 23/66 (34%), Positives = 37/66 (56%), Gaps = 3/66 (4%)
Query: 110 SLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLK 169
SL+ V+LVME M D L + ++ +++ +++LHS GIIHRDLK
Sbjct: 89 SLEEFQDVYLVMELM---DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 145
Query: 170 PDNMLI 175
P N+++
Sbjct: 146 PSNIVV 151
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 12/141 (8%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVS--QVLRERNALALT 99
D E + I GAFG V+ + ++ A+K M + +N+VS +V RE L
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRV-ALKKMPN---VFQNLVSCKRVFRELKMLCFF 56
Query: 100 HSPFCVQLFYSLQTSSC-----VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLA 154
+ LQ +++V E M D+ +I + L D + +++
Sbjct: 57 KHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 155 LQYLHSHGIIHRDLKPDNMLI 175
L+YLHS GI+HRD+KP N+L+
Sbjct: 116 LKYLHSAGILHRDIKPGNLLV 136
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 22/74 (29%), Positives = 33/74 (44%), Gaps = 3/74 (4%)
Query: 280 ILALLKSDPTQR-PSGHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDTSYF-HADKTN 337
I LL DP R S +++ P FK DW+++ + +PPFVP+ DTS F +
Sbjct: 265 ICRLL-CDPEDRLGSFEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDTSNFDDFEDDK 323
Query: 338 SYMDSTLSTTHGNG 351
D +
Sbjct: 324 DLSDYLSQNSKKLN 337
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 19/72 (26%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 263 LEWPEDEEALNPSTEETILALLKSDPTQR---PSGHQVRRLPMFKDYDWDSILDQEPPFV 319
L++P++ L+P ++ I L + +R ++++ P FK DW+ I ++ P +
Sbjct: 258 LQFPDEVP-LSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPII 315
Query: 320 PQPDDVFDTSYF 331
P+ + DTS F
Sbjct: 316 PELKSITDTSNF 327
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 35/138 (25%), Positives = 58/138 (42%), Gaps = 16/138 (11%)
Query: 44 EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPF 103
++++ + G FG+V+ G N A+K +K M L E + P
Sbjct: 9 QLLRKLGAGQFGEVWEGL--WNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPK 62
Query: 104 CVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGA----LPE--DMAAFYAAEVVLALQY 157
+QL+ +++V E M G + + LP+ DMAA +V + Y
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA----QVASGMAY 118
Query: 158 LHSHGIIHRDLKPDNMLI 175
L + IHRDL N+L+
Sbjct: 119 LEAQNYIHRDLAARNVLV 136
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 24/67 (35%), Positives = 40/67 (59%), Gaps = 2/67 (2%)
Query: 110 SLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLK 169
SL+ + V+LV M G D+ +++ L +D F +++ L+Y+HS IIHRDLK
Sbjct: 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 147
Query: 170 PDNMLIS 176
P N+ ++
Sbjct: 148 PSNLAVN 154
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 37/153 (24%), Positives = 73/153 (47%), Gaps = 32/153 (20%)
Query: 43 FEIVKAISRGAFGKVF-LGYKKTNKDQLYAIKVMKKDEMINKNMVSQ-VLRE-------- 92
+E++K + +GA+G V +T++++ AIK K + +K ++++ LRE
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIK--KITNVFSKKILAKRALRELKLLRHFR 59
Query: 93 --RNALAL------THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMA 144
+N L F + ++L E M D+ +I + L +
Sbjct: 60 GHKNITCLYDMDIVFPGNF-----------NELYLYEELM-EADLHQIIRSGQPLTDAHF 107
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177
+ +++ L+Y+HS ++HRDLKP N+L++A
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA 140
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 37/160 (23%), Positives = 72/160 (45%), Gaps = 21/160 (13%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+ ++K ++ G+ G+VF+ K D + +K+ +K + + M+ Q + + + + +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPV-VLKIGQKGTTLIEAMLLQNVNHPSVIRMKDT- 125
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSH 161
L T C+ L D+ + + LP D A +++ L+YLH+
Sbjct: 126 ----LVSGAIT--CMVLPH---YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ 176
Query: 162 GIIHRDLKPDNMLISAQ---------APHCPIVNTLFLAI 192
IIHRD+K +N+ I+ A P+V FL +
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216
|
Length = 357 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 34/137 (24%), Positives = 62/137 (45%), Gaps = 7/137 (5%)
Query: 45 IVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM--INKNMVSQVLRERNALALTHSP 102
+ + + +G+FG V+L K +KV+K+ + +N N Q +E L+ P
Sbjct: 4 LQQRLGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGD----VKSLIAANGALPEDMAAFYAAEVVLALQYL 158
V+ S ++ EY G D ++ L L E+ + +++L + Y+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 159 HSHGIIHRDLKPDNMLI 175
H I+HRDLK N+ +
Sbjct: 123 HQRRILHRDLKAKNIFL 139
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 36/138 (26%), Positives = 59/138 (42%), Gaps = 7/138 (5%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
D +K + G FG V G + D AIK++K+ M + + + + L+H
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEA---KVMMKLSH- 58
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAF-YAAEVVLALQYLHS 160
VQL+ +++V EYM G + + + +G + +V + YL S
Sbjct: 59 EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES 118
Query: 161 HGIIHRDLKPDNMLISAQ 178
IHRDL N L+ Q
Sbjct: 119 KQFIHRDLAARNCLVDDQ 136
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 42/171 (24%), Positives = 72/171 (42%), Gaps = 47/171 (27%)
Query: 40 ISDFEIVKAISRGAFGKVFL------------------GYKKTNKDQLYAIKVMKKDEMI 81
++++E++K I G FG+VFL G K+ K QL I+V E+
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQL-VIEVNVMRELK 70
Query: 82 NKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN----G 137
+KN+V + R N + + ++++ME+ GD+ I G
Sbjct: 71 HKNIVRYIDRFLN-----------------KANQKLYILMEFCDAGDLSRNIQKCYKMFG 113
Query: 138 ALPEDMAAFYAAEVVLALQYLHS-------HGIIHRDLKPDNMLISAQAPH 181
+ E +++ AL Y H+ ++HRDLKP N+ +S H
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164
|
Length = 1021 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 38/156 (24%), Positives = 57/156 (36%), Gaps = 23/156 (14%)
Query: 42 DFEIVKAISRGAFGKVFLG----YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
D + + + GAFGKVFL T L A+K +K + + RE L
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLT 62
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAA----------------NGALPE 141
V+ + + +V EYM GD+ + A G L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 142 DMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177
A+++ + YL S +HRDL N L+ A
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 34/134 (25%), Positives = 65/134 (48%), Gaps = 11/134 (8%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHSPFCV 105
K + G FG+V++ NK A+K MK M V L E N + L H V
Sbjct: 12 KKLGAGQFGEVWMA--TYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKL-V 64
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAF--YAAEVVLALQYLHSHGI 163
+L +++ T ++++ E+M G + + ++ + + ++A++ + ++
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 123
Query: 164 IHRDLKPDNMLISA 177
IHRDL+ N+L+SA
Sbjct: 124 IHRDLRAANILVSA 137
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 35/154 (22%), Positives = 55/154 (35%), Gaps = 18/154 (11%)
Query: 40 ISDFEIVKAISRGAFGKVFLG--YKKTNKD--QLYAIKVMKK-------DEMINKNMVSQ 88
+S ++ + GAFGKV+ G + AIK +K+ E + +
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63
Query: 89 VLRERNALAL-----THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDM 143
L+ N + L P C+ Y FLV D
Sbjct: 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 144 AAFY--AAEVVLALQYLHSHGIIHRDLKPDNMLI 175
+ F A ++ ++YL SH +HRDL N L+
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 34/134 (25%), Positives = 69/134 (51%), Gaps = 17/134 (12%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVM------KKDEMINKNMVSQVLRERNALALTHSP 102
I G+ G V + K++ +L A+K M +++ + N+ ++ + + N
Sbjct: 28 IGEGSTGIVCIATVKSS-GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV------- 79
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
V+++ S +++VME++ GG + I + + E+ A V+ AL LH+ G
Sbjct: 80 --VEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQG 136
Query: 163 IIHRDLKPDNMLIS 176
+IHRD+K D++L++
Sbjct: 137 VIHRDIKSDSILLT 150
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 37/149 (24%), Positives = 58/149 (38%), Gaps = 20/149 (13%)
Query: 45 IVKAISRGAFGKVFLG----YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
+ + + GAFGKVFLG + N +L A+K +K E + + RE L
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREAELLTNFQ 66
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGA--------------LPEDMAAF 146
V+ + +V EYM GD+ + ++G L
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 147 YAAEVVLALQYLHSHGIIHRDLKPDNMLI 175
A ++ + YL S +HRDL N L+
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLV 155
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 4e-05
Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 30/195 (15%)
Query: 49 ISRGAFGKVFLGYKKTNKDQL-YAIKVMKKDEMINKNMVSQV-----LRERNALALTHSP 102
+ RG +G V+ +K KD+ YA+K ++ I+ + ++ L+ N +AL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQ--- 64
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGA---------LPEDMAAFYAAEVVL 153
++F S + V+L+ +Y D+ +I + A LP M +++
Sbjct: 65 ---KVFLS-HSDRKVWLLFDYA-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQAPH---CPIVNTLFLAILQQPIVYLEISDLVNGTP 210
+ YLH++ ++HRDLKP N+L+ + P I + F + P+ L D V T
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT- 178
Query: 211 NAFNIRTPGQLLSLK 225
F R P LL +
Sbjct: 179 --FWYRAPELLLGAR 191
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 22/67 (32%), Positives = 31/67 (46%), Gaps = 7/67 (10%)
Query: 272 LNPSTEETILALLKSDPTQRPSG-----HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDD 324
L+P + + LLK DP QR G ++ F +W ++ + EPPF PQ
Sbjct: 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTS 277
Query: 325 VFDTSYF 331
DT YF
Sbjct: 278 ETDTRYF 284
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 23/59 (38%), Positives = 37/59 (62%), Gaps = 3/59 (5%)
Query: 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
+LVM YM D++ ++ L ED + +++ L+Y+HS GIIHRDLKP N+ ++
Sbjct: 96 YLVMPYMQT-DLQKIMGHP--LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN 151
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 12/139 (8%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQV--LRERNAL-ALTHSPF 103
K I G FGKV LG + N +V+ K+ ++ ++ Q+ L E +L HS
Sbjct: 1 KEIGNGWFGKVILG--EVNSG-YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNL 57
Query: 104 CVQLFYSLQTSSCVFLVMEYMIGGDVKSLI----AANGALPEDMA-AFYAAEVVLALQYL 158
+Q + LVME+ GD+K + A P+ A E+ L L +L
Sbjct: 58 -LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 159 HSHGIIHRDLKPDNMLISA 177
H + IH DL N L++A
Sbjct: 117 HKNNFIHSDLALRNCLLTA 135
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 34/156 (21%), Positives = 59/156 (37%), Gaps = 24/156 (15%)
Query: 47 KAISRGAFGKVFLGYKKT-----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
+ GAFG+V+ G + A+K ++K + + L+E + ++ +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNH 58
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAA------------ 149
P V+L + +++ME M GGD+ S + + F
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRD-----ARVERFGPPLLTLKELLDICL 113
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185
+V YL IHRDL N L+S + V
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRV 149
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 37/159 (23%), Positives = 66/159 (41%), Gaps = 22/159 (13%)
Query: 40 ISDFEIVKAISRGAFGKVFLGY---KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
+S ++ + AFGK++ G+ + QL AIK +K ++ N + +E + +
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLM 61
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-----------------AANGAL 139
A H P V L + V ++ EY+ GD+ + +L
Sbjct: 62 AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSL 121
Query: 140 PEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
A ++ ++YL SH +H+DL N+LI Q
Sbjct: 122 DHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 33/144 (22%), Positives = 54/144 (37%), Gaps = 24/144 (16%)
Query: 46 VKAISRGAFGKVFLGYKKTNKDQ---LYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+K + G FGKV L D A+K + + S RE L
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG--EEQHRSDFEREIEILRTLDHE 66
Query: 103 FCVQLFY--------SLQTSSCVFLVMEYMIGGDVKSLI---AANGALPEDMAAFYAAEV 151
V+ SL+ L+MEY+ G ++ + L + +++++
Sbjct: 67 NIVKYKGVCEKPGGRSLR------LIMEYLPSGSLRDYLQRHRDQINLKRLLL--FSSQI 118
Query: 152 VLALQYLHSHGIIHRDLKPDNMLI 175
+ YL S IHRDL N+L+
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILV 142
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 37/147 (25%), Positives = 59/147 (40%), Gaps = 17/147 (11%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQ--LYAIKVMKKDEMINKNMVSQVLRERNALAL 98
S I K I G FG+V G K + AIK +K + L E + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQ 61
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQ-- 156
P ++L + S V ++ EYM G + + L E+ F ++V L+
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENG------SLDKFLRENDGKFTVGQLVGMLRGI 115
Query: 157 -----YLHSHGIIHRDLKPDNMLISAQ 178
YL +HRDL N+L+++
Sbjct: 116 ASGMKYLSEMNYVHRDLAARNILVNSN 142
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 36/139 (25%), Positives = 66/139 (47%), Gaps = 15/139 (10%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLY--AIKVMKKDEMINKNMVSQVLRERNAL-ALTHSPF 103
K + G+FG V G T+ ++ A+K +K D++ +++ L+E + +L H
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDH-EN 57
Query: 104 CVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-----AANGALPEDMAAFYAAEVVLALQYL 158
++L Y + + + +V E G SL+ A G YA ++ ++YL
Sbjct: 58 LIRL-YGVVLTHPLMMVTELAPLG---SLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 159 HSHGIIHRDLKPDNMLISA 177
S IHRDL N+L+++
Sbjct: 114 ESKRFIHRDLAARNILLAS 132
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 21/57 (36%), Positives = 32/57 (56%), Gaps = 7/57 (12%)
Query: 282 ALLKSDPTQR-PSGHQ----VRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYF 331
LL+ +P +R SG + V++ P F+D +WD +L ++ PPFVP D S F
Sbjct: 234 RLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNF 290
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 37/152 (24%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 25 NSLCD-VSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK 83
C+ S S + + I+ +++ G+ G+VF+ K ++ + KV+ K K
Sbjct: 75 QEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRK---KVIVKAVTGGK 131
Query: 84 NMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDM 143
++ + ++H + L ++ + S V +VM D+ + + +G LP +
Sbjct: 132 TPGREIDILKT---ISHRAI-INLIHAYRWKSTVCMVMPKY-KCDLFTYVDRSGPLPLEQ 186
Query: 144 AAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI 175
A ++ AL YLH GIIHRD+K +N+ +
Sbjct: 187 AITIQRRLLEALAYLHGRGIIHRDVKTENIFL 218
|
Length = 392 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 35/140 (25%), Positives = 60/140 (42%), Gaps = 10/140 (7%)
Query: 47 KAISRGAFGKVFLG--YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFC 104
I G FGKV LG ++ +K ++ +K ++ ++ + L+E + P
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARV-VVKELRASATPDEQL--LFLQEVQPYRELNHPNV 57
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-----GALPEDMAAFYAAEVVLALQYLH 159
+Q S LV+E+ GD+K+ + +N +D+ A EV L +LH
Sbjct: 58 LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 160 SHGIIHRDLKPDNMLISAQA 179
IH DL N ++A
Sbjct: 118 QADFIHSDLALRNCQLTADL 137
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 39/141 (27%), Positives = 70/141 (49%), Gaps = 21/141 (14%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMV--SQVLRERNALALTH 100
+++K + G FG+V++G N + A+K +K M ++ + +Q++++ L H
Sbjct: 8 LQLIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKK-----LRH 60
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI----AANGALPE--DMAAFYAAEVVLA 154
VQL Y++ + +++V EYM G + + LP DMAA AA
Sbjct: 61 DKL-VQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA----G 114
Query: 155 LQYLHSHGIIHRDLKPDNMLI 175
+ Y+ IHRDL+ N+L+
Sbjct: 115 MAYIERMNYIHRDLRSANILV 135
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 35/148 (23%), Positives = 59/148 (39%), Gaps = 26/148 (17%)
Query: 49 ISRGAFGKVFLG----YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFC 104
+ GAFGKVFL L A+K +K+ +++ RE L +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTVLQHQHI 69
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG-----------------ALPEDMAAFY 147
V+ + + +V EYM GD+ + ++G L + +A
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI-- 127
Query: 148 AAEVVLALQYLHSHGIIHRDLKPDNMLI 175
A+++ + YL S +HRDL N L+
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLV 155
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 37/129 (28%), Positives = 61/129 (47%), Gaps = 7/129 (5%)
Query: 52 GAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHSPFCVQLFYS 110
G++ V+ G K QL A+K ++ + + +RE + L L H+ V L
Sbjct: 16 GSYATVYKGRSKLT-GQLVALKEIRLEH--EEGAPFTAIREASLLKDLKHANI-VTLHDI 71
Query: 111 LQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLK 169
+ T + LV EY+ D+K + G L + +++ L Y H ++HRDLK
Sbjct: 72 IHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLK 130
Query: 170 PDNMLISAQ 178
P N+LIS +
Sbjct: 131 PQNLLISER 139
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 7/130 (5%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LTHSPFCVQL 107
+ G + VF G K ++ L A+K ++ + + +RE + L L H+ V L
Sbjct: 13 LGEGTYATVFKGRSKLTEN-LVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANI-VTL 68
Query: 108 FYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPE-DMAAFYAAEVVLALQYLHSHGIIHR 166
+ T C+ LV EY+ D+K + G L + +++ L Y H I+HR
Sbjct: 69 HDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 167 DLKPDNMLIS 176
DLKP N+LI+
Sbjct: 128 DLKPQNLLIN 137
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 2e-04
Identities = 18/56 (32%), Positives = 28/56 (50%), Gaps = 7/56 (12%)
Query: 283 LLKSDPTQR-----PSGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYF 331
LL+ D T+R + ++ P F DW ++L + E PF+P+ DTS F
Sbjct: 232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 21/75 (28%), Positives = 35/75 (46%), Gaps = 2/75 (2%)
Query: 262 QLEWPEDEEALNPSTEETILALLKSDPTQ--RPSGHQVRRLPMFKDYDWDSILDQEPPFV 319
++P D ++ ++ I L+ S T+ R + P F+ DWD+I + P+V
Sbjct: 226 HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYV 285
Query: 320 PQPDDVFDTSYFHAD 334
P+ DTS F D
Sbjct: 286 PEVSSPTDTSNFDVD 300
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 22/62 (35%), Positives = 30/62 (48%), Gaps = 6/62 (9%)
Query: 283 LLKSDPTQRPSGH----QVRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYFHADKT 336
LL +P R H +++ P F D DWD + ++ PPF P D D S F + T
Sbjct: 232 LLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFT 291
Query: 337 NS 338
NS
Sbjct: 292 NS 293
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 48/192 (25%), Positives = 80/192 (41%), Gaps = 24/192 (12%)
Query: 49 ISRGAFGKVFLGYKKTNKD-QLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP--FCV 105
+ RG +G V+ +K KD + YA+K ++ + RE L P +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALK-----QIEGTGISMSACREIALLRELKHPNVISL 63
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGA---------LPEDMAAFYAAEVVLALQ 156
Q + V+L+ +Y D+ +I + A LP M +++ +
Sbjct: 64 QKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 157 YLHSHGIIHRDLKPDNMLISAQAPH---CPIVNTLFLAILQQPIVYLEISDLVNGTPNAF 213
YLH++ ++HRDLKP N+L+ + P I + F + P+ L D V T F
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT---F 179
Query: 214 NIRTPGQLLSLK 225
R P LL +
Sbjct: 180 WYRAPELLLGAR 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 37/129 (28%), Positives = 58/129 (44%), Gaps = 7/129 (5%)
Query: 49 ISRGAFGKVFLGYKKTNKDQL-YAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQL 107
+ +G FG+V +K T KD+ A+K K+D + + + + L E L P V+L
Sbjct: 3 LGKGNFGEV---FKGTLKDKTPVAVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKL 57
Query: 108 FYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLALQYLHSHGIIHR 166
+++VME + GGD S + L +A + + YL S IHR
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 167 DLKPDNMLI 175
DL N L+
Sbjct: 118 DLAARNCLV 126
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 38/163 (23%), Positives = 68/163 (41%), Gaps = 20/163 (12%)
Query: 29 DVSKSCLKAPEISD-----------FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKK 77
+ K C+ PE + + + + R F+ + ++ + KV+ K
Sbjct: 44 EAYKKCVDLPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRGSDPKE----KVVAK 99
Query: 78 DEMINKNMVSQVLR-ERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGD----VKSL 132
M+N + R E + LA V+ F ++ + L+MEY GGD +K
Sbjct: 100 FVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQR 159
Query: 133 IAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI 175
+ + E ++VLAL +HS ++HRDLK N+ +
Sbjct: 160 LKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL 202
|
Length = 478 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 12/91 (13%)
Query: 272 LNPSTEETILALLKSDPTQR----PS-GHQVRRLPMFKDYDWDSILDQ--EPPFVP---Q 321
L P + + LLK +P+ R P +V+ P F+ +WD +L + EPPF P
Sbjct: 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQS 282
Query: 322 PDDV--FDTSYFHADKTNSYMDSTLSTTHGN 350
+DV FD+ + +S DSTLS +
Sbjct: 283 EEDVSQFDSKFTRQTPVDSPDDSTLSESANQ 313
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 38/142 (26%), Positives = 67/142 (47%), Gaps = 12/142 (8%)
Query: 45 IVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI--NKNMVS---QVLRERNALALT 99
I + + GA G V L K+ + + +A+KV+ + M +KN L + ++
Sbjct: 36 ISRVLGSGATGTV-LCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIV 94
Query: 100 --HSPFCVQLFYSLQTSSCVFLVMEYMIGGD----VKSLIAANGALPEDMAAFYAAEVVL 153
H F + + + + LV++Y GD +KS N E A +V+L
Sbjct: 95 KCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154
Query: 154 ALQYLHSHGIIHRDLKPDNMLI 175
A+ ++HS +IHRD+K N+L+
Sbjct: 155 AVHHVHSKHMIHRDIKSANILL 176
|
Length = 496 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 38/141 (26%), Positives = 64/141 (45%), Gaps = 11/141 (7%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
++ +K I GA G V Y D+ AIK + + N+ + RE + +
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 76
Query: 103 FCVQLF------YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQ 156
+ L SL+ V+LVME M D L + ++ +++ ++
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELM---DANLCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 157 YLHSHGIIHRDLKPDNMLISA 177
+LHS GIIHRDLKP N+++ +
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKS 154
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 23/68 (33%), Positives = 39/68 (57%), Gaps = 3/68 (4%)
Query: 110 SLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLK 169
SL+ V+LVME M D + L + ++ +++ +++LHS GIIHRDLK
Sbjct: 94 SLEEFQDVYLVMELM---DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 150
Query: 170 PDNMLISA 177
P N+++ +
Sbjct: 151 PSNIVVKS 158
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 17/147 (11%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQ-----LYAIKVMKKDEMINKNMVSQVLRERNALA 97
+E V I GA+G V YK + L +++V ++ + + V +V + A
Sbjct: 2 YEPVAEIGVGAYGTV---YKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA 58
Query: 98 LTHSPFCVQLFYSLQTSSC-----VFLVMEYMIGGDVKSLI--AANGALPEDMAAFYAAE 150
H P V+L TS V LV E+ + D+++ + LP + +
Sbjct: 59 FDH-PNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 151 VVLALQYLHSHGIIHRDLKPDNMLISA 177
+ L +LH++ I+HRDLKP+N+L+++
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTS 143
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 4e-04
Identities = 13/30 (43%), Positives = 18/30 (60%), Gaps = 2/30 (6%)
Query: 304 KDYDWDSILDQE--PPFVPQPDDVFDTSYF 331
+ DWD + ++E PPFVP+ DTS F
Sbjct: 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNF 30
|
Length = 64 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 39/140 (27%), Positives = 62/140 (44%), Gaps = 18/140 (12%)
Query: 46 VKAISRGAFGKVFL-GYKKTNKD--QLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHS 101
++ + G FGKV L Y N ++ A+K +K++ + S +E N L L H
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHE 66
Query: 102 PF-----CVQLFYSLQTSSCVFLVMEYM-IGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
C S Q + L+MEY+ +G L L + + +A ++ +
Sbjct: 67 NIVKYKGCC----SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL--LFAQQICEGM 120
Query: 156 QYLHSHGIIHRDLKPDNMLI 175
YLHS IHRDL N+L+
Sbjct: 121 AYLHSQHYIHRDLAARNVLL 140
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 5e-04
Identities = 17/58 (29%), Positives = 27/58 (46%), Gaps = 7/58 (12%)
Query: 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
+VMEY+ G +K +I E E+ + LH GI+H DL N+++
Sbjct: 74 IVMEYIEGKPLKDVIEEGN--DE-----LLREIGRLVGKLHKAGIVHGDLTTSNIIVR 124
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 33/132 (25%), Positives = 58/132 (43%), Gaps = 15/132 (11%)
Query: 56 KVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115
K F N+ L A+K++++D NKN + L+E ++ P ++L TS
Sbjct: 35 KDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSD 92
Query: 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAA------------FYAAEVVLALQYLHSHGI 163
+ ++ EYM GD+ ++ + E F A ++ ++YL S
Sbjct: 93 PLCMITEYMENGDLNQFLSRH-EPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF 151
Query: 164 IHRDLKPDNMLI 175
+HRDL N L+
Sbjct: 152 VHRDLATRNCLV 163
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 22/67 (32%), Positives = 31/67 (46%), Gaps = 7/67 (10%)
Query: 272 LNPSTEETILALLKSDPTQRPSG-----HQVRRLPMFKDYDWDSILDQE--PPFVPQPDD 324
L+P + + LLK DP QR G +V F +W ++ ++ PPF PQ
Sbjct: 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTS 277
Query: 325 VFDTSYF 331
DT YF
Sbjct: 278 EVDTRYF 284
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 35/132 (26%), Positives = 60/132 (45%), Gaps = 9/132 (6%)
Query: 49 ISRGAFGKVFLGYKKTN--KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQ 106
I +G FG V+ G + + A+K + + + + V Q L+E + P +
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE--VEQFLKEGIIMKDFSHPNVLS 60
Query: 107 LF-YSLQTSSCVFLVMEYMIGGDVKSLIAANGALP--EDMAAFYAAEVVLALQYLHSHGI 163
L L + +V+ YM GD+++ I + P +D+ F +V ++YL S
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGF-GLQVAKGMEYLASKKF 119
Query: 164 IHRDLKPDN-ML 174
+HRDL N ML
Sbjct: 120 VHRDLAARNCML 131
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 37/146 (25%), Positives = 56/146 (38%), Gaps = 20/146 (13%)
Query: 47 KAISRGAFGKVFLG--YKKTNKDQ--LYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+ + GAFGKVFL Y + L A+K +K + N RE L
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQHE 67
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGA-------------LPEDMAAFYAA 149
V+ + + +V EYM GD+ + A+G L + A
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLI 175
++ + YL S +HRDL N L+
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLV 153
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 22/68 (32%), Positives = 38/68 (55%), Gaps = 3/68 (4%)
Query: 110 SLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLK 169
SL+ V++VME M D L + ++ +++ +++LHS GIIHRDLK
Sbjct: 97 SLEEFQDVYIVMELM---DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 153
Query: 170 PDNMLISA 177
P N+++ +
Sbjct: 154 PSNIVVKS 161
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 38/168 (22%), Positives = 67/168 (39%), Gaps = 45/168 (26%)
Query: 41 SDFEIVKAISRGAFGKVFL----GYKKTNKDQLYAIKVMKKD-----------EMINKNM 85
+ K + GAFG+V G N+ A+K++K D EM M
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEM---EM 68
Query: 86 VSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPE---- 141
+ + + +N + L C Q +++V+EY G+++ + A E
Sbjct: 69 MKMIGKHKNIINLLGV--CTQ-------EGPLYVVVEYAAHGNLRDFLRARRPPGEYASP 119
Query: 142 -------------DMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
D+ +F A +V +++L S IHRDL N+L++
Sbjct: 120 DDPRPPEETLTQKDLVSF-AYQVARGMEFLASKKCIHRDLAARNVLVT 166
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 30/151 (19%), Positives = 65/151 (43%), Gaps = 21/151 (13%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVL-----RERNAL 96
+++I K I G FG V+ ++ V K + + N+ +V + L + + +
Sbjct: 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQA-VAKIENLENETIVMETLVYNNIYDIDKI 71
Query: 97 AL-------THSPFCVQLFYSL-----QTSSCVFLVMEYMIGGDVKSLIAANGALPEDMA 144
AL H + +Y F+++E ++ + K + + +
Sbjct: 72 ALWKNIHNIDH--LGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLI 128
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLI 175
+++ L+Y+H HGI H D+KP+N+++
Sbjct: 129 KNIMKDMLTTLEYIHEHGISHGDIKPENIMV 159
|
Length = 294 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 37/160 (23%), Positives = 63/160 (39%), Gaps = 28/160 (17%)
Query: 44 EIVKAISRGAFGKVFL-------------GYKKTNKDQ--LYAIKVMKKDEMINKNMVSQ 88
V+ + G FG+V L + N D L A+KV++ D + N
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNARED 65
Query: 89 VLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDV----KSLIAANGALPEDMA 144
L+E L+ P +L + ++MEYM GD+ + +A L +
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 145 A-------FYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177
+ + A ++ ++YL S +HRDL N L+
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 42/151 (27%), Positives = 61/151 (40%), Gaps = 20/151 (13%)
Query: 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN--KNMVSQVLRERNAL 96
E+S +E + I +G FG+VF K K I +KK M N + LRE L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQ----IVALKKVLMENEKEGFPITALREIKIL 65
Query: 97 ALTHSPFCVQLF---YSLQTS-----SCVFLVMEYMIGGDVKSL---IAANGALPEDMAA 145
L V L + T +LV E+ D+ L L E
Sbjct: 66 QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF-CEHDLAGLLSNKNVKFTLSEIKKV 124
Query: 146 FYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
++ L Y+H + I+HRD+K N+LI+
Sbjct: 125 M--KMLLNGLYYIHRNKILHRDMKAANILIT 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 13/131 (9%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQV-LRERNALALTHSPFCVQL 107
I G FG V G Q A+K +K D + +Q L E + H V+L
Sbjct: 14 IGEGEFGAVLQG---EYTGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRL 64
Query: 108 FYSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIH 165
+ + +++VME M G++ + + G + ++ +V ++YL S ++H
Sbjct: 65 L-GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVH 123
Query: 166 RDLKPDNMLIS 176
RDL N+L+S
Sbjct: 124 RDLAARNILVS 134
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 32/141 (22%), Positives = 54/141 (38%), Gaps = 21/141 (14%)
Query: 49 ISRGAFGKVFLGY-------KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
I +GA ++L K + Y + DE + + + RE LA
Sbjct: 4 IKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPEL--DEKLRR---ERTRREARILAKARE 58
Query: 102 P-FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
V + Y + + +VMEY+ G +K + E+ EV + LH
Sbjct: 59 AGVPVPIVYDVDPDN-GLIVMEYIEGELLKDAL-------EEARPDLLREVGRLVGKLHK 110
Query: 161 HGIIHRDLKPDNMLISAQAPH 181
GI+H DL N+++S +
Sbjct: 111 AGIVHGDLTTSNIILSGGRIY 131
|
Length = 204 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 36/161 (22%), Positives = 61/161 (37%), Gaps = 28/161 (17%)
Query: 42 DFEIVKAISRGAFGKVF----LGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
+ E V+ I +GAFG+VF G + A+K++K++ + +M + RE +A
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 63
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFY---------- 147
P V+L + L+ EYM GD+ + + +
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 148 ------------AAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
A +V + YL +HRDL N L+
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG 164
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 35/152 (23%), Positives = 63/152 (41%), Gaps = 27/152 (17%)
Query: 49 ISRGAFGKV----------FLGYKKTNKDQ---LYAIKVMKKDEMINKNMVSQVLRERNA 95
+ G FG+V FLG D L A+K+++ D + K + L+E
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKI 70
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGD---------VKSLIAANGALPEDMAA- 145
++ +P ++L + + ++ EYM GD ++S +P A
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 146 --FYAAEVVLALQYLHSHGIIHRDLKPDNMLI 175
+ A ++ ++YL S +HRDL N L+
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 15/146 (10%)
Query: 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL 98
E + F I++ + GA G F + + V+K + + +LR A+
Sbjct: 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHV----VIKAGQRGGTATEAHILR-----AI 140
Query: 99 THSPFCVQLFYSLQTSSCVFLVM-EYMIGGDVKSLIAANGALPE-DMAAFYAAEVVLALQ 156
H P +QL + + L++ Y D+ +AA + D+ A + V+ A+Q
Sbjct: 141 NH-PSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERS-VLRAIQ 196
Query: 157 YLHSHGIIHRDLKPDNMLISAQAPHC 182
YLH + IIHRD+K +N+ I+ C
Sbjct: 197 YLHENRIIHRDIKAENIFINHPGDVC 222
|
Length = 391 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 35/133 (26%), Positives = 65/133 (48%), Gaps = 17/133 (12%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMV--SQVLRERNALALTHSPFCVQ 106
+ +G FG+V++G N AIK +K M + + +QV+++ L H VQ
Sbjct: 14 LGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKK-----LRHEKL-VQ 65
Query: 107 LFYSLQTSSCVFLVMEYMIGGDVKSLIAANGA----LPEDMAAFYAAEVVLALQYLHSHG 162
L Y++ + +++V EYM G + + LP+ + AA++ + Y+
Sbjct: 66 L-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIASGMAYVERMN 122
Query: 163 IIHRDLKPDNMLI 175
+HRDL+ N+L+
Sbjct: 123 YVHRDLRAANILV 135
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 14/27 (51%), Positives = 21/27 (77%)
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLIS 176
+++ AL LHS GI+HRD+KP N++ S
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFS 289
|
Length = 566 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 30/126 (23%), Positives = 53/126 (42%), Gaps = 21/126 (16%)
Query: 69 LYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGD 128
L A+K+++ D NKN + L+E L+ P ++L + ++ EYM GD
Sbjct: 48 LVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 129 VKSLIAA----------NGALPED---------MAAFYAAEVVLALQYLHSHGIIHRDLK 169
+ +++ N A+P A ++ ++YL S +HRDL
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165
Query: 170 PDNMLI 175
N L+
Sbjct: 166 TRNCLV 171
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 33/154 (21%), Positives = 68/154 (44%), Gaps = 15/154 (9%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
F + + + +G FG V K+ Q A+K++K D + + + + + LRE +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD-IFSSSDIEEFLREAACMKEFD 59
Query: 101 SPFCVQLF-YSLQTSS-----CVFLVMEYMIGGDVKSLIAANG------ALPEDMAAFYA 148
P ++L SL++ + +++ +M GD+ + + + LP +
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 149 AEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHC 182
++ ++YL S IHRDL N +++ C
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVC 153
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 36/148 (24%), Positives = 61/148 (41%), Gaps = 17/148 (11%)
Query: 39 EISDFEIVKAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
+ S +I K I G FG+V G K ++ AIK +K + L E + +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIM 59
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVV---- 152
P + L + S V +V EYM G + + + + F ++V
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG------QFTVIQLVGMLR 113
Query: 153 ---LALQYLHSHGIIHRDLKPDNMLISA 177
++YL G +HRDL N+L+++
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILVNS 141
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 22/72 (30%), Positives = 33/72 (45%), Gaps = 7/72 (9%)
Query: 272 LNPSTEETILALLKSDPTQRPSG-----HQVRRLPMFKDYDWDSILDQE--PPFVPQPDD 324
L+P + + LLK DP QR G ++ + F W + +++ PPF PQ
Sbjct: 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTS 278
Query: 325 VFDTSYFHADKT 336
DT YF + T
Sbjct: 279 ETDTRYFDEEFT 290
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 34/139 (24%), Positives = 65/139 (46%), Gaps = 7/139 (5%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQL---YAIKVMKKDEMINKNMVSQVLRERNALA 97
++ + VK + GAFG V+ G + + + AIKV++++ N ++L E +A
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMA 64
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQ 156
SP+ +L + +S V LV + M G + + N + + ++ +
Sbjct: 65 GVGSPYVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123
Query: 157 YLHSHGIIHRDLKPDNMLI 175
YL ++HRDL N+L+
Sbjct: 124 YLEEVRLVHRDLAARNVLV 142
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 33/135 (24%), Positives = 60/135 (44%), Gaps = 5/135 (3%)
Query: 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCV 105
++ + G + VF G K + L A+K ++ + + +RE + L V
Sbjct: 11 LEKLGEGTYATVFKGRSKLT-ENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIV 67
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPE-DMAAFYAAEVVLALQYLHSHGII 164
L + T + LV EY+ D+K + G + + +++ L Y H ++
Sbjct: 68 TLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVL 126
Query: 165 HRDLKPDNMLISAQA 179
HRDLKP N+LI+ +
Sbjct: 127 HRDLKPQNLLINERG 141
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 36/153 (23%), Positives = 65/153 (42%), Gaps = 30/153 (19%)
Query: 45 IVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRER----NAL 96
+++ + +G+FG V+ G + + A+K + + S LRER N
Sbjct: 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE---------SASLRERIEFLNEA 60
Query: 97 ALTHSPFC---VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAA--------NGALPEDMAA 145
++ C V+L + +VME M GD+KS + + G P +
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 146 F--YAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
AAE+ + YL++ +HRDL N +++
Sbjct: 121 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA 153
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 473 | |||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0612|consensus | 1317 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0986|consensus | 591 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0603|consensus | 612 | 100.0 | ||
| KOG0614|consensus | 732 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0581|consensus | 364 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0583|consensus | 370 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0595|consensus | 429 | 100.0 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0607|consensus | 463 | 100.0 | ||
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0586|consensus | 596 | 100.0 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0584|consensus | 632 | 100.0 | ||
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.98 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.98 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0668|consensus | 338 | 99.97 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| KOG1095|consensus | 1025 | 99.97 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0670|consensus | 752 | 99.97 | ||
| KOG1006|consensus | 361 | 99.97 | ||
| KOG1035|consensus | 1351 | 99.97 | ||
| KOG0669|consensus | 376 | 99.97 | ||
| KOG1027|consensus | 903 | 99.97 | ||
| KOG0606|consensus | 1205 | 99.97 | ||
| KOG4250|consensus | 732 | 99.97 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG0196|consensus | 996 | 99.97 | ||
| KOG4257|consensus | 974 | 99.97 | ||
| KOG1152|consensus | 772 | 99.96 | ||
| KOG1094|consensus | 807 | 99.96 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0665|consensus | 369 | 99.96 | ||
| KOG4278|consensus | 1157 | 99.96 | ||
| KOG1290|consensus | 590 | 99.96 | ||
| KOG1167|consensus | 418 | 99.96 | ||
| KOG0199|consensus | 1039 | 99.96 | ||
| KOG0576|consensus | 829 | 99.95 | ||
| KOG0664|consensus | 449 | 99.95 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG2052|consensus | 513 | 99.94 | ||
| KOG1345|consensus | 378 | 99.94 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0984|consensus | 282 | 99.94 | ||
| KOG0200|consensus | 609 | 99.94 | ||
| KOG1025|consensus | 1177 | 99.94 | ||
| KOG3653|consensus | 534 | 99.93 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG0590|consensus | 601 | 99.9 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG0606|consensus | 1205 | 99.9 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1024|consensus | 563 | 99.86 | ||
| KOG1165|consensus | 449 | 99.85 | ||
| KOG4158|consensus | 598 | 99.85 | ||
| KOG1163|consensus | 341 | 99.85 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG1164|consensus | 322 | 99.82 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| KOG1240|consensus | 1431 | 99.77 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| KOG0590|consensus | 601 | 99.7 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| KOG1166|consensus | 974 | 99.69 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG0195|consensus | 448 | 99.63 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| KOG1023|consensus | 484 | 99.35 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.23 | |
| KOG1033|consensus | 516 | 99.2 | ||
| KOG0601|consensus | 524 | 99.19 | ||
| KOG0601|consensus | 524 | 99.17 | ||
| KOG3087|consensus | 229 | 99.16 | ||
| KOG1243|consensus | 690 | 99.16 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| KOG1266|consensus | 458 | 98.91 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.9 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| KOG3741|consensus | 655 | 98.72 | ||
| KOG1035|consensus | 1351 | 98.64 | ||
| PRK09902 | 216 | hypothetical protein; Provisional | 98.54 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.51 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 98.43 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.41 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| KOG2137|consensus | 700 | 98.33 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.32 | |
| KOG0599|consensus | 411 | 98.28 | ||
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.28 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.09 | |
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 98.01 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.0 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.92 | |
| KOG1235|consensus | 538 | 97.89 | ||
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.85 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.69 | |
| KOG0576|consensus | 829 | 97.67 | ||
| KOG0033|consensus | 355 | 97.62 | ||
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.47 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.44 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.4 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.39 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.33 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.26 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.24 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.12 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.02 | |
| KOG0032|consensus | 382 | 96.98 | ||
| KOG2270|consensus | 520 | 96.92 | ||
| PLN02236 | 344 | choline kinase | 96.85 | |
| KOG2268|consensus | 465 | 96.67 | ||
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.53 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.51 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.37 | |
| KOG0607|consensus | 463 | 96.27 | ||
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.14 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.12 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.0 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.71 | |
| KOG0615|consensus | 475 | 95.63 | ||
| KOG0659|consensus | 318 | 95.63 | ||
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.6 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.55 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.36 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.32 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.18 | |
| KOG0595|consensus | 429 | 95.16 |
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-74 Score=550.95 Aligned_cols=336 Identities=32% Similarity=0.493 Sum_probs=284.2
Q ss_pred cccccccccccCC-CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC
Q psy622 24 ENSLCDVSKSCLK-APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102 (473)
Q Consensus 24 ~~~~~~~~~~~~~-~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp 102 (473)
.+.+..+.++... .+.+++|+++++||+|+||+|++++++. +++.||||+|+|+.+..++.++++..|++||..++||
T Consensus 7 ~~~~~~~~p~~~~~~~~~~dF~~lkviGkG~fGkV~~Vrk~d-t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hP 85 (357)
T KOG0598|consen 7 RNGNTSYKPSNNAEMVGPDDFEILKVIGKGSFGKVFQVRKKD-TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHP 85 (357)
T ss_pred ccCccccCCCcccccCChhheeeeeeeeccCCceEEEEEEcc-cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCC
Confidence 3344444444443 7789999999999999999999999885 7899999999999999999999999999999999999
Q ss_pred CeeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCce
Q psy622 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHC 182 (473)
Q Consensus 103 ~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~i 182 (473)
|||+++++||++.++|+|+||+.||+|+.+|++++.|+|..+++|+++|+.||.|||++|||||||||||||||.+ |||
T Consensus 86 Fiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~-GHi 164 (357)
T KOG0598|consen 86 FIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GHI 164 (357)
T ss_pred cEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC-CcE
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999999 999
Q ss_pred eEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh
Q psy622 183 PIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT 255 (473)
Q Consensus 183 kL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~ 255 (473)
+|||||+|+..-. ....+.+.||||+|| |||++. .+|||++|++ ++|++|.+||...... ...
T Consensus 165 ~LtDFgL~k~~~~---~~~~t~tfcGT~eYm---APEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~----~~~ 234 (357)
T KOG0598|consen 165 KLTDFGLCKEDLK---DGDATRTFCGTPEYM---APEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----KMY 234 (357)
T ss_pred EEeccccchhccc---CCCccccccCCcccc---ChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH----HHH
Confidence 9999999997322 223345689999999 999875 5899999976 5799999999864321 112
Q ss_pred hhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCC----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCC
Q psy622 256 STAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPS----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTS 329 (473)
Q Consensus 256 ~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s 329 (473)
..+.+.++..+ +..++.++++||++||++||++|++ +++|++||||++|||+++.++ .|||+|++.+..|++
T Consensus 235 ~~I~~~k~~~~--p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~ 312 (357)
T KOG0598|consen 235 DKILKGKLPLP--PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTS 312 (357)
T ss_pred HHHhcCcCCCC--CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccc
Confidence 33444443333 2569999999999999999999984 789999999999999999987 799999999999999
Q ss_pred CCCCCCCCCCCCCCCCcc-CCCCCceecccCCCCCCCCccccCch
Q psy622 330 YFHADKTNSYMDSTLSTT-HGNGSFVCCSNLNSHTASGMDVDSPS 373 (473)
Q Consensus 330 ~Fd~~~t~~~~~~~~~~~-~~~~~~~~~~~~~~~~f~g~~~~~p~ 373 (473)
+||.+||....+.+.... .....+...+......|.||+|++|+
T Consensus 313 ~Fd~eft~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~gft~~~~s 357 (357)
T KOG0598|consen 313 NFDNEFTSYTVDYSPVDSSPDMSAFTAFSRTYNKIFPGFTYVASS 357 (357)
T ss_pred cccHHHHhccccCCccccCcccccccccccccccccCCccccCCC
Confidence 999999998655554432 22222333344566789999999875
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-70 Score=560.36 Aligned_cols=316 Identities=29% Similarity=0.490 Sum_probs=280.1
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTS 114 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 114 (473)
+...+++|.++++||+|+||+|++|..+. +++.||||+++|..+..+..+++++.|.+|+... +|||+++|+++||++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~-~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKG-TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcC-CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 57789999999999999999999999887 6789999999999999999999999999999988 599999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
.++|+||||+.||| ..++++.+.|+|..+++|+++|+.||+|||++||||||||.+|||||.+ ||+||+|||+||..
T Consensus 442 ~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~- 518 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE-GHVKIADFGLCKEG- 518 (694)
T ss_pred CeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc-CcEEeccccccccc-
Confidence 99999999999999 4555556799999999999999999999999999999999999999999 99999999999983
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCccc-cccCCCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTFQ-DVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l~-~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
......+++.||||+|| |||++. ++|||++|+|. +|+.|+.||++... ......+....+.+|
T Consensus 519 --m~~g~~TsTfCGTpey~---aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE----ee~FdsI~~d~~~yP- 588 (694)
T KOG0694|consen 519 --MGQGDRTSTFCGTPEFL---APEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE----EEVFDSIVNDEVRYP- 588 (694)
T ss_pred --CCCCCccccccCChhhc---ChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCCCCCC-
Confidence 22224567889999999 999864 68999999885 69999999996322 122345555677777
Q ss_pred ccccCChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYM 340 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~ 340 (473)
.++|.++.+++++||++||++|++ +++|++||||+.|||++|+++ +|||+|.++++.|++|||++||++.+
T Consensus 589 --~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p 666 (694)
T KOG0694|consen 589 --RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKP 666 (694)
T ss_pred --CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCCC
Confidence 799999999999999999999997 589999999999999999988 89999999999999999999999988
Q ss_pred CCCCCccCCCCCceecccCCCCCCCCccccCch
Q psy622 341 DSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPS 373 (473)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~ 373 (473)
..+..+... +..++|..|.||+|++|.
T Consensus 667 ~Lt~~~~~~------l~~~~q~~F~~Fs~~~~~ 693 (694)
T KOG0694|consen 667 ALTPSDPRP------LTEEEQEAFRDFSFVAEW 693 (694)
T ss_pred ccCCCCccc------cchhhHHHhcCccccCCC
Confidence 887633322 255689999999999985
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-68 Score=533.04 Aligned_cols=327 Identities=33% Similarity=0.564 Sum_probs=273.8
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
.++++||+++++||+|+||.||+|+++. ||.+||||+|+|..+...+++++++.|++||...++|+||+|+++||+..+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~-Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKD-TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEcc-CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 6789999999999999999999999887 799999999999999999999999999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+||||||++|||+.++|.+.+.|+|+++++|+++++.||+.||+.|||||||||+|+|||.. |||||+|||||+.+...
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLDKK 294 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC-CCEeeccccccchhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999 99999999999754221
Q ss_pred cc---------------------cc-----------------------ccccccCCCCcccccCCccccc------cCCc
Q psy622 197 IV---------------------YL-----------------------EISDLVNGTPNAFNIRTPGQLL------SLKT 226 (473)
Q Consensus 197 ~~---------------------~~-----------------------~~~~~~~gtp~y~~~~ape~i~------~~~~ 226 (473)
.. .. .......|||+|| |||+++ ..||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYi---APEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYI---APEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCcccc---chHHHhcCCCCccccH
Confidence 00 00 0112357999999 999875 4789
Q ss_pred CCCCcc-ccccCCCCCchhHhhhcCCCCChhh---Hhh--hccCCCCccccCChhHHHHHHhccccCCCCCCC---HHHH
Q psy622 227 GTFPTF-QDVQNSQAPFPSALRVAGSQIPTST---AAQ--LQLEWPEDEEALNPSTEETILALLKSDPTQRPS---GHQV 297 (473)
Q Consensus 227 ~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~---~~~--~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps---a~ei 297 (473)
||+|++ ++|+.|.+||... .+.++ +.. ..+.+|.. ..++++|+|||.+||+ ||++|++ ++||
T Consensus 372 WSLG~ImyEmLvGyPPF~s~-------tp~~T~rkI~nwr~~l~fP~~-~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSE-------TPQETYRKIVNWRETLKFPEE-VDLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHHHhhhccCCCc-CcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 999965 5799999999853 22222 222 23666765 6789999999999999 9999996 8999
Q ss_pred hcCCCCCCCCccccccCCCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCC-CCcee--c--ccCCCCCCCCccccCc
Q psy622 298 RRLPMFKDYDWDSILDQEPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGN-GSFVC--C--SNLNSHTASGMDVDSP 372 (473)
Q Consensus 298 l~HPFF~~idw~~l~~~~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~-~~~~~--~--~~~~~~~f~g~~~~~p 372 (473)
++||||++|||+.|.+..|||+|.+.++.||+||| +|+++......++..+. ..... - .+..+..|.||+|.+-
T Consensus 443 K~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFd-dF~e~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~FvgfTyk~~ 521 (550)
T KOG0605|consen 443 KKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFD-DFPEEDSMTPTADKSGPSRKMLSMVDTNNSSKDINFVGFTYKNF 521 (550)
T ss_pred hcCCccccCCcchhhcCCCCCCCCCCCcccccccc-cCcccccCcccccccccchhhhhcccccCCcccccccceeeecc
Confidence 99999999999999999999999999999999999 56654333333332211 00000 0 1235568999999988
Q ss_pred hhhhcc
Q psy622 373 SALYSK 378 (473)
Q Consensus 373 ~~~~~~ 378 (473)
..+...
T Consensus 522 ~~~~~~ 527 (550)
T KOG0605|consen 522 DGLNKA 527 (550)
T ss_pred cccccc
Confidence 887655
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-68 Score=499.77 Aligned_cols=324 Identities=29% Similarity=0.460 Sum_probs=285.8
Q ss_pred cCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 34 CLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 34 ~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
...++.+++|+.+++||+|+||+|.+++.|. +++.||||+++|..+..+..+++.+.|-++|+..+|||+..|.++||+
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKa-t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKA-TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeecc-cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 3456789999999999999999999999887 789999999999999999999999999999999999999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
.+++|+||||..||+|+.+|.+.+.|+|..+|+|-++|+.||.|||+++|||||||.+|+|||.+ |||||+|||+|+.
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkD-GHIKitDFGLCKE- 317 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKD-GHIKITDFGLCKE- 317 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccC-CceEeeecccchh-
Confidence 99999999999999999999999999999999999999999999999999999999999999999 9999999999997
Q ss_pred cCCccccccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
.........+.||||+|+ |||++ ..++||+.|+. |+|++|+.||... ......+.+.-..+++|
T Consensus 318 --~I~~g~t~kTFCGTPEYL---APEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~----dh~kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 318 --EIKYGDTTKTFCGTPEYL---APEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK----DHEKLFELILMEDLKFP 388 (516)
T ss_pred --cccccceeccccCChhhc---CchhhccccccceeehhhhhHHHHHHHhccCccccc----chhHHHHHHHhhhccCC
Confidence 223334567789999999 89976 36899999965 5799999999852 12233456666788999
Q ss_pred CccccCChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSY 339 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~ 339 (473)
..++++|+.|+..||.+||++|++ +.||.+|+||.+|||+++..+ .|||+|++.++.||+|||.+||..+
T Consensus 389 ---r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT~q~ 465 (516)
T KOG0690|consen 389 ---RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEEFTSQP 465 (516)
T ss_pred ---ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhhhhcce
Confidence 699999999999999999999996 789999999999999999877 7999999999999999999999988
Q ss_pred CCCCCCccCCCCCceecccCCCCCCCCccccCchh
Q psy622 340 MDSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPSA 374 (473)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~ 374 (473)
+..++.+..+. -++-..-.+..|.-|+|.+...
T Consensus 466 v~lTPP~r~~~--~~~~~~e~~~~FpQFsy~~~~~ 498 (516)
T KOG0690|consen 466 VTLTPPDRYGS--TVDEDEERRPHFPQFSYSASMG 498 (516)
T ss_pred eEecCCCCCCc--ccchhhhhccCCcceeeecchh
Confidence 77775554332 3333444556899998876544
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-67 Score=486.71 Aligned_cols=312 Identities=29% Similarity=0.488 Sum_probs=280.1
Q ss_pred ccchhhHHHHhHhhhcccccccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHH
Q psy622 9 GADKENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ 88 (473)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~ 88 (473)
...++...++++.....-...+..+..+...+++|++++.||.|+||+|.+++.+. ++..||+|+++|..+.+.+++++
T Consensus 12 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~dfe~~~tlGtGSFGrV~LVr~k~-~g~yYAmKvL~k~~vVklKQveH 90 (355)
T KOG0616|consen 12 SNSKESVKEFLDKAREDFPKKWANTPQNPYSLQDFERLKTLGTGSFGRVHLVREKH-SGNYYAMKVLDKQKVVKLKQVEH 90 (355)
T ss_pred ccchhHHHHHHHHHHHhhhhhhcCCCCCCcchhhhhheeeeccCccceEEEEEEcc-CCceeehhhcCHHHHHHHHHHHH
Confidence 33455566777888888777777777777899999999999999999999999998 57899999999999999999999
Q ss_pred HHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Q psy622 89 VLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168 (473)
Q Consensus 89 ~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDL 168 (473)
+.+|+.+|+.+.|||+++++++|++.+++||||||++||.|+.+|++.++|++..||||++||++||+|||+++|+||||
T Consensus 91 ~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDL 170 (355)
T KOG0616|consen 91 THNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDL 170 (355)
T ss_pred HhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCC
Q psy622 169 KPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAP 241 (473)
Q Consensus 169 KpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~p 241 (473)
||||||||.+ |++||+|||+|+..... +-+.||||+|+ |||++. ++|||++|++ ++|+.|.+|
T Consensus 171 KPENiLlD~~-G~iKitDFGFAK~v~~r------T~TlCGTPeYL---APEii~sk~ynkavDWWalGVLIYEMlaG~pP 240 (355)
T KOG0616|consen 171 KPENLLLDQN-GHIKITDFGFAKRVSGR------TWTLCGTPEYL---APEIIQSKGYNKAVDWWALGVLIYEMLAGYPP 240 (355)
T ss_pred ChHHeeeccC-CcEEEEeccceEEecCc------EEEecCCcccc---ChHHhhcCCCCcchhHHHHHHHHHHHHcCCCC
Confidence 9999999999 99999999999986432 34689999999 999876 5899999987 579999999
Q ss_pred chhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--
Q psy622 242 FPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ-- 314 (473)
Q Consensus 242 f~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~-- 314 (473)
|...... -..+.+...++.+| ..+++++++||++||+.|-.+|. +..+|++||||++++|++++++
T Consensus 241 F~~~~~~----~iY~KI~~~~v~fP---~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~i 313 (355)
T KOG0616|consen 241 FYDDNPI----QIYEKILEGKVKFP---SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKI 313 (355)
T ss_pred CcCCChH----HHHHHHHhCcccCC---cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccc
Confidence 9863221 11256667889999 68999999999999999999996 4789999999999999999987
Q ss_pred CCCCcC-CCCCCCCCCCCCCCCCCC
Q psy622 315 EPPFVP-QPDDVFDTSYFHADKTNS 338 (473)
Q Consensus 315 ~pPf~P-~~~~~~D~s~Fd~~~t~~ 338 (473)
+|||+| .+..+.|+++||.--++.
T Consensus 314 e~P~~pp~~~~~gdtsnfd~y~e~~ 338 (355)
T KOG0616|consen 314 EPPFEPPNIHGPGDTSNFDDYEEED 338 (355)
T ss_pred cCCCCCccccCCccccccccccccc
Confidence 899998 889999999999776653
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-64 Score=487.72 Aligned_cols=321 Identities=30% Similarity=0.465 Sum_probs=287.9
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQT 113 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~ 113 (473)
...+.+.+|.++.+||+|+||+|.+|..+. +.+.||||+++|+.+.+..+++..+.|.++|... +-||+++++.+||+
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkg-tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKG-TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccC-cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence 346667899999999999999999998876 6789999999999999999999999999999988 78999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
-+.+|+||||+.||||..+|++-|+|.|..|.+|+++|+.||-+||++||||||||.+|||||.+ |||||+|||+|+.-
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e-GHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEN 500 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC-CceEeeeccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999 99999999999972
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
......+.+.||||+|+ |||++. +++||++|++ ++|+.|++||.+... ......+....+.+|
T Consensus 501 ---i~~~~TTkTFCGTPdYi---APEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE----~elF~aI~ehnvsyP 570 (683)
T KOG0696|consen 501 ---IFDGVTTKTFCGTPDYI---APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQAIMEHNVSYP 570 (683)
T ss_pred ---ccCCcceeeecCCCccc---ccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHccCcCc
Confidence 22334566789999999 999875 6899999987 569999999986321 122345556677888
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCH-----HHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSG-----HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSY 339 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa-----~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~ 339 (473)
..+|.+|.++++.+|.+.|.+|+++ .+|+.||||+.|||++++++ +|||+|.++...|++|||..||.++
T Consensus 571 ---KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~ 647 (683)
T KOG0696|consen 571 ---KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREP 647 (683)
T ss_pred ---ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCC
Confidence 6899999999999999999999974 68999999999999999988 7999999999999999999999999
Q ss_pred CCCCCCccCCCCCceecccCCCCCCCCccccCchhhh
Q psy622 340 MDSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPSALY 376 (473)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~~~ 376 (473)
.+.|+.+-... .+++|..|.||||+||.++.
T Consensus 648 ~~lTPpD~~v~------~nldq~eF~gFsfvNpefv~ 678 (683)
T KOG0696|consen 648 TDLTPPDKLVM------MNLDQSEFEGFSFVNPEFVK 678 (683)
T ss_pred CCCCCchHHHH------hcCchhhcCceeeeChhhcC
Confidence 88887765444 68899999999999999864
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-62 Score=520.94 Aligned_cols=326 Identities=31% Similarity=0.477 Sum_probs=274.6
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
..+.+||+++++||+|+||.|.+++++. ++++||||+++|..+.+....+.|..|+.||...++++|++++++||++.+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~-t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKS-TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeec-cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 4556899999999999999999999997 789999999999998888889999999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+|||||+||||..++.+.++++|..|+||+++|+.||+-||+.|+|||||||+|||||.. |||||+|||.|..+...
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~-GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS-GHIKLADFGSCLKMDAD 228 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc-CcEeeccchhHHhcCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999 99999999999987532
Q ss_pred ccccccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 264 (473)
....+.+..|||+|+ +||++. ..|||++|++ |+|+.|..||+...-..... ...-.+..+.
T Consensus 229 --G~V~s~~aVGTPDYI---SPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~--KIm~hk~~l~ 301 (1317)
T KOG0612|consen 229 --GTVRSSVAVGTPDYI---SPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG--KIMNHKESLS 301 (1317)
T ss_pred --CcEEeccccCCCCcc---CHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH--HHhchhhhcC
Confidence 234466778999999 898764 4789999987 56999999999754322111 0011134678
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCC---HHHHhcCCCCCCCCccccccCCCCCcCCCCCCCCCCCCCCCCCCCCCC
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPS---GHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDTSYFHADKTNSYMD 341 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRps---a~eil~HPFF~~idw~~l~~~~pPf~P~~~~~~D~s~Fd~~~t~~~~~ 341 (473)
||.. ..+|+++++||+++|+ +|..|+| +++++.||||.+++|+.+++..|||+|.++++.||+|||.........
T Consensus 302 FP~~-~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnFd~~~dd~~~~ 379 (1317)
T KOG0612|consen 302 FPDE-TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNFDVDEDDLRDA 379 (1317)
T ss_pred CCcc-cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccccccccccccchh
Confidence 8844 5699999999999998 8999998 999999999999999999999999999999999999996554443333
Q ss_pred CCCCccCCCCCceecccCCCCCCCCccccCchhhhccc
Q psy622 342 STLSTTHGNGSFVCCSNLNSHTASGMDVDSPSALYSKL 379 (473)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~~~~~~ 379 (473)
.+..+.... . ..=++-.|.||+|.. ..+.+.+
T Consensus 380 e~~p~~~~~-~----f~Gn~LPFIGfTy~~-~~~~ss~ 411 (1317)
T KOG0612|consen 380 ETFPPRIPK-A----FSGNHLPFIGFTYTH-ESLLSSS 411 (1317)
T ss_pred hccCCCCCC-C----CcCCcCCeeeeeecc-chhhccC
Confidence 333322221 1 112556899999998 5555544
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-62 Score=458.91 Aligned_cols=324 Identities=27% Similarity=0.450 Sum_probs=288.0
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTS 114 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 114 (473)
..+.+++|+++++||+|+|.+|.+++.+. +.+.||||+++|.-+...+.+..++.|..+..+. +|||+|-++.+||++
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~-t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKK-TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcc-cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 46678999999999999999999999988 6799999999998887888899999999999887 899999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+++|.||++||+|.-+++++++++|++|++|.++|+.||.|||++||||||||.+|+|||.. |||||+|+|+|+.-
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae-ghikltdygmcke~- 401 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEG- 401 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC-CceeecccchhhcC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999 99999999999972
Q ss_pred CCccccccccccCCCCcccccCCcccc------ccCCcCCCCccc-cccCCCCCchhHhhhc----CCCCChhhHhhhcc
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTFQ-DVQNSQAPFPSALRVA----GSQIPTSTAAQLQL 263 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l~-~~~~g~~pf~~~~~~~----~~~~~~~~~~~~~~ 263 (473)
-.....+++.||||+|+ |||++ ++++||++|+++ +|+.|+.||.-.-... ......+.+....+
T Consensus 402 --l~~gd~tstfcgtpnyi---apeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 402 --LGPGDTTSTFCGTPNYI---APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI 476 (593)
T ss_pred --CCCCcccccccCCCccc---chhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence 23335567889999999 88875 578999999886 6999999997421111 01112244555677
Q ss_pred CCCCccccCChhHHHHHHhccccCCCCCCC------HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCC
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQRPS------GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADK 335 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~kRps------a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~ 335 (473)
.+| ..+|-.+..+++..|++||++|++ ..+++.|+||+.|||+.++++ .|||.|.+.++.+..|||..|
T Consensus 477 rip---rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qf 553 (593)
T KOG0695|consen 477 RIP---RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQF 553 (593)
T ss_pred ccc---ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCcccccccc
Confidence 778 689999999999999999999985 689999999999999999987 799999999999999999999
Q ss_pred CCCCCCCCCCccCCCCCceecccCCCCCCCCccccCchhhh
Q psy622 336 TNSYMDSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPSALY 376 (473)
Q Consensus 336 t~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~~~ 376 (473)
|+|.++.++.+.+.. ..++|.+|.||.|+||--+.
T Consensus 554 t~e~~qltpdd~d~i------~ridqsefegfeyinpl~ms 588 (593)
T KOG0695|consen 554 TSEPVQLTPDDEDAI------KRIDQSEFEGFEYINPLLMS 588 (593)
T ss_pred ccCCcccCCCCHHHH------HhcchhhcCcceecchhhcc
Confidence 999999998877666 66899999999999998764
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-57 Score=454.84 Aligned_cols=269 Identities=32% Similarity=0.525 Sum_probs=239.3
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSS 115 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~ 115 (473)
.-...||.+.+.||.|+|++|++|+.+. +++.||||++.|..+.+++.++-+.+|+.+|.+| .||+|++|+..|||+.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~-t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKA-TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecC-CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 4457899999999999999999999988 7899999999999999988899999999999999 8999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+|+||+++|+|.++|++.|.|+|..+|+|++||+.||+|||++|||||||||||||||.+ +|+||+|||.|+.+..
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d-mhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD-GHIKITDFGSAKILSP 226 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC-CcEEEeeccccccCCh
Confidence 999999999999999999999999999999999999999999999999999999999999999 9999999999998753
Q ss_pred Cccc----------cccccccCCCCcccccCCccccc------cCCcCCCCccc-cccCCCCCchhHhhhcCCCCChhhH
Q psy622 196 PIVY----------LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTFQ-DVQNSQAPFPSALRVAGSQIPTSTA 258 (473)
Q Consensus 196 ~~~~----------~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l~-~~~~g~~pf~~~~~~~~~~~~~~~~ 258 (473)
.... ......+.||.+|+ +||.+. +.|.|+|||+. -|+.|.+||.+... -...+.+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYV---SPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yliFqkI 299 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYV---SPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YLIFQKI 299 (604)
T ss_pred hhccccCccCcccccCcccceeeeeccc---CHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HHHHHHH
Confidence 2221 01124578999999 999864 57889999765 49999999986322 1233566
Q ss_pred hhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccCCCC
Q psy622 259 AQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPP 317 (473)
Q Consensus 259 ~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~~pP 317 (473)
......|| +.+++.++|||+++|.+||.+|+|++||++||||.+|||+.|.+++||
T Consensus 300 ~~l~y~fp---~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP 355 (604)
T KOG0592|consen 300 QALDYEFP---EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPP 355 (604)
T ss_pred HHhcccCC---CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCC
Confidence 66788888 689999999999999999999999999999999999999999988443
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-57 Score=436.11 Aligned_cols=285 Identities=29% Similarity=0.464 Sum_probs=244.2
Q ss_pred ccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q psy622 33 SCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ 112 (473)
Q Consensus 33 ~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 112 (473)
.+...+.+++|++++.||.|.-|+||+|+.+. ++..+|||++.|..+..++...+++.|.+||+.++|||+++||..|+
T Consensus 69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~-t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe 147 (459)
T KOG0610|consen 69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRG-TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE 147 (459)
T ss_pred cCCCccCHHHHHHHHHcCCCCceeEEEEEecC-CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence 44567778899999999999999999999887 56899999999999888888999999999999999999999999999
Q ss_pred eCCEEEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
+++..|+|||||+||||..+++++ +.|+++.+|||+++|+.||+|||-.||||||||||||||.++ |||.|+||.|+
T Consensus 148 t~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred-GHIMLsDFDLS 226 (459)
T KOG0610|consen 148 TDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED-GHIMLSDFDLS 226 (459)
T ss_pred ccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC-CcEEeeecccc
Confidence 999999999999999999999985 479999999999999999999999999999999999999999 99999999997
Q ss_pred hhhcCC----------------------------------cc-------------------ccccccccCCCCcccccCC
Q psy622 191 AILQQP----------------------------------IV-------------------YLEISDLVNGTPNAFNIRT 217 (473)
Q Consensus 191 ~~~~~~----------------------------------~~-------------------~~~~~~~~~gtp~y~~~~a 217 (473)
..+... .. .........||-||+ |
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl---A 303 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL---A 303 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc---c
Confidence 643110 00 001122346888888 9
Q ss_pred ccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCC
Q psy622 218 PGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQ 290 (473)
Q Consensus 218 pe~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~k 290 (473)
||+|. .+|||+||++ |+|+.|..||.+..+ .....++....+.+|.. ..++..++|||++||.+||.+
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----~~Tl~NIv~~~l~Fp~~-~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----KETLRNIVGQPLKFPEE-PEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc----hhhHHHHhcCCCcCCCC-CcchhHHHHHHHHHhccChhh
Confidence 99985 5899999987 569999999986432 22224445567788876 378899999999999999999
Q ss_pred CCC----HHHHhcCCCCCCCCccccccCCCCCcCCCCCCCC
Q psy622 291 RPS----GHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFD 327 (473)
Q Consensus 291 Rps----a~eil~HPFF~~idw~~l~~~~pPf~P~~~~~~D 327 (473)
|++ |+||++||||++++|.-++...||++|...+..+
T Consensus 379 Rlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~~ 419 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGGL 419 (459)
T ss_pred hhccccchHHhhcCccccCCChhheeccCCCcCCCccccCc
Confidence 997 9999999999999999656669999998876544
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-57 Score=453.20 Aligned_cols=306 Identities=28% Similarity=0.410 Sum_probs=253.9
Q ss_pred hcccccccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC
Q psy622 23 SENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102 (473)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp 102 (473)
.+.++..+.-.+-.+....-|..++.||-|+||+|.+|++.+ +...||+|.|.|..+..++++.++..|++||...+++
T Consensus 611 L~QKESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvD-T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~ 689 (1034)
T KOG0608|consen 611 LQQKESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVD-TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNE 689 (1034)
T ss_pred HHhhhhhHHHHHHhhccccceEEEeeecccccceeEEEeecc-hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCc
Confidence 333444444444445555679999999999999999998776 6889999999999999999999999999999999999
Q ss_pred CeeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCce
Q psy622 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHC 182 (473)
Q Consensus 103 ~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~i 182 (473)
+||+||++||+.+++|+||||++|||+..+|.+.|.|.|..||||++++.+|+++.|+.|+|||||||+|||||.+ |||
T Consensus 690 WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd-GHI 768 (1034)
T KOG0608|consen 690 WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHI 768 (1034)
T ss_pred ceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-Cce
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999999 999
Q ss_pred eEeecchhhhhcCCc--c-------------------------------------ccccccccCCCCcccccCCccccc-
Q psy622 183 PIVNTLFLAILQQPI--V-------------------------------------YLEISDLVNGTPNAFNIRTPGQLL- 222 (473)
Q Consensus 183 kL~DFGla~~~~~~~--~-------------------------------------~~~~~~~~~gtp~y~~~~ape~i~- 222 (473)
||+|||||.-+.-.. . ...+.....|||+|+ |||++.
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyi---apevl~r 845 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYI---APEVLAR 845 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCccc---ChHHhcc
Confidence 999999997532100 0 001234567999999 898864
Q ss_pred -----cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCC---
Q psy622 223 -----SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPS--- 293 (473)
Q Consensus 223 -----~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps--- 293 (473)
..+||+.|++ ++|+.|++||..........-...+. ..+.+|.. .++|+++.+||.+|.+ +++.|++
T Consensus 846 ~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~--~~l~~~~~-~~ls~e~~~li~kLc~-sad~RLGkng 921 (1034)
T KOG0608|consen 846 TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR--NFLHIPYQ-GNLSKEALDLIQKLCC-SADSRLGKNG 921 (1034)
T ss_pred cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh--hccccccc-cccCHHHHHHHHHHhc-Chhhhhcccc
Confidence 5899999965 67999999998643221111111111 12233322 6899999999999887 8999996
Q ss_pred HHHHhcCCCCCCCCccccccCCCCCcCCCCCCCCCCCCCCCCCC
Q psy622 294 GHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDTSYFHADKTN 337 (473)
Q Consensus 294 a~eil~HPFF~~idw~~l~~~~pPf~P~~~~~~D~s~Fd~~~t~ 337 (473)
++||+.||||++|||..|+++.+||+|.+.++.||||||....+
T Consensus 922 ~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHptDTSNFdpvdpe 965 (1034)
T KOG0608|consen 922 ADQVKAHPFFKGIDFSSLRKQRAPYIPRITHPTDTSNFDPVDPE 965 (1034)
T ss_pred hhhhhcCccccccchHhhhhccCCcCccccCCCccccCCcCCcc
Confidence 78899999999999999888899999999999999999987664
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-53 Score=413.45 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=219.2
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK----NMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~----~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
..+.|.+.+.||+|+||.|-+|..+. +++.||||+++|...... .....+.+|++||++++||+||+++++|...
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~-tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK-TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc-cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 34568889999999999999999887 789999999999865432 1234578999999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC--CCceeEeecchhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ--APHCPIVNTLFLAI 192 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~--~g~ikL~DFGla~~ 192 (473)
...||||||+.||+|++.+-.++.+.|+..+.|+.||+.||.|||++||+||||||||||+..+ ...+||+|||+||.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999999999999999999999999999999999999999999999999999754 25799999999998
Q ss_pred hcCCccccccccccCCCCcccccCCccccc---------cCCcCCCCccc-cccCCCCCchhHhhhcCCCCChhhHhhhc
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTFQ-DVQNSQAPFPSALRVAGSQIPTSTAAQLQ 262 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l~-~~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 262 (473)
.+. .....+.||||.|+ |||++. .+|.|++|++. .+++|.+||.+... .....+.+.++.
T Consensus 329 ~g~----~sfm~TlCGTpsYv---APEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~---~~sl~eQI~~G~ 398 (475)
T KOG0615|consen 329 SGE----GSFMKTLCGTPSYV---APEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT---DPSLKEQILKGR 398 (475)
T ss_pred ccc----ceehhhhcCCcccc---ChhheecCCeecccchheeeeccceEEEEeccCCCcccccC---CccHHHHHhcCc
Confidence 542 35567789999999 999875 36889999765 49999999986421 111223333333
Q ss_pred cCC-CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCc
Q psy622 263 LEW-PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDW 308 (473)
Q Consensus 263 ~~~-P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw 308 (473)
..+ |.....+|.++++||.+||..||++||+++|+++||||+.++-
T Consensus 399 y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 399 YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 333 3444689999999999999999999999999999999998763
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=415.57 Aligned_cols=287 Identities=27% Similarity=0.460 Sum_probs=248.3
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
..+..+.|+.-++||+|+||.|+-++.+. ||+.||+|.+.|+.+..+......++|..||.+++.+|||.+-++|++.+
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvra-TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRA-TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEec-chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 44556889999999999999999998876 79999999999998877777788999999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 116 CVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
.+|+||..|+||||..||.+.| .|+|+.++||++||+.||+|||+.+||||||||+|||||+. |||+|+|.|||..+
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~-GhvRISDLGLAvei 337 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH-GHVRISDLGLAVEI 337 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC-CCeEeeccceEEec
Confidence 9999999999999999999876 79999999999999999999999999999999999999999 99999999999987
Q ss_pred cCCccccccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
.....- .-..||.+|| |||++ ++.|||++|++ ++|+.|..||..........-....+.....++|
T Consensus 338 ~~g~~~----~~rvGT~GYM---APEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~ 410 (591)
T KOG0986|consen 338 PEGKPI----RGRVGTVGYM---APEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS 410 (591)
T ss_pred CCCCcc----ccccCccccc---CHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc
Confidence 544322 1237999999 99976 47899999986 5699999999763322111112233344566777
Q ss_pred CccccCChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCC-----CCCCCCCCCCC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPD-----DVFDTSYFHAD 334 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~-----~~~D~s~Fd~~ 334 (473)
+.+|+++++|++.||++||.+|++ ++++++||||+++||..|.+. +|||+|... +.+|...|++.
T Consensus 411 ---~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs~V 487 (591)
T KOG0986|consen 411 ---DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFSTV 487 (591)
T ss_pred ---cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhcccc
Confidence 689999999999999999999996 789999999999999999987 899999875 67888888844
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=415.04 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=222.1
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
.+|...+.||+|||.+||.+++.. +|+.||+|++.|..+.+..+.+.+.+|++|.+.++|||||+++.+|++.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~-tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD-TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC-CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 569999999999999999999876 6899999999999988899999999999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
+|+|..|+|..++++.+.++|.+|++|+.||+.||.|||+++|||||||..|++|+.+ -++||+|||||..+....
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~-~~VKIgDFGLAt~le~~~--- 172 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN-MNVKIGDFGLATQLEYDG--- 172 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc-CcEEecccceeeeecCcc---
Confidence 9999999999999999999999999999999999999999999999999999999999 899999999999875332
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCccc-cccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTFQ-DVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l~-~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
+...+.||||+|+ |||++. .+|.|++|++. .++.|++||....-. ..-..+......+| ..+|
T Consensus 173 Erk~TlCGTPNYI---APEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk----ety~~Ik~~~Y~~P---~~ls 242 (592)
T KOG0575|consen 173 ERKKTLCGTPNYI---APEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK----ETYNKIKLNEYSMP---SHLS 242 (592)
T ss_pred cccceecCCCccc---ChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH----HHHHHHHhcCcccc---cccC
Confidence 2335689999999 999874 68999999765 599999999853110 01123344566667 5899
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
.+|++||.+||+.||.+||++++|+.|+||+
T Consensus 243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 9999999999999999999999999999993
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-53 Score=431.18 Aligned_cols=380 Identities=24% Similarity=0.381 Sum_probs=323.2
Q ss_pred eecccCceEEEEEEEeC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEeccc
Q psy622 48 AISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCVFLVMEYM 124 (473)
Q Consensus 48 ~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lVmEy~ 124 (473)
++|+|+||+|++++... ..++.||+|++++.....+... +...|+.++..++ ||++|++++.||++.++|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 47999999999986433 2467899999999876554444 8888999999996 999999999999999999999999
Q ss_pred CcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccccc
Q psy622 125 IGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISD 204 (473)
Q Consensus 125 ~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~ 204 (473)
.||+|+..+.+...+.+...++|.++++.|++++|+.+|+|||+|++||+++.+ ||++++|||+++..-..+.
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~------ 152 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKI------ 152 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc-CccccCCchhhhHhHhhhh------
Confidence 999999999999999999999999999999999999999999999999999999 9999999999998533221
Q ss_pred ccCCCCcccccCCccccc----cCCcCCCCccc-cccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHH
Q psy622 205 LVNGTPNAFNIRTPGQLL----SLKTGTFPTFQ-DVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEET 279 (473)
Q Consensus 205 ~~~gtp~y~~~~ape~i~----~~~~~s~g~l~-~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dL 279 (473)
.|||.+|+ |||++. ..+||++|++. ++++|..||... ....+...++..| ..++..++++
T Consensus 153 -~cgt~eym---ApEI~~gh~~a~D~ws~gvl~felltg~~pf~~~--------~~~~Il~~~~~~p---~~l~~~a~~~ 217 (612)
T KOG0603|consen 153 -ACGTYEYR---APEIINGHLSAADWWSFGVLAFELLTGTLPFGGD--------TMKRILKAELEMP---RELSAEARSL 217 (612)
T ss_pred -cccchhhh---hhHhhhccCCcccchhhhhhHHHHhhCCCCCchH--------HHHHHhhhccCCc---hhhhHHHHHH
Confidence 28999998 888764 78999999886 699999999761 1123444466667 6899999999
Q ss_pred HHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCC-CCCCCCccCCCC
Q psy622 280 ILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSY-MDSTLSTTHGNG 351 (473)
Q Consensus 280 I~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~-~~~~~~~~~~~~ 351 (473)
+..++.++|..|++ +.|+++|+||..|+|+.+.++ .|||+|.+..+.|+.+||++||... .++...+.
T Consensus 218 ~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~---- 293 (612)
T KOG0603|consen 218 FRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVPADSPLLSA---- 293 (612)
T ss_pred HHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCcccCCCCCC----
Confidence 99999999999996 589999999999999999876 7999999999999999999999853 22222222
Q ss_pred CceecccCCCCCCCCccccCchhhhccccccCCCCCCccCCccCCCCceeecCCCCCCCCCcccc---cccccCcchHHH
Q psy622 352 SFVCCSNLNSHTASGMDVDSPSALYSKLSTMDCMSPPNAHNLSGVSPFLAMDRSPPDNSELEWPE---DEEALNPSTEET 428 (473)
Q Consensus 352 ~~~~~~~~~~~~f~g~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 428 (473)
+..+...|+||+|++|+.+....+..--..-.. ....|.++|++|+||.+.-+..+||| +++++|+|+|+.
T Consensus 294 -----~~s~~~if~g~sfva~~il~~~~~~~~~~~y~~-~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~ 367 (612)
T KOG0603|consen 294 -----SGSDHTIFSGPSFVAPGVLEDAVTAPFTESYEF-REELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIP 367 (612)
T ss_pred -----CccccchhcCCCccChHHhhccccCCcchhhcc-ccccCCCCccceeeeeccccccchhheeccccccccccccc
Confidence 233558999999999999998433210001111 23489999999999999999999999 777899999999
Q ss_pred HHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 429 ILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
|+.+|.+||||+++.+|+.++..+|+|+.+|.
T Consensus 368 ~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 368 ISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 99999999999999999999999999999986
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=413.08 Aligned_cols=285 Identities=25% Similarity=0.466 Sum_probs=254.0
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
...+.+++++++..||-|+||.|-+++.+. ....+|+|+++|..+....+.+++..|++||...++||||++|..|.+.
T Consensus 414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~-~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 414 FAQVKLSDLKRIATLGVGGFGRVELVKVNS-QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS 492 (732)
T ss_pred hcccchhhhhhhhhcccCccceEEEEEecc-cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence 456778999999999999999999997765 2345999999999999999999999999999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
+++|++||-|-||+|++.|+..|.|++..++||+++++.|++|||++|||||||||||+|||.+ |.+||.|||+||.+.
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC-CceEEeehhhHHHhc
Confidence 9999999999999999999999999999999999999999999999999999999999999999 999999999999987
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh--hhccCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA--QLQLEW 265 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~ 265 (473)
....+ -++||||+|+ |||+++ ++++|++|++ +++++|.+||.+....... ..+. -..+.|
T Consensus 572 ~g~KT----wTFcGTpEYV---APEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY----n~ILkGid~i~~ 640 (732)
T KOG0614|consen 572 SGRKT----WTFCGTPEYV---APEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY----NLILKGIDKIEF 640 (732)
T ss_pred cCCce----eeecCCcccc---cchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH----HHHHhhhhhhhc
Confidence 66544 3579999999 999986 5889999988 4699999999753111000 1111 145677
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADK 335 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~ 335 (473)
| ..++..+.+||++|...+|.+|++ +.+|++|.||.+.||+.|..+ .|||+|.+.++.|++|||.-.
T Consensus 641 P---r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~p 714 (732)
T KOG0614|consen 641 P---RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNFP 714 (732)
T ss_pred c---cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCCC
Confidence 7 689999999999999999999996 899999999999999999987 799999999999999999654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=393.63 Aligned_cols=308 Identities=28% Similarity=0.422 Sum_probs=250.3
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCc
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIG 126 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 126 (473)
++||+|+||+||+|+++. +++.||||++++..........++.+|+.+|+.++||||+++++++++.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKA-TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 479999999999998876 5789999999987655556667889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccccccc
Q psy622 127 GDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLV 206 (473)
Q Consensus 127 g~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 206 (473)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~---~~~~~~ 155 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDG---ATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCC---Ccccce
Confidence 9999999998899999999999999999999999999999999999999998 999999999998632111 112345
Q ss_pred CCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHH
Q psy622 207 NGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEET 279 (473)
Q Consensus 207 ~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dL 279 (473)
+||+.|+ |||++. ..|+|++|++ ++|++|..||...... .....+......+| ..+++++.+|
T Consensus 156 ~gt~~y~---aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~~~~~~~~~p---~~~~~~~~~l 225 (323)
T cd05571 156 CGTPEYL---APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEEIRFP---RTLSPEAKSL 225 (323)
T ss_pred ecCcccc---ChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH----HHHHHHHcCCCCCC---CCCCHHHHHH
Confidence 7899888 898754 4799999965 5799999999642110 00111222334455 5799999999
Q ss_pred HHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCC
Q psy622 280 ILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGS 352 (473)
Q Consensus 280 I~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~ 352 (473)
|.+||+.||++|| ++.++++||||++++|+.+..+ .||+.|.+.+..|+.+|+.++++.....+...... +
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--~ 303 (323)
T cd05571 226 LAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQSITITPPDRYD--S 303 (323)
T ss_pred HHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccCCCCccc--c
Confidence 9999999999999 7999999999999999999865 69999999999999999999888655444332221 1
Q ss_pred ceecccCCCCCCCCccccC
Q psy622 353 FVCCSNLNSHTASGMDVDS 371 (473)
Q Consensus 353 ~~~~~~~~~~~f~g~~~~~ 371 (473)
...-+......|.+|+|.+
T Consensus 304 ~~~~~~~~~~~~~~~~~~~ 322 (323)
T cd05571 304 LGLLQLEERPHFPQFSYSA 322 (323)
T ss_pred cccccccccccCCCCeeeC
Confidence 1111223456899998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=388.00 Aligned_cols=308 Identities=28% Similarity=0.451 Sum_probs=252.7
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
+.||+|+||+||+|+.+. +++.||+|++++.........+.+.+|+.++..+ +||+|+++++++++.+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK-NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 479999999999998877 5789999999987655555677889999999888 79999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPG---DTTST 155 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC-CCEEEeccccceeccCCC---Cceec
Confidence 99999999988899999999999999999999999999999999999999999 999999999997532111 11234
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh---hhHhhhccCCCCccccCChh
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT---STAAQLQLEWPEDEEALNPS 275 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~P~~~~~ls~~ 275 (473)
.+||+.|+ |||++. ..|+|++|++ +++++|..||............. ..+......+| ..++..
T Consensus 156 ~~gt~~y~---aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p---~~~~~~ 229 (327)
T cd05617 156 FCGTPNYI---APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP---RFLSVK 229 (327)
T ss_pred ccCCcccC---CHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC---CCCCHH
Confidence 57888888 888753 4789999965 57999999996421110001101 11122233444 578999
Q ss_pred HHHHHHhccccCCCCCCC------HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy622 276 TEETILALLKSDPTQRPS------GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTT 347 (473)
Q Consensus 276 a~dLI~~LL~~dP~kRps------a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~ 347 (473)
+.++|.+||+.||++|++ ++++++||||+.++|+.+..+ .|||+|.+.+..+.++|++.+.+++...+..+.
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFDTQFTSEPVQLTPDDE 309 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCCcchhhcCCccccCcccCCCCCc
Confidence 999999999999999997 579999999999999988765 789999999999999999998888776665554
Q ss_pred CCCCCceecccCCCCCCCCccccC
Q psy622 348 HGNGSFVCCSNLNSHTASGMDVDS 371 (473)
Q Consensus 348 ~~~~~~~~~~~~~~~~f~g~~~~~ 371 (473)
... +.+++..|.||+|.|
T Consensus 310 ~~~------~~~~~~~~~~~~~~~ 327 (327)
T cd05617 310 DVI------KRIDQSEFEGFEYIN 327 (327)
T ss_pred ccc------ccccccccCCCcCCC
Confidence 434 556889999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=376.05 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=216.7
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
..+.+++.+.+++||+|..|+||+|+++. +++.||+|++.-. .+....+++.+|+++|+..+||+||++|++|..+.
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~-t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKP-TGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcC-CCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 34556789999999999999999999997 6899999999543 34566779999999999999999999999999999
Q ss_pred E-EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 116 C-VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 116 ~-l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
. ++|+||||.||+|...+...++++|.....++.+|++||.|||+ ++||||||||+|||+++. |.|||||||.++.+
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk-GeVKicDFGVS~~l 229 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK-GEVKICDFGVSGIL 229 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC-CCEEeccccccHHh
Confidence 5 99999999999999999999999999999999999999999995 999999999999999999 99999999999987
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCc-cccccCCCCCchhHhhhcCCCCChh---hH-hhhc
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPT-FQDVQNSQAPFPSALRVAGSQIPTS---TA-AQLQ 262 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~-l~~~~~g~~pf~~~~~~~~~~~~~~---~~-~~~~ 262 (473)
... .+++..||-.|| |||.+. ..|.|++|. +.++.+|+.||...... .....+ .+ ....
T Consensus 230 vnS-----~a~tfvGT~~YM---sPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~--~~~~~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 230 VNS-----IANTFVGTSAYM---SPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP--YLDIFELLCAIVDEPP 299 (364)
T ss_pred hhh-----hccccccccccc---ChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC--CCCHHHHHHHHhcCCC
Confidence 543 556778999999 999875 478999994 57899999999864100 000001 11 1123
Q ss_pred cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 263 LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 263 ~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
..+|. ..+|+++++||..||++||.+|++++|+++|||+++..
T Consensus 300 P~lP~--~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 300 PRLPE--GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCCCc--ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 33442 24999999999999999999999999999999998654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=393.29 Aligned_cols=316 Identities=26% Similarity=0.435 Sum_probs=244.9
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||+|+||+||+|+++. +++.||||++++...........+.+|+.++..++||||+++++.+++...+|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD-TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC-CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 479999999999999999998876 5789999999987655555667889999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc-
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY- 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~- 199 (473)
|||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+++.+......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CCEEEeeccCccccccccccc
Confidence 9999999999999998899999999999999999999999999999999999999998 99999999999864321100
Q ss_pred -------------------------------cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCC
Q psy622 200 -------------------------------LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAP 241 (473)
Q Consensus 200 -------------------------------~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~p 241 (473)
.......+||+.|+ |||++. ..|+|++|++ ++|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~---aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYI---APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCcccc---CHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 00112357899988 899764 3689999965 579999999
Q ss_pred chhHhhhcCCCCChhhHhh--hccCCCCccccCChhHHHHHHhccccCCCC---CCCHHHHhcCCCCCCCCccccccCCC
Q psy622 242 FPSALRVAGSQIPTSTAAQ--LQLEWPEDEEALNPSTEETILALLKSDPTQ---RPSGHQVRRLPMFKDYDWDSILDQEP 316 (473)
Q Consensus 242 f~~~~~~~~~~~~~~~~~~--~~~~~P~~~~~ls~~a~dLI~~LL~~dP~k---Rpsa~eil~HPFF~~idw~~l~~~~p 316 (473)
|....... ....+.. ..+.+|.. ..+++++++||.+|+. +|.+ ||+++||++||||++++|+.+..+.+
T Consensus 236 f~~~~~~~----~~~~i~~~~~~~~~p~~-~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~~ 309 (363)
T cd05628 236 FCSETPQE----TYKKVMNWKETLIFPPE-VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIRERPA 309 (363)
T ss_pred CCCCCHHH----HHHHHHcCcCcccCCCc-CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCCC
Confidence 96421100 0011111 12334432 3578999999999876 4554 57899999999999999999988766
Q ss_pred CCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCCceecccCCCCCCCCcccc
Q psy622 317 PFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGSFVCCSNLNSHTASGMDVD 370 (473)
Q Consensus 317 Pf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 370 (473)
+..+.+.+..|+++|+.-.+.....++...+.....+ ....+..|.||+|.
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 360 (363)
T cd05628 310 AIPIEIKSIDDTSNFDEFPDSDILKPTVATSNHPETD---YKNKDWVFINYTYK 360 (363)
T ss_pred CCCccCCCcchhhccCCCCccccccccccccCCcccc---cCcCCcccCCceee
Confidence 6666788899999998755443222222221111111 12244569999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=394.96 Aligned_cols=319 Identities=29% Similarity=0.450 Sum_probs=245.8
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
..|++++.||+|+||+||+|+++. +++.||||++.+..........++.+|+++++.++||||+++++++++..++|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVD-THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 369999999999999999999876 6789999999987666666778899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc-
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY- 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~- 199 (473)
|||++||+|.+++.+.+.+++..++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||+++.+......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC-CCEEEeeCcCCcccccccccc
Confidence 9999999999999988899999999999999999999999999999999999999998 99999999998643110000
Q ss_pred -------------------------------------------cccccccCCCCcccccCCccccc------cCCcCCCC
Q psy622 200 -------------------------------------------LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFP 230 (473)
Q Consensus 200 -------------------------------------------~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g 230 (473)
.......+||+.|+ |||++. ..|+|++|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~---aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYI---APEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCcccc---CHHHHcCCCCCCccceeehh
Confidence 00112356888888 898753 47999999
Q ss_pred cc-ccccCCCCCchhHhhhcCCCCChhhHh--hhccCCCCccccCChhHHHHHHhcccc--CCCCCCCHHHHhcCCCCCC
Q psy622 231 TF-QDVQNSQAPFPSALRVAGSQIPTSTAA--QLQLEWPEDEEALNPSTEETILALLKS--DPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 231 ~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~P~~~~~ls~~a~dLI~~LL~~--dP~kRpsa~eil~HPFF~~ 305 (473)
++ ++|++|..||....... ....+. .....+|.. ..+++++++||.+||.. +|.+|++++|+++||||++
T Consensus 236 ~il~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~-~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTE----TQLKVINWENTLHIPPQ-VKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHH----HHHHHHccccccCCCCC-CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 65 67999999996421100 000011 112333422 36899999999996654 5555999999999999999
Q ss_pred CCccccccC-CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCCceecccC---CCCCCCCcccc
Q psy622 306 YDWDSILDQ-EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGSFVCCSNL---NSHTASGMDVD 370 (473)
Q Consensus 306 idw~~l~~~-~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~~~~~~~~---~~~~f~g~~~~ 370 (473)
++|...... .+|+.|.+.++.|+++|+......+......++..... ..|+.. ....|.||+|.
T Consensus 311 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 378 (381)
T cd05626 311 VDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWD-TLCSPNGKHPEHAFYEFTFR 378 (381)
T ss_pred CChhHHhhcCCCCccCcCCCcchhhhcCCCCcccccccCCccchhhhc-cccCcccccccccccccEee
Confidence 999886554 78999999999999999876544322111111111100 112222 24689999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=383.87 Aligned_cols=309 Identities=29% Similarity=0.455 Sum_probs=250.6
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCCEEEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS-PFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~~~~~l~lV 120 (473)
+|++++.||+|+||.||+|+++. +++.||||++++.........+.+..|++++..++| ++|+++++++++.+.+|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 68999999999999999998876 578999999998755555566788899999999965 5689999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~--- 155 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGG--- 155 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC-CCEEEeecCcceecCCCC---
Confidence 9999999999999988899999999999999999999999999999999999999998 999999999987532111
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
......+||+.|+ |||++. ..|+|++|++ +++++|..||...... .....+......+| ..++
T Consensus 156 ~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~~~~~~~~---~~~~ 225 (324)
T cd05587 156 KTTRTFCGTPDYI---APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----ELFQSIMEHNVSYP---KSLS 225 (324)
T ss_pred CceeeecCCcccc---ChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCC---CCCC
Confidence 1123457888888 898754 3689999965 5799999999642110 00112222334444 5789
Q ss_pred hhHHHHHHhccccCCCCCCCH-----HHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy622 274 PSTEETILALLKSDPTQRPSG-----HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLST 346 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa-----~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~ 346 (473)
+++.++|.+||++||.+|+++ +++++||||+.++|..+..+ .+|+.|.+....++++|+..++......+..+
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (324)
T cd05587 226 KEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFFTREPPVLTPPD 305 (324)
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchhhhcCcccccCccccCCCC
Confidence 999999999999999999975 89999999999999988765 78999999999999999988766544333222
Q ss_pred cCCCCCceecccCCCCCCCCccccC
Q psy622 347 THGNGSFVCCSNLNSHTASGMDVDS 371 (473)
Q Consensus 347 ~~~~~~~~~~~~~~~~~f~g~~~~~ 371 (473)
.. .-.++++..|++|+|+|
T Consensus 306 ~~------~~~~~~~~~~~~~~~~~ 324 (324)
T cd05587 306 KL------VIANIDQSEFQGFSFVN 324 (324)
T ss_pred cc------ccccccccccCCCcccC
Confidence 11 11455778999999985
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=383.61 Aligned_cols=311 Identities=27% Similarity=0.434 Sum_probs=250.3
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCc
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIG 126 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 126 (473)
++||+|+||.||+|+++. +++.||+|++++...........+.+|+++++.++||||+++++++++...+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKA-SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 479999999999999876 5789999999987655556677889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccccccc
Q psy622 127 GDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLV 206 (473)
Q Consensus 127 g~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 206 (473)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... ......
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~---~~~~~~ 155 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDA---ATMKTF 155 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-CcEEEecCcCCccCCCcc---cccccc
Confidence 9999999988899999999999999999999999999999999999999998 999999999987632211 112335
Q ss_pred CCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHH
Q psy622 207 NGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEET 279 (473)
Q Consensus 207 ~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dL 279 (473)
+||+.|+ |||.+. ..|+|++|++ +++++|..||....... ....+......+| ..+++++.+|
T Consensus 156 ~gt~~y~---aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~----~~~~~~~~~~~~p---~~~~~~~~~l 225 (328)
T cd05593 156 CGTPEYL---APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEDIKFP---RTLSADAKSL 225 (328)
T ss_pred cCCcCcc---ChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH----HHHHhccCCccCC---CCCCHHHHHH
Confidence 7898888 898764 4689999965 57999999996421100 0011112233445 5789999999
Q ss_pred HHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCC
Q psy622 280 ILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGS 352 (473)
Q Consensus 280 I~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~ 352 (473)
|.+||++||++|+ ++.|+++||||.+++|..+... .||+.|...++.|+.+|+.+++.+....+.........
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (328)
T cd05593 226 LSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQTITITPPEKYDEDG 305 (328)
T ss_pred HHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCcccccCCcccCCcccccccc
Confidence 9999999999997 7999999999999999988765 79999999999999999999987643322222222222
Q ss_pred ceecccCCCCCCCCccccCc
Q psy622 353 FVCCSNLNSHTASGMDVDSP 372 (473)
Q Consensus 353 ~~~~~~~~~~~f~g~~~~~p 372 (473)
..+........|.+|+|.+.
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~ 325 (328)
T cd05593 306 MDCMDNERRPHFPQFSYSAS 325 (328)
T ss_pred ccccccccccccCCceeeCC
Confidence 23333345567888887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=386.53 Aligned_cols=286 Identities=29% Similarity=0.531 Sum_probs=242.1
Q ss_pred cccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q psy622 32 KSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSL 111 (473)
Q Consensus 32 ~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 111 (473)
+.......+++|++.+.||+|+||.||+|+++...+..||+|++.+.........+.+.+|+.+++.++||||+++++++
T Consensus 21 ~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred cccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 33445667899999999999999999999877644578999999887655556677889999999999999999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
+++..+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+++
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~ikL~DFG~a~ 179 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAK 179 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEecCCCCe
Confidence 9999999999999999999999998899999999999999999999999999999999999999998 999999999998
Q ss_pred hhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccC
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 264 (473)
.+... ....+||+.|+ |||++. ..|+|++|++ ++|++|..||...... .....+......
T Consensus 180 ~~~~~------~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~~~~i~~~~~~ 246 (340)
T PTZ00426 180 VVDTR------TYTLCGTPEYI---APEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL----LIYQKILEGIIY 246 (340)
T ss_pred ecCCC------cceecCChhhc---CHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH----HHHHHHhcCCCC
Confidence 75321 12357888888 898753 4689999965 5799999999752110 011122223344
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCC
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHAD 334 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~ 334 (473)
+| ..++++++++|++||+.||.+|+ +++++++||||++++|..+..+ .+|++|......|.++|...
T Consensus 247 ~p---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 320 (340)
T PTZ00426 247 FP---KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERV 320 (340)
T ss_pred CC---CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCCcchhhcCCC
Confidence 55 57899999999999999999996 8999999999999999998866 79999999999999998643
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=383.59 Aligned_cols=305 Identities=30% Similarity=0.490 Sum_probs=249.8
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
++||+|+||+||+|+++. +++.||||++++.........+....|+.++... +||||+++++++++...+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG-TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 479999999999998876 5789999999986544445556677788888765 89999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... .....
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~---~~~~~ 155 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGE---GKAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCC---Ccccc
Confidence 99999999988899999999999999999999999999999999999999999 999999999998642221 22234
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEE 278 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~d 278 (473)
.+||+.|+ |||.+. ..|+|++|++ ++|++|..||..... ...........+..+..++.++.+
T Consensus 156 ~~gt~~y~---aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~~ 225 (316)
T cd05592 156 FCGTPDYI---APEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-------DELFDSILNDRPHFPRWISKEAKD 225 (316)
T ss_pred ccCCcccc---CHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCCCCCCHHHHH
Confidence 57888888 888753 4789999965 579999999974211 111111111122233678999999
Q ss_pred HHHhccccCCCCCCCH-HHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCCcee
Q psy622 279 TILALLKSDPTQRPSG-HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGSFVC 355 (473)
Q Consensus 279 LI~~LL~~dP~kRpsa-~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~~~~ 355 (473)
||.+||+.||.+|+++ +++++||||+.++|..+..+ .|||.|......|.++|+..++.+....+..+....
T Consensus 226 ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 300 (316)
T cd05592 226 CLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLSPVDKKLL----- 300 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccccccCCCcccccc-----
Confidence 9999999999999986 58999999999999988765 689999999999999999999887665555544333
Q ss_pred cccCCCCCCCCccccCc
Q psy622 356 CSNLNSHTASGMDVDSP 372 (473)
Q Consensus 356 ~~~~~~~~f~g~~~~~p 372 (473)
..+++..|.||+|.+|
T Consensus 301 -~~~~~~~~~~~~~~~~ 316 (316)
T cd05592 301 -ASMDQEQFRGFSFTNP 316 (316)
T ss_pred -ccccccccCCCcccCc
Confidence 5678999999999987
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=385.31 Aligned_cols=308 Identities=27% Similarity=0.445 Sum_probs=251.1
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
++||+|+||+||+|+++. +++.||+|++++...........+.+|+.++..+ +||||++++++|++...+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK-TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 479999999999999887 5789999999987555555567789999999988 79999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... .....
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~---~~~~~ 155 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPG---DTTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEECcCccccccccCC---Ccccc
Confidence 99999999888899999999999999999999999999999999999999998 999999999997532111 12234
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcC-CC-C---ChhhHhhhccCCCCccccCC
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAG-SQ-I---PTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~-~~-~---~~~~~~~~~~~~P~~~~~ls 273 (473)
.+||+.|+ |||++. ..|+|++|++ +++++|..||........ .. . ....+......+| ..++
T Consensus 156 ~~gt~~y~---aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p---~~~~ 229 (329)
T cd05588 156 FCGTPNYI---APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP---RSLS 229 (329)
T ss_pred ccCCcccc---CHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC---CCCC
Confidence 57888888 888753 4799999965 579999999963211100 00 0 0112222334445 5789
Q ss_pred hhHHHHHHhccccCCCCCCC------HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy622 274 PSTEETILALLKSDPTQRPS------GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLS 345 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRps------a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~ 345 (473)
.++.+||.+||+.||.+|+| ++++++||||++++|+.+..+ .||+.|.+....|..+|+..+.++....++.
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 309 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPD 309 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCcchhhhcCCccccCccccCCC
Confidence 99999999999999999997 789999999999999988764 6899999999999999999998876665544
Q ss_pred ccCCCCCceecccCCCCCCCCccccC
Q psy622 346 TTHGNGSFVCCSNLNSHTASGMDVDS 371 (473)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~f~g~~~~~ 371 (473)
+.... ..+++..|.||.|.|
T Consensus 310 ~~~~~------~~~~~~~~~~~~~~~ 329 (329)
T cd05588 310 DPDVI------ARIDQSEFEGFEYIN 329 (329)
T ss_pred Ccccc------ccccccccCCCcccC
Confidence 44333 455778999998864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=386.00 Aligned_cols=304 Identities=29% Similarity=0.448 Sum_probs=245.5
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
++||+|+||+||+|+++. +++.||||++++.........+.+..|..++..+ +||||+++++++++.+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE-SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcC-CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 479999999999999876 5789999999987554455567788899999876 79999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... .....
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~---~~~~~ 155 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNG---KTTST 155 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCC---Ccccc
Confidence 99999999988899999999999999999999999999999999999999999 999999999987632111 12234
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEE 278 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~d 278 (473)
.+||+.|+ |||.+. ..|+|++|++ +++++|..||...... .....+......+| ..++.++++
T Consensus 156 ~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i~~~~~~~~---~~~~~~~~~ 225 (320)
T cd05590 156 FCGTPDYI---APEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----DLFEAILNDEVVYP---TWLSQDAVD 225 (320)
T ss_pred cccCcccc---CHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHhcCCCCCC---CCCCHHHHH
Confidence 57898888 898754 4689999965 5799999999642110 00112222333444 578999999
Q ss_pred HHHhccccCCCCCCCH------HHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCC
Q psy622 279 TILALLKSDPTQRPSG------HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGN 350 (473)
Q Consensus 279 LI~~LL~~dP~kRpsa------~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~ 350 (473)
||++||++||.+|+++ +++++||||++++|+.+..+ .|||.|.+.+..|.++|+.++..+.+..+..+..-.
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (320)
T cd05590 226 ILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKEDPVLTPIEESLL 305 (320)
T ss_pred HHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCccCCCCccccc
Confidence 9999999999999997 89999999999999998765 799999999999999999887775332221111101
Q ss_pred CCceecccCCCCCCCCccccC
Q psy622 351 GSFVCCSNLNSHTASGMDVDS 371 (473)
Q Consensus 351 ~~~~~~~~~~~~~f~g~~~~~ 371 (473)
...++..|.+|+|.+
T Consensus 306 ------~~~~~~~~~~~~~~~ 320 (320)
T cd05590 306 ------PMINQDEFRNFSYTA 320 (320)
T ss_pred ------ccccccCcCCCcccC
Confidence 234778899998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=383.60 Aligned_cols=308 Identities=29% Similarity=0.445 Sum_probs=249.3
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+|++++.||+|+||+||+|+++. +++.||||++++..............|..++..+ +||+|+++++++++.+.+|+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 68999999999999999998876 5789999999987554555566788888888877 689999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+++......
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~--- 155 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDG--- 155 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC-CcEEEccCCCceecCCCC---
Confidence 9999999999999988899999999999999999999999999999999999999999 999999999997532111
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
......+||+.|+ |||++. ..|+|++|++ +++++|..||...... .....+......+| ..++
T Consensus 156 ~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~~~~~~~p---~~~s 225 (323)
T cd05616 156 VTTKTFCGTPDYI---APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEHNVAYP---KSMS 225 (323)
T ss_pred CccccCCCChhhc---CHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCC---CcCC
Confidence 1123457888888 898754 4699999965 5799999999742110 00112222344455 5789
Q ss_pred hhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy622 274 PSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLST 346 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~ 346 (473)
.++.+||.+||++||.+|++ ..++++||||+.++|+.+.++ +||+.|... ..|..+|+..+...+...+.++
T Consensus 226 ~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 304 (323)
T cd05616 226 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKAC-GRDAENFDKFFTRHPPVLTPPD 304 (323)
T ss_pred HHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC-CchhhhcCchhccCCccCCCCC
Confidence 99999999999999999997 489999999999999999876 799999875 4788889887775543333222
Q ss_pred cCCCCCceecccCCCCCCCCccccC
Q psy622 347 THGNGSFVCCSNLNSHTASGMDVDS 371 (473)
Q Consensus 347 ~~~~~~~~~~~~~~~~~f~g~~~~~ 371 (473)
.... ..+++..|.||+|++
T Consensus 305 ~~~~------~~~~~~~~~~~~~~~ 323 (323)
T cd05616 305 QEVI------MNLDQSEFEGFSYVN 323 (323)
T ss_pred cccc------ccccccccCCCcccC
Confidence 2222 345778999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=383.38 Aligned_cols=284 Identities=28% Similarity=0.480 Sum_probs=240.3
Q ss_pred ccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q psy622 33 SCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ 112 (473)
Q Consensus 33 ~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 112 (473)
.......+++|++.+.||+|+||+||+|+++. +++.||+|++++.........+.+.+|+.+|+.++||||++++++++
T Consensus 10 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 10 PDTSSWKLSDFEMGETLGTGSFGRVRIAKHKG-TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred cccCCCCchheEEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34456668999999999999999999999876 57899999999876555556678999999999999999999999999
Q ss_pred eCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
+++.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKK 167 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC-CCEEEeeccCceE
Confidence 999999999999999999999998899999999999999999999999999999999999999999 9999999999987
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
..... ...+||+.|+ |||++. ..|+|++|++ ++|++|..||...... .....+......+
T Consensus 168 ~~~~~------~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i~~~~~~~ 234 (329)
T PTZ00263 168 VPDRT------FTLCGTPEYL---APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIYEKILAGRLKF 234 (329)
T ss_pred cCCCc------ceecCChhhc---CHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHHHHHhcCCcCC
Confidence 53221 2357888888 898753 4789999965 5799999999642110 0011222234445
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHAD 334 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~ 334 (473)
| ..++.++++||.+||+.||.+|++ ++++++||||++++|+.+..+ .+|+.|.+....|+++|+..
T Consensus 235 p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (329)
T PTZ00263 235 P---NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEKY 307 (329)
T ss_pred C---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcccchhccCC
Confidence 5 578999999999999999999997 799999999999999998865 57888888888899998743
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=383.63 Aligned_cols=304 Identities=30% Similarity=0.454 Sum_probs=247.4
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
++||+|+||+||+|+++. +++.||||++++.........+.+..|.+++..+ +||||++++++|++.+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG-TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECC-CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 479999999999998876 6789999999987555555667788899999876 89999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~---~~~~~ 155 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNG---VTTTT 155 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeecccceecccCC---ccccc
Confidence 99999999988899999999999999999999999999999999999999999 999999999987532211 12234
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEE 278 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~d 278 (473)
.+||+.|+ |||++. ..|+|++|++ +++++|..||...... .....+......+| ..+++++.+
T Consensus 156 ~~gt~~y~---aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~----~~~~~i~~~~~~~p---~~~~~~~~~ 225 (321)
T cd05591 156 FCGTPDYI---APEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED----DLFESILHDDVLYP---VWLSKEAVS 225 (321)
T ss_pred cccCcccc---CHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCC---CCCCHHHHH
Confidence 56888888 888653 4699999965 5799999999742110 00111222233444 578999999
Q ss_pred HHHhccccCCCCCC-------CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCC
Q psy622 279 TILALLKSDPTQRP-------SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHG 349 (473)
Q Consensus 279 LI~~LL~~dP~kRp-------sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~ 349 (473)
||.+||++||++|+ +++++++||||++++|..+..+ .|||.|......|.++|+.+++.+....+.+.+..
T Consensus 226 ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (321)
T cd05591 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTKEEPVLTPVDPAV 305 (321)
T ss_pred HHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhhcCCccccCccccCCCCccc
Confidence 99999999999999 8999999999999999998765 79999999999999999988876533333222222
Q ss_pred CCCceecccCCCCCCCCccccC
Q psy622 350 NGSFVCCSNLNSHTASGMDVDS 371 (473)
Q Consensus 350 ~~~~~~~~~~~~~~f~g~~~~~ 371 (473)
. ..+++..|.||++.+
T Consensus 306 ~------~~~~~~~~~~~~~~~ 321 (321)
T cd05591 306 I------KQINQEEFRGFSFFN 321 (321)
T ss_pred c------ccccccccCCCcccC
Confidence 2 457889999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=390.57 Aligned_cols=315 Identities=29% Similarity=0.486 Sum_probs=249.1
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||+|+||+||+|+++. +++.||||++++...........+.+|+.+|..++||||++++++|+++..+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD-TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 479999999999999999999886 5789999999987655556677889999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+.......
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEeecccceecccccccc
Confidence 9999999999999988899999999999999999999999999999999999999999 999999999997643211100
Q ss_pred -----------------------------------ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCC
Q psy622 201 -----------------------------------EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNS 238 (473)
Q Consensus 201 -----------------------------------~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g 238 (473)
......+||+.|+ |||++. ..|+|++|++ ++|++|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYI---APEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCcccc---CHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 0111246888888 898753 4689999965 579999
Q ss_pred CCCchhHhhhcCCCCChhhHhh--hccCCCCccccCChhHHHHHHhccccCCCCCCC---HHHHhcCCCCCCCCcccccc
Q psy622 239 QAPFPSALRVAGSQIPTSTAAQ--LQLEWPEDEEALNPSTEETILALLKSDPTQRPS---GHQVRRLPMFKDYDWDSILD 313 (473)
Q Consensus 239 ~~pf~~~~~~~~~~~~~~~~~~--~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps---a~eil~HPFF~~idw~~l~~ 313 (473)
..||........ ...+.. ....+|.. ..+++++++||.+||. +|.+|++ ++|+++||||++++|+.+..
T Consensus 236 ~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~-~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~ 309 (364)
T cd05599 236 YPPFCSDNPQET----YRKIINWKETLQFPDE-VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRE 309 (364)
T ss_pred CCCCCCCCHHHH----HHHHHcCCCccCCCCC-CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHhh
Confidence 999964211000 000111 12233322 3579999999999997 9999998 99999999999999999888
Q ss_pred CCCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCCceecccCCCCCCCCccccC
Q psy622 314 QEPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGSFVCCSNLNSHTASGMDVDS 371 (473)
Q Consensus 314 ~~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 371 (473)
..||+.|.+.+..|+++|+...+.. .+...++.. ........+-.|.||+|.+
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 362 (364)
T cd05599 310 RPAPIIPELKSITDTSNFDDFEEID-LDVPTSPGP----PRGKIKSKDLAFIGYTYKR 362 (364)
T ss_pred cCCCCCCCCCCchhhhhcccccccc-ccccCCCcc----ccccccccCCCCCCCeeeC
Confidence 8999999999999999998643332 222222111 1112334667899998864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=381.44 Aligned_cols=305 Identities=29% Similarity=0.460 Sum_probs=246.1
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
++||+|+||.||+|+++. +++.||+|++++..............|..++... +||||+++++++++.+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG-KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 479999999999999886 6789999999986543344456778888888765 89999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... .....
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGD---NRAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEeCccCCCeecccCC---Cceec
Confidence 99999999988899999999999999999999999999999999999999999 999999999987532111 12234
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEE 278 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~d 278 (473)
.+||+.|+ |||++. ..|+|++|++ +++++|..||..... ...........+..+..++.++++
T Consensus 156 ~~gt~~y~---aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 225 (316)
T cd05620 156 FCGTPDYI---APEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------DELFESIRVDTPHYPRWITKESKD 225 (316)
T ss_pred cCCCcCcc---CHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCCCCCHHHHH
Confidence 57888888 888753 4789999965 579999999964211 111111122223333679999999
Q ss_pred HHHhccccCCCCCCCH-HHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCCcee
Q psy622 279 TILALLKSDPTQRPSG-HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGSFVC 355 (473)
Q Consensus 279 LI~~LL~~dP~kRpsa-~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~~~~ 355 (473)
||.+||+.||++|+++ +++++||||++++|..+..+ .||+.|....+.|.++|+.+...+......+.....
T Consensus 226 li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 300 (316)
T cd05620 226 ILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLSYSDKNLI----- 300 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccccccCcccCCCccccc-----
Confidence 9999999999999997 68999999999999988655 699999999999999999888765443333222222
Q ss_pred cccCCCCCCCCccccCc
Q psy622 356 CSNLNSHTASGMDVDSP 372 (473)
Q Consensus 356 ~~~~~~~~f~g~~~~~p 372 (473)
...++..|.||+|.+|
T Consensus 301 -~~~~~~~~~~~~~~~~ 316 (316)
T cd05620 301 -DSMDQSAFAGFSFINP 316 (316)
T ss_pred -ccccccCcCCCcccCC
Confidence 3457789999999887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=391.42 Aligned_cols=319 Identities=28% Similarity=0.458 Sum_probs=246.1
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.|+++++||+|+||+||+|+++. +++.||||++.+...........+.+|+.+++.++||||++++++|++...+|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVD-TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECC-CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 369999999999999999999876 5789999999987655566677899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc--
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV-- 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~-- 198 (473)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ |++||+|||+|..+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEeECCCCcccccccccc
Confidence 9999999999999988889999999999999999999999999999999999999998 9999999999854311000
Q ss_pred ------------------------------------------ccccccccCCCCcccccCCccccc------cCCcCCCC
Q psy622 199 ------------------------------------------YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFP 230 (473)
Q Consensus 199 ------------------------------------------~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g 230 (473)
........+||+.|+ |||++. ..|+|++|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~---aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYI---APEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccC---CHHHhcCCCCCCeeeEEech
Confidence 000112346888888 899764 36899999
Q ss_pred cc-ccccCCCCCchhHhhhcCCCCChhhHhh--hccCCCCccccCChhHHHHHHhccccCCCCCCC---HHHHhcCCCCC
Q psy622 231 TF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ--LQLEWPEDEEALNPSTEETILALLKSDPTQRPS---GHQVRRLPMFK 304 (473)
Q Consensus 231 ~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps---a~eil~HPFF~ 304 (473)
++ ++|++|..||....... ....+.. .....|.. ..+++++.+||.+|+ .+|.+|++ ++|+++||||+
T Consensus 236 vil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~p~~-~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~ 309 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLE----TQMKVINWQTSLHIPPQ-AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFK 309 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHH----HHHHHHccCCCcCCCCc-ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcC
Confidence 65 57999999997421100 0000111 12233322 468999999999986 59999997 99999999999
Q ss_pred CCCccccccC-CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccC---CCCCceecccCCCCCCCCcccc
Q psy622 305 DYDWDSILDQ-EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTH---GNGSFVCCSNLNSHTASGMDVD 370 (473)
Q Consensus 305 ~idw~~l~~~-~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~---~~~~~~~~~~~~~~~f~g~~~~ 370 (473)
+++|.....+ .+|+.|.+..+.|+++|+.....+.......+.. ....+..-.......|.||+|.
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (382)
T cd05625 310 TIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVNDTLNGWYKNGKHPEHAFYEFTFR 379 (382)
T ss_pred CcChHHHHhcCCCCccCcCCCcchhhhcCCCCccccccccccccccccccccccccccccCcccccceec
Confidence 9999975544 7999999999999999987654332111111110 0111122233355688888886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=382.71 Aligned_cols=308 Identities=29% Similarity=0.459 Sum_probs=249.4
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
+.||+|+||+||+|+++. +++.||+|++++...........+.+|+.++..+ +||||+++++++++.+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK-TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 479999999999999886 5789999999987555555667788999998877 89999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~---~~~~~ 155 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPG---DTTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CCEEEeeCCccccccCCC---Ccccc
Confidence 99999999988899999999999999999999999999999999999999999 999999999997632211 11234
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCC-CCC----hhhHhhhccCCCCccccCC
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGS-QIP----TSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~-~~~----~~~~~~~~~~~P~~~~~ls 273 (473)
.+||+.|+ |||++. ..|+|++|++ +++++|..||......... ... ...+......+| ..++
T Consensus 156 ~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p---~~~~ 229 (329)
T cd05618 156 FCGTPNYI---APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---RSLS 229 (329)
T ss_pred ccCCcccc---CHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC---CCCC
Confidence 57888888 888753 4789999965 5799999999532110000 000 011222344455 5789
Q ss_pred hhHHHHHHhccccCCCCCCC------HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy622 274 PSTEETILALLKSDPTQRPS------GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLS 345 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRps------a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~ 345 (473)
.++.+||.+||+.||++|++ ++++++||||++++|+.+.++ .||++|.+.+..+..+|++..+++....+..
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQLTPD 309 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCcccchhcCcccccCCccCCCC
Confidence 99999999999999999998 579999999999999988765 7999999999999999999888876655544
Q ss_pred ccCCCCCceecccCCCCCCCCccccC
Q psy622 346 TTHGNGSFVCCSNLNSHTASGMDVDS 371 (473)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~f~g~~~~~ 371 (473)
+.... +.++...|.||+|.|
T Consensus 310 ~~~~~------~~~~~~~~~~~~~~~ 329 (329)
T cd05618 310 DDDIV------RKIDQSEFEGFEYIN 329 (329)
T ss_pred ccccc------ccccccccCCCcccC
Confidence 33222 345668999998865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=380.71 Aligned_cols=305 Identities=29% Similarity=0.472 Sum_probs=247.2
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
+.||+|+||+||+|+++. +++.||||++++..............|..++... +||||+++++++++.+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 479999999999999876 5789999999986543344456677888888765 99999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGD---AKTCT 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEccCCcceECCCCC---Cceee
Confidence 99999999988889999999999999999999999999999999999999999 999999999987532111 11223
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEE 278 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~d 278 (473)
.+||+.|+ |||++. ..|+|++|++ +++++|..||..... ..........-+..+..++.++++
T Consensus 156 ~~gt~~y~---aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~~ 225 (316)
T cd05619 156 FCGTPDYI---APEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-------EELFQSIRMDNPCYPRWLTREAKD 225 (316)
T ss_pred ecCCcccc---CHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCccCCHHHHH
Confidence 46888888 888754 3688999965 679999999964211 111111111112223578999999
Q ss_pred HHHhccccCCCCCCCHH-HHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCCcee
Q psy622 279 TILALLKSDPTQRPSGH-QVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGSFVC 355 (473)
Q Consensus 279 LI~~LL~~dP~kRpsa~-eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~~~~ 355 (473)
||.+||+.||.+|+++. ++++||||+.++|..+..+ .||+.|...+..|.++|+.++.++.......+....
T Consensus 226 li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 300 (316)
T cd05619 226 ILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSVTDRMLI----- 300 (316)
T ss_pred HHHHHhccCHhhcCCChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChhhhcCCcccCCCccccc-----
Confidence 99999999999999986 9999999999999988765 799999999999999999999887655443333222
Q ss_pred cccCCCCCCCCccccCc
Q psy622 356 CSNLNSHTASGMDVDSP 372 (473)
Q Consensus 356 ~~~~~~~~f~g~~~~~p 372 (473)
..++++.|.+|+|.+|
T Consensus 301 -~~~~~~~~~~~~~~~~ 316 (316)
T cd05619 301 -NSMDQNMFENFSFINP 316 (316)
T ss_pred -ccccccccCCCcccCc
Confidence 3568889999999887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=381.93 Aligned_cols=303 Identities=31% Similarity=0.480 Sum_probs=248.7
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
+.||+|+||+||+|+++. +++.||||++++...........+.+|..++..+ +||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG-TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 479999999999998876 5789999999987655555567788999999888 79999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGG---VTTST 155 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC-CcEEecccCCCeecCcCC---Ccccc
Confidence 99999999988899999999999999999999999999999999999999999 999999999987522111 11223
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEE 278 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~d 278 (473)
.+|++.|+ |||.+. ..|.|++|++ +++++|..||...... .....+......+| ..++.++.+
T Consensus 156 ~~g~~~y~---aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~----~~~~~i~~~~~~~~---~~~~~~~~~ 225 (318)
T cd05570 156 FCGTPDYI---APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED----ELFQSILEDEVRYP---RWLSKEAKS 225 (318)
T ss_pred eecCcccc---CHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH----HHHHHHHcCCCCCC---CcCCHHHHH
Confidence 46888887 888754 3688999965 5799999999642110 00011222233444 578999999
Q ss_pred HHHhccccCCCCCCCH-----HHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCC
Q psy622 279 TILALLKSDPTQRPSG-----HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNG 351 (473)
Q Consensus 279 LI~~LL~~dP~kRpsa-----~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~ 351 (473)
||++||+.||.+||++ .++++||||+.++|..+..+ .||++|.+....|.++|+..+.......+..+....
T Consensus 226 li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 304 (318)
T cd05570 226 ILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAII- 304 (318)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCchhccCcccCCCCccccc-
Confidence 9999999999999999 99999999999999987765 799999999999999999988776554444443333
Q ss_pred CceecccCCCCCCCCcccc
Q psy622 352 SFVCCSNLNSHTASGMDVD 370 (473)
Q Consensus 352 ~~~~~~~~~~~~f~g~~~~ 370 (473)
..+++..|+||+|+
T Consensus 305 -----~~~~~~~~~~~~~~ 318 (318)
T cd05570 305 -----RNIDQEEFRGFSYI 318 (318)
T ss_pred -----ccccccccCCCCCC
Confidence 45688999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=379.01 Aligned_cols=314 Identities=32% Similarity=0.456 Sum_probs=249.6
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||+|+||+||+|+++. +++.||+|++++.........+.+.+|+.+++.++||||+++++++++...+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA-TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 479999999999999999999876 5789999999987654455567788999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++..+......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT-GHIKLADFGSAARLTANKMV 158 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC-CCEEeccCCCCeECCCCCce
Confidence 9999999999999886 689999999999999999999999999999999999999998 99999999999875432211
Q ss_pred cccccccCCCCcccccCCccccc------------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh--hhccC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA--QLQLE 264 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~ 264 (473)
......||+.|+ |||++. ..|+|++|++ ++|++|..||....... ....+. .....
T Consensus 159 --~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----~~~~i~~~~~~~~ 229 (330)
T cd05601 159 --NSKLPVGTPDYI---APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK----TYNNIMNFQRFLK 229 (330)
T ss_pred --eeecccCCcccc---CHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH----HHHHHHcCCCccC
Confidence 223346888887 888753 4699999965 57999999996421100 000111 11233
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccCCCCCcCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDTSYFHADKTNSYMDSTL 344 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~ 344 (473)
+|.. ..+++++.+||.+||+ ||.+||+++++++||||+.++|+.+....||+.|.+....|+++|++...+.......
T Consensus 230 ~~~~-~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (330)
T cd05601 230 FPED-PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNFDEPEKNSTRRSQS 307 (330)
T ss_pred CCCC-CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHHhhCCCCccCcCCCcchhhhcCCCcccccccccc
Confidence 4432 3689999999999998 9999999999999999999999999888999999999999999998776655433332
Q ss_pred CccCCCCCceecccCCCCCCCCcccc
Q psy622 345 STTHGNGSFVCCSNLNSHTASGMDVD 370 (473)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~f~g~~~~ 370 (473)
+...... ....-....|.||+|.
T Consensus 308 ~~~~~~~---~~~~~~~~~~~~~~~~ 330 (330)
T cd05601 308 STTQLKP---NGFSGKDLPFVGFSFI 330 (330)
T ss_pred ccccCCC---cCCCCCCCCccCceeC
Confidence 2221110 0011244688888873
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=376.68 Aligned_cols=299 Identities=28% Similarity=0.504 Sum_probs=243.4
Q ss_pred ecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCC
Q psy622 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGD 128 (473)
Q Consensus 49 LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~ 128 (473)
||+|+||+||+|+++. +++.||+|++++...........+.+|+.+|..++||||+++++++++...+|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRD-TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 7999999999999876 578999999987655555667788999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCC
Q psy622 129 VKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNG 208 (473)
Q Consensus 129 L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~g 208 (473)
|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... ......+|
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~---~~~~~~~g 155 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDD---DKTNTFCG 155 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-CcEEEEECcccccCccCC---CccccccC
Confidence 99999988899999999999999999999999999999999999999999 999999999998632211 12234578
Q ss_pred CCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHH
Q psy622 209 TPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETIL 281 (473)
Q Consensus 209 tp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~ 281 (473)
|+.|+ |||++. ..|.|++|++ +++++|..||...... .....+......+| ..+++++++||.
T Consensus 156 t~~y~---aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~li~ 225 (312)
T cd05585 156 TPEYL---APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN----EMYRKILQEPLRFP---DGFDRDAKDLLI 225 (312)
T ss_pred CcccC---CHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH----HHHHHHHcCCCCCC---CcCCHHHHHHHH
Confidence 88888 898753 4689999965 5799999999642110 00112222344455 579999999999
Q ss_pred hccccCCCCCC---CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCC-CCCCCCccCCCCCcee
Q psy622 282 ALLKSDPTQRP---SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSY-MDSTLSTTHGNGSFVC 355 (473)
Q Consensus 282 ~LL~~dP~kRp---sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~-~~~~~~~~~~~~~~~~ 355 (473)
+||+.||.+|| ++.|+++||||+.++|..+..+ .||+.|.+.+..|+++|+.+++... .++...+...
T Consensus 226 ~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 299 (312)
T cd05585 226 GLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSVVDDSHL------ 299 (312)
T ss_pred HHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCccccccccccCCCccccc------
Confidence 99999999998 4799999999999999988765 7999999999999999999887642 2222222211
Q ss_pred cccCCCCCCCCccc
Q psy622 356 CSNLNSHTASGMDV 369 (473)
Q Consensus 356 ~~~~~~~~f~g~~~ 369 (473)
+...+..|.||+|
T Consensus 300 -~~~~~~~~~~~~~ 312 (312)
T cd05585 300 -SETVQQQFGGWSY 312 (312)
T ss_pred -cchhccccCCCCC
Confidence 2335678888876
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=382.22 Aligned_cols=313 Identities=33% Similarity=0.554 Sum_probs=251.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||+|+||+||+|+++. +++.||||++++...........+.+|++++..++||||+++++++++.+++|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD-TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC-CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 479999999999999999999886 5789999999987655556677899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc--
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV-- 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~-- 198 (473)
|||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEeecCCCCccCcccCccc
Confidence 9999999999999988899999999999999999999999999999999999999999 9999999999987543220
Q ss_pred ------------------------ccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhh
Q psy622 199 ------------------------YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALR 247 (473)
Q Consensus 199 ------------------------~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~ 247 (473)
.........||+.|+ |||++. ..|.|++|++ ++|++|..||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYI---APEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCcccc---CHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 001123346888887 888753 4788999965 679999999975211
Q ss_pred hcCCCCChhhHhh--hccCCCCccccCChhHHHHHHhccccCCCCCCC-HHHHhcCCCCCCCCccccccCCCCCcCCCCC
Q psy622 248 VAGSQIPTSTAAQ--LQLEWPEDEEALNPSTEETILALLKSDPTQRPS-GHQVRRLPMFKDYDWDSILDQEPPFVPQPDD 324 (473)
Q Consensus 248 ~~~~~~~~~~~~~--~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps-a~eil~HPFF~~idw~~l~~~~pPf~P~~~~ 324 (473)
.. ....+.. ....+|.. ..+++++.+||.+||+ ||.+|++ ++|+++||||++++|+......||++|.+.+
T Consensus 236 ~~----~~~~i~~~~~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~ 309 (350)
T cd05573 236 QE----TYNKIINWKESLRFPPD-PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLRETKPPFVPELSS 309 (350)
T ss_pred HH----HHHHHhccCCcccCCCC-CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHHHhhCCCCcCCCCCC
Confidence 00 0011111 12334432 3479999999999997 9999999 9999999999999999988778999999999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCccCCCCCceecccCCCCCCCCccc
Q psy622 325 VFDTSYFHADKTNSYMDSTLSTTHGNGSFVCCSNLNSHTASGMDV 369 (473)
Q Consensus 325 ~~D~s~Fd~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~ 369 (473)
..|+++|+....+.......+.. ... ...-.+..|.||+|
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~ 349 (350)
T cd05573 310 PLDTSNFDDFEDDKDLSDYLSQN-SKK----LNKGKQLAFVGFTY 349 (350)
T ss_pred chhhhhcCCCCcccccccccccc-ccc----ccccccCccCCCcc
Confidence 99999999876655332221111 111 13346678999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=377.67 Aligned_cols=307 Identities=30% Similarity=0.457 Sum_probs=248.1
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHH---hcCCCCeeeEEEEEEeCCEEEE
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA---LTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~---~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
|++++.||+|+||.||+|+++. +++.||||++++.........+.+.+|++++. .++||||+++++++++.+.+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK-TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 7899999999999999998876 57899999999875544555667888877764 5579999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||||++||+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~-- 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFG-- 155 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CcEEeCcccCCccCCCCC--
Confidence 9999999999988865 579999999999999999999999999999999999999999 999999999987532211
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
......+|++.|+ |||.+. ..|+|++|++ +++++|..||...... .....+......+| ..+
T Consensus 156 -~~~~~~~g~~~y~---aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~----~~~~~i~~~~~~~p---~~~ 224 (324)
T cd05589 156 -DRTSTFCGTPEFL---APEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----EVFDSIVNDEVRYP---RFL 224 (324)
T ss_pred -CcccccccCcccc---CHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCC---CCC
Confidence 1223457888888 888653 3689999965 5799999999642110 00011222233444 578
Q ss_pred ChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy622 273 NPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLS 345 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~ 345 (473)
++++.+||.+||+.||.+|| +++++++||||++++|..+..+ .||+.|.+....|.++|+..++......+..
T Consensus 225 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 304 (324)
T cd05589 225 SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPVLTPP 304 (324)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcchhhhcCccccccccccCCC
Confidence 99999999999999999999 5899999999999999988765 6999999999999999999888766555544
Q ss_pred ccCCCCCceecccCCCCCCCCcccc
Q psy622 346 TTHGNGSFVCCSNLNSHTASGMDVD 370 (473)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~f~g~~~~ 370 (473)
.+.... +.-.+..|++|+|+
T Consensus 305 ~~~~~~-----~~~~~~~~~~~~~~ 324 (324)
T cd05589 305 REPRLL-----TEEEQELFRGFDYV 324 (324)
T ss_pred cccccc-----chhhhcccCCcccC
Confidence 332111 34488999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=374.55 Aligned_cols=309 Identities=27% Similarity=0.442 Sum_probs=243.7
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA-LALTHSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
+.||+|+||+||+|+++. +++.||+|++.+..........+++.|+.+ ++.++||||+++++.+++...+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA-DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 479999999999999876 578999999988655444455667777665 567899999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHS---KTTST 155 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeccCCCcccccCC---Ccccc
Confidence 99999999988899999999999999999999999999999999999999999 999999999987532111 12234
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEE 278 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~d 278 (473)
.+||+.|+ |||++. ..|+|++|++ ++|++|..||....... ....+.......+ ..+++++.+
T Consensus 156 ~~gt~~y~---aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~---~~~~~~~~~ 225 (323)
T cd05575 156 FCGTPEYL---APEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----MYDNILNKPLRLK---PNISVSARH 225 (323)
T ss_pred ccCChhhc---ChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----HHHHHHcCCCCCC---CCCCHHHHH
Confidence 57888888 888753 4789999965 57999999996421000 0011112233333 468999999
Q ss_pred HHHhccccCCCCCCCH----HHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCC
Q psy622 279 TILALLKSDPTQRPSG----HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGS 352 (473)
Q Consensus 279 LI~~LL~~dP~kRpsa----~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~ 352 (473)
||.+||+.||.+||++ .++++||||+.++|..+.++ .+|+.|.+....+.+.|+.+++.+........+.....
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (323)
T cd05575 226 LLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVL 305 (323)
T ss_pred HHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhcCccccccccccccCCCccccc
Confidence 9999999999999986 69999999999999998765 79999999999999999988887654443332222211
Q ss_pred ceecccCCCCCCCCcccc
Q psy622 353 FVCCSNLNSHTASGMDVD 370 (473)
Q Consensus 353 ~~~~~~~~~~~f~g~~~~ 370 (473)
...........|.||+|.
T Consensus 306 ~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05575 306 VSASVKEADDAFLGFSYA 323 (323)
T ss_pred ccccccccccccCCCccC
Confidence 111123356789999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=377.47 Aligned_cols=308 Identities=28% Similarity=0.450 Sum_probs=247.7
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+|++.+.||+|+||+||+|+++. +++.||||++++.........+.+..|..++..+ +|++|+++++++++.+.+|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 58899999999999999998876 5789999999987554455567788899999888 467888999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~--- 155 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDG--- 155 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeccccccccCCCC---
Confidence 9999999999999988899999999999999999999999999999999999999999 999999999998632211
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
......+||+.|+ |||++. ..|+|++|++ +++++|..||...... .....+......+| ..++
T Consensus 156 ~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~~~~~~~p---~~~~ 225 (323)
T cd05615 156 VTTRTFCGTPDYI---APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----ELFQSIMEHNVSYP---KSLS 225 (323)
T ss_pred ccccCccCCcccc---CHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCC---ccCC
Confidence 1123356888888 888754 3789999965 5799999999752110 00112222334445 5789
Q ss_pred hhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy622 274 PSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLST 346 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~ 346 (473)
.++.+++.+||++||.+|++ .+++++||||+.++|..+.++ .|||.|.... .+..+|+..+++.........
T Consensus 226 ~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 304 (323)
T cd05615 226 KEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCG-KGAENFDKFFTRGQPVLTPPD 304 (323)
T ss_pred HHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCC-CchhhcCccccccCCCCCCCc
Confidence 99999999999999999997 479999999999999999876 7999998766 468899888876533333222
Q ss_pred cCCCCCceecccCCCCCCCCccccC
Q psy622 347 THGNGSFVCCSNLNSHTASGMDVDS 371 (473)
Q Consensus 347 ~~~~~~~~~~~~~~~~~f~g~~~~~ 371 (473)
.... .+.+...|.||+|++
T Consensus 305 ~~~~------~~~~~~~~~~~~~~~ 323 (323)
T cd05615 305 QLVI------ANIDQADFEGFSYVN 323 (323)
T ss_pred cccc------ccccccccCCCcccC
Confidence 2222 445668999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=384.39 Aligned_cols=318 Identities=30% Similarity=0.480 Sum_probs=245.9
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||+|+||+||+|+++. +++.||||++.+.........+++.+|+++++.++||||++++++|++..++|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD-TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 479999999999999999998877 6789999999886655555677889999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc-
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY- 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~- 199 (473)
|||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++........
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEEeecccccccccccccc
Confidence 9999999999999988899999999999999999999999999999999999999998 99999999999643211000
Q ss_pred -----------c--------------------------------ccccccCCCCcccccCCccccc------cCCcCCCC
Q psy622 200 -----------L--------------------------------EISDLVNGTPNAFNIRTPGQLL------SLKTGTFP 230 (473)
Q Consensus 200 -----------~--------------------------------~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g 230 (473)
. ......+||+.|+ |||++. ..|+|++|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYI---APEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCcccc---CHHHHccCCCCCceeeEecc
Confidence 0 0001246888888 898753 47899999
Q ss_pred cc-ccccCCCCCchhHhhhcCCCCChhhHh--hhccCCCCccccCChhHHHHHHhccccCCCCCC---CHHHHhcCCCCC
Q psy622 231 TF-QDVQNSQAPFPSALRVAGSQIPTSTAA--QLQLEWPEDEEALNPSTEETILALLKSDPTQRP---SGHQVRRLPMFK 304 (473)
Q Consensus 231 ~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRp---sa~eil~HPFF~ 304 (473)
++ ++|++|..||....... . ...+. .....+|.. ..++.++++||.+||+ +|.+|+ ++.|+++||||+
T Consensus 236 vil~elltG~~Pf~~~~~~~---~-~~~i~~~~~~~~~p~~-~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~ 309 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHE---T-YRKIINWRETLYFPDD-IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFR 309 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHH---H-HHHHHccCCccCCCCC-CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcC
Confidence 65 67999999996421100 0 00111 112334432 3588999999999998 777765 899999999999
Q ss_pred CCCccccccCCCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCCceecccCCCCCCCCcccc
Q psy622 305 DYDWDSILDQEPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGSFVCCSNLNSHTASGMDVD 370 (473)
Q Consensus 305 ~idw~~l~~~~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 370 (473)
+++|+.+....+|+.|.+....|+.+|..+.......+........ .....+...+..|.||+|.
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 374 (377)
T cd05629 310 GVDWDTIRQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAP-AQQEESVELDLAFIGYTYK 374 (377)
T ss_pred CCCHHHHccCCCCcccCCCCccccccCCccccccCccccccccccc-cccccccccCcccccceec
Confidence 9999999877999999999999999998777654222221111110 0001122355677788764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=375.41 Aligned_cols=313 Identities=26% Similarity=0.456 Sum_probs=245.1
Q ss_pred CeEEEceecccCceEEEEEEEeC--CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMIN-KNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l 117 (473)
+|++++.||+|+||+||+|++.. .+++.||+|++.+..... ....+++.+|++++..+ +||+|++++++++..+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 58999999999999999997643 357899999998754332 33456788999999999 699999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC-CCEEEeeCcCCccccccC
Confidence 9999999999999999988889999999999999999999999999999999999999999 999999999998643222
Q ss_pred cccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
.. .....+||+.|+ |||.+. ..|.|++|++ +++++|..||...............+......+|
T Consensus 160 ~~--~~~~~~gt~~y~---aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 231 (332)
T cd05614 160 KE--RTYSFCGTIEYM---APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP--- 231 (332)
T ss_pred CC--ccccccCCcccc---CHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC---
Confidence 11 122357888888 888653 3689999965 5799999999632110000000011111222333
Q ss_pred ccCChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDS 342 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~ 342 (473)
..+++.+++||.+||+.||++|| +++++++||||++++|..+... .+||.|......|.++|..+.++..+..
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (332)
T cd05614 232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVY 311 (332)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCccc
Confidence 57899999999999999999999 7889999999999999988654 7999999999999999987766532211
Q ss_pred CCCccCCCCCceecccCCCCCCCCccccCc
Q psy622 343 TLSTTHGNGSFVCCSNLNSHTASGMDVDSP 372 (473)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p 372 (473)
++... +......|+||+|+.|
T Consensus 312 --~~~~~-------~~~~~~~~~~~~~~~~ 332 (332)
T cd05614 312 --SPAGT-------PPSGARVFQGYSFVAP 332 (332)
T ss_pred --CCCCC-------CcccccccCCceecCC
Confidence 11110 1224578999999865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=374.58 Aligned_cols=278 Identities=28% Similarity=0.468 Sum_probs=234.1
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCc
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIG 126 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 126 (473)
+.||+|+||.||+|+++. +++.||+|++++...........+.+|+++++.++||||++++++|+....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 479999999999998876 5789999999987555555677888999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccccccc
Q psy622 127 GDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLV 206 (473)
Q Consensus 127 g~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 206 (473)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~---~~~~~~ 155 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDG---ATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-CCEEecccHHhccccCCC---Cccccc
Confidence 9999999988899999999999999999999999999999999999999998 999999999988632211 112235
Q ss_pred CCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHH
Q psy622 207 NGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEET 279 (473)
Q Consensus 207 ~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dL 279 (473)
+||+.|+ |||++. ..|.|++|++ +++++|..||...... .....+......+| ..+++++++|
T Consensus 156 ~gt~~y~---aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~~~~~~~~~p---~~~~~~~~~l 225 (323)
T cd05595 156 CGTPEYL---APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEEIRFP---RTLSPEAKSL 225 (323)
T ss_pred cCCcCcC---CcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCCCCC---CCCCHHHHHH
Confidence 6888888 899764 3688999965 5799999999642110 00011112233445 5789999999
Q ss_pred HHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCC
Q psy622 280 ILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSY 339 (473)
Q Consensus 280 I~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~ 339 (473)
|.+||+.||.+|+ ++.++++||||.+++|..+..+ .||+.|...++.++.+|+.+++...
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (323)
T cd05595 226 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQS 292 (323)
T ss_pred HHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCcccccCC
Confidence 9999999999998 7999999999999999998765 6999999999999999999988754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=379.86 Aligned_cols=284 Identities=29% Similarity=0.498 Sum_probs=231.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||+|+||+||+|+++. +++.||||++++..........++.+|+.++..++||||+++++.|++.+++|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD-TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 479999999999999999999886 6789999999986655566677889999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc-
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY- 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~- 199 (473)
|||++||+|.+++.+.+.+++..++.+++||+.||+|||++||+||||||+|||++.+ |++||+|||+++.+......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEeeccCCcccccccccc
Confidence 9999999999999988899999999999999999999999999999999999999998 99999999998764321100
Q ss_pred -------------------------------cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCC
Q psy622 200 -------------------------------LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAP 241 (473)
Q Consensus 200 -------------------------------~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~p 241 (473)
.......+||+.|+ |||++. ..|+|++|++ ++|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~---APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYI---APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCcccc---CHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 00112346888888 898753 4689999965 579999999
Q ss_pred chhHhhhcCCCCChhhHhh--hccCCCCccccCChhHHHHHHhccccCCCCCCC---HHHHhcCCCCCCCCccccccCCC
Q psy622 242 FPSALRVAGSQIPTSTAAQ--LQLEWPEDEEALNPSTEETILALLKSDPTQRPS---GHQVRRLPMFKDYDWDSILDQEP 316 (473)
Q Consensus 242 f~~~~~~~~~~~~~~~~~~--~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps---a~eil~HPFF~~idw~~l~~~~p 316 (473)
|....... ....+.. ....+|.. ..+++++++||.+|+. ||.+|++ ++|+++||||++++|..+.++.+
T Consensus 236 f~~~~~~~----~~~~i~~~~~~~~~p~~-~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~ 309 (360)
T cd05627 236 FCSETPQE----TYRKVMNWKETLVFPPE-VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHIRERPA 309 (360)
T ss_pred CCCCCHHH----HHHHHHcCCCceecCCC-CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCC
Confidence 96421100 0001111 12334432 3479999999999875 9999985 79999999999999999988765
Q ss_pred CCcCCCCCCCCCCCCCCCC
Q psy622 317 PFVPQPDDVFDTSYFHADK 335 (473)
Q Consensus 317 Pf~P~~~~~~D~s~Fd~~~ 335 (473)
+..+.+.+..|+++|++-.
T Consensus 310 ~~~~~~~~~~~~~~~~~~~ 328 (360)
T cd05627 310 AIPIEIKSIDDTSNFDEFP 328 (360)
T ss_pred CCCccCCCcchhhhcCCCC
Confidence 5556788899999998543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=382.37 Aligned_cols=314 Identities=31% Similarity=0.473 Sum_probs=247.5
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
....++|++.+.||+|+||+||+|+++. +++.||+|++++.........+.+.+|+.+++.++||||++++++++++..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKS-SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4557899999999999999999998876 678999999987655555556678899999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+||||++||+|..++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC-CCEEEEeccceeeccCC
Confidence 99999999999999998764 68999999999999999999999999999999999999999 99999999999875322
Q ss_pred ccccccccccCCCCcccccCCccccc----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh--hcc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ--LQL 263 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~ 263 (473)
.. ......+||+.|+ |||.+. ..|+|++|++ ++|++|..||....... ....+.. ...
T Consensus 196 ~~--~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~~~~ 266 (370)
T cd05596 196 GM--VRCDTAVGTPDYI---SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYSKIMDHKNSL 266 (370)
T ss_pred Cc--ccCCCCCCCcCeE---CHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----HHHHHHcCCCcC
Confidence 11 1223457899988 888653 3699999965 57999999997521100 0011111 124
Q ss_pred CCCCccccCChhHHHHHHhccccCCCC--CCCHHHHhcCCCCCCCCccccc--cCCCCCcCCCCCCCCCCCCCCCCCCCC
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQ--RPSGHQVRRLPMFKDYDWDSIL--DQEPPFVPQPDDVFDTSYFHADKTNSY 339 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~k--Rpsa~eil~HPFF~~idw~~l~--~~~pPf~P~~~~~~D~s~Fd~~~t~~~ 339 (473)
.+|.. ..+|.++++||.+||+.+|.+ |++++|+++||||++.+|.... ...+|+.|...+..|+++|++...++.
T Consensus 267 ~~~~~-~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 345 (370)
T cd05596 267 TFPDD-IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDIEDDDK 345 (370)
T ss_pred CCCCc-CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChhhHHhcCCCcCccCcCCCcchhhhcCCcccccc
Confidence 44532 358999999999999999988 9999999999999999887543 337999999999999999987655542
Q ss_pred CCCCCCccCCCCCceecccCCCCCCCCcccc
Q psy622 340 MDSTLSTTHGNGSFVCCSNLNSHTASGMDVD 370 (473)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 370 (473)
...+...+.. ...++..|.||+|.
T Consensus 346 ~~~~~~~~~~-------~~~~~~~~~~~~~~ 369 (370)
T cd05596 346 NEETFPLPKA-------FAGNQLPFIGFTYS 369 (370)
T ss_pred ccccCCCccc-------cccccCccCCCeec
Confidence 2222222211 11133459999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=371.52 Aligned_cols=310 Identities=27% Similarity=0.427 Sum_probs=241.6
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA-LALTHSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
++||+|+||+||+|+++. +++.||+|++.+...........+..|+.+ ++.++||||++++++++..+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL-DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 479999999999998876 578999999987654444455666777664 567899999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~---~~~~~ 155 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQS---DTTTT 155 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEeecCCcccCCCCC---CCccc
Confidence 99999999988899999999999999999999999999999999999999999 999999999987532111 11234
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEE 278 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~d 278 (473)
.+||+.|+ |||++. ..|+|++|++ ++|++|..||....... ....+.......+ ...+.++.+
T Consensus 156 ~~gt~~y~---aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~ 225 (325)
T cd05604 156 FCGTPEYL---APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE----MYDNILHKPLVLR---PGASLTAWS 225 (325)
T ss_pred ccCChhhC---CHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH----HHHHHHcCCccCC---CCCCHHHHH
Confidence 57888888 888753 4789999965 57999999996421000 0011111222233 468899999
Q ss_pred HHHhccccCCCCCCCH----HHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCC
Q psy622 279 TILALLKSDPTQRPSG----HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGS 352 (473)
Q Consensus 279 LI~~LL~~dP~kRpsa----~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~ 352 (473)
+|++||++||.+||++ .++++||||+.++|..+..+ .+|+.|...+..|.++|+..++.+.......... ..+
T Consensus 226 ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 304 (325)
T cd05604 226 ILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSS-DYS 304 (325)
T ss_pred HHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCCccccCCcccCccccc-ccc
Confidence 9999999999999975 69999999999999998765 6899999999999999998887664332221110 011
Q ss_pred ceecccC-CCCCCCCccccCc
Q psy622 353 FVCCSNL-NSHTASGMDVDSP 372 (473)
Q Consensus 353 ~~~~~~~-~~~~f~g~~~~~p 372 (473)
....+.. -...|.||+|..|
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~ 325 (325)
T cd05604 305 IVNASVLEADDAFVGFSYAPP 325 (325)
T ss_pred cccccccccccccCCCEecCC
Confidence 1111111 3468999999876
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=379.04 Aligned_cols=314 Identities=31% Similarity=0.494 Sum_probs=244.4
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
....++|++.+.||+|+||.||+|+++. +++.||+|++.+...........+.+|+.+++.++||||++++++++++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKS-SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3456889999999999999999999886 578999999987655555556678899999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+|+.+...
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEEecccceecccC
Confidence 99999999999999999764 68999999999999999999999999999999999999998 99999999999875322
Q ss_pred ccccccccccCCCCcccccCCccccc----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh--hcc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ--LQL 263 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~ 263 (473)
.. ....+.+||+.|+ |||++. ..|+|++|++ ++|++|..||....... ....+.. ...
T Consensus 196 ~~--~~~~~~~gt~~Y~---aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~----~~~~i~~~~~~~ 266 (370)
T cd05621 196 GM--VRCDTAVGTPDYI---SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG----TYSKIMDHKNSL 266 (370)
T ss_pred Cc--eecccCCCCcccC---CHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCccc
Confidence 11 1223567999988 888653 4789999965 57999999997531100 0011111 124
Q ss_pred CCCCccccCChhHHHHHHhccccCCCC--CCCHHHHhcCCCCCCCCcccc--ccCCCCCcCCCCCCCCCCCCCCCCCCCC
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQ--RPSGHQVRRLPMFKDYDWDSI--LDQEPPFVPQPDDVFDTSYFHADKTNSY 339 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~k--Rpsa~eil~HPFF~~idw~~l--~~~~pPf~P~~~~~~D~s~Fd~~~t~~~ 339 (473)
.+|.. ..++..++++|.+||+.+|.+ |++++|+++||||++.+|+.. ....+|+.|.+.+..|.++|+.......
T Consensus 267 ~~p~~-~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 345 (370)
T cd05621 267 NFPED-VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDKG 345 (370)
T ss_pred CCCCc-ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcChHhcCCCCCCcCCCCCCcchhhhcCCcccccc
Confidence 44532 357999999999999865544 889999999999999766543 3447999999999999999985433322
Q ss_pred CCCCCCccCCCCCceecccCCCCCCCCcccc
Q psy622 340 MDSTLSTTHGNGSFVCCSNLNSHTASGMDVD 370 (473)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 370 (473)
.-.++..+ ..++ .++..|.||+|+
T Consensus 346 ~~~~~~~~---~~~~----~~~~~~~~~~~~ 369 (370)
T cd05621 346 DVETFPIP---KAFV----GNQLPFIGFTYY 369 (370)
T ss_pred ccccCCCC---cccc----ccccccCCCEec
Confidence 11111111 1111 234899999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=373.59 Aligned_cols=275 Identities=29% Similarity=0.501 Sum_probs=234.6
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||+|+||+||+|+++. +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI-SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 479999999999999999998876 5789999999876544445566789999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ |.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEEecCcchhccCC----
Confidence 9999999999999998899999999999999999999999999999999999999998 99999999999875322
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
....+|++.|+ |||++. ..|+|++|++ +++++|..||...... .....+......+| ..++
T Consensus 155 --~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~~---~~~~ 222 (291)
T cd05612 155 --TWTLCGTPEYL---APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF----GIYEKILAGKLEFP---RHLD 222 (291)
T ss_pred --cccccCChhhc---CHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCcCCC---ccCC
Confidence 12346888887 888754 3688999965 5799999999642110 00122223344555 5689
Q ss_pred hhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCC
Q psy622 274 PSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHA 333 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~ 333 (473)
+.+++||++||+.||.+|++ ++|+++||||+.++|..+..+ .||..|.+....|+.||+.
T Consensus 223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 289 (291)
T cd05612 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDD 289 (291)
T ss_pred HHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCccccccccC
Confidence 99999999999999999995 999999999999999988765 7999999999999999985
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=379.15 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=219.2
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEe
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK--NMVSQVLRERNALALTH-SPFCVQLFYSLQT 113 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~--~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~ 113 (473)
....+.|++.+.||+|+||+|++|++.. ++..||+|++++...... ...+.+.+|+.+++.++ ||||++++.++.+
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~-t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRL-TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeecc-CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 4557899999999999999999999887 578999998887643312 34557789999999998 9999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..++|+||||+.||+|++++.+.+++.|.+++.++.||+.||+|||++||+||||||||||+|.+.+.+||+|||++...
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999987679999999999985
Q ss_pred cCCccccccccccCCCCcccccCCcccccc--------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLLS--------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~~--------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 264 (473)
. .......+.||||.|+ |||++.. .|+|++|++ +.|++|..||.... .......+......
T Consensus 172 ~---~~~~~l~t~cGsp~Y~---aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~----~~~l~~ki~~~~~~ 241 (370)
T KOG0583|consen 172 P---GEDGLLKTFCGSPAYA---APEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN----VPNLYRKIRKGEFK 241 (370)
T ss_pred C---CCCCcccCCCCCcccC---CHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc----HHHHHHHHhcCCcc
Confidence 3 1224456789999999 8997643 678999976 55999999998521 01111335556777
Q ss_pred CCCccccC-ChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 265 WPEDEEAL-NPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 265 ~P~~~~~l-s~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+| .++ |+++++||.+||..||.+|+++.+|++||||+.-
T Consensus 242 ~p---~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 242 IP---SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred CC---CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 78 577 9999999999999999999999999999999964
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=379.22 Aligned_cols=287 Identities=30% Similarity=0.487 Sum_probs=233.3
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+++|+.++||||+++++.|++++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD-TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC-CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 479999999999999999999876 5789999999876555555567889999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc--
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV-- 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~-- 198 (473)
|||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+|..+.....
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC-CCEEEEeCCCCcccccccccc
Confidence 9999999999999998899999999999999999999999999999999999999998 9999999999853210000
Q ss_pred --------------------------------------ccccccccCCCCcccccCCccccc------cCCcCCCCcc-c
Q psy622 199 --------------------------------------YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-Q 233 (473)
Q Consensus 199 --------------------------------------~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~ 233 (473)
........+||+.|+ |||++. ..|+|++|++ +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYI---APEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcccc---CHHHHcCCCCCcceeeeeccceee
Confidence 000112346888888 899764 3689999965 5
Q ss_pred cccCCCCCchhHhhhcCCCCChhhHhh--hccCCCCccccCChhHHHHHHhccccCCCCCC---CHHHHhcCCCCCCCCc
Q psy622 234 DVQNSQAPFPSALRVAGSQIPTSTAAQ--LQLEWPEDEEALNPSTEETILALLKSDPTQRP---SGHQVRRLPMFKDYDW 308 (473)
Q Consensus 234 ~~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRp---sa~eil~HPFF~~idw 308 (473)
+|++|..||........ ...+.. .....|.. ..+++++.+||.+|+ .+|.+|+ ++.|+++||||++++|
T Consensus 236 ell~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~-~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 236 EMLVGQPPFLADTPAET----QLKVINWETTLHIPSQ-AKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred ehhhCCCCCCCCCHHHH----HHHHhccCccccCCCC-CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 79999999975211000 000100 11122221 468999999999977 5999999 8999999999999999
Q ss_pred cccccC-CCCCcCCCCCCCCCCCCCCCCCCC
Q psy622 309 DSILDQ-EPPFVPQPDDVFDTSYFHADKTNS 338 (473)
Q Consensus 309 ~~l~~~-~pPf~P~~~~~~D~s~Fd~~~t~~ 338 (473)
..+..+ .+|+.|.+..+.|+++|+....+.
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (376)
T cd05598 310 ASLIRRQKAPYIPKITHPTDTSNFDPVDPEK 340 (376)
T ss_pred HHHhhcCCCCCCCcCCCcchhhhcCCCCccc
Confidence 998654 799999999999999998765443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=369.99 Aligned_cols=280 Identities=29% Similarity=0.472 Sum_probs=234.3
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCc
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIG 126 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 126 (473)
+.||+|+||+||+|+++. +++.||+|++++...........+.+|++++..++||||+++++++++...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA-TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 479999999999998876 6789999999987655555667888999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 127 GDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 127 g~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
|+|..++.+.+.+++..++.++.||+.||+|||+ .||+||||||+|||++.+ +.+||+|||+++...... .....
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~---~~~~~ 155 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDG---ATMKT 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC-CCEEEecCCCCeecCCCC---ccccc
Confidence 9999999988899999999999999999999997 799999999999999999 999999999987532111 11223
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEE 278 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~d 278 (473)
.+||+.|+ |||++. ..|.|++|++ +++++|..||...... .....+......+| ..+++++.+
T Consensus 156 ~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~----~~~~~i~~~~~~~p---~~~~~~~~~ 225 (325)
T cd05594 156 FCGTPEYL---APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEEIRFP---RTLSPEAKS 225 (325)
T ss_pred ccCCcccC---CHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH----HHHHHHhcCCCCCC---CCCCHHHHH
Confidence 56888888 898753 4789999965 5799999999642110 00111222334445 578999999
Q ss_pred HHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCC
Q psy622 279 TILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMD 341 (473)
Q Consensus 279 LI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~ 341 (473)
||.+||+.||++|+ ++.++++||||++++|..+..+ .||+.|...+..|+.+|++++++....
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (325)
T cd05594 226 LLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMIT 295 (325)
T ss_pred HHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCchhhcCccc
Confidence 99999999999997 8999999999999999988765 699999999999999999998875433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=372.41 Aligned_cols=282 Identities=31% Similarity=0.524 Sum_probs=235.2
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||+|+||.||+|+++. +++.||+|++++...........+.+|+.++..++||||+++++++++...+|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD-TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 479999999999999999999876 5789999999987554445567889999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEEEeCcCCccccc-----
Confidence 9999999999999988899999999999999999999999999999999999999998 9999999999987432
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh--hccCCCCc---
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ--LQLEWPED--- 268 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~P~~--- 268 (473)
......||+.|+ |||++. ..|+|++|++ ++|++|..||....... . ...+.. .....|..
T Consensus 154 -~~~~~~gt~~y~---aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~-~~~i~~~~~~~~~~~~~~~ 225 (333)
T cd05600 154 -YANSVVGSPDYM---APEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---T-WENLKYWKETLQRPVYDDP 225 (333)
T ss_pred -ccCCcccCcccc---ChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---H-HHHHHhccccccCCCCCcc
Confidence 223356888887 888753 4789999965 67999999996421100 0 000000 11112211
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccCCCCCcCCCCCCCCCCCCCCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDTSYFHADKTN 337 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~~pPf~P~~~~~~D~s~Fd~~~t~ 337 (473)
...+++++.+||.+||+.+|.+|++++|+++||||++++|..+.+..||+.|.+.+..|.++|+.....
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPELESEIDTGYFDDFENE 294 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHHHhhCCCCCCCCCCCcchhhhccCCCCc
Confidence 125789999999999999999999999999999999999999887789999999999999988765443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=370.65 Aligned_cols=306 Identities=29% Similarity=0.505 Sum_probs=244.0
Q ss_pred EceecccCceEEEEEEEeC--CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEec
Q psy622 46 VKAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMI-NKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
++.||+|+||.||+|++.. .+++.||+|++++.... ......++.+|+.+|+.++||||+++++.|++++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 3689999999999998643 35789999999876432 23345578899999999999999999999999999999999
Q ss_pred ccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccc
Q psy622 123 YMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEI 202 (473)
Q Consensus 123 y~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~ 202 (473)
|++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~---~~ 156 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEG---TV 156 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEeeCcCCeecccCC---Cc
Confidence 99999999999998899999999999999999999999999999999999999998 999999999987532211 12
Q ss_pred ccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChh
Q psy622 203 SDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPS 275 (473)
Q Consensus 203 ~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~ 275 (473)
....+||+.|+ |||++. ..|.|++|++ +++++|..||....... ....+......+| ..++++
T Consensus 157 ~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----~~~~~~~~~~~~~---~~~~~~ 226 (323)
T cd05584 157 THTFCGTIEYM---APEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----TIDKILKGKLNLP---PYLTPE 226 (323)
T ss_pred ccccCCCcccc---ChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCC---CCCCHH
Confidence 23457888888 888753 4789999965 67999999997521100 0111222333444 578999
Q ss_pred HHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccC
Q psy622 276 TEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTH 348 (473)
Q Consensus 276 a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~ 348 (473)
+.+||.+||++||.+|+ +++++++||||+..+|+.+..+ .||+.|...+..|.+.|+..++........++..
T Consensus 227 ~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (323)
T cd05584 227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDST 306 (323)
T ss_pred HHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCchhcccccccCccccc
Confidence 99999999999999999 7999999999999999998765 7899999999999999998776542211111110
Q ss_pred CCCCceecccCCCCCCCCccccCc
Q psy622 349 GNGSFVCCSNLNSHTASGMDVDSP 372 (473)
Q Consensus 349 ~~~~~~~~~~~~~~~f~g~~~~~p 372 (473)
-+...+..|.||+|.+|
T Consensus 307 -------~~~~~~~~~~~~~~~~~ 323 (323)
T cd05584 307 -------LSESANQIFLGFTYVAP 323 (323)
T ss_pred -------cccccccCcCCCeecCC
Confidence 12224578999999876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=371.44 Aligned_cols=277 Identities=32% Similarity=0.512 Sum_probs=229.3
Q ss_pred ecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT---HSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 49 LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
||+|+||+||+|+++. +++.||+|++.+..........+...|..++... +||+|++++..+++...+|+||||++
T Consensus 1 lG~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKD-TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECC-CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 7999999999998876 5789999999876655555566777788888765 79999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~---~~~~~ 155 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDN---KTTNT 155 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCC---CCccC
Confidence 99999999998899999999999999999999999999999999999999999 999999999987632211 12234
Q ss_pred cCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHH
Q psy622 206 VNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTE 277 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~ 277 (473)
.+||+.|+ |||++. ..|.|++|++ ++|++|..||...... .....+......+|. ..++++++
T Consensus 156 ~~gt~~y~---aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~--~~~~~~~~ 226 (330)
T cd05586 156 FCGTTEYL---APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ----QMYRNIAFGKVRFPK--NVLSDEGR 226 (330)
T ss_pred ccCCcccc---CHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH----HHHHHHHcCCCCCCC--ccCCHHHH
Confidence 57888888 888653 3789999965 5799999999642110 000112222344453 35899999
Q ss_pred HHHHhccccCCCCCC----CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCC
Q psy622 278 ETILALLKSDPTQRP----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSY 339 (473)
Q Consensus 278 dLI~~LL~~dP~kRp----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~ 339 (473)
+||++||+.||.+|| +++|+++||||++++|+.+..+ .||+.|.+....|.++|+.+++++.
T Consensus 227 ~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (330)
T cd05586 227 QFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFTNSS 294 (330)
T ss_pred HHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcCccccccc
Confidence 999999999999998 6899999999999999988765 7899999999999999998887653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=370.42 Aligned_cols=287 Identities=31% Similarity=0.516 Sum_probs=234.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||+|+||+||+|+.+. +++.||+|++++.........+.+.+|+.++..++||||++++++|++++++|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN-TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 579999999999999999998876 5789999999876555555667789999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||++..+.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~- 157 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGT- 157 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC-CCEEEEECCceeecCCCCC-
Confidence 999999999999987 4579999999999999999999999999999999999999998 9999999999876532221
Q ss_pred cccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh--hhccCC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA--QLQLEW 265 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~ 265 (473)
......+||+.|+ |||++. ..|+|++|++ ++|++|..||....... . ...+. .....+
T Consensus 158 -~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~---~-~~~i~~~~~~~~~ 229 (331)
T cd05597 158 -VQSNVAVGTPDYI---SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---T-YGKIMNHKEHFQF 229 (331)
T ss_pred -ccccceecccccc---CHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH---H-HHHHHcCCCcccC
Confidence 1122346888888 888754 3699999965 57999999996421100 0 00011 112333
Q ss_pred CCccccCChhHHHHHHhccccCCCC--CCCHHHHhcCCCCCCCCccccccCCCCCcCCCCCCCCCCCCCCCCCCC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQ--RPSGHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDTSYFHADKTNS 338 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~k--Rpsa~eil~HPFF~~idw~~l~~~~pPf~P~~~~~~D~s~Fd~~~t~~ 338 (473)
|.....+++++++||++||+.++++ |++++++++||||++++|..+....||+.|...+..|+++|+...+..
T Consensus 230 ~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (331)
T cd05597 230 PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNFDVDDDDL 304 (331)
T ss_pred CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHHhhCCCCccCcCCCcchhhhcCCccccc
Confidence 4333468999999999999764444 789999999999999999999888999999999999999998766543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=368.46 Aligned_cols=311 Identities=26% Similarity=0.435 Sum_probs=240.7
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN-ALALTHSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
+.||+|+||+||+|+++. +++.||+|++.+...........+..|.. +++.++||||+++++++++.+.+|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA-EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 479999999999999876 57899999998765444444455566655 4677899999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~---~~~~~ 155 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHN---GTTST 155 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEEccCCCCcccccCC---CCccc
Confidence 99999999988889999999999999999999999999999999999999998 999999999997632211 12234
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEE 278 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~d 278 (473)
.+||+.|+ |||++. ..|+|++|++ ++|++|..||....... ....+......++ ..+++++.+
T Consensus 156 ~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~---~~~~~~~~~ 225 (325)
T cd05602 156 FCGTPEYL---APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNILNKPLQLK---PNITNSARH 225 (325)
T ss_pred ccCCcccc---CHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----HHHHHHhCCcCCC---CCCCHHHHH
Confidence 57899888 898653 4799999965 57999999996421100 0011111222333 478999999
Q ss_pred HHHhccccCCCCCCCHH----HHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCC
Q psy622 279 TILALLKSDPTQRPSGH----QVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGS 352 (473)
Q Consensus 279 LI~~LL~~dP~kRpsa~----eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~ 352 (473)
+|.+||++||.+|+++. ++++|+||..++|+.+..+ .||+.|.+.++.++..|+..++.++.............
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (325)
T cd05602 226 LLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDSIL 305 (325)
T ss_pred HHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhcCCccccCCcccccCCCchhhh
Confidence 99999999999999864 8999999999999999765 78999999999999999988877654433222211110
Q ss_pred ceecccCCCCCCCCccccCc
Q psy622 353 FVCCSNLNSHTASGMDVDSP 372 (473)
Q Consensus 353 ~~~~~~~~~~~f~g~~~~~p 372 (473)
...........|.||+|-.|
T Consensus 306 ~~~~~~~~~~~~~g~~~~~~ 325 (325)
T cd05602 306 VTASVKEAAEAFLGFSYAPP 325 (325)
T ss_pred hcccccccccccCCCccCCC
Confidence 11111224456889988665
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=367.90 Aligned_cols=286 Identities=29% Similarity=0.500 Sum_probs=233.9
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||+|+||.||+|+++. +++.||+|++++...........+..|+.++..++|++|+++++++++.+.+|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH-TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 579999999999999999998876 5789999999876544555566788999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~- 157 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGT- 157 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC-CCEEEEeccceeeccCCCc-
Confidence 999999999999987 4689999999999999999999999999999999999999998 9999999999987533211
Q ss_pred cccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh--hhccCC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA--QLQLEW 265 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~ 265 (473)
......+||+.|+ |||++. ..|+|++|++ ++|++|..||....... ....+. .....+
T Consensus 158 -~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~~~ 229 (331)
T cd05624 158 -VQSSVAVGTPDYI---SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TYGKIMNHEERFQF 229 (331)
T ss_pred -eeeccccCCcccC---CHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH----HHHHHHcCCCcccC
Confidence 1123356888888 888653 3689999965 57999999996421100 000111 112334
Q ss_pred CCccccCChhHHHHHHhccccCCCC--CCCHHHHhcCCCCCCCCccccccCCCCCcCCCCCCCCCCCCCCCCCC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQ--RPSGHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDTSYFHADKTN 337 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~k--Rpsa~eil~HPFF~~idw~~l~~~~pPf~P~~~~~~D~s~Fd~~~t~ 337 (473)
|.....+++++++||.+||+.++++ |++++++++||||++++|+.+.+..+|+.|...++.++++|+.+.+.
T Consensus 230 p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 303 (331)
T cd05624 230 PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSNFDVDDDV 303 (331)
T ss_pred CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHHhhCCCCccCCCCCcchhhhcCCcccc
Confidence 5433467999999999999976554 46899999999999999999988899999999999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=362.09 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=217.3
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
..+.+|.+.+.||.|+||+||+|+++. ++..||||.+.+..+ .++.++.+..|+.||+.++|||||.++++.++.+++
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~-~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKK-SGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred cccccceehhhccCcceEEEEEeEecc-CCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 347899999999999999999999998 468999999998865 566678899999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC--C---CceeEeecchhhh
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ--A---PHCPIVNTLFLAI 192 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~--~---g~ikL~DFGla~~ 192 (473)
|||||||.||||..+|++.+.++|..++.++.||+.||++||+++||||||||+||||+.. . ..+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999999999999999999999999999999999999999999999999864 1 4689999999999
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
+... ....+.||+|-|| |||++. ..|.|+.|++ +.+++|.+||....... ....+++..--.
T Consensus 165 L~~~----~~a~tlcGSplYM---APEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e----L~~~~~k~~~~~ 233 (429)
T KOG0595|consen 165 LQPG----SMAETLCGSPLYM---APEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE----LLLYIKKGNEIV 233 (429)
T ss_pred CCch----hHHHHhhCCcccc---CHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH----HHHHHhcccccc
Confidence 8643 3445689999999 999874 4788999954 67999999998521110 001222223333
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
|..+..++....+|+..+|+++|..|.+..+-..|+|...
T Consensus 234 ~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 234 PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 4444688889999999999999999999999999988754
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=366.89 Aligned_cols=283 Identities=29% Similarity=0.505 Sum_probs=232.1
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|+++++||+|+||.||+++.+. +++.||+|++.+...........+..|+.++..++|+||+++++++++...+|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN-ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC-CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 479999999999999999998876 5789999999876554455566788899999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+++.+.....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~~- 157 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGT- 157 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEeecchheecccCCc-
Confidence 999999999999987 4679999999999999999999999999999999999999998 9999999999976432211
Q ss_pred cccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh--hhccCC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA--QLQLEW 265 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~ 265 (473)
......+||+.|+ |||++. ..|+|++|++ +++++|..||....... ....+. .....+
T Consensus 158 -~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~~~ 229 (332)
T cd05623 158 -VQSSVAVGTPDYI---SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TYGKIMNHKERFQF 229 (332)
T ss_pred -ceecccccCcccc---CHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH----HHHHHhCCCccccC
Confidence 1123457899888 888653 4789999965 57999999997421100 000111 112344
Q ss_pred CCccccCChhHHHHHHhccccCCCC--CCCHHHHhcCCCCCCCCccccccCCCCCcCCCCCCCCCCCCCCC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQ--RPSGHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDTSYFHAD 334 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~k--Rpsa~eil~HPFF~~idw~~l~~~~pPf~P~~~~~~D~s~Fd~~ 334 (473)
|.....+++++++||++||+.++.+ |++++|+++||||.+++|+.+.+..+|+.|...++.++++++..
T Consensus 230 p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (332)
T cd05623 230 PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSNFDVD 300 (332)
T ss_pred CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHhhCCCCccCCCCCCcccccCCCC
Confidence 5444578999999999999765554 67899999999999999999988899999999999999988654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=374.80 Aligned_cols=316 Identities=32% Similarity=0.494 Sum_probs=243.6
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
.....++|++.+.||+|+||.||+|+++. +++.||+|++.+.........+.+.+|+.+++.++||||+++++++++..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKS-TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECC-CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34556899999999999999999999887 67899999998765545555667889999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+||||++||+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+++.+..
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC-CCEEEEeCCceeEcCc
Confidence 999999999999999999764 68999999999999999999999999999999999999998 9999999999987532
Q ss_pred CccccccccccCCCCcccccCCccccc----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh--hc
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ--LQ 262 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~--~~ 262 (473)
... ......+||+.|+ |||++. ..|+|++|++ ++|++|..||....... ....+.. ..
T Consensus 195 ~~~--~~~~~~~gt~~y~---aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~~~~ 265 (371)
T cd05622 195 EGM--VRCDTAVGTPDYI---SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYSKIMNHKNS 265 (371)
T ss_pred CCc--ccccCcccCcccc---CHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCc
Confidence 211 1223457999988 888653 4789999965 57999999997521100 0011111 12
Q ss_pred cCCCCccccCChhHHHHHHhccccCCCC--CCCHHHHhcCCCCCCCCc--cccccCCCCCcCCCCCCCCCCCCCCCCCCC
Q psy622 263 LEWPEDEEALNPSTEETILALLKSDPTQ--RPSGHQVRRLPMFKDYDW--DSILDQEPPFVPQPDDVFDTSYFHADKTNS 338 (473)
Q Consensus 263 ~~~P~~~~~ls~~a~dLI~~LL~~dP~k--Rpsa~eil~HPFF~~idw--~~l~~~~pPf~P~~~~~~D~s~Fd~~~t~~ 338 (473)
..+|.. ..++.++++||.+||+.++.+ |++++|+++||||++.+| ..+.+..+|++|.+.+..++++|+....+.
T Consensus 266 ~~~~~~-~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (371)
T cd05622 266 LTFPDD-NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDIEEDK 344 (371)
T ss_pred ccCCCc-CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChhHHhcCCCCCCCCCCCCCcchhhhcCCCcccc
Confidence 344432 468999999999999844433 678999999999998655 455455899999999999999998544433
Q ss_pred CCCCCCCccCCCCCceecccCCCCCCCCccccC
Q psy622 339 YMDSTLSTTHGNGSFVCCSNLNSHTASGMDVDS 371 (473)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 371 (473)
....+...+ .. -...+..|.||+|++
T Consensus 345 ~~~~~~~~~---~~----~~~~~~~~~~~~~~~ 370 (371)
T cd05622 345 GEEETFPIP---KA----FVGNQLPFVGFTYYS 370 (371)
T ss_pred cccccCCCC---cc----ccccccccCCCeecC
Confidence 221111111 00 111237899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=364.38 Aligned_cols=306 Identities=28% Similarity=0.441 Sum_probs=240.9
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN-ALALTHSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
++||+|+||+||+|+++. +++.||+|++.+...........+..|+. +++.++||||+++++++++.+.+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS-DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 479999999999999876 57899999998865544444556666765 5678899999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ |.+||+|||+++...... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPE---ETTST 155 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEccCCCCccCCCCC---Ccccc
Confidence 99999999988889999999999999999999999999999999999999999 999999999987532211 12234
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEE 278 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~d 278 (473)
.+||+.|+ |||.+. ..|+|++|++ ++|++|..||...... .....+......+| ...+.++.+
T Consensus 156 ~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~~~~~~~---~~~~~~~~~ 225 (321)
T cd05603 156 FCGTPEYL---APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS----QMYDNILHKPLQLP---GGKTVAACD 225 (321)
T ss_pred ccCCcccC---CHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH----HHHHHHhcCCCCCC---CCCCHHHHH
Confidence 57888887 888753 4799999965 6799999999642100 00111222233444 568899999
Q ss_pred HHHhccccCCCCCCCH----HHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCC
Q psy622 279 TILALLKSDPTQRPSG----HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGS 352 (473)
Q Consensus 279 LI~~LL~~dP~kRpsa----~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~ 352 (473)
+|.+||++||.+|+++ .|+++||||..++|..+..+ .||+.|......++..|++.++.+......+.......
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (321)
T cd05603 226 LLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTA 305 (321)
T ss_pred HHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCCcccccccccccCCCCcccc
Confidence 9999999999999975 59999999999999998765 79999999999999999998887655444333222111
Q ss_pred ceecccCCCCCCCCcccc
Q psy622 353 FVCCSNLNSHTASGMDVD 370 (473)
Q Consensus 353 ~~~~~~~~~~~f~g~~~~ 370 (473)
. +......|.||+|.
T Consensus 306 ~---~~~~~~~~~~~~~~ 320 (321)
T cd05603 306 S---SSSASSAFLGFSYA 320 (321)
T ss_pred c---ccccccccCCCccC
Confidence 1 22234568888763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=378.17 Aligned_cols=261 Identities=21% Similarity=0.355 Sum_probs=227.3
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
..-.++-|++.+.||+|+-|.|-+|++.. ||+..|||++.+..-........+.+|+-||+.+.||||+++++++.+..
T Consensus 7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~-TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAE-TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred ccccccceeccccccCCCCceehhhhccc-ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 34457789999999999999999999887 79999999999986555666778999999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
++|+|+||++||.|+++|-+.|+++|.+++.|+.||+.|+.|+|..+|+||||||||+|||.. +.|||+|||+|..-.
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~-~nIKIADFGMAsLe~- 163 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK-NNIKIADFGMASLEV- 163 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc-cCEeeeccceeeccc-
Confidence 999999999999999999999999999999999999999999999999999999999999999 789999999998732
Q ss_pred CccccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
...+-.+.||.|.|. +||++.+ .|+|+-|++ +.+++|..||.+..- ......++.+...+|
T Consensus 164 ---~gklLeTSCGSPHYA---~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi----r~LLlKV~~G~f~MP- 232 (786)
T KOG0588|consen 164 ---PGKLLETSCGSPHYA---APEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI----RVLLLKVQRGVFEMP- 232 (786)
T ss_pred ---CCccccccCCCcccC---CchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH----HHHHHHHHcCcccCC-
Confidence 224455679999999 8999864 688999965 569999999985321 111234455677778
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSIL 312 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~ 312 (473)
..+|++|++||++||..||.+|+|.+||++|||+.+..-....
T Consensus 233 --s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 233 --SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred --CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 6999999999999999999999999999999999887654433
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=361.06 Aligned_cols=302 Identities=29% Similarity=0.459 Sum_probs=238.8
Q ss_pred EceecccCceEEEEEEEeC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecc
Q psy622 46 VKAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEY 123 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 123 (473)
++.||+|+||.||++++.. .+++.||+|++++.... .....++.+|+++|+.++||||+++++++++++.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 3689999999999997642 35789999999876432 23345678899999999999999999999999999999999
Q ss_pred cCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccc
Q psy622 124 MIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEIS 203 (473)
Q Consensus 124 ~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~ 203 (473)
++||+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... ...
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~---~~~ 155 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHE---KKA 155 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC-CcEEEeeccCCcccCCCC---Cce
Confidence 9999999999988889999999999999999999999999999999999999998 999999999998643221 112
Q ss_pred cccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhH
Q psy622 204 DLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPST 276 (473)
Q Consensus 204 ~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a 276 (473)
...+|++.|+ +||.+. ..|.|++|++ +++++|..||....... ....+......+| ..+++++
T Consensus 156 ~~~~g~~~y~---aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~i~~~~~~~p---~~~~~~~ 225 (318)
T cd05582 156 YSFCGTVEYM---APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE----TMTMILKAKLGMP---QFLSPEA 225 (318)
T ss_pred ecccCChhhc---CHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH----HHHHHHcCCCCCC---CCCCHHH
Confidence 2357888888 888643 4789999965 67999999996421100 0011222334445 5789999
Q ss_pred HHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCC
Q psy622 277 EETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHG 349 (473)
Q Consensus 277 ~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~ 349 (473)
.+||++||+.||.+||+ ++++++||||+.++|..+..+ .||+.|......+..++++.+....+... +...
T Consensus 226 ~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 303 (318)
T cd05582 226 QSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDS--PGIP 303 (318)
T ss_pred HHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCCCcchhhhcCcccccCccccC--CCCc
Confidence 99999999999999999 678999999999999988765 68999998888888888887764322211 1111
Q ss_pred CCCceecccCCCCCCCCcccc
Q psy622 350 NGSFVCCSNLNSHTASGMDVD 370 (473)
Q Consensus 350 ~~~~~~~~~~~~~~f~g~~~~ 370 (473)
. +.-....|+||+|+
T Consensus 304 ~------s~~~~~~~~~~~~~ 318 (318)
T cd05582 304 P------SANAHQLFRGFSFV 318 (318)
T ss_pred c------ccccccccCCCEeC
Confidence 1 22255688999885
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=359.32 Aligned_cols=268 Identities=25% Similarity=0.395 Sum_probs=218.2
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
.|++.+.||+|+||+||+|.++. +++.||+|++.+...........+.+|+.+++.++|++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec-CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 38899999999999999999887 57899999998765544444557889999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 122 EYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++........
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGET- 157 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCCe-
Confidence 999999999888653 369999999999999999999999999999999999999998 9999999999986432211
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
.....||+.|+ |||.+. ..|+|++|++ +++++|..||......................++ ..+
T Consensus 158 ---~~~~~g~~~y~---aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 228 (285)
T cd05631 158 ---VRGRVGTVGYM---APEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYS---EKF 228 (285)
T ss_pred ---ecCCCCCCCcc---CHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCC---ccC
Confidence 12235777777 888753 3689999965 6799999999752110000000001111122333 578
Q ss_pred ChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCC
Q psy622 273 NPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQ 321 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~ 321 (473)
++++.+||++||+.||.+||+ ++++++||||++++|+.+.++ +|||+|+
T Consensus 229 s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence 999999999999999999997 899999999999999999987 8999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=340.36 Aligned_cols=257 Identities=22% Similarity=0.349 Sum_probs=226.9
Q ss_pred cccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q psy622 32 KSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSL 111 (473)
Q Consensus 32 ~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 111 (473)
....+...+++|++.+.||+|.||.||+|+.+. ++..||+|++.|..+...+..+++.+|++|.+.++||||+++|++|
T Consensus 13 ~~~~~~~~l~dfeigr~LgkgkFG~vYlarekk-s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 13 SRATKTWTLDDFEIGRPLGKGKFGNVYLAREKK-SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccccccchhhccccccccCCccccEeEeeecc-CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 345577889999999999999999999999888 5789999999999988777788999999999999999999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecch
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIA--ANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~--~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
.+...+|+++||.++|+|+..|+ ...+|++..+..|+.|++.||.|+|..+||||||||+|+|++.. |.+||+|||.
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~-~~lkiAdfGw 170 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA-GELKIADFGW 170 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC-CCeeccCCCc
Confidence 99999999999999999999999 55689999999999999999999999999999999999999999 9999999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCccc-cccCCCCCchhHhhhcCCCCChhhHhhhc
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTFQ-DVQNSQAPFPSALRVAGSQIPTSTAAQLQ 262 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l~-~~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 262 (473)
+..-.. ....+.|||-.|+ +||.+. .++.|++|++. +++.|.+||..... .-....+.+.+
T Consensus 171 sV~~p~-----~kR~tlcgt~dyl---~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~----~etYkrI~k~~ 238 (281)
T KOG0580|consen 171 SVHAPS-----NKRKTLCGTLDYL---PPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH----SETYKRIRKVD 238 (281)
T ss_pred eeecCC-----CCceeeecccccC---CHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh----HHHHHHHHHcc
Confidence 987322 2345689998888 888764 57889999986 59999999986432 11123445567
Q ss_pred cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 263 LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 263 ~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
+.+| ..++.+++|||.+||.++|.+|+...|++.|||...
T Consensus 239 ~~~p---~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 239 LKFP---STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ccCC---cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 7788 689999999999999999999999999999999864
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=361.51 Aligned_cols=261 Identities=30% Similarity=0.431 Sum_probs=212.8
Q ss_pred ccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch-----------hHHHHHHHHHHHHHhcCC
Q psy622 33 SCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK-----------NMVSQVLRERNALALTHS 101 (473)
Q Consensus 33 ~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~-----------~~~~~~~~E~~iL~~l~h 101 (473)
.......+++|++++.||+|.||+|-+|+... +++.||||++.|.....+ ...+++++|+.||++++|
T Consensus 89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~-~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H 167 (576)
T KOG0585|consen 89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEV-DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH 167 (576)
T ss_pred CcccceehhheehhhhhcCCccceEEEEeecC-CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence 34456668999999999999999999999876 689999999988753321 124689999999999999
Q ss_pred CCeeeEEEEEEeC--CEEEEEecccCcCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC
Q psy622 102 PFCVQLFYSLQTS--SCVFLVMEYMIGGDVKSLIAANGA-LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178 (473)
Q Consensus 102 p~Iv~l~~~f~~~--~~l~lVmEy~~gg~L~~~L~~~~~-~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~ 178 (473)
||||+|+++..+. .++|||+|||..|.+...=. .+. +++.+||.|+..++.||+|||.+|||||||||.|+||+++
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence 9999999999875 57999999999988854322 234 9999999999999999999999999999999999999999
Q ss_pred CCceeEeecchhhhhcCCc---cccccccccCCCCcccccCCccccc----------cCCcCCCCcc-ccccCCCCCchh
Q psy622 179 APHCPIVNTLFLAILQQPI---VYLEISDLVNGTPNAFNIRTPGQLL----------SLKTGTFPTF-QDVQNSQAPFPS 244 (473)
Q Consensus 179 ~g~ikL~DFGla~~~~~~~---~~~~~~~~~~gtp~y~~~~ape~i~----------~~~~~s~g~l-~~~~~g~~pf~~ 244 (473)
|++||+|||.+....... ....+.. ..|||.++ |||..+ ..|+|++|+- |-++.|+.||.+
T Consensus 247 -g~VKIsDFGVs~~~~~~~~~~~d~~L~~-tvGTPAF~---APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 247 -GTVKISDFGVSNEFPQGSDEGSDDQLSR-TVGTPAFF---APELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred -CcEEeeccceeeecccCCccccHHHHhh-cCCCcccc---chHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 999999999998652211 1112222 57999999 888654 3788999965 558999999986
Q ss_pred HhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 245 ALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
..... ....+....+.+|.. ..+..+++|||.+||++||.+|++..+|+.|||...
T Consensus 322 ~~~~~----l~~KIvn~pL~fP~~-pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 322 DFELE----LFDKIVNDPLEFPEN-PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred chHHH----HHHHHhcCcccCCCc-ccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 43221 123455567888875 468999999999999999999999999999999753
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=347.95 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=208.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--EE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS--CV 117 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~--~l 117 (473)
..++...+.||+|+||.||++..+. ++..+|||.+..... ...+.+.+|+.+|..++|||||++++...... .+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~-~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKK-TGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred cchhhhhccccCccceEEEEEEecC-CCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 5678899999999999999998876 478999999987632 22667899999999999999999999754444 79
Q ss_pred EEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC-CCCceeEeecchhhhhcC
Q psy622 118 FLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA-QAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~-~~g~ikL~DFGla~~~~~ 195 (473)
++.|||++||+|.+++.+.+ .|+|..++.|++||+.||+|||++|||||||||+|||++. + +.+||+|||+++....
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~-~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSN-GDVKLADFGLAKKLES 170 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCC-CeEEeccCcccccccc
Confidence 99999999999999999977 8999999999999999999999999999999999999999 6 8999999999998653
Q ss_pred CccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hccCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQLEWP 266 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P 266 (473)
............|||.|| |||++. ..|.|++|+. .+|++|..||.... ......... ..-..|
T Consensus 171 ~~~~~~~~~~~~Gtp~~m---aPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig~~~~~P 242 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYM---APEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIGREDSLP 242 (313)
T ss_pred ccccccccccccCCcccc---CchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHhccCCCC
Confidence 122222233467999999 898876 5789999965 68999999997620 000000000 011234
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
..+..+|+++++||.+||.+||++||||+++++|||.+..
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 4557899999999999999999999999999999999753
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=342.05 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=198.9
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.|+.+.++|+|+||+||+++++. ||++||||++.... .+....+-.+||+++|++++|||+|.|+++|...+++++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~-TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD-TGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC-cccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 568999999999999999999987 79999999988653 2233344679999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc-c
Q psy622 121 MEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI-V 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~-~ 198 (473)
+|||.. ++.+.|.+. ..++++.++.|+.|++.|+.|+|+++|||||||||||||..+ |.+||||||+|+.+..+. .
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN-GVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC-CcEEeccchhhHhhcCCcch
Confidence 999955 666666654 469999999999999999999999999999999999999999 999999999999975322 1
Q ss_pred ccccccccCCCCcccccCCccccc-------cCCcCCCCccc-cccCCCCCchhH---------hhhcCCCCChh-hHhh
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTFQ-DVQNSQAPFPSA---------LRVAGSQIPTS-TAAQ 260 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l~-~~~~g~~pf~~~---------~~~~~~~~~~~-~~~~ 260 (473)
+... ..+.+|+|||.+. .+|.|+.|++. +|++|.+.|++. ....+.-++.. .+..
T Consensus 158 YTDY-------VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 158 YTDY-------VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred hhhh-------hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 1111 1113567888765 38899999765 799999999872 12222222221 0000
Q ss_pred -----hccCCCCc---------cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 261 -----LQLEWPED---------EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 261 -----~~~~~P~~---------~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.-+.+|+. ...++.-+.||+++||..||.+|++.+|++.||||.+
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 01111111 1367888999999999999999999999999999954
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=359.84 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=205.1
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC-E
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSS-C 116 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~-~ 116 (473)
-.++|.++++||.|+||.||+|+.+. ++..||||.++++... -+...-+||+..|++++ |||||+|.+++.+.. .
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~-~~~~VAIK~MK~Kf~s--~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE-TGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC-CCceeeHHHHHhhhcc--HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 35789999999999999999999887 6789999999987432 23345588999999998 999999999998887 9
Q ss_pred EEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
+|+||||| ..+|+++++.+ +.|+|..++.|+.||++||+|+|++|+.||||||||||+..+ ..|||+|||+|+.+.+
T Consensus 85 L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~-~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN-DVIKIADFGLAREVRS 162 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc-ceeEeccccccccccc
Confidence 99999999 77999999875 479999999999999999999999999999999999999977 7999999999999765
Q ss_pred CccccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhH---------hhhcCCCCChhhH
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSA---------LRVAGSQIPTSTA 258 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~---------~~~~~~~~~~~~~ 258 (473)
...+...- . +.+|+|||+++. +|.|++|++ .++.+.++.|++. ....+.+......
T Consensus 163 kpPYTeYV----S---TRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 163 KPPYTEYV----S---TRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred CCCcchhh----h---cccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 44332211 1 136679998764 677788865 4677888888862 2333333222111
Q ss_pred h------hhccCCCC--------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 259 A------QLQLEWPE--------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 259 ~------~~~~~~P~--------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
. ...+.+|. .....++++.+||.+||..||.+||||+|+++||||+.-
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 1 12333432 124589999999999999999999999999999999854
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=362.80 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=217.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|.+.+.||+|+||.||+|++|. +.++||||.+.|.. ..+++.+.+.+|++|++.++|||||.++++|++..++|+
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~-t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKY-TIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred CcchhHHHHhcCCccceeeeccccc-ceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence 3679999999999999999999887 67999999999875 345568889999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|+||+.| +|+++|...+.++|+.++.++.+++.||.|||+++|+|||+||.||||+.. |++|+||||+++.+....
T Consensus 79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t-- 154 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNT-- 154 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-CceeechhhhhhhcccCc--
Confidence 9999966 999999999999999999999999999999999999999999999999999 999999999999865422
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
..-+.+.|||-|| |||.+. ..|.|++|++ |++..|++||....-. -....+.....+|| .++
T Consensus 155 -~vltsikGtPlYm---APElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~----~Lv~~I~~d~v~~p---~~~ 223 (808)
T KOG0597|consen 155 -SVLTSIKGTPLYM---APELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT----QLVKSILKDPVKPP---STA 223 (808)
T ss_pred -eeeeeccCccccc---CHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH----HHHHHHhcCCCCCc---ccc
Confidence 3334568999999 898754 4678999965 6799999999863110 01234555677788 589
Q ss_pred ChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 273 NPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
|..+++|++.||++||.+|++..+++.|||.++
T Consensus 224 S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 224 SSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred cHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 999999999999999999999999999999875
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=348.58 Aligned_cols=246 Identities=20% Similarity=0.354 Sum_probs=214.2
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
-+|++.+.||+|+||+|-+|+.+. .|+.||||.++|+.+..+++.-++.+|++||..++||||+++|.+|++.+++.||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~-sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHK-SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhcc-CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 469999999999999999998876 6899999999999998888889999999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||..+|+|++++..++.++|.+++.+++||+.|+.|+|+++++|||||.+|||||.+ +++||+|||++-.+...
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N-~NiKIADFGLSNly~~~---- 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN-NNIKIADFGLSNLYADK---- 206 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC-CCeeeeccchhhhhccc----
Confidence 9999999999999999999999999999999999999999999999999999999999 99999999999876443
Q ss_pred ccccccCCCCcccccCCccccc-------cCCcCCCCcccc-ccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTFQD-VQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l~~-~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
.+-.++||+|-|. +||++. .++.|++|++.+ +..|..||.+.... .....+..+...-| .-
T Consensus 207 kfLqTFCGSPLYA---SPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk----~lvrQIs~GaYrEP----~~ 275 (668)
T KOG0611|consen 207 KFLQTFCGSPLYA---SPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK----RLVRQISRGAYREP----ET 275 (668)
T ss_pred cHHHHhcCCcccC---CccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH----HHHHHhhcccccCC----CC
Confidence 3445689999998 888875 478999998865 88999999863211 00111111222223 45
Q ss_pred ChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 273 NPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
+.+|.-||+.||..||++|.|+++|..|=|.
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 6789999999999999999999999999765
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=348.51 Aligned_cols=255 Identities=20% Similarity=0.318 Sum_probs=205.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS--SCV 117 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~l 117 (473)
.+.|+.+++||+|+||.||+|++.. +|+.||+|++.... .+........+|+.||++++||||++|.+...+. +.+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~-tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLE-TGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecc-cCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3569999999999999999999887 78999999999864 2344466789999999999999999999998776 789
Q ss_pred EEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|||+||| .-||.-++...+ .|++.+++.|+.||+.||+|||++||+|||||..|||||.+ |.+||+|||||+.+...
T Consensus 194 YlVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 194 YLVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN-GVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC-CCEEeccccceeeccCC
Confidence 9999999 559999998855 79999999999999999999999999999999999999999 99999999999976433
Q ss_pred ccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchh---------HhhhcCCCCChhhHh
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPS---------ALRVAGSQIPTSTAA 259 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~---------~~~~~~~~~~~~~~~ 259 (473)
.... . ..-.-+++|++||.++ .+|.|+.|++ .+|+.|++.|.+ +++..+.+....+.
T Consensus 272 ~~~~-~----T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~- 345 (560)
T KOG0600|consen 272 GSAP-Y----TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP- 345 (560)
T ss_pred CCcc-c----ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-
Confidence 2211 1 1111235677888765 5888999966 579999999986 34444443322221
Q ss_pred hhccCC--------------CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 260 QLQLEW--------------PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 260 ~~~~~~--------------P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
..++.+ .+....+++.+.+|+..||..||.+|.||.++++|+||.
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 111111 011357899999999999999999999999999999994
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=339.49 Aligned_cols=268 Identities=25% Similarity=0.390 Sum_probs=215.8
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
.|++.++||+|+||+||+|.... +++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC-CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 48999999999999999998776 57899999998765443444556788999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 122 EYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||++||+|..++... ..+++..++.++.||+.||.|||+.||+||||||+||+++++ +.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC-CCEEEeeCCCceecCCCCc-
Confidence 999999999988754 469999999999999999999999999999999999999998 9999999999886432211
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
.....|++.|+ +||.+. ..|+|++|++ +++++|..||...............+......++ ..+
T Consensus 158 ---~~~~~~~~~y~---aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 228 (285)
T cd05605 158 ---IRGRVGTVGYM---APEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS---EKF 228 (285)
T ss_pred ---cccccCCCCcc---CcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccC---ccc
Confidence 11235777777 888653 4689999965 6799999999742110000000011111122233 568
Q ss_pred ChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCC
Q psy622 273 NPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQ 321 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~ 321 (473)
+..+.+||.+||+.||.+|| +++++++||||...+|+.+.+. .|||+|.
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05605 229 SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284 (285)
T ss_pred CHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCC
Confidence 99999999999999999999 8999999999999999998766 6899984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=331.77 Aligned_cols=253 Identities=21% Similarity=0.328 Sum_probs=213.5
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.|++.++||+|.|+.|+++.++. +|+.+|+|+++.+.+... ..+.+.+|++|-+.++|||||+|+.+++..+..|||
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~-tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhcc-chHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 568999999999999999998776 789999999998766544 577899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--CceeEeecchhhhhcCCcc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA--PHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~--g~ikL~DFGla~~~~~~~~ 198 (473)
+|+|.||+|..-|-..-.++|..+-.|+.||+.||.|+|.+||||||+||+|+||.+.. .-+||+|||+++.++.+.
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~- 167 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE- 167 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc-
Confidence 99999999998877667899999999999999999999999999999999999997642 458999999999876332
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCccc-cccCCCCCchhHhhhcCCCCChhhHhhhccCCCC-ccc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTFQ-DVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE-DEE 270 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l~-~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~-~~~ 270 (473)
...-..|||.|| |||++. .++.|+-|++. -++.|.+||.+..+ ....+.+.+....+|. ..+
T Consensus 168 ---~~~G~~GtP~fm---aPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~----~rlye~I~~g~yd~~~~~w~ 237 (355)
T KOG0033|consen 168 ---AWHGFAGTPGYL---SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYEQIKAGAYDYPSPEWD 237 (355)
T ss_pred ---ccccccCCCccc---CHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH----HHHHHHHhccccCCCCcccC
Confidence 222247999999 999864 47888999765 48999999986211 1112344445555554 446
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
++++++++||++||+.||++|+|+.|+++|||+.+-
T Consensus 238 ~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 238 TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 899999999999999999999999999999999853
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.79 Aligned_cols=262 Identities=29% Similarity=0.471 Sum_probs=209.9
Q ss_pred ecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCC
Q psy622 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGD 128 (473)
Q Consensus 49 LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~ 128 (473)
||+|+||+||+|.++. +++.||+|++.+...........+..|+++++.++||||+++++++.....+|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRA-TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEcc-CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 7999999999998876 578999999987655444455678899999999999999999999999999999999999999
Q ss_pred HHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccccc
Q psy622 129 VKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISD 204 (473)
Q Consensus 129 L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~ 204 (473)
|..++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++..+..... ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~---~~~ 155 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQS---KTK 155 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCccceecCCCCc---ccc
Confidence 9988753 3469999999999999999999999999999999999999998 9999999999986543221 122
Q ss_pred ccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHH
Q psy622 205 LVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTE 277 (473)
Q Consensus 205 ~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~ 277 (473)
...||+.|+ |||.+. ..|.|++|++ +++++|..||......................+| ..+++++.
T Consensus 156 ~~~g~~~y~---aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 229 (280)
T cd05608 156 GYAGTPGFM---APELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYP---DKFSPASK 229 (280)
T ss_pred ccCCCcCcc---CHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCc---ccCCHHHH
Confidence 346788877 888753 4788999965 6799999999642110000000001111122333 56899999
Q ss_pred HHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCC
Q psy622 278 ETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQ 321 (473)
Q Consensus 278 dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~ 321 (473)
+|+.+||+.||++|+ +++++++||||++++|+.+... .|||.|.
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~ 280 (280)
T cd05608 230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280 (280)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCCC
Confidence 999999999999999 7899999999999999998765 6788773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=347.51 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=215.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~ 118 (473)
...|++.+.||+|.||.||+|+.+. +|+.||+|+++|...........+.+|+.||+.+. |||||+++++|++...+|
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~-tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKS-TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecC-CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4569999999999999999999987 58999999999988776666789999999999997 999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC---CceeEeecchhhhhcC
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA---PHCPIVNTLFLAILQQ 195 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~---g~ikL~DFGla~~~~~ 195 (473)
+|||+|.||+|++.|.+. .++|..+..++.||+.|+.|||+.||+||||||||+|+.... +.+|++|||+++....
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999999999999887 499999999999999999999999999999999999997652 4799999999998654
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCccc-cccCCCCCchhHhhhcCCCCChhhHhhhccCCCC-
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTFQ-DVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE- 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l~-~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~- 267 (473)
. ......+|||.|+ |||++. ..+.|+.|++. .|++|.+||....... ....+......++.
T Consensus 192 ~----~~~~~~~Gtp~y~---APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~----~~~~i~~~~~~f~~~ 260 (382)
T KOG0032|consen 192 G----ERLHTIVGTPEYV---APEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE----IFLAILRGDFDFTSE 260 (382)
T ss_pred C----ceEeeecCCcccc---CchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH----HHHHHHcCCCCCCCC
Confidence 2 2334579999999 899865 47899999765 5999999998632111 01122222333321
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
..+.+|..|+++|++||..||.+|+++.++++|||+++.
T Consensus 261 ~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 261 PWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred CccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 125789999999999999999999999999999998764
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=333.78 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=206.6
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----CC
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT-----SS 115 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-----~~ 115 (473)
..|..++.||+|+||.|+.|.++. +|+.||||++... +.+.-..++..+|+++|+.++|+||+.+.+.+.. -+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~-t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKR-TGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ceecccccccCcceeeEEEEEEcC-CCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 346668999999999999999987 5799999999853 3445567899999999999999999999999965 35
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+|+|+| +.||.+.|+.+..++++++++++.||+.||.|+|+.||+||||||.|+|++.+ ..+||+|||+|+....
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~-c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD-CDLKICDFGLARYLDK 177 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC-CCEEeccccceeeccc
Confidence 699999999 88999999998889999999999999999999999999999999999999999 8999999999998643
Q ss_pred CccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhH---------hhhcCCCCChhhH
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSA---------LRVAGSQIPTSTA 258 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~---------~~~~~~~~~~~~~ 258 (473)
... ...+.+.-.+.+|+|||+++ .+|.||.|++ .+|++|++.|++. ....+.+ ..+..
T Consensus 178 ~~~----~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP-~~e~l 252 (359)
T KOG0660|consen 178 FFE----DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP-SEEDL 252 (359)
T ss_pred cCc----ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC-CHHHH
Confidence 211 11112223334667888754 5889999965 5799999999872 2222222 11111
Q ss_pred hh----------------hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 259 AQ----------------LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 259 ~~----------------~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
.. ....|....++.++.|.||+.+||..||.+|+|++|+++||||....-.
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 11 1112222335899999999999999999999999999999999876543
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=335.43 Aligned_cols=275 Identities=32% Similarity=0.560 Sum_probs=233.5
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||+|+||.||+|+++. +++.||+|++.+...........+.+|+++++.++||||+++++++.+...+|+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG-SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 479999999999999999999876 5789999999887655556677899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||+|.||+++.+ +.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEeeCCCccccCCC----
Confidence 9999999999999998899999999999999999999999999999999999999999 99999999999875432
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
....++++.|+ +||.+. ..|.|++|++ +++++|..||...... .....+......+| ..++
T Consensus 155 --~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~---~~~~ 222 (290)
T cd05580 155 --TYTLCGTPEYL---APEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYEKILEGKVRFP---SFFS 222 (290)
T ss_pred --CCCCCCCcccc---ChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCccCC---ccCC
Confidence 22346777777 788653 4688999965 6799999998642110 00011112233444 5679
Q ss_pred hhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCC
Q psy622 274 PSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHA 333 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~ 333 (473)
..++++|.+||+.||.+|+ +++|+++||||+.++|..+... .+|++|......|++.|+.
T Consensus 223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (290)
T cd05580 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDD 289 (290)
T ss_pred HHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCCccccccccC
Confidence 9999999999999999999 8999999999999999999865 7999999999999888863
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=318.61 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=204.5
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|..+++||+|+||.||+|++.. +|+.||||+++.... .........||++.|+.++|+||+.++++|-....+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~-t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE-TGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC-CCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 578899999999999999999887 789999999998743 223344789999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
+||| ..||...|+... .++..+++.|+.+++.||+|||++.|+||||||.|+||+++ |.+||+|||+++........
T Consensus 80 fEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 80 FEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC-CcEEeecccchhccCCCCcc
Confidence 9999 679999998754 79999999999999999999999999999999999999999 99999999999987554332
Q ss_pred cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchh---------HhhhcCCCCChhhHhh--
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPS---------ALRVAGSQIPTSTAAQ-- 260 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~---------~~~~~~~~~~~~~~~~-- 260 (473)
.... .-..+|+|||.++ .++.|+.|++ .+++.+.+.|++ +++..+.+.+..+..-
T Consensus 158 ~~~~------V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 158 QTHQ------VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred cccc------eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 1110 1124567888765 4788889865 568888877876 3344444433322111
Q ss_pred ----hcc-CCCC-----ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 261 ----LQL-EWPE-----DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 261 ----~~~-~~P~-----~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.++ .+|. .....+.++.||+.+||..||.+|+++.|+++||||+.
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 000 1111 12457888999999999999999999999999999985
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.65 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=215.1
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
.++.++|++..+||.|.-++||+|+... ++.+||||+++-....+ ..+.+++|+..++.++||||++++++|..+..
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p-~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIP-TNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecc-cCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 4567899999999999999999999887 57999999999876533 37789999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 117 VFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
+|+||.||.+|++.++++.. ..|+|..++.++++++.||.|||++|.||||||+.||||+++ |.|||+|||.+..+-
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d-G~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD-GTVKLADFGVSASLF 177 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC-CcEEEcCceeeeeec
Confidence 99999999999999999873 359999999999999999999999999999999999999999 999999999987663
Q ss_pred CCccccccc-cccCCCCcccccCCcccc--------ccCCcCCCCcc-ccccCCCCCchhHh------hhcCCCCChhhH
Q psy622 195 QPIVYLEIS-DLVNGTPNAFNIRTPGQL--------LSLKTGTFPTF-QDVQNSQAPFPSAL------RVAGSQIPTSTA 258 (473)
Q Consensus 195 ~~~~~~~~~-~~~~gtp~y~~~~ape~i--------~~~~~~s~g~l-~~~~~g~~pf~~~~------~~~~~~~~~~~~ 258 (473)
......... .+..|||.|| |||++ ...|.|+||+- .++.+|..||...- .......+.-.
T Consensus 178 ~~G~R~~~rf~tfvgtp~wm---APEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~- 253 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWM---APEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL- 253 (516)
T ss_pred ccCceeeEeeccccCccccc---ChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc-
Confidence 332222233 6778999999 99984 34788999976 58999999997521 11111111000
Q ss_pred hhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccc
Q psy622 259 AQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDS 310 (473)
Q Consensus 259 ~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~ 310 (473)
-..... +....++.+++.+|..||.+||.+||||.++++|+||+...-.+
T Consensus 254 -t~~~~~-d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 254 -TSGLDK-DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred -cccCCh-HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 000011 11246778999999999999999999999999999999875433
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=324.53 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=202.3
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CC
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT--SS 115 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~~ 115 (473)
-++++|+.+..|++|+||.||+|+++. ++++||+|+++-.. ....---.-+||+++|.+++|||||.+-.+... -+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~-t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKK-TDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCC-cceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 346789999999999999999999987 68999999998654 222223356899999999999999999998864 35
Q ss_pred EEEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 116 CVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
.+||||||| .-||..++.+-+ +|.+.+++.++.|++.||+|||.+.|+||||||+|+|+... |.+||+|||+|+.+.
T Consensus 151 ~iy~VMe~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~-G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 151 KIYIVMEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK-GILKIADFGLAREYG 228 (419)
T ss_pred eeeeeHHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC-CcEEecccchhhhhc
Confidence 799999999 559999999865 89999999999999999999999999999999999999999 999999999999976
Q ss_pred CCccccccccccCCCCc--ccccCCccccc-------cCCcCCCCcc-ccccCCCCCchh---------HhhhcCCCCCh
Q psy622 195 QPIVYLEISDLVNGTPN--AFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPS---------ALRVAGSQIPT 255 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~--y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~---------~~~~~~~~~~~ 255 (473)
++... .||- +++|+|||.++ .+|.|++|++ .+++.+.+.|++ +++..+.+...
T Consensus 229 sp~k~--------~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 229 SPLKP--------YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred CCccc--------CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 65322 1211 24566777654 5788999976 479999998886 22222222111
Q ss_pred ------------------hhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 256 ------------------STAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 256 ------------------~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
....+....|+. ..++..+.+|+.+||..||.+|+||+|.++|+||++.
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~--~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGA--LSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccc--cccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 011112223332 1277999999999999999999999999999999874
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=323.71 Aligned_cols=254 Identities=20% Similarity=0.298 Sum_probs=210.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI-----NKNMVSQVLRERNALALT-HSPFCVQLFYSLQT 113 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~ 113 (473)
.+.|+-.+.||.|..+.|-.+.++. +++.+|+|++...... -....+...+|+.||+++ .||+|+++.++|++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~-t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKE-TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcc-cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 4567778899999999999998887 5788999998654211 233355678999999998 79999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
+..+++|+|.|+-|.|+++|...-.++|..++.+++||+.|++|||.++||||||||||||+|++ ..|||+|||+++.+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn-~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN-MNIKISDFGFACQL 173 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc-cceEEeccceeecc
Confidence 99999999999999999999998899999999999999999999999999999999999999999 89999999999987
Q ss_pred cCCccccccccccCCCCcccccCCccc------------cccCCcCCCCcccc-ccCCCCCchhHhhhcCCCCChhhHhh
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQ------------LLSLKTGTFPTFQD-VQNSQAPFPSALRVAGSQIPTSTAAQ 260 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~------------i~~~~~~s~g~l~~-~~~g~~pf~~~~~~~~~~~~~~~~~~ 260 (473)
..++.. . ..||||+|+ |||. -..++.|+.|++++ ++.|.+||....+.. ....+++
T Consensus 174 ~~GekL---r-elCGTPgYL---APEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml----MLR~Ime 242 (411)
T KOG0599|consen 174 EPGEKL---R-ELCGTPGYL---APETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML----MLRMIME 242 (411)
T ss_pred CCchhH---H-HhcCCCccc---ChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH----HHHHHHh
Confidence 655433 2 369999999 5554 34578888897754 999999997632211 1123444
Q ss_pred hccCCCC-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 261 LQLEWPE-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 261 ~~~~~P~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
++..+.+ ...++|..++|||.+||+.||.+|+|++|++.||||..+
T Consensus 243 GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 243 GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 4444422 125799999999999999999999999999999999755
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.43 Aligned_cols=262 Identities=24% Similarity=0.394 Sum_probs=207.4
Q ss_pred ecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCC
Q psy622 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGD 128 (473)
Q Consensus 49 LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~ 128 (473)
||+|+||.||+|+.+. +++.||+|++.+..............|+++++.++||||+++++.+++..++|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKN-TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEcc-CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 7999999999998876 578999999987654444444566779999999999999999999999999999999999999
Q ss_pred HHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccccccc
Q psy622 129 VKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLV 206 (473)
Q Consensus 129 L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 206 (473)
|..++...+ .+++..+..++.||+.||+|||+.||+||||||+||+++.+ +.++|+|||++........ ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~----~~~~ 154 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKT----ITQR 154 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-CCEEEeeceeeeecCCCce----eecc
Confidence 999886543 58999999999999999999999999999999999999998 9999999999987543211 1223
Q ss_pred CCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHH
Q psy622 207 NGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEET 279 (473)
Q Consensus 207 ~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dL 279 (473)
.|++.|+ |||++. ..|.|++|++ +++++|..||.......................+ ...+++++++|
T Consensus 155 ~~~~~y~---aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 229 (277)
T cd05607 155 AGTNGYM---APEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE--HQNFTEESKDI 229 (277)
T ss_pred CCCCCcc---CHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc--cccCCHHHHHH
Confidence 5777777 888643 4688999965 6799999999642110000000000111112222 24689999999
Q ss_pred HHhccccCCCCCCCH----HHHhcCCCCCCCCccccccC--CCCCcCC
Q psy622 280 ILALLKSDPTQRPSG----HQVRRLPMFKDYDWDSILDQ--EPPFVPQ 321 (473)
Q Consensus 280 I~~LL~~dP~kRpsa----~eil~HPFF~~idw~~l~~~--~pPf~P~ 321 (473)
|.+||+.||.+||++ +++++||||+.++|+.+... .|||+|+
T Consensus 230 i~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~ 277 (277)
T cd05607 230 CRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFVPD 277 (277)
T ss_pred HHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCCCC
Confidence 999999999999998 77889999999999999876 7888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=334.04 Aligned_cols=269 Identities=28% Similarity=0.438 Sum_probs=216.2
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
.|++.++||+|+||.||+|.++. +++.||+|.+.+...........+.+|+.+++.++|++|+++++.+.+...+|+||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC-CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 47889999999999999999887 57899999998765544444567788999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 122 EYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||++||+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++........
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeccceeecCCCcc-
Confidence 9999999999986543 59999999999999999999999999999999999999998 8999999999876432111
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
.....|++.|+ |||.+. ..|.|++|++ +++++|..||......................++ ..+
T Consensus 158 ---~~~~~g~~~y~---aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 228 (285)
T cd05630 158 ---IKGRVGTVGYM---APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYS---EKF 228 (285)
T ss_pred ---ccCCCCCcccc---ChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcC---ccC
Confidence 11235777777 888764 3688999965 5799999999742110000000000011112223 568
Q ss_pred ChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCC
Q psy622 273 NPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQP 322 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~ 322 (473)
++++++||.+||+.||.+|+| ++|+++||||+.++|..+... .|||+|.+
T Consensus 229 ~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05630 229 SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP 285 (285)
T ss_pred CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCCC
Confidence 899999999999999999999 899999999999999988764 79999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=345.48 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=209.4
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
...|+...+||+|+-|.||.|+... +++.||||++....... .+-+++|+.+|+..+|+|||.++++|--.+.+|+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~-~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKIS-TKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeecc-CCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 4568888999999999999998887 57899999999875333 3478999999999999999999999998899999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|||||+||+|-+.+... .++|.+++.+..++++||+|||.+||||||||.+|||++.+ |.+||+|||+|..+.....
T Consensus 348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD-GSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC-CcEEEeeeeeeeccccccC-
Confidence 99999999999988865 59999999999999999999999999999999999999999 9999999999998654332
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh-hhH-hhh--ccCCCCc
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT-STA-AQL--QLEWPED 268 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~-~~~-~~~--~~~~P~~ 268 (473)
...+..|||.|| |||++. .+|+|++|++ .+|.-|++||.... .+.. ..+ ..+ +++.|
T Consensus 425 --KR~TmVGTPYWM---APEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-----PlrAlyLIa~ng~P~lk~~-- 492 (550)
T KOG0578|consen 425 --KRSTMVGTPYWM---APEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----PLRALYLIATNGTPKLKNP-- 492 (550)
T ss_pred --ccccccCCCCcc---chhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-----hHHHHHHHhhcCCCCcCCc--
Confidence 345679999999 999875 4899999987 48999999997311 0000 011 112 33334
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
+.+|+++++||.+||+.||.+|++|.|+|+||||+.
T Consensus 493 -~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 493 -EKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred -cccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 789999999999999999999999999999999953
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=329.52 Aligned_cols=283 Identities=36% Similarity=0.594 Sum_probs=229.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||+|+||.||+|+++. +++.||+|.+.+...........+.+|+++++.++||||+++++.+.++.++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE-TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC-CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 479999999999999999998876 5789999999877544445566888999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc-
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY- 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~- 199 (473)
|||++||+|.+++...+.+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++........
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC-CCEEEeeCCCccccCcCcccc
Confidence 9999999999999988899999999999999999999999999999999999999998 99999999998742110000
Q ss_pred -----------cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhh
Q psy622 200 -----------LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQL 261 (473)
Q Consensus 200 -----------~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~ 261 (473)
........+++.|+ +||.+. ..+.|++|++ +++++|..||.+.... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----~~~~~~~~~ 231 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYI---APEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELFGQVISD 231 (305)
T ss_pred ccccccccchhhccccCCccCcccc---CchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhc
Confidence 00011234555565 788653 3688899965 6799999999642110 000111122
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCC---HHHHhcCCCCCCCCccccccCCCCCcCCCCCCCCCCCCC
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPS---GHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDTSYFH 332 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps---a~eil~HPFF~~idw~~l~~~~pPf~P~~~~~~D~s~Fd 332 (473)
...+|.....++.++.++|.+||+.||.+||+ +.++++||||...+|..+.+...+++|.+....|++|||
T Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (305)
T cd05609 232 DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESEDDTSYFD 305 (305)
T ss_pred ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCCCCCCCccccccCC
Confidence 33444433468899999999999999999997 789999999999999999888889999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=337.68 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=218.1
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
.=|++.+.||+|.|.+|-+|++.- +|..||||++.|.++.. ....+++.|+++|+.++|||||+||++..+..++|||
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVF-TGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVF-TGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhc-ccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 348999999999999999998876 78999999999987543 3356899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
+|+-.||||+++|-+. ..+.|+.++.|++||+.|+.|+|+..+|||||||||+++...-|-+||+|||++-.+..++..
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL 175 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL 175 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence 9999999999999875 479999999999999999999999999999999999999887799999999999886654332
Q ss_pred cccccccCCCCcccccCCcccccc-------CCcCCCCcccc-ccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcccc
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTFQD-VQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l~~-~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ 271 (473)
.+.||+-.|- |||++++ +++|++|++.+ +.+|++||.+... .-....+...+...| ..
T Consensus 176 ----~TsCGSLAYS---APEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----SETLTmImDCKYtvP---sh 241 (864)
T KOG4717|consen 176 ----TTSCGSLAYS---APEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----SETLTMIMDCKYTVP---SH 241 (864)
T ss_pred ----hcccchhhcc---CchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----hhhhhhhhcccccCc---hh
Confidence 3457875554 9998764 78899998766 6799999986432 112234555677777 68
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
+|.++++||.+||.+||++|.+.+||..|+|.+.+|-.
T Consensus 242 vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 242 VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred hhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 99999999999999999999999999999999999854
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=325.88 Aligned_cols=244 Identities=23% Similarity=0.337 Sum_probs=204.6
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEE-EEEeC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFY-SLQTS 114 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~f~~~ 114 (473)
....+.+|+++++||+|+||+||+|.+.. +|..+|.|.++-. ..+.+..+.+..|+.+|++++|||||++++ .|..+
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~-~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLL-DGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED 91 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeecc-Ccchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc
Confidence 45668899999999999999999999887 6899999999954 455666788999999999999999999998 77666
Q ss_pred CE-EEEEecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--CC--eeecCCCCcceEecCCCCceeEe
Q psy622 115 SC-VFLVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHS--HG--IIHRDLKPDNMLISAQAPHCPIV 185 (473)
Q Consensus 115 ~~-l~lVmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~--~g--IiHRDLKpeNILld~~~g~ikL~ 185 (473)
+. ++||||||.+|||.++|+. .+.++|..++.|+.|++.||.++|+ .+ |+||||||.||+|+.+ |.+||.
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLG 170 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLG 170 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-Cceeec
Confidence 65 9999999999999999975 3579999999999999999999999 44 9999999999999999 999999
Q ss_pred ecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhH
Q psy622 186 NTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTA 258 (473)
Q Consensus 186 DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~ 258 (473)
|||+++.+... ........|||-|| +||.+. ..|.|++|++ ++|...++||.+..-. -....+
T Consensus 171 DfGL~r~l~s~---~tfA~S~VGTPyYM---SPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~----~L~~KI 240 (375)
T KOG0591|consen 171 DFGLGRFLSSK---TTFAHSLVGTPYYM---SPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL----SLCKKI 240 (375)
T ss_pred cchhHhHhcch---hHHHHhhcCCCccc---CHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH----HHHHHH
Confidence 99999997543 24456678999999 999875 4688999976 5799999999874110 011233
Q ss_pred hhhccCCCCcc-ccCChhHHHHHHhccccCCCCCCCH
Q psy622 259 AQLQLEWPEDE-EALNPSTEETILALLKSDPTQRPSG 294 (473)
Q Consensus 259 ~~~~~~~P~~~-~~ls~~a~dLI~~LL~~dP~kRpsa 294 (473)
.++ .+|..| +.+|.++..||..|+..||+.||+.
T Consensus 241 ~qg--d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 241 EQG--DYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HcC--CCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 333 343333 6899999999999999999999985
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=330.57 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=198.3
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++++.||+|+||+||+|+++. +++.||||++++... ......+.+|+.+++.++||||+++++++++...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV-NGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC-CCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 4789999999999999999999876 578999999986532 2223467889999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||||+ +++|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 81 VFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT-GELKLADFGLARAKSVPS- 157 (303)
T ss_pred EEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECCCCcceeccCCC-
Confidence 99999 57888887664 579999999999999999999999999999999999999998 999999999987542211
Q ss_pred ccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhh----------cCCCCChhh---
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRV----------AGSQIPTST--- 257 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~----------~~~~~~~~~--- 257 (473)
.......|++.|+ |||++. ..|+|++|++ +++++|..||...... .+.......
T Consensus 158 --~~~~~~~~~~~y~---aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 158 --HTYSNEVVTLWYR---PPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred --ccCCCCcccCCCC---ChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccch
Confidence 1112245677777 888653 2588899965 5799999999742100 000000000
Q ss_pred -------HhhhccCCCC------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCc
Q psy622 258 -------AAQLQLEWPE------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDW 308 (473)
Q Consensus 258 -------~~~~~~~~P~------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw 308 (473)
........|. .....++++++||.+||+.||++|||++|+++||||+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 0000000000 00135678999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=333.38 Aligned_cols=260 Identities=21% Similarity=0.294 Sum_probs=200.6
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----CE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS-----SC 116 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~-----~~ 116 (473)
+|++.++||+|+||.||+|+++. +++.||||+++... .......++.+|+++++.++||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC-CCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 58999999999999999999876 57899999987542 2223345788999999999999999999988543 35
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+||||+ +++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 79 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 79 IYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEccCccccccccc
Confidence 89999999 67999999988889999999999999999999999999999999999999999 99999999999864322
Q ss_pred ccccccccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChhhH
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTSTA 258 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~~~ 258 (473)
...........||+.|+ |||++. ..|+|++|++ ++|++|..||..... ..+.. +....
T Consensus 157 ~~~~~~~~~~~~t~~y~---aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~ 232 (338)
T cd07859 157 TPTAIFWTDYVATRWYR---APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP-SPETI 232 (338)
T ss_pred cCccccccCCCCCCCcC---CHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC-CHHHH
Confidence 21111222346788887 888643 3688999965 579999999964210 00000 00000
Q ss_pred h------------h----hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 259 A------------Q----LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 259 ~------------~----~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
. . ....+......+++++.++|.+||+.||++||+++|+++||||+++...
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV 299 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence 0 0 0011111113577889999999999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=325.43 Aligned_cols=269 Identities=26% Similarity=0.412 Sum_probs=215.7
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
.|+..+.||+|+||+||+|.+.. +++.||+|++.+...........+.+|+++|+.++|++|+++++++.+++.+|+||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA-TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC-CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 37889999999999999998876 57899999998765544444556788999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 122 EYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||+++|+|..++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.+ +.+||+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC-CCEEEecCCcceecCCCCc-
Confidence 999999999988754 369999999999999999999999999999999999999998 8999999999876432211
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
.....|++.|+ |||.+. ..|.|++|++ +++++|..||......................++ ..+
T Consensus 158 ---~~~~~g~~~~~---aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 228 (285)
T cd05632 158 ---IRGRVGTVGYM---APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS---AKF 228 (285)
T ss_pred ---ccCCCCCcCcc---ChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccC---ccC
Confidence 12235777776 888753 3688999965 5799999999642110000000001111122233 568
Q ss_pred ChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCC
Q psy622 273 NPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQP 322 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~ 322 (473)
+.++.+|+.+||+.||++||+ +.++++||||+.++|+.+.+. .|||+|.+
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05632 229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP 285 (285)
T ss_pred CHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCCC
Confidence 899999999999999999999 889999999999999988765 79999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=323.93 Aligned_cols=254 Identities=20% Similarity=0.305 Sum_probs=197.3
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
++++|+++++||+|+||.||+|+++. +++.||+|+++.... ......+.+|+.+++.++||||+++++++.++..+|
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKL-TENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLT 79 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECC-CCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 57889999999999999999998876 678999999976532 222446788999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 119 LVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+||||+. |+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 80 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 80 LVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKSVPT 157 (288)
T ss_pred EEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEECcCcceeeccCCC
Confidence 9999996 59999987654 58999999999999999999999999999999999999998 999999999997643221
Q ss_pred cccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChhhHh-
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTSTAA- 259 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~~~~- 259 (473)
. ......+++.|+ |||.+. ..|+|++|++ +++++|..||..... ..+.........
T Consensus 158 ~---~~~~~~~~~~y~---aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 158 K---TYSNEVVTLWYR---PPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred c---cccCceeccccc---ChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence 1 112234666666 788653 3678899965 579999999964210 011110000000
Q ss_pred -----hhccCCCC--------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 260 -----QLQLEWPE--------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 260 -----~~~~~~P~--------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.....+|. ....+++++++||++||+.||.+|||++|+++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00011111 113578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=322.14 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=199.2
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||+|+||.||+|+++. +++.||+|+++.... .....+.+.+|+.+++.++||||++++++++..+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE-TKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC-CCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 479999999999999999999876 578999999987532 233456788999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||++++.+..+....+.+++..++.++.||+.||+|||+.||+||||||+||+++.+ +.+||+|||++..+......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~- 156 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNA- 156 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccCcccccccccc-
Confidence 9999887776665555679999999999999999999999999999999999999998 99999999999875322111
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhh--------hcCCCCChhhHh------
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALR--------VAGSQIPTSTAA------ 259 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~--------~~~~~~~~~~~~------ 259 (473)
......|++.|+ |||++. ..|+|++|++ +++++|..||..... ......+.....
T Consensus 157 -~~~~~~~~~~y~---aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 157 -NYTEYVATRWYR---SPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred -cccccccccccC---CcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 112245777777 888653 3688999965 579999999974210 000111111000
Q ss_pred -hhccCCCC----------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 260 -QLQLEWPE----------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 260 -~~~~~~P~----------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.....+|. ....+|.++++||++||+.||++|||++|+++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00111111 012478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=315.78 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=201.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCC---
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPF-CVQLFYSLQTSS--- 115 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~~~~--- 115 (473)
...|+.+++||+|+||+||+|+.+. +|+.||+|++.-..-. +..-....+|+.+|+.++|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~-~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKR-TGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEec-CCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence 4568888999999999999999987 6899999999875321 233456799999999999999 999999998877
Q ss_pred ---EEEEEecccCcCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecc
Q psy622 116 ---CVFLVMEYMIGGDVKSLIAANG----ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 116 ---~l~lVmEy~~gg~L~~~L~~~~----~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
.+++|+||+ .-||..++...+ .++...++.++.||+.||+|||++||+||||||+||||+++ |.+||+|||
T Consensus 88 ~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~-G~lKlaDFG 165 (323)
T KOG0594|consen 88 GIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSS-GVLKLADFG 165 (323)
T ss_pred ccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCC-CcEeeeccc
Confidence 899999999 779999998755 57888999999999999999999999999999999999998 999999999
Q ss_pred hhhhhcCCccccccccccCCCCc--ccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhH---------hhhc
Q psy622 189 FLAILQQPIVYLEISDLVNGTPN--AFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSA---------LRVA 249 (473)
Q Consensus 189 la~~~~~~~~~~~~~~~~~gtp~--y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~---------~~~~ 249 (473)
+|+...-+... -|++ .++|+|||+++ .+|.|++|++ .+|.++++.|++. ++..
T Consensus 166 lAra~~ip~~~--------yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l 237 (323)
T KOG0594|consen 166 LARAFSIPMRT--------YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL 237 (323)
T ss_pred hHHHhcCCccc--------ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence 99975433221 2232 24567888765 3677888865 5799999999873 2222
Q ss_pred CCCCChhhHh-----hhccCCCCc---------cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 250 GSQIPTSTAA-----QLQLEWPED---------EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 250 ~~~~~~~~~~-----~~~~~~P~~---------~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
+.+....+.. ..+..++.. ....++++.+++.+||+.+|.+|.|++.++.||||..+.
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 3221111111 011122211 134456899999999999999999999999999999873
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=332.72 Aligned_cols=255 Identities=19% Similarity=0.198 Sum_probs=198.1
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
...+...+|++++.||+|+||.||+|+++. +++.||||+... ..+.+|+++|+.++||||++++++|+..
T Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~d~~-~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 86 RAGIEKAGFSILETFTPGAEGFAFACIDNK-TCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred hcccccCCcEEEEEEcCCCCeEEEEEEECC-CCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence 345566789999999999999999999887 678999997542 2467899999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
...|+|||++ +++|..++...+.+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++...
T Consensus 156 ~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 156 KFTCLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAACFPV 233 (391)
T ss_pred CeeEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC-CCEEEEeCCcccccc
Confidence 9999999999 68999999888889999999999999999999999999999999999999998 999999999997532
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhc----------------CC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVA----------------GS 251 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~----------------~~ 251 (473)
.... .......||+.|+ |||++. ..|+|++|++ +++++|..||....... +.
T Consensus 234 ~~~~--~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 234 DINA--NKYYGWAGTIATN---APELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred cccc--cccccccCccCCC---ChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 2111 1122346888887 898764 3688899965 67999988765321000 00
Q ss_pred ---CCChh---hHh-------hhccCCCC------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 252 ---QIPTS---TAA-------QLQLEWPE------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 252 ---~~~~~---~~~-------~~~~~~P~------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
..+.. ... ......|. ....++.++.+||.+||+.||.+|||++|+++||||+.+
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 00000 000 00000010 012356789999999999999999999999999999864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=329.49 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=201.2
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
....+++|++++.||+|+||.||+|+++. +++.||||++.+.. .......+.+|+++++.++|+||+++++++...+
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 145 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHRP-TGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEECC-CCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence 44557889999999999999999998876 57899999997643 2334567899999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+||||+.+|+|... ....+..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 146 ~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQ 220 (353)
T ss_pred eEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEcccccceeccc
Confidence 99999999999998543 346788889999999999999999999999999999999998 9999999999987532
Q ss_pred CccccccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hc
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQ 262 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~ 262 (473)
... ......||+.|+ |||.+. ..|+|++|++ +++++|..||..... .. ....... ..
T Consensus 221 ~~~---~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~---~~-~~~~~~~~~~ 290 (353)
T PLN00034 221 TMD---PCNSSVGTIAYM---SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ---GD-WASLMCAICM 290 (353)
T ss_pred ccc---cccccccCcccc---CccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---cc-HHHHHHHHhc
Confidence 211 122346888887 888652 4689999965 679999999962110 00 0000000 01
Q ss_pred cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 263 LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 263 ~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
...+..+..++.++++||.+||+.||++||++.|+++||||..-
T Consensus 291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 11122235789999999999999999999999999999999874
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.61 Aligned_cols=256 Identities=21% Similarity=0.216 Sum_probs=194.1
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC---
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS--- 114 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--- 114 (473)
...++|++.++||+|+||+||+|+++. +++.||||++.+.. ....+|+.+|+.++||||++++++|...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICID-TSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECC-CCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 345689999999999999999998876 57899999986542 1345799999999999999999887532
Q ss_pred -----CEEEEEecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEe
Q psy622 115 -----SCVFLVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185 (473)
Q Consensus 115 -----~~l~lVmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~ 185 (473)
..+|+||||++ ++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+++.+||+
T Consensus 135 ~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 25789999995 577776653 45799999999999999999999999999999999999999774579999
Q ss_pred ecchhhhhcCCccccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHh---------hh
Q psy622 186 NTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSAL---------RV 248 (473)
Q Consensus 186 DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~---------~~ 248 (473)
|||+|+.+..... .....||+.|+ |||++.. .|+|++|++ ++|++|.+||.+.. ..
T Consensus 214 DFGla~~~~~~~~----~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 214 DFGSAKNLLAGQR----SVSYICSRFYR---APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred ccccchhccCCCC----cccCCCCcCcc---CHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 9999987543221 12245788777 8987542 578899965 57999999997521 11
Q ss_pred cCCCCChhhH----hhhccCCCC---------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 249 AGSQIPTSTA----AQLQLEWPE---------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 249 ~~~~~~~~~~----~~~~~~~P~---------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
.+........ ......+|. .+...++++++||.+||+.||.+|||+.|+++||||+++.+.
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence 1111000000 000111111 114578899999999999999999999999999999887553
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=315.70 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=194.7
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--C---E
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS--S---C 116 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~---~ 116 (473)
.|+-.+++|.|+||.||.|...+ +++.||||++-.+.- --.+|+++|+.++|||||+|..+|... . .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e-~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE-TEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC-CCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 58889999999999999999888 478999999876532 234699999999999999999999632 2 4
Q ss_pred EEEEecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 117 VFLVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
+.+||||| ..+|...++. +..++.-.++.|+.||++||.|||+.||+||||||+|+|+|.++|.+||||||.|+.
T Consensus 97 lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 67899999 5699999884 468999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCcccccc-ccccCCCCcccccCCcccc-------ccCCcCCCCcc-ccccCCCCCchhH---------hhhcCCCCC
Q psy622 193 LQQPIVYLEI-SDLVNGTPNAFNIRTPGQL-------LSLKTGTFPTF-QDVQNSQAPFPSA---------LRVAGSQIP 254 (473)
Q Consensus 193 ~~~~~~~~~~-~~~~~gtp~y~~~~ape~i-------~~~~~~s~g~l-~~~~~g~~pf~~~---------~~~~~~~~~ 254 (473)
+..++..... ++.. |+|||.+ ...|+||.|+. .+|+.|++.|++. .+..+.+..
T Consensus 176 L~~~epniSYicSRy--------YRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 176 LVKGEPNISYICSRY--------YRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred eccCCCceeEEEecc--------ccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 7655443221 2222 4466654 46899999965 5799999999872 222222211
Q ss_pred hhhHhh-----hccCCCC---------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 255 TSTAAQ-----LQLEWPE---------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 255 ~~~~~~-----~~~~~P~---------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
+.+.. ...++|. .....++++.+|+.++|+.+|.+|.++.|++.||||....
T Consensus 248 -e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 248 -EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred -HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 11111 1111111 2256889999999999999999999999999999997653
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=313.19 Aligned_cols=260 Identities=21% Similarity=0.251 Sum_probs=213.6
Q ss_pred eEEE-ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEE
Q psy622 43 FEIV-KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 43 y~i~-~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lV 120 (473)
|++. +.||+|+|+.|--+.... +++.||||++.|.. .....++++|++++.+. .|+||++|+++|+++.++|||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~-t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQ-TGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeec-cchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 4443 579999999999987776 68999999999873 34466999999999999 699999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--CceeEeecchhhhhcCCcc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA--PHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~--g~ikL~DFGla~~~~~~~~ 198 (473)
||.|.||.|..+|++...|+|.+|..++.+|+.||+|||.+||.||||||||||-.+.+ .-+|||||.+..-+.....
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999999999999999999999999999999999999999999999999999997652 2379999998765422111
Q ss_pred cc----ccccccCCCCcccccCCccccc-----------cCCcCCCCccc-cccCCCCCchhHhhhcCCC----------
Q psy622 199 YL----EISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTFQ-DVQNSQAPFPSALRVAGSQ---------- 252 (473)
Q Consensus 199 ~~----~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l~-~~~~g~~pf~~~~~~~~~~---------- 252 (473)
-. .--.+.+|+.+|| |||++- ..+.|++|++. .|+.|.+||.+........
T Consensus 235 ~spastP~L~tPvGSAEfM---APEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFM---APEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCccccCcccchhhc---chhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 10 1122467888888 899752 36889999765 5999999998754322211
Q ss_pred -CChhhHhhhccCCCCc-cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 253 -IPTSTAAQLQLEWPED-EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 253 -~~~~~~~~~~~~~P~~-~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
...+.++.+..+||+. ...+|.+++|||..||.+|+.+|+++.++++|||++.+--+
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 2335677788888864 46799999999999999999999999999999999877443
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=318.78 Aligned_cols=275 Identities=32% Similarity=0.534 Sum_probs=221.2
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||+|+||.||+|.... +++.||+|.+.+.........+.+..|+++++.++||+|+++++.+.+....|+|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG-TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC-CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 479999999999999999998876 5789999999987655445667899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 121 MEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
|||+.|++|.+++.+. ..+++..++.++.||+.||+|||+.|++||||||+||+++.+ +.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC-CCEEEeecchhhccccccc
Confidence 9999999999999864 479999999999999999999999999999999999999998 9999999999876432211
Q ss_pred cc--------------------------ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhH
Q psy622 199 YL--------------------------EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSA 245 (473)
Q Consensus 199 ~~--------------------------~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~ 245 (473)
.. .......|++.|+ +||.+. ..|+|++|++ +++++|..||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~---aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYI---APEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCc---CHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 00 0011224566666 888654 3588899965 5799999999642
Q ss_pred hhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCC----HHHHhcCCCCCCCCccccccCCCCCcCC
Q psy622 246 LRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPS----GHQVRRLPMFKDYDWDSILDQEPPFVPQ 321 (473)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps----a~eil~HPFF~~idw~~l~~~~pPf~P~ 321 (473)
.... ....+......++.. ..++.+++++|.+||..||++||+ ++|+++||||++++|..+....||-.|.
T Consensus 236 ~~~~----~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~ 310 (316)
T cd05574 236 NRDE----TFSNILKKEVTFPGS-PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPR 310 (316)
T ss_pred chHH----HHHHHhcCCccCCCc-cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCC
Confidence 1100 001111223334432 237899999999999999999999 9999999999999999998877887776
Q ss_pred CCCC
Q psy622 322 PDDV 325 (473)
Q Consensus 322 ~~~~ 325 (473)
+...
T Consensus 311 ~~~~ 314 (316)
T cd05574 311 PDDG 314 (316)
T ss_pred cccc
Confidence 6543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=322.46 Aligned_cols=258 Identities=19% Similarity=0.311 Sum_probs=206.1
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+..++|++++.||+|+||.||+|+++. ++..||+|++.... ......++.+|+++|+.++||||+++++++.+.+.+
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKP-SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECC-CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 346899999999999999999999876 67899999998642 233456799999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH-GIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~-gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+||||++||+|.+++.+.+.+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++..+...
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC-CcEEEccCccccccccc
Confidence 99999999999999999888899999999999999999999986 69999999999999999 99999999999865322
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhh-----hcCCCCC----------
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALR-----VAGSQIP---------- 254 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~-----~~~~~~~---------- 254 (473)
......|++.|+ |||++. ..|.|++|++ +++++|..||..... ..+....
T Consensus 158 -----~~~~~~g~~~y~---aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (331)
T cd06649 158 -----MANSFVGTRSYM---SPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSI 229 (331)
T ss_pred -----ccccCCCCcCcC---CHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcccc
Confidence 122346788777 888754 3688899965 679999999963110 0000000
Q ss_pred --------------------hh--------hHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 255 --------------------TS--------TAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 255 --------------------~~--------~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.. .........+. ..+++++++||.+||++||++||+++|+++||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPN--GVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCC--ccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00 00000111111 3578899999999999999999999999999999875
Q ss_pred Ccc
Q psy622 307 DWD 309 (473)
Q Consensus 307 dw~ 309 (473)
...
T Consensus 308 ~~~ 310 (331)
T cd06649 308 EVE 310 (331)
T ss_pred ccc
Confidence 544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=308.83 Aligned_cols=252 Identities=27% Similarity=0.348 Sum_probs=206.6
Q ss_pred CCCCeEEE-ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEE----
Q psy622 39 EISDFEIV-KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQ---- 112 (473)
Q Consensus 39 ~~~~y~i~-~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~---- 112 (473)
-.++|.+- ++||-|-.|+|..+.++. +++.+|+|++... ...++|+++--.. .|||||.++++|.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~-T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKR-TQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEEecc-chhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 35788886 689999999999999887 6889999998754 2567788877665 7999999999875
Q ss_pred eCCEEEEEecccCcCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--CceeEeecc
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAANGA--LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA--PHCPIVNTL 188 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~~~--~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~--g~ikL~DFG 188 (473)
..+.+.+|||.|+||+|+..|+.++. |+|.+|..++.||..|+.|||+.+|.||||||||+|..... ..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 45679999999999999999998764 99999999999999999999999999999999999997542 568999999
Q ss_pred hhhhhcCCccccccccccCCCCcccccCCcccc------ccCCcCCCCcccc-ccCCCCCchhHhhhcCCCCChhhHhhh
Q psy622 189 FLAILQQPIVYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTFQD-VQNSQAPFPSALRVAGSQIPTSTAAQL 261 (473)
Q Consensus 189 la~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l~~-~~~g~~pf~~~~~~~~~~~~~~~~~~~ 261 (473)
+||.-... ..-.+.|.||-|. |||++ -+.+.|++|+.++ +++|.+||+..-...-..-....+...
T Consensus 210 FAK~t~~~----~~L~TPc~TPyYv---aPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 210 FAKETQEP----GDLMTPCFTPYYV---APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred cccccCCC----ccccCCccccccc---CHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 99983321 2234568899988 88875 3688999998765 999999998743222222223455556
Q ss_pred ccCCCCc-cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 262 QLEWPED-EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 262 ~~~~P~~-~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
...||+. ...+|++++|+|++||+.+|.+|+|++|++.|||....
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 6777753 35689999999999999999999999999999999764
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=315.07 Aligned_cols=261 Identities=30% Similarity=0.498 Sum_probs=206.9
Q ss_pred ecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCC
Q psy622 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGD 128 (473)
Q Consensus 49 LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~ 128 (473)
||+|+||+||+|.++. +++.||+|++.+...........+..|+++|+.++||||+++++++...+.+|+||||++|++
T Consensus 1 lg~g~~g~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKA-TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcC-CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 6999999999998776 578999999987654444445567889999999999999999999999999999999999999
Q ss_pred HHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccccccc
Q psy622 129 VKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLV 206 (473)
Q Consensus 129 L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 206 (473)
|.+++.+.+ .+++..++.++.||+.||.|||+.||+||||||+||+++.+ +.+||+|||.+........ ....
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~----~~~~ 154 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKK----IKGR 154 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEccCcchhhhccCCc----cccc
Confidence 999998765 79999999999999999999999999999999999999998 9999999999987532111 1122
Q ss_pred CCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHH
Q psy622 207 NGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEET 279 (473)
Q Consensus 207 ~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dL 279 (473)
.+++.|+ +||... ..+.|++|++ +++++|..||.......................| ..+++++.++
T Consensus 155 ~~~~~y~---~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 228 (277)
T cd05577 155 AGTPGYM---APEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYP---DKFSPEAKDL 228 (277)
T ss_pred cCCCCcC---CHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCC---ccCCHHHHHH
Confidence 3455555 777642 4688999965 5799999999642110000000000111122223 4679999999
Q ss_pred HHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCC
Q psy622 280 ILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQ 321 (473)
Q Consensus 280 I~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~ 321 (473)
|.+||+.||.+|| ++.++++||||+.++|..+.+. .|||.|+
T Consensus 229 i~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~ 277 (277)
T cd05577 229 CEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIPD 277 (277)
T ss_pred HHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCCC
Confidence 9999999999999 8889999999999999988654 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=326.86 Aligned_cols=258 Identities=20% Similarity=0.243 Sum_probs=199.4
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----E
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS-----C 116 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~-----~ 116 (473)
+|++++.||+|+||+||+|++.. +++.||||++.+.. .......++.+|+.+|+.++||||+++++++.+.. .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR-DGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC-CCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 58899999999999999998876 57899999987542 22334567899999999999999999999998876 8
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+||||+ +++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 79 ~~lv~e~~-~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 79 IYVVTELM-QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEEeecc-ccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC-CCEEeccccceeecccC
Confidence 99999999 57899999888889999999999999999999999999999999999999999 99999999999864322
Q ss_pred ccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChhh--
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTST-- 257 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~~-- 257 (473)
.. .......+++.|+ |||.+. ..|+|++|++ ++|++|..||..... ..+.......
T Consensus 157 ~~--~~~~~~~~~~~y~---aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 157 ES--KHMTQEVVTQYYR---APEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cc--ccCCCCCcCCCcC---CHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 11 1111234666666 888653 3588999965 579999999964210 0111100000
Q ss_pred --------HhhhccCCC------CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCc
Q psy622 258 --------AAQLQLEWP------EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDW 308 (473)
Q Consensus 258 --------~~~~~~~~P------~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw 308 (473)
........| ......++++.+||.+||+.||++|||+.|+++||||++..+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 296 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRL 296 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcc
Confidence 000000001 011356889999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=349.68 Aligned_cols=152 Identities=62% Similarity=0.957 Sum_probs=142.5
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
|.+++|++++.||+|+||+||+|++.. +++.||||++++...........+.+|+.++..++||||++++++++...++
T Consensus 1 p~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 79 (669)
T cd05610 1 PSIEEFVIVKPISRGAFGKVYLGRKKN-NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNV 79 (669)
T ss_pred CccCCEEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEE
Confidence 457899999999999999999999886 5789999999987666666677899999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
|+||||+.||+|..++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+ +++||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~-g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE-GHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence 9999999999999999988889999999999999999999999999999999999999998 999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=320.51 Aligned_cols=255 Identities=28% Similarity=0.454 Sum_probs=216.1
Q ss_pred eEEE--ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 43 FEIV--KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 43 y~i~--~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
|++. ++||+|.||+||-|+++. +|+.||||++.|-.+..++ ..++++|+.||..++||.||.+...|++..++++|
T Consensus 564 YQif~devLGSGQFG~VYgg~hRk-tGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVV 641 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRK-TGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVV 641 (888)
T ss_pred HHhhhHhhccCCcceeeecceecc-cCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEE
Confidence 5543 789999999999999988 6899999999998766554 57899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--CceeEeecchhhhhcCC
Q psy622 121 MEYMIGGDVKSLIAA--NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA--PHCPIVNTLFLAILQQP 196 (473)
Q Consensus 121 mEy~~gg~L~~~L~~--~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~--g~ikL~DFGla~~~~~~ 196 (473)
||.+ .||+.+.|-. .|+++|...+|++.||+.||.|||-+||+|+|||||||||.+.+ ..+||||||+++.+...
T Consensus 642 MEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 642 MEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred ehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 9999 7788777643 57999999999999999999999999999999999999998653 57999999999986542
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcccc-ccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc-
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTFQD-VQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED- 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l~~-~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~- 268 (473)
.+.....|||.|+ |||++. +.+.|+.|++.+ -+.|..||.+.- ++ ...+++....+|..
T Consensus 721 ----sFRrsVVGTPAYL---aPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dI-ndQIQNAaFMyPp~P 787 (888)
T KOG4236|consen 721 ----SFRRSVVGTPAYL---APEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DI-NDQIQNAAFMYPPNP 787 (888)
T ss_pred ----hhhhhhcCCcccc---CHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----ch-hHHhhccccccCCCc
Confidence 3445678999999 999864 688999997755 799999997631 11 23344445555533
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC-Ccccccc
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY-DWDSILD 313 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i-dw~~l~~ 313 (473)
...++++|.|||..||+..-.+|.++++.+.|||+++. -|-+|+.
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRe 833 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRE 833 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHH
Confidence 36799999999999999999999999999999999987 4877765
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=321.80 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=201.7
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
..+..++..+.+.||+|+||+||+|.++.. ..||+|++......... .+.+.+|+.+|..++|||||++++++.++.
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~--~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGT--DVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeCCc--eeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 445566778888899999999999988752 34999999987654444 779999999999999999999999998887
Q ss_pred -EEEEEecccCcCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCCcceEecCCCC-ceeEeecchh
Q psy622 116 -CVFLVMEYMIGGDVKSLIAA--NGALPEDMAAFYAAEVVLALQYLHSHG-IIHRDLKPDNMLISAQAP-HCPIVNTLFL 190 (473)
Q Consensus 116 -~l~lVmEy~~gg~L~~~L~~--~~~~~e~~~~~~~~qI~~aL~yLH~~g-IiHRDLKpeNILld~~~g-~ikL~DFGla 190 (473)
.+++||||+++|+|..+|.+ .+.++...+..++.||+.|++|||+++ ||||||||+|||++.+ + ++||+|||++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~-~~~~KI~DFGls 191 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLK-GKTLKIADFGLS 191 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCC-CCEEEECCCccc
Confidence 79999999999999999988 578999999999999999999999999 9999999999999999 7 9999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCcccccc--------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhH-hh
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS--------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTA-AQ 260 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~--------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~-~~ 260 (473)
+...... ...+...||+.|| |||++.. .|+++||++ +++++|..||...... .+..... ..
T Consensus 192 r~~~~~~---~~~~~~~GT~~wM---APEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~~~v~~~~ 262 (362)
T KOG0192|consen 192 REKVISK---TSMTSVAGTYRWM---APEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVASAVVVGG 262 (362)
T ss_pred eeecccc---ccccCCCCCcccc---ChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcC
Confidence 8754321 1112257898888 9998762 577899964 7899999999863210 0011111 11
Q ss_pred hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHh
Q psy622 261 LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVR 298 (473)
Q Consensus 261 ~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil 298 (473)
....+| ..+++.+..||.+||..||.+||++.++.
T Consensus 263 ~Rp~~p---~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 263 LRPPIP---KECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred CCCCCC---ccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 233334 56999999999999999999999988766
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=321.84 Aligned_cols=256 Identities=22% Similarity=0.318 Sum_probs=219.6
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
........|.+++.||+|.|++|.+|++.. ++..||||++.|....... .+.+.+|+++|+.++|||||+++.+..++
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~-t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~ 127 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHIL-TGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETE 127 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecC-CCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeec
Confidence 345567789999999999999999999887 6889999999998755444 44599999999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+|+||||+.||+++++|.+.++..+..++.++.|++.|++|||+++|||||||.+||||+.+ -.+||+|||++..+.
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDEN-MNIKIADFGFSTFFD 206 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccc-cceeeeccccceeec
Confidence 9999999999999999999999999999999999999999999999999999999999999999 789999999999865
Q ss_pred CCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
.. ....+.||+|.|. |||... .++.|++|++ +.++.|..||.+..- ..........+..+|
T Consensus 207 ~~----~~lqt~cgsppyA---aPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----k~Lr~rvl~gk~rIp 275 (596)
T KOG0586|consen 207 YG----LMLQTFCGSPPYA---APELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----KELRPRVLRGKYRIP 275 (596)
T ss_pred cc----ccccccCCCCCcc---ChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc----ccccchheeeeeccc
Confidence 33 3345689999998 888654 4788999965 559999999986321 111122233455666
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
-.++.++.+||+++|-.+|.+|++.+++++|+|...-.
T Consensus 276 ---~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 276 ---FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred ---ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 57999999999999999999999999999999986543
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=309.00 Aligned_cols=255 Identities=26% Similarity=0.473 Sum_probs=200.5
Q ss_pred eecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh---cCCCCeeeEEEEEEeCCEEEEEeccc
Q psy622 48 AISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL---THSPFCVQLFYSLQTSSCVFLVMEYM 124 (473)
Q Consensus 48 ~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~---l~hp~Iv~l~~~f~~~~~l~lVmEy~ 124 (473)
.||+|+||.||+|++.. +++.||+|.+.+.............+|..+++. .+||+|+.+++.+..++..|+||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECC-CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 48999999999998876 578999999987654433333344555544443 47999999999999999999999999
Q ss_pred CcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccccc
Q psy622 125 IGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISD 204 (473)
Q Consensus 125 ~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~ 204 (473)
+||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.++|+|||++........ .
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~~~-----~ 153 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKP-----H 153 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-CCEEEccCCcceeccccCc-----c
Confidence 999999999988899999999999999999999999999999999999999998 9999999999876432211 1
Q ss_pred ccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh----hccCCCCccccC
Q psy622 205 LVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ----LQLEWPEDEEAL 272 (473)
Q Consensus 205 ~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~P~~~~~l 272 (473)
...|++.|+ |||... ..|.|++|++ +++++|..||..... ... ..... .....| ..+
T Consensus 154 ~~~~~~~y~---aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~-~~~~~~~~~~~~~~~---~~~ 222 (279)
T cd05633 154 ASVGTHGYM---APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDK-HEIDRMTLTVNVELP---DSF 222 (279)
T ss_pred CcCCCcCcc---CHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC----cCH-HHHHHHhhcCCcCCc---ccc
Confidence 235777777 787643 2588899965 579999999964211 000 11111 122233 578
Q ss_pred ChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcC
Q psy622 273 NPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVP 320 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P 320 (473)
+.+++++|.+||+.||.+|+ +++|+++||||++++|..+... .||-+|
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~ 277 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP 277 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcCCCCCCCCC
Confidence 99999999999999999999 5999999999999999987644 344444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=319.21 Aligned_cols=255 Identities=20% Similarity=0.322 Sum_probs=202.4
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+..++|++.+.||+|+||.||+|+++. +++.+|+|++.... .......+.+|+++++.++||||++++++|.+.+.+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~-~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKP-SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECC-CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence 345789999999999999999998876 57899999988652 233456789999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH-GIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~-gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++..+...
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC-CCEEEeeCCcchhhhhh
Confidence 99999999999999999888899999999999999999999975 79999999999999998 99999999999865321
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhh-----cC----CCC-------
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRV-----AG----SQI------- 253 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~-----~~----~~~------- 253 (473)
......|++.|+ |||.+. ..|+|++|++ +++++|..||...... .+ ...
T Consensus 158 -----~~~~~~~~~~y~---aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (333)
T cd06650 158 -----MANSFVGTRSYM---SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP 229 (333)
T ss_pred -----ccccCCCCcccc---CHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence 112345777777 888754 3688899965 5799999998642100 00 000
Q ss_pred -----------------Chhh----H----hhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 254 -----------------PTST----A----AQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 254 -----------------~~~~----~----~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+... . .......+. ..++.++++||.+||++||++||+++|+++||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS--GVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCC--CCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000 0 000011111 2467899999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=313.94 Aligned_cols=257 Identities=19% Similarity=0.303 Sum_probs=198.1
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
++++|++++.||+|+||.||+|+++. +++.||+|+++.... ......+.+|+++++.++||||+++++++.+++..|
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKL-TENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecC-CCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence 46789999999999999999998876 578999999986532 222346778999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 119 LVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+||||++ ++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 81 LVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSVPT 158 (309)
T ss_pred EEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECccccceecCCCc
Confidence 9999995 58988887654 58999999999999999999999999999999999999998 999999999997643221
Q ss_pred cccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCChhhH--
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPTSTA-- 258 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~~~~-- 258 (473)
. ......+++.|+ |||.+. ..|.|++|++ +++++|..||.... +..+........
T Consensus 159 ~---~~~~~~~~~~y~---aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 159 K---TYSNEVVTLWYR---PPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred c---cccccccccccc---CCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence 1 111234666666 788653 3578899965 67999999996421 111111000000
Q ss_pred ----hhhccCCCC--------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 259 ----AQLQLEWPE--------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 259 ----~~~~~~~P~--------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
......+|. ....+++++++||.+||+.||.+|||++|+++||||+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 000111111 113578999999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=307.01 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=191.6
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCCeeeEEEEEE-----
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT---HSPFCVQLFYSLQ----- 112 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~----- 112 (473)
++|++++.||+|+||+||+|++...+++.||+|+++..... ........+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 47999999999999999999886555788999999865322 22234566777777665 6999999999885
Q ss_pred eCCEEEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
....+|+||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 80 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~-~~~kl~Dfg~~ 157 (290)
T cd07862 80 RETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLA 157 (290)
T ss_pred CCCcEEEEEccC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC-CCEEEccccce
Confidence 345799999999 47999999764 358999999999999999999999999999999999999998 99999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCC
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIP 254 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~ 254 (473)
+..... .......||+.|+ |||.+. ..|.|++|++ +++++|.+||..... ..+...+
T Consensus 158 ~~~~~~----~~~~~~~~~~~y~---aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 158 RIYSFQ----MALTSVVVTLWYR---APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230 (290)
T ss_pred EeccCC----ccccccccccccc---ChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 864322 1223346788877 888653 3688999965 568999999964211 0000000
Q ss_pred hhhHhhh-----------ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 255 TSTAAQL-----------QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 255 ~~~~~~~-----------~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
....... ...++.....+++.+++||.+||+.||++||++.|+++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0000000 000001113578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=304.03 Aligned_cols=253 Identities=25% Similarity=0.448 Sum_probs=199.2
Q ss_pred eecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHH---HHhcCCCCeeeEEEEEEeCCEEEEEeccc
Q psy622 48 AISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA---LALTHSPFCVQLFYSLQTSSCVFLVMEYM 124 (473)
Q Consensus 48 ~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~i---L~~l~hp~Iv~l~~~f~~~~~l~lVmEy~ 124 (473)
+||+|+||.||+|++.. +++.||+|.+.+..............|..+ +...+||+|+++++.+.+...+|+||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEec-CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 48999999999998876 578999999987654333222234444443 44457999999999999999999999999
Q ss_pred CcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccccc
Q psy622 125 IGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISD 204 (473)
Q Consensus 125 ~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~ 204 (473)
+||+|..++.+.+.+++..++.++.|++.||+|||+++|+||||||+||+++.+ +.+||+|||+++...... ..
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~~-----~~ 153 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-----PH 153 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC-CCEEEccCcCccccCccC-----Cc
Confidence 999999999888899999999999999999999999999999999999999998 999999999987643221 12
Q ss_pred ccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhH
Q psy622 205 LVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPST 276 (473)
Q Consensus 205 ~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a 276 (473)
...|++.|+ +||.+. ..|.|++|++ +++++|..||........... ..........+| ..++.++
T Consensus 154 ~~~~~~~y~---aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~---~~~s~~~ 226 (278)
T cd05606 154 ASVGTHGYM---APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTMAVELP---DSFSPEL 226 (278)
T ss_pred CcCCCcCCc---CcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HHHhhccCCCCC---CcCCHHH
Confidence 346777777 787653 2588999965 579999999975311000000 011111223334 4679999
Q ss_pred HHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC
Q psy622 277 EETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ 314 (473)
Q Consensus 277 ~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~ 314 (473)
.++|.+||..+|.+|+ +++++++||||++++|+.+..+
T Consensus 227 ~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~ 269 (278)
T cd05606 227 RSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269 (278)
T ss_pred HHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhc
Confidence 9999999999999999 9999999999999999988765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=324.13 Aligned_cols=259 Identities=20% Similarity=0.243 Sum_probs=201.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKT-NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
..+|++++.||+|+||.||+|..+. ..++.||+|.+.+.. ...+|+++|+.++||||+++++++.....+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 3579999999999999999997643 245789999987642 3457999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
+|||++ +++|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 163 lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 163 MVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEccCccccccCcccc
Confidence 999999 67999999877889999999999999999999999999999999999999999 9999999999987543222
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhh------------cC---CCCChh
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRV------------AG---SQIPTS 256 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~------------~~---~~~~~~ 256 (473)
. .......||+.|+ |||++. ..|+|++|++ +++++|..||.+.... .. ...+..
T Consensus 241 ~-~~~~~~~gt~~y~---aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 241 T-PQCYGWSGTLETN---SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred c-ccccccccccCcc---CHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 1 1122346888887 888764 3688999965 5799999999642100 00 000000
Q ss_pred -------hHhh----hc--cCCCCc--cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccc
Q psy622 257 -------TAAQ----LQ--LEWPED--EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSIL 312 (473)
Q Consensus 257 -------~~~~----~~--~~~P~~--~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~ 312 (473)
...+ .. ...|.. ...++.++++||.+||+.||.+||++.|++.||||...+|+.+.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~~ 387 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLLN 387 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhhc
Confidence 0000 00 011110 02457789999999999999999999999999999999998664
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=308.13 Aligned_cols=267 Identities=27% Similarity=0.515 Sum_probs=211.6
Q ss_pred CeEEEceecccCceEEEEEEEeC--CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMIN-KNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l 117 (473)
+|++.+.||+|+||.||+|+... .+++.||+|++++..... ....+++.+|+++|..+ +|++|++++++|+.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 48899999999999999998753 256889999998754322 23346788999999999 699999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+|||++.+ +.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC-CCEEEeeCccceeccccc
Confidence 9999999999999999988889999999999999999999999999999999999999998 999999999998753221
Q ss_pred cccccccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh---hhccCC
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA---QLQLEW 265 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~ 265 (473)
. .......|++.|+ +||.+. ..+.|++|++ +++++|..||..... ......... .....+
T Consensus 160 ~--~~~~~~~~~~~y~---aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 231 (290)
T cd05613 160 V--ERAYSFCGTIEYM---APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE---KNSQAEISRRILKSEPPY 231 (290)
T ss_pred c--cccccccCCcccC---ChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc---cccHHHHHHHhhccCCCC
Confidence 1 1112235666666 787653 4688899965 569999999853110 000011111 112223
Q ss_pred CCccccCChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVP 320 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P 320 (473)
| ..+++.+.+++.+||+.||.+|+ +++++++||||..++|+.+..+ .+||.|
T Consensus 232 ~---~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (290)
T cd05613 232 P---QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290 (290)
T ss_pred C---ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhhccCCCCCCC
Confidence 3 56889999999999999999997 7899999999999999988655 566654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=299.14 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=201.1
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI--NKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
++|++.+.||+|+||.||+|.... +++.||+|++.+.... .....+.+.+|+++++.++||||++++++++++..+|
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC-CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 569999999999999999998776 5789999998865322 2234567889999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
+|+||++|++|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+||+++.+ +.++|+|||+++.+.....
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecccccc
Confidence 999999999999999988889999999999999999999999999999999999999998 9999999999986533221
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh--hccCCCCcc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ--LQLEWPEDE 269 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~P~~~ 269 (473)
.........+++.|+ |||.+. ..|.|++|++ +++++|..||..... ...... .....+..+
T Consensus 160 ~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~ 229 (263)
T cd06625 160 SGTGMKSVTGTPYWM---SPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------MAAIFKIATQPTNPQLP 229 (263)
T ss_pred ccccccCCCcCcccc---CcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------HHHHHHHhccCCCCCCC
Confidence 111112234555666 888653 4688899965 679999999864211 000000 011112222
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
..++.++.++|.+||+.+|.+||++.|+++||||
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 230 SHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 5789999999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=317.59 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=215.4
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+.-..|+.+..||+|+||.||+|.+.. +++.||||++..... +..++.+++|+.+|.+++++||.++|++|-.+..+
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~-t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNK-TKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred Ccccccccchhccccccceeeeeeecc-ccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence 334568888999999999999999987 689999999997653 44577899999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|++||||.||++.++|+..+.+.|..+..++++++.||.|||.++.+|||||+.|||+..+ |.+||+|||.+..+....
T Consensus 87 wiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-CcEEEEecceeeeeechh
Confidence 9999999999999999998888999999999999999999999999999999999999999 999999999998865432
Q ss_pred cccccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~ 270 (473)
....++.|||-|| |||++.. .|.|++|+. ++|.+|.+|+...-.. .+.... .+-..|....
T Consensus 166 ---~rr~tfvGTPfwM---APEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---rvlflI---pk~~PP~L~~ 233 (467)
T KOG0201|consen 166 ---KRRKTFVGTPFWM---APEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM---RVLFLI---PKSAPPRLDG 233 (467)
T ss_pred ---hcccccccccccc---chhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc---eEEEec---cCCCCCcccc
Confidence 2236679999999 9998863 688999976 5799999999753110 000000 1122233345
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
.+|+.+++||..||++||+.||+|.++++|+|++...
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 7899999999999999999999999999999999754
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.13 Aligned_cols=252 Identities=18% Similarity=0.261 Sum_probs=202.8
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
...|.+.+.||+|+||.||+|.+..+.++.||+|.+.... ......+.+|+.+|+.++||||++++++++..+++|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 4459999999999999999998776546788999775432 3445678889999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 120 VMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
||||++||+|.++|.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~-~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC-CcEEEEeCcCceecCC
Confidence 9999999999988754 3469999999999999999999999999999999999999998 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~ 267 (473)
... .......+||+.|+ |||++. ..|+|++|++ +++++|..||..... ...... .....+.
T Consensus 222 ~~~-~~~~~~~~gt~~y~---aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~~~~ 290 (478)
T PTZ00267 222 SVS-LDVASSFCGTPYYL---APELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQVLYGKYDP 290 (478)
T ss_pred ccc-cccccccCCCcccc---CHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCC
Confidence 221 12234467999988 888653 3688899965 579999999964211 000110 0111122
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.+..++.++++||.+||+.||++||++++++.|||++.+
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 225789999999999999999999999999999999754
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.63 Aligned_cols=251 Identities=18% Similarity=0.246 Sum_probs=188.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC------CCCeeeEEEEEEe
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH------SPFCVQLFYSLQT 113 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~------hp~Iv~l~~~f~~ 113 (473)
.++|+++++||+|+||+||+|+++. +++.||||++++.. ........|++++..++ |++|++++++|+.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRK-RKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcC-CCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 4789999999999999999998876 57899999997532 12234556777766654 4568999999976
Q ss_pred C-CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCC-----------
Q psy622 114 S-SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAP----------- 180 (473)
Q Consensus 114 ~-~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g----------- 180 (473)
+ .++|+|||++ |++|.+++.+.+.+++..++.++.||+.||+|||+ .|||||||||+|||++.+ +
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~-~~~~~~~~~~~~ 280 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETS-DTVVDPVTNRAL 280 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecC-Cccccccccccc
Confidence 5 5899999998 88999999988899999999999999999999998 599999999999999876 4
Q ss_pred -----ceeEeecchhhhhcCCccccccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCCchhHhh-
Q psy622 181 -----HCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAPFPSALR- 247 (473)
Q Consensus 181 -----~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~pf~~~~~- 247 (473)
.+||+|||++..... .....+||+.|+ |||++.. .|+|++|++ ++|++|+.||.....
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~---APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH------SRTAIVSTRHYR---SPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred CCCCceEEECCCCccccCcc------ccccccCCcccc---CcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998865221 123457898888 9998653 588999965 579999999964210
Q ss_pred -------hcCCCCChhhHhh-------------hccC---CC-----------CccccCChhHHHHHHhccccCCCCCCC
Q psy622 248 -------VAGSQIPTSTAAQ-------------LQLE---WP-----------EDEEALNPSTEETILALLKSDPTQRPS 293 (473)
Q Consensus 248 -------~~~~~~~~~~~~~-------------~~~~---~P-----------~~~~~ls~~a~dLI~~LL~~dP~kRps 293 (473)
......+...... ..+. .| .....-++.+.|||.+||+.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 0001111110000 0000 00 000012466889999999999999999
Q ss_pred HHHHhcCCCCCCC
Q psy622 294 GHQVRRLPMFKDY 306 (473)
Q Consensus 294 a~eil~HPFF~~i 306 (473)
++|+++||||...
T Consensus 432 a~e~L~Hp~~~~~ 444 (467)
T PTZ00284 432 ARQMTTHPYVLKY 444 (467)
T ss_pred HHHHhcCcccccc
Confidence 9999999999753
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.19 Aligned_cols=248 Identities=22% Similarity=0.312 Sum_probs=183.8
Q ss_pred EceecccCceEEEEEEEeC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCEEEEEec
Q psy622 46 VKAISRGAFGKVFLGYKKT-NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT--SSCVFLVME 122 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~~~l~lVmE 122 (473)
.++||+|+||+||+|+++. .+++.||+|++..... .....+|+++|+.++||||++++++|.. ...+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 4689999999999998764 2467899999876532 2356789999999999999999999854 567999999
Q ss_pred ccCcCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec----CCCCceeEeecch
Q psy622 123 YMIGGDVKSLIAAN---------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS----AQAPHCPIVNTLF 189 (473)
Q Consensus 123 y~~gg~L~~~L~~~---------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld----~~~g~ikL~DFGl 189 (473)
|+ +++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .+ +.+||+|||+
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~-~~~kl~DfG~ 158 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER-GRVKIADMGF 158 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCc-CcEEEeecCc
Confidence 99 67998887632 2589999999999999999999999999999999999994 44 7899999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCC--------
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQI-------- 253 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~-------- 253 (473)
++................||+.|+ |||++. ..|+|++|++ +++++|.+||...........
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYR---APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235 (317)
T ss_pred eeccCCCCccccccCCcccccccc---CCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence 987543322212223346788877 888653 3688999965 579999999963211100000
Q ss_pred --------Ch-hhHhh-h-------------ccCC---------CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCC
Q psy622 254 --------PT-STAAQ-L-------------QLEW---------PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLP 301 (473)
Q Consensus 254 --------~~-~~~~~-~-------------~~~~---------P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HP 301 (473)
+. ..... . ...+ .......+.++.+||++||+.||.+|+|++|+++||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp 315 (317)
T cd07868 236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 315 (317)
T ss_pred HHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 00 00000 0 0000 000123456799999999999999999999999999
Q ss_pred CC
Q psy622 302 MF 303 (473)
Q Consensus 302 FF 303 (473)
||
T Consensus 316 ~f 317 (317)
T cd07868 316 YF 317 (317)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.16 Aligned_cols=251 Identities=22% Similarity=0.346 Sum_probs=195.9
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-C-----CCeeeEEEEEEeCC
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-S-----PFCVQLFYSLQTSS 115 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-h-----p~Iv~l~~~f~~~~ 115 (473)
+|+++++||+|+||+|.+|.++. +++.||||+++.. +....+.+.|+.||..++ | -|+|+++++|.-.+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~-T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHK-TGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecC-CCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 68999999999999999999887 6899999999976 444567889999999886 3 48999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC-CceeEeecchhhh
Q psy622 116 CVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA-PHCPIVNTLFLAI 192 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~-g~ikL~DFGla~~ 192 (473)
|+|||+|.+ +.+|+++|+.++ .|+...+|.++.||+.||.+||+.||||+|||||||||.... ..|||+|||++..
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999999 889999999864 699999999999999999999999999999999999997531 5799999999987
Q ss_pred hcCCccccccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCCchhHh---------hhcCCC----
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQ---- 252 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~---- 252 (473)
.... .|.......|+|||++++ .|.||+|++ .||.+|.+.|++.. ...+..
T Consensus 341 ~~q~---------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 341 ESQR---------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cCCc---------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 4322 121122245679999864 789999965 57999998898621 111110
Q ss_pred ----------------CCh----hh-H---------h-----hhccCCCCc-------cc-cCChhHHHHHHhccccCCC
Q psy622 253 ----------------IPT----ST-A---------A-----QLQLEWPED-------EE-ALNPSTEETILALLKSDPT 289 (473)
Q Consensus 253 ----------------~~~----~~-~---------~-----~~~~~~P~~-------~~-~ls~~a~dLI~~LL~~dP~ 289 (473)
.+. .. . . ......|.. .. .-...+.|||++||..||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 000 00 0 0 011112210 01 2335579999999999999
Q ss_pred CCCCHHHHhcCCCCCCCC
Q psy622 290 QRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 290 kRpsa~eil~HPFF~~id 307 (473)
+|+|+.|+++||||+...
T Consensus 492 ~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 492 ERITPAQALNHPFLTGTS 509 (586)
T ss_pred hcCCHHHHhcCccccccc
Confidence 999999999999998653
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=312.98 Aligned_cols=254 Identities=19% Similarity=0.265 Sum_probs=194.2
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC---
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS--- 115 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~--- 115 (473)
-+++|++.+.||+|+||.||+|+++. +++.||+|++.+.. ........+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV-LGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC-CCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 46899999999999999999998876 67899999997653 23344567889999999999999999999986543
Q ss_pred ---EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 116 ---CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 116 ---~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
.+|+||||+. ++|...+.. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 97 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~-~~~kl~Dfg~a~~ 172 (359)
T cd07876 97 EFQDVYLVMELMD-ANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLART 172 (359)
T ss_pred ccceeEEEEeCCC-cCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEecCCCccc
Confidence 5899999995 567777653 58999999999999999999999999999999999999999 9999999999976
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCCh-
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPT- 255 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~- 255 (473)
..... ......||+.|+ |||.+. ..|.|++|++ ++|++|..||..... ..+.....
T Consensus 173 ~~~~~----~~~~~~~t~~y~---aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 173 ACTNF----MMTPYVVTRYYR---APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred cccCc----cCCCCcccCCCC---CchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 42211 112245777777 888754 3688999965 579999999964210 00000000
Q ss_pred -----hh---HhhhccC--------------CCC---ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 256 -----ST---AAQLQLE--------------WPE---DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 256 -----~~---~~~~~~~--------------~P~---~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.. ....... +|. .....++++++||.+||+.||++|||++|+++||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00 0000000 010 11235678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=297.11 Aligned_cols=245 Identities=28% Similarity=0.533 Sum_probs=203.5
Q ss_pred ecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCC
Q psy622 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGD 128 (473)
Q Consensus 49 LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~ 128 (473)
||.|+||.||+|+.+. +++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.++..+|+||||++||+
T Consensus 1 lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKS-KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECC-CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 7999999999999876 578999999988765555556789999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCC
Q psy622 129 VKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNG 208 (473)
Q Consensus 129 L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~g 208 (473)
|.+++.+.+.+++..++.++.||+.||+|||++|++|+||||+||+++.+ +.++|+|||+++...... ......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~----~~~~~~~ 154 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQ----KTWTFCG 154 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-CCEEEeeCCcccccCccc----ccccccC
Confidence 99999988889999999999999999999999999999999999999998 999999999998754322 1122356
Q ss_pred CCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh-----hhccCCCCccccCChhH
Q psy622 209 TPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA-----QLQLEWPEDEEALNPST 276 (473)
Q Consensus 209 tp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~~P~~~~~ls~~a 276 (473)
++.|+ +||.+. ..|.|++|++ +++++|..||..... ....... .....+| ...++++
T Consensus 155 ~~~~~---~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~---~~~~~~~ 223 (262)
T cd05572 155 TPEYV---APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNGKLEFP---NYIDKAA 223 (262)
T ss_pred CcCcc---ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCCCCCCC---cccCHHH
Confidence 77777 777643 3588999965 679999999964320 0111111 1223334 4568999
Q ss_pred HHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccc
Q psy622 277 EETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDS 310 (473)
Q Consensus 277 ~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~ 310 (473)
+++|.+||+.||.+|++ ++|+++||||++.+|+.
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 262 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWEG 262 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCCC
Confidence 99999999999999999 99999999999999973
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=303.43 Aligned_cols=256 Identities=23% Similarity=0.333 Sum_probs=205.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.|++++.||+|+||.||+|+.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++.+..++.+|+|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKE-TGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECC-CCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 559999999999999999998876 57899999997652 44566788999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|||++|++|..++.+ .+.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++........
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC-CCEEEccCccceecccccc-
Confidence 999999999988765 4579999999999999999999999999999999999999988 9999999999875322111
Q ss_pred cccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hccCCC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQLEWP 266 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P 266 (473)
......+++.|+ +||.+. ..|+|++|++ +++++|..||..... .....+ .....|
T Consensus 166 --~~~~~~~~~~y~---aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~ 233 (292)
T cd06644 166 --RRDSFIGTPYWM---APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPP 233 (292)
T ss_pred --ccceecCCcccc---CceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHHhcCCCc
Confidence 111234566666 777653 3689999965 579999999864211 000000 011111
Q ss_pred --CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccC
Q psy622 267 --EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQ 314 (473)
Q Consensus 267 --~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~ 314 (473)
..+..++.++.++|.+||+.||++||+++|+++||||..++|+...+.
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~ 283 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRE 283 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchhHHH
Confidence 112467889999999999999999999999999999999999976543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=299.90 Aligned_cols=249 Identities=21% Similarity=0.357 Sum_probs=199.2
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|+++++||+|+||.||+|++.. +++.||+|++.+.. .......+.+|++++++++||||+++++.+...+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL-TRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC-CCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 478999999999999999998876 57899999997652 233455788999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||+++|+|..+ ..+++..+..++.||+.||+|||+.||+|+||||+|||++.+ +.++|+|||++......
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC-CCEEEeeCCcceecccc----
Confidence 999999999654 357899999999999999999999999999999999999999 99999999999865322
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh----hccCCCCcc
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ----LQLEWPEDE 269 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~P~~~ 269 (473)
......|++.|+ |||.+. ..|.|++|++ +++++|..||.................. .....+.
T Consensus 149 -~~~~~~~~~~y~---aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 222 (279)
T cd06619 149 -IAKTYVGTNAYM---APERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV-- 222 (279)
T ss_pred -cccCCCCChhhc---CceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCC--
Confidence 122346777777 888754 3688899965 5799999999753221111111111110 1111221
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
...+++++++|.+||+.||.+||+++|+++||||...+
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 35788999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=305.80 Aligned_cols=258 Identities=19% Similarity=0.297 Sum_probs=199.0
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
++++|++++.||+|+||.||+|+++. +++.||+|.++.... ......+.+|+.+++.++||||+++++++.++..+|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKL-TDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcC-CCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 57899999999999999999998876 578999999976532 222346778999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 119 LVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+||||++ ++|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPT 158 (301)
T ss_pred EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC-CcEEECcCcchhccCCCC
Confidence 9999995 6999888764 468999999999999999999999999999999999999999 999999999997643221
Q ss_pred cccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChhh---
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTST--- 257 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~~--- 257 (473)
. ......+++.|+ +||... ..|+|++|++ ++|++|..||..... ..........
T Consensus 159 ~---~~~~~~~~~~y~---~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 159 K---TYSNEVVTLWYR---PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred C---cccccceeeccc---CcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 1 111224566666 788643 3578899965 579999999964211 0000000000
Q ss_pred Hhh---hccCCCC--------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 258 AAQ---LQLEWPE--------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 258 ~~~---~~~~~P~--------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
... ....+|. ....+++++++||.+||+.||.+|||++|+++||||+..-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 0111111 1135788999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=304.57 Aligned_cols=270 Identities=26% Similarity=0.468 Sum_probs=210.8
Q ss_pred CeEEEceecccCceEEEEEEEeC--CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMIN-KNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l 117 (473)
+|++.+.||+|+||.||+|++.. ..++.||||++++..... .....++.+|++++..+ +||+|+++++.++....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 48999999999999999997643 246789999998754322 23345788999999999 699999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+||||++||+|..++.+.+.+++..++.++.|++.||+|||+.|++||||||+||+++.+ +.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEEECcccccccccc
Confidence 9999999999999999887889999999999999999999999999999999999999998 999999999987653321
Q ss_pred cccccccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
.. ......|++.|+ +||... ..+.|++|++ +++++|..||..... ...............+..
T Consensus 160 ~~--~~~~~~~~~~y~---aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 231 (288)
T cd05583 160 EE--RAYSFCGTIEYM---APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE---QNSQSEISRRILKSKPPF 231 (288)
T ss_pred cc--ccccccCCcccc---CHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc---cchHHHHHHHHHccCCCC
Confidence 11 112234666666 777542 4688899955 679999999853110 000011111111111222
Q ss_pred cccCChhHHHHHHhccccCCCCCCC---HHHHhcCCCCCCCCccccccC--CCCCcC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPS---GHQVRRLPMFKDYDWDSILDQ--EPPFVP 320 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRps---a~eil~HPFF~~idw~~l~~~--~pPf~P 320 (473)
+..++.+++++|.+||+.||++||| +.++++||||+.++|+.+.++ .|||.|
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 288 (288)
T cd05583 232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288 (288)
T ss_pred CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhhccCCCCCC
Confidence 3568899999999999999999998 578899999999999988776 577765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.52 Aligned_cols=254 Identities=21% Similarity=0.329 Sum_probs=203.9
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC---
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS--- 115 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~--- 115 (473)
..++|++.+.||+|+||+||+|+++. +++.||||++..... .......+.+|+.+|..++|++|++++..+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVS-DGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcC-CCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34789999999999999999998876 578999999987643 3445667889999999999999999998875432
Q ss_pred -----EEEEEecccCcCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEee
Q psy622 116 -----CVFLVMEYMIGGDVKSLIAAN----GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVN 186 (473)
Q Consensus 116 -----~l~lVmEy~~gg~L~~~L~~~----~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~D 186 (473)
.+++||||+++|+|.++|... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~-~~vkL~D 186 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGD 186 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC-CCEEEEe
Confidence 478999999999999999753 469999999999999999999999999999999999999998 9999999
Q ss_pred cchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh
Q psy622 187 TLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA 259 (473)
Q Consensus 187 FGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~ 259 (473)
||+++.+...... ......+||+.|+ |||++. ..|+|++|++ +++++|..||..... .....
T Consensus 187 FGls~~~~~~~~~-~~~~~~~Gt~~Y~---aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~ 255 (496)
T PTZ00283 187 FGFSKMYAATVSD-DVGRTFCGTPYYV---APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMH 255 (496)
T ss_pred cccCeeccccccc-cccccccCCccee---CHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHH
Confidence 9999875332111 2233467899888 898764 3688899965 679999999964211 00011
Q ss_pred h-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 260 Q-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 260 ~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
. .....+..+..+++++.+||.+||+.||.+||++.++++|||++..
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 256 KTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 0 1111222236789999999999999999999999999999998754
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.44 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=195.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS----- 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~----- 114 (473)
.++|++++.||+|+||+||+|++.. +++.||||++.+... .......+.+|+.+|+.++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTR-LRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3679999999999999999998876 578999999986532 223345678999999999999999999988643
Q ss_pred -CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 -SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 -~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..+|++++++ |++|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~ 168 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-CELRILDFGLARQA 168 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC-CCEEEcCCccceec
Confidence 4589999998 8899888764 579999999999999999999999999999999999999999 99999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCCh-
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPT- 255 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~- 255 (473)
... .....||+.|+ |||++. ..|.|++|++ ++|++|..||..... ..+...+.
T Consensus 169 ~~~------~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 169 DDE------MTGYVATRWYR---APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred CCC------cCCcccccccc---CchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 321 12235777776 888753 3789999965 569999999964210 00010000
Q ss_pred ------hhHhhh---ccCCC-----CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 256 ------STAAQL---QLEWP-----EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 256 ------~~~~~~---~~~~P-----~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
...... ....| ......++.+.+||.+||+.||.+|||+.|+++||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 000000 00011 01124677899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=313.91 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=193.8
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS---- 114 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~---- 114 (473)
.+++|++.+.||+|+||.||+|+++. +++.||||++.+.. ........+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI-LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC-CCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 46899999999999999999998876 57899999998653 2233456788999999999999999999988643
Q ss_pred --CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 115 --SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 115 --~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
..+|+||||+ +++|...+.. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 100 ~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~ 175 (364)
T cd07875 100 EFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLART 175 (364)
T ss_pred ccCeEEEEEeCC-CCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC-CcEEEEeCCCccc
Confidence 4689999999 5578887764 58899999999999999999999999999999999999998 9999999999986
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCChh
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPTS 256 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~~ 256 (473)
..... ......||+.|+ |||++. ..|.|++|++ ++|++|..||.... ...+...+..
T Consensus 176 ~~~~~----~~~~~~~t~~y~---aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 176 AGTSF----MMTPYVVTRYYR---APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred cCCCC----cccCCcccCCcC---CHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 43221 112345777777 888753 3688999965 57999999996421 0001100000
Q ss_pred ---------hHhhhcc--------------CCC---CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 257 ---------TAAQLQL--------------EWP---EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 257 ---------~~~~~~~--------------~~P---~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
....... .++ ......+.++++||.+||+.||.+|||++|+++||||..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0000000 000 001224568999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=313.30 Aligned_cols=253 Identities=23% Similarity=0.390 Sum_probs=211.5
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE-E
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC-V 117 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~-l 117 (473)
.+++|..++++|+|+||.+++++++. .++.|++|.+.-.....+. .....+|..+++++.|||||.+.++|..++. +
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~-~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l 79 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKS-DDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL 79 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhcc-CCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence 36789999999999999999999887 4679999999987654433 4478899999999999999999999988887 9
Q ss_pred EEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 118 FLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
||||+||+||+|.+.|.+.+ .|+|+.+..|+.||+.||+|||+++|+|||||+.||++..+ +.|||.|||+|+.+..
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD-KKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc-CceeecchhhhhhcCC
Confidence 99999999999999998753 69999999999999999999999999999999999999999 8999999999999765
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCc-cccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPT-FQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~-l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
.. ....+..|||.|+ .||++. ..+.|++|+ +++|++-+.+|...... -....+. ...+...
T Consensus 159 ~~---~~a~tvvGTp~Ym---cPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~----~Li~ki~--~~~~~Pl 226 (426)
T KOG0589|consen 159 ED---SLASTVVGTPYYM---CPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS----ELILKIN--RGLYSPL 226 (426)
T ss_pred ch---hhhheecCCCccc---CHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH----HHHHHHh--hccCCCC
Confidence 43 3456678999999 688653 578999996 56799999999752110 0001111 1122333
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+...+.+++.||+.||.++|..||++.+++.+|.....
T Consensus 227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 47899999999999999999999999999999987643
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=304.05 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=195.3
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEec
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
|++.+.||+|+||+||+|+.+. +++.||+|++......... .....+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~-~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK-NGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT-TTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC-CCeEEEEEEeccccccccc-cchhhhhhhcccccccccccccccccccccccccccc
Confidence 7899999999999999999887 5789999999987533222 2344569999999999999999999999999999999
Q ss_pred ccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccc
Q psy622 123 YMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEI 202 (473)
Q Consensus 123 y~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~ 202 (473)
|+++++|.+++.+.+.+++..+..++.||+.||++||++||+||||||+||+++.+ +.++|+|||.+...... ...
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~---~~~ 154 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN-GEVKLIDFGSSVKLSEN---NEN 154 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-SEEEESSGTTTEESTST---TSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc---ccc
Confidence 99999999999977889999999999999999999999999999999999999988 99999999999753111 111
Q ss_pred ccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh-hhHhhhccCCCCccccCC
Q psy622 203 SDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT-STAAQLQLEWPEDEEALN 273 (473)
Q Consensus 203 ~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~P~~~~~ls 273 (473)
.....+++.|. |||.+. ..|+|++|++ ++|++|..||............. ............ ....+
T Consensus 155 ~~~~~~~~~y~---aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 230 (260)
T PF00069_consen 155 FNPFVGTPEYM---APEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ-SREKS 230 (260)
T ss_dssp BSSSSSSGGGS---CHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS-HTTSH
T ss_pred ccccccccccc---ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc-cchhH
Confidence 22345677766 888754 3567788865 57999999997530000000000 000001111110 01234
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.++.++|.+||+.||++||++.++++||||
T Consensus 231 ~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 231 EELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 899999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=293.29 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=201.9
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||.|+||+||+|.... +++.+|+|++.+..... ....+.+|+.+|+.++|+||+++++.+......|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP-NNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC-CCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence 579999999999999999998776 57899999998654322 567889999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 121 MEYMIGGDVKSLIAAN---GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~---~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
||+++|++|..++.+. +.+++..++.++.||+.||+|||++||+||||||+||+++++ +.++|+|||++..+....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASLADGG 156 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccchHHHhccCc
Confidence 9999999999999874 469999999999999999999999999999999999999998 899999999998765432
Q ss_pred ccc-ccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 198 VYL-EISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 198 ~~~-~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
... .......|++.|+ +||.+.. .|+|++|++ +++++|..||...... .............++..
T Consensus 157 ~~~~~~~~~~~~~~~y~---~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 230 (267)
T cd06610 157 DRTRKVRKTFVGTPCWM---APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPPSLETG 230 (267)
T ss_pred cccccccccccCChhhc---ChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCCCcCCc
Confidence 221 1223345676676 7886543 588999965 5799999999642110 00001111111111111
Q ss_pred --cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 269 --EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 269 --~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
...+++++.++|.+||+.||.+||+++++++||||
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 13678999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=304.16 Aligned_cols=251 Identities=21% Similarity=0.345 Sum_probs=199.5
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||+|+||.||+|+++. +++.||+|.++... ......++.+|+++++.++||||+++++++.+++.+|+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP-SGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC-CCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence 479999999999999999998876 57899999987542 233456788999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||+ .+++||||||+|||++.+ +.+||+|||++.......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC-CcEEEccCCCcccccccc--
Confidence 9999999999999988899999999999999999999997 599999999999999998 999999999987643211
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhc-----CCC---CChh--------
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVA-----GSQ---IPTS-------- 256 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~-----~~~---~~~~-------- 256 (473)
.....|++.|+ +||... ..|.|++|++ +++++|..||....... ... ....
T Consensus 155 ---~~~~~~~~~~~---aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ---ANSFVGTRSYM---SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ---cccCCCCcCcc---ChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccC
Confidence 12345677766 777643 3688899965 67999999986321000 000 0000
Q ss_pred -----------------hHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 257 -----------------TAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 257 -----------------~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.........|. ..++.++++||.+||..||++||+++|+++||||.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00000111121 236889999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=297.18 Aligned_cols=247 Identities=36% Similarity=0.607 Sum_probs=196.0
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hcCCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LTHSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
+.||+|+||.||+|.++. +++.||+|++.+...........+..|..++. ..+||||+++++++.....+|+||||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecC-CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 579999999999998876 57899999998765443444445566666554 4589999999999999999999999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
|++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+||+++.+ +.+||+|||+++.... ...
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~-------~~~ 152 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE-------NKK 152 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEeecccceeccc-------ccc
Confidence 99999999988889999999999999999999999999999999999999998 9999999999876322 122
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc-cccCChhHH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED-EEALNPSTE 277 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~-~~~ls~~a~ 277 (473)
..+++.|+ +||... ..++|++|++ +++++|..||...... ............++.. ...+++++.
T Consensus 153 ~~~~~~y~---~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05611 153 FVGTPDYL---APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD----AVFDNILSRRINWPEEVKEFCSPEAV 225 (260)
T ss_pred CCCCcCcc---ChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhcccCCCCcccccCCHHHH
Confidence 34666666 777543 3688999965 5799999999642110 0001111222333321 136889999
Q ss_pred HHHHhccccCCCCCCC---HHHHhcCCCCCCCCcc
Q psy622 278 ETILALLKSDPTQRPS---GHQVRRLPMFKDYDWD 309 (473)
Q Consensus 278 dLI~~LL~~dP~kRps---a~eil~HPFF~~idw~ 309 (473)
++|.+||+.||++||+ ++|++.||||++++|+
T Consensus 226 ~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 226 DLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred HHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 9999999999999995 5799999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=300.31 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=188.0
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCCeeeEEEEEEe-----
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT---HSPFCVQLFYSLQT----- 113 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~~----- 113 (473)
+|++.+.||+|+||+||+|+++. +++.||+|+++..... ........+|+.+++.+ +||||+++++++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~-~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH-SGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC-CCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 58999999999999999999887 5789999999865321 22223456677777655 79999999998864
Q ss_pred CCEEEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
...+++||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 79 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~kl~dfg~~~ 156 (288)
T cd07863 79 ETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLAR 156 (288)
T ss_pred CceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccCccc
Confidence 356899999995 5999998764 358999999999999999999999999999999999999999 999999999998
Q ss_pred hhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhh---------cCCCCCh
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRV---------AGSQIPT 255 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~---------~~~~~~~ 255 (473)
....... .....||+.|+ |||++. ..|+|++|++ +++++|.+||...... .+.....
T Consensus 157 ~~~~~~~----~~~~~~~~~y~---aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 157 IYSCQMA----LTPVVVTLWYR---APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred cccCccc----CCCcccccccc---CchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 7532211 12235677766 888653 4689999965 5688999998532100 0000000
Q ss_pred hhHhhhc-----------cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 256 STAAQLQ-----------LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 256 ~~~~~~~-----------~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
....... ..+......++.++++||.+||+.||++|||+.|++.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000000 00001113578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=300.24 Aligned_cols=254 Identities=20% Similarity=0.322 Sum_probs=203.1
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||.|+||.||+|+.+. +++.||+|++... .....+.+.+|+++++.++||||+++++.+.+...+|+|
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKE-TGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcC-CCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 569999999999999999998876 5789999999754 244456788999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|||+++|+|..++.+. +.+++..++.++.||+.||.|||++||+||||||+||+++.+ +.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC-CCEEEccCccchhhccccc-
Confidence 9999999999999874 479999999999999999999999999999999999999998 9999999999876432211
Q ss_pred cccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
......+++.|+ +||.+. ..|.|++|++ +++++|..||....... . .............
T Consensus 159 --~~~~~~~~~~y~---~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~-~~~~~~~~~~~~~ 229 (280)
T cd06611 159 --KRDTFIGTPYWM---APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---V-LLKILKSEPPTLD 229 (280)
T ss_pred --ccceeecchhhc---CHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---H-HHHHhcCCCCCcC
Confidence 112235677766 777642 4688999965 57999999996421100 0 0001111111111
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
.+..++.++.++|.+||+.+|.+||+++++++||||++..+.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 271 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN 271 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccchh
Confidence 124688999999999999999999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=297.05 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=198.3
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++.+.||+|+||.||+|++.. +++.||+|+++... ......+.+|+.+++.++||||++++++++..+.+|+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVN-TGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcC-CCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 3579999999999999999998876 57899999987653 2334567889999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITATI-- 160 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECcceeeeEccCcc--
Confidence 99999999999999988899999999999999999999999999999999999999998 999999999987643211
Q ss_pred cccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC--C
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP--E 267 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P--~ 267 (473)
.......|++.|+ |||.+. ..|.|++|++ +++++|..||....... . ...........+ .
T Consensus 161 -~~~~~~~~~~~y~---aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~-~~~~~~~~~~~~~~~ 232 (267)
T cd06645 161 -AKRKSFIGTPYWM---APEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---A-LFLMTKSNFQPPKLK 232 (267)
T ss_pred -cccccccCccccc---ChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---h-HHhhhccCCCCCccc
Confidence 1112345777777 788642 3688999965 57999999986421100 0 000000111111 1
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPM 302 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPF 302 (473)
....++..+.++|.+||+.||++||+++++++|||
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 11256788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=295.60 Aligned_cols=249 Identities=20% Similarity=0.311 Sum_probs=198.2
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
..++|++.+.||+|+||.||+|+.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.....+|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLH-TGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECC-CCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence 35689999999999999999998876 57899999997542 233456788999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
+||||+++|+|.+++.+.+.+++..+..++.|++.||+|||+.||+||||||+||+++.+ +.+||+|||++..+.....
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN-GDVKLADFGVAAKITATIA 161 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEECcCccceeeccccc
Confidence 999999999999999888889999999999999999999999999999999999999998 8999999999987532211
Q ss_pred ccccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC--
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP-- 266 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P-- 266 (473)
......|++.|+ +||.+. ..|+|++|++ +++++|..||........ . ..........+
T Consensus 162 ---~~~~~~~~~~y~---~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~--~~~~~~~~~~~~~ 231 (267)
T cd06646 162 ---KRKSFIGTPYWM---APEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L--FLMSKSNFQPPKL 231 (267)
T ss_pred ---ccCccccCcccc---CHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--h--eeeecCCCCCCCC
Confidence 112234666666 777542 4688999964 679999999864211100 0 00000011111
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPM 302 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPF 302 (473)
.....++.++.+||++||+.||++||+++++++|+|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 111357899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=309.21 Aligned_cols=254 Identities=21% Similarity=0.299 Sum_probs=193.4
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS---- 114 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~---- 114 (473)
.+++|++++.||+|+||.||+|++.. +++.||||++.+.. ........+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC-CCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 36899999999999999999998776 57899999997653 2233456788999999999999999999998643
Q ss_pred --CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 115 --SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 115 --~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
..+|+||||++ ++|...+.. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 93 ~~~~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~-~~~kl~Dfg~~~~ 168 (355)
T cd07874 93 EFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLART 168 (355)
T ss_pred ccceeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC-CCEEEeeCccccc
Confidence 35899999995 577777764 58999999999999999999999999999999999999998 9999999999986
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCChh
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPTS 256 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~~ 256 (473)
..... ......||+.|+ |||.+. ..|.|++|++ ++|++|..||.... ...+...+..
T Consensus 169 ~~~~~----~~~~~~~t~~y~---aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 169 AGTSF----MMTPYVVTRYYR---APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred CCCcc----ccCCccccCCcc---CHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 43221 112345777777 888653 3688999965 57999999996411 0000000000
Q ss_pred ------hHh---hh-----ccC---------CC---CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 257 ------TAA---QL-----QLE---------WP---EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 257 ------~~~---~~-----~~~---------~P---~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
... .. ... +| ......+.++++||.+||+.||++|||+.|+++||||..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 000 00 000 00 011234678899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=307.04 Aligned_cols=247 Identities=18% Similarity=0.257 Sum_probs=188.2
Q ss_pred CCCeEEEceecccCceEEEEEEEe----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKK----TNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTS 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~----~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 114 (473)
.++|++.++||+|+||.||+|.+. ..+++.||+|+++... .......+.+|+.+|..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999753 2245689999998642 233456789999999999 899999999988754
Q ss_pred -CEEEEEecccCcCCHHHHHHhC---------------------------------------------------------
Q psy622 115 -SCVFLVMEYMIGGDVKSLIAAN--------------------------------------------------------- 136 (473)
Q Consensus 115 -~~l~lVmEy~~gg~L~~~L~~~--------------------------------------------------------- 136 (473)
..+|+||||++||+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999999753
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCc
Q psy622 137 -----GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPN 211 (473)
Q Consensus 137 -----~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~ 211 (473)
..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+...... .......+++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~~ 241 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDY-VRKGSARLPLK 241 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcEEEeecccccccccCcch-hcccCCCCCcc
Confidence 237788899999999999999999999999999999999998 99999999999865322111 11112234556
Q ss_pred ccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCCccccCChhHHHHHHh
Q psy622 212 AFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDEEALNPSTEETILA 282 (473)
Q Consensus 212 y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~~~ls~~a~dLI~~ 282 (473)
|+ |||++. ..|+|++|++ +++++ |..||.... ........ .....+..+..+++++.+||.+
T Consensus 242 y~---aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 312 (338)
T cd05102 242 WM---APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ------INEEFCQRLKDGTRMRAPENATPEIYRIMLA 312 (338)
T ss_pred cc---CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC------ccHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 66 888653 4688999965 56775 999997521 01100000 0001111225788999999999
Q ss_pred ccccCCCCCCCHHHHhc
Q psy622 283 LLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 283 LL~~dP~kRpsa~eil~ 299 (473)
||+.||.+||++.|+++
T Consensus 313 cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 313 CWQGDPKERPTFSALVE 329 (338)
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=293.20 Aligned_cols=251 Identities=21% Similarity=0.336 Sum_probs=200.1
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccc------hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN------KNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~------~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
+|.+.+.||+|+||.||+|.+.. +++.||+|.+.+..... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecC-CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence 37788999999999999998776 57899999987653321 223457889999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
..++||||+++++|..++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.+ +.++|+|||+++.+..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK-GGIKISDFGISKKLEA 158 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC-CCEEecccCCCccccc
Confidence 999999999999999999988889999999999999999999999999999999999999998 9999999999987642
Q ss_pred Ccccc---ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 196 PIVYL---EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 196 ~~~~~---~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
..... .......|++.|+ +||.+. ..|.|++|++ +++++|..||...... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~---~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~ 229 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWM---APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKIGENAS 229 (267)
T ss_pred ccccCCccccccccCCCcCcc---ChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHHhccCC
Confidence 21110 1111234666666 787643 3688999965 5799999999742110 00011111222
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
|..+..++.++.++|++||+.||.+||++.|+++||||
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 33335788999999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=293.98 Aligned_cols=249 Identities=30% Similarity=0.534 Sum_probs=204.4
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++.+.||.|+||.||+|+++. +++.||+|++.+.........+.+.+|+++++.++||||+++++.+.++..+|+|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD-TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc-CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 58999999999999999998876 57899999999876555556778999999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc
Q psy622 122 EYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE 201 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~ 201 (473)
||+.|++|..++.+...+++..+..++.||+.||.|||++||+|+||||+||+++++ +.++|+|||++.......
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~---- 154 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDT---- 154 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC-CCEEEeecccccccCCCc----
Confidence 999999999999887889999999999999999999999999999999999999999 999999999988753321
Q ss_pred cccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCCh
Q psy622 202 ISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNP 274 (473)
Q Consensus 202 ~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~ 274 (473)
......|+..|+ +||.+. ..+.|++|++ +++++|..||...... .............+..+..++.
T Consensus 155 ~~~~~~~~~~y~---~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 227 (258)
T cd05578 155 LTTSTSGTPGYM---APEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETADVLYPATWST 227 (258)
T ss_pred cccccCCChhhc---CHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhccccccCcccCcH
Confidence 112234666666 787643 4788999965 5699999999743210 0111111111012222357889
Q ss_pred hHHHHHHhccccCCCCCCCH--HHHhcCCCC
Q psy622 275 STEETILALLKSDPTQRPSG--HQVRRLPMF 303 (473)
Q Consensus 275 ~a~dLI~~LL~~dP~kRpsa--~eil~HPFF 303 (473)
++.++|.+||+.||.+|+++ +|+++||||
T Consensus 228 ~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 228 EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 99999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=300.52 Aligned_cols=251 Identities=21% Similarity=0.379 Sum_probs=200.0
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||+|+||.||+|+++. +++.||+|.++... .......+.+|+++++.++||||+++++++...+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP-TGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC-CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence 478999999999999999998876 57899999987542 233456788999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 121 MEYMIGGDVKSLIAAN---GALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~---~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|||++|++|..++... +.+++..++.++.||+.||.|||+ .||+||||||+||+++.+ +.+||+|||++..+...
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC-CCEEEeecCCcccccCC
Confidence 9999999999998763 379999999999999999999997 599999999999999998 99999999999765322
Q ss_pred ccccccccccCCCCcccccCCcccc------------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhcc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQL------------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQL 263 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i------------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 263 (473)
......+++.|+ +||.+ ...+.|++|++ +++++|..||..... .............
T Consensus 157 -----~~~~~~~~~~y~---aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~ 225 (286)
T cd06622 157 -----LAKTNIGCQSYM---APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQLSAIVDG 225 (286)
T ss_pred -----ccccCCCccCcc---CcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHHHHHhhc
Confidence 112234666666 77764 24688999965 679999999964210 0000000000111
Q ss_pred CCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
..+..+..+++++.+||.+||+.+|.+||+++++++||||...
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 226 DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 1222235689999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=292.20 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=197.2
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM--INKNMVSQVLRERNALALTHSPFCVQLFYSLQT--SSC 116 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~~~ 116 (473)
.+|++.+.||+|+||.||+|.+.. +++.||+|++.+... ...+....+.+|+.+++.++||||+++++++.+ ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD-TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC-CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 468999999999999999998876 578999999876432 123345678999999999999999999999875 467
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+++++||+++++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++..+...
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCCCccccccc
Confidence 89999999999999999988889999999999999999999999999999999999999998 89999999999865322
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh--hccCCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ--LQLEWPE 267 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~P~ 267 (473)
...........++..|+ |||.+. ..|.|++|++ +++++|..||..... ...+.. .....|.
T Consensus 160 ~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~~~~~~~~~~~~~ 229 (266)
T cd06651 160 CMSGTGIRSVTGTPYWM---SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAAIFKIATQPTNPQ 229 (266)
T ss_pred cccCCccccCCcccccc---CHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcCCCCCC
Confidence 11111111234566666 888653 3688999965 579999999964211 111111 1111233
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
.+..+++.++++| +||..+|++||+++||++||||+
T Consensus 230 ~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 230 LPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 3356889999999 56668999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=295.26 Aligned_cols=249 Identities=21% Similarity=0.298 Sum_probs=198.5
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEec
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
|++++.||+|+||.||+|+++. ++..+|+|.+.... ......+.+|+++++.++||||+++++.+......|+|||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKE-TGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECC-CCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 6888999999999999998876 57889999987543 3446678899999999999999999999999999999999
Q ss_pred ccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc
Q psy622 123 YMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE 201 (473)
Q Consensus 123 y~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~ 201 (473)
|+++|+|..++.+ .+.+++..+..++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||++....... .
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~---~ 158 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTI---Q 158 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-CCEEEccccccccccccc---c
Confidence 9999999998865 4579999999999999999999999999999999999999998 999999999987643211 1
Q ss_pred cccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 202 ISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 202 ~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
......+++.|+ +||.+. ..|.|++|++ +++++|..||....... . ..............+
T Consensus 159 ~~~~~~~~~~y~---aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~-~~~~~~~~~~~~~~~ 231 (282)
T cd06643 159 RRDSFIGTPYWM---APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---V-LLKIAKSEPPTLAQP 231 (282)
T ss_pred cccccccccccc---CHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---H-HHHHhhcCCCCCCCc
Confidence 112235777777 788652 4789999965 67999999986421100 0 000111111111112
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
..++.++++||.+||+.||.+||+++++++||||+..
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 4678999999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=291.65 Aligned_cols=252 Identities=19% Similarity=0.309 Sum_probs=199.1
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccc---cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM---INKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~---~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
+|++.+.||+|+||.||+|... +++.+|+|.++.... .......++.+|+++|+.++|+||+++++++.+...+|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEc--CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEE
Confidence 5888999999999999999753 468899999875421 22334567899999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
+||||++||+|.+++.+.+.+++..+..++.||+.||+|||+.||+|+||||+||+++++ +.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-CeEEeccchhhHhhhhccc
Confidence 999999999999999988889999999999999999999999999999999999999998 9999999999987532111
Q ss_pred c---cccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 199 Y---LEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 199 ~---~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
. ........|++.|+ +||.. ...|.|++|++ +++++|..||....... ............|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~---~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~ 230 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWM---APEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----AMFYIGAHRGLMPRL 230 (265)
T ss_pred cccccccccccCCCcccc---ChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH----HHHHhhhccCCCCCC
Confidence 1 11112234666666 77764 34788899965 57999999996421100 000111111122333
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
+..++.++.++|++||+.+|.+||++.|+++||||
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 35789999999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=287.73 Aligned_cols=247 Identities=21% Similarity=0.354 Sum_probs=197.5
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCEEEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT-SSCVFLV 120 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-~~~l~lV 120 (473)
+|++++.||+|+||.||+|+++. +++.||+|.+..... .....+.+.+|+++++.++||||+++++.+.. ...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT-DGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC-CCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 58999999999999999999876 578899999976542 23345678899999999999999999998874 4578999
Q ss_pred ecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 121 MEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
|||+++++|.+++... ..+++.+++.++.||+.||++||++||+||||||+||+++.+ +.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC-CcEEEecccceEEecccC-
Confidence 9999999999999763 468999999999999999999999999999999999999998 999999999998753321
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcccc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ 271 (473)
.......+++.|+ |||... ..|+|++|++ +++++|..||....... . ..... ....+..+..
T Consensus 157 --~~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~-~~~~~--~~~~~~~~~~ 225 (257)
T cd08223 157 --DMASTLIGTPYYM---SPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS---L-VYRII--EGKLPPMPKD 225 (257)
T ss_pred --CccccccCCcCcc---ChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---H-HHHHH--hcCCCCCccc
Confidence 1122345777777 888653 4688999965 57999999986421000 0 00011 1112222357
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.++++.++|.+||+.||.+||++.++++||||
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 226 YSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred cCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 88999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=303.84 Aligned_cols=257 Identities=18% Similarity=0.251 Sum_probs=192.5
Q ss_pred EEceeccc--CceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEec
Q psy622 45 IVKAISRG--AFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 45 i~~~LG~G--~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
++++||+| +||+||+++++. +++.||+|+++.... .......+.+|+.+++.++||||++++++|++++.+|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP-TGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecc-cCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 56899999 789999998887 689999999986532 23345678889999999999999999999999999999999
Q ss_pred ccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 123 YMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 123 y~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.++++||+.+..........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-CcEEEcccchhhccccccccc
Confidence 99999999999753 469999999999999999999999999999999999999998 899999998765532111110
Q ss_pred c----cccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCchhHhh------hcCCCCCh------
Q psy622 201 E----ISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFPSALR------VAGSQIPT------ 255 (473)
Q Consensus 201 ~----~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~~~~~------~~~~~~~~------ 255 (473)
. ......++..|+ |||++. ..|+|++|++ +++++|..||..... .....++.
T Consensus 159 ~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 159 RVVHDFPKYSVKVLPWL---SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred cccccccccccceeccc---ChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence 0 011122334444 787653 3688999965 579999999964110 00000000
Q ss_pred ---hhHhh------h------------------ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 256 ---STAAQ------L------------------QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 256 ---~~~~~------~------------------~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
..... . ..........+++++.+||.+||+.||++|||++|+++||||+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 00000 0 0000001134678999999999999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=292.36 Aligned_cols=250 Identities=39% Similarity=0.645 Sum_probs=200.9
Q ss_pred ecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCC
Q psy622 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGD 128 (473)
Q Consensus 49 LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~ 128 (473)
||+|+||.||+|++.. +++.||+|++.+.....+...+.+.+|+++++.++||||+++++.+.+...+|+||||++|++
T Consensus 1 lg~g~~~~vy~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKS-TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECC-CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 6899999999998876 578999999987765555667789999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc-----cccc
Q psy622 129 VKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY-----LEIS 203 (473)
Q Consensus 129 L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~-----~~~~ 203 (473)
|.+++.+.+.+++..+..++.||+.||+|||++|++||||+|+||+++.+ +.++|+|||++......... ....
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccccccc
Confidence 99999988899999999999999999999999999999999999999999 99999999998864322110 0011
Q ss_pred cccCCCCcccccCCcccc------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhH
Q psy622 204 DLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPST 276 (473)
Q Consensus 204 ~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a 276 (473)
....+++.|+ +||.. ...|.|++|++ +++++|..||....... ...........+|.. ..++.++
T Consensus 159 ~~~~~~~~~~---~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~-~~~~~~~ 230 (265)
T cd05579 159 KRIVGTPDYI---APEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----IFQNILNGKIEWPED-VEVSDEA 230 (265)
T ss_pred cCcccCcccc---CHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCcCCCcc-ccCCHHH
Confidence 2234555665 77754 24688899965 56899999996421100 001111123344432 2248999
Q ss_pred HHHHHhccccCCCCCCCH---HHHhcCCCCCCCCc
Q psy622 277 EETILALLKSDPTQRPSG---HQVRRLPMFKDYDW 308 (473)
Q Consensus 277 ~dLI~~LL~~dP~kRpsa---~eil~HPFF~~idw 308 (473)
.++|.+||+.+|.+||++ .++++||||++++|
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 999999999999999998 99999999999999
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=295.87 Aligned_cols=252 Identities=21% Similarity=0.343 Sum_probs=193.5
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++++.||+|+||.||+|+++. +++.||||+++.... .......+.+|+.+++.++||||++++++++++..+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK-TGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECC-CCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 58999999999999999998876 578999999876432 2233457888999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 122 EYMIGGDVKSLIAAN---GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~---~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||++ ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++........
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVR 156 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC-CcEEECcccceeecCCCcc
Confidence 9996 6898888653 469999999999999999999999999999999999999998 9999999999976432211
Q ss_pred ccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCCh-----h
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPT-----S 256 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~-----~ 256 (473)
......+++.|+ |||++. ..|.|++|++ +++++|..||..... ..+..... .
T Consensus 157 ---~~~~~~~~~~y~---aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 157 ---VYTHEVVTLWYR---APEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred ---cccCCccccccc---ChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 111224556666 787643 3578899965 579999999964210 00000000 0
Q ss_pred hHhhhccCCC--------CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 257 TAAQLQLEWP--------EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 257 ~~~~~~~~~P--------~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
........++ .....+++++++||++||+.||.+||++.+|++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000000000 0113588999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=309.58 Aligned_cols=248 Identities=19% Similarity=0.268 Sum_probs=187.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
..+|++++.||+|+||+||+|+++. +++.||+|+..+. ....|+.+++.++||||+++++++......|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPG-QPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECC-CCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 4579999999999999999998876 5788999986543 23568999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
|||++ .|+|..++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.+ +.+||+|||+++......
T Consensus 135 v~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 135 VLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV-DQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEecCccccccccCc-
Confidence 99999 5688888865 4579999999999999999999999999999999999999999 999999999997532211
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCc-hhHh------------------hhcC--
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPF-PSAL------------------RVAG-- 250 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf-~~~~------------------~~~~-- 250 (473)
......||+.|+ |||++. ..++|++|++ ++++++..++ .... ...+
T Consensus 212 ---~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 212 ---AFLGLAGTVETN---APEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred ---cccccccccccc---CCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 112245777777 888754 3688899965 5676644433 2100 0000
Q ss_pred -CCCCh---hhHhh--------hccCCCC----ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 251 -SQIPT---STAAQ--------LQLEWPE----DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 251 -~~~~~---~~~~~--------~~~~~P~----~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
...+. ..... ....+.. ....++.++.+||.+||+.||++|||++|+++||||+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 00000 00000 0000000 012567788999999999999999999999999999864
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=299.07 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=192.0
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++.+.||+|+||.||+|+++. +|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+...+|+|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~-~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC-CCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 48999999999999999999887 578999999976532 2223456788999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 122 EYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 122 Ey~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
||+. ++|..++.+ .+.+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||+++........
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 79 EYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC-CcEEECccchhhccCCCCCC-
Confidence 9995 688888765 5679999999999999999999999999999999999999998 99999999999865322111
Q ss_pred ccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHh----------hhcCCCCChhhHh---
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSAL----------RVAGSQIPTSTAA--- 259 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~----------~~~~~~~~~~~~~--- 259 (473)
.....+++.|+ |||.+. ..|.|++|++ ++|++|..|+.... ...+.........
T Consensus 156 --~~~~~~~~~y~---aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 156 --YSAEVVTLWYR---PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred --cCCCccccCCc---ChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 11223455555 788643 3578899965 56888888853210 0000000000000
Q ss_pred ----------hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 260 ----------QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 260 ----------~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.....+......+++++++||.+||+.||.+|||++|+++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00001111123678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=293.65 Aligned_cols=245 Identities=23% Similarity=0.338 Sum_probs=194.3
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe------
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQT------ 113 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~------ 113 (473)
+.|++.+.||+|+||.||+|+.+. +++.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~-~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcC-CCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 568999999999999999998876 57899999997642 2235678899999988 79999999999875
Q ss_pred CCEEEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++.
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~-~~~~l~Dfg~~~ 159 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSA 159 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC-CCEEEccCCCce
Confidence 35799999999999999999874 368999999999999999999999999999999999999999 899999999998
Q ss_pred hhcCCccccccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA 259 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~ 259 (473)
...... .......|++.|+ +||++. ..|+|++|++ +++++|..||........ .....
T Consensus 160 ~~~~~~---~~~~~~~g~~~y~---aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~----~~~~~ 229 (272)
T cd06637 160 QLDRTV---GRRNTFIGTPYWM---APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----LFLIP 229 (272)
T ss_pred eccccc---ccCCccccccccc---CHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH----HHHHh
Confidence 643211 1123346777777 788653 4788999965 679999999964211000 00000
Q ss_pred h-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 260 Q-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 260 ~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
. .....+ ...++.++.+||.+||+.||.+||++.|+++||||
T Consensus 230 ~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 230 RNPAPRLK--SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCCCCCCC--CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0 011111 13578899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=299.50 Aligned_cols=265 Identities=21% Similarity=0.332 Sum_probs=216.6
Q ss_pred cccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeE
Q psy622 28 CDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQL 107 (473)
Q Consensus 28 ~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l 107 (473)
..+..+.+.++-.+-|+++.+||+|+||.||+|.++. +|+++|||.+... .+.+.+..|+.|+.++++|+||++
T Consensus 20 ~KLd~~sL~K~PEEVFDi~~KLGEGSYGSV~KAIH~E-sG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKY 93 (502)
T KOG0574|consen 20 FKLDSSALNKPPEEVFDIVGKLGEGSYGSVHKAIHRE-SGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKY 93 (502)
T ss_pred cccChhhhcCChHHHHHHHHHhcCCcchHHHHHHHhc-cCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhh
Confidence 3444444545545669999999999999999999998 6899999998874 346789999999999999999999
Q ss_pred EEEEEeCCEEEEEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEee
Q psy622 108 FYSLQTSSCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVN 186 (473)
Q Consensus 108 ~~~f~~~~~l~lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~D 186 (473)
|++|-....+|+|||||..|++.+.++. +.+++|+++..++..-+.||+|||...-||||||..||||+.+ |+.||+|
T Consensus 94 YGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~-G~AKLAD 172 (502)
T KOG0574|consen 94 YGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD-GIAKLAD 172 (502)
T ss_pred hhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc-chhhhhh
Confidence 9999999999999999999999999986 4589999999999999999999999999999999999999999 9999999
Q ss_pred cchhhhhcCCccccccccccCCCCcccccCCcccccc------CCcCCCCccc-cccCCCCCchhHhhhcCC-CCChhhH
Q psy622 187 TLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTFQ-DVQNSQAPFPSALRVAGS-QIPTSTA 258 (473)
Q Consensus 187 FGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l~-~~~~g~~pf~~~~~~~~~-~~~~~~~ 258 (473)
||.+-.+... ....++..|||-|| |||++.. .+.|++|+-. +|..|++||..+-..... -++...
T Consensus 173 FGVAGQLTDT---MAKRNTVIGTPFWM---APEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~P- 245 (502)
T KOG0574|consen 173 FGVAGQLTDT---MAKRNTVIGTPFWM---APEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKP- 245 (502)
T ss_pred ccccchhhhh---HHhhCccccCcccc---cHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCC-
Confidence 9999876432 23345678999999 9998753 5778999764 799999999764211000 011000
Q ss_pred hhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccc
Q psy622 259 AQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDS 310 (473)
Q Consensus 259 ~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~ 310 (473)
--..+-| ...|.++.|+|++||.++|++|-||.++++|||.++..=-.
T Consensus 246 -PPTF~KP---E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 246 -PPTFKKP---EEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCD 293 (502)
T ss_pred -CCCCCCh---HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence 0011223 56889999999999999999999999999999999865433
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=299.04 Aligned_cols=247 Identities=22% Similarity=0.308 Sum_probs=182.1
Q ss_pred ceecccCceEEEEEEEeCC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCEEEEEecc
Q psy622 47 KAISRGAFGKVFLGYKKTN-KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ--TSSCVFLVMEY 123 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~-~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--~~~~l~lVmEy 123 (473)
.+||+|+||+||+|+.+.. +++.||+|.+..... ...+.+|+++|+.++||||+++++++. ....+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 5899999999999987542 457899999876532 235778999999999999999999985 45689999999
Q ss_pred cCcCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe----cCCCCceeEeecchh
Q psy622 124 MIGGDVKSLIAAN---------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI----SAQAPHCPIVNTLFL 190 (473)
Q Consensus 124 ~~gg~L~~~L~~~---------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILl----d~~~g~ikL~DFGla 190 (473)
+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.+ +.+||+|||++
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~-~~~kl~DfG~a 159 (317)
T cd07867 82 A-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER-GRVKIADMGFA 159 (317)
T ss_pred e-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCC-CcEEEeeccce
Confidence 8 56888887531 258899999999999999999999999999999999999 344 79999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCC--------
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIP-------- 254 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~-------- 254 (473)
+................||+.|+ |||.+. ..|+|++|++ +++++|.+||...........+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYR---APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred eccCCCcccccccCcceeccccc---CcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 87543322212222345777777 888653 3588999965 5799999999642111000000
Q ss_pred ----------hhh--H--------hhhc---c---------CCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCC
Q psy622 255 ----------TST--A--------AQLQ---L---------EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPM 302 (473)
Q Consensus 255 ----------~~~--~--------~~~~---~---------~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPF 302 (473)
... . .... . ..+......+..+.+||.+||+.||.+|||++|+++|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 000 0 0000 0 000011234567899999999999999999999999999
Q ss_pred C
Q psy622 303 F 303 (473)
Q Consensus 303 F 303 (473)
|
T Consensus 317 f 317 (317)
T cd07867 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=289.19 Aligned_cols=251 Identities=21% Similarity=0.284 Sum_probs=197.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM--INKNMVSQVLRERNALALTHSPFCVQLFYSLQTS--SC 116 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~ 116 (473)
.+|++.+.||+|+||.||+|+++. +++.||||++..... ......+.+.+|+.+++.++||||+++++++++. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD-TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC-CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 579999999999999999998876 578999999875321 2234466889999999999999999999998763 57
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+||||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+||+++.+ +.++|+|||++......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV-GNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC-CCEEECcCccccccccc
Confidence 89999999999999999988889999999999999999999999999999999999999998 99999999999865322
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh--hccCCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ--LQLEWPE 267 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~P~ 267 (473)
...........|+..|+ |||... ..|+|++|++ +++++|..||...... ..... .....+.
T Consensus 160 ~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~ 229 (265)
T cd06652 160 CLSGTGMKSVTGTPYWM---SPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPV 229 (265)
T ss_pred cccccccccCCCCcccc---ChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-------HHHHHHhcCCCCCC
Confidence 11111112234666666 788653 3588899965 6799999998642100 00110 0111122
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
.+..++..+.++|.+||. +|++||+++|+++|||++
T Consensus 230 ~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 230 LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 235688899999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=290.87 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=199.9
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI---NKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~---~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
+|+..+.||+|+||.||+|+.+. +++.||+|++.+.... .....+.+.+|+++++.++||||+++++++++.+.++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~-~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK-TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcC-CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEE
Confidence 47888999999999999998766 5789999999865322 1223568899999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++..+||+|||++..+.....
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 99999999999999998889999999999999999999999999999999999999988734699999999987643211
Q ss_pred cc-ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh--hccCCCCc
Q psy622 199 YL-EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ--LQLEWPED 268 (473)
Q Consensus 199 ~~-~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~P~~ 268 (473)
.. .......++..|+ +||... ..|.|++|++ +++++|..||..... ......+.. .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~---~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd06630 160 GAGEFQGQLLGTIAFM---APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH----SNHLALIFKIASATTAPSI 232 (268)
T ss_pred cCCcccccccccccee---CHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----cchHHHHHHHhccCCCCCC
Confidence 10 1112234555555 787643 3688899965 579999999863211 000011111 01112223
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
+..+++++.+++.+||..+|.+||++.++++||||+
T Consensus 233 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred chhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 357889999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=329.40 Aligned_cols=257 Identities=21% Similarity=0.319 Sum_probs=204.5
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT-- 113 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-- 113 (473)
....+++|++++.||+|+||+||+|+++. +++.||+|++..... .......+..|+.+|+.++|||||+++++|.+
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~-tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKR-TQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECC-CCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 34557899999999999999999999887 678999999987643 33446688999999999999999999999854
Q ss_pred CCEEEEEecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-------CeeecCCCCcceEecCC----
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSH-------GIIHRDLKPDNMLISAQ---- 178 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~-------gIiHRDLKpeNILld~~---- 178 (473)
...+||||||+++|+|..+|.. .+.+++..++.++.||+.||+|||+. +||||||||+||||+..
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 4679999999999999999975 25799999999999999999999985 49999999999999642
Q ss_pred ------------CCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccC
Q psy622 179 ------------APHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQN 237 (473)
Q Consensus 179 ------------~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~ 237 (473)
.+.+||+|||++..+.... ......||+.|+ |||++. ..|+|++|++ ++|++
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~Ym---APEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYW---SPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc----cccccCCCcccc---CHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 1458999999998753221 122346888887 899763 3589999965 57999
Q ss_pred CCCCchhHhhhcCCCCChhhHhh--hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 238 SQAPFPSALRVAGSQIPTSTAAQ--LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 238 g~~pf~~~~~~~~~~~~~~~~~~--~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
|..||.... ........ ....+|. ...+.++.+||.+||+.+|.+||++.|++.||||+.+...
T Consensus 239 Gk~PF~~~~------~~~qli~~lk~~p~lpi--~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 239 GKTPFHKAN------NFSQLISELKRGPDLPI--KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred CCCCCCcCC------cHHHHHHHHhcCCCCCc--CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 999996421 00011111 1112221 3578999999999999999999999999999999987543
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=313.38 Aligned_cols=249 Identities=22% Similarity=0.253 Sum_probs=189.4
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
...|.+.+.||+|+||.||+|++.. +++.||||.... ....+|+++|+.++|||||++++++...+..|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~-~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD-YPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC-CCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 4579999999999999999998876 578999996432 245689999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
|||++ .++|..++... +.+++..++.++.||+.||.|||++|||||||||+||||+.+ +.+||+|||+++.+.....
T Consensus 238 v~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 238 VLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC-CCEEEcccCCceecccccc
Confidence 99999 57999888764 479999999999999999999999999999999999999998 8999999999986532211
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHh----------------hhcC---CC
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSAL----------------RVAG---SQ 252 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~----------------~~~~---~~ 252 (473)
. .......||+.|+ +||++. ..|+|++|++ +++++|..++.... .... ..
T Consensus 316 ~-~~~~~~~GT~~Y~---APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 316 T-PFHYGIAGTVDTN---APEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred c-ccccccCCCcCCc---CHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 1 1122346888887 888754 3588999965 56766654432110 0000 00
Q ss_pred CChh-------hHhh-----h-----ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 253 IPTS-------TAAQ-----L-----QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 253 ~~~~-------~~~~-----~-----~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.+.. .... . ...|... ..++.++.+||.+||+.||.+|||++|+++||||+.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRY-YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhh-ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000 0000 0 0001111 145678999999999999999999999999999974
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=293.18 Aligned_cols=254 Identities=23% Similarity=0.292 Sum_probs=195.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||+|+||.||+|+++. +++.||+|++.+... .....+.+.+|+.+++.++||||+++++++++...+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE-TGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC-CCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence 479999999999999999999876 578999999876532 122234678899999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||++++.|..++.....+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++..+......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~- 156 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDD- 156 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC-CcEEECccccceecCCCccc-
Confidence 9999999998888777789999999999999999999999999999999999999999 99999999999875432211
Q ss_pred ccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhc--------CCCCChhhHhh----
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVA--------GSQIPTSTAAQ---- 260 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~--------~~~~~~~~~~~---- 260 (473)
.....++..|+ +||.+. ..++|++|++ +++++|..||.+..... ...........
T Consensus 157 --~~~~~~~~~~~---aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 157 --YTDYVATRWYR---APELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred --ccCcccccccC---CHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 11123444554 777542 3688899965 57999999996421100 00000000000
Q ss_pred ---hccCCCC---------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 261 ---LQLEWPE---------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 261 ---~~~~~P~---------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.....|. ....++..+.+||.+||+.||++||++.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000110 013568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=293.39 Aligned_cols=257 Identities=16% Similarity=0.238 Sum_probs=195.6
Q ss_pred CCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
..++|++.+.||+|+||.||+|..+. ..+..||+|.++... .......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45789999999999999999997653 124579999987543 222344678899999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeE
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANG----------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPI 184 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~----------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL 184 (473)
...|+||||+++|+|.+++.+.+ .++...+..++.||+.||.|||++||+||||||+||+++.+ +.++|
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~-~~~~L 160 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKI 160 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC-CcEEE
Confidence 99999999999999999997632 34667889999999999999999999999999999999998 99999
Q ss_pred eecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChh
Q psy622 185 VNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTS 256 (473)
Q Consensus 185 ~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~ 256 (473)
+|||+++.+...... .......++..|+ +||.+. ..+.|++|++ +++++ |..||...... .+. .
T Consensus 161 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~---~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~-~ 232 (288)
T cd05061 161 GDFGMTRDIYETDYY-RKGGKGLLPVRWM---APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVL-K 232 (288)
T ss_pred CcCCccccccccccc-cccCCCccccccc---CHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH-H
Confidence 999999865332211 1111123344555 777643 3588899965 56766 78888542110 000 0
Q ss_pred hHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc------CCCCCCCCc
Q psy622 257 TAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR------LPMFKDYDW 308 (473)
Q Consensus 257 ~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~------HPFF~~idw 308 (473)
.+ .....+..+...++.+++++.+||+.||++||++.++++ ||||++++|
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 233 FV--MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HH--HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 00 111122222567899999999999999999999988876 999999999
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=294.39 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=199.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++++.||+|+||.||+|+.+. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+.....+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIA-TGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECC-CCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 4789999999999999999998776 578999999976542 234568899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||||++|++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.++|+|||++........
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEECcCccceEccCCcc-
Confidence 9999999999999975 468999999999999999999999999999999999999998 9999999999876432211
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
......+++.|+ +||.+. ..|.|++|++ +++++|..||....... ... . ...........+..+
T Consensus 171 --~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--~~~-~-~~~~~~~~~~~~~~~ 241 (297)
T cd06656 171 --KRSTMVGTPYWM---APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALY-L-IATNGTPELQNPERL 241 (297)
T ss_pred --CcCcccCCcccc---CHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--hee-e-eccCCCCCCCCcccc
Confidence 112335666666 777643 3688899965 57999999996421100 000 0 000000011112568
Q ss_pred ChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 273 NPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+..+++||.+||+.||++||+++++++||||+..
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 8899999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=292.86 Aligned_cols=251 Identities=20% Similarity=0.285 Sum_probs=200.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
..+|++++.||+|+||.||+|+++. +++.||+|.+..... .....+.+|+.+++.++||||+++++.+....+.|+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECC-CCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 4689999999999999999998776 578999999987543 224578899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||||++||+|.+++.+ +.+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++........
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEECccccchhcccccc-
Confidence 9999999999999875 468999999999999999999999999999999999999998 8999999999886432211
Q ss_pred cccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
......+++.|+ +||.. ...|.|++|++ +++++|..||....... .. .............+..+
T Consensus 172 --~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~--~~~~~~~~~~~~~~~~~ 242 (296)
T cd06654 172 --KRSTMVGTPYWM---APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--AL--YLIATNGTPELQNPEKL 242 (296)
T ss_pred --ccCcccCCcccc---CHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hH--HHHhcCCCCCCCCcccc
Confidence 112235777776 77754 34688899965 57999999996421100 00 00000011011112468
Q ss_pred ChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 273 NPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+..+.+||.+||..||.+||++.++++||||...
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 8999999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=322.84 Aligned_cols=284 Identities=17% Similarity=0.199 Sum_probs=202.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEe--------------ecccccchhHHHHHHHHHHHHHhcCCCCee
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVM--------------KKDEMINKNMVSQVLRERNALALTHSPFCV 105 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l--------------~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv 105 (473)
+++|++++.||+|+||+||+|..+...+...+.|.+ .+...........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999999776544444444321 111111223345688999999999999999
Q ss_pred eEEEEEEeCCEEEEEecccCcCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC
Q psy622 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-----GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP 180 (473)
Q Consensus 106 ~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~-----~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g 180 (473)
++++++++.+..|+|++++ +++|..++... .......++.++.||+.||+|||++|||||||||+|||++.+ +
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~-~ 304 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD-G 304 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-C
Confidence 9999999999999999999 67888877543 234567788999999999999999999999999999999999 9
Q ss_pred ceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCC-chhHh------
Q psy622 181 HCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAP-FPSAL------ 246 (473)
Q Consensus 181 ~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~p-f~~~~------ 246 (473)
.+||+|||+++.+..... .......||+.|+ |||++. ..|+|++|++ ++|++|..+ +....
T Consensus 305 ~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 305 KIVLGDFGTAMPFEKERE--AFDYGWVGTVATN---SPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CEEEEeCCCceecCcccc--cccccccCCcCCC---CchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 999999999987543221 1122346787777 888764 3688999965 568877644 32110
Q ss_pred --hhc------CCCCChh------hHhhhcc-----CCCCc--cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 247 --RVA------GSQIPTS------TAAQLQL-----EWPED--EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 247 --~~~------~~~~~~~------~~~~~~~-----~~P~~--~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
... ...++.. .+..... .++.. ...++.++.++|.+||+.||++|||+.|++.||||..
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 000 0000000 0000000 00000 0235678899999999999999999999999999999
Q ss_pred CCccccccC---------CCCCcCCCCCCCCCCC
Q psy622 306 YDWDSILDQ---------EPPFVPQPDDVFDTSY 330 (473)
Q Consensus 306 idw~~l~~~---------~pPf~P~~~~~~D~s~ 330 (473)
..++.+.-. -.|++|.+..+.||.-
T Consensus 460 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 493 (501)
T PHA03210 460 EEEEEILFIHGLKSGAAHFKPIKPACRIESDTAA 493 (501)
T ss_pred CCchHHHHHHhhhccccccccCCchheecccccc
Confidence 887765421 4688888887777754
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=292.71 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=192.1
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
.+++|++.+.||+|+||.||+|+.+. +++.||||.+..... ......+.+|+++++.++||||+++++++++....|
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKL-TGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLT 79 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcC-CCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence 46899999999999999999998876 578999999976432 122335678999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 119 LVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+||||+. ++|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||+++......
T Consensus 80 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 80 LVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER-GELKLADFGLARAKSVPS 157 (291)
T ss_pred EEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC-CCEEECccccccccCCCC
Confidence 9999996 5999998764 468999999999999999999999999999999999999999 999999999987642211
Q ss_pred cccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHh----------hhcCCCCChhhHh
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSAL----------RVAGSQIPTSTAA 259 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~----------~~~~~~~~~~~~~ 259 (473)
.. .....+++.|+ +||... ..|+|++|++ ++|++|..||.... ...+.........
T Consensus 158 ~~---~~~~~~~~~~~---aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 158 KT---YSNEVVTLWYR---PPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred cc---ccccccccccC---CcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence 11 11123455554 777543 2588999965 57999999995421 0000000000000
Q ss_pred ------hhccCCC--------CccccCC--hhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 260 ------QLQLEWP--------EDEEALN--PSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 260 ------~~~~~~P--------~~~~~ls--~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.....++ .....++ .++.++|.+||+.||++||++.|+++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000000 0001344 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=266.52 Aligned_cols=254 Identities=23% Similarity=0.402 Sum_probs=198.0
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
..|+-.++||+|+||+|++|+.+. ++++||+|.++-+. ..+..-...++|+-+|+.++|.|||++++....++++-+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~-t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRE-THEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCC-ccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence 357778899999999999999887 78999999998764 2233455789999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
+||| ..+|..+... +|.++.+.++.++.|++.||.++|+++++||||||+|+||+.+ |.+||+|||+++.++-+..
T Consensus 80 fe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n-gelkladfglarafgipvr- 156 (292)
T KOG0662|consen 80 FEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVR- 156 (292)
T ss_pred HHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC-CcEEecccchhhhcCCceE-
Confidence 9999 6789888876 5789999999999999999999999999999999999999999 9999999999998654322
Q ss_pred cccccccCCCCc--ccccCCccccc-------cCCcCCCCccc-c-ccCCCCCchh---------HhhhcCCCCChhhHh
Q psy622 200 LEISDLVNGTPN--AFNIRTPGQLL-------SLKTGTFPTFQ-D-VQNSQAPFPS---------ALRVAGSQIPTSTAA 259 (473)
Q Consensus 200 ~~~~~~~~gtp~--y~~~~ape~i~-------~~~~~s~g~l~-~-~~~g~~pf~~---------~~~~~~~~~~~~~~~ 259 (473)
|-+.+ .++|+.|.+++ +.+.|+-|++. + .-.|.+.|++ +++..+......+..
T Consensus 157 -------cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 157 -------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred -------eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence 11111 23455666654 57788888654 4 4567888876 223333221111110
Q ss_pred h----h---------ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 260 Q----L---------QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 260 ~----~---------~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
. . ...|.+.-+.++...+||++++|.-+|.+|++++++++||||.+.
T Consensus 230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 0 0 011111224677789999999999999999999999999999864
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=297.82 Aligned_cols=257 Identities=23% Similarity=0.312 Sum_probs=194.7
Q ss_pred CeEEEceecccCceEEEEEEEeCC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTN-KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS--SCVF 118 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~-~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~l~ 118 (473)
.|++.+.||+|+||.||+|..+.. .++.||+|++.+...........+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 489999999999999999988762 4789999999985433334456778899999999999999999999988 8899
Q ss_pred EEecccCcCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC----CCCceeEeecch
Q psy622 119 LVMEYMIGGDVKSLIAAN-----GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA----QAPHCPIVNTLF 189 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~-----~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~----~~g~ikL~DFGl 189 (473)
+||||++ ++|..++... ..+++..++.++.||+.||+|||+.||+||||||+||+++. + +.+||+|||+
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~-~~~kl~Dfg~ 158 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER-GVVKIGDLGL 158 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCcc-ceEEECCCcc
Confidence 9999995 5787777532 36899999999999999999999999999999999999998 7 8999999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh------
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT------ 255 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~------ 255 (473)
++.+..............+++.|+ |||.+. ..+.|++|++ +++++|..||...........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYR---APELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred ccccCCCcccccccCCcccccccc---CHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 987543322111122335666666 888643 2578899965 56999999986432111000000
Q ss_pred ----------------------hhH---hhhccCCCC--------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCC
Q psy622 256 ----------------------STA---AQLQLEWPE--------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPM 302 (473)
Q Consensus 256 ----------------------~~~---~~~~~~~P~--------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPF 302 (473)
... ......++. .....+.++.++|.+||+.||++|||++|+++|||
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 000 000001110 00157788999999999999999999999999999
Q ss_pred C
Q psy622 303 F 303 (473)
Q Consensus 303 F 303 (473)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=284.33 Aligned_cols=246 Identities=25% Similarity=0.382 Sum_probs=200.7
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++.+.||+|+||.||+|..+. +++.|++|.+...... ......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA-DKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC-CCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 58999999999999999998876 5789999999865433 445667899999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 122 EYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||++|++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.+ +.++|+|||+++.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC-CCEEEcccccceeccCccc-
Confidence 999999999999874 578999999999999999999999999999999999999998 9999999999987543221
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh-hhccCCCCcccc
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA-QLQLEWPEDEEA 271 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~P~~~~~ 271 (473)
......|++.|+ |||+.. ..|.|++|++ +++++|..||..... ..... ......+..+..
T Consensus 157 --~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~ 224 (256)
T cd08529 157 --FANTIVGTPYYL---SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-------GALILKIIRGVFPPVSQM 224 (256)
T ss_pred --hhhccccCcccc---CHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCCccc
Confidence 122345666666 777642 4788999965 579999999964221 11111 111222333347
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
++.++.++|.+||+.+|++||++.++++|||+
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 88999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=304.27 Aligned_cols=284 Identities=21% Similarity=0.301 Sum_probs=209.6
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT----SSC 116 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~----~~~ 116 (473)
++|++.+.||+|+||.||+|..+. +++.||+|++.+... .......+.+|+.+|+.++||||++++++|.. ...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~-~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTR-SGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcC-CCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 679999999999999999998886 578999999986532 22345678889999999999999999998863 457
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 83 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 83 VYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED-CELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEEehh-hhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEecccccceeeccc
Confidence 99999999 57999999888889999999999999999999999999999999999999999 99999999999865332
Q ss_pred ccc-cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChhh-
Q psy622 197 IVY-LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTST- 257 (473)
Q Consensus 197 ~~~-~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~~- 257 (473)
... ........|++.|+ +||.+. ..++|++|++ +++++|..||..... ..+.. +...
T Consensus 161 ~~~~~~~~~~~~~~~~y~---~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~-~~~~~ 236 (334)
T cd07855 161 PTEHKYFMTEYVATRWYR---APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP-SEEVL 236 (334)
T ss_pred CcCCCccccccccccccc---ChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC-hhHhh
Confidence 211 11112234566665 788642 3788999965 569999999964210 00000 0000
Q ss_pred -------Hh----h----hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccCCCCCcCCC
Q psy622 258 -------AA----Q----LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVPQP 322 (473)
Q Consensus 258 -------~~----~----~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~~pPf~P~~ 322 (473)
+. . ....+.......+++++++|++||+.+|.+||++++++.||||+...-. ..+|...|..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~---~~~~~~~~~~ 313 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP---DDEPTCPPPF 313 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC---cccccCCCCC
Confidence 00 0 0111111113578999999999999999999999999999999854322 1134444555
Q ss_pred CCCCCCCCCCCCC
Q psy622 323 DDVFDTSYFHADK 335 (473)
Q Consensus 323 ~~~~D~s~Fd~~~ 335 (473)
...++...++.++
T Consensus 314 ~~~~~~~~~~~~~ 326 (334)
T cd07855 314 DFDFEAIELSREQ 326 (334)
T ss_pred CCChhhhhcChhh
Confidence 5555554444444
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=279.40 Aligned_cols=258 Identities=21% Similarity=0.377 Sum_probs=210.1
Q ss_pred ccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q psy622 33 SCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSL 111 (473)
Q Consensus 33 ~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 111 (473)
+......+++.+++..||.|+-|+||+++.+. +|...|||.+.+.. +++..+++++.++++... ++|+||+.+++|
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs-~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRS-TGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcc-cceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 45567788999999999999999999999988 68999999999874 466677899999988777 599999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCceeEeecch
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
..+..+++.||.| +.-+..+|++ .++++|..+-.+...++.||.||-. +||||||+||+|||+|.. |.|||||||.
T Consensus 161 i~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~-GniKlCDFGI 238 (391)
T KOG0983|consen 161 ITNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GNIKLCDFGI 238 (391)
T ss_pred eeCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC-CCEEeecccc
Confidence 9999999999998 6677777766 4689999999999999999999985 589999999999999999 9999999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCcccc---------ccCCcCCCCc-cccccCCCCCchhHhhhcCCCCCh-hhH
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQL---------LSLKTGTFPT-FQDVQNSQAPFPSALRVAGSQIPT-STA 258 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i---------~~~~~~s~g~-l~~~~~g~~pf~~~~~~~~~~~~~-~~~ 258 (473)
+-.+..... .+...|.|.|| |||.+ ...++|++|+ ++++.+|+.||.+.. .++.. ..+
T Consensus 239 sGrlvdSkA----htrsAGC~~YM---aPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~----tdFe~ltkv 307 (391)
T KOG0983|consen 239 SGRLVDSKA----HTRSAGCAAYM---APERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK----TDFEVLTKV 307 (391)
T ss_pred cceeecccc----cccccCCcccc---CccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC----ccHHHHHHH
Confidence 987643321 22346888888 77754 3579999996 567999999998621 11111 111
Q ss_pred h-hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 259 A-QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 259 ~-~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
. .....+|.. ..+|+++++|+..||++|+.+||.-.++++|||+...+
T Consensus 308 ln~ePP~L~~~-~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 308 LNEEPPLLPGH-MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HhcCCCCCCcc-cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 1 122233332 45999999999999999999999999999999998653
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=285.66 Aligned_cols=250 Identities=21% Similarity=0.294 Sum_probs=194.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.+.+.....||+|+||.||+|+++. +++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..+...|+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLS-TQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecC-CCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445555689999999999998776 57889999987653 3345678999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 120 VMEYMIGGDVKSLIAAN-GAL--PEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~-~~~--~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+||++|++|..++... +.+ ++..+..++.||+.||+|||++||+||||||+||+++.+.+.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999999999864 456 889999999999999999999999999999999999874489999999998765322
Q ss_pred ccccccccccCCCCcccccCCcccc--------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQL--------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i--------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
.. ......|++.|+ +||.+ ...+.|++|++ +++++|..||....... ............+.
T Consensus 163 ~~---~~~~~~~~~~~~---aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~ 232 (268)
T cd06624 163 NP---CTETFTGTLQYM---APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ----AAMFKVGMFKIHPE 232 (268)
T ss_pred CC---ccccCCCCcccc---ChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh----hhHhhhhhhccCCC
Confidence 11 111234666666 77754 24688999965 57899999996421100 00000000011122
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.+..+++++++|+.+||+.+|.+||+++|++.||||
T Consensus 233 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 233 IPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 235788999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=308.14 Aligned_cols=243 Identities=22% Similarity=0.322 Sum_probs=204.6
Q ss_pred eecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcC
Q psy622 48 AISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGG 127 (473)
Q Consensus 48 ~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg 127 (473)
+||+|+||+||.|+++. +....|||.+..+. ....+-+..|+.+-+.++|.|||++++++..++++-|.||-++||
T Consensus 582 VLGKGTYG~VYA~RD~~-tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD-TQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeecccc-ceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 79999999999999987 56778999998754 445667888999999999999999999999999999999999999
Q ss_pred CHHHHHHh-CCCC--CHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccccc
Q psy622 128 DVKSLIAA-NGAL--PEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISD 204 (473)
Q Consensus 128 ~L~~~L~~-~~~~--~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~ 204 (473)
+|..+|+. .|++ .|...-+|..||++||.|||.+.|||||||-+|+|++--+|.+||+|||.+|.+.... ..+.
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin---P~TE 734 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN---PCTE 734 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC---cccc
Confidence 99999986 5888 8999999999999999999999999999999999998766999999999999874332 3345
Q ss_pred ccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChh-hHhhhcc-CCCCccccCC
Q psy622 205 LVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTS-TAAQLQL-EWPEDEEALN 273 (473)
Q Consensus 205 ~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~-~~P~~~~~ls 273 (473)
++.||-.|| |||++- ..+.|+||+- .+|.+|++||.+.-. +.. ..+-+.. .-|+.|..+|
T Consensus 735 TFTGTLQYM---APEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs------pqAAMFkVGmyKvHP~iPeels 805 (1226)
T KOG4279|consen 735 TFTGTLQYM---APEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS------PQAAMFKVGMYKVHPPIPEELS 805 (1226)
T ss_pred ccccchhhh---ChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC------hhHhhhhhcceecCCCCcHHHH
Confidence 678999998 899863 3788999975 589999999986311 111 1111111 1244557899
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.+++.+|.+|+..||.+||+|.+++..||++.-
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 999999999999999999999999999999864
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=288.44 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=201.6
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||.|+||.||+|+++. +++.||+|++.... .......+.+|+++++.++||||+++++++.++..+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR-TNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC-CCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence 478999999999999999998876 57899999998653 233456788999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
+||+++++|.+++... .+++..++.++.||+.||.|||+++++||||+|+||+++++ +.++|+|||+++.+.....
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~-- 153 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMS-- 153 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEcccccceeeccccc--
Confidence 9999999999999875 89999999999999999999999999999999999999998 9999999999987643211
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhc-cCCCCcccc-
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQ-LEWPEDEEA- 271 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~P~~~~~- 271 (473)
......+++.|+ +||.+. ..|+|++|++ +++++|..||..... ........ ...|.....
T Consensus 154 -~~~~~~~~~~y~---~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~ 222 (274)
T cd06609 154 -KRNTFVGTPFWM---APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-------MRVLFLIPKNNPPSLEGNK 222 (274)
T ss_pred -ccccccCCcccc---ChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-------HHHHHHhhhcCCCCCcccc
Confidence 112234666666 788653 4688999965 679999999964211 11111101 111111123
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
++.++.++|.+||..||.+||+++++++||||++..
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 788999999999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=283.33 Aligned_cols=246 Identities=22% Similarity=0.324 Sum_probs=198.8
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++.+.||+|+||.||+++.+. +++.||+|.+...... ......+.+|+.+++.++||||+++++.+.+.++.|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~-~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE-DGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC-CCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 58999999999999999998876 5789999999865432 334567899999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 122 EYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||+.+++|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.+ +.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEEeeccceeecCcchhh
Confidence 9999999999997643 58999999999999999999999999999999999999998 89999999999865332211
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh-hhccCCCCcccc
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA-QLQLEWPEDEEA 271 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~P~~~~~ 271 (473)
.....|++.|+ +||... ..|.|++|++ +++++|..||..... ..... ......+..+..
T Consensus 158 ---~~~~~~~~~~~---~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 224 (256)
T cd08218 158 ---ARTCIGTPYYL---SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKIIRGSYPPVSSH 224 (256)
T ss_pred ---hhhccCCcccc---CHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHhcCCCCCCccc
Confidence 12234666666 787643 3688999965 569999999864210 01110 011122222357
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
++.++.++|.+||+.+|.+||++.++++||||
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 88999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=288.11 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=194.2
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA-LALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
++|++.+.||+|+||.||+|+++. +++.||||++++.... .....+..|..+ ++..+||||+++++++...+.+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP-TGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC-CCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence 479999999999999999999886 5799999999875321 223455666665 556699999999999999999999
Q ss_pred EecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 120 VMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSH-GIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~-gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
||||++ |+|.+++.. ...+++..++.++.||+.||+|||++ +++||||||+||+++.+ +.+||+|||++..+.
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~~ 155 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYLV 155 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeecccccccc
Confidence 999995 788887764 24699999999999999999999997 99999999999999998 999999999998653
Q ss_pred CCccccccccccCCCCcccccCCcccc----------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhcc
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQL----------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQL 263 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i----------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 263 (473)
... ......+++.|+ +||.+ ...+.|++|++ +++++|..||....... ............
T Consensus 156 ~~~----~~~~~~~~~~y~---aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~ 226 (283)
T cd06617 156 DSV----AKTIDAGCKPYM---APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQLKQVVEEPSP 226 (283)
T ss_pred ccc----ccccccCCcccc---ChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHHHHHHhcCCC
Confidence 211 111234666666 77754 23688999965 67999999985311000 000001111112
Q ss_pred CCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
..|. ..++.++.++|.+||..+|.+||+++++++||||+...+.
T Consensus 227 ~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 227 QLPA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred CCCc--cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 2232 3578999999999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=311.79 Aligned_cols=256 Identities=22% Similarity=0.322 Sum_probs=207.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.++|+..||.|+||+||+|..+. ++-..|-|+|.... ....+.++.|++||..++||+||+|+++|.-++++||+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nke-t~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKE-TKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhccc-chhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 347899999999999999998886 56667888887543 55677899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
.|||.||-+...+-. .+.+++.+++.+.+|++.||.|||+++|||||||..|||+.-+ |.|+|+|||.+.... ..
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~---~t 183 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD-GDIRLADFGVSAKNK---ST 183 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec-CcEeeecccccccch---hH
Confidence 999999999877765 4579999999999999999999999999999999999999999 999999999987632 22
Q ss_pred cccccccCCCCcccccCCccccc-----------cCCcCCCCc-cccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPT-FQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~-l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
....+.+.|||-|| |||++. ..++|++|+ +.+|..+.+|-++..... +. ..+......--.
T Consensus 184 ~qkRDsFIGTPYWM---APEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR---Vl-lKiaKSePPTLl 256 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWM---APEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VL-LKIAKSEPPTLL 256 (1187)
T ss_pred HhhhccccCCcccc---cchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH---HH-HHHhhcCCCccc
Confidence 23345678999999 899763 478899996 457888888876521100 00 001111111101
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSI 311 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l 311 (473)
.|...+..+.|++.+||.+||..||++.|+++||||.+++-++.
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ 300 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKM 300 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchH
Confidence 12578889999999999999999999999999999999987654
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=282.24 Aligned_cols=246 Identities=21% Similarity=0.354 Sum_probs=199.7
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|+++++||.|+||.||+++... +++.+++|.+...... ......+.+|+++++.++|+||+++++++.+...+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~-~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE-DDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC-CCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 58999999999999999998876 5788999998765432 344567889999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 122 EYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||++||+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC-CCEEECcCcceEEcccccc-
Confidence 999999999999875 468999999999999999999999999999999999999998 9999999999986533221
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hccCCCCcccc
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDEEA 271 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~~~ 271 (473)
......+++.|. +||... ..++|++|++ +++++|..||.... ....... ....++.....
T Consensus 157 --~~~~~~~~~~y~---ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd08221 157 --MAETVVGTPYYM---SPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-------PLNLVVKIVQGNYTPVVSV 224 (256)
T ss_pred --cccccCCCcccc---CHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCCCCCccc
Confidence 122345677766 788653 3588999965 57999999986421 1111111 11222222356
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
++.++.++|.+||+.+|.+||+++++++|||+
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 225 YSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 88999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=301.14 Aligned_cols=257 Identities=20% Similarity=0.297 Sum_probs=195.2
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----C
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS-----S 115 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~-----~ 115 (473)
++|++.+.||+|+||.||+|+++. +++.||+|+++... .......+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKP-TGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcC-CCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 689999999999999999998876 57899999987532 233455788899999999999999999887543 4
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+|+||+ +++|..++.. +.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++....
T Consensus 82 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 82 DVYIVQELM-ETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN-CDLKICDFGLARIADP 158 (336)
T ss_pred eEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEECcccceeeccc
Confidence 689999999 5689888864 579999999999999999999999999999999999999998 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChh--
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTS-- 256 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~-- 256 (473)
............|++.|+ |||.+. ..|+|++|++ +++++|..||..... ..+......
T Consensus 159 ~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 159 EHDHTGFLTEYVATRWYR---APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccCCcCCcCcCCCcc---ChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 222212222345677776 888643 3588899965 579999999964210 000000000
Q ss_pred ---------hHhh----hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 257 ---------TAAQ----LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 257 ---------~~~~----~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.... ....++......++++.+||.+||+.||++||++.|+++||||+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000 0001111113568899999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=283.83 Aligned_cols=247 Identities=24% Similarity=0.362 Sum_probs=197.0
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||+|+||.||+|+.+. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+...+|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIA-TGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecC-CCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 679999999999999999998876 56889999998653 23466889999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|||+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED-GDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC-CCEEECccccchhhhhhhh-
Confidence 9999999999999876 789999999999999999999999999999999999999998 9999999999987533211
Q ss_pred cccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCC--CC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW--PE 267 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--P~ 267 (473)
......+++.|+ +||.+. ..|.|++|++ ++|++|..||........ ........... ..
T Consensus 157 --~~~~~~~~~~y~---~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~ 227 (262)
T cd06613 157 --KRKSFIGTPYWM---APEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA----LFLISKSNFPPPKLK 227 (262)
T ss_pred --ccccccCCcccc---CchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccCCCcccc
Confidence 111234555555 677643 2588899965 679999999964211000 00001110111 11
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPM 302 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPF 302 (473)
.....+.+++++|.+||..||.+||++.+++.|||
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 11356788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=281.76 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=199.0
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++.+.||+|+||.||+|..+. +++.+|+|.+...... ......+.+|+++|+.++||||+++++.+.....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA-DQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC-CCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 58999999999999999998876 5789999999876433 344678899999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 122 EYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||++|++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.+++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 999999999999874 35899999999999999999999999999999999999987646789999999987543221
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
.....+++.|+ +||.+. ..|+|++|++ +++++|..||.... .............+..+..+
T Consensus 158 ---~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd08220 158 ---AYTVVGTPCYI---SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN------LPALVLKIMSGTFAPISDRY 225 (256)
T ss_pred ---ccccccCCccc---CchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc------hHHHHHHHHhcCCCCCCCCc
Confidence 12235666776 777643 4788899965 56899999986421 11111111111112222568
Q ss_pred ChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 273 NPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
+.+++++|.+||+.||.+||++.|+++||||
T Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 226 SPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=288.30 Aligned_cols=247 Identities=23% Similarity=0.329 Sum_probs=194.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe-----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQT----- 113 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~----- 113 (473)
.+.|++.+.||+|+||.||+|+++. +++.||+|++.... .....+..|+.+++.+ +||||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcC-CCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4789999999999999999999876 57899999987642 2345678899999988 79999999999853
Q ss_pred -CCEEEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 114 -SSCVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 114 -~~~l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.+ +.++|+|||++
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~-~~~~l~dfg~~ 168 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN-AEVKLVDFGVS 168 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCcch
Confidence 46899999999999999999763 358899999999999999999999999999999999999998 89999999998
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhH
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTA 258 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~ 258 (473)
........ ......|++.|+ |||.+. ..|.|++|++ +++++|..||........ +. ...
T Consensus 169 ~~~~~~~~---~~~~~~~~~~y~---aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~-~~~ 239 (282)
T cd06636 169 AQLDRTVG---RRNTFIGTPYWM---APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LF-LIP 239 (282)
T ss_pred hhhhcccc---CCCccccccccc---CHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hh-hHh
Confidence 86532111 112345677776 787653 3689999965 679999999964211100 00 000
Q ss_pred hhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 259 AQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 259 ~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
........ ...++.++.+||.+||+.||.+||++.|+++||||
T Consensus 240 ~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 240 RNPPPKLK--SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred hCCCCCCc--ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00011111 14578999999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=289.34 Aligned_cols=250 Identities=23% Similarity=0.388 Sum_probs=200.9
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||.|+||.||+|.++. +++.+|+|++.+... ......+.+|+++++.++||||+++++.+.....+|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP-TGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC-CCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 478899999999999999999876 578999999987632 34456789999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 121 MEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
+||++|++|.+++... ..+++..+..++.||+.||+|||+ .|++||||||+||+++.+ +.++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC-CCEEEeecccchhhHHHHh
Confidence 9999999999999876 789999999999999999999999 999999999999999998 9999999999887532211
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh----hhccCCCC
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA----QLQLEWPE 267 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~P~ 267 (473)
. ...+++.|+ +||.+. ..|.|++|++ +++++|..||...... ......... ......+.
T Consensus 157 ~-----~~~~~~~y~---~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 226 (265)
T cd06605 157 K-----TFVGTSSYM---APERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEPPPRLPS 226 (265)
T ss_pred h-----cccCChhcc---CHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCCCCCCCh
Confidence 1 145666666 777643 3688899965 5799999999643110 000011111 11112221
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
..++++++++|.+||..||.+||++.|++.||||+..
T Consensus 227 --~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 227 --GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred --hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 1288999999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=287.62 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=187.8
Q ss_pred CCeEEEcee--cccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q psy622 41 SDFEIVKAI--SRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 41 ~~y~i~~~L--G~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l 117 (473)
++|++.+.+ |+|+||.||+++.+. +++.+|+|++.+..... .|..+...+ +||||+++++.|...+.+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKP-TQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcC-CCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 456666665 999999999998877 57899999998753211 122222222 799999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+.|++||||||+||+++.+++.++|+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 9999999999999999988899999999999999999999999999999999999999998339999999998764321
Q ss_pred cccccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~ 270 (473)
....+++.|+ |||++.. .++|++|++ +++++|..||..... ..+............+..+.
T Consensus 164 ------~~~~~~~~y~---aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (267)
T PHA03390 164 ------SCYDGTLDYF---SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED---EELDLESLLKRQQKKLPFIK 231 (267)
T ss_pred ------ccCCCCCccc---ChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc---chhhHHHHHHhhcccCCccc
Confidence 1235677776 7876532 588999965 579999999973211 11111111111111112224
Q ss_pred cCChhHHHHHHhccccCCCCCCC-HHHHhcCCCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPS-GHQVRRLPMFKD 305 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRps-a~eil~HPFF~~ 305 (473)
.+++.+.+||.+||+.||.+|++ ++|+++||||++
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 232 NVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 78999999999999999999996 699999999974
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=287.73 Aligned_cols=248 Identities=21% Similarity=0.309 Sum_probs=192.8
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEE-----e
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQ-----T 113 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~-----~ 113 (473)
.++|++++.||+|+||+||+|+++. +++.||+|+++... .....+.+|+.+++.+ +||||+++++++. +
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKK-NGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECC-CCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 5789999999999999999998876 57899999987532 1234677899999998 7999999999873 4
Q ss_pred CCEEEEEecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecch
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
...+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||+++|+||||||+||+++.+ +.+||+|||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~kl~dfg~ 170 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGV 170 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC-CCEEEccCCc
Confidence 5679999999999999998753 3468999999999999999999999999999999999999998 8999999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhh
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTST 257 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~ 257 (473)
++.+..... ......|++.|+ |||.+. ..++|++|++ +++++|..||........ . ...
T Consensus 171 ~~~~~~~~~---~~~~~~~~~~y~---aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~-~~~ 241 (286)
T cd06638 171 SAQLTSTRL---RRNTSVGTPFWM---APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--L-FKI 241 (286)
T ss_pred eeecccCCC---ccccccCCCccc---ChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--H-hhc
Confidence 886532211 112335777777 888642 4688999965 579999999864211000 0 000
Q ss_pred HhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 258 AAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 258 ~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
......... .+..++.++.+||.+||+.||.+||++.|+++||||
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 242 PRNPPPTLH-QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cccCCCccc-CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 000001111 113567899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=287.91 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=197.1
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++.+.||+|+||.||+|+++. +++.||+|++...... ......+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE-TGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC-CCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 58999999999999999998876 5789999999876432 334567899999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 122 EYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
||+ |++|..++... +.+++..++.++.||+.||+|||++||+|+||||+||+++.+ +.++|+|||++........
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~-- 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEP-- 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCC--
Confidence 999 99999999763 579999999999999999999999999999999999999998 9999999999987543221
Q ss_pred ccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChhhH-----
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTSTA----- 258 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~~~----- 258 (473)
.......|++.|+ +||.+. ..|+|++|++ +++++|.++|..... ..+........
T Consensus 155 ~~~~~~~~~~~y~---aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYR---APELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCccccc---CceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 1111234666666 788643 4678899965 579999888754210 00000000000
Q ss_pred -hhhccCCC--------CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 259 -AQLQLEWP--------EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 259 -~~~~~~~P--------~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
......++ ......+.++.+||++||+.||.+||+++++++||||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00011111 11135678999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=292.30 Aligned_cols=256 Identities=21% Similarity=0.255 Sum_probs=196.2
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI--NKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+|++++.||+|+||.||+|.++. +++.||||+++..... .......+..|+++++.++|+||+++++++.+...+|+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE-TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC-CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 48899999999999999998876 4789999999876533 12334567889999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||||+ +|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+||+++.+ +.++|+|||+++.......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC-CCEEEccceeeeeccCCCc
Confidence 99999 999999998876 79999999999999999999999999999999999999998 9999999999987543221
Q ss_pred ccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChhhHh--
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTSTAA-- 259 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~~~~-- 259 (473)
. .....+++.|+ |||.+. ..|.|++|++ +++++|.++|..... ............
T Consensus 158 ~---~~~~~~~~~y~---aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 158 K---MTHQVVTRWYR---APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred c---ccccccceeee---CHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 1 11123445555 777542 3678899965 578999777753110 000000000000
Q ss_pred --------hh--ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 260 --------QL--QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 260 --------~~--~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.. ...........+.++.++|.+||+.||++||+++|+++||||++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 00 000000113567899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=290.80 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=194.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS--SCV 117 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~l 117 (473)
+++|++.+.||.|+||.||+|.++. +++.+|+|.++..... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKK-TGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECC-CCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 5689999999999999999998876 5789999999865432 22334677899999999999999999999877 899
Q ss_pred EEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+||||++ ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGSP 159 (293)
T ss_pred EEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CcEEEeecCceeeccCC
Confidence 99999995 59999987754 59999999999999999999999999999999999999999 99999999999875432
Q ss_pred ccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChh---
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTS--- 256 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~--- 256 (473)
... .....+++.|+ +||.+. ..|.|++|++ +++++|..||..... ..+......
T Consensus 160 ~~~---~~~~~~~~~~~---aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 160 LKP---YTQLVVTLWYR---APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred ccc---ccccccccccc---CchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence 211 11234556565 787643 3678899965 579999999864110 000000000
Q ss_pred ---------------hHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 257 ---------------TAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 257 ---------------~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
........++. ..+++.+.+||++||+.||++||+++|+++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPA--LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhccchhcccccccccchhhhccccc--cCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00001111221 1158899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=302.13 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=202.5
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~ 116 (473)
++-..|+++++||+||-++||+++..+ .+.||+|.+.... .+...+..+.+|+.+|.++ .|-+||+|+++-.+++.
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~--~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSD--KQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCC--CcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 344679999999999999999997543 3678888776543 3455678899999999999 69999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGA-LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~-~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
+||||||- ..||..+|++... .+.-..++|..|+++|+.++|++||||.||||.|+|+-+ |.+||+|||.|+.+..
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk--G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK--GRLKLIDFGIANAIQP 511 (677)
T ss_pred EEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe--eeEEeeeechhcccCc
Confidence 99999975 7899999998654 444699999999999999999999999999999999987 8999999999998754
Q ss_pred CccccccccccCCCCcccccCCccccc-----------------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhh
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-----------------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTST 257 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-----------------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~ 257 (473)
.. ........+||+.|| +||.+. ..|+|++|++ |.|+.|++||......... +....
T Consensus 512 DT-TsI~kdsQvGT~NYM---sPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aK-l~aI~ 586 (677)
T KOG0596|consen 512 DT-TSIVKDSQVGTVNYM---SPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAK-LHAIT 586 (677)
T ss_pred cc-cceeeccccCccccc---CHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHH-HHhhc
Confidence 32 223455678999999 777542 3688999975 5699999999874321100 00000
Q ss_pred HhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 258 AAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 258 ~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
--...++||..+. ..++.++++.||.+||++|+++.++++|||...+
T Consensus 587 ~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 587 DPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred CCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 0012456665322 2339999999999999999999999999999753
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=286.09 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=203.6
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||+|++|.||+|.++. +++.||+|++...... .....+.+|+.++..++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP-TGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence 479999999999999999998887 5789999999876421 4456889999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|||++|++|.+++...+.+++..+..++.||+.||+|||+ .|++||||+|+||+++.+ +.++|+|||++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC-CCEEEccCccceecccCCCc
Confidence 9999999999999988889999999999999999999999 999999999999999998 99999999999875332211
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hccCCCCcccc
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDEEA 271 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~~~ 271 (473)
.....+++.|+ +||... ..|.|++|++ +++++|..||...... . ....... .....+.....
T Consensus 157 ---~~~~~~~~~y~---~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~-~~~~~~~~~~~~~~~~~~~ 226 (264)
T cd06623 157 ---CNTFVGTVTYM---SPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---S-FFELMQAICDGPPPSLPAE 226 (264)
T ss_pred ---ccceeeccccc---CHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---C-HHHHHHHHhcCCCCCCCcc
Confidence 11234555565 777543 4688899965 5799999999653210 0 0011111 01111222234
Q ss_pred -CChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 272 -LNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 272 -ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
++..+.++|.+||+.+|++||++.|+++||||+.++
T Consensus 227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 889999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=303.92 Aligned_cols=249 Identities=18% Similarity=0.248 Sum_probs=191.3
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQ 112 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~ 112 (473)
...++|++.+.||+|+||.||+|++.. .+++.||+|+++.... ......+.+|+++++.+ +||||+++++++.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 335679999999999999999998643 2335799999986532 33456788999999999 8999999999999
Q ss_pred eCCEEEEEecccCcCCHHHHHHhC--------------------------------------------------------
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAAN-------------------------------------------------------- 136 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~-------------------------------------------------------- 136 (473)
..+.+|+||||+++|+|.+++.+.
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999999999998642
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccc
Q psy622 137 --------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEI 202 (473)
Q Consensus 137 --------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~ 202 (473)
.++++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+++.+...... ..
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~-~~ 270 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNY-VV 270 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEeeceeeeeccCCcce-ee
Confidence 247888999999999999999999999999999999999988 99999999999875332211 11
Q ss_pred ccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCCccccCC
Q psy622 203 SDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDEEALN 273 (473)
Q Consensus 203 ~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~~~ls 273 (473)
.....+++.|+ |||++. ..|+|++|++ +++++ |..||...... ......... .....| ..++
T Consensus 271 ~~~~~~~~~y~---aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~---~~~~~~~~~~~~~~~~---~~~~ 341 (374)
T cd05106 271 KGNARLPVKWM---APESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN---SKFYKMVKRGYQMSRP---DFAP 341 (374)
T ss_pred ccCCCCcccee---CHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc---HHHHHHHHcccCccCC---CCCC
Confidence 11223444565 888653 4688999965 56775 99999753210 000000100 111222 4678
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
++++++|.+||+.||.+||+++++.+
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=291.76 Aligned_cols=254 Identities=21% Similarity=0.281 Sum_probs=196.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||+|+||.||+|.++. +++.||+|++.+..... ...+.+.+|+++++.++||||+++++++.++..+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE-TGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC-CCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence 479999999999999999998876 57899999987754322 3345788999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||+++++|..+....+.+++..++.++.||+.||.|||+.||+||||+|+||+++++ +.++|+|||++..+.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGE-- 155 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCcc--
Confidence 9999999998888776679999999999999999999999999999999999999998 9999999999987533221
Q ss_pred ccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhh--------cCCCCChhhH------
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRV--------AGSQIPTSTA------ 258 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~--------~~~~~~~~~~------ 258 (473)
......+++.|+ |||+.. ..|+|++|++ +++++|.+||...... ..........
T Consensus 156 -~~~~~~~~~~y~---aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 156 -VYTDYVATRWYR---APELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred -ccCcccceeecc---CcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 111223555555 777542 3688999965 5799999988531100 0000000000
Q ss_pred -hhhccCCCC---------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 259 -AQLQLEWPE---------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 259 -~~~~~~~P~---------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.......|. ....++..+.+|+.+||+.+|.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000000110 013678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=283.84 Aligned_cols=247 Identities=23% Similarity=0.378 Sum_probs=198.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++.+.||+|+||.||+|+.+. +++.||+|.+..... .+.+.+|+++++.++||||+++++.+.+...+|+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKE-TGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcC-CCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 3689999999999999999998876 568999999876521 5688999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
++||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||+|+||+++.+ +.+||+|||++........
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC-CcEEEcccccchhcccCcc
Confidence 9999999999999976 4478999999999999999999999999999999999999998 9999999999987543221
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcccc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ 271 (473)
......+++.|+ +||.+. ..+.|++|++ +++++|..||......... .............+..
T Consensus 155 ---~~~~~~~~~~y~---~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~ 224 (256)
T cd06612 155 ---KRNTVIGTPFWM---APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI----FMIPNKPPPTLSDPEK 224 (256)
T ss_pred ---ccccccCCcccc---CHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh----hhhccCCCCCCCchhh
Confidence 112234666666 788643 3688899964 6799999999642111000 0000000111111245
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
++.++.++|.+||+.||.+||++.|+++||||
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 78899999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=288.57 Aligned_cols=244 Identities=15% Similarity=0.121 Sum_probs=192.8
Q ss_pred CCCCCCCeEEE--ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 36 KAPEISDFEIV--KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 36 ~~~~~~~y~i~--~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
+.+..++++.. ..||+|++|.||+|+. +|+.||||++++.....+...+.+.+|+.+|++++||||+++++++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 89 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIF---NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEE---CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence 33344455554 6799999999999976 357899999987654444446788899999999999999999999876
Q ss_pred ----CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCceeEeecc
Q psy622 114 ----SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 114 ----~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
...+++||||++||+|.+++.+.+.+++..+..++.+++.||.|||+ .+++||||||+|||++.+ +.+||+|||
T Consensus 90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~-~~~kl~dfg 168 (283)
T PHA02988 90 IVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN-YKLKIICHG 168 (283)
T ss_pred cccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC-CcEEEcccc
Confidence 45799999999999999999988889999999999999999999998 499999999999999999 999999999
Q ss_pred hhhhhcCCccccccccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh
Q psy622 189 FLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA 259 (473)
Q Consensus 189 la~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~ 259 (473)
+++.+..... ...|++.|+ |||.+. ..|.|++|++ +++++|..||...... .+. ..+.
T Consensus 169 ~~~~~~~~~~------~~~~~~~y~---aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~-~~i~ 235 (283)
T PHA02988 169 LEKILSSPPF------KNVNFMVYF---SYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIY-DLII 235 (283)
T ss_pred hHhhhccccc------cccCccccc---CHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHH-HHHH
Confidence 9987533211 124666666 777653 4789999965 6799999999742110 000 1111
Q ss_pred h--hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 260 Q--LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 260 ~--~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
. .....| ..+++++++||.+||+.||++||+++|+++
T Consensus 236 ~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 236 NKNNSLKLP---LDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred hcCCCCCCC---CcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1 122223 468899999999999999999999999874
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=292.15 Aligned_cols=253 Identities=19% Similarity=0.208 Sum_probs=188.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeC---------------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCe
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKT---------------NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFC 104 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~---------------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 104 (473)
.++|++.+.||+|+||.||+|+++. .++..||+|++.... .......+.+|+++|..++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999997542 234579999998653 23445678999999999999999
Q ss_pred eeEEEEEEeCCEEEEEecccCcCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCeee
Q psy622 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG-------------------ALPEDMAAFYAAEVVLALQYLHSHGIIH 165 (473)
Q Consensus 105 v~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~-------------------~~~e~~~~~~~~qI~~aL~yLH~~gIiH 165 (473)
+++++++.+...+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999987532 3677889999999999999999999999
Q ss_pred cCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-cccc--
Q psy622 166 RDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQ-- 236 (473)
Q Consensus 166 RDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~-- 236 (473)
|||||+|||++.+ +.+||+|||+++.+...... .......+++.|+ |||++. ..|+|++|++ ++++
T Consensus 162 ~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 162 RDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWM---AWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred cCcchhheEEcCC-ccEEECCCccceecccCcee-EecCcCCCCcccc---CHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 9999999999998 99999999999865332211 1222334556666 888653 3688999965 4554
Q ss_pred CCCCCchhHhhhcCCCCChhhHh-hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 237 NSQAPFPSALRVAGSQIPTSTAA-QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 237 ~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
++..||................. ......+..+..++..+.+||.+||+.||++||+++||.+
T Consensus 237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 237 CKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred cCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 46677764211000000000000 0011111122467899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=286.95 Aligned_cols=248 Identities=23% Similarity=0.316 Sum_probs=193.4
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTS---- 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~---- 114 (473)
.++|++.+.||+|+||.||+|..+. +++.||+|++.+.. .....+.+|+.++..+ +||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~-~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKK-DGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECC-CCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 5789999999999999999998876 57899999987642 2234677899999988 899999999998653
Q ss_pred -CEEEEEecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecch
Q psy622 115 -SCVFLVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 115 -~~l~lVmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
..+|+||||++||+|.++++. ...+++..++.++.||+.||+|||+.||+||||||+||+++.+ +.+||+|||+
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~-~~~kl~dfg~ 174 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGV 174 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEeeccc
Confidence 468999999999999998863 3579999999999999999999999999999999999999998 8999999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCcccc-----------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhh
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQL-----------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTST 257 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i-----------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~ 257 (473)
+..+...... .....|++.|+ +||.+ ...|+|++|++ +++++|..||........ ...
T Consensus 175 ~~~~~~~~~~---~~~~~~~~~y~---aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~----~~~ 244 (291)
T cd06639 175 SAQLTSTRLR---RNTSVGTPFWM---APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT----LFK 244 (291)
T ss_pred chhccccccc---ccCccCCcccc---ChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH----HHH
Confidence 9875322111 11234566665 77753 34788999965 579999999964211000 000
Q ss_pred Hhhh-ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 258 AAQL-QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 258 ~~~~-~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
+... ...+. .+...+.++.+||.+||+.||.+||++.|+++||||+
T Consensus 245 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 245 IPRNPPPTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HhcCCCCCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0000 01111 1245678899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=280.93 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=200.3
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++.+.||+|+||.||+|.... +++.||+|+++..... ....+.+.+|+.+++.++|+||+++++.+.+...+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~-~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD-TGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC-CCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 58899999999999999998776 5789999999876532 456778999999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc
Q psy622 122 EYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE 201 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~ 201 (473)
||+++++|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+||+++.+ +.+||+|||++...........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEcccccccccCCCCCccc
Confidence 999999999999988789999999999999999999999999999999999999998 9999999999987643222111
Q ss_pred c-ccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccc
Q psy622 202 I-SDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270 (473)
Q Consensus 202 ~-~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~ 270 (473)
. .....+++.|+ +||.+. ..+.|++|++ +++++|..||....... .............+|.. .
T Consensus 158 ~~~~~~~~~~~~~---~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~-~ 231 (264)
T cd06626 158 EEVQSLAGTPAYM---APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIMFHVGAGHKPPIPDS-L 231 (264)
T ss_pred ccccCCcCCcCcc---ChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHHHHHhcCCCCCCCcc-c
Confidence 1 11234566666 777543 3588899954 67999999996421000 00000000111223321 2
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.+++.+.++|.+||+.+|.+||++.|++.|||+
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 232 QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 458999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=287.74 Aligned_cols=253 Identities=22% Similarity=0.291 Sum_probs=190.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++.+.||+|+||.||+|+++. +++.||+|++..... ......+.+|+.+++.++|+||+++++++.++...|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI-NGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC-CCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 4789999999999999999998876 578999999976532 2223466789999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||||+ +++|...+.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 81 VFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL-GELKLADFGLARAKSIPSQ 158 (291)
T ss_pred EEecc-cCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC-CcEEEeccccccccCCCCC
Confidence 99999 4777777654 4568899999999999999999999999999999999999998 9999999999876422111
Q ss_pred ccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcC--------CCCChhhH----
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAG--------SQIPTSTA---- 258 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~--------~~~~~~~~---- 258 (473)
. .....+++.|+ +||.+. ..|+|++|++ +++++|..||........ ...+....
T Consensus 159 ~---~~~~~~~~~y~---aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 159 T---YSSEVVTLWYR---PPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred C---CCCcccccccc---CCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhh
Confidence 1 11223566666 788653 2588999965 579999999964211000 00000000
Q ss_pred h-------h-hccCCCC------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 259 A-------Q-LQLEWPE------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 259 ~-------~-~~~~~P~------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
. . .....+. ..-..++++.+++.+||+.||++|||++|++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 0 0000000 001235789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=287.86 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=196.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||+|+||.||+|.++. +++.||+|+++.... .......+.+|+++++.++|+||+++++.+.+.+.+|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA-TGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC-CCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 479999999999999999998876 578999999986532 233456789999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||++++.+..++.+...+++..+..++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES-GVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEEeeecccccCCCcc--
Confidence 9999887777777766779999999999999999999999999999999999999998 9999999999987543321
Q ss_pred ccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHhhh--------cCCCCChhh-------
Q psy622 201 EISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSALRV--------AGSQIPTST------- 257 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~~~--------~~~~~~~~~------- 257 (473)
.......+++.|+ +||++.. .|.|++|++ +++++|..||...... .....+...
T Consensus 156 ~~~~~~~~~~~~~---~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 SPLTDYVATRWYR---APELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccccCcccccCCc---CCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 1112234566666 7776533 578899965 5799999998632100 000000000
Q ss_pred -------------HhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 258 -------------AAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 258 -------------~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.......++ ..++.++++||++||..+|++||+++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYP---GKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcC---CccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000001122 3468999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=289.67 Aligned_cols=251 Identities=30% Similarity=0.493 Sum_probs=204.9
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~l 119 (473)
++|++.+.||+|+||.||+|+.+. +++.||+|++.+...........+.+|+.++..++ ||||+++++.+.+.+.+|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE-TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC-CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 479999999999999999998876 57899999998866555555678899999999998 9999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||||+++++|.+++.+.+.+++..++.++.||+.||.|||+.|++|+||||+||+++.+ ++++|+|||++.........
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEecCCccccccCCcccc
Confidence 99999999999999998899999999999999999999999999999999999999998 99999999999875432211
Q ss_pred -----------------cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh
Q psy622 200 -----------------LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT 255 (473)
Q Consensus 200 -----------------~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~ 255 (473)
........+++.|+ +||... ..+.|++|++ +++++|..||...... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~ 231 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYV---SPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----LTF 231 (280)
T ss_pred ccCCCCCccccccccccccccccccCCcccc---CHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH----HHH
Confidence 01112234556665 787542 4678889965 5688999999743110 001
Q ss_pred hhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCH----HHHhcCCCC
Q psy622 256 STAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSG----HQVRRLPMF 303 (473)
Q Consensus 256 ~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa----~eil~HPFF 303 (473)
.........+| ..+++.+.+||.+||+.||.+||++ +|+++||||
T Consensus 232 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 232 QKILKLEYSFP---PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHhcCCCCC---CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 11122233444 5779999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=289.29 Aligned_cols=251 Identities=21% Similarity=0.310 Sum_probs=200.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
..+|++.+.||.|+||.||+|++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+.....+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVA-TGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcC-CCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 4679999999999999999998776 57899999997653 2234578899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|+||++||+|..++.+. .+++.++..++.||+.||+|||++|++||||||+||+++.+ +.+||+|||++..+.....
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 94 VMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred EEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccchhcccccc-
Confidence 99999999999998764 68999999999999999999999999999999999999998 9999999999887533221
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
......+++.|+ +||.+. ..|.|++|++ +++++|..||........ ..............+..+
T Consensus 171 --~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06655 171 --KRSTMVGTPYWM---APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYLIATNGTPELQNPEKL 241 (296)
T ss_pred --cCCCcCCCcccc---CcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcCCcccCCcccC
Confidence 112235666666 788643 3688899965 569999999964211000 000000011111122568
Q ss_pred ChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 273 NPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
++.+.+||.+||..||.+||++.++++||||+..
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 8999999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.20 Aligned_cols=256 Identities=20% Similarity=0.280 Sum_probs=197.0
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----C
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS-----S 115 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~-----~ 115 (473)
++|.+.+.||+|+||+||+|++.. +++.||||.+.+... .......+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSE-TNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecC-CCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 579999999999999999998876 678999999876432 233355778899999999999999999988644 3
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+|+||+ +++|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.+ +.+||+|||+++....
T Consensus 83 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 83 DVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARTTSE 160 (337)
T ss_pred cEEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECcCccccccCC
Confidence 589999999 57999999888899999999999999999999999999999999999999998 9999999999987533
Q ss_pred CccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCCh---
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPT--- 255 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~--- 255 (473)
.. .......++..|+ |||.+. ..+.|++|++ +++++|..||..... ..+.....
T Consensus 161 ~~---~~~~~~~~~~~y~---aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 161 KG---DFMTEYVVTRWYR---APELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred Cc---ccccccccccCcc---ChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 21 1112234555555 777543 4788999965 568999999964210 00000000
Q ss_pred --------hhHhh----hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 256 --------STAAQ----LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 256 --------~~~~~----~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
..... ....+......+++++++||++||+.||++|||++|+++||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000 0000011114688999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=291.59 Aligned_cols=258 Identities=22% Similarity=0.282 Sum_probs=194.5
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS--SC 116 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~ 116 (473)
.+++|++.+.||+|+||.||+|+++. +++.||+|+++.... .......+.+|+.+++.++|+||+++++++... +.
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTT-SGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECC-CCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 47889999999999999999999876 678999999976532 122233567899999999999999999999765 57
Q ss_pred EEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
+|+||||+. ++|..++... ..+++..++.++.||+.||+|||+.|++||||||+||+++.+ +.+||+|||++.....
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK-GCLKIADFGLARTYGL 160 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccceeeecCC
Confidence 999999995 6898888763 579999999999999999999999999999999999999998 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhh---------cCCCCChhh-
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRV---------AGSQIPTST- 257 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~---------~~~~~~~~~- 257 (473)
.... .....+++.|+ |||.+. ..|.|++|++ +++++|..||...... .+.......
T Consensus 161 ~~~~---~~~~~~~~~y~---aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 161 PAKP---MTPKVVTLWYR---APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred ccCC---CCccccccccc---ChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence 2111 11112345555 777653 3678899965 5799999999642100 000000000
Q ss_pred -H----hhhccCCCC--------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 258 -A----AQLQLEWPE--------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 258 -~----~~~~~~~P~--------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
. .......+. .....++++.+||.+||+.||++||+++|+++||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0 000000110 012468999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=285.08 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=194.4
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC---
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSS--- 115 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~--- 115 (473)
.++|++.+.||+|+||.||+|+++. +++.||+|++..... ..+.+.+|+.+++.+ +||||+++++++.+..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKK-TGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECC-CCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 4789999999999999999998876 578999999886532 345788999999998 7999999999997644
Q ss_pred ---EEEEEecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecc
Q psy622 116 ---CVFLVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 116 ---~l~lVmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
.+|+||||+++++|.+++.. ...+++..++.++.||+.||+|||++|++||||+|+||+++.+ +.+||+|||
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~-~~~~l~d~~ 158 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN-AEVKLVDFG 158 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC-CeEEECCCc
Confidence 59999999999999999875 3579999999999999999999999999999999999999998 999999999
Q ss_pred hhhhhcCCccccccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChh
Q psy622 189 FLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTS 256 (473)
Q Consensus 189 la~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~ 256 (473)
++....... .......|++.|+ |||.+. ..|.|++|++ +++++|..||....... ....
T Consensus 159 ~~~~~~~~~---~~~~~~~~~~~y~---aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~ 229 (275)
T cd06608 159 VSAQLDSTL---GRRNTFIGTPYWM---APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---ALFK 229 (275)
T ss_pred cceecccch---hhhcCcccccccc---CHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---HHHH
Confidence 987643221 1112235666776 777542 3689999965 57999999996421100 0000
Q ss_pred hHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 257 TAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 257 ~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
........+.. +..++.++++||.+||..||.+||+++|+++|||+
T Consensus 230 ~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 230 IPRNPPPTLKS-PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhccCCCCCCc-hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 00000111111 13477899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=289.07 Aligned_cols=252 Identities=23% Similarity=0.377 Sum_probs=193.0
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++++.||+|+||.||+|+++. +++.||||+++.... .......+.+|+++++.++||||+++++++++.+..|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC-CCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence 58999999999999999998876 578999999876532 2223457889999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 122 EYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||+. ++|..++... +.+++..++.++.||+.||+|||+.|++||||+|+||+++.+ +.+||+|||++..+......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEeeccchhhcccCccc
Confidence 9995 6899988763 468999999999999999999999999999999999999999 99999999999865332111
Q ss_pred cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChh-----h
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTS-----T 257 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~-----~ 257 (473)
.....+++.|+ +||... ..|.|++|++ +++++|..||..... ..+...... .
T Consensus 157 ---~~~~~~~~~y~---aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 157 ---YTHEVVTLWYR---APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred ---ccccccccccc---CCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence 11123455555 777543 3577899965 679999999964210 000000000 0
Q ss_pred HhhhccCCCC--------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 258 AAQLQLEWPE--------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 258 ~~~~~~~~P~--------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.......++. ....++++++++|.+||+.||.+||+++++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0000001110 013578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=278.08 Aligned_cols=241 Identities=21% Similarity=0.327 Sum_probs=193.8
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++.+.||+|+||.||++.++. +++.||+|.++.... ....+.+.+|+.+++.++||||+++++++++.+.+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN-SDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC-CCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence 58999999999999999998876 578999999876432 334567889999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 122 EYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||+++|+|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++........
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC-CcEEEcccCcceeeccccc-
Confidence 999999999998753 368999999999999999999999999999999999999998 9999999999876532211
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hccCCCCcccc
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDEEA 271 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~~~ 271 (473)
......|++.|+ |||+.. ..|.|++|++ ++|++|..||..... ...... .....+..+..
T Consensus 156 --~~~~~~~~~~~~---aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~ 223 (255)
T cd08219 156 --YACTYVGTPYYV---PPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNLILKVCQGSYKPLPSH 223 (255)
T ss_pred --ccccccCCcccc---CHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-------HHHHHHHhcCCCCCCCcc
Confidence 112235666666 788653 4688999965 579999999964211 000000 11112222256
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
++..+++||.+||+.||.+||++.+++.
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 8899999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=281.35 Aligned_cols=247 Identities=24% Similarity=0.384 Sum_probs=197.9
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCEEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT--SSCVFL 119 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~~~l~l 119 (473)
+|++++.||.|+||.||+|.+.. +++.||+|+++.... .....+++..|+++++.++||||+++++.+.. ...+|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS-DGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC-CCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 58999999999999999998876 578999999987643 34446678899999999999999999998753 467899
Q ss_pred EecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 120 VMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLH-----SHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH-----~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
+|||+++++|.+++.+ .+.+++..++.++.||+.||+||| +.+|+||||||+||+++.+ +.+||+|||++
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~~ 157 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLA 157 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEeccccc
Confidence 9999999999999976 357999999999999999999999 8999999999999999998 99999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhcc
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQL 263 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 263 (473)
........ ......+++.|+ +||.+. ..|.|++|++ +++++|..||...... .....+ ...
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~---~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~--~~~ 225 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYM---SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL----QLASKI--KEG 225 (265)
T ss_pred ccccCCcc---cccccccCCCcc---ChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH----HHHHHH--hcC
Confidence 87643221 112235667766 777653 3588899965 5799999999642100 000111 112
Q ss_pred CCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
..+..+..++.++.+++.+||+.+|++||++++|++|||+
T Consensus 226 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 226 KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 2233335788999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=281.03 Aligned_cols=247 Identities=20% Similarity=0.383 Sum_probs=199.2
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM--INKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+|+..+.||+|+||+||+|..+. +++.||+|.+.+... ..+...+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD-DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcC-CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence 47788999999999999998875 468999999976532 223446688999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|+||++|++|.+++.+.+.+++..++.++.||+.||+|||++||+|+||||+||+++.+ +.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccceeccccc--
Confidence 99999999999999988889999999999999999999999999999999999999998 999999999988753322
Q ss_pred cccccccCCCCcccccCCcccc-------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hccCCCCccc
Q psy622 200 LEISDLVNGTPNAFNIRTPGQL-------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDEE 270 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i-------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~~ 270 (473)
......|++.|+ +||.+ ...|.|++|++ +++++|..||...... ...... .....+..+.
T Consensus 157 --~~~~~~~~~~y~---~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~ 225 (258)
T cd06632 157 --FAKSFKGSPYWM---APEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELPPIPD 225 (258)
T ss_pred --cccccCCCccee---CHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCCCcCC
Confidence 112234666666 67643 23678899965 6799999999642110 000000 1112233335
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.+++++++++.+||+.+|.+||++.+++.|||+
T Consensus 226 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 226 HLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred CcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 788999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=285.22 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=195.8
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI-------NKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~-------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
+|.+.+.||+|+||.||+|..+. +++.||+|.++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT-TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecC-CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 47889999999999999998776 5789999998643211 112245678899999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+++||||++||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.+ +.++|+|||+++...
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~ 159 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKKSD 159 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-CeEEEeecccccccc
Confidence 9999999999999999999988899999999999999999999999999999999999999998 999999999998643
Q ss_pred CCccccccccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
..... .......|+..|+ +||... ..|+|++|++ +++++|..||........ ............+
T Consensus 160 ~~~~~-~~~~~~~~~~~y~---~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~ 233 (272)
T cd06629 160 DIYDN-DQNMSMQGSVFWM---APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKLGNKRSAPPI 233 (272)
T ss_pred ccccc-cccccccCCcccc---CHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHHhhccccCCcC
Confidence 22111 1112234566666 777532 3578899965 578999999853211000 0000000011112
Q ss_pred CC-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 266 PE-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 266 P~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
+. ....++.+++++|.+||+.+|.+||+++++++||||
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 21 113568999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=289.45 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=201.5
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
++.++|++++.||+|+||+||+|++.. +++.||+|++.... .....+.+.+|+++++.++||||++++++++....+
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIP-TGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcC-CCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence 346789999999999999999998876 57899999987642 233456889999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+||||+++|+|..++.+.+.+++..++.++.+++.||.|||+ .|++||||||+||+++.+ +.++|+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC-CcEEEccCCcccchhhh
Confidence 9999999999999999988889999999999999999999997 689999999999999998 99999999998764221
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCC-CCCh---hhHh----hh
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGS-QIPT---STAA----QL 261 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~-~~~~---~~~~----~~ 261 (473)
. .....|+..|+ +||.+. ..+.|++|++ +++++|..||......... ..+. .... ..
T Consensus 158 ~-----~~~~~~~~~~~---aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd06620 158 I-----ADTFVGTSTYM---SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229 (284)
T ss_pred c-----cCccccCcccC---CHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence 1 12235666666 777643 4678899965 5789999999743211000 0000 0001 11
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
...++. ..++.++.+||.+||+.||.+||+++|+++||||..
T Consensus 230 ~~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 230 PPRLPS--SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred CCCCCc--hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 112221 237789999999999999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=288.74 Aligned_cols=259 Identities=21% Similarity=0.352 Sum_probs=195.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+++|++.+.||+|++|.||+|+++. +++.||+|.+..... .......+.+|+++++.++||||+++++++.+....|+
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRV-TNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecC-CCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence 4689999999999999999998876 578999999876532 22334568889999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 120 VMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
||||+ +++|..++.... .+++..++.++.||+.||+|||++||+||||||+||+++.+++.+||+|||++.......
T Consensus 79 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 79 VFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEecc-cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 99999 568888887644 368899999999999999999999999999999999999654689999999997643221
Q ss_pred cccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChh----
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTS---- 256 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~---- 256 (473)
. ......+++.|+ +||.+. ..++|++|++ +++++|..||..... .........
T Consensus 158 ~---~~~~~~~~~~y~---~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 158 R---TFTHEVVTLWYR---APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred c---ccccCceeeccc---CHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence 1 111123455555 777542 3678899965 579999999963110 000000000
Q ss_pred ----hHhhhccCCCC-----ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 257 ----TAAQLQLEWPE-----DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 257 ----~~~~~~~~~P~-----~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
........++. ....++++++++|.+||+.||++||++.++++||||++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 00000001110 0135789999999999999999999999999999998764
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.68 Aligned_cols=239 Identities=21% Similarity=0.337 Sum_probs=191.0
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
.+++++.||+|-||.||+|+++.. ..||+|.++...+. .+.+.+|+++|++++|++||++++++..++.+||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~--~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGS--TKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCC--CcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 356788999999999999998863 46999999986432 347889999999999999999999999988999999
Q ss_pred cccCcCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 122 EYMIGGDVKSLIAA--NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 122 Ey~~gg~L~~~L~~--~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|||+.|+|.++|+. .+.+...+...+++||+.|++||+++++|||||-..|||++++ ..+||+||||++...+....
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-LVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-ceEEEcccccccccCCCcee
Confidence 99999999999997 4579999999999999999999999999999999999999999 99999999999964433322
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCccc-cc-cCCCCCchhHhhhcCCCCChhhHhhhccCCCCcccc
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTFQ-DV-QNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l~-~~-~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ 271 (473)
.. .|.---+.|.|||.+. ..|+||||++. ++ ..|+.||...... ++........++.-| +.
T Consensus 360 ~~-----~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---ev~~~le~GyRlp~P---~~ 428 (468)
T KOG0197|consen 360 AS-----EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---EVLELLERGYRLPRP---EG 428 (468)
T ss_pred ec-----CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---HHHHHHhccCcCCCC---CC
Confidence 11 2222224556999753 57999999874 54 4588888753211 011111111233344 68
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHh
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVR 298 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil 298 (473)
+++++.+++..||+.+|++|||++.+.
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 999999999999999999999988655
|
|
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.78 Aligned_cols=281 Identities=20% Similarity=0.300 Sum_probs=215.5
Q ss_pred CCCCccchhhHHHHhHhhhcccccccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccc-cch
Q psy622 5 GLFSGADKENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM-INK 83 (473)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~-~~~ 83 (473)
..+...+++++.+.-.. .+.++..........++-.-.+...+||+|+|-+||+|.+.. +|..||=-.++...+ ...
T Consensus 5 ~~~~~~~~~~~~~~~~~-~~~~e~~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~-~giEVAWnqvk~~d~~q~~ 82 (632)
T KOG0584|consen 5 EFPRDIEAENIEERSEQ-ESESEPDESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEE-EGIEVAWNQVKIRDVTQSP 82 (632)
T ss_pred Ccccchhhhhhhhhhhh-hhhhccccccccccCCCCceeehhhhcccccceeeeeccccc-cchhhHHHHHhHHHhhcCh
Confidence 33444555555553322 222223333334445544445777899999999999999865 666666444443332 234
Q ss_pred hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE--EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy622 84 NMVSQVLRERNALALTHSPFCVQLFYSLQTSSC--VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161 (473)
Q Consensus 84 ~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~--l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~ 161 (473)
...+++..|+.+|+.|+||||+++|++|.+..+ +.+|+|++.+|+|+.++++.++++...++.|++||+.||.|||++
T Consensus 83 ~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~ 162 (632)
T KOG0584|consen 83 EELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ 162 (632)
T ss_pred HHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC
Confidence 556899999999999999999999999987655 889999999999999999999999999999999999999999999
Q ss_pred C--eeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCcccc-----ccCCcCCCC-ccc
Q psy622 162 G--IIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQL-----LSLKTGTFP-TFQ 233 (473)
Q Consensus 162 g--IiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i-----~~~~~~s~g-~l~ 233 (473)
. |||||||-+||+|+.+.|.|||.|.|||+.+.... .....|||+|| |||.. -.+|+|+|| ++.
T Consensus 163 ~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-----aksvIGTPEFM---APEmYEE~YnE~VDVYaFGMCmL 234 (632)
T KOG0584|consen 163 DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-----AKSVIGTPEFM---APEMYEENYNELVDVYAFGMCML 234 (632)
T ss_pred CCCccccccccceEEEcCCcCceeecchhHHHHhhccc-----cceeccCcccc---ChHHHhhhcchhhhhhhhhHHHH
Confidence 6 99999999999999998999999999999865432 22368999999 88753 368999999 457
Q ss_pred cccCCCCCchhHh------hhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 234 DVQNSQAPFPSAL------RVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 234 ~~~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+|.++.+||.+.. +....++.+.... .--.+++++||.+||.. .++|+++.|+++||||..-
T Consensus 235 EMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~----------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 235 EMVTSEYPYSECTNPAQIYKKVTSGIKPAALS----------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHhccCChhhhCCHHHHHHHHHcCCCHHHhh----------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 8999999998742 2111222211111 12257999999999998 9999999999999999864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.93 Aligned_cols=249 Identities=18% Similarity=0.256 Sum_probs=189.4
Q ss_pred CCCCeEEEceecccCceEEEEEEEe----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKK----TNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQT 113 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~----~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~ 113 (473)
..++|++.+.||+|+||.||+|.+. ..++..||+|+++.... ....+.+.+|+.+|..+ +||||+++++++.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 3458999999999999999999642 23456899999976432 23356788999999999 89999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCC--------------------------------------------------------
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANG-------------------------------------------------------- 137 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~-------------------------------------------------------- 137 (473)
....|+||||++||+|.+++...+
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 999999999999999999997532
Q ss_pred -------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 138 -------------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 138 -------------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
.+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIRNDSN 269 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-CcEEEecCccceeccCccc
Confidence 46788899999999999999999999999999999999988 8999999999986533221
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCCcc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDE 269 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~ 269 (473)
. .......+++.|+ |||.+. ..|+|++|++ +++++ |..||...... ..+ ...... .....|
T Consensus 270 ~-~~~~~~~~~~~y~---aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~-~~~~~~~~~~~~~--- 339 (375)
T cd05104 270 Y-VVKGNARLPVKWM---APESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKF-YKMIKEGYRMLSP--- 339 (375)
T ss_pred c-cccCCCCCCccee---ChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHH-HHHHHhCccCCCC---
Confidence 1 1111223344555 888653 4788999965 56775 88888642100 000 001111 111122
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
...+.++++||.+||+.||++||++.||++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 4578899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=283.76 Aligned_cols=248 Identities=16% Similarity=0.215 Sum_probs=191.0
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
++.++|++.+.||+|+||.||+|..+. ..+..||+|+++... .......+.+|+.+++.++||||+++++++....
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 345789999999999999999997653 235689999998753 2334567899999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 116 CVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
.+|+||||+++|+|.+++.+. +.+++..++.++.||+.||+|||++|++||||||+|||++.+ +.+||+|||.+....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~-~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-LVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC-CcEEECCCccccccc
Confidence 999999999999999999874 579999999999999999999999999999999999999998 999999999876532
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-cccc-CCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQ-NSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
.... .......+++.|+ |||.+. ..|.|++|++ ++++ .|..||....... + ...+.. ....|
T Consensus 159 ~~~~--~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~-~~~~~~-~~~~~ 228 (266)
T cd05064 159 SEAI--YTTMSGKSPVLWA---APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---V-IKAVED-GFRLP 228 (266)
T ss_pred ccch--hcccCCCCceeec---CHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H-HHHHHC-CCCCC
Confidence 1111 1111122334454 888653 4688899965 5644 5999996421100 0 001111 11112
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.+..++..+.+++.+||+.+|.+||+++||++
T Consensus 229 -~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 229 -APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 22578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=289.64 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=197.3
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~ 118 (473)
.++|+..+.||+|+||.||+++++. +++.||+|.+.+... ......+.+|+.++.++. ||||+++++++..+...+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKP-SGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECC-CCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence 4678888999999999999999876 578999999986542 234567889999999985 999999999999999999
Q ss_pred EEecccCcCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 119 LVMEYMIGGDVKSLIA-----ANGALPEDMAAFYAAEVVLALQYLHSH-GIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~-----~~~~~~e~~~~~~~~qI~~aL~yLH~~-gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
++|||+ +++|..+.. ..+.+++..+..++.|++.||+|||+. ||+||||||+||+++.+ +.+||+|||++..
T Consensus 80 ~~~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~ 157 (288)
T cd06616 80 ICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN-GNIKLCDFGISGQ 157 (288)
T ss_pred EEEecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC-CcEEEeecchhHH
Confidence 999998 456554432 235799999999999999999999975 99999999999999998 9999999999987
Q ss_pred hcCCccccccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhc
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQ 262 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 262 (473)
+..... .....|++.|+ +||.+. ..|+|++|++ +++++|..||........ .+ ........
T Consensus 158 ~~~~~~----~~~~~~~~~y~---aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~-~~~~~~~~ 228 (288)
T cd06616 158 LVDSIA----KTRDAGCRPYM---APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD-QL-TQVVKGDP 228 (288)
T ss_pred hccCCc----cccccCccCcc---CHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHH-HH-hhhcCCCC
Confidence 533211 11234666666 777542 3688999965 579999999964210000 00 00000001
Q ss_pred cCCC-CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccc
Q psy622 263 LEWP-EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSIL 312 (473)
Q Consensus 263 ~~~P-~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~ 312 (473)
...+ .....++.++.+||.+||+.||.+||++++|++||||+...|.+..
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~~~ 279 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVD 279 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcchh
Confidence 1111 1113588999999999999999999999999999999988777543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=295.20 Aligned_cols=258 Identities=21% Similarity=0.280 Sum_probs=193.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS------ 114 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~------ 114 (473)
++|++.+.||.|+||.||+|+++. +++.||+|++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~-~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSD-CDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECC-CCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 689999999999999999998876 578999999876542 3456788999999999999999999776543
Q ss_pred --------CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEee
Q psy622 115 --------SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVN 186 (473)
Q Consensus 115 --------~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~D 186 (473)
..+|+||||++ ++|..++.. +.+++..++.++.||+.||+|||+.||+||||||+||+++.+++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 46899999995 699888864 47999999999999999999999999999999999999986647899999
Q ss_pred cchhhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh-----hc--CC
Q psy622 187 TLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR-----VA--GS 251 (473)
Q Consensus 187 FGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~-----~~--~~ 251 (473)
||+++.+..............+++.|+ |||.+. ..+.|++|++ +++++|..||..... .. ..
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYR---SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred cccceecCCcccccccccccccccccc---CHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999986533221111112223555555 788542 3688999965 579999999963210 00 00
Q ss_pred CCChh------------hHh--hhccCCC--CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 252 QIPTS------------TAA--QLQLEWP--EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 252 ~~~~~------------~~~--~~~~~~P--~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
..... ... ......| .....++.++++||.+||+.||.+||++.|+++||||+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 00000 000 0000011 01135789999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=284.83 Aligned_cols=249 Identities=22% Similarity=0.376 Sum_probs=197.9
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH---SPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~~~~~l~ 118 (473)
.|++.+.||+|+||.||+|.++. +++.||+|++++.. .......+.+|+.+++.++ ||||+++++++.+....|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP-TGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC-CCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence 47889999999999999999876 57899999987652 2334567889999999886 999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
+||||++|++|.++++. +.+++..+..++.||+.||.|||+.||+||||+|+||+++.+ +.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT-GNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC-CCEEEccCCceeecCCCcc
Confidence 99999999999999876 479999999999999999999999999999999999999998 9999999999987543221
Q ss_pred ccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hccCCCCcc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDE 269 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~ 269 (473)
......|++.|+ +||... ..+.|++|++ +++++|..||......... ..... ....++.
T Consensus 157 ---~~~~~~~~~~y~---aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~~~~-- 224 (277)
T cd06917 157 ---KRSTFVGTPYWM---APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM----MLIPKSKPPRLED-- 224 (277)
T ss_pred ---ccccccCCccee---CHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh----hccccCCCCCCCc--
Confidence 112234666666 777542 4688899965 5799999999653111000 00000 0111221
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
..++.++.+++.+||+.||.+||++.|+++||||++..
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 225 NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 23788999999999999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=281.07 Aligned_cols=247 Identities=21% Similarity=0.318 Sum_probs=196.3
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+++|++.+.||+|+||.||+|+.+. +++.||||.++............+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLL-DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeC-CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 4689999999999999999999876 578999999887555555556788999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 120 VMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
||||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.+ +.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC-CCEEECccccceeccc
Confidence 9999999999988863 3458999999999999999999999999999999999999998 8999999999887533
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~ 267 (473)
... ......|++.|+ |||... ..|.|++|++ +++++|..||..... . ....... .....|.
T Consensus 159 ~~~---~~~~~~~~~~~~---aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~-~~~~~~~~~~~~~~~ 227 (267)
T cd08228 159 KTT---AAHSLVGTPYYM---SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----N-LFSLCQKIEQCDYPP 227 (267)
T ss_pred hhH---HHhcCCCCcccc---ChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----c-HHHHHHHHhcCCCCC
Confidence 211 112235666666 777643 3688899965 579999999854210 0 0011111 1112222
Q ss_pred c-cccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 268 D-EEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 268 ~-~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
. ....+..+.++|.+||+.+|.+||++.++++
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 1 1357789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.58 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=192.4
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS----- 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~----- 114 (473)
.++|++++.||+|+||.||+|+++. +++.||||++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTV-TGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECC-CCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 5789999999999999999998876 57899999987642 2233455778899999999999999999998644
Q ss_pred -CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 -SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 -~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..+|+||||+ +++|.+.+... +++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++..
T Consensus 93 ~~~~~lv~e~~-~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~ 168 (353)
T cd07850 93 FQDVYLVMELM-DANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTA 168 (353)
T ss_pred cCcEEEEEecc-CCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCccceeC
Confidence 3589999999 56898888754 8999999999999999999999999999999999999999 99999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCCh--
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPT-- 255 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~-- 255 (473)
..... .....+++.|+ |||.+. ..|+|++|++ +++++|..||.... ...+.....
T Consensus 169 ~~~~~----~~~~~~~~~y~---aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 169 GTSFM----MTPYVVTRYYR---APEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred CCCCC----CCCCccccccc---CHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 32211 12234666666 888653 3688999965 57999999986321 000000000
Q ss_pred --------hhHh-----------h--hccCCCCc----cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 256 --------STAA-----------Q--LQLEWPED----EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 256 --------~~~~-----------~--~~~~~P~~----~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
.... + ....++.. ....++++++||.+||+.||++||++.|+++||||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 0000 0 00001100 123567799999999999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=296.87 Aligned_cols=254 Identities=19% Similarity=0.282 Sum_probs=194.8
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS---- 115 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~---- 115 (473)
.++|++++.||+|+||.||+|..+. +++.||||++++.. ........+.+|+.+|+.++||||++++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRR-TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECC-CCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 4679999999999999999998876 57899999987642 22333457889999999999999999999997654
Q ss_pred --EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 116 --CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 116 --~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
.+|+||||+ |++|..++.. +.+++..++.++.||+.||+|||+.||+||||||+||+++.+ +.+||+|||++...
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~-~~~kl~dfg~~~~~ 168 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQT 168 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeccccccc
Confidence 469999999 8899988875 579999999999999999999999999999999999999998 99999999999864
Q ss_pred cCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhh--------cCCCCChhh
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRV--------AGSQIPTST 257 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~--------~~~~~~~~~ 257 (473)
.... ....+++.|+ +||.+. ..+.|++|++ +++++|..||...... .....+...
T Consensus 169 ~~~~------~~~~~~~~y~---aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 169 DSEM------TGYVVTRWYR---APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccCc------cccccCCccc---CHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 3211 1124556665 777543 3688899965 5689999999632100 000000000
Q ss_pred H------------hhh-c---cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 258 A------------AQL-Q---LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 258 ~------------~~~-~---~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
. ... . ..+......+++++.++|.+||+.||.+||++.++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0 000 0 001111246788999999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=295.51 Aligned_cols=258 Identities=21% Similarity=0.264 Sum_probs=199.1
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----E
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS-----C 116 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~-----~ 116 (473)
+|++.+.||.|+||.||+|+... +++.||||++.+.. ......+.+.+|+.+++.++||||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR-TGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC-CCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 58999999999999999998776 57899999998653 22344567899999999999999999999998775 8
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+||||++ ++|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.++|+|||++......
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPD 156 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEeeccc
Confidence 999999995 6899999887899999999999999999999999999999999999999999 99999999999876443
Q ss_pred ccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCCh----
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPT---- 255 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~---- 255 (473)
...........+++.|+ +||.+. ..+.|++|++ +++++|..||..... ..+...+.
T Consensus 157 ~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 157 EDEKGFLTEYVVTRWYR---APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccccccccccccccCcC---CceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 21111112234565555 777653 3578899965 579999999964211 00000000
Q ss_pred -------hhHhh----hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 256 -------STAAQ----LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 256 -------~~~~~----~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
..... ....+......++.++.+||.+||+.+|.+||+++++++||||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 00000 0111111123578999999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=286.97 Aligned_cols=248 Identities=19% Similarity=0.278 Sum_probs=197.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.+.|++.+.||+|+||.||+|+.+. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcC-CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3569999999999999999998876 578999999976554445556678999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.+ +.+||+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSASLVSPA-- 168 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC-CCEEEeecCcceecCCC--
Confidence 999995 677777764 4579999999999999999999999999999999999999999 99999999998764321
Q ss_pred ccccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
....+++.|+ +||.+. ..++|++|++ +++++|..||........ ............+
T Consensus 169 -----~~~~~~~~y~---aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~-- 235 (307)
T cd06607 169 -----NSFVGTPYWM---APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQNDSPTLS-- 235 (307)
T ss_pred -----CCccCCcccc---CceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---HHHHhcCCCCCCC--
Confidence 1234666666 787653 3688999965 579999999864211000 0000000111111
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
...++.+++++|.+||+.||.+||++.+++.||||..
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 236 SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 1346789999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=284.93 Aligned_cols=250 Identities=17% Similarity=0.236 Sum_probs=194.4
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCC----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNK----DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~----~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
..+++|++.+.||+|+||.||+|...... .+.||+|.++... .......+.+|+.++..++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34678999999999999999999876521 2579999987543 23345578899999999999999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN----------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~----------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~ 177 (473)
....|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999999999999864 45788999999999999999999999999999999999999
Q ss_pred CCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhc
Q psy622 178 QAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVA 249 (473)
Q Consensus 178 ~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~ 249 (473)
+ +.+||+|||+++........ .......+++.|+ |||.+. ..|+|++|++ +++++ |..||.+....
T Consensus 160 ~-~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~- 233 (283)
T cd05048 160 G-LTVKISDFGLSRDIYSADYY-RVQSKSLLPVRWM---PPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ- 233 (283)
T ss_pred C-CcEEECCCcceeeccccccc-cccCCCccccccc---CHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 8 99999999999864322211 1122234556666 888653 3688999965 56776 99998642110
Q ss_pred CCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 250 GSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 250 ~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.+ ...+. ....+..+..+++++.+|+.+||+.||.+||++.||++|
T Consensus 234 --~~-~~~i~--~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 234 --EV-IEMIR--SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred --HH-HHHHH--cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 01111 111122235789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=275.28 Aligned_cols=247 Identities=23% Similarity=0.426 Sum_probs=201.7
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++.+.||+|++|.||+|+++. +++.||+|.+.+.... ......+.+|+++++.++||+++++++++.+....|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE-TGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC-CCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 58899999999999999998776 5789999999887532 345678999999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc
Q psy622 122 EYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE 201 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~ 201 (473)
||+++++|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.++|+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~-- 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKD-- 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC-CCEEEeccccceecCCCccc--
Confidence 999999999999988899999999999999999999999999999999999999998 99999999999875432221
Q ss_pred cccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCCh
Q psy622 202 ISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNP 274 (473)
Q Consensus 202 ~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~ 274 (473)
.....+++.|+ +||.. ...+.|++|++ +++++|..||..... . ...........+..+..++.
T Consensus 156 -~~~~~~~~~y~---~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~-~~~~~~~~~~~~~~~~~~~~ 225 (254)
T cd06627 156 -DASVVGTPYWM---APEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----M-AALFRIVQDDHPPLPEGISP 225 (254)
T ss_pred -ccccccchhhc---CHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----H-HHHHHHhccCCCCCCCCCCH
Confidence 12234666666 77753 34678889955 579999999864210 0 00001111222233367889
Q ss_pred hHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 275 STEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 275 ~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.+.++|.+||+.+|++||++.+++.||||
T Consensus 226 ~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 226 ELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=286.21 Aligned_cols=258 Identities=20% Similarity=0.240 Sum_probs=190.8
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC---
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS--- 115 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~--- 115 (473)
.+++|++.+.||+|+||.||+|+++. +++.||||++..... .......+.+|+++++.++||||+++++++.+..
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKK-TKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECC-CCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 36789999999999999999998876 578999999876432 2222345678999999999999999999987643
Q ss_pred -----EEEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecch
Q psy622 116 -----CVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 116 -----~l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
..|+||||+ +++|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~ 165 (310)
T cd07865 88 NRYKGSFYLVFEFC-EHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGL 165 (310)
T ss_pred cCCCceEEEEEcCC-CcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC-CcEEECcCCC
Confidence 469999999 568988887654 79999999999999999999999999999999999999998 9999999999
Q ss_pred hhhhcCCcccc-ccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhh--------cCCC
Q psy622 190 LAILQQPIVYL-EISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRV--------AGSQ 252 (473)
Q Consensus 190 a~~~~~~~~~~-~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~--------~~~~ 252 (473)
+.......... .......+++.|+ |||.+. ..|.|++|++ +++++|..||...... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYR---PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred cccccCCcccCCCCccCcccCcccc---CcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 98753322111 1111123444555 788542 3688999965 5688999888542110 0001
Q ss_pred CChhhH-------hhhccCCCCc----------cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 253 IPTSTA-------AQLQLEWPED----------EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 253 ~~~~~~-------~~~~~~~P~~----------~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.+.... .......|.. ....+..+++||.+||+.||.+||+++|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 110000 0000111110 01246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=285.99 Aligned_cols=247 Identities=19% Similarity=0.227 Sum_probs=189.8
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQ--LYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQ 112 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~--~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~ 112 (473)
+.++.++|++.+.||+|+||.||+|+++.+ +. .+|+|.++.. ........+.+|+.++..+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~-~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred CccchhhceeeeeecCCCCceEEEEEEccC-CceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 456788999999999999999999988763 43 4677776643 2344456788999999999 8999999999999
Q ss_pred eCCEEEEEecccCcCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAANG----------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~~----------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld 176 (473)
+.+.+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 158 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec
Confidence 9999999999999999999997643 578999999999999999999999999999999999999
Q ss_pred CCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccC-CCCCchhHhhh
Q psy622 177 AQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQN-SQAPFPSALRV 248 (473)
Q Consensus 177 ~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~-g~~pf~~~~~~ 248 (473)
.+ +.+||+|||++....... ......+++.|+ +||.+ ...|.|++|++ +++++ |..||.....
T Consensus 159 ~~-~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~- 229 (303)
T cd05088 159 EN-YVAKIADFGLSRGQEVYV----KKTMGRLPVRWM---AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC- 229 (303)
T ss_pred CC-CcEEeCccccCcccchhh----hcccCCCccccc---CHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-
Confidence 98 899999999986421110 011112233444 67653 34789999965 56876 9999864211
Q ss_pred cCCCCChhhHhhhccC-CCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 249 AGSQIPTSTAAQLQLE-WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 249 ~~~~~~~~~~~~~~~~-~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.......... .+..+...++++.+||.+||+.+|.+||++++++.+
T Consensus 230 ------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 230 ------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ------HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0111111111 111124578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=283.72 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=199.9
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
..|+.++.||+|+||.||+|.++. +++.||+|++.+... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc-CCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 458889999999999999998876 578999999986532 34456889999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||++||+|.+++.. +.+++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++..+.....
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC-CCEEEcccccceeccCCcc--
Confidence 999999999999875 579999999999999999999999999999999999999998 9999999999976532211
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
......++..|+ +||... ..|.|++|++ +++++|..||....... .. .... ....|.....++
T Consensus 157 -~~~~~~~~~~y~---apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~-~~~~--~~~~~~~~~~~~ 226 (277)
T cd06640 157 -KRNTFVGTPFWM---APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VL-FLIP--KNNPPTLTGEFS 226 (277)
T ss_pred -ccccccCccccc---CHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hh-hhhh--cCCCCCCchhhh
Confidence 111223555555 777642 3688899965 57999999996532110 00 0000 111122224678
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCc
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDW 308 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw 308 (473)
..+.++|.+||+.+|.+||+++++++||||.....
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 89999999999999999999999999999987644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=281.72 Aligned_cols=250 Identities=19% Similarity=0.267 Sum_probs=192.2
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKT---NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~---~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
..+++|++.+.||+|+||+||+|.... ..++.||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 457899999999999999999997532 235789999998642 234456788999999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC
Q psy622 115 SCVFLVMEYMIGGDVKSLIAAN-----------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~-----------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~ 177 (473)
...|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999999999998632 24788999999999999999999999999999999999999
Q ss_pred CCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhc
Q psy622 178 QAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVA 249 (473)
Q Consensus 178 ~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~ 249 (473)
+ +.+||+|||+++........ .......++..|+ +||... ..|+|++|++ +++++ |..||.+....
T Consensus 160 ~-~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~- 233 (283)
T cd05090 160 Q-LHVKISDLGLSREIYSADYY-RVQPKSLLPIRWM---PPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ- 233 (283)
T ss_pred C-CcEEeccccccccccCCcce-ecccCCCccceec---ChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 8 89999999999875432211 1112223444455 777643 4688999965 56776 88888642100
Q ss_pred CCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 250 GSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 250 ~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.+. .... ....+..+..+++++++++.+||+.||.+||++.+|+++
T Consensus 234 --~~~-~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 234 --EVI-EMVR--KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred --HHH-HHHH--cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 000 0000 111122225788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.02 Aligned_cols=239 Identities=23% Similarity=0.353 Sum_probs=194.9
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~ 116 (473)
+..++|++...+|.|+|+.|-.+.++. +++.+++|++.+.. ....+|+.++... +||||+++++.+.+..+
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~-t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSP-TDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccc-cccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCce
Confidence 446789999999999999999998887 67899999998862 1345677777666 89999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec-CCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS-AQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld-~~~g~ikL~DFGla~~~~~ 195 (473)
.|+|||++.||.|...+...+.+. ..+..|++||+.|+.|||.+|||||||||+|||++ +. |+++|||||.++....
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~-g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSA-GHLRLTYFGFWSELER 468 (612)
T ss_pred eeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCC-CcEEEEEechhhhCch
Confidence 999999999999999998876666 88889999999999999999999999999999994 66 9999999999998543
Q ss_pred CccccccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
. ..+.|-|-.|. |||++ ...|||++|++ ++|++|+.||...- .+ . .+ ...+..|..
T Consensus 469 ~------~~tp~~t~~y~---APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P----~~--~-ei-~~~i~~~~~ 531 (612)
T KOG0603|consen 469 S------CDTPALTLQYV---APEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP----AG--I-EI-HTRIQMPKF 531 (612)
T ss_pred h------hcccchhhccc---ChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC----ch--H-HH-HHhhcCCcc
Confidence 2 11223344444 77754 46899999976 56999999997421 11 0 11 112333333
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
..++|.+|++||++||+.||.+||++.|++.||||
T Consensus 532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 36899999999999999999999999999999999
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=289.67 Aligned_cols=249 Identities=19% Similarity=0.320 Sum_probs=196.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.|.....||+|+||.||+|.... +++.||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKH-TGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECC-CCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence 456667889999999999998776 57899999987543 33455788999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||+++++|..++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.+ +.++|+|||++........
T Consensus 98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEccCcchhhcccccc--
Confidence 999999999998864 479999999999999999999999999999999999999998 9999999999976432211
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hccCCCCccccC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDEEAL 272 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~~~l 272 (473)
......|++.|+ |||... ..|.|++|++ +++++|..||....... . ...... .....+ ....+
T Consensus 174 -~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~-~~~~~~~~~~~~~-~~~~~ 244 (292)
T cd06658 174 -KRKSLVGTPYWM---APEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---A-MRRIRDNLPPRVK-DSHKV 244 (292)
T ss_pred -cCceeecCcccc---CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H-HHHHHhcCCCccc-ccccc
Confidence 112235677776 888653 3788899954 67999999986421100 0 000000 011111 11357
Q ss_pred ChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 273 NPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+..+.++|.+||..||.+||+++|+++||||+..
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 8899999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=325.27 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=208.4
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEec
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
+.-...||.|.||+||.|.... +|...|+|-++-.... ......+-+|..+|..++|||+|+++++-.....+||.||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~-tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLD-TGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eccccccCCcceeeeEEeecCC-ccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 4456689999999999998876 6899999999877544 4446678899999999999999999999999999999999
Q ss_pred ccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc-cc
Q psy622 123 YMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY-LE 201 (473)
Q Consensus 123 y~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~-~~ 201 (473)
||+||+|.++++..+..+|...+.|..|++.||.|||++|||||||||.||+|+.+ |.||+.|||.|+.+.....+ ..
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC-CcEEeecccceeEecCchhcCCH
Confidence 99999999999998889999999999999999999999999999999999999999 89999999999987544211 11
Q ss_pred cccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcccc
Q psy622 202 ISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271 (473)
Q Consensus 202 ~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ 271 (473)
.-.-..|||-|| |||++. ..|+|++|+. .+|.+|+.||....... .|..... -...|..|..
T Consensus 1394 el~~~~GT~~YM---APEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~--aIMy~V~---~gh~Pq~P~~ 1465 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYM---APEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW--AIMYHVA---AGHKPQIPER 1465 (1509)
T ss_pred HHHhhcCCchhc---CchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh--HHHhHHh---ccCCCCCchh
Confidence 122357999999 999875 3688999966 58999999998631110 0111111 2223444467
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
+|++.++||.+||..||++|.++.|+++|.|=+
T Consensus 1466 ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1466 LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred hhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 999999999999999999999999999998864
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=281.57 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=192.1
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++.+.||.|++|+||+|+++. +++.||||+++.... ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT-TGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC-CCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence 58999999999999999999876 578999999987532 222456778999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 122 EYMIGGDVKSLIAAN---GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~---~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||++ |+|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||+++++ +.++|+|||++........
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 78 EYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVN 155 (284)
T ss_pred ecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCcc
Confidence 9996 5898888764 368999999999999999999999999999999999999998 9999999999986532211
Q ss_pred ccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhh---------cCCCCCh--hhHh
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRV---------AGSQIPT--STAA 259 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~---------~~~~~~~--~~~~ 259 (473)
......+++.|+ +||... ..++|++|++ +++++|..||...... ....... ....
T Consensus 156 ---~~~~~~~~~~y~---~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 156 ---TFSNEVVTLWYR---APDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred ---cccccccccccc---ChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 111223555565 777542 3578899965 5799999998642100 0000000 0000
Q ss_pred h---hccCCCC--------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 260 Q---LQLEWPE--------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 260 ~---~~~~~P~--------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
. ....+|. ....++.+++++|.+||+.||.+||++.|+++||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 0000110 012468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=277.23 Aligned_cols=243 Identities=20% Similarity=0.279 Sum_probs=187.9
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
+.++|++.+.||+|+||.||+|+.+. +..+|+|.+.+... ..+.+.+|+++|+.++||||+++++++.....+|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~--~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA--QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY 75 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc--CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence 45789999999999999999998764 35799999876532 1346888999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 119 LVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++......
T Consensus 76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC-CeEEECCCCCccccCCCc
Confidence 99999999999999975 3578999999999999999999999999999999999999998 899999999998643221
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
... .....++..|+ |||.+. ..+.|++|++ +++++ |..||...... ..............|
T Consensus 155 ~~~--~~~~~~~~~y~---aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~~~~~~~~~--- 223 (256)
T cd05114 155 YTS--SSGAKFPVKWS---PPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMISRGFRLYRP--- 223 (256)
T ss_pred eec--cCCCCCchhhC---ChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCCCCCCCC---
Confidence 110 01111222344 787653 4688999965 56887 88998642110 000000011111223
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
...+.++.+++.+||+.||.+||+++++++
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=276.86 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=196.9
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDE--MINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS--SC 116 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~--~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~ 116 (473)
.+|++.+.||+|+||.||+|+++. +++.||+|++.... .........+.+|+++++.++||||+++++.+.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD-TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC-CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 579999999999999999998876 57899999986532 12234456889999999999999999999998764 56
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+++||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.+ +.++|+|||+++.....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECccccccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999998 89999999999875322
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-h-ccCCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-L-QLEWPE 267 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~-~~~~P~ 267 (473)
...........+++.|+ +||.+. ..|+|++|++ +++++|..||..... ...+.+ . ....+.
T Consensus 160 ~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~ 229 (264)
T cd06653 160 CMSGTGIKSVTGTPYWM---SPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------MAAIFKIATQPTKPM 229 (264)
T ss_pred cccCccccccCCccccc---CHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-------HHHHHHHHcCCCCCC
Confidence 11111111234666666 788653 3588999965 579999999964210 011111 1 111122
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.+..+++++.++|.+||+ +|.+||++.+++.|||.
T Consensus 230 ~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 230 LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 336799999999999999 67999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=278.02 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=197.2
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++.+.||+|+||.||+|..+. +++.||+|.+...... ....+.+.+|+++++.++|+||+++++.+.+...+|+|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC-CCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 58999999999999999999887 5788999999875432 233557889999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 122 EYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||+++++|.+++.+.. .+++..++.++.||+.||.|||+.+++|+||||+||+++.++..+||+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME- 157 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence 9999999999997643 5899999999999999999999999999999999999998834579999999987543221
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh-hhccCCCCcccc
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA-QLQLEWPEDEEA 271 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~P~~~~~ 271 (473)
......|++.|+ |||... ..+.|++|++ +++++|..||..... ..... .....++.....
T Consensus 158 --~~~~~~~~~~~~---ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~ 225 (257)
T cd08225 158 --LAYTCVGTPYYL---SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQGYFAPISPN 225 (257)
T ss_pred --cccccCCCcccc---CHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhcccCCCCCCC
Confidence 112234666666 787543 3688899965 579999999864211 11111 111122222246
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
++.+++++|.+||+.+|++||+++|+++||||
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 78899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=295.70 Aligned_cols=262 Identities=20% Similarity=0.300 Sum_probs=195.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS------ 114 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~------ 114 (473)
++|.+.+.||+|+||.||+|+++. +++.||+|++++... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKR-TGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCC-CCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 579999999999999999998876 578999999986532 222345688999999999999999999998754
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+|+||||+. ++|..++. ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++...
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~-~~~kL~dfg~~~~~~ 168 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED-CELKILDFGLARHAD 168 (342)
T ss_pred ceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCCCCcCCC
Confidence 35799999994 57776653 368999999999999999999999999999999999999999 999999999987642
Q ss_pred CCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCCh--
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPT-- 255 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~-- 255 (473)
... ....+++.|+ |||.+. ..|+|++|++ +++++|..||..... ..+...+.
T Consensus 169 ~~~------~~~~~~~~y~---aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 169 AEM------TGYVVTRWYR---APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCC------CCceeeeccc---ChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 211 1124555565 777643 3688899965 579999999964210 00000000
Q ss_pred --------hhHhhhccCCC-----CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccCCCC
Q psy622 256 --------STAAQLQLEWP-----EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPP 317 (473)
Q Consensus 256 --------~~~~~~~~~~P-----~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~~pP 317 (473)
..........+ ......++++.+||.+||+.||.+||+++|++.||||+.+.+....+...|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~ 314 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP 314 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc
Confidence 00000000001 001257788999999999999999999999999999999876544443333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=283.58 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=190.2
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCE---
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSC--- 116 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~--- 116 (473)
++|++.+.||+|+||.||+|+++. +++.||+|+++... ........+.+|+.+++.+ +||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~-~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN-TGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC-CCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 479999999999999999999876 57899999987653 2222345788899999999 57999999999987665
Q ss_pred --EEEEecccCcCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecch
Q psy622 117 --VFLVMEYMIGGDVKSLIAAN-----GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 117 --l~lVmEy~~gg~L~~~L~~~-----~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
+|+||||+++ +|..++... ..+++..++.++.||+.||+|||++||+||||||+||+++.+.+.+||+|||+
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999965 898888653 35899999999999999999999999999999999999998338999999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhh---------cCCC
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRV---------AGSQ 252 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~---------~~~~ 252 (473)
++.+...... .....+++.|+ |||++. ..|+|++|++ +++++|..||...... ....
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~~~---aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 231 (295)
T cd07837 158 GRAFSIPVKS---YTHEIVTLWYR---APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231 (295)
T ss_pred ceecCCCccc---cCCcccccCCC---ChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9864322111 01123455555 777543 3688899965 5699999998642100 0000
Q ss_pred CChhhH----hhhccCCC--------CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 253 IPTSTA----AQLQLEWP--------EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 253 ~~~~~~----~~~~~~~P--------~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
...... ......++ .....++.++.+||.+||+.||.+||+++|++.||||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000000 00000000 01135789999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=280.98 Aligned_cols=248 Identities=19% Similarity=0.312 Sum_probs=195.8
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+++|++.+.||+|+||.||+|+.+. +++.||||.+.+...........+.+|+.+++.++||||+++++++...+.+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLL-DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecC-CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 4689999999999999999998876 578999999887655555556788999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 120 VMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEECcchhhhcccc
Confidence 9999999999999874 3468999999999999999999999999999999999999998 9999999999886532
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC-
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE- 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~- 267 (473)
... ......|++.|+ +||.+. ..|.|++|++ +++++|..||...... ............++.
T Consensus 159 ~~~---~~~~~~~~~~~~---ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~ 228 (267)
T cd08229 159 KTT---AAHSLVGTPYYM---SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQCDYPPL 228 (267)
T ss_pred CCc---ccccccCCcCcc---CHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhhcCCCCCC
Confidence 211 112235666666 777643 3588999965 5799999998642110 000000001112221
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
....++++++++|.+||+.||.+|||+++|.+
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 12468889999999999999999999997763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=280.47 Aligned_cols=248 Identities=22% Similarity=0.375 Sum_probs=196.8
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
-|++++.||+|+||.||+|.++. +++.||+|++..... ......+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~-~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECC-CCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 37888999999999999998776 578999999876532 334567889999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc
Q psy622 122 EYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE 201 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~ 201 (473)
||+++|+|..++.+ +.+++..+..++.||+.||.|||+.|++|+||||+||+++.+ +.++|+|||++..+.....
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~--- 156 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQI--- 156 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-CCEEEeecccceecccchh---
Confidence 99999999999875 478999999999999999999999999999999999999998 9999999999876532211
Q ss_pred cccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCCh
Q psy622 202 ISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNP 274 (473)
Q Consensus 202 ~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~ 274 (473)
......++..|+ +||.+. ..+.|++|++ +++++|..||....... ....+. ....+.....++.
T Consensus 157 ~~~~~~~~~~y~---~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~--~~~~~~~~~~~~~ 227 (277)
T cd06641 157 KRNTFVGTPFWM---APEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK----VLFLIP--KNNPPTLEGNYSK 227 (277)
T ss_pred hhccccCCcccc---ChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH----HHHHHh--cCCCCCCCcccCH
Confidence 111234555555 677543 3578899965 57999999986421100 000000 1112222356889
Q ss_pred hHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 275 STEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 275 ~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
++.++|.+||+.+|.+||++.++++||||...
T Consensus 228 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 228 PLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=274.06 Aligned_cols=247 Identities=26% Similarity=0.452 Sum_probs=200.4
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++.+.||.|+||.||+|.+.. +++.||+|++..... .......+.+|+++++.++|||++++++.+......++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS-DGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC-CCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 58999999999999999999876 578999999987543 2344667889999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 122 EYMIGGDVKSLIAAN----GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~----~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
||++|++|.+++.+. ..+++..+..++.+|+.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTV 157 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC-CcEEECCccceeecccCc
Confidence 999999999999874 679999999999999999999999999999999999999998 999999999998754322
Q ss_pred cccccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~ 270 (473)
.......|++.|+ +||.. ...+.|++|++ +++++|..||.... .............+..+.
T Consensus 158 ---~~~~~~~~~~~y~---~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~ 225 (258)
T cd08215 158 ---DLAKTVVGTPYYL---SPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILKGQYPPIPS 225 (258)
T ss_pred ---ceecceeeeeccc---ChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhcCCCCCCCC
Confidence 1223345676666 77753 34788899965 56889999986421 000000111122233335
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.++.++.++|.+||+.+|.+||++.++++||||
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=287.86 Aligned_cols=251 Identities=20% Similarity=0.316 Sum_probs=197.6
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
...|+....||+|+||.||+|+++. +++.||+|++..... ...+.+.+|+.+++.++||||+++++.+..++..|+
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKH-SGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcC-CCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence 3556667789999999999998876 578999999976432 234568899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||||+++++|..++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++..+.....
T Consensus 96 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~~- 172 (297)
T cd06659 96 LMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVP- 172 (297)
T ss_pred EEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-CcEEEeechhHhhcccccc-
Confidence 9999999999998765 578999999999999999999999999999999999999999 9999999999976432211
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
......|++.|+ +||.+. ..|.|++|++ +++++|..||........ .................+
T Consensus 173 --~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 243 (297)
T cd06659 173 --KRKSLVGTPYWM---APEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA----MKRLRDSPPPKLKNAHKI 243 (297)
T ss_pred --cccceecCcccc---CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhccCCCCccccCCC
Confidence 112345777777 888654 3688899965 579999999863210000 000001111111122467
Q ss_pred ChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 273 NPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+.++.++|.+||+.+|.+||+++++++||||.+-
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 8899999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=283.26 Aligned_cols=251 Identities=21% Similarity=0.310 Sum_probs=199.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++.+.||+|+||.||+|..+. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+......|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA-TGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC-CCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 4789999999999999999998766 46889999987543 2334678899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|+||++||+|.+++.+. .+++..+..++.||+.||.|||++|++||||||+||+++.+ +.++|+|||++........
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC-CCEEEccCcceeccccccc-
Confidence 99999999999999764 68999999999999999999999999999999999999998 8999999999876432211
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
......+++.|+ +||.+. ..|+|++|++ +++++|..||....... ... .........++ .+..+
T Consensus 171 --~~~~~~~~~~y~---~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~--~~~-~~~~~~~~~~~-~~~~~ 241 (293)
T cd06647 171 --KRSTMVGTPYWM---APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALY-LIATNGTPELQ-NPEKL 241 (293)
T ss_pred --ccccccCChhhc---CchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh--hee-ehhcCCCCCCC-Ccccc
Confidence 112235666666 777643 4688999965 57999999996421110 000 00000111111 12457
Q ss_pred ChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 273 NPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+..++++|.+||+.+|.+||++.+++.||||+..
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 8899999999999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=281.62 Aligned_cols=250 Identities=19% Similarity=0.315 Sum_probs=197.1
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
..|...+.||+|++|.||+|..+. +++.+|+|+++... ....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKS-TGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECC-CCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence 346666899999999999998776 57899999986542 23345688999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
+||++|++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.+ +.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC-CcEEEcccccchhhccCCc--
Confidence 999999999999987 679999999999999999999999999999999999999998 9999999999876432211
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
......|++.|+ +||... ..|.|++|++ +++++|..||....... ..................++
T Consensus 171 -~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 242 (285)
T cd06648 171 -RRKSLVGTPYWM---APEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ----AMKRIRDNLPPKLKNLHKVS 242 (285)
T ss_pred -ccccccCCcccc---CHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH----HHHHHHhcCCCCCcccccCC
Confidence 112235777777 787653 3688999965 57999999986421100 00001111111111113478
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
..+.++|.+||+.+|++||++.++++||||++.
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 899999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=286.81 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=199.3
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.|+..+.||+|+||.||+|.+.. +++.||+|.++.... ....+.+.+|+++++.++||||+++++.+.+...+|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR-TKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC-CCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 347778899999999999998876 578999999886532 33456789999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||++|++|.+++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.+ +.++|+|||++..+.....
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC-CCEEEccccccccccCcch--
Confidence 999999999998875 578999999999999999999999999999999999999998 9999999999987543211
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
......++..|+ +||.+. ..|.|++|++ +++++|..||....... .. ... .....+.....++
T Consensus 157 -~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~-~~~--~~~~~~~~~~~~~ 226 (277)
T cd06642 157 -KRNTFVGTPFWM---APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VL-FLI--PKNSPPTLEGQYS 226 (277)
T ss_pred -hhhcccCccccc---CHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HH-hhh--hcCCCCCCCcccC
Confidence 111234555555 777543 3678899965 57999999986421100 00 000 0111222224678
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
.++.++|.+||+.+|.+||++.++++||||....+.
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKK 262 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhh
Confidence 899999999999999999999999999999876544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=313.88 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=191.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+++|++.++||+|+||.||+|+++. +++.||||++++.........+++.+|+++++.++||||+++++++.+.+..|+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~-tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPV-CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECC-CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 4789999999999999999998876 578999999987644444456689999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecc
Q psy622 120 VMEYMIGGDVKSLIAAN-----------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~-----------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
||||++||+|.+++.+. ..++...+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d-g~vKLiDFG 158 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-GEVVILDWG 158 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC-CCEEEEecC
Confidence 99999999999998742 234566778899999999999999999999999999999998 999999999
Q ss_pred hhhhhcCCccc---------------cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHh
Q psy622 189 FLAILQQPIVY---------------LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSAL 246 (473)
Q Consensus 189 la~~~~~~~~~---------------~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~ 246 (473)
+++........ ........||+.|+ |||.+. ..|+|++|++ ++|++|..||....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~Ym---APE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYM---APERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCC---CHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 99875211100 01112246888888 898754 3688999965 57999999996521
Q ss_pred hhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHH
Q psy622 247 RVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQ 296 (473)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~e 296 (473)
. ..+.............. ...+++.+.+++.+||+.||++|++..+
T Consensus 236 ~---~ki~~~~~i~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~e 281 (932)
T PRK13184 236 G---RKISYRDVILSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQ 281 (932)
T ss_pred h---hhhhhhhhccChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 1 00100000000111111 1467899999999999999999987543
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=275.10 Aligned_cols=246 Identities=21% Similarity=0.318 Sum_probs=194.9
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||+|+||.||+|..+. +++.||+|.++..........+.+.+|+++++.++|++|+++++++...+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL-DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC-CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 689999999999999999998875 5789999999876555555577899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 121 MEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 121 mEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|||++||+|..++.+ ...+++..++.++.||+.||.|||+.||+||||||+||+++.+ +.++|+|||++..+...
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC-CcEEEeccceeeeccCC
Confidence 999999999999865 2458999999999999999999999999999999999999998 99999999998764322
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hccCCCCc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQLEWPED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~ 268 (473)
.. ......+++.|. +||.+. ..+.|++|++ +++++|..||..... . ....... ....++..
T Consensus 160 ~~---~~~~~~~~~~y~---apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~-~~~~~~~~~~~~~~~~ 228 (267)
T cd08224 160 TT---AAHSLVGTPYYM---SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----N-LYSLCKKIEKCDYPPL 228 (267)
T ss_pred Cc---ccceecCCcccc---CHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----c-HHHHHhhhhcCCCCCC
Confidence 11 111234666665 777643 4688999966 579999999854210 0 0000000 01111111
Q ss_pred c-ccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 269 E-EALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 269 ~-~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
+ ..++.++.++|.+||..+|.+||++.+|++
T Consensus 229 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 229 PADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1 367889999999999999999999998774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=281.01 Aligned_cols=248 Identities=19% Similarity=0.255 Sum_probs=193.3
Q ss_pred CCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
..++|.+.+.||+|+||.||+|+... .+++.||+|++++.. .....+.+.+|+++|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 46789999999999999999997653 235789999997653 233456889999999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANG--------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP 180 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~--------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g 180 (473)
...|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.+ +
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~ 159 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD-L 159 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC-C
Confidence 99999999999999999997643 47899999999999999999999999999999999999999 9
Q ss_pred ceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCC
Q psy622 181 HCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQ 252 (473)
Q Consensus 181 ~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~ 252 (473)
.+||+|||+++........ .......+++.|+ |||.+. ..|+|++|++ +++++ |..||......
T Consensus 160 ~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---- 231 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWM---PPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---- 231 (280)
T ss_pred eEEECCcccceecccCcce-ecCCCCcccceec---ChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence 9999999999764322111 1112223455565 788643 4788999965 56887 99998642110
Q ss_pred CChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 253 IPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 253 ~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.....+.... .+..+..++..++++|.+||+.||.+||+++|+++
T Consensus 232 ~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 232 EVIECITQGR--LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHHHcCC--cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0001111111 22222578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=281.22 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=194.6
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT--SSCVF 118 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~~~l~ 118 (473)
++|+..+.||.|++|.||+|+++. +++.||+|.+.+... ......+.+|+++++.++||||++++++|.+ .+.+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN-TGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC-CCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 479999999999999999999876 578999999986532 2345678999999999999999999998865 44799
Q ss_pred EEecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 119 LVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
+||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++||||+|+||+++.+ +.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~ 156 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC-CeEEEeecccccccc
Confidence 99999999999988754 3468999999999999999999999999999999999999998 899999999987643
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh----hcc
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ----LQL 263 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~----~~~ 263 (473)
.... ....++..|+ +||.+. ..+.|++|++ +++++|..||...... .......... ...
T Consensus 157 ~~~~-----~~~~~~~~y~---~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 226 (287)
T cd06621 157 NSLA-----GTFTGTSFYM---APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELLSYIVNMPNP 226 (287)
T ss_pred cccc-----ccccCCcccc---CHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHHHHHhcCCch
Confidence 2211 1223455555 677543 4678899965 5799999999753110 0000111110 011
Q ss_pred CCCCc---cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 264 EWPED---EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 264 ~~P~~---~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
..+.. ....++++.++|.+||..||.+|||+.|+++||||++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 11111 023467899999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=281.12 Aligned_cols=248 Identities=18% Similarity=0.250 Sum_probs=192.1
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
++-.+|.+.+.||+|+||+||+|.... .++..+|+|.+.+.. ......+.+|+.+++.++||||++++++++.
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 345679999999999999999997532 234579999987642 3445678999999999999999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANG-------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP 180 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~-------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g 180 (473)
...+|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~-~ 157 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-L 157 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-C
Confidence 999999999999999999997643 48999999999999999999999999999999999999998 9
Q ss_pred ceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCC
Q psy622 181 HCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQ 252 (473)
Q Consensus 181 ~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~ 252 (473)
.+||+|||+++........ .......+++.|+ |||.+. ..|.|++|++ ++|++ |..||.......
T Consensus 158 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--- 230 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWM---PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--- 230 (288)
T ss_pred cEEeccCCccccccCCcee-ecCCCCCcccccc---CHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999865322211 1112223455566 888653 4788899966 56877 889986421100
Q ss_pred CChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 253 IPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 253 ~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
. ...+.... .+..+..++.++.+|+.+||+.||.+||+++++.+
T Consensus 231 ~-~~~i~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 231 V-IECITQGR--VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred H-HHHHHcCC--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 01111111 11222568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=308.13 Aligned_cols=242 Identities=22% Similarity=0.252 Sum_probs=193.6
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEE-e-----
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQ-T----- 113 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~-~----- 113 (473)
-+++|.++|.+|||+.||+|+... .+..||+|++-.. ++...+.+.+|+++|++|. |+|||.++++.. .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~-~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVK-GGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecC-CCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 457899999999999999998876 3488999998865 3666778999999999995 999999999432 1
Q ss_pred -CCEEEEEecccCcCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCCcceEecCCCCceeEeecc
Q psy622 114 -SSCVFLVMEYMIGGDVKSLIAA--NGALPEDMAAFYAAEVVLALQYLHSHG--IIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 114 -~~~l~lVmEy~~gg~L~~~L~~--~~~~~e~~~~~~~~qI~~aL~yLH~~g--IiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
.-.++|+||||.||.|.+++.+ ...|+|.++..|+.++++||.+||... |||||||.|||||+.+ |++||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-GNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-CCEEeCccc
Confidence 2358999999999999999985 346999999999999999999999998 9999999999999999 999999999
Q ss_pred hhhhhcCCc-ccccc-----ccccCCCCcccccCCcccc---------ccCCcCCCCcccc-ccCCCCCchhHhhhcCCC
Q psy622 189 FLAILQQPI-VYLEI-----SDLVNGTPNAFNIRTPGQL---------LSLKTGTFPTFQD-VQNSQAPFPSALRVAGSQ 252 (473)
Q Consensus 189 la~~~~~~~-~~~~~-----~~~~~gtp~y~~~~ape~i---------~~~~~~s~g~l~~-~~~g~~pf~~~~~~~~~~ 252 (473)
.+...-... ..... .-..+-||.|. |||.+ -..|.|++|+|.| ++....||.+.-
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YR---sPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------ 262 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYR---SPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------ 262 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCcccc---ChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------
Confidence 987632211 11000 00123455544 88864 2478999999876 788999997531
Q ss_pred CChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 253 IPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 253 ~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
...|......+|.. +.++..+++||+.||+.||.+||++.|++.
T Consensus 263 --~laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 263 --KLAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred --ceeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 12344456777765 589999999999999999999999888765
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=281.13 Aligned_cols=248 Identities=23% Similarity=0.284 Sum_probs=187.7
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC--CEEEE
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTS--SCVFL 119 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~--~~l~l 119 (473)
|++++.||+|+||.||+|..+. +++.||+|++++.... . ......+|+.++..+ +||||+++++++.+. +.+|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~-~~~~~aik~~~~~~~~-~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK-TGKYYAIKCMKKHFKS-L-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcC-CCcEEEEEEehhccCC-c-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 6789999999999999998876 5789999998865321 1 223446788888888 599999999999987 89999
Q ss_pred EecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||||++ |+|.+.+... +.+++..++.++.||+.||+|||+.||+||||||+||+++. +.+||+|||+++.+.....
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccCCC
Confidence 999995 5888888764 57999999999999999999999999999999999999998 7999999999987533221
Q ss_pred ccccccccCCCCcccccCCcccc-------ccCCcCCCCcc-ccccCCCCCchhHhhh--------cCCCCChhhHhh--
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQL-------LSLKTGTFPTF-QDVQNSQAPFPSALRV--------AGSQIPTSTAAQ-- 260 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i-------~~~~~~s~g~l-~~~~~g~~pf~~~~~~--------~~~~~~~~~~~~-- 260 (473)
. ....+++.|+ |||.+ ...|+|++|++ +++++|..||...... ............
T Consensus 155 ~----~~~~~~~~y~---aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 155 Y----TEYISTRWYR---APECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred c----CCCCCCcccC---ChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 1 1224555555 77753 24688899965 5689999999642100 000000000000
Q ss_pred ----hccCCCC--------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 261 ----LQLEWPE--------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 261 ----~~~~~P~--------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
....+|. ....++.++.+||.+||++||.+||+++++++||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0111111 013578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=289.34 Aligned_cols=259 Identities=20% Similarity=0.289 Sum_probs=196.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe--CCE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQT--SSC 116 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~--~~~ 116 (473)
.++|++.+.||+|+||.||+|.++. +++.+|+|++.+.. ........+.+|+.+++.+ +||||+++++++.. ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRR-TKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcC-CCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 5689999999999999999998876 57899999987642 2233345678899999999 99999999999864 347
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+||||++ ++|..++.+. .+++..++.++.||+.||+|||+.||+||||||+||+++.+ +.+||+|||+++.+...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD-CRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccchhccccc
Confidence 899999995 6999998875 88999999999999999999999999999999999999999 99999999999875432
Q ss_pred ccc--cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhc--------CCCCChhhH
Q psy622 197 IVY--LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVA--------GSQIPTSTA 258 (473)
Q Consensus 197 ~~~--~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~--------~~~~~~~~~ 258 (473)
... ........|++.|+ +||.+. ..|.|++|++ +++++|..||....... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 161 EENPENPVLTDYVATRWYR---APEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccCcchhccccccccc---CceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 211 01112234666666 888653 3688899965 57999999996311000 000000000
Q ss_pred h----------------hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 259 A----------------QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 259 ~----------------~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
. ............++.++.++|.+||+.||.+||++.++++||||+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 00001111113478999999999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=277.59 Aligned_cols=248 Identities=19% Similarity=0.243 Sum_probs=192.1
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTN--KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~--~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
..++|++.+.||+|+||+||+|+.+.. +...||||++++.. .......+.+|+.+++.++||||+++++.+.....
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 457899999999999999999987643 23579999987653 23345678899999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.|+||||+++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.+ +.++|+|||+++....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRRLED 158 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CCEEECccchhhcccc
Confidence 99999999999999999764 479999999999999999999999999999999999999998 9999999999998642
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWP 266 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P 266 (473)
.... .......+++.|+ +||.+. ..|+|++|++ +++++ |..||...... .. ...+.. .....+
T Consensus 159 ~~~~-~~~~~~~~~~~y~---~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~-~~~~~~~~~~~~~ 230 (266)
T cd05033 159 SEAT-YTTKGGKIPIRWT---APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DV-IKAVEDGYRLPPP 230 (266)
T ss_pred cccc-eeccCCCCCcccc---ChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HH-HHHHHcCCCCCCC
Confidence 1111 1111122334455 777643 3688999966 45665 88898542110 00 011111 111222
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
...++.+.+|+.+||+.+|++||+++|++++
T Consensus 231 ---~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 231 ---MDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=276.41 Aligned_cols=244 Identities=19% Similarity=0.296 Sum_probs=192.0
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+...+|++.+.||+|+||.||+|..+. .++.||+|++.+.. ...+.+.+|+++++.++||||+++++++.....+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEec-CCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 345679999999999999999999876 56889999987642 2355788999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 118 FLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~ 156 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CcEEeCCCcccccccc
Confidence 9999999999999999764 358999999999999999999999999999999999999998 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWP 266 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P 266 (473)
..... .....+++.|+ |||.+. ..|+|++|++ +++++ |..||....... . ...... .....|
T Consensus 157 ~~~~~--~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~-~~~~~~~~~~~~~ 227 (263)
T cd05052 157 DTYTA--HAGAKFPIKWT---APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V-YELLEKGYRMERP 227 (263)
T ss_pred ceeec--cCCCCCccccC---CHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H-HHHHHCCCCCCCC
Confidence 22111 11112234455 777653 4788999965 56876 889986421100 0 000111 122223
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..++.++.++|.+||+.||++||++.++++
T Consensus 228 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 228 ---EGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ---CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=288.12 Aligned_cols=257 Identities=20% Similarity=0.229 Sum_probs=193.0
Q ss_pred CeEEEceecccCceEEEEEEEeCCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe----C
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNK--DQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQT----S 114 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~--~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~----~ 114 (473)
+|++.+.||+|+||.||+|+... . ++.||+|++.... ......+.+.+|+.+++.+ +||||+++++.+.. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~-~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAE-TSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCC-CCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 58999999999999999998775 4 6789999987542 2233355788899999998 69999999987532 3
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+|+++||+ +++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+++.+.
T Consensus 79 ~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 79 NELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLARGFS 156 (332)
T ss_pred CcEEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC-CCEEeCcCCCceecc
Confidence 5689999999 57999999888889999999999999999999999999999999999999998 999999999998754
Q ss_pred CCcccc-ccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCChh
Q psy622 195 QPIVYL-EISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPTS 256 (473)
Q Consensus 195 ~~~~~~-~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~~ 256 (473)
...... .......|++.|+ |||... ..|+|++|++ +++++|..||.... ...+......
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~---aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYR---APEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccCcccCcccc---CcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 322111 1112235677766 888653 2578899965 56889999986411 0001000000
Q ss_pred ----------hHh-----hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 257 ----------TAA-----QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 257 ----------~~~-----~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
... .....++......+.++.+||.+||+.||.+||++.|++.||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 000 0001111111346889999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=287.03 Aligned_cols=268 Identities=22% Similarity=0.325 Sum_probs=199.8
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT-SSCVF 118 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-~~~l~ 118 (473)
.++|++++.||+|+||.||+|+++. +++.||+|++.+.. ......+.+.+|+.+++.++||||++++++|.. ....|
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQL-TGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECC-CCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4679999999999999999998876 57899999987643 223345678899999999999999999999876 56799
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
+||||+ +++|..++.. +.+++..++.++.||+.||+|||++||+||||||.||+++.+ +.++|+|||++.......
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~~~- 162 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-CDLKICDFGLARIQDPQM- 162 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC-CCEEeCccccccccCCCc-
Confidence 999999 7799888875 468999999999999999999999999999999999999998 999999999987642211
Q ss_pred ccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhh--------cCCCCChhhH----
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRV--------AGSQIPTSTA---- 258 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~--------~~~~~~~~~~---- 258 (473)
....+++.|+ +||.+. ..+.|++|++ +++++|..||...... .....+....
T Consensus 163 -----~~~~~~~~y~---aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 163 -----TGYVSTRYYR---APEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred -----CCCccccccc---CceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 1123555555 777543 3678899965 5799999999642110 0000010000
Q ss_pred --------hhh----ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccCCCCCcCCCCCCC
Q psy622 259 --------AQL----QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVF 326 (473)
Q Consensus 259 --------~~~----~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~~pPf~P~~~~~~ 326 (473)
... ...+......++.+++++|++||+.+|++||++++++.||||... +.|+..|.-...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~-------~~~~~~~~~~~~~ 307 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY-------HDPTDEPVAEEKF 307 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc-------cCCccccCchhhc
Confidence 000 001111113578899999999999999999999999999999632 2444455544444
Q ss_pred CC
Q psy622 327 DT 328 (473)
Q Consensus 327 D~ 328 (473)
|.
T Consensus 308 ~~ 309 (328)
T cd07856 308 DW 309 (328)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=267.02 Aligned_cols=260 Identities=19% Similarity=0.241 Sum_probs=202.9
Q ss_pred ccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q psy622 33 SCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ 112 (473)
Q Consensus 33 ~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 112 (473)
.....++-++|++.+.||+|||+.|++++... +++.||+|++.-.. .++++..++|++.-++++||||++++++..
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s-~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLS-TGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccC-cccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 33445667899999999999999999998666 67899999998754 566789999999999999999999987653
Q ss_pred e-----CCEEEEEecccCcCCHHHHHHhC---C-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCCcceEecCCCCc
Q psy622 113 T-----SSCVFLVMEYMIGGDVKSLIAAN---G-ALPEDMAAFYAAEVVLALQYLHSHG--IIHRDLKPDNMLISAQAPH 181 (473)
Q Consensus 113 ~-----~~~l~lVmEy~~gg~L~~~L~~~---~-~~~e~~~~~~~~qI~~aL~yLH~~g--IiHRDLKpeNILld~~~g~ 181 (473)
. ....||+++|...|+|.+.++.. | .++|.++..|+.+|+.||++||... +.||||||.|||+..+ +.
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~~ 167 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-GL 167 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-Cc
Confidence 2 34599999999999999999763 3 6999999999999999999999999 9999999999999998 99
Q ss_pred eeEeecchhhhhcCCcc-----------ccccccccCCCCcccccCCccc-cccCCcCCCCc-cccccCCCCCchhHhhh
Q psy622 182 CPIVNTLFLAILQQPIV-----------YLEISDLVNGTPNAFNIRTPGQ-LLSLKTGTFPT-FQDVQNSQAPFPSALRV 248 (473)
Q Consensus 182 ikL~DFGla~~~~~~~~-----------~~~~~~~~~gtp~y~~~~ape~-i~~~~~~s~g~-l~~~~~g~~pf~~~~~~ 248 (473)
++|.|||.+........ ....++..+.+|+.+...+--. .-..|.|++|+ +|.|+.|..||.....
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~- 246 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ- 246 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-
Confidence 99999999876421111 1112222233333222111111 13579999995 5679999999998765
Q ss_pred cCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 249 AGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 249 ~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.+. -..-.+....+.+|+.. .+|..+.+||+.||+.||.+||++.+++.+
T Consensus 247 ~Gg-SlaLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 247 QGG-SLALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cCC-eEEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 222 22233445577888764 499999999999999999999999998864
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=295.48 Aligned_cols=250 Identities=16% Similarity=0.222 Sum_probs=190.0
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTN----KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQ 112 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~ 112 (473)
...++|++.+.||+|+||.||+|.+... ++..||||+++... .....+.+.+|+++|+.+. ||||++++++++
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3357899999999999999999976432 23469999997643 2334567899999999995 999999999999
Q ss_pred eCCEEEEEecccCcCCHHHHHHhC--------------------------------------------------------
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAAN-------------------------------------------------------- 136 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~-------------------------------------------------------- 136 (473)
+...+|+|||||++|+|.++|.+.
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999999999988652
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec
Q psy622 137 ----------------------------------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176 (473)
Q Consensus 137 ----------------------------------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld 176 (473)
+.+++..+..++.||+.||+|||+.||+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 2377888899999999999999999999999999999999
Q ss_pred CCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhh
Q psy622 177 AQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRV 248 (473)
Q Consensus 177 ~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~ 248 (473)
.+ +.+||+|||+++.+...... .......+++.|+ |||.+. ..|+|++|++ +++++ |..||......
T Consensus 272 ~~-~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 272 QG-KIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWM---APESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred CC-CEEEEEeCCcceeccccccc-cccCCcCCCcceE---ChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 98 89999999999865322211 1112234556666 888653 3688999965 56765 88998653110
Q ss_pred cCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 249 AGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 249 ~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
. .+............+ ..++.++.++|.+||+.||++||++.+|.+
T Consensus 347 ~--~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 S--TFYNKIKSGYRMAKP---DHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred H--HHHHHHhcCCCCCCC---ccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 0 000000000112222 578899999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=277.54 Aligned_cols=249 Identities=18% Similarity=0.241 Sum_probs=190.5
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNK--DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~--~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
...+|++.+.||+|+||.||+|+++.++ +..+|+|.+++.. .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 3568999999999999999999876432 2479999987643 23345688999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
+|+||||++||+|.+++.+. +.+++..+..++.||+.||.|||++|++||||||+|||++.+ +.++|+|||++..+..
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN-LVCKVSDFGLSRVLED 158 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC-CeEEeCCCCccccccc
Confidence 99999999999999999875 468999999999999999999999999999999999999998 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
............+++.|+ +||.+. ..|.|++|++ +++++ |..||...... ... ..+.. ....|.
T Consensus 159 ~~~~~~~~~~~~~~~~y~---~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~-~~~~~-~~~~~~ 230 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWT---APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVI-KAIEE-GYRLPA 230 (267)
T ss_pred ccceeeecCCCccceeec---CHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHH-HHHhC-CCcCCC
Confidence 221111111111233344 777654 3688999965 45564 99998642110 000 01111 111221
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
+..+++.+.+++.+||+++|.+||++.++++
T Consensus 231 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 231 -PMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 2467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=296.39 Aligned_cols=246 Identities=20% Similarity=0.280 Sum_probs=202.7
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
-|.-++.||.|+||.||-|++.. +.++||||++.-..-......+.++.|+..|.+++|||++.+-++|-.+...||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~-n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccC-ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 36778899999999999999987 46899999998776555666778999999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 122 EYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 122 Ey~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
||| -|+-.++|.- .+++.|.++..+..+.+.||.|||+++.||||||..||||... |.|||+|||.+.....
T Consensus 106 EYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~-g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP-GLVKLADFGSASIMAP----- 178 (948)
T ss_pred HHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC-CeeeeccccchhhcCc-----
Confidence 999 6788888764 3579999999999999999999999999999999999999999 9999999999987432
Q ss_pred ccccccCCCCcccccCCcccccc---------CCcCCCCccc-cccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccc
Q psy622 201 EISDLVNGTPNAFNIRTPGQLLS---------LKTGTFPTFQ-DVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~~---------~~~~s~g~l~-~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~ 270 (473)
.+.+.|||-|| |||+|+. +|+|++|+-+ ++.-.++|+....... ......++....++. .
T Consensus 179 --AnsFvGTPywM---APEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS---ALYHIAQNesPtLqs--~ 248 (948)
T KOG0577|consen 179 --ANSFVGTPYWM---APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNESPTLQS--N 248 (948)
T ss_pred --hhcccCCcccc---chhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH---HHHHHHhcCCCCCCC--c
Confidence 23468999999 9999863 7889999876 4666777765422100 000111112223333 4
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
..|..+++||..||++=|.+|||.+++++|+|...
T Consensus 249 eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 249 EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 67899999999999999999999999999999863
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=278.56 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=203.3
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.+.|++.+.||+|+||.||+|+++. +++.||+|++..... ....+.+|+++++.++|+||+++++.+......|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRA-TGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEcc-CCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 4569999999999999999998876 468899999986532 45678899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
|+||++|++|.+++...+ .+++..+..++.||+.||.|||+.||+|+||||+||+++.+ +.++|+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC-CCEEECccchhhhhccchh
Confidence 999999999999999876 89999999999999999999999999999999999999998 9999999999876543221
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh-hhccCCCCccc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA-QLQLEWPEDEE 270 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~P~~~~ 270 (473)
......+++.|+ +||.+. ..|.|++|++ +++++|..||....... ....+. ......+ ...
T Consensus 172 ---~~~~~~~~~~y~---~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~-~~~ 240 (286)
T cd06614 172 ---KRNSVVGTPYWM---APEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR----ALFLITTKGIPPLK-NPE 240 (286)
T ss_pred ---hhccccCCcccC---CHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCCCc-chh
Confidence 112234666666 777543 4788899965 67999999986421100 000000 0111111 113
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
.++.+++++|.+||+.+|.+||++.++++||||+...|.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 279 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK 279 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCch
Confidence 478899999999999999999999999999999997776
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=285.22 Aligned_cols=253 Identities=19% Similarity=0.284 Sum_probs=198.7
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
.+..-...|+..+.||+|+||.||+|++.. +++.||+|++.+...........+.+|+++++.++|||++++++++.+.
T Consensus 19 ~~~~~~~~f~~~~~lg~G~~~~v~~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (317)
T cd06635 19 FKEDPEKLFTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE 97 (317)
T ss_pred cCCCchhhhhhhheeccCCCeEEEEEEEcC-CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 333334558999999999999999998876 5789999999876444445566889999999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
...|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.+ +.+||+|||++...
T Consensus 98 ~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~ 175 (317)
T cd06635 98 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASIA 175 (317)
T ss_pred CeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC-CCEEEecCCCcccc
Confidence 99999999996 578777754 4579999999999999999999999999999999999999998 99999999998763
Q ss_pred cCCccccccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhcc
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQL 263 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 263 (473)
... ....|++.|+ +||.+. ..++|++|++ +++++|..||...... ............
T Consensus 176 ~~~-------~~~~~~~~y~---aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~~~~ 242 (317)
T cd06635 176 SPA-------NSFVGTPYWM---APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESP 242 (317)
T ss_pred CCc-------ccccCCcccc---ChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHhccCC
Confidence 321 1235666666 777652 3578899965 5799999998642110 000000011111
Q ss_pred CCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
..+ ....++.++++|.+||+.+|.+||++.++++|||+..
T Consensus 243 ~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 243 TLQ--SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCC--CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 111 1457889999999999999999999999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=289.05 Aligned_cols=253 Identities=19% Similarity=0.296 Sum_probs=188.5
Q ss_pred ceeccc--CceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEeccc
Q psy622 47 KAISRG--AFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYM 124 (473)
Q Consensus 47 ~~LG~G--~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~ 124 (473)
..||+| +||+||+|+++. +++.||+|++..... .....+.+.+|+.+++.++||||++++++|+.+..+|+||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP-TGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcC-CCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 456766 999999998876 579999999986532 2344578899999999999999999999999999999999999
Q ss_pred CcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc-
Q psy622 125 IGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE- 201 (473)
Q Consensus 125 ~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~- 201 (473)
.+|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.++++||+.+...........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCccccc
Confidence 999999999874 358999999999999999999999999999999999999998 9999999987654321111100
Q ss_pred ---cccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCchhHhhh------cCC-CCChh------
Q psy622 202 ---ISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFPSALRV------AGS-QIPTS------ 256 (473)
Q Consensus 202 ---~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~~~~~~------~~~-~~~~~------ 256 (473)
......++..|+ +||++. ..|.|++|++ +++++|..||...... ... .....
T Consensus 161 ~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 161 VYDFPQFSTSVLPWL---SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred cccccccccCccCcc---ChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 001111223334 788653 3588999965 6799999999642110 000 00000
Q ss_pred ----------------------------hHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 257 ----------------------------TAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 257 ----------------------------~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.........+. ...+++++.+||++||+.||++|||++|+++||||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS-SKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchh-hhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00000011111 13467889999999999999999999999999999765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=277.52 Aligned_cols=262 Identities=23% Similarity=0.378 Sum_probs=193.4
Q ss_pred CCCeEEEceecccCceEEEEEEEeC-CC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CC
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKT-NK--DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT-SS 115 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~-~~--~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-~~ 115 (473)
+..|++++.||+|+||.||+|..+. +. .+.||||.++..+- .........+|+.+++.++||||+.|..+|.+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 5679999999999999999995443 32 23799999986531 12223467899999999999999999999977 88
Q ss_pred EEEEEecccCcCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC---CceeEeec
Q psy622 116 CVFLVMEYMIGGDVKSLIAAN-----GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA---PHCPIVNT 187 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~-----~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~---g~ikL~DF 187 (473)
.+|+++||.+ -||.+.|+-. +.++...++.++.||+.|+.|||++-|+||||||.|||+..++ |.+||+|+
T Consensus 102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 9999999994 5999998642 4699999999999999999999999999999999999998653 78999999
Q ss_pred chhhhhcCCccccccccccCCCCcccccCCcccccc-------CCcCCCCccc-cccCCCCCchhHhhhcCCCCChhhHh
Q psy622 188 LFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTFQ-DVQNSQAPFPSALRVAGSQIPTSTAA 259 (473)
Q Consensus 188 Gla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l~-~~~~g~~pf~~~~~~~~~~~~~~~~~ 259 (473)
|+++.+..+-...... .+-.-+++|+|||.+++ ++.|+.|+++ ++++..+.|.+.-.......|...-+
T Consensus 181 GlaR~~~~plkpl~s~---d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASL---DPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred cHHHHhhccccccccC---CceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999876543221111 11112356779997764 6888999764 68888777765322111111110000
Q ss_pred -----h-----hccCC------CCc-----------------------cccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 260 -----Q-----LQLEW------PED-----------------------EEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 260 -----~-----~~~~~------P~~-----------------------~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
. ..-.| |+. ...-++.+.+|+.+||+.||.+|+|++|+++|
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 0 00011 110 11245669999999999999999999999999
Q ss_pred CCCCCC
Q psy622 301 PMFKDY 306 (473)
Q Consensus 301 PFF~~i 306 (473)
+||+.-
T Consensus 338 ~yF~~d 343 (438)
T KOG0666|consen 338 PYFTED 343 (438)
T ss_pred cccccC
Confidence 999853
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=271.29 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=201.6
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS--SCVFL 119 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~l~l 119 (473)
+|++.+.||+|++|.||+|..+. +++.|++|++...... ....+.+.+|+.+++.++||||+++++.+... ..+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD-TGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC-CCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 58899999999999999998876 5789999999876432 34567889999999999999999999999988 89999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|+||+++++|.+++.+...+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEcccccEEeccccccc
Confidence 99999999999999988899999999999999999999999999999999999999998 99999999999875433210
Q ss_pred cccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh--hccCCCCccc
Q psy622 200 LEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ--LQLEWPEDEE 270 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~P~~~~ 270 (473)
.......+++.|+ +||.. ...|.|++|++ +++++|..||.... ........ .....+..+.
T Consensus 158 -~~~~~~~~~~~y~---~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd06606 158 -EGTGSVRGTPYWM---APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGEPPEIPE 227 (260)
T ss_pred -ccccCCCCCcccc---CHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCCCcCCCc
Confidence 0112234666666 77754 34688899965 56899999996531 00000000 0112223335
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.++.++.++|.+||+.||.+||++.|+++||||
T Consensus 228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 779999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=277.60 Aligned_cols=251 Identities=18% Similarity=0.251 Sum_probs=192.4
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTN----KDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSL 111 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 111 (473)
.+..++|++.+.||+|+||.||+|..+.. ....+|+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45567899999999999999999987642 23689999998653 233456788999999999 899999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAAN----------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI 175 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~----------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILl 175 (473)
...+.+|+||||+++|+|..++... +.+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999999642 468999999999999999999999999999999999999
Q ss_pred cCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCccc-cccC-CCCCchhHhh
Q psy622 176 SAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTFQ-DVQN-SQAPFPSALR 247 (473)
Q Consensus 176 d~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l~-~~~~-g~~pf~~~~~ 247 (473)
+.+ +.+||+|||+++.+...... .......+++.|+ +||.+. ..|+|++|++. ++++ |..||.....
T Consensus 166 ~~~-~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 166 TED-HVMKIADFGLARDIHHIDYY-RKTTNGRLPVKWM---APEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred cCC-CeEEeCccccccccccccce-eccCCCCCCcccc---CHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 998 99999999999875432211 1111112334454 888653 36999999764 5665 8888864210
Q ss_pred hcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 248 VAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.. .............| ...+.++.+|+.+||..||++|||++|++++
T Consensus 241 ~~---~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 241 EE---LFKLLKEGYRMEKP---QNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HH---HHHHHHcCCcCCCC---CCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 00 00000001111222 5678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=278.12 Aligned_cols=247 Identities=16% Similarity=0.204 Sum_probs=190.0
Q ss_pred CCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
.++|++.+.||+|+||.||+|+++. .++..||+|++++.. .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4679999999999999999997653 234679999987543 2233457889999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEe
Q psy622 116 CVFLVMEYMIGGDVKSLIAANG----------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~----------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~ 185 (473)
..++||||+++|+|.+++.+.+ .++...+..++.|++.||+|||+.|++||||||+||+++.+ +.++|+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~-~~~~l~ 161 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIG 161 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC-CCEEEC
Confidence 9999999999999999997632 35678889999999999999999999999999999999998 999999
Q ss_pred ecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhh
Q psy622 186 NTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTST 257 (473)
Q Consensus 186 DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~ 257 (473)
|||+++.+...... .......+++.|+ |||.+. ..|.|++|++ +++++ |..||.+... ...
T Consensus 162 dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------~~~ 230 (277)
T cd05062 162 DFGMTRDIYETDYY-RKGGKGLLPVRWM---SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQV 230 (277)
T ss_pred CCCCccccCCccee-ecCCCCccCHhhc---ChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHH
Confidence 99999865332211 1111223455666 788653 3588899965 56777 6888864211 111
Q ss_pred Hh-hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 258 AA-QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 258 ~~-~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.. ......+..+..++.++++++.+||+.||++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 231 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 01111222235788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=276.44 Aligned_cols=240 Identities=19% Similarity=0.283 Sum_probs=185.0
Q ss_pred ceecccCceEEEEEEEe-CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKK-TNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~-~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
+.||+|+||.||+|..+ ..+++.+|+|+++... ......+.+.+|+.+++.++||||++++++++ ....++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 36899999999999653 2356789999987553 23345668899999999999999999999875 456799999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
+|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||.||+++.+ +.+||+|||+++.+............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC-CeEEECCCccccccCCCCCeeeecCC
Confidence 99999999988889999999999999999999999999999999999999998 89999999999875433221111111
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCCccccCChhH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDEEALNPST 276 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~~~ls~~a 276 (473)
..+++.|+ |||.+. ..|.|++|++ +++++ |..||...... .+. ..+.+ .....| ..+++++
T Consensus 158 ~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~-~~i~~~~~~~~~---~~~~~~l 227 (257)
T cd05116 158 GKWPVKWY---APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVT-QMIESGERMECP---QRCPPEM 227 (257)
T ss_pred CCCCcccc---CHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH-HHHHCCCCCCCC---CCCCHHH
Confidence 22344555 788643 4788999965 56776 89999642111 000 11111 122233 5789999
Q ss_pred HHHHHhccccCCCCCCCHHHHhc
Q psy622 277 EETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 277 ~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
++||.+||+.||.+||++++|.+
T Consensus 228 ~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 228 YDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHHhccCchhCcCHHHHHH
Confidence 99999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=274.54 Aligned_cols=240 Identities=37% Similarity=0.607 Sum_probs=197.3
Q ss_pred ecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCC
Q psy622 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGD 128 (473)
Q Consensus 49 LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~ 128 (473)
||.|+||.||+|.+.. .++.||+|++.+...........+..|+.+++.++||||+++++.++++..+|+||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKD-TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECC-CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 6999999999998876 578999999998766555567789999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCC
Q psy622 129 VKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNG 208 (473)
Q Consensus 129 L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~g 208 (473)
|.+++.+.+.+++..+..++.||+.||.|||+.+++|+||||+||+++.+ +.++|+|||++....... .......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~---~~~~~~~~ 155 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEG---SRTNTFCG 155 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-CcEEEeecCcceecccCC---CcccCCcC
Confidence 99999988889999999999999999999999999999999999999998 999999999998753321 11122345
Q ss_pred CCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHH
Q psy622 209 TPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETIL 281 (473)
Q Consensus 209 tp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~ 281 (473)
+..|+ +||... ..|.|++|++ +++++|..||...... ............+| ..++.++.++|+
T Consensus 156 ~~~~~---~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~---~~~~~~l~~~i~ 225 (250)
T cd05123 156 TPEYL---APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILKDPLRFP---EFLSPEARDLIS 225 (250)
T ss_pred Ccccc---ChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHhcCCCCCC---CCCCHHHHHHHH
Confidence 55555 777643 4678899965 5789999999642110 00111112233444 567899999999
Q ss_pred hccccCCCCCCCH---HHHhcCCCC
Q psy622 282 ALLKSDPTQRPSG---HQVRRLPMF 303 (473)
Q Consensus 282 ~LL~~dP~kRpsa---~eil~HPFF 303 (473)
+||..||.+||++ +++++||||
T Consensus 226 ~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 226 GLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHhcCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=285.32 Aligned_cols=249 Identities=16% Similarity=0.211 Sum_probs=189.9
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNK---DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~---~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
....+|++.+.||+|+||+||+|+++.+. ...||+|+++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 45678999999999999999999876522 1248999987542 233456788999999999999999999998764
Q ss_pred CEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..++|+||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~-~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP-QHVKITDFGLAKLL 159 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC-CcEEEccccccccc
Confidence 578999999999999999874 468999999999999999999999999999999999999998 89999999999876
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
........ .....+++.|+ +||.+. ..|+|++|++ +++++ |..||....... ..........+
T Consensus 160 ~~~~~~~~-~~~~~~~~~y~---apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~ 230 (316)
T cd05108 160 GADEKEYH-AEGGKVPIKWM---ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILEKGERL 230 (316)
T ss_pred cCCCccee-ccCCccceeec---ChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHhCCCCC
Confidence 43222111 11112334455 787653 3689999965 56665 899986421100 01111112222
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
|. +..++.++.+++.+||..||.+||++.+++.+
T Consensus 231 ~~-~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 231 PQ-PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CC-CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22 25678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=280.25 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=192.9
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEec
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
|++++.||.|++|.||+|+++. +++.||+|++..... .......+.+|+++++.++||||+++++++.+....|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL-TGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC-CCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 6788999999999999999876 578999999986532 22334568889999999999999999999999999999999
Q ss_pred ccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 123 YMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 123 y~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|+ +++|.+++.... .+++..+..++.||+.||+|||+++++||||+|+||+++.+ +.++|+|||++.........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 79 FL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred cc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CcEEEeecccccccCCCccc-
Confidence 99 579999998765 79999999999999999999999999999999999999998 99999999999764322111
Q ss_pred ccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChh-------
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTS------- 256 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~------- 256 (473)
.....+++.|+ |||++. ..|+|++|++ +++++|..||..... .........
T Consensus 156 --~~~~~~~~~~~---aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 156 --YTHEVVTLWYR---APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred --cCccccccCCC---CCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence 11123455555 777542 3677899965 579999999863210 000000000
Q ss_pred -hHhhhc-----cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 257 -TAAQLQ-----LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 257 -~~~~~~-----~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
...... .........++.++.++|.+||+.||.+||+++|+++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 000000 00011124678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=275.11 Aligned_cols=244 Identities=18% Similarity=0.306 Sum_probs=189.9
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+..++|+++++||+|+||.||+|.... ++.||+|.+.... ...+.+.+|+.+++.++||||+++++.+.+....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~--~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNN--STKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecC--CceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 456789999999999999999998654 4679999987643 2246789999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 118 FLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.|++||||||+||+++.+ +.+||+|||++.....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES-LMCKIADFGLARVIED 155 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC-CcEEECCCccceecCC
Confidence 9999999999999999763 468899999999999999999999999999999999999998 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
.... ......++..|+ |||.+. ..|+|++|++ +++++ |..||....... ...... ....+|.
T Consensus 156 ~~~~--~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----~~~~~~-~~~~~~~ 225 (261)
T cd05072 156 NEYT--AREGAKFPIKWT---APEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD----VMSALQ-RGYRMPR 225 (261)
T ss_pred Ccee--ccCCCccceecC---CHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH----HHHHHH-cCCCCCC
Confidence 2111 011112333444 777542 4689999965 56886 899996421100 000111 1112222
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
...++.++.+++.+||+.+|++||+++++.+
T Consensus 226 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 226 -MENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 2468899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=275.05 Aligned_cols=238 Identities=21% Similarity=0.278 Sum_probs=183.6
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCc
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIG 126 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 126 (473)
+.||+|+||.||+|+++. +++.||+|.+.+.. .......+.+|+++++.++||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~-~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA-DNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEec-CCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 479999999999999876 57899999987542 233456789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 127 GDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 127 g~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
++|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++......... .....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~-~~~~~ 155 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYA-STGGM 155 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-CcEEECccccCccccccccc-ccCCC
Confidence 99999997654 68999999999999999999999999999999999999998 89999999998864321111 00111
Q ss_pred cCCCCcccccCCcccccc------CCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhH-hhhccCCCCccccCChhH
Q psy622 206 VNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTA-AQLQLEWPEDEEALNPST 276 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~P~~~~~ls~~a 276 (473)
..++..|+ |||.+.. .|+|++|++ +++++ |..||....... ..... .......| ...+..+
T Consensus 156 ~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~ 225 (252)
T cd05084 156 KQIPVKWT---APEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----TREAIEQGVRLPCP---ELCPDAV 225 (252)
T ss_pred CCCceeec---CchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH----HHHHHHcCCCCCCc---ccCCHHH
Confidence 11223344 8886543 588999965 56775 888885321100 00011 11122223 5678999
Q ss_pred HHHHHhccccCCCCCCCHHHHhc
Q psy622 277 EETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 277 ~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.+|+.+||+.||++||++.++++
T Consensus 226 ~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 226 YRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=271.84 Aligned_cols=245 Identities=21% Similarity=0.325 Sum_probs=198.9
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++.+.||+|+||.||+|+++. +++.||+|.+.+.... ......+.+|+++++.++||||+++++++.+....|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS-DNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC-CCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 58999999999999999998776 5789999999876432 344567889999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 122 EYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 122 Ey~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
||+++++|..++.+ ...+++..+..++.||+.||+|||+.|++||||||+||+++.+ +.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC-CcEEEeeccchhhhccC-
Confidence 99999999999876 3568999999999999999999999999999999999999998 99999999999876433
Q ss_pred cccccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~ 270 (473)
......+++.|+ +||.. ...+.|++|++ +++++|..||..... ...........++..+.
T Consensus 157 ----~~~~~~~~~~~~---~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~ 223 (256)
T cd08530 157 ----MAKTQIGTPHYM---APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM------QDLRYKVQRGKYPPIPP 223 (256)
T ss_pred ----CcccccCCcccc---CHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCCCCCCch
Confidence 111234666665 77754 24688899955 578999999964211 00001112233343335
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.++.+++++|.+||+.+|.+||++.|+++||+.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=279.60 Aligned_cols=250 Identities=19% Similarity=0.264 Sum_probs=191.5
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCC---------------CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCC
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNK---------------DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPF 103 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~---------------~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~ 103 (473)
..++|++++.||+|+||.||+|...... +..||+|.+.+... ....+.+.+|+++++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3578999999999999999999765421 24689999887532 345678899999999999999
Q ss_pred eeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcc
Q psy622 104 CVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG-----------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDN 172 (473)
Q Consensus 104 Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~-----------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeN 172 (473)
|+++++++..+..+++||||+++++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999998765 68999999999999999999999999999999999
Q ss_pred eEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC--CCCCch
Q psy622 173 MLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN--SQAPFP 243 (473)
Q Consensus 173 ILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~--g~~pf~ 243 (473)
|+++.+ +.++|+|||++..+...... .......+++.|+ +||... ..|.|++|++ +++++ +..||.
T Consensus 161 ili~~~-~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 161 CLVGKN-YTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWM---AWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred eeecCC-CceEEccccceeecccCcce-eecCcCCCCceec---CHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999 99999999999865332211 1122334555666 888654 3789999965 45554 667775
Q ss_pred hHhhhcCCCCChhhHh-----hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 244 SALRVAGSQIPTSTAA-----QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 244 ~~~~~~~~~~~~~~~~-----~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..... .+...... ......+ .+..++.++.+||.+||+.||.+||++.||.+
T Consensus 236 ~~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLTDQ---QVIENAGHFFRDDGRQIYLP-RPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcChH---HHHHHHHhccccccccccCC-CccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 31100 00000000 0011111 12457789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=288.18 Aligned_cols=253 Identities=20% Similarity=0.315 Sum_probs=195.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE---
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC--- 116 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~--- 116 (473)
.++|++.+.||+|+||.||+|+.+. +++.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTK-TGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECC-CCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 5689999999999999999999876 57899999987642 223345678889999999999999999988866554
Q ss_pred ---EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 117 ---VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 117 ---l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
+|+|+||+ |++|.+++.. +.+++..++.++.||+.||+|||+.||+||||||+||+++.+ +.+||+|||++...
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~-~~~kL~dfg~~~~~ 168 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARHT 168 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEccccccccc
Confidence 99999999 7899999876 579999999999999999999999999999999999999998 99999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhc--------CCCCChhh
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVA--------GSQIPTST 257 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~--------~~~~~~~~ 257 (473)
... .....+++.|+ +||.+. ..|+|++|++ +++++|..||....... ....+...
T Consensus 169 ~~~------~~~~~~~~~y~---aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 169 DDE------MTGYVATRWYR---APEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccc------ccCCccccccc---CHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 322 11234566665 787642 3688899965 57999999996421100 00000000
Q ss_pred Hh-----------h-----hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 258 AA-----------Q-----LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 258 ~~-----------~-----~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.. . ....++.....+++++.+||.+||+.||.+|||+.||++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 00 0 0000111112468999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=287.02 Aligned_cols=253 Identities=19% Similarity=0.303 Sum_probs=193.0
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS----- 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~----- 114 (473)
.++|++.+.||+|+||.||+|.++. +++.||+|++++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcC-CCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 3789999999999999999998776 578999999986432 223345788899999999999999999988643
Q ss_pred -CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 -SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 -~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
...|++++++ |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++...
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~dfg~~~~~ 170 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHT 170 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC-CCEEEecccccccc
Confidence 4588999988 8899888865 469999999999999999999999999999999999999999 99999999998864
Q ss_pred cCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCC----
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQ---- 252 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~---- 252 (473)
... .....+++.|+ |||... ..|+|++|++ +++++|..||..... .....
T Consensus 171 ~~~------~~~~~~~~~y~---aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T cd07877 171 DDE------MTGYVATRWYR---APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241 (345)
T ss_pred ccc------ccccccCCCcc---CHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 321 11234566665 788542 3688999965 579999999963110 00000
Q ss_pred ---CChh---hHhhh-----ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 253 ---IPTS---TAAQL-----QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 253 ---~~~~---~~~~~-----~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+... ...+. ...+.......++++++||.+||+.||.+|+++.+++.||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 0000 00000 001111112468899999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=281.14 Aligned_cols=247 Identities=19% Similarity=0.284 Sum_probs=194.4
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEec
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
|...+.||+|+||+||+|++.. +++.||+|++.............+.+|+.+++.++|||++++++++.+....|+|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSH-TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECC-CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 6677889999999999998766 578999999987654445556678899999999999999999999999999999999
Q ss_pred ccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc
Q psy622 123 YMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE 201 (473)
Q Consensus 123 y~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~ 201 (473)
|+. |+|..++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~-~~~kL~dfg~~~~~~~------ 173 (313)
T cd06633 102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASKSSP------ 173 (313)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-CCEEEeecCCCcccCC------
Confidence 994 678777765 4579999999999999999999999999999999999999998 8999999999865321
Q ss_pred cccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcccc
Q psy622 202 ISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271 (473)
Q Consensus 202 ~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ 271 (473)
.....|++.|+ +||.+. ..++|++|++ +++++|..||....... .............+ ...
T Consensus 174 -~~~~~~~~~y~---aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~--~~~ 244 (313)
T cd06633 174 -ANSFVGTPYWM---APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNDSPTLQ--SNE 244 (313)
T ss_pred -CCCcccccccc---ChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcCCCCCC--ccc
Confidence 11235666666 777652 2588899965 57999999986421000 00000000011111 135
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
++..+++||.+||+.+|.+||++.+++.||||+..+
T Consensus 245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 245 WTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 678899999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=275.90 Aligned_cols=251 Identities=16% Similarity=0.193 Sum_probs=186.3
Q ss_pred CCe-EEEceecccCceEEEEEEEe---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Q psy622 41 SDF-EIVKAISRGAFGKVFLGYKK---TNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT--S 114 (473)
Q Consensus 41 ~~y-~i~~~LG~G~fG~V~~a~~~---~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~ 114 (473)
++| ++++.||+|+||+||++..+ ..+++.||+|+++... .......+.+|+++|+.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 345 89999999999999987532 2356789999998652 12335678899999999999999999998765 3
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+|+||||+++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~ 158 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVP 158 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC-CcEEEeecccccccC
Confidence 4689999999999999999864 69999999999999999999999999999999999999998 999999999998754
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhh-------cCCCCChhhHh-
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRV-------AGSQIPTSTAA- 259 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~-------~~~~~~~~~~~- 259 (473)
.............++..|+ +||.+. ..|+|++|++ +++++|..||...... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~---~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWY---AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred CcchhhccCCCCCCCceee---CHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 3222111111122333344 777543 4688999965 5799999887532110 00000000000
Q ss_pred --hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 260 --QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 260 --~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
......+ .+..++.++.+++.+||+.||++||+++++++
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 236 LLERGMRLP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0011111 12567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=273.50 Aligned_cols=249 Identities=17% Similarity=0.207 Sum_probs=192.3
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTN----KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
+..++|++.+.||+|+||.||+|..+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 3457899999999999999999987642 34689999987653 23345578899999999999999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCcee
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANG----------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCP 183 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~----------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ik 183 (473)
....|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.+ +.+|
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~-~~~k 159 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED-LTVK 159 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC-CCEE
Confidence 999999999999999999997532 36788999999999999999999999999999999999999 9999
Q ss_pred EeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCCh
Q psy622 184 IVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPT 255 (473)
Q Consensus 184 L~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~ 255 (473)
|+|||+++.+...... .......++..|+ |||.+. ..|.|++|++ +++++ |..||....... . .
T Consensus 160 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~-~ 231 (277)
T cd05032 160 IGDFGMTRDIYETDYY-RKGGKGLLPVRWM---APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---V-L 231 (277)
T ss_pred ECCcccchhhccCccc-ccCCCCCcccccc---CHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---H-H
Confidence 9999999875432211 1112234455555 787643 3688999965 56776 888986421100 0 0
Q ss_pred hhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 256 STAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 256 ~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.... ....+..+..++.++.++|.+||+.+|++|||+.++++
T Consensus 232 ~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 232 KFVI--DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHh--cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0111 11112223567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=267.35 Aligned_cols=245 Identities=24% Similarity=0.403 Sum_probs=196.3
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+|++.+.||+|++|.||+|..+. +++.+++|++..... .....+.+|+.+++.++||+|+++++.+......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC-CCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 58899999999999999998876 578999999987642 34568899999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 122 EYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
||++|++|.+++... +.+++..+..++.|++.||.+||++|++||||+|+||+++.+ +.++|+|||.+........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC-CeEEEeecccccccccccc--
Confidence 999999999999876 689999999999999999999999999999999999999998 9999999999987543321
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
.....++..|+ +||.+. ..|.|++|++ +++++|..||....... .............+. ...++
T Consensus 154 --~~~~~~~~~~~---~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~-~~~~~ 224 (253)
T cd05122 154 --RNTMVGTPYWM---APEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALFKIATNGPPGLRN-PEKWS 224 (253)
T ss_pred --ccceecCCccc---CHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHhcCCCCcCc-ccccC
Confidence 12335666666 777643 4688899965 56999999986420000 000000001111121 12348
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhcCCC
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRRLPM 302 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~HPF 302 (473)
.++.++|.+||+.||++||++.|+++|||
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 89999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=273.21 Aligned_cols=246 Identities=18% Similarity=0.262 Sum_probs=186.7
Q ss_pred eEEEceecccCceEEEEEEEeCC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTN--KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS----- 115 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~--~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----- 115 (473)
|++.+.||+|+||.||+|....+ ++..||+|+++... ........+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 57889999999999999987653 24679999998643 23445678999999999999999999999875544
Q ss_pred -EEEEEecccCcCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecc
Q psy622 116 -CVFLVMEYMIGGDVKSLIAAN------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 116 -~l~lVmEy~~gg~L~~~L~~~------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
..++||||+++|+|..++... ..+++..++.++.||+.||+|||++||+||||||+||+++++ +.+||+|||
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg 158 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-MTVCVADFG 158 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC-CeEEECCcc
Confidence 389999999999999998542 368999999999999999999999999999999999999998 899999999
Q ss_pred hhhhhcCCccccccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh
Q psy622 189 FLAILQQPIVYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ 260 (473)
Q Consensus 189 la~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~ 260 (473)
+++........ .......+++.|+ +||.+ ...|+|++|++ +++++ |..||...... .+. ....
T Consensus 159 ~~~~~~~~~~~-~~~~~~~~~~~~~---~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~-~~~~- 229 (273)
T cd05035 159 LSKKIYSGDYY-RQGRIAKMPVKWI---AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIY-DYLR- 229 (273)
T ss_pred ceeeccccccc-cccccccCCcccc---CHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHH-HHHH-
Confidence 99875432211 1111122334444 67654 24789999965 56777 88888642110 000 0111
Q ss_pred hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 261 LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 261 ~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
....+..+..+++++.+++.+||+.||.+||++.|++++
T Consensus 230 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 230 -HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111122235789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=277.07 Aligned_cols=248 Identities=19% Similarity=0.252 Sum_probs=191.7
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
.+..+|.+.+.||+|+||.||+|+... ..+..+++|.+.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 346789999999999999999997543 134568999987543 2334578899999999999999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANG----------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~----------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~ 177 (473)
....++||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999999999999997642 3889999999999999999999999999999999999999
Q ss_pred CCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhc
Q psy622 178 QAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVA 249 (473)
Q Consensus 178 ~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~ 249 (473)
+ +.++|+|||+++........ .......+++.|+ +||.+. ..|.|++|++ +++++ |..||.......
T Consensus 159 ~-~~~~l~dfg~a~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 159 N-LLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWM---PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred C-CcEEECCCCcccccCCCcee-ecCCCCCcceeec---ChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9 99999999999865332211 1122234555666 788643 4788999965 56887 999985421100
Q ss_pred CCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 250 GSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 250 ~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
...... ...++..+..++..+.+++.+||+.||++||++.++++
T Consensus 234 ----~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 234 ----VIECIT--QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred ----HHHHHh--CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 000011 11122222567889999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=271.92 Aligned_cols=222 Identities=23% Similarity=0.309 Sum_probs=177.7
Q ss_pred cCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCCHHH
Q psy622 52 GAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS 131 (473)
Q Consensus 52 G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~ 131 (473)
|.||+||+|+++. +++.||+|++.+.. ...+|...+....||||+++++++++....|+||||++||+|.+
T Consensus 4 g~~~~v~~~~~~~-~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTR-TQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEcc-CCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 8999999999887 57899999998753 12334555556679999999999999999999999999999999
Q ss_pred HHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCc
Q psy622 132 LIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPN 211 (473)
Q Consensus 132 ~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~ 211 (473)
++.+.+.+++..+..++.||+.||+|||++||+||||||+||+++.+ +.++|+|||++........ ...+++.
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~~~------~~~~~~~ 147 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDSCD------GEAVENM 147 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEecccchhccccccc------cCCcCcc
Confidence 99887789999999999999999999999999999999999999999 9999999998876433211 1233444
Q ss_pred ccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhcc
Q psy622 212 AFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALL 284 (473)
Q Consensus 212 y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL 284 (473)
|+ |||... ..|.|++|++ +++++|..|+...... + ........| ..+++.++++|.+||
T Consensus 148 y~---aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----~----~~~~~~~~~---~~~~~~~~~li~~~l 213 (237)
T cd05576 148 YC---APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----I----NTHTTLNIP---EWVSEEARSLLQQLL 213 (237)
T ss_pred cc---CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----c----ccccccCCc---ccCCHHHHHHHHHHc
Confidence 44 676542 4688999965 5789998887532110 0 001122344 578999999999999
Q ss_pred ccCCCCCCCH-----HHHhcCCCC
Q psy622 285 KSDPTQRPSG-----HQVRRLPMF 303 (473)
Q Consensus 285 ~~dP~kRpsa-----~eil~HPFF 303 (473)
+.||.+|+++ +|+++||||
T Consensus 214 ~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 214 QFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cCCHHHhcCCCccchHHHHcCCCC
Confidence 9999999985 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=272.44 Aligned_cols=244 Identities=18% Similarity=0.209 Sum_probs=188.1
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
+.++|++++.||+|+||+||+|+.+. +..+|+|.+..... ....+.+|+.+++.++||||+++++++.....+|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~--~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG--QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY 75 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC--CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence 45789999999999999999997654 34699999876532 1346889999999999999999999999889999
Q ss_pred EEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 119 LVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.|++||||||+||+++.+ +.+||+|||+++......
T Consensus 76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CCEEECCCccceecCCCc
Confidence 999999999999999874 478999999999999999999999999999999999999998 899999999988653321
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
... ..++.....+.+||... ..+.|++|++ +++++ |..||...... .....+.+. ..+..+
T Consensus 155 ~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~--~~~~~~ 223 (256)
T cd05113 155 YTS-----SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----ETVEKVSQG--LRLYRP 223 (256)
T ss_pred eee-----cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHHhcC--CCCCCC
Confidence 110 11222212233777643 3788999965 56777 88898642110 000111111 111112
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
...+..+++++.+||+.||.+||++.+++++
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 4678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=286.36 Aligned_cols=248 Identities=18% Similarity=0.251 Sum_probs=188.2
Q ss_pred CCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe-C
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQT-S 114 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~-~ 114 (473)
++|++.++||+|+||.||+|+... .+++.||+|+++... .......+.+|+.++..+ +||||+++++++.. .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 579999999999999999997533 235789999987542 233456788999999999 89999999998864 4
Q ss_pred CEEEEEecccCcCCHHHHHHhC----------------------------------------------------------
Q psy622 115 SCVFLVMEYMIGGDVKSLIAAN---------------------------------------------------------- 136 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~---------------------------------------------------------- 136 (473)
..+++||||+++|+|.++|...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 6799999999999999998642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCccc
Q psy622 137 ---GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAF 213 (473)
Q Consensus 137 ---~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~ 213 (473)
..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++..+....... ......+++.|+
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~-~~~~~~~~~~y~ 242 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYV-RKGDARLPLKWM 242 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEEEeccccchhcccCcchh-hccCCCCCcccc
Confidence 257899999999999999999999999999999999999998 899999999998753322111 112233445565
Q ss_pred ccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccc
Q psy622 214 NIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLK 285 (473)
Q Consensus 214 ~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~ 285 (473)
|||++. ..|+|++|++ +++++ |..||..... ........... ..+..+...++++.+++.+||+
T Consensus 243 ---aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~cl~ 314 (337)
T cd05054 243 ---APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---DEEFCRRLKEG--TRMRAPEYATPEIYSIMLDCWH 314 (337)
T ss_pred ---CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc---cHHHHHHHhcc--CCCCCCccCCHHHHHHHHHHcc
Confidence 888653 4689999965 56776 9999964210 00000011110 1111124678999999999999
Q ss_pred cCCCCCCCHHHHhcC
Q psy622 286 SDPTQRPSGHQVRRL 300 (473)
Q Consensus 286 ~dP~kRpsa~eil~H 300 (473)
.+|++||+++|+++|
T Consensus 315 ~~p~~RPs~~ell~~ 329 (337)
T cd05054 315 NNPEDRPTFSELVEI 329 (337)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=274.76 Aligned_cols=244 Identities=21% Similarity=0.302 Sum_probs=187.8
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
...+|++.+.||+|+||.||+|+++. +..+|+|++.+... ....+.+|+++++.++||||+++++++...+..|
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~--~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRG--KIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIF 75 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecC--CccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceE
Confidence 45679999999999999999998763 46799999876532 1336788999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 119 LVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+||||++|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC-CcEEECCcccceeccccc
Confidence 999999999999999764 478999999999999999999999999999999999999998 999999999987643221
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
.. ...++...+.+.+||.+. ..++|++|++ +++++ |..||...... ..............|
T Consensus 155 ~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~~~~~~~--- 223 (256)
T cd05059 155 YT-----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVESVSAGYRLYRP--- 223 (256)
T ss_pred cc-----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHHHcCCcCCCC---
Confidence 11 111222112233777643 4788899964 56777 78888642110 000000001112223
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
...+.++.+++.+||+.+|++||++.|+++.
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 4689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=283.95 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=187.2
Q ss_pred eeccc--CceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 48 AISRG--AFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 48 ~LG~G--~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
+||+| ++|.||+++.+. +++.||+|++++.. ......+.+.+|+++++.++||||++++++|.+....|++|||++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 44443 456667766665 67899999998763 234456789999999999999999999999999999999999999
Q ss_pred cCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc----
Q psy622 126 GGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY---- 199 (473)
Q Consensus 126 gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~---- 199 (473)
+|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||.+..+......
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC-CceEEecCccceeecccccccccc
Confidence 99999999863 468999999999999999999999999999999999999998 99999999998764322111
Q ss_pred cccccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCchhHhh------hcCCCCCh----hhHh-
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFPSALR------VAGSQIPT----STAA- 259 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~~~~~------~~~~~~~~----~~~~- 259 (473)
........++..|+ |||.+. ..+.|++|++ +++++|..||..... ......+. ....
T Consensus 162 ~~~~~~~~~~~~y~---aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 162 HDFPKSSVKNLPWL---SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccc---CHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence 01112223444555 777542 3688899965 579999999964210 00000000 0000
Q ss_pred -----------------hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 260 -----------------QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 260 -----------------~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
...... .....++.++.+||.+||+.||++||+++|+++||||+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDH-PYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hcCCcCcccccccccchhhhhhc-chhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000000 01134567899999999999999999999999999998663
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=284.80 Aligned_cols=260 Identities=20% Similarity=0.220 Sum_probs=193.1
Q ss_pred CCeE-EEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchh-----------HHHHHHHHHHHHHhcCCCCeeeEE
Q psy622 41 SDFE-IVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN-----------MVSQVLRERNALALTHSPFCVQLF 108 (473)
Q Consensus 41 ~~y~-i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~-----------~~~~~~~E~~iL~~l~hp~Iv~l~ 108 (473)
++|. +.+.||.|+||+||+|+++. +++.||+|++++....... ....+.+|+++++.++||||++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTL-TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECC-CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 4565 45779999999999998876 5789999999765332210 012467899999999999999999
Q ss_pred EEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecc
Q psy622 109 YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 109 ~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
+++..+..+|+||||+. |+|.+++.....+++..+..++.||+.||+|||+.||+||||||+||+++.+ +.+||+|||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~-~~~kl~dfg 164 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK-GICKIADFG 164 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC-CCEEECCcc
Confidence 99999999999999995 7999999888889999999999999999999999999999999999999999 999999999
Q ss_pred hhhhhcCCccc-----------cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhh-
Q psy622 189 FLAILQQPIVY-----------LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRV- 248 (473)
Q Consensus 189 la~~~~~~~~~-----------~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~- 248 (473)
++......... ........+++.|+ +||.+. ..|.|++|++ +++++|..||......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYR---APELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCC---CChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99865411100 00011122444555 788653 3577889965 5799999999642110
Q ss_pred --------cCCCCChhhHhh------------hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 249 --------AGSQIPTSTAAQ------------LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 249 --------~~~~~~~~~~~~------------~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.+.......... ....+.......+.++.++|.+||+.+|.+||+++|++.||||+..
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 000000000000 0000001113568899999999999999999999999999999853
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=273.57 Aligned_cols=253 Identities=17% Similarity=0.213 Sum_probs=188.2
Q ss_pred CeEEEceecccCceEEEEEEEe---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKK---TNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS--SC 116 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~---~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~ 116 (473)
-|++++.||+|+||.||+|+.. ..+++.||+|.++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 4789999999999999999743 2356889999987542 233456789999999999999999999998775 67
Q ss_pred EEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.++||||++|++|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+||+++.+ +.++|+|||++..+..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIET 161 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC-CCEEECCCcccccccc
Confidence 999999999999999997653 68999999999999999999999999999999999999998 9999999999987643
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhh----cC---CCCChh-hHhh
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRV----AG---SQIPTS-TAAQ 260 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~----~~---~~~~~~-~~~~ 260 (473)
............++..|+ |||... ..|.|++|++ ++++++..|+...... .+ ...... ....
T Consensus 162 ~~~~~~~~~~~~~~~~y~---apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWY---APECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred CccceeecCCCCCCcccc---CHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 322111122233444455 777643 4789999965 5688766554321110 00 000000 0000
Q ss_pred -hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 261 -LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 261 -~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
........+..++.++.+||.+||+.||.+||++++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0111111225689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=281.76 Aligned_cols=258 Identities=21% Similarity=0.295 Sum_probs=190.1
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT----- 113 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~----- 113 (473)
.+++|++.+.||+|+||.||+|+++. +++.||+|++...... ......+.+|+++++.++||||+++++.+..
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIK-TGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECC-CCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 37899999999999999999999876 5788999998765321 2223456789999999999999999988743
Q ss_pred ---CCEEEEEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecch
Q psy622 114 ---SSCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 114 ---~~~l~lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
...+|+||||+ +++|...+.. ...+++..++.++.||+.||+|||++||+||||||+||+++++ +.+||+|||+
T Consensus 84 ~~~~~~~~lv~~~~-~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~ 161 (311)
T cd07866 84 KRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ-GILKIADFGL 161 (311)
T ss_pred cccCceEEEEEecC-CcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECcCcc
Confidence 33579999999 4578777765 3479999999999999999999999999999999999999999 9999999999
Q ss_pred hhhhcCCccccc--------cccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh------
Q psy622 190 LAILQQPIVYLE--------ISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR------ 247 (473)
Q Consensus 190 a~~~~~~~~~~~--------~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~------ 247 (473)
+........... ......+++.|+ |||.+. ..|+|++|++ +++++|..||.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYR---PPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcC---ChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 987533221111 011123455555 788542 3688999965 579999999864211
Q ss_pred ---hcCCCCChhhHh----------hhccCCCC----ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 248 ---VAGSQIPTSTAA----------QLQLEWPE----DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 248 ---~~~~~~~~~~~~----------~~~~~~P~----~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
......+..... ......+. ....+++.+.++|.+||+.||.+||++.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000000000000 00000010 012456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=279.29 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=195.0
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTS 114 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 114 (473)
.....++|++.+.||+|+||+||+|.++. +++.||||++++... ......+..|+.++... +||||+++++++.+.
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECC-CCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 45567899999999999999999998876 578999999987532 22344667777777666 599999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
..+|+||||+ +++|..++.. .+.+++..+..++.||+.||+|||+ .||+||||+|+||+++++ +.+||+|||++..
T Consensus 87 ~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~-~~~kL~dfg~~~~ 164 (296)
T cd06618 87 SDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-GNVKLCDFGISGR 164 (296)
T ss_pred CeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC-CCEEECccccchh
Confidence 9999999998 5678877766 4579999999999999999999997 599999999999999988 9999999999986
Q ss_pred hcCCccccccccccCCCCcccccCCccccc----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhh
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQL 261 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~ 261 (473)
+...... ....+++.|+ |||.+. ..|.|++|++ +++++|..||....... ..........
T Consensus 165 ~~~~~~~----~~~~~~~~y~---aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~ 235 (296)
T cd06618 165 LVDSKAK----TRSAGCAAYM---APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVLTKILQEE 235 (296)
T ss_pred ccCCCcc----cCCCCCcccc---CHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHHHHHhcCC
Confidence 5322111 1123555665 777543 3588899965 67999999996421100 0000000011
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
...++. ...++.++.+||.+||+.||.+||+++++++||||..
T Consensus 236 ~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 236 PPSLPP-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred CCCCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 112221 1247889999999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=272.34 Aligned_cols=241 Identities=22% Similarity=0.294 Sum_probs=190.4
Q ss_pred ceecccCceEEEEEEEeC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEeccc
Q psy622 47 KAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYM 124 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~ 124 (473)
+.||+|+||.||+|.... .++..||+|+++...... ..+.+.+|++++..++|+||+++++++.+...+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 479999999999998775 126789999998764322 4678899999999999999999999999999999999999
Q ss_pred CcCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 125 IGGDVKSLIAAN---------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 125 ~gg~L~~~L~~~---------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||.+.....
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVYD 157 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC-CcEEEccccccccccc
Confidence 999999999885 689999999999999999999999999999999999999999 9999999999987643
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
.... .......+++.|+ |||... ..|.|++|++ +++++ |..||...... .+............|
T Consensus 158 ~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~~~~~~~- 229 (262)
T cd00192 158 DDYY-RKKTGGKLPIRWM---APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYLRKGYRLPKP- 229 (262)
T ss_pred cccc-ccccCCCcCcccc---CHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCCC-
Confidence 3211 1122234556665 888654 3688999965 56776 68898653110 000001111122223
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..+++++.+++.+||+.||.+||+++|+++|
T Consensus 230 --~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 230 --EYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred --ccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 5789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=283.83 Aligned_cols=259 Identities=19% Similarity=0.258 Sum_probs=207.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEE-eC
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI----NKNMVSQVLRERNALALTHSPFCVQLFYSLQ-TS 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-~~ 114 (473)
-++|-++..||+|+|+.||+|.+.. .+++||+|+-..++-+ +.+..++..+|.+|-+.++||.||++|++|. +.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~-EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLT-EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccc-hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3679999999999999999998876 5789999986544333 2344678999999999999999999999995 66
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCCcceEecCCC--CceeEeecchh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH--GIIHRDLKPDNMLISAQA--PHCPIVNTLFL 190 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~--gIiHRDLKpeNILld~~~--g~ikL~DFGla 190 (473)
+.+|-|+|||+|.||..+|+..+.++|.+|+.++.||+.||.||... .|||-||||.||||-+.+ |.|||+|||++
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 78999999999999999999999999999999999999999999977 499999999999996532 88999999999
Q ss_pred hhhcCCccc----cccccccCCCCcccccCCccc----------cccCCcCCCCcccc-ccCCCCCchhHhhhcCCCCCh
Q psy622 191 AILQQPIVY----LEISDLVNGTPNAFNIRTPGQ----------LLSLKTGTFPTFQD-VQNSQAPFPSALRVAGSQIPT 255 (473)
Q Consensus 191 ~~~~~~~~~----~~~~~~~~gtp~y~~~~ape~----------i~~~~~~s~g~l~~-~~~g~~pf~~~~~~~~~~~~~ 255 (473)
+.++..... ..+++...||.-|+ +||+ ...+++|+.|++.+ ++.|+.||...... ..+..
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYL---PPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILq 695 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYL---PPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQ 695 (775)
T ss_pred hhccCCccCcccceeeecccCceeeec---CcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHh
Confidence 998654332 23444455665555 5554 45689999997654 99999999653211 01111
Q ss_pred --hhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 256 --STAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 256 --~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
..+....+.||.. +-+++++++||++||+..-+.|..+.|+..||||..
T Consensus 696 eNTIlkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 696 ENTILKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhchhcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 1112245667755 579999999999999999999999999999999963
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=271.08 Aligned_cols=250 Identities=16% Similarity=0.209 Sum_probs=191.2
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~--~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
+..++|+..+.||+|+||.||+|+.+.+.+ ..+|+|.++... .....+.+..|+++++.++||||+++++++.+.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 456789999999999999999998875322 379999987653 2334567889999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 116 CVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..|+||||+++|+|..++... +.+++..+..++.|++.||+|||+.||+||||||+||+++.+ +.+||+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~ 158 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-LECKVSDFGLSRVLE 158 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC-CcEEECCCccceecc
Confidence 999999999999999999764 579999999999999999999999999999999999999998 999999999998653
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
..............++.|+ +||.+. ..|+|++|++ +++++ |..||...... .. ...+.. ....|
T Consensus 159 ~~~~~~~~~~~~~~~~~y~---~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~-~~~i~~-~~~~~ 230 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWT---APEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EV-MKAIND-GFRLP 230 (268)
T ss_pred cccccceeccCCCcCceec---CHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH-HHHHhc-CCCCC
Confidence 3221111111111223344 777643 3688999965 56675 99998642110 00 001111 11222
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
. ...++.++.+++.+||+.+|.+||++++|++
T Consensus 231 ~-~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 A-PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred C-CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1 2467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=289.03 Aligned_cols=228 Identities=22% Similarity=0.283 Sum_probs=193.1
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
...-++.||.|+-|.||+|+.+. +.||||+++.- -..+++-|++++||||+.+.+++...-.+||||
T Consensus 125 ~IsELeWlGSGaQGAVF~Grl~n---etVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 125 EISELEWLGSGAQGAVFLGRLHN---ETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred HhhhhhhhccCcccceeeeeccC---ceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 34446789999999999998764 57999987642 124678899999999999999999999999999
Q ss_pred cccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc
Q psy622 122 EYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE 201 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~ 201 (473)
|||..|-|...|+..+.++......|..+|+.|+.|||.+.|||||||.-||||..+ ..|||+|||.++.+......
T Consensus 192 EfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STk-- 268 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTK-- 268 (904)
T ss_pred eccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc-ceEEeccccchHhhhhhhhh--
Confidence 999999999999999999999999999999999999999999999999999999999 89999999999987543221
Q ss_pred cccccCCCCcccccCCccccc------cCCcCCCCc-cccccCCCCCchhHh-----hhcCCCCChhhHhhhccCCCCcc
Q psy622 202 ISDLVNGTPNAFNIRTPGQLL------SLKTGTFPT-FQDVQNSQAPFPSAL-----RVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 202 ~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~-l~~~~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
-.++||..|| |||+|. .+++|+||+ ||+|++|..||.... +..+... ..+..|
T Consensus 269 --MSFaGTVaWM---APEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNs-------L~LpvP--- 333 (904)
T KOG4721|consen 269 --MSFAGTVAWM---APEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNS-------LHLPVP--- 333 (904)
T ss_pred --hhhhhhHhhh---CHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCc-------ccccCc---
Confidence 2358888888 999875 589999995 679999999997531 1111111 244455
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..+++.++=||++||+..|..||++.||+.|
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 6899999999999999999999999999988
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=277.79 Aligned_cols=250 Identities=14% Similarity=0.195 Sum_probs=192.0
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTN----KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
+++.+|++.+.||+|+||+||+|....+ .++.||||+++... .......+.+|..++..++||||+++++++.+
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 4567899999999999999999986542 24689999998653 23334578899999999999999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN----------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~----------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~ 177 (473)
...+++++||+.+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 99999999999999999998632 34888899999999999999999999999999999999998
Q ss_pred CCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhc
Q psy622 178 QAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVA 249 (473)
Q Consensus 178 ~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~ 249 (473)
+ +.+||+|||+++........ .......+++.|+ |||.+. ..|+|++|++ +++++ |..||......
T Consensus 160 ~-~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~- 233 (283)
T cd05091 160 K-LNVKISDLGLFREVYAADYY-KLMGNSLLPIRWM---SPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ- 233 (283)
T ss_pred C-CceEecccccccccccchhe-eeccCccCCcccc---CHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 8 89999999999875332211 1112223455666 888653 4688999965 56776 78888642110
Q ss_pred CCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 250 GSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 250 ~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.+ ...+.. ...+..+..++.++.+|+.+||+.+|.+||++++|+..
T Consensus 234 --~~-~~~i~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 234 --DV-IEMIRN--RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred --HH-HHHHHc--CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 00 011111 11111225789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=292.58 Aligned_cols=249 Identities=15% Similarity=0.191 Sum_probs=194.7
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
.+..+++.+...||+|.||+||+|++..+ ||||+++.... ...+.+.|.+|+.+|++-+|.||+-+.+++..+..
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whGd----VAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHGD----VAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccCHHHhhccceeccccccceeecccccc----eEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 34456788899999999999999998863 99999998764 44578899999999999999999999999988777
Q ss_pred EEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.||+.+|+|-+|+.+|+-.+ .|.....+.|+.||++|+.|||.++|||||||..||+|.++ +.|||+|||++..-..
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATVKTR 540 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceeeeee
Confidence 99999999999999998643 79999999999999999999999999999999999999999 9999999999876221
Q ss_pred CccccccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hccC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQLE 264 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~ 264 (473)
-... .-....-.+++|.|||++. ..|+|+||+. |++++|..||....+ .+|....-.. ....
T Consensus 541 w~g~----~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---dqIifmVGrG~l~pd 613 (678)
T KOG0193|consen 541 WSGE----QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---DQIIFMVGRGYLMPD 613 (678)
T ss_pred eccc----cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---hheEEEecccccCcc
Confidence 1110 1111222345666999874 4688899965 579999999973211 1111100000 0111
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.......+++++++|+..||+.++++||.+.+|+.
T Consensus 614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 11112567789999999999999999999998884
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=273.22 Aligned_cols=248 Identities=18% Similarity=0.221 Sum_probs=188.4
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQ---LYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~---~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
.+.++|+++++||+|+||+||+|+++.++.. .||+|+++... .......+.+|+.+++.++||||+++++.+...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 4568899999999999999999987653322 48999987643 233456788999999999999999999998754
Q ss_pred CEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..++++||+++|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~-~~~kL~dfG~~~~~ 159 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP-NHVKITDFGLARLL 159 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC-CcEEECCCCceeec
Confidence 578999999999999999874 579999999999999999999999999999999999999988 89999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
........ .....+++.|+ +||... ..|+|++|++ +++++ |..||....... + ...+.. ...
T Consensus 160 ~~~~~~~~-~~~~~~~~~y~---~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~-~~~~~~--~~~ 229 (279)
T cd05109 160 DIDETEYH-ADGGKVPIKWM---ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---I-PDLLEK--GER 229 (279)
T ss_pred ccccceee-cCCCccchhhC---CHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H-HHHHHC--CCc
Confidence 43221111 11112334455 788653 3588999965 56676 888885421100 0 011111 111
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
+..+..++.++.++|.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1122568899999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=280.41 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=196.6
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
-..|+..+.||+|+||.||+|+.+. +++.+|+|.+............++.+|+++++.++|+|++++++++......|+
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcC-CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 3458889999999999999999876 578999999976433344455678899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||||+. |+|..++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.+ +.++|+|||++......
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC-CcEEECCcccceeecCc--
Confidence 999995 688877754 4568999999999999999999999999999999999999998 99999999998764321
Q ss_pred ccccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
....+++.|+ |||.+. ..++|++|++ +++++|..||...... ..............+
T Consensus 169 -----~~~~~~~~y~---aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-- 235 (308)
T cd06634 169 -----NXFVGTPYWM---APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPALQ-- 235 (308)
T ss_pred -----ccccCCcccc---CHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---HHHHHHhhcCCCCcC--
Confidence 1234666666 787642 3689999965 5799999998542110 000000011111111
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
...++..+.+||.+||+.+|.+||+++++++|||+...
T Consensus 236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 14688899999999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=275.60 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=192.2
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEEEEE
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS--SCVFLV 120 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~l~lV 120 (473)
|++.+.||.|+||.||+|+.+. +++.||+|++.+.. ........+.+|+++++.++||||+++++++.+. +.+|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK-TGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC-CCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 6889999999999999998876 57899999999764 2333455788999999999999999999999988 899999
Q ss_pred ecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|||++ ++|..++.+. ..+++..++.++.||+.||+|||+.|++|+||||+||+++++ +.+||+|||++.........
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 79 FEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-CCEEEccccceeeccCCCcc
Confidence 99995 5999998765 579999999999999999999999999999999999999999 99999999999875433211
Q ss_pred cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChhh-----
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTST----- 257 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~~----- 257 (473)
......+++.|+ +||.+. ..+.|++|++ +++++|..||..... ..........
T Consensus 157 --~~~~~~~~~~y~---~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 157 --DYTNRVITLWYR---PPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred --cccccccccccC---CceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 111123444455 788543 3578899965 579999999864210 0000000000
Q ss_pred ---Hhhh--ccCCC----Ccccc-CChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 258 ---AAQL--QLEWP----EDEEA-LNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 258 ---~~~~--~~~~P----~~~~~-ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.... ....+ ..... +++++.++|++||+.||.+||+++++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0000 00000 00012 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=275.28 Aligned_cols=250 Identities=19% Similarity=0.262 Sum_probs=190.5
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTN----KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
..++|++.+.||+|+||.||+|..+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 346799999999999999999987641 35789999887542 233345788999999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--CceeEe
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANG-------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA--PHCPIV 185 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~-------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~--g~ikL~ 185 (473)
...|+||||++||+|.+++.+.+ .+++..+..++.||+.||+|||++|++||||||+||+++.++ ..+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999998753 489999999999999999999999999999999999998751 369999
Q ss_pred ecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhh
Q psy622 186 NTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTST 257 (473)
Q Consensus 186 DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~ 257 (473)
|||+++.+........ ......++.|+ +||++. ..|.|++|++ +++++ |..||....... +....
T Consensus 162 dfg~~~~~~~~~~~~~-~~~~~~~~~y~---aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRK-GGRAMLPIKWM---PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEFV 234 (277)
T ss_pred cCccccccCCccceec-CCCCCccHhhC---CHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence 9999987532211110 11112233444 788653 4688999965 56775 999986421100 00000
Q ss_pred HhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 258 AAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 258 ~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.......+| ..++..+.+++.+||+.||++||++.++++|
T Consensus 235 ~~~~~~~~~---~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 235 TGGGRLDPP---KGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011122233 5788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=277.15 Aligned_cols=257 Identities=19% Similarity=0.278 Sum_probs=191.3
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS-- 115 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~-- 115 (473)
...++|++.+.||+|+||.||+|.++. +++.||+|+++.... .......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKD-TGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECC-CCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 346889999999999999999999876 578999999986532 2223346778999999999999999999987654
Q ss_pred --------EEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEee
Q psy622 116 --------CVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVN 186 (473)
Q Consensus 116 --------~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~D 186 (473)
.+|+|+||+++ +|...+.+. ..+++..++.++.||+.||+|||+.||+||||||+||+++++ +.+||+|
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~kl~d 159 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLAD 159 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CcEEeCc
Confidence 89999999965 777777654 479999999999999999999999999999999999999999 9999999
Q ss_pred cchhhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hc
Q psy622 187 TLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VA 249 (473)
Q Consensus 187 FGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~ 249 (473)
||++..+...... ......+++.|+ +||.+. ..+.|++|++ +++++|.+||..... ..
T Consensus 160 fg~~~~~~~~~~~--~~~~~~~~~~y~---~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 160 FGLARLYNSEESR--PYTNKVITLWYR---PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred ccccccccCCccc--ccccceeccCcc---ChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999875332211 001112344444 666432 3688899966 568899999964210 00
Q ss_pred CCCCChhh--Hhhhc------------cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 250 GSQIPTST--AAQLQ------------LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 250 ~~~~~~~~--~~~~~------------~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
+...+... ..... ..+......++..+.++|.+||+.||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 11100000 00000 00000113578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=277.00 Aligned_cols=250 Identities=16% Similarity=0.219 Sum_probs=191.4
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSL 111 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 111 (473)
....++|++.+.||+|+||.||+|.... .++..||+|++++.. .....+.+.+|+.+++.+ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 4445689999999999999999997532 234679999988653 233456789999999999 899999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecch
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
+..+.+|+||||+++|+|.++++... .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|||+
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~dfg~ 187 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDFGL 187 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC-CeEEECCCcc
Confidence 99999999999999999999998643 38999999999999999999999999999999999999988 8999999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhh
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQL 261 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~ 261 (473)
++.+...... .......+++.|+ |||.+. ..|.|++|++ +++++ |..||..... ........
T Consensus 188 ~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~------~~~~~~~~ 257 (302)
T cd05055 188 ARDIMNDSNY-VVKGNARLPVKWM---APESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV------DSKFYKLI 257 (302)
T ss_pred cccccCCCce-eecCCCCcccccC---CHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc------hHHHHHHH
Confidence 9865332211 1111223445555 888653 3588999966 46776 8999864210 00000000
Q ss_pred ccCC-CCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 262 QLEW-PEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 262 ~~~~-P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
...+ +..+...++++.+++.+||+.+|++||++.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 258 KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0011 1112467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=270.95 Aligned_cols=249 Identities=18% Similarity=0.262 Sum_probs=191.0
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNK--DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~--~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
.+++|++.+.||+|+||.||+|+.+.+. +..||||++++.. .......+..|+.+++.++||||+++++++.++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 4678999999999999999999877632 2369999987642 34446689999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
+++||||+++|+|.+++... +.+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLED 158 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC-CcEEECCCcccccccc
Confidence 99999999999999999864 578999999999999999999999999999999999999988 8999999999876533
Q ss_pred CccccccccccCC--CCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 196 PIVYLEISDLVNG--TPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 196 ~~~~~~~~~~~~g--tp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
............+ +..|+ +||... ..++|++|++ +++++ |..||...... .+. ..+. ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~---~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~-~~i~-~~~~~ 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWT---APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVI-NAIE-QDYRL 230 (269)
T ss_pred CccccccccccCCCcceeec---CHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHH-HHHH-cCCcC
Confidence 2221111111111 12333 777653 3688999965 56664 99998642110 000 0111 11122
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
|. +..++..+.+++.+||+.+|.+||++++|+.
T Consensus 231 ~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 231 PP-PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CC-cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22 1467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=273.36 Aligned_cols=246 Identities=20% Similarity=0.280 Sum_probs=190.7
Q ss_pred CCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
+-.+|++.++||+|+||.||+|.... .++..+|+|.+.+.. ......+.+|+++++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 45679999999999999999997532 235679999987643 34456889999999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANG---------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA 179 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~---------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~ 179 (473)
...|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~- 158 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG- 158 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC-
Confidence 99999999999999999998643 48899999999999999999999999999999999999998
Q ss_pred CceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCC
Q psy622 180 PHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGS 251 (473)
Q Consensus 180 g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~ 251 (473)
+.+||+|||++......... .......+++.|+ +||... ..|+|++|++ +++++ |..||.......
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 232 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWM---PPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-- 232 (280)
T ss_pred CCEEECCCCceeEcCCCcee-ecCCCcccccccc---CHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--
Confidence 99999999999764322111 1112223455566 788543 3688999966 56776 899985421100
Q ss_pred CCChhhHhh-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 252 QIPTSTAAQ-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 252 ~~~~~~~~~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
. ...... .....| ..+++.+.+||.+||+.||.+||++++|++
T Consensus 233 -~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 233 -A-IECITQGRELERP---RTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred -H-HHHHHcCccCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 001111 111222 578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=276.85 Aligned_cols=250 Identities=17% Similarity=0.219 Sum_probs=189.5
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCC------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTN------KDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFY 109 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 109 (473)
.+..++|.+.+.||+|+||.||+|++... ..+.+|+|.+++.. .......+.+|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 33457899999999999999999976431 23469999998652 233456788899999999 7999999999
Q ss_pred EEEeCCEEEEEecccCcCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcce
Q psy622 110 SLQTSSCVFLVMEYMIGGDVKSLIAANG----------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNM 173 (473)
Q Consensus 110 ~f~~~~~l~lVmEy~~gg~L~~~L~~~~----------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNI 173 (473)
++...+.+|+||||+++|+|.+++...+ .++...+..++.||+.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999998642 478899999999999999999999999999999999
Q ss_pred EecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhH
Q psy622 174 LISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSA 245 (473)
Q Consensus 174 Lld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~ 245 (473)
+++.+ +.+||+|||+++......... ......+++.|+ |||.+. ..|+|++|++ ++|++ |..||...
T Consensus 172 ll~~~-~~~kL~dfg~a~~~~~~~~~~-~~~~~~~~~~y~---aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 172 LVTED-NVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWM---APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred EEcCC-CcEEECCCcccccccccchhh-ccccCCCcccee---ChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 99998 999999999987653221111 011112334455 788653 3688899965 56776 78888532
Q ss_pred hhhcCCCCChhhHhhhccC-CCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 246 LRVAGSQIPTSTAAQLQLE-WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~-~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.. .......... .+..+..++.++++||.+||..+|.+||++.+++++
T Consensus 247 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 247 PV-------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CH-------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 10 0111110011 112225688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=271.68 Aligned_cols=252 Identities=18% Similarity=0.236 Sum_probs=185.8
Q ss_pred CCCeEEEceecccCceEEEEEEEe---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKK---TNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT--S 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~---~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~ 114 (473)
-.+|++++.||+|+||.||+|+.+ ..+++.||+|+++... ....+.+.+|+++++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 357999999999999999999743 2356789999987643 4446678999999999999999999998643 4
Q ss_pred CEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..+|+||||+++|+|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++..+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~ 158 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE-NRVKIGDFGLTKVL 158 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC-CeEEECCCcccccc
Confidence 5799999999999999999764 468999999999999999999999999999999999999998 89999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhh----cCCCCC----hhh-
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRV----AGSQIP----TST- 257 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~----~~~~~~----~~~- 257 (473)
..............++..|+ +||... ..|+|++|++ ++++++..++...... ...... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWY---APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cCCCcceeecCCCCCceEee---CHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 43221111111111222233 777643 3688999965 5687776554321100 001000 000
Q ss_pred --HhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 258 --AAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 258 --~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.......+| .+..++.++.+||.+||..+|++|||++||++
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 236 IELLKNNGRLP-APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHhcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 011111222 22568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=271.66 Aligned_cols=243 Identities=19% Similarity=0.298 Sum_probs=188.1
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
..++|++.+.||+|+||.||+|.... ++.||+|.++.... ..+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN--TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC--CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 45679999999999999999998654 46799999886532 2346888999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 119 LVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-NICKVADFGLARVIKED 156 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC-CCEEECCcceEEEccCC
Confidence 9999999999999998754 68999999999999999999999999999999999999999 99999999999875422
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
..... ....++..|+ +||... ..|.|++|++ +++++ |..||....... ....+. .....+ .
T Consensus 157 ~~~~~--~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~~-~~~~~~-~ 225 (261)
T cd05068 157 IYEAR--EGAKFPIKWT---APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----VLQQVD-QGYRMP-C 225 (261)
T ss_pred ccccc--CCCcCceecc---CccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHH-cCCCCC-C
Confidence 11100 0001122344 777643 4688899965 56777 899986421100 000111 111111 1
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
+...+..+.+++.+||+.+|.+||++.++.+
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=274.49 Aligned_cols=245 Identities=18% Similarity=0.256 Sum_probs=184.4
Q ss_pred eEEEceecccCceEEEEEEEeCCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe------CC
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKD-QLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT------SS 115 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~-~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------~~ 115 (473)
|.+.++||+|+||.||+|+...+.. ..+|+|.++... ......+.+.+|.++++.++||||+++++.+.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999998765322 258999987653 234556788999999999999999999987632 23
Q ss_pred EEEEEecccCcCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecch
Q psy622 116 CVFLVMEYMIGGDVKSLIAAN------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
..++||||+++|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~ 158 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADFGL 158 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC-CCEEECCCCc
Confidence 579999999999999887431 348999999999999999999999999999999999999998 9999999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ- 260 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~- 260 (473)
++........ .......+++.|+ +||... ..|+|++|++ +++++ |..||...... .+. ..+..
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~~~~---~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~-~~~~~~ 230 (272)
T cd05075 159 SKKIYNGDYY-RQGRIAKMPVKWI---AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIY-DYLRQG 230 (272)
T ss_pred ccccCcccce-ecCCcccCCcccC---CHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH-HHHHcC
Confidence 9875432211 1122334556666 677643 4688899965 56777 78888642110 000 11111
Q ss_pred hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 261 LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 261 ~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.....+ ..++..+.++|.+||+.||.+||++.+++++
T Consensus 231 ~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 231 NRLKQP---PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 111222 5688899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=270.21 Aligned_cols=239 Identities=19% Similarity=0.252 Sum_probs=183.0
Q ss_pred ceecccCceEEEEEEEeCCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEeccc
Q psy622 47 KAISRGAFGKVFLGYKKTNK--DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYM 124 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~--~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~ 124 (473)
++||+|+||.||+|+..... +..||+|.+...... ...+.+.+|+++++.++||||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999765532 368999999876532 34567899999999999999999999876 45689999999
Q ss_pred CcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccccc
Q psy622 125 IGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISD 204 (473)
Q Consensus 125 ~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~ 204 (473)
++|+|.+++.+.+.+++..+..++.||+.||+|||++|++||||||+|||++.+ +.+||+|||+++.+...........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC-CcEEeccccccceeecCCccccccc
Confidence 999999999988889999999999999999999999999999999999999999 9999999999987543222111111
Q ss_pred ccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCCccccCChh
Q psy622 205 LVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDEEALNPS 275 (473)
Q Consensus 205 ~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~~~ls~~ 275 (473)
...++..| .+||... ..|.|++|++ +++++ |..||...... .+ ...+.+ .....| ..++..
T Consensus 157 ~~~~~~~y---~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~-~~~~~~~~~~~~~---~~~~~~ 226 (257)
T cd05060 157 AGRWPLKW---YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EV-IAMLESGERLPRP---EECPQE 226 (257)
T ss_pred Cccccccc---cCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HH-HHHHHcCCcCCCC---CCCCHH
Confidence 11112233 3787643 4788999965 56776 89998642110 00 011111 111222 578899
Q ss_pred HHHHHHhccccCCCCCCCHHHHhc
Q psy622 276 TEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 276 a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
++++|.+||+.||++||++.++++
T Consensus 227 l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 227 IYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=277.43 Aligned_cols=247 Identities=20% Similarity=0.325 Sum_probs=193.1
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEec
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
|+...+||+|+||.||+|..+. +++.||||++.... ......+.+|+.+++.++||||+++++.+...+..|+|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKS-SGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcC-CCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence 3445789999999999998876 57899999986432 2345678899999999999999999999999999999999
Q ss_pred ccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccc
Q psy622 123 YMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEI 202 (473)
Q Consensus 123 y~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~ 202 (473)
|+++++|.+++.. +.+++..++.++.||+.||+|||+.|++||||||+||+++.+ +.++|+|||++........ .
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~---~ 172 (292)
T cd06657 98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVP---R 172 (292)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEcccccceecccccc---c
Confidence 9999999998754 578999999999999999999999999999999999999998 8999999999876432211 1
Q ss_pred ccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh-hhccCCCCccccCCh
Q psy622 203 SDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA-QLQLEWPEDEEALNP 274 (473)
Q Consensus 203 ~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~P~~~~~ls~ 274 (473)
.....|++.|+ +||... ..|.|++|++ +++++|..||....... . ..... .....++. ...+++
T Consensus 173 ~~~~~~~~~y~---~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~-~~~~~~~~~~~~~~-~~~~~~ 244 (292)
T cd06657 173 RKSLVGTPYWM---APELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---A-MKMIRDNLPPKLKN-LHKVSP 244 (292)
T ss_pred ccccccCcccc---CHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H-HHHHHhhCCcccCC-cccCCH
Confidence 12235666666 777543 3688899965 57999999986421100 0 00000 01111111 145789
Q ss_pred hHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 275 STEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 275 ~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.+.++|.+||+.||.+||++.++++||||...
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 99999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.00 Aligned_cols=249 Identities=18% Similarity=0.266 Sum_probs=186.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe-
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQT- 113 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~- 113 (473)
.++|++.+.||+|+||+||+|++.. .+++.||||+++... .......+.+|+.+|..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4689999999999999999997532 246789999997653 233456788999999999 78999999998765
Q ss_pred CCEEEEEecccCcCCHHHHHHhC---------------------------------------------------------
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN--------------------------------------------------------- 136 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~--------------------------------------------------------- 136 (473)
...+|+||||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45689999999999999998753
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccccccc
Q psy622 137 ----------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLV 206 (473)
Q Consensus 137 ----------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 206 (473)
..++...+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++........... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~-~~~~ 241 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVR-KGDA 241 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-CcEEEEecccccccccCcchhh-cCCC
Confidence 136778889999999999999999999999999999999998 9999999999987532211111 1112
Q ss_pred CCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHH
Q psy622 207 NGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEE 278 (473)
Q Consensus 207 ~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~d 278 (473)
.+++.|+ +||.+. ..+.|++|++ +++++ |..||...... ..+............| ...++++.+
T Consensus 242 ~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~ 313 (343)
T cd05103 242 RLPLKWM---APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTRMRAP---DYTTPEMYQ 313 (343)
T ss_pred CCCcceE---CcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHHHhccCCCCCC---CCCCHHHHH
Confidence 3344555 788653 3588899965 56664 88898642100 0000000011122223 467889999
Q ss_pred HHHhccccCCCCCCCHHHHhcC
Q psy622 279 TILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 279 LI~~LL~~dP~kRpsa~eil~H 300 (473)
++.+||+.||.+||++.||++|
T Consensus 314 ~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 314 TMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=272.17 Aligned_cols=249 Identities=20% Similarity=0.261 Sum_probs=190.9
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTN----KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
..++|++++.||+|+||.||+|+.+.+ ..+.||+|.+.... .....+.+.+|+++++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 347899999999999999999987642 24679999987643 223456789999999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEe
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANG---------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~---------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~ 185 (473)
...|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.+ +.++|+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~ 159 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ-REVKVS 159 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC-CcEEEc
Confidence 99999999999999999998765 69999999999999999999999999999999999999998 999999
Q ss_pred ecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhh
Q psy622 186 NTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTST 257 (473)
Q Consensus 186 DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~ 257 (473)
|||+++........ . .....+++.|+ +||.+. ..|+|++|++ +++++ |..||..... ......
T Consensus 160 ~~~~~~~~~~~~~~-~-~~~~~~~~~y~---~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----~~~~~~ 230 (275)
T cd05046 160 LLSLSKDVYNSEYY-K-LRNALIPLRWL---APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----EEVLNR 230 (275)
T ss_pred ccccccccCccccc-c-cCCceeEEeec---ChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch----HHHHHH
Confidence 99998754221111 1 11112333344 666543 3688999966 45666 7888854211 000111
Q ss_pred HhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 258 AAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 258 ~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.......++. +..++..+.+++.+||+.||.+||++.|++.+
T Consensus 231 ~~~~~~~~~~-~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 231 LQAGKLELPV-PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHcCCcCCCC-CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 1112223332 14688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=274.81 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=192.0
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEec
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
|++.+.||+|+||.||+|+... +++.||+|++++.. ........+..|+.+++.++||+|+++++++.+...+|+|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK-TGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecC-CCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 6788999999999999998876 57899999998764 223334577889999999999999999999999999999999
Q ss_pred ccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc
Q psy622 123 YMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE 201 (473)
Q Consensus 123 y~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~ 201 (473)
|++ ++|.+++.+. ..+++..++.++.||+.||+|||++||+||||+|+||+++.+ +.++|+|||+++........
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~-- 154 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRT-- 154 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-CCEEEecCCcccccCCCccc--
Confidence 996 6999999886 589999999999999999999999999999999999999998 99999999999875332111
Q ss_pred cccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhh---------cCCCCChhhHh--h--
Q psy622 202 ISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRV---------AGSQIPTSTAA--Q-- 260 (473)
Q Consensus 202 ~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~---------~~~~~~~~~~~--~-- 260 (473)
.....+++.|+ |||.+. ..|.|++|++ +++++|..||...... ........... .
T Consensus 155 -~~~~~~~~~~~---aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 155 -YTHEVVTLWYR---APEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred -cCccccCcCcC---ChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 11122334444 777543 3588899965 5789999998642110 00000000000 0
Q ss_pred -hccCCC--------CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 261 -LQLEWP--------EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 261 -~~~~~P--------~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
....++ .....++.++.++|.+||..||++||++++++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 000001 0012458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=270.84 Aligned_cols=250 Identities=20% Similarity=0.280 Sum_probs=187.8
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCCeeeEEEEEEeCCE---
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT---HSPFCVQLFYSLQTSSC--- 116 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~~~~~--- 116 (473)
|++.+.||+|+||.||+|+++. +++.||+|+++.... .......+.+|+.+++.+ +||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN-TGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECC-CCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 7889999999999999999876 578999999986532 222334566788877665 69999999999988776
Q ss_pred --EEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 117 --VFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 117 --l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
+|++|||+. ++|.+++.+.. .+++..++.++.||+.||.|||+.|++|+||||+||+++.+ +.+||+|||++..
T Consensus 79 ~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~~ 156 (287)
T cd07838 79 LKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLARI 156 (287)
T ss_pred ceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCccee
Confidence 999999995 58999887743 59999999999999999999999999999999999999999 9999999999987
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhc---------CCC----
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVA---------GSQ---- 252 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~---------~~~---- 252 (473)
....... ....+++.|+ +||... ..|+|++|++ +++++|.+||....... ...
T Consensus 157 ~~~~~~~----~~~~~~~~~~---~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 157 YSFEMAL----TSVVVTLWYR---APEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred ccCCccc----cccccccccc---ChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 5332111 1123455555 777643 4689999966 56889998886421100 000
Q ss_pred CChhh------Hh-hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 253 IPTST------AA-QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 253 ~~~~~------~~-~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.+... .. .....+......+++.+.++|.+||+.||.+||+++|++.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00000 00 00000011112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=289.18 Aligned_cols=251 Identities=16% Similarity=0.188 Sum_probs=190.2
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSL 111 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f 111 (473)
.+..++|.+.+.||+|+||.||+|+++. ..++.||+|+++... .....+.+.+|+.+|..+. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 3344678899999999999999998643 234689999998653 2333457889999999997 99999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhCC------------------------------------------------------
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAANG------------------------------------------------------ 137 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~~------------------------------------------------------ 137 (473)
+..+.+|+||||+++|+|.++|++.+
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999999999997532
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcce
Q psy622 138 --------------------------------------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNM 173 (473)
Q Consensus 138 --------------------------------------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNI 173 (473)
.+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 356777888999999999999999999999999999
Q ss_pred EecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhH
Q psy622 174 LISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSA 245 (473)
Q Consensus 174 Lld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~ 245 (473)
|++.+ +.+||+|||+++.+...... .......+++.|+ +||.+. ..|+|++|++ +++++ |..||...
T Consensus 271 Ll~~~-~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 271 LICEG-KLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWM---APESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred EEeCC-CEEEEEecCcceeccccccc-ccCCCcCCCCcee---ChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99998 89999999999864322111 1111234566666 788654 3588899965 56776 88888642
Q ss_pred hhhcCCCCChhhHhh-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 246 LRVAGSQIPTSTAAQ-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 246 ~~~~~~~~~~~~~~~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.... ........ .....| ..++.++.+||.+||+.+|.+||++.+|++.
T Consensus 346 ~~~~---~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 346 PMNE---QFYNAIKRGYRMAKP---AHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CchH---HHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1000 00000000 111223 5688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=274.73 Aligned_cols=250 Identities=16% Similarity=0.234 Sum_probs=190.9
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeC------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKT------NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFY 109 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 109 (473)
.+..++|++.+.||+|+||.||+|+... ..+..||+|.++... .......+.+|+.+++.+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 4667889999999999999999997532 123579999987642 234456789999999999 8999999999
Q ss_pred EEEeCCEEEEEecccCcCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcce
Q psy622 110 SLQTSSCVFLVMEYMIGGDVKSLIAAN----------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNM 173 (473)
Q Consensus 110 ~f~~~~~l~lVmEy~~gg~L~~~L~~~----------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNI 173 (473)
++.....+|+||||+++|+|.+++.+. ..++...+..++.||+.||+|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999999864 2467888999999999999999999999999999999
Q ss_pred EecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhH
Q psy622 174 LISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSA 245 (473)
Q Consensus 174 Lld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~ 245 (473)
+++.+ +.+||+|||+++.+...... .......+++.|+ |||++. ..|+|++|++ +++++ |..||...
T Consensus 169 li~~~-~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 169 LVTEN-NVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWM---APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred EEcCC-CcEEECCCccceeccccccc-ccccCCCCCceee---CchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 99988 99999999999875432211 1112223445565 888653 4688899965 56665 77887532
Q ss_pred hhhcCCCCChhhHhh-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 246 LRVAGSQIPTSTAAQ-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 246 ~~~~~~~~~~~~~~~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.... + ...... .....| ..++.++++||.+||..+|.+||++.|+++.
T Consensus 244 ~~~~---~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEE---L-FKLLKEGHRMDKP---ANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHH---H-HHHHHcCCcCCCC---CCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 1000 0 000100 111122 5688999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=271.96 Aligned_cols=247 Identities=21% Similarity=0.312 Sum_probs=191.3
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI--NKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+|.+.+.||+|+||.||+|++.. ++..+++|+++..... ......++..|+.+++.++||||+++++++.+....|+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK-AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC-CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 58899999999999999998776 3556777776653221 22234467789999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 120 VMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
||||+++++|..++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++. +.++|+|||+++....
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~--~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN--NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec--CCEeecccCceeecCC
Confidence 9999999999998864 346999999999999999999999999999999999999975 5799999999877532
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
.. .......|++.|+ +||... ..++|++|++ +++++|..||..... ............|..
T Consensus 158 ~~---~~~~~~~~~~~~~---~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 225 (260)
T cd08222 158 SC---DLATTFTGTPYYM---SPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIVEGPTPSL 225 (260)
T ss_pred Cc---ccccCCCCCcCcc---CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHcCCCCCC
Confidence 21 1122345666666 777542 3688899965 568899999863210 000001111122222
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
+..++.++.++|.+||+.||.+||++.|+++||||
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred cchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 35788999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=268.76 Aligned_cols=238 Identities=20% Similarity=0.277 Sum_probs=180.8
Q ss_pred eecccCceEEEEEEEeC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCc
Q psy622 48 AISRGAFGKVFLGYKKT-NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIG 126 (473)
Q Consensus 48 ~LG~G~fG~V~~a~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 126 (473)
.||+|+||.||+|..+. ..+..||+|++.... .....+.+.+|+.+++.++||||++++++++. ...|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 48999999999997653 234579999987652 23445678999999999999999999998864 578999999999
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 127 GDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 127 g~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
|+|.+++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.+ +.+||+|||++...............
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC-CcEEeccCCccccccCCccceeccCC
Confidence 999999975 4579999999999999999999999999999999999999998 89999999999865332221111111
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCCccccCChhH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDEEALNPST 276 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~~~ls~~a 276 (473)
..+++.|+ |||.+. ..|.|++|++ +++++ |..||....... +. ..+.+ .....| ...++++
T Consensus 158 ~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~-~~~~~~~~~~~~---~~~~~~l 227 (257)
T cd05115 158 GKWPLKWY---APECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VM-SFIEQGKRLDCP---AECPPEM 227 (257)
T ss_pred CCCCcccC---CHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HH-HHHHCCCCCCCC---CCCCHHH
Confidence 12234555 787643 4688999965 56664 999996421100 00 01111 122233 5788999
Q ss_pred HHHHHhccccCCCCCCCHHHHhc
Q psy622 277 EETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 277 ~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.++|.+||..||++||++.+|++
T Consensus 228 ~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 228 YALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=274.87 Aligned_cols=248 Identities=17% Similarity=0.242 Sum_probs=188.7
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeC------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKT------NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYS 110 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 110 (473)
+..++|.+.+.||+|+||.||+|+... .....+|+|.+++.. .......+..|+++++.+ +||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 445789999999999999999997532 123579999988642 234466788999999999 69999999999
Q ss_pred EEeCCEEEEEecccCcCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceE
Q psy622 111 LQTSSCVFLVMEYMIGGDVKSLIAAN----------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNML 174 (473)
Q Consensus 111 f~~~~~l~lVmEy~~gg~L~~~L~~~----------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNIL 174 (473)
+.+.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 99999999999999999999999763 24888999999999999999999999999999999999
Q ss_pred ecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHh
Q psy622 175 ISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSAL 246 (473)
Q Consensus 175 ld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~ 246 (473)
++.+ +.+||+|||+++........ .......+++.|+ +||.+. ..|+|++|++ +++++ |..||....
T Consensus 167 l~~~-~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 167 VTED-NVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWM---APEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EcCC-CcEEEccccccccccccccc-cccccCCCCcccc---CHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 9998 89999999999875322111 1111112334455 888643 4688999965 46776 788886421
Q ss_pred hhcCCCCChhhHhh-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 247 RVAGSQIPTSTAAQ-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 247 ~~~~~~~~~~~~~~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.. .. ...... .....| ..++.++++||.+||+.||++||++.|+++
T Consensus 242 ~~---~~-~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VE---EL-FKLLREGHRMDKP---SNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HH---HH-HHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00 00 000111 111222 567889999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=272.05 Aligned_cols=242 Identities=20% Similarity=0.298 Sum_probs=189.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
..+|++.++||+|+||.||+|+.+. ++.+|+|++.+.. ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~--~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN--RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC--CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 4579999999999999999998876 5789999998764 2234568889999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 120 VMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED-LVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC-ceEEEccccchhhcCCcc
Confidence 99999999999999863 368999999999999999999999999999999999999998 999999999998753221
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
.. .....+++.|+ +||... ..++|++|++ +++++ |..||...... ... .... .....+ .+
T Consensus 159 ~~---~~~~~~~~~~~---~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~-~~~~-~~~~~~-~~ 226 (261)
T cd05148 159 YL---SSDKKIPYKWT---APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVY-DQIT-AGYRMP-CP 226 (261)
T ss_pred cc---ccCCCCceEec---CHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHH-HHHH-hCCcCC-CC
Confidence 11 11122344444 777643 3688999965 46776 88999642110 000 0111 111111 12
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+++++.++|.+||+.||.+||++.++++
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=267.52 Aligned_cols=241 Identities=19% Similarity=0.242 Sum_probs=186.6
Q ss_pred ceecccCceEEEEEEEeCCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEeccc
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQ--LYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYM 124 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~--~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~ 124 (473)
++||+|+||.||+|.+....++ .||||.+.+.... ...+.+.+|+++++.++||||+++++.+.+ ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 4789999999999987653333 6999999887543 556789999999999999999999999988 8999999999
Q ss_pred CcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccc
Q psy622 125 IGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEI 202 (473)
Q Consensus 125 ~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~ 202 (473)
++|+|.+++.+.. .+++..++.++.||+.||+|||++|++||||||+||+++.+ +.+||+|||+++.+.........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC-CEEEeccccccccccccccceec
Confidence 9999999998754 68999999999999999999999999999999999999999 99999999999876432221111
Q ss_pred ccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCccccCCh
Q psy622 203 SDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNP 274 (473)
Q Consensus 203 ~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~ 274 (473)
.....++..|+ +||.+. ..|.|++|++ ++|++ |..||...... ... ..+......++ .+..++.
T Consensus 157 ~~~~~~~~~y~---~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~-~~~~~~~~~~~-~~~~~~~ 228 (257)
T cd05040 157 EEHLKVPFAWC---APESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QIL-KKIDKEGERLE-RPEACPQ 228 (257)
T ss_pred ccCCCCCceec---CHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHH-HHHHhcCCcCC-CCccCCH
Confidence 22233445555 788653 3788999965 56877 99998532110 000 01110111111 1246789
Q ss_pred hHHHHHHhccccCCCCCCCHHHHhc
Q psy622 275 STEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 275 ~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
++.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 229 DIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=272.95 Aligned_cols=251 Identities=20% Similarity=0.267 Sum_probs=186.2
Q ss_pred CCeEEEceecccCceEEEEEEEeC---------------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCee
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKT---------------NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCV 105 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~---------------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv 105 (473)
++|++.+.||+|+||.||+|+++. .+...||+|+++... .......+.+|+++++.++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 579999999999999999986432 123469999998652 234456889999999999999999
Q ss_pred eEEEEEEeCCEEEEEecccCcCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceE
Q psy622 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG-----------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNML 174 (473)
Q Consensus 106 ~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~-----------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNIL 174 (473)
++++++.....+|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+.||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999998642 3677889999999999999999999999999999999
Q ss_pred ecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccC--CCCCchhH
Q psy622 175 ISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQN--SQAPFPSA 245 (473)
Q Consensus 175 ld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~--g~~pf~~~ 245 (473)
++.+ +.++|+|||+++.+...... .......+++.|+ +||.. ...|+|++|++ +++++ |..||...
T Consensus 163 i~~~-~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~---~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 163 VGKN-YTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWM---SWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EcCC-CCEEeccCcccccccCCcce-eccCcCcCccccC---CHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9988 99999999999865332211 1111223344555 77643 24789999965 56765 67888532
Q ss_pred hhhcCCCCChhhH-hh-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 246 LRVAGSQIPTSTA-AQ-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 246 ~~~~~~~~~~~~~-~~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
............. .. ....+| .+..+++.+.+|+.+||+.||.+||++.+|.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLP-KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1100000000000 00 011112 12467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=274.10 Aligned_cols=244 Identities=18% Similarity=0.238 Sum_probs=185.2
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKD-QLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~-~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~ 118 (473)
++|++.++||+|+||+||+|+.+.+.. ..+++|.++.. ......+.+.+|+.++.++ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999998765322 34788887742 2233456788999999999 7999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCce
Q psy622 119 LVMEYMIGGDVKSLIAANG----------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHC 182 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~----------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~i 182 (473)
+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~ 158 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-LAS 158 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC-CeE
Confidence 9999999999999997642 48899999999999999999999999999999999999998 899
Q ss_pred eEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCC
Q psy622 183 PIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIP 254 (473)
Q Consensus 183 kL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~ 254 (473)
||+|||++........ ......+..|+ +||.+. ..|+|++|++ ++|++ |..||....... ..
T Consensus 159 kl~dfg~~~~~~~~~~----~~~~~~~~~y~---aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVYVK----KTMGRLPVRWM---AIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LY 228 (297)
T ss_pred EECCcCCCccccceec----cCCCCcCcccc---CchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH
Confidence 9999999864321100 01111122344 777542 4788999976 56775 999996421100 00
Q ss_pred hhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 255 TSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 255 ~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
...........| ..++.++.+||.+||+.+|.+||+++++++.
T Consensus 229 ~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 229 EKLPQGYRMEKP---RNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHhcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000111111222 5688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=266.58 Aligned_cols=242 Identities=19% Similarity=0.338 Sum_probs=185.6
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
.-++|+++++||+|+||.||+|..+. ++.||+|.+.+... ....+.+|+.+++.++||||+++++++. ....|
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~--~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNG--HTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCC--CceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 34689999999999999999998654 57899999986542 2347889999999999999999998874 46799
Q ss_pred EEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 119 LVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+||||+.+|+|.+++... ..+++..+..++.||+.||+|||+.|++||||||+||+++.+ +.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET-LCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC-CCEEEccCcceeecCCC
Confidence 999999999999998763 368999999999999999999999999999999999999998 99999999999875421
Q ss_pred ccccccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
... ......++..|+ +||.+ ...|.|++|++ +++++ |..||....... .............+
T Consensus 156 ~~~--~~~~~~~~~~y~---~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~-- 225 (260)
T cd05067 156 EYT--AREGAKFPIKWT---APEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNLERGYRMPRP-- 225 (260)
T ss_pred Ccc--cccCCccccccc---CHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHHcCCCCCCC--
Confidence 111 111112334444 77754 24688999965 56787 999996421100 00000000111222
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
...+.++.++|.+||+.+|++||+++++++
T Consensus 226 -~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 226 -DNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=270.67 Aligned_cols=249 Identities=25% Similarity=0.396 Sum_probs=189.5
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEe
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lVm 121 (473)
|++.+.||+|+||+||+|+... +++.||||.+.+.... .......+|+..++.++ ||||+++++++.+....|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE-TGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECC-CCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence 6789999999999999998876 5789999998765321 22234567899999998 999999999999999999999
Q ss_pred cccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 122 EYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||+ +|+|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.+ +.++|+|||+++........
T Consensus 78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 78 EYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred ecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CCEEEeecccceeccCCCCc
Confidence 999 889999998764 78999999999999999999999999999999999999998 99999999999865332111
Q ss_pred cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChhhHh---
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTSTAA--- 259 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~~~~--- 259 (473)
....++..|+ |||++. ..+.|++|++ +++++|..||..... ..+.........
T Consensus 156 ----~~~~~~~~~~---aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 156 ----TDYVSTRWYR---APEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred ----CCCCCccccc---CceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 1123555555 777542 4688999965 579999999854210 000000000000
Q ss_pred ---hhccCCC--------CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 260 ---QLQLEWP--------EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 260 ---~~~~~~P--------~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
.....++ ......+.++.++|++||+.||.+||+++|++.||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0000000 0012347889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=271.17 Aligned_cols=243 Identities=19% Similarity=0.279 Sum_probs=187.1
Q ss_pred CeEEEceecccCceEEEEEEEeCC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTN----KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+|++.+.||+|+||.||+|+.... ....+|+|.+.+.. .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 588999999999999999976531 23578999987653 233456789999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcce
Q psy622 118 FLVMEYMIGGDVKSLIAAN------------------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNM 173 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~------------------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNI 173 (473)
|+||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998752 2478899999999999999999999999999999999
Q ss_pred EecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhH
Q psy622 174 LISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSA 245 (473)
Q Consensus 174 Lld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~ 245 (473)
|++++ +.+||+|||+++.......... .....++..|+ +||.+. ..|.|++|++ +++++ |..||...
T Consensus 159 ll~~~-~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~---apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 159 LVAEG-RKMKISDFGLSRDVYEEDSYVK-RSKGRIPVKWM---AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEcCC-CcEEeccccccccccCccchhc-ccCCCCCcccc---CHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99998 8999999999986532221111 11223444555 777543 3588899965 56887 88998642
Q ss_pred hhhcCCCCChhhHhh--hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 246 LRVAGSQIPTSTAAQ--LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 246 ~~~~~~~~~~~~~~~--~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
. +...... ....++ .+..++.++.+++.+||+.||++||++.|+++
T Consensus 234 ~-------~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 234 A-------PERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred C-------HHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 1 1111111 111121 22578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.00 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=202.7
Q ss_pred ccCCCCCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEE
Q psy622 33 SCLKAPEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108 (473)
Q Consensus 33 ~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 108 (473)
.....+...+.++.+.||+|+||+||+|+... ...+.||||.++... ..+..+.|++|+++|..++|||||+|+
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 34456667888999999999999999997543 123689999999874 244577999999999999999999999
Q ss_pred EEEEeCCEEEEEecccCcCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceE
Q psy622 109 YSLQTSSCVFLVMEYMIGGDVKSLIAAN--------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNML 174 (473)
Q Consensus 109 ~~f~~~~~l~lVmEy~~gg~L~~~L~~~--------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNIL 174 (473)
+++..++-+|+|+|||..|||.++|... ..++..+...++.||+.|++||-++.+|||||-.+|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 9999999999999999999999999753 12888999999999999999999999999999999999
Q ss_pred ecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCc-ccc-ccCCCCCchhHh
Q psy622 175 ISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPT-FQD-VQNSQAPFPSAL 246 (473)
Q Consensus 175 ld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~-l~~-~~~g~~pf~~~~ 246 (473)
+.++ -.|||+||||++.+.+.+.+.....+ .-. +.|.+||.|+ ..|+|+||+ +++ .-.|..||.+..
T Consensus 636 Vge~-l~VKIsDfGLsRdiYssDYYk~~~~t-~lP---IRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 636 VGEN-LVVKISDFGLSRDIYSSDYYKVRGNT-LLP---IRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred eccc-eEEEecccccchhhhhhhhhcccCCc-eee---eecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 9999 99999999999987765554322222 112 2344888765 479999995 467 567999998632
Q ss_pred hhcCCCCChhhHhhhcc-CCCCccccCChhHHHHHHhccccCCCCCCCHHHHh
Q psy622 247 RVAGSQIPTSTAAQLQL-EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVR 298 (473)
Q Consensus 247 ~~~~~~~~~~~~~~~~~-~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil 298 (473)
. +-..+.+.+..+ .-| ++++.++.+|+..||+.+|++||++.||-
T Consensus 711 n----~EVIe~i~~g~lL~~P---e~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 711 N----QEVIECIRAGQLLSCP---ENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred h----HHHHHHHHcCCcccCC---CCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 1 112233444343 334 79999999999999999999999998864
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=282.08 Aligned_cols=245 Identities=22% Similarity=0.361 Sum_probs=192.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCC--cE-EEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKD--QL-YAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~--~~-vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
++..+.++||+|+||.||+|+.+...+ .. ||+|..+......+.++..+++|.+++++++|||||+++++...+.-+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 456677999999999999998775322 23 899999975556678889999999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+|||+|+||+|.++|++.+ .++..+...++.+.+.||+|||++++|||||-.+|+|++.+ +.+||+|||+++.-.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~-~~vKISDFGLs~~~~-- 313 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK-GVVKISDFGLSRAGS-- 313 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-CeEEeCccccccCCc--
Confidence 99999999999999999987 59999999999999999999999999999999999999998 889999999988632
Q ss_pred ccccccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccc-cCCCCCchhHhhhcCCCCChhhHhh--hccCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDV-QNSQAPFPSALRVAGSQIPTSTAAQ--LQLEWP 266 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~-~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~P 266 (473)
........+--| +.|.|||.+ ...|+|+||++ +++ ..|..||++.... .....+.. .....|
T Consensus 314 --~~~~~~~~~klP--irWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 314 --QYVMKKFLKKLP--IRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKNGYRMPIP 385 (474)
T ss_pred --ceeeccccccCc--ceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhcCccCCCC
Confidence 111111112111 233378764 34788999987 454 4588899863211 00111111 122333
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
...+.+...++.+|+..||++|+++.++.+
T Consensus 386 ---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 386 ---SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ---CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 477889999999999999999999988774
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=273.28 Aligned_cols=253 Identities=16% Similarity=0.207 Sum_probs=187.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeCC-------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeee
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTN-------------KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQ 106 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~-------------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~ 106 (473)
.++|++.+.||+|+||.||+|++... ....||+|+++... .......+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 46899999999999999999976531 12358999998642 2344567899999999999999999
Q ss_pred EEEEEEeCCEEEEEecccCcCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceE
Q psy622 107 LFYSLQTSSCVFLVMEYMIGGDVKSLIAANG------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNML 174 (473)
Q Consensus 107 l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNIL 174 (473)
+++++......|+||||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999996532 3688899999999999999999999999999999999
Q ss_pred ecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC--CCCCchhH
Q psy622 175 ISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN--SQAPFPSA 245 (473)
Q Consensus 175 ld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~--g~~pf~~~ 245 (473)
++.+ +.+||+|||++..+...... .......+++.|+ |||... ..|+|++|++ +++++ +..||...
T Consensus 162 l~~~-~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 162 VGNH-YTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWM---AWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred EcCC-CcEEecccccccccccCcce-eccCcCcCceeec---ChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 9988 89999999999865322211 1111223344555 787643 4788999966 45655 66777542
Q ss_pred hhhc-CCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 246 LRVA-GSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 246 ~~~~-~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.... ...............+...+..+++.+.+|+.+||+.||.+||++++|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 237 SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1100 00000000000111112222467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=276.00 Aligned_cols=250 Identities=17% Similarity=0.223 Sum_probs=189.1
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCC------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTN------KDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFY 109 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 109 (473)
.+...+|++.+.||+|+||.||+|++... ....||+|+++... .....+.+.+|+++++++ +||||+++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 34445799999999999999999976431 22368999887542 234466889999999999 8999999999
Q ss_pred EEEeCCEEEEEecccCcCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcce
Q psy622 110 SLQTSSCVFLVMEYMIGGDVKSLIAANG----------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNM 173 (473)
Q Consensus 110 ~f~~~~~l~lVmEy~~gg~L~~~L~~~~----------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNI 173 (473)
++...+.+|+||||+++|+|.+++.+.+ .++...+..++.||+.||+|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 9999999999999999999999997632 377788899999999999999999999999999999
Q ss_pred EecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhH
Q psy622 174 LISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSA 245 (473)
Q Consensus 174 Lld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~ 245 (473)
|++.+ +.+||+|||+++........ .......+++.|+ |||.+. ..|.|++|++ +++++ |..||...
T Consensus 166 ll~~~-~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 166 LVTED-NVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWM---APEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred EEcCC-CcEEECCcccceeccccccc-ccccCCCcCceEc---CHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99998 99999999999865332111 1111112233454 888653 3688999965 56776 78888642
Q ss_pred hhhcCCCCChhhHhhh-ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 246 LRVAGSQIPTSTAAQL-QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 246 ~~~~~~~~~~~~~~~~-~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.. ....... ....+..+..++.++.+||.+||+.+|.+||++.|++++
T Consensus 241 ~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 241 PV-------EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CH-------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 10 0000000 001111224678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=268.92 Aligned_cols=253 Identities=18% Similarity=0.207 Sum_probs=190.3
Q ss_pred CCCeEEEceecccCceEEEEEEEeC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKT---NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT--S 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~---~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~ 114 (473)
-++|++.+.||+|+||.||+|+... .+++.||+|++++.... .....+.+|+++++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 3578899999999999999998642 24678999999876432 346689999999999999999999999877 6
Q ss_pred CEEEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
...|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+||+++.+ +.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~ 159 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGLAKVL 159 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEccccccccc
Confidence 68999999999999999998754 69999999999999999999999999999999999999999 99999999999876
Q ss_pred cCCccccccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccCCCCCchhHhhhcCC--------CCChhhH
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQNSQAPFPSALRVAGS--------QIPTSTA 258 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~--------~~~~~~~ 258 (473)
..............++..|+ +||.. ...+.|++|++ +++++|..|+......... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~---~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWY---APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred ccCCcceeccCCCCCccccc---CcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 42222111111111222233 66643 34688999965 5799999887642211100 0000000
Q ss_pred --hhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 259 --AQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 259 --~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.......+. +..++.++.+|+.+||+.+|.+||++.||++
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKEGERLPR-PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHcCCcCCC-CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 011112221 2467789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=267.27 Aligned_cols=242 Identities=19% Similarity=0.289 Sum_probs=188.7
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+..++|++.+.||+|+||.||+|..+. ++.||||.+..... ..+.+.+|+.+++.++||||+++++++.+...+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~--~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNG--TTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcC--CceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 346789999999999999999998654 36799999886542 235688999999999999999999999998999
Q ss_pred EEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 118 FLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++..+..
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-LVCKIADFGLARLIED 155 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC-CCEEECccccceeccc
Confidence 99999999999999998643 68999999999999999999999999999999999999999 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhh--ccCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQL--QLEW 265 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~--~~~~ 265 (473)
..... .....++..|+ +||... ..|.|++|++ +++++ |..||..... ....... ....
T Consensus 156 ~~~~~--~~~~~~~~~y~---~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------~~~~~~~~~~~~~ 223 (261)
T cd05034 156 DEYTA--REGAKFPIKWT---APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-------REVLEQVERGYRM 223 (261)
T ss_pred hhhhh--hhccCCCcccc---CHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCC
Confidence 21110 11112233344 777543 4688999965 56776 8999864211 1111111 1111
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
+ .+...+.++.+++.+||+.+|.+||+++++.+
T Consensus 224 ~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 P-RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred C-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1 12456889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=269.34 Aligned_cols=252 Identities=20% Similarity=0.334 Sum_probs=196.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-C-C----CeeeEEEEEEe
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-S-P----FCVQLFYSLQT 113 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-h-p----~Iv~l~~~f~~ 113 (473)
-.+|.+++.+|+|+||+|..+.++.. +..||||+++.- ....+..+-|+++|.++. + | .+|++.++|.-
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~-~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRET-KEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCC-CceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 57899999999999999999998885 789999999853 334556788999999883 2 2 47888899999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC-------------
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ------------- 178 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~------------- 178 (473)
.++.|||+|.+ |-+++++|..++ +|+..+++.+++||+.++++||+.+++|-||||||||+.+.
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999999999 889999998864 79999999999999999999999999999999999999642
Q ss_pred ------CCceeEeecchhhhhcCCccccccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCCchh-
Q psy622 179 ------APHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAPFPS- 244 (473)
Q Consensus 179 ------~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~pf~~- 244 (473)
+.+|+|+|||.|....... ++...|-.|. |||++++ .|.||+|++ .++.+|...|..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYR---APEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYR---APEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc------ceeeeccccC---CchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 1569999999998743222 3345665555 9999876 466899955 579999998864
Q ss_pred -------HhhhcCCCCChhhHhh---------hccCCCCcc----------------------ccCChhHHHHHHhcccc
Q psy622 245 -------ALRVAGSQIPTSTAAQ---------LQLEWPEDE----------------------EALNPSTEETILALLKS 286 (473)
Q Consensus 245 -------~~~~~~~~~~~~~~~~---------~~~~~P~~~----------------------~~ls~~a~dLI~~LL~~ 286 (473)
.+...-+++|...+.. ..+.||+.. +.--.++-|||++||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 2223333444433222 244454310 11123488999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q psy622 287 DPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 287 dP~kRpsa~eil~HPFF~~i 306 (473)
||.+|+|+.|++.||||+..
T Consensus 393 DP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 393 DPARRITLREALSHPFFARL 412 (415)
T ss_pred CccccccHHHHhcCHHhhcC
Confidence 99999999999999999753
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=265.09 Aligned_cols=237 Identities=22% Similarity=0.334 Sum_probs=187.4
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
..++|++.+.||.|+||.||+|... ++.||+|.++.... ..+++.+|+.+++.++|+||+++++.+.+....|
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~---~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec---CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 4678999999999999999999754 57899999986532 4568899999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 119 LVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.+ +.+||+|||.++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED-LVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC-CCEEEcccccccccccc
Confidence 9999999999999998765 79999999999999999999999999999999999999998 99999999999875321
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPE 267 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~ 267 (473)
.. ...++..| .+||.+. ..+.|++|++ +++++ |..||....... ....... .....|
T Consensus 156 ~~------~~~~~~~~---~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~~~~~~~- 221 (256)
T cd05039 156 QD------SGKLPVKW---TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPHVEKGYRMEAP- 221 (256)
T ss_pred cc------cCCCcccc---cCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHhcCCCCCCc-
Confidence 11 11122223 3777543 3588899965 46665 888886421100 0000000 111222
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+++++.++|.+||+.+|.+||++.++++
T Consensus 222 --~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 222 --EGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --cCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=268.38 Aligned_cols=242 Identities=20% Similarity=0.322 Sum_probs=184.9
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
..++|++.+.||+|+||.||+|..+. +..+|+|.++.... ..+.+.+|+.+++.++||+|+++++.+. ....|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~--~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNG--NTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecC--CceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 35689999999999999999997654 45799999987542 1346889999999999999999999885 45689
Q ss_pred EEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 119 LVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.++|+|||++..+...
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ceEEeCCceeeeeccCc
Confidence 999999999999999763 358999999999999999999999999999999999999998 89999999999875332
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
..... ....++..|+ |||... ..+.|++|++ +++++ |..||...... ..............+
T Consensus 156 ~~~~~--~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-- 225 (260)
T cd05070 156 EYTAR--QGAKFPIKWT---APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVERGYRMPCP-- 225 (260)
T ss_pred ccccc--cCCCCCcccc---ChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCCC--
Confidence 21111 0111223344 777643 4788999965 56877 88898642110 000000001111222
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
...+..+.+|+.+||+.||.+|||++++.+
T Consensus 226 -~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 226 -QDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -CcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 567899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=270.57 Aligned_cols=249 Identities=18% Similarity=0.220 Sum_probs=188.9
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
+..++|++.+.||+|+||.||+|+.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 346789999999999999999998653 245789999987653 23334578899999999999999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCc
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN----------------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPD 171 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~----------------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpe 171 (473)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 99999999999999999999753 13788889999999999999999999999999999
Q ss_pred ceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCch
Q psy622 172 NMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFP 243 (473)
Q Consensus 172 NILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~ 243 (473)
||+++.+ +.++|+|||++..+........ .....+++.|+ |||.+. ..|+|++|++ +++++ |..||.
T Consensus 160 nil~~~~-~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 160 NCLVGEN-MVVKIADFGLSRNIYSADYYKA-SENDAIPIRWM---PPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred heEecCC-CceEECccccceecccCccccc-cCCCccChhhc---CHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999998 9999999999876432221111 11112333444 788643 3688999966 45665 777885
Q ss_pred hHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 244 SALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
...... .. ..+. ....+..+..++.++.+||.+||+.||.+||++.|+++
T Consensus 235 ~~~~~~---~~-~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 GMAHEE---VI-YYVR--DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCHHH---HH-HHHh--cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 421100 00 0111 11111112568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=271.76 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=191.5
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEec
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
|++.+.||.|++|.||+|+... +++.+|+|+++.... .......+.+|+.+|+.++||+|+++++++.++..+|+|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL-TGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCC-CCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 6778999999999999998876 578999999886542 22345678889999999999999999999999999999999
Q ss_pred ccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc
Q psy622 123 YMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE 201 (473)
Q Consensus 123 y~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~ 201 (473)
|++ ++|.+++... +.+++..+..++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||.+........
T Consensus 79 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~--- 153 (283)
T cd05118 79 FMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVR--- 153 (283)
T ss_pred ccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcc---
Confidence 995 5888888764 589999999999999999999999999999999999999998 9999999999987543321
Q ss_pred cccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChh---h---H
Q psy622 202 ISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTS---T---A 258 (473)
Q Consensus 202 ~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~---~---~ 258 (473)
......+++.|+ +||.+. ..|.|++|++ +++++|..||..... ..+...+.. . .
T Consensus 154 ~~~~~~~~~~~~---~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 PYTHYVVTRWYR---APELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred cccCccCccccc---CcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 111123444444 777643 3577899965 569999999864211 000000000 0 0
Q ss_pred hhhccCC--------CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 259 AQLQLEW--------PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 259 ~~~~~~~--------P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
......+ +.....++.++.++|.+||+.||.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0000001 11123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=268.47 Aligned_cols=240 Identities=18% Similarity=0.296 Sum_probs=184.9
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
..++|++.++||+|+||.||+|++.. + ..||+|++++... ..+.+.+|+++++.++||||+++++.+.. ...|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNG-T-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecC-C-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 35679999999999999999998765 3 4699999986432 23468899999999999999999998754 5689
Q ss_pred EEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 119 LVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.||+||||||+||+++.+ +.+||+|||++..+...
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC-CcEEeccCCceeecccc
Confidence 999999999999999863 358999999999999999999999999999999999999998 99999999999765332
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhh--ccCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQL--QLEWP 266 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~--~~~~P 266 (473)
... ......++..|+ +||... ..|.|++|++ +++++ |..||..... ....... ....+
T Consensus 156 ~~~--~~~~~~~~~~y~---~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-------~~~~~~~~~~~~~~ 223 (262)
T cd05071 156 EYT--ARQGAKFPIKWT---APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMP 223 (262)
T ss_pred ccc--cccCCcccceec---CHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-------HHHHHHHhcCCCCC
Confidence 211 111122334455 788653 4788999965 56887 8888864211 0111110 11111
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
. ...++.++.++|.+||++||++||+++++++
T Consensus 224 ~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 224 C-PPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred C-ccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 1 2468899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.78 Aligned_cols=262 Identities=19% Similarity=0.207 Sum_probs=175.7
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCC----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEE-
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNK----DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYS- 110 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~----~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~- 110 (473)
.....++|++.+.||+|+||.||+|++.. + ++.||+|+++.... .+....| .+....+.++..+...
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~-~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVN-KQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGF 198 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcC-CccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhh
Confidence 34567899999999999999999998876 4 67899999875321 1111111 1111122222222222
Q ss_pred -----EEeCCEEEEEecccCcCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCeee
Q psy622 111 -----LQTSSCVFLVMEYMIGGDVKSLIAANGA--------------------LPEDMAAFYAAEVVLALQYLHSHGIIH 165 (473)
Q Consensus 111 -----f~~~~~l~lVmEy~~gg~L~~~L~~~~~--------------------~~e~~~~~~~~qI~~aL~yLH~~gIiH 165 (473)
......+++|+||+.+++|.+++..... ..+..++.++.||+.||+|||++||+|
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH 278 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 2456789999999999999999875421 123456789999999999999999999
Q ss_pred cCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc-----------------------
Q psy622 166 RDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL----------------------- 222 (473)
Q Consensus 166 RDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~----------------------- 222 (473)
|||||+|||++.+.+.+||+|||+++.+..... ......+++|.|+ |||.+.
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~---APE~~~~~~~~~~~~~~~~~~~~sp~l~~ 353 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYA---APEQYIMSTQTPSAPSAPVATALSPVLWQ 353 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCcc---ChHHhhccCCCCCCccccccccccchhcc
Confidence 999999999997548999999999986533221 1223456788887 787431
Q ss_pred -----cCCcCCCCcc-ccccCCCCCchhHhhh-------cCCCCChhhHhhhccCCC-------CccccCChhHHHHHHh
Q psy622 223 -----SLKTGTFPTF-QDVQNSQAPFPSALRV-------AGSQIPTSTAAQLQLEWP-------EDEEALNPSTEETILA 282 (473)
Q Consensus 223 -----~~~~~s~g~l-~~~~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~P-------~~~~~ls~~a~dLI~~ 282 (473)
..|.|++|++ ++|+++..++...... ...... ..........+ ...+..+..+++||.+
T Consensus 354 ~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 354 LNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLV-AWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred ccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHH-HHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 1399999965 5687766665432110 011000 00000000000 0002234457799999
Q ss_pred ccccCCCCCCCHHHHhcCCCCCCCCcccc
Q psy622 283 LLKSDPTQRPSGHQVRRLPMFKDYDWDSI 311 (473)
Q Consensus 283 LL~~dP~kRpsa~eil~HPFF~~idw~~l 311 (473)
||++||++|||++|+++||||++.++..+
T Consensus 433 mL~~dP~kR~ta~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 433 MMRFKGRQRISAKAALAHPYFDREGLLGL 461 (566)
T ss_pred HccCCcccCCCHHHHhCCcCcCCCCcccc
Confidence 99999999999999999999999887643
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=265.07 Aligned_cols=243 Identities=22% Similarity=0.285 Sum_probs=187.7
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
...+|++.+.||+|+||.||+|.+.. ++.+|+|++.+.... ...+.+|+++++.++||+|+++++++......|
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~--~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLE--KRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC 75 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeC--CCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence 35689999999999999999998763 467999998765332 346788999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 119 LVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+||||+++|+|.+++... +.+++..++.++.|++.||+|||+.|++||||||+||+++.+ +.+||+|||++.......
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-CeEEECCCcceeecccCc
Confidence 999999999999999864 468999999999999999999999999999999999999988 899999999987643221
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCCc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPED 268 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~ 268 (473)
.. ......++..|+ +||... ..|.|++|++ +++++ |..||....... .. ..... .....|
T Consensus 155 ~~--~~~~~~~~~~~~---aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~-~~~~~~~~~~~~-- 223 (256)
T cd05112 155 YT--SSTGTKFPVKWS---SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VV-ETINAGFRLYKP-- 223 (256)
T ss_pred cc--ccCCCccchhhc---CHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HH-HHHhCCCCCCCC--
Confidence 11 001111223344 787654 3688999965 56776 899986421100 00 00010 111122
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
...+.++.+|+.+||+.+|++||++.+++++
T Consensus 224 -~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 224 -RLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -CCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 4578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=264.46 Aligned_cols=237 Identities=20% Similarity=0.332 Sum_probs=184.0
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEE-EeCCE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSL-QTSSC 116 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f-~~~~~ 116 (473)
++.++|++.+.||+|+||.||+|..+ ++.||+|.++... ..+.+.+|+.+++.++|++|+++++++ .....
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc---CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 34678999999999999999999654 4679999986542 245788999999999999999999875 55678
Q ss_pred EEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 117 VFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
.|+||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++...
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~ 153 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEAS 153 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC-CcEEecCCccceecc
Confidence 999999999999999998754 48899999999999999999999999999999999999998 999999999988643
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccC-C
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLE-W 265 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~-~ 265 (473)
... ....++..|+ |||+.. ..|+|++|++ +++++ |..||..... .......... -
T Consensus 154 ~~~------~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~ 217 (256)
T cd05082 154 STQ------DTGKLPVKWT---APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPRVEKGYK 217 (256)
T ss_pred ccC------CCCccceeec---CHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcCCC
Confidence 221 1122333444 676542 4688999965 56775 8888864211 0111100001 1
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
+..+..+++.+.++|.+||+.+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1122578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=266.48 Aligned_cols=248 Identities=18% Similarity=0.252 Sum_probs=190.0
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKD---QLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~---~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
..+..+|++.+.||+|+||+||+|..+.+.. ..+|+|.+.+... ......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 3456789999999999999999998765321 3689999877632 3445678899999999999999999999887
Q ss_pred CCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
...++||||+++|+|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++.
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kL~dfg~~~~ 158 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP-QHVKITDFGLAKL 158 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC-CeEEECCCccccc
Confidence 7899999999999999999874 479999999999999999999999999999999999999998 8999999999987
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hcc
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQL 263 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~ 263 (473)
+........ .....+++.|+ +||... ..|.|++|++ +++++ |..||...... .+. ..+.. ...
T Consensus 159 ~~~~~~~~~-~~~~~~~~~y~---~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~-~~~~~~~~~ 230 (279)
T cd05057 159 LDVDEKEYH-AEGGKVPIKWM---ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIP-DLLEKGERL 230 (279)
T ss_pred ccCccccee-cCCCccccccc---CHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHH-HHHhCCCCC
Confidence 543221111 11111233444 777643 3678999965 56776 99998642110 000 11111 111
Q ss_pred CCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..| ...+..+.+++.+||..||.+||++.++++
T Consensus 231 ~~~---~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 PQP---PICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 222 467889999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=268.05 Aligned_cols=232 Identities=15% Similarity=0.187 Sum_probs=177.0
Q ss_pred eecccCceEEEEEEEeCC-----------------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCe
Q psy622 48 AISRGAFGKVFLGYKKTN-----------------------KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFC 104 (473)
Q Consensus 48 ~LG~G~fG~V~~a~~~~~-----------------------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 104 (473)
.||+|+||.||+|..... ....||+|++.... ......+.+|..+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999975321 12358999987642 2334578889999999999999
Q ss_pred eeEEEEEEeCCEEEEEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC----
Q psy622 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA---- 179 (473)
Q Consensus 105 v~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~---- 179 (473)
+++++++.+....|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999976 46799999999999999999999999999999999999997641
Q ss_pred --CceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccc-cCCCCCchhHhhh
Q psy622 180 --PHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDV-QNSQAPFPSALRV 248 (473)
Q Consensus 180 --g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~-~~g~~pf~~~~~~ 248 (473)
+.+||+|||++....... ...+++.|+ +||.+. ..|.|++|++ +++ ..|..||......
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~-------~~~~~~~~~---aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSRE-------ERVERIPWI---APECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred ccceeeecCCcccccccccc-------ccccCCccc---CchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 348999999986532111 123455555 777553 3678899964 565 5788988642110
Q ss_pred cCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 249 AGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 249 ~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
............| ...++++.++|.+||+.+|.+||++++++++
T Consensus 229 -----~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 229 -----EKERFYEKKHRLP---EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -----HHHHHHHhccCCC---CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 0011111222333 3467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=266.35 Aligned_cols=242 Identities=21% Similarity=0.196 Sum_probs=180.4
Q ss_pred ceecccCceEEEEEEEeC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKT-NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
+.||+|+||.||+|.... .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 468999999999997653 2456799999876532 2234578889999999999999999999999999999999999
Q ss_pred cCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 126 GGDVKSLIAANG-----ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 126 gg~L~~~L~~~~-----~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
+|+|.+++.... ..++..++.++.||+.||+|||+.|++||||||+||+++.+ +++||+|||+++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~- 156 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDYY- 156 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEECCccccccccCccee-
Confidence 999999997532 45677888999999999999999999999999999999998 99999999999754322111
Q ss_pred ccccccCCCCcccccCCccccc-------------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL-------------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~-------------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
.......+++.|+ |||++. ..|.|++|++ +++++ |..||....... ............+
T Consensus 157 ~~~~~~~~~~~y~---aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~~~ 230 (269)
T cd05087 157 VTPDQLWVPLRWI---APELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTVREQQLKL 230 (269)
T ss_pred ecCCCcCCccccc---CHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHhhcccCCC
Confidence 1112234566666 888652 4688999965 56774 999996421100 0000111111111
Q ss_pred --CCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 266 --PEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 266 --P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
|......++.+.+++.+|+ .+|.+||+++||..
T Consensus 231 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 231 PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 2222356788999999998 58999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=268.42 Aligned_cols=232 Identities=15% Similarity=0.195 Sum_probs=179.7
Q ss_pred ceecccCceEEEEEEEeCCC------CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 47 KAISRGAFGKVFLGYKKTNK------DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~------~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.||+|+||.||+|.++... ...+|+|.+.+.. ....+.+..|..+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 46999999999999875421 2348888876543 34456788899999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCc--------eeEeecchhh
Q psy622 121 MEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH--------CPIVNTLFLA 191 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~--------ikL~DFGla~ 191 (473)
|||+++|+|..++...+ .+++..++.++.||+.||+|||++||+||||||+||+++.+ +. ++|+|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIRE-EDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecc-cccccCCCceEEeccccccc
Confidence 99999999999998754 58999999999999999999999999999999999999877 43 6999999987
Q ss_pred hhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCC-CCchhHhhhcCCCCChhhHhhhc
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQ-APFPSALRVAGSQIPTSTAAQLQ 262 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~-~pf~~~~~~~~~~~~~~~~~~~~ 262 (473)
..... ....+++.|+ +||++. ..++|++|++ +++++|. .||...... .........
T Consensus 157 ~~~~~-------~~~~~~~~y~---aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-----~~~~~~~~~ 221 (258)
T cd05078 157 TVLPK-------EILLERIPWV---PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-----KKLQFYEDR 221 (258)
T ss_pred ccCCc-------hhccccCCcc---CchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-----HHHHHHHcc
Confidence 64221 2235666666 787653 3588999965 5688884 555432110 001111122
Q ss_pred cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 263 LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 263 ~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..+| ...+.++.+||.+||+.||++||+++++++.
T Consensus 222 ~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 222 HQLP---APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ccCC---CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 3334 4567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=266.17 Aligned_cols=247 Identities=13% Similarity=0.162 Sum_probs=185.2
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQ----LYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~----~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
...++|++++.||+|+||+||+|+...+ ++ .+++|.+.... .+.....+..|..+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~-~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~- 79 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPE-GDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP- 79 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCC-CCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-
Confidence 3457899999999999999999987653 44 36777765331 2233456778888999999999999999875
Q ss_pred CCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
....++|+||+++|+|.+++... +.+++..++.++.||+.||+|||++|++||||||+|||++.+ +.+||+|||+++.
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~kl~Dfg~~~~ 158 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVADL 158 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEEcCCcccee
Confidence 45678999999999999999864 579999999999999999999999999999999999999998 9999999999986
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccC
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLE 264 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 264 (473)
....... .......++..|+ +||... ..|.|++|++ +++++ |..||....... ........ .
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~---~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~~~~--~ 228 (279)
T cd05111 159 LYPDDKK-YFYSEHKTPIKWM---ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----VPDLLEKG--E 228 (279)
T ss_pred ccCCCcc-cccCCCCCccccc---CHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHCC--C
Confidence 5322211 1112233445555 777653 3688999965 56776 999986421100 00111111 1
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.+..+...+.++.+++.+||..||.+||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 229 RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11112456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=262.39 Aligned_cols=243 Identities=22% Similarity=0.302 Sum_probs=188.8
Q ss_pred eEEEceecccCceEEEEEEEeCCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNK---DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~---~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
|++.+.||.|+||.||+|++.... +..||+|+++.... ....+.+..|+.++..++|+||+++++.+.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467889999999999999887632 37899999976532 2256789999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 120 VMEYMIGGDVKSLIAANGA--LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~--~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+|||++|++|.+++..... +++..+..++.||+.||+|||+.|++||||||+||+++.+ +.++|+|||++.......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC-CeEEEcccCCceeccccc
Confidence 9999999999999987544 9999999999999999999999999999999999999999 899999999998754331
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
.... ....+++.|+ +||... ..+.|++|++ +++++ |..||...... .. ...... ...+..+
T Consensus 158 ~~~~--~~~~~~~~y~---~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~-~~~~~~--~~~~~~~ 226 (258)
T smart00219 158 YYKK--KGGKLPIRWM---APESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EV-LEYLKK--GYRLPKP 226 (258)
T ss_pred cccc--ccCCCccccc---ChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HH-HHHHhc--CCCCCCC
Confidence 1111 1122555665 777542 3678889965 45766 78888641100 00 001111 1111222
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..++.++.+++.+||+.||.+|||+.|+++
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 227 ENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 568999999999999999999999999885
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=284.42 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=202.8
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEE-----eC
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQ-----TS 114 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~-----~~ 114 (473)
+-|+++.+||+|.||+||+++.+. .++..|+|++.... ...+.+..|.+||+.. +|||++.++++|. .+
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~-~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVK-TGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeee-cCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 459999999999999999999887 57899999988763 2234567789999887 8999999999985 35
Q ss_pred CEEEEEecccCcCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAA--NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~--~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
+.+|||||||.||+.-+++++ .+++.|..+.+++.+++.||.|||++.+||||||-.|||++.+ |.+||+|||.+..
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e-~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQ 172 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEecc-CcEEEeeeeeeee
Confidence 689999999999999999986 3579999999999999999999999999999999999999999 9999999999988
Q ss_pred hcCCccccccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhc-CCCCChhhHh
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVA-GSQIPTSTAA 259 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~-~~~~~~~~~~ 259 (473)
++.. .....+..|||-|| |||++. ..|.|++|+. .+|..|.+|+....... --.++....
T Consensus 173 ldsT---~grRnT~iGtP~WM---APEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP- 245 (953)
T KOG0587|consen 173 LDST---VGRRNTFIGTPYWM---APEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP- 245 (953)
T ss_pred eecc---cccccCcCCCcccc---cceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC-
Confidence 6543 23345678999999 888763 4788999976 47999999987532110 011111000
Q ss_pred hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 260 QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 260 ~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.++.-| ...++++.++|..||.+|-.+||+..++++|||.+.-
T Consensus 246 -PkLkrp---~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 246 -PKLKRP---KKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred -ccccch---hhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 012222 5778999999999999999999999999999999843
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=259.85 Aligned_cols=236 Identities=20% Similarity=0.285 Sum_probs=181.8
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCc
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIG 126 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 126 (473)
++||+|+||.||+|..+ .++.||+|+++... .......+.+|+++++.++||||+++++.+......++||||++|
T Consensus 1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec--CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 47899999999999754 35789999987653 233345788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 127 GDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 127 g~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++........ .....
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~--~~~~~ 153 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIY--SSSGL 153 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC-CeEEECCCccceecccccc--ccCCC
Confidence 9999998764 468999999999999999999999999999999999999998 8999999999875322111 11111
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHh-hhccCCCCccccCChhH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAA-QLQLEWPEDEEALNPST 276 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~P~~~~~ls~~a 276 (473)
..+++.|+ +||++. ..|.|++|++ +++++ |..||....... . ...+. ......+ ..++.++
T Consensus 154 ~~~~~~y~---aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~-~~~~~~~~~~~~~---~~~~~~~ 223 (250)
T cd05085 154 KQIPIKWT---APEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---A-REQVEKGYRMSCP---QKCPDDV 223 (250)
T ss_pred CCCccccc---CHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---H-HHHHHcCCCCCCC---CCCCHHH
Confidence 22334444 787643 3688899965 55776 899986421110 0 00111 0111222 5688999
Q ss_pred HHHHHhccccCCCCCCCHHHHhc
Q psy622 277 EETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 277 ~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.+++.+||+.+|++||++.|+++
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHHHHcccCcccCCCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=266.79 Aligned_cols=242 Identities=20% Similarity=0.227 Sum_probs=178.0
Q ss_pred ceecccCceEEEEEEEeCC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTN-KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~-~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
+.||+|+||+||+|..... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.+...+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 4689999999999965432 33578888876542 23334578899999999999999999999999999999999999
Q ss_pred cCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 126 GGDVKSLIAANG-----ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 126 gg~L~~~L~~~~-----~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
+|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~- 156 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYY- 156 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC-CcEEEeccccccccccchhe-
Confidence 999999997643 35678889999999999999999999999999999999999 99999999998753221111
Q ss_pred ccccccCCCCcccccCCccccc-------------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL-------------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~-------------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
.......+++.|+ |||+.. ..|+|++|++ +++++ |..||...... .............+
T Consensus 157 ~~~~~~~~~~~y~---aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~~~~ 230 (269)
T cd05042 157 ITKDCHAVPLRWL---APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVLKQVVREQDIKL 230 (269)
T ss_pred eccCCCCCccccc---CHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHHhhccCccC
Confidence 1111223444555 787632 4678899965 56776 77888642110 00001111111122
Q ss_pred --CCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 266 --PEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 266 --P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
|.....+++...+++..|+ .||++||++++|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 231 PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 2223568888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=268.45 Aligned_cols=243 Identities=23% Similarity=0.330 Sum_probs=181.6
Q ss_pred EEEceecccCceEEEEEEEeC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 44 EIVKAISRGAFGKVFLGYKKT---NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 44 ~i~~~LG~G~fG~V~~a~~~~---~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
.+.+.||.|+||.||+|..+. ..+..|+||+++.. ......+.+.+|++++++++||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 577899999999999998881 23468999999653 2344477899999999999999999999999988889999
Q ss_pred ecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 121 MEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
|||+++|+|.++|... ..+++.....++.||+.||.|||+++|+|++|+++||+++.+ +.+||+|||++........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT-TEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccc
Confidence 9999999999999986 689999999999999999999999999999999999999999 9999999999987522211
Q ss_pred ccccccccCCCCcccccCCcccc------ccCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCccc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~ 270 (473)
. .......+...|+ |||.+ ...|.|+||++ +++++ |..||...... .+........... .+.
T Consensus 159 ~-~~~~~~~~~~~~~---aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---~~~~~~~~~~~~~---~~~ 228 (259)
T PF07714_consen 159 Y-KNDSSQQLPLRYL---APEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---EIIEKLKQGQRLP---IPD 228 (259)
T ss_dssp E-EESTTSESGGGGS----HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---HHHHHHHTTEETT---SBT
T ss_pred c-ccccccccccccc---cccccccccccccccccccccccccccccccccccccccc---cccccccccccce---ecc
Confidence 1 1111222333444 88864 34688999965 57887 67888642110 0001111111222 235
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.++..+.++|.+||..||.+||++++|++
T Consensus 229 ~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 229 NCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp TSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred chhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 78999999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=262.49 Aligned_cols=241 Identities=18% Similarity=0.280 Sum_probs=183.6
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++...||+|+||.||+|..+. + ..+|+|.+..... ..+.+.+|+++++.++||||+++++++. ....|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNG-T-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcC-C-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 4679999999999999999998765 2 4689999876532 2346788999999999999999998875 456899
Q ss_pred EecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 120 VMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+.||+||||||+||+++++ +.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN-LVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CeEEECCCccceEccCCc
Confidence 999999999999997643 48899999999999999999999999999999999999998 999999999997653221
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
.. ......++..|+ +||... ..|.|++|+. +++++ |..||....... . ..... ..... ..+
T Consensus 157 ~~--~~~~~~~~~~y~---~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~-~~~~~-~~~~~-~~~ 225 (260)
T cd05069 157 YT--ARQGAKFPIKWT---APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---V-LEQVE-RGYRM-PCP 225 (260)
T ss_pred cc--ccCCCccchhhC---CHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H-HHHHH-cCCCC-CCC
Confidence 11 111112333444 777543 4688899965 56887 899987521100 0 00011 01111 112
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..++..+++++.+||++||.+||+++++++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 568899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=262.91 Aligned_cols=248 Identities=19% Similarity=0.269 Sum_probs=188.3
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTN--KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~--~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
+..++|.+.+.||+|+||.||+|.+... ....||||...... .....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3456799999999999999999987643 23468999987653 23445688999999999999999999998875 4
Q ss_pred EEEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 116 CVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||+.|++||||||+||+++.+ +.+||+|||+++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~ 158 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-DCVKLGDFGLSRYLE 158 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC-CCeEEccCceeeecc
Confidence 5789999999999999998754 68999999999999999999999999999999999999998 999999999998653
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-cccc-CCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQ-NSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
..... ......+++.|+ +||.+. ..|.|++|++ ++++ .|..||...... ..............|
T Consensus 159 ~~~~~--~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 230 (270)
T cd05056 159 DESYY--KASKGKLPIKWM---APESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIENGERLPMP 230 (270)
T ss_pred cccce--ecCCCCcccccc---ChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCCcCCCC
Confidence 32111 111112334454 777543 3688899965 5666 499998643110 000000011122223
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..++.++.++|.+||..+|.+||++.+++..
T Consensus 231 ---~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 231 ---PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5788999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=259.68 Aligned_cols=243 Identities=17% Similarity=0.296 Sum_probs=185.8
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+..++|++.+.||+|+||.||+|.... +..+|+|.+.+.. ...+.+.+|+++++.++|+||+++++.+.. ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~--~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNK--HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecC--CccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 346789999999999999999997554 4579999987642 235578899999999999999999999987 788
Q ss_pred EEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 118 FLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
|+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+.|++||||||+||+++.+ +.+||+|||++..+..
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIED 154 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCCcceeeccC
Confidence 9999999999999999863 357888999999999999999999999999999999999998 9999999999986532
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
..... .....++..|+ +||.+. ..|.|++|++ +++++ |..||....... . ...+.. ....+
T Consensus 155 ~~~~~--~~~~~~~~~y~---~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~-~~~~~~-~~~~~- 223 (260)
T cd05073 155 NEYTA--REGAKFPIKWT---APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V-IRALER-GYRMP- 223 (260)
T ss_pred CCccc--ccCCccccccc---CHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---H-HHHHhC-CCCCC-
Confidence 21110 11112223333 777643 3689999966 56787 899986421100 0 000111 11111
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.+...+.++.+++.+||+.||++||++.++++
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 12568899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=264.99 Aligned_cols=249 Identities=17% Similarity=0.226 Sum_probs=190.3
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTN---KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT- 113 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~---~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~- 113 (473)
++.++|++.++||+|+||.||+|.++.. +++.||+|++... ........+.+|..+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 4567899999999999999999987752 2578999998754 234556788999999999999999999997654
Q ss_pred CCEEEEEecccCcCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEe
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN--------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~--------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~ 185 (473)
....++++||+++|+|..++... ..+++..+..++.||+.||+|||++|++||||||+||+++.+ +.+||+
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kl~ 159 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE-LQVKIT 159 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC-CcEEEC
Confidence 57899999999999999999763 358999999999999999999999999999999999999998 999999
Q ss_pred ecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhh
Q psy622 186 NTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTST 257 (473)
Q Consensus 186 DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~ 257 (473)
|||+++.+...... .......++..|+ |||... ..|.|++|++ +++++ |..||...... .+ ..
T Consensus 160 d~g~~~~~~~~~~~-~~~~~~~~~~~y~---apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~--~~ 230 (280)
T cd05043 160 DNALSRDLFPMDYH-CLGDNENRPVKWM---ALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EM--AA 230 (280)
T ss_pred CCCCcccccCCceE-EeCCCCCcchhcc---CHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HH--HH
Confidence 99999865322211 1111122333444 777543 4688999965 56776 99998642110 00 00
Q ss_pred HhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 258 AAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 258 ~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.......++ ....+++++.+++.+||+.||++||++.++++
T Consensus 231 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 231 YLKDGYRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHcCCCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000111111 12467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=275.15 Aligned_cols=247 Identities=20% Similarity=0.238 Sum_probs=184.5
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-EEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS-CVFL 119 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~-~l~l 119 (473)
++|.-..+||+|+||.||+|.... ++.||||++....... ...+.+|+.+|.+++|||+|+|+++|.+.+ +.+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~--~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD--GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC--CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 678888899999999999998765 3789999887754221 345999999999999999999999999888 5999
Q ss_pred EecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 120 VMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHG---IIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~g---IiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
|+|||+.|+|.++|.... .+++.....|+.+++.||+|||... |||||||++|||||.+ ...||+|||+|+...
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCC
Confidence 999999999999998765 8999999999999999999999864 9999999999999999 999999999997632
Q ss_pred CCcccccccccc-CCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChh---hHhhh--
Q psy622 195 QPIVYLEISDLV-NGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTS---TAAQL-- 261 (473)
Q Consensus 195 ~~~~~~~~~~~~-~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~---~~~~~-- 261 (473)
.. . ....+. .||..|+ +||++. ..|+++||++ .++++|+.+..............+ .....
T Consensus 229 ~~-~--~~~~~~~~gt~gY~---~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~ 302 (361)
T KOG1187|consen 229 EG-D--TSVSTTVMGTFGYL---APEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL 302 (361)
T ss_pred cc-c--cceeeecCCCCccC---ChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence 21 1 111112 6888888 788653 5789999976 489999977653210000001110 00000
Q ss_pred -ccCCCCcc-ccCC--hh---HHHHHHhccccCCCCCCCHHHHhc
Q psy622 262 -QLEWPEDE-EALN--PS---TEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 262 -~~~~P~~~-~~ls--~~---a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.+--|... ...+ .+ +..+..+|++.+|.+||++.||.+
T Consensus 303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 00001110 1222 22 556677999999999999998753
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=261.49 Aligned_cols=237 Identities=19% Similarity=0.231 Sum_probs=179.1
Q ss_pred ceecccCceEEEEEEEeCCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEeccc
Q psy622 47 KAISRGAFGKVFLGYKKTNKD-QLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLVMEYM 124 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~-~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~ 124 (473)
++||+|+||.||+|+.+.+.. ..+|+|.++... .......+.+|++++..+ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999998876322 247888887532 234456788999999999 8999999999999999999999999
Q ss_pred CcCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecc
Q psy622 125 IGGDVKSLIAANG----------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 125 ~gg~L~~~L~~~~----------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
++|+|.+++...+ .+++..++.++.||+.||+|||+.|++||||||+|||++.+ +.+||+|||
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~-~~~kl~dfg 157 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFG 157 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC-CeEEECCCC
Confidence 9999999997643 47899999999999999999999999999999999999999 999999999
Q ss_pred hhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh
Q psy622 189 FLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ 260 (473)
Q Consensus 189 la~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~ 260 (473)
++...... ........++.|+ |||++. ..|.|++|++ +++++ |..||....... ........
T Consensus 158 l~~~~~~~----~~~~~~~~~~~y~---apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVY----VKKTMGRLPVRWM---AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLPQG 227 (270)
T ss_pred Cccccchh----hhccCCCCccccC---ChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHHhCC
Confidence 98642111 0011112233455 777642 4788999965 56775 999996421100 00000000
Q ss_pred hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 261 LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 261 ~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.....+ ..++.++.+|+.+||+.||.+||+++++++
T Consensus 228 ~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 YRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCCC---CcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 111222 467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=260.64 Aligned_cols=232 Identities=14% Similarity=0.160 Sum_probs=176.4
Q ss_pred ceecccCceEEEEEEEeCC-----------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 47 KAISRGAFGKVFLGYKKTN-----------KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~-----------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
+.||+|+||.||+|+.... ....+|+|++.... ......+..|..++..++||||+++++++.+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4689999999999975321 12358888877542 333457788899999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCc-------eeEeec
Q psy622 116 CVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH-------CPIVNT 187 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~-------ikL~DF 187 (473)
..++||||+++|+|..++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +. ++++||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLARE-GIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecC-CccCCCCceeEeCCC
Confidence 999999999999999988764 579999999999999999999999999999999999999876 43 899999
Q ss_pred chhhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-cccc-CCCCCchhHhhhcCCCCChhhH
Q psy622 188 LFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQ-NSQAPFPSALRVAGSQIPTSTA 258 (473)
Q Consensus 188 Gla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~-~g~~pf~~~~~~~~~~~~~~~~ 258 (473)
|++...... ....++..|+ |||.+. ..|.|++|++ ++++ .|..||....... ....
T Consensus 157 g~~~~~~~~-------~~~~~~~~y~---aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~ 221 (262)
T cd05077 157 GIPITVLSR-------QECVERIPWI---APECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----KERF 221 (262)
T ss_pred CCCccccCc-------cccccccccc---ChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----HHHH
Confidence 998764321 1123555565 788653 3588999965 5565 6888876421100 0001
Q ss_pred hhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 259 AQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 259 ~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
........ ...+.++.+||.+||+.||.+||++.+|+++
T Consensus 222 ~~~~~~~~---~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 222 YEGQCMLV---TPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HhcCccCC---CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 11111111 2356789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=259.61 Aligned_cols=237 Identities=19% Similarity=0.252 Sum_probs=183.1
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCc
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIG 126 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 126 (473)
++||+|+||.||+|.+.. ++.||+|++...... .....+.+|+++++.++||||+++++++.+....|+||||++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~--~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG--NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC--CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 479999999999998764 688999998875432 3456889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 127 GDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 127 g~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
++|.+++.+. ..+++..+..++.+++.||+|||++|++||||||+||+++.+ +.+||+|||++......... .....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYT-VSDGL 154 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC-CcEEEeeccccccccCCcce-ecccc
Confidence 9999999764 468999999999999999999999999999999999999998 99999999999864321111 00011
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCCccccCChhH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDEEALNPST 276 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~~~ls~~a 276 (473)
..++..|+ +||.+. ..|+|++|++ +++++ |..||....... ....... .....| ..++.++
T Consensus 155 ~~~~~~y~---~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~ 224 (251)
T cd05041 155 KQIPIKWT---APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ----TRERIESGYRMPAP---QLCPEEI 224 (251)
T ss_pred CcceeccC---ChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH----HHHHHhcCCCCCCC---ccCCHHH
Confidence 12233344 777543 4688999965 56777 788886421100 0011110 111222 5688999
Q ss_pred HHHHHhccccCCCCCCCHHHHhc
Q psy622 277 EETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 277 ~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.+++.+||+.+|.+||++.|+++
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHH
Confidence 99999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=260.03 Aligned_cols=246 Identities=21% Similarity=0.307 Sum_probs=189.8
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccc-------cchhHHHHHHHHHHHHHh-cCCCCeeeEEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM-------INKNMVSQVLRERNALAL-THSPFCVQLFYSLQT 113 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~-------~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~~ 113 (473)
+|++.+.||+|+||.||+|+.+.++++.+|+|.+..... ........+.+|+.++.. ++||||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 488999999999999999998875678999999874321 223345567888888875 699999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCceeEeecc
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
.+..|+||||++|++|.+++.. ...+++..++.++.||+.||.|||+ .|++||||||+||+++.+ +.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~-~~~~l~dfg 159 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED-DKVTITDFG 159 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC-CcEEEeccc
Confidence 9999999999999999998853 3469999999999999999999996 789999999999999999 999999999
Q ss_pred hhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhh
Q psy622 189 FLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQL 261 (473)
Q Consensus 189 la~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~ 261 (473)
++....... ......|+..|+ +||... ..+.|++|++ +++++|..||....... .......
T Consensus 160 ~~~~~~~~~----~~~~~~~~~~~~---~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~----~~~~~~~- 227 (269)
T cd08528 160 LAKQKQPES----KLTSVVGTILYS---CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS----LATKIVE- 227 (269)
T ss_pred ceeeccccc----ccccccCcccCc---ChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH----HHHHHhh-
Confidence 998754322 112234666666 777654 3578899965 57999999986421100 0001111
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
....|.....+++++.++|.+||+.||++||++.|+..+
T Consensus 228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 228 AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 111122223678999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=258.80 Aligned_cols=236 Identities=20% Similarity=0.285 Sum_probs=181.7
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
.+++|++.+.||+|+||.||++.. +++.||+|+++... ....+.+|+.+++.++||||+++++++... ..|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 74 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY 74 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc---CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence 457899999999999999999853 45789999987542 235788999999999999999999998754 479
Q ss_pred EEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 119 LVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.+ +.+||+|||++......
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED-GVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CcEEECCCccceecccc
Confidence 9999999999999998653 58999999999999999999999999999999999999998 89999999998763221
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
.. ....++.|+ +||.+. ..|.|++|++ +++++ |..||....... ........ .. +..
T Consensus 154 ~~------~~~~~~~y~---~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~-~~-~~~ 218 (254)
T cd05083 154 VD------NSKLPVKWT---APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE----VKECVEKG-YR-MEP 218 (254)
T ss_pred CC------CCCCCceec---CHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH----HHHHHhCC-CC-CCC
Confidence 11 111223333 676543 3688999966 56775 899986421100 00111111 11 111
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
+..++.++.+++.+||+.+|.+||+++++++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=260.96 Aligned_cols=242 Identities=17% Similarity=0.190 Sum_probs=176.4
Q ss_pred ceecccCceEEEEEEEeCC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKTN-KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~-~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
+.||+|+||+||+|+.... ....+++|.++... .......+.+|..+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975542 22346677666542 12345688999999999999999999999999999999999999
Q ss_pred cCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc
Q psy622 126 GGDVKSLIAAN----GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE 201 (473)
Q Consensus 126 gg~L~~~L~~~----~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~ 201 (473)
+|+|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.+ +++||+|||++....... ...
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~-~~~ 156 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKED-YIE 156 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-ccEEecccccccccCcch-hhh
Confidence 99999999864 246777889999999999999999999999999999999998 999999999986422111 111
Q ss_pred cccccCCCCcccccCCccccc-------------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhcc--C
Q psy622 202 ISDLVNGTPNAFNIRTPGQLL-------------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQL--E 264 (473)
Q Consensus 202 ~~~~~~gtp~y~~~~ape~i~-------------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~--~ 264 (473)
.....++++.|+ |||++. ..|+|++|++ +++++ +..||...... ............ .
T Consensus 157 ~~~~~~~~~~y~---aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~ 230 (268)
T cd05086 157 TEDDKCVPLRWL---APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHVIKDQQVKLF 230 (268)
T ss_pred cccCCcCccccc---CchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhhcccccC
Confidence 112345666666 777642 3688999965 56664 57777531100 000000111111 1
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
-|.....+++.+.+++..|| .+|.+||+++||++
T Consensus 231 ~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 231 KPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 12223457889999999999 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-33 Score=252.22 Aligned_cols=257 Identities=23% Similarity=0.378 Sum_probs=191.6
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC--C
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTS--S 115 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~--~ 115 (473)
..++|++.+++|+|.|+.|+.|+... +++.++||+++.-+ .+.+.+|+.||..+. ||||++|++...+. +
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~-~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINIT-NNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccC-CCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 46889999999999999999998776 46789999998632 347889999999995 99999999999765 4
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
..-+|+||++..|...+.. .++...+++|+.||+.||.|+|++||+|||+||.|++||...-.++|+|.|+|.....
T Consensus 109 tpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred CchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 5789999999988887765 4788899999999999999999999999999999999998767899999999998755
Q ss_pred Cccc-cccccccCCCCcccccCCccccccCCcCCCCccc-cccCCCCCchh----------HhhhcCCC-----------
Q psy622 196 PIVY-LEISDLVNGTPNAFNIRTPGQLLSLKTGTFPTFQ-DVQNSQAPFPS----------ALRVAGSQ----------- 252 (473)
Q Consensus 196 ~~~~-~~~~~~~~gtp~y~~~~ape~i~~~~~~s~g~l~-~~~~g~~pf~~----------~~~~~~~~----------- 252 (473)
.... ....+...--|+.+ ..-+.+-.+.+.||+|++. .|...+-||.. +-+..+..
T Consensus 186 ~~eYnVRVASRyfKGPELL-Vdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred CceeeeeeehhhcCCchhe-eechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 4433 22222222223321 0012234578999999765 58877777742 11111111
Q ss_pred -CCh--hhHhh--hccCC-----CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 253 -IPT--STAAQ--LQLEW-----PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 253 -~~~--~~~~~--~~~~~-----P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
..+ ..+.. .+..| +....-.++++.|||.++|..|-.+||||.|++.||||..+
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 000 00000 11111 12223456999999999999999999999999999999754
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=256.91 Aligned_cols=241 Identities=17% Similarity=0.213 Sum_probs=177.8
Q ss_pred ceecccCceEEEEEEEeCC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCCEEEEEecc
Q psy622 47 KAISRGAFGKVFLGYKKTN--KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ-TSSCVFLVMEY 123 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~--~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-~~~~l~lVmEy 123 (473)
+.||+|+||.||+|..... ....||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 4689999999999986542 23579999986432 2344668889999999999999999999765 45678999999
Q ss_pred cCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc-c
Q psy622 124 MIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL-E 201 (473)
Q Consensus 124 ~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~-~ 201 (473)
+.+|+|.+++.+. ..+++..+..++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+++.+....... .
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCccccccccCCcceeec
Confidence 9999999999864 356788888999999999999999999999999999999998 899999999998653221110 1
Q ss_pred cccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCC-CCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 202 ISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNS-QAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 202 ~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
......+++.|+ |||... ..|+|++|++ +++++| .+||...... ... .... ....+..+..++
T Consensus 158 ~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~-~~~~--~~~~~~~~~~~~ 228 (262)
T cd05058 158 NHTGAKLPVKWM---ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DIT-VYLL--QGRRLLQPEYCP 228 (262)
T ss_pred ccccCcCCcccc---ChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH-HHHh--cCCCCCCCCcCC
Confidence 111223445555 777543 4688899965 567774 5566531100 000 0000 111111224678
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
+.+.+++.+||+.+|++||++.|+++
T Consensus 229 ~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 229 DPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 89999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=289.99 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=203.4
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEE
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQ----LYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYS 110 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~----~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 110 (473)
++.++-+..++.+.||+|+||.||.|......+. .||||.+++. .+.+++..|++|..+|+.++|||||+++++
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEe
Confidence 4456677899999999999999999987765443 4899998875 346668899999999999999999999999
Q ss_pred EEeCCEEEEEecccCcCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCcee
Q psy622 111 LQTSSCVFLVMEYMIGGDVKSLIAAN-------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCP 183 (473)
Q Consensus 111 f~~~~~l~lVmEy~~gg~L~~~L~~~-------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ik 183 (473)
+-+....+|++|||+||||..+|++. ..++......++.+|+.|.+||+++++|||||-.+|+||+.. ..+|
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VK 842 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVK 842 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEE
Confidence 99999999999999999999999986 248899999999999999999999999999999999999999 9999
Q ss_pred EeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-cc-ccCCCCCchhHhhhcCCCCCh
Q psy622 184 IVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QD-VQNSQAPFPSALRVAGSQIPT 255 (473)
Q Consensus 184 L~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~-~~~g~~pf~~~~~~~~~~~~~ 255 (473)
|+|||+|+.+.....+..-.. ..-. +.|.+||.+. ..|+|+||++ |+ +..|..||+.... .++..
T Consensus 843 IaDFGlArDiy~~~yyr~~~~-a~lP---vkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n---~~v~~ 915 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGE-AMLP---VKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN---FEVLL 915 (1025)
T ss_pred EcccchhHhhhhchheeccCc-cccc---eecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch---HHHHH
Confidence 999999996654443322111 0111 2344888654 4799999987 56 5678999986321 11222
Q ss_pred hhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 256 STAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 256 ~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
......++..| ..++..+.++|.+||+.+|++||++..|++
T Consensus 916 ~~~~ggRL~~P---~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 916 DVLEGGRLDPP---SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHhCCccCCC---CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 23333455556 689999999999999999999999988886
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=256.89 Aligned_cols=229 Identities=16% Similarity=0.178 Sum_probs=174.2
Q ss_pred ceecccCceEEEEEEEeCCCC---------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 47 KAISRGAFGKVFLGYKKTNKD---------QLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~---------~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+.||+|+||.||+|..+...+ ..+++|++.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 478999999999998876321 357888776543 115678899999999999999999999988 778
Q ss_pred EEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC-------ceeEeecch
Q psy622 118 FLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP-------HCPIVNTLF 189 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g-------~ikL~DFGl 189 (473)
|+||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.+ + .+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~-~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY-GLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecC-ccccCCceeEEeCCCCc
Confidence 99999999999999998766 79999999999999999999999999999999999999988 6 799999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHh
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAA 259 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~ 259 (473)
+....... ...+++.|+ +||.+. ..|.|++|++ +++++ |..||..... .......
T Consensus 155 a~~~~~~~-------~~~~~~~y~---aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-----~~~~~~~ 219 (259)
T cd05037 155 PITVLSRE-------ERVERIPWI---APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-----SEKERFY 219 (259)
T ss_pred cccccccc-------ccccCCCcc---ChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-----hhHHHHH
Confidence 98753311 122333444 666532 3688899965 56766 5777754210 0000111
Q ss_pred hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 260 QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 260 ~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
......| ......+.++|.+||+.+|.+||++.++++
T Consensus 220 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 220 QDQHRLP---MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred hcCCCCC---CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111222 223478999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=276.89 Aligned_cols=263 Identities=16% Similarity=0.161 Sum_probs=182.4
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeC---------------CCCcEEEEEEeecccccc-----------hhHHHHH
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKT---------------NKDQLYAIKVMKKDEMIN-----------KNMVSQV 89 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~---------------~~~~~vAiK~l~k~~~~~-----------~~~~~~~ 89 (473)
...+.++|++.++||+|+||+||+|.... ..++.||||.++...... ....+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 45667899999999999999999996421 124679999987532110 0112234
Q ss_pred HHHHHHHHhcCCCCe-----eeEEEEEE--------eCCEEEEEecccCcCCHHHHHHhC--------------------
Q psy622 90 LRERNALALTHSPFC-----VQLFYSLQ--------TSSCVFLVMEYMIGGDVKSLIAAN-------------------- 136 (473)
Q Consensus 90 ~~E~~iL~~l~hp~I-----v~l~~~f~--------~~~~l~lVmEy~~gg~L~~~L~~~-------------------- 136 (473)
..|..++.+++|.++ ++++++|. +.+..|+|+||+++|+|.++|+..
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 457777777766554 56666653 245689999999999999998742
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcc
Q psy622 137 ----GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNA 212 (473)
Q Consensus 137 ----~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y 212 (473)
..+++..++.++.||+.||.|||+++|+||||||+|||++.+ +.+||+|||++......... ......++|.|
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~--~~~~g~~tp~Y 376 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINF--NPLYGMLDPRY 376 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-CcEEEEeCcCccccccCCcc--CccccCCCcce
Confidence 123567889999999999999999999999999999999998 89999999999764322111 11112346777
Q ss_pred cccCCccccc----------------------------cCCcCCCCcc-ccccCCCC-CchhHhhh------cCCCCCh-
Q psy622 213 FNIRTPGQLL----------------------------SLKTGTFPTF-QDVQNSQA-PFPSALRV------AGSQIPT- 255 (473)
Q Consensus 213 ~~~~ape~i~----------------------------~~~~~s~g~l-~~~~~g~~-pf~~~~~~------~~~~~~~- 255 (473)
+ +||.+. ..|+|++|++ ++|+++.. ||...... .......
T Consensus 377 ~---aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~ 453 (507)
T PLN03224 377 S---PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW 453 (507)
T ss_pred e---ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH
Confidence 6 777642 1488999966 45877764 66432110 0000000
Q ss_pred hhHhhhccCCCCccccCChhHHHHHHhccccCC---CCCCCHHHHhcCCCCCC
Q psy622 256 STAAQLQLEWPEDEEALNPSTEETILALLKSDP---TQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 256 ~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP---~kRpsa~eil~HPFF~~ 305 (473)
.........++. .+..++.++||+.+||.++| .+|+|++|+++||||..
T Consensus 454 r~~~~~~~~~~~-~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 454 RMYKGQKYDFSL-LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred HhhcccCCCccc-ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 001112333432 25688999999999999876 68999999999999964
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=265.20 Aligned_cols=249 Identities=15% Similarity=0.196 Sum_probs=186.9
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKD---QLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~---~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
...++|+..+.||+|+||.||+|.++.+.. ..+|+|.+..... ......+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 456789999999999999999998776322 2478898876432 23344688999999999999999999998754
Q ss_pred CEEEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..++|+||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++.+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~-~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP-NHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC-CceEEccccccccc
Confidence 4679999999999999998754 68999999999999999999999999999999999999988 89999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
........ .....+++.|+ +||.+. ..+.|++|++ +++++ |..||....... . .... ......
T Consensus 160 ~~~~~~~~-~~~~~~~~~y~---~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~-~~~~-~~~~~~ 230 (303)
T cd05110 160 EGDEKEYN-ADGGKMPIKWM---ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---I-PDLL-EKGERL 230 (303)
T ss_pred cCcccccc-cCCCccccccC---CHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H-HHHH-HCCCCC
Confidence 43221111 11122344555 787653 3588899965 56665 888886421100 0 0011 111112
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
+. +...+.++.+++.+||..+|++||+++++++.
T Consensus 231 ~~-~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 PQ-PPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 21 24578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=259.78 Aligned_cols=246 Identities=18% Similarity=0.244 Sum_probs=184.1
Q ss_pred eEEEceecccCceEEEEEEEeCC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTN--KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS----- 115 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~--~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----- 115 (473)
|++.++||+|+||.||+|..+.. +++.||||++.... ......+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 67889999999999999986542 46789999997653 33444677899999999999999999999886432
Q ss_pred -EEEEEecccCcCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecc
Q psy622 116 -CVFLVMEYMIGGDVKSLIAAN------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 116 -~l~lVmEy~~gg~L~~~L~~~------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
..++++||+.+|+|..++... ..+++..++.++.||+.||+|||+.||+||||||+||+++.+ +.+||+|||
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~-~~~kl~dfg 158 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVADFG 158 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC-CCEEECccc
Confidence 257899999999999887532 247899999999999999999999999999999999999988 899999999
Q ss_pred hhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh
Q psy622 189 FLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ 260 (473)
Q Consensus 189 la~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~ 260 (473)
+++........ .......+++.|+ +||... ..|+|++|++ +++++ |..||....... +.......
T Consensus 159 ~~~~~~~~~~~-~~~~~~~~~~~~~---~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~~ 231 (273)
T cd05074 159 LSKKIYSGDYY-RQGCASKLPVKWL---ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLIKG 231 (273)
T ss_pred ccccccCCcce-ecCCCccCchhhc---CHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHHcC
Confidence 99875322211 1111223445555 677542 4689999965 56776 888886421100 00001111
Q ss_pred hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 261 LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 261 ~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.....+ ...+..+.+++.+||+.+|.+||++.+++++
T Consensus 232 ~~~~~~---~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 232 NRLKQP---PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112222 4678999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=259.12 Aligned_cols=240 Identities=21% Similarity=0.258 Sum_probs=181.5
Q ss_pred ceecccCceEEEEEEEeCC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 47 KAISRGAFGKVFLGYKKTN-----KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~-----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+.||+|+||.||+|+.+.. .++.+|||.+.+... ......+.+|+++++.++||||+++++++.+....|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 4689999999999987642 236799999876421 233557889999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC-----ceeEeecch
Q psy622 122 EYMIGGDVKSLIAAN-------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP-----HCPIVNTLF 189 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~-------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g-----~ikL~DFGl 189 (473)
||++||+|.+++.+. ..+++..+..++.||+.||+|||+.+++||||||+||+++.+ + .++|+|||+
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~~~~~~l~dfg~ 157 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEK-GYDADRVVKIGDFGL 157 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecC-CCCCCcceEECCccc
Confidence 999999999999752 247889999999999999999999999999999999999987 6 899999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhh
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQL 261 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~ 261 (473)
++.+...... .......+++.|+ +||.+. ..|.|++|++ +++++ |..||....... .........
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYY-RKEGEGLLPVRWM---APESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHVTAGG 230 (269)
T ss_pred cccccccccc-ccCcccCCCcccc---CHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHHhcCC
Confidence 9865332211 1111122344455 777653 3688999965 56776 999986421100 000000011
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
....+ ..++.++.++|.+||+.+|.+||+++++++
T Consensus 231 ~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 RLQKP---ENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ccCCc---ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 12222 568899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=268.24 Aligned_cols=252 Identities=20% Similarity=0.340 Sum_probs=196.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC------CCCeeeEEEEEEe
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH------SPFCVQLFYSLQT 113 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~------hp~Iv~l~~~f~~ 113 (473)
-++|.+....|+|-|++|..|++.. .|+.||||+|..+.+.. +.=+.|++||++|+ --++++|+..|..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~-r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQA-RGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccC-CCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3679999999999999999998876 57799999999875433 34578999999984 3489999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANG---ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~---~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
.+++|||+|-+ ..+|.+.|++.| .|....++.|+.|++.||.+|-+.||+|.||||+|||++.....+||||||.|
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 99999999998 889999999876 48889999999999999999999999999999999999988678999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCcccccc------CCcCCCCc-cccccCCCCCchhHh-----h---hcCCCCCh
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPT-FQDVQNSQAPFPSAL-----R---VAGSQIPT 255 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~-l~~~~~g~~pf~~~~-----~---~~~~~~~~ 255 (473)
........+..+-+ -.|+|||++++ .++|+.|+ +|++.+|+..|++.. + .....++.
T Consensus 585 ~~~~eneitPYLVS--------RFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 585 SFASENEITPYLVS--------RFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred cccccccccHHHHH--------HhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 87554332211111 14678888764 68899995 677999999998621 0 01111111
Q ss_pred hhHh------------------------------------------h---hccCCCCccccCChhHHHHHHhccccCCCC
Q psy622 256 STAA------------------------------------------Q---LQLEWPEDEEALNPSTEETILALLKSDPTQ 290 (473)
Q Consensus 256 ~~~~------------------------------------------~---~~~~~P~~~~~ls~~a~dLI~~LL~~dP~k 290 (473)
..+. . ....+|......-.++++||.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 1110 0 011123222334456999999999999999
Q ss_pred CCCHHHHhcCCCCCC
Q psy622 291 RPSGHQVRRLPMFKD 305 (473)
Q Consensus 291 Rpsa~eil~HPFF~~ 305 (473)
|+++.|+++||||..
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999974
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=249.99 Aligned_cols=253 Identities=21% Similarity=0.326 Sum_probs=197.8
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTS 114 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 114 (473)
-.-+-++.+-+..||.|+||+|++..++. +|+..|||.+..... ....++++.|.+...+. ++|+||++|++.-.+
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~-sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKP-SGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCc-cCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 34444566778899999999999999887 689999999998754 45567899999877665 899999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCceeEeecc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAA-----NGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~-----~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
+..||.||+| ..+|..+... ...++|...-.+....+.||+||-. .+|||||+||+|||||.. |.+||||||
T Consensus 136 GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~-G~vKLCDFG 213 (361)
T KOG1006|consen 136 GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH-GDVKLCDFG 213 (361)
T ss_pred CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC-CCEeeeccc
Confidence 9999999999 7777665532 4579999999999999999999985 589999999999999999 999999999
Q ss_pred hhhhhcCCccccccccccCCCCcccccCCcccc--------ccCCcCCCCc-cccccCCCCCchhHhhhcCCCCChhhHh
Q psy622 189 FLAILQQPIVYLEISDLVNGTPNAFNIRTPGQL--------LSLKTGTFPT-FQDVQNSQAPFPSALRVAGSQIPTSTAA 259 (473)
Q Consensus 189 la~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i--------~~~~~~s~g~-l~~~~~g~~pf~~~~~~~~~~~~~~~~~ 259 (473)
.|-.+..... .+.-.|.-.|| |||.+ ...+.||+|+ +++..+|..||..-.... +.+.
T Consensus 214 IcGqLv~SiA----kT~daGCrpYm---APERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf------eql~ 280 (361)
T KOG1006|consen 214 ICGQLVDSIA----KTVDAGCRPYM---APERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF------EQLC 280 (361)
T ss_pred chHhHHHHHH----hhhccCCcccc---ChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH------HHHH
Confidence 9987643211 11234666666 66654 3467899995 678999999997521110 0011
Q ss_pred h---h---ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 260 Q---L---QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 260 ~---~---~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+ + .+..+....+.+..++.+|.-||.+|-..||...++++|||++..
T Consensus 281 ~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 281 QVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 1 0 122222224688999999999999999999999999999999865
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=290.45 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=187.3
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe------
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT------ 113 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------ 113 (473)
+.+|+.+++||+||||.||+|+.+- .|+.||||+|.-.. .......+.+|+.+|++++|||||+++.+|..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKl-DGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKL-DGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecc-cchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4679999999999999999999988 57999999998764 45556789999999999999999999766521
Q ss_pred --------------------------------------------------------------------------------
Q psy622 114 -------------------------------------------------------------------------------- 113 (473)
Q Consensus 114 -------------------------------------------------------------------------------- 113 (473)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CEEEEEecccCcCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHH
Q psy622 114 -------------------------S--------SCVFLVMEYMIGGDVKSLIAANGAL-PEDMAAFYAAEVVLALQYLH 159 (473)
Q Consensus 114 -------------------------~--------~~l~lVmEy~~gg~L~~~L~~~~~~-~e~~~~~~~~qI~~aL~yLH 159 (473)
+ ..+||=||||+...|.+++.++... ....++.+++||+.||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1358999999887787777776444 47889999999999999999
Q ss_pred HCCeeecCCCCcceEecCCCCceeEeecchhhhhc----CCcc-----------ccccccccCCCCcccccCCccccc--
Q psy622 160 SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ----QPIV-----------YLEISDLVNGTPNAFNIRTPGQLL-- 222 (473)
Q Consensus 160 ~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~----~~~~-----------~~~~~~~~~gtp~y~~~~ape~i~-- 222 (473)
++|||||||||.||+||++ +.|||.|||+++... .... .....+...||.-|+ |||...
T Consensus 715 ~~giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYv---APEll~~~ 790 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYV---APELLSDT 790 (1351)
T ss_pred hCceeeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeee---cHHHhccc
Confidence 9999999999999999999 999999999998721 0000 000122345666666 888653
Q ss_pred -------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc---cccCChhHHHHHHhccccCCCCC
Q psy622 223 -------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED---EEALNPSTEETILALLKSDPTQR 291 (473)
Q Consensus 223 -------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~---~~~ls~~a~dLI~~LL~~dP~kR 291 (473)
..|.+++|++ .+|+. ||...+.... +. .... ...+|.. ...--+....+|+.||+.||.+|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~--iL-~~LR--~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS--IL-TNLR--KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHH--HH-Hhcc--cCCCCCCcccccccchHHHHHHHHHhcCCCccC
Confidence 3566788865 46664 4654322110 00 0111 2222322 23444678899999999999999
Q ss_pred CCHHHHhcCCCCC
Q psy622 292 PSGHQVRRLPMFK 304 (473)
Q Consensus 292 psa~eil~HPFF~ 304 (473)
|||.|++++.||-
T Consensus 863 PtA~eLL~s~llp 875 (1351)
T KOG1035|consen 863 PTATELLNSELLP 875 (1351)
T ss_pred CCHHHHhhccCCC
Confidence 9999999999997
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-34 Score=259.58 Aligned_cols=260 Identities=20% Similarity=0.273 Sum_probs=189.4
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT----- 113 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~----- 113 (473)
..+.|+-+.+||+|+||.||+|+.+. +++.||+|++--.. .+..--...++|+++|..++|+|++.+++.+.+
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n-~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKN-TGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcC-ccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 45678888999999999999999886 67888988764321 122233467899999999999999998876632
Q ss_pred ---CCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecch
Q psy622 114 ---SSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 114 ---~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
...+|+||++| ..||..+|.+. .+|+..+++.++.+++.||.|+|++.|+|||+|++|+||+.+ |.+||+|||+
T Consensus 93 ~r~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d-gilklADFGl 170 (376)
T KOG0669|consen 93 NRDRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD-GILKLADFGL 170 (376)
T ss_pred ccccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC-ceEEeecccc
Confidence 34599999999 56999999876 589999999999999999999999999999999999999999 9999999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCccc-cccCCCCCchhHh---------hhcCCC
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTFQ-DVQNSQAPFPSAL---------RVAGSQ 252 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l~-~~~~g~~pf~~~~---------~~~~~~ 252 (473)
++.+........... ....-.+.|++||.++ ..+.|+-|++. +|.++.+.+.+.. ...+.-
T Consensus 171 ar~fs~~~n~~kpry--tnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRY--TNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccceecccccCCCCc--ccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 987643322211110 0001124566777665 36778888664 6999888886521 111111
Q ss_pred CCh--------hhHhhhccC-CCCc----------cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 253 IPT--------STAAQLQLE-WPED----------EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 253 ~~~--------~~~~~~~~~-~P~~----------~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
.+. ...+...++ .|.. +-.-++++.+|+.+||..||.+|+.+.++++|.||.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 111 001111111 1110 122356899999999999999999999999999995
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=277.34 Aligned_cols=243 Identities=23% Similarity=0.297 Sum_probs=185.5
Q ss_pred eEEEceecccCceE-EEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEE
Q psy622 43 FEIVKAISRGAFGK-VFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 43 y~i~~~LG~G~fG~-V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lV 120 (473)
|.-.+++|.|+-|+ ||+|... ++.||||.+-.. -....++|+..|+.. +|||||++++.-++..++||+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye---~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE---GREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC---CceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 33446789999886 7888653 578999997643 245678999999988 799999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC---C-CCceeEeecchhhh
Q psy622 121 MEYMIGGDVKSLIAANGA----LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA---Q-APHCPIVNTLFLAI 192 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~----~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~---~-~g~ikL~DFGla~~ 192 (473)
.|.| ..+|.+++...+. ......+..+.|++.||+|||+.+||||||||+||||+. + ...++|+|||+||.
T Consensus 582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9999 7799999987411 112456889999999999999999999999999999987 3 15789999999999
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-cc-ccCCCCCchhHhhhcCCCCChhhHhhhccC
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QD-VQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~-~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 264 (473)
+..............||-+|+ |||++. .+|..++|++ ++ +..|..||........ .|...... ...
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~---APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl~~~~~--L~~ 734 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQ---APEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NILTGNYT--LVH 734 (903)
T ss_pred cCCCcchhhcccCCCCccccc---CHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhhcCccc--eee
Confidence 876665555555566777776 999864 4688899965 45 4556999976443221 11111100 111
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
+.. ....+|++||.+||+.+|..||+|.+|+.||||=
T Consensus 735 L~~---~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 735 LEP---LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred ecc---CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 111 1112999999999999999999999999999993
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=289.13 Aligned_cols=280 Identities=34% Similarity=0.531 Sum_probs=218.6
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
...+...+|+.++.|..|+||.||+++++. +.+.+|+ .++|+.+.-+ +||.....||+|
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~-trqrfa~-kiNkq~lilR----------nilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKE-TRQRFAM-KINKQNLILR----------NILTFAGNPFVV--------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccc-cccchhh-cccccchhhh----------ccccccCCccee---------
Confidence 567778999999999999999999999997 5789999 5566543221 266777788877
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
||-..+++.-+.++.+. +.|++|||+.||+|||+||+|++|..- ||+|++|||+++...
T Consensus 136 ------------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~m-GhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 ------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGL 194 (1205)
T ss_pred ------------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeec-ccccccchhhhhhhh
Confidence 78888888877777554 889999999999999999999999999 999999999998631
Q ss_pred CCc-----------ccccc-ccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh
Q psy622 195 QPI-----------VYLEI-SDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT 255 (473)
Q Consensus 195 ~~~-----------~~~~~-~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~ 255 (473)
-.. ....+ ..-.||||+|+ |||++.. +|||++|++ ++.+.|..||.+. .++
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyi---aPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd-------tpe 264 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYI---APEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-------TPE 264 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCcccc---ChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC-------CHH
Confidence 100 11112 23459999999 9999864 689999965 5699999999764 222
Q ss_pred h---hHhhhccCCCCccccCChhHHHHHHhccccCCCCCCC---HHHHhcCCCCCCCCccccccCCCCCcCCCCCCCCCC
Q psy622 256 S---TAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPS---GHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDTS 329 (473)
Q Consensus 256 ~---~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps---a~eil~HPFF~~idw~~l~~~~pPf~P~~~~~~D~s 329 (473)
+ ......+.||+....+.++++++|.+||+.+|..|++ +-++++|+||+.+||..|++++++|+|.+.++.||+
T Consensus 265 elfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddts 344 (1205)
T KOG0606|consen 265 ELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTS 344 (1205)
T ss_pred HHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccccch
Confidence 2 2223567888877889999999999999999999985 789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCC---CCCC--ccCCCCCceecccCCCCCCCC
Q psy622 330 YFHADKTNSYMD---STLS--TTHGNGSFVCCSNLNSHTASG 366 (473)
Q Consensus 330 ~Fd~~~t~~~~~---~~~~--~~~~~~~~~~~~~~~~~~f~g 366 (473)
|||+.-+.--.. .+.+ .....+.|+.|+......+..
T Consensus 345 yfdTRs~Ryh~~~se~~~~ees~~~~~qFsscs~r~~kv~ss 386 (1205)
T KOG0606|consen 345 YFDTRSDRYHHFESEDTGDEESSLEFRQFSSCSPRFSKVYSS 386 (1205)
T ss_pred hhcccchheeeccccCCccccccccccccccccccccccccc
Confidence 999886542111 1111 223456777777655554443
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=277.79 Aligned_cols=193 Identities=26% Similarity=0.375 Sum_probs=163.9
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------C
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS------S 115 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~------~ 115 (473)
-+..-+.||+|+||.||+++++. +|+.||||..++.. ....++...+|+++|++++|||||++.++=++. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnke-tG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKE-TGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred ceeehhhhcCCccceeeeecccc-cccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 35566899999999999999887 78999999999864 344567889999999999999999999887544 3
Q ss_pred EEEEEecccCcCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC---CceeEeecch
Q psy622 116 CVFLVMEYMIGGDVKSLIAAN---GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA---PHCPIVNTLF 189 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~---~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~---g~ikL~DFGl 189 (473)
...+|||||.||||+..|++. ..++|.+...++..++.||.|||++||+||||||+||++.... ...||||||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 578999999999999999863 3699999999999999999999999999999999999996432 2469999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchh
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPS 244 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~ 244 (473)
|+.+.... .....+||++|+ +||..- .+|.||+|+. |++.+|..||..
T Consensus 171 Arel~d~s----~~~S~vGT~~YL---hPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 171 ARELDDNS----LFTSLVGTEEYL---HPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccCCCCC----eeeeecCchhhc---ChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 99976543 345579999999 777543 4899999975 569999999964
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=256.34 Aligned_cols=253 Identities=13% Similarity=0.114 Sum_probs=178.8
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCC--CcEEEEEEeecccccc--hhH------HHHHHHHHHHHHhcCCCCeeeE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNK--DQLYAIKVMKKDEMIN--KNM------VSQVLRERNALALTHSPFCVQL 107 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~--~~~vAiK~l~k~~~~~--~~~------~~~~~~E~~iL~~l~hp~Iv~l 107 (473)
+.-++|++.++||+|+||+||+|++..+. +..+|+|+........ ... ......+...+..++|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 34468999999999999999999876531 4567777644322110 000 0112233344556789999999
Q ss_pred EEEEEeCC----EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCcee
Q psy622 108 FYSLQTSS----CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCP 183 (473)
Q Consensus 108 ~~~f~~~~----~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ik 183 (473)
+++..... ..+++++++ ..++.+.+.....+++..++.++.||+.||+|||+++|+||||||+|||++.+ +.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~-~~~~ 166 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN-NRGY 166 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CcEE
Confidence 98765443 458889988 56788888776668899999999999999999999999999999999999988 8999
Q ss_pred EeecchhhhhcCCccc----cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcC-C
Q psy622 184 IVNTLFLAILQQPIVY----LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAG-S 251 (473)
Q Consensus 184 L~DFGla~~~~~~~~~----~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~-~ 251 (473)
|+|||+|+.+...... ........||+.|+ |||+.. ..|.|++|+. +++++|..||........ .
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~---ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYA---GLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCcccc---CHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999875321111 11122346888887 787643 4688999965 679999999975311000 0
Q ss_pred C-CCh---hhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 252 Q-IPT---STAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 252 ~-~~~---~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
. ... ..+.+..... ...++++.++++.|++.+|.+||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKI----KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhhhcc----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 000 0111112222 356899999999999999999999999875
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=271.75 Aligned_cols=253 Identities=19% Similarity=0.242 Sum_probs=205.7
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNK--DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~--~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
+++..+...|.++||.|.||.|+.|+.+... ...||||.|+... ..++...|+.|..||-+++||||++|.++...
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 5666788999999999999999999988643 2469999999864 45667789999999999999999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
.+-+.||+|||+.|+|..+|+++ |.|+..+..-+++.|+.|+.||-+.|+|||||-..|||++++ -.+|++|||+++.
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-LvCKVsDFGLSRv 780 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-LVCKVSDFGLSRV 780 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-eEEEeccccceee
Confidence 99999999999999999999874 689999999999999999999999999999999999999999 8999999999998
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-cc-ccCCCCCchhHhhhcCCCCChhhHhhhccC
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QD-VQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~-~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 264 (473)
+.+.... ..++ .|-.--+.|.|||.|. ..|+|+||+. ++ |-.|..||.+.... ++ ...++ ....
T Consensus 781 ledd~~~--~ytt-~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---dV-IkaIe-~gyR 852 (996)
T KOG0196|consen 781 LEDDPEA--AYTT-LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DV-IKAIE-QGYR 852 (996)
T ss_pred cccCCCc--cccc-cCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---HH-HHHHH-hccC
Confidence 7543311 1112 2222225667999764 5799999965 56 88999999763211 11 11111 1233
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
+|.. ..++..+..|+..||++|-.+||.+.||+.+
T Consensus 853 LPpP-mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 853 LPPP-MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CCCC-CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 3432 7899999999999999999999999999864
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=262.00 Aligned_cols=263 Identities=20% Similarity=0.304 Sum_probs=198.9
Q ss_pred eEEEceecccCceEEEEEEEeCC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTN---KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~---~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++.+.||.|-||.||.|..... ..-.||||..+++.. ....+.|+.|..+++.++|||||+|++++. +.-.||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeE
Confidence 44567899999999999975432 233599999998643 334678999999999999999999999985 457899
Q ss_pred EecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
|||+++-|.|..+|+.+. .++......|+.||+.||.|||+.+.|||||-..|||+.+. ..+||+|||+++.+.....
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP-QCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc-ceeeecccchhhhccccch
Confidence 999999999999999764 79999999999999999999999999999999999999998 8999999999998765443
Q ss_pred ccccccccCCCCcccccCCcccc------ccCCcCCCCc-ccc-ccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPT-FQD-VQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~-l~~-~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~ 270 (473)
+.. +...-...|| |||-+ ...|+|-||+ +|+ +..|..||.+. .+.++....-....+..| +
T Consensus 547 Yka--S~~kLPIKWm---aPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv---kNsDVI~~iEnGeRlP~P---~ 615 (974)
T KOG4257|consen 547 YKA--SRGKLPIKWM---APESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV---KNSDVIGHIENGERLPCP---P 615 (974)
T ss_pred hhc--cccccceeec---CccccchhcccchhhHHHHHHHHHHHHHhcCCccccc---cccceEEEecCCCCCCCC---C
Confidence 321 1111222334 88865 2468899995 466 67899999862 122222111122344555 7
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHH-------------------hcCCCCCCCCccccccCCCCCcC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQV-------------------RRLPMFKDYDWDSILDQEPPFVP 320 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~ei-------------------l~HPFF~~idw~~l~~~~pPf~P 320 (473)
++++.+..|+.+||..+|.+||.+.|+ +....-..+-|+.-...++|-+|
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~Eq~r~~R~~a~~~~~~~~~~e~PPKP 684 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSEQLRRQRKVASMIWQNSDDIEIPPKP 684 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHHHHHhhhcccceeeccCCccCCCCCc
Confidence 999999999999999999999985443 33445555667655545434355
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=260.44 Aligned_cols=195 Identities=22% Similarity=0.305 Sum_probs=168.1
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhH-----HHHHHHHHHHHHhcC---CCCeeeEEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNM-----VSQVLRERNALALTH---SPFCVQLFYS 110 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~-----~~~~~~E~~iL~~l~---hp~Iv~l~~~ 110 (473)
+..+|..++.+|.|+||+|++|.+|.+ +..|+||.+.|..+.-... .-.+-.|++||..++ |+||++++++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n-~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKEN-NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred ccccceeeeeccccccceEEEeeeccc-ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 357899999999999999999999985 7899999999986653332 224567999999997 9999999999
Q ss_pred EEeCCEEEEEecc-cCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecch
Q psy622 111 LQTSSCVFLVMEY-MIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 111 f~~~~~l~lVmEy-~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
|++.+++||+||- -+|.||+++|.....++|.+++.++.||+.|++|||++||||||||-||++++++ |.+||+|||.
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~-g~~klidfgs 716 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN-GFVKLIDFGS 716 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecC-CeEEEeeccc
Confidence 9999999999997 4578999999999999999999999999999999999999999999999999999 9999999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCcccccc-------CCcCCCCcccc-ccCCCCCch
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTFQD-VQNSQAPFP 243 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l~~-~~~g~~pf~ 243 (473)
+....++. -++..||-+|. |||++.+ .+.|++|++.+ +.....||+
T Consensus 717 aa~~ksgp-----fd~f~gtv~~a---apevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGP-----FDVFVGTVDYA---APEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCC-----cceeeeecccc---chhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98754332 24567887776 8998753 68899998865 777777875
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-30 Score=257.51 Aligned_cols=250 Identities=19% Similarity=0.203 Sum_probs=192.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+...+.++||+|-||.|.++.... +..||+|+++... .+.....+.+|+++|.+++||||+.|++++...+.+|+|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg--~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG--PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC--ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 456889999999999999997553 4789999999864 344467899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 121 MEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||||+.|||.++|.+.. .+.......++.||+.|++||.+.++|||||.+.|+|+|.+ +++||+|||+++.+.....
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e-~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE-FTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-ccEEecCcccccccccCCc
Confidence 99999999999999863 33445556699999999999999999999999999999999 9999999999998766554
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCc-ccc--ccCCCCCchhHhhhcCCCCCh-hhHhhhccCCCCc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPT-FQD--VQNSQAPFPSALRVAGSQIPT-STAAQLQLEWPED 268 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~-l~~--~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~P~~ 268 (473)
+.. .....-...|| |+|.++ ..|.|+||+ +++ +++...||.........+... -...+....++..
T Consensus 693 y~v-qgr~vlpiRwm---awEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 693 YRV-QGRAVLPIRWM---AWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred eee-ecceeeeeeeh---hHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence 322 11112223344 777653 578999995 555 678899997643211100000 0000111222333
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
|.-++.++..||.+||+++-++||+++++-.
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 4688999999999999999999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=236.83 Aligned_cols=237 Identities=32% Similarity=0.537 Sum_probs=186.4
Q ss_pred CceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCCHHHH
Q psy622 53 AFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSL 132 (473)
Q Consensus 53 ~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~ 132 (473)
+||.||+|.... +++.+|+|++........ ...+.+|++.++.++|++|+++++.+......++++||+++++|..+
T Consensus 1 ~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKK-TGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECC-CCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 589999998876 578999999987643221 56889999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcc
Q psy622 133 IAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNA 212 (473)
Q Consensus 133 L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y 212 (473)
+.....+++..+..++.+++.+|.+||+.||+|+||+|.||+++.+ +.++|+|||.+....... ......+++.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~ 152 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-GHVKLADFGLARQLDPGG----LLTTFVGTPEY 152 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-CcEEEccccceeeecccc----ccccccCCcCC
Confidence 9887679999999999999999999999999999999999999999 999999999998754321 11223466666
Q ss_pred cccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccc
Q psy622 213 FNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLK 285 (473)
Q Consensus 213 ~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~ 285 (473)
+ +||... ..+.|++|++ +++++|..||..... .....................++.++.+++.+||.
T Consensus 153 ~---~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 226 (244)
T smart00220 153 M---APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ---LLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLV 226 (244)
T ss_pred C---CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHhccCCCCccccccCCHHHHHHHHHHcc
Confidence 6 777543 4688889965 568899999864100 00000111111111111101188999999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q psy622 286 SDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 286 ~dP~kRpsa~eil~HPFF 303 (473)
.+|++||++.++++||||
T Consensus 227 ~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 227 KDPEKRLTAEEALQHPFF 244 (244)
T ss_pred CCchhccCHHHHhhCCCC
Confidence 999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=241.47 Aligned_cols=263 Identities=21% Similarity=0.293 Sum_probs=195.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS----- 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~----- 114 (473)
..+|.-++.+|.|.- .|..|-+.. .++.||+|++... ..+....++..+|..++..++|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v-~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQV-LGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhh-ccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 467888888999988 676776655 5789999998876 44455567899999999999999999999999543
Q ss_pred -CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 -SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 -~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..+|+|||+| .++|...+.- .++-..+++++.|+++|++|||+.||+||||||+||++..+ +.+||.|||+++.-
T Consensus 93 ~~e~y~v~e~m-~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 93 FQEVYLVMELM-DANLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKILDFGLARTE 168 (369)
T ss_pred HHhHHHHHHhh-hhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch-hheeeccchhhccc
Confidence 4589999999 7899998884 57889999999999999999999999999999999999999 99999999999873
Q ss_pred cCCccccccccccCCCCc--ccccCCcccccc------CCcCCCCccc-cccCCCCCchhHhh---------hcCCCCCh
Q psy622 194 QQPIVYLEISDLVNGTPN--AFNIRTPGQLLS------LKTGTFPTFQ-DVQNSQAPFPSALR---------VAGSQIPT 255 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~--y~~~~ape~i~~------~~~~s~g~l~-~~~~g~~pf~~~~~---------~~~~~~~~ 255 (473)
+.. ...||- ...|+|||++.+ ++.|+.|+.. +|+.|...|++... ..+...+.
T Consensus 169 ~~~---------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 169 DTD---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred Ccc---------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 211 122322 124569998764 7889999765 79999988876211 11111000
Q ss_pred ------------------hhHhhh-----ccCCCCc---cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 256 ------------------STAAQL-----QLEWPED---EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 256 ------------------~~~~~~-----~~~~P~~---~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
...... ...||.. ...-+..+++|+.+||..||++|.+++++++||||+ -|-
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~--vw~ 317 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK--VWY 317 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee--eec
Confidence 000000 1111111 123446699999999999999999999999999999 574
Q ss_pred ccccCCCCCcC
Q psy622 310 SILDQEPPFVP 320 (473)
Q Consensus 310 ~l~~~~pPf~P 320 (473)
.-.+-+.|..|
T Consensus 318 ~~~ev~ap~pe 328 (369)
T KOG0665|consen 318 DPDEVEAPPPE 328 (369)
T ss_pred ccccccCCCCc
Confidence 33333344333
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=256.61 Aligned_cols=241 Identities=20% Similarity=0.314 Sum_probs=194.0
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
.+..+..+||.|.||.||.|.++.. .-.||||.++.+. -.++.|+.|..+|+.++|||+|+|+++|..+--+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKky-slTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeecc-ceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 4577788999999999999999874 3569999999764 3477899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 121 MEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
+|||..|+|.++|+.+. -++.-...+++.||..|++||..+++|||||-..|+|+..+ ..+|++||||++.+.....
T Consensus 342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-hiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc-ceEEeeccchhhhhcCCce
Confidence 99999999999999864 46777778889999999999999999999999999999999 8999999999998754433
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCcc-cc-ccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QD-VQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~-~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~ 270 (473)
.. -.|+.--+.|.|||-+. ..++|+||++ |+ ...|..||+++..-..... .-......-| +
T Consensus 421 TA-----HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L---LEkgyRM~~P---e 489 (1157)
T KOG4278|consen 421 TA-----HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL---LEKGYRMDGP---E 489 (1157)
T ss_pred ec-----ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH---HhccccccCC---C
Confidence 21 13444445566888653 4789999986 45 5679999997532111110 0111123334 6
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHh
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVR 298 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil 298 (473)
.+++...+|++.||+.+|..||++.|+-
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 8999999999999999999999987654
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=245.22 Aligned_cols=131 Identities=28% Similarity=0.506 Sum_probs=115.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----C---CCeeeEEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-----S---PFCVQLFYSLQ 112 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----h---p~Iv~l~~~f~ 112 (473)
.+|.+.++||.|.|++||+|.+.. ..+.||+|+.+.. +...+..+.|+++|++++ | ..||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq-~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQ-NKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred ceEEEEEeccccccceeEEEeecc-CCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 679999999999999999999887 4689999999976 344567889999998872 2 36999999996
Q ss_pred ----eCCEEEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEecC
Q psy622 113 ----TSSCVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSH-GIIHRDLKPDNMLISA 177 (473)
Q Consensus 113 ----~~~~l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~-gIiHRDLKpeNILld~ 177 (473)
.+.++|||+|++ |-+|..+|... +.++...++.|+.||+.||.|||.. ||||-|||||||||..
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCS 223 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeec
Confidence 456999999999 99999999875 4699999999999999999999965 8999999999999964
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=244.64 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=193.2
Q ss_pred CCeEEEceecccCceEEEEEEEeC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l 117 (473)
+.|.++.+||.|+|+.||+|.+.. ++++.||+|.+.... ...++.+|+++|..+ .+.||+++.+++..+++.
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 458999999999999999996554 256789999998753 245799999999998 699999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
.+||||++..+..+++.. ++...++.|+.+++.||.++|++|||||||||.|+|.+...+.-.|+|||++...+...
T Consensus 111 ~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred EEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 999999999999988875 67899999999999999999999999999999999999988999999999998311000
Q ss_pred ------c------cc-----------------------------ccccccCCCCcccccCCccccc-------cCCcCCC
Q psy622 198 ------V------YL-----------------------------EISDLVNGTPNAFNIRTPGQLL-------SLKTGTF 229 (473)
Q Consensus 198 ------~------~~-----------------------------~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~ 229 (473)
. .. .......|||+|. |||+++ .++.|+.
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfR---aPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFR---APEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCC---chHHHhhccCcCCccceeec
Confidence 0 00 0001123666664 899864 4899999
Q ss_pred Cccc-cccCCCCCchhHh------------------hh----cCC-------CCCh---hhHhhhcc-------------
Q psy622 230 PTFQ-DVQNSQAPFPSAL------------------RV----AGS-------QIPT---STAAQLQL------------- 263 (473)
Q Consensus 230 g~l~-~~~~g~~pf~~~~------------------~~----~~~-------~~~~---~~~~~~~~------------- 263 (473)
|++. -++++..||.... +. .+. .++. .......+
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 9764 5888899985310 00 000 0000 00000000
Q ss_pred CCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
......+..+..+.+|+.+||..||.+|+||+++++||||...+
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 00011144566899999999999999999999999999998654
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=255.54 Aligned_cols=246 Identities=18% Similarity=0.270 Sum_probs=196.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQ--LYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~--~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
.++.++.+.||+|.||.|+.|.++...|+ .||||.++...... ....|++|..+|.+++|||+++||++.-+ ..+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 45677889999999999999988875554 58999999876432 46689999999999999999999999987 788
Q ss_pred EEEecccCcCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 118 FLVMEYMIGGDVKSLIAA--NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~--~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.||||++++|+|.+.|++ ...|.......|+.||+.|+.||.+++.|||||-..|+||... ..|||+||||.+.+..
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RTVKICDFGLMRALGE 264 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ceeeeecccceeccCC
Confidence 999999999999999997 3579999999999999999999999999999999999999998 8999999999999866
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCc-ccccc-CCCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPT-FQDVQ-NSQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~-l~~~~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
.+....+.. .-+--+.|.|||.+. ..|+|.||+ +|+|. .|..||.+... .+|....-....+.-|
T Consensus 265 ned~Yvm~p---~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---~qIL~~iD~~erLpRP- 337 (1039)
T KOG0199|consen 265 NEDMYVMAP---QRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---IQILKNIDAGERLPRP- 337 (1039)
T ss_pred CCcceEecC---CCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---HHHHHhccccccCCCC-
Confidence 554332211 011124566999763 479999995 67765 57889876311 1111111122334444
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHh
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVR 298 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil 298 (473)
..++.++.+++.+||..+|.+||++..|.
T Consensus 338 --k~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 338 --KYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred --CCChHHHHHHHHHhccCCccccccHHHHH
Confidence 68999999999999999999999987765
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-30 Score=261.31 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=198.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
-++|+++..+|.|+||.||+||++. +++..|+|+++-.. ....+-++.|+-+++..+|||||.+++.+-....+|+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~-s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKR-SGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccc-cCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 4789999999999999999999987 68999999998653 3345677889999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
+||||.||+|.+.-+-.+.++|.++.+..++.++||+|||+.|-+|||||-.|||+++. |.+||+|||.+..+....
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~-gDvklaDfgvsaqitati-- 166 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE-GDVKLADFGVSAQITATI-- 166 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc-CceeecccCchhhhhhhh--
Confidence 99999999999998888999999999999999999999999999999999999999999 999999999988754221
Q ss_pred cccccccCCCCcccccCCcccc---------ccCCcCCCCccc-cccCCCCCchhHhhhcC-CCCChhhHhhhccCCCCc
Q psy622 200 LEISDLVNGTPNAFNIRTPGQL---------LSLKTGTFPTFQ-DVQNSQAPFPSALRVAG-SQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i---------~~~~~~s~g~l~-~~~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~P~~ 268 (473)
.......|||-+| |||+. ...+.|+.|+-. ++.-.++|......... .-......+...++-
T Consensus 167 -~KrksfiGtpywm---apEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkD--- 239 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWM---APEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKD--- 239 (829)
T ss_pred -hhhhcccCCcccc---chhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccC---
Confidence 1233467999999 78763 346778777443 33333444321100000 000000000011221
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
....++-+.+|++.+|.++|++||+++.++.|||...-
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 25678899999999999999999999999999998765
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=235.30 Aligned_cols=254 Identities=21% Similarity=0.301 Sum_probs=189.3
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----EE
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS-----CV 117 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~-----~l 117 (473)
.+--+-||-|+||.||.+.+.. .|+.||+|++..- ..+-...+++.+|+++|..++|.|++..++..|-.. .+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPR-dgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPR-SGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CCCCCcccccceeEEEeccCCC-CccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3344789999999999998776 5789999998643 223344678999999999999999999999988654 48
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+|+|+| ..||...|-....++.++++.++.||+.||.|||+.||+||||||.|+|++++ ..+||||||+++......
T Consensus 133 YV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN-CILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC-ceEEecccccccccchhh
Confidence 9999999 77999999888899999999999999999999999999999999999999999 999999999999754322
Q ss_pred cccccccccCCCCccc--ccCCccccc-------cCCcCCCCccc-cccCCCCCchh---------HhhhcCCCCChh--
Q psy622 198 VYLEISDLVNGTPNAF--NIRTPGQLL-------SLKTGTFPTFQ-DVQNSQAPFPS---------ALRVAGSQIPTS-- 256 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~--~~~ape~i~-------~~~~~s~g~l~-~~~~g~~pf~~---------~~~~~~~~~~~~-- 256 (473)
.. ..|-+.+ .|+|||++. .++.|+.|++. +++..+..|.. +....+....+.
T Consensus 211 ~~-------hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr 283 (449)
T KOG0664|consen 211 RL-------NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMK 283 (449)
T ss_pred hh-------hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHH
Confidence 21 1222211 345888765 47889999654 55555555542 111122221110
Q ss_pred --------hHhhhccCCCCc--------cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 257 --------TAAQLQLEWPED--------EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 257 --------~~~~~~~~~P~~--------~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
.+.....+-|.. +..-..++.+++.++|..||.+|.+.++++.|++...-.
T Consensus 284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 011111121211 134456789999999999999999999999999987654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=271.41 Aligned_cols=235 Identities=16% Similarity=0.210 Sum_probs=173.3
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
.|...++||+|+||.||+|+.+. +++.||||+++.... ....|++++++++|||||++++++.+....|+||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIK-NGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECC-CCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 46667899999999999998876 578999999875431 1124578899999999999999999999999999
Q ss_pred cccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 122 EYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH---SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH---~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||++||+|.++++. +++..+..++.||+.||+||| +.+|+||||||+||+++.+ +..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc---
Confidence 99999999999963 789999999999999999999 6699999999999999988 777765 665543211
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhh--------Hhh-hc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTST--------AAQ-LQ 262 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~--------~~~-~~ 262 (473)
.....+|+.|+ |||++. ..|+|++|++ +++++|+.||....... ..+.... ... ..
T Consensus 835 ----~~~~~~t~~y~---aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 906 (968)
T PLN00113 835 ----DTKCFISSAYV---APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSDCHLDMWID 906 (968)
T ss_pred ----CCCcccccccc---CcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC-CcHHHHHHHhcCccchhheeC
Confidence 11224677777 888653 4799999965 67999999985321100 0000000 000 00
Q ss_pred cCCC---CccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 263 LEWP---EDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 263 ~~~P---~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
...+ ........++.+++.+||+.||++||++.|+++.
T Consensus 907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000 0001122357789999999999999999998853
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=230.26 Aligned_cols=268 Identities=15% Similarity=0.226 Sum_probs=189.5
Q ss_pred hHHHHhHhhhcccc-cccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHH
Q psy622 14 NILEITNKASENSL-CDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRE 92 (473)
Q Consensus 14 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E 92 (473)
-++++++.+.++.. ..++.-.+.. --.+..+.+.||+|.||.||+|+++. ..||||++.... .....+|
T Consensus 184 tl~Dll~~~~tSGSGSGlplLVQRT-iarqI~L~e~IGkGRyGEVwrG~wrG---e~VAVKiF~srd------E~SWfrE 253 (513)
T KOG2052|consen 184 TLKDLLDDLETSGSGSGLPLLVQRT-IARQIVLQEIIGKGRFGEVWRGRWRG---EDVAVKIFSSRD------ERSWFRE 253 (513)
T ss_pred cHHHHHHhhccCCCCCCchhHhHHh-hhheeEEEEEecCccccceeeccccC---CceEEEEecccc------hhhhhhH
Confidence 35666655554422 2222222222 24679999999999999999999875 579999988642 4578899
Q ss_pred HHHHHh--cCCCCeeeEEEEEEeC----CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-----
Q psy622 93 RNALAL--THSPFCVQLFYSLQTS----SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH----- 161 (473)
Q Consensus 93 ~~iL~~--l~hp~Iv~l~~~f~~~----~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~----- 161 (473)
.+|.+. ++|+||+.++++=... ..+|||++|-+.|+|+++|.+ ..++......++..++.||+|||..
T Consensus 254 tEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTq 332 (513)
T KOG2052|consen 254 TEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQ 332 (513)
T ss_pred HHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCC
Confidence 999875 4999999999876433 259999999999999999998 4899999999999999999999953
Q ss_pred ---CeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc-cccccCCCCcccccCCccccc------------cCC
Q psy622 162 ---GIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE-ISDLVNGTPNAFNIRTPGQLL------------SLK 225 (473)
Q Consensus 162 ---gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~-~~~~~~gtp~y~~~~ape~i~------------~~~ 225 (473)
.|.|||||..|||+.++ |.+.|+|+|||........... ..+..+||..|| |||++- ..|
T Consensus 333 gKPaIAHRDlKSKNILVKkn-~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYM---APEvLdetin~~~Fesyk~AD 408 (513)
T KOG2052|consen 333 GKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYM---APEVLDETINMKHFESYKRAD 408 (513)
T ss_pred CCchhhccccccccEEEccC-CcEEEeeceeeEEecccCCcccCCCCCccceeecc---ChHHhhhhcChhhhhhhhHHH
Confidence 39999999999999999 9999999999987654432222 245668999999 999853 257
Q ss_pred cCCCC-cccccc----CC------CCCchhHhhhcCCCCCh----hhHhhhccCCCCccccCCh----hHHHHHHhcccc
Q psy622 226 TGTFP-TFQDVQ----NS------QAPFPSALRVAGSQIPT----STAAQLQLEWPEDEEALNP----STEETILALLKS 286 (473)
Q Consensus 226 ~~s~g-~l~~~~----~g------~~pf~~~~~~~~~~~~~----~~~~~~~~~~P~~~~~ls~----~a~dLI~~LL~~ 286 (473)
.|+|| +++++. .| +.||.+...... .+.. --.++.....|+ .+-+. .+..|++.||..
T Consensus 409 IYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP-s~eeMrkVVCv~~~RP~ipn--rW~s~~~l~~m~klMkeCW~~ 485 (513)
T KOG2052|consen 409 IYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP-SFEEMRKVVCVQKLRPNIPN--RWKSDPALRVMAKLMKECWYA 485 (513)
T ss_pred HHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC-CHHHHhcceeecccCCCCCc--ccccCHHHHHHHHHHHHhhcC
Confidence 77888 334432 11 356654211100 0000 011122333443 33333 356678889999
Q ss_pred CCCCCCCHHHHhc
Q psy622 287 DPTQRPSGHQVRR 299 (473)
Q Consensus 287 dP~kRpsa~eil~ 299 (473)
||.-|+||--|++
T Consensus 486 Np~aRltALriKK 498 (513)
T KOG2052|consen 486 NPAARLTALRIKK 498 (513)
T ss_pred CchhhhHHHHHHH
Confidence 9999999866653
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=219.95 Aligned_cols=255 Identities=18% Similarity=0.220 Sum_probs=185.1
Q ss_pred CCCCCC-CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEE-EE
Q psy622 35 LKAPEI-SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFY-SL 111 (473)
Q Consensus 35 ~~~~~~-~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~-~f 111 (473)
++.+.+ +.|.+.+.||+|.||++-+|+++. +++.+++|.+.+.. ...+.+.+|...--.+ .|.||+.-|+ +|
T Consensus 17 l~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~-s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF 91 (378)
T KOG1345|consen 17 LKKVDLEDVYTINKQLGEGRFGKILLAEHRQ-SKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAF 91 (378)
T ss_pred ccccchhhhhhHHHHhcccceeeEEeeeccC-CceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHh
Confidence 344443 569999999999999999999998 67899999998863 2355788887655445 6999998776 68
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC-CCCceeEeecchh
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA-QAPHCPIVNTLFL 190 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~-~~g~ikL~DFGla 190 (473)
|+.+.+.+++||++-|||..-+... .+.|...+.+++|++.||+|+|+.++||||||.+||||-. +.-.|||||||++
T Consensus 92 qt~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 92 QTSDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred hcCceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccc
Confidence 9999999999999999999888764 4889999999999999999999999999999999999953 3358999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCcc---ccccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh--hhHhhhccC
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPG---QLLSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT--STAAQLQLE 264 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape---~i~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~ 264 (473)
...+..-...... ..+..|+......-| +.-+.+.|.||++ +++++|..||....-.. ...-. ...+.....
T Consensus 171 ~k~g~tV~~~~~~-~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 171 RKVGTTVKYLEYV-NNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQWLKRKNPA 248 (378)
T ss_pred cccCceehhhhhh-cccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHHHhcccCcc
Confidence 8743321111110 011222211111001 1236799999976 56999999997432111 11100 122223445
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCHHHH
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQV 297 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~ei 297 (473)
.|.....+|+.+..+.++.|..+|++|-...++
T Consensus 249 ~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 249 LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred CchhhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence 666667799999999999999999999543333
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=229.83 Aligned_cols=150 Identities=19% Similarity=0.185 Sum_probs=120.8
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM--INKNMVSQVLRERNALALTHSPFCVQLFYSLQ 112 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 112 (473)
+..+-.++|++.++||+|+||+||+|+++..+++.||||++..... ......+.+.+|+++|+.++|+||+..+..+
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 4455578899999999999999999988765678899998764311 1233456799999999999999998533322
Q ss_pred eCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC-CCcceEecCCCCceeEeecchhh
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL-KPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDL-KpeNILld~~~g~ikL~DFGla~ 191 (473)
+..|+||||++|++|.. +... . ...++.|++.||+|||++||+|||| ||+|||++.+ +.+||+|||+|+
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~-~~ikLiDFGlA~ 160 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-ARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD-GEAAVIDFQLAS 160 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC-CCEEEEECccce
Confidence 46899999999999963 2211 1 1467899999999999999999999 9999999988 899999999999
Q ss_pred hhcC
Q psy622 192 ILQQ 195 (473)
Q Consensus 192 ~~~~ 195 (473)
.+..
T Consensus 161 ~~~~ 164 (365)
T PRK09188 161 VFRR 164 (365)
T ss_pred eccc
Confidence 7643
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=208.88 Aligned_cols=195 Identities=24% Similarity=0.382 Sum_probs=160.0
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~ 116 (473)
+..++..-+..||+|+||.|-+.++.. +|+..|+|.+.... +.+..++.++|+++.... .+|++|++++.+-++..
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~-sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQ-SGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeecc-CCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 334566677889999999999999887 68999999998763 455677889999987665 89999999999999999
Q ss_pred EEEEecccCcCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 117 VFLVMEYMIGGDVKSLIA----ANGALPEDMAAFYAAEVVLALQYLHSH-GIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~----~~~~~~e~~~~~~~~qI~~aL~yLH~~-gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
+|+.||.| ..+|..+-. +.+.++|...-.++..++.||+|||++ .+||||+||.||||+.+ |++|+||||.+-
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~-GqVKiCDFGIsG 197 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD-GQVKICDFGISG 197 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC-CcEEEcccccce
Confidence 99999999 778866543 457899999999999999999999976 89999999999999999 999999999998
Q ss_pred hhcCCccccccccccCCCCcccccCCcccc----------ccCCcCCCCcc-ccccCCCCCchh
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQL----------LSLKTGTFPTF-QDVQNSQAPFPS 244 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i----------~~~~~~s~g~l-~~~~~g~~pf~~ 244 (473)
.+.+... .+.-.|...|+ |||.+ ...+.|++|+- .++.+++.||..
T Consensus 198 ~L~dSiA----kt~daGCkpYm---aPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVDSIA----KTMDAGCKPYM---APERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhhhH----HHHhcCCCccC---ChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 7643211 11234666677 67654 34788999965 578999999863
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=246.63 Aligned_cols=250 Identities=20% Similarity=0.275 Sum_probs=191.7
Q ss_pred CeEEEceecccCceEEEEEEEeCC------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTN------KDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTS 114 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 114 (473)
+..+.+.||+|.||+|++|..+.- ....||||.++.... ..+.+.+..|+++|+.+ +||||+.+++++...
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 346677999999999999964421 135799999998653 35677899999999998 799999999999989
Q ss_pred CEEEEEecccCcCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANG----------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~----------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~ 178 (473)
+.+++|+||+..|+|..+|+..+ .++......++.||+.|++||++.++|||||-.+|||+..+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN 454 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence 99999999999999999999865 38889999999999999999999999999999999999999
Q ss_pred CCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-cc-ccCCCCCchhHhhhcC
Q psy622 179 APHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QD-VQNSQAPFPSALRVAG 250 (473)
Q Consensus 179 ~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~-~~~g~~pf~~~~~~~~ 250 (473)
..+||+|||+|+.......+....+ .|+-. +.|.|||.+. ..|+|+||++ ++ .-.|..||++... .
T Consensus 455 -~~~kIaDFGlar~~~~~~~y~~~~~--~~~LP-~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~ 528 (609)
T KOG0200|consen 455 -KVIKIADFGLARDHYNKDYYRTKSS--AGTLP-VKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--T 528 (609)
T ss_pred -CEEEEccccceeccCCCCceEecCC--CCccc-eeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--H
Confidence 8999999999997543333221111 12211 2244887643 4699999976 45 4568899986210 0
Q ss_pred CCCChhhHh-hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 251 SQIPTSTAA-QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 251 ~~~~~~~~~-~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
..+ .+... ..+...| ..++++..++++.||+.+|++||++.|+.+ +|..
T Consensus 529 ~~l-~~~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~ 578 (609)
T KOG0200|consen 529 EEL-LEFLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFEK 578 (609)
T ss_pred HHH-HHHHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHHH
Confidence 001 11111 1233445 688999999999999999999999988873 4544
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=243.67 Aligned_cols=244 Identities=17% Similarity=0.187 Sum_probs=189.0
Q ss_pred CCeEEEceecccCceEEEEEEEeCCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNK---DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~---~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
...+..++||+|+||+||+|.+--.. .-+||||++......+ ....++.|.-+|..++|||+++|+++++... +
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~--~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK--ASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch--hhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 34566789999999999999765422 2369999998765432 3457999999999999999999999998766 8
Q ss_pred EEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
-||++|+++|.|.++++.. +.+..+....|..||++|+.|||.+++|||||-.+|+|+.+- .++|++|||+++.+...
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP-~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP-NHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC-CeEEEEecchhhccCcc
Confidence 8999999999999999875 479999999999999999999999999999999999999998 89999999999987544
Q ss_pred ccccccccccCCCCcccccCCcccc------ccCCcCCCCcc-cc-ccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QD-VQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~-~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
...... ......+.+| |.|.+ -..|+|+||+. |+ |..|..|+.++-. ..|+.......++.-|
T Consensus 852 ~~ey~~-~~gK~pikwm---ale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~---~eI~dlle~geRLsqP-- 922 (1177)
T KOG1025|consen 852 EKEYSA-PGGKVPIKWM---ALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA---EEIPDLLEKGERLSQP-- 922 (1177)
T ss_pred cccccc-cccccCcHHH---HHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH---HHhhHHHhccccCCCC--
Confidence 332211 1112223344 44433 35799999975 66 7789999976321 1122222222334444
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHh
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVR 298 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil 298 (473)
+.++-++.-++.+||..|+..||+++++.
T Consensus 923 -piCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 923 -PICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred -CCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 68999999999999999999999987654
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-27 Score=232.35 Aligned_cols=241 Identities=20% Similarity=0.253 Sum_probs=179.1
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc--CCCCeeeEEEEEEeCC-
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT--HSPFCVQLFYSLQTSS- 115 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~~~f~~~~- 115 (473)
++...+++++||+|.||.||+|... ++.||||++... +.+.+++|++|.+.. .|+||++++++-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~---~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD---NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc---CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 3567888999999999999999764 378999998753 456899999999875 8999999999876544
Q ss_pred ---EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CeeecCCCCcceEecCCCCcee
Q psy622 116 ---CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH---------GIIHRDLKPDNMLISAQAPHCP 183 (473)
Q Consensus 116 ---~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~---------gIiHRDLKpeNILld~~~g~ik 183 (473)
.++||++|.+.|+|.++|..+ .+++.....++.-++.||+|||+. .|+|||||..|||+.++ +...
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTcc 356 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCC 356 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEE
Confidence 899999999999999999975 799999999999999999999963 59999999999999999 9999
Q ss_pred EeecchhhhhcCCccccccccccCCCCcccccCCccccc------------cCCcCCCC-ccccccCCC--------CCc
Q psy622 184 IVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------------SLKTGTFP-TFQDVQNSQ--------APF 242 (473)
Q Consensus 184 L~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------------~~~~~s~g-~l~~~~~g~--------~pf 242 (473)
|+|||+|..+........... ..||..|| |||++- ..|+|+.| +++++.... ++|
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~-qVGT~RYM---APEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHG-QVGTRRYM---APEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred eeccceeEEecCCCCCcchhh-hhhhhhhc---CHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 999999998764443333222 57888888 898753 35666777 445543221 112
Q ss_pred hhHhhhcCCCCCh-h------hHhhhccCCCCcc--ccCChhHHHHHHhccccCCCCCCCH
Q psy622 243 PSALRVAGSQIPT-S------TAAQLQLEWPEDE--EALNPSTEETILALLKSDPTQRPSG 294 (473)
Q Consensus 243 ~~~~~~~~~~~~~-~------~~~~~~~~~P~~~--~~ls~~a~dLI~~LL~~dP~kRpsa 294 (473)
...+...-..-|. + ...+.+..+|... ...-..+++.+..||..||+.|+|+
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 2111111111111 1 1112334444321 1223558899999999999999996
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=205.02 Aligned_cols=206 Identities=31% Similarity=0.523 Sum_probs=166.4
Q ss_pred ecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCC
Q psy622 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGD 128 (473)
Q Consensus 49 LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~ 128 (473)
||+|++|.||++.... +++.+++|++....... ..+.+.+|+++++.+.|++|+++++++......++++|++.|++
T Consensus 1 l~~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecC-CCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 6899999999998765 57899999998764221 35689999999999999999999999999999999999999999
Q ss_pred HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC-CCCceeEeecchhhhhcCCcccccccccc
Q psy622 129 VKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA-QAPHCPIVNTLFLAILQQPIVYLEISDLV 206 (473)
Q Consensus 129 L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~-~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 206 (473)
|..++... ..++...++.++.+++.+|++||+.|++|+||+|.||+++. + +.++|+|||.+........ .....
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~-~~~~l~d~~~~~~~~~~~~---~~~~~ 153 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN-GKVKLADFGLSKLLTSDKS---LLKTI 153 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC-CcEEEecCCceEEccCCcc---hhhcc
Confidence 99999876 57899999999999999999999999999999999999999 7 8999999999987533211 01112
Q ss_pred CCCCcccccCCcccccc-------CCcCCCCccccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHH
Q psy622 207 NGTPNAFNIRTPGQLLS-------LKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEET 279 (473)
Q Consensus 207 ~gtp~y~~~~ape~i~~-------~~~~s~g~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dL 279 (473)
.+.+.|+ +||.... .+.|++|.+...+ ..+.++
T Consensus 154 ~~~~~~~---~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~ 193 (215)
T cd00180 154 VGTPAYM---APEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDL 193 (215)
T ss_pred cCCCCcc---ChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHH
Confidence 3444444 5664422 3334444221100 678999
Q ss_pred HHhccccCCCCCCCHHHHhcCC
Q psy622 280 ILALLKSDPTQRPSGHQVRRLP 301 (473)
Q Consensus 280 I~~LL~~dP~kRpsa~eil~HP 301 (473)
+.+||+.||.+||+++++++|+
T Consensus 194 l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 194 IRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHhhCCcccCcCHHHHhhCC
Confidence 9999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=198.41 Aligned_cols=142 Identities=20% Similarity=0.144 Sum_probs=111.7
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeecccccchh-----------------------HHHHHHHHHHHHHhcCCC
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN-----------------------MVSQVLRERNALALTHSP 102 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~-----------------------~~~~~~~E~~iL~~l~hp 102 (473)
...||+|+||.||+|... +|+.||||++++....... ......+|.++|..+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 468999999999999875 5789999999875321111 012345699999999877
Q ss_pred CeeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCeeecCCCCcceEecCCCCc
Q psy622 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL-HSHGIIHRDLKPDNMLISAQAPH 181 (473)
Q Consensus 103 ~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yL-H~~gIiHRDLKpeNILld~~~g~ 181 (473)
++......... . .+|||||++|+++...+.+.+.+++..+..++.||+.+|.++ |+.||+||||||+|||++ + +.
T Consensus 80 ~v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~-~~ 155 (190)
T cd05147 80 GIPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-D-GK 155 (190)
T ss_pred CCCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-C-Cc
Confidence 76443332222 2 389999999888876654557899999999999999999999 799999999999999998 4 78
Q ss_pred eeEeecchhhhh
Q psy622 182 CPIVNTLFLAIL 193 (473)
Q Consensus 182 ikL~DFGla~~~ 193 (473)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=232.45 Aligned_cols=261 Identities=19% Similarity=0.222 Sum_probs=190.5
Q ss_pred CCe-EEEceecccCceEEEEEEEeCCCCcEEEEEEeec---ccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 41 SDF-EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKK---DEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 41 ~~y-~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k---~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
+.| ....++|.|++|.|+.+.... ..+.++.|.... ...........+..|.-+-..+.|||++..+..++....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~-~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRS-DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred cccCCccceeeecccCceEEEEecC-CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 334 466789999999888876554 233444444331 111112222235667777778899999888777776666
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
.+-+||||++ ||+.++...+.++..++..++.||+.||+|+|+.||.||||||+|+|+..+ |.+||+|||.+.....+
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN-GILKIIDFGAASVFRYP 473 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC-CceEEeecCcceeeccC
Confidence 6666999999 999999998899999999999999999999999999999999999999999 99999999999876433
Q ss_pred ccc-cccccccCCCCcccccCCccccc-------cCCcCCCCccc-cccCCCCCchhHhhhcCC--CCChhhHhhhccCC
Q psy622 197 IVY-LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTFQ-DVQNSQAPFPSALRVAGS--QIPTSTAAQLQLEW 265 (473)
Q Consensus 197 ~~~-~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l~-~~~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~ 265 (473)
... .....-.+|+..|+ |||.+. -+++|+.|+.+ .|.+|+.||......... ..............
T Consensus 474 ~e~~~~~~~g~~gS~pY~---apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYL---APEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred cchhhhhhcCcccCCcCc---CcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence 322 23344568899998 898764 37888888665 599999999754322111 00000000011111
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
-.....++.+.+.+|.+||+.||.+|.++++|++.+||+.|+
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 111256788899999999999999999999999999999885
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=195.63 Aligned_cols=193 Identities=32% Similarity=0.543 Sum_probs=161.0
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEec
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
|++.+.||.|++|.||+|.... +++.+|+|.+...... ...+.+.+|++.++.++|+|++++++.+......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG-TGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC-CCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence 6788999999999999998876 4688999999876432 246688899999999999999999999999999999999
Q ss_pred ccCcCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc
Q psy622 123 YMIGGDVKSLIAANGA-LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE 201 (473)
Q Consensus 123 y~~gg~L~~~L~~~~~-~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~ 201 (473)
++++++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.+ +.++|+|||++........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~--~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLA--A 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCccc--c
Confidence 9999999999998766 8999999999999999999999999999999999999998 9999999999987543220 0
Q ss_pred cccccCCCCcccccCCcccc-------ccCCcCCCCcc-ccccCCCCCchh
Q psy622 202 ISDLVNGTPNAFNIRTPGQL-------LSLKTGTFPTF-QDVQNSQAPFPS 244 (473)
Q Consensus 202 ~~~~~~gtp~y~~~~ape~i-------~~~~~~s~g~l-~~~~~g~~pf~~ 244 (473)
......++..|+ +||.. ...++|++|++ +++++|..||..
T Consensus 155 ~~~~~~~~~~~~---~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYL---APEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcC---CHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 111234444444 66654 35788888865 578899999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=231.83 Aligned_cols=333 Identities=28% Similarity=0.347 Sum_probs=265.4
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
.....+++.+.+-+-+|++|.++.+.... ++...++|+..+.......+.+....+..++-...+|.++.....|....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~-sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAG-SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS 877 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccc-cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC
Confidence 35678999999999999999999997655 67788999988877666666777888888887788999998888888888
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.++||++|+.|++|...|++.+..+++-++.++..+++++++||...++|||++|.|+|+..+ |+.+++|||+......
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGL 956 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhccc-CCcccCcccccccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999 9999999984432110
Q ss_pred C--------c--------------------cccccccccCCCCcccccCCccccc------cCCcCCCCc-cccccCCCC
Q psy622 196 P--------I--------------------VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPT-FQDVQNSQA 240 (473)
Q Consensus 196 ~--------~--------------------~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~-l~~~~~g~~ 240 (473)
. . ..........|||.|+ +||... ..+||+.|+ +.+.++|.+
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~l---aPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYL---APEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCccc---CCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 0 0 0001122346788888 788754 367888885 467999999
Q ss_pred CchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHH---HHhcCCCCCCCCccccccCCCC
Q psy622 241 PFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGH---QVRRLPMFKDYDWDSILDQEPP 317 (473)
Q Consensus 241 pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~---eil~HPFF~~idw~~l~~~~pP 317 (473)
||..... +-..+.+......||..+...+.++++++.++|..+|.+|.++. +++.||||++++|+.|..+..+
T Consensus 1034 p~na~tp----q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~~ 1109 (1205)
T KOG0606|consen 1034 PFNAETP----QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQKAE 1109 (1205)
T ss_pred CCCCcch----hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccccCc
Confidence 9975321 11224555678899998899999999999999999999999875 9999999999999999999999
Q ss_pred CcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCC----------------CCceecccCCCCCCCCccccCchhhhcccc
Q psy622 318 FVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGN----------------GSFVCCSNLNSHTASGMDVDSPSALYSKLS 380 (473)
Q Consensus 318 f~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~f~g~~~~~p~~~~~~~~ 380 (473)
|+|...+..|++||.+.++.+..+++.+-...- ..=..|.++ .|.+|+|.+++.+++-..
T Consensus 1110 ~~p~~~s~~dtS~~~~r~~~~~~~e~~sg~s~~~~~~s~~~~~~~~~pe~~~~~~~~~---sl~~~~~k~~s~l~s~~p 1185 (1205)
T KOG0606|consen 1110 FVPQPESTQDTSYFESRFSEESQDETVSGSSSGSKLDSPDESPECTTPELKPAMCGNL---SLINFSFKNLSQLASINP 1185 (1205)
T ss_pred cCCCCCCCCccchhhcccccccccccccCCCcccCccCccccccccCccccCCcCccc---cccccCccChhhccccCh
Confidence 999999999999999999966555554322100 001223322 288888888888776633
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=189.88 Aligned_cols=143 Identities=20% Similarity=0.142 Sum_probs=113.6
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeecccccch-----------------------hHHHHHHHHHHHHHhcCCC
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK-----------------------NMVSQVLRERNALALTHSP 102 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~-----------------------~~~~~~~~E~~iL~~l~hp 102 (473)
.+.||+|+||+||+|++. +|+.||||+++....... .......+|.+.+..+.|+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 578999999999999865 578999999987531100 0022346889999999989
Q ss_pred CeeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCc
Q psy622 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPH 181 (473)
Q Consensus 103 ~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ 181 (473)
+|.....+.... .|+||||++|+++...+.....+++..+..++.|++.+|.++|+ .||+||||||+|||++ + +.
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~-~~ 155 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D-GK 155 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-CC
Confidence 875544433332 48999999888665443344678899999999999999999999 9999999999999998 6 89
Q ss_pred eeEeecchhhhhc
Q psy622 182 CPIVNTLFLAILQ 194 (473)
Q Consensus 182 ikL~DFGla~~~~ 194 (473)
++|+|||+++.+.
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-24 Score=237.26 Aligned_cols=193 Identities=12% Similarity=0.058 Sum_probs=133.8
Q ss_pred CCeeeEEEEEE-------eCCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcce
Q psy622 102 PFCVQLFYSLQ-------TSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNM 173 (473)
Q Consensus 102 p~Iv~l~~~f~-------~~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNI 173 (473)
+||++++++|. ....++++||++ +++|.++|... +.+++.+++.++.||+.||+|||++|||||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 47777777772 234688889988 77999999763 4699999999999999999999999999999999999
Q ss_pred EecCC------------------CCceeEeecchhhhhcCCcc-----c--------cccccccCCCCcccccCCccccc
Q psy622 174 LISAQ------------------APHCPIVNTLFLAILQQPIV-----Y--------LEISDLVNGTPNAFNIRTPGQLL 222 (473)
Q Consensus 174 Lld~~------------------~g~ikL~DFGla~~~~~~~~-----~--------~~~~~~~~gtp~y~~~~ape~i~ 222 (473)
||+.. .+.+|++|||+++....... . ........||+.|+ |||++.
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~---APE~~~ 188 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT---SPEEDN 188 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE---Chhhhc
Confidence 99654 13455556665543211000 0 00011234677777 899764
Q ss_pred ------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHH
Q psy622 223 ------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGH 295 (473)
Q Consensus 223 ------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~ 295 (473)
..|+|++|++ ++|+++.+|+....... ..... ...|.......+.+.+++.+||+.||.+||++.
T Consensus 189 ~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~------~~~~~--~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ 260 (793)
T PLN00181 189 GSSSNCASDVYRLGVLLFELFCPVSSREEKSRTM------SSLRH--RVLPPQILLNWPKEASFCLWLLHPEPSCRPSMS 260 (793)
T ss_pred cCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHH------HHHHH--hhcChhhhhcCHHHHHHHHHhCCCChhhCcChH
Confidence 4688999976 57888888876432110 00000 011211112345678999999999999999999
Q ss_pred HHhcCCCCCCC
Q psy622 296 QVRRLPMFKDY 306 (473)
Q Consensus 296 eil~HPFF~~i 306 (473)
|+++||||...
T Consensus 261 eil~h~~~~~~ 271 (793)
T PLN00181 261 ELLQSEFINEP 271 (793)
T ss_pred HHhhchhhhhh
Confidence 99999999763
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=180.57 Aligned_cols=137 Identities=15% Similarity=0.201 Sum_probs=108.4
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-----CCCCeeeEEEEEEeCC---EE
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-----HSPFCVQLFYSLQTSS---CV 117 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~f~~~~---~l 117 (473)
.+.||+|+||.||. +.. .+.. +||++.... ....+.+.+|+.+++.+ +||||++++++++++. .+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~-~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPE-DAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCC-CcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 46899999999995 454 3334 699887643 22345789999999999 5799999999999874 43
Q ss_pred E-EEecc--cCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCeeecCCCCcceEecCC---CCceeEeecchh
Q psy622 118 F-LVMEY--MIGGDVKSLIAANGALPEDMAAFYAAEVVLAL-QYLHSHGIIHRDLKPDNMLISAQ---APHCPIVNTLFL 190 (473)
Q Consensus 118 ~-lVmEy--~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL-~yLH~~gIiHRDLKpeNILld~~---~g~ikL~DFGla 190 (473)
+ +|||| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+++||||||||+|||++.. .+.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 78999 5579999999764 57766 35688888888 99999999999999999999753 147999995555
Q ss_pred hh
Q psy622 191 AI 192 (473)
Q Consensus 191 ~~ 192 (473)
..
T Consensus 157 ~~ 158 (210)
T PRK10345 157 ST 158 (210)
T ss_pred cc
Confidence 43
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.3e-21 Score=186.35 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=189.9
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC-CeeeEEEEEEeCCEEEEEe
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP-FCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~f~~~~~l~lVm 121 (473)
|.+.+.||.|+||.||++.+. ..+|+|.+.+...........+.+|..++..+.|+ +|+++++.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 788999999999999999766 57999999987654444567899999999999888 7999999998888899999
Q ss_pred cccCcCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC-ceeEeecchhhhhcCCc
Q psy622 122 EYMIGGDVKSLIAANG---ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP-HCPIVNTLFLAILQQPI 197 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~---~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g-~ikL~DFGla~~~~~~~ 197 (473)
+++.++++..++.... .+.+..+..++.|++.+++|+|+.|++||||||+||+++.. + .++++|||.++......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~-~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRD-GRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCC-CCeEEEeccCcceecCCCC
Confidence 9999999998887765 79999999999999999999999999999999999999998 6 79999999998643322
Q ss_pred cccc---cccccCCCCcccccCCcccccc---------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccC
Q psy622 198 VYLE---ISDLVNGTPNAFNIRTPGQLLS---------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264 (473)
Q Consensus 198 ~~~~---~~~~~~gtp~y~~~~ape~i~~---------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 264 (473)
.... ......|++.|+ +||.+.. .+.|++|+. +.++.|..||......................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~---~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYM---APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccC---CHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 2111 234457787777 7775543 455566743 45788888865421100000000111111111
Q ss_pred -CCCc-ccc----CChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 265 -WPED-EEA----LNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 265 -~P~~-~~~----ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.... ... ....+.+++.+++..+|..|.+..+...++|....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 1100 011 12579999999999999999999988888665543
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-22 Score=193.67 Aligned_cols=244 Identities=17% Similarity=0.213 Sum_probs=187.6
Q ss_pred CCeEEEceecccCceEEEEEEEeCC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCC
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTN----KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ-TSS 115 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-~~~ 115 (473)
.++++..++-+|+||.||.|.+++. ..+.|-+|.++... .+-++..++.|-..|..+.|||+.++.++.. +..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 5688889999999999999976642 22456667766542 3445678899999999999999999998774 556
Q ss_pred EEEEEecccCcCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeec
Q psy622 116 CVFLVMEYMIGGDVKSLIAAN--------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNT 187 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~--------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DF 187 (473)
..++++.++.-|+|..+|+.+ +.++..+...++.||+.|++|||++||||.||-.+|++||+. -.+||+|=
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-LqVkltDs 440 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-LQVKLTDS 440 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-eeEEeccc
Confidence 788889999999999999832 357888999999999999999999999999999999999999 89999999
Q ss_pred chhhhhcCCccccccccccCCCCcccccCCcccc------ccCCcCCCCcc-cc-ccCCCCCchhHhhhcCCCCChhhHh
Q psy622 188 LFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQL------LSLKTGTFPTF-QD-VQNSQAPFPSALRVAGSQIPTSTAA 259 (473)
Q Consensus 188 Gla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i------~~~~~~s~g~l-~~-~~~g~~pf~~~~~~~~~~~~~~~~~ 259 (473)
.+++.+-.. ++....+..+..-.|| ++|.+ ...|.|+||++ |+ |..|+.||.++... ..+...
T Consensus 441 aLSRDLFP~-DYhcLGDnEnRPvkWM---slEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-----Em~~yl 511 (563)
T KOG1024|consen 441 ALSRDLFPG-DYHCLGDNENRPVKWM---SLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-----EMEHYL 511 (563)
T ss_pred hhccccCcc-cccccCCCCCCccccc---CHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-----HHHHHH
Confidence 999876332 2333344334444455 77754 35799999976 56 67799999764221 111121
Q ss_pred h--hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 260 Q--LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 260 ~--~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
+ .++.-| -++++++-.++..||...|++||+++|+..
T Consensus 512 kdGyRlaQP---~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 512 KDGYRLAQP---FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred hccceecCC---CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1 223334 689999999999999999999999998763
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-21 Score=183.51 Aligned_cols=197 Identities=23% Similarity=0.338 Sum_probs=160.0
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~l 119 (473)
-.|++.++||+|+||+.++|...- .++.||||.=..+ ...-++..|.+..+.+ ..+.|.++|++-+.+.+-.|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~-nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLY-NNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred ccceeccccccCcceeeecccccc-cCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 369999999999999999998776 5789999985443 2234677788888877 68999999999999999999
Q ss_pred EecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC----CCceeEeecchhhhhc
Q psy622 120 VMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ----APHCPIVNTLFLAILQ 194 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~----~g~ikL~DFGla~~~~ 194 (473)
|+|++ |-+|.++..-++ +|+..++..++.|++.-++|+|++..|||||||+|+||... ...|.++|||+||...
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99999 999999998765 79999999999999999999999999999999999999643 2568999999999986
Q ss_pred CCccccc----cccccCCCCcccccCC---ccccccCCcCCCC-ccccccCCCCCchh
Q psy622 195 QPIVYLE----ISDLVNGTPNAFNIRT---PGQLLSLKTGTFP-TFQDVQNSQAPFPS 244 (473)
Q Consensus 195 ~~~~~~~----~~~~~~gtp~y~~~~a---pe~i~~~~~~s~g-~l~~~~~g~~pf~~ 244 (473)
++..... ......||..||.+-+ -|....-|.-++| +|++.+-|..||.+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 5544322 2445679999985432 1333334455777 67789999999986
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-21 Score=187.86 Aligned_cols=286 Identities=19% Similarity=0.226 Sum_probs=187.9
Q ss_pred hHHHHhHhhhcccccccccccCCCCCCCCeEEEceecccCceEEEEEEEeCC---------C------------------
Q psy622 14 NILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTN---------K------------------ 66 (473)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~---------~------------------ 66 (473)
|+...-+..+......+++....+-.+++|++...||+|....||.|+.+.. +
T Consensus 130 Eir~~~~~ks~~whDei~~r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q 209 (598)
T KOG4158|consen 130 EIRYNEDLKSTEWHDEIPNRIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQ 209 (598)
T ss_pred HHHHHHhhhccCCCCcCcchhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCc
Confidence 3445455555556667777777888899999999999999999999875431 0
Q ss_pred -------CcEEEEEEeecccccch-hH-HHHHHHHH------HHH---------------Hh-cCCCCeeeEEEEEEe--
Q psy622 67 -------DQLYAIKVMKKDEMINK-NM-VSQVLRER------NAL---------------AL-THSPFCVQLFYSLQT-- 113 (473)
Q Consensus 67 -------~~~vAiK~l~k~~~~~~-~~-~~~~~~E~------~iL---------------~~-l~hp~Iv~l~~~f~~-- 113 (473)
.-+.|||.+-.-..... .. .+..-+|. ..+ .. .+|||||++..+|.+
T Consensus 210 ~~~p~~~aFPLAiKmMfN~~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv 289 (598)
T KOG4158|consen 210 VSKPAQKAFPLAIKMMFNFEHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSV 289 (598)
T ss_pred ccCccccccchHHHHhcccccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhh
Confidence 01356666543222111 00 11111111 011 11 269999999988864
Q ss_pred -------------------------CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Q psy622 114 -------------------------SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168 (473)
Q Consensus 114 -------------------------~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDL 168 (473)
+..+|+||..+ ..+|.+++..+ ..+....+.+++|+++|+.|||++||.||||
T Consensus 290 ~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDl 367 (598)
T KOG4158|consen 290 KVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDL 367 (598)
T ss_pred ccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcc
Confidence 34689999988 56999999864 5677889999999999999999999999999
Q ss_pred CCcceEecCC---CCceeEeecchhhhhcCCcccccc--ccc-cCCCCcccccCCcccc------------ccCCcCCCC
Q psy622 169 KPDNMLISAQ---APHCPIVNTLFLAILQQPIVYLEI--SDL-VNGTPNAFNIRTPGQL------------LSLKTGTFP 230 (473)
Q Consensus 169 KpeNILld~~---~g~ikL~DFGla~~~~~~~~~~~~--~~~-~~gtp~y~~~~ape~i------------~~~~~~s~g 230 (473)
|.+||||.-+ ...+.|+|||+|-..+........ ... .-|....| |||+. -..|.|..|
T Consensus 368 KSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm---APEi~ta~PGp~avvny~kAD~WA~G 444 (598)
T KOG4158|consen 368 KSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM---APEIATAVPGPNAVVNYEKADTWAAG 444 (598)
T ss_pred cccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec---chhhhhcCCCCceeeccchhhhhhhh
Confidence 9999999432 256789999998753221110000 000 01222222 66652 246788888
Q ss_pred cc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCC---HHHHhcCCCCCCC
Q psy622 231 TF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPS---GHQVRRLPMFKDY 306 (473)
Q Consensus 231 ~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps---a~eil~HPFF~~i 306 (473)
.+ |+++....||+..-.. .....+.+ +-.+|..+..+++.+++|+..+|++||++|++ ++.+++---|..-
T Consensus 445 alaYEIfg~~NPFY~rGem---~L~~r~Yq--e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~ 519 (598)
T KOG4158|consen 445 ALAYEIFGRSNPFYKRGEM---LLDTRTYQ--ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMG 519 (598)
T ss_pred hhHHHHhccCCcccccchh---eechhhhh--hhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCc
Confidence 76 5678888999862111 01111222 22345555789999999999999999999998 4667765555554
Q ss_pred Ccc
Q psy622 307 DWD 309 (473)
Q Consensus 307 dw~ 309 (473)
+|-
T Consensus 520 ~~v 522 (598)
T KOG4158|consen 520 EDV 522 (598)
T ss_pred hHH
Confidence 443
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=172.88 Aligned_cols=271 Identities=15% Similarity=0.186 Sum_probs=186.6
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTS 114 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~ 114 (473)
.-+-...|+++++||+|+||.+|+|.... .|..||||+=.+.. ..-++..|..+...++ ...|..+..+....
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~-~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISIT-SGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeecc-CCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 44557889999999999999999998876 68899999966542 1226778888888884 56777888888888
Q ss_pred CEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC--CCceeEeecchhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ--APHCPIVNTLFLA 191 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~--~g~ikL~DFGla~ 191 (473)
.+-.+||+.+ |.+|.+++.-+ +.|+..++...+-|++.-|+|+|.+++|||||||+|+|..-+ ...+-|+|||+++
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 8999999999 99999999864 579999999999999999999999999999999999999753 1457899999999
Q ss_pred hhcCCcccc----ccccccCCCCcccccCCc---cccccCCcCCCC-ccccccCCCCCchhHhhhcCCCCChhhHhhhcc
Q psy622 192 ILQQPIVYL----EISDLVNGTPNAFNIRTP---GQLLSLKTGTFP-TFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQL 263 (473)
Q Consensus 192 ~~~~~~~~~----~~~~~~~gtp~y~~~~ap---e~i~~~~~~s~g-~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 263 (473)
...+..... .......||..|..+.|- |....-|.-+.| ++.+..-|..||.+....... -..+.+.+.+.
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~-QKyEkI~EkK~ 241 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK-QKYEKISEKKM 241 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH-HHHHHHHHhhc
Confidence 875543322 223345688887755443 223334555677 566788899999874321110 01122222222
Q ss_pred CCC--CccccCChhHHHHHHhccccCCCCCCC---HHHH-------hcCCCCCCCCccccccC
Q psy622 264 EWP--EDEEALNPSTEETILALLKSDPTQRPS---GHQV-------RRLPMFKDYDWDSILDQ 314 (473)
Q Consensus 264 ~~P--~~~~~ls~~a~dLI~~LL~~dP~kRps---a~ei-------l~HPFF~~idw~~l~~~ 314 (473)
..| .....++.++.-.+.-|=..-=++-|. ..++ ++|-+=--.||+.+.++
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk 304 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQK 304 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHH
Confidence 222 112345566666666554444444443 1221 23333234689988765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=179.80 Aligned_cols=147 Identities=17% Similarity=0.126 Sum_probs=114.4
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccc---------------------hhHHHHHHHHHHHHHhcC
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN---------------------KNMVSQVLRERNALALTH 100 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~---------------------~~~~~~~~~E~~iL~~l~ 100 (473)
.|++.+.||+|+||.||+|.+...+|+.||||+++...... ......+.+|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998232357899999998643110 001134678999999996
Q ss_pred CCC--eeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCCcceEecC
Q psy622 101 SPF--CVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG-IIHRDLKPDNMLISA 177 (473)
Q Consensus 101 hp~--Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~g-IiHRDLKpeNILld~ 177 (473)
+.. +.+++.. ...|+||||++|++|...+.....+.+..++.++.||+.+|++||++| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 532 3344432 235899999999888776644556777788899999999999999999 99999999999999
Q ss_pred CCCceeEeecchhhhhc
Q psy622 178 QAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 178 ~~g~ikL~DFGla~~~~ 194 (473)
+ +.++|+|||++....
T Consensus 184 ~-~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 D-GKVVIIDVSQSVELD 199 (237)
T ss_pred C-CCEEEEEChhhhccC
Confidence 5 899999999998643
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=180.64 Aligned_cols=249 Identities=20% Similarity=0.206 Sum_probs=169.9
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC----CCCeeeEEEEE-EeCCE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH----SPFCVQLFYSL-QTSSC 116 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~----hp~Iv~l~~~f-~~~~~ 116 (473)
+|++.+.||+|+||.||+|.+.......+|+|+......... ..+..|..++..+. .+++.++++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 899999999999999999987764345799999877532111 15677888888775 36889999999 58889
Q ss_pred EEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC----CceeEeecchh
Q psy622 117 VFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA----PHCPIVNTLFL 190 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~----g~ikL~DFGla 190 (473)
-|+||+.+ |.+|.++.... +.|+..++..++.|++.+|++||+.|+|||||||.|+++.... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 99999988654 5899999999999999999999999999999999999998752 35999999999
Q ss_pred h--hhcCCc----ccccc-ccccCCCCcccccCCc---cccccCCcCCCC-ccccccCCCCCchhHhhhcCCCCChhhHh
Q psy622 191 A--ILQQPI----VYLEI-SDLVNGTPNAFNIRTP---GQLLSLKTGTFP-TFQDVQNSQAPFPSALRVAGSQIPTSTAA 259 (473)
Q Consensus 191 ~--~~~~~~----~~~~~-~~~~~gtp~y~~~~ap---e~i~~~~~~s~g-~l~~~~~g~~pf~~~~~~~~~~~~~~~~~ 259 (473)
+ ...... ..... .....||..|....+. |.-..-|.|++. ++.++..|..||....... ......
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~----~~~~~~ 250 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD----LKSKFE 250 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc----hHHHHH
Confidence 8 321111 11111 1234588777632211 122234555544 3346777888885421100 011111
Q ss_pred hh--ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHh
Q psy622 260 QL--QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVR 298 (473)
Q Consensus 260 ~~--~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil 298 (473)
+. ...........+.+...+...+-..+...+|.-..+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~ 291 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLA 291 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence 10 1111101123456777777777778888888755443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.2e-20 Score=171.43 Aligned_cols=141 Identities=16% Similarity=0.151 Sum_probs=116.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ------VLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~------~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
-++|+++++||.|+||.||++.. . ++.+|||++............+ +.+|++.+.++.||+|..+..++..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-D--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-C--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 46899999999999999999744 2 4579999998765444443444 5789999999999999999888764
Q ss_pred C--------CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEe
Q psy622 114 S--------SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185 (473)
Q Consensus 114 ~--------~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~ 185 (473)
. ...++||||++|.+|.++.. +++. ...+|+.+|..+|+.|++|||+||.||+++.+ | ++|+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~-g-i~li 176 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKN-G-LRII 176 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCC-C-EEEE
Confidence 3 35899999999999988732 3433 45699999999999999999999999999988 7 9999
Q ss_pred ecchhhhh
Q psy622 186 NTLFLAIL 193 (473)
Q Consensus 186 DFGla~~~ 193 (473)
|||..+..
T Consensus 177 Dfg~~~~~ 184 (232)
T PRK10359 177 DLSGKRCT 184 (232)
T ss_pred ECCCcccc
Confidence 99998764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=166.42 Aligned_cols=137 Identities=25% Similarity=0.265 Sum_probs=114.6
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN-----KNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~-----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
+.||+|++|.||+|+. .+..+++|+........ .....++.+|..++..+.|++|.....++.+....++||
T Consensus 2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 6799999999999976 34578999866432211 112346788999999999999887777777778899999
Q ss_pred cccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 122 EYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
||++|++|.+++..... ....++.+|+.+|.++|+.|++|||++|.|||++ + +.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 99999999999976432 7888999999999999999999999999999999 5 8899999999876
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.5e-19 Score=163.01 Aligned_cols=136 Identities=18% Similarity=0.189 Sum_probs=108.0
Q ss_pred EEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhH-HHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEe
Q psy622 44 EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNM-VSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 44 ~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~-~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
.+...|++|+||+|+++.. .+..++.+.+.......... ...+.+|+++|+++ +|++|.+++++ ...|++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~---~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG---GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec---CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 4567999999999998754 35678888877654322211 22578999999999 45889999886 4469999
Q ss_pred cccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC-CCcceEecCCCCceeEeecchhhhhc
Q psy622 122 EYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL-KPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDL-KpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
||+.|.+|...+.. . ...++.|++.+|+++|++||+|||| ||+|||++.+ |.++|+|||+++...
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-GSPAVIDFQLAVRGN 143 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC-CCEEEEECCCceecC
Confidence 99999999765432 1 2357889999999999999999999 7999999988 899999999998643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=165.22 Aligned_cols=156 Identities=12% Similarity=0.108 Sum_probs=114.9
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 127 GDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 127 g~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
|+|.+++.+. +.+++.+++.++.||+.||+|||+++ ||+|||++.+ +.+|+ ||+++..... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~--------~ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPE--------Q 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeeccc--------c
Confidence 7899999874 46999999999999999999999999 9999999998 89999 9999874321 1
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC---CccccCCh-
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP---EDEEALNP- 274 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P---~~~~~ls~- 274 (473)
..||+.|+ |||++. ..|+|++|++ +++++|..||....... ..............+ ..+..++.
T Consensus 64 ~~g~~~y~---aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 64 SRVDPYFM---APEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDPRDRSNLESVSAA 138 (176)
T ss_pred CCCccccc---ChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCccccccHHHHHhh
Confidence 25788887 898764 3688999965 67999999996421100 000000000000100 01123344
Q ss_pred -hHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 275 -STEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 275 -~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
+++++|.+||+.||.+||++.|+++|+|+.
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 699999999999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=161.23 Aligned_cols=133 Identities=19% Similarity=0.178 Sum_probs=107.4
Q ss_pred eecccCceEEEEEEEeCCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEec
Q psy622 48 AISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN-----KNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 48 ~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~-----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
.||+|+||.||+|.. .++.+++|+........ .....++.+|.+++..+.|+++.....++......++|||
T Consensus 1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec---CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence 489999999999974 34679999865432211 1223577899999999988776555555556677899999
Q ss_pred ccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 123 YMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 123 y~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
|++|++|.+++...+. .++.+++.+|.+||+.|++|||+||.||+++ + +.++++|||++..
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-DKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence 9999999998865421 7899999999999999999999999999999 5 8999999999876
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.4e-20 Score=196.60 Aligned_cols=247 Identities=19% Similarity=0.213 Sum_probs=177.2
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccc-ccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDE-MINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~-~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+|...+.||.+.|=+|.+|++++ | .|+||++-+.. ...-....+-+.|++ ....++||++.+.-+..+.+..|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e--G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE--G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC--c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 78899999999999999998775 3 48999987754 223333444555555 6667999999998888888899999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
=+|+ .-+|++.|..+..+..-+.++|+.||+.||.-+|+.||+|+|||.|||||.+- +.+.|+||..-|....+++..
T Consensus 100 Rqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 100 RQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee-chhhhhcccccCCccCCCCCc
Confidence 9999 66999999998889999999999999999999999999999999999999998 899999999887643333221
Q ss_pred ccccccCCC-CcccccCCcccccc-----------------CCcCCCCcc-cc-ccCCCCCchhHhhhcCCCCChhhHhh
Q psy622 201 EISDLVNGT-PNAFNIRTPGQLLS-----------------LKTGTFPTF-QD-VQNSQAPFPSALRVAGSQIPTSTAAQ 260 (473)
Q Consensus 201 ~~~~~~~gt-p~y~~~~ape~i~~-----------------~~~~s~g~l-~~-~~~g~~pf~~~~~~~~~~~~~~~~~~ 260 (473)
.--....-| -.-.||-|||...+ +|..+.|+. .+ ++-|+++|.-........-.....++
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~ 257 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ 257 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence 111111111 11124447775332 444567754 45 55678888753221111100111111
Q ss_pred hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 261 LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 261 ~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
...+++ +...++||..|+++||.+|++|++.++-
T Consensus 258 ~Le~Ie------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 258 LLEKIE------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHhCc------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 122222 3478999999999999999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=161.38 Aligned_cols=140 Identities=18% Similarity=0.132 Sum_probs=108.9
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch-------------------hHHHHHHHHHHHHHhcCCCC
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK-------------------NMVSQVLRERNALALTHSPF 103 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~-------------------~~~~~~~~E~~iL~~l~hp~ 103 (473)
|.+.+.||+|+||.||+|..+ +++.||||++........ .......+|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 777899999999999999765 478999999875421000 01123677888898887763
Q ss_pred --eeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCc
Q psy622 104 --CVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH 181 (473)
Q Consensus 104 --Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ 181 (473)
+.+.+. ....++||||++|++|..+... ..+..++.+|+.++.++|+.||+||||||+||+++.+ +.
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~~ 163 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-EK 163 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-Cc
Confidence 444443 2456899999999999765431 3466788999999999999999999999999999988 89
Q ss_pred eeEeecchhhhhcC
Q psy622 182 CPIVNTLFLAILQQ 195 (473)
Q Consensus 182 ikL~DFGla~~~~~ 195 (473)
++|+|||++.....
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999977543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.2e-18 Score=181.89 Aligned_cols=140 Identities=17% Similarity=0.098 Sum_probs=112.5
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI-----NKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
..|...+.||+|+||.||+|.... +.+++|+..+.... .....+++.+|.++++.++|++|+....+..+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~---~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG---RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC---ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 345667899999999999997654 23444443222111 1122457889999999999999988877777777
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..++||||++|++|.+++. ....++.+|+.+|.+||+.||+||||||+|||+ .+ +.++|+|||+++..
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~-~~~~liDFGla~~~ 477 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RD-DRLYLIDFGLGKYS 477 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-EC-CcEEEEeCcccccC
Confidence 8899999999999999886 356789999999999999999999999999999 45 79999999999873
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=153.80 Aligned_cols=139 Identities=17% Similarity=0.171 Sum_probs=99.8
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHH---------------------HHHHHHHHHHhcCCCC-
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVS---------------------QVLRERNALALTHSPF- 103 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~---------------------~~~~E~~iL~~l~hp~- 103 (473)
.+.||+|+||+||+|++. +++.||||+++........... ....|.+.+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 468999999999999865 4689999998864322111111 1235666666664332
Q ss_pred -eeeEEEEEEeCCEEEEEecccCcCCHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCC
Q psy622 104 -CVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAP 180 (473)
Q Consensus 104 -Iv~l~~~f~~~~~l~lVmEy~~gg~L~~-~L~~~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g 180 (473)
+.++++. ...++||||++|+.+.. .+... ... ..++.++.+++.++.++|. .||+||||||+||+++ + +
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~ 151 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-G 151 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-C
Confidence 4444443 23589999999855432 22221 111 6788999999999999999 9999999999999999 6 8
Q ss_pred ceeEeecchhhhhc
Q psy622 181 HCPIVNTLFLAILQ 194 (473)
Q Consensus 181 ~ikL~DFGla~~~~ 194 (473)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-18 Score=184.38 Aligned_cols=259 Identities=17% Similarity=0.215 Sum_probs=202.0
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~ 118 (473)
-..|.+.+.||+|+|+.|-++....+....+|+|.+.... .......++..|..+-+.+. |+|++++++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5678999999999999999887655566678888877653 22333456667888877775 999999999999999999
Q ss_pred EEecccCcCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCCcceEecCCCC-ceeEeecchhhhhc
Q psy622 119 LVMEYMIGGDVKSLI-AANG-ALPEDMAAFYAAEVVLALQYLH-SHGIIHRDLKPDNMLISAQAP-HCPIVNTLFLAILQ 194 (473)
Q Consensus 119 lVmEy~~gg~L~~~L-~~~~-~~~e~~~~~~~~qI~~aL~yLH-~~gIiHRDLKpeNILld~~~g-~ikL~DFGla~~~~ 194 (473)
++++|..||+++.-+ .... ..+...+.+|+.|+..++.|+| ..++.||||||+|.+++.. + .+++.|||++....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s-~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDES-GSALKIADFGLATAYR 176 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccC-CCcccCCCchhhcccc
Confidence 999999999999999 5554 6888999999999999999999 9999999999999999999 8 99999999999865
Q ss_pred CCccccccccccCC-CCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 195 QPIVYLEISDLVNG-TPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 195 ~~~~~~~~~~~~~g-tp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
............+| ++.|. |||...+ .+.|+.|+. ..+++|..|+.......... ..........-
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~---a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~--~~~~~~~~~~~ 251 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYG---APEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY--SSWKSNKGRFT 251 (601)
T ss_pred ccCCcceeeecccCCCCCCC---CcccccchhhcCCCcccccccccccccccCCCCccccccccccc--eeecccccccc
Confidence 42222233445678 88888 8887654 678888865 46899999987543322110 01111110000
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
......++..+.+++.++|..+|..|.+.+++..+||+..
T Consensus 252 ~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 252 QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 1112578999999999999999999999999999999987
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.9e-17 Score=158.14 Aligned_cols=233 Identities=21% Similarity=0.237 Sum_probs=137.7
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-----------CCeeeEEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS-----------PFCVQLFYS 110 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-----------p~Iv~l~~~ 110 (473)
.+...+.||.|+++.||.|.+.. +++.+|+|+............+.+.+|.-....+.+ .+++. ++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~-t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P-~d~ 90 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVE-TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP-LDL 90 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B----SEE
T ss_pred EEEEccccccCCceEEEEEEEcc-CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee-eEE
Confidence 46778899999999999999887 789999999876554444456666666544433221 22222 222
Q ss_pred E---------EeC---C-----EEEEEecccCcCCHHHHHHh---CCCC---CHHHHHH-HHHHHHHHHHHHHHCCeeec
Q psy622 111 L---------QTS---S-----CVFLVMEYMIGGDVKSLIAA---NGAL---PEDMAAF-YAAEVVLALQYLHSHGIIHR 166 (473)
Q Consensus 111 f---------~~~---~-----~l~lVmEy~~gg~L~~~L~~---~~~~---~e~~~~~-~~~qI~~aL~yLH~~gIiHR 166 (473)
. +.. . +.+++|+-+ .+||..++.- .... ....|+. +..|++..+++||++|++|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 1 111 1 347788887 7798887652 2222 1233433 44899999999999999999
Q ss_pred CCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCC-----cc--ccccCCcCCCCcc-ccccCC
Q psy622 167 DLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRT-----PG--QLLSLKTGTFPTF-QDVQNS 238 (473)
Q Consensus 167 DLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~a-----pe--~i~~~~~~s~g~l-~~~~~g 238 (473)
||||+|++++.+ |.+.|+||+.....+..... .... ...+|..+...+ .+ .....|.|.+|+. +.+.++
T Consensus 170 di~~~nfll~~~-G~v~Lg~F~~~~r~g~~~~~-~~~~-~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQD-GGVFLGDFSSLVRAGTRYRC-SEFP-VAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TT-S-EEE--GGGEEETTEEEEG-GGS--TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCC-CCEEEcChHHHeecCceeec-cCCC-cccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999 99999999887764322111 1111 111221111000 01 1234688899965 568999
Q ss_pred CCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCC
Q psy622 239 QAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQR 291 (473)
Q Consensus 239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kR 291 (473)
..||........ ... .|..- ..+++..+.||++||++||.+|
T Consensus 247 ~lPf~~~~~~~~---~~~-------~f~~C-~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEAD---PEW-------DFSRC-RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGST---SGG-------GGTTS-S---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccc---ccc-------cchhc-CCcCHHHHHHHHHHccCCcccC
Confidence 999975322111 111 12211 3678899999999999999988
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.9e-16 Score=151.67 Aligned_cols=137 Identities=13% Similarity=0.174 Sum_probs=105.6
Q ss_pred ceec-ccCceEEEEEEEeCCCCcEEEEEEeeccccc----------chhHHHHHHHHHHHHHhcCCCCe--eeEEEEEEe
Q psy622 47 KAIS-RGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI----------NKNMVSQVLRERNALALTHSPFC--VQLFYSLQT 113 (473)
Q Consensus 47 ~~LG-~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~----------~~~~~~~~~~E~~iL~~l~hp~I--v~l~~~f~~ 113 (473)
.+|| .|+.|+||.+... +..+++|......+. ......++.+|.+++..+.|++| ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~---~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP---GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC---CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 4677 7888888888543 467899988653321 11234578899999999988775 666666433
Q ss_pred C-C---EEEEEecccCc-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecc
Q psy622 114 S-S---CVFLVMEYMIG-GDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 114 ~-~---~l~lVmEy~~g-g~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
. . ..++|||+++| .+|.+++.. +.+++.. +.+|+.+|.+||++||+||||||+|||++.+ +.++|+|||
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~-~~v~LIDfg 187 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPD-GKFWLIDFD 187 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCC-CCEEEEECC
Confidence 2 2 23599999997 699988865 4566554 5689999999999999999999999999988 899999999
Q ss_pred hhhh
Q psy622 189 FLAI 192 (473)
Q Consensus 189 la~~ 192 (473)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 9886
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=6e-17 Score=177.24 Aligned_cols=154 Identities=24% Similarity=0.343 Sum_probs=121.0
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
.+....|.|-+.||+|+||+||+|.... ++.||+|+=+....+.-....+++.-++ +.. -+.|.++..++.-.+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~--~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~--~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN--GKLVALKVEKPPNPWEFYICLQVMERLK-PQM--LPSIMHISSAHVFQNA 768 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC--CcEEEEEeecCCCceeeeehHHHHHhhc-hhh--hcchHHHHHHHccCCc
Confidence 3444679999999999999999998765 7899999987764433222222222222 111 2556666666666666
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC------CCCceeEeecchh
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA------QAPHCPIVNTLFL 190 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~------~~g~ikL~DFGla 190 (473)
-+||+||.+.|+|.++++..+.+++..+.+++.|++.-|++||..+|||+||||+|+||.. +..-++|+|||.+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 7899999999999999998889999999999999999999999999999999999999953 2256999999999
Q ss_pred hhhcC
Q psy622 191 AILQQ 195 (473)
Q Consensus 191 ~~~~~ 195 (473)
..+..
T Consensus 849 iDm~l 853 (974)
T KOG1166|consen 849 IDMKL 853 (974)
T ss_pred eeeeE
Confidence 87643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.7e-16 Score=135.71 Aligned_cols=132 Identities=22% Similarity=0.280 Sum_probs=112.2
Q ss_pred EEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCCEEEEEec
Q psy622 45 IVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS--PFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 45 i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~~~~~l~lVmE 122 (473)
+++.||+|.++.||++.... +.+++|...+... ...+.+|..++..+.| ..+.+++.++...+..|++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~---~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD---EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC---CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence 45789999999999997643 5799999876532 3568889999999965 589999999888889999999
Q ss_pred ccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 123 YMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH---GIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 123 y~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~---gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
|++|+.+..+ +......++.+++.+|.+||.. +++|+||+|.||+++.. +.++++|||.+..
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence 9988877654 5566777899999999999985 69999999999999987 8999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.7e-17 Score=151.55 Aligned_cols=240 Identities=15% Similarity=0.271 Sum_probs=179.4
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
...+..++..++.+|.+...|+.|+|++..+ .++.|+++...... .....|..|.-.|+.+.||||+.++++++.+
T Consensus 184 ~~gid~~~lnl~tkl~e~hsgelwrgrwqgn---divakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 184 YTGIDVSSLNLITKLAESHSGELWRGRWQGN---DIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred ccCcchhhhhhhhhhccCCCcccccccccCc---chhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 4556667788889999999999999998763 47788888765432 2234678888899999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCCcceEecCCCCceeEe--ecc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHG--IIHRDLKPDNMLISAQAPHCPIV--NTL 188 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~g--IiHRDLKpeNILld~~~g~ikL~--DFG 188 (473)
.++.++..||+.|+|+..|+... ..+..++..++.+|+.|++|||+.. |.---|....++||++ -..+|. |--
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltarismad~k 338 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARISMADTK 338 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhheecccce
Confidence 99999999999999999999754 4678899999999999999999985 4444688899999988 665553 211
Q ss_pred hhhhhcCCccccccccccCCCCcccccCCcccc---------ccCCcCCCCcc-ccccCCCCCchhHhhh-cCCCCChhh
Q psy622 189 FLAILQQPIVYLEISDLVNGTPNAFNIRTPGQL---------LSLKTGTFPTF-QDVQNSQAPFPSALRV-AGSQIPTST 257 (473)
Q Consensus 189 la~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i---------~~~~~~s~g~l-~~~~~g~~pf~~~~~~-~~~~~~~~~ 257 (473)
++-. .. . ....|.++ +||.+ ...+.|+|.++ +++.+...||...... .+-. ..
T Consensus 339 fsfq--e~------g--r~y~pawm---spealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---ia 402 (448)
T KOG0195|consen 339 FSFQ--EV------G--RAYSPAWM---SPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---IA 402 (448)
T ss_pred eeee--cc------c--cccCcccC---CHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh---hh
Confidence 1111 00 0 12345555 55543 35788999976 6789999999752111 0100 11
Q ss_pred HhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHh
Q psy622 258 AAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVR 298 (473)
Q Consensus 258 ~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil 298 (473)
.+...+.+| +.++.....|+.-|++.||.+||.++.|.
T Consensus 403 leglrv~ip---pgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 403 LEGLRVHIP---PGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred hccccccCC---CCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 122345556 68999999999999999999999987665
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-14 Score=152.29 Aligned_cols=145 Identities=21% Similarity=0.320 Sum_probs=99.3
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc--------------------------c-h----hHHHHH
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI--------------------------N-K----NMVSQV 89 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~--------------------------~-~----~~~~~~ 89 (473)
.+|+. +.||+|++|+||.|+.+. +|+.||||++++.... + . +..+.+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~-~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD-NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC-CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 45776 789999999999999876 5789999999865200 0 0 112223
Q ss_pred HH------HHHHHHhc----CCCCeeeEEEEEEe-CCEEEEEecccCcCCHHHH--HHhCC----CCCHHHHHHHHHHHH
Q psy622 90 LR------ERNALALT----HSPFCVQLFYSLQT-SSCVFLVMEYMIGGDVKSL--IAANG----ALPEDMAAFYAAEVV 152 (473)
Q Consensus 90 ~~------E~~iL~~l----~hp~Iv~l~~~f~~-~~~l~lVmEy~~gg~L~~~--L~~~~----~~~e~~~~~~~~qI~ 152 (473)
.+ |...+.++ .+...+.+-.++.+ ...-+|||||+.|+.|.+. +...+ .+.+..+..++.||+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 33 33333333 23333333333322 3456799999999999764 44444 355566666666665
Q ss_pred HHHHHHHHCCeeecCCCCcceEecCCCC----ceeEeecchhhhhcC
Q psy622 153 LALQYLHSHGIIHRDLKPDNMLISAQAP----HCPIVNTLFLAILQQ 195 (473)
Q Consensus 153 ~aL~yLH~~gIiHRDLKpeNILld~~~g----~ikL~DFGla~~~~~ 195 (473)
..|++|+|+||.||+++.+ | .++++|||++..+..
T Consensus 278 -------~~GffHaDpHPGNIlv~~~-g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYD-PPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hCCeeeCCCChHHeEEecC-CCCCCeEEEEecceEEECCH
Confidence 5899999999999999988 6 999999999987643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.7e-13 Score=142.31 Aligned_cols=141 Identities=17% Similarity=0.187 Sum_probs=96.3
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccch---------------------------h----HH------HHH
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK---------------------------N----MV------SQV 89 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~---------------------------~----~~------~~~ 89 (473)
+.||.|++|+||+|+.+. |+.||||+.+......- . .. -.+
T Consensus 123 ~plasaSigQVh~A~l~~--G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVD--GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEecC--CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 569999999999998764 68999999875420000 0 00 023
Q ss_pred HHHHHHHHhc-----CCCCeeeEEEEE-EeCCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHHC
Q psy622 90 LRERNALALT-----HSPFCVQLFYSL-QTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVL-ALQYLHSH 161 (473)
Q Consensus 90 ~~E~~iL~~l-----~hp~Iv~l~~~f-~~~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~-aL~yLH~~ 161 (473)
.+|...+..+ ++++| .+-..+ .-....+|||||++|++|.+..... ..+. ...++..++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4455555444 23443 222222 2234568999999999998876532 1222 2345555555 47889999
Q ss_pred CeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 162 GIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 162 gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
|++|+|+||.||+++.+ |.++|+|||++..+.
T Consensus 277 g~~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 99999999999999988 999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.5e-12 Score=119.95 Aligned_cols=144 Identities=19% Similarity=0.126 Sum_probs=102.7
Q ss_pred EceecccCceEEEEEEEeCC-----CCcEEEEEEeecccc-------------------cchhHHH----HHHHHHHHHH
Q psy622 46 VKAISRGAFGKVFLGYKKTN-----KDQLYAIKVMKKDEM-------------------INKNMVS----QVLRERNALA 97 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~-----~~~~vAiK~l~k~~~-------------------~~~~~~~----~~~~E~~iL~ 97 (473)
...||.|-=+.||.|....+ .+..+|||+.+.... .+....+ ...+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 35789999999999975421 246899999853210 0011122 3458999998
Q ss_pred hcC--CCCeeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCeeecCCCCcceE
Q psy622 98 LTH--SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL-HSHGIIHRDLKPDNML 174 (473)
Q Consensus 98 ~l~--hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yL-H~~gIiHRDLKpeNIL 174 (473)
++. .-.+.+++++ ..-+|||||+.++.+..-.-+...+++..+..+..+++.+|..| |+.||||+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 884 2455556654 45679999996654432222233566677788889999999998 8999999999999999
Q ss_pred ecCCCCceeEeecchhhhhcC
Q psy622 175 ISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 175 ld~~~g~ikL~DFGla~~~~~ 195 (473)
++. +.+.|+|||.+.....
T Consensus 158 ~~~--~~v~iIDF~qav~~~h 176 (197)
T cd05146 158 WHD--GKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEC--CcEEEEECCCceeCCC
Confidence 974 6899999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.1e-13 Score=119.98 Aligned_cols=128 Identities=16% Similarity=0.232 Sum_probs=95.3
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEEEEeccc
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFC-VQLFYSLQTSSCVFLVMEYM 124 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~f~~~~~l~lVmEy~ 124 (473)
++.|+.|.++.||+++.. ++.|++|+...... ......+|..+++.+.+..+ .+++.... ...++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~---~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA---NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC---CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEec
Confidence 467899999999998753 46799999765421 11245678888888754443 34554433 3357999999
Q ss_pred CcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCe-----eecCCCCcceEecCCCCceeEeecchhhh
Q psy622 125 IGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGI-----IHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 125 ~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gI-----iHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
+|.++... ......++.+++.+|..||+.++ +|+|++|.||+++ + +.++++|||.+..
T Consensus 74 ~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEecccccC
Confidence 99887543 11124467899999999999985 9999999999999 5 7899999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.35 E-value=8e-13 Score=136.17 Aligned_cols=200 Identities=16% Similarity=0.151 Sum_probs=139.2
Q ss_pred HHhcCCCCeeeEEEEEEeCCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCe-eecCCCCcce
Q psy622 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGI-IHRDLKPDNM 173 (473)
Q Consensus 96 L~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gI-iHRDLKpeNI 173 (473)
|+.+.|.|+.++++...++...++|.+||.-|+|.+.+... ..++.-..-.++++|+.||+|||+..| .|+.|+..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35678999999999999999999999999999999999883 367777888889999999999999876 9999999999
Q ss_pred EecCCCCceeEeecchhhhhcCC----ccccccccccCCCCcccccC-Ccc----ccccCCcCCCCcc-ccccCCCCCch
Q psy622 174 LISAQAPHCPIVNTLFLAILQQP----IVYLEISDLVNGTPNAFNIR-TPG----QLLSLKTGTFPTF-QDVQNSQAPFP 243 (473)
Q Consensus 174 Lld~~~g~ikL~DFGla~~~~~~----~~~~~~~~~~~gtp~y~~~~-ape----~i~~~~~~s~g~l-~~~~~g~~pf~ 243 (473)
++|.. -.+||+|||+....... ..........+..|+.+..+ +.. .....+.+++|++ ++++....||.
T Consensus 81 lvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 81 LVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred eeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999 89999999998875320 00111111222333322111 000 1123567788865 56888899997
Q ss_pred hHhhhcCCCCChhhHhh-----hccCCCCcc--ccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 244 SALRVAGSQIPTSTAAQ-----LQLEWPEDE--EALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 244 ~~~~~~~~~~~~~~~~~-----~~~~~P~~~--~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
........ .+.+.. ...-.|... ....++...++.+||..+|.+||+++++..
T Consensus 160 ~~~~~~~~---~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 160 LRNLVEDP---DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cccccCCh---HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 63222111 111111 111112111 145567999999999999999999887653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=9e-11 Score=105.16 Aligned_cols=134 Identities=20% Similarity=0.152 Sum_probs=101.9
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI-----NKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
..+++|+=+.++.+.... ..+++|.=.++... .+-...+..+|.++|.++.--.|....-++.+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~g---~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG---LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeeccC---cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence 467899999999985543 34666654333222 2222457889999999886555555555556777888999
Q ss_pred cccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 122 EYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
||++|-.|.+.|... .-.++..|-.-+.-||..||||+||.++||++... .+.++||||+..
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence 999998888888865 24567778888899999999999999999999875 599999999986
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.4e-12 Score=130.69 Aligned_cols=173 Identities=16% Similarity=0.190 Sum_probs=123.4
Q ss_pred CEEEEEecccCcCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANG---ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~---~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
.++||.|++|.-.+|.++|.+.. .-+......++.|+..|++| +|.+|||+||.||....+ +.+||.|||+..
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-~q~kIgDFgl~t 404 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-DQLKIGDFGLVT 404 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-hhhhhhhhhhee
Confidence 36899999999999999997543 35677888999999999999 999999999999999998 899999999988
Q ss_pred hhcCCcc---ccccccccCCCCcccccCCccccc------cCCcCCCCccc-cccC-CCCCchhHhhhcCCCCChhhHhh
Q psy622 192 ILQQPIV---YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTFQ-DVQN-SQAPFPSALRVAGSQIPTSTAAQ 260 (473)
Q Consensus 192 ~~~~~~~---~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l~-~~~~-g~~pf~~~~~~~~~~~~~~~~~~ 260 (473)
....... ...-.+...||.-|+ +||.+. .++.+++|++. +++. -...|...-.. .. .
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~Ym---sPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~-------~d--~ 472 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYM---SPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL-------TD--I 472 (516)
T ss_pred ecccCCcccchhhhhhhcccccccC---CHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh-------hh--h
Confidence 7544331 111223446888888 899875 46777888654 4443 23334321100 00 0
Q ss_pred hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 261 LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 261 ~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
....||...-.-.++...|+.+||...|.+||++.+.-.|+|.
T Consensus 473 r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1223332111223567799999999999999988888877764
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.8e-11 Score=124.98 Aligned_cols=255 Identities=20% Similarity=0.170 Sum_probs=170.4
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~ 116 (473)
-...+|..+..||.|.|+.|+.+..+.-++..|++|.+.+.......+ ..-+.|..+...+ -|.+++..+..|..-.+
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 346789999999999999999987663467899999998764433332 2345666666666 68999999999988888
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
.|+=.|||.|+++...+.-...+++...+....|++.|+.++|+..++|+|+||+||++..+++..++.|||+.+.+.-.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 88999999999998877655678999999999999999999999999999999999999987577899999998742211
Q ss_pred ccccccccccC-CCCcccccCCccccccCCcCCCCccccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChh
Q psy622 197 IVYLEISDLVN-GTPNAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPS 275 (473)
Q Consensus 197 ~~~~~~~~~~~-gtp~y~~~~ape~i~~~~~~s~g~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~ 275 (473)
.......+..+ +.+..+ ..-+..-..+..+++.-.....+..++.+.. ..-..+.... .|.. .....+
T Consensus 421 ~~~~~~~~r~~p~~~~~~--e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~------~~~~~i~~~~--~p~~-~~~~~~ 489 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILL--EDYPHLSKADIFSLGLSVDEAITGSPLSESG------VQSLTIRSGD--TPNL-PGLKLQ 489 (524)
T ss_pred cccccccccccccchhhc--cccccccccccccccccccccccCcccCccc------ccceeeeccc--ccCC-CchHHh
Confidence 11000000001 000000 0001112233345553222222223332210 0001111111 2222 234488
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 276 TEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 276 a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
+..+.+.++..++..|+.+.++..|.=|.
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhh
Confidence 99999999999999999999988886553
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.7e-11 Score=126.53 Aligned_cols=254 Identities=18% Similarity=0.130 Sum_probs=173.4
Q ss_pred CCeEEEceecc--cCceEEEEEEE--eCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q psy622 41 SDFEIVKAISR--GAFGKVFLGYK--KTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSS 115 (473)
Q Consensus 41 ~~y~i~~~LG~--G~fG~V~~a~~--~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~ 115 (473)
..|.+.+-+|. |.+|.||.++. +. ....+|+|.-+... .......+-.+|....+.+ .|++.++.+..+.+.+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~-s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSE-SPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCccc-CCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCC
Confidence 34777888999 99999999977 55 45788998854331 1112223445566666666 5999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGA-LPEDMAAFYAAEVVL----ALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~-~~e~~~~~~~~qI~~----aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
.+|+=+|+| |.+|..+...... +++..++.++.+... ||.++|+.+|+|-|+||.||++..+...++++|||+.
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 999999999 7888888877554 889999999999999 9999999999999999999999988567899999999
Q ss_pred hhhcCCccccccc--cccCCCCcccccCCcccccc-----CCcCCCCc-cccccCCCCCc-hhHhhhcCCCCChhhHhhh
Q psy622 191 AILQQPIVYLEIS--DLVNGTPNAFNIRTPGQLLS-----LKTGTFPT-FQDVQNSQAPF-PSALRVAGSQIPTSTAAQL 261 (473)
Q Consensus 191 ~~~~~~~~~~~~~--~~~~gtp~y~~~~ape~i~~-----~~~~s~g~-l~~~~~g~~pf-~~~~~~~~~~~~~~~~~~~ 261 (473)
..+.......... .-..|-.-|+ +||.... .+..++|. +.+..++..+. .+.. ..+.+..
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~---~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~~~r 339 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYA---AKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWSQLR 339 (524)
T ss_pred EEccCCccccceeeeecCCCCceEe---ChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC--------CCccccc
Confidence 9875543221111 0112334444 6665432 33445552 22222222111 1100 0000000
Q ss_pred ccCCC-CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCc
Q psy622 262 QLEWP-EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDW 308 (473)
Q Consensus 262 ~~~~P-~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw 308 (473)
....| +.....+.+....+..++..+|..|++++.+++|++......
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~ 387 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLF 387 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhh
Confidence 11111 112456777788999999999999999999999999985543
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.16 E-value=5e-10 Score=99.99 Aligned_cols=146 Identities=19% Similarity=0.152 Sum_probs=109.7
Q ss_pred EEceecccCceEEEEEEEeCCCCcEEEEEEeeccc-----ccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 45 IVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDE-----MINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 45 i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~-----~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.+..|-+|+-+.|+++... |+.+.||.-..+. +..+-..++..+|.++|.++.--.|.-..-+|.+...-.|
T Consensus 11 ~l~likQGAEArv~~~~~~---Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS---GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC---CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE
Confidence 5678889999999998653 5677777644332 2223335688999999998864455555556667777789
Q ss_pred EecccCc-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCce--eEeecchhhhh
Q psy622 120 VMEYMIG-GDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHC--PIVNTLFLAIL 193 (473)
Q Consensus 120 VmEy~~g-g~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~i--kL~DFGla~~~ 193 (473)
+|||++| .++.+++.... .....-...++..|-..|.-||.++|||+||..+||+|.++++.+ .|+|||++...
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9999966 47888887642 223333378889999999999999999999999999998875555 89999998763
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.2e-10 Score=119.60 Aligned_cols=124 Identities=13% Similarity=0.243 Sum_probs=102.9
Q ss_pred EEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCCCC
Q psy622 60 GYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGAL 139 (473)
Q Consensus 60 a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~ 139 (473)
|..+. .+.+|.|.+.+...- .......+-++-|+.++||+|++++..+..++.+|||+|.+. .|...+.+.+
T Consensus 31 ~t~k~-~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 31 GTRKA-DGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-- 102 (690)
T ss_pred cceec-cCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--
Confidence 44454 467888888876532 344566777888999999999999999999999999999983 5666777643
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 140 PEDMAAFYAAEVVLALQYLH-SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 140 ~e~~~~~~~~qI~~aL~yLH-~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
...+..-+.||+.||.||| +.+++|++|.-..|+++.. |+.||.+|-++...
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES-GEWKLGGLELVSKA 155 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC-CcEEEeeeEEEecc
Confidence 6778888999999999998 6689999999999999999 99999999888653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.4e-10 Score=108.89 Aligned_cols=140 Identities=16% Similarity=0.199 Sum_probs=105.6
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CCeeeEEEEEEeC---CEEEEEe
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS--PFCVQLFYSLQTS---SCVFLVM 121 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~~~---~~l~lVm 121 (473)
+.|+.|..+.||++.... |+.|++|+....... .....+.+|.+++..+.+ ..+.+++.+.... +..|+||
T Consensus 4 ~~l~~G~~n~~~~v~~~~--g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG--GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC--CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 578999999999997643 467999998765321 123467889999999864 3456677766543 3678999
Q ss_pred cccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q psy622 122 EYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS----------------------------------------- 160 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~----------------------------------------- 160 (473)
||++|+++...+.. +.+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999988765532 356777777777777777777773
Q ss_pred ---------------CCeeecCCCCcceEecC--CCCceeEeecchhhh
Q psy622 161 ---------------HGIIHRDLKPDNMLISA--QAPHCPIVNTLFLAI 192 (473)
Q Consensus 161 ---------------~gIiHRDLKpeNILld~--~~g~ikL~DFGla~~ 192 (473)
..++|+|++|.||+++. + +.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~-~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEP-RVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCC-cEEEEEecccccc
Confidence 24699999999999998 5 6789999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=5e-09 Score=101.75 Aligned_cols=126 Identities=15% Similarity=0.123 Sum_probs=90.6
Q ss_pred CcEEEEEEeeccccc---ch-----hHHHHHHHHHHHHHhcCCCCe--eeEEEEEEe-----CCEEEEEecccCcC-CHH
Q psy622 67 DQLYAIKVMKKDEMI---NK-----NMVSQVLRERNALALTHSPFC--VQLFYSLQT-----SSCVFLVMEYMIGG-DVK 130 (473)
Q Consensus 67 ~~~vAiK~l~k~~~~---~~-----~~~~~~~~E~~iL~~l~hp~I--v~l~~~f~~-----~~~l~lVmEy~~gg-~L~ 130 (473)
|+.|.||........ +. .-...+.+|...+..+..-.| .+++++... ...-+||||+++|. +|.
T Consensus 45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~ 124 (268)
T PRK15123 45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE 124 (268)
T ss_pred CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence 467888876433210 00 111247788888877732232 334444432 23578999999876 799
Q ss_pred HHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC------CCCceeEeecchhhh
Q psy622 131 SLIAA--NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA------QAPHCPIVNTLFLAI 192 (473)
Q Consensus 131 ~~L~~--~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~------~~g~ikL~DFGla~~ 192 (473)
+++.. ....++.....++.+|+..+.-||..||+|+||++.|||++. +.+.+.|+||+.+..
T Consensus 125 ~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 125 DYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99864 345677788899999999999999999999999999999985 126899999998864
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.7e-10 Score=106.48 Aligned_cols=205 Identities=17% Similarity=0.164 Sum_probs=129.8
Q ss_pred HHhcCCCCeeeEEEEEEeCC-----EEEEEecccCcCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ee
Q psy622 96 LALTHSPFCVQLFYSLQTSS-----CVFLVMEYMIGGDVKSLIAAN----GALPEDMAAFYAAEVVLALQYLHSHG--II 164 (473)
Q Consensus 96 L~~l~hp~Iv~l~~~f~~~~-----~l~lVmEy~~gg~L~~~L~~~----~~~~e~~~~~~~~qI~~aL~yLH~~g--Ii 164 (473)
|.++.|.|||+++.++.+.+ ...+++|||..|+|.++|++. ..+.+...+.|+.||+.||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 34557999999999986543 488999999999999999863 35888899999999999999999885 99
Q ss_pred ecCCCCcceEecCCCCceeEeecchhhhhcCCcccccc-ccccCCCCcccccCCccc------cccCCcCCCCcc-cccc
Q psy622 165 HRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEI-SDLVNGTPNAFNIRTPGQ------LLSLKTGTFPTF-QDVQ 236 (473)
Q Consensus 165 HRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~-~~~~~gtp~y~~~~ape~------i~~~~~~s~g~l-~~~~ 236 (473)
|+++..+-|++..+ |-||+.--.-...-......... .....+-|.|. +|+. .-..+.+.+|+- .+|.
T Consensus 201 hgnlTc~tifiq~n-gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~---a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHN-GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFS---APESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred cCCcchhheeecCC-ceEEecccCccccchhhhhhhHhhhhccccCCccc---cCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999987 88887421111000000000000 11122344444 4432 123455666622 2333
Q ss_pred CCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccccc
Q psy622 237 NSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILD 313 (473)
Q Consensus 237 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~ 313 (473)
.+..--.. ....-++...+....+...+ .--++++.+||+-.|..||++.+++.||-.-+++-.+++.
T Consensus 277 ilEiq~tn---seS~~~~ee~ia~~i~~len------~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslkll~ 344 (458)
T KOG1266|consen 277 ILEIQSTN---SESKVEVEENIANVIIGLEN------GLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLKLLM 344 (458)
T ss_pred HheeccCC---CcceeehhhhhhhheeeccC------ccccCcCcccccCCCCCCcchhhhhcCceeeecchHHHHh
Confidence 22211000 00011222333332333221 2346789999999999999999999999988887666553
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=1e-08 Score=94.14 Aligned_cols=129 Identities=18% Similarity=0.175 Sum_probs=83.9
Q ss_pred EEEEEEEeCCCCcEEEEEEeeccc-----------------------ccchhHHHHHHHHHHHHHhcCCC--CeeeEEEE
Q psy622 56 KVFLGYKKTNKDQLYAIKVMKKDE-----------------------MINKNMVSQVLRERNALALTHSP--FCVQLFYS 110 (473)
Q Consensus 56 ~V~~a~~~~~~~~~vAiK~l~k~~-----------------------~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~ 110 (473)
.||.|.... +..+|+|+.+... ........+..+|.+.|..+..- ++.+++.+
T Consensus 1 ~Vy~~~~~~--~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAIDPD--GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEECT--TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEECCC--CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 388887643 5789999975321 01111234678999999999655 45555544
Q ss_pred EEeCCEEEEEecccC--cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCeeecCCCCcceEecCCCCceeEeec
Q psy622 111 LQTSSCVFLVMEYMI--GGDVKSLIAANGALPEDMAAFYAAEVVLALQY-LHSHGIIHRDLKPDNMLISAQAPHCPIVNT 187 (473)
Q Consensus 111 f~~~~~l~lVmEy~~--gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~y-LH~~gIiHRDLKpeNILld~~~g~ikL~DF 187 (473)
.+ -+|||||++ |..+..+... .++......++.+++..+.. +|..||||+||.+.|||++.+ .+.++||
T Consensus 79 --~~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf 150 (188)
T PF01163_consen 79 --NR--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDF 150 (188)
T ss_dssp --ET--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--G
T ss_pred --eC--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEec
Confidence 22 359999998 6566554432 12245667788888886655 579999999999999999874 8999999
Q ss_pred chhhhhc
Q psy622 188 LFLAILQ 194 (473)
Q Consensus 188 Gla~~~~ 194 (473)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9988743
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.1e-08 Score=91.91 Aligned_cols=106 Identities=19% Similarity=0.226 Sum_probs=84.9
Q ss_pred HHHHHHHHHHHHhcCCC--CeeeEEEEEEeC----CEEEEEecccCcC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q psy622 86 VSQVLRERNALALTHSP--FCVQLFYSLQTS----SCVFLVMEYMIGG-DVKSLIAANGALPEDMAAFYAAEVVLALQYL 158 (473)
Q Consensus 86 ~~~~~~E~~iL~~l~hp--~Iv~l~~~f~~~----~~l~lVmEy~~gg-~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yL 158 (473)
..+..+|...+..+..- .+.+.+++.... ...++|+|+++|. +|.+++......+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 34678888887766322 234455554432 3468999999874 8999998755577888899999999999999
Q ss_pred HHCCeeecCCCCcceEecCCCC---ceeEeecchhhh
Q psy622 159 HSHGIIHRDLKPDNMLISAQAP---HCPIVNTLFLAI 192 (473)
Q Consensus 159 H~~gIiHRDLKpeNILld~~~g---~ikL~DFGla~~ 192 (473)
|.+||+|+|+++.|||++.+ + .+.|+||+.++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~-~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPD-DGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCC-CCceeEEEEcchhcee
Confidence 99999999999999999988 5 799999998876
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.72 E-value=5.1e-08 Score=99.37 Aligned_cols=211 Identities=14% Similarity=0.118 Sum_probs=139.1
Q ss_pred eEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCEEEEEecccCc-CCH
Q psy622 55 GKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT----SSCVFLVMEYMIG-GDV 129 (473)
Q Consensus 55 G~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~----~~~l~lVmEy~~g-g~L 129 (473)
.+.|+|.... +|..|++|+++.......+ ....-.++++++.|+|||++.++|++ ...+++|++|+++ ++|
T Consensus 290 ~Ttyk~~s~~-DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 290 ITTYKATSNV-DGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ceeEeeeecc-CCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 4678887776 5789999999655433322 22334678899999999999999984 3569999999875 577
Q ss_pred HHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 130 KSLIAA---------------NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 130 ~~~L~~---------------~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
.++--. ....+|...+.|+.||..||.++|+.|..-+-|.|.+||++.+ .+|+|...|....+.
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~-~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK-MRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc-ceEEEecccceeeec
Confidence 665421 2357899999999999999999999999999999999999977 677776555444332
Q ss_pred CCccccccccccCCCCcccccCCccccccCCcCCCCccc-cccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLLSLKTGTFPTFQ-DVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~~~~~~s~g~l~-~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
... ++ ..|.....|...+|.+. .+.+|..- .......++..+.. ....+|
T Consensus 445 ~d~----------~~-------~le~~Qq~D~~~lG~ll~aLAt~~~n----------s~~~d~~~~s~~~~--I~~~yS 495 (655)
T KOG3741|consen 445 EDP----------TE-------PLESQQQNDLRDLGLLLLALATGTEN----------SNRTDSTQSSHLTR--ITTTYS 495 (655)
T ss_pred CCC----------Cc-------chhHHhhhhHHHHHHHHHHHhhcccc----------cccccchHHHHHHH--hhhhhh
Confidence 211 00 12334444555556432 23333210 00011111111111 115788
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.+++++|.-+...++++ .++++++.|
T Consensus 496 ~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 496 TDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999999999988886 456665543
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.5e-07 Score=103.98 Aligned_cols=297 Identities=14% Similarity=0.078 Sum_probs=164.5
Q ss_pred hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC---C-EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q psy622 84 NMVSQVLRERNALALTHSPFCVQLFYSLQTS---S-CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159 (473)
Q Consensus 84 ~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~---~-~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH 159 (473)
.++.....|...+....|+|++.++.+--.. + .+.+..++|.+-++..+++..+.++...++.+..+++.||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 3455566677788888999999987765322 2 23455689999999999999999999999999999999999999
Q ss_pred HCCeeecCCCCc---ceEecCCCCceeEe--ecchhhhhcCCccccccccccCCCCcccccCCccccc--------cCCc
Q psy622 160 SHGIIHRDLKPD---NMLISAQAPHCPIV--NTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL--------SLKT 226 (473)
Q Consensus 160 ~~gIiHRDLKpe---NILld~~~g~ikL~--DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~--------~~~~ 226 (473)
++...|.-|... +--.+.. +.+..+ ||+.++.+...... ... ..++.+. +++... ..+.
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~--~~~--~~~~~~~---~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKS--FSD--LLAEIRN---ADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred HhccceeEEecccccccccCcc-ceeecchhhhcccccCCCcccc--hhh--cCccccc---cccccccccchhhhhhHH
Confidence 995555444433 3333344 556555 88877765332211 111 1111111 222211 0122
Q ss_pred CCCCcccc-ccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 227 GTFPTFQD-VQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 227 ~s~g~l~~-~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
|.+|.+.. +..+..+ +.. ......-.+ .....+..+++.+|+..++++|+++.+++.|||.+-
T Consensus 376 ~~lgll~~~~~~~~~i------------~~~-~~~~~~~l~---~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDI------------SEK-SAVPVSLLD---VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred HHHHHHHhhhhhcCcc------------ccc-ccchhhhhc---cccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 22222211 1111111 000 000000011 112227788899999999999999999999999863
Q ss_pred CCccccccCCCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCCceecccCCCCCCCCccccCchhhhccccccCCC
Q psy622 306 YDWDSILDQEPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPSALYSKLSTMDCM 385 (473)
Q Consensus 306 idw~~l~~~~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~~~~~~~~~~~~ 385 (473)
-.-. ..++|-|.. .+..+... .++.......+..| |.+..-
T Consensus 440 ~~~~----~~~~~~~~~-------------------~~~~~~~~-~r~~~~~s~~~r~~--------SRY~~D------- 480 (1351)
T KOG1035|consen 440 PTDN----ESSEFAPND-------------------ETSVPQFR-LRFSGAMSPLQRQF--------SRYLND------- 480 (1351)
T ss_pred cccc----ccccccCcc-------------------ccccCccC-CCCccccCccccch--------hhHhhh-------
Confidence 2111 122222220 00000000 00000000011111 111111
Q ss_pred CCCccCCccCCCCceeecCCCCCCCCCcccccccccC--------cchHHHHHHhhcCCCcEEeccccc
Q psy622 386 SPPNAHNLSGVSPFLAMDRSPPDNSELEWPEDEEALN--------PSTEETILALLKSDPIVFMGDDTW 446 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~ 446 (473)
..-....|++-|-..=+..-++..-+|||+|--.+ =-+||..|+++ .|||||.----|
T Consensus 481 --FEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAW 546 (1351)
T KOG1035|consen 481 --FEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAW 546 (1351)
T ss_pred --hHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhh
Confidence 00124478888876666666888889999554333 34699999998 699999754443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.1e-06 Score=81.58 Aligned_cols=139 Identities=13% Similarity=0.108 Sum_probs=99.7
Q ss_pred cccCceEEEEEEEeCCCCcEEEEEEeecc---cccchhHHHHHHHHHHHHHhcCC--CCeeeEEEEEEe----CCEEEEE
Q psy622 50 SRGAFGKVFLGYKKTNKDQLYAIKVMKKD---EMINKNMVSQVLRERNALALTHS--PFCVQLFYSLQT----SSCVFLV 120 (473)
Q Consensus 50 G~G~fG~V~~a~~~~~~~~~vAiK~l~k~---~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~~----~~~l~lV 120 (473)
|+||-+.|+..... |+.|-+|.-... .+....-...+.+|...|..+.. -.+.++...-.. .-..+||
T Consensus 27 ~rgG~SgV~r~~~~---g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN---GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC---CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 56888888886543 235777776421 11112235678999999988742 224555522221 2247899
Q ss_pred ecccCc-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCc--eeEeecchhhh
Q psy622 121 MEYMIG-GDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH--CPIVNTLFLAI 192 (473)
Q Consensus 121 mEy~~g-g~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~--ikL~DFGla~~ 192 (473)
+|-+.| -||.+++.+. .+.++.....++.+|+.+|.-||+.|+.|+|+.+.||+++.+ |. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence 997743 6888888763 356788888999999999999999999999999999999876 66 99999876664
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.9e-07 Score=86.01 Aligned_cols=138 Identities=18% Similarity=0.144 Sum_probs=101.1
Q ss_pred EEEceecccCceEEEEEEEeCCCCcEEEEEEeecccc-------------------cchhHHHHHHHHHHHHHhcCCC--
Q psy622 44 EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM-------------------INKNMVSQVLRERNALALTHSP-- 102 (473)
Q Consensus 44 ~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~-------------------~~~~~~~~~~~E~~iL~~l~hp-- 102 (473)
.+...||-|-=+.||.|... .|..+|||.=+.... +-.-......+|.++|..+...
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred hhccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45678999999999999765 367899997432100 0011134568899999988533
Q ss_pred CeeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCce
Q psy622 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHC 182 (473)
Q Consensus 103 ~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~i 182 (473)
.|.+.++. +.-.+||||++|-.|... +++.+.+..++..|+.-+.-+-..||||+|+.+-||+++.+ |.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d-g~~ 241 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED-GDI 241 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC-CCE
Confidence 44444443 566799999988766433 22456677777888888877779999999999999999999 999
Q ss_pred eEeecchhhhh
Q psy622 183 PIVNTLFLAIL 193 (473)
Q Consensus 183 kL~DFGla~~~ 193 (473)
.++||--+...
T Consensus 242 ~vIDwPQ~v~~ 252 (304)
T COG0478 242 VVIDWPQAVPI 252 (304)
T ss_pred EEEeCcccccC
Confidence 99999877663
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.6e-06 Score=80.75 Aligned_cols=140 Identities=21% Similarity=0.266 Sum_probs=91.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHH------HHHHHHHHhcC---CCCeeeEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQV------LRERNALALTH---SPFCVQLFYS 110 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~------~~E~~iL~~l~---hp~Iv~l~~~ 110 (473)
-.+|.+++++-......|.+-.- .++.|++|..+............+ .+++..+..+. --....++.+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei---~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI---DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE---CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 46789999998888777777532 357899999876432222211111 22333333332 1222222222
Q ss_pred EE-----eCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEe
Q psy622 111 LQ-----TSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185 (473)
Q Consensus 111 f~-----~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~ 185 (473)
.. -....++||||++|..|.++.. +++ .+...|+.++.-||+.|+.|+|.+|.|++++.+ .++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iI 176 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRII 176 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEE
Confidence 21 2245678999999988866543 333 244667788999999999999999999999965 59999
Q ss_pred ecchhhh
Q psy622 186 NTLFLAI 192 (473)
Q Consensus 186 DFGla~~ 192 (473)
||+..+.
T Consensus 177 D~~~k~~ 183 (229)
T PF06176_consen 177 DTQGKRM 183 (229)
T ss_pred ECccccc
Confidence 9987665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.3e-07 Score=70.88 Aligned_cols=61 Identities=26% Similarity=0.407 Sum_probs=44.6
Q ss_pred CCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCCceecccCCCCCCCCcccc
Q psy622 304 KDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNGSFVCCSNLNSHTASGMDVD 370 (473)
Q Consensus 304 ~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 370 (473)
++|||+.|+++ .|||+|.+.+..|+++|+.+++.+....+....... ....+..|.||+|+
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~~~~~s~~~~~~~------~~~~~~~F~gfsy~ 63 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEETPVLTPVDSPAS------GGSQQEPFRGFSYV 63 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCCCCCCCCCCcccc------ccccccccCCCccc
Confidence 47999999876 799999999999999999988876544333222111 11124689999986
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=6.9e-07 Score=94.03 Aligned_cols=142 Identities=18% Similarity=0.193 Sum_probs=92.1
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccc---------------------------cchhH----HH------HH
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM---------------------------INKNM----VS------QV 89 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~---------------------------~~~~~----~~------~~ 89 (473)
.-|+.++-|+||.|+.++ |+.||||+.+..-. .-... .+ .+
T Consensus 131 ~PiAsASIaQVH~A~L~s--G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVLKS--GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEecC--CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 568899999999999875 78999999865410 00000 11 12
Q ss_pred HHHHHHHHhc-----CCCCeeeEEEEEEeCCEEEEEecccCcCCHHHH--HHhCCCCCHHHHHHHHHHHHHH-HHHHHHC
Q psy622 90 LRERNALALT-----HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSL--IAANGALPEDMAAFYAAEVVLA-LQYLHSH 161 (473)
Q Consensus 90 ~~E~~iL~~l-----~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~--L~~~~~~~e~~~~~~~~qI~~a-L~yLH~~ 161 (473)
.+|...+..+ +.|+|.-..-+++-.+.-.|+|||+.|..+.+. ++.. .++. +.++..++.+ +..+=..
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~-g~d~---k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA-GIDR---KELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc-CCCH---HHHHHHHHHHHHHHHHhc
Confidence 3444444433 245543333333434556799999999999877 4442 3442 2222222222 2333348
Q ss_pred CeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 162 GIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 162 gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
|+.|.|.+|.||+++.+ |++.+.|||+...+..
T Consensus 285 gffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence 99999999999999999 9999999999887543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.5e-06 Score=79.45 Aligned_cols=141 Identities=18% Similarity=0.183 Sum_probs=98.1
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeecccccc-------------------h--hHHHHHHHHHHHHHhcC--CC
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN-------------------K--NMVSQVLRERNALALTH--SP 102 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~-------------------~--~~~~~~~~E~~iL~~l~--hp 102 (473)
...|++|--..||+|... .+..+|+|+.+.....- . ........|...|.++. +=
T Consensus 53 ~g~istGKEA~Vy~a~~~--~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 53 VGCISTGKEANVYLAETG--DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred EeeecCCcceEEEeeccC--CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 347788888899999653 35789999986442111 1 11235677888887772 44
Q ss_pred CeeeEEEEEEeCCEEEEEecccCcCCH-HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCC
Q psy622 103 FCVQLFYSLQTSSCVFLVMEYMIGGDV-KSLIAANGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAP 180 (473)
Q Consensus 103 ~Iv~l~~~f~~~~~l~lVmEy~~gg~L-~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g 180 (473)
.+.+.+.++. -.|||||+....+ .-.|..- .+...++..+..+++..+.-|-. .|+||+||..-|||+. + +
T Consensus 131 rvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~-~ 203 (268)
T COG1718 131 RVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D-G 203 (268)
T ss_pred CCCCceeecC----CeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C-C
Confidence 4555666543 3599999943211 1112221 23444788889999999988877 8999999999999999 5 7
Q ss_pred ceeEeecchhhhhcC
Q psy622 181 HCPIVNTLFLAILQQ 195 (473)
Q Consensus 181 ~ikL~DFGla~~~~~ 195 (473)
.+.++|+|-+....+
T Consensus 204 ~p~iID~~QaV~~~h 218 (268)
T COG1718 204 EPYIIDVSQAVTIDH 218 (268)
T ss_pred eEEEEECccccccCC
Confidence 899999999987543
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.1e-07 Score=95.91 Aligned_cols=155 Identities=16% Similarity=0.279 Sum_probs=100.8
Q ss_pred HHHHHHHHHHHC-CeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc------cccccccCCCCcccccCCccccc
Q psy622 150 EVVLALQYLHSH-GIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY------LEISDLVNGTPNAFNIRTPGQLL 222 (473)
Q Consensus 150 qI~~aL~yLH~~-gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~------~~~~~~~~gtp~y~~~~ape~i~ 222 (473)
+++.|+.|+|.. ++||++|.|++|.++.. |..||+.|++|.....+... ....-...... .+.+||++.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~---~f~apE~~~ 182 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHL---NFLAPEYLL 182 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCc---ccccchhhc
Confidence 445899999965 89999999999999999 99999999999875442211 01111111112 344888765
Q ss_pred ------cCCcCCCCcccc-cc-CCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCH
Q psy622 223 ------SLKTGTFPTFQD-VQ-NSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSG 294 (473)
Q Consensus 223 ------~~~~~s~g~l~~-~~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa 294 (473)
..+..++|++.+ +. .|+..+......................++ .++++++++=|.++|..++..||++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s---~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYS---NNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccccc---ccCcHHHHHHHHHHhcCCcccCcch
Confidence 356778888765 33 344444321111101111011111122233 5788999999999999999999999
Q ss_pred HHHhcCCCCCCCCcccc
Q psy622 295 HQVRRLPMFKDYDWDSI 311 (473)
Q Consensus 295 ~eil~HPFF~~idw~~l 311 (473)
.++..-|||.+..-..|
T Consensus 260 ~~l~~~~ff~D~~~~aL 276 (700)
T KOG2137|consen 260 DLLLSIPFFSDPGLKAL 276 (700)
T ss_pred hhhhcccccCCchhhhh
Confidence 99999999998654444
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.1e-05 Score=75.99 Aligned_cols=139 Identities=19% Similarity=0.231 Sum_probs=81.1
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--CeeeEEEEE---EeCCEEEEE
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP--FCVQLFYSL---QTSSCVFLV 120 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f---~~~~~l~lV 120 (473)
++.|+.|..+.||++.... ..+++|..... .....+.+|..++..+... -+.+++... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~---~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD---GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT---SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC---cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 5689999999999986543 47999996654 2345677888888877322 245555533 234468999
Q ss_pred ecccCcCCHHH----------------HHH---hC----CCCCHHH---HH---HH---------------HHHHHH-HH
Q psy622 121 MEYMIGGDVKS----------------LIA---AN----GALPEDM---AA---FY---------------AAEVVL-AL 155 (473)
Q Consensus 121 mEy~~gg~L~~----------------~L~---~~----~~~~e~~---~~---~~---------------~~qI~~-aL 155 (473)
|++++|..+.. .+. +. ..+.... .. .. ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999988877 111 11 0111000 00 00 111222 23
Q ss_pred HHHH-------HCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 156 QYLH-------SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 156 ~yLH-------~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
+.++ ...++|+|+.|.|||++.+++.+-|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 3333 235999999999999993326778999988765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=98.28 E-value=4e-07 Score=85.91 Aligned_cols=67 Identities=18% Similarity=0.193 Sum_probs=54.5
Q ss_pred CCCCceeecCCCCCCCCCcccc------cccc---------cCcchHHHHHHhhcCCCcEEecccccccccceehhhccc
Q psy622 395 GVSPFLAMDRSPPDNSELEWPE------DEEA---------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAM 459 (473)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~------~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (473)
|++--+..+||.++.+.+|||| +.++ .-|-.|++||+-+.|||+||.+.|+|.+.+.+|+|.|+|
T Consensus 26 grgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~ 105 (411)
T KOG0599|consen 26 GRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLM 105 (411)
T ss_pred cccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhc
Confidence 3333346889999999999999 1111 024569999999999999999999999999999999999
Q ss_pred CC
Q psy622 460 SP 461 (473)
Q Consensus 460 ~~ 461 (473)
.-
T Consensus 106 pr 107 (411)
T KOG0599|consen 106 PR 107 (411)
T ss_pred cc
Confidence 53
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.7e-05 Score=73.09 Aligned_cols=128 Identities=20% Similarity=0.231 Sum_probs=89.3
Q ss_pred CCeEEEceecccCc-eEEEEEEEeCCCCcEEEEEEeecccc----------cch--------hHHHHHHHHHHHHHhc--
Q psy622 41 SDFEIVKAISRGAF-GKVFLGYKKTNKDQLYAIKVMKKDEM----------INK--------NMVSQVLRERNALALT-- 99 (473)
Q Consensus 41 ~~y~i~~~LG~G~f-G~V~~a~~~~~~~~~vAiK~l~k~~~----------~~~--------~~~~~~~~E~~iL~~l-- 99 (473)
.+++.++.||.|.- |.||+++.. |+.||+|+.+.-.. ... ....-+..|-+...++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~---g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID---GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC---CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 68999999999999 999999764 47999999332110 000 1233566777776665
Q ss_pred -CCCCe--eeEEEEEEeC------------------CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q psy622 100 -HSPFC--VQLFYSLQTS------------------SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158 (473)
Q Consensus 100 -~hp~I--v~l~~~f~~~------------------~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yL 158 (473)
.+..+ |++++++--. ...-||.||++... .++. .-+.+|..-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHH
Confidence 45566 8999887211 12467888775543 1222 3356778888999
Q ss_pred HHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 159 HSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 159 H~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
|+.||+=+|+|+.|.. + | ||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~---~-G--~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR---G-G--KLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc---C-C--EEEecccC
Confidence 9999999999999976 2 3 88999864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.1e-05 Score=76.68 Aligned_cols=133 Identities=11% Similarity=0.105 Sum_probs=82.8
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCC--eeeEEEEEEeCCEEEEEeccc
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPF--CVQLFYSLQTSSCVFLVMEYM 124 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~f~~~~~l~lVmEy~ 124 (473)
..||+|..+.||+. . +..+++|...... ....+.+|.+++..+..-. +.+.+.+..+.+..++|||++
T Consensus 7 ~~i~~G~t~~~y~~---~--~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH---K--TGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe---c--CCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 57899999999984 1 3357788876532 2335688999998874322 466777777778889999999
Q ss_pred CcCC-HH--------------HHH-------HhC--CC--CCHHHHHHHHHH----------HHHH-HHHHHH----CCe
Q psy622 125 IGGD-VK--------------SLI-------AAN--GA--LPEDMAAFYAAE----------VVLA-LQYLHS----HGI 163 (473)
Q Consensus 125 ~gg~-L~--------------~~L-------~~~--~~--~~e~~~~~~~~q----------I~~a-L~yLH~----~gI 163 (473)
+|.+ +. ..+ +.. .. ++... ..+..+ +... ..+|.. ..+
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 8864 11 111 110 01 11110 111100 1111 122221 247
Q ss_pred eecCCCCcceEecCCCCceeEeecchhhh
Q psy622 164 IHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 164 iHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
+|+|+.|.||+++.+ + +.++||+.+..
T Consensus 156 ~HgD~~~~Nii~~~~-~-~~iIDwe~a~~ 182 (226)
T TIGR02172 156 LHGDFQIGNLITSGK-G-TYWIDLGDFGY 182 (226)
T ss_pred EecCCCCCcEEEcCC-C-cEEEechhcCc
Confidence 899999999999987 6 99999998865
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.09 E-value=3e-05 Score=74.33 Aligned_cols=134 Identities=13% Similarity=0.062 Sum_probs=82.0
Q ss_pred ecccCc-eEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEecccCc
Q psy622 49 ISRGAF-GKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFLVMEYMIG 126 (473)
Q Consensus 49 LG~G~f-G~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~g 126 (473)
|..|.. ..||++... +..+.+|+..... .....+|.++++.+ .+--+.+++++....+..++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~~---~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGK---NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCC---CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 444555 788988532 2468888876542 23466788888877 344456777777777778999999999
Q ss_pred CCHHHHH-------------------HhCC----CCCHH------HHHHHHH----------------HHHHHHHHHH--
Q psy622 127 GDVKSLI-------------------AANG----ALPED------MAAFYAA----------------EVVLALQYLH-- 159 (473)
Q Consensus 127 g~L~~~L-------------------~~~~----~~~e~------~~~~~~~----------------qI~~aL~yLH-- 159 (473)
.+|.... +... .+... .....+. .+...++.|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 8776431 1100 11100 0000000 0111112221
Q ss_pred -----HCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 160 -----SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 160 -----~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
...++|+|+.|.|||++.+ +.+.|+||+.+..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~-~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPG-KFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCC-cEEEEEEcccccc
Confidence 2348999999999999987 7788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.01 E-value=6.7e-07 Score=62.98 Aligned_cols=47 Identities=21% Similarity=0.116 Sum_probs=30.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-ccCCCCCceecccCCCCCCCCccccCch
Q psy622 321 QPDDVFDTSYFHADKTNSYMDSTLS-TTHGNGSFVCCSNLNSHTASGMDVDSPS 373 (473)
Q Consensus 321 ~~~~~~D~s~Fd~~~t~~~~~~~~~-~~~~~~~~~~~~~~~~~~f~g~~~~~p~ 373 (473)
+++++.|++|||++||++.+..+.. ..... +...+..|.||+|++|+
T Consensus 1 ~v~~~~DtsnFD~eFt~~~~~~t~~~~~~~~------~~~~~~~F~GFTy~~~s 48 (48)
T PF00433_consen 1 KVKSETDTSNFDPEFTEEPPVDTPPSDPSPL------SSSMQENFQGFTYVNPS 48 (48)
T ss_dssp S-SSTT-GTTSCHHHHTSSSSS--S--HHHH------CTSSGGGGTT-CEETCT
T ss_pred CCCchhhhhhcCcccccCCCCCCCcccCCcc------cccccCcCCCCeecCCC
Confidence 4688999999999999987665543 11111 23355669999999986
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=3.2e-05 Score=69.28 Aligned_cols=131 Identities=20% Similarity=0.220 Sum_probs=93.2
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEec
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
-+..+.||+|++|.||++.++. ..+|+|+-+.+. ....+..|.++|..+...++..=++.+ +.-.+.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~---~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRG---GEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeeccC---ceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhh
Confidence 3456789999999999998764 478999876543 245788899999999877765544433 22345699
Q ss_pred ccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC-CcceEecCCCCceeEeecchhhh
Q psy622 123 YMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLK-PDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 123 y~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLK-peNILld~~~g~ikL~DFGla~~ 192 (473)
|+.|-.|..+-... + +.-+..++.+---|-..||-|..|. |...+|-.+ +.+.|+||..|+.
T Consensus 93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 99888887665431 1 2334445555555777899999987 555555555 6899999999985
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00017 Score=66.89 Aligned_cols=131 Identities=20% Similarity=0.230 Sum_probs=91.7
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccc-------------cchhHHHHHHHHHHHHHhcC------CCCeeeE
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM-------------INKNMVSQVLRERNALALTH------SPFCVQL 107 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~-------------~~~~~~~~~~~E~~iL~~l~------hp~Iv~l 107 (473)
..||+|+.-.||.- ..+ .-..||++..... .......+..+|+.....+. +.+|.++
T Consensus 7 ~~i~~G~~R~cy~H--P~d--p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDD--PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred cccccCCCceEEEC--CCC--CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 57899999999974 332 3478999987650 01112345566665555444 8899999
Q ss_pred EEEEEeCCEEEEEecccCc------CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--
Q psy622 108 FYSLQTSSCVFLVMEYMIG------GDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA-- 179 (473)
Q Consensus 108 ~~~f~~~~~l~lVmEy~~g------g~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~-- 179 (473)
++..+++.-+-+|+|.+.. -+|.+++.+. .+++ ..+.. +-.-.+||-+++|+.+||+|.||++...+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999998653 3688888554 5665 33333 33445688899999999999999997542
Q ss_pred C-ceeEee
Q psy622 180 P-HCPIVN 186 (473)
Q Consensus 180 g-~ikL~D 186 (473)
. .+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 2 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.89 E-value=4.2e-05 Score=80.52 Aligned_cols=141 Identities=18% Similarity=0.283 Sum_probs=87.1
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccc----------------------------cchhHHHH------HHHH
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM----------------------------INKNMVSQ------VLRE 92 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~----------------------------~~~~~~~~------~~~E 92 (473)
+-||.-+.|+|++|+.+. |+.||||+-+..-- .-++..+. +.+|
T Consensus 167 ~piaaASlaQVhrA~L~~--G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN--GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC--CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 578999999999999886 78999999865410 00011112 2233
Q ss_pred HHHHH----hcCCCC------eeeEEEEEEeCCEEEEEecccCcCCHHHH--HHhCCCCCHHHHHHHHHHHHHH-HHHHH
Q psy622 93 RNALA----LTHSPF------CVQLFYSLQTSSCVFLVMEYMIGGDVKSL--IAANGALPEDMAAFYAAEVVLA-LQYLH 159 (473)
Q Consensus 93 ~~iL~----~l~hp~------Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~--L~~~~~~~e~~~~~~~~qI~~a-L~yLH 159 (473)
.+... .+.|-+ |.+++..+ ...-.|+||||+|.-+.++ |.+. .++...+. ..+.++ ++-+=
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~---~~l~~~~~~qIf 318 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDIL---NKLVEAYLEQIF 318 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHH---HHHHHHHHHHHH
Confidence 33222 223444 33333332 2356799999999877544 4444 34444332 233332 12233
Q ss_pred HCCeeecCCCCcceEecC---CCCceeEeecchhhhhcC
Q psy622 160 SHGIIHRDLKPDNMLISA---QAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 160 ~~gIiHRDLKpeNILld~---~~g~ikL~DFGla~~~~~ 195 (473)
..|++|+|-.|.||++.. .++.+.+-|||+.+.+..
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 568999999999999994 237899999999987643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00015 Score=81.76 Aligned_cols=81 Identities=17% Similarity=0.228 Sum_probs=55.8
Q ss_pred EceecccCceEEEEEEEeCCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCe--eeEEEEEEeC---CEEE
Q psy622 46 VKAISRGAFGKVFLGYKKTNK-DQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFC--VQLFYSLQTS---SCVF 118 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~-~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~I--v~l~~~f~~~---~~l~ 118 (473)
++.|+.|.++.+|+....... ...+++|+........ ....+.+|.++|+.+. |++| .+++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 577899999999998654321 1357777765432211 1346789999999884 6654 6777777654 4689
Q ss_pred EEecccCcCC
Q psy622 119 LVMEYMIGGD 128 (473)
Q Consensus 119 lVmEy~~gg~ 128 (473)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999998754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0004 Score=69.95 Aligned_cols=230 Identities=14% Similarity=0.163 Sum_probs=138.1
Q ss_pred EEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEE----EE---EeCCE
Q psy622 45 IVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFY----SL---QTSSC 116 (473)
Q Consensus 45 i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~----~f---~~~~~ 116 (473)
..+-||+|+-+-+|-.-.- .-.+-|+..+.....+ ...+..|... .||-+..=+. .. .....
T Consensus 15 ~gr~LgqGgea~ly~l~e~----~d~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV----RDQVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCccccCCccceeeecchh----hchhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 3467999999999875221 1245577776532111 1123334443 5664332111 11 12233
Q ss_pred EEEEecccCcCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecch
Q psy622 117 VFLVMEYMIGGDVKSLIAA-------NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~-------~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
+-+.|+.+.|..=-..+.+ ...+.++.+...++.|+.|.+-||..|.+-+|++++|+|+.++ +.+.|.|-..
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~V~LVdsDs 163 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SKVVLVDSDS 163 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ceEEEEcccc
Confidence 7889999987643333321 2346788889999999999999999999999999999999998 8999987433
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc-----------cCCcCCCCccc-c-ccCCCCCchhHhhhcCCCCChh
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTFQ-D-VQNSQAPFPSALRVAGSQIPTS 256 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l~-~-~~~g~~pf~~~~~~~~~~~~~~ 256 (473)
-.....+ ....-..|.++|. .||.-. ..|-.+++++. . ++.|+.||.++.......-+.+
T Consensus 164 fqi~~ng----~~~~cpVg~~eft---PPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E 236 (637)
T COG4248 164 FQINANG----TLHLCPVGVSEFT---PPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE 236 (637)
T ss_pred eeeccCC----ceEecccCccccC---CHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence 2221111 1111234777776 666421 12333444543 3 5667999988654333222222
Q ss_pred -hHhh---------------hccCCCCccccCChhHHHHHHhcccc--CCCCCCCH
Q psy622 257 -TAAQ---------------LQLEWPEDEEALNPSTEETILALLKS--DPTQRPSG 294 (473)
Q Consensus 257 -~~~~---------------~~~~~P~~~~~ls~~a~dLI~~LL~~--dP~kRpsa 294 (473)
.+.. ....||- .-+++++..|..+|+.. ++.-||++
T Consensus 237 ~~Ia~g~f~ya~~~~~g~~p~P~~~P~--~~Lpp~vqAlF~qaF~~~~~~~~RP~a 290 (637)
T COG4248 237 TDIAHGRFAYASDQRRGLKPPPRSIPL--SMLPPDVQALFQQAFTESGVATPRPTA 290 (637)
T ss_pred hhhhcceeeechhccCCCCCCCCCCCh--hhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence 1111 1122232 56889999999999974 46689985
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.67 E-value=1.1e-05 Score=84.73 Aligned_cols=237 Identities=16% Similarity=0.124 Sum_probs=146.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCCEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPF-CVQLFYSLQTSSCVFL 119 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~~~~~l~l 119 (473)
..+...+-+++|+++++++.|... .+....+.+... ....-++++|.+++||| .+..++.++.+...++
T Consensus 242 kws~~fh~fvK~altknpKkRpta--eklL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTA--EKLLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCCh--hhheeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 457778889999999999976433 233334444322 24556889999999999 7777777888899999
Q ss_pred EecccCcC-CHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 120 VMEYMIGG-DVKSLI-AANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 120 VmEy~~gg-~L~~~L-~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+++++.+| +..... ...-.|.+.+.....+.-..+++++|+.--+||| ||+..+ +..|+.||+....+....
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~--~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE--EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc--cccccccccCCcccCccc
Confidence 99999777 221111 1112355555666677778899999998888999 888876 578999999887754332
Q ss_pred cccccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCCchhHhhhc-CCCCCh-hhHhhhccCCCCc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAPFPSALRVA-GSQIPT-STAAQLQLEWPED 268 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~pf~~~~~~~-~~~~~~-~~~~~~~~~~P~~ 268 (473)
...+..++|+.+ +||++.. .+.|+.+.- ..+.-|.+|-....... ...... ......+..|
T Consensus 386 ----~~~t~~~~~~~~---~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~~~~g~~p~s~~L~~~~aw--- 455 (829)
T KOG0576|consen 386 ----KPRTAIGTPEPL---APEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVLPMIGNGPNSPMLTDKSAW--- 455 (829)
T ss_pred ----ccccCCCCCCCC---CchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccccCCCCCCCCccccchhhhc---
Confidence 234567889988 8887643 233343321 12333333322100000 000000 0000000111
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
-...-.++...|+..-|..|+....+..|.+|.+-
T Consensus 456 ---~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 456 ---SPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred ---CcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 11112246678899999999988888888888753
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=97.62 E-value=9.6e-06 Score=75.67 Aligned_cols=73 Identities=18% Similarity=0.196 Sum_probs=58.8
Q ss_pred cCCCCceeecCCCCCCCCCcccc--------ccc-ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCCCcc
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPE--------DEE-ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSPTYG 464 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~--------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (473)
.|.+|||..+||.+.-++.+||+ +.+ -..-.||+.|-+.+ +|||||.|-|+.++-.+-|+|.|+|.- |
T Consensus 19 igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~~ylvFe~m~G--~ 95 (355)
T KOG0033|consen 19 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG--G 95 (355)
T ss_pred HccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcccceeEEEEecccc--h
Confidence 78899999999999999999999 222 11334677777666 699999999999999999999999953 4
Q ss_pred hhhhh
Q psy622 465 SQCLE 469 (473)
Q Consensus 465 ~~~~~ 469 (473)
.-|.|
T Consensus 96 dl~~e 100 (355)
T KOG0033|consen 96 ELFED 100 (355)
T ss_pred HHHHH
Confidence 44443
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00045 Score=65.83 Aligned_cols=30 Identities=23% Similarity=0.398 Sum_probs=25.7
Q ss_pred CeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 162 GIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 162 gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
+++|+|+.|.|||++.+ +..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~-~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDG-RLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECC-CEEEEEeCcccCc
Confidence 58999999999999865 5567999998865
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00036 Score=64.25 Aligned_cols=99 Identities=19% Similarity=0.159 Sum_probs=77.6
Q ss_pred HHHHHHHHhcCC-CCeeeEEEEEEeCCEEEEEecccCcCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q psy622 90 LRERNALALTHS-PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSL---IAANGALPEDMAAFYAAEVVLALQYLHS---HG 162 (473)
Q Consensus 90 ~~E~~iL~~l~h-p~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~---L~~~~~~~e~~~~~~~~qI~~aL~yLH~---~g 162 (473)
..|.-+|+.+.+ +++.++++++-+ ++|.||...+++... +.....-++.....++.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 347777888854 699999999832 468899977766421 1222235788999999999999999998 34
Q ss_pred eeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 163 IIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 163 IiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
+...|++|+|+.++++ |++|++|.......
T Consensus 83 ~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDD-GRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCC-CcEEEEechhcchh
Confidence 7779999999999988 99999999887653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0011 Score=62.82 Aligned_cols=76 Identities=17% Similarity=0.222 Sum_probs=47.3
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEeccc
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCVFLVMEYM 124 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lVmEy~ 124 (473)
++.|..|-...||++....+.++.|++|+...... . .....+|..++..+. +....++++.+.. .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---L-IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---c-eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 45677888889999854321245788997664321 1 112346888888773 3344555554432 3799999
Q ss_pred CcCCH
Q psy622 125 IGGDV 129 (473)
Q Consensus 125 ~gg~L 129 (473)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 88765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0029 Score=62.86 Aligned_cols=163 Identities=16% Similarity=0.225 Sum_probs=93.2
Q ss_pred CCCCccchhhHHHHhHhhhcccccccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchh
Q psy622 5 GLFSGADKENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN 84 (473)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~ 84 (473)
|.|+....+.+.+.++.. .++....++.++.|.-..+|++... . ..+++|+..... .
T Consensus 2 ~~~~~~~~~~l~~~l~~y----------------~~~~~~~i~~~~~G~~n~~y~v~t~--~-~~~vLK~~~~~~--~-- 58 (307)
T TIGR00938 2 AVYTSVSDEEMSSFLDGY----------------DLGELLSLKGIAEGVENSNYLLTTD--V-GRYILTLYEKRV--K-- 58 (307)
T ss_pred CccccCCHHHHHHHHHhc----------------CCCCceeccccCCccccceEEEEeC--C-CcEEEEEecCCC--C--
Confidence 345555566666655432 2334555778888888899987532 2 357888865521 1
Q ss_pred HHHHHHHHHHHHHhcCCC--CeeeEEEE------EEeCCEEEEEecccCcCCHH-----------HHH---HhC-CCC--
Q psy622 85 MVSQVLRERNALALTHSP--FCVQLFYS------LQTSSCVFLVMEYMIGGDVK-----------SLI---AAN-GAL-- 139 (473)
Q Consensus 85 ~~~~~~~E~~iL~~l~hp--~Iv~l~~~------f~~~~~l~lVmEy~~gg~L~-----------~~L---~~~-~~~-- 139 (473)
...+..|.+++..+... .+.+++.. ....+..++|++|++|..+. ..| ++. ..+
T Consensus 59 -~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~ 137 (307)
T TIGR00938 59 -AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPE 137 (307)
T ss_pred -HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCC
Confidence 22445566777666211 13344332 12346789999999885431 111 110 011
Q ss_pred ------CHH-HHH--------------HHHHHHHHHHHHHHH-------CCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 140 ------PED-MAA--------------FYAAEVVLALQYLHS-------HGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 140 ------~e~-~~~--------------~~~~qI~~aL~yLH~-------~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
... ... .....+..+++++.. .+++|+|+++.||+++.+ +...|+||+.+.
T Consensus 138 ~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~ 216 (307)
T TIGR00938 138 NRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFAC 216 (307)
T ss_pred CCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECC-ceEEEeeccccc
Confidence 000 000 001123345555543 589999999999999987 767899999986
Q ss_pred h
Q psy622 192 I 192 (473)
Q Consensus 192 ~ 192 (473)
.
T Consensus 217 ~ 217 (307)
T TIGR00938 217 T 217 (307)
T ss_pred C
Confidence 5
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00077 Score=65.09 Aligned_cols=133 Identities=13% Similarity=0.104 Sum_probs=75.5
Q ss_pred eecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEEEEecccCc
Q psy622 48 AISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFC-VQLFYSLQTSSCVFLVMEYMIG 126 (473)
Q Consensus 48 ~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~f~~~~~l~lVmEy~~g 126 (473)
.+..|-.+.+|+.. . .++.+++|+.......- .-...+|..+++.+....+ .++++... -++||||++|
T Consensus 3 ~~~~G~tn~~y~~~--~-~~~~~vlR~~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--H-PGISFVWRPQSPVCKAL---GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEE--e-CCccEEEeeCCcccccc---cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccC
Confidence 34567788899875 2 34678888865432110 0124668888887743222 33444432 2689999988
Q ss_pred CCHHH--------------HHHh---CC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------CCeeecC
Q psy622 127 GDVKS--------------LIAA---NG----ALPE-DMAAFYAAEV---------VLALQYLHS--------HGIIHRD 167 (473)
Q Consensus 127 g~L~~--------------~L~~---~~----~~~e-~~~~~~~~qI---------~~aL~yLH~--------~gIiHRD 167 (473)
..+.. .+.+ .. .++. ..+..|..++ ...+..+-. ..++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 66531 1111 11 1111 1222322222 111222221 2589999
Q ss_pred CCCcceEecCCCCceeEeecchhhh
Q psy622 168 LKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 168 LKpeNILld~~~g~ikL~DFGla~~ 192 (473)
+.|.||+++.+ + +.|+||..+..
T Consensus 153 l~~~Nil~~~~-~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQ-G-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCC-C-CEEEeccccCc
Confidence 99999999987 5 78999988875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0068 Score=62.25 Aligned_cols=80 Identities=14% Similarity=0.128 Sum_probs=53.6
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeecccc-c-c--hhHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCEEE
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM-I-N--KNMVSQVLRERNALALTH---SPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~-~-~--~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~~~~~l~ 118 (473)
.+.||.|.+..||++.... +++.++||.-....- . . .-..++...|.+.|..+. ..++.+++.+ ++...+
T Consensus 31 ~~elggGn~N~VyrV~~~~-g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTE-GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeEcCCCceEEEEEEEeCC-CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 4678999999999997653 225789998542110 0 0 123457788888888762 2456666666 446678
Q ss_pred EEecccCcCC
Q psy622 119 LVMEYMIGGD 128 (473)
Q Consensus 119 lVmEy~~gg~ 128 (473)
+|||++++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998644
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0023 Score=63.10 Aligned_cols=138 Identities=14% Similarity=0.155 Sum_probs=82.0
Q ss_pred EEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--CeeeEEEE------EEeCCE
Q psy622 45 IVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP--FCVQLFYS------LQTSSC 116 (473)
Q Consensus 45 i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~------f~~~~~ 116 (473)
-++.|..|.-..+|+.... +..+++|+.... . ...+..|.+++..+.+. .+.+++.. ....+.
T Consensus 18 ~i~~i~~G~~n~~y~v~~~---~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD---SGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred heecccCccccceEEEEeC---CCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 3567777888899987532 246888987641 1 23456677777766322 24444332 234566
Q ss_pred EEEEecccCcCCHHH-----------HH---HhC-CCCC--------HHHHH------------HHHHHHHHHHHHHHH-
Q psy622 117 VFLVMEYMIGGDVKS-----------LI---AAN-GALP--------EDMAA------------FYAAEVVLALQYLHS- 160 (473)
Q Consensus 117 l~lVmEy~~gg~L~~-----------~L---~~~-~~~~--------e~~~~------------~~~~qI~~aL~yLH~- 160 (473)
.++|+++++|..+.. .| +.. ..+. ..... .....+..++.++.+
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 789999998876421 11 110 0010 00000 011123334445443
Q ss_pred ------CCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 161 ------HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 161 ------~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
.+++|+|+.|.|||++.+ +.+.|+||+.|..
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~ 205 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGD-ELSGVIDFYFACT 205 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCC-ceEEEeehhhhcC
Confidence 479999999999999987 6678999998865
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.011 Score=58.92 Aligned_cols=31 Identities=29% Similarity=0.476 Sum_probs=26.5
Q ss_pred CCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 161 HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 161 ~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
.++||+|+.|.|||++.+ ...-|+||+.|..
T Consensus 187 ~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGD-RLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECC-ceEEEEecccccC
Confidence 379999999999999965 5558999999865
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0036 Score=61.95 Aligned_cols=77 Identities=14% Similarity=0.131 Sum_probs=47.7
Q ss_pred EceecccCceEEEEEEEeC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEE
Q psy622 46 VKAISRGAFGKVFLGYKKT-----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~-----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~l 119 (473)
++.|..|--..||++.... ..++.|++|+..... .......+|..++..+. +--..++++++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3456667777888885432 124678999966542 11224567888888773 2234456666643 26
Q ss_pred EecccCcCCHH
Q psy622 120 VMEYMIGGDVK 130 (473)
Q Consensus 120 VmEy~~gg~L~ 130 (473)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.00032 Score=71.71 Aligned_cols=69 Identities=14% Similarity=0.165 Sum_probs=60.4
Q ss_pred CccCCCCceeecCCCCCCCCCcccc---ccccc-------CcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPE---DEEAL-------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|++.|....+|..+.+..+||+ .++.. .-.+||+||+.+++|||||.+.|+|.+-.++|+|+.+..
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 3489999999999999999889999 33321 556899999999999999999999999999999998876
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0076 Score=60.27 Aligned_cols=144 Identities=21% Similarity=0.178 Sum_probs=96.2
Q ss_pred EEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc----------------------chhHHH-HHHHHHHHHHhcC
Q psy622 44 EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI----------------------NKNMVS-QVLRERNALALTH 100 (473)
Q Consensus 44 ~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~----------------------~~~~~~-~~~~E~~iL~~l~ 100 (473)
++-..|..|--..||.|... .|..+|||+.+..-+. .+..++ +...|.+-|++++
T Consensus 147 ~inGCiSTGKEANVYHat~~--dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~ 224 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE--DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN 224 (520)
T ss_pred ecccccccCccceeEeeecC--CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence 34567888888999999654 3577999998754211 112222 4556777777775
Q ss_pred CCCeeeEEEEEEeCCEEEEEecccCcCCHH--HHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCCcceEecC
Q psy622 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVK--SLIAANGALPEDMAAFYAAEVVLALQYLH-SHGIIHRDLKPDNMLISA 177 (473)
Q Consensus 101 hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~--~~L~~~~~~~e~~~~~~~~qI~~aL~yLH-~~gIiHRDLKpeNILld~ 177 (473)
...|.-.--..- ..-.|||+++. ++=+ -.|+ .-.++...++.+-.|++.-+.-|- ..+.||.||.--|+|+..
T Consensus 225 ~aGIP~PePIlL--k~hVLVM~FlG-rdgw~aPkLK-d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 225 NAGIPCPEPILL--KNHVLVMEFLG-RDGWAAPKLK-DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD 300 (520)
T ss_pred hcCCCCCCceee--ecceEeeeecc-CCCCcCcccc-cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC
Confidence 443322111111 23469999994 3321 2222 235778888888888888887765 568999999999999986
Q ss_pred CCCceeEeecchhhhhcC
Q psy622 178 QAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 178 ~~g~ikL~DFGla~~~~~ 195 (473)
|.+.++|-+-+.....
T Consensus 301 --G~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 301 --GKLYIIDVSQSVEHDH 316 (520)
T ss_pred --CEEEEEEccccccCCC
Confidence 7999999988877544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.02 Score=57.87 Aligned_cols=172 Identities=13% Similarity=0.135 Sum_probs=97.2
Q ss_pred CCCCCccchhhHHHHhHhhhcccccccccccCCCCCCCCeEEEceecccCceEEEEEEEeCC---CCcEEEEEEeecccc
Q psy622 4 SGLFSGADKENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTN---KDQLYAIKVMKKDEM 80 (473)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~---~~~~vAiK~l~k~~~ 80 (473)
-++.+..+..++..+......+... .++.+..++. .|..|--..+|++..... .++.|++|+.....
T Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~w~~--------~~~~~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t- 77 (344)
T PLN02236 8 VGLSSGRIPDELKRILHSLASKWGD--------VVDDEALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV- 77 (344)
T ss_pred ccccCCCChHHHHHHHHHhcchhcC--------CCCcCcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-
Confidence 3556677777787777653322211 0123445554 444477788999864321 23678999876542
Q ss_pred cchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEecccCcCCHHHH--------------H---HhCC----C
Q psy622 81 INKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSL--------------I---AANG----A 138 (473)
Q Consensus 81 ~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~--------------L---~~~~----~ 138 (473)
...+.+ .+|..+++.+. +.--.++++.+... .|.+|++|.+|... | ++.. .
T Consensus 78 --~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~ 150 (344)
T PLN02236 78 --ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPK 150 (344)
T ss_pred --Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCC
Confidence 111222 56888888774 33334566776443 57899977665311 1 1111 0
Q ss_pred -C-CHHHHHHHHHHH-----------------HHHHHHH----H----HCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 139 -L-PEDMAAFYAAEV-----------------VLALQYL----H----SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 139 -~-~e~~~~~~~~qI-----------------~~aL~yL----H----~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
+ ...++..+..++ ...+..| . ...++|+|+++.|||++.+++.+.|+||..|.
T Consensus 151 ~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 151 NVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 122233333221 1112222 1 22589999999999998643689999998887
Q ss_pred h
Q psy622 192 I 192 (473)
Q Consensus 192 ~ 192 (473)
.
T Consensus 231 ~ 231 (344)
T PLN02236 231 Y 231 (344)
T ss_pred c
Confidence 5
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0022 Score=63.03 Aligned_cols=139 Identities=12% Similarity=0.124 Sum_probs=93.6
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccc-------------------cchhHHHHHHHHHHHHHhc-CCC
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM-------------------INKNMVSQVLRERNALALT-HSP 102 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~-------------------~~~~~~~~~~~E~~iL~~l-~hp 102 (473)
+.+...||=|--+-||.+-+.. |+..++|.=.-... +-.-..-...+|...|+.+ .|-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~--G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE--GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhccccccccccceEEEecCC--CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3456788999999999997654 57788886321100 0000122356788888777 344
Q ss_pred Ceee-EEEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCc
Q psy622 103 FCVQ-LFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH 181 (473)
Q Consensus 103 ~Iv~-l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ 181 (473)
|=|+ .+ +.+..|+|||++.|-.|.+.-+- ..+..+...+..-+--|..+|+||+|.+--||+++.+ ++
T Consensus 172 fpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd-~~ 240 (465)
T KOG2268|consen 172 FPVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD-DK 240 (465)
T ss_pred CCCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecC-CC
Confidence 4222 22 44678999999988777544321 1233444555566777889999999999999999988 89
Q ss_pred eeEeecchhhhhc
Q psy622 182 CPIVNTLFLAILQ 194 (473)
Q Consensus 182 ikL~DFGla~~~~ 194 (473)
++++||--+....
T Consensus 241 i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 241 IVVIDFPQMVSTS 253 (465)
T ss_pred EEEeechHhhccC
Confidence 9999998876543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.019 Score=57.72 Aligned_cols=144 Identities=10% Similarity=0.110 Sum_probs=81.0
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNK--DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFC-VQLFYSLQTSSC 116 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~--~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~f~~~~~ 116 (473)
.++.++....| |--..+|++...... +..|++|+..... ...+ .-.+|..+++.+..-.+ .++++++..+
T Consensus 14 ~~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~G-- 86 (330)
T PLN02421 14 DSDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVI-DRERELQAIKYLSAAGFGAKLLGVFGNG-- 86 (330)
T ss_pred cCceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCc---CeEe-chHHHHHHHHHHHhcCCCCceeEEeCCc--
Confidence 45566655554 666778887543311 2378899876532 1111 22467888887743333 4666666432
Q ss_pred EEEEecccCcCCHHH--------------HHH---hCC-C----C-CHHHHHHHHHHH----------------------
Q psy622 117 VFLVMEYMIGGDVKS--------------LIA---ANG-A----L-PEDMAAFYAAEV---------------------- 151 (473)
Q Consensus 117 l~lVmEy~~gg~L~~--------------~L~---~~~-~----~-~e~~~~~~~~qI---------------------- 151 (473)
+|.+|++|-.|.. .++ ... + + ....+..|..++
T Consensus 87 --~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l 164 (330)
T PLN02421 87 --MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEEL 164 (330)
T ss_pred --EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHH
Confidence 5899997765421 111 111 0 1 122233333222
Q ss_pred HHHHHHHH----HC----CeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 152 VLALQYLH----SH----GIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 152 ~~aL~yLH----~~----gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
..-+..+. .. -.+|.||.+.|||++.+++.++++||..|..
T Consensus 165 ~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 165 RDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11122221 12 2799999999999975437899999998875
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.057 Score=53.44 Aligned_cols=30 Identities=20% Similarity=0.400 Sum_probs=25.8
Q ss_pred CCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 161 HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 161 ~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECccccc
Confidence 47999999999999987 4678999997754
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.044 Score=55.36 Aligned_cols=84 Identities=17% Similarity=0.139 Sum_probs=51.0
Q ss_pred eecccCceEEEEEEEeCCCCcEEEEEEeecccc----cchhHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeCCEEEEEe
Q psy622 48 AISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM----INKNMVSQVLRERNALALTH--SPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 48 ~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~----~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~f~~~~~l~lVm 121 (473)
.||.|.-.-||++.... +++-++||.-....- .-.-...+...|...|+... .|..|.-++.| ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~-g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE-GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCC-CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-ccccceehH
Confidence 57999999999998643 235789987542211 11233557778888887662 34333333333 455567999
Q ss_pred cccCcC-CHHHHH
Q psy622 122 EYMIGG-DVKSLI 133 (473)
Q Consensus 122 Ey~~gg-~L~~~L 133 (473)
|+++.. .|.+.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999543 333444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.00081 Score=65.31 Aligned_cols=59 Identities=7% Similarity=0.049 Sum_probs=45.8
Q ss_pred ecCCCCCCCCCcccc---ccc----ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 402 MDRSPPDNSELEWPE---DEE----ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 402 ~~~~~~~~~~~~~~~---~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..-|+.-.+..|||| ++- .+--=|||+++..|++||||+.|+|-|.|-...|+|..-|.
T Consensus 94 Vqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 94 VQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred eeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 334444555559999 321 11234899999999999999999999999999999998885
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.046 Score=53.48 Aligned_cols=31 Identities=23% Similarity=0.388 Sum_probs=25.7
Q ss_pred CeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 162 GIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 162 gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
.++|+|++|.|||++.++...-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997513456999999876
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.048 Score=54.27 Aligned_cols=146 Identities=21% Similarity=0.213 Sum_probs=79.3
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCC--E
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS--PFCVQLFYSLQTSS--C 116 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~~~~--~ 116 (473)
....++..+..|.-..+|.... +++.+++. ... ............+|..+++.+.- --+...++.+.++. .
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~---~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~ 99 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGD---TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGT 99 (321)
T ss_pred CCCceeeeccCCcccceEEEec---CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCC
Confidence 3344555554443344444432 25678877 331 12223345566778888877632 12233455555544 6
Q ss_pred EEEEecccCcCCHHH------------------HHHh---C--------C---CCCHHHHHHHHHHH-------------
Q psy622 117 VFLVMEYMIGGDVKS------------------LIAA---N--------G---ALPEDMAAFYAAEV------------- 151 (473)
Q Consensus 117 l~lVmEy~~gg~L~~------------------~L~~---~--------~---~~~e~~~~~~~~qI------------- 151 (473)
.|.||+|++|..+.. .|.. - + .+...+...+..+.
T Consensus 100 pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 100 PFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred ceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 799999998843221 1110 0 0 01111112222221
Q ss_pred -HHHHHHHHHC--------CeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 152 -VLALQYLHSH--------GIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 152 -~~aL~yLH~~--------gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
..-..+|+.+ .++|+|+.+.||+++.+ +-+-+.||+++..
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~l 228 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCC-CeeEEEecccccc
Confidence 1122344432 48999999999999998 6699999999876
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.32 Score=48.78 Aligned_cols=104 Identities=14% Similarity=0.061 Sum_probs=60.9
Q ss_pred CCCCCCCCccchhhHHHHhHhhhcccccccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccc
Q psy622 1 MDSSGLFSGADKENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM 80 (473)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~ 80 (473)
|++++.|+....+.+.++.... . +..-..+..|+ +.-..||.+... .++.|++|+.+....
T Consensus 2 ~~~~~~~~~l~p~~~~~a~~~~--g--------------~~~~~~~~~l~-s~eN~vy~v~~~--~~~~~vlKv~r~~~~ 62 (325)
T PRK11768 2 NDSAFPFQTLTPDLILDALESL--G--------------LRVDGRLLALN-SYENRVYQFGDE--DGRRVVAKFYRPERW 62 (325)
T ss_pred CCCCCCCCCCChHHHHHHHHHc--C--------------CCCccceEeec-cccceEEEEecC--CCCEEEEEEcCcccC
Confidence 7889999999999999988543 0 10001122343 344578887543 346799998764321
Q ss_pred cchhHHHHHHHHHHHHHhcC---CCCeeeEE---E--EEEeCCEEEEEecccCcCC
Q psy622 81 INKNMVSQVLRERNALALTH---SPFCVQLF---Y--SLQTSSCVFLVMEYMIGGD 128 (473)
Q Consensus 81 ~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~---~--~f~~~~~l~lVmEy~~gg~ 128 (473)
....+..|.+.+..+. -| ++... + ....++..+.|+++++|..
T Consensus 63 ----~~~~i~~E~~~l~~L~~~gip-v~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 63 ----SDAQILEEHAFALELAEAEIP-VVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ----CHHHHHHHHHHHHHHHHCCCC-CCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 2334556777666552 11 22211 1 1233567888999997764
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.073 Score=52.69 Aligned_cols=104 Identities=14% Similarity=0.086 Sum_probs=72.5
Q ss_pred EEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-C--CCeeeEEEEEEe---CCEEE
Q psy622 45 IVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-S--PFCVQLFYSLQT---SSCVF 118 (473)
Q Consensus 45 i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-h--p~Iv~l~~~f~~---~~~l~ 118 (473)
-.+.||.|..+.||.....+ + .+.+|..+... ....+.+|...|+.+. + -.+.++++.+.+ .+..+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~--~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ--G-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred eeeecCCccceeEEEEEcCC--C-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 45689999999999974322 3 46677743210 1236788999998874 2 356777777654 36689
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~ 161 (473)
||||+++|+++.+. .........+..+++.+|.-||+.
T Consensus 90 LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 90 LLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999887651 123445566778888999999985
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.0076 Score=60.57 Aligned_cols=66 Identities=15% Similarity=0.147 Sum_probs=48.8
Q ss_pred cCCCCceeecCCCCCCCCCcccc---ccc-----------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhccc
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPE---DEE-----------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAM 459 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~---~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (473)
.|.+-|-..|.-.-+.+...||| +++ +.+-++|++||+.+ +|||||.+.|.|..--+.|.|+..|
T Consensus 180 LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~ds~YmVlE~v 258 (475)
T KOG0615|consen 180 LGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVPDSSYMVLEYV 258 (475)
T ss_pred ecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecCCceEEEEEEe
Confidence 45555555555555555557777 221 22346899999998 6999999999999999999999877
Q ss_pred C
Q psy622 460 S 460 (473)
Q Consensus 460 ~ 460 (473)
.
T Consensus 259 ~ 259 (475)
T KOG0615|consen 259 E 259 (475)
T ss_pred c
Confidence 5
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.0043 Score=58.98 Aligned_cols=39 Identities=21% Similarity=0.181 Sum_probs=35.9
Q ss_pred CcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 422 NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
++=|||..|+.++ |||||.|+|||...+-+-+|+|.|.-
T Consensus 47 talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lVfEfm~t 85 (318)
T KOG0659|consen 47 TALREIKLLQELK-HPNIIELIDVFPHKSNLSLVFEFMPT 85 (318)
T ss_pred HHHHHHHHHHHcc-CcchhhhhhhccCCCceEEEEEeccc
Confidence 4568999999999 99999999999999999999999963
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.031 Score=52.23 Aligned_cols=30 Identities=23% Similarity=0.454 Sum_probs=20.7
Q ss_pred CeeecCCCCcceEe-cCCCCceeEeecchhhh
Q psy622 162 GIIHRDLKPDNMLI-SAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 162 gIiHRDLKpeNILl-d~~~g~ikL~DFGla~~ 192 (473)
.++|.||.|.|||+ +.+ +.++|+||-.|..
T Consensus 144 v~cHnDl~~~Nil~~~~~-~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKD-GEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSS-SCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCC-CeEEEecHHHHhh
Confidence 48999999999999 555 8999999988865
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.11 Score=53.34 Aligned_cols=82 Identities=17% Similarity=0.161 Sum_probs=47.1
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcE-----EEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQL-----YAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQ 112 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~-----vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~ 112 (473)
..++.++..+.| |--..+|++......+.. |.+.+.... ....-.-.+|.++++.+. +..-.++++.|.
T Consensus 49 ~~~~i~i~~l~g-GLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~ 123 (383)
T PTZ00384 49 NPEFIEIKKMNN-GITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG 123 (383)
T ss_pred CcccEEEEEeCC-cccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecC
Confidence 345566554444 778889988644322222 333332111 111112356888998884 445566777775
Q ss_pred eCCEEEEEecccCcCCH
Q psy622 113 TSSCVFLVMEYMIGGDV 129 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L 129 (473)
. ++|.||++|-+|
T Consensus 124 ~----g~l~efIeGr~l 136 (383)
T PTZ00384 124 D----FTIQEWVEGNTM 136 (383)
T ss_pred C----EEEEEEeccccC
Confidence 3 599999988765
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.063 Score=50.29 Aligned_cols=86 Identities=19% Similarity=0.204 Sum_probs=60.5
Q ss_pred HHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--CCeee
Q psy622 88 QVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS--HGIIH 165 (473)
Q Consensus 88 ~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~--~gIiH 165 (473)
-+..+.+++++++ .|+++..- +..++-+++|+|-.. .....-++.+. +.+|.-.|+ .+.+|
T Consensus 104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~------------~i~~~N~i~ag-i~~L~~fH~~~~~~lH 166 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI------------KINFSNFITAG-IKDLMDFHSENQHCLH 166 (308)
T ss_pred hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc------------ccchhHHHHHh-HHHHHHhhccCCCeec
Confidence 5678889998874 67777733 455688999998321 11112222222 356777784 46999
Q ss_pred cCCCCcceEecCCCCceeEeecchhh
Q psy622 166 RDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 166 RDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
+|-.|+|||-|+. |.+||.|=+...
T Consensus 167 GD~np~NiM~D~~-G~lKlVDP~~Ll 191 (308)
T PF07387_consen 167 GDCNPDNIMCDKF-GYLKLVDPVCLL 191 (308)
T ss_pred CCCChhheeecCC-CCEEecChhhhh
Confidence 9999999999999 999999966543
|
The function of this family is unknown. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.21 Score=51.39 Aligned_cols=77 Identities=13% Similarity=0.104 Sum_probs=51.1
Q ss_pred EEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch----hHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCEE
Q psy622 45 IVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK----NMVSQVLRERNALALTH---SPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 45 i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~----~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~~~~~l 117 (473)
..+.||.|.-..||++... ++.|+||.-........ ....+...|...|+.+. ...+.+++.+.. ..-
T Consensus 36 ~~~eiggGn~N~VyrV~~~---~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~ 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS---SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMA 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcC---CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCC
Confidence 3678899999999998653 34588888652211111 13456677788887653 246777777765 445
Q ss_pred EEEecccCc
Q psy622 118 FLVMEYMIG 126 (473)
Q Consensus 118 ~lVmEy~~g 126 (473)
++|||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 788999976
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.46 Score=47.17 Aligned_cols=30 Identities=13% Similarity=0.114 Sum_probs=27.5
Q ss_pred CeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 162 GIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 162 gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
+++|+|+.+.|+|++.+ +.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence 79999999999999988 7899999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.0072 Score=60.62 Aligned_cols=64 Identities=19% Similarity=0.075 Sum_probs=49.8
Q ss_pred cCCCCceeecCCCCCCCCCcccccc---------cccCcchHHHHHHhhcCCCcEEecccccccccceehhhcc
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDE---------EALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDA 458 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (473)
.|.++|...=+-.|+.+..+-|+++ ..-+--+||.||+-++ |||||.+.|+.-+..+||+|++.
T Consensus 18 iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 18 IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEEEEEEe
Confidence 6778888776666666666666611 1113467999999999 99999999999999999999864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 473 | ||||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-31 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-31 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-31 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-30 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-27 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-27 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-27 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-27 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-26 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-26 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-26 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-26 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-26 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-26 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-26 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-26 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-26 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-26 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-26 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-26 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-26 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-26 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-26 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-26 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-26 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-26 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-26 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-26 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-26 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-26 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-26 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-26 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-26 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-26 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-26 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-26 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-26 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-26 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-26 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-26 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-26 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-26 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-26 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-26 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-26 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-26 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-26 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-26 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-25 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-25 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-25 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-25 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-25 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-25 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-25 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-25 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-25 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-25 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-25 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-25 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-25 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-25 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-24 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-24 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-24 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-24 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-24 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-24 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-24 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-24 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-24 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-24 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-24 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-24 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-24 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-24 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-24 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-24 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-23 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-23 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-23 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-22 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-22 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-22 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-22 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-22 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-22 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-22 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-22 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-22 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-22 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-22 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-22 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-21 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-21 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-21 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-21 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-21 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-20 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-20 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-20 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-18 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-08 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 9e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 9e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-05 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 2e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 7e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 8e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-04 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-04 |
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 5e-58
Identities = 58/167 (34%), Positives = 94/167 (56%), Gaps = 6/167 (3%)
Query: 13 ENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAI 72
+ + + A V + + DFEI+K I RGAF +V + K Q+YA+
Sbjct: 37 KYVADFLQWAEPI----VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTG-QVYAM 91
Query: 73 KVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSL 132
K+M K +M+ + VS ER+ L + QL ++ Q + ++LVMEY +GGD+ +L
Sbjct: 92 KIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTL 151
Query: 133 IAANGA-LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
++ G +P +MA FY AE+V+A+ +H G +HRD+KPDN+L+
Sbjct: 152 LSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC 198
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 29/123 (23%), Positives = 39/123 (31%), Gaps = 20/123 (16%)
Query: 260 QLQLEWPEDEEALNPSTEETILALLKSDPTQR---PSGHQVRRLPMFKDYDWDSILDQEP 316
+ L P +E + + I LL P R R P F DWD + D P
Sbjct: 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVP 344
Query: 317 PFVPQPDDVFDTSYFHADKTN-----SYMDSTLSTTHGNG-----------SFVCCSNLN 360
PF P + DT F + S TLS S+ C + +
Sbjct: 345 PFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMALRD 404
Query: 361 SHT 363
S
Sbjct: 405 SEV 407
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 5e-57
Identities = 50/139 (35%), Positives = 79/139 (56%), Gaps = 1/139 (0%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
DF+ K + G+F V L + + YAIK+++K +I +N V V RER+ ++
Sbjct: 29 PEDFKFGKILGEGSFSTVVLARELATS-REYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
PF V+L+++ Q ++ + Y G++ I G+ E FY AE+V AL+YLH
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 160 SHGIIHRDLKPDNMLISAQ 178
GIIHRDLKP+N+L++
Sbjct: 148 GKGIIHRDLKPENILLNED 166
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 7e-57
Identities = 69/166 (41%), Positives = 105/166 (63%), Gaps = 6/166 (3%)
Query: 13 ENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAI 72
+NI ++ + ++K + D+E+VK I RGAFG+V L K+ + ++YA+
Sbjct: 45 KNIDNFLSRYKDT----INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-KVYAM 99
Query: 73 KVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSL 132
K++ K EMI ++ + ER+ +A +SP+ VQLFY+ Q +++VMEYM GGD+ +L
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL 159
Query: 133 IAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
+ +N +PE A FY AEVVLAL +HS G IHRD+KPDNML+
Sbjct: 160 M-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 204
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 22/95 (23%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 260 QLQLEWPEDEEALNPSTEETILALLKSDPTQR--PSG-HQVRRLPMFKDYDWDSIL--DQ 314
+ L +P+D + ++ + I A L D R +G +++R FK+ W D
Sbjct: 289 KNSLTFPDDND-ISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDT 346
Query: 315 EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHG 349
P VP DTS F + + + T
Sbjct: 347 VAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKA 381
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 8e-57
Identities = 60/167 (35%), Positives = 94/167 (56%), Gaps = 6/167 (3%)
Query: 13 ENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAI 72
+NILE A SK DFEI+K I RGAFG+V + K +++A+
Sbjct: 50 KNILEYLEWAKPF----TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD-KVFAM 104
Query: 73 KVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSL 132
K++ K EM+ + + ER+ L S + L Y+ Q + ++LVM+Y +GGD+ +L
Sbjct: 105 KILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTL 164
Query: 133 IA-ANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
++ LPE+MA FY AE+V+A+ +H +HRD+KPDN+L+
Sbjct: 165 LSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN 211
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 22/129 (17%), Positives = 45/129 (34%), Gaps = 15/129 (11%)
Query: 260 QLQLEWPEDEEALNPSTEETILALLKSDPTQR---PSGHQVRRLPMFKDYDWDSILDQEP 316
+ + ++P ++ + ++ I L+ R ++ P F DWD+I + E
Sbjct: 297 KERFQFPTQVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEA 355
Query: 317 PFVPQPDDVFDTSYFHADKTNSYMDSTLSTTHGNG-----------SFVCCSNLNSHTAS 365
P++P+ DTS F D T+ ++ L+ +
Sbjct: 356 PYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTSSCVLSDRSCL 415
Query: 366 GMDVDSPSA 374
+ SA
Sbjct: 416 RVTAGPTSA 424
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 5e-56
Identities = 51/139 (36%), Positives = 82/139 (58%), Gaps = 1/139 (0%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
FEI++AI +G+FGKV + K K ++YA+K M K + + +N V V +E +
Sbjct: 14 FDHFEILRAIGKGSFGKVCIVQKNDTK-KMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
PF V L+YS Q +F+V++ ++GGD++ + N E+ + E+V+AL YL
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 160 SHGIIHRDLKPDNMLISAQ 178
+ IIHRD+KPDN+L+
Sbjct: 133 NQRIIHRDMKPDNILLDEH 151
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 15/55 (27%), Positives = 27/55 (49%), Gaps = 4/55 (7%)
Query: 280 ILALLKSDPTQRPSG-HQVRRLPMFKDYDWDSILDQE--PPFVPQPDDV-FDTSY 330
+ LL+ +P QR S V+ P D +WD++ + P F+P + D ++
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTF 305
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 6e-56
Identities = 53/139 (38%), Positives = 90/139 (64%), Gaps = 1/139 (0%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
+ DF+I++ + G+FG+V L + N + YA+KV+KK+ ++ V ER L++
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHNG-RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
PF ++++ + Q + +F++M+Y+ GG++ SL+ + P +A FYAAEV LAL+YLH
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 160 SHGIIHRDLKPDNMLISAQ 178
S II+RDLKP+N+L+
Sbjct: 124 SKDIIYRDLKPENILLDKN 142
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 47.1 bits (113), Expect = 6e-06
Identities = 20/77 (25%), Positives = 34/77 (44%), Gaps = 11/77 (14%)
Query: 263 LEWPEDEEALNPSTEETILALLKSDPTQR----PSGHQ-VRRLPMFKDYDWDSILDQE-- 315
L +P N ++ + L+ D +QR +G + V+ P FK+ W+ +L +
Sbjct: 220 LRFPPF---FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIE 276
Query: 316 PPFVPQ-PDDVFDTSYF 331
P+ P DTS F
Sbjct: 277 TPYEPPIQQGQGDTSQF 293
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 9e-56
Identities = 58/177 (32%), Positives = 102/177 (57%), Gaps = 1/177 (0%)
Query: 2 DSSGLFSGADKENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGY 61
+++ G+++E++ E KA E+ L ++ F+ +K + G+FG+V L
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 62 KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121
K + YA+K++ K +++ + L E+ L + PF V+L +S + +S +++VM
Sbjct: 62 HKESG-NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 122 EYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
EY+ GG++ S + G E A FYAA++VL +YLHS +I+RDLKP+N+LI Q
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 18/76 (23%), Positives = 34/76 (44%), Gaps = 10/76 (13%)
Query: 263 LEWPEDEEALNPSTEETILALLKSDPTQR----PSGHQ-VRRLPMFKDYDWDSILDQE-- 315
+ +P + ++ + LL+ D T+R +G ++ F DW +I ++
Sbjct: 255 VRFPSH---FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVE 311
Query: 316 PPFVPQPDDVFDTSYF 331
PF+P+ DTS F
Sbjct: 312 APFIPKFKGPGDTSNF 327
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-55
Identities = 59/163 (36%), Positives = 99/163 (60%), Gaps = 3/163 (1%)
Query: 18 ITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVM 75
+ E ++ K + + S FE++K + +G+FGKVFL K + D QLYA+KV+
Sbjct: 1 MEGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 76 KKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAA 135
KK + ++ V + ER+ L + PF V+L Y+ QT ++L+++++ GGD+ + ++
Sbjct: 61 KKATLKVRDRV-RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK 119
Query: 136 NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
E+ FY AE+ LAL +LHS GII+RDLKP+N+L+ +
Sbjct: 120 EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE 162
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 47.5 bits (114), Expect = 5e-06
Identities = 19/59 (32%), Positives = 27/59 (45%), Gaps = 7/59 (11%)
Query: 280 ILALLKSDPTQR----PSG-HQVRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYF 331
+ L K +P R P G +++R F DW+ + +E PPF P DT YF
Sbjct: 257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYF 315
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 6e-55
Identities = 49/139 (35%), Positives = 83/139 (59%), Gaps = 1/139 (0%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
++DF+ +K + +G FGKV L +K + YA+K+++K+ +I K+ V+ + E L T
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
PF L Y+ QT + VMEY GG++ ++ E+ A FY AE+V AL+YLH
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 160 SHGIIHRDLKPDNMLISAQ 178
S +++RD+K +N+++
Sbjct: 123 SRDVVYRDIKLENLMLDKD 141
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 21/59 (35%), Positives = 28/59 (47%), Gaps = 7/59 (11%)
Query: 280 ILALLKSDPTQR----PSGHQ-VRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYF 331
+ LLK DP QR PS + V F +W ++ ++ PPF PQ DT YF
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYF 294
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 1e-54
Identities = 81/333 (24%), Positives = 137/333 (41%), Gaps = 59/333 (17%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
++DF + + I RG FG+V+ K ++YA+K + K + K + L ER L+L
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTG-KMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 100 HS---PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQ 156
+ PF V + Y+ T + +++ M GGD+ ++ +G E FYAAE++L L+
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 157 YLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL------VNGTP 210
++H+ +++RDLKP N+L+ ++ ISDL P
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHG-------------------HVRISDLGLACDFSKKKP 347
Query: 211 NAFNIRTPG----QLLSLKTG-TFP--------TFQDVQNSQAPFPSALRVAGSQIPTST 257
+A + T G ++L + +PF +I T
Sbjct: 348 HAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 406
Query: 258 AAQLQLEWPEDEEALNPSTEETILALLKSDPTQR----PSGHQ-VRRLPMFKDYDWDSIL 312
+ +E P+ +P + LL+ D +R G Q V+ P F+ DW +
Sbjct: 407 -LTMAVELPDS---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVF 462
Query: 313 DQ--EPPFVPQP-----DDVFDTSYFHADKTNS 338
Q PP +P D FD F + T
Sbjct: 463 LQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKG 495
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-54
Identities = 53/142 (37%), Positives = 86/142 (60%), Gaps = 3/142 (2%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMI-NKNMVSQVLRERNAL 96
FE+++ + +G +GKVF K T + +++A+KV+KK ++ N + ERN L
Sbjct: 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQ 156
PF V L Y+ QT ++L++EY+ GG++ + G ED A FY AE+ +AL
Sbjct: 76 EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 157 YLHSHGIIHRDLKPDNMLISAQ 178
+LH GII+RDLKP+N++++ Q
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQ 157
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 22/76 (28%), Positives = 32/76 (42%), Gaps = 12/76 (15%)
Query: 280 ILALLKSDPTQR----PSGHQ-VRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYFH 332
+ LLK + R P V+ P F+ +W+ +L ++ PPF P D S F
Sbjct: 252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFD 311
Query: 333 ADKTN-----SYMDST 343
+ T S DST
Sbjct: 312 SKFTRQTPVDSPDDST 327
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 5e-54
Identities = 53/143 (37%), Positives = 85/143 (59%), Gaps = 4/143 (2%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINK-NMVSQVLRERNAL 96
I +FE++K + GA+GKVFL K + D +LYA+KV+KK ++ K ER L
Sbjct: 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 97 ALT-HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
SPF V L Y+ QT + + L+++Y+ GG++ + ++ E Y E+VLAL
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 156 QYLHSHGIIHRDLKPDNMLISAQ 178
++LH GII+RD+K +N+L+ +
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSN 195
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 17/59 (28%), Positives = 25/59 (42%), Gaps = 7/59 (11%)
Query: 280 ILALLKSDPTQR----PSGHQ-VRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYF 331
I LL DP +R P ++ F+ +WD + ++ PF P D D S F
Sbjct: 297 IQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-52
Identities = 56/140 (40%), Positives = 88/140 (62%), Gaps = 2/140 (1%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL- 98
+ DF++++ I RG++ KV L K D++YA+KV+KK+ + + + V E++
Sbjct: 8 LQDFDLLRVIGRGSYAKVLLVRLKKT-DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
++ PF V L QT S +F V+EY+ GGD+ + LPE+ A FY+AE+ LAL YL
Sbjct: 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 159 HSHGIIHRDLKPDNMLISAQ 178
H GII+RDLK DN+L+ ++
Sbjct: 127 HERGIIYRDLKLDNVLLDSE 146
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 19/87 (21%), Positives = 32/87 (36%), Gaps = 13/87 (14%)
Query: 280 ILALLKSDPTQR------PSGHQVRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYF 331
+ + L DP +R ++ P F++ DWD + ++ PPF P F F
Sbjct: 250 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNF 309
Query: 332 HADKTN-----SYMDSTLSTTHGNGSF 353
+ TN + D + F
Sbjct: 310 DSQFTNEPVQLTPDDDDIVRKIDQSEF 336
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-52
Identities = 58/140 (41%), Positives = 84/140 (60%), Gaps = 2/140 (1%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL- 98
I DF + K + +G+FGKVFL K +Q +AIK +KKD ++ + V + E+ L+L
Sbjct: 16 IEDFILHKMLGKGSFGKVFLAEFKKT-NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
PF +F + QT +F VMEY+ GGD+ I + A FYAAE++L LQ+L
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 159 HSHGIIHRDLKPDNMLISAQ 178
HS GI++RDLK DN+L+
Sbjct: 135 HSKGIVYRDLKLDNILLDKD 154
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 21/82 (25%), Positives = 38/82 (46%), Gaps = 8/82 (9%)
Query: 280 ILALLKSDPTQR-PSGHQVRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYFHADKT 336
++ L +P +R +R+ P+F++ +W+ + +E PPF P+ FD S F +
Sbjct: 249 LVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFL 308
Query: 337 N-----SYMDSTLSTTHGNGSF 353
N S+ D L + F
Sbjct: 309 NEKPRLSFADRALINSMDQNMF 330
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 6e-52
Identities = 55/140 (39%), Positives = 83/140 (59%), Gaps = 2/140 (1%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL- 98
SDF +K I +G+FGKV L K + YA+KV++K ++ K ++ ERN L
Sbjct: 37 PSDFHFLKVIGKGSFGKVLLARHKAEE-VFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 95
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
PF V L +S QT+ ++ V++Y+ GG++ + E A FYAAE+ AL YL
Sbjct: 96 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYL 155
Query: 159 HSHGIIHRDLKPDNMLISAQ 178
HS I++RDLKP+N+L+ +Q
Sbjct: 156 HSLNIVYRDLKPENILLDSQ 175
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 5e-06
Identities = 14/58 (24%), Positives = 26/58 (44%), Gaps = 6/58 (10%)
Query: 280 ILALLKSDPTQR---PSGHQ-VRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYF 331
+ LL+ D T+R ++ F +WD +++++ PPF P D +F
Sbjct: 270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHF 327
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 57/140 (40%), Positives = 85/140 (60%), Gaps = 2/140 (1%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL- 98
++DF + + +G+FGKV L +K D+LYA+K++KKD +I + V + E+ LAL
Sbjct: 19 LTDFNFLMVLGKGSFGKVMLSERKGT-DELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
PF QL QT ++ VMEY+ GGD+ I G E A FYAAE+ + L +L
Sbjct: 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 159 HSHGIIHRDLKPDNMLISAQ 178
S GII+RDLK DN+++ ++
Sbjct: 138 QSKGIIYRDLKLDNVMLDSE 157
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 5e-05
Identities = 16/84 (19%), Positives = 30/84 (35%), Gaps = 13/84 (15%)
Query: 282 ALLKSDPTQR----PSGHQ-VRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYFHAD 334
L+ P +R P G + ++ F+ DW+ + +E PP+ P+ + F
Sbjct: 254 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACG-RNAENFDRF 312
Query: 335 KTN-----SYMDSTLSTTHGNGSF 353
T + D + F
Sbjct: 313 FTRHPPVLTPPDQEVIRNIDQSEF 336
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 60/159 (37%), Positives = 89/159 (55%), Gaps = 2/159 (1%)
Query: 21 KASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM 80
K S + + I +FE ++ + +G+FGKV L K LYA+KV+KKD +
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKET-GDLYAVKVLKKDVI 61
Query: 81 INKNMVSQVLRERNALAL-THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGAL 139
+ + V + E+ L+L + PF QLF QT +F VME++ GGD+ I +
Sbjct: 62 LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF 121
Query: 140 PEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
E A FYAAE++ AL +LH GII+RDLK DN+L+ +
Sbjct: 122 DEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE 160
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 6e-06
Identities = 18/60 (30%), Positives = 28/60 (46%), Gaps = 8/60 (13%)
Query: 280 ILALLKSDPTQR----PSG--HQVRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYF 331
+ + + +PT R G H + R P FK+ DW + ++ PPF P+ D S F
Sbjct: 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNF 314
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-51
Identities = 55/140 (39%), Positives = 88/140 (62%), Gaps = 2/140 (1%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL- 98
+ DF++++ I RG++ KV L K D++YA++V+KK+ + + + V E++
Sbjct: 51 LQDFDLLRVIGRGSYAKVLLVRLKKT-DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA 109
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
++ PF V L QT S +F V+EY+ GGD+ + LPE+ A FY+AE+ LAL YL
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 159 HSHGIIHRDLKPDNMLISAQ 178
H GII+RDLK DN+L+ ++
Sbjct: 170 HERGIIYRDLKLDNVLLDSE 189
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 15/58 (25%), Positives = 24/58 (41%), Gaps = 8/58 (13%)
Query: 282 ALLKSDPTQR------PSGHQVRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYF 331
+ L DP +R ++ P F++ DWD + ++ PPF P F F
Sbjct: 295 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNF 352
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 6e-51
Identities = 52/140 (37%), Positives = 82/140 (58%), Gaps = 2/140 (1%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
+++FE +K + +G FGKV L +K + YA+K++KK+ ++ K+ V+ L E L +
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKAT-GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
PF L YS QT + VMEY GG++ ++ ED A FY AE+V AL YLH
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 160 S-HGIIHRDLKPDNMLISAQ 178
S +++RDLK +N+++
Sbjct: 266 SEKNVVYRDLKLENLMLDKD 285
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 20/67 (29%), Positives = 29/67 (43%), Gaps = 7/67 (10%)
Query: 272 LNPSTEETILALLKSDPTQR----PSGHQ-VRRLPMFKDYDWDSILDQE--PPFVPQPDD 324
L P + + LLK DP QR + + + F W + +++ PPF PQ
Sbjct: 372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTS 431
Query: 325 VFDTSYF 331
DT YF
Sbjct: 432 ETDTRYF 438
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 9e-50
Identities = 50/149 (33%), Positives = 76/149 (51%), Gaps = 6/149 (4%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
F + + RG FG+VF K +LYA K + K + + + E+ LA
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKAT-GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVK----SLIAANGALPEDMAAFYAAEVVLAL 155
HS F V L Y+ +T + + LVM M GGD++ ++ N E A FY A++V L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPI 184
++LH II+RDLKP+N+L+ + I
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDG-NVRI 330
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 12/65 (18%)
Query: 283 LLKSDPTQR----PSGHQ-VRRLPMFKDYDWDSILDQE--PPFVPQPD-----DVFDTSY 330
LL+ DP +R +R P+F+D W + PPFVP ++ D
Sbjct: 427 LLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGA 486
Query: 331 FHADK 335
F K
Sbjct: 487 FSTVK 491
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-49
Identities = 39/139 (28%), Positives = 76/139 (54%), Gaps = 1/139 (0%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
I DF+I + + +G FG V+L +K NK + A+KV+ K ++ + + Q+ RE +
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNK-FIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
P ++++ ++L++E+ G++ + +G E +A + E+ AL Y H
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 131
Query: 160 SHGIIHRDLKPDNMLISAQ 178
+IHRD+KP+N+L+ +
Sbjct: 132 ERKVIHRDIKPENLLMGYK 150
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-49
Identities = 43/139 (30%), Positives = 74/139 (53%), Gaps = 1/139 (0%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
+ DFEI + + +G FG V+L +K +K + A+KV+ K ++ + Q+ RE +
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
P ++L+ ++ V+L++EY G V + E A Y E+ AL Y H
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 160 SHGIIHRDLKPDNMLISAQ 178
S +IHRD+KP+N+L+ +
Sbjct: 127 SKRVIHRDIKPENLLLGSA 145
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 6e-48
Identities = 57/140 (40%), Positives = 85/140 (60%), Gaps = 2/140 (1%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL- 98
++DF + + +G+FGKV L +K D+LYA+K++KKD +I + V + E+ LAL
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGT-DELYAVKILKKDVVIQDDDVECTMVEKRVLALP 398
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
PF QL QT ++ VMEY+ GGD+ I G E A FYAAE+ + L +L
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 159 HSHGIIHRDLKPDNMLISAQ 178
S GII+RDLK DN+++ ++
Sbjct: 459 QSKGIIYRDLKLDNVMLDSE 478
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 16/84 (19%), Positives = 29/84 (34%), Gaps = 13/84 (15%)
Query: 282 ALLKSDPTQR----PSG-HQVRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYFHAD 334
L+ P +R P G ++ F+ DW+ + +E PP+ P+ + F
Sbjct: 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASGR-NAENFDRF 633
Query: 335 KTN-----SYMDSTLSTTHGNGSF 353
T + D + F
Sbjct: 634 FTRHPPVLTPPDQEVIRNIDQSEF 657
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-47
Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 4/147 (2%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
+ F + + +G FG+V + ++YA K ++K + + + L E+ L
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI--AANGALPEDMAAFYAAEVVLALQY 157
+S F V L Y+ +T + LV+ M GGD+K I PE A FYAAE+ L+
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 158 LHSHGIIHRDLKPDNMLISAQAPHCPI 184
LH I++RDLKP+N+L+ H I
Sbjct: 302 LHRERIVYRDLKPENILLDDHG-HIRI 327
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 17/75 (22%), Positives = 30/75 (40%), Gaps = 7/75 (9%)
Query: 280 ILALLKSDPTQR-----PSGHQVRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDTSYFH 332
LL DP +R S +V+ P+FK ++ + PPF P P ++
Sbjct: 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLD 479
Query: 333 ADKTNSYMDSTLSTT 347
++ ++ L T
Sbjct: 480 IEQFSTVKGVELEPT 494
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-43
Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 5/141 (3%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-L 98
F+ + + G++G+VF K + +LYA+K K+ ++ L E + +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDG-RLYAVKRSMSPFRGPKD-RARKLAEVGSHEKV 113
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGA-LPEDMAAFYAAEVVLALQY 157
P CV+L + + ++L E G ++ A GA LPE Y + +LAL +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 158 LHSHGIIHRDLKPDNMLISAQ 178
LHS G++H D+KP N+ + +
Sbjct: 173 LHSQGLVHLDVKPANIFLGPR 193
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 8e-42
Identities = 42/343 (12%), Positives = 100/343 (29%), Gaps = 81/343 (23%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKK--------------DEMINKNM 85
I+D+ I++ +++G F K+ L K ++ YA+K +K D++ K+
Sbjct: 30 INDYRIIRTLNQGKFNKIILCEKD---NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86
Query: 86 VSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGAL------ 139
E + + +C+ + V+++ EYM + L
Sbjct: 87 YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 140 --PEDMAAFYAAEVVLALQYLHSH-GIIHRDLKPDNMLI-------------SAQAPHCP 183
P + V+ + Y+H+ I HRD+KP N+L+ S
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD-K 205
Query: 184 IVNTL-----FLA---ILQQPIVYLEISD----------LVNGTP---NAFNIRTPGQLL 222
+ F+ + D + ++
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE----- 260
Query: 223 SLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILA 282
F +++ +P + + ++ +
Sbjct: 261 --------LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDF-------LKL 305
Query: 283 LLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVPQPDDV 325
L+ +P +R + + D + + + + + +
Sbjct: 306 FLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKRKKL 348
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-39
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 19/152 (12%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
SDFE + + +GAFG+V + + YAIK ++ E +S +L E LA +
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDS-RYYAIKKIRHTE----EKLSTILSEVMLLASLN 60
Query: 101 SPFCVQLFYS-------------LQTSSCVFLVMEYMIGGDVKSLIAANGA-LPEDMAAF 146
+ V+ + + ++ S +F+ MEY G + LI + D
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 147 YAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
+++ AL Y+HS GIIHRDLKP N+ I
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDES 152
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-38
Identities = 64/298 (21%), Positives = 102/298 (34%), Gaps = 60/298 (20%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTH 100
+ I+K I G KVF + Q+YAIK + +E + + E L L
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQ 85
Query: 101 -SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
S ++L+ T +++VME D+ S + ++ Y ++ A+ +H
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 160 SHGIIHRDLKPDNMLISAQAPHCPIVNTL----F-LAILQQPIVYLEISDLVNGTPN--- 211
HGI+H DLKP N LI L F +A QP + D GT N
Sbjct: 145 QHGIVHSDLKPANFLIVD--------GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 212 ---------AFNIRTPGQLLSLK--------------TGTFPTFQDVQNSQAPFPSALRV 248
+ +S K G P FQ + N +
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-FQQIIN---QISKLHAI 252
Query: 249 AGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306
+E+P+ ++ + LK DP QR S ++ P +
Sbjct: 253 IDPNHE--------IEFPDI---PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 2/140 (1%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
I DF++ + +G+F V+ AIK++ K M MV +V E
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTG-LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDV-KSLIAANGALPEDMAAFYAAEVVLALQYL 158
P ++L+ + S+ V+LV+E G++ + L E+ A + +++ + YL
Sbjct: 69 KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 159 HSHGIIHRDLKPDNMLISAQ 178
HSHGI+HRDL N+L++
Sbjct: 129 HSHGILHRDLTLSNLLLTRN 148
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 38/137 (27%), Positives = 61/137 (44%), Gaps = 6/137 (4%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LTH 100
+ I+K I G KVF + Q+YAIK + +E + + E L L
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQ 66
Query: 101 -SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
S ++L+ T +++VME D+ S + ++ Y ++ A+ +H
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 160 SHGIIHRDLKPDNMLIS 176
HGI+H DLKP N LI
Sbjct: 126 QHGIVHSDLKPANFLIV 142
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 34/159 (21%), Positives = 67/159 (42%), Gaps = 1/159 (0%)
Query: 20 NKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDE 79
A+ ++ + + + + + +G F K F K +++A K++ K
Sbjct: 20 APAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTK-EVFAGKIVPKSL 78
Query: 80 MINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGAL 139
++ + ++ E + V + + VF+V+E + L AL
Sbjct: 79 LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL 138
Query: 140 PEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
E A +Y ++VL QYLH + +IHRDLK N+ ++
Sbjct: 139 TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED 177
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-37
Identities = 33/150 (22%), Positives = 65/150 (43%), Gaps = 1/150 (0%)
Query: 29 DVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ 88
++ + + + + + +G F K F K +++A K++ K ++ + +
Sbjct: 3 EIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREK 61
Query: 89 VLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYA 148
+ E + V + + VF+V+E + L AL E A +Y
Sbjct: 62 MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 121
Query: 149 AEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
++VL QYLH + +IHRDLK N+ ++
Sbjct: 122 RQIVLGCQYLHRNRVIHRDLKLGNLFLNED 151
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 63/300 (21%), Positives = 102/300 (34%), Gaps = 60/300 (20%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-AL 98
+ I+K I G KVF + Q+YAIK + +E + + E L L
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL 111
Query: 99 TH-SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
S ++L+ T +++VME D+ S + ++ Y ++ A+
Sbjct: 112 QQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 158 LHSHGIIHRDLKPDNMLISAQAPHCPIVNTL----F-LAILQQPIVYLEISDLVNGTPN- 211
+H HGI+H DLKP N LI L F +A QP + D G N
Sbjct: 171 IHQHGIVHSDLKPANFLIVD--------GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222
Query: 212 ----AFNIRTPGQ---------------------LLSLKTGTFPTFQDVQNSQAPFPSAL 246
A + + L + G P FQ + N
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-FQQIIN---QISKLH 278
Query: 247 RVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306
+ +E+P+ ++ + LK DP QR S ++ P +
Sbjct: 279 AIIDPNHE--------IEFPDI---PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-35
Identities = 45/170 (26%), Positives = 69/170 (40%), Gaps = 7/170 (4%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LT 99
++F ++ I G FG VF K+ + +YAIK KK + + LRE A A L
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDG-CIYAIKRSKKPLAGSVD-EQNALREVYAHAVLG 68
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN----GALPEDMAAFYAAEVVLAL 155
V+ F + + + EY GG + I+ N E +V L
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205
+Y+HS ++H D+KP N+ IS + V +I DL
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 4/152 (2%)
Query: 29 DVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ 88
D+ L + + ++ I G+FGK L + + Y IK + M + +
Sbjct: 12 DLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDG-RQYVIKEINISRM-SSKEREE 69
Query: 89 VLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI--AANGALPEDMAAF 146
RE LA P VQ S + + +++VM+Y GGD+ I ED
Sbjct: 70 SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129
Query: 147 YAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
+ ++ LAL+++H I+HRD+K N+ ++
Sbjct: 130 WFVQICLALKHVHDRKILHRDIKSQNIFLTKD 161
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-34
Identities = 36/149 (24%), Positives = 61/149 (40%), Gaps = 8/149 (5%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
+ + + +GA VF G K L+AIKV V +RE L +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTG-DLFAIKVFNNISF--LRPVDVQMREFEVLKKLNH 66
Query: 102 PFCVQLF--YSLQTSSCVFLVMEYMIGGDVKSLIAANG---ALPEDMAAFYAAEVVLALQ 156
V+LF T+ L+ME+ G + +++ LPE +VV +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 157 YLHSHGIIHRDLKPDNMLISAQAPHCPIV 185
+L +GI+HR++KP N++ +
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVY 155
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 27/143 (18%), Positives = 56/143 (39%), Gaps = 12/143 (8%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKD----QLYAIKVMKKDEMINKNMVSQVLRERNALA 97
+ + GAF +V+ + D Q + +KV K + +Q L
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ---LMERLK 122
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-----AANGALPEDMAAFYAAEVV 152
+ ++ + + + LV E G + + I +P+ + +A ++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 153 LALQYLHSHGIIHRDLKPDNMLI 175
++ +H IIH D+KPDN ++
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFIL 205
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 41/143 (28%), Positives = 78/143 (54%), Gaps = 1/143 (0%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+I + + + G FGKV +G + A+K++ + ++ + ++V ++ RE
Sbjct: 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTG-HKVAVKILNRQKIRSLDVVGKIKREIQN 64
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
L L P ++L+ + T + F+VMEY+ GG++ I +G + E A +++ A+
Sbjct: 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 156 QYLHSHGIIHRDLKPDNMLISAQ 178
Y H H ++HRDLKP+N+L+ A
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAH 147
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 36/145 (24%), Positives = 60/145 (41%), Gaps = 8/145 (5%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
+ + + +GA VF G K L+AIKV V +RE L +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTG-DLFAIKVFNNISF--LRPVDVQMREFEVLKKLNH 66
Query: 102 PFCVQLF--YSLQTSSCVFLVMEYMIGGDVKSLIAANG---ALPEDMAAFYAAEVVLALQ 156
V+LF T+ L+ME+ G + +++ LPE +VV +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 157 YLHSHGIIHRDLKPDNMLISAQAPH 181
+L +GI+HR++KP N++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDG 151
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 36/156 (23%), Positives = 62/156 (39%), Gaps = 26/156 (16%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
DF+ ++ I G FG+VF + + + Y IK +K + + RE ALA
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDG-KTYVIKRVKYNNE-------KAEREVKALAKLD 62
Query: 101 SPFCVQLFYS----------------LQTSSCVFLVMEYMIGGDVKSLI--AANGALPED 142
V + C+F+ ME+ G ++ I L +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 143 MAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
+A ++ + Y+HS +I+RDLKP N+ +
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 34/145 (23%), Positives = 72/145 (49%), Gaps = 5/145 (3%)
Query: 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
+++F I K I RG F +V+ + A+K ++ ++++ + ++E + L
Sbjct: 29 NTLANFRIEKKIGRGQFSEVYRAACLLDG-VPVALKKVQIFDLMDAKARADCIKEIDLLK 87
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI----AANGALPEDMAAFYAAEVVL 153
+ P ++ + S + + +V+E GD+ +I +PE Y ++
Sbjct: 88 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQ 178
AL+++HS ++HRD+KP N+ I+A
Sbjct: 148 ALEHMHSRRVMHRDIKPANVFITAT 172
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 46/143 (32%), Positives = 81/143 (56%), Gaps = 2/143 (1%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+ P I ++ ++K I +G F KV L ++ AIK++ K + +N + ++ RE
Sbjct: 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREV-AIKIIDKTQ-LNPTSLQKLFREVRI 67
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
+ + + P V+LF ++T ++L+MEY GG+V + A+G + E A ++V A+
Sbjct: 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 127
Query: 156 QYLHSHGIIHRDLKPDNMLISAQ 178
QY H I+HRDLK +N+L+ A
Sbjct: 128 QYCHQKRIVHRDLKAENLLLDAD 150
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 53/190 (27%), Positives = 88/190 (46%), Gaps = 14/190 (7%)
Query: 30 VSKSCLKAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKD-----EMINK 83
V + + D + + K + GA G+V L +++ + AI+++ K
Sbjct: 123 VDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC-KKVAIRIISKRKFAIGSAREA 181
Query: 84 NMVSQVLRERNAL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPED 142
+ V E L L H P +++ ++V+E M GG++ + N L E
Sbjct: 182 DPALNVETEIEILKKLNH-PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEA 239
Query: 143 MAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLE 201
Y +++LA+QYLH +GIIHRDLKP+N+L+S+Q C I T F + + +
Sbjct: 240 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM- 298
Query: 202 ISDLVNGTPN 211
L GTP
Sbjct: 299 -RTLC-GTPT 306
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 4/151 (2%)
Query: 36 KAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
SD ++ + + +G+FG+V L K Q A+KV+ K ++ K +LRE
Sbjct: 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITG-QECAVKVISKRQVKQKTDKESLLREVQ 78
Query: 95 AL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
L L H P ++L+ + +LV E GG++ I + E AA +V+
Sbjct: 79 LLKQLDH-PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQAPHCPI 184
+ Y+H + I+HRDLKP+N+L+ +++ I
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANI 168
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 41/143 (28%), Positives = 74/143 (51%), Gaps = 2/143 (1%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
I + I + + G+FGKV L + Q A+K + + + +M +V RE +
Sbjct: 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQ-QKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
L L P ++L+ + T + + +V+EY GG++ I + ED + +++ A+
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 156 QYLHSHGIIHRDLKPDNMLISAQ 178
+Y H H I+HRDLKP+N+L+
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDN 144
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 9/182 (4%)
Query: 32 KSCLKAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVL 90
++ ++ + IV + +G+FG+V + + Q YA+KV+ K NK+ S +L
Sbjct: 12 ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKD-TSTIL 69
Query: 91 RERNAL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAA 149
RE L L H P ++LF L+ SS ++V E GG++ I E AA
Sbjct: 70 REVELLKKLDH-PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK 128
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLEISDLVNG 208
+V + Y+H H I+HRDLKP+N+L+ ++ C I F L+ Q + D + G
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRI-G 185
Query: 209 TP 210
T
Sbjct: 186 TA 187
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 51/181 (28%), Positives = 92/181 (50%), Gaps = 16/181 (8%)
Query: 35 LKAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVS---QVL 90
++ I F ++ + GAF +VFL ++ +L+A+K +KK + + VL
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTG-KLFALKCIKKSPAFRDSSLENEIAVL 60
Query: 91 RERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAE 150
++ + H V L ++++ +LVM+ + GG++ I G E A+ +
Sbjct: 61 KK-----IKH-ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ 114
Query: 151 VVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLEISDLVNGT 209
V+ A++YLH +GI+HRDLKP+N+L + I+ T F L+ ++Q + S GT
Sbjct: 115 VLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STAC-GT 170
Query: 210 P 210
P
Sbjct: 171 P 171
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-31
Identities = 33/141 (23%), Positives = 73/141 (51%), Gaps = 3/141 (2%)
Query: 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
+ P + D+++V+ + GA+G+V L + + + A+K++ ++ + +E
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD--CPENIKKEIC 57
Query: 95 ALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLA 154
+ + V+ + + + +L +EY GG++ I + +PE A + +++
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 155 LQYLHSHGIIHRDLKPDNMLI 175
+ YLH GI HRD+KP+N+L+
Sbjct: 118 VVYLHGIGITHRDIKPENLLL 138
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 37/153 (24%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
++DFE ++ + RG FG VF K + YAIK ++ + +V+RE ALA
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDD-CNYAIKRIRLPNR--ELAREKVMREVKALAKL 60
Query: 100 HSPFCVQLFYS------------LQTSSCVFLVMEYMIGGDVKSLIAANGAL---PEDMA 144
P V+ F + +++ M+ ++K + + +
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177
++ A+++LHS G++HRDLKP N+ +
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM 153
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 42/139 (30%), Positives = 77/139 (55%), Gaps = 1/139 (0%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
I + + + G FGKV +G + A+K++ + ++ + ++V ++ RE L L
Sbjct: 15 IGHYILGDTLGVGTFGKVKVGKHELTG-HKVAVKILNRQKIRSLDVVGKIRREIQNLKLF 73
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
P ++L+ + T S +F+VMEY+ GG++ I NG L E + +++ + Y H
Sbjct: 74 RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH 133
Query: 160 SHGIIHRDLKPDNMLISAQ 178
H ++HRDLKP+N+L+ A
Sbjct: 134 RHMVVHRDLKPENVLLDAH 152
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-30
Identities = 36/158 (22%), Positives = 63/158 (39%), Gaps = 12/158 (7%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+E+ + + G FG V + +Q AIK +++ ++ + E
Sbjct: 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQ-VAIKQCRQE--LSPKNRERWCLEIQI 65
Query: 96 LALTHSPFCVQLF------YSLQTSSCVFLVMEYMIGGDVKSLIAANG---ALPEDMAAF 146
+ + P V L + L MEY GGD++ + L E
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 147 YAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPI 184
+++ AL+YLH + IIHRDLKP+N+++
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIH 163
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 14/181 (7%)
Query: 39 EISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKD-----EMINKNMVSQVLRE 92
+ D + + K + GA G+V L +++ + AIK++ K + V E
Sbjct: 7 ALRDEYIMSKTLGSGACGEVKLAFERKTC-KKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 93 RNAL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEV 151
L L H P +++ ++V+E M GG++ + N L E Y ++
Sbjct: 66 IEILKKLNH-PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 152 VLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLEISDLVNGTP 210
+LA+QYLH +GIIHRDLKP+N+L+S+Q C I T F + + + L GTP
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLC-GTP 180
Query: 211 N 211
Sbjct: 181 T 181
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-30
Identities = 37/150 (24%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL 98
D+E++ I G++G+ +K++ ++ K + M ++ E N L
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDG-KILVWKELDYGSMTEAE-KQMLVSEVNLLRE 61
Query: 99 THSPFCVQLF--YSLQTSSCVFLVMEYMIGGDVKSLI----AANGALPEDMAAFYAAEVV 152
P V+ + +T++ +++VMEY GGD+ S+I L E+ ++
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 153 LALQYLHS-----HGIIHRDLKPDNMLISA 177
LAL+ H H ++HRDLKP N+ +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDG 151
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 33/141 (23%), Positives = 73/141 (51%), Gaps = 3/141 (2%)
Query: 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
+ P + D+++V+ + GA+G+V L + + + A+K++ ++ + +E
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD--CPENIKKEIC 57
Query: 95 ALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLA 154
+ + V+ + + + +L +EY GG++ I + +PE A + +++
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 155 LQYLHSHGIIHRDLKPDNMLI 175
+ YLH GI HRD+KP+N+L+
Sbjct: 118 VVYLHGIGITHRDIKPENLLL 138
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-30
Identities = 29/145 (20%), Positives = 56/145 (38%), Gaps = 12/145 (8%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
+ ++ + G F V L + YA+K + + + RE + L +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDG-HFYALKRILCH---EQQDREEAQREADMHRLFNH 85
Query: 102 PFCVQLFYSLQTSS----CVFLVMEYMIGGDV----KSLIAANGALPEDMAAFYAAEVVL 153
P ++L +L++ + G + + L L ED + +
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQ 178
L+ +H+ G HRDLKP N+L+ +
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDE 170
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-30
Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 29/165 (17%)
Query: 40 ISDFEIVKAISRGAFGKVFLGY-KKTNKDQLYAIKVMKKDEMI----------------- 81
++ + + I +G++G V L Y + N YA+KV+ K ++I
Sbjct: 12 LNQYTLKDEIGKGSYGVVKLAYNENDN--TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 82 ------NKNMVSQVLRERNALALTHSPFCVQLF--YSLQTSSCVFLVMEYMIGGDVKSLI 133
+ + QV +E L P V+L +++V E + G V +
Sbjct: 70 PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-V 128
Query: 134 AANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
L ED A FY +++ ++YLH IIHRD+KP N+L+
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED 173
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 40/151 (26%), Positives = 77/151 (50%), Gaps = 9/151 (5%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ---VLRE 92
+ +++ + + +G FG VF G++ T++ Q+ AIKV+ ++ ++ + +S E
Sbjct: 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQV-AIKVIPRNRVLGWSPLSDSVTCPLE 84
Query: 93 RNALALTHS----PFCVQLFYSLQTSSCVFLVMEYMI-GGDVKSLIAANGALPEDMAAFY 147
L + P ++L +T LV+E + D+ I G L E + +
Sbjct: 85 VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF 144
Query: 148 AAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
+VV A+Q+ HS G++HRD+K +N+LI +
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLR 175
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 50/155 (32%), Positives = 81/155 (52%), Gaps = 5/155 (3%)
Query: 32 KSCLKAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVL 90
++ ++ + IV + +G+FG+V + + Q YA+KV+ K NK+ S +L
Sbjct: 12 ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKD-TSTIL 69
Query: 91 RERNAL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAA 149
RE L L H P ++LF L+ SS ++V E GG++ I E AA
Sbjct: 70 REVELLKKLDH-PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK 128
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPI 184
+V + Y+H H I+HRDLKP+N+L+ ++ C I
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI 163
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 5/151 (3%)
Query: 36 KAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
K +S+ ++ VK + GA+G+V L K AIK+++K + + S++L E
Sbjct: 31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTH-VERAIKIIRKTSVSTSS-NSKLLEEVA 88
Query: 95 AL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
L L H P ++L+ + +LVME GG++ I E AA +V+
Sbjct: 89 VLKLLDH-PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS 147
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQAPHCPI 184
+ YLH H I+HRDLKP+N+L+ ++ I
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALI 178
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 53/187 (28%), Positives = 88/187 (47%), Gaps = 14/187 (7%)
Query: 32 KSCLKAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVL 90
++ I D F + + GAFG V L ++++ IK + KD + + Q+
Sbjct: 12 ENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSG-LERVIKTINKDRS--QVPMEQIE 68
Query: 91 RERNAL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGD----VKSLIAANGALPEDMAA 145
E L +L H P +++F + +++VME GG+ + S A AL E A
Sbjct: 69 AEIEVLKSLDH-PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127
Query: 146 FYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLEISD 204
+++ AL Y HS ++H+DLKP+N+L +PH PI F LA L + + ++
Sbjct: 128 ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TN 185
Query: 205 LVNGTPN 211
GT
Sbjct: 186 AA-GTAL 191
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 36/149 (24%), Positives = 65/149 (43%), Gaps = 7/149 (4%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKK-----DEMINKNMVSQVL 90
+ + + + GAFG V+ K + +K +KK D I + +V
Sbjct: 19 EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKN-KEVVVKFIKKEKVLEDCWIEDPKLGKVT 77
Query: 91 RERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMI-GGDVKSLIAANGALPEDMAAFYAA 149
E L+ +++ + LVME G D+ + I + L E +A++
Sbjct: 78 LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
++V A+ YL IIHRD+K +N++I+
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAED 166
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 37/148 (25%), Positives = 74/148 (50%), Gaps = 7/148 (4%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVS---QVLRE 92
K P S +++ + G FG V+ G + ++ + AIK ++KD + + + +V E
Sbjct: 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV-AIKHVEKDRISDWGELPNGTRVPME 96
Query: 93 RNALA-LTHS-PFCVQLFYSLQTSSCVFLVMEYMIG-GDVKSLIAANGALPEDMAAFYAA 149
L ++ ++L + L++E D+ I GAL E++A +
Sbjct: 97 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 156
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLISA 177
+V+ A+++ H+ G++HRD+K +N+LI
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILIDL 184
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 3e-29
Identities = 46/179 (25%), Positives = 84/179 (46%), Gaps = 11/179 (6%)
Query: 36 KAPEISDF-EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
+I+ + + I RG++G+V + +K + A K + K + + + +E
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTR-IRRAAKKIPKYFVEDVDRF---KQEIE 58
Query: 95 AL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
+ +L H P ++L+ + + ++ ++LVME GG++ + E AA +V+
Sbjct: 59 IMKSLDH-PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 117
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLEISDLVNGTPN 211
A+ Y H + HRDLKP+N L +P P+ F LA +P + V GTP
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKV-GTPY 173
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 38/142 (26%), Positives = 73/142 (51%), Gaps = 6/142 (4%)
Query: 39 EISDFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
+ DFE + + G G VF +K + + A K++ + + +Q++RE L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSG--LVMARKLIHLEI--KPAIRNQIIRELQVLH 86
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
+SP+ V + + + + + ME+M GG + ++ G +PE + + V+ L Y
Sbjct: 87 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 146
Query: 158 LHS-HGIIHRDLKPDNMLISAQ 178
L H I+HRD+KP N+L++++
Sbjct: 147 LREKHKIMHRDVKPSNILVNSR 168
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 48/178 (26%), Positives = 88/178 (49%), Gaps = 9/178 (5%)
Query: 37 APEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+ + SD +++ + + +GAF V KT +A K++ ++ ++ ++ RE
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTG-LEFAAKIINTKKLSARD-FQKLEREARI 58
Query: 96 L-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLA 154
L H P V+L S+Q S +LV + + GG++ I A E A+ +++ +
Sbjct: 59 CRKLQH-PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 117
Query: 155 LQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLEISDLVNGTPN 211
+ Y HS+GI+HR+LKP+N+L++++A + F LAI GTP
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFA-GTPG 172
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 42/144 (29%), Positives = 72/144 (50%), Gaps = 10/144 (6%)
Query: 41 SDFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN-ALAL 98
D E + + RGA+G V + + Q+ A+K ++ +N ++L + + ++
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSG--QIMAVKRIRAT--VNSQEQKRLLMDLDISMRT 62
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGG---DVKSLIAANGALPEDMAAFYAAEVVLAL 155
PF V + +L V++ ME M K +I +PED+ A +V AL
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 156 QYLHS-HGIIHRDLKPDNMLISAQ 178
++LHS +IHRD+KP N+LI+A
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINAL 146
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 59/320 (18%), Positives = 102/320 (31%), Gaps = 56/320 (17%)
Query: 38 PEISDFEIVKAISRGA--FGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
PE +E++ I +G V L K + ++ + + + MV+ + E +
Sbjct: 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTG-EYVTVRRINLEA-CSNEMVTFLQGELHV 79
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI--AANGALPEDMAAFYAAEVVL 153
L + P V + + +++V +M G K LI + E A+ V+
Sbjct: 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQ-------------------------APHCPIVNTL 188
AL Y+H G +HR +K ++LIS V L
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 189 F-LA---ILQQPIVYLEISD----------LVNGTPNAFNIRTPGQLLSLK--------- 225
L+ + Q Y SD L NG ++ Q+L K
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM-PATQMLLEKLNGTVPCLL 258
Query: 226 -TGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALL 284
T T P + + ++ T + +P + L
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318
Query: 285 KSDPTQRPSGHQVRRLPMFK 304
+ +P RPS + FK
Sbjct: 319 QRNPDARPSASTLLNHSFFK 338
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 48/178 (26%), Positives = 88/178 (49%), Gaps = 9/178 (5%)
Query: 36 KAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
+ + SD +++ + + +GAF V KT +A K++ ++ ++ ++ RE
Sbjct: 23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTG-LEFAAKIINTKKLSARD-FQKLEREAR 80
Query: 95 AL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
L H P V+L S+Q S +LV + + GG++ I A E A+ +++
Sbjct: 81 ICRKLQH-PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLEISDLVNGTP 210
++ Y HS+GI+HR+LKP+N+L++++A + F LAI GTP
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFA-GTP 194
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 5/146 (3%)
Query: 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN-KNMVSQVLRERNA 95
A I + + + G++GKV A+K++KK ++ N + V +E
Sbjct: 1 AKLIGKYLMGDLLGEGSYGKVKEVLDSETL-CRRAVKILKKKKLRRIPNGEANVKKEIQL 59
Query: 96 LALTHSPFCVQLF--YSLQTSSCVFLVMEYMIGGDVKSL-IAANGALPEDMAAFYAAEVV 152
L +QL + +++VMEY + G + L P A Y +++
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI 119
Query: 153 LALQYLHSHGIIHRDLKPDNMLISAQ 178
L+YLHS GI+H+D+KP N+L++
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTG 145
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 9/145 (6%)
Query: 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
E+ + RG+FG+V K A+K ++ + + E A A
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTG-FQCAVKKVRLE--------VFRVEELVACA 105
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
SP V L+ +++ V + ME + GG + LI G LPED A +Y + + L+Y
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEY 165
Query: 158 LHSHGIIHRDLKPDNMLISAQAPHC 182
LH+ I+H D+K DN+L+S+
Sbjct: 166 LHTRRILHGDVKADNVLLSSDGSRA 190
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 41/139 (29%), Positives = 65/139 (46%), Gaps = 5/139 (3%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+ ++ VK I G FG L K K +L A+K +++ I++ V RE
Sbjct: 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTK-ELVAVKYIERGAAIDE----NVQREIIN 69
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
P V+ + T + + ++MEY GG++ I G ED A F+ +++ +
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGV 129
Query: 156 QYLHSHGIIHRDLKPDNML 174
Y HS I HRDLK +N L
Sbjct: 130 SYCHSMQICHRDLKLENTL 148
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 35 LKAPEISDF----EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVL 90
+K K + G+F K + Q +A+K+ I+K M +
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSN-QAFAVKI------ISKRMEANTQ 53
Query: 91 RERNAL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAA 149
+E AL P V+L FLVME + GG++ I E A++
Sbjct: 54 KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR 113
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPI 184
++V A+ ++H G++HRDLKP+N+L + + + I
Sbjct: 114 KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEI 148
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 37/155 (23%), Positives = 72/155 (46%), Gaps = 5/155 (3%)
Query: 35 LKAPEISDF-EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNM---VSQVL 90
K ++ DF +I + + G F V +K+ YA K +KK + ++
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTG-LEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 91 RERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAE 150
RE + L + L + + V L++E + GG++ +A +L E+ A + +
Sbjct: 64 REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 151 VVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185
++ + YLH+ I H DLKP+N+++ + P +
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-28
Identities = 70/317 (22%), Positives = 108/317 (34%), Gaps = 58/317 (18%)
Query: 19 TNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKD 78
++ + E D S + +IS F + GA G + N+D A+K
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKIS-FCPKDVLGHGAEGTIVYRGMFDNRD--VAVKR---- 55
Query: 79 EMINKNMVSQVLRERNAL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG 137
I S RE L P ++ F + + ++ +E ++ +
Sbjct: 56 --ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD 112
Query: 138 -ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196
A + L +LHS I+HRDLKP N+LIS H I
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIK----------- 161
Query: 197 IVYLEISDL-----VNGTPNAFNIR-----TPG----QLLSLKTGTFPTFQ-DVQ----- 236
ISD + ++F+ R T G ++LS PT+ D+
Sbjct: 162 ---AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218
Query: 237 ------NSQAPFPSAL-RVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPT 289
PF +L R A + + L E ED A I ++ DP
Sbjct: 219 FYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARE-----LIEKMIAMDPQ 273
Query: 290 QRPSGHQVRRLPMFKDY 306
+RPS V + P F
Sbjct: 274 KRPSAKHVLKHPFFWSL 290
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 43/142 (30%), Positives = 75/142 (52%), Gaps = 5/142 (3%)
Query: 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
PE F ++ I +G+FG+VF G + ++ AIK++ +E ++ + + +E L+
Sbjct: 20 PE-ELFTKLEKIGKGSFGEVFKGIDNRTQ-KVVAIKIIDLEE--AEDEIEDIQQEITVLS 75
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
SP+ + + S + ++++MEY+ GG L+ G L E A E++ L Y
Sbjct: 76 QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDY 134
Query: 158 LHSHGIIHRDLKPDNMLISAQA 179
LHS IHRD+K N+L+S
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHG 156
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 6/157 (3%)
Query: 33 SCLKAPEISDF-EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNM---VSQ 88
+ + + D+ + + + G F V +K+ YA K +KK +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTG-LQYAAKFIKKRRTKSSRRGVSRED 60
Query: 89 VLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYA 148
+ RE + L P + L + + V L++E + GG++ +A +L E+ A +
Sbjct: 61 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 149 AEVVLALQYLHSHGIIHRDLKPDN-MLISAQAPHCPI 184
+++ + YLHS I H DLKP+N ML+ P I
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI 157
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 44/143 (30%), Positives = 73/143 (51%), Gaps = 7/143 (4%)
Query: 39 EISDFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL- 96
EI+D E + + G G+V+ ++KT + A+K M++ NK ++L + + +
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTG--HVIAVKQMRRS--GNKEENKRILMDLDVVL 78
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQ 156
P+ VQ F + T++ VF+ ME M K G +PE + +V AL
Sbjct: 79 KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALY 138
Query: 157 YLHS-HGIIHRDLKPDNMLISAQ 178
YL HG+IHRD+KP N+L+ +
Sbjct: 139 YLKEKHGVIHRDVKPSNILLDER 161
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 14/161 (8%)
Query: 36 KAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNM--------- 85
K +I + + V+ + GA+G+V L +K AIKV+KK +
Sbjct: 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH-SEKAIKVIKKSQFDKGRYSDDNKNIEK 88
Query: 86 -VSQVLRERNAL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDM 143
++ E + L +L H P ++LF + +LV E+ GG++ I E
Sbjct: 89 FHEEIYNEISLLKSLDH-PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 144 AAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPI 184
AA +++ + YLH H I+HRD+KP+N+L+ + I
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 39/137 (28%), Positives = 63/137 (45%), Gaps = 5/137 (3%)
Query: 51 RGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHSPFCVQLFY 109
RG F V K+ Q YA K +KK +++L E L P + L
Sbjct: 39 RGKFAVVRQCISKSTG-QEYAAKFLKKRRRGQDC-RAEILHEIAVLELAKSCPRVINLHE 96
Query: 110 SLQTSSCVFLVMEYMIGGDVKSLIAA--NGALPEDMAAFYAAEVVLALQYLHSHGIIHRD 167
+ +S + L++EY GG++ SL + E+ +++ + YLH + I+H D
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLD 156
Query: 168 LKPDNMLISAQAPHCPI 184
LKP N+L+S+ P I
Sbjct: 157 LKPQNILLSSIYPLGDI 173
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 38/155 (24%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 35 LKAPEISDF-EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN---MVSQVL 90
K ++ DF +I + + G F V +K+ YA K +KK + ++
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTG-LEYAAKFIKKRQSRASRRGVCREEIE 63
Query: 91 RERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAE 150
RE + L P + L + + V L++E + GG++ +A +L E+ A + +
Sbjct: 64 REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 151 VVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185
++ + YLH+ I H DLKP+N+++ + P +
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 11/146 (7%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
D+E+ + I GA V Y K + AIK + ++ + ++L+E A++ H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKK-EKVAIKRINLEKCQTS--MDELLKEIQAMSQCH 71
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI--------AANGALPEDMAAFYAAEVV 152
P V + S ++LVM+ + GG V +I +G L E A EV+
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 153 LALQYLHSHGIIHRDLKPDNMLISAQ 178
L+YLH +G IHRD+K N+L+
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGED 157
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 41/146 (28%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNM---VSQVLRERNALALT 99
+E+ + + G F V +K + YA K +KK + + ++ RE N L
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTG-KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
P + L + + V L++E + GG++ +A +L ED A + +++ + YLH
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 160 SHGIIHRDLKPDN-MLISAQAPHCPI 184
S I H DLKP+N ML+ P+ I
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRI 151
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 38/149 (25%), Positives = 74/149 (49%), Gaps = 9/149 (6%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ--VLRERNAL-ALT 99
+E+ + I +G F V + Q +A+K++ + + +S + RE + L
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETG-QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG----ALPEDMAAFYAAEVVLAL 155
H P V+L + + +++V E+M G D+ I E +A+ Y +++ AL
Sbjct: 85 H-PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPI 184
+Y H + IIHRD+KP +L++++ P+
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPV 172
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 41/141 (29%), Positives = 59/141 (41%), Gaps = 2/141 (1%)
Query: 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
PE F ++ I G+FG V+ N ++ AIK M + +++E L
Sbjct: 52 PE-KLFSDLREIGHGSFGAVYFARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
P +Q +LVMEY +G L L E A + L Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 158 LHSHGIIHRDLKPDNMLISAQ 178
LHSH +IHRD+K N+L+S
Sbjct: 170 LHSHNMIHRDVKAGNILLSEP 190
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
P +EIV + GAFGKV+ K L A KV++ + + + E LA
Sbjct: 17 PN-EVWEIVGELGDGAFGKVYKAKNKETG-ALAAAKVIETKS---EEELEDYIVEIEILA 71
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLALQ 156
P+ V+L + +++++E+ GG V +++ + L E +++ AL
Sbjct: 72 TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 157 YLHSHGIIHRDLKPDNMLISAQA 179
+LHS IIHRDLK N+L++ +
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEG 154
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 36/145 (24%), Positives = 64/145 (44%), Gaps = 11/145 (7%)
Query: 41 SDFEIVKAISRGAFGKVFLGY-KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN-ALAL 98
D + + I RGA+G V K + Q+ A+K ++ ++ Q+L + + +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSG--QIMAVKRIRSTV--DEKEQKQLLMDLDVVMRS 77
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLA 154
+ P+ VQ + +L ++ ME M K + +PE++ V A
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 155 LQYLHS-HGIIHRDLKPDNMLISAQ 178
L +L IIHRD+KP N+L+
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRS 162
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 33/151 (21%), Positives = 73/151 (48%), Gaps = 5/151 (3%)
Query: 36 KAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
++ +++ + + +GAF V K Q YA ++ ++ ++ ++ RE
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAG-QEYAAMIINTKKLSARD-HQKLEREAR 62
Query: 95 AL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
L H P V+L S+ +L+ + + GG++ I A E A+ +++
Sbjct: 63 ICRLLKH-PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 121
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQAPHCPI 184
A+ + H G++HR+LKP+N+L++++ +
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAV 152
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 40/139 (28%), Positives = 60/139 (43%), Gaps = 5/139 (3%)
Query: 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHSPFCV 105
+ GA +V Q YA+K+++K + S+V RE L +
Sbjct: 19 DVLGEGAHARVQTCINLITS-QEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVL 74
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIH 165
+L + +LV E M GG + S I E A+ +V AL +LH+ GI H
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAH 134
Query: 166 RDLKPDNMLISAQAPHCPI 184
RDLKP+N+L P+
Sbjct: 135 RDLKPENILCEHPNQVSPV 153
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 56/178 (31%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 36 KAPEISDF-EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
+SDF E+ + RGA V+ +K + YA+KV+KK V E
Sbjct: 47 NRDALSDFFEVESELGRGATSIVYRCKQKGT-QKPYALKVLKK-----TVDKKIVRTEIG 100
Query: 95 AL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
L L+H P ++L +T + + LV+E + GG++ I G E AA +++
Sbjct: 101 VLLRLSH-PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE 159
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLEISDLVNGTP 210
A+ YLH +GI+HRDLKP+N+L + AP P+ F L+ + + V + + GTP
Sbjct: 160 AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVC-GTP 214
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 32/144 (22%), Positives = 69/144 (47%), Gaps = 6/144 (4%)
Query: 35 LKAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRER 93
+K + D ++I++ + GAFG V +K +++ K + ++K V E
Sbjct: 44 VKQGSVYDYYDILEELGSGAFGVVHRCVEKATG-RVFVAKFINTPYPLDKYTV---KNEI 99
Query: 94 NALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGD-VKSLIAANGALPEDMAAFYAAEVV 152
+ + H P + L + + + L++E++ GG+ + A + + E Y +
Sbjct: 100 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 159
Query: 153 LALQYLHSHGIIHRDLKPDNMLIS 176
L+++H H I+H D+KP+N++
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCE 183
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 39/178 (21%), Positives = 68/178 (38%), Gaps = 43/178 (24%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM--INKNMVSQVLRERNALAL 98
+ + AI +G++G V + + + + AIK+M K+++ IN V ++ E +
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTR-AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG--------------------- 137
H P +L+ + + LVME GG + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 138 -------------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
E + + ++ AL YLH+ GI HRD+KP+N L S
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS 202
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 37/142 (26%), Positives = 64/142 (45%), Gaps = 6/142 (4%)
Query: 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
P+ + + I +GA G V+ Q AI+ M + K ++ E +
Sbjct: 18 PK-KKYTRFEKIGQGASGTVYTAMDVATG-QEVAIRQMNLQQQPKKELIIN---EILVMR 72
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
+P V S +++VMEY+ GG + ++ + E A E + AL++
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEF 131
Query: 158 LHSHGIIHRDLKPDNMLISAQA 179
LHS+ +IHRD+K DN+L+
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDG 153
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 33/149 (22%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 35 LKAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRER 93
+K + D ++I + + GAFG V ++ +A K + +K V +E
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATG-NNFAAKFVMTPHESDKETV---RKEI 205
Query: 94 NALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGD-VKSLIAANGALPEDMAAFYAAEVV 152
+++ P V L + + + + ++ E+M GG+ + + + + ED A Y +V
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 153 LALQYLHSHGIIHRDLKPDNMLISAQAPH 181
L ++H + +H DLKP+N++ + + +
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSN 294
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 21/174 (12%)
Query: 18 ITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK- 76
+ + + SL ++ S L+ P FE+V+ + G +G+V+ G QL AIKVM
Sbjct: 2 MASDSPARSLDEIDLSALRDPA-GIFELVELVGNGTYGQVYKGRHVKTG-QLAAIKVMDV 59
Query: 77 ---KDEMINKNMVSQVLRERNALALTHSPFCVQLF------YSLQTSSCVFLVMEYMIGG 127
++E I + + +L++ +H + ++LVME+ G
Sbjct: 60 TGDEEEEIKQEI--NMLKK-----YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAG 112
Query: 128 DVKSLI--AANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA 179
V LI L E+ A+ E++ L +LH H +IHRD+K N+L++ A
Sbjct: 113 SVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA 166
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 34/152 (22%), Positives = 64/152 (42%), Gaps = 10/152 (6%)
Query: 36 KAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
+ + +D +E+ + I G++ K +A+K+ I+K+ E
Sbjct: 16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATN-MEFAVKI------IDKSKRD-PTEEIE 67
Query: 95 ALA-LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
L P + L V++V E M GG++ I E A+ +
Sbjct: 68 ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITK 127
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185
++YLH+ G++HRDLKP N+L ++ + +
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESI 159
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 58/325 (17%), Positives = 109/325 (33%), Gaps = 79/325 (24%)
Query: 36 KAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN------KNMVSQ 88
+ +E + + RG V K + YA+K++ + + +
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKE-YAVKIIDVTGGGSFSAEEVQELREA 69
Query: 89 VLRERNAL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFY 147
L+E + L ++ P +QL + +T++ FLV + M G++ + L E
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 148 AAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLEISDLV 206
++ + LH I+HRDLKP+N+L+ I T F + P L ++
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKL--REVC 184
Query: 207 NGTPN-----------AFNIRTPGQ-------------LLSLKTGTFP--------TFQD 234
GTP+ N G+ LL+ G+ P +
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA---GSPPFWHRKQMLMLRM 240
Query: 235 VQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE-DEEALNPSTEETILALLKSDPTQRPS 293
+ + F S EW + + + + L P +R +
Sbjct: 241 IMSGNYQFGSP------------------EWDDYSDTVKD-----LVSRFLVVQPQKRYT 277
Query: 294 GHQVRRLPMFKDYDWDSILDQEPPF 318
+ P F+ Y + + F
Sbjct: 278 AEEALAHPFFQQYVVEEV----RHF 298
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 31/149 (20%), Positives = 55/149 (36%), Gaps = 17/149 (11%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHS 101
K + G+ G V + A+K M D L E L
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRP--VAVKRMLID------FCDIALMEIKLLTESDDH 68
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAE-------VVLA 154
P ++ + S T +++ +E +++ L+ + E++ +
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 155 LQYLHSHGIIHRDLKPDNMLISAQAPHCP 183
+ +LHS IIHRDLKP N+L+S +
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTA 156
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 18/177 (10%), Positives = 47/177 (26%), Gaps = 34/177 (19%)
Query: 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
+ + + + + + V E N + Q+ E
Sbjct: 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETG-ESFEVHVPYFTERPPSNAIKQMKEEVL 125
Query: 95 A-------------------------LALTHSPFCVQLFYSLQTSSC--VFLVMEYM--- 124
+ +++ + F + M
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 125 ---IGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
G + S + + +L +V+ L LH +G++H L+P ++++ +
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR 242
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 39/180 (21%), Positives = 68/180 (37%), Gaps = 8/180 (4%)
Query: 8 SGADKENILEITNKASENSLCDVSKSCLKAPEISD-FEIVKAISRGAFGKVFLGYKKTNK 66
D + D A E ++ I RG V +
Sbjct: 60 KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119
Query: 67 DQLYAIKVMKKDEMINK-----NMVSQVLRERNAL-ALTHSPFCVQLFYSLQTSSCVFLV 120
+A+K+M+ + RE + L + P + L S ++SS +FLV
Sbjct: 120 -HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP 180
+ M G++ + AL E ++ A+ +LH++ I+HRDLKP+N+L+
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ 238
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 3/135 (2%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRE-RNALALTHS 101
++IV + G V+L + T + AIK + + + + RE N+ L+H
Sbjct: 13 YKIVDKLGGGGMSTVYLA-EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH- 70
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
V + + C +LVMEY+ G + I ++G L D A + +++ +++ H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 162 GIIHRDLKPDNMLIS 176
I+HRD+KP N+LI
Sbjct: 131 RIVHRDIKPQNILID 145
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 34/142 (23%), Positives = 68/142 (47%), Gaps = 6/142 (4%)
Query: 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
P + I G+ G V L +K + + A+K+M + + ++ E +
Sbjct: 43 PR-LLLDSYVKIGEGSTGIVCLAREKHSG-RQVAVKMMDLRKQQRRELLFN---EVVIMR 97
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
V+++ S ++++ME++ GG + +++ L E+ A V+ AL Y
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAY 156
Query: 158 LHSHGIIHRDLKPDNMLISAQA 179
LH+ G+IHRD+K D++L++
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDG 178
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 37/138 (26%), Positives = 70/138 (50%), Gaps = 7/138 (5%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
F++++ + G++G V+ K Q+ AIK + + + + +++E + + SP
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETG-QIVAIKQVPVESDLQE-----IIKEISIMQQCDSP 84
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLALQYLHSH 161
V+ + S ++ +++VMEY G V +I N L ED A + L+YLH
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 162 GIIHRDLKPDNMLISAQA 179
IHRD+K N+L++ +
Sbjct: 145 RKIHRDIKAGNILLNTEG 162
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 7/150 (4%)
Query: 31 SKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVL 90
S E + + +G +G V+ G +N+ AIK + + + +
Sbjct: 12 SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQ-VRIAIKEIPER---DSRYSQPLH 67
Query: 91 RERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-GALP--EDMAAFY 147
E VQ S + + + ME + GG + +L+ + G L E FY
Sbjct: 68 EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127
Query: 148 AAEVVLALQYLHSHGIIHRDLKPDNMLISA 177
+++ L+YLH + I+HRD+K DN+LI+
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINT 157
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 34/137 (24%), Positives = 64/137 (46%), Gaps = 6/137 (4%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
+ I + + RG FG V + ++K + Y K +K V +E + L +
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSK-KTYMAKFVKV----KGTDQVLVKKEISILNIAR 59
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDV-KSLIAANGALPEDMAAFYAAEVVLALQYLH 159
+ L S ++ + ++ E++ G D+ + + + L E Y +V ALQ+LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 160 SHGIIHRDLKPDNMLIS 176
SH I H D++P+N++
Sbjct: 120 SHNIGHFDIRPENIIYQ 136
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 32/160 (20%), Positives = 68/160 (42%), Gaps = 14/160 (8%)
Query: 36 KAPEI--SDFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVL-- 90
+ P + ++ E K I +G FG V G K AIK + + + + +
Sbjct: 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSV--VAIKSLILGDSEGETEMIEKFQE 69
Query: 91 --RERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIA-ANGALPEDMAAFY 147
RE ++ + P V+L+ + +VME++ GD+ + + +
Sbjct: 70 FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRL 127
Query: 148 AAEVVLALQYLHSHG--IIHRDLKPDNMLISAQAPHCPIV 185
++ L ++Y+ + I+HRDL+ N+ + + + P+
Sbjct: 128 MLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC 167
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 17/157 (10%)
Query: 36 KAPEISDFEIV-KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
K I D+++ + + G GKV + K + + +A+K+++ RE
Sbjct: 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQ-EKFALKMLQDCPK--------ARREVE 62
Query: 95 AL-ALTHSPFCVQLF--Y--SLQTSSCVFLVMEYMIGGDVKSLIAANGALP--EDMAAFY 147
+ P V++ Y C+ +VME + GG++ S I G E A+
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 148 AAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPI 184
+ A+QYLHS I HRD+KP+N+L +++ P+ +
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 159
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 32/134 (23%), Positives = 63/134 (47%), Gaps = 5/134 (3%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
+ + G FG+V + A K++K M +K V E + +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATG-LKLAAKIIKTRGMKDKEEV---KNEISVMNQLDH 145
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDV-KSLIAANGALPEDMAAFYAAEVVLALQYLHS 160
+QL+ + ++ + + LVMEY+ GG++ +I + L E + ++ ++++H
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 161 HGIIHRDLKPDNML 174
I+H DLKP+N+L
Sbjct: 206 MYILHLDLKPENIL 219
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
I + E+ + + RGAFG V + + AIK ++ + + E L
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKA---KWRAKDVAIKQIESESERK-----AFIVELRQL 55
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG---ALPEDMAAFYAAEVVL 153
+ + P V+L+ + C LVMEY GG + +++ A + +
Sbjct: 56 SRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 154 ALQYLHSH---GIIHRDLKPDNMLISAQAPHCPI 184
+ YLHS +IHRDLKP N+L+ A I
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI 147
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 5e-24
Identities = 41/328 (12%), Positives = 77/328 (23%), Gaps = 92/328 (28%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
++V+ + G VFL + +A+KV +++ + ++ A A
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERL-EDFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 102 PFCVQLF--------------------------YSLQTSSCVFLVMEYMIG------GDV 129
+ + L+M +
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 130 KSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ----------- 178
+ G A+++ L S G++H PDN+ I
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 179 ----APHCPIVNTLFLA----ILQQPIVYLEISD-----------LVNGTPNAFNIRTPG 219
+ A + + + P F + TPG
Sbjct: 242 WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--FGLVTPG 299
Query: 220 QLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEET 279
S K P+ + F S + P+ + L
Sbjct: 300 IKGSWK---RPSLRVPGTDSLAFGSCTPL-----------------PDFVKTL------- 332
Query: 280 ILALLKSDPTQRPSGHQVRRLPMFKDYD 307
I L D +R + P F
Sbjct: 333 IGRFLNFDRRRRLLPLEAMETPEFLQLQ 360
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 41/176 (23%), Positives = 73/176 (41%), Gaps = 18/176 (10%)
Query: 18 ITNKASENSLCDVSKSCLKAPEISD-FEIVK-AISRGAFGKVFLGYKKTNKDQLYAIKVM 75
+ S K ++D +++ K + G GKV + + Q A+K++
Sbjct: 4 HHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTG-QKCALKLL 62
Query: 76 KKDEMINKNMVSQVLRERNAL-ALTHSPFCVQL--FY--SLQTSSCVFLVMEYMIGGDVK 130
+E + + P V + Y C+ ++ME M GG++
Sbjct: 63 YDSPK--------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF 114
Query: 131 SLIAANGALP--EDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPI 184
S I G E AA ++ A+Q+LHSH I HRD+KP+N+L +++ +
Sbjct: 115 SRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLY----AIKVMKKDEMINKNMVSQVLRE-RNALA 97
+E+ + + G +V L +D A+KV++ D + + + RE +NA A
Sbjct: 14 YELGEILGFGGMSEVHLA-----RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 98 LTHSPFCVQLF----YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
L H P V ++ ++VMEY+ G ++ ++ G + A A+
Sbjct: 69 LNH-PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 154 ALQYLHSHGIIHRDLKPDNMLIS 176
AL + H +GIIHRD+KP N++IS
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMIS 150
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 37/167 (22%), Positives = 71/167 (42%), Gaps = 8/167 (4%)
Query: 17 EITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK 76
E N+ ++ +K+ + + + I RG+F V+ G A ++
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETT-VEVAWCELQ 60
Query: 77 KDEMINKNMVSQVLRERNALALTHSPFCVQLFYS----LQTSSCVFLVMEYMIGGDVKSL 132
+ + K+ + E L P V+ + S ++ C+ LV E M G +K+
Sbjct: 61 DRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY 119
Query: 133 IAANGALPEDMAAFYAAEVVLALQYLHSHG--IIHRDLKPDNMLISA 177
+ + + + +++ LQ+LH+ IIHRDLK DN+ I+
Sbjct: 120 LKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 166
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 34/136 (25%), Positives = 67/136 (49%), Gaps = 3/136 (2%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRE-RNALALTHS 101
+ + + + RG G V+ T ++++ A+K+M + + +++ RE R A L
Sbjct: 36 YRLRRLVGRGGMGDVYEAED-TVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE- 93
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
P V + + +++ M + G D+ +++ G L A ++ AL H+
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 162 GIIHRDLKPDNMLISA 177
G HRD+KP+N+L+SA
Sbjct: 154 GATHRDVKPENILVSA 169
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 6e-23
Identities = 38/140 (27%), Positives = 66/140 (47%), Gaps = 11/140 (7%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LTHS 101
+E+ I+ G G ++L + + +K + + + + ER LA + H
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVH- 138
Query: 102 PFCVQLF-----YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQ 156
P VQ+F ++VMEY+ G +K LP A Y E++ AL
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALS 196
Query: 157 YLHSHGIIHRDLKPDNMLIS 176
YLHS G+++ DLKP+N++++
Sbjct: 197 YLHSIGLVYNDLKPENIMLT 216
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 37/145 (25%), Positives = 64/145 (44%), Gaps = 11/145 (7%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
+I D I + I G+FG V A+K++ + + + V++ LRE +
Sbjct: 33 DIPWCDLNIKEKIGAGSFGTVHRA---EWHGSDVAVKILMEQDF-HAERVNEFLREVAIM 88
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGA---LPEDMAAFYAAEVVL 153
P V ++ + +V EY+ G + L+ +GA L E A +V
Sbjct: 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 154 ALQYLHSHG--IIHRDLKPDNMLIS 176
+ YLH+ I+HR+LK N+L+
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVD 173
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 1e-22
Identities = 20/168 (11%), Positives = 47/168 (27%), Gaps = 34/168 (20%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL---T 99
+ + + + + + V E N + Q+ E L L
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQET-GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 100 HSPFCVQLFYSLQTSSCV------------------------FLVMEYM------IGGDV 129
+ ++ + F + M G +
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 130 KSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177
S + + +L +V+ L LH +G++H L+P ++++
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ 246
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 36 KAPEISDFEIV-KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
K I D+++ + + G GKV + K +++ +A+K+++ RE
Sbjct: 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK-FALKMLQDCPK--------ARREVE 106
Query: 95 AL-ALTHSPFCVQL--FY--SLQTSSCVFLVMEYMIGGDVKSLIAANGALP--EDMAAFY 147
+ P V++ Y C+ +VME + GG++ S I G E A+
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 148 AAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPI 184
+ A+QYLHS I HRD+KP+N+L +++ P+ +
Sbjct: 167 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 203
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-22
Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 10/154 (6%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN-KNMVSQVLRERNA 95
EI ++ + + I G FGKV+ A+K + D + + V +E
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRA---FWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
A+ P + L + LVME+ GG + +++ +P D+ +A ++ +
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGM 118
Query: 156 QYLHSHG---IIHRDLKPDNMLISAQAPHCPIVN 186
YLH IIHRDLK N+LI + + + N
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 39/190 (20%), Positives = 69/190 (36%), Gaps = 25/190 (13%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHS 101
+ + ++ G F V+ + + YA+K + + + +++E + L+
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSG-REYALKRLLSN---EEEKNRAIIQEVCFMKKLSGH 85
Query: 102 PFCVQLFYSLQTSSC--------VFLVMEYMIGGDVKSLI--AANGALPEDMAAFYAAEV 151
P VQ + L+ E G V+ L + G L D +
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 152 VLALQYLHSHG--IIHRDLKPDNMLISAQAP--------HCPIVNTLFLAILQQPIVYLE 201
A+Q++H IIHRDLK +N+L+S Q I + + Q +E
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 202 ISDLVNGTPN 211
N TP
Sbjct: 206 EEITRNTTPM 215
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-21
Identities = 31/141 (21%), Positives = 55/141 (39%), Gaps = 11/141 (7%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
EI + + I G+FG V+ G + A+K++ + E
Sbjct: 20 EIPDGQITVGQRIGSGSFGTVYKGKWHGD-----VAVKMLNVTAP-TPQQLQAFKNEVGV 73
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLA 154
L T + LF T+ + +V ++ G + + A+ A +
Sbjct: 74 LRKTRHV-NILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 155 LQYLHSHGIIHRDLKPDNMLI 175
+ YLH+ IIHRDLK +N+ +
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFL 153
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 37/142 (26%), Positives = 63/142 (44%), Gaps = 12/142 (8%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+I EI + I +G FG+V+ G + AI+++ + N++ + RE A
Sbjct: 29 DIPFEQLEIGELIGKGRFGQVYHGRWHGE-----VAIRLIDIERD-NEDQLKAFKREVMA 82
Query: 96 LALTHSPFCVQLFYSLQTSS-CVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVL 153
T V LF S + ++ G + S++ A L + A E+V
Sbjct: 83 YRQTRHE-NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVK 141
Query: 154 ALQYLHSHGIIHRDLKPDNMLI 175
+ YLH+ GI+H+DLK N+
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFY 163
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-20
Identities = 34/145 (23%), Positives = 64/145 (44%), Gaps = 15/145 (10%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKK-DEMINKNMVS--QVLRE 92
SD + + +G FG+ +++T + +K + + DE + + +V+R
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEV--MVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 93 RNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEV 151
L H P ++ L + + EY+ GG ++ +I + + P +A ++
Sbjct: 64 -----LEH-PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDI 117
Query: 152 VLALQYLHSHGIIHRDLKPDNMLIS 176
+ YLHS IIHRDL N L+
Sbjct: 118 ASGMAYLHSMNIIHRDLNSHNCLVR 142
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 20/145 (13%), Positives = 51/145 (35%), Gaps = 12/145 (8%)
Query: 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL 98
+ + ++ G+++ G + +KV+K + + E L +
Sbjct: 8 DFKQLNFLTKLNENHSGELWKG---RWQGNDIVVKVLKVRD-WSTRKSRDFNEECPRLRI 63
Query: 99 THSPFCVQLFY--SLQT-SSCVFLVMEYMIGGDVKSLI--AANGALPEDMAAFYAAEVVL 153
P V + L+ +M G + +++ N + + A +A ++
Sbjct: 64 FSHP-NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 154 ALQYLHSHG--IIHRDLKPDNMLIS 176
+ +LH+ I L +++I
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMID 147
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 3e-19
Identities = 38/142 (26%), Positives = 70/142 (49%), Gaps = 13/142 (9%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK---KDEMINKNMVSQVLRERNAL 96
+ ++ ++ + G +G V+ ++ A+K ++ +DE I S +RE + L
Sbjct: 20 MEKYQKLEKVGEGTYGVVYKAKDSQG--RIVALKRIRLDAEDEGIP----STAIREISLL 73
Query: 97 -ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLA 154
L H P V L + + C+ LV E+M D+K ++ L + Y +++
Sbjct: 74 KELHH-PNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 155 LQYLHSHGIIHRDLKPDNMLIS 176
+ + H H I+HRDLKP N+LI+
Sbjct: 132 VAHCHQHRILHRDLKPQNLLIN 153
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 4e-19
Identities = 38/142 (26%), Positives = 69/142 (48%), Gaps = 13/142 (9%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK---KDEMINKNMVSQVLRERNAL 96
+ + ++ I G +G V+ + +A+K ++ +DE I S +RE + L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYG--ETFALKKIRLEKEDEGIP----STTIREISIL 54
Query: 97 -ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLA 154
L H V+L+ + T + LV E++ D+K L+ G L A + +++
Sbjct: 55 KELKH-SNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 155 LQYLHSHGIIHRDLKPDNMLIS 176
+ Y H ++HRDLKP N+LI+
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLIN 134
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 39/142 (27%), Positives = 60/142 (42%), Gaps = 12/142 (8%)
Query: 42 DFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKK---DEMINKNMVSQVLRERNALA 97
+E + I G++G VF + T Q+ AIK + D +I LRE L
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTG--QIVAIKKFLESEDDPVIK----KIALREIRMLK 57
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLALQ 156
P V L + + LV EY V + +PE + + + A+
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 157 YLHSHGIIHRDLKPDNMLISAQ 178
+ H H IHRD+KP+N+LI+
Sbjct: 117 FCHKHNCIHRDVKPENILITKH 138
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 17/136 (12%), Positives = 46/136 (33%), Gaps = 5/136 (3%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRE-RNALALTHS 101
+ ++ + + T D+ A+ + ++ +++ + L +
Sbjct: 33 YRLLIFHGGVPPLQFWQALD-TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK- 90
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
P ++ + T + +V E++ GG ++ + P A + A H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVG-AIRAMQSLAAAADAAHRA 148
Query: 162 GIIHRDLKPDNMLISA 177
G+ P + +S
Sbjct: 149 GVALSIDHPSRVRVSI 164
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 31/146 (21%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK---KDEMINKNMVSQVLRERNAL 96
I + + + G +G+V+ ++ AIK ++ ++E + +RE + L
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVT-NETVAIKRIRLEHEEEGVP----GTAIREVSLL 87
Query: 97 -ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
L H ++L + + + L+ EY D+K + N + + + +++ +
Sbjct: 88 KELQH-RNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPH 181
+ HS +HRDLKP N+L+S
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDAS 171
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 41/138 (29%), Positives = 66/138 (47%), Gaps = 13/138 (9%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALT 99
D+++V+ + RG + +VF TN ++ +K++K + ++ RE L L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITN-NEKVVVKILKPVKK------KKIKREIKILENLR 88
Query: 100 HSPFCVQLF--YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
P + L S LV E++ D K L L + FY E++ AL Y
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 145
Query: 158 LHSHGIIHRDLKPDNMLI 175
HS GI+HRD+KP N++I
Sbjct: 146 CHSMGIMHRDVKPHNVMI 163
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 33/141 (23%), Positives = 59/141 (41%), Gaps = 10/141 (7%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK---KDEMINKNMVSQVLRERNALAL 98
+E + + G++G V K ++ AIK D+M+ +RE L
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTG-RIVAIKKFLESDDDKMVK----KIAMREIKLLKQ 80
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLALQY 157
V L + +LV E++ + + L + Y +++ + +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 158 LHSHGIIHRDLKPDNMLISAQ 178
HSH IIHRD+KP+N+L+S
Sbjct: 140 CHSHNIIHRDIKPENILVSQS 160
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 41/143 (28%), Positives = 76/143 (53%), Gaps = 13/143 (9%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK---KDEMINKNMVSQVLRERNAL 96
+ +F+ V+ I G +G V+ K ++ A+K ++ + E + S +RE + L
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP----STAIREISLL 56
Query: 97 -ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGA--LPEDMAAFYAAEVVL 153
L H P V+L + T + ++LV E++ D+K + A+ +P + Y +++
Sbjct: 57 KELNH-PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 154 ALQYLHSHGIIHRDLKPDNMLIS 176
L + HSH ++HRDLKP N+LI+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLIN 137
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 40/142 (28%), Positives = 69/142 (48%), Gaps = 12/142 (8%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK---KDEMINKNMVSQVLRERNAL 96
+ +E ++ I G +G VF + ++ A+K ++ DE + S LRE L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRET-HEIVALKRVRLDDDDEGVP----SSALREICLL 55
Query: 97 -ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLA 154
L H V+L L + + LV E+ D+K + NG L ++ + +++
Sbjct: 56 KELKH-KNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 155 LQYLHSHGIIHRDLKPDNMLIS 176
L + HS ++HRDLKP N+LI+
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLIN 135
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 38/147 (25%), Positives = 70/147 (47%), Gaps = 16/147 (10%)
Query: 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK--KDEMINKNMVSQVLRERNAL 96
S F+ ++ + G + V+ G KT A+K +K +E S +RE + +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTT-GVYVALKEVKLDSEEGTP----STAIREISLM 57
Query: 97 -ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI------AANGALPEDMAAFYAA 149
L H V+L+ + T + + LV E+M D+K + L ++ ++
Sbjct: 58 KELKH-ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLIS 176
+++ L + H + I+HRDLKP N+LI+
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLIN 142
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 38/145 (26%), Positives = 66/145 (45%), Gaps = 24/145 (16%)
Query: 43 FEIVKAISRGAFGKVFLGY-KKTNKDQLYAIKVMKKD-EMINKNMVSQVLRERNALALTH 100
+ K I G+FG VF ++++ AIK + +D N+ + Q++R + H
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE---VAIKKVLQDKRFKNREL--QIMRI-----VKH 91
Query: 101 SPFCVQLFYSLQTSS------CVFLVMEYMIGGDVKSLI----AANGALPEDMAAFYAAE 150
P V L ++ + LV+EY+ V +P + Y +
Sbjct: 92 -PNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 151 VVLALQYLHSHGIIHRDLKPDNMLI 175
++ +L Y+HS GI HRD+KP N+L+
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLL 174
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 23/164 (14%), Positives = 59/164 (35%), Gaps = 5/164 (3%)
Query: 17 EITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK 76
I E + V + ++ IV+ A+ + + D+++
Sbjct: 38 RIRLPNRELAREKVMREVKALAKLEHPGIVRYF--NAWLETPPEKWQEEMDEIWLKDEST 95
Query: 77 KDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN 136
+ + + + + + + V +++ M+ ++K +
Sbjct: 96 DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155
Query: 137 GAL---PEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177
+L + ++ A+++LHS G++HRDLKP N+ +
Sbjct: 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM 199
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 24/84 (28%), Positives = 36/84 (42%), Gaps = 3/84 (3%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
+DFE ++ + RG FG VF K + YAIK ++ +V+RE ALA
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDD-CNYAIKRIRLPNRELARE--KVMREVKALAKLE 62
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYM 124
P V+ F + + E
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMD 86
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 38/147 (25%), Positives = 61/147 (41%), Gaps = 21/147 (14%)
Query: 43 FEIVKAISRGAFGKVFLGY-KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
+ K I G+FG V+ + +L AIK + +D+ RE +
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSG--ELVAIKKVLQDKRFK-------NRELQIMRKLDH 106
Query: 102 PFCVQLFYSLQTSS------CVFLVMEYMIGGDVKSLI----AANGALPEDMAAFYAAEV 151
V+L Y +S + LV++Y+ V + A LP Y ++
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 152 VLALQYLHSHGIIHRDLKPDNMLISAQ 178
+L Y+HS GI HRD+KP N+L+
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPD 192
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 35/141 (24%), Positives = 61/141 (43%), Gaps = 11/141 (7%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKV--MKKDEMINKNMVSQVLRERNAL- 96
+ + + + G + V+ G K D L A+K ++ +E +RE + L
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLT-DNLVALKEIRLEHEEGAP----CTAIREVSLLK 55
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLAL 155
L H V L + T + LV EY+ D+K + + + +++ L
Sbjct: 56 DLKH-ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 156 QYLHSHGIIHRDLKPDNMLIS 176
Y H ++HRDLKP N+LI+
Sbjct: 114 AYCHRQKVLHRDLKPQNLLIN 134
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 37/152 (24%), Positives = 65/152 (42%), Gaps = 16/152 (10%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK--KDEMINKNMVSQVLRERNAL- 96
S +E V I GA+G V+ + A+K ++ + +RE L
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHS-GHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 97 ---ALTHSPFCVQLF-----YSLQTSSCVFLVMEYMIGGDVKSLIAANGA--LPEDMAAF 146
A H P V+L V LV E++ D+++ + LP +
Sbjct: 67 RLEAFEH-PNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKD 124
Query: 147 YAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
+ + L +LH++ I+HRDLKP+N+L+++
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSG 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 29/158 (18%), Positives = 60/158 (37%), Gaps = 25/158 (15%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+ + K I G FG ++L + ++ A V+K + N + E
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEK-DARHVVKVEYQEN----GPLFSELKFYQRVAKK 93
Query: 103 FCVQLFYSLQTSSCV-------------------FLVMEYMIGGDVKSLIAANGALPEDM 143
C++ + + + F+VME + G D++ + NG +
Sbjct: 94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKST 152
Query: 144 AAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH 181
++ L+Y+H + +H D+K N+L+ + P
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 33/135 (24%), Positives = 61/135 (45%), Gaps = 9/135 (6%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHS 101
+++ + I G+FG +F G N Q AIK + ++ Q+ E L
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNN-QQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 65
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHS 160
++Y Q LV++ ++G ++ L+ G A A +++ +Q +H
Sbjct: 66 TGIPNVYYFGQEGLHNVLVID-LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 161 HGIIHRDLKPDNMLI 175
+++RD+KPDN LI
Sbjct: 125 KSLVYRDIKPDNFLI 139
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 40/141 (28%), Positives = 63/141 (44%), Gaps = 7/141 (4%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKV--MKKDEMINKNMVSQVLRERNAL- 96
+E + + G F V+ K +Q+ AIK + + LRE L
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNT-NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLAL 155
L+H P + L + S + LV ++M D++ +I N L Y + L
Sbjct: 68 ELSH-PNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 156 QYLHSHGIIHRDLKPDNMLIS 176
+YLH H I+HRDLKP+N+L+
Sbjct: 126 EYLHQHWILHRDLKPNNLLLD 146
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 30/135 (22%), Positives = 55/135 (40%), Gaps = 9/135 (6%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHS 101
+ + + I G+FG ++LG + AIK+ K Q+ E +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAG-EEVAIKLECV-----KTKHPQLHIESKIYKMMQGG 64
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHS 160
+ + +VME ++G ++ L A +++ ++Y+HS
Sbjct: 65 VGIPTIRWCGAEGDYNVMVME-LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 161 HGIIHRDLKPDNMLI 175
IHRD+KPDN L+
Sbjct: 124 KNFIHRDVKPDNFLM 138
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 39/160 (24%), Positives = 66/160 (41%), Gaps = 14/160 (8%)
Query: 27 LCDVSKSCLKAP------EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKD 78
L S L + D + + I RG FG+VF G + + A+K ++
Sbjct: 92 LTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTL-VAVKSCRET 150
Query: 79 EMINKNMVSQVLRERNAL-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG 137
++ ++ L+E L +H P V+L +++VME + GGD + + G
Sbjct: 151 LP--PDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG 207
Query: 138 -ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
L + ++YL S IHRDL N L++
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT 247
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-16
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 16/151 (10%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMV-SQVLRERNAL-- 96
+E V I GA+GKVF N + A+K ++ + + +RE L
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT--GEEGMPLSTIREVAVLRH 67
Query: 97 --ALTHSPFCVQLF-----YSLQTSSCVFLVMEYMIGGDVKSLI--AANGALPEDMAAFY 147
H P V+LF + + LV E++ D+ + + +P +
Sbjct: 68 LETFEH-PNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM 125
Query: 148 AAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
+++ L +LHSH ++HRDLKP N+L+++
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSS 156
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 25/164 (15%), Positives = 61/164 (37%), Gaps = 34/164 (20%)
Query: 43 FEIVKAISRGAFGKVFLGY-------KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
+++ +R G ++ + Q +++K+ KD ++ E+N
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNF 95
Query: 96 LALTHSPFCVQLFYSLQTSSCV----------------FLVMEYMIGGDVKSLIAANG-- 137
P V + L ++ + FLV+ + G ++S + +
Sbjct: 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKH 154
Query: 138 ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH 181
L E A ++ AL++LH + +H ++ +N+ + +
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS 198
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 36/140 (25%), Positives = 63/140 (45%), Gaps = 6/140 (4%)
Query: 41 SDFEIVKAISRGAFGKVFLG-YKKTNKDQLY-AIKVMKKDEMINKNMVSQVLRERNALA- 97
D +++ + G+FG V G + + + A+K +K D + + +RE NA+
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLALQ 156
L H ++L Y + + + +V E G + L G + YA +V +
Sbjct: 78 LDH-RNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 157 YLHSHGIIHRDLKPDNMLIS 176
YL S IHRDL N+L++
Sbjct: 136 YLESKRFIHRDLAARNLLLA 155
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 21/153 (13%)
Query: 43 FEIVKA-ISRGAFGKVFLGYKKTNK-DQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALT 99
FE + RG +G V+ +K K D+ YA+K ++ + RE L L
Sbjct: 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-----GISMSACREIALLRELK 76
Query: 100 HSPFCVQLF--YSLQTSSCVFLVMEYMIGGDVKSLI---------AANGALPEDMAAFYA 148
H P + L + V+L+ +Y D+ +I LP M
Sbjct: 77 H-PNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 149 AEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH 181
+++ + YLH++ ++HRDLKP N+L+ + P
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPE 167
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 32/134 (23%), Positives = 61/134 (45%), Gaps = 5/134 (3%)
Query: 47 KAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LTHSPFC 104
K + G FG V G Y+ + A+K++K + + + ++L E N + L + P+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDN-PYI 80
Query: 105 VQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGII 164
V++ + + LVME G + + N + + +V + ++YL +
Sbjct: 81 VRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 165 HRDLKPDNMLISAQ 178
HRDL N+L+ Q
Sbjct: 140 HRDLAARNVLLVTQ 153
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 27/163 (16%), Positives = 59/163 (36%), Gaps = 32/163 (19%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKD----QLYAIKVMKKDEMINKNMVSQVLRERNALAL 98
+++ I +G FG ++L +++ +KV D + E
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD-------NGPLFTELKFYQR 89
Query: 99 THSPFCVQLFYSLQTSSCV-------------------FLVMEYMIGGDVKSLIAANG-A 138
P +Q + + + F++M+ G D++ + AN
Sbjct: 90 AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKR 148
Query: 139 LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH 181
+ ++ L+Y+H H +H D+K N+L++ + P
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 36/147 (24%), Positives = 64/147 (43%), Gaps = 18/147 (12%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ-VLRE------- 92
+EI I G++G V Y K K + AIK K + + + +LRE
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVV-AIK--KILRVFEDLIDCKRILREIAILNRL 109
Query: 93 --RNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAE 150
+ + + + + ++ +++V+E D K L L E
Sbjct: 110 NHDHVVKVLD----IVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYN 164
Query: 151 VVLALQYLHSHGIIHRDLKPDNMLISA 177
+++ ++Y+HS GI+HRDLKP N L++
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQ 191
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 34/150 (22%), Positives = 62/150 (41%), Gaps = 11/150 (7%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHS 101
F + K I G FG++ LG + AIK+ K+ Q+ E L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEY-VAIKLEP-----MKSRAPQLHLEYRFYKQLGSG 64
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHS 160
Q++Y +V+E ++G ++ L + A +++ ++Y+HS
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLE-LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 161 HGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190
+I+RD+KP+N LI P + +
Sbjct: 124 KNLIYRDVKPENFLIG--RPGNKTQQVIHI 151
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 33/147 (22%), Positives = 60/147 (40%), Gaps = 11/147 (7%)
Query: 36 KAPEI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRER 93
A EI + + +G FG+V++G AIK +K M + L+E
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAF----LQEA 230
Query: 94 NALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAF--YAAEV 151
+ VQL Y++ + +++V EYM G + + + AA++
Sbjct: 231 QVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 289
Query: 152 VLALQYLHSHGIIHRDLKPDNMLISAQ 178
+ Y+ +HRDL+ N+L+
Sbjct: 290 ASGMAYVERMNYVHRDLRAANILVGEN 316
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 30/167 (17%), Positives = 64/167 (38%), Gaps = 35/167 (20%)
Query: 43 FEIVKAISRGAFGKVFLGY----------KKTNKDQLYA---IKVMK------------- 76
+ + K + G+FG V + KK +D Y + +MK
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 77 ----KDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSL 132
DE + + + + + + ++MEY+ + +
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKV 127
Query: 133 I----AANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI 175
+ + ++P ++ + Y ++ A+ ++HS GI HRD+KP N+L+
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 40/154 (25%), Positives = 67/154 (43%), Gaps = 25/154 (16%)
Query: 38 PEISDFEIVKAISRGAFGKVFLGY-KKTNKDQLYAIKVMKK--DEMINKNMVSQVLRERN 94
E+ F++ + +G FG V LG K T AIK K + +N Q++++
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTG--MSVAIK---KVIQDPRFRNRELQIMQD-- 72
Query: 95 ALALTHSPFCVQLFYSLQTSS-------CVFLVMEYMIGGDVKSLI----AANGALPEDM 143
LA+ H P VQL T + +VMEY+ + A P +
Sbjct: 73 -LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130
Query: 144 AAFYAAEVVLALQYLH--SHGIIHRDLKPDNMLI 175
+ +++ ++ LH S + HRD+KP N+L+
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV 164
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 37/172 (21%), Positives = 62/172 (36%), Gaps = 30/172 (17%)
Query: 23 SENSLCDVSKSCL--KAPEI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKD 78
E S S S L ++VK I +G +G+V++G + + A+KV
Sbjct: 15 IEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMG---KWRGEKVAVKVFFTT 71
Query: 79 EMINKNMVSQVLRERN--ALALTHSPFCVQLFY-----SLQTSSCVFLVMEYMIGGDVKS 131
E + RE L + F + + ++L+ +Y G +
Sbjct: 72 EE------ASWFRETEIYQTVLMRHE-NILGFIAADIKGTGSWTQLYLITDYHENGSLYD 124
Query: 132 LIAANGALPEDMAAFYAAEVVLALQYLHSH--------GIIHRDLKPDNMLI 175
+ + L A V L +LH+ I HRDLK N+L+
Sbjct: 125 YLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 28/149 (18%), Positives = 52/149 (34%), Gaps = 24/149 (16%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN--ALAL 98
+ ++I +G FG+V+ G + + A+K+ E RE +
Sbjct: 42 RTIVLQESIGKGRFGEVWRG---KWRGEEVAVKIFSSREE------RSWFREAEIYQTVM 92
Query: 99 THSPFCVQLFYS----LQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLA 154
+ + T + ++LV +Y G + + + + A
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASG 151
Query: 155 LQYLHSH--------GIIHRDLKPDNMLI 175
L +LH I HRDLK N+L+
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILV 180
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 32/133 (24%), Positives = 56/133 (42%), Gaps = 8/133 (6%)
Query: 41 SDFEIVKAISRGAFGKVFLG-YKKTNKDQLY--AIKVMKKDEMINKNMVSQVLRERNALA 97
+ ++ + G FGKV L Y TN A+K +K D S +E + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--PQHRSGWKQEIDILR 88
Query: 98 LTHSPFCVQLF--YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
+ ++ ++ + LVMEY+ G ++ + + + F A ++ +
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF-AQQICEGM 147
Query: 156 QYLHSHGIIHRDL 168
YLH+ IHRDL
Sbjct: 148 AYLHAQHYIHRDL 160
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 28/150 (18%), Positives = 54/150 (36%), Gaps = 28/150 (18%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-- 99
D +++ + +G +G+V+ G + + + A+K+ + RE
Sbjct: 9 DITLLECVGKGRYGEVWRG---SWQGENVAVKIFSSRDE------KSWFRETELYNTVML 59
Query: 100 -HSPFCVQLFY-----SLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
H + F S +S+ ++L+ Y G + + L +
Sbjct: 60 RHE--NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIAS 116
Query: 154 ALQYLHS--------HGIIHRDLKPDNMLI 175
L +LH I HRDLK N+L+
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 6e-14
Identities = 32/143 (22%), Positives = 62/143 (43%), Gaps = 8/143 (5%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLG-YKKTNKDQLY-AIKVMKKDEMINKNMVSQVLRERN 94
I D + + + G FG+V+ G Y +++ A+K KKD + + + E
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAV 65
Query: 95 ALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVL 153
+ P V+L + +++ME G++ L +L Y+ ++
Sbjct: 66 IMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICK 124
Query: 154 ALQYLHSHGIIHRDLKPDNMLIS 176
A+ YL S +HRD+ N+L++
Sbjct: 125 AMAYLESINCVHRDIAVRNILVA 147
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 37/141 (26%), Positives = 58/141 (41%), Gaps = 13/141 (9%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL--TH 100
+EIV + GAFGKV + A+K++K E L T
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----VDRYCEAARSEIQVLEHLNTT 71
Query: 101 SPF----CVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLA 154
P CVQ+ + + +V E ++G I NG D A ++ +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 155 LQYLHSHGIIHRDLKPDNMLI 175
+ +LHS+ + H DLKP+N+L
Sbjct: 131 VNFLHSNKLTHTDLKPENILF 151
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 32/135 (23%), Positives = 60/135 (44%), Gaps = 9/135 (6%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHS 101
F + + I G+FG+++LG ++ AIK+ K Q+L E L
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEE-VAIKLENV-----KTKHPQLLYESKIYRILQGG 62
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHS 160
+ + LVM+ ++G ++ L + L A +++ ++++HS
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMD-LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 161 HGIIHRDLKPDNMLI 175
+HRD+KPDN L+
Sbjct: 122 KSFLHRDIKPDNFLM 136
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-14
Identities = 29/142 (20%), Positives = 61/142 (42%), Gaps = 7/142 (4%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLY---AIKVMKKDEMINKNMVSQVLRERNALA 97
++F+ +K + GAFG V+ G +++ AIK +++ ++L E +A
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLALQ 156
+P +L + +S V L+ + M G + + + + ++ +
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 157 YLHSHGIIHRDLKPDNMLISAQ 178
YL ++HRDL N+L+
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTP 153
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 38/142 (26%), Positives = 64/142 (45%), Gaps = 8/142 (5%)
Query: 41 SDFEIVKA-ISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA- 97
+ I + G FG V G Y+ K AIKV+K+ K +++RE +
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQ 66
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLALQ 156
L + P+ V+L + + + LVME GG + L+ +P A +V + ++
Sbjct: 67 LDN-PYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 124
Query: 157 YLHSHGIIHRDLKPDNMLISAQ 178
YL +HRDL N+L+ +
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNR 146
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 29/143 (20%), Positives = 58/143 (40%), Gaps = 11/143 (7%)
Query: 41 SDFEIVKAISRGAFGKVFLGY---KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
+ ++ + +G FG V + + N ++ A+K ++ + RE L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILK 66
Query: 98 LTHSPFCVQLF---YSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVL 153
V+ YS + + L+MEY+ G ++ L + Y +++
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 154 ALQYLHSHGIIHRDLKPDNMLIS 176
++YL + IHRDL N+L+
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVE 148
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 34/140 (24%), Positives = 59/140 (42%), Gaps = 13/140 (9%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL---- 98
F +++ + G FG+V L NK + YA+KV++ K E + L
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNK-KYYAVKVVRN----IKKYTRSAKIEADILKKIQND 91
Query: 99 -THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLAL 155
++ V+ + L+ E +G + +I N + Y E++ AL
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150
Query: 156 QYLHSHGIIHRDLKPDNMLI 175
YL + H DLKP+N+L+
Sbjct: 151 NYLRKMSLTHTDLKPENILL 170
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 32/144 (22%), Positives = 66/144 (45%), Gaps = 11/144 (7%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
EI ++ K + G FG+V++ + A+K MK M V L E N +
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSM----SVEAFLAEANVM 237
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAF--YAAEVVLA 154
V+L +++ T ++++ E+M G + + ++ + + ++A++
Sbjct: 238 KTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 155 LQYLHSHGIIHRDLKPDNMLISAQ 178
+ ++ IHRDL+ N+L+SA
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSAS 320
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 33/146 (22%), Positives = 60/146 (41%), Gaps = 11/146 (7%)
Query: 37 APEI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
A EI + + +G FG+V++G AIK +K M + L+E
Sbjct: 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAF----LQEAQ 314
Query: 95 ALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAF--YAAEVV 152
+ VQL Y++ + +++V EYM G + + + AA++
Sbjct: 315 VMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 153 LALQYLHSHGIIHRDLKPDNMLISAQ 178
+ Y+ +HRDL+ N+L+
Sbjct: 374 SGMAYVERMNYVHRDLRAANILVGEN 399
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 54/312 (17%), Positives = 97/312 (31%), Gaps = 70/312 (22%)
Query: 38 PEI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN- 94
P + + ++++ I RG +G V+ G + ++ A+KV + E+N
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKG---SLDERPVAVKVFSFANR------QNFINEKNI 58
Query: 95 -ALALTHSPFCVQLF-----YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYA 148
+ L + + LVMEY G + ++ + + A
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-A 117
Query: 149 AEVVLALQYLHS---------HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199
V L YLH+ I HRDL N+L+ +++ L++
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND--GTCVISDFGLSMRLTGNRL 175
Query: 200 LEISDLVN------GTP---------NAFNIRTPGQ----------------LLSLKTGT 228
+ + N GT A N+R + T
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 229 FPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQ-------LEWPEDEEALNPSTEETIL 281
FP + V Q F + + + + W E+ A+ S +ETI
Sbjct: 236 FP-GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV-RSLKETIE 293
Query: 282 ALLKSDPTQRPS 293
D R +
Sbjct: 294 DCWDQDAEARLT 305
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 40/145 (27%), Positives = 64/145 (44%), Gaps = 8/145 (5%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGY--KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
EI E+ + I G FG V G N AIK K ++ + L+E
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEAL 68
Query: 95 ALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVL 153
+ P V+L + T + V+++ME G+++S L +L YA ++
Sbjct: 69 TMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQ 178
AL YL S +HRD+ N+L+S+
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSN 152
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 29/143 (20%), Positives = 58/143 (40%), Gaps = 11/143 (7%)
Query: 41 SDFEIVKAISRGAFGKVFLGY---KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
+ ++ + +G FG V + + N ++ A+K ++ + RE L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILK 97
Query: 98 LTHSPFCVQLF---YSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVL 153
V+ YS + + L+MEY+ G ++ L + Y +++
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 154 ALQYLHSHGIIHRDLKPDNMLIS 176
++YL + IHRDL N+L+
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVE 179
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 31/141 (21%), Positives = 52/141 (36%), Gaps = 13/141 (9%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL--TH 100
+EIV + G FGKV A+K+++ E N L
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN----VGKYREAARLEINVLKKIKEK 76
Query: 101 SPF----CVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLA 154
CV + + + E ++G + + N P A ++ A
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 155 LQYLHSHGIIHRDLKPDNMLI 175
L++LH + + H DLKP+N+L
Sbjct: 136 LRFLHENQLTHTDLKPENILF 156
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 31/142 (21%), Positives = 60/142 (42%), Gaps = 8/142 (5%)
Query: 41 SDFEIVKAISRGAFGKVFLGY---KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
+ ++ + G FGKV L + N + A+K +K + N ++ + +E L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILR 78
Query: 98 LTHSPFCVQLF--YSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLA 154
+ V+ + + + L+ME++ G +K L + YA ++
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 155 LQYLHSHGIIHRDLKPDNMLIS 176
+ YL S +HRDL N+L+
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVE 160
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 36/151 (23%), Positives = 63/151 (41%), Gaps = 20/151 (13%)
Query: 39 EISDFEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINKNMV-SQVLRERNA 95
E+S +E + I +G FG+V +K ++ Q A+K + + K LRE
Sbjct: 15 EVSKYEKLAKIGQGTFGEV---FKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKI 69
Query: 96 L-ALTHSPFCVQLF--------YSLQTSSCVFLVMEYMIGGDVKSLIAA-NGALPEDMAA 145
L L H V L + ++LV ++ D+ L++
Sbjct: 70 LQLLKH-ENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIK 127
Query: 146 FYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
++ L Y+H + I+HRD+K N+LI+
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLIT 158
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 35/153 (22%), Positives = 58/153 (37%), Gaps = 25/153 (16%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIK-VMKKDEMINKNMVSQ-------VLRE-- 92
+ + + IS G++G V G AIK V + VLRE
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEG--IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 93 -------RNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMA 144
N L L + + + ++LV E M D+ +I +
Sbjct: 82 LLNHFHHPNILGLRD----IFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177
++ ++L L LH G++HRDL P N+L++
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD 169
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 32/141 (22%), Positives = 61/141 (43%), Gaps = 14/141 (9%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL---- 98
+E++K I +G+FG+V Y Q A+K+++ K Q E L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVH-QHVALKMVRN----EKRFHRQAAEEIRILEHLRKQ 153
Query: 99 --THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLA 154
++ + + + + + + E + ++ LI N + +A ++
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 155 LQYLHSHGIIHRDLKPDNMLI 175
L LH + IIH DLKP+N+L+
Sbjct: 213 LDALHKNRIIHCDLKPENILL 233
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 5/132 (3%)
Query: 49 ISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQL 107
+ G FG V G Y+ K AIKV+K+ K +++RE + +P+ V+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRL 401
Query: 108 FYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHR 166
+ + + LVME GG + L+ +P A +V + ++YL +HR
Sbjct: 402 -IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 167 DLKPDNMLISAQ 178
+L N+L+ +
Sbjct: 461 NLAARNVLLVNR 472
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 36/143 (25%), Positives = 58/143 (40%), Gaps = 11/143 (7%)
Query: 41 SDFEIVKAISRGAFGKVFLGY---KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
+ + + +G FG V L N L A+K ++ + RE L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP---DQQRDFQREIQILK 79
Query: 98 LTHSPFCVQLF---YSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVL 153
HS F V+ Y S + LVMEY+ G ++ L L Y++++
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQS-LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 154 ALQYLHSHGIIHRDLKPDNMLIS 176
++YL S +HRDL N+L+
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVE 161
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 26/159 (16%), Positives = 57/159 (35%), Gaps = 14/159 (8%)
Query: 38 PEI--SDFEIVKAISRGAFGKVFLG-YKKTNKDQLY-----AIKVMKKDEMINKNMVSQV 89
+I D +++ +G F K+F G ++ +KV+ K N
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESF 59
Query: 90 LRERNALA-LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFY 147
+ ++ L+H V + LV E++ G + + L +
Sbjct: 60 FEAASMMSKLSH-KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 148 AAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVN 186
A ++ A+ +L + +IH ++ N+L+ +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNP 157
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 38/145 (26%), Positives = 62/145 (42%), Gaps = 7/145 (4%)
Query: 37 APEI--SDFEIVKAISRGAFGKVFLG-YKKTNKDQLY-AIKVMKKDEMINKNMVSQVLRE 92
A E+ ++ I K + G FG+V G K +K ++ AIK +K + L E
Sbjct: 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGE 96
Query: 93 RNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEV 151
+ + P ++L + S V +V EYM G + S L + +
Sbjct: 97 ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 152 VLALQYLHSHGIIHRDLKPDNMLIS 176
++YL G +HRDL N+LI+
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILIN 181
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 37/150 (24%), Positives = 62/150 (41%), Gaps = 8/150 (5%)
Query: 32 KSCLKAPEISDFEIVKAISRGAFGKVFLGY--KKTNKDQLYAIKVMKKDEMINKNMVSQV 89
+ + P + I RG FG V+ G K A+K + + + VSQ
Sbjct: 16 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQF 73
Query: 90 LRERNALALTHSPFCVQLF-YSLQTSSCVFLVMEYMIGGDVKSLIAANGALP--EDMAAF 146
L E + P + L L++ +V+ YM GD+++ I P +D+ F
Sbjct: 74 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 147 YAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
+V ++YL S +HRDL N ++
Sbjct: 134 -GLQVAKGMKYLASKKFVHRDLAARNCMLD 162
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 36/146 (24%), Positives = 57/146 (39%), Gaps = 9/146 (6%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLG-YKKTNKDQLY-AIKVMKKDEMINKNMVSQVLRERN 94
EI S I K I G G+V G + + + AIK +K + L E +
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEAS 102
Query: 95 ALA-LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVV 152
+ H P ++L + +V EYM G + + L +G V
Sbjct: 103 IMGQFDH-PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 153 LALQYLHSHGIIHRDLKPDNMLISAQ 178
++YL G +HRDL N+L+ +
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSN 187
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 8/145 (5%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLG-YKKTNKDQLY-AIKVMKKDEMINKNMVSQVLRERN 94
EI E+ + I G FG V G Y + AIK K ++ + L+E
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEAL 443
Query: 95 ALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVL 153
+ P V+L + T + V+++ME G+++S L +L YA ++
Sbjct: 444 TMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQ 178
AL YL S +HRD+ N+L+S+
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSSN 527
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 34/143 (23%), Positives = 60/143 (41%), Gaps = 11/143 (7%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
E+ +D + + G +G+V+ G K A+K +K+D M V + L+E +
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTM----EVEEFLKEAAVM 270
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGAL--PEDMAAFYAAEVVL 153
P VQL +++ E+M G++ L N + A ++
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISS 329
Query: 154 ALQYLHSHGIIHRDLKPDNMLIS 176
A++YL IHR+L N L+
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVG 352
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 8e-13
Identities = 39/143 (27%), Positives = 59/143 (41%), Gaps = 13/143 (9%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
I S+ V+ I G FG V LG + +K AIK +++ M + E
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDK---VAIKTIREGAM----SEEDFIEEAEV 56
Query: 96 LA-LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVL 153
+ L+H P VQL+ + + LV E+M G + L G + +V
Sbjct: 57 MMKLSH-PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 154 ALQYLHSHGIIHRDLKPDNMLIS 176
+ YL +IHRDL N L+
Sbjct: 116 GMAYLEEACVIHRDLAARNCLVG 138
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 37/144 (25%), Positives = 66/144 (45%), Gaps = 15/144 (10%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
+ + ++++ I +G FG V LG + NK A+K +K D L E + +
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDYRGNK---VAVKCIKND-----ATAQAFLAEASVM 240
Query: 97 A-LTHSPFCVQLF-YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAF--YAAEVV 152
L H VQL ++ +++V EYM G + + + G ++ +V
Sbjct: 241 TQLRH-SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 299
Query: 153 LALQYLHSHGIIHRDLKPDNMLIS 176
A++YL + +HRDL N+L+S
Sbjct: 300 EAMEYLEGNNFVHRDLAARNVLVS 323
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 29/142 (20%), Positives = 61/142 (42%), Gaps = 7/142 (4%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLY---AIKVMKKDEMINKNMVSQVLRERNALA 97
++F+ +K + GAFG V+ G +++ AIK +++ ++L E +A
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLALQ 156
+P +L + +S V L+ + M G + + + + ++ +
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 157 YLHSHGIIHRDLKPDNMLISAQ 178
YL ++HRDL N+L+
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTP 153
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 36/150 (24%), Positives = 62/150 (41%), Gaps = 8/150 (5%)
Query: 32 KSCLKAPEISDFEIVKAISRGAFGKVFLGY--KKTNKDQLYAIKVMKKDEMINKNMVSQV 89
+ + P + I RG FG V+ G K A+K + + + VSQ
Sbjct: 80 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQF 137
Query: 90 LRERNALALTHSPFCVQLF-YSLQTSSCVFLVMEYMIGGDVKSLIAANGALP--EDMAAF 146
L E + P + L L++ +V+ YM GD+++ I P +D+ F
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197
Query: 147 YAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
+V +++L S +HRDL N ++
Sbjct: 198 -GLQVAKGMKFLASKKFVHRDLAARNCMLD 226
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 39/144 (27%), Positives = 68/144 (47%), Gaps = 15/144 (10%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
+ + ++++ I +G FG V LG + NK A+K +K D L E + +
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDYRGNK---VAVKCIKNDATAQA-----FLAEASVM 68
Query: 97 -ALTHSPFCVQLF-YSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVV 152
L H VQL ++ +++V EYM G + + + G L D ++ +V
Sbjct: 69 TQLRH-SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 127
Query: 153 LALQYLHSHGIIHRDLKPDNMLIS 176
A++YL + +HRDL N+L+S
Sbjct: 128 EAMEYLEGNNFVHRDLAARNVLVS 151
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 36/142 (25%), Positives = 62/142 (43%), Gaps = 11/142 (7%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
E+ + ++K + G FG V LG K D A+K++K+ M + +E +
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYD--VAVKMIKEGSM----SEDEFFQEAQTM 57
Query: 97 -ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLA 154
L+H P V+ + +++V EY+ G + + L + L +V
Sbjct: 58 MKLSH-PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 155 LQYLHSHGIIHRDLKPDNMLIS 176
+ +L SH IHRDL N L+
Sbjct: 117 MAFLESHQFIHRDLAARNCLVD 138
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 38/142 (26%), Positives = 60/142 (42%), Gaps = 11/142 (7%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
EI D +K + G FG V G + D AIK++K+ M + + E +
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYD--VAIKMIKEGSM----SEDEFIEEAKVM 73
Query: 97 -ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLA 154
L+H VQL+ +F++ EYM G + + L +V A
Sbjct: 74 MNLSH-EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 155 LQYLHSHGIIHRDLKPDNMLIS 176
++YL S +HRDL N L++
Sbjct: 133 MEYLESKQFLHRDLAARNCLVN 154
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 33/146 (22%), Positives = 57/146 (39%), Gaps = 8/146 (5%)
Query: 37 APEI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLY---AIKVMKKDEMINKNMVSQVLR 91
EI S K I G FG+V+ G KT+ + AIK +K + + L
Sbjct: 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLG 95
Query: 92 ERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAE 150
E + ++L + + ++ EYM G + L +G
Sbjct: 96 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 151 VVLALQYLHSHGIIHRDLKPDNMLIS 176
+ ++YL + +HRDL N+L++
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVN 181
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 37/144 (25%), Positives = 67/144 (46%), Gaps = 15/144 (10%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
E+ ++V+ + G FG+V++G Y K A+K +K+ M L E N
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSM----SPDAFLAEANL 61
Query: 96 L-ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVV 152
+ L H V+L Y++ T ++++ EYM G + + L + AA++
Sbjct: 62 MKQLQH-QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 153 LALQYLHSHGIIHRDLKPDNMLIS 176
+ ++ IHRDL+ N+L+S
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVS 143
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 38/153 (24%), Positives = 66/153 (43%), Gaps = 22/153 (14%)
Query: 41 SDFEIVKAISRGAFGKVFLGY-KKTNKDQLYAIKVMKKDEMINKNMVSQVLRE------- 92
S + +K + G G VF + + AIK K + + V LRE
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCD--KRVAIK---KIVLTDPQSVKHALREIKIIRRL 65
Query: 93 --RNALALTH-----SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAA 145
N + + SL + V++V EYM D+ +++ L E+ A
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQG-PLLEEHAR 123
Query: 146 FYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
+ +++ L+Y+HS ++HRDLKP N+ I+ +
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTE 156
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 31/155 (20%), Positives = 57/155 (36%), Gaps = 34/155 (21%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK---KDEMINKNMVSQV--LRERNA 95
++++ +RG FG V +K ++ A+K+ K N+ V + ++ N
Sbjct: 24 MPLQLLEVKARGRFGCV---WKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80
Query: 96 LAL-----THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAE 150
L + V L+ L+ + G + + AN + + A
Sbjct: 81 LQFIGAEKRGTSVDVDLW----------LITAFHEKGSLSDFLKAN-VVSWNELCHIAET 129
Query: 151 VVLALQYLHSH----------GIIHRDLKPDNMLI 175
+ L YLH I HRD+K N+L+
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 39/147 (26%), Positives = 65/147 (44%), Gaps = 18/147 (12%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ-VLRE------- 92
++ I I RG++G V+L Y K + + AIK K + M + + +LRE
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNV-AIK--KVNRMFEDLIDCKRILREITILNRL 82
Query: 93 --RNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAE 150
+ L + + L +++V+E D+K L L E+
Sbjct: 83 KSDYIIRLYD----LIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYN 137
Query: 151 VVLALQYLHSHGIIHRDLKPDNMLISA 177
++L ++H GIIHRDLKP N L++
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQ 164
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 7e-12
Identities = 31/152 (20%), Positives = 54/152 (35%), Gaps = 15/152 (9%)
Query: 38 PEISDFEI---------VKAISRGAFGKVFLGY--KKTNKDQLYAIKVMKKDEMINKNMV 86
E+ D I + I +G FG V+ G + AIK + + V
Sbjct: 9 AEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQV 66
Query: 87 SQVLRERNALALTHSPFCVQLF-YSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMA 144
LRE + + P + L L +++ YM GD+ + +
Sbjct: 67 EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL 126
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
+ +V ++YL +HRDL N ++
Sbjct: 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLD 158
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 36/143 (25%), Positives = 64/143 (44%), Gaps = 11/143 (7%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
E+ +D + + G +G+V+ G K A+K +K+D M V + L+E +
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTM----EVEEFLKEAAVM 63
Query: 97 -ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANG-ALPEDMAAFYAAEVVL 153
+ H P VQL +++ E+M G++ L N + + + A ++
Sbjct: 64 KEIKH-PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 154 ALQYLHSHGIIHRDLKPDNMLIS 176
A++YL IHRDL N L+
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVG 145
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 32/147 (21%), Positives = 58/147 (39%), Gaps = 9/147 (6%)
Query: 36 KAPEI--SDFEIVKAISRGAFGKVFLG-YKKTNKDQLY--AIKVMKKDEMINKNMVSQVL 90
A ++ +K + G FG V G + + IKV++ + V
Sbjct: 6 LARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVT 63
Query: 91 RERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAA 149
A+ V+L L S + LV +Y+ G + + GAL + +
Sbjct: 64 DHMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLIS 176
++ + YL HG++HR+L N+L+
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLK 149
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 32/152 (21%), Positives = 61/152 (40%), Gaps = 24/152 (15%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL---- 98
+ +V+ + G F V+L N A+K+++ +K E L
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNN-THVAMKIVRG----DKVYTEAAEDEIKLLQRVNDA 75
Query: 99 -------THSPFCVQLF----YSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAA 145
+ ++L + V +V E + G ++ +LI +P
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134
Query: 146 FYAAEVVLALQYLHSH-GIIHRDLKPDNMLIS 176
+ +++L L Y+H GIIH D+KP+N+L+
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 31/158 (19%), Positives = 64/158 (40%), Gaps = 17/158 (10%)
Query: 35 LKAPEI--SDFEIVKAISRGAFGKVFLGY--KKTNKDQLYAIKVMKKDEMINKNMVSQVL 90
L+ I F + + + +G FG V ++ A+K++K D + + + + L
Sbjct: 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFL 73
Query: 91 RERNALALTHSPFCVQLF------YSLQTSSCVFLVMEYMIGGDVKSLIAAN------GA 138
RE + P +L + +++ +M GD+ + + A+
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 139 LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
LP + ++ ++YL S IHRDL N +++
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA 171
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 35/146 (23%), Positives = 66/146 (45%), Gaps = 18/146 (12%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRE-------- 92
+ + I GA+G V Y NK ++ AIK K ++ + LRE
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRV-AIK--KISPFEHQTYCQRTLREIKILLRFR 83
Query: 93 -RNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEV 151
N + + + +++ V++V + M D+ L+ L D ++ ++
Sbjct: 84 HENIIGIND----IIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYFLYQI 137
Query: 152 VLALQYLHSHGIIHRDLKPDNMLISA 177
+ L+Y+HS ++HRDLKP N+L++
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNT 163
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 36/158 (22%), Positives = 65/158 (41%), Gaps = 17/158 (10%)
Query: 38 PEI--SDFEIVKAISRGAFGKVFLG----YKKTNKDQLYAIKVMKKDEMINKNMVSQVLR 91
E+ + +++ + GAFG+V+ G A+K + + + L
Sbjct: 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLM 82
Query: 92 ERNALALTHSPFCVQLF-YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAF---- 146
E ++ + V+ SLQ+ F++ME M GGD+KS + P ++
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 147 ---YAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH 181
A ++ QYL + IHRD+ N L++ P
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 16/143 (11%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL--TH 100
+EI I +G+FG+V Y + + + AIK++K K ++Q E L L H
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQ-EWVAIKIIKN----KKAFLNQAQIEVRLLELMNKH 110
Query: 101 SP----FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLA 154
+ V L + + LV E M+ ++ L+ + ++ +A ++ A
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 155 LQYLHSH--GIIHRDLKPDNMLI 175
L +L + IIH DLKP+N+L+
Sbjct: 170 LLFLATPELSIIHCDLKPENILL 192
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 32/166 (19%), Positives = 63/166 (37%), Gaps = 22/166 (13%)
Query: 23 SENSLCDVSKSCLKAPEISDFEI-------VKAISRGAFGKVFLGY--KKTNKDQLYAIK 73
+ L L+ ++ D I K + G FG V G ++ A+K
Sbjct: 10 HSSGLVPRGSEELQ-NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVK 68
Query: 74 VMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF-----YSLQTSSCVFLVMEYMIGGD 128
MK D ++ + + L E + P ++L S Q +++ +M GD
Sbjct: 69 TMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD 127
Query: 129 VKSLIAAN------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168
+ + + + +P + ++ L ++YL + +HRDL
Sbjct: 128 LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL 173
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 18/144 (12%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRE---------R 93
F++ + GA+G V K + + AIK K + + LRE
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIV-AIK--KIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 94 NALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
N + + + +Q S + + V+++ E M D+ +I+ L +D ++ + +
Sbjct: 70 NIITIFN----IQRPDSFENFNEVYIIQELM-QTDLHRVISTQ-MLSDDHIQYFIYQTLR 123
Query: 154 ALQYLHSHGIIHRDLKPDNMLISA 177
A++ LH +IHRDLKP N+LI++
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINS 147
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 29/152 (19%), Positives = 59/152 (38%), Gaps = 16/152 (10%)
Query: 41 SDFEIVKAISRGAFGKVFLGY----KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
+ + + +G+FG V+ G K + AIK + + + L E + +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVM 82
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAF---------- 146
+ V+L + ++ME M GD+KS + + +
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 147 YAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
A E+ + YL+++ +HRDL N +++
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAED 174
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 37/178 (20%), Positives = 70/178 (39%), Gaps = 17/178 (9%)
Query: 18 ITNKASENSLCDVSKSCLKAPEI--SDFEIVKAISRGAFGKVFLG----YKKTNKDQLYA 71
+T+ + S E+ + +++ + GAFG+V+ G A
Sbjct: 46 MTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA 105
Query: 72 IKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF-YSLQTSSCVFLVMEYMIGGDVK 130
+K + + + L E ++ + V+ SLQ+ F+++E M GGD+K
Sbjct: 106 VKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP-RFILLELMAGGDLK 162
Query: 131 SLIAANGALPEDMAAF-------YAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH 181
S + P ++ A ++ QYL + IHRD+ N L++ P
Sbjct: 163 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 33/144 (22%), Positives = 63/144 (43%), Gaps = 13/144 (9%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ-VLRERNALALT 99
+ + GA+G V K + +++ AIK K + ++ RE L
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKV-AIK--KLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 100 HSPFCVQLF------YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
+ L SL+ +LVM +M D++ ++ E+ + +++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLK 137
Query: 154 ALQYLHSHGIIHRDLKPDNMLISA 177
L+Y+HS G++HRDLKP N+ ++
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNE 161
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 38/151 (25%), Positives = 63/151 (41%), Gaps = 25/151 (16%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHS 101
+ +++ + G F V+L + A+KV+K E + L E L ++ +S
Sbjct: 39 YHVIRKLGWGHFSTVWLS-WDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNS 93
Query: 102 -------PFCVQLFYSLQTSS------CVFLVMEYMIGGDVKSLIAAN--GALPEDMAAF 146
VQL + S C +V E + G + I + LP
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHIC--MVFEVL-GHHLLKWIIKSNYQGLPLPCVKK 150
Query: 147 YAAEVVLALQYLHSH-GIIHRDLKPDNMLIS 176
+V+ L YLH+ IIH D+KP+N+L+S
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.7 bits (146), Expect = 3e-10
Identities = 29/191 (15%), Positives = 56/191 (29%), Gaps = 49/191 (25%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVM--------------KKDEMI 81
+ + I G FG+VF AIK++ +E++
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQT---IADHTPVAIKIIAIEGPDLVNGSHQKTFEEIL 71
Query: 82 NKNMVSQVLRERNALALTHSPFCVQLF-------------------YSLQTSSC------ 116
+ ++S+ L + + + L Y+ S
Sbjct: 72 PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131
Query: 117 -----VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH-SHGIIHRDLKP 170
+F+V+E+ GG + A ++ +L S HRDL
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 171 DNMLISAQAPH 181
N+L+ +
Sbjct: 191 GNVLLKKTSLK 201
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 41/144 (28%), Positives = 75/144 (52%), Gaps = 10/144 (6%)
Query: 39 EISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ-VLRERNAL 96
+ +E+VK + +GA+G V+ + + + A+K K + + +Q RE L
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVV-AVK--KIFDAFQNSTDAQRTFREIMIL 62
Query: 97 -ALTHSPFCVQLFYSLQTSSC--VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
L+ V L L+ + V+LV +YM D+ ++I AN L + +++
Sbjct: 63 TELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN-ILEPVHKQYVVYQLIK 120
Query: 154 ALQYLHSHGIIHRDLKPDNMLISA 177
++YLHS G++HRD+KP N+L++A
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNA 144
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 37/144 (25%), Positives = 64/144 (44%), Gaps = 12/144 (8%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ-VLRERNALALT 99
+ + ++ + GA+G V ++ AIK K + ++ RE L
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKV-AIK--KLYRPFQSELFAKRAYRELRLLKHM 81
Query: 100 HSPFCVQLF------YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
+ L +L + +LVM +M G D+ L+ L ED F +++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE-KLGEDRIQFLVYQMLK 139
Query: 154 ALQYLHSHGIIHRDLKPDNMLISA 177
L+Y+H+ GIIHRDLKP N+ ++
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNE 163
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 35/142 (24%), Positives = 64/142 (45%), Gaps = 12/142 (8%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ-VLRERNALALTHS 101
++ + + GA+G V + ++ A+K K + ++ RE L
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRV-AVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 102 PFCVQLF------YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
+ L SL+ + V+LV M G D+ +++ L +D F +++ L
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGL 145
Query: 156 QYLHSHGIIHRDLKPDNMLISA 177
+Y+HS IIHRDLKP N+ ++
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNE 167
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 7e-10
Identities = 30/155 (19%), Positives = 54/155 (34%), Gaps = 24/155 (15%)
Query: 36 KAPEI--SDFEIVKAISRGAFGKVFLGY----KKTNKDQLYAIKVMKKDEMINKNMVSQV 89
K EI S ++ + FGKV+ G+ + Q AIK +K + +
Sbjct: 2 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEF 59
Query: 90 LRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFY-- 147
E A P V L + + ++ Y GD+ + + +
Sbjct: 60 RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 148 --------------AAEVVLALQYLHSHGIIHRDL 168
A++ ++YL SH ++H+DL
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDL 154
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 9e-10
Identities = 58/392 (14%), Positives = 109/392 (27%), Gaps = 141/392 (35%)
Query: 32 KSCLKAPEISDFEIVKAISRGAFGKVF---LGYKKTNKDQLYAIKVMKKDEMINKNMVSQ 88
K+ + +++ + K+F L + + L ++ + I+ N S+
Sbjct: 163 KTWVALDVCLSYKVQCKMD----FKIFWLNLKNCNSPETVLEMLQKLLYQ--IDPNWTSR 216
Query: 89 VLRERNALALTHS--PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAF 146
N HS +L S +C+ LV+ +V++ + AF
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCL-LVLL-----NVQN--------AKAWNAF 262
Query: 147 YAAEV---VLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVN-----------TLFLAI 192
+ +L + R + + L +A H + + +L L
Sbjct: 263 ---NLSCKIL---------LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310
Query: 193 LQQPIVYLEISDL----VNGTPNAFNIRTPGQLLSLKTGTFPTFQDVQ------------ 236
L DL + P +I + + T+ ++ V
Sbjct: 311 LD-----CRPQDLPREVLTTNPRRLSI--IAESIRDGLATWDNWKHVNCDKLTTIIESSL 363
Query: 237 NSQAP------------FPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETIL--- 281
N P FP + IPT L L W + + S ++
Sbjct: 364 NVLEPAEYRKMFDRLSVFPP-----SAHIPTIL---LSLIWFDVIK----SDVMVVVNKL 411
Query: 282 ---ALLKSDP------------------TQRPSGHQ--VRRLPMFKDYDWDSILDQEPPF 318
+L++ P + H+ V + K +D D
Sbjct: 412 HKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDD-------L 464
Query: 319 VPQPDDVFDTSYF------HADKTNSYMDSTL 344
+P D YF H TL
Sbjct: 465 IPPYLD----QYFYSHIGHHLKNIEHPERMTL 492
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 1e-05
Identities = 62/468 (13%), Positives = 134/468 (28%), Gaps = 137/468 (29%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKD-----------EMINKNMVSQVL 90
DFE G+ YK A + +++K + ++
Sbjct: 8 DFET---------GEHQYQYKDILSVFEDAFV---DNFDCKDVQDMPKSILSKEEIDHII 55
Query: 91 RERNALALTHSPFCVQLFYSL--QTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYA 148
++A++ T +LF++L + V +E ++ + K L++ +
Sbjct: 56 MSKDAVSGTL-----RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR 110
Query: 149 AEVVLALQYLHSHGIIHRD---LKPDNMLISAQAPHCPIVNTLFLAILQ-QPIVYLEISD 204
Y+ ++ D N+ L A+L+ +P +
Sbjct: 111 -------MYIEQRDRLYNDNQVFAKYNV------SRLQPYLKLRQALLELRPAKNV---- 153
Query: 205 LVNGTPNAFNIRTPG-QLLSLKTGTFPTFQDVQNSQAPFPSA-LRVAGSQIPTSTAAQLQ 262
L++G + G ++L Q + F L + P + LQ
Sbjct: 154 LIDGVLGS------GKTWVALDVCLSYKVQC----KMDFKIFWLNLKNCNSPETVLEMLQ 203
Query: 263 LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVPQP 322
+L + + T R +L + L + P+
Sbjct: 204 ----------------KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY-ENC 246
Query: 323 ----DDVFDTSYFHADKTNSYMD---STLSTTHGNGSFVCCSNLNSHTASGMDVDSPSAL 375
+V + ++A + L TT D SA
Sbjct: 247 LLVLLNVQNAKAWNA------FNLSCKILLTTRFKQ----------------VTDFLSAA 284
Query: 376 YSKLSTMD----CMSPPNAHNLSGVSPFLAMDRSPPDNSELEWPEDEEALNPSTEETILA 431
+ ++D ++P +L + +L +L P + NP I
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSL--LLKYLDCR-----PQDL--PREVLTTNPRRLSIIAE 335
Query: 432 LLKSDPIVFMGDDTWSSF---------SAIFNTLDAMSPTYGSQCLEA 470
++ TW ++ + I ++L+ + P + +
Sbjct: 336 SIRDGL------ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR 377
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 40/175 (22%), Positives = 61/175 (34%), Gaps = 35/175 (20%)
Query: 31 SKSCLKAPEI--SDFEIVKAISRGAFGKVFLGY----KKTNKDQLYAIKVMKKDEMINKN 84
S + I D + + + GAFGKVFL T L A+K +K +
Sbjct: 3 MHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---A 59
Query: 85 MVSQVLRERNALALTHSPFCVQLFYSLQTSSC-----VFLVMEYMIGGDVKS-------- 131
RE L V+ + C + +V EYM GD+
Sbjct: 60 ARKDFQREAELLTNLQHEHIVKFY-----GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPD 114
Query: 132 -LIAANGALPEDMAAFY-------AAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178
+I +G + A+++ + YL S +HRDL N L+ A
Sbjct: 115 AMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 169
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 13/144 (9%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ-VLRERNALALT 99
++ +K I GA G V Y + AIK K ++ RE +
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNV-AIK--KLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 100 HSPFCVQLF------YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
+ + L +L+ V+LVME M ++ +I L + ++ +++
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 175
Query: 154 ALQYLHSHGIIHRDLKPDNMLISA 177
+++LHS GIIHRDLKP N+++ +
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKS 199
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 13/143 (9%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ-VLRERNALALTHS 101
++ +K I GA G V Y + + AIK K ++ RE + +
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNV-AIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 102 PFCVQLF------YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
+ L SL+ V++VME M ++ +I L + ++ +++ +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGI 140
Query: 156 QYLHSHGIIHRDLKPDNMLISAQ 178
++LHS GIIHRDLKP N+++ +
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD 163
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 37/157 (23%), Positives = 52/157 (33%), Gaps = 24/157 (15%)
Query: 33 SCLKAPEI--SDFEIVKAISRGAFGKVFLGY----KKTNKDQLYAIKVMKKDEMINKNMV 86
S I D + + GAFGKVFL L A+K +K+ +
Sbjct: 31 SDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SAR 87
Query: 87 SQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS--------------- 131
RE L + V+ F + +V EYM GD+
Sbjct: 88 QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGG 147
Query: 132 LIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168
A G L A++V + YL +HRDL
Sbjct: 148 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDL 184
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 35/179 (19%), Positives = 62/179 (34%), Gaps = 47/179 (26%)
Query: 30 VSKSCLKAPEISDFEI-------VKAISRGAFGKVFLGY----KKTNKDQLYAIKVMKKD 78
+S K E +E K + G FGKV K A+K++K++
Sbjct: 5 LSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN 64
Query: 79 EMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC-----VFLVMEYMIGGDVKS-- 131
+ + +L E N L + P ++L+ +C + L++EY G ++
Sbjct: 65 AS--PSELRDLLSEFNVLKQVNHPHVIKLY-----GACSQDGPLLLIVEYAKYGSLRGFL 117
Query: 132 ----------------------LIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168
AL +A ++ +QYL ++HRDL
Sbjct: 118 RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 36/170 (21%), Positives = 59/170 (34%), Gaps = 32/170 (18%)
Query: 29 DVSKSCLKAPEI--SDFEIVKAISRGAFGKVFLGY----KKTNKDQLYAIKVMKKDEMIN 82
+ L + E ++ E V+ I GAFG+VF + A+K++K++
Sbjct: 33 LLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-- 90
Query: 83 KNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS----------- 131
+M + RE +A +P V+L + L+ EYM GD+
Sbjct: 91 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 150
Query: 132 -------------LIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168
L A +V + YL +HRDL
Sbjct: 151 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 38/159 (23%), Positives = 58/159 (36%), Gaps = 22/159 (13%)
Query: 38 PEI--SDFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
P + +D + I G FG+V KK AIK MK+ K+ E
Sbjct: 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELE 77
Query: 95 ALA-LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS----------------LIAANG 137
L L H P + L + + ++L +EY G++ +
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 138 ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
L +AA+V + YL IHRDL N+L+
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 35/169 (20%), Positives = 60/169 (35%), Gaps = 39/169 (23%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGY----KKTNKDQLYAIKVMKKDEMINKNMVSQVLRE 92
E + K + GAFGKV K++ A+K++K ++ E
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSE 76
Query: 93 RNALA-LTHSPFCVQLFYSLQTSSC-----VFLVMEYMIGGDVKS--------------- 131
L+ L + V L +C ++ EY GD+ +
Sbjct: 77 LKVLSYLGNHMNIVNLL-----GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 132 ----LIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
ED+ +F + +V + +L S IHRDL N+L++
Sbjct: 132 PAIMEDDELALDLEDLLSF-SYQVAKGMAFLASKNCIHRDLAARNILLT 179
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 7e-08
Identities = 29/155 (18%), Positives = 60/155 (38%), Gaps = 28/155 (18%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGY----KKTNKDQLYAIKVMKKDEMINKNMVSQVLRE 92
E ++ K + RGAFG+V KT + A+K++K+ + ++ E
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSE 80
Query: 93 RNAL-ALTHSPFCVQLF-YSLQTSSCVFLVMEYMIGGDVKS-----------------LI 133
L + H V L + + +++E+ G++ + +
Sbjct: 81 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 134 AANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168
+ E + + + +V +++L S IHRDL
Sbjct: 141 YKDFLTLEHLICY-SFQVAKGMEFLASRKCIHRDL 174
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 27/161 (16%), Positives = 59/161 (36%), Gaps = 39/161 (24%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGY------KKTNKDQLYAIKVMKKDEMINKNMVSQVL 90
E + K + G FG+V + K + A+K++K D + +S ++
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLV 134
Query: 91 RERNALA-LTHSPFCVQLFYSLQTSSC-----VFLVMEYMIGGDVKS------------- 131
E + + + L +C +++++EY G+++
Sbjct: 135 SEMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 132 ---LIAANGAL-PEDMAAFYAAEVVLALQYLHSHGIIHRDL 168
+ +D+ + ++ ++YL S IHRDL
Sbjct: 190 YDINRVPEEQMTFKDLVSC-TYQLARGMEYLASQKCIHRDL 229
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 9e-08
Identities = 37/172 (21%), Positives = 61/172 (35%), Gaps = 49/172 (28%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGY----KKTNKDQLYAIKVMKKDEMINKNMVSQVLRE 92
E ++ + K + GAFGKV K + A+K++K E
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH---------ADE 92
Query: 93 RNAL--------ALTHSPFCVQLFYSLQTSSC-----VFLVMEYMIGGDVKS-------- 131
+ AL L V L +C V ++ EY GD+ +
Sbjct: 93 KEALMSELKIMSHLGQHENIVNLL-----GACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147
Query: 132 ------LIAANGAL-PEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
AN D+ F +++V + +L S IHRD+ N+L++
Sbjct: 148 LETDPAFAIANSTASTRDLLHF-SSQVAQGMAFLASKNCIHRDVAARNVLLT 198
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 34/170 (20%), Positives = 65/170 (38%), Gaps = 41/170 (24%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGY------KKTNKDQLYAIKVMKKDEMINKNMVSQVL 90
E+ + K + GAFG+V L K N+ A+K++K D + +S ++
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLI 122
Query: 91 RERNAL-ALTHSPFCVQLFYSLQTSSCV------FLVMEYMIGGDVKS------------ 131
E + + + L ++++EY G+++
Sbjct: 123 SEMEMMKMIGKHKNIINLL------GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 176
Query: 132 ----LIAANGAL-PEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176
L +D+ + A +V ++YL S IHRDL N+L++
Sbjct: 177 SYNPSHNPEEQLSSKDLVSC-AYQVARGMEYLASKKCIHRDLAARNVLVT 225
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 27/156 (17%), Positives = 55/156 (35%), Gaps = 29/156 (18%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGY------KKTNKDQLYAIKVMKKDEMINKNMVSQVL 90
E + K + GAFG+V + K + A+K++K D + +S ++
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLV 88
Query: 91 RERNAL-ALTHSPFCVQLF-YSLQTSSCVFLVMEYMIGGDVKS----------------L 132
E + + + L Q +++++EY G+++
Sbjct: 89 SEMEMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 133 IAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168
+ ++ ++YL S IHRDL
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 183
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 40/181 (22%), Positives = 61/181 (33%), Gaps = 58/181 (32%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGY----KKTNKDQLYAIKVMKKDEMINKNMVSQVLRE 92
E + E K + GAFGKV KT A+K++K+ E
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD---------SSE 91
Query: 93 RNAL--------ALTHSPFCVQLFYSLQTSSC-----VFLVMEYMIGGDVKS-------- 131
R AL L V L +C ++L+ EY GD+ +
Sbjct: 92 REALMSELKMMTQLGSHENIVNLL-----GACTLSGPIYLIFEYCCYGDLLNYLRSKREK 146
Query: 132 ---------------LIAANGAL-PEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI 175
L ED+ F A +V +++L +HRDL N+L+
Sbjct: 147 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCF-AYQVAKGMEFLEFKSCVHRDLAARNVLV 205
Query: 176 S 176
+
Sbjct: 206 T 206
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 35/134 (26%), Positives = 53/134 (39%), Gaps = 15/134 (11%)
Query: 49 ISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN-KNMVSQVLRERNALALTHSPFCVQL 107
+ G FG V YK + A+K + I + + Q +E +A V+L
Sbjct: 39 MGEGGFGVV---YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 108 F-YSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPED----MA-AFYAAEVVLALQYLHS 160
+S + LV YM G + L +G P A AA + +LH
Sbjct: 96 LGFSSD-GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN---GINFLHE 151
Query: 161 HGIIHRDLKPDNML 174
+ IHRD+K N+L
Sbjct: 152 NHHIHRDIKSANIL 165
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 5e-05
Identities = 38/151 (25%), Positives = 58/151 (38%), Gaps = 35/151 (23%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLR----ERNALA 97
+F+ I G FGKV+ G + A+K + SQ + E L+
Sbjct: 40 NFDHKFLIGHGVFGKVYKGVLRDG--AKVALKRRTPES-------SQGIEEFETEIETLS 90
Query: 98 LTHSPFCVQLF-YSLQTSSCV-----FLVMEYMIGGDVKSLIAANGALPEDMA------- 144
P V L + C L+ +YM G++K + + M+
Sbjct: 91 FCRHPHLVSLIGF------CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 145 AFYAAEVVLALQYLHSHGIIHRDLKPDNMLI 175
AA L YLH+ IIHRD+K N+L+
Sbjct: 145 CIGAAR---GLHYLHTRAIIHRDVKSINILL 172
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 473 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.5 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.45 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.19 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.11 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.9 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.68 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.55 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.29 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.29 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.03 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.87 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.83 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.77 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 96.63 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 96.6 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 96.59 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.59 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.59 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.57 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 96.43 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 96.38 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 96.29 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 96.29 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 96.16 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.97 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 95.94 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 95.8 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.77 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 95.74 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 95.66 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 95.29 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.24 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 94.87 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 94.78 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 93.98 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 93.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 93.86 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 93.76 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 93.57 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 92.99 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 92.83 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 92.72 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 92.64 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 92.59 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 92.57 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 92.56 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 92.53 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 92.49 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 92.34 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 92.34 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 92.21 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 91.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 91.88 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 91.74 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 91.73 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 91.66 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 91.65 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 91.64 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 91.52 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 91.39 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 91.22 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 91.18 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 91.07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 91.05 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 90.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 90.7 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 90.67 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 90.45 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.44 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 90.38 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 90.34 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 90.29 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 90.03 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 89.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 89.78 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 89.72 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 89.46 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 89.42 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 89.4 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 89.39 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 89.33 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 89.17 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 89.13 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 89.04 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 89.01 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 88.83 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 88.59 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 88.58 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 88.5 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 88.44 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 88.31 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 88.23 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 88.22 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 88.06 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 88.06 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 87.8 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 87.77 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 87.76 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 87.69 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 87.67 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 87.57 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 87.51 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 87.46 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 87.45 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 87.44 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 87.39 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 87.31 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 87.2 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 87.17 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 86.96 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 86.92 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 86.9 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 86.84 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 86.69 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 86.44 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 86.33 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 86.29 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 86.23 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 86.23 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 86.22 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 86.21 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 86.2 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 86.2 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 86.16 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 86.13 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 86.01 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 85.94 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 85.85 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 85.85 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 85.82 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 85.81 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 85.79 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 85.77 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 85.66 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 85.66 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 85.58 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 85.51 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 85.31 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 85.16 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 85.1 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 85.01 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 85.01 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 84.85 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 84.84 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 84.76 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 84.36 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 84.26 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 84.15 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 84.15 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 84.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 83.92 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 83.77 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 83.7 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 83.62 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 83.36 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 83.21 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 83.2 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 83.15 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 83.06 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 83.04 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 83.02 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 82.95 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 82.95 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 82.77 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 82.54 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 82.3 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 82.24 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 82.16 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 82.14 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 81.95 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 81.94 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 81.86 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 81.74 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 81.67 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 81.19 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 81.18 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 81.13 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 80.85 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 80.71 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 80.46 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 80.43 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 80.38 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 80.2 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 80.17 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 80.09 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 80.04 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-63 Score=488.26 Aligned_cols=273 Identities=27% Similarity=0.486 Sum_probs=234.7
Q ss_pred cCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 34 CLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 34 ~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
.......++|+++++||+|+||+||+|+++. +++.||||++++..+......+++.+|+++|+.++|||||+++++|++
T Consensus 25 ~~~~~~~~dy~i~~~lG~G~fg~V~~a~~~~-~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 103 (311)
T 4aw0_A 25 QPRKKRPEDFKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 103 (311)
T ss_dssp --CCCCGGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCCCCccccEEEEEEecccCeEEEEEEECC-CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 3345567899999999999999999999887 689999999998776666667899999999999999999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
++++|||||||+||+|.++|.+.+.++|.+++.|++||+.||+|||++|||||||||+||||+.+ |++||+|||+|+.+
T Consensus 104 ~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~-g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 104 DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVL 182 (311)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC-CCEEEEEcCCceec
Confidence 99999999999999999999998999999999999999999999999999999999999999999 99999999999986
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
...... ....+.||||.|+ |||++. ..|+|++|++ ++|++|..||.+.... .....+......+|
T Consensus 183 ~~~~~~-~~~~~~~GTp~Ym---APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~~~~~~p 254 (311)
T 4aw0_A 183 SPESKQ-ARANSFVGTAQYV---SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG----LIFAKIIKLEYDFP 254 (311)
T ss_dssp CTTTTC-CCBCCCCSCGGGC---CHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCC
T ss_pred CCCCCc-ccccCcccCcccC---CHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCC
Confidence 432222 2345679999999 999864 4688999965 5799999999742110 01123344556666
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHH------HhcCCCCCCCCccccccCCCCCc
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQ------VRRLPMFKDYDWDSILDQEPPFV 319 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~e------il~HPFF~~idw~~l~~~~pPf~ 319 (473)
..+|+++++||.+||++||++|||++| |++||||+++||+.|.+++||..
T Consensus 255 ---~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 255 ---EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp ---TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred ---cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 589999999999999999999999887 69999999999999999888753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-62 Score=523.78 Aligned_cols=313 Identities=23% Similarity=0.398 Sum_probs=252.2
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHH---HHhcCCCCeeeEEEEE
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA---LALTHSPFCVQLFYSL 111 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~i---L~~l~hp~Iv~l~~~f 111 (473)
...+++++|+++++||+|+||+||+|+++. +|+.||||++++..+........+.+|+.+ ++.++|||||+++++|
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~-tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f 261 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 261 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECC-CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence 457889999999999999999999999887 689999999998776555555566666554 4566899999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
++.+++|||||||+||+|.++|.+.+.|+|..+++|++||+.||+|||++|||||||||+||||+.+ |++||+|||+|+
T Consensus 262 ~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~-G~vKL~DFGlA~ 340 (689)
T 3v5w_A 262 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLAC 340 (689)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred EECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC-CCEEecccceee
Confidence 9999999999999999999999999999999999999999999999999999999999999999999 999999999998
Q ss_pred hhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhcc
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQL 263 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 263 (473)
.+... ...+.||||.|+ |||++. .+|+|++|++ ++|++|.+||.+....... .....+.....
T Consensus 341 ~~~~~-----~~~t~~GTp~Ym---APEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~i~~~i~~~~~ 411 (689)
T 3v5w_A 341 DFSKK-----KPHASVGTHGYM---APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAV 411 (689)
T ss_dssp ECSSC-----CCCSCCSCGGGC---CHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-HHHHHHHHCCC
T ss_pred ecCCC-----CCCCccCCcCcc---CHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhhcCCCC
Confidence 75432 234569999999 999874 2588999976 5699999999753110000 00112233445
Q ss_pred CCCCccccCChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCC-----
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYF----- 331 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~F----- 331 (473)
.+| ..+|+++++||.+||++||.+|+| ++||++||||++|||+.|.++ .|||+|.+.+..|+++|
T Consensus 412 ~~p---~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~~~fD~~~f 488 (689)
T 3v5w_A 412 ELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSF 488 (689)
T ss_dssp CCC---TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTTBCCC----
T ss_pred CCC---ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCcCCCCCCccC
Confidence 556 689999999999999999999997 799999999999999999877 79999988766555555
Q ss_pred CCCCCCCCCCCCCCccCCCCCceecccCCCCCCCCccccCchhhh
Q psy622 332 HADKTNSYMDSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPSALY 376 (473)
Q Consensus 332 d~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~~~ 376 (473)
|++++.... ....++..|.||+|..|....
T Consensus 489 d~e~~~~~~---------------~~~~d~~~f~~Fs~~~~~~~q 518 (689)
T 3v5w_A 489 DEEDTKGIK---------------LLDSDQELYRNFPLTISERWQ 518 (689)
T ss_dssp -----CCCC---------------CCHHHHTTTTTCCEECHHHHH
T ss_pred CccccCCCC---------------CCchHHHHHhCCCccCccchh
Confidence 444443210 122367889999998766543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-60 Score=489.15 Aligned_cols=326 Identities=28% Similarity=0.460 Sum_probs=265.1
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQT 113 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~ 113 (473)
.....+++|+++++||+|+||+||+|+++. +++.||||++++.........+.+.+|+.+|..+ +||||++++++|++
T Consensus 46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~ 124 (396)
T 4dc2_A 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKK-TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 124 (396)
T ss_dssp ---CCGGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ccCCChhHcEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence 345678999999999999999999999887 6899999999988766666667889999999887 89999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
...+|+||||++||+|..++.+.+.+++..+++|++||+.||+|||++||+||||||+||||+.+ |++||+|||+|+..
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG 203 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCC
T ss_pred CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC-CCEEEeecceeeec
Confidence 99999999999999999999998899999999999999999999999999999999999999999 99999999999863
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcC-CCC----ChhhHhhh
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAG-SQI----PTSTAAQL 261 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~-~~~----~~~~~~~~ 261 (473)
... .......+|||.|+ |||++. ..|+|++|++ ++|++|..||........ ... ....+...
T Consensus 204 ~~~---~~~~~~~~gt~~Y~---aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~ 277 (396)
T 4dc2_A 204 LRP---GDTTSTFCGTPNYI---APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277 (396)
T ss_dssp CCT---TCCBCCCCBCGGGC---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC
T ss_pred ccC---CCccccccCCcccC---CchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc
Confidence 221 12234568999998 899764 4688999966 579999999964211100 000 11223334
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCCH------HHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCC
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSG------HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHA 333 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa------~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~ 333 (473)
...+| ..+++++++||++||++||.+|||+ +||++||||+++||+.+.++ .|||+|.++++.|++|||+
T Consensus 278 ~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~ 354 (396)
T 4dc2_A 278 QIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDS 354 (396)
T ss_dssp CCCCC---TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCH
T ss_pred ccCCC---CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcCh
Confidence 55666 6899999999999999999999985 79999999999999999876 7999999999999999999
Q ss_pred CCCCCCCCCCCCccCCCCCceecccCCCCCCCCccccCchhhhc
Q psy622 334 DKTNSYMDSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPSALYS 377 (473)
Q Consensus 334 ~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~~~~ 377 (473)
+||++++..+..+.... +.+++..|.||+|++|..+..
T Consensus 355 ~~~~~~~~~~~~~~~~~------~~~~~~~f~~f~~~~~~~~~~ 392 (396)
T 4dc2_A 355 QFTNEPVQLTPDDDDIV------RKIDQSEFEGFEYINPLLMSA 392 (396)
T ss_dssp HHHTSCCCCCCCCHHHH------TTSCGGGGTTCCEECC-----
T ss_pred hhccCCCccCCCcchhh------ccccccccCCcEeECcccccc
Confidence 99998766554433211 345778999999999998753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-61 Score=473.46 Aligned_cols=270 Identities=30% Similarity=0.505 Sum_probs=222.1
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
.....++|++++.||+|+||+||+|++.. .+++.||||++++...... ...++.+|+++|+.++|||||+++++|++
T Consensus 19 ~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp CCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEE
T ss_pred ccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 44556899999999999999999998753 3578999999988654322 23468889999999999999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
++.+|||||||+||+|.++|.+.+.+++.+++.|++||+.||+|||++|||||||||+|||++.+ |++||+|||+|+..
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKES 176 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-SCEEEESSEEEEC-
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC-CCEEecccccceec
Confidence 99999999999999999999999999999999999999999999999999999999999999999 99999999999864
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
.... ....+.+|||.|+ |||++. ..|+||+|++ ++|++|..||.+.... .....+......+|
T Consensus 177 ~~~~---~~~~~~~GT~~Ym---APE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~~~~~~~p 246 (304)
T 3ubd_A 177 IDHE---KKAYSFCGTVEYM---APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK----ETMTMILKAKLGMP 246 (304)
T ss_dssp -------CCCCSCCCCGGGC---CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCC
T ss_pred cCCC---ccccccccCcccC---CHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH----HHHHHHHcCCCCCC
Confidence 3221 2234578999999 999764 4688999965 6799999999752110 01122333455555
Q ss_pred CccccCChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVP 320 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P 320 (473)
..+|+++++||.+||++||++||| ++|+++||||+++||+.+.++ +|||+|
T Consensus 247 ---~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 247 ---QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred ---CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 689999999999999999999998 489999999999999999877 799998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-59 Score=473.81 Aligned_cols=321 Identities=29% Similarity=0.454 Sum_probs=260.5
Q ss_pred ccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q psy622 33 SCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSL 111 (473)
Q Consensus 33 ~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 111 (473)
.....+.+++|+++++||+|+||+||+|+++. +++.||||++++...........+.+|+.+|+.+ +||||++++++|
T Consensus 15 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 15 NSSNRLGIDNFEFIRVLGKGSFGKVMLARVKE-TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp --------CCEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCcCCCchhheEEEEEEeeCCCEEEEEEEEcC-CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 34456778999999999999999999999886 6789999999987665666678899999999988 799999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
++.+.+|+||||++||+|..++.+.+.+++..++.|++||+.||+|||++||+||||||+|||++.+ |++||+|||+|+
T Consensus 94 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-g~ikL~DFG~a~ 172 (353)
T 3txo_A 94 QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCK 172 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCB
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC-CCEEEcccccee
Confidence 9999999999999999999999998899999999999999999999999999999999999999999 999999999998
Q ss_pred hhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccC
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 264 (473)
..... .......+||+.|+ |||++. ..|+|++|++ ++|++|..||...... .....+......
T Consensus 173 ~~~~~---~~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~~~~ 242 (353)
T 3txo_A 173 EGICN---GVTTATFCGTPDYI---APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED----DLFEAILNDEVV 242 (353)
T ss_dssp CSCC------------CCGGGC---CHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCC
T ss_pred ecccC---CccccccCCCcCeE---ChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCC
Confidence 63221 12234568999998 999753 4789999965 5799999999752110 011233334555
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCH------HHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCC
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSG------HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKT 336 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa------~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t 336 (473)
+| ..+++++++||++||++||.+||++ +|+++||||++++|+.+..+ +|||+|.+.+..|++|||.+++
T Consensus 243 ~p---~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~~~~~ 319 (353)
T 3txo_A 243 YP---TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFI 319 (353)
T ss_dssp CC---TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCHHHH
T ss_pred CC---CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCcccccccCcccc
Confidence 66 5799999999999999999999998 89999999999999999876 7999999999999999999999
Q ss_pred CCCCCCCCCccCCCCCceecccCCCCCCCCccccCchh
Q psy622 337 NSYMDSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPSA 374 (473)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~ 374 (473)
.+.+..+..+... ...+++..|.||+|++|+.
T Consensus 320 ~~~~~~~~~~~~~------~~~~~~~~f~~f~~~~~~~ 351 (353)
T 3txo_A 320 KEEPVLTPIDEGH------LPMINQDEFRNFEYVSPEL 351 (353)
T ss_dssp TSCCCCCCCCTTS------GGGSCGGGGTTCCEECC--
T ss_pred cCCCcCCCccccc------cCcccccccCCceeeCccc
Confidence 8755433222211 1345678999999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-58 Score=461.98 Aligned_cols=319 Identities=28% Similarity=0.465 Sum_probs=232.6
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTS 114 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 114 (473)
....+++|+++++||+|+||+||+|+++. +++.||||++++...........+.+|+.+|..+ +||||++++++|++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 45678999999999999999999999886 6899999999987654455677889999999887 999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+|+||||++||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+ |++||+|||+++...
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENM 169 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC-CCEEEeEChhhhhcc
Confidence 9999999999999999999988899999999999999999999999999999999999999999 999999999998642
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
... ......+||+.|+ |||++. ..|+|++|++ ++|++|..||...... .....+......+|
T Consensus 170 ~~~---~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~p- 238 (345)
T 1xjd_A 170 LGD---AKTNTFCGTPDYI---APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIRMDNPFYP- 238 (345)
T ss_dssp CTT---CCBCCCCSCGGGC---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCC-
T ss_pred cCC---CcccCCCCCcccC---ChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHHhCCCCCC-
Confidence 211 1234568999998 899764 3688899965 5799999999742110 00112222344455
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHH-HHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGH-QVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTL 344 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~-eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~ 344 (473)
..+++++++||.+||+.||++|||+. ||++||||++++|+.+.++ .|||+|.+.++.|++|||.+++++....+.
T Consensus 239 --~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~ 316 (345)
T 1xjd_A 239 --RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSF 316 (345)
T ss_dssp --TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC----------------------------
T ss_pred --cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcchhhcccCccCCc
Confidence 68999999999999999999999998 9999999999999999876 799999999999999999999887554333
Q ss_pred CccCCCCCceecccCCCCCCCCccccCchhh
Q psy622 345 STTHGNGSFVCCSNLNSHTASGMDVDSPSAL 375 (473)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~~ 375 (473)
.+.... ...++..|.||+|++|+..
T Consensus 317 ~~~~~~------~~~~~~~f~~f~~~~~~~~ 341 (345)
T 1xjd_A 317 ADRALI------NSMDQNMFRNFSFMNPGME 341 (345)
T ss_dssp ----------------CCTTTTCCC------
T ss_pred cccccc------ccccccccCCCeeeChhhh
Confidence 222111 2346789999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=457.73 Aligned_cols=320 Identities=26% Similarity=0.423 Sum_probs=259.4
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+++++|++++.||+|+||+||+|+++. +++.||||++++..........++.+|+++|+.++||||++++++|++.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence 567899999999999999999999876 6899999999987655556677899999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ |++||+|||+++......
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC-CCEEEeeccchhhcccCC
Confidence 9999999999999999988899999999999999999999999999999999999999999 999999999998632211
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~ 270 (473)
......+||+.|+ |||++. ..|+|++|++ ++|++|..||...... .....+......+| .
T Consensus 160 ---~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~p---~ 226 (337)
T 1o6l_A 160 ---ATMKTFCGTPEYL---APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEEIRFP---R 226 (337)
T ss_dssp ---CCBCCCEECGGGC---CGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCC---T
T ss_pred ---CcccccccChhhC---ChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCC---C
Confidence 1234568999998 899764 4678899965 5799999999642110 00122233445566 5
Q ss_pred cCChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDST 343 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~ 343 (473)
.+++++++||.+||++||++|| +++|+++||||++++|+.+.++ .|||+|.+.++.|++|||.+++.+....+
T Consensus 227 ~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~ 306 (337)
T 1o6l_A 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITIT 306 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC--
T ss_pred CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhcccchhccCccCcC
Confidence 7999999999999999999999 8999999999999999999876 79999999999999999999988765444
Q ss_pred CCccCCC-CCceecccCCCCCCCCccccCc
Q psy622 344 LSTTHGN-GSFVCCSNLNSHTASGMDVDSP 372 (473)
Q Consensus 344 ~~~~~~~-~~~~~~~~~~~~~f~g~~~~~p 372 (473)
..+.... .........++..|.||+|+++
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 336 (337)
T 1o6l_A 307 PPDRYDSLGLLELDQREEQEMFEDFDYIAD 336 (337)
T ss_dssp ------------------CCTTTTCCEECC
T ss_pred CCcccccccccccccccccccCCCceecCC
Confidence 3221111 0000001124679999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-58 Score=463.27 Aligned_cols=320 Identities=27% Similarity=0.432 Sum_probs=261.5
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTS 114 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 114 (473)
....+++|+++++||+|+||+||+|+++. +++.||||++++.........+.+.+|+.+|..+ +||||++++++|++.
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETT-EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 45678999999999999999999999876 6789999999987655555677899999999987 899999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
+.+|+||||++||+|.+++.+.+.+++..++.|++||+.||+|||++||+||||||+|||++.+ |++||+|||+++...
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENI 172 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC-CcEEEEeCCcccccc
Confidence 9999999999999999999988899999999999999999999999999999999999999999 999999999998632
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
... ......+|||.|+ |||++. ..|+|++|++ ++|++|..||...... .....+......+|
T Consensus 173 ~~~---~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~~~~~p- 241 (353)
T 2i0e_A 173 WDG---VTTKTFCGTPDYI---APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEHNVAYP- 241 (353)
T ss_dssp CTT---CCBCCCCSCGGGC---CHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCC-
T ss_pred cCC---cccccccCCcccc---ChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH----HHHHHHHhCCCCCC-
Confidence 211 2234568999998 899764 4688999965 5799999999742110 01122333445566
Q ss_pred ccccCChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYM 340 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~ 340 (473)
..+++++++||.+||++||.+||+ ++||++||||+++||+.+.++ .|||+|.+.+. |++|||..++.+..
T Consensus 242 --~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~-~~~~f~~~~~~~~~ 318 (353)
T 2i0e_A 242 --KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTRHPP 318 (353)
T ss_dssp --TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC---CHHHHHHHHSCC
T ss_pred --CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc-chhhccchhccCCc
Confidence 589999999999999999999995 699999999999999999876 79999999999 99999998887654
Q ss_pred CCCCCccCCCCCceecccCCCCCCCCccccCchhhhc
Q psy622 341 DSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPSALYS 377 (473)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~~~~ 377 (473)
..+..+.. .....++..|.||+|++|+.+..
T Consensus 319 ~~~~~~~~------~~~~~~~~~f~~f~~~~~~~~~~ 349 (353)
T 2i0e_A 319 VLTPPDQE------VIRNIDQSEFEGFSFVNSEFLKP 349 (353)
T ss_dssp CCCCCCHH------HHHHSCTTTTCSCCEECTTCCCC
T ss_pred ccCCcccc------ccccccccccCCCeeeCccccCh
Confidence 43322110 01224678999999999987543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-57 Score=455.05 Aligned_cols=321 Identities=28% Similarity=0.471 Sum_probs=264.9
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTS 114 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 114 (473)
....+++|++++.||+|+||+||+|+++. +++.||||++++.........+.+.+|+.++..+ +||||++++++|++.
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKK-TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 45678899999999999999999999876 6899999999988766677788899999999988 899999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+|+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ |++||+|||+++...
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGL 161 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCGGGCBCSC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEEecccccccc
Confidence 9999999999999999999988899999999999999999999999999999999999999999 999999999998632
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCC--CC---ChhhHhhhc
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGS--QI---PTSTAAQLQ 262 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~--~~---~~~~~~~~~ 262 (473)
... ......+||+.|+ |||++. ..|+|++|++ ++|++|..||......... .. ....+....
T Consensus 162 ~~~---~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~ 235 (345)
T 3a8x_A 162 RPG---DTTSTFCGTPNYI---APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235 (345)
T ss_dssp CTT---CCBCCCCSCGGGC---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC
T ss_pred CCC---CcccccCCCcccc---CccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC
Confidence 211 2234568999998 899764 3688899965 5799999999642110000 00 011223344
Q ss_pred cCCCCccccCChhHHHHHHhccccCCCCCCCH------HHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCC
Q psy622 263 LEWPEDEEALNPSTEETILALLKSDPTQRPSG------HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHAD 334 (473)
Q Consensus 263 ~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa------~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~ 334 (473)
..+| ..+++++++||.+||+.||.+|||+ +|+++||||++++|+.+.++ .|||+|.+.++.|+++||.+
T Consensus 236 ~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~ 312 (345)
T 3a8x_A 236 IRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQ 312 (345)
T ss_dssp CCCC---TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCGGGSCHH
T ss_pred CCCC---CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcc
Confidence 5555 5799999999999999999999985 89999999999999999876 79999999999999999999
Q ss_pred CCCCCCCCCCCccCCCCCceecccCCCCCCCCccccCch
Q psy622 335 KTNSYMDSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPS 373 (473)
Q Consensus 335 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~ 373 (473)
++++....+..+... .....+..|.||+|++|.
T Consensus 313 ~~~~~~~~~~~~~~~------~~~~~~~~f~~f~~~~~~ 345 (345)
T 3a8x_A 313 FTNEPVQLTPDDDDI------VRKIDQSEFEGFEYINPL 345 (345)
T ss_dssp HHTSCSSCCCCCHHH------HTTSCGGGGTTCCEECCC
T ss_pred cccCcccCCCccccc------cccccccccCCCEeeCCC
Confidence 888765433222110 122466789999999884
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=461.27 Aligned_cols=327 Identities=26% Similarity=0.430 Sum_probs=225.6
Q ss_pred ccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhcCCCCeeeEEEEE
Q psy622 33 SCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHSPFCVQLFYSL 111 (473)
Q Consensus 33 ~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~f 111 (473)
.......+++|+++++||+|+||+||+|+++. +++.||||++++..........++.+|+.++ +.++||||++++++|
T Consensus 30 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 30 SSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA-EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp TBCTTCCGGGEEEEEEEECCTTCEEEEEEETT-TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE
T ss_pred CCCCCCChhheEEEEEEeeCCCeEEEEEEEcC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 33456778999999999999999999999876 6789999999998776666677888898874 668999999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
++.+.+|+||||++||+|.+++.+.+.+++..+++|++||+.||+|||++||+||||||+|||++.+ |++||+|||+++
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~ikL~DFG~a~ 187 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCK 187 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCBCG
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEeeCcccc
Confidence 9999999999999999999999998899999999999999999999999999999999999999999 999999999998
Q ss_pred hhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccC
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 264 (473)
...... ......+||+.|+ |||++. ..|+|++|++ ++|++|..||...... .....+......
T Consensus 188 ~~~~~~---~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~~~~ 257 (373)
T 2r5t_A 188 ENIEHN---STTSTFCGTPEYL---APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----EMYDNILNKPLQ 257 (373)
T ss_dssp GGBCCC---CCCCSBSCCCCCC---CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH----HHHHHHHHSCCC
T ss_pred ccccCC---CccccccCCcccc---CHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHhcccC
Confidence 743221 2234568999998 899754 4688899965 5799999999642110 001222333445
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCH----HHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCC
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSG----HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNS 338 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa----~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~ 338 (473)
+| ..+++++++||.+||++||.+||++ +|+++||||+++||+.+.++ .|||+|.+.++.|++|||.+++++
T Consensus 258 ~~---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~ 334 (373)
T 2r5t_A 258 LK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEE 334 (373)
T ss_dssp CC---SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC--------------
T ss_pred CC---CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcchhhhcCcccccc
Confidence 55 5799999999999999999999986 69999999999999999876 799999999999999999999987
Q ss_pred CCCCCCCccCCCCCceecc-cCCCCCCCCccccCchhh
Q psy622 339 YMDSTLSTTHGNGSFVCCS-NLNSHTASGMDVDSPSAL 375 (473)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~-~~~~~~f~g~~~~~p~~~ 375 (473)
............ .....+ .-.+..|.||+|++|+.+
T Consensus 335 ~~~~~~~~~~~~-~~~~~~~~~~~~~f~~f~~~~~~~~ 371 (373)
T 2r5t_A 335 PVPNAIGKAPDS-VLVTASVKEAAEAFLGFSYAPPTDS 371 (373)
T ss_dssp --------------------------------------
T ss_pred cccccccCCccc-cccccccccccccCCCCcccCchhh
Confidence 643222111100 000011 113467999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-57 Score=462.84 Aligned_cols=323 Identities=31% Similarity=0.467 Sum_probs=259.1
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
....++|+++++||+|+||+||+|+++. +++.||||++++.........+.+.+|+.+++.++||||++++++|++...
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKS-TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECC-CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 4567899999999999999999999886 678999999998655444445578899999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+||||++||+|.+++++. .+++..+++|++||+.||+|||++||+||||||+|||++.+ |++||+|||+|+.+...
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred EEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC-CCEEEeccceeEeeccC
Confidence 99999999999999999864 79999999999999999999999999999999999999999 99999999999875432
Q ss_pred ccccccccccCCCCcccccCCccccc----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh--hcc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ--LQL 263 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~ 263 (473)
. .......+|||.|+ |||++. ..|+|++|++ ++|++|..||....... ....+.. ...
T Consensus 222 ~--~~~~~~~~gt~~Y~---APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~~~~~ 292 (410)
T 3v8s_A 222 G--MVRCDTAVGTPDYI---SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYSKIMNHKNSL 292 (410)
T ss_dssp S--EEECCSCCSCGGGC---CHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTHHHHC
T ss_pred C--cccccCCcCCcccc---CHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh----HHHHHHhccccc
Confidence 2 12234568999999 899763 4688999966 57999999997421100 0011111 234
Q ss_pred CCCCccccCChhHHHHHHhccccCCCC--CCCHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCC
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQ--RPSGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSY 339 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~k--Rpsa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~ 339 (473)
.+|.. ..+++++++||++||+.+|.+ |++++||++||||++++|+.+..+ .|||+|.+.++.|++|||..++.+.
T Consensus 293 ~~p~~-~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~~~~~~~ 371 (410)
T 3v8s_A 293 TFPDD-NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKG 371 (410)
T ss_dssp CCCTT-CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCCCCSCCS
T ss_pred cCCCc-ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhcCCcccccc
Confidence 55532 479999999999999999988 999999999999999999887655 8999999999999999999887654
Q ss_pred CCCCCCccCCCCCceecccCCCCCCCCccccCchhhhccc
Q psy622 340 MDSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPSALYSKL 379 (473)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~~~~~~ 379 (473)
...+...+.. ...++..|.||+|++|..+-.+.
T Consensus 372 ~~~~~~~~~~-------~~~~~~~f~~f~~~~~~~~~~~~ 404 (410)
T 3v8s_A 372 EEETFPIPKA-------FVGNQLPFVGFTYYSNRRYLSSA 404 (410)
T ss_dssp CCCCCCCCSS-------CCCTTGGGTTCCEECC-------
T ss_pred ccccCCCchh-------hcccccccccceEeCcccccccC
Confidence 3322221111 11357899999999998876553
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=463.22 Aligned_cols=326 Identities=27% Similarity=0.438 Sum_probs=259.7
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
....++|+++++||+|+||+||+|+++. +++.||||++++...........+.+|+.++..++||||++++++|++.+.
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKN-ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcC-CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 4456899999999999999999999886 679999999998655444445568999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
+|+|||||+||+|.++|.+ .+.+++..++.|++||+.||+|||++|||||||||+||||+.+ |++||+|||+|+.+..
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC-CCEEEcchhhhhhccc
Confidence 9999999999999999987 5689999999999999999999999999999999999999999 9999999999987533
Q ss_pred CccccccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh--hh
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA--QL 261 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~--~~ 261 (473)
... ......+||+.|+ |||++. ..|+|++|++ ++|++|..||....... ....+. ..
T Consensus 228 ~~~--~~~~~~~GT~~Y~---APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~ 298 (437)
T 4aw2_A 228 DGT--VQSSVAVGTPDYI---SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TYGKIMNHKE 298 (437)
T ss_dssp TSC--EECCSCCSCGGGC---CHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTHHH
T ss_pred CCC--cccccccCCcCee---ChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH----HHHhhhhccc
Confidence 221 2233468999998 999865 4688999965 57999999997421100 001111 13
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCC--CCCHHHHhcCCCCCCCCccccccCCCCCcCCCCCCCCCCCCCCCCCCCC
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQ--RPSGHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDTSYFHADKTNSY 339 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~k--Rpsa~eil~HPFF~~idw~~l~~~~pPf~P~~~~~~D~s~Fd~~~t~~~ 339 (473)
...+|.....+++++++||++||+.+|++ |++++|+++||||+++||+.+.+.+|||+|.+.++.|++|||.+++...
T Consensus 299 ~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~~P~~~~~~d~~~fd~~~~~~~ 378 (437)
T 4aw2_A 299 RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLK 378 (437)
T ss_dssp HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSCCCCCSSTTCCTTSCCC-----
T ss_pred cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCCCCcCCCccchhhcCCcccccc
Confidence 45667555679999999999999998888 9999999999999999999998779999999999999999999886543
Q ss_pred CCCCCCccCCCCCceecccCCCCCCCCccccCchhhhcc
Q psy622 340 MDSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPSALYSK 378 (473)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~~~~~ 378 (473)
...+..+.... . ..-.+..|.||+|++++.+...
T Consensus 379 ~~~~~~~~~~~-~----~~~~~~~f~~~~~~~~~~~~~~ 412 (437)
T 4aw2_A 379 NSETMPPPTHT-A----FSGHHLPFVGFTYTSSCVLSDR 412 (437)
T ss_dssp ------------------CCTTGGGTTCCEESSCTTSTT
T ss_pred cccCCCCCccc-c----ccccCccccCCCcCCchhhccC
Confidence 32222211111 0 1113468999999999987544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=457.82 Aligned_cols=325 Identities=30% Similarity=0.431 Sum_probs=251.1
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
....++|+++++||+|+||+||+|+++. +++.||||++++.........+.+.+|+.+|..++||||++++++|++.++
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~-~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQ-TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 4567899999999999999999999876 689999999998665555556678999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
+|+||||++||+|.+++.+.+ .+++..+++|++||+.||+|||++|||||||||+|||++.+ |++||+|||+++.+..
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~-g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC-CCEEEeechhheeccC
Confidence 999999999999999998754 79999999999999999999999999999999999999999 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc-------------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-------------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ- 260 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-------------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~- 260 (473)
... ......+||+.|+ |||++. ..|+|++|++ ++|++|..||....... ....+..
T Consensus 215 ~~~--~~~~~~~Gt~~Y~---APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~ 285 (412)
T 2vd5_A 215 DGT--VRSLVAVGTPDYL---SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE----TYGKIVHY 285 (412)
T ss_dssp TSC--EECSSCCSCGGGC---CHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTH
T ss_pred CCc--cccceeccccCcC---CHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH----HHHHHHhc
Confidence 221 1223468999998 999764 3688999965 57999999997521100 0011111
Q ss_pred -hccCCCCccccCChhHHHHHHhccccCCCCCC---CHHHHhcCCCCCCCCccccccCCCCCcCCCCCCCCCCCCCCCCC
Q psy622 261 -LQLEWPEDEEALNPSTEETILALLKSDPTQRP---SGHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDTSYFHADKT 336 (473)
Q Consensus 261 -~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRp---sa~eil~HPFF~~idw~~l~~~~pPf~P~~~~~~D~s~Fd~~~t 336 (473)
....+|.....+++++++||++||+ +|.+|+ +++|+++||||+++||+.+.+..|||+|.+.++.|++|||...+
T Consensus 286 ~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~ 364 (412)
T 2vd5_A 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVED 364 (412)
T ss_dssp HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC-----CCSSCC--CC
T ss_pred ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCcCCCcccccccCcccc
Confidence 2344554446799999999999999 999985 79999999999999999998889999999999999999997543
Q ss_pred CCCC-CC----CCCccCCCCCceecccCCCCCCCCccccCchhhhcc
Q psy622 337 NSYM-DS----TLSTTHGNGSFVCCSNLNSHTASGMDVDSPSALYSK 378 (473)
Q Consensus 337 ~~~~-~~----~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~~~~~ 378 (473)
.... .+ +.++.... . ..-.+..|.||+|+++....+.
T Consensus 365 ~~~~~~~~~~~~~~~~~~~----~-~~~~~~~f~g~~~~~~~~~~~~ 406 (412)
T 2vd5_A 365 GLTAMVSGGGETLSDIREG----A-PLGVHLPFVGYSYSCMALRDSE 406 (412)
T ss_dssp CCCTTSSSSSCCTTTC----------CCTTGGGTTCCBSCCCCCGGG
T ss_pred cccccccccCCCcccccCC----C-ccccCCCCCCCcccCccccccc
Confidence 3211 11 11111100 0 1113468999999988754443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-57 Score=490.01 Aligned_cols=320 Identities=27% Similarity=0.430 Sum_probs=268.2
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTS 114 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 114 (473)
....+++|+++++||+|+||+||+|+++. +++.||||++++.........+.+.+|+.+|..+ +||||++++++|++.
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESS-SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECC-CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 45678999999999999999999999887 6789999999987655556677899999999987 799999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+||||||++||+|..+|.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+ |++||+|||+++...
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~-g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENI 493 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS-SCEEECCCTTCEECC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC-CcEEEeecceeeccc
Confidence 9999999999999999999998899999999999999999999999999999999999999999 999999999998632
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
... ......+||+.|+ |||++. ..|+|++|++ ++|++|..||...... .....+......+|
T Consensus 494 ~~~---~~~~~~~GT~~Y~---APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~----~~~~~i~~~~~~~p- 562 (674)
T 3pfq_A 494 WDG---VTTKTFCGTPDYI---APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEHNVAYP- 562 (674)
T ss_dssp CTT---CCBCCCCSCSSSC---CHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHSSCCCCC-
T ss_pred cCC---cccccccCCCccc---CHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH----HHHHHHHhCCCCCC-
Confidence 211 2234568999998 999764 4688999965 5799999999752110 01123333455566
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCH-----HHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSG-----HQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYM 340 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa-----~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~ 340 (473)
..+++++++||++||++||.+||++ +||++||||+++||+.+.++ .|||+|.+.+ .|++|||.+||++.+
T Consensus 563 --~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~-~~~~~f~~~~~~~~~ 639 (674)
T 3pfq_A 563 --KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG-RNAENFDRFFTRHPP 639 (674)
T ss_dssp --TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG-GGHHHHTTTTTSSCS
T ss_pred --ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC-CchhhcCchhccCCC
Confidence 6899999999999999999999987 99999999999999999877 7999999998 999999999999866
Q ss_pred CCCCCccCCCCCceecccCCCCCCCCccccCchhhhc
Q psy622 341 DSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPSALYS 377 (473)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~~~~ 377 (473)
..+..+... ...+++..|.||+|++|+.+..
T Consensus 640 ~~~~~~~~~------~~~~~~~~f~~f~~~~~~~~~~ 670 (674)
T 3pfq_A 640 VLTPPDQEV------IRNIDQSEFEGFSFVNSEFLKP 670 (674)
T ss_dssp SCCCCCHHH------HTTCCGGGGTTCCEECSSCCCC
T ss_pred ccCCCchhh------hhcccccccCCCcccChhhhch
Confidence 544433211 1345778999999999988654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-56 Score=433.70 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=198.3
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
..+++|++++.||+|+||+||+|+++. +++.||||++++..........++.+|+++|+.++|||||+++++|++++.+
T Consensus 10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 10 AHIGNYQIVKTLGEGSFGKVKLAYHTT-TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp ----CCEEEEEEEC---CCEEEEECTT-TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CEeeCeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 347899999999999999999998876 6899999999987766666677899999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+||||| +|+|.++|.+.+.+++.+++.++.||+.||+|||++|||||||||+|||++.+ +++||+|||+|+......
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-CCEEECCSSCC-------
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC-CCEEEeecCCCeecCCCC
Confidence 9999999 78999999999999999999999999999999999999999999999999999 999999999998754322
Q ss_pred cccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
...+.+|||.|+ |||++. ..|+|++|++ ++|++|..||...... .....+......+|
T Consensus 167 ----~~~~~~GT~~Y~---APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~----~~~~~i~~~~~~~p--- 232 (275)
T 3hyh_A 167 ----FLKTSCGSPNYA---APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP----VLFKNISNGVYTLP--- 232 (275)
T ss_dssp ------------CTTS---CHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCC---
T ss_pred ----ccCCeeECcccC---ChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHcCCCCCC---
Confidence 234568999999 999763 3578899965 5799999999742110 01122333445555
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
..+|+++++||.+||++||++|||++|+++||||+
T Consensus 233 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 233 KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 68999999999999999999999999999999996
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=442.48 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=207.7
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
.++++|++++.||+|+||+||+|+++. +++.||||++++... .....+++.+|+++|+.++|||||+++++|++++.+
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTE-DGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSL 98 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETT-TCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CcccceEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence 357899999999999999999999887 689999999998754 344577899999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 118 FLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
|||||||+||+|.++|... ..++|.+++.|+.||+.||+|||++|||||||||+||||+.+ |++||+|||+|+.+..
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT-CCEEECSTTEESCCCH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CCEEEcccccceeecC
Confidence 9999999999999999764 358999999999999999999999999999999999999999 9999999999997543
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhH-hhhccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTA-AQLQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~P~ 267 (473)
. .......+|||.|+ |||++. ..|+|++|++ ++|++|..||.+... .... ......+|.
T Consensus 178 ~---~~~~~~~~GT~~Ym---APE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~~~ 244 (350)
T 4b9d_A 178 T---VELARACIGTPYYL---SPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-------KNLVLKIISGSFPP 244 (350)
T ss_dssp H---HHHHHHHHSCCTTC---CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCCC
T ss_pred C---cccccccCCCcccc---CHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCCCCC
Confidence 2 12234568999999 999865 3688999965 679999999975211 1111 111223344
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.+..+|+++++||.+||++||++|||++|+++||||+.
T Consensus 245 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 44689999999999999999999999999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-55 Score=440.07 Aligned_cols=315 Identities=27% Similarity=0.473 Sum_probs=262.4
Q ss_pred CCccchhhHHHHhHhhhcccccccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHH
Q psy622 7 FSGADKENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMV 86 (473)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~ 86 (473)
-.....+.+.+.+..+.+.....+.........+++|++++.||+|+||+||+|+++. +++.||||++++.........
T Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~ 85 (350)
T 1rdq_E 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQI 85 (350)
T ss_dssp -------CHHHHHHHHHHHHHHHHHSCCCCCCCGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCH
T ss_pred ccccchhhHHHHhhhhHHHHHhhhccccccCCCHHHCEEEEEeecCcCcEEEEEEECC-CCCEEEEEEEEhHHhccHHHH
Confidence 3444455566666666666666666666778889999999999999999999999876 678999999998765555567
Q ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Q psy622 87 SQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHR 166 (473)
Q Consensus 87 ~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHR 166 (473)
+++.+|+++|+.++||||+++++++++...+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||
T Consensus 86 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr 165 (350)
T 1rdq_E 86 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165 (350)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 78999999999999999999999999999999999999999999999988899999999999999999999999999999
Q ss_pred CCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCC
Q psy622 167 DLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQ 239 (473)
Q Consensus 167 DLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~ 239 (473)
||||+|||++.+ |++||+|||+++..... ....+||+.|+ |||++. ..|+|++|++ ++|++|.
T Consensus 166 Dlkp~NIll~~~-g~~kL~DFg~a~~~~~~------~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~g~ 235 (350)
T 1rdq_E 166 DLKPENLLIDQQ-GYIQVTDFGFAKRVKGR------TWTLCGTPEAL---APEIILSKGYNKAVDWWALGVLIYEMAAGY 235 (350)
T ss_dssp CCSGGGEEECTT-SCEEECCCTTCEECSSC------BCCCEECGGGC---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cCccceEEECCC-CCEEEcccccceeccCC------cccccCCcccc---CHHHhcCCCCCCcCCEecccHhHhHHhhCC
Confidence 999999999999 99999999999875332 22457999988 898754 4678899965 5799999
Q ss_pred CCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC
Q psy622 240 APFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ 314 (473)
Q Consensus 240 ~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~ 314 (473)
.||...... .....+......+| ..+++++++||.+||+.||.+||+ ++||++||||+++||+.+.++
T Consensus 236 ~Pf~~~~~~----~~~~~i~~~~~~~p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~ 308 (350)
T 1rdq_E 236 PPFFADQPI----QIYEKIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308 (350)
T ss_dssp CSSCCSSHH----HHHHHHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTT
T ss_pred CCCCCCCHH----HHHHHHHcCCCCCC---CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhc
Confidence 999642110 00122333445556 579999999999999999999998 999999999999999999876
Q ss_pred --CCCCcCCCCCCCCCCCCCCCCCCCCC
Q psy622 315 --EPPFVPQPDDVFDTSYFHADKTNSYM 340 (473)
Q Consensus 315 --~pPf~P~~~~~~D~s~Fd~~~t~~~~ 340 (473)
+|||+|.+.++.|++||| +++.+..
T Consensus 309 ~~~~p~~p~~~~~~~~~~f~-~~~~~~~ 335 (350)
T 1rdq_E 309 KVEAPFIPKFKGPGDTSNFD-DYEEEEI 335 (350)
T ss_dssp CSCCSCCCCCCSTTCCTTSC-CCCCCCC
T ss_pred cCCCCCCCCCCCcccccccc-ccccccc
Confidence 799999999999999999 5665543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-55 Score=437.56 Aligned_cols=250 Identities=19% Similarity=0.306 Sum_probs=208.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.|++++.||+|+||+||+|+++. +|+.||||++++..... .+.+.+|+++|+.++|||||+++++|++++.+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~-tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECC-CCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 569999999999999999999887 68999999998764332 34688999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
||||+||+|.+++.+ +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+ |++||+|||+|+.+....
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~--- 224 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEV--- 224 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSS---
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC-CCEEEecCcCceecCCCC---
Confidence 999999999999987 579999999999999999999999999999999999999999 999999999998764322
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
....+.+|||.|+ |||++. ..|+|++|++ ++|++|..||.+..... ....+..........+..+|
T Consensus 225 ~~~~~~~GTp~Ym---APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~~~~~~~~~~~~~s 297 (346)
T 4fih_A 225 PRRKSLVGTPYWM---APELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRDNLPPRLKNLHKVS 297 (346)
T ss_dssp CCBCCCCSCGGGC---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSSCCCCSCGGGSC
T ss_pred CcccccccCcCcC---CHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHcCCCCCCCccccCC
Confidence 2234579999999 999764 3688999965 67999999997521100 00111111111112235799
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+++++||.+||++||++|||++|+++||||+..
T Consensus 298 ~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 298 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 999999999999999999999999999999853
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=418.62 Aligned_cols=249 Identities=20% Similarity=0.331 Sum_probs=204.5
Q ss_pred CCe-EEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CC
Q psy622 41 SDF-EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT----SS 115 (473)
Q Consensus 41 ~~y-~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~----~~ 115 (473)
.+| ++.++||+|+||+||+|+++. +++.||+|++.+... .....+++.+|+++|+.++|||||+++++|++ +.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECC-CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 344 788899999999999999887 678999999987654 34456789999999999999999999999975 35
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG--IIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~g--IiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
.+|||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+...|++||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 69999999999999999999889999999999999999999999999 9999999999999863389999999999863
Q ss_pred cCCccccccccccCCCCcccccCCccccc-----cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhh--ccCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL-----SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQL--QLEW 265 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~-----~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~ 265 (473)
.. ....+.+|||.|+ |||++. ..|+||+|++ ++|++|..||.+... ........ ....
T Consensus 183 ~~-----~~~~~~~GTp~Ym---APE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~~i~~~~~~ 248 (290)
T 3fpq_A 183 RA-----SFAKAVIGTPEFM---APEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKP 248 (290)
T ss_dssp CT-----TSBEESCSSCCCC---CGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCC
T ss_pred CC-----CccCCcccCcccc---CHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHHHHHHcCCCC
Confidence 32 2234568999999 999764 3678899965 679999999964210 00111110 1111
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
+..+..+++++++||.+||++||++|||++|+++||||++
T Consensus 249 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1223568899999999999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=426.27 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=205.7
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
.+++|++.++||+|+||+||+|+++. +|+.||||++++... ..+|+.+|+.++|||||+++++|++++.+|
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~-~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQ-TGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECC-CCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45679999999999999999999887 689999999987643 246999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||||||+||+|.++|++.+.+++.+++.|+.||+.||+|||++|||||||||+||||+.++.++||+|||+|+.+.....
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999999999999899999999999999999999999999999999999999999833799999999997643322
Q ss_pred cc--ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 199 YL--EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 199 ~~--~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
.. ......+|||.|+ |||++. ..|+|++|++ ++|++|..||.+... ......+......++..+
T Consensus 207 ~~~~~~~~~~~GT~~Ym---APE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~ 279 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHM---APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR----GPLCLKIASEPPPIREIP 279 (336)
T ss_dssp -------CCCCCCGGGC---CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC----SCCHHHHHHSCCGGGGSC
T ss_pred ccceecCCccccCcccc---CHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH----HHHHHHHHcCCCCchhcC
Confidence 11 2234568999999 999865 3688999965 679999999975311 111122222232222333
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHH-------------hcCCCCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQV-------------RRLPMFKDY 306 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~ei-------------l~HPFF~~i 306 (473)
..+++++++||.+||++||++|||++|+ ++|||+..+
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 6899999999999999999999999997 568888754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=437.67 Aligned_cols=250 Identities=19% Similarity=0.306 Sum_probs=208.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.|++++.||+|+||+||+|+++. +|+.||||++++..... .+.+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~-tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECC-CCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 569999999999999999999887 68999999998764322 34688999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
||||+||+|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+ |++||+|||+|+.+....
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~~--- 301 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEV--- 301 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT-CCEEECCCTTCEECCSSC---
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEecCccceECCCCC---
Confidence 999999999999976 479999999999999999999999999999999999999999 999999999998764322
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
....+.+|||.|+ |||++. ..|+|++|++ ++|++|..||.+..... ....+..........+..+|
T Consensus 302 ~~~~~~~GTp~Ym---APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~~~~~~~~~~~~~s 374 (423)
T 4fie_A 302 PRRKSLVGTPYWM---APELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRDNLPPRLKNLHKVS 374 (423)
T ss_dssp CCBCCCEECTTTC---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSCCCCCSCTTSSC
T ss_pred ccccccccCcCcC---CHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHcCCCCCCcccccCC
Confidence 2234578999999 999764 3688999965 57999999997521100 00111111111112225799
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+++++||.+||++||++|||++|+++||||+..
T Consensus 375 ~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 375 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 999999999999999999999999999999853
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=423.37 Aligned_cols=280 Identities=30% Similarity=0.534 Sum_probs=231.2
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
...+++|++++.||+|+||+||+|+++. +++.||||++++.........+.+.+|+.+++.++||||+++++++++...
T Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 80 (318)
T 1fot_A 2 KYSLQDFQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 80 (318)
T ss_dssp -CCGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE
T ss_pred CCChHHcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE
Confidence 3567899999999999999999999876 689999999998755445557788999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ |++||+|||+++.....
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSSC
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC-CCEEEeecCcceecCCc
Confidence 99999999999999999998899999999999999999999999999999999999999999 99999999999874321
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
....+||+.|+ |||++. ..|+|++|++ ++|++|..||...... .....+......+|
T Consensus 160 ------~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~p--- 223 (318)
T 1fot_A 160 ------TYTLCGTPDYI---APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----KTYEKILNAELRFP--- 223 (318)
T ss_dssp ------BCCCCSCTTTC---CHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHCCCCCC---
T ss_pred ------cccccCCcccc---CHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCC---
Confidence 23468999998 898754 4688899965 5799999999642110 00122233445566
Q ss_pred ccCChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCC-CCCCCCCCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPD-DVFDTSYFHAD 334 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~-~~~D~s~Fd~~ 334 (473)
..+++++++||.+||+.||++|| +++|+++||||++++|+.+.++ .|||+|.+. +..|+++||..
T Consensus 224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~d~~~f~~~ 296 (318)
T 1fot_A 224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKY 296 (318)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-------------
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCCccchhhcCCC
Confidence 57999999999999999999999 8999999999999999999876 799999998 58999999964
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-53 Score=414.70 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=194.0
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS----- 115 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----- 115 (473)
++|++++.||+|+||+||+|+++. +++.||||++++.. .....+++.+|+++|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV-DDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT-TCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECC-CCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 579999999999999999999887 68999999998653 3444568999999999999999999999997544
Q ss_pred -------EEEEEecccCcCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEe
Q psy622 116 -------CVFLVMEYMIGGDVKSLIAANGA---LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185 (473)
Q Consensus 116 -------~l~lVmEy~~gg~L~~~L~~~~~---~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~ 185 (473)
.+|+|||||+||+|.+++.+.+. .++..++.|+.||+.||+|||++|||||||||+||||+.+ |++||+
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~-~~vKl~ 160 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVG 160 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEEC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC-CcEEEc
Confidence 48999999999999999998765 4456789999999999999999999999999999999999 999999
Q ss_pred ecchhhhhcCCcccc---------ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhc
Q psy622 186 NTLFLAILQQPIVYL---------EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVA 249 (473)
Q Consensus 186 DFGla~~~~~~~~~~---------~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~ 249 (473)
|||+|+.+....... ......+|||.|+ |||++. ..|+|++|++ ++|++ ||.......
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Ym---APE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~ 234 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYM---SPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV 234 (299)
T ss_dssp CCCCC--------------------------CCCTTS---CHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCcccc---CHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH
Confidence 999999865432211 1123458999999 999764 3688999965 56774 775422110
Q ss_pred CCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccc
Q psy622 250 GSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDS 310 (473)
Q Consensus 250 ~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~ 310 (473)
..........+|......++++.+||++||++||++|||++|+++||||+++||..
T Consensus 235 -----~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 235 -----RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290 (299)
T ss_dssp -----HHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred -----HHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence 01111123445544456778899999999999999999999999999999999953
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=424.71 Aligned_cols=262 Identities=21% Similarity=0.266 Sum_probs=208.1
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe------C
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT------S 114 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------~ 114 (473)
++|++++.||+|+||+||+|+++. +|+.||||++++.. ......+++++|+++|+.++|||||++++++++ .
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~-t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRL-TGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCeEEEEEEecccCeEEEEEEECC-CCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 579999999999999999999887 68999999998754 234456789999999999999999999999864 3
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
+++||||||| +|+|.++|.+.+.+++.+++.|+.||+.||+|||++|||||||||+|||++.+ |++||+|||+|+.+.
T Consensus 132 ~~~~ivmE~~-~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~-~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 132 KSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN-CELKIGDFGMARGLC 209 (398)
T ss_dssp CCEEEEEECC-SEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBCC-
T ss_pred CEEEEEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC-CCEEEeecceeeecc
Confidence 6899999999 57899999998999999999999999999999999999999999999999999 999999999998764
Q ss_pred CCc-cccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCChh
Q psy622 195 QPI-VYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPTS 256 (473)
Q Consensus 195 ~~~-~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~~ 256 (473)
... .......+.+|||.|+ |||++.+ .|+|++|++ ++|++|.+||.+.. ...+......
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~---APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYR---APELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp ------CCCCCSSCCCCTTC---CHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cCccccccccccceeChHhc---CHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 322 2223345678999999 9997642 578899965 57999999997521 1111110000
Q ss_pred -------hHhhhccCCCC--------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 257 -------TAAQLQLEWPE--------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 257 -------~~~~~~~~~P~--------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
........+|. ....+|++++|||.+||++||++|||++|+++||||+.+.+.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 00000001111 113579999999999999999999999999999999987654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=431.29 Aligned_cols=287 Identities=29% Similarity=0.476 Sum_probs=229.1
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
.+..++|++++.||+|+||.||+|+++. +++.||||++++..........++.+|+.+|+.++||||+++++++++.+.
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKA-TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcC-CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 4566889999999999999999999876 689999999998765555666788999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
+|+||||++||+|..++.+.+.+++..++.++.||+.||+|||+ +|||||||||+||||+.+ +++||+|||+++....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS-SCEEECCCCCCCTTCC
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC-CCEEEccCCCceeccC
Confidence 99999999999999999988899999999999999999999998 999999999999999999 9999999999986422
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
.. ......+||+.|+ |||++. ..|+|++|++ ++|++|..||...... .....+......+|
T Consensus 302 ~~---~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~p-- 369 (446)
T 4ejn_A 302 DG---ATMKTFCGTPEYL---APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEEIRFP-- 369 (446)
T ss_dssp --------CCSSSCGGGC---CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCC--
T ss_pred CC---cccccccCCcccc---CHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHHhCCCCCC--
Confidence 21 2233468999988 899764 3578899965 5799999999642110 00122223344555
Q ss_pred cccCChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNS 338 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~ 338 (473)
..+++++++||.+||+.||.+|| +++|+++||||++++|+.+.++ .|||+|.+.++.|++|||++||.+
T Consensus 370 -~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~~~~~~ 445 (446)
T 4ejn_A 370 -RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQ 445 (446)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC-------
T ss_pred -ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhcchhhhcC
Confidence 57999999999999999999999 9999999999999999999876 799999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=416.14 Aligned_cols=287 Identities=26% Similarity=0.475 Sum_probs=243.0
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
...+.+++|++++.||+|+||+||+|+++. +++.||||++++...........+.+|+++|+.++||||++++++|++.
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKND-TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 356678999999999999999999999876 6889999999987655566678899999999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+|+||||+.||+|..++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+ |++||+|||+++.+.
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIAAMLP 166 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC-CCEEEeccceeeecc
Confidence 9999999999999999999998899999999999999999999999999999999999999999 999999999998754
Q ss_pred CCccccccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh---hhHhhh
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT---STAAQL 261 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~---~~~~~~ 261 (473)
.. ......+||+.|+ |||++. ..|+|++|++ ++|++|..||..... .... ..+...
T Consensus 167 ~~----~~~~~~~gt~~Y~---aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~~~~~ 235 (384)
T 4fr4_A 167 RE----TQITTMAGTKPYM---APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS----TSSKEIVHTFETT 235 (384)
T ss_dssp TT----CCBCCCCSCGGGC---CGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT----SCHHHHHHHHHHC
T ss_pred CC----CceeccCCCcccc---CCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC----ccHHHHHHHHhhc
Confidence 32 2234568999988 899764 3578899965 579999999963210 1111 112223
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCC-HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCC
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPS-GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNS 338 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps-a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~ 338 (473)
...+| ..+++++.+||.+||+.||.+||+ ++++++||||++++|+.+.++ .|||+|.. +..|||..|+.+
T Consensus 236 ~~~~p---~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~----~~~~~~~~~~~~ 308 (384)
T 4fr4_A 236 VVTYP---SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNK----GRLNCDPTFELE 308 (384)
T ss_dssp CCCCC---TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSC----CSSCCCCCCCST
T ss_pred ccCCC---CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCCCCCCCCC----CCCCCCCccChh
Confidence 34445 689999999999999999999998 899999999999999999877 79999986 456777777765
Q ss_pred CCC
Q psy622 339 YMD 341 (473)
Q Consensus 339 ~~~ 341 (473)
..-
T Consensus 309 ~~~ 311 (384)
T 4fr4_A 309 EMI 311 (384)
T ss_dssp TSC
T ss_pred hhh
Confidence 443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=409.74 Aligned_cols=256 Identities=20% Similarity=0.306 Sum_probs=198.5
Q ss_pred CCeEEEceecccCceEEEEEEEeC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l 117 (473)
++|++++.||+|+||+||+|+++. .+++.||||++.+.. ...++.+|+++|+.+ +|||||+++++|++.+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 569999999999999999998763 356889999987643 244688999999988 799999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+|||||+||+|.++++ .+++.+++.|+.||+.||+|||++|||||||||+|||++.+.+++||+|||+|+......
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999999999984 599999999999999999999999999999999999998876899999999998643221
Q ss_pred cc-------------------------cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchh
Q psy622 198 VY-------------------------LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPS 244 (473)
Q Consensus 198 ~~-------------------------~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~ 244 (473)
.. .......+|||.|+ |||++. ..|+|++|++ ++|++|..||..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~---APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFR---APEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGC---CHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccccccccccccCcccc---CHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 10 01123457999999 999764 2588899965 579999999942
Q ss_pred Hh----------hhcC------------------CCCChhhH----h---hhccCCC-------------CccccCChhH
Q psy622 245 AL----------RVAG------------------SQIPTSTA----A---QLQLEWP-------------EDEEALNPST 276 (473)
Q Consensus 245 ~~----------~~~~------------------~~~~~~~~----~---~~~~~~P-------------~~~~~ls~~a 276 (473)
.. ...+ ...+.... . ......| .....+|+++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 10 0000 00000000 0 0000000 1124689999
Q ss_pred HHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 277 EETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 277 ~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
+|||++||+.||++|+|++|+++||||++++
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999999885
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=431.99 Aligned_cols=312 Identities=26% Similarity=0.406 Sum_probs=247.4
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
.....++|+++++||+|+||+||+|+++. +++.||||++++...........+.+|+++|+.++||||++++++|++..
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~-tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKA-TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT 258 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence 45678999999999999999999999876 68999999999876555555778999999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 116 CVFLVMEYMIGGDVKSLIAAN----GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~----~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
.+|+||||++||+|..++.+. ..+++..++.|+.||+.||+|||++||+||||||+|||++.+ |++||+|||+++
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~-g~vkL~DFGla~ 337 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAV 337 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC-CCEEEeecceee
Confidence 999999999999999999874 369999999999999999999999999999999999999999 999999999998
Q ss_pred hhcCCccccccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccC
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 264 (473)
.+.... ......+|||.|+ |||++.. .|+|++|++ ++|++|..||...............+......
T Consensus 338 ~~~~~~---~~~~~~~GT~~Y~---APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~ 411 (543)
T 3c4z_A 338 ELKAGQ---TKTKGYAGTPGFM---APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411 (543)
T ss_dssp ECCTTC---CCBCCCCSCTTTS---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC
T ss_pred eccCCC---cccccccCCcccc---ChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC
Confidence 754322 1223458999998 9997643 688899965 57999999997531100000001122223445
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCC-----CCCCCCCCC
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPD-----DVFDTSYFH 332 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~-----~~~D~s~Fd 332 (473)
+| ..+++++++||.+||++||.+||+ +++|++||||++++|+.+.++ .|||+|.+. +..|+++|+
T Consensus 412 ~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~d~~~f~ 488 (543)
T 3c4z_A 412 YP---DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFS 488 (543)
T ss_dssp CC---TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCSSSCCSCC----CCCC
T ss_pred CC---cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCccccccCCchhhhhcc
Confidence 55 689999999999999999999996 589999999999999999876 799999875 445666665
Q ss_pred CCCCCCCCCCCCCccCCCCCceecccCCCCCCCCccccCchhh
Q psy622 333 ADKTNSYMDSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPSAL 375 (473)
Q Consensus 333 ~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~~ 375 (473)
+... . .. ..-++..|.+|++.+++.-
T Consensus 489 ~~~~---~--------~~------~~~~~~~f~~f~~~~~~~~ 514 (543)
T 3c4z_A 489 TVKG---V--------AF------EKADTEFFQEFASGTCPIP 514 (543)
T ss_dssp ---C---C--------CC------CHHHHHHHHHHCCEECHHH
T ss_pred ccCC---C--------CC------CcchhhHhhcCCCCCCChh
Confidence 3210 0 00 1224567889988876653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=403.23 Aligned_cols=291 Identities=29% Similarity=0.494 Sum_probs=216.9
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeC--CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMIN-KNMVSQVLRERNALALTHSPFCVQLFYSL 111 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 111 (473)
...+..++|++++.||+|+||+||+|++.. .+++.||||++++..... ......+.+|+.+|+.++||||+++++++
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 345667899999999999999999998752 367899999998864332 23455788999999999999999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
++.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ |++||+|||+++
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~ 169 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCK 169 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-SCEEECCCSCC-
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC-CcEEEEeCCccc
Confidence 9999999999999999999999988899999999999999999999999999999999999999998 999999999998
Q ss_pred hhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccC
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 264 (473)
...... ......+||+.|+ |||.+. ..|+|++|++ +++++|..||....... ....+......
T Consensus 170 ~~~~~~---~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~ 239 (327)
T 3a62_A 170 ESIHDG---TVTHTFCGTIEYM---APEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK----TIDKILKCKLN 239 (327)
T ss_dssp ------------CTTSSCCTTS---CHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHTCCC
T ss_pred ccccCC---ccccccCCCcCcc---CHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhCCCC
Confidence 643221 2233457899988 898764 3578899965 57999999997421100 01122233445
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCC
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTN 337 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~ 337 (473)
+| ..+++++++||.+||+.||.+|| +++|+++||||++++|+.+.++ .|||+|.+.+..|+++|+.+++.
T Consensus 240 ~p---~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~ 316 (327)
T 3a62_A 240 LP---PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 316 (327)
T ss_dssp CC---TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC----------------
T ss_pred CC---CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcCChhhhhhcchhhhc
Confidence 55 57999999999999999999999 7899999999999999999876 79999999999999999998876
Q ss_pred CC
Q psy622 338 SY 339 (473)
Q Consensus 338 ~~ 339 (473)
..
T Consensus 317 ~~ 318 (327)
T 3a62_A 317 QT 318 (327)
T ss_dssp --
T ss_pred cc
Confidence 53
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=427.03 Aligned_cols=286 Identities=27% Similarity=0.440 Sum_probs=231.9
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
..+..++|+++++||+|+||+||+|+++. +++.||||++.+..+........+.+|+++|+.++||||++++++|++.+
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 45677899999999999999999999876 68999999999876555556678899999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 116 CVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
.+|+||||++||+|.+++...+ .+++..++.|+.||+.||+|||++|||||||||+||||+.+ |++||+|||+++.+
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~-g~vKL~DFGla~~~ 336 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHV 336 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC-CCeEEEecccceec
Confidence 9999999999999999998765 49999999999999999999999999999999999999999 99999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
..... ....+||+.|+ |||++. ..|+|++|++ ++|++|..||...............+......+|
T Consensus 337 ~~~~~----~~~~~GT~~Y~---APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p 409 (576)
T 2acx_A 337 PEGQT----IKGRVGTVGYM---APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409 (576)
T ss_dssp CTTCC----EECCCSCGGGC---CHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC
T ss_pred ccCcc----ccccCCCcccc---CHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC
Confidence 43221 22358999998 899764 3688999965 5799999999752110000000112222344455
Q ss_pred CccccCChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCC-----CCCCCCCCCC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPD-----DVFDTSYFHA 333 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~-----~~~D~s~Fd~ 333 (473)
..+++++++||.+||+.||.+|| +++||++||||++++|+.+.++ .|||+|.+. +..|+++|++
T Consensus 410 ---~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~~~~~~~~~~d~~~f~~ 485 (576)
T 2acx_A 410 ---ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFST 485 (576)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCCCC-----------
T ss_pred ---ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCccccccCCcccHhhccc
Confidence 67999999999999999999999 6899999999999999999876 799999875 3455666653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=425.73 Aligned_cols=260 Identities=18% Similarity=0.269 Sum_probs=216.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+++|++++.||+|+||+||+|+++. +|+.||||++++.. ....+.+.+|+++|+.++|||||+++++|++.+++||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~-tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 5789999999999999999999887 68999999998754 3345678999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC-CCceeEeecchhhhhcCCc
Q psy622 120 VMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ-APHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~-~g~ikL~DFGla~~~~~~~ 197 (473)
|||||+||+|.++|.+ .+.|++.+++.|++||+.||+|||++||+||||||+|||++.+ .+++||+|||+|+.+....
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999999999999965 4689999999999999999999999999999999999999853 3799999999999865332
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC-cc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE-DE 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~-~~ 269 (473)
...+.+|||.|+ |||++. ..|+|++|++ ++|++|..||.+..... ....+......++. ..
T Consensus 312 ----~~~~~~GT~~y~---APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~ 380 (573)
T 3uto_A 312 ----SVKVTTGTAEFA---APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----TLRNVKSCDWNMDDSAF 380 (573)
T ss_dssp ----EEEEECSSGGGC---CHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTTCCCCCSGGG
T ss_pred ----ceeeeEECcccc---CHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHhCCCCCCcccc
Confidence 223468999999 999865 3678999976 56999999997521100 01122222333332 22
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQ 314 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~ 314 (473)
..+|+++++||.+||++||.+|||++|+++||||+..+|.....+
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~~~ 425 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 425 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTTCE
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCchhh
Confidence 579999999999999999999999999999999999999865443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=388.97 Aligned_cols=252 Identities=18% Similarity=0.268 Sum_probs=202.8
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSL 111 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 111 (473)
..+..++|.+.+.||+|+||+||+|+++. .+++.||||++++.. ....+.+.+|+++|++++|||||++++++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 45566889999999999999999998753 246789999998643 44567899999999999999999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAAN-------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ 178 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~-------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~ 178 (473)
.+++.+|||||||+||+|.++|++. ..+++.++..++.||+.||+|||+++||||||||+||||+.+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 9999999999999999999999864 369999999999999999999999999999999999999999
Q ss_pred CCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcC
Q psy622 179 APHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAG 250 (473)
Q Consensus 179 ~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~ 250 (473)
+++||+|||+|+........ ......+||+.|+ |||++. ..|+||+|++ ++|++ |+.||.+....
T Consensus 165 -~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ym---APE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-- 237 (299)
T 4asz_A 165 -LLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWM---PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-- 237 (299)
T ss_dssp -GCEEECCCSCHHHHTGGGCE-EETTTEEECGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--
T ss_pred -CcEEECCcccceecCCCCce-eecCceecChhhc---CHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence 99999999999976433222 2233456888888 999764 4688999965 57887 89999752110
Q ss_pred CCCChhhHhh-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 251 SQIPTSTAAQ-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 251 ~~~~~~~~~~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
.+ ...+.. .....| ..+++++.+||.+||+.||++|||++||. +|++
T Consensus 238 -~~-~~~i~~~~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 238 -EV-IECITQGRVLQRP---RTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp -HH-HHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred -HH-HHHHHcCCCCCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 00 011111 122334 68999999999999999999999999984 4554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=391.22 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=198.4
Q ss_pred ccccCCCCCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeee
Q psy622 31 SKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQ 106 (473)
Q Consensus 31 ~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~ 106 (473)
.......+..++|.+.++||+|+||+||+|+.+. .+++.||||++++.. ....+.+.+|+++|++++|||||+
T Consensus 31 ~~~~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~ 107 (329)
T 4aoj_A 31 SDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVR 107 (329)
T ss_dssp --CCSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred chhhhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCc
Confidence 3344556677899999999999999999998653 246889999998643 445678999999999999999999
Q ss_pred EEEEEEeCCEEEEEecccCcCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCc
Q psy622 107 LFYSLQTSSCVFLVMEYMIGGDVKSLIAAN---------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPD 171 (473)
Q Consensus 107 l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~---------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpe 171 (473)
+++++.+...+|||||||+||+|.++|++. +++++.++..++.||+.||+|||+++||||||||+
T Consensus 108 l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~ 187 (329)
T 4aoj_A 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATR 187 (329)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHh
Confidence 999999999999999999999999999763 35999999999999999999999999999999999
Q ss_pred ceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCch
Q psy622 172 NMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFP 243 (473)
Q Consensus 172 NILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~ 243 (473)
||||+.+ +++||+|||+++.+...... ......+||+.|+ |||++. ..|+|+||++ ++|++ |+.||.
T Consensus 188 NILl~~~-~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ym---APE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~ 262 (329)
T 4aoj_A 188 NCLVGQG-LVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWM---PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262 (329)
T ss_dssp GEEEETT-TEEEECCCC-----------------CCCCGGGC---CHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred hEEECCC-CcEEEcccccceeccCCCcc-eecCccccccccc---ChhhhcCCCCCccccccchHHHHHHHHcCCCCCCC
Confidence 9999999 99999999999976433222 2334467999998 999764 3688999965 57887 899997
Q ss_pred hHhhhcCCCCChhhHhh-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 244 SALRVAGSQIPTSTAAQ-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 244 ~~~~~~~~~~~~~~~~~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
...... +. ..+.. .....| ..+++++.+||.+||+.||++|||++||+++
T Consensus 263 ~~~~~~---~~-~~i~~g~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 263 QLSNTE---AI-DCITQGRELERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp SSCHHH---HH-HHHHHTCCCCCC---TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCHHH---HH-HHHHcCCCCCCc---ccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 521100 00 11111 233344 6899999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=382.50 Aligned_cols=248 Identities=14% Similarity=0.149 Sum_probs=193.9
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
++..+++++.+.||+|+||+||+|+.+. .||||+++... ......+.+.+|+.+|++++|||||++++++. ++.
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~----~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~ 105 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG----DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDN 105 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS----EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC----cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCe
Confidence 4567899999999999999999997543 48999998653 33455678999999999999999999999875 467
Q ss_pred EEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
+|||||||+||+|.++|... +.+++.++..++.||+.||+|||++|||||||||+||||+++ +++||+|||+|+....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSR 184 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-EEEEECCCSSCBC---
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-CcEEEeeccCceeccc
Confidence 89999999999999999864 579999999999999999999999999999999999999999 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh--hcc
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ--LQL 263 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~ 263 (473)
.... ......+|||.|+ |||++. ..|+||+|++ ++|++|..||.+..... ........ ...
T Consensus 185 ~~~~-~~~~~~~GT~~ym---APE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~---~~~~~~~~~~~~p 257 (307)
T 3omv_A 185 WSGS-QQVEQPTGSVLWM---APEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD---QIIFMVGRGYASP 257 (307)
T ss_dssp ----------CCCCTTSC---CHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHTTCCCC
T ss_pred CCcc-eeecccccCCCcc---CHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH---HHHHHHhcCCCCC
Confidence 2222 2234568999999 999763 3588999965 67999999997521000 00000111 111
Q ss_pred CCCCccccCChhHHHHHHhccccCCCCCCCHHHHh
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVR 298 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil 298 (473)
..+..+..+++++.+||.+||+.||++|||+.||+
T Consensus 258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~ 292 (307)
T 3omv_A 258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL 292 (307)
T ss_dssp CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 22233467899999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=384.56 Aligned_cols=253 Identities=17% Similarity=0.237 Sum_probs=203.6
Q ss_pred cCCCCCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEE
Q psy622 34 CLKAPEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFY 109 (473)
Q Consensus 34 ~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 109 (473)
..+++..+++++++.||+|+||+||+|+... .+++.||||+++... .....+.+.+|+.+|++++|||||++++
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g 96 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLG 96 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcce
Confidence 4456778899999999999999999998642 246789999998653 2334568999999999999999999999
Q ss_pred EEEeCCEEEEEecccCcCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcce
Q psy622 110 SLQTSSCVFLVMEYMIGGDVKSLIAAN----------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNM 173 (473)
Q Consensus 110 ~f~~~~~l~lVmEy~~gg~L~~~L~~~----------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNI 173 (473)
++.+++.+|||||||++|+|.++|... +.+++..+..++.||+.||+|||+++||||||||+||
T Consensus 97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NI 176 (308)
T 4gt4_A 97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV 176 (308)
T ss_dssp EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccce
Confidence 999999999999999999999999753 3589999999999999999999999999999999999
Q ss_pred EecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhH
Q psy622 174 LISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSA 245 (473)
Q Consensus 174 Lld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~ 245 (473)
||+++ +++||+|||+++.+...... ......+||+.|+ |||++. ..|+||||++ +++++ |..||.+.
T Consensus 177 Ll~~~-~~~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ym---APE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 177 LVYDK-LNVKISDLGLFREVYAADYY-KLLGNSLLPIRWM---APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp EECGG-GCEEECCSCCBCGGGGGGCB-CSSSSSCBCGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred EECCC-CCEEECCcccceeccCCCce-eEecccccCCccc---CHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 99999 99999999999876433222 2334457899888 999764 4688999965 57887 89999752
Q ss_pred hhhcCCCCChhhHhh-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 246 LRVAGSQIPTSTAAQ-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 246 ~~~~~~~~~~~~~~~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
... .+ ...+.. .....| ..+++++.+||.+||+.||++|||+.||+++
T Consensus 252 ~~~---~~-~~~i~~~~~~~~p---~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 252 SNQ---DV-VEMIRNRQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CHH---HH-HHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHH---HH-HHHHHcCCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 110 00 011111 122233 6899999999999999999999999999865
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=390.75 Aligned_cols=285 Identities=26% Similarity=0.469 Sum_probs=230.9
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeC--CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhc-CCCCeeeEEEE
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMIN-KNMVSQVLRERNALALT-HSPFCVQLFYS 110 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 110 (473)
.....+++|++++.||+|+||+||+|++.. .+++.||||++++..... ......+.+|+++|+.+ +||||++++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 48 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp CCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 345667899999999999999999998753 357899999998754321 22234677899999999 79999999999
Q ss_pred EEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 111 LQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 111 f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
+++...+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a 206 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLS 206 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEE
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CcEEEeeCCCC
Confidence 99999999999999999999999988899999999999999999999999999999999999999999 99999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChh---hH
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTS---TA 258 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~---~~ 258 (473)
+....... ......+||+.|+ |||++. ..|+|++|++ +++++|..||..... ...... ..
T Consensus 207 ~~~~~~~~--~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~ 278 (355)
T 1vzo_A 207 KEFVADET--ERAYDFCGTIEYM---APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE---KNSQAEISRRI 278 (355)
T ss_dssp EECCGGGG--GGGCGGGSCCTTC---CHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS---CCCHHHHHHHH
T ss_pred eecccCCC--CcccCcccCcCcc---ChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc---cchHHHHHHHH
Confidence 86432211 1223457899988 898764 2578899965 579999999964211 001111 11
Q ss_pred hhhccCCCCccccCChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCC
Q psy622 259 AQLQLEWPEDEEALNPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYF 331 (473)
Q Consensus 259 ~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~F 331 (473)
......+| ..++..+++||.+||+.||.+|| +++|+++||||++++|+.+..+ .|||.|.+++..|++||
T Consensus 279 ~~~~~~~~---~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~~~d~~~~ 355 (355)
T 1vzo_A 279 LKSEPPYP---QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355 (355)
T ss_dssp HHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CCC---
T ss_pred hccCCCCC---cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCccccccccccC
Confidence 11222333 67999999999999999999999 9999999999999999999877 69999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=372.45 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=216.9
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
..+.+++|++++.||+|+||+||+|+++. +++.||||++.+... .....+++.+|+++|+.++||||+++++++.+.+
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHIL-TGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 45567899999999999999999999876 678999999988643 3445678899999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD-MNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTCCGGGSS
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC-CCEEEeeccCceecCC
Confidence 999999999999999999988899999999999999999999999999999999999999999 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
.. .....+||+.|+ |||++. ..|+|++|++ +++++|..||...... .....+......+|
T Consensus 167 ~~----~~~~~~gt~~y~---aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~p- 234 (328)
T 3fe3_A 167 GG----KLDAFCGAPPYA---APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK----ELRERVLRGKYRIP- 234 (328)
T ss_dssp SC----GGGTTSSSGGGC---CHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCC-
T ss_pred CC----ccccccCCccee---CcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCC-
Confidence 32 223468999988 899753 3678899965 5799999999752110 00112223344455
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
..+++++.+||++||+.||.+|||++|+++||||+...+.
T Consensus 235 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (328)
T 3fe3_A 235 --FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274 (328)
T ss_dssp --TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred --CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence 5799999999999999999999999999999999876543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=380.05 Aligned_cols=247 Identities=18% Similarity=0.255 Sum_probs=201.1
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTN----KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQ 112 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~ 112 (473)
+..++|++.+.||+|+||+||+|+++.. +++.||||+++... .....+.+.+|+++|..++ |||||++++++.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 4457899999999999999999987752 23689999998753 2344668999999999995 599999999986
Q ss_pred e-CCEEEEEecccCcCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe
Q psy622 113 T-SSCVFLVMEYMIGGDVKSLIAAN----------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI 175 (473)
Q Consensus 113 ~-~~~l~lVmEy~~gg~L~~~L~~~----------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILl 175 (473)
. ++.+|||||||+||+|.++|++. ..+++.++..|+.||+.||+|||+++||||||||+|||+
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl 218 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 218 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence 5 46799999999999999999863 348999999999999999999999999999999999999
Q ss_pred cCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhh
Q psy622 176 SAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALR 247 (473)
Q Consensus 176 d~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~ 247 (473)
+.+ +++||+|||+|+.+...... ......+||+.|+ |||++. ..|+||||++ ++|++ |..||.+..
T Consensus 219 ~~~-~~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ym---APE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~- 292 (353)
T 4ase_A 219 SEK-NVVKICDFGLARDIYKDPDY-VRKGDARLPLKWM---APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK- 292 (353)
T ss_dssp CGG-GCEEECCCGGGSCTTTCTTS-EEETTEEECGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-
T ss_pred CCC-CCEEECcchhhhhcccCCCc-eeecccccccccc---CHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC-
Confidence 999 99999999999976433222 2234467899988 999764 4688999975 57887 899997521
Q ss_pred hcCCCCChh---hHh-hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 248 VAGSQIPTS---TAA-QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 248 ~~~~~~~~~---~~~-~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.... .+. ......| ..+++++.+||.+||+.||++|||+.||++|
T Consensus 293 -----~~~~~~~~i~~g~~~~~p---~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 293 -----IDEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp -----CSHHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----HHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 1111 111 1233344 6899999999999999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=371.17 Aligned_cols=261 Identities=19% Similarity=0.270 Sum_probs=215.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK---NMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
.++|++.+.||+|+||+||+|+++. +++.||+|++++...... ...+.+.+|+.+|+.++||||++++++|++...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECC-CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3579999999999999999999886 678999999998653221 135678999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC----ceeEeecchhhh
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP----HCPIVNTLFLAI 192 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g----~ikL~DFGla~~ 192 (473)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ + ++||+|||+++.
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDK-NIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCT-TSSSCCEEECCCSSCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCC-CCCccCEEEEecCCceE
Confidence 99999999999999999988899999999999999999999999999999999999999887 5 799999999987
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
+.... .....+|||.|+ |||++. ..|+|++|++ +++++|..||.+..... ....+......+
T Consensus 169 ~~~~~----~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~~ 237 (361)
T 2yab_A 169 IEDGV----EFKNIFGTPEFV---APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANITAVSYDF 237 (361)
T ss_dssp CCTTC----CCCCCCSCGGGC---CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTTCCCC
T ss_pred cCCCC----ccccCCCCccEE---CchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCC
Confidence 54322 123457999998 899764 3678899965 57999999996421100 001122223333
Q ss_pred CC-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccccc
Q psy622 266 PE-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILD 313 (473)
Q Consensus 266 P~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~ 313 (473)
+. ....+++++++||.+||+.||.+|||++|+++||||++++|.....
T Consensus 238 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~ 286 (361)
T 2yab_A 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMV 286 (361)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHHHHHH
T ss_pred CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchhhhhh
Confidence 31 1247899999999999999999999999999999999999986654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=377.24 Aligned_cols=267 Identities=19% Similarity=0.237 Sum_probs=197.4
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----C
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT-----S 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-----~ 114 (473)
.++|+++++||+|+||+||+|+++. +++.||||++.+.. ......+++.+|+++|+.++||||+++++++.. .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKL-EKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC---CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECC-CCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 3789999999999999999999887 57899999997642 344556789999999999999999999999943 3
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+|+||||+ +|+|..++...+.+++..++.++.||+.||+|||++|||||||||+||||+.+ +++||+|||+++...
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD-CSVKVCDFGLARTVD 207 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBCTT
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC-CCEeecccccchhcc
Confidence 6799999998 78999999988899999999999999999999999999999999999999999 999999999998764
Q ss_pred CCcccc------------------------ccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccC-----
Q psy622 195 QPIVYL------------------------EISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQN----- 237 (473)
Q Consensus 195 ~~~~~~------------------------~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~----- 237 (473)
...... ......+||+.|+ |||++. ..|+|++|++ ++|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~---aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR---APELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTC---CHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred CccccccccccCccccccccccccccccccccccCCccccccc---ChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 221110 1123346788887 999653 3588899965 56887
Q ss_pred ------CCCCchhHhhh-----------------------------cCCCCChhhHh--------h--------hccCCC
Q psy622 238 ------SQAPFPSALRV-----------------------------AGSQIPTSTAA--------Q--------LQLEWP 266 (473)
Q Consensus 238 ------g~~pf~~~~~~-----------------------------~~~~~~~~~~~--------~--------~~~~~P 266 (473)
|.++|++.... .+.. ...... . ....+.
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTP-SEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCC-CHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCC-CHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 66666542100 0000 000000 0 000111
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQ 314 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~ 314 (473)
.....+++++.+||.+||+.||++|||++|+++||||++++|..+...
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~ 411 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETN 411 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCC
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCC
Confidence 112357999999999999999999999999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=363.11 Aligned_cols=252 Identities=24% Similarity=0.391 Sum_probs=210.9
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
...+++|++.+.||+|+||+||+|+++. +++.||+|++.+...........+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYK-TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD 83 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 3457899999999999999999999876 678999999987654333445678999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+||||+ +|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTS
T ss_pred EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC-CCEEEEEeccceeccCC
Confidence 99999999 88999999888899999999999999999999999999999999999999999 99999999999875432
Q ss_pred ccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
. .....+|||.|+ |||.+. ..|+|++|++ +++++|..||...... .....+......+|
T Consensus 162 ~----~~~~~~gt~~y~---aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~p-- 228 (336)
T 3h4j_B 162 N----FLKTSCGSPNYA---APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP----NLFKKVNSCVYVMP-- 228 (336)
T ss_dssp B----TTCCCTTSTTTS---CGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST----TCBCCCCSSCCCCC--
T ss_pred c----ccccccCCcCcC---CHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH----HHHHHHHcCCCCCc--
Confidence 2 223457999988 899753 3677899965 5799999999752111 01111111223334
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
..+++++++||++||+.||.+|||++|+++||||+.
T Consensus 229 -~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 229 -DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp -TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred -ccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 679999999999999999999999999999999974
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=361.89 Aligned_cols=270 Identities=18% Similarity=0.235 Sum_probs=208.0
Q ss_pred CCCCCCeEEEceeccc--CceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 37 APEISDFEIVKAISRG--AFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G--~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
.+..++|++++.||+| +||.||+|+++. +++.||||++++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKP-TGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETT-TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcC-CCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 4557889999999999 999999999886 678999999987643 345567889999999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
+.+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~-~~~kl~dfg~~~~ 177 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLS 177 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCGGGCEE
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEccccccee
Confidence 9999999999999999999876 679999999999999999999999999999999999999998 9999999999876
Q ss_pred hcCCccc----cccccccCCCCcccccCCcccccc--------CCcCCCCcc-ccccCCCCCchhHhh------hcCCCC
Q psy622 193 LQQPIVY----LEISDLVNGTPNAFNIRTPGQLLS--------LKTGTFPTF-QDVQNSQAPFPSALR------VAGSQI 253 (473)
Q Consensus 193 ~~~~~~~----~~~~~~~~gtp~y~~~~ape~i~~--------~~~~s~g~l-~~~~~g~~pf~~~~~------~~~~~~ 253 (473)
....... .......+||+.|+ |||++.. .|+|++|++ ++|++|..||..... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWL---SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGS---CHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ecccccccccccccccccccccccc---CHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 4322111 11122346777777 8987643 477899965 579999999975210 000000
Q ss_pred Ch---------hhH------------------------hhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 254 PT---------STA------------------------AQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 254 ~~---------~~~------------------------~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
+. ... ..........+..+++++++||.+||+.||++|||++|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 000 000000001125689999999999999999999999999999
Q ss_pred CCCCCCCccccc
Q psy622 301 PMFKDYDWDSIL 312 (473)
Q Consensus 301 PFF~~idw~~l~ 312 (473)
|||+.+.|....
T Consensus 335 p~f~~~~~~~~~ 346 (389)
T 3gni_B 335 SFFKQIKRRASE 346 (389)
T ss_dssp GGGGGC---CCS
T ss_pred HHHHHHhhcchh
Confidence 999999886443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=363.61 Aligned_cols=277 Identities=19% Similarity=0.275 Sum_probs=217.6
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~ 118 (473)
.++|++.+.||+|+||+||+|+++. +++.||||++++... ...+|++++..+ +||||+++++++++...+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKA-TNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 3579999999999999999999886 689999999987642 234688888877 8999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC---ceeEeecchhhhhcC
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP---HCPIVNTLFLAILQQ 195 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g---~ikL~DFGla~~~~~ 195 (473)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+..+.+ .+||+|||+++....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999999999999889999999999999999999999999999999999999854423 599999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh---hhHhhhccCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT---STAAQLQLEW 265 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~ 265 (473)
.. ......+||+.|+ |||++. ..|+|++|++ ++|++|..||.... ..... ..+......+
T Consensus 173 ~~---~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~~~~i~~~~~~~ 242 (342)
T 2qr7_A 173 EN---GLLMTPCYTANFV---APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP----DDTPEEILARIGSGKFSL 242 (342)
T ss_dssp TT---CCBCCSSCCSSCC---CHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST----TSCHHHHHHHHHHCCCCC
T ss_pred CC---CceeccCCCcccc---CHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC----cCCHHHHHHHHccCCccc
Confidence 21 2233468899988 999764 4689999965 57999999996411 01111 1122222332
Q ss_pred CC-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCC
Q psy622 266 PE-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKT 336 (473)
Q Consensus 266 P~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t 336 (473)
+. ....+++++++||++||+.||++|||++|+++||||. +|+.+.+. .+|+.|......+...|+..++
T Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 314 (342)
T 2qr7_A 243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV--HWDQLPQYQLNRQDAPHLVKGAMAATYSALNR 314 (342)
T ss_dssp CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH--TGGGSCCSCCCCCCCHHHHHHHHHHHHHHHTT
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec--CccccccccCCCccchhhhhhHHHHHHhhhcc
Confidence 21 1246899999999999999999999999999999994 68877655 5677765433333334444433
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=365.05 Aligned_cols=268 Identities=20% Similarity=0.252 Sum_probs=204.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS----- 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~----- 114 (473)
.++|++++.||+|+||+||+|+++. +++.||||++++.. ......+++.+|+++|+.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKN-TEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECC-CCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 4789999999999999999999886 68999999998652 3445567899999999999999999999999776
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+|+||||+ +|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 103 DELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD-CSVKVCDFGLARTIN 180 (432)
T ss_dssp CCEEEEEECC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC-
T ss_pred CeEEEEEecC-CcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC-CCEEEccCCCccccc
Confidence 6799999999 57999999988889999999999999999999999999999999999999999 999999999998754
Q ss_pred CCcccc-------------------ccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh
Q psy622 195 QPIVYL-------------------EISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR 247 (473)
Q Consensus 195 ~~~~~~-------------------~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~ 247 (473)
...... ......+||+.|+ |||++. ..|+|++|++ ++|++|..||.....
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~---APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR---APELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp ------------------------------CCCCCTTC---CHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred ccccccccccccccccccccccchhccccCCCCCcccc---CHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 322110 1124457888888 999753 3578899965 568875444432100
Q ss_pred h-------------------------------------cCCCCC-------hhhH----hhhccCCC----CccccCChh
Q psy622 248 V-------------------------------------AGSQIP-------TSTA----AQLQLEWP----EDEEALNPS 275 (473)
Q Consensus 248 ~-------------------------------------~~~~~~-------~~~~----~~~~~~~P----~~~~~ls~~ 275 (473)
. .+.... .... .......+ .....++++
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 0 000000 0000 00000000 011368999
Q ss_pred HHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccC
Q psy622 276 TEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQ 314 (473)
Q Consensus 276 a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~ 314 (473)
+.+||.+||+.||++|||++|+++||||++++|......
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~ 376 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENF 376 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC--
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcC
Confidence 999999999999999999999999999999999977653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=352.97 Aligned_cols=258 Identities=16% Similarity=0.300 Sum_probs=207.3
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+-+++|++++.||+|+||+||+|+++. +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECC-CCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 457899999999999999999999886 5789999999765422 2235688999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETT
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC-CCEEEEEeeccceeccCC
Confidence 9999999999999999888889999999999999999999999999999999999999999 999999999998754322
Q ss_pred cccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
.. ......+||+.|+ |||++. ..|+|++|++ +++++|..||..... ..................
T Consensus 160 ~~-~~~~~~~gt~~y~---aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 231 (323)
T 3tki_A 160 RE-RLLNKMCGTLPYV---APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD----SCQEYSDWKEKKTYLNPW 231 (323)
T ss_dssp EE-CCBCSCCSCGGGS---CHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT----TSHHHHHHHTTCTTSTTG
T ss_pred cc-cccCCCccCcCcc---CcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch----HHHHHHHHhcccccCCcc
Confidence 22 2233457899888 898753 3678899965 579999999964210 000000001111111122
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
..+++++.+||.+||+.||.+|||++|+++||||+..-
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 57899999999999999999999999999999998653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=353.66 Aligned_cols=248 Identities=15% Similarity=0.148 Sum_probs=182.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----E
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS----C 116 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----~ 116 (473)
++|.+.+.||+|+||+||+|++ +|+.||||+++... ........|+.++..++|||||++++++.+++ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE---TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 4689999999999999999976 36899999997642 11112234555556789999999999997653 6
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeecCCCCcceEecCCCCceeEeecc
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH--------GIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~--------gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
+|||||||+||+|.++|++. .+++..+..++.|++.||+|||++ +||||||||+||||+.+ +++||+|||
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DFG 153 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLG 153 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeCC
Confidence 89999999999999999875 689999999999999999999987 99999999999999999 999999999
Q ss_pred hhhhhcCCccccc-cccccCCCCcccccCCccccc------------cCCcCCCCcc-ccccCCCCCchhHhhh------
Q psy622 189 FLAILQQPIVYLE-ISDLVNGTPNAFNIRTPGQLL------------SLKTGTFPTF-QDVQNSQAPFPSALRV------ 248 (473)
Q Consensus 189 la~~~~~~~~~~~-~~~~~~gtp~y~~~~ape~i~------------~~~~~s~g~l-~~~~~g~~pf~~~~~~------ 248 (473)
+|+.......... .....+|||.|+ |||++. ..|+||||++ ++|++|.+||......
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ym---APE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYM---APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGC---CHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred CCccccCCCCceeeeccccccccccc---CHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 9987654332221 233457999999 999764 3689999965 6799987776431100
Q ss_pred c-CCCCChhhHhh------hccCCCCccc--cCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 249 A-GSQIPTSTAAQ------LQLEWPEDEE--ALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 249 ~-~~~~~~~~~~~------~~~~~P~~~~--~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
. ........... ....+|.... ..+..+.+|+.+||+.||++|||+.||+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0 00000011110 1122332111 123468899999999999999999998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=358.61 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=199.1
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
.....++|++++.||+|+||+||+|+++. +++.||||++.+.... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp CCCCTTTEEEEEEESSSTTSSEEEEEETT-TCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCCCcEEEEEEeccCCCEEEEEEEECC-CCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 34456889999999999999999999886 6789999999875432 246789999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCc--eeEeecchhhhh
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH--CPIVNTLFLAIL 193 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~--ikL~DFGla~~~ 193 (473)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +. +||+|||+++..
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~-~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS-SSCCEEECCCCCC---
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCceEEEeecCccccc
Confidence 999999999999999999988899999999999999999999999999999999999999876 54 999999999853
Q ss_pred cCCccccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh---hhHhhhc
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT---STAAQLQ 262 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~---~~~~~~~ 262 (473)
.... ......||+.|+ |||++.. .|+|++|++ +++++|..||...... .... ..+....
T Consensus 169 ~~~~----~~~~~~gt~~y~---aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~~~~~~~ 238 (361)
T 3uc3_A 169 VLHS----QPKSTVGTPAYI---APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---RDYRKTIQRILSVK 238 (361)
T ss_dssp ----------------CTTS---CHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C---CCHHHHHHHHHTTC
T ss_pred cccC----CCCCCcCCCCcC---ChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHhcCC
Confidence 2211 122346888888 8997532 588899965 5799999999753210 0111 1112223
Q ss_pred cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 263 LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 263 ~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
..+|.. ..+++++++||.+||+.||.+|||++|+++||||..
T Consensus 239 ~~~~~~-~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 239 YSIPDD-IRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp CCCCTT-SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred CCCCCc-CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 344432 468999999999999999999999999999999943
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=343.70 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=199.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+++|++++.||+|+||+||+|+++. +++.||+|+++.... .......+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECC-CCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence 4789999999999999999999886 578999999987643 34445678899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||||++| +|...+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 79 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 79 VFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPV- 155 (292)
T ss_dssp EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCSCC-
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecCCcc-
Confidence 9999965 55555544 6789999999999999999999999999999999999999999 999999999998753221
Q ss_pred ccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhH----------hhhcCCCCChhhHh-
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSA----------LRVAGSQIPTSTAA- 259 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~----------~~~~~~~~~~~~~~- 259 (473)
.......||+.|+ |||++. ..|+|++|++ +++++|..||... ....+.........
T Consensus 156 --~~~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 156 --RCYSAEVVTLWYR---PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp --SCCCSCCSCGGGC---CHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred --ccccCCccccCCc---ChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 1223346788877 888653 3477889965 5688887775321 01111100000000
Q ss_pred -h--h---------ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 260 -Q--L---------QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 260 -~--~---------~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
. . ..........+++++++||.+||+.||++|||++|+++||||+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 0 0 000111124688999999999999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=347.04 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=205.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++++.||+|+||+||+|+++. +++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTT-TCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECC-CCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 5789999999999999999998776 6789999999876432 24578899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||||++||+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTC-
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC-CCEEEeeCCCceecCCccc-
Confidence 99999999999999875 69999999999999999999999999999999999999999 9999999999987543221
Q ss_pred cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
.....+||+.|+ |||.+. ..|+|++|++ +++++|..||....... ...............+..+
T Consensus 172 --~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~ 242 (297)
T 3fxz_A 172 --KRSTMVGTPYWM---APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLIATNGTPELQNPEKL 242 (297)
T ss_dssp --CBCCCCSCGGGC---CHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHHCSCCCSCGGGS
T ss_pred --ccCCccCCcCcc---ChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCCCcccc
Confidence 223457888888 898754 3578899965 57999999996421100 0000111111111223679
Q ss_pred ChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 273 NPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
++.+++||.+||+.||.+|||++|+++||||+..
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 243 SAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999999999999854
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=369.41 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=214.6
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
.....+++|++.+.||+|+||+||+|+++. +|+.||||++++...........+.+|+.+|+.++||||+++++++.+.
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHEL-TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETT-TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 345667899999999999999999999876 6789999999886544444567899999999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~-~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMS 167 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT-CCEEECCCSSCEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC-CCeEEEeccchhhcc
Confidence 9999999999999999999988899999999999999999999999999999999999999999 999999999998754
Q ss_pred CCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
.. ......+|||.|+ |||++. ..|+|++|++ +++++|..||..... ......+.......|
T Consensus 168 ~~----~~~~~~~gt~~y~---aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p 236 (476)
T 2y94_A 168 DG----EFLRTSCGSPNYA---APEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV----PTLFKKICDGIFYTP 236 (476)
T ss_dssp TT----CCBCCCCSCSTTC---CHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS----HHHHHHHHTTCCCCC
T ss_pred cc----ccccccCCCcCeE---ChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH----HHHHHHHhcCCcCCC
Confidence 32 1233468999988 898753 3678899965 579999999964210 000111222233334
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
..+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus 237 ---~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 237 ---QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp ---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred ---ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 578999999999999999999999999999999985
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=349.63 Aligned_cols=260 Identities=22% Similarity=0.354 Sum_probs=201.5
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
-.++|++++.||+|+||+||+|+++. ++.||+|+++... ........+.+|+++++.++||||+++++++.++..+|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQ--GRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETT--SCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECC--CCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 36889999999999999999998753 6899999998653 22334567889999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 119 LVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+||||++ |+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 96 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 96 LVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEETTSCC
T ss_pred EEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC-CCEEEccCcCceecCCCc
Confidence 9999996 5888888765 469999999999999999999999999999999999999999 999999999998754322
Q ss_pred cccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCChhhHh-
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPTSTAA- 259 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~~~~~- 259 (473)
. ......||+.|+ |||++.. .|+|++|++ +++++|..||.... ...+...+.....
T Consensus 174 ~---~~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 174 R---SYTHEVVTLWYR---APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp C------CCCCCCTTC---CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred c---cccCCcccCCcC---CHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 1 122346788887 8887542 477899965 57999999996421 1111111100000
Q ss_pred -------h------hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 260 -------Q------LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 260 -------~------~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
. ....+......+++++.+||.+||+.||++|||++|+++||||++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence 0 0000011124578999999999999999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=359.10 Aligned_cols=261 Identities=21% Similarity=0.308 Sum_probs=193.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC--E
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSS--C 116 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~--~ 116 (473)
+++|++++.||+|+||.||+|+++. +++.||||++.+.. .......++.+|+.+|+.+. ||||+++++++...+ .
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETT-TCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cCceEEEEEeeeCCCeEEEEEEECC-CCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 5789999999999999999999887 67899999997652 34555678899999999996 999999999998654 7
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+|||||+ |+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+|+.+...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEESSSC
T ss_pred EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC-CCEEecCCccccccccc
Confidence 999999995 699999987 479999999999999999999999999999999999999999 99999999999865321
Q ss_pred cc------------------ccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHh----
Q psy622 197 IV------------------YLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSAL---- 246 (473)
Q Consensus 197 ~~------------------~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~---- 246 (473)
.. ........+||+.|+ |||++.. .|+|++|++ ++|++|.+||.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYR---APEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGC---CHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcC---CHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 10 011223357888887 8997643 578899965 57999999996521
Q ss_pred -----hhcCCCCCh-----------hhHhhh-------ccCCCC-------------ccccCChhHHHHHHhccccCCCC
Q psy622 247 -----RVAGSQIPT-----------STAAQL-------QLEWPE-------------DEEALNPSTEETILALLKSDPTQ 290 (473)
Q Consensus 247 -----~~~~~~~~~-----------~~~~~~-------~~~~P~-------------~~~~ls~~a~dLI~~LL~~dP~k 290 (473)
...+..... ...... ...+.. ....+++++.+||.+||+.||++
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 000100000 000000 000000 01367999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCc
Q psy622 291 RPSGHQVRRLPMFKDYDW 308 (473)
Q Consensus 291 Rpsa~eil~HPFF~~idw 308 (473)
|||++|+++||||+.+..
T Consensus 320 R~t~~e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 320 RISANDALKHPFVSIFHN 337 (388)
T ss_dssp SCCHHHHTTSTTTTTTCC
T ss_pred CCCHHHHhCCHHHHHhcC
Confidence 999999999999876643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=362.77 Aligned_cols=253 Identities=18% Similarity=0.283 Sum_probs=206.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||+|+||+||+|+++. +++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~-~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVL-AGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETT-TTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECC-CCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 579999999999999999999887 689999999987653 234466789999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC--CCceeEeecchhhhhcCCcc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ--APHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~--~g~ikL~DFGla~~~~~~~~ 198 (473)
|||+.||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ ++.+||+|||+++......
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~- 167 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ- 167 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC-
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC-
Confidence 9999999999999999999999999999999999999999999999999999999842 2789999999998754322
Q ss_pred ccccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc-cc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED-EE 270 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~-~~ 270 (473)
......+|||.|+ |||++.. .|.|++|++ +++++|..||...... .....+......+|.. ..
T Consensus 168 --~~~~~~~gt~~Y~---APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~ 238 (444)
T 3soa_A 168 --QAWFGFAGTPGYL---SPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH----RLYQQIKAGAYDFPSPEWD 238 (444)
T ss_dssp --CBCCCSCSCGGGC---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHTCCCCCTTTTT
T ss_pred --ceeecccCCcccC---CHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHhCCCCCCccccc
Confidence 1123357999988 8997643 578899965 5799999999642110 0011222223333321 14
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.+++++++||.+||+.||.+||+++|+++||||++
T Consensus 239 ~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 78999999999999999999999999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=351.80 Aligned_cols=265 Identities=20% Similarity=0.305 Sum_probs=199.0
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
....+++|++++.||+|+||+||+|+++. +++.||||+++.... .......+.+|+.+|+.++||||+++++++.+..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTV-TNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETT-TTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECC-CCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 45567899999999999999999998876 689999999986532 2333557789999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC----CCceeEeecchhh
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ----APHCPIVNTLFLA 191 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~----~g~ikL~DFGla~ 191 (473)
.+|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9999999996 5999999998899999999999999999999999999999999999999533 1569999999998
Q ss_pred hhcCCccccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCC
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIP 254 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~ 254 (473)
....... ......||+.|+ |||++.. .|+|++|++ +++++|..||..... ..+....
T Consensus 186 ~~~~~~~---~~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 186 AFGIPIR---QFTHEIITLWYR---PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp HHC--------------CCTTC---CHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccCCccc---ccCCCcCCcccc---CHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 7643221 122346788887 8887543 477889965 579999999964211 0000000
Q ss_pred hhh-----HhhhccCCCC---------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 255 TST-----AAQLQLEWPE---------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 255 ~~~-----~~~~~~~~P~---------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
... .......++. ....+++++++||.+||+.||.+|||++|+++||||++++|+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 000 0000001110 012378999999999999999999999999999999999997
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=348.25 Aligned_cols=260 Identities=20% Similarity=0.276 Sum_probs=212.2
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK---NMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
++|++.+.||+|+||.||+|+++. +++.||+|++++...... ...+.+.+|+.+|+.++||||+++++++.+...+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cceEeceEEeeCCCeEEEEEEECC-CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 569999999999999999999876 678999999987643221 1356789999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC----ceeEeecchhhhh
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP----HCPIVNTLFLAIL 193 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g----~ikL~DFGla~~~ 193 (473)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ + .+||+|||+++..
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~-~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR-NVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCS-SSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecC-CCCCCCEEEEECCCCeEC
Confidence 9999999999999999988899999999999999999999999999999999999999987 6 8999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
..... ....+||+.|+ |||++. ..|+|++|++ +++++|..||....... ....+......++
T Consensus 169 ~~~~~----~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~~~~~~~~~~ 237 (326)
T 2y0a_A 169 DFGNE----FKNIFGTPEFV---APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANVSAVNYEFE 237 (326)
T ss_dssp CTTSC----CCCCCSCTTTC---CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHHTCCCCC
T ss_pred CCCCc----cccccCCcCcC---CceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----HHHHHHhcCCCcC
Confidence 43221 22357898888 898754 3678899965 57999999996421100 0011111222222
Q ss_pred C-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccccc
Q psy622 267 E-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILD 313 (473)
Q Consensus 267 ~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~ 313 (473)
. ....+++++++||.+||+.||.+|||++|+++||||+..+|.....
T Consensus 238 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~ 285 (326)
T 2y0a_A 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS 285 (326)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSHHHHHH
T ss_pred ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcchhhhh
Confidence 1 1246899999999999999999999999999999999998875543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=348.36 Aligned_cols=249 Identities=19% Similarity=0.265 Sum_probs=205.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++.+.||+|+||.||+|+++. +++.||+|+++.. ......+.+|+.+|+.++||||+++++++++...+|+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECC-CCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 4789999999999999999999876 6799999999754 2335578899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC--CCCceeEeecchhhhhcCC
Q psy622 120 VMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA--QAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~--~~g~ikL~DFGla~~~~~~ 196 (473)
||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. + +.+||+|||+++.+...
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~-~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS-STIKIIEFGQARQLKPG 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC-CCEEECCCTTCEECCTT
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCC-CCEEEEECCCCeECCCC
Confidence 999999999999998754 7999999999999999999999999999999999999997 5 89999999999875432
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC-c
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE-D 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~-~ 268 (473)
.. ....+|||.|+ |||++. ..|+|++|++ +++++|..||....... ....+......++. .
T Consensus 158 ~~----~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~ 226 (321)
T 1tki_A 158 DN----FRLLFTAPEYY---APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----IIENIMNAEYTFDEEA 226 (321)
T ss_dssp CE----EEEEESCGGGS---CHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCCCHHH
T ss_pred Cc----cccccCChhhc---CcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH----HHHHHHcCCCCCChhh
Confidence 21 23357899988 898753 4688899965 57999999996421100 00112222233321 1
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
...+++++++||.+||+.||.+|||++|+++||||++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 2468999999999999999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=353.43 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=208.0
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||+|+||.||+|+++. +++.||+|++++... .....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECC-CCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 579999999999999999999876 678999999987653 344567899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--CceeEeecchhhhhcCCcc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA--PHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~--g~ikL~DFGla~~~~~~~~ 198 (473)
|||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ +.+||+|||+++......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~- 185 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence 99999999999999888999999999999999999999999999999999999998651 469999999998754322
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc-cc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED-EE 270 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~-~~ 270 (473)
.....+||+.|+ |||++. ..|+|++|++ +++++|..||...... .....+......+|.. ..
T Consensus 186 ---~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~ 255 (362)
T 2bdw_A 186 ---AWHGFAGTPGYL---SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQIKAGAYDYPSPEWD 255 (362)
T ss_dssp ---SCCCSCSCTTTC---CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCTTGGG
T ss_pred ---ccccCCCCcccc---CHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhCCCCCCccccc
Confidence 123357899988 899754 3678899965 5799999999642110 0001122223333321 24
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.+++++++||.+||+.||.+||+++|+++||||.+
T Consensus 256 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 256 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp GSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 68999999999999999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=344.32 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=200.2
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch-----------------------hHHHHHHHHHH
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK-----------------------NMVSQVLRERN 94 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~-----------------------~~~~~~~~E~~ 94 (473)
..+++|++.+.||+|+||.||+|+++. +++.||||++.+...... ...+.+.+|++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNEN-DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETT-TTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECC-CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 457899999999999999999998876 679999999987643221 12356899999
Q ss_pred HHHhcCCCCeeeEEEEEEe--CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcc
Q psy622 95 ALALTHSPFCVQLFYSLQT--SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDN 172 (473)
Q Consensus 95 iL~~l~hp~Iv~l~~~f~~--~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeN 172 (473)
+|+.++||||+++++++.+ ...+|+||||+++|+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 9999999999999999987 678999999999999988654 4579999999999999999999999999999999999
Q ss_pred eEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCcccccc---------CCcCCCCcc-ccccCCCCCc
Q psy622 173 MLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS---------LKTGTFPTF-QDVQNSQAPF 242 (473)
Q Consensus 173 ILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~---------~~~~s~g~l-~~~~~g~~pf 242 (473)
||++.+ +.+||+|||+++...... .......||+.|+ |||.+.. .|+|++|++ +++++|..||
T Consensus 168 il~~~~-~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 168 LLVGED-GHIKIADFGVSNEFKGSD---ALLSNTVGTPAFM---APESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp EEECTT-SCEEECCCTTCEECSSSS---CEECCCCSCGGGC---CGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEECCC-CCEEEecCCCcccccccc---ccccCCcCCcccc---ChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 999999 999999999998754322 1123357888888 8997632 488899965 5799999999
Q ss_pred hhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 243 PSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
....... ....+......+|.. ..+++++++||.+||+.||++||+++|+++||||+
T Consensus 241 ~~~~~~~----~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 241 MDERIMC----LHSKIKSQALEFPDQ-PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp CCSSHHH----HHHHHHHCCCCCCSS-SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred CCccHHH----HHHHHhcccCCCCCc-cccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 6421100 001112223334432 47899999999999999999999999999999995
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=357.46 Aligned_cols=256 Identities=19% Similarity=0.280 Sum_probs=205.5
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN--KNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
++|++.+.||+|+||+||+|+++. +++.||||++++..... ....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRE-TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECC-CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 579999999999999999999876 67899999998654321 113567899999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--CceeEeecchhhh
Q psy622 119 LVMEYMIGGDVKSLIAAN----GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA--PHCPIVNTLFLAI 192 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~----~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~--g~ikL~DFGla~~ 192 (473)
+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ +.+||+|||+++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999888643 3589999999999999999999999999999999999998761 3499999999987
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
..... ......+||+.|+ |||++. ..|+|++|++ +++++|..||...... ....+......+
T Consensus 183 ~~~~~---~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~i~~~~~~~ 251 (351)
T 3c0i_A 183 LGESG---LVAGGRVGTPHFM---APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-----LFEGIIKGKYKM 251 (351)
T ss_dssp CCTTS---CBCCCCCSCGGGC---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-----HHHHHHHTCCCC
T ss_pred ecCCC---eeecCCcCCcCcc---CHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-----HHHHHHcCCCCC
Confidence 54321 1223457899888 899764 3578899965 5799999999752110 001111122222
Q ss_pred C-CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCc
Q psy622 266 P-EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDW 308 (473)
Q Consensus 266 P-~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw 308 (473)
+ .....+++++++||.+||+.||++||++.|+++||||++.++
T Consensus 252 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295 (351)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHH
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCcc
Confidence 2 112468999999999999999999999999999999987655
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=338.86 Aligned_cols=257 Identities=21% Similarity=0.337 Sum_probs=198.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+++|++++.||+|+||+||+|+++ +++.||+|+++.... .......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CccchhhhhcccCCCEEEEEEEcC--CCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence 478999999999999999999873 468999999976532 22234578899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||||++ |+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 78 VFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEECCS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC---
T ss_pred EEEecC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEeECccccccCcccc
Confidence 999996 5999999874 679999999999999999999999999999999999999999 9999999999987643221
Q ss_pred ccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChhhH--h
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTSTA--A 259 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~~~--~ 259 (473)
......||+.|+ |||++. ..|+|++|++ +++++|..||..... ..+........ .
T Consensus 156 ---~~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 156 ---KYTHEIVTLWYR---APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ---------CCCTTC---CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ---cccccccccccc---CchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 112346788887 888653 3577889965 579999999964210 00110000000 0
Q ss_pred ---h--------hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 260 ---Q--------LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 260 ---~--------~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
. ....+......+++++.+||.+||+.||++|||++|+++||||++.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC--
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcC
Confidence 0 00111112246899999999999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=340.75 Aligned_cols=266 Identities=22% Similarity=0.293 Sum_probs=201.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+++|++++.||+|+||+||+|+++. +++.||+|++.+.. ......+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRD-TGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCC-CCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 5789999999999999999999876 57899999997653 233445678899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||||+++++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC-----
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC-CCEEEeeCCCchhccCccc-
Confidence 99999999999999988889999999999999999999999999999999999999998 9999999999987542221
Q ss_pred cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChhhHh---
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTSTAA--- 259 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~~~~--- 259 (473)
......||+.|+ |||.+. ..|.|++|++ +++++|..||..... ..+...+.....
T Consensus 158 --~~~~~~~~~~y~---aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 158 --YYDDEVATRWYR---SPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ----------GGGC---CHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred --ccCCCcCCcccc---ChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 122346788877 888654 3577888965 579999999964211 001100000000
Q ss_pred ---hhccCCCC---------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccC
Q psy622 260 ---QLQLEWPE---------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQ 314 (473)
Q Consensus 260 ---~~~~~~P~---------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~ 314 (473)
......|. ....+++++.+||.+||+.||.+|||++|+++||||+++.|.....+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~ 299 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAK 299 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-------
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHHHHH
Confidence 00011111 01368899999999999999999999999999999999988765544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=338.78 Aligned_cols=255 Identities=23% Similarity=0.373 Sum_probs=210.1
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
.+...+++|++.+.||+|+||.||+|+++. +++.||+|++.+...........+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (279)
T 3fdn_A 3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 81 (279)
T ss_dssp -CCCCGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cceeecccEEEeeEEecCCCeEEEEEEEcc-CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence 345678999999999999999999998876 5789999999876544444466789999999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+|+||||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP 160 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT-SCEEECSCCEESCC-
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC-CCEEEEeccccccCC
Confidence 9999999999999999999988899999999999999999999999999999999999999998 999999999986543
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
... .....|++.|+ |||.+. ..|.|++|++ +++++|..||...... .....+......+|
T Consensus 161 ~~~-----~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~- 227 (279)
T 3fdn_A 161 SSR-----RTDLCGTLDYL---PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISRVEFTFP- 227 (279)
T ss_dssp ------------CCCCTTC---CHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHTCCCCC-
T ss_pred ccc-----ccccCCCCCcc---CHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH----HHHHHHHhCCCCCC-
Confidence 221 12346888887 888653 3577888865 5699999999642110 00112222334445
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
..+++++++||.+||+.||.+||+++|+++||||++.
T Consensus 228 --~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 228 --DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp --TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred --CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 5789999999999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=343.36 Aligned_cols=252 Identities=21% Similarity=0.331 Sum_probs=200.3
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS---- 115 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~---- 115 (473)
+++|++++.||+|+||+||+|+++. +++.||||+++... .....+.+.+|+++|+.++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKV-DDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETT-TCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 3579999999999999999999876 57899999998653 2344668999999999999999999999986543
Q ss_pred -----------------------------------------------------EEEEEecccCcCCHHHHHHhCCC---C
Q psy622 116 -----------------------------------------------------CVFLVMEYMIGGDVKSLIAANGA---L 139 (473)
Q Consensus 116 -----------------------------------------------------~l~lVmEy~~gg~L~~~L~~~~~---~ 139 (473)
.+|+|||||+||+|.+++.+... .
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 48999999999999999997643 5
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc---------ccccccCCCC
Q psy622 140 PEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL---------EISDLVNGTP 210 (473)
Q Consensus 140 ~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~---------~~~~~~~gtp 210 (473)
++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......... ......+||+
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 666789999999999999999999999999999999998 999999999998764432111 1123346888
Q ss_pred cccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhc
Q psy622 211 NAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILAL 283 (473)
Q Consensus 211 ~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~L 283 (473)
.|+ |||.+. ..|+|++|++ +++++|..|+....... .......+|......++++.+||.+|
T Consensus 241 ~y~---aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 241 LYM---SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRII--------TDVRNLKFPLLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp GGS---CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHH--------HHHHTTCCCHHHHHHCHHHHHHHHHH
T ss_pred Ccc---ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHH--------HHhhccCCCcccccCChhHHHHHHHH
Confidence 887 898754 3578899965 57899888876532211 11112333433356778899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q psy622 284 LKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 284 L~~dP~kRpsa~eil~HPFF~~i 306 (473)
|+.||++||+++|+++||||+++
T Consensus 310 l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 310 LSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp HCSSGGGSCCHHHHHHSTTCCCC
T ss_pred ccCCCCcCCCHHHHhhchhhhcC
Confidence 99999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=343.51 Aligned_cols=252 Identities=22% Similarity=0.312 Sum_probs=186.7
Q ss_pred CCeEEE---ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCE
Q psy622 41 SDFEIV---KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSC 116 (473)
Q Consensus 41 ~~y~i~---~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~ 116 (473)
++|++. +.||+|+||+||+|+++. +++.||||++.+. ......+|+.+++.+. ||||+++++++.+...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKK-SNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETT-TCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hccccccCCCccccCCCeEEEEEEECC-CCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence 457775 789999999999999886 5789999999764 2456788999999996 9999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC---ceeEeecchhhhh
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP---HCPIVNTLFLAIL 193 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g---~ikL~DFGla~~~ 193 (473)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ + .+||+|||+++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE-NDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----CEEEECCCTTCEEC
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecC-CCcccEEEeccccceec
Confidence 99999999999999999998899999999999999999999999999999999999999876 4 8999999999864
Q ss_pred cCCccccccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCChh---hHhhhcc
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTS---TAAQLQL 263 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~---~~~~~~~ 263 (473)
.... ......+||+.|+ |||++.. .|+|++|++ +++++|..||.............. .+.....
T Consensus 160 ~~~~---~~~~~~~~t~~y~---aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 160 PPDN---QPLKTPCFTLHYA---APELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp CC----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred CCCC---CcccccCCCcCcc---CHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 3221 1223456888888 8987643 578899965 579999999975322111111111 1111222
Q ss_pred CCCCc-cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 264 EWPED-EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 264 ~~P~~-~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.++.. ...+++++++||.+||+.||.+||+++|+++||||++.
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 22211 13689999999999999999999999999999999853
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=344.33 Aligned_cols=260 Identities=22% Similarity=0.335 Sum_probs=189.3
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++++.||+|+||+||+|+++. +++.||+|+++.... ......+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT-TGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSS-SCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECC-CCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 5789999999999999999998776 678999999986542 2234578899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 120 VMEYMIGGDVKSLIAAN------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
||||++ |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAF 158 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCSSCEET
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC-CCEEECcCccceec
Confidence 999996 6999998753 359999999999999999999999999999999999999999 99999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChh
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTS 256 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~ 256 (473)
..... ......||+.|+ |||++. ..|+|++|++ +++++|..||..... ..+......
T Consensus 159 ~~~~~---~~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 159 GIPVN---TFSSEVVTLWYR---APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp TSCCC---CCCCCCSCCTTC---CHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred CCCcc---cCCCCccccccc---CchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 42211 122346788887 888754 2477889965 579999999964211 001000000
Q ss_pred h--Hhh---hccCC-------------CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccc
Q psy622 257 T--AAQ---LQLEW-------------PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDS 310 (473)
Q Consensus 257 ~--~~~---~~~~~-------------P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~ 310 (473)
. ... ....+ +.....+++++++||.+||+.||++|||++|+++||||++..|..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence 0 000 00000 011136889999999999999999999999999999999887763
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=338.43 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=210.9
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
....+++|++.+.||+|+||.||+|+++. +++.||+|++.+...........+.+|+++++.++||||+++++++.+.+
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQ-NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcC-CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 45667899999999999999999998876 57899999998765433444567899999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+||||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK-GELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-CCEEECCCTTCEECSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC-CCEEEecccccccCcc
Confidence 999999999999999999988899999999999999999999999999999999999999998 9999999999876432
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
.. .....|++.|+ |||.+. ..|.|++|++ +++++|..||....... ....+......+|
T Consensus 167 ~~-----~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~-- 232 (284)
T 2vgo_A 167 LR-----RRTMCGTLDYL---PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE----THRRIVNVDLKFP-- 232 (284)
T ss_dssp SC-----BCCCCSCGGGC---CHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTTCCCCC--
T ss_pred cc-----cccccCCCCcC---CHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH----HHHHHhccccCCC--
Confidence 21 22356888887 888653 4677889965 57999999996421100 0011222334445
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
..++.++++||.+||+.||.+||+++|+++||||+..
T Consensus 233 -~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 233 -PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred -CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 5789999999999999999999999999999999853
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.50 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=209.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch-----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK-----NMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~-----~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
.++|++++.||+|+||.||+|+++. +++.||||++++...... .....+.+|+.+|+.++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKE-KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETT-TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ccceEEEeEEEecCCEEEEEEEECC-CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3579999999999999999999877 679999999987643221 1334677899999999999999999999999
Q ss_pred CEEEEEecccCcC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 SCVFLVMEYMIGG-DVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 ~~l~lVmEy~~gg-~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
+.+|+||||+.+| +|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED-FTIKLIDFGSAAYL 180 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC-CcEEEeecccceEC
Confidence 9999999998766 999999998899999999999999999999999999999999999999998 99999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
..... ....+||+.|+ |||++. ..|+|++|++ +++++|..||....... ......
T Consensus 181 ~~~~~----~~~~~gt~~y~---aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------~~~~~~ 243 (335)
T 3dls_A 181 ERGKL----FYTFCGTIEYC---APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV----------EAAIHP 243 (335)
T ss_dssp CTTCC----BCEECSCGGGC---CHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----------TTCCCC
T ss_pred CCCCc----eeccCCCcccc---ChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----------hhccCC
Confidence 43221 22357888888 898753 3477899965 57999999997532211 112222
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC------CCccccccC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD------YDWDSILDQ 314 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~------idw~~l~~~ 314 (473)
| ..+++++.+||.+||+.||.+||+++|+++||||++ ++|+.+.+.
T Consensus 244 ~---~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~ 295 (335)
T 3dls_A 244 P---YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRV 295 (335)
T ss_dssp S---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCCCGGGCCHHHHC--
T ss_pred C---cccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCccccccCHHHHhhh
Confidence 3 568999999999999999999999999999999965 566666554
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=331.94 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=194.8
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
.+++|++.+.||+|+||.||+|+++. +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIH-TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEcc-CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 46789999999999999999998876 57899999998765444444678999999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 119 LVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+||||+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT-CCEEECCCTTCEECC---
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEEeecceeeccCCC
Confidence 999999999999999875 579999999999999999999999999999999999999998 999999999998753221
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~ 270 (473)
. ......||+.|+ |||.+. ..|.|++|++ +++++|..||...... ... ..........| .
T Consensus 167 ~---~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~-~~~~~~~~~~~---~ 233 (278)
T 3cok_A 167 E---KHYTLCGTPNYI---SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK---NTL-NKVVLADYEMP---S 233 (278)
T ss_dssp -------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCCC---T
T ss_pred C---cceeccCCCCcC---CcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH---HHH-HHHhhcccCCc---c
Confidence 1 112346888887 888653 4688899965 5799999999642110 000 00111122334 5
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.++.++.+||.+||+.||.+||+++|+++||||...
T Consensus 234 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 789999999999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=338.53 Aligned_cols=262 Identities=21% Similarity=0.247 Sum_probs=200.6
Q ss_pred CCCeEEE-ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q psy622 40 ISDFEIV-KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 40 ~~~y~i~-~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l 117 (473)
.+.|++. +.||+|+||+||+|+++. +++.||||++++.. ......+.+|+.+|.++ +||||+++++++.+.+.+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLI-TSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSS-SCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcC-CCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 4679996 789999999999998776 57899999998753 23356789999999885 899999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCc---eeEeecchhhhhc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH---CPIVNTLFLAILQ 194 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~---ikL~DFGla~~~~ 194 (473)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +. +||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHP-NQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCS-SSSCSEEECCTTCCC---
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccC-CCcCceEEEEccCccccc
Confidence 9999999999999999988899999999999999999999999999999999999999987 54 9999999998653
Q ss_pred CCccc----cccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCC----C-
Q psy622 195 QPIVY----LEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQ----I- 253 (473)
Q Consensus 195 ~~~~~----~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~----~- 253 (473)
..... .......+||+.|+ |||++. ..|+|++|++ +++++|..||.......... .
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYM---APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp ----------------CCSGGGC---CHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred cCCccccccccccccccCCcCcc---ChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 22111 01122346888888 899764 3688999965 57999999997531100000 0
Q ss_pred ------ChhhHhhhccCCCCc-cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 254 ------PTSTAAQLQLEWPED-EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 254 ------~~~~~~~~~~~~P~~-~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
....+......+|.. ...+++++++||.+||+.||.+||+++|+++||||++..|+
T Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305 (316)
T ss_dssp HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence 001222233344421 13589999999999999999999999999999999988766
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=345.72 Aligned_cols=253 Identities=24% Similarity=0.293 Sum_probs=191.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++.+.||+|+||+||+|+++. +++.||||++++.. ..+.+.+|+.+|+.++||||+++++++.+...+|+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKG-TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECC-CCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 4679999999999999999999876 57899999998653 23467889999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC---CCCceeEeecchhhhhcCC
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA---QAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~---~~g~ikL~DFGla~~~~~~ 196 (473)
||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++. + +.+||+|||+++.....
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~-~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPD-APLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTT-CCEEECCCC--------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCC-CCEEEccCccccccCcc
Confidence 9999999999999998888999999999999999999999999999999999999975 5 89999999999875332
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC-Cc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP-ED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P-~~ 268 (473)
. .....+||+.|+ |||++. ..|+|++|++ +++++|..||...... ......+......++ ..
T Consensus 205 ~----~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~i~~~~~~~~~~~ 274 (349)
T 2w4o_A 205 V----LMKTVCGTPGYC---APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD---QFMFRRILNCEYYFISPW 274 (349)
T ss_dssp ------------CGGGS---CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH---HHHHHHHHTTCCCCCTTT
T ss_pred c----ccccccCCCCcc---CHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc---HHHHHHHHhCCCccCCch
Confidence 1 223457888888 898754 3677899965 5799999999642110 000011111122221 11
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
...++.++++||.+||+.||++||++.|+++||||.+..++
T Consensus 275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred hhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence 24689999999999999999999999999999999876554
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=346.51 Aligned_cols=256 Identities=20% Similarity=0.273 Sum_probs=197.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS----- 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~----- 114 (473)
.++|++++.||+|+||.||+|+++. +++.||||++.+.. ......+++.+|+++|+.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETT-TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECC-CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 4689999999999999999999876 67899999997653 3344567899999999999999999999999765
Q ss_pred -CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 -SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 -~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..+|+||||+ |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQA 178 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC-CCEEEEeeeccccc
Confidence 3579999999 9999999987 579999999999999999999999999999999999999999 99999999999874
Q ss_pred cCCccccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCChh
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPTS 256 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~~ 256 (473)
... .....||+.|+ |||++.. .|+|++|++ +++++|..||.+.. ...+.. +..
T Consensus 179 ~~~------~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~-~~~ 248 (367)
T 1cm8_A 179 DSE------MTGYVVTRWYR---APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP-PAE 248 (367)
T ss_dssp CSS------CCSSCSCGGGC---CTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC-CHH
T ss_pred ccc------cCcCcCCCCcC---CHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC-CHH
Confidence 321 12346787777 8987543 577889965 57999999997421 111111 110
Q ss_pred hHh-----------h-----hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccc
Q psy622 257 TAA-----------Q-----LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDS 310 (473)
Q Consensus 257 ~~~-----------~-----~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~ 310 (473)
... . ....+.......++++.+||.+||+.||.+|||++|+++||||+.+.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 318 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence 000 0 01112222246799999999999999999999999999999999887653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=338.17 Aligned_cols=261 Identities=18% Similarity=0.260 Sum_probs=212.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK---NMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
.++|++.+.||+|+||.||+|+++. +++.||+|++++...... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hccEEEeeEeeecCCEEEEEEEECC-CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3569999999999999999999876 678999999987643221 135678999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC----ceeEeecchhhh
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP----HCPIVNTLFLAI 192 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g----~ikL~DFGla~~ 192 (473)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ + ++||+|||+++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~-~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDK-NIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCT-TSSSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecC-CCCcCCEEEccCcccee
Confidence 99999999999999999988889999999999999999999999999999999999999988 6 799999999987
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
...... .....||+.|+ |||.+. ..|+|++|++ +++++|..||....... ....+......+
T Consensus 169 ~~~~~~----~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~ 237 (321)
T 2a2a_A 169 IEDGVE----FKNIFGTPEFV---APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANITSVSYDF 237 (321)
T ss_dssp CCTTCC----CCCCCSCGGGC---CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTTCCCC
T ss_pred cCcccc----ccccCCCCCcc---CcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhccccc
Confidence 543221 12346888887 888654 3577899965 57999999996421100 001111112222
Q ss_pred CC-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccccc
Q psy622 266 PE-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILD 313 (473)
Q Consensus 266 P~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~ 313 (473)
+. ....+++++++||.+||+.||++|||++|+++||||++++|.....
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~~~~~ 286 (321)
T 2a2a_A 238 DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286 (321)
T ss_dssp CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHHHHHH
T ss_pred ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcccccc
Confidence 21 1246889999999999999999999999999999999999876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=351.78 Aligned_cols=254 Identities=19% Similarity=0.311 Sum_probs=206.8
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++++.||+|+||+||+|+++. +++.||+|++.+.. ......+.+|+.+|+.++||||+++++++.+...+|+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 4689999999999999999999886 67899999998753 2334578899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC-CCceeEeecchhhhhcCCc
Q psy622 120 VMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ-APHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~-~g~ikL~DFGla~~~~~~~ 197 (473)
||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++.+....
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 999999999999998654 79999999999999999999999999999999999999853 2789999999998754321
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC-Ccc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP-EDE 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P-~~~ 269 (473)
.....+||+.|+ |||++. ..|+|++|++ ++|++|..||....... ....+......++ ...
T Consensus 206 ----~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~ 274 (387)
T 1kob_A 206 ----IVKVTTATAEFA---APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQNVKRCDWEFDEDAF 274 (387)
T ss_dssp ----CEEEECSSGGGC---CHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHHCCCCCCSSTT
T ss_pred ----ceeeeccCCCcc---CchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCcccc
Confidence 122347899888 899764 3678899965 57999999996421100 0011111122222 112
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCc
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDW 308 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw 308 (473)
..+++++++||.+||+.||.+||+++|+++||||++..+
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 468999999999999999999999999999999987654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=358.68 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=202.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN-----KNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~-----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
.++|++.+.||+|+||+||+|+++. +++.||||++.+..... ......+.+|+.+|+.++||||+++++++. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERK-TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECC-CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 3689999999999999999999887 67899999998764321 122235789999999999999999999985 4
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--CceeEeecchhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA--PHCPIVNTLFLAI 192 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~--g~ikL~DFGla~~ 192 (473)
..+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ +.+||+|||+++.
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 56899999999999999998888999999999999999999999999999999999999997651 4599999999987
Q ss_pred hcCCccccccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhc
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQ 262 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 262 (473)
.... ......+||+.|+ |||++. ..|+|++|++ +++++|..||..... .......+....
T Consensus 292 ~~~~----~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~i~~~~ 361 (419)
T 3i6u_A 292 LGET----SLMRTLCGTPTYL---APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QVSLKDQITSGK 361 (419)
T ss_dssp CC---------------CTTC---CTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS---SCCHHHHHHTTC
T ss_pred cCCC----ccccccCCCCCcc---CceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc---hHHHHHHHhcCC
Confidence 5432 2223467999988 899763 3578899965 579999999964210 111111222222
Q ss_pred cCC-CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccc
Q psy622 263 LEW-PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSI 311 (473)
Q Consensus 263 ~~~-P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l 311 (473)
..+ |.....+++++.+||.+||+.||.+||+++|+++||||++.+|...
T Consensus 362 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~ 411 (419)
T 3i6u_A 362 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 411 (419)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHHH
T ss_pred CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHHH
Confidence 222 2222468999999999999999999999999999999999887653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=364.36 Aligned_cols=257 Identities=21% Similarity=0.280 Sum_probs=211.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++.++||+|+||.||+|+++. +++.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECC-CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3579999999999999999999876 678999999988765555557789999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec---CCCCceeEeecchhhhhcCC
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS---AQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld---~~~g~ikL~DFGla~~~~~~ 196 (473)
||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .+ +.+||+|||+++.....
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~-~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKD-ANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTT-CCEEECCTTHHHHBCCC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCC-CcEEEEeeeeeEEcccc
Confidence 999999999999999988999999999999999999999999999999999999995 45 89999999999876433
Q ss_pred ccccccccccCCCCcccccCCccccc-----cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC-cc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL-----SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE-DE 269 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~-----~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~-~~ 269 (473)
.. ....+|||.|+ |||++. ..|+|++|++ +++++|..||....... ....+......++. ..
T Consensus 183 ~~----~~~~~gt~~y~---aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~ 251 (484)
T 3nyv_A 183 KK----MKDKIGTAYYI---APEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYD----ILKKVEKGKYTFELPQW 251 (484)
T ss_dssp CS----HHHHTTGGGTC---CHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCSGGG
T ss_pred cc----cccCCCCcccc---CceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHcCCCCCCCccc
Confidence 21 12346899888 898754 3577899965 56999999997421100 00111222222221 12
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
..+++++++||.+||+.||.+|||++|+++||||+...++
T Consensus 252 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~ 291 (484)
T 3nyv_A 252 KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE 291 (484)
T ss_dssp GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence 4689999999999999999999999999999999876654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=352.96 Aligned_cols=251 Identities=25% Similarity=0.304 Sum_probs=195.1
Q ss_pred CCCCCeEEE-ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCCeeeEEEEEEe--
Q psy622 38 PEISDFEIV-KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL-THSPFCVQLFYSLQT-- 113 (473)
Q Consensus 38 ~~~~~y~i~-~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~~-- 113 (473)
..+++|.+. ++||+|+||+||+|+++. +++.||||++++. ..+.+|+.++.. .+||||++++++|..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~-~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECC-CCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 346789888 789999999999999876 6789999999753 246678888754 589999999999976
Q ss_pred --CCEEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC---CCCceeEee
Q psy622 114 --SSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA---QAPHCPIVN 186 (473)
Q Consensus 114 --~~~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~---~~g~ikL~D 186 (473)
...+|+|||||+||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. + +.+||+|
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~-~~~kl~D 207 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTD 207 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTT-CCEEECC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCC-ccEEEEe
Confidence 678999999999999999998754 5999999999999999999999999999999999999998 5 8999999
Q ss_pred cchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh
Q psy622 187 TLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA 259 (473)
Q Consensus 187 FGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~ 259 (473)
||+++...... .....+||+.|+ |||++. ..|+|++|++ ++|++|..||...............+.
T Consensus 208 FG~a~~~~~~~----~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~ 280 (400)
T 1nxk_A 208 FGFAKETTSHN----SLTTPCYTPYYV---APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280 (400)
T ss_dssp CTTCEECC---------------CTTC---CGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred cccccccCCCC----ccccCCCCCCcc---CHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence 99998643221 123457899888 899764 3578899965 579999999975321110001112222
Q ss_pred hhccCCCCc-cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 260 QLQLEWPED-EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 260 ~~~~~~P~~-~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.....+|.. ...+++++++||++||+.||.+|||++|+++||||.+
T Consensus 281 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp HTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 233333321 1468999999999999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=339.31 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=214.0
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
...++|++.+.||+|+||.||+|+++. +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 345789999999999999999999876 6789999999987666666777899999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCSTT
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC-CCEEEeeccCceecccCc
Confidence 9999999999999999988899999999999999999999999999999999999999998 999999999998753221
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~ 270 (473)
.......||+.|+ |||++. ..|+|++|++ +++++|..||....... ....+......+| .
T Consensus 196 ---~~~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~---~ 262 (335)
T 2owb_A 196 ---ERKKVLCGTPNYI---APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLRIKKNEYSIP---K 262 (335)
T ss_dssp ---CCBCCCCSCCSSC---CHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCCC---T
T ss_pred ---ccccccCCCcccc---CHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH----HHHHHhcCCCCCC---c
Confidence 1123456888887 898753 4678899965 57999999996421100 0011222333444 5
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
.+++++.+||.+||+.||.+||+++|+++||||+...
T Consensus 263 ~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 263 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 7899999999999999999999999999999998654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=329.05 Aligned_cols=260 Identities=20% Similarity=0.311 Sum_probs=211.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++.+.||+|+||.||+|.++. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcC-CCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 4789999999999999999998876 578999999987653 34456788999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--CceeEeecchhhhhcCCc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA--PHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~--g~ikL~DFGla~~~~~~~ 197 (473)
||||++||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++ +.+||+|||++.......
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 999999999999999888999999999999999999999999999999999999998761 349999999998754322
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc-c
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED-E 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~-~ 269 (473)
. .....||+.|+ |||.+. ..|+|++|++ +++++|..||....... ....+......+|.. .
T Consensus 163 ~----~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~ 231 (284)
T 3kk8_A 163 A----WHGFAGTPGYL---SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQIKAGAYDYPSPEW 231 (284)
T ss_dssp B----CCCSCSCGGGC---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCCTTTT
T ss_pred c----ccCCCCCcCCc---CchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH----HHHHHHhccccCCchhh
Confidence 1 12346888887 888753 3677889965 57999999996421100 001111222222221 1
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccc
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSIL 312 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~ 312 (473)
..+++++.+||.+||+.||.+||+++|+++||||++..+....
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 232 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence 4789999999999999999999999999999999988766443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=333.28 Aligned_cols=262 Identities=18% Similarity=0.253 Sum_probs=208.6
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc------chhHHHHHHHHHHHHHhcC-CCCeeeEEEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI------NKNMVSQVLRERNALALTH-SPFCVQLFYS 110 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~------~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~ 110 (473)
...++|++.+.||+|+||.||+|+++. +++.||||+++..... .....+.+.+|+++++.+. ||||++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcC-cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 346899999999999999999999876 6799999999865311 1233557889999999995 9999999999
Q ss_pred EEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 111 LQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 111 f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
+.+...+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~ 171 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFS 171 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTC
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC-CcEEEecccch
Confidence 99999999999999999999999988899999999999999999999999999999999999999999 99999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc------------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhh
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTST 257 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~ 257 (473)
........ .....|++.|+ |||.+. ..|.|++|++ +++++|..||....... ....
T Consensus 172 ~~~~~~~~----~~~~~~~~~y~---aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~ 240 (298)
T 1phk_A 172 CQLDPGEK----LREVCGTPSYL---APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----MLRM 240 (298)
T ss_dssp EECCTTCC----BCCCCSCGGGC---CHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH
T ss_pred hhcCCCcc----cccccCCcccc---CHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH----HHHH
Confidence 87543221 22346788777 888753 4588899965 57999999996421100 0011
Q ss_pred HhhhccCCCC-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccc
Q psy622 258 AAQLQLEWPE-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSIL 312 (473)
Q Consensus 258 ~~~~~~~~P~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~ 312 (473)
+......++. ....++.++.+||.+||+.||.+||+++|+++||||++..|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-----
T ss_pred HhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhhc
Confidence 1112222221 124689999999999999999999999999999999999988664
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=332.58 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=199.0
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++.+.||+|+||.||+|+++. +++.||+|++.+... ....+.+.+|+++|+.++||||+++++++.+...+|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERS-SGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEcc-CCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 3679999999999999999998876 578999999987642 2235678999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec---CCCCceeEeecchhhh
Q psy622 120 VMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS---AQAPHCPIVNTLFLAI 192 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld---~~~g~ikL~DFGla~~ 192 (473)
||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ .+ +.+||+|||+++.
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~-~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPH-SPIKIIDFGLAEL 176 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTT-CCEEECCCCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCC-CCEEEEeeeccee
Confidence 9999999999999864 36799999999999999999999999999999999999994 34 7899999999986
Q ss_pred hcCCccccccccccCCCCcccccCCccccc-----cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL-----SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-----~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
..... ......||+.|+ |||.+. ..|+|++|++ +++++|..||....... ...........++
T Consensus 177 ~~~~~----~~~~~~~t~~y~---aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~----~~~~~~~~~~~~~ 245 (285)
T 3is5_A 177 FKSDE----HSTNAAGTALYM---APEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE----VQQKATYKEPNYA 245 (285)
T ss_dssp --------------CTTGGGC---CHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC
T ss_pred cCCcc----cCcCcccccCcC---ChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH----HHhhhccCCcccc
Confidence 54322 123356888887 888643 4677899965 57999999996421100 0011111122222
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.....+++++.+||.+||+.||++||+++|+++||||++
T Consensus 246 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 222458899999999999999999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=343.67 Aligned_cols=260 Identities=22% Similarity=0.350 Sum_probs=205.5
Q ss_pred CCeEEE-ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEE
Q psy622 41 SDFEIV-KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 41 ~~y~i~-~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~ 118 (473)
++|.+. +.||+|+||.||+|+++. +++.||+|++++.... ......+.+|+.++..+ +||||+++++++.+...+|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKS-TGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECC-CCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 357777 899999999999999876 5789999999876432 23356789999999998 6799999999999999999
Q ss_pred EEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC---CCCceeEeecchhhhh
Q psy622 119 LVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA---QAPHCPIVNTLFLAIL 193 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~---~~g~ikL~DFGla~~~ 193 (473)
+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++. + +.+||+|||+++..
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~-~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPL-GDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTB-CCEEECCGGGCEEC
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCC-CcEEEeeCcccccc
Confidence 999999999999998653 67999999999999999999999999999999999999998 5 89999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
..... ....+||+.|+ |||++. ..|+|++|++ +++++|..||....... ....+......++
T Consensus 185 ~~~~~----~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~ 253 (327)
T 3lm5_A 185 GHACE----LREIMGTPEYL---APEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE----TYLNISQVNVDYS 253 (327)
T ss_dssp -------------CCCGGGC---CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCC
T ss_pred CCccc----cccccCCcCcc---CCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH----HHHHHHhcccccC
Confidence 43221 12357888888 888754 3577899965 57999999996421100 0011111222222
Q ss_pred C-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccC
Q psy622 267 E-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQ 314 (473)
Q Consensus 267 ~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~ 314 (473)
. ....+++.+++||.+||+.||.+|||++|+++||||++++|+.+...
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~~~ 302 (327)
T 3lm5_A 254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHP 302 (327)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC---
T ss_pred chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccccCc
Confidence 1 12468999999999999999999999999999999999999977543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=330.80 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=213.2
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
...++|++.+.||+|+||.||+|+++. +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECC-CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 346789999999999999999999876 5789999999987666666677899999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCSTT
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC-CCEEEEeccCceecccCc
Confidence 9999999999999999988899999999999999999999999999999999999999998 999999999998753221
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~ 270 (473)
.......||+.|+ |||.+. ..|.|++|++ +++++|..||....... ....+......+| .
T Consensus 170 ---~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~---~ 236 (294)
T 2rku_A 170 ---ERKKVLCGTPNYI---APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLRIKKNEYSIP---K 236 (294)
T ss_dssp ---CCBCCCCSCCSSC---CHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTTCCCCC---T
T ss_pred ---cccccccCCCCcC---CcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhhccCCCc---c
Confidence 1123356888887 888653 4677889965 57999999996421100 0011122233344 5
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
.+++++.+||.+||+.||++||+++|+++||||++..
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 237 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred ccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 7899999999999999999999999999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=357.03 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=192.8
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS----- 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~----- 114 (473)
.++|++++.||+|+||+||+|+++. +++.||||++.+.. ......+++.+|+.+|+.++||||++++++|...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECC-CCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 5789999999999999999999887 68999999998763 3455567899999999999999999999999654
Q ss_pred -CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 -SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 -~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..+|+||||+++ +|...+.. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+++..
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTA 214 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCCC---
T ss_pred CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC-CCEEEEEEEeeeec
Confidence 468999999955 57777753 59999999999999999999999999999999999999999 99999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCChh-
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPTS- 256 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~~- 256 (473)
... ......+||+.|+ |||++. ..|+|++|++ ++|++|..||.+.. ...+...+..
T Consensus 215 ~~~----~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 215 GTS----FMMTPYVVTRYYR---APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp --C----CCC----CCCTTC---CHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred CCC----cccCCCccccccc---CHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 432 1223457898888 899764 4678899965 57999999997521 1111111100
Q ss_pred -----hHh---hhc-----cC----CCCc--------cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 257 -----TAA---QLQ-----LE----WPED--------EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 257 -----~~~---~~~-----~~----~P~~--------~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
... ... .. +|.. ....++++++||.+||+.||++|||++|+++||||+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 000 000 00 0100 0011578999999999999999999999999999984
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=336.71 Aligned_cols=250 Identities=19% Similarity=0.316 Sum_probs=202.5
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
.|+..+.||+|+||.||+|+++. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKH-SGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECC-CCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence 48888999999999999998876 57899999998654 223557889999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc
Q psy622 122 EYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE 201 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~ 201 (473)
||++||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~--- 196 (321)
T 2c30_A 122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVP--- 196 (321)
T ss_dssp CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSC---
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CcEEEeeeeeeeecccCcc---
Confidence 99999999999875 479999999999999999999999999999999999999998 9999999999987543211
Q ss_pred cccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCCh
Q psy622 202 ISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNP 274 (473)
Q Consensus 202 ~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~ 274 (473)
......||+.|+ |||++. ..|+|++|++ +++++|..||....... ....+.............+++
T Consensus 197 ~~~~~~gt~~y~---aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2c30_A 197 KRKSLVGTPYWM---APEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----AMKRLRDSPPPKLKNSHKVSP 269 (321)
T ss_dssp CBCCCCSCGGGC---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSSCCCCTTGGGSCH
T ss_pred ccccccCCcccc---CHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCCCCcCccccCCH
Confidence 123457888888 898753 3678899965 57999999996421100 000111111111111246899
Q ss_pred hHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 275 STEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 275 ~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
++++||.+||+.||++||+++|+++||||....
T Consensus 270 ~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 270 VLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999999999999998654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=335.18 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=193.8
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~l 119 (473)
++|+++++||+|+||+||+|+++. +++.||||++...... .........|...+..+ +||||+++++++.+.+.+|+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKE-DGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT-TSCEEEEEEESSSCCS-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECC-CCeEEEEEEecccccC-hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 569999999999999999999886 5789999998765332 33344556666666555 99999999999999999999
Q ss_pred EecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||||+ +|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG-GCEEECCCTTCEECC----
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEccceeeeecccCC-
Confidence 99999 78999988764 469999999999999999999999999999999999999999 999999999988753321
Q ss_pred ccccccccCCCCcccccCCccccc-----cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccC
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL-----SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~-----~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~l 272 (473)
......||+.|+ |||++. ..|+|++|++ +++++|..|+...... ..... ....+..+..+
T Consensus 212 ---~~~~~~gt~~y~---aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~~~~~-~~~~~~~~~~~ 277 (311)
T 3p1a_A 212 ---AGEVQEGDPRYM---APELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGW-------QQLRQ-GYLPPEFTAGL 277 (311)
T ss_dssp ------CCCCCGGGC---CGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-------HHHTT-TCCCHHHHTTS
T ss_pred ---CCcccCCCcccc---CHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------HHHhc-cCCCcccccCC
Confidence 223456888888 899764 3577889965 6788886665432110 00000 00011122578
Q ss_pred ChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 273 NPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 273 s~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
++++.+||.+||+.||++||+++|+++||||++
T Consensus 278 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 278 SSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=325.13 Aligned_cols=245 Identities=22% Similarity=0.273 Sum_probs=197.8
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~l 119 (473)
++|++++.||+|+||+||+|+++. +++.||+|++++.... ......+.+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcC-CCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 579999999999999999999876 5789999999875432 33456788999999998 99999999999999999999
Q ss_pred EecccCcCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC-----------------
Q psy622 120 VMEYMIGGDVKSLIAAN----GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ----------------- 178 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~----~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~----------------- 178 (473)
||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999999999864 679999999999999999999999999999999999999844
Q ss_pred -CCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhc
Q psy622 179 -APHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVA 249 (473)
Q Consensus 179 -~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~ 249 (473)
...+||+|||++....... ...||+.|+ |||.+. ..|+|++|++ +++++|.+++.....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~-------~~~gt~~y~---aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-- 236 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQ-------VEEGDSRFL---ANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-- 236 (289)
T ss_dssp -CCCEEECCCTTCEETTCSC-------CCCCCGGGC---CHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred CceEEEEcccccccccCCcc-------ccCCCcccc---ChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence 1479999999998754321 235888877 888653 4678899965 467777766542110
Q ss_pred CCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 250 GSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 250 ~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
...+. ....+..+..+++++.+||.+||+.||.+||++.|+++||||++.
T Consensus 237 -----~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 237 -----WHEIR--QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp -----HHHHH--TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred -----HHHHH--cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 01111 122233336899999999999999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=358.38 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=207.4
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|+++++||+|+||+||+|+++. +++.||||++.+.... ......+.+|+++|+.++||||+++++++.+...+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETT-TCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECC-CCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 4679999999999999999999876 5789999999875432 2235678999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC--CCceeEeecchhhhhcCCc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ--APHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~--~g~ikL~DFGla~~~~~~~ 197 (473)
|||||.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.. .+.+||+|||+++......
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 99999999999999888899999999999999999999999999999999999999643 1679999999998754322
Q ss_pred cccccccccCCCCcccccCCcccccc-----CCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC-Cccc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLLS-----LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP-EDEE 270 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~~-----~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P-~~~~ 270 (473)
. ....+|||.|+ |||++.. .|+|++|++ +++++|..||....... ....+......++ ....
T Consensus 179 ~----~~~~~gt~~y~---aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 247 (486)
T 3mwu_A 179 K----MKDRIGTAYYI---APEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVETGKYAFDLPQWR 247 (486)
T ss_dssp -------CCTTGGGGC---CGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCSCSGGGG
T ss_pred c----cCCCcCCCCCC---CHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCCcccC
Confidence 1 22357888888 8997653 577899965 56999999996421100 0011112222221 1125
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCc
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDW 308 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw 308 (473)
.+|+++++||.+||+.||.+|||+.|+++||||+....
T Consensus 248 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 78999999999999999999999999999999987643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=340.07 Aligned_cols=257 Identities=19% Similarity=0.284 Sum_probs=202.6
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----C
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS-----S 115 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~-----~ 115 (473)
++|++++.||+|+||.||+|+++. +++.||||++.... .....+.+.+|+++|+.++||||+++++++... .
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECC-CCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 589999999999999999998876 57899999998642 344457889999999999999999999999765 4
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADP 180 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCG
T ss_pred eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC-CCEEEEeCcceEecCC
Confidence 7999999995 699999986 479999999999999999999999999999999999999998 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChhh-
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTST- 257 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~~- 257 (473)
...........+||+.|+ |||++. ..|+|++|++ +++++|..||..... ..+.......
T Consensus 181 ~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYR---APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp GGCBCCTTCCCCSCGGGC---CHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred CCCccccccccccccCCC---CCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 332222234457888888 898653 3477899965 579999999964210 0011000000
Q ss_pred ------Hhh--------hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 258 ------AAQ--------LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 258 ------~~~--------~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
... ....+......+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 000 0011111124678999999999999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=329.17 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=203.5
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
..+.+++|++.+.||+|+||.||+|+++. +++.||||+++..........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQL-TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECC-CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 35567899999999999999999998876 57899999998765434445668899999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+||||++|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT-SCEEECCCCGGGCCCC
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC-CCEEEeecccccccCC
Confidence 999999999999999999988899999999999999999999999999999999999999998 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
.. ......|++.|+ |||.+. ..|.|++|++ +++++|..||....... ....+......+|
T Consensus 164 ~~----~~~~~~~~~~y~---aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~- 231 (276)
T 2h6d_A 164 GE----FLRTSCGSPNYA---APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT----LFKKIRGGVFYIP- 231 (276)
T ss_dssp -----------------C---CTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC-
T ss_pred Cc----ceecccCCcccc---CHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHhhcCcccCc-
Confidence 21 122346788777 888753 3677889965 57999999996421100 0011122223334
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
..++.++.+||.+||+.||.+||+++|+++||||++
T Consensus 232 --~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 232 --EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred --hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 578999999999999999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=326.04 Aligned_cols=255 Identities=16% Similarity=0.286 Sum_probs=206.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+++|++++.||+|+||.||+|+++. +++.||+|+++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECC-CCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 4679999999999999999998876 578999999986543 2335678999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++.........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETTEE
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC-CCEEEeeCCCccccCCCcch
Confidence 99999999999999887789999999999999999999999999999999999999998 99999999999865332211
Q ss_pred cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcccc
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ 271 (473)
.......||+.|+ |||.+. ..|+|++|++ +++++|..||...... ..............+ ....
T Consensus 162 -~~~~~~~~~~~y~---aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-~~~~ 233 (276)
T 2yex_A 162 -RLLNKMCGTLPYV---APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDWKEKKTYLN-PWKK 233 (276)
T ss_dssp -CCBCCCCSCGGGC---CGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT---SHHHHHHHTTCTTST-TGGG
T ss_pred -hcccCCccccCcc---ChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHhhhcccccC-chhh
Confidence 2223456888887 888753 3677899965 5799999999642110 000001111111111 1257
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 234 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred cCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 89999999999999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.62 Aligned_cols=256 Identities=21% Similarity=0.280 Sum_probs=204.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch----------hHHHHHHHHHHHHHhcCCCCeeeEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK----------NMVSQVLRERNALALTHSPFCVQLFY 109 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~----------~~~~~~~~E~~iL~~l~hp~Iv~l~~ 109 (473)
.++|++++.||+|+||+||+|+++. +++.||+|++++...... ...+.+.+|+.+|+.++||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKN-GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETT-TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECC-CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4789999999999999999999876 678999999987643321 33567899999999999999999999
Q ss_pred EEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--CceeEeec
Q psy622 110 SLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA--PHCPIVNT 187 (473)
Q Consensus 110 ~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~--g~ikL~DF 187 (473)
++++...+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999999888999999999999999999999999999999999999999872 26999999
Q ss_pred chhhhhcCCccccccccccCCCCcccccCCccccc-----cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhh
Q psy622 188 LFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-----SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQL 261 (473)
Q Consensus 188 Gla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-----~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~ 261 (473)
|+++...... .....+||+.|+ |||++. ..|+|++|++ +++++|..||....... ....+...
T Consensus 194 g~a~~~~~~~----~~~~~~gt~~y~---aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~ 262 (504)
T 3q5i_A 194 GLSSFFSKDY----KLRDRLGTAYYI---APEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD----IIKKVEKG 262 (504)
T ss_dssp TTCEECCTTS----CBCCCCSCTTTC---CHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHC
T ss_pred CCCEEcCCCC----ccccccCCcCCC---CHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcC
Confidence 9998754321 123357898888 898754 3577899965 56999999997521100 00111222
Q ss_pred ccCCCC-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 262 QLEWPE-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 262 ~~~~P~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
...++. ....+++++++||++||+.||.+|||++|+++||||+...
T Consensus 263 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 263 KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 222221 1246899999999999999999999999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=346.16 Aligned_cols=260 Identities=21% Similarity=0.307 Sum_probs=202.8
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI--NKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
++|++.+.||+|+||.||+|+++. +++.||+|++.+.... .....+.+.+|+++++.++||||+++++++.+.+.+|
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQ-TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeeecCCeEEEEEEECC-CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 579999999999999999998876 6789999999876432 2345678999999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q psy622 119 LVMEYMIGGDVKSLIAA----------------------------------------NGALPEDMAAFYAAEVVLALQYL 158 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~----------------------------------------~~~~~e~~~~~~~~qI~~aL~yL 158 (473)
+||||++||+|.+++.. ...+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999999852 11246888999999999999999
Q ss_pred HHCCeeecCCCCcceEecCCCC--ceeEeecchhhhhcCCcccc-ccccccCCCCcccccCCccccc--------cCCcC
Q psy622 159 HSHGIIHRDLKPDNMLISAQAP--HCPIVNTLFLAILQQPIVYL-EISDLVNGTPNAFNIRTPGQLL--------SLKTG 227 (473)
Q Consensus 159 H~~gIiHRDLKpeNILld~~~g--~ikL~DFGla~~~~~~~~~~-~~~~~~~gtp~y~~~~ape~i~--------~~~~~ 227 (473)
|++||+||||||+|||++.+ + .+||+|||+++.+....... .......||+.|+ |||.+. ..|+|
T Consensus 185 H~~~ivH~Dlkp~NIll~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV---APEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHTTEECCCCCGGGEEESCS-SSCCEEECCCTTCEEGGGTTCC--------CCCGGGC---CHHHHTCSSSCCCTHHHHH
T ss_pred HHCCccccCCChhhEEEecC-CCceEEEeeccccccccccCccccccccccCCCcccc---CchhhccCCCCCCcHHHHH
Confidence 99999999999999999876 5 89999999998653322111 1123456888888 898763 35778
Q ss_pred CCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 228 TFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 228 s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
++|++ +++++|..||....... ...........++. ....+++++++||.+||+.||.+||++.|+++||||++
T Consensus 261 slG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDAD----TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHHHHCCCCCCCCChHH----HHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence 99965 57999999996421100 00111111222221 11358999999999999999999999999999999998
Q ss_pred CCcc
Q psy622 306 YDWD 309 (473)
Q Consensus 306 idw~ 309 (473)
+.|.
T Consensus 337 ~~~~ 340 (345)
T 3hko_A 337 FSDK 340 (345)
T ss_dssp TSSC
T ss_pred ChHh
Confidence 8765
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=334.11 Aligned_cols=256 Identities=21% Similarity=0.305 Sum_probs=199.0
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEe--
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQT-- 113 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~-- 113 (473)
-...++|++++.||+|+||.||+|+++. +++.||||+++... .+.+.+|+.+|+.++ ||||+++++++.+
T Consensus 32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 32 WGNQDDYQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp CEEGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred ccCCCceEEEEEecccCCeEEEEEEECC-CCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 3345789999999999999999999876 57899999997542 357889999999996 9999999999988
Q ss_pred CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
....++||||+++++|.++++ .+++..++.++.||+.||+|||++||+||||||+|||++.+++.+||+|||+++..
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 678999999999999999885 48999999999999999999999999999999999999987348999999999865
Q ss_pred cCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHh----------hhc------
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSAL----------RVA------ 249 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~----------~~~------ 249 (473)
..... .....|++.|+ |||.+. ..|+|++|++ +++++|..||.... ...
T Consensus 182 ~~~~~----~~~~~~~~~y~---aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 182 HPGQE----YNVRVASRYFK---GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 254 (330)
T ss_dssp CTTCC----CCSCCSCGGGC---CHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred CCCCc----ccccccccccc---ChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhh
Confidence 43221 22346777777 888654 3577889965 57999999993210 000
Q ss_pred ------CCCCChhhHhh---------hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 250 ------GSQIPTSTAAQ---------LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 250 ------~~~~~~~~~~~---------~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
........... ....-......+++++++||.+||+.||.+|||++|+++||||+++.|+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence 00000000000 0000011123489999999999999999999999999999999999886
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=349.06 Aligned_cols=257 Identities=15% Similarity=0.085 Sum_probs=188.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc--CCCCeeeEE-------EE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT--HSPFCVQLF-------YS 110 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~-------~~ 110 (473)
..+|++.+.||+|+||.||+|+++. +++.||||++++.........+.+.+|+.+++.+ +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVE-RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECC-CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 4569999999999999999999876 5799999999987654555667788886555544 699988865 45
Q ss_pred EEeC-----------------CEEEEEecccCcCCHHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHHCCeeec
Q psy622 111 LQTS-----------------SCVFLVMEYMIGGDVKSLIAANG-ALPEDMA------AFYAAEVVLALQYLHSHGIIHR 166 (473)
Q Consensus 111 f~~~-----------------~~l~lVmEy~~gg~L~~~L~~~~-~~~e~~~------~~~~~qI~~aL~yLH~~gIiHR 166 (473)
+... .++|+||||++ |+|.+++...+ .+++... ..++.||+.||+|||++||+||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 5433 34899999997 89999998743 3444444 4666999999999999999999
Q ss_pred CCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCcccccc--------CCcCCCCcc-ccccC
Q psy622 167 DLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS--------LKTGTFPTF-QDVQN 237 (473)
Q Consensus 167 DLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~--------~~~~s~g~l-~~~~~ 237 (473)
||||+|||++.+ +.+||+|||+++....... ...+|+.|+ |||++.. .|+|++|++ ++|++
T Consensus 219 Dikp~NIll~~~-~~~kL~DFG~a~~~~~~~~------~~~~t~~y~---aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 219 HFTPDNLFIMPD-GRLMLGDVSALWKVGTRGP------ASSVPVTYA---PREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp TCSGGGEEECTT-SCEEECCGGGEEETTCEEE------GGGSCGGGC---CHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred cCCHHHEEECCC-CCEEEEecceeeecCCCcc------CccCCcCCc---ChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999999999 9999999999987532211 234567777 8887643 578899965 57999
Q ss_pred CCCCchhHhhhcCCCCCh---hhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 238 SQAPFPSALRVAGSQIPT---STAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 238 g~~pf~~~~~~~~~~~~~---~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
|..||............. .........++.. ..+++++.+||.+||+.||++||+++|+++||||+++.|.
T Consensus 289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 362 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSC-TPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE 362 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTS-SCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred CCCCCCCcCcccccchhhhhhhhccccccchhhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence 999998642211111110 0011112223321 4789999999999999999999999999999999998875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=331.40 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=203.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++++.||+|+||.||+|+++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKE-TGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETT-TCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcC-CCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 4679999999999999999999876 57899999997653 3345688999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||||++||+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-SCEEECCCHHHHHHHHHH-
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC-CCEEEEECCCCccccccc-
Confidence 9999999999999876 4679999999999999999999999999999999999999998 999999999987532111
Q ss_pred ccccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
.......||+.|+ |||.+. ..|+|++|++ +++++|..||....... .............
T Consensus 172 --~~~~~~~~~~~y~---aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~ 242 (302)
T 2j7t_A 172 --QKRDSFIGTPYWM---APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----VLLKIAKSDPPTL 242 (302)
T ss_dssp --HC-----CCGGGC---CHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSCCCCC
T ss_pred --cccccccCChhhc---CCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH----HHHHHhccCCccc
Confidence 1122346788877 888752 4688899965 57999999997521100 0000111111111
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccc
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSIL 312 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~ 312 (473)
..+..++.++.+||.+||+.||.+|||++|+++||||+++.|....
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~ 288 (302)
T 2j7t_A 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKAL 288 (302)
T ss_dssp SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHHH
T ss_pred CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccchhH
Confidence 1225789999999999999999999999999999999999987643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=345.12 Aligned_cols=264 Identities=20% Similarity=0.309 Sum_probs=212.5
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
......++|++++.||+|+||.||+|+++. +++.||+|+++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECC-CCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 456667899999999999999999999876 57899999998753 344567899999999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH-GIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~-gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||+. ||+||||||+|||++.+ +.+||+|||+++..
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 182 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHH
T ss_pred CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC-CCEEEEECCCCccc
Confidence 99999999999999999999888999999999999999999999996 99999999999999999 99999999999865
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhh-----cCCC---------
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRV-----AGSQ--------- 252 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~-----~~~~--------- 252 (473)
... ......||+.|+ |||++. ..|+|++|++ +++++|..||...... ....
T Consensus 183 ~~~-----~~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3eqc_A 183 IDS-----MANSFVGTRSYM---SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254 (360)
T ss_dssp HHH-----C----CCCCTTC---CHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred ccc-----cccCCCCCCCeE---CHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence 321 122357888887 898754 3577899965 5799999999641100 0000
Q ss_pred --------------------CC-hhhH----hhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 253 --------------------IP-TSTA----AQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 253 --------------------~~-~~~~----~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
.. .... .......+ ...++.++.+||.+||+.||.+|||++|+++||||++.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -------------------CCCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCC--cccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 00 0000 00111112 145789999999999999999999999999999999988
Q ss_pred ccccc
Q psy622 308 WDSIL 312 (473)
Q Consensus 308 w~~l~ 312 (473)
|+.+.
T Consensus 333 ~~~~~ 337 (360)
T 3eqc_A 333 AEEVD 337 (360)
T ss_dssp HSCCC
T ss_pred Hhhhh
Confidence 87663
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=341.24 Aligned_cols=259 Identities=20% Similarity=0.307 Sum_probs=195.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+++|++++.||+|+||.||+|+++. +++.||+|+++.... ......+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKL-TDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECC-CCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence 4789999999999999999999876 578999999976531 1112245679999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 120 VMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||||++ |+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPT- 154 (324)
T ss_dssp EEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT-CCEEECSSSEEECC-----
T ss_pred Eecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC-CCEEEccCcccccccCCc-
Confidence 999995 69999988754 69999999999999999999999999999999999999999 999999999998643221
Q ss_pred ccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCChhhH---
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPTSTA--- 258 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~~~~--- 258 (473)
.......||+.|+ |||++.. .|+|++|++ +++++|..||.... ...+........
T Consensus 155 --~~~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 155 --KTYDNEVVTLWYR---PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp ----------CGGGC---CHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred --cccccccCccccc---ChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence 1122346787777 8886542 577889965 57999999996521 111111100000
Q ss_pred ---hhhccCCCC--------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 259 ---AQLQLEWPE--------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 259 ---~~~~~~~P~--------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
......++. ....+++++++||.+||+.||.+|||++|+++||||.++.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 000111111 113678999999999999999999999999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=338.16 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=200.3
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCC
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS--PFCVQLFYSLQTSS 115 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~~~~ 115 (473)
+.-++|++++.||+|+||.||+|++. +++.||||+++.... .....+.+.+|+.+|..++| |||+++++++.+..
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 34567999999999999999999764 468999999987642 34456788999999999976 99999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+|||+ .+|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++ + +.+||+|||+++....
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~-~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-GMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-T-TEEEECCCSSSCCC--
T ss_pred EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-C-CcEEEeecccccccCc
Confidence 99999995 5899999999999999999999999999999999999999999999999997 4 7899999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc-----------------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhh
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-----------------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTST 257 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-----------------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~ 257 (473)
.... ......+||+.|+ |||++. ..|+|++|++ +++++|..||......... .....
T Consensus 160 ~~~~-~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~ 234 (343)
T 3dbq_A 160 DTTS-VVKDSQVGTVNYM---PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-LHAII 234 (343)
T ss_dssp -----------CCCCSSC---CHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHHHH
T ss_pred cccc-ccCCCCcCCcCcC---CHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH-HHHHh
Confidence 2211 1233457999988 899864 2688999965 5799999999642110000 00000
Q ss_pred HhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 258 AAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 258 ~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.......+| ...++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 235 ~~~~~~~~~---~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 235 DPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CTTSCCCCC---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred cCCcccCCc---ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 001123344 567889999999999999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=355.63 Aligned_cols=255 Identities=24% Similarity=0.316 Sum_probs=202.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||+|+||+||+|+++. +++.||+|++++..... .....+.+|+.+|+.++||||+++++++++...+|+|
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKV-THVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETT-TCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECC-CCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 469999999999999999999876 57899999998764322 2245789999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC--CCceeEeecchhhhhcCCcc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ--APHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~--~g~ikL~DFGla~~~~~~~~ 198 (473)
||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.. .+.+||+|||+++......
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~- 193 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK- 193 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence 9999999999999988899999999999999999999999999999999999999764 1569999999998754322
Q ss_pred ccccccccCCCCcccccCCccccc-----cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC-cccc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL-----SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE-DEEA 271 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~-----~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~-~~~~ 271 (473)
.....+||+.|+ |||++. ..|+|++|++ +++++|..||....... ....+......++. ....
T Consensus 194 ---~~~~~~gt~~y~---aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~ 263 (494)
T 3lij_A 194 ---KMKERLGTAYYI---APEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE----ILRKVEKGKYTFDSPEWKN 263 (494)
T ss_dssp ---CBCCCCSCTTTC---CHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCCSGGGTT
T ss_pred ---cccccCCCcCee---CHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCchhccc
Confidence 123357899888 898753 3577899965 57999999997421100 00112222223221 1246
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCc
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDW 308 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw 308 (473)
+++++++||++||+.||.+|||++|+++||||+.+.+
T Consensus 264 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300 (494)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred CCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence 8999999999999999999999999999999987543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=325.29 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=201.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CC
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT----SS 115 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~----~~ 115 (473)
...|++.+.||+|+||.||+|++.. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecC-CceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 4559999999999999999998876 678999999987643 34456789999999999999999999999875 46
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCCcceEec-CCCCceeEeecchhhh
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG--IIHRDLKPDNMLIS-AQAPHCPIVNTLFLAI 192 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~g--IiHRDLKpeNILld-~~~g~ikL~DFGla~~ 192 (473)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+ +.+||+|||++..
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT-GSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTT-SCEEECCTTGGGG
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCC-CCEEEeeCCCccc
Confidence 79999999999999999998889999999999999999999999999 99999999999998 55 8999999999976
Q ss_pred hcCCccccccccccCCCCcccccCCccccc-----cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh--hccC
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL-----SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ--LQLE 264 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-----~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~ 264 (473)
..... .....||+.|+ |||.+. ..|.|++|++ +++++|..||..... ....... ....
T Consensus 182 ~~~~~-----~~~~~~t~~y~---aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~ 247 (290)
T 1t4h_A 182 KRASF-----AKAVIGTPEFM---APEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVK 247 (290)
T ss_dssp CCTTS-----BEESCSSCCCC---CGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCC
T ss_pred ccccc-----cccccCCcCcC---CHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCc------HHHHHHHHhccCC
Confidence 43221 22346888887 888654 3577888965 579999999964210 0000110 0111
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.+..+...++++.+||.+||+.||.+||+++|+++||||++-
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 112225677899999999999999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=349.65 Aligned_cols=243 Identities=9% Similarity=0.029 Sum_probs=193.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHH---HHhcCCCCeeeEE-------E
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA---LALTHSPFCVQLF-------Y 109 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~i---L~~l~hp~Iv~l~-------~ 109 (473)
.++|++.+.||+|+||+||+|+++. +++.||||++++.........+.+.+|+.+ |+.++||||++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE-TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C-CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CceEEEcceeecCCCEEEEEEEECC-CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 4789999999999999999998776 578999999997655556667789999954 4555899999998 7
Q ss_pred EEEeCCE-----------------EEEEecccCcCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHCCeee
Q psy622 110 SLQTSSC-----------------VFLVMEYMIGGDVKSLIAANGALPE-------DMAAFYAAEVVLALQYLHSHGIIH 165 (473)
Q Consensus 110 ~f~~~~~-----------------l~lVmEy~~gg~L~~~L~~~~~~~e-------~~~~~~~~qI~~aL~yLH~~gIiH 165 (473)
++++.+. .|+||||+ +|+|.+++.+.+.+++ ..+..++.||+.||+|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 7766543 89999999 7899999987665666 778889999999999999999999
Q ss_pred cCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCcccccc-----------------CCcCC
Q psy622 166 RDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS-----------------LKTGT 228 (473)
Q Consensus 166 RDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~-----------------~~~~s 228 (473)
|||||+|||++.+ +.+||+|||+++.... .....+| +.|+ |||++.. .|+|+
T Consensus 230 rDikp~NIll~~~-~~~kL~DFG~a~~~~~------~~~~~~g-~~y~---aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 230 TYLRPVDIVLDQR-GGVFLTGFEHLVRDGA------RVVSSVS-RGFE---PPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp SCCCGGGEEECTT-CCEEECCGGGCEETTC------EEECCCC-TTCC---CHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred CCCCHHHEEEcCC-CCEEEEechhheecCC------cccCCCC-cCcc---ChhhhcccccccccccccccCChhhhHHH
Confidence 9999999999999 9999999999986322 1223467 7777 8887654 47889
Q ss_pred CCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 229 FPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 229 ~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+|++ +++++|..||....... ... . ....+ ..+++++.+||.+||+.||.+||++.|+++||||+++
T Consensus 299 lG~il~elltg~~Pf~~~~~~~---~~~-~----~~~~~---~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALG---GSE-W----IFRSC---KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHHHHHSSCCC------C---CSG-G----GGSSC---CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHHHCCCCCccccccc---chh-h----hhhhc---cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 9965 57999999997532211 110 0 11111 4789999999999999999999999999999999865
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=336.70 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=198.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----CCCeeeEEEEEEeC
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-----SPFCVQLFYSLQTS 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----hp~Iv~l~~~f~~~ 114 (473)
.++|+++++||+|+||+||+|+++. +++.||||++++. .........|..+++.+. ||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHID-NKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred cCEEEEEEEEcccCCeEEEEEEECC-CCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 4789999999999999999999876 5789999999853 334556788999999886 99999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC---------------
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA--------------- 177 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~--------------- 177 (473)
+.+|+||||+ |++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence 9999999999 999999998764 5999999999999999999999999999999999999975
Q ss_pred ----------CCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCC
Q psy622 178 ----------QAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQA 240 (473)
Q Consensus 178 ----------~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~ 240 (473)
+ +.+||+|||+++..... .....||+.|+ |||++. ..|+|++|++ +++++|..
T Consensus 188 ~~~~~~~~~~~-~~~kl~DFG~a~~~~~~------~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 188 GKKIQIYRTKS-TGIKLIDFGCATFKSDY------HGSIINTRQYR---APEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp CCEEEEEEESC-CCEEECCCTTCEETTSC------CCSCCSCGGGC---CHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccCC-CCEEEEeccCceecCCC------CcCccCccccc---CcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 5 89999999999864322 12357888887 898764 4577899965 57999999
Q ss_pred CchhHh--------hhcCCCCChhhHh--------------hhccCCCC-----------------ccccCChhHHHHHH
Q psy622 241 PFPSAL--------RVAGSQIPTSTAA--------------QLQLEWPE-----------------DEEALNPSTEETIL 281 (473)
Q Consensus 241 pf~~~~--------~~~~~~~~~~~~~--------------~~~~~~P~-----------------~~~~ls~~a~dLI~ 281 (473)
||.... .......+..... .....||. .....++.+.+||.
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 996411 0111111111110 01112221 11233577889999
Q ss_pred hccccCCCCCCCHHHHhcCCCCC
Q psy622 282 ALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 282 ~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
+||+.||++|||++|+++||||+
T Consensus 338 ~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHhcCChhhCCCHHHHhcCcccC
Confidence 99999999999999999999996
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=325.33 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=204.6
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++.+.||+|+||.||+|+++. +++.||+|++.+... ...+.+.+|+++++.++||||+++++++.+...+|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKG-TRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCC-CCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 569999999999999999998876 578999999987643 2355789999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe---cCCCCceeEeecchhhhhcCCc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI---SAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILl---d~~~g~ikL~DFGla~~~~~~~ 197 (473)
|||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.+ +.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT-CCEEECCCTTCEECCTTS
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCC-CcEEEEecccceeccCcc
Confidence 9999999999999988899999999999999999999999999999999999999 666 899999999998754322
Q ss_pred cccccccccCCCCcccccCCccccc-----cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc-cc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL-----SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED-EE 270 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~-----~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~-~~ 270 (473)
......||+.|+ |||.+. ..|.|++|++ +++++|..||....... ....+......+|.. ..
T Consensus 164 ----~~~~~~~t~~y~---aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~ 232 (277)
T 3f3z_A 164 ----MMRTKVGTPYYV---SPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE----VMLKIREGTFTFPEKDWL 232 (277)
T ss_dssp ----CBCCCCSCTTTC---CHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCHHHHT
T ss_pred ----chhccCCCCCcc---ChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhCCCCCCchhhh
Confidence 223346888887 888653 4577888865 57999999996421100 001112222233321 12
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.+++++.+||.+||+.||.+||++.|+++||||++.
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 233 NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 689999999999999999999999999999999753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=342.31 Aligned_cols=257 Identities=21% Similarity=0.306 Sum_probs=199.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS---- 115 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~---- 115 (473)
.++|++.+.||+|+||.||+|+++. +++.||||+++............+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLR-DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECC-CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 5789999999999999999999876 57999999998876555666778999999999999999999999987643
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT-SCEEECCCSCC-----
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC-CCEEEeeccCcccccc
Confidence 459999999999999999988899999999999999999999999999999999999999999 9999999999987644
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC-C
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP-E 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P-~ 267 (473)
............||+.|+ |||.+. ..|+|++|++ +++++|..||....... .. ..........+ .
T Consensus 169 ~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~---~~-~~~~~~~~~~~~~ 241 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYL---SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---VA-YQHVREDPIPPSA 241 (311)
T ss_dssp -------------CCTTC---CHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH-HHHHHCCCCCHHH
T ss_pred cccccccccccCcCcccC---CHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HH-HHHhcCCCCCccc
Confidence 333222333456898888 899754 3578899965 57999999996421100 00 00000000000 1
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
....+++++.+||.+||+.||.+||++.+++.|+|++.
T Consensus 242 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 12468999999999999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.60 Aligned_cols=259 Identities=20% Similarity=0.250 Sum_probs=193.7
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhc---CCCCeeeEEEEEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN--KNMVSQVLRERNALALT---HSPFCVQLFYSLQ 112 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~--~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~ 112 (473)
...++|++++.||+|+||+||+|+++. +++.||||+++...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPH-SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTT-TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 335789999999999999999998776 67899999998643211 11123566777777665 5999999999998
Q ss_pred eCC-----EEEEEecccCcCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEe
Q psy622 113 TSS-----CVFLVMEYMIGGDVKSLIAANGA--LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185 (473)
Q Consensus 113 ~~~-----~l~lVmEy~~gg~L~~~L~~~~~--~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~ 185 (473)
+.. .+|+||||+. |+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~ 162 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLA 162 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT-SCEEEC
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEEe
Confidence 765 6899999995 699999998654 9999999999999999999999999999999999999999 999999
Q ss_pred ecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhh---------hc
Q psy622 186 NTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALR---------VA 249 (473)
Q Consensus 186 DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~ 249 (473)
|||+++...... .....+||+.|+ |||++. ..|+|++|++ +++++|..||..... ..
T Consensus 163 Dfg~a~~~~~~~----~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (308)
T 3g33_A 163 DFGLARIYSYQM----ALTPVVVTLWYR---APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235 (308)
T ss_dssp SCSCTTTSTTCC----CSGGGGCCCSSC---CHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred eCccccccCCCc----ccCCcccccccc---CchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999998753322 123457888888 898753 4678899965 579999999964211 00
Q ss_pred CCCCChhhHhh---hccCCC--------CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 250 GSQIPTSTAAQ---LQLEWP--------EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 250 ~~~~~~~~~~~---~~~~~P--------~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
+.......... ....++ .....+++++.+||.+||+.||++|||++|+++||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 00000000000 000000 0113688999999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=338.76 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=204.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI-----NKNMVSQVLRERNALALT-HSPFCVQLFYSLQTS 114 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 114 (473)
++|++.+.||+|+||.||+|+++. +|+.||||+++..... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRA-TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhcccceEEecCCCEEEEEEEECC-CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 469999999999999999999876 5789999999865311 112245788999999999 899999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
...|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+ |.+||+|||++..+.
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCHLE 251 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEEecCcccccC
Confidence 9999999999999999999988889999999999999999999999999999999999999999 999999999998754
Q ss_pred CCccccccccccCCCCcccccCCccccc------------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhh
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQL 261 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~ 261 (473)
.... ....+||+.|+ |||++. ..|+|++|++ +++++|..||....... ....+...
T Consensus 252 ~~~~----~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~~i~~~ 320 (365)
T 2y7j_A 252 PGEK----LRELCGTPGYL---APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL----MLRMIMEG 320 (365)
T ss_dssp TTCC----BCCCCSCGGGC---CHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHT
T ss_pred CCcc----cccCCCCCCcc---ChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhC
Confidence 3221 23357888888 898753 4688899965 57999999996421100 00111112
Q ss_pred ccCCCC-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 262 QLEWPE-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 262 ~~~~P~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
...++. ....+++++.+||.+||+.||++||+++|+++||||+
T Consensus 321 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 321 QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp CCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 222221 1146889999999999999999999999999999997
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=341.04 Aligned_cols=271 Identities=20% Similarity=0.285 Sum_probs=198.0
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC---
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS--- 115 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~--- 115 (473)
.+++|++++.||+|+||.||+|+++. +++.||||++.+.. ......+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAI-LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECC-CCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 35889999999999999999998876 67899999998753 33445678899999999999999999999997665
Q ss_pred ---EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 116 ---CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 116 ---~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
.+|+||||+. |+|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 101 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 101 EFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLART 176 (371)
T ss_dssp TCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC---
T ss_pred cccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEEEeecccc
Confidence 8999999995 58888886 369999999999999999999999999999999999999999 9999999999987
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChh
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTS 256 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~ 256 (473)
..... .....+||+.|+ |||++. ..|+|++|++ +++++|..||.+... ..+...+..
T Consensus 177 ~~~~~----~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 177 AGTSF----MMTPYVVTRYYR---APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp -----------------CTTC---CHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred ccccc----ccCCceecCCcc---CHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 53221 122356888887 898754 3677899965 579999999965211 000000000
Q ss_pred ------hH---hhhccC--------------CCCc---cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccc
Q psy622 257 ------TA---AQLQLE--------------WPED---EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDS 310 (473)
Q Consensus 257 ------~~---~~~~~~--------------~P~~---~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~ 310 (473)
.. ...... +|.. ....++++++||.+||+.||++|||++|+++||||+......
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 329 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS 329 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCcc
Confidence 00 000000 1100 011257899999999999999999999999999998643332
Q ss_pred cccCCCCCcCCC
Q psy622 311 ILDQEPPFVPQP 322 (473)
Q Consensus 311 l~~~~pPf~P~~ 322 (473)
.....||..|..
T Consensus 330 ~~~~~~~~~~~~ 341 (371)
T 2xrw_A 330 EAEAPPPKIPDK 341 (371)
T ss_dssp HHTCCCCCCCTT
T ss_pred ccCCCCCCCCCh
Confidence 233356666653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=336.51 Aligned_cols=274 Identities=21% Similarity=0.276 Sum_probs=207.7
Q ss_pred ccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEE
Q psy622 29 DVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108 (473)
Q Consensus 29 ~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 108 (473)
....+..--..+++|++++.||+|+||.||+|+++. +++.||+|++.... ......+.+.+|+.+++.++||||++++
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 90 (331)
T 4aaa_A 13 DLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKD-TGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLL 90 (331)
T ss_dssp ------CCCBCGGGEEEEEEGGGGTTSSEEEEEETT-TCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccchhhhhhhhhheeeeEEeecCCEEEEEEEECC-CCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEE
Confidence 334444555567899999999999999999999876 57899999997653 2344456788999999999999999999
Q ss_pred EEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecc
Q psy622 109 YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 109 ~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
+++.+.+.+|+||||++|++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg 169 (331)
T 4aaa_A 91 EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS-GVVKLCDFG 169 (331)
T ss_dssp EEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCT
T ss_pred EEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC-CcEEEEeCC
Confidence 9999999999999999999999988887889999999999999999999999999999999999999999 999999999
Q ss_pred hhhhhcCCccccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHhh---------hcCC
Q psy622 189 FLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSALR---------VAGS 251 (473)
Q Consensus 189 la~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~ 251 (473)
+++.+.... .......||+.|+ |||.+.. .|+|++|++ +++++|..||..... ..+.
T Consensus 170 ~~~~~~~~~---~~~~~~~~t~~y~---aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (331)
T 4aaa_A 170 FARTLAAPG---EVYDDEVATRWYR---APELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243 (331)
T ss_dssp TC---------------CCCCCTTC---CHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred CceeecCCc---cccCCCcCCcccc---CcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 998754322 1122346888877 8886532 477889965 579999999964211 0011
Q ss_pred CCChhhH--h----hhccCCCC---------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccc
Q psy622 252 QIPTSTA--A----QLQLEWPE---------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSI 311 (473)
Q Consensus 252 ~~~~~~~--~----~~~~~~P~---------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l 311 (473)
..+.... . .....+|. ....+++++.+||.+||+.||.+||+++|+++||||+..+|...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 318 (331)
T 4aaa_A 244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAER 318 (331)
T ss_dssp CCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHHH
T ss_pred CChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhhh
Confidence 0000000 0 00011111 11367899999999999999999999999999999998776543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=340.13 Aligned_cols=266 Identities=20% Similarity=0.195 Sum_probs=201.1
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT---- 113 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~---- 113 (473)
-.+++|++++.||+|+||+||+|+++. +++.||||++...... ......+.+|+++|+.++||||+++++++.+
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETT-TCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred ccccceeEEEEEecCCCcEEEEEEECC-CCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 357899999999999999999999876 5789999999765432 2234467899999999999999999999987
Q ss_pred ----CCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecc
Q psy622 114 ----SSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 114 ----~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
.+.+|+||||++ |+|...+... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 92 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg 169 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFG 169 (351)
T ss_dssp -----CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCT
T ss_pred cccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CCEEEccch
Confidence 457999999996 5787777654 579999999999999999999999999999999999999999 999999999
Q ss_pred hhhhhcCCccc-cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhh--------cCC
Q psy622 189 FLAILQQPIVY-LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRV--------AGS 251 (473)
Q Consensus 189 la~~~~~~~~~-~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~--------~~~ 251 (473)
+++.+...... ........||+.|+ |||++. ..|+|++|++ +++++|..||...... ...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYR---PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGC---CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred hcccccccccccccccCCcccccCcc---CchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99875422211 11223346788887 898654 3577889965 5799999999752110 000
Q ss_pred CCChhhHh-------hhccCCCCc----------cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccc
Q psy622 252 QIPTSTAA-------QLQLEWPED----------EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDS 310 (473)
Q Consensus 252 ~~~~~~~~-------~~~~~~P~~----------~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~ 310 (473)
..+..... ......... ....++++++||.+||+.||++|||++|+++||||++..+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 00000000 000000000 001378899999999999999999999999999998766553
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=337.57 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=203.1
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI-----NKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
++|++.+.||+|+||.||+|+++. +++.||||++.+.... .......+.+|+++|+.++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERK-TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hceeEeeEEecCCCEEEEEEEEcC-CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 579999999999999999999876 6789999999875421 1222346789999999999999999999997665
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--CceeEeecchhhhh
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA--PHCPIVNTLFLAIL 193 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~--g~ikL~DFGla~~~ 193 (473)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ +.+||+|||+++..
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 899999999999999999888999999999999999999999999999999999999998761 24999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhcc
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQL 263 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 263 (473)
.... ......||+.|+ |||++. ..|+|++|++ +++++|..||..... .......+.....
T Consensus 168 ~~~~----~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~ 237 (322)
T 2ycf_A 168 GETS----LMRTLCGTPTYL---APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QVSLKDQITSGKY 237 (322)
T ss_dssp CCCH----HHHHHHSCCTTC---CHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC---SSCHHHHHHHTCC
T ss_pred cccc----ccccccCCcCcc---CchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---HHHHHHHHHhCcc
Confidence 4321 122346888887 888752 4678899965 579999999964211 0011111222222
Q ss_pred CC-CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccc
Q psy622 264 EW-PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSI 311 (473)
Q Consensus 264 ~~-P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l 311 (473)
.+ |.....+++++.+||.+||+.||.+||+++|+++||||++.+|...
T Consensus 238 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~~~ 286 (322)
T 2ycf_A 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 286 (322)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHHHH
T ss_pred ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHHHH
Confidence 22 2222468999999999999999999999999999999999887543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=330.47 Aligned_cols=268 Identities=24% Similarity=0.335 Sum_probs=183.1
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
-.+..++|++.+.||+|+||.||+|++.. +++.||||++..... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAP-KKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC-----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred cccchhhhhhhheeccccceEEEEEEECC-CCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 35567899999999999999999998775 578999999976532 233557889999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeec
Q psy622 116 CVFLVMEYMIGGDVKSLIAA--------NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNT 187 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~--------~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DF 187 (473)
.+|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~df 165 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADF 165 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECCC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC-CCEEEEec
Confidence 99999999999999999974 4569999999999999999999999999999999999999998 99999999
Q ss_pred chhhhhcCCcc--ccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhh------cCC
Q psy622 188 LFLAILQQPIV--YLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRV------AGS 251 (473)
Q Consensus 188 Gla~~~~~~~~--~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~------~~~ 251 (473)
|++........ .........||+.|+ |||.+. ..|.|++|++ +++++|..||...... ...
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 242 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWM---APEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242 (303)
T ss_dssp HHHHHCC---------------CCCTTC---CHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred cchheeccCCCccchhhhcccCCCcccc---CHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence 99987543211 111223456888887 888653 3678899965 5799999999752110 000
Q ss_pred CCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccccc
Q psy622 252 QIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILD 313 (473)
Q Consensus 252 ~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~ 313 (473)
..+... .....+.....+++++.+||.+||+.||.+||++.|+++||||++..+..+.+
T Consensus 243 ~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~q 301 (303)
T 2vwi_A 243 DPPSLE---TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQ 301 (303)
T ss_dssp SCCCTT---C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----------
T ss_pred CCCccc---cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCcccc
Confidence 000000 00011112246889999999999999999999999999999999988776554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.31 Aligned_cols=254 Identities=19% Similarity=0.247 Sum_probs=199.7
Q ss_pred CeEE--EceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 42 DFEI--VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 42 ~y~i--~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.|++ .+.||+|+||.||+|+++. +++.||+|+++... ....+.+.+|+++|+.++||||+++++++.+.+.+|+
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETA-TGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETT-TCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcC-CCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3555 6789999999999998876 57899999998754 2345678999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe--cCCCCceeEeecchhhhhcCC
Q psy622 120 VMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI--SAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILl--d~~~g~ikL~DFGla~~~~~~ 196 (473)
||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.+ +.+||+|||+++.+...
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDA-KQIKIIDFGLARRYKPR 242 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTT-TEEEECCCSSCEECCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCC-CcEEEEeCCCceecCCc
Confidence 99999999999998765 469999999999999999999999999999999999999 445 79999999999875432
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC-Cc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP-ED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P-~~ 268 (473)
.. ....+||+.|+ |||++. ..|+|++|++ ++|++|..||....... ....+......++ ..
T Consensus 243 ~~----~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~ 311 (373)
T 2x4f_A 243 EK----LKVNFGTPEFL---APEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE----TLNNILACRWDLEDEE 311 (373)
T ss_dssp CB----CCCCCSSCTTC---CHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCSCSGG
T ss_pred cc----cccccCCCcEe---ChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccCCCChhh
Confidence 21 22346899888 898653 4688899965 57999999996421100 0011111122222 11
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccc
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSI 311 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l 311 (473)
...+++++++||.+||+.||.+||+++|+++||||++..|...
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~~~~ 354 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSR 354 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCchhhh
Confidence 2468999999999999999999999999999999998876543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=330.98 Aligned_cols=272 Identities=20% Similarity=0.297 Sum_probs=206.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS----- 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~----- 114 (473)
.++|++.+.||+|+||.||+|+++. +++.||||+++... .......+.+|+++++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKP-TGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECC-CCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 4789999999999999999998876 67999999997542 344456788999999999999999999988654
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+|+||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN-CDLKVCDFGLARIID 163 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC-CcEEEEecccccccc
Confidence 67999999995 699999987 579999999999999999999999999999999999999998 999999999998754
Q ss_pred CCccccc-------cccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcC
Q psy622 195 QPIVYLE-------ISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAG 250 (473)
Q Consensus 195 ~~~~~~~-------~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~ 250 (473)
....... .....+||+.|+ |||++. ..|+|++|++ +++++|..||..... ..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYR---APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ----------------CCCCCCGGGC---CHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccccccCccccccchhhcccccccc---CCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 3211100 112346788887 898653 3578899965 579999999964210 000
Q ss_pred CCC--------ChhhHhh---hccCCC-----CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccC
Q psy622 251 SQI--------PTSTAAQ---LQLEWP-----EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQ 314 (473)
Q Consensus 251 ~~~--------~~~~~~~---~~~~~P-----~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~ 314 (473)
... ....... ....++ .....+++++.+||.+||+.||++|||++|+++||||+.+.|......
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~ 320 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPE 320 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCC
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccc
Confidence 000 0000000 000111 111468999999999999999999999999999999999888754433
Q ss_pred CCCCcC
Q psy622 315 EPPFVP 320 (473)
Q Consensus 315 ~pPf~P 320 (473)
..|..|
T Consensus 321 ~~~~~~ 326 (353)
T 2b9h_A 321 GEPIPP 326 (353)
T ss_dssp CCCCCG
T ss_pred cCCCCc
Confidence 333333
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=341.73 Aligned_cols=256 Identities=20% Similarity=0.306 Sum_probs=186.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS------ 114 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~------ 114 (473)
++|++++.||+|+||.||+|+++. +++.||||++.+.. ......+++.+|+++|+.++||||+++++++...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETT-TTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEeeEEeecCCeEEEEEEECC-CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 789999999999999999998876 68999999997643 3344567889999999999999999999999754
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+|+||||+ |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTA 183 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECC--------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC-CCEEEeecccccccc
Confidence 5689999999 8999999876 579999999999999999999999999999999999999999 999999999998743
Q ss_pred CCccccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHh---------hhcCCC-----
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQ----- 252 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~----- 252 (473)
.. .....||+.|+ |||++.. .|+|++|++ ++|++|..||.+.. ...+..
T Consensus 184 ~~------~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 184 DE------MTGYVATRWYR---APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp -------------CCCTTC---CHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cc------CCCcCcCcCcc---ChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 21 12346788877 8887543 577889965 57999999997521 111111
Q ss_pred --CChhhHh---hh-----ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccc
Q psy622 253 --IPTSTAA---QL-----QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDS 310 (473)
Q Consensus 253 --~~~~~~~---~~-----~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~ 310 (473)
+...... .. ...++......++++.+||.+||+.||.+|||++|+++||||+.+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence 0000000 00 0011111235789999999999999999999999999999999876553
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=341.98 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=200.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeCCEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH--SPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~f~~~~~l 117 (473)
.++|++++.||+|+||+||+|+++. ++.||||++++... .....+.+.+|+.+|+.+. ||||+++++++.....+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~--~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC--CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 3569999999999999999997653 68999999987643 3445678999999999995 59999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+||| +.+|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++ + +.+||+|||+++.+....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~-~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-S-SCEEECCCSSSCCC----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-C-CeEEEEecCccccccCCC
Confidence 99999 55899999999988999999999999999999999999999999999999996 4 799999999998754322
Q ss_pred cccccccccCCCCcccccCCcccccc-----------------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLLS-----------------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA 259 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~~-----------------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~ 259 (473)
.. ......+||+.|+ |||++.. .|+|++|++ +++++|..||........ ....+.
T Consensus 209 ~~-~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~~~~ 281 (390)
T 2zmd_A 209 TS-VVKDSQVGAVNYM---PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAII 281 (390)
T ss_dssp ------CCSCCCGGGC---CHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHH
T ss_pred cc-ccCCCCCcCCCcc---ChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH---HHHHHh
Confidence 11 1233457999988 8997643 588999965 579999999964210000 000001
Q ss_pred --hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 260 --QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 260 --~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.....+| ...+.++++||.+||+.||.+||++.|+++||||+..
T Consensus 282 ~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 282 DPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CTTSCCCCC---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CccccCCCC---ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 1122334 5678999999999999999999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=338.68 Aligned_cols=262 Identities=17% Similarity=0.293 Sum_probs=209.8
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchh--------------HHHHHHHHHHHHHhcCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN--------------MVSQVLRERNALALTHS 101 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~--------------~~~~~~~E~~iL~~l~h 101 (473)
....+++|++.+.||+|+||.||+|++ +++.||||++......... ..+.+.+|+.+++.++|
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 445568999999999999999999987 4789999999876432221 12689999999999999
Q ss_pred CCeeeEEEEEEeCCEEEEEecccCcCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcc
Q psy622 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSL------IAA--NGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDN 172 (473)
Q Consensus 102 p~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~------L~~--~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeN 172 (473)
|||+++++++.+.+.+|+||||++||+|.++ +.+ .+.+++..++.++.||+.||+|||+ +||+||||||+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999999999999999999999999999998 665 5689999999999999999999999 999999999999
Q ss_pred eEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCch
Q psy622 173 MLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFP 243 (473)
Q Consensus 173 ILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~ 243 (473)
|+++.+ +.+||+|||++...... ......|++.|+ |||.+. ..|+|++|++ +++++|..||.
T Consensus 183 il~~~~-~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~---aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 183 ILMDKN-GRVKLSDFGESEYMVDK-----KIKGSRGTYEFM---PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp EEECTT-SCEEECCCTTCEECBTT-----EECSSCSCGGGC---CGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEEcCC-CcEEEeccccccccccc-----cccCCCCCcCcc---CchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999 99999999999875332 122346777777 888653 4577899965 57999999996
Q ss_pred hHhhhcCCCCChhhHhhhccCCCC----------------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 244 SALRVAGSQIPTSTAAQLQLEWPE----------------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~P~----------------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
..... ......+......+|. ....+++++.+||.+||+.||.+||+++|+++||||++++
T Consensus 254 ~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 254 LKISL---VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp CSSCS---HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred CCCcH---HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 42100 0000011111222221 0146899999999999999999999999999999999999
Q ss_pred ccccc
Q psy622 308 WDSIL 312 (473)
Q Consensus 308 w~~l~ 312 (473)
|..+.
T Consensus 331 ~~~~~ 335 (348)
T 2pml_X 331 IEDLR 335 (348)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=327.05 Aligned_cols=256 Identities=21% Similarity=0.287 Sum_probs=203.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN-KNMVSQVLRERNALALTHSPFCVQLFYSLQ--TSSC 116 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--~~~~ 116 (473)
+++|++.+.||+|+||.||+|+++. +++.||+|++++..... ......+.+|+++++.++||||+++++++. +...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSE-TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTT-TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECC-CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 5789999999999999999998776 67899999998764322 234568999999999999999999999984 4568
Q ss_pred EEEEecccCcCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 117 VFLVMEYMIGGDVKSLIAA--NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~--~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
+|+||||+++| |.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALH 160 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC-CcEEeeccccccccC
Confidence 99999999776 8787776 3579999999999999999999999999999999999999998 999999999998754
Q ss_pred CCccccccccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
..... .......||+.|+ |||++. ..|.|++|++ +++++|..||....... ....+......+
T Consensus 161 ~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~i~~~~~~~ 232 (305)
T 2wtk_C 161 PFAAD-DTCRTSQGSPAFQ---PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK----LFENIGKGSYAI 232 (305)
T ss_dssp TTCSS-CEECCCCSCGGGC---CHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHCCCCC
T ss_pred ccccc-cccccCCCCCCCc---ChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHHHHhcCCCCC
Confidence 22211 1223446888887 888653 3578899965 57999999996421100 001122233344
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
| ..+++++.+||.+||+.||.+||+++|+++||||++....
T Consensus 233 ~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 233 P---GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp C---SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred C---CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 4 5789999999999999999999999999999999886654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=325.54 Aligned_cols=258 Identities=20% Similarity=0.288 Sum_probs=206.3
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK---NMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
++|++.+.||+|+||.||+|+++. +++.||+|++++...... ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKG-TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcC-CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 469999999999999999999876 578999999987643321 1356789999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC----ceeEeecchhhhh
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP----HCPIVNTLFLAIL 193 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g----~ikL~DFGla~~~ 193 (473)
|+||||++|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.+ + .+||+|||++...
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDK-NVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS-SSSSCCEEECCCTTCEEC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecC-CCCCCceEEEecccceec
Confidence 9999999999999999988889999999999999999999999999999999999999887 5 8999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
..... .....|++.|+ |||.+. ..|+|++|++ +++++|..||....... ....+......++
T Consensus 163 ~~~~~----~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~ 231 (283)
T 3bhy_A 163 EAGNE----FKNIFGTPEFV---APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE----TLTNISAVNYDFD 231 (283)
T ss_dssp C------------CCCGGGC---CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTTCCCCC
T ss_pred cCCCc----ccccCCCcCcc---CcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH----HHHHhHhcccCCc
Confidence 33221 12346788877 888654 3677889965 57999999996421100 0011111111221
Q ss_pred -CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccc
Q psy622 267 -EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSI 311 (473)
Q Consensus 267 -~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l 311 (473)
.....+++.+.+||.+||+.||.+||++.|+++||||+.+.|...
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence 112467899999999999999999999999999999998876644
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=335.80 Aligned_cols=265 Identities=19% Similarity=0.269 Sum_probs=202.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE--
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV-- 117 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l-- 117 (473)
.++|++.+.||+|+||.||+|+++. +++.||||++.+.. ......+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccEEEEeEEecCCCeEEEEEEECC-CCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 3689999999999999999999886 68999999998753 3344567889999999999999999999999877654
Q ss_pred ----EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 118 ----FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 118 ----~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
|+||||+. |+|..++. ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHA 194 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECSTTCC---
T ss_pred ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC-CCEEEEecCccccc
Confidence 99999995 78888874 359999999999999999999999999999999999999999 99999999999875
Q ss_pred cCCccccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCChh
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPTS 256 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~~ 256 (473)
... .....||+.|+ |||.+.. .|+|++|++ +++++|..||.... ...+.. ...
T Consensus 195 ~~~------~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~ 264 (371)
T 4exu_A 195 DAE------MTGYVVTRWYR---APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP-GTE 264 (371)
T ss_dssp -----------CTTCCCTTS---CHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CHH
T ss_pred ccC------cCCcccCcccc---CHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-cHH
Confidence 322 12346788887 8887543 577889965 57999999996421 000000 000
Q ss_pred hH-----------hhhc-----cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccC-CCCCc
Q psy622 257 TA-----------AQLQ-----LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQ-EPPFV 319 (473)
Q Consensus 257 ~~-----------~~~~-----~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~-~pPf~ 319 (473)
.. .... ..++.....+++++++||.+||+.||.+|||++|+++||||+.+.+...... ..||.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~ 344 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFD 344 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCC
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcC
Confidence 00 0000 0011112467999999999999999999999999999999998876654433 34544
Q ss_pred C
Q psy622 320 P 320 (473)
Q Consensus 320 P 320 (473)
+
T Consensus 345 ~ 345 (371)
T 4exu_A 345 D 345 (371)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=335.56 Aligned_cols=248 Identities=20% Similarity=0.274 Sum_probs=202.3
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.|++++.||+|+||+||+|++.. +++.||||++...........+.+.+|+++|+.++||||+++++++.++..+|+|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEcc-CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 459999999999999999998876 6799999999876544455567899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|||+. |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSSB---
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEeeccCceecCCC---
Confidence 99996 688887754 5689999999999999999999999999999999999999998 99999999999874321
Q ss_pred cccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
....||+.|+ |||++. ..|+|++|++ +++++|..||....... .............+ .
T Consensus 208 ----~~~~gt~~y~---aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---~~~~~~~~~~~~~~--~ 275 (348)
T 1u5q_A 208 ----NSFVGTPYWM---APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNESPALQ--S 275 (348)
T ss_dssp ----CCCCSCGGGC---CHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSCCCCCC--C
T ss_pred ----CcccCCccee---CHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcCCCCCC--C
Confidence 2347888888 898763 3578899965 57999999996421100 00000011111111 2
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
..+++.+++||.+||+.||++|||++|+++||||...
T Consensus 276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 5789999999999999999999999999999999654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=332.58 Aligned_cols=273 Identities=15% Similarity=0.192 Sum_probs=195.4
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQL----YAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSL 111 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~----vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 111 (473)
...+.++|++++.||+|+||+||+|+++. +++. ||+|++..... ......+.+|+.+++.++||||+++++++
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECC-TTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcC-CCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 44567899999999999999999999876 3444 67777654321 22234677899999999999999999988
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
. ....|+||||+.+|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||++
T Consensus 85 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a 162 (325)
T 3kex_A 85 P-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP-SQVQVADFGVA 162 (325)
T ss_dssp C-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS-SCEEECSCSGG
T ss_pred c-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC-CeEEECCCCcc
Confidence 6 45689999999999999999875 579999999999999999999999999999999999999998 99999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-h
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-L 261 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~ 261 (473)
+.+...... .......|++.|+ |||.+. ..|+|++|++ +++++ |..||..... ......+.. .
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~ 234 (325)
T 3kex_A 163 DLLPPDDKQ-LLYSEAKTPIKWM---ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL----AEVPDLLEKGE 234 (325)
T ss_dssp GGSCCCTTC-CC-----CCTTTS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT----THHHHHHHTTC
T ss_pred cccCccccc-ccccCCCCccccc---ChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH----HHHHHHHHcCC
Confidence 986433222 1223345666777 898754 4688899965 56888 9999975211 000011111 1
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc-------------------------CCCCCCCCccccccC--
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR-------------------------LPMFKDYDWDSILDQ-- 314 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~-------------------------HPFF~~idw~~l~~~-- 314 (473)
....| ..++.++.+||.+||+.||.+||++.|+++ +|.+.+++|..+.++
T Consensus 235 ~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 311 (325)
T 3kex_A 235 RLAQP---QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVEL 311 (325)
T ss_dssp BCCCC---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHHHBCCCSSSSCCCBCCCCCCC-----------
T ss_pred CCCCC---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhccccCCCCCCCCCCccccchhhccccccc
Confidence 22233 578899999999999999999999988765 466666777666554
Q ss_pred CCCCcCCCCC
Q psy622 315 EPPFVPQPDD 324 (473)
Q Consensus 315 ~pPf~P~~~~ 324 (473)
+|||.|..+.
T Consensus 312 ~~~~~~~~d~ 321 (325)
T 3kex_A 312 EPELDLDLDL 321 (325)
T ss_dssp ----------
T ss_pred chhccCCccc
Confidence 5666665443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=329.65 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=201.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++.+.||+|+||.||+|+++. +++.||+|++++... .....+.+|+.+++.++||||+++++++.+...+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECC-CCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 3579999999999999999999876 578999999987532 223468899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe---cCCCCceeEeecchhhhhcCC
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI---SAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILl---d~~~g~ikL~DFGla~~~~~~ 196 (473)
||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||++ +.+ +.+||+|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEEN-SKIMITDFGLSKMEQNG 162 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCCCCB
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCC-CCEEEccCCcceecCCC
Confidence 99999999999999888899999999999999999999999999999999999999 566 89999999999764321
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC-Cc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP-ED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P-~~ 268 (473)
.....+||+.|+ |||.+. ..|.|++|++ +++++|..||....... ....+......++ ..
T Consensus 163 -----~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~ 230 (304)
T 2jam_A 163 -----IMSTACGTPGYV---APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK----LFEKIKEGYYEFESPF 230 (304)
T ss_dssp -----TTHHHHSCCCBC---CTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHCCCCCCTTT
T ss_pred -----ccccccCCCCcc---ChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHcCCCCCCccc
Confidence 112346888887 888764 3677899965 57999999996421100 0011111222222 11
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
...+++++.+||.+||+.||.+||+++|+++||||++.
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 24689999999999999999999999999999999763
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=343.00 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=184.0
Q ss_pred CCeEEE-ceecccCceEEEEEEEeCC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCE
Q psy622 41 SDFEIV-KAISRGAFGKVFLGYKKTN-KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT--SSC 116 (473)
Q Consensus 41 ~~y~i~-~~LG~G~fG~V~~a~~~~~-~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~~~ 116 (473)
+.|++. ++||+|+||+||+|+++.. +++.||||++.+... ...+.+|+.+|+.++||||+++++++.+ ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 347764 5899999999999987642 468899999986532 2367889999999999999999999954 779
Q ss_pred EEEEecccCcCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe----cCCCCcee
Q psy622 117 VFLVMEYMIGGDVKSLIAAN---------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI----SAQAPHCP 183 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~---------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILl----d~~~g~ik 183 (473)
+|+||||+ +|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.+ +.+|
T Consensus 95 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~k 172 (405)
T 3rgf_A 95 VWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER-GRVK 172 (405)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT-TCEE
T ss_pred EEEEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC-CcEE
Confidence 99999999 56888888632 249999999999999999999999999999999999999 566 8999
Q ss_pred EeecchhhhhcCCccccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHhhh-------
Q psy622 184 IVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSALRV------- 248 (473)
Q Consensus 184 L~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~~~------- 248 (473)
|+|||+++...............+||+.|+ |||++.. .|+|++|++ ++|++|..||......
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYR---APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp ECCTTCCC----------------CCCTTC---CHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred EEECCCceecCCCCcccccCCCceecCccc---CchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 999999987654322222334467898888 8987643 577899965 5799999999632110
Q ss_pred -----------cCCCCChhh----------Hhhhcc---CCC---------CccccCChhHHHHHHhccccCCCCCCCHH
Q psy622 249 -----------AGSQIPTST----------AAQLQL---EWP---------EDEEALNPSTEETILALLKSDPTQRPSGH 295 (473)
Q Consensus 249 -----------~~~~~~~~~----------~~~~~~---~~P---------~~~~~ls~~a~dLI~~LL~~dP~kRpsa~ 295 (473)
.+....... ...... .++ ......++++.+||.+||+.||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 000000000 000000 000 00012378899999999999999999999
Q ss_pred HHhcCCCCCCCCcccc
Q psy622 296 QVRRLPMFKDYDWDSI 311 (473)
Q Consensus 296 eil~HPFF~~idw~~l 311 (473)
|+++||||++..|...
T Consensus 330 e~L~hp~f~~~~~~~~ 345 (405)
T 3rgf_A 330 QAMQDPYFLEDPLPTS 345 (405)
T ss_dssp HHHTSGGGTSSSCCCS
T ss_pred HHhcChhhccCCCCcc
Confidence 9999999998877654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.55 Aligned_cols=253 Identities=17% Similarity=0.273 Sum_probs=193.4
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT----- 113 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~----- 113 (473)
..++|++.+.||+|+||+||+|+++. +++.||||++..... ...+|+++|+.++||||++++++|..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIE-SGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETT-TCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECC-CCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 35789999999999999999999876 679999999976532 22369999999999999999999843
Q ss_pred ---------------------------------CCEEEEEecccCcCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHH
Q psy622 114 ---------------------------------SSCVFLVMEYMIGGDVKSLIA----ANGALPEDMAAFYAAEVVLALQ 156 (473)
Q Consensus 114 ---------------------------------~~~l~lVmEy~~gg~L~~~L~----~~~~~~e~~~~~~~~qI~~aL~ 156 (473)
...+|+||||++ |+|.+.+. ..+.+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 345999999996 57776665 3568999999999999999999
Q ss_pred HHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCC
Q psy622 157 YLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTF 229 (473)
Q Consensus 157 yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~ 229 (473)
|||++||+||||||+|||++.+.+.+||+|||+++.+..... .....||+.|+ |||.+. ..|+|++
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~---aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYR---APELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCC---CHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCcc---CHHHhcCCCCCCcchhhhhH
Confidence 999999999999999999985338999999999987533221 22346777777 888654 3577889
Q ss_pred Ccc-ccccCCCCCchhHh---------hhcCCCCChhhHhh-----hccCCCC---------ccccCChhHHHHHHhccc
Q psy622 230 PTF-QDVQNSQAPFPSAL---------RVAGSQIPTSTAAQ-----LQLEWPE---------DEEALNPSTEETILALLK 285 (473)
Q Consensus 230 g~l-~~~~~g~~pf~~~~---------~~~~~~~~~~~~~~-----~~~~~P~---------~~~~ls~~a~dLI~~LL~ 285 (473)
|++ ++|++|..||.+.. ...+.... ..... ....+|. .+..+++++.+||.+||+
T Consensus 229 G~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTK-EQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH-HHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH-HHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 965 57999999997521 11111110 00000 0111111 124688999999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCCc
Q psy622 286 SDPTQRPSGHQVRRLPMFKDYDW 308 (473)
Q Consensus 286 ~dP~kRpsa~eil~HPFF~~idw 308 (473)
.||.+|||+.|+++||||+++.+
T Consensus 308 ~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 308 YEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp SSGGGSCCHHHHHTSGGGHHHHH
T ss_pred CChhhCCCHHHHhcCHHHHHHHh
Confidence 99999999999999999987643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=332.81 Aligned_cols=266 Identities=20% Similarity=0.238 Sum_probs=198.8
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN--KNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
..++|++++.||+|+||.||+|+++. +++.||||+++...... ......+.+|+.+++.++||||+++++++.+...
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSS-CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECC-CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 46789999999999999999998876 57899999998653221 1112467899999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
+|+||||+++ +|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGS 164 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTS
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC-CCEEEEecccceeccC
Confidence 9999999965 898888765 369999999999999999999999999999999999999999 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCChhhH
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPTSTA 258 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~~~~ 258 (473)
.. ......+||+.|+ |||++. ..|+|++|++ +++++|.+||.... ...+........
T Consensus 165 ~~---~~~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 165 PN---RAYTHQVVTRWYR---APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp CC---CCCCCSCCCCTTC---CHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred Cc---ccCCccccccccc---CchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 22 1223357888888 888753 3577899965 56899999986521 111110000000
Q ss_pred hh----hcc---CCCC-----ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccccc
Q psy622 259 AQ----LQL---EWPE-----DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILD 313 (473)
Q Consensus 259 ~~----~~~---~~P~-----~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~ 313 (473)
.. ... ..|. ....+++++++||.+||+.||.+|||++|+++||||++..|.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~ 305 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 305 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCcc
Confidence 00 000 0010 1145789999999999999999999999999999999887764433
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=324.82 Aligned_cols=254 Identities=20% Similarity=0.287 Sum_probs=188.4
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+..++|++++.||+|+||.||+|+++. +++.||+|+++.... ..........+...++.++||||+++++++.+++..
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVP-SGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecC-CCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 456899999999999999999999876 679999999986532 222233444455557778999999999999999999
Q ss_pred EEEecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 118 FLVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSH-GIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~-gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
|+||||++ |+|.+++.. .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+++.
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGISGY 159 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT-CCEEBCCC-----
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeecCCccc
Confidence 99999996 588777654 46899999999999999999999998 99999999999999998 9999999999987
Q ss_pred hcCCccccccccccCCCCcccccCCccccc----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhh
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQL 261 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~ 261 (473)
..... ......||+.|+ |||.+. ..|.|++|++ +++++|..||....... ..........
T Consensus 160 ~~~~~----~~~~~~~t~~y~---aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~ 230 (290)
T 3fme_A 160 LVDDV----AKDIDAGCKPYM---APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQLKQVVEEP 230 (290)
T ss_dssp --------------CCCCCCS---CHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--HHHHHHHHSC
T ss_pred ccccc----cccccCCCcccc---ChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--HHHHHHhccC
Confidence 54322 122346888887 888751 3578899965 57999999996310000 0000111111
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
....+ ...+++++.+||.+||+.||++|||++|+++||||+..
T Consensus 231 ~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 231 SPQLP--ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CCCCC--TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCcc--cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 12222 24789999999999999999999999999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=340.13 Aligned_cols=258 Identities=21% Similarity=0.276 Sum_probs=194.1
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
......+|++.++||+|+||+||+|+++. ++ .||+|++.+... ...+|+++|+.++||||++++++|....
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~-~~-~~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVE-SD-EVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETT-TE-EEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECC-CC-eEEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 34445679999999999999999998775 33 488888765432 1236999999999999999999995433
Q ss_pred ------EEEEEecccCcCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec-CCCCceeE
Q psy622 116 ------CVFLVMEYMIGGDVKSLIA----ANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS-AQAPHCPI 184 (473)
Q Consensus 116 ------~l~lVmEy~~gg~L~~~L~----~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld-~~~g~ikL 184 (473)
.+|+||||++++ +...+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++ .+ +++||
T Consensus 106 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~~kL 183 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPS-GVLKL 183 (394)
T ss_dssp SSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEE
T ss_pred CCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCC-CcEEE
Confidence 489999999665 443333 256899999999999999999999999999999999999999 56 99999
Q ss_pred eecchhhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHh---------h
Q psy622 185 VNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSAL---------R 247 (473)
Q Consensus 185 ~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~---------~ 247 (473)
+|||+++.+..... .....||+.|+ |||.+. ..|+|++|++ ++|++|..||.+.. .
T Consensus 184 ~DFG~a~~~~~~~~----~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~ 256 (394)
T 4e7w_A 184 IDFGSAKILIAGEP----NVSYICSRYYR---APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256 (394)
T ss_dssp CCCTTCEECCTTCC----CCSSCSCGGGC---CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eeCCCcccccCCCC----CcccccCcCcc---CHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999987533221 12346788877 888754 3577899965 57999999997521 1
Q ss_pred hcCCCCChhhHhh-----hccCCCC---------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccc
Q psy622 248 VAGSQIPTSTAAQ-----LQLEWPE---------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSIL 312 (473)
Q Consensus 248 ~~~~~~~~~~~~~-----~~~~~P~---------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~ 312 (473)
..+.... ..+.. ....+|. ....+++++.+||.+||+.||.+|||+.|+++||||+++.|....
T Consensus 257 ~~g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 257 VLGTPSR-EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp HHCCCCH-HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCC
T ss_pred HhCCCCH-HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccccc
Confidence 1111110 00000 0111111 113588999999999999999999999999999999999887543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=322.40 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=198.2
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
.-.++|++++.||+|+||.||+|+++. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTI-LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETT-TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECC-CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 335789999999999999999998876 5789999999876555566677899999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+++......
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCSSSTTC----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEEeCCCcccccccc
Confidence 9999999999999999998899999999999999999999999999999999999999999 999999999998754322
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC---
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE--- 267 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~--- 267 (473)
. ......+||+.|+ |||.+. ..|+|++|++ +++++|..||...... ...........|.
T Consensus 166 ~--~~~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~~ 234 (294)
T 4eqm_A 166 L--TQTNHVLGTVQYF---SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSVPNVTT 234 (294)
T ss_dssp -----------CCSSC---CHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCCCCHHH
T ss_pred c--cccCccccCcccc---CHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccCCCcch
Confidence 1 1223457899888 898754 3577899965 5799999999752110 0000000111111
Q ss_pred -ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCC
Q psy622 268 -DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPM 302 (473)
Q Consensus 268 -~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPF 302 (473)
....+++.+.++|.+||+.||.+||+..+.+.+.|
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 12468899999999999999999995444444443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=339.39 Aligned_cols=257 Identities=20% Similarity=0.261 Sum_probs=196.5
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT--- 113 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--- 113 (473)
.+...+|+++++||+|+||+||+|+++. +++.||||++.+... ...+|+++|+.++||||++++++|..
T Consensus 50 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~ 121 (420)
T 1j1b_A 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGE 121 (420)
T ss_dssp CCEEEEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred CcccceEEeeeEEeeCCCEEEEEEEECC-CCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCC
Confidence 3444579999999999999999999876 578999999976531 23469999999999999999998853
Q ss_pred ---CCEEEEEecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEee
Q psy622 114 ---SSCVFLVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVN 186 (473)
Q Consensus 114 ---~~~l~lVmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~D 186 (473)
...+++||||+++ +|...+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+++.+||+|
T Consensus 122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEecc
Confidence 2247899999965 67666543 467999999999999999999999999999999999999997646789999
Q ss_pred cchhhhhcCCccccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHh---------hhc
Q psy622 187 TLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSAL---------RVA 249 (473)
Q Consensus 187 FGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~---------~~~ 249 (473)
||+++.+..... .....||+.|+ |||++.. .|+|++|++ ++|++|..||.+.. ...
T Consensus 201 FG~a~~~~~~~~----~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~l 273 (420)
T 1j1b_A 201 FGSAKQLVRGEP----NVSYICSRYYR---APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273 (420)
T ss_dssp CTTCEECCTTCC----CCSCCSCTTSC---CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred chhhhhcccCCC----ceeeeeCCCcC---CHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999987533221 12346788887 8987643 478899965 57999999997521 111
Q ss_pred CCCCChhhHhh-----hccCCCC---------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccc
Q psy622 250 GSQIPTSTAAQ-----LQLEWPE---------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDS 310 (473)
Q Consensus 250 ~~~~~~~~~~~-----~~~~~P~---------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~ 310 (473)
+... ...+.. ....+|. ....+++++++||.+||+.||.+||++.|+++||||+++.|..
T Consensus 274 g~p~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 274 GTPT-REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347 (420)
T ss_dssp CSCC-HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred CCCC-HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence 1111 011111 0112221 1135789999999999999999999999999999999876653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=327.04 Aligned_cols=262 Identities=20% Similarity=0.260 Sum_probs=194.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE-------
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ------- 112 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~------- 112 (473)
.++|++++.||+|+||.||+|+++. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDND-CDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETT-TTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECC-CCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 4789999999999999999999876 67999999998653 455678899999999999999999999873
Q ss_pred -------eCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEe
Q psy622 113 -------TSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185 (473)
Q Consensus 113 -------~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~ 185 (473)
+...+|+||||++ |+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+++.+||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4478999999996 699999865 5799999999999999999999999999999999999998553799999
Q ss_pred ecchhhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhc--------
Q psy622 186 NTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVA-------- 249 (473)
Q Consensus 186 DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~-------- 249 (473)
|||+++................+|+.|+ |||.+. ..|.|++|++ +++++|..||.......
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYR---SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTC---CHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cCccccccCCCccccccccccccccccc---CcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999987543221112222345677776 888653 3588899965 67999999996421100
Q ss_pred CCCCChhhHhh----------hccCCC-----CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccc
Q psy622 250 GSQIPTSTAAQ----------LQLEWP-----EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDS 310 (473)
Q Consensus 250 ~~~~~~~~~~~----------~~~~~P-----~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~ 310 (473)
........... .....+ .....+++++++||.+||+.||.+||+++|+++||||+.++|..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 00000000000 000001 11246899999999999999999999999999999999998874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=330.12 Aligned_cols=261 Identities=21% Similarity=0.269 Sum_probs=208.8
Q ss_pred ccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcC--CCC
Q psy622 29 DVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK---NMVSQVLRERNALALTH--SPF 103 (473)
Q Consensus 29 ~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~--hp~ 103 (473)
.+.+.....+..++|++.+.||+|+||.||+|+++. +++.||||++++...... .....+.+|+.+++.++ |||
T Consensus 31 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~ 109 (320)
T 3a99_A 31 KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109 (320)
T ss_dssp ---------CCTTTEEEEEECSSSSSCEEEEEEETT-TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred ccCcccccCCccCceEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence 344455556667899999999999999999998876 579999999987643321 11235678999999995 699
Q ss_pred eeeEEEEEEeCCEEEEEecccCc-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCce
Q psy622 104 CVQLFYSLQTSSCVFLVMEYMIG-GDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHC 182 (473)
Q Consensus 104 Iv~l~~~f~~~~~l~lVmEy~~g-g~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~i 182 (473)
|+++++++.+.+.+++|||++.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+
T Consensus 110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEE
T ss_pred ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCE
Confidence 99999999999999999999976 99999999888999999999999999999999999999999999999999433899
Q ss_pred eEeecchhhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCC
Q psy622 183 PIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIP 254 (473)
Q Consensus 183 kL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~ 254 (473)
||+|||+++...... .....||+.|+ |||.+. ..|+|++|++ +++++|..||.....
T Consensus 190 kL~Dfg~~~~~~~~~-----~~~~~gt~~y~---aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------- 254 (320)
T 3a99_A 190 KLIDFGSGALLKDTV-----YTDFDGTRVYS---PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------- 254 (320)
T ss_dssp EECCCTTCEECCSSC-----BCCCCSCGGGS---CHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred EEeeCcccccccccc-----ccCCCCCccCC---ChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------
Confidence 999999998754321 12346888887 898643 3588899965 579999999975322
Q ss_pred hhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccc
Q psy622 255 TSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSI 311 (473)
Q Consensus 255 ~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l 311 (473)
.......++ ..+++++.+||.+||+.||.+||+++|+++||||+++.+...
T Consensus 255 ---~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~ 305 (320)
T 3a99_A 255 ---IIRGQVFFR---QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQE 305 (320)
T ss_dssp ---HHHCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHHH
T ss_pred ---hhccccccc---ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCccc
Confidence 111223334 578999999999999999999999999999999998876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=330.86 Aligned_cols=250 Identities=15% Similarity=0.212 Sum_probs=199.4
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeC------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKT------NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFY 109 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 109 (473)
....++|++.+.||+|+||+||+|++.. .++..||||++++.. .....+.+.+|+.+|+.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3445789999999999999999998753 234679999998753 345567899999999999 8999999999
Q ss_pred EEEeCCEEEEEecccCcCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcce
Q psy622 110 SLQTSSCVFLVMEYMIGGDVKSLIAANG----------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNM 173 (473)
Q Consensus 110 ~f~~~~~l~lVmEy~~gg~L~~~L~~~~----------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNI 173 (473)
++.+.+.+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999998753 489999999999999999999999999999999999
Q ss_pred EecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhH
Q psy622 174 LISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSA 245 (473)
Q Consensus 174 Lld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~ 245 (473)
|++.+ +++||+|||+++.+...... .......+|+.|+ |||++. ..|+|++|++ ++|++ |..||...
T Consensus 235 ll~~~-~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~---aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 235 LVTEN-NVMKIADFGLARDINNIDYY-KKTTNGRLPVKWM---APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp EECTT-CCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGC---CHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EECCC-CCEEEccccCCcccCcccce-ecccCCCcccceE---CHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999 99999999999875432221 1122335667777 899754 3678899965 56887 99999752
Q ss_pred hhhcCCCCChhhHhh-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 246 LRVAGSQIPTSTAAQ-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 246 ~~~~~~~~~~~~~~~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.. ...... .....+..+..+++++.+||.+||+.||.+||++.|++++
T Consensus 310 ~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 310 PV-------EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CG-------GGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CH-------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 111111 0111122236789999999999999999999999998864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=328.58 Aligned_cols=251 Identities=19% Similarity=0.216 Sum_probs=195.8
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--EE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS--CV 117 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~--~l 117 (473)
-++|++.++||+|+||+||+|+++. +++.||||++++.... ...+.+.+|+++|+.++||||+++++++.... .+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 4679999999999999999999886 5789999999875432 23567789999999999999999999998765 89
Q ss_pred EEEecccCcCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe----cCCCCceeEeecchh
Q psy622 118 FLVMEYMIGGDVKSLIAANG---ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI----SAQAPHCPIVNTLFL 190 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~---~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILl----d~~~g~ikL~DFGla 190 (473)
|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+ +.+ +.+||+|||++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~Dfg~a 163 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAA 163 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSC-EEEEECCCTTC
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCC-ceEEEccCCCc
Confidence 99999999999999998753 39999999999999999999999999999999999999 776 88999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc--------------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL--------------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT 255 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~--------------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~ 255 (473)
+....... ....+||+.|+ |||++. ..|+|++|++ +++++|..||.............
T Consensus 164 ~~~~~~~~----~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 164 RELEDDEQ----FVSLYGTEEYL---HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp EECCTTCC----BCCCCSCGGGC---CHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred eecCCCCc----eeecccCCCcc---CHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 87543321 12346888887 888653 4688899965 57999999996311000000000
Q ss_pred hhHhhh---------------cc----CCC---CccccCChhHHHHHHhccccCCCCCCCHHHHhcCC
Q psy622 256 STAAQL---------------QL----EWP---EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLP 301 (473)
Q Consensus 256 ~~~~~~---------------~~----~~P---~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HP 301 (473)
..+... .. .+| .....+++.+.+||.+||+.||++|||++|+++||
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 000000 00 111 11134567899999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=329.54 Aligned_cols=257 Identities=18% Similarity=0.257 Sum_probs=199.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE----
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC---- 116 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~---- 116 (473)
++|++.+.||+|+||.||+|+++. +++.||||++.+.. ........+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred ceEEEeeeEecCCCeEEEEEEECC-CCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 689999999999999999999876 68999999998753 334456788999999999999999999999987654
Q ss_pred --EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 117 --VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 117 --l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
+|+||||+. |+|.+++.. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHAD 177 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-CCEEECSTTCTTC--
T ss_pred eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC-CcEEEeecccccCCC
Confidence 599999995 688887753 59999999999999999999999999999999999999998 999999999998743
Q ss_pred CCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCC-----
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQ----- 252 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~----- 252 (473)
.. .....||+.|+ |||.+. ..|+|++|++ +++++|..||..... ..+..
T Consensus 178 ~~------~~~~~~t~~y~---aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 178 AE------MTGYVVTRWYR---APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp ------------CCSBCCS---CHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred CC------ccccccCcCcC---CHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 21 12246788877 888654 3577889965 579999999974210 00000
Q ss_pred --CChh----hHhh----hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccc
Q psy622 253 --IPTS----TAAQ----LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSIL 312 (473)
Q Consensus 253 --~~~~----~~~~----~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~ 312 (473)
+... .... ....++.....+++++.+||.+||+.||.+||+++|+++||||+.+.+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~ 318 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE 318 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcccc
Confidence 0000 0000 0112222234689999999999999999999999999999999987765433
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=323.94 Aligned_cols=260 Identities=21% Similarity=0.331 Sum_probs=203.0
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
.....++|++++.||+|+||.||+|+++. +++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKE-TGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT 97 (314)
T ss_dssp ------CEEEEEECC----CEEEEEEETT-TCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred hhcchhhhhhheeeccCCCeEEEEEEECC-CCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 34446789999999999999999998876 57899999998643 2346889999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 116 CVFLVMEYMIGGDVKSLIA-ANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~-~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
.+|+||||++||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLT 176 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECB
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC-CCEEEeecccchhhh
Confidence 9999999999999999997 45689999999999999999999999999999999999999998 999999999998753
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhh-ccCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQL-QLEWP 266 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~P 266 (473)
... .......|++.|+ |||.+. ..|.|++|++ +++++|..||........ ....... ...+
T Consensus 177 ~~~---~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~- 245 (314)
T 3com_A 177 DTM---AKRNTVIGTPFWM---APEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA----IFMIPTNPPPTF- 245 (314)
T ss_dssp TTB---SCBCCCCSCGGGC---CHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSCCCCC-
T ss_pred hhc---cccCccCCCCCcc---ChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHhcCCCccc-
Confidence 321 1122346787777 888653 3577899965 579999999975211000 0000001 1111
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccccc
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILD 313 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~ 313 (473)
..+..++.++.+||.+||+.||.+||+++|+++||||++..+....+
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~~ 292 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILR 292 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGGH
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchHHH
Confidence 11256899999999999999999999999999999999988776654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.78 Aligned_cols=250 Identities=19% Similarity=0.272 Sum_probs=195.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc------CCCCeeeEEEEEEe
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT------HSPFCVQLFYSLQT 113 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l------~hp~Iv~l~~~f~~ 113 (473)
..+|+++++||+|+||+||+|+++. +++.||||+++.. ......+.+|+++++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~-~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHK-VHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETT-TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECC-CCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 4579999999999999999998876 6799999999864 23345677888888776 57899999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCc--eeEeecch
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH--CPIVNTLF 189 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~--ikL~DFGl 189 (473)
...+|+||||+ +|+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.+ +. +||+|||+
T Consensus 171 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~-~~~~vkL~DFG~ 248 (429)
T 3kvw_A 171 RNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ-GRSGIKVIDFGS 248 (429)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST-TSCCEEECCCTT
T ss_pred CCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC-CCcceEEeeccc
Confidence 99999999999 579999998764 49999999999999999999999999999999999999998 76 99999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCC
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQI 253 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~ 253 (473)
++..... ....+||+.|+ |||++. ..|+|++|++ +++++|..||..... ..+..
T Consensus 249 a~~~~~~------~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p- 318 (429)
T 3kvw_A 249 SCYEHQR------VYTYIQSRFYR---APEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP- 318 (429)
T ss_dssp CEETTCC------CCSSCSCGGGC---CHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC-
T ss_pred ceecCCc------ccccCCCCCcc---ChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-
Confidence 9764321 22357888887 899764 3678899965 579999999964211 00000
Q ss_pred ChhhHhh--------hccCCC----------------------------C--------ccccCChhHHHHHHhccccCCC
Q psy622 254 PTSTAAQ--------LQLEWP----------------------------E--------DEEALNPSTEETILALLKSDPT 289 (473)
Q Consensus 254 ~~~~~~~--------~~~~~P----------------------------~--------~~~~ls~~a~dLI~~LL~~dP~ 289 (473)
+...... ....+| . .....++++.+||.+||+.||+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~ 398 (429)
T 3kvw_A 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398 (429)
T ss_dssp CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence 0000000 000000 0 0123478899999999999999
Q ss_pred CCCCHHHHhcCCCCCCC
Q psy622 290 QRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 290 kRpsa~eil~HPFF~~i 306 (473)
+|||++|+++||||+..
T Consensus 399 ~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 399 VRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TSCCHHHHHTSTTTC--
T ss_pred hCCCHHHHhCChhhccC
Confidence 99999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=325.54 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=200.2
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe----
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQT---- 113 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~---- 113 (473)
..++|++++.||+|+||.||+|++.. +++.||||++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECC-CCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 35789999999999999999999876 57899999998653 2235788999999998 89999999999987
Q ss_pred --CCEEEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecch
Q psy622 114 --SSCVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 114 --~~~l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
...+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~ 175 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGV 175 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECCCTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC-CCEEEeeCcC
Confidence 56899999999999999999875 479999999999999999999999999999999999999998 9999999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhh
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTST 257 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~ 257 (473)
+....... .......||+.|+ |||.+. ..|+|++|++ +++++|..||...... ...
T Consensus 176 ~~~~~~~~---~~~~~~~~~~~y~---aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~ 243 (326)
T 2x7f_A 176 SAQLDRTV---GRRNTFIGTPYWM---APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RAL 243 (326)
T ss_dssp TC----------------CCGGGC---CHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH
T ss_pred ceecCcCc---cccccccCCcccc---ChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHH
Confidence 98753221 1122346888887 888764 3578899965 5799999999642110 000
Q ss_pred HhhhccCCC-CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccc
Q psy622 258 AAQLQLEWP-EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDS 310 (473)
Q Consensus 258 ~~~~~~~~P-~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~ 310 (473)
........+ .....+++++.+||.+||+.||.+||+++|+++||||++..+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~ 297 (326)
T 2x7f_A 244 FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER 297 (326)
T ss_dssp HHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHH
T ss_pred HHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcccc
Confidence 000011111 11256899999999999999999999999999999999887654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=319.46 Aligned_cols=250 Identities=18% Similarity=0.265 Sum_probs=200.3
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
...++|++.++||+|+||+||+|+++. +++.||+|++.+. .....+.+.+|+++++.++||||+++++++.+.+.+
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRE-TGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECC-CCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 346789999999999999999999876 5789999998654 345567899999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN-KNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT-SCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC-CCEEEeecccceecccc
Confidence 999999999999999998 4679999999999999999999999999999999999999998 99999999999875332
Q ss_pred cccc-----------ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhH
Q psy622 197 IVYL-----------EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTA 258 (473)
Q Consensus 197 ~~~~-----------~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~ 258 (473)
.... ......+||+.|+ |||.+. ..|+|++|++ +++++|..||........ .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~-~~~~~~~ 237 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWM---APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM-DFGLNVR 237 (310)
T ss_dssp ------------------CCCCSCGGGC---CHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT-TSSBCHH
T ss_pred cccccccccccccccccccccCCCccee---CHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH-HHhhhhh
Confidence 2111 0111457888888 898754 3577899965 578999999875321111 0111111
Q ss_pred hhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 259 AQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 259 ~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.......| ..+++++.+||.+||+.||.+||+++|+++
T Consensus 238 ~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 238 GFLDRYCP---PNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHTCC---TTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccccCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11122233 578999999999999999999999999885
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=318.08 Aligned_cols=253 Identities=19% Similarity=0.247 Sum_probs=198.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|....+||+|+||.||+|+++. +++.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLS-NQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETT-TCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECC-CCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 3445555699999999999999876 57899999998753 3335678999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 120 VMEYMIGGDVKSLIAANG---ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~---~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++...+.+||+|||+++.....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999999998752 56799999999999999999999999999999999999983389999999999875332
Q ss_pred ccccccccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hccCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQLEWP 266 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P 266 (473)
. .......|++.|+ |||++. ..|+|++|++ +++++|..||....... ...... .....+
T Consensus 177 ~---~~~~~~~~~~~y~---aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~ 245 (295)
T 2clq_A 177 N---PCTETFTGTLQYM---APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMFKVHP 245 (295)
T ss_dssp -------CCCCCCGGGC---CHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHHCCCC
T ss_pred C---CcccccCCCcccc---ChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhccccccc
Confidence 1 1123346788877 888653 3578899965 57999999997421100 000000 011112
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
..+..+++++.+||.+||+.||++||+++|+++||||+...
T Consensus 246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 22367899999999999999999999999999999998653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=321.63 Aligned_cols=257 Identities=23% Similarity=0.325 Sum_probs=206.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++++.||+|+||.||+|+++. +++.||+|++.+.... ......+.+|+++++.++||||+++++++.+...+|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcC-CCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 3679999999999999999998876 5789999999876432 3345688999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--CceeEeecchhhhhcCCc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA--PHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~--g~ikL~DFGla~~~~~~~ 197 (473)
||||++|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++ +.+||+|||++.......
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 999999999999998888999999999999999999999999999999999999997652 479999999998754322
Q ss_pred cccccccccCCCCcccccCCccccc-----cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC-ccc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL-----SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE-DEE 270 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~-----~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~-~~~ 270 (473)
. .....||+.|+ |||.+. ..|.|++|++ +++++|..||....... ....+......++. ...
T Consensus 179 ~----~~~~~~~~~y~---aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~ 247 (287)
T 2wei_A 179 K----MKDRIGTAYYI---APEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVETGKYAFDLPQWR 247 (287)
T ss_dssp S----CSCHHHHHTTC---CHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCSGGGT
T ss_pred c----cccccCccccc---ChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCchhhh
Confidence 1 11224666666 888654 3577889965 57999999996421100 00111112222211 114
Q ss_pred cCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 271 ~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
.+++++.+||.+||+.||.+||+++|+++||||++.+|+
T Consensus 248 ~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred hcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccccC
Confidence 689999999999999999999999999999999987765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=334.75 Aligned_cols=263 Identities=17% Similarity=0.187 Sum_probs=204.7
Q ss_pred cCCCCCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEE
Q psy622 34 CLKAPEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFY 109 (473)
Q Consensus 34 ~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 109 (473)
....+..++|++++.||+|+||+||+|+... .+++.||||+++... .......+.+|+.+++.++||||+++++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 141 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIG 141 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3456667899999999999999999998532 256789999997542 3444567899999999999999999999
Q ss_pred EEEeCCEEEEEecccCcCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--C
Q psy622 110 SLQTSSCVFLVMEYMIGGDVKSLIAANG-------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA--P 180 (473)
Q Consensus 110 ~f~~~~~l~lVmEy~~gg~L~~~L~~~~-------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~--g 180 (473)
++.+....|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCc
Confidence 9999999999999999999999998743 599999999999999999999999999999999999999651 3
Q ss_pred ceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCC
Q psy622 181 HCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQ 252 (473)
Q Consensus 181 ~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~ 252 (473)
.+||+|||+++.+...... .......||+.|+ |||++. ..|+|++|++ +++++ |..||.......
T Consensus 222 ~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~---aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--- 294 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYY-RKGGCAMLPVKWM---PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--- 294 (367)
T ss_dssp CEEECCCHHHHHHHHHSSC-TTCCGGGSCGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred eEEECCCcccccccccccc-ccCCCcCCcccEE---CHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 5999999999875322211 1223346788887 899753 4688999966 56887 999997521100
Q ss_pred CChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCc
Q psy622 253 IPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDW 308 (473)
Q Consensus 253 ~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw 308 (473)
+ ...+. ....+..+..+++++.+||.+||+.||.+||+++||++|.++-.-+.
T Consensus 295 ~-~~~i~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 295 V-LEFVT--SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp H-HHHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred H-HHHHH--cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 0 01111 11112222678999999999999999999999999999877644333
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=322.70 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=198.0
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC------CeeeEEEEEEe
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP------FCVQLFYSLQT 113 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp------~Iv~l~~~f~~ 113 (473)
.++|++++.||+|+||+||+|++...+++.||||+++.. ....+.+.+|+++++.++|+ +|+++++++.+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 578999999999999999999885556789999999764 33456788899999887654 59999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC-------------
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ------------- 178 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~------------- 178 (473)
.+.+|+||||+ +++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++..
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999999 999999998865 68999999999999999999999999999999999999873
Q ss_pred -----CCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHh
Q psy622 179 -----APHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSAL 246 (473)
Q Consensus 179 -----~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~ 246 (473)
.+.+||+|||+++..... .....||+.|+ |||++. ..|+|++|++ +++++|..||....
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYR---APEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGC---CHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccCCCceEeeCcccccCccc------cccccCCcccc---ChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 168999999999864321 22357888887 888754 3577889965 57999999996421
Q ss_pred h--------hcCCCCChhhHhh---------hccCCCC--------------------ccccCChhHHHHHHhccccCCC
Q psy622 247 R--------VAGSQIPTSTAAQ---------LQLEWPE--------------------DEEALNPSTEETILALLKSDPT 289 (473)
Q Consensus 247 ~--------~~~~~~~~~~~~~---------~~~~~P~--------------------~~~~ls~~a~dLI~~LL~~dP~ 289 (473)
. ......+...... ....|+. .....++++.+||.+||+.||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 0 0011111111100 0111110 0123457799999999999999
Q ss_pred CCCCHHHHhcCCCCCCCC
Q psy622 290 QRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 290 kRpsa~eil~HPFF~~id 307 (473)
+|||++|+++||||+.+.
T Consensus 319 ~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 319 KRITLREALKHPFFDLLK 336 (339)
T ss_dssp TSCCHHHHTTSGGGGGGG
T ss_pred cccCHHHHhcCHHHHHHh
Confidence 999999999999998653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=317.15 Aligned_cols=252 Identities=21% Similarity=0.332 Sum_probs=202.4
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ--TSSC 116 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--~~~~ 116 (473)
..++|++++.||+|+||.||+|+++. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++. ....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred chhheeeehhccCCCCcEEEEEEECC-CCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 36789999999999999999998876 578999999987643 3445678999999999999999999999885 4678
Q ss_pred EEEEecccCcCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCCcceEecCCCCceeEeec
Q psy622 117 VFLVMEYMIGGDVKSLIAAN----GALPEDMAAFYAAEVVLALQYLHSHG-----IIHRDLKPDNMLISAQAPHCPIVNT 187 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~----~~~~e~~~~~~~~qI~~aL~yLH~~g-----IiHRDLKpeNILld~~~g~ikL~DF 187 (473)
+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~df 160 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDF 160 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecC
Confidence 99999999999999999763 34999999999999999999999999 9999999999999998 99999999
Q ss_pred chhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh
Q psy622 188 LFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ 260 (473)
Q Consensus 188 Gla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~ 260 (473)
|+++....... ......|++.|+ |||.+. ..|.|++|++ +++++|..||....... ....+..
T Consensus 161 g~~~~~~~~~~---~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~i~~ 230 (279)
T 2w5a_A 161 GLARILNHDTS---FAKTFVGTPYYM---SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIRE 230 (279)
T ss_dssp CHHHHC---CH---HHHHHHSCCTTC---CHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHH
T ss_pred chheeeccccc---cccccCCCcccc---ChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH----HHHHHhh
Confidence 99987543221 122346788887 888754 3678899965 57999999996421100 0011111
Q ss_pred hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 261 LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 261 ~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
..++..+..+++++.+||.+||+.||.+||+++|+++|+|+.+
T Consensus 231 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 231 --GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp --TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred --cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 1222233578999999999999999999999999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=322.03 Aligned_cols=265 Identities=17% Similarity=0.231 Sum_probs=180.7
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~--~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
+..++|++.+.||+|+||.||+|+++.+.+ ..||||+++.... .....+.+.+|+++++.++||||+++++++.+..
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 445789999999999999999998765322 2799999987643 2344678999999999999999999999998776
Q ss_pred EE------EEEecccCcCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCcee
Q psy622 116 CV------FLVMEYMIGGDVKSLIAANG------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCP 183 (473)
Q Consensus 116 ~l------~lVmEy~~gg~L~~~L~~~~------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ik 183 (473)
.. |+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+|
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~-~~~k 177 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTVC 177 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC-CCEE
Confidence 65 99999999999999997532 59999999999999999999999999999999999999999 9999
Q ss_pred EeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCCh
Q psy622 184 IVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPT 255 (473)
Q Consensus 184 L~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~ 255 (473)
|+|||+++........ .......+++.|+ |||.+. ..|+|++|++ +++++ |..||...... ....
T Consensus 178 l~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~ 250 (323)
T 3qup_A 178 VADFGLSRKIYSGDYY-RQGCASKLPVKWL---ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYN 250 (323)
T ss_dssp ECCCCC------------------CCGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH
T ss_pred Eeeccccccccccccc-cccccccCccccc---CchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHH
Confidence 9999999875433221 1122234566666 888653 4678899965 56888 89999752110 0000
Q ss_pred hhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCC-------HHHHhcCCCCCCCCccccccC
Q psy622 256 STAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPS-------GHQVRRLPMFKDYDWDSILDQ 314 (473)
Q Consensus 256 ~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps-------a~eil~HPFF~~idw~~l~~~ 314 (473)
..........+ ..+++++.+||.+||+.||.+||+ .+++++|||+....++.+...
T Consensus 251 ~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~~ 313 (323)
T 3qup_A 251 YLIGGNRLKQP---PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYIN 313 (323)
T ss_dssp HHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------------
T ss_pred HHhcCCCCCCC---CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Confidence 11111122223 678999999999999999999999 678999999998877765543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=332.45 Aligned_cols=248 Identities=19% Similarity=0.298 Sum_probs=194.4
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--------CCCeeeEEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH--------SPFCVQLFYS 110 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--------hp~Iv~l~~~ 110 (473)
-.++|++++.||+|+||+||+|+++. +++.||||++++. ....+.+.+|+.+|+.++ ||||++++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQ-GKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecC-CCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 34789999999999999999998876 6799999999864 334567889999999884 7889999999
Q ss_pred EE----eCCEEEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEecCCCC---
Q psy622 111 LQ----TSSCVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSH-GIIHRDLKPDNMLISAQAP--- 180 (473)
Q Consensus 111 f~----~~~~l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~-gIiHRDLKpeNILld~~~g--- 180 (473)
|. +...+|+||||+ +|+|.+.+.+. +.+++..++.++.||+.||+|||++ ||+||||||+|||++.+ +
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~-~~~~ 187 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN-EQYI 187 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC-HHHH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc-chhh
Confidence 98 556899999999 77777777654 4699999999999999999999998 99999999999999977 4
Q ss_pred ----------------------------------------------ceeEeecchhhhhcCCccccccccccCCCCcccc
Q psy622 181 ----------------------------------------------HCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFN 214 (473)
Q Consensus 181 ----------------------------------------------~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~ 214 (473)
.+||+|||+++..... ....+||+.|+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~- 260 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYR- 260 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGC-
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCccc-
Confidence 7999999999875322 12346888887
Q ss_pred cCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhh--------------cCCCCChhhHh--------------
Q psy622 215 IRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRV--------------AGSQIPTSTAA-------------- 259 (473)
Q Consensus 215 ~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~--------------~~~~~~~~~~~-------------- 259 (473)
|||++. ..|+|++|++ ++|++|..||...... .....+.....
T Consensus 261 --aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 261 --SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp --CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred --CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 898754 3578899965 5799999999631100 00011111000
Q ss_pred ----------------hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 260 ----------------QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 260 ----------------~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.....++ ...++++++||.+||+.||++|||++|+++||||++
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWS---QEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCC---HHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccccccCCcchhHhhhhhcccc---hhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0011112 345678999999999999999999999999999974
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=322.64 Aligned_cols=252 Identities=19% Similarity=0.235 Sum_probs=197.8
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTN--KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~--~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
..+..++|++.+.||+|+||.||+|+++.+ .+..||||+++... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 455668899999999999999999998752 23469999998653 34456789999999999999999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
.+.+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN-LVCKVSDFGLSRV 200 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCSSCEE
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC-CCEEECCCCcccc
Confidence 99999999999999999999765 589999999999999999999999999999999999999998 9999999999987
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccC
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLE 264 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 264 (473)
...............+|+.|+ |||.+. ..|+|++|++ +++++ |..||....... +...........
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~---aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~~~~~~~ 274 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWT---APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VISSVEEGYRLP 274 (325)
T ss_dssp CC----CCEECC---CCGGGS---CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHTTCCCC
T ss_pred cccCccceeeccCCCCccccc---CHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHcCCCCC
Confidence 643322222222234566666 898764 4688999966 56887 999996421100 000000111222
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.| ..+++++.+||.+||+.||.+||++.||++
T Consensus 275 ~~---~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 AP---MGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC---CCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 23 578999999999999999999999998875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=317.98 Aligned_cols=248 Identities=22% Similarity=0.374 Sum_probs=203.3
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.|++++.||+|+||.||+|+++. +++.||||+++.... ....+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECC-CCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 569999999999999999998876 578999999987643 23466899999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++........
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~~~-- 174 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQI-- 174 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECBTTBC--
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC-CCEEEeecccceecCcccc--
Confidence 999999999999875 579999999999999999999999999999999999999998 9999999999987543221
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
......||+.|+ |||.+. ..|.|++|++ +++++|..||....... . ...+. ....+.....++
T Consensus 175 -~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~-~~~~~--~~~~~~~~~~~~ 244 (303)
T 3a7i_A 175 -KRNTFVGTPFWM---APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---V-LFLIP--KNNPPTLEGNYS 244 (303)
T ss_dssp -CBCCCCSCGGGC---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H-HHHHH--HSCCCCCCSSCC
T ss_pred -ccCccCCCcCcc---CHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---H-HHHhh--cCCCCCCccccC
Confidence 123346788877 888753 3577889965 57999999996421100 0 00011 111222235789
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.++.+||.+||+.||.+||++.|+++||||..
T Consensus 245 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 245 KPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 99999999999999999999999999999964
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=327.47 Aligned_cols=260 Identities=18% Similarity=0.227 Sum_probs=200.8
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCC------eeeEEEEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPF------CVQLFYSLQ 112 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~------Iv~l~~~f~ 112 (473)
-.++|++++.||+|+||+||+|+++.+.++.||+|++++. ....+.+.+|+.+++.++|++ ++.+++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 3578999999999999999999987755579999999864 234557888999998886555 999999999
Q ss_pred eCCEEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe---------------
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI--------------- 175 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILl--------------- 175 (473)
..+.+|+||||+ +|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999999 778888777653 69999999999999999999999999999999999999
Q ss_pred ----cCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchh
Q psy622 176 ----SAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPS 244 (473)
Q Consensus 176 ----d~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~ 244 (473)
+.+ +.+||+|||+++..... .....||+.|+ |||++. ..|+|++|++ +++++|..||..
T Consensus 172 ~~~~~~~-~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 172 EEKSVKN-TSIRVADFGSATFDHEH------HTTIVATRHYR---PPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CEEEESC-CCEEECCCTTCEETTSC------CCSSCSCGGGC---CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccCC-CcEEEeecCcccccccc------ccCCcCCCccc---CCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 455 89999999999864322 12357888887 898764 3677899965 579999999964
Q ss_pred Hhh--------hcCCCCChhhHhh---------hccCCCC--------------------ccccCChhHHHHHHhccccC
Q psy622 245 ALR--------VAGSQIPTSTAAQ---------LQLEWPE--------------------DEEALNPSTEETILALLKSD 287 (473)
Q Consensus 245 ~~~--------~~~~~~~~~~~~~---------~~~~~P~--------------------~~~~ls~~a~dLI~~LL~~d 287 (473)
... ......+...... ....|+. .....+.++.+||.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 210 0011111111100 0001110 00223468999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCCcccccc
Q psy622 288 PTQRPSGHQVRRLPMFKDYDWDSILD 313 (473)
Q Consensus 288 P~kRpsa~eil~HPFF~~idw~~l~~ 313 (473)
|++|||++|+++||||++++|+....
T Consensus 322 P~~Rpt~~e~l~hp~f~~~~~~~~~~ 347 (355)
T 2eu9_A 322 PAQRITLAEALLHPFFAGLTPEERSF 347 (355)
T ss_dssp TTTSCCHHHHTTSGGGGGCCHHHHC-
T ss_pred hhhCcCHHHHhcChhhcCCChhhccc
Confidence 99999999999999999999886543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=319.70 Aligned_cols=260 Identities=21% Similarity=0.269 Sum_probs=199.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCCeeeEEEEEE-----
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT---HSPFCVQLFYSLQ----- 112 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~----- 112 (473)
++|++++.||+|+||.||+|++...+++.||+|+++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 68999999999999999999986446789999999865422 11123456777777665 8999999999987
Q ss_pred eCCEEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
....+|+||||+. |+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~-~~~kl~Dfg~~ 167 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLA 167 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCCSC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC-CCEEEecCccc
Confidence 5678999999996 69999998754 49999999999999999999999999999999999999998 99999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCC
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIP 254 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~ 254 (473)
+...... ......||+.|+ |||.+. ..|+|++|++ +++++|..||..... ..+....
T Consensus 168 ~~~~~~~----~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 168 RIYSFQM----ALTSVVVTLWYR---APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CCCCGGG----GGCCCCCCCTTC---CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred ccccCCC----Ccccccccccee---CHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 8653221 122356788877 888654 3577889965 579999999964211 0000000
Q ss_pred hhhHh----------h-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccc
Q psy622 255 TSTAA----------Q-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDS 310 (473)
Q Consensus 255 ~~~~~----------~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~ 310 (473)
..... . ...........+++++++||.+||+.||.+||++.|+++||||++++|..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 00000 0 00000111246889999999999999999999999999999999998763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=318.24 Aligned_cols=246 Identities=23% Similarity=0.331 Sum_probs=192.5
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
-.+..++|++.+.||+|+||+||+|++ .++.||||++.+... .....+.+.+|+++|+.++||||+++++++.+..
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 345567899999999999999999975 357899999987643 3445678999999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCCcceEecCCCCceeEeecchh
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGA---LPEDMAAFYAAEVVLALQYLHSHG--IIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~---~~e~~~~~~~~qI~~aL~yLH~~g--IiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
.+|+||||++||+|.+++.+.+. +++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a 186 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLS 186 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC--
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCCCC
Confidence 99999999999999999987653 999999999999999999999999 9999999999999999 99999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhH--hhh
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTA--AQL 261 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~--~~~ 261 (473)
+...... .......||+.|+ |||++. ..|+|++|++ +++++|..||....... . .... ...
T Consensus 187 ~~~~~~~---~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~-~~~~~~~~~ 256 (309)
T 3p86_A 187 RLKASTF---LSSKSAAGTPEWM---APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---V-VAAVGFKCK 256 (309)
T ss_dssp ------------------CCTTS---CHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---H-HHHHHHSCC
T ss_pred ccccccc---cccccCCCCcccc---ChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H-HHHHHhcCC
Confidence 8643221 1123457888888 898754 3578899965 57999999997521100 0 0000 111
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
...+| ..+++++.+||.+||+.||.+||+++|+++
T Consensus 257 ~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 257 RLEIP---RNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp CCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC---ccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22333 689999999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=325.12 Aligned_cols=251 Identities=18% Similarity=0.273 Sum_probs=195.7
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----------CCCeee
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-----------SPFCVQ 106 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----------hp~Iv~ 106 (473)
...++|++++.||+|+||+||+|+++. +++.||||++.+.. .....+.+|+.+++.++ ||||++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecC-CCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 345789999999999999999998876 57999999998642 33457788999998875 899999
Q ss_pred EEEEEEeCC----EEEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEecCC-
Q psy622 107 LFYSLQTSS----CVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSH-GIIHRDLKPDNMLISAQ- 178 (473)
Q Consensus 107 l~~~f~~~~----~l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~-gIiHRDLKpeNILld~~- 178 (473)
+++++...+ .+++||||+ |++|.+++... +.+++..++.++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999998654 899999999 99999999874 4599999999999999999999998 99999999999999533
Q ss_pred ----CCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhh
Q psy622 179 ----APHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALR 247 (473)
Q Consensus 179 ----~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~ 247 (473)
.+.+||+|||+++..... .....||+.|+ |||++. ..|+|++|++ +++++|..||.....
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~---aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH------YTNSIQTREYR---SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGC---CHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred CCcCcceEEEcccccccccCCC------CCCCCCCcccc---CcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 148999999999875322 12346888887 898754 3578899965 579999999974321
Q ss_pred hc--------------CCCCChh------------------------------hHhhhccCCCCccccCChhHHHHHHhc
Q psy622 248 VA--------------GSQIPTS------------------------------TAAQLQLEWPEDEEALNPSTEETILAL 283 (473)
Q Consensus 248 ~~--------------~~~~~~~------------------------------~~~~~~~~~P~~~~~ls~~a~dLI~~L 283 (473)
.. ....+.. ........++ ..+++++.+||.+|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~ 317 (373)
T 1q8y_A 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS---KDEAKEISDFLSPM 317 (373)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC---HHHHHHHHHHHGGG
T ss_pred cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCC---cchHHHHHHHHHHH
Confidence 00 0001110 0011112222 45678899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q psy622 284 LKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 284 L~~dP~kRpsa~eil~HPFF~~i 306 (473)
|+.||.+|||++|+++||||++.
T Consensus 318 L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 318 LQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp GCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hccCccccCCHHHHhhChhhhcc
Confidence 99999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=317.32 Aligned_cols=257 Identities=23% Similarity=0.343 Sum_probs=194.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-------
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT------- 113 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------- 113 (473)
++|++++.||+|+||.||+|+++. +++.||||+++.. ....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNAL-DSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccchhhheeccCCcEEEEEEEEcC-CCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 469999999999999999998876 5789999999764 3446688999999999999999999998865
Q ss_pred ------CCEEEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEee
Q psy622 114 ------SSCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVN 186 (473)
Q Consensus 114 ------~~~l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~D 186 (473)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~-~~~kl~d 159 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGD 159 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC-CCEEEee
Confidence 457999999999999999998754 68899999999999999999999999999999999999998 9999999
Q ss_pred cchhhhhcCCccc-----------cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh
Q psy622 187 TLFLAILQQPIVY-----------LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR 247 (473)
Q Consensus 187 FGla~~~~~~~~~-----------~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~ 247 (473)
||+++........ ........||+.|+ |||.+. ..|+|++|++ +++++ ||.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYV---ATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp CCCCSCTTC-------------------------CTTS---CHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCccccc---CcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 9999875322110 01122345777777 888654 3577888865 56776 4432110
Q ss_pred hcCCCCChhhHhhhccCCCC-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccc
Q psy622 248 VAGSQIPTSTAAQLQLEWPE-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSIL 312 (473)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~P~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~ 312 (473)
.. ............+|. .....++.+++||.+||+.||.+|||++|+++||||+...++...
T Consensus 234 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~ 296 (303)
T 1zy4_A 234 RV---NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVI 296 (303)
T ss_dssp HH---HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHHHH
T ss_pred HH---HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHHHH
Confidence 00 000111111222322 124567889999999999999999999999999999988776543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=323.60 Aligned_cols=268 Identities=24% Similarity=0.288 Sum_probs=177.6
Q ss_pred hhhcccccccccccCC-CCCCCCeEEEc-eecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHH-HHHH
Q psy622 21 KASENSLCDVSKSCLK-APEISDFEIVK-AISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRER-NALA 97 (473)
Q Consensus 21 ~~~~~~~~~~~~~~~~-~~~~~~y~i~~-~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~-~iL~ 97 (473)
++++++......+..+ ..-.++|++++ +||+|+||+||+|+++. +++.||||++.+.. ...+|. ..++
T Consensus 7 ~~~~~~~~~~~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~--------~~~~e~~~~~~ 77 (336)
T 3fhr_A 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRR-TGQKCALKLLYDSP--------KARQEVDHHWQ 77 (336)
T ss_dssp -------------CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEESSH--------HHHHHHHHHHH
T ss_pred cccCCccccccCCCCCCccccceeEecceeeeeCCCeEEEEEEECC-CCCEEEEEEecCcH--------HHHHHHHHHHH
Confidence 3344443333333333 33457899965 69999999999999886 57899999997642 122233 3456
Q ss_pred hcCCCCeeeEEEEEEe----CCEEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCc
Q psy622 98 LTHSPFCVQLFYSLQT----SSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPD 171 (473)
Q Consensus 98 ~l~hp~Iv~l~~~f~~----~~~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpe 171 (473)
.+.||||+++++++.. ...+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+
T Consensus 78 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~ 157 (336)
T 3fhr_A 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE 157 (336)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred hcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 6799999999999976 556999999999999999998764 6999999999999999999999999999999999
Q ss_pred ceEecCC--CCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCc
Q psy622 172 NMLISAQ--APHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPF 242 (473)
Q Consensus 172 NILld~~--~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf 242 (473)
|||++.+ .+.+||+|||+++..... .....+||+.|+ |||.+. ..|+|++|++ +++++|..||
T Consensus 158 NIll~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~t~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 158 NLLYTSKEKDAVLKLTDFGFAKETTQN-----ALQTPCYTPYYV---APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp GEEESCSSTTCCEEECCCTTCEEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred HEEEEecCCCceEEEeccccceecccc-----ccccCCCCcCcc---ChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999864 156999999999864322 122356788888 898764 3688999965 5799999999
Q ss_pred hhHhhhcCCCCChhhHhhhccCCCC-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 243 PSALRVAGSQIPTSTAAQLQLEWPE-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~P~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
...............+......+|. ....+++++++||.+||+.||.+|||++|+++||||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 230 YSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred CCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 7543211100001111111222221 11468999999999999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.24 Aligned_cols=267 Identities=21% Similarity=0.228 Sum_probs=196.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~l 119 (473)
.+|++.++||+|+||+|+... .. +++.||||++.+.... .+.+|+++|+.+ +||||+++++++++...+|+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~-~~-~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRG-MF-DNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEE-ES-SSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred EEEecCCeeecCcCEEEEEEE-Ee-CCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 459999999999999976433 33 4689999999765321 346799999999 89999999999999999999
Q ss_pred EecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCC--C--ceeEeecchhhhhc
Q psy622 120 VMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQA--P--HCPIVNTLFLAILQ 194 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~--g--~ikL~DFGla~~~~ 194 (473)
||||| +|+|.+++.... .+.+..++.++.||+.||+|||++||+||||||+|||++.++ + .+||+|||+++.+.
T Consensus 96 v~E~~-~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 96 AIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEECC-SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEECC-CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 99999 569999998754 466677889999999999999999999999999999995321 3 46799999998764
Q ss_pred CCccccccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhh--
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQL-- 261 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~-- 261 (473)
............+||+.|+ |||++. ..|+|++|++ +++++ |..||...... .......
T Consensus 175 ~~~~~~~~~~~~~gt~~y~---APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~------~~~~~~~~~ 245 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWI---APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR------QANILLGAC 245 (432)
T ss_dssp -----------CCSCTTSC---CGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH------HHHHHTTCC
T ss_pred CCCcceeeccccCCCcCcc---ChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH------HHHHHhccC
Confidence 3332222334467899988 999875 3688999965 57888 89998532110 0000000
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc---------ccccC--CCCCcCCCCCC
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD---------SILDQ--EPPFVPQPDDV 325 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~---------~l~~~--~pPf~P~~~~~ 325 (473)
...........+..+++||.+||+.||.+|||++|+++||||.+++|. .+... .+|+++.+...
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 320 (432)
T 3p23_A 246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERG 320 (432)
T ss_dssp CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHHHHHHHHHHHHHCSCSCSSCHHHHHHHHT
T ss_pred CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHHHHHHHHHHHHHhhcccccchHHHHHHHc
Confidence 111111113456679999999999999999999999999999999883 33322 56776655443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=327.65 Aligned_cols=256 Identities=20% Similarity=0.232 Sum_probs=184.3
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS---- 115 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~---- 115 (473)
+++|++.+.||+|+||+||+|+++. +++.||||++.+.... ..+..+|++.+..++||||++++++|.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKS-TGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HTTEEEC----------CEEEEETT-TCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred ccceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 6789999999999999999999876 5789999999765322 235667788888899999999999996543
Q ss_pred ---EEEEEecccCcCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCCcceEecCCCCceeEee
Q psy622 116 ---CVFLVMEYMIGGDVKSLIA----ANGALPEDMAAFYAAEVVLALQYLH--SHGIIHRDLKPDNMLISAQAPHCPIVN 186 (473)
Q Consensus 116 ---~l~lVmEy~~gg~L~~~L~----~~~~~~e~~~~~~~~qI~~aL~yLH--~~gIiHRDLKpeNILld~~~g~ikL~D 186 (473)
.+|+||||+++ +|...+. ....+++..++.++.||+.||.||| ++||+||||||+|||++...+.+||+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 38999999965 5554443 4567999999999999999999999 999999999999999997338999999
Q ss_pred cchhhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hc
Q psy622 187 TLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VA 249 (473)
Q Consensus 187 FGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~ 249 (473)
||+++....... .....||+.|+ |||++. ..|+|++|++ +++++|..||..... ..
T Consensus 176 fg~a~~~~~~~~----~~~~~gt~~y~---aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 176 FGSAKKLSPSEP----NVAYICSRYYR---APELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp CTTCBCCCTTSC----CCSTTSCGGGC---CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred CCCceecCCCCC----cccccCCccee---CHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 999987543221 22346788877 888653 3577889965 579999999964211 00
Q ss_pred CCCCChhhHhhh-------------c----cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 250 GSQIPTSTAAQL-------------Q----LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 250 ~~~~~~~~~~~~-------------~----~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
+.. +....... . ..++......++++++||.+||+.||.+|||+.|+++||||+++.+.
T Consensus 249 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 249 GCP-SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp CCC-CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred CCC-CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 000 00000000 0 00111123467899999999999999999999999999999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=321.02 Aligned_cols=254 Identities=18% Similarity=0.233 Sum_probs=200.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~ 118 (473)
.++|++.+.||+|+||+||+|+++. +++.||||++..... ...+.+|+.+++.+ +||||+++++++.+....|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLY-TNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETT-TTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECC-CCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 3689999999999999999998776 679999999986532 22578899999999 9999999999999999999
Q ss_pred EEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCc-----eeEeecchhhh
Q psy622 119 LVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH-----CPIVNTLFLAI 192 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~-----ikL~DFGla~~ 192 (473)
+||||+ ||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +. +||+|||+++.
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRP-GNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-GGTCTTSEEECCCTTCEE
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccC-CCCCCceEEEEEccccee
Confidence 999999 99999999874 689999999999999999999999999999999999999988 76 99999999987
Q ss_pred hcCCcccc----ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh---hhH
Q psy622 193 LQQPIVYL----EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT---STA 258 (473)
Q Consensus 193 ~~~~~~~~----~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~---~~~ 258 (473)
+....... ......+||+.|+ |||++. ..|+|++|++ +++++|..||.... ..... ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~----~~~~~~~~~~i 232 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYM---SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK----ADTLKERYQKI 232 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTC---CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC----CSSHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCcccc---ChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc----cccHHHHHHHH
Confidence 54332211 1123567899988 898764 3588899965 57999999997521 01111 111
Q ss_pred hhhccCCCCc--cccCChhHHHHHHhccccCCCCCCCHHHHhc----------CCCCCCCCcc
Q psy622 259 AQLQLEWPED--EEALNPSTEETILALLKSDPTQRPSGHQVRR----------LPMFKDYDWD 309 (473)
Q Consensus 259 ~~~~~~~P~~--~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~----------HPFF~~idw~ 309 (473)
.......|.. ...++ ++.+||.+||+.||.+||++++|++ .++...+||+
T Consensus 233 ~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 233 GDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred HhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 1111112210 12244 9999999999999999999877654 4566788998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=323.05 Aligned_cols=268 Identities=20% Similarity=0.285 Sum_probs=193.3
Q ss_pred cccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCCeeeEE
Q psy622 30 VSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN-ALALTHSPFCVQLF 108 (473)
Q Consensus 30 ~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~ 108 (473)
+.+...-....++|++++.||+|+||.||+|+++. +++.||||+++... .......+..|.. +++.++||||++++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~ 87 (327)
T 3aln_A 11 ISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKP-SGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFY 87 (327)
T ss_dssp CCCCEEECCCSCSEEC-CEEEECSSEEEEEEEETT-TTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEE
T ss_pred CChHHhcccCHHHhhehheeccCCCEEEEEEEEcC-CCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeee
Confidence 34444456778999999999999999999999876 57999999998753 2333445666666 66677999999999
Q ss_pred EEEEeCCEEEEEecccCcCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEecCCCCce
Q psy622 109 YSLQTSSCVFLVMEYMIGGDVKSLIAA-----NGALPEDMAAFYAAEVVLALQYLHSH-GIIHRDLKPDNMLISAQAPHC 182 (473)
Q Consensus 109 ~~f~~~~~l~lVmEy~~gg~L~~~L~~-----~~~~~e~~~~~~~~qI~~aL~yLH~~-gIiHRDLKpeNILld~~~g~i 182 (473)
+++.+.+..|+||||++ |+|.+++.. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.+
T Consensus 88 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~-~~~ 165 (327)
T 3aln_A 88 GALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNI 165 (327)
T ss_dssp EEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT-TEE
T ss_pred eEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC-CCE
Confidence 99999999999999996 588888764 56899999999999999999999999 99999999999999998 999
Q ss_pred eEeecchhhhhcCCccccccccccCCCCcccccCCccccc----------cCCcCCCCcc-ccccCCCCCchhHhhhcCC
Q psy622 183 PIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGS 251 (473)
Q Consensus 183 kL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~ 251 (473)
||+|||+++....... .....||+.|+ |||.+. ..|+|++|++ +++++|..||.......
T Consensus 166 kl~Dfg~~~~~~~~~~----~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-- 236 (327)
T 3aln_A 166 KLCDFGISGQLVDSIA----KTRDAGCRPYM---APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-- 236 (327)
T ss_dssp EECCCSSSCC-------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------
T ss_pred EEccCCCceecccccc----cccCCCCcccc---CceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--
Confidence 9999999987533211 12236888877 888762 4578899965 57999999997521110
Q ss_pred CCChhhHhhhccCCCC-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccc
Q psy622 252 QIPTSTAAQLQLEWPE-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSI 311 (473)
Q Consensus 252 ~~~~~~~~~~~~~~P~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l 311 (473)
.............++. ....+++++.+||.+||+.||.+||++.|+++||||...++..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~ 297 (327)
T 3aln_A 237 DQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297 (327)
T ss_dssp ---CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCC
T ss_pred HHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhHH
Confidence 0000000001111111 11468999999999999999999999999999999998777654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=324.23 Aligned_cols=247 Identities=18% Similarity=0.270 Sum_probs=197.2
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQ 112 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~ 112 (473)
...++|++.+.||+|+||.||+|++.. .+++.||||++++.. .....+.+.+|++++..+ +||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 345789999999999999999998542 246899999998753 244466899999999999 8999999999998
Q ss_pred eCC-EEEEEecccCcCCHHHHHHhCCC-----------------------------------------------------
Q psy622 113 TSS-CVFLVMEYMIGGDVKSLIAANGA----------------------------------------------------- 138 (473)
Q Consensus 113 ~~~-~l~lVmEy~~gg~L~~~L~~~~~----------------------------------------------------- 138 (473)
+.+ .+|+||||++||+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 755 49999999999999999987543
Q ss_pred -------------CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 139 -------------LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 139 -------------~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+...... .....
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~-~~~~~ 254 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDY-VRKGD 254 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTC-EEC--
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CcEEEEeccceeeecccccc-hhccc
Confidence 8999999999999999999999999999999999999998 99999999999875432222 12233
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChh---hHh-hhccCCCCccccCC
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTS---TAA-QLQLEWPEDEEALN 273 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~---~~~-~~~~~~P~~~~~ls 273 (473)
..||+.|+ |||++. ..|+|++|++ +++++ |..||.... .... ... ......| ..++
T Consensus 255 ~~~t~~y~---aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~~~~~~~~~~~~~~~~---~~~~ 322 (359)
T 3vhe_A 255 ARLPLKWM---APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP---DYTT 322 (359)
T ss_dssp CEECGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC------CSHHHHHHHHHTCCCCCC---TTCC
T ss_pred cCCCceeE---ChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc------hhHHHHHHHHcCCCCCCC---CCCC
Confidence 45777777 898653 4688899965 56887 999997521 1111 111 1122333 6789
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
+++.+||.+||+.||.+||+++|+++|
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 999999999999999999999999876
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=314.99 Aligned_cols=239 Identities=25% Similarity=0.322 Sum_probs=187.7
Q ss_pred CCCCCCCeEEE-ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhcCCCCeeeEEEEEEe
Q psy622 36 KAPEISDFEIV-KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL-ALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 36 ~~~~~~~y~i~-~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~f~~ 113 (473)
...-+++|.++ ++||+|+||.||+|+++. +++.||+|+++.. ....+|+.++ +..+||||+++++++.+
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcC-CCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 34446889998 789999999999999876 5789999999753 2467788888 55699999999999987
Q ss_pred ----CCEEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC---CCCceeE
Q psy622 114 ----SSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA---QAPHCPI 184 (473)
Q Consensus 114 ----~~~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~---~~g~ikL 184 (473)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. + +.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-~~~kl 161 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKL 161 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT-CCEEE
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCC-CcEEE
Confidence 778999999999999999998864 6999999999999999999999999999999999999998 5 88999
Q ss_pred eecchhhhhcCCccccccccccCCCCcccccCCccccccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhcc
Q psy622 185 VNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQL 263 (473)
Q Consensus 185 ~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 263 (473)
+|||++...... ......|+|++|++ +++++|..||.....................
T Consensus 162 ~Dfg~a~~~~~~----------------------~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 162 TDFGFAKETTGE----------------------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219 (299)
T ss_dssp CCCTTCEECTTC----------------------GGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC
T ss_pred eccccccccccc----------------------cCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc
Confidence 999999763211 11224688899965 5799999999653221100000011111122
Q ss_pred CCCC-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 264 EWPE-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 264 ~~P~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.+|. ....+++++.+||.+||+.||.+||+++|+++||||++.
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 2221 114689999999999999999999999999999999763
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=319.69 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=195.9
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhc----CCCCeeeEEE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK---NMVSQVLRERNALALT----HSPFCVQLFY 109 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~---~~~~~~~~E~~iL~~l----~hp~Iv~l~~ 109 (473)
..-.++|++.+.||+|+||.||+|+++. +++.||||+++....... .....+.+|+.++..+ +||||+++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLT-DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTT-TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEcc-CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4445789999999999999999998776 578999999987643221 1233466789999888 8999999999
Q ss_pred EEEeCCEEEEEecc-cCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec-CCCCceeEeec
Q psy622 110 SLQTSSCVFLVMEY-MIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS-AQAPHCPIVNT 187 (473)
Q Consensus 110 ~f~~~~~l~lVmEy-~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld-~~~g~ikL~DF 187 (473)
++.+.+..|+|||+ +.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++ .+ +.+||+||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~df 184 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR-GCAKLIDF 184 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTT-TEEEECCC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCC-CeEEEEEc
Confidence 99999999999999 78999999999888899999999999999999999999999999999999999 56 89999999
Q ss_pred chhhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh
Q psy622 188 LFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA 259 (473)
Q Consensus 188 Gla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~ 259 (473)
|+++...... .....|++.|+ |||++. ..|+|++|++ +++++|..||..... ..
T Consensus 185 g~~~~~~~~~-----~~~~~~~~~y~---aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~ 246 (312)
T 2iwi_A 185 GSGALLHDEP-----YTDFDGTRVYS---PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------IL 246 (312)
T ss_dssp SSCEECCSSC-----BCCCCSCTTTS---CHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------HH
T ss_pred chhhhcccCc-----ccccCCccccc---CceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------Hh
Confidence 9998754322 12346788877 888642 4688899965 579999999975322 22
Q ss_pred hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 260 QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 260 ~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
.....++ ..+++++++||.+||+.||++||+++|+++||||+...
T Consensus 247 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 247 EAELHFP---AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HTCCCCC---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred hhccCCc---ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 2234444 57899999999999999999999999999999998754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=326.31 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=191.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CC-----CeeeEEEEEEe
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SP-----FCVQLFYSLQT 113 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp-----~Iv~l~~~f~~ 113 (473)
.++|++.+.||+|+||+||+|+++. +++.||||++++. ......+.+|+.+++.++ |+ +|+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRV-EQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcC-CCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 5889999999999999999999876 5789999999864 333556788888888774 55 49999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCCcceEecC--CCCceeEeec
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLH--SHGIIHRDLKPDNMLISA--QAPHCPIVNT 187 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH--~~gIiHRDLKpeNILld~--~~g~ikL~DF 187 (473)
.+.+|+||||+ +|+|.+++... +.+++..++.++.||+.||.||| +.|||||||||+|||++. + +.+||+||
T Consensus 128 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~-~~~kL~DF 205 (382)
T 2vx3_A 128 RNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR-SAIKIVDF 205 (382)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTS-CCEEECCC
T ss_pred CCceEEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCC-CcEEEEec
Confidence 99999999999 56999999875 46999999999999999999999 579999999999999954 5 78999999
Q ss_pred chhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCC
Q psy622 188 LFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGS 251 (473)
Q Consensus 188 Gla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~ 251 (473)
|+++..... .....||+.|+ |||++. ..|+|++|++ +++++|..||..... ..+.
T Consensus 206 G~a~~~~~~------~~~~~~t~~y~---aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 206 GSSCQLGQR------IYQYIQSRFYR---SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp TTCEETTCC------CCSSCSCGGGC---CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred cCceecccc------cccccCCcccc---ChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999875322 12356888887 898764 3677899965 579999999974210 0000
Q ss_pred CCChhhHhh------hccCCCCc------------------c-------------------------ccCChhHHHHHHh
Q psy622 252 QIPTSTAAQ------LQLEWPED------------------E-------------------------EALNPSTEETILA 282 (473)
Q Consensus 252 ~~~~~~~~~------~~~~~P~~------------------~-------------------------~~ls~~a~dLI~~ 282 (473)
.+...... .-..+|.. . ...++++++||.+
T Consensus 277 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 277 -PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp -CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred -CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 00000000 00000000 0 0011478999999
Q ss_pred ccccCCCCCCCHHHHhcCCCCCCCCc
Q psy622 283 LLKSDPTQRPSGHQVRRLPMFKDYDW 308 (473)
Q Consensus 283 LL~~dP~kRpsa~eil~HPFF~~idw 308 (473)
||+.||++|||++|+++||||++..|
T Consensus 356 mL~~dP~~Rpta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQHSFFKKTAD 381 (382)
T ss_dssp HTCSCTTTSCCHHHHTTSGGGCC---
T ss_pred hcCCChhhCCCHHHHhcCcccccCCC
Confidence 99999999999999999999998655
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=323.41 Aligned_cols=257 Identities=21% Similarity=0.264 Sum_probs=191.3
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccc--------cchhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM--------INKNMVSQVLRERNALALTHSPFCVQLFYSL 111 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~--------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 111 (473)
.++|++.+.||+|+||.||+|++.. ++.||||++.+... ......+.+.+|+++|+.++||||+++++++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT--SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC--CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 4689999999999999999998653 68999999976432 1233357899999999999999999999998
Q ss_pred Ee-----CCEEEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEe
Q psy622 112 QT-----SSCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIV 185 (473)
Q Consensus 112 ~~-----~~~l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~ 185 (473)
.. ...+|+||||+. |+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~ 176 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN-NDITIC 176 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEEC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC-CCEEEE
Confidence 43 447999999996 68888887643 79999999999999999999999999999999999999998 999999
Q ss_pred ecchhhhhcCCccccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHhh---------h
Q psy622 186 NTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSALR---------V 248 (473)
Q Consensus 186 DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~~---------~ 248 (473)
|||+++...... ......||+.|+ |||.+.. .|+|++|++ +++++|..||..... .
T Consensus 177 Dfg~~~~~~~~~----~~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 249 (362)
T 3pg1_A 177 DFNLAREDTADA----NKTHYVTHRWYR---APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249 (362)
T ss_dssp CTTC-------------------CGGGC---CHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ecCccccccccc----ccceecccceec---CcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999998643221 122346788777 8886543 577889965 579999999964210 0
Q ss_pred cCCCCChhh-----------HhhhccCCC-----CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 249 AGSQIPTST-----------AAQLQLEWP-----EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 249 ~~~~~~~~~-----------~~~~~~~~P-----~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
.+....... ........+ .....+++.+.+||.+||+.||.+|||++|+++||||+.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 000000000 000000011 11246789999999999999999999999999999999873
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=324.18 Aligned_cols=253 Identities=18% Similarity=0.240 Sum_probs=200.8
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeC------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeE
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKT------NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQL 107 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 107 (473)
...+..++|++.+.||+|+||.||+|++.. ..++.||+|+++... .......+.+|+++++.+ +||||+++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 334555789999999999999999998754 223579999998753 345567899999999999 99999999
Q ss_pred EEEEEeCCEEEEEecccCcCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCc
Q psy622 108 FYSLQTSSCVFLVMEYMIGGDVKSLIAANG----------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPD 171 (473)
Q Consensus 108 ~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~----------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpe 171 (473)
++++.+.+.+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 999999999999999999999999998754 4999999999999999999999999999999999
Q ss_pred ceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCch
Q psy622 172 NMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFP 243 (473)
Q Consensus 172 NILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~ 243 (473)
|||++.+ +.+||+|||+++........ .......+|+.|+ |||++. ..|+|++|++ +++++ |..||.
T Consensus 221 NIll~~~-~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~---aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 221 NVLVTED-NVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWM---APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp GEEECTT-CCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGS---CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eEEEcCC-CcEEEcccCccccccccccc-ccccCCCCCccee---CHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999 99999999999875432221 1122335667776 898753 4688899965 56887 999997
Q ss_pred hHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 244 SALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
...... +............| ..+++++.+||.+||+.||.+||+++|+++|
T Consensus 296 ~~~~~~---~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 296 GVPVEE---LFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TCCHHH---HHHHHHTTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHH---HHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 421100 00000011122223 6789999999999999999999999999975
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=308.57 Aligned_cols=244 Identities=18% Similarity=0.234 Sum_probs=195.6
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+..++|++++.||+|+||.||+|++.. ++.||+|++.+.... .+.+.+|+++++.++||||+++++++.+...+
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT--TEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred eChhhceeeheecCCCccEEEEEEecC--CCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 456789999999999999999998764 577999999876422 34688999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-GCEEECCTTGGGGBCCH
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-CCEEecccccccccccc
Confidence 9999999999999999764 469999999999999999999999999999999999999998 99999999999875332
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhh-ccCCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQL-QLEWPE 267 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~P~ 267 (473)
.. .......+|+.|+ |||.+. ..|+|++|++ +++++ |..||..... ....... ....+.
T Consensus 160 ~~--~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-------~~~~~~~~~~~~~~ 227 (269)
T 4hcu_A 160 QY--TSSTGTKFPVKWA---SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGFRLY 227 (269)
T ss_dssp HH--HSTTSTTCCGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCCC
T ss_pred cc--ccccCcccccccC---CHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhcCccCC
Confidence 21 1122234566666 898754 4688899965 56888 8999964211 1111110 111112
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.+..+++++.+||.+||+.||.+||++.|+++|
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 225789999999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=315.59 Aligned_cols=254 Identities=16% Similarity=0.210 Sum_probs=193.4
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEe---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKK---TNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ 112 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~---~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 112 (473)
.....++|++++.||+|+||+||+|+.+ ..+++.||||++.... ....+.+.+|+++|+.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4556789999999999999999999842 2367899999998653 445668999999999999999999999985
Q ss_pred e--CCEEEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecch
Q psy622 113 T--SSCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 113 ~--~~~l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
. ...+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~ 160 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGL 160 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCS
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC-CeEEEccCcc
Confidence 4 456999999999999999998864 59999999999999999999999999999999999999999 9999999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhh----cCCCCChh--
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRV----AGSQIPTS-- 256 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~----~~~~~~~~-- 256 (473)
++................+++.|+ |||.+. ..|+|++|++ +++++|..|+...... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWY---APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp CC-------------CTTCGGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred cccccCCcceeeeccCCCCcccee---CcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 987644332222233334555566 898754 4678899965 5799998887643211 11111000
Q ss_pred ---hH----hhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 257 ---TA----AQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 257 ---~~----~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.. .......| ..+++++.+||.+||+.||.+||+++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRP---DGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccCcCCCC---cCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 01122223 689999999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=313.47 Aligned_cols=253 Identities=15% Similarity=0.232 Sum_probs=195.1
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
....+++|++.+.||+|+||.||+|+++. +++.||+|++++.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTV-RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETT-TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcC-CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 44557899999999999999999998876 57899999998775555555678999999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+||||++|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD-DFAYLVDFGIASATTD 186 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSCCC------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC-CCEEEecCccCccccc
Confidence 999999999999999999988899999999999999999999999999999999999999998 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
... .......|++.|+ |||.+. ..|+|++|++ +++++|..||....... ...............
T Consensus 187 ~~~--~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~ 257 (309)
T 2h34_A 187 EKL--TQLGNTVGTLYYM---APERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV----MGAHINQAIPRPSTV 257 (309)
T ss_dssp ------------CCGGGC---CGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH----HHHHHHSCCCCGGGT
T ss_pred ccc--ccccccCCCcCcc---CHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH----HHHHhccCCCCcccc
Confidence 211 1122346788777 888753 4688899965 57999999997532110 000011000011111
Q ss_pred cccCChhHHHHHHhccccCCCCCC-CHHHHhc
Q psy622 269 EEALNPSTEETILALLKSDPTQRP-SGHQVRR 299 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRp-sa~eil~ 299 (473)
+..+++++.+||.+||+.||.+|| +++++++
T Consensus 258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 257899999999999999999999 7887774
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.00 Aligned_cols=251 Identities=18% Similarity=0.224 Sum_probs=199.9
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ 112 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 112 (473)
....++|++++.||+|+||.||+|+++. .+++.||||++++.. .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4456789999999999999999999874 245789999998753 3445668999999999999999999999999
Q ss_pred eCCEEEEEecccCcCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAAN------------------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~------------------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDL 168 (473)
+.+.+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999874 56999999999999999999999999999999
Q ss_pred CCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCC
Q psy622 169 KPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQA 240 (473)
Q Consensus 169 KpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~ 240 (473)
||+|||++.+ +.+||+|||+++........ .......+|+.|+ |||.+. ..|+|++|++ +++++ |..
T Consensus 201 kp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~---aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 201 ATRNCLVGEN-MVVKIADFGLSRNIYSADYY-KADGNDAIPIRWM---PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp SGGGEEECGG-GCEEECCCSCHHHHTGGGCB-C----CCBCGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CcceEEECCC-CeEEEeecCCCcccccCccc-cccCCCcccceec---ChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999998 99999999999876432211 1122345677777 898653 4678899965 56887 999
Q ss_pred CchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 241 PFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 241 pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
||....... + ...+. ....+..+..+++++.+||.+||+.||.+||++.+++++
T Consensus 276 p~~~~~~~~---~-~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 276 PYYGMAHEE---V-IYYVR--DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTTTSCHHH---H-HHHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCChHH---H-HHHHh--CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 996521100 0 01111 111222236789999999999999999999999998863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=306.91 Aligned_cols=246 Identities=17% Similarity=0.205 Sum_probs=195.6
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
....++|++++.||+|+||.||+|+.+. ++.||+|+++.... ..+.+.+|+++++.++||||+++++++.+...
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKG--QYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETT--TEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred EechhheeeeeeeccCCCceEEEEEecC--ceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 3456789999999999999999997663 56799999987542 23468899999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++....
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT-CCEEECCTTCEEECCT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC-CCEEEccCccceecch
Confidence 999999999999999998754 59999999999999999999999999999999999999999 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
.... ......+|+.|+ |||.+. ..|+|++|++ +++++ |..||....... . ..... ....+.
T Consensus 157 ~~~~--~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~-~~~~~--~~~~~~ 225 (268)
T 3sxs_A 157 DQYV--SSVGTKFPVKWS---APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---V-VLKVS--QGHRLY 225 (268)
T ss_dssp TCEE--ECCSCCCCGGGC---CHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---H-HHHHH--TTCCCC
T ss_pred hhhh--cccCCCcCcccC---CHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---H-HHHHH--cCCCCC
Confidence 3221 111223455566 898753 4688899965 56887 999996421100 0 00111 111111
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.+...++++.+||.+||+.||.+||++.|+++|
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 225689999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.76 Aligned_cols=245 Identities=18% Similarity=0.217 Sum_probs=193.7
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
.+..++|++++.||+|+||.||+|+++. ++.||+|+++..... .+.+.+|+++++.++||||+++++++.+.+.
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRG--QYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETT--TEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcC--CCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 4556799999999999999999997763 578999999876432 3468899999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
+|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-SCEEECSTTGGGGBCC
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC-CCEEEccccccccccc
Confidence 9999999999999999987 4579999999999999999999999999999999999999998 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWP 266 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P 266 (473)
.... ......+|+.|+ |||.+. ..|+|++|++ +++++ |..||....... ....+.. .....|
T Consensus 173 ~~~~--~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~----~~~~~~~~~~~~~~ 243 (283)
T 3gen_A 173 DEYT--SSVGSKFPVRWS---PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAEHIAQGLRLYRP 243 (283)
T ss_dssp HHHH--STTSTTSCGGGC---CHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHHHHHTTCCCCCC
T ss_pred cccc--cccCCccCcccC---CHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH----HHHHHhcccCCCCC
Confidence 2211 112234556666 898754 4678899965 56887 999997421100 0011111 112222
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
...++++.+||.+||+.||.+||+++|+++|
T Consensus 244 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 244 ---HLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 5789999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=318.44 Aligned_cols=265 Identities=16% Similarity=0.207 Sum_probs=208.3
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ 112 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 112 (473)
.+..++|++.+.||+|+||.||+|+++. .+++.||+|++++.. .......+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 3445789999999999999999998763 245789999998653 2344567899999999999999999999999
Q ss_pred eCCEEEEEecccCcCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCce
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAAN----------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHC 182 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~----------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~i 182 (473)
+.+..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-~~~ 177 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTV 177 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC-CeE
Confidence 999999999999999999999753 357999999999999999999999999999999999999998 999
Q ss_pred eEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCC
Q psy622 183 PIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIP 254 (473)
Q Consensus 183 kL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~ 254 (473)
||+|||+++........ .......+|+.|+ |||++. ..|+|++|++ +++++ |..||....... .
T Consensus 178 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~- 249 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWM---SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---V- 249 (322)
T ss_dssp EECCTTCCCGGGGGGCE-EGGGSSEECGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---H-
T ss_pred EECcCcccccccccccc-ccccCCCCCCCcc---ChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---H-
Confidence 99999999875432211 1222335677777 888753 3688899965 56887 889986421100 0
Q ss_pred hhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC------CCCCCCCccccccC
Q psy622 255 TSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL------PMFKDYDWDSILDQ 314 (473)
Q Consensus 255 ~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H------PFF~~idw~~l~~~ 314 (473)
.... .....+..+..+++++.+||.+||+.||.+||++.|+++| |+|+.++|....+.
T Consensus 250 ~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~~~~~ 313 (322)
T 1p4o_A 250 LRFV--MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEEN 313 (322)
T ss_dssp HHHH--HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTSTTC
T ss_pred HHHH--HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccccccccc
Confidence 0011 1112222236789999999999999999999999998876 88888887755544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=312.56 Aligned_cols=251 Identities=17% Similarity=0.221 Sum_probs=200.1
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ 112 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 112 (473)
....++|++.+.||+|+||.||+|++.. .+++.||+|+++... .....+.+.+|+++++.++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 4456789999999999999999998743 235789999998653 3455678999999999999999999999999
Q ss_pred eCCEEEEEecccCcCCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAANGA------------------------LPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~~~------------------------~~e~~~~~~~~qI~~aL~yLH~~gIiHRDL 168 (473)
+.+.+|+||||++||+|.+++...+. +++..++.++.||+.||+|||++||+||||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 99999999999999999999987543 899999999999999999999999999999
Q ss_pred CCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCC
Q psy622 169 KPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQA 240 (473)
Q Consensus 169 KpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~ 240 (473)
||+|||++.+ +.+||+|||+++........ .......+++.|+ |||.+. ..|+|++|++ +++++ |..
T Consensus 177 kp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 177 AARNILVAEG-RKMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWM---AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp SGGGEEEETT-TEEEECCCTTCEECTTTSCE-ECSSCCCSCGGGC---CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred chheEEEcCC-CCEEEccccccccccccccc-eeccCCCCccccc---ChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999998 99999999999875432221 1122335667777 898653 4688999965 56888 999
Q ss_pred CchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 241 PFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 241 pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
||...... ....... ....+..+..+++++.+||.+||+.||.+||+++|+++|
T Consensus 252 p~~~~~~~----~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 252 PYPGIPPE----RLFNLLK--TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SSTTCCGG----GHHHHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHH----HHHHHhh--cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99742110 0001111 111122236789999999999999999999999999865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=311.93 Aligned_cols=243 Identities=14% Similarity=0.180 Sum_probs=194.3
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCC------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEE
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKD------QLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFY 109 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~------~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 109 (473)
..+..++|++.+.||+|+||+||+|+++.+.. +.||+|++.+.. ....+.+.+|+.+++.++||||+++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~ 79 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYG 79 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 34567899999999999999999998876321 469999997653 344568999999999999999999999
Q ss_pred EEEeCCEEEEEecccCcCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCc-------
Q psy622 110 SLQTSSCVFLVMEYMIGGDVKSLIAANGA-LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH------- 181 (473)
Q Consensus 110 ~f~~~~~l~lVmEy~~gg~L~~~L~~~~~-~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~------- 181 (473)
++.+.+..|+||||++||+|.+++.+.+. +++..++.++.||+.||+|||++||+||||||+|||++.+ +.
T Consensus 80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~~~~~~~ 158 (289)
T 4fvq_A 80 VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE-EDRKTGNPP 158 (289)
T ss_dssp EECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEEC-CBGGGTBCC
T ss_pred EEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecC-Ccccccccc
Confidence 99999999999999999999999988654 9999999999999999999999999999999999999988 66
Q ss_pred -eeEeecchhhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCC-chhHhhhcCC
Q psy622 182 -CPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAP-FPSALRVAGS 251 (473)
Q Consensus 182 -ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~p-f~~~~~~~~~ 251 (473)
+||+|||++...... ....||+.|+ |||.+. ..|+|++|++ +++++|..| |......
T Consensus 159 ~~kl~Dfg~~~~~~~~-------~~~~~~~~y~---aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--- 225 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-------DILQERIPWV---PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--- 225 (289)
T ss_dssp EEEECCCCSCTTTSCH-------HHHHHTTTTS---CHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---
T ss_pred eeeeccCcccccccCc-------cccCCcCccc---CHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH---
Confidence 999999999764322 1234677776 888654 3578899965 568885544 4321100
Q ss_pred CCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 252 QIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 252 ~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
............| ...++++.+||.+||+.||.+||+++|+++|
T Consensus 226 --~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 226 --RKLQFYEDRHQLP---APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp --HHHHHHHTTCCCC---CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred --HHHHHhhccCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0011111223333 5678999999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.15 Aligned_cols=251 Identities=22% Similarity=0.293 Sum_probs=196.7
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeCCEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH--SPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~f~~~~~l 117 (473)
-++|++++.||+|+||.||+|+++ +++.||||+++.... .....+.+.+|+.++..++ ||||+++++++.+...+
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC--CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 457999999999999999999865 368899999987542 3445678899999999996 69999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+|||+ .+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+++......
T Consensus 104 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 104 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCC-----
T ss_pred EEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC--CeEEEeeccccccccCcc
Confidence 999994 58999999999889999999999999999999999999999999999999964 799999999998754322
Q ss_pred cccccccccCCCCcccccCCccccc-----------------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL-----------------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA 259 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~-----------------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~ 259 (473)
.. .......||+.|+ |||.+. ..|+|++|++ +++++|..||........ ......
T Consensus 181 ~~-~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~ 253 (313)
T 3cek_A 181 TS-VVKDSQVGTVNYM---PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAII 253 (313)
T ss_dssp ----------CCGGGC---CHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHH
T ss_pred cc-ccccCCCCCCCcC---CHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHH
Confidence 11 1223346888887 888764 3578899965 579999999964211000 000000
Q ss_pred --hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 260 --QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 260 --~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.....+| ...++++.+||.+||+.||.+||+++|+++||||+..
T Consensus 254 ~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 254 DPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CTTSCCCCC---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred hcccccCCc---ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 0122333 5678999999999999999999999999999999753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=309.78 Aligned_cols=253 Identities=19% Similarity=0.246 Sum_probs=197.1
Q ss_pred ccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhH----HHHHHHHHHHHHhcCCCCeee
Q psy622 31 SKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNM----VSQVLRERNALALTHSPFCVQ 106 (473)
Q Consensus 31 ~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~----~~~~~~E~~iL~~l~hp~Iv~ 106 (473)
..........++|++.+.||+|+||+||+|+++. +++.||+|++.......... .+.+.+|+.+++.++||||++
T Consensus 9 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 87 (287)
T 4f0f_A 9 PKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVK-DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87 (287)
T ss_dssp ---CCCBCCSTTEEEEEECCCCSSSCEEEEEETT-TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCC
T ss_pred cchhhhhhhhccceehhccccCCceeEEEEEEcC-CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchh
Confidence 3444556667899999999999999999999876 57899999997654332222 167899999999999999999
Q ss_pred EEEEEEeCCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCCcceEecCCCCc--
Q psy622 107 LFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHG--IIHRDLKPDNMLISAQAPH-- 181 (473)
Q Consensus 107 l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~g--IiHRDLKpeNILld~~~g~-- 181 (473)
+++++.+.. ++||||++||+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.
T Consensus 88 ~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~ 164 (287)
T 4f0f_A 88 LYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENA 164 (287)
T ss_dssp EEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTC
T ss_pred hheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCC
Confidence 999997766 6999999999999988765 47999999999999999999999999 9999999999999887 65
Q ss_pred ---eeEeecchhhhhcCCccccccccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCchhHhhhc
Q psy622 182 ---CPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFPSALRVA 249 (473)
Q Consensus 182 ---ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~~~~~~~ 249 (473)
+||+|||+++..... .....||+.|+ |||.+. ..|+|++|++ +++++|..||......
T Consensus 165 ~~~~kl~Dfg~~~~~~~~------~~~~~g~~~y~---aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~- 234 (287)
T 4f0f_A 165 PVCAKVADFGLSQQSVHS------VSGLLGNFQWM---APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG- 234 (287)
T ss_dssp SCCEEECCCTTCBCCSSC------EECCCCCCTTS---CGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-
T ss_pred ceeEEeCCCCcccccccc------ccccCCCcccc---CchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-
Confidence 999999999863321 12346888887 888762 3688899965 5799999999642100
Q ss_pred CCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 250 GSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 250 ~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..............+..+..+++++.+||.+||+.||.+||+++|+++
T Consensus 235 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 235 --KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp --HHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000000000111112223678999999999999999999999999885
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=310.52 Aligned_cols=254 Identities=17% Similarity=0.225 Sum_probs=196.8
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEe---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKK---TNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~---~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
....++|++++.||+|+||.||+|+.. ..+++.||+|+++... .....+.+.+|+++++.++||||+++++++.+
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 344567999999999999999999842 2367899999998653 23345688999999999999999999999987
Q ss_pred C--CEEEEEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 114 S--SCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 114 ~--~~l~lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
. ..+|+||||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~ 173 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLT 173 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTC
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC-CCEEECccccc
Confidence 6 679999999999999999954 4579999999999999999999999999999999999999999 99999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhh----cCCCCCh---h
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRV----AGSQIPT---S 256 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~----~~~~~~~---~ 256 (473)
+................||+.|+ |||.+. ..|.|++|++ +++++|..|+...... ....... .
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWY---APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGC---CHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred ccccCCCcceeccCCCCCCcccc---CCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 87654433323334456777777 898753 4688999965 5799999887543211 0111000 0
Q ss_pred h-H----hhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 257 T-A----AQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 257 ~-~----~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
. . .......| ..+++++.+||.+||+.||.+||+++|+++
T Consensus 251 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCP---PNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCCCCCC---CCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0 0 01122223 678999999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=327.12 Aligned_cols=247 Identities=21% Similarity=0.272 Sum_probs=196.4
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+..++|++.+.||+|+||.||+|+++. +++.||||+++... .....+.+.+|+++|+.++||||+++++++.+...+
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRA-DNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEec-CCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 445789999999999999999999876 57899999998642 234455788999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADG 266 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECTTS
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC-CcEEECcCCCceecCCC
Confidence 99999999999999998754 69999999999999999999999999999999999999998 99999999999864322
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHh-hhccCCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAA-QLQLEWPE 267 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~P~ 267 (473)
... .......+++.|+ |||.+. ..|+|++|++ +++++ |..||....... . ..... ......|
T Consensus 267 ~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~-~~~~~~~~~~~~~- 337 (377)
T 3cbl_A 267 VYA-ASGGLRQVPVKWT---APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---T-REFVEKGGRLPCP- 337 (377)
T ss_dssp EEE-CCSSCCEEEGGGS---CHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---H-HHHHHTTCCCCCC-
T ss_pred cee-ecCCCCCCCcCcC---CHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H-HHHHHcCCCCCCC-
Confidence 111 1111122344555 899754 4788999966 56776 999997521100 0 00111 1122333
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+++++.+||.+||+.||.+|||++++++
T Consensus 338 --~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 338 --ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 578999999999999999999999998874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=316.95 Aligned_cols=250 Identities=16% Similarity=0.216 Sum_probs=196.1
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSL 111 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 111 (473)
....++|++.+.||+|+||.||+|++.. .+++.||+|++++.. .....+.+.+|+.+|+.+ +||||+++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3445789999999999999999998742 345689999998653 233456889999999999 999999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAANG-----------------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~~-----------------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDL 168 (473)
.+.+.+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 99999999999999999999998753 3799999999999999999999999999999
Q ss_pred CCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCC
Q psy622 169 KPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQA 240 (473)
Q Consensus 169 KpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~ 240 (473)
||+|||++.+ +.+||+|||+++........ .......||+.|+ |||.+. ..|+|++|++ +++++ |..
T Consensus 199 kp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~---aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 199 AARNVLVTHG-KVVKICDFGLARDIMSDSNY-VVRGNARLPVKWM---APESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp SGGGEEEETT-TEEEECCCGGGSCGGGCTTS-EEETTEEECGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ChhhEEEcCC-CcEEeCCCccCcccccCccc-eeccCccCccCcc---CHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 9999999998 99999999999876433221 1222345666777 898653 3688899965 56887 999
Q ss_pred CchhHhhhcCCCCChh--hHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 241 PFPSALRVAGSQIPTS--TAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 241 pf~~~~~~~~~~~~~~--~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
||.... .... ........ +..+..+++++.+||.+||+.||.+||++.|+++|
T Consensus 274 p~~~~~------~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 274 PYPGIP------VDANFYKLIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp SSTTCC------CSHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCC------cHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 997521 1111 01111111 12225789999999999999999999999999876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=313.16 Aligned_cols=257 Identities=19% Similarity=0.231 Sum_probs=201.0
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEe---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE-
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKK---TNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ- 112 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~---~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~- 112 (473)
-.+.++|++++.||+|+||.||+|+.+ ..+++.||||++.+.. ....+.+.+|+++++.++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 345678999999999999999999852 2367899999998753 444567899999999999999999999886
Q ss_pred -eCCEEEEEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 113 -TSSCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 113 -~~~~l~lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
+...+|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~ 174 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-AHVKIADFGLA 174 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCGGGC
T ss_pred CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC-CCEEEcccccc
Confidence 56779999999999999999987 4569999999999999999999999999999999999999999 99999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhc------CCCCCh--
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVA------GSQIPT-- 255 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~------~~~~~~-- 255 (473)
+................||+.|+ |||.+. ..|+|++|++ +++++|..||....... ....+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWY---APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGS---CHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred eecccCCccceeeccCCcccccc---CHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence 87644333223333445777777 899653 4688999965 57999999987533210 011111
Q ss_pred hhHhh-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 256 STAAQ-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 256 ~~~~~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..... .....+..+..+++++.+||.+||+.||.+||+++|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000 1111122236899999999999999999999999998654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=313.31 Aligned_cols=249 Identities=16% Similarity=0.220 Sum_probs=189.4
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQL----YAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSL 111 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~----vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 111 (473)
.....++|++++.||+|+||+||+|+++. +++. ||+|.++... .....+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 86 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcC-CCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 34556889999999999999999998775 3443 5777776532 233456889999999999999999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
.+.. .++|+||+.+|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||++
T Consensus 87 ~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a 164 (327)
T 3poz_A 87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLA 164 (327)
T ss_dssp ESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTHH
T ss_pred ecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC-CCEEEccCcce
Confidence 8765 78999999999999999874 579999999999999999999999999999999999999999 99999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-h
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-L 261 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~ 261 (473)
+......... ......+|+.|+ |||.+. ..|+|++|++ +++++ |..||...... ........ .
T Consensus 165 ~~~~~~~~~~-~~~~~~~t~~y~---aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~~~~~ 236 (327)
T 3poz_A 165 KLLGAEEKEY-HAEGGKVPIKWM---ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEKGE 236 (327)
T ss_dssp HHHTTTCC--------CCCGGGS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHHTTC
T ss_pred eEccCCcccc-cccCCCcccccc---ChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH----HHHHHHHcCC
Confidence 9865433221 122234566776 899753 4688899965 56888 99999742110 00011111 1
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
....| ..++.++.+||.+||+.||.+||++.|+++|
T Consensus 237 ~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 237 RLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CCCCC---TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCCCC---ccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 12222 6789999999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=313.00 Aligned_cols=257 Identities=21% Similarity=0.323 Sum_probs=186.9
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
...+++|++++.||+|+||.||+|+++. +++.||||++.+... .....+.+..+..+++.++||||+++++++.+...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRK-TGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETT-TCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhccccccceeeecCCeeEEEEEEec-CCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 5567899999999999999999999876 578999999987642 12223334445556778899999999999999999
Q ss_pred EEEEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 117 VFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSH-GIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~-gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
+|+||||+ ++.+..++.. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||++....
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT-SCEEECCCTTC----
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC-CCEEEEECCCchhcc
Confidence 99999999 6677666654 56899999999999999999999995 99999999999999998 999999999998753
Q ss_pred CCccccccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhc
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQ 262 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 262 (473)
.... .....||+.|+ |||.+. ..|+|++|++ +++++|..||....... ...........
T Consensus 177 ~~~~----~~~~~~~~~y~---aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~ 247 (318)
T 2dyl_A 177 DDKA----KDRSAGCAAYM---APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVLTKVLQEEP 247 (318)
T ss_dssp --------------CCTTC---CHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHHHHSCC
T ss_pred CCcc----ccccCCCcccc---ChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHHHHHhccCC
Confidence 3221 22346788877 888763 3588899965 57999999996411000 00000011111
Q ss_pred cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 263 LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 263 ~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
..+|. ...+++++.+||.+||+.||.+||+++|+++||||++.+
T Consensus 248 ~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 248 PLLPG-HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp CCCCS-SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred CCCCc-cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 12222 135899999999999999999999999999999998654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=312.98 Aligned_cols=249 Identities=16% Similarity=0.146 Sum_probs=190.4
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS-- 115 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~-- 115 (473)
...++|+++++||+|+||+||+|++. ++.||||+++... .......+|+.+|+.++||||+++++++.+..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL---NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET---TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cchhhchhhheecccCceEEEEEEEC---CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 34578999999999999999999764 5899999997652 23345666888999999999999999998743
Q ss_pred --EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------CeeecCCCCcceEecCCCCcee
Q psy622 116 --CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH----------GIIHRDLKPDNMLISAQAPHCP 183 (473)
Q Consensus 116 --~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~----------gIiHRDLKpeNILld~~~g~ik 183 (473)
.+|+||||+++|+|.+++... .+++..++.++.||+.||+|||+. ||+||||||+|||++.+ +.+|
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~-~~~k 171 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTAC 171 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT-CCEE
T ss_pred CceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC-CeEE
Confidence 589999999999999999874 699999999999999999999999 99999999999999998 9999
Q ss_pred EeecchhhhhcCCccccccccccCCCCcccccCCcccccc-----------CCcCCCCcc-ccccCCCCCchhHhhhcCC
Q psy622 184 IVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS-----------LKTGTFPTF-QDVQNSQAPFPSALRVAGS 251 (473)
Q Consensus 184 L~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~-----------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~ 251 (473)
|+|||+++.+...... .......||+.|+ |||++.. .|+|++|++ +++++|..||.........
T Consensus 172 L~DFg~a~~~~~~~~~-~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 172 IADFGLALKFEAGKSA-GDTHGQVGTRRYM---APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp ECCCTTCEEECTTSCC-CCCTTCCCCGGGC---CHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred EccCCcccccccccCc-cccccCccCcccc---CHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 9999999875433221 1123356888888 9997653 388999965 6799999998652111000
Q ss_pred CC--------ChhhHhh---hccCCCCcc-----ccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 252 QI--------PTSTAAQ---LQLEWPEDE-----EALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 252 ~~--------~~~~~~~---~~~~~P~~~-----~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.. ....... .....|... ...++++.+||.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00 0000000 011111110 122355999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=305.64 Aligned_cols=248 Identities=19% Similarity=0.267 Sum_probs=186.1
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTN--KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~--~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
.+..++|++.+.||+|+||.||+|++..+ .+..||+|+++... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 34467899999999999999999987652 34679999987642 3445668899999999999999999999984 5
Q ss_pred CEEEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
+.+|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYM 166 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC-------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC-CCEEECcccccccc
Confidence 67899999999999999998754 69999999999999999999999999999999999999998 99999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLE 264 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~ 264 (473)
...... ......+++.|+ |||.+. ..|+|++|++ +++++ |..||...... . ....+.. ....
T Consensus 167 ~~~~~~--~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~-~~~~i~~~~~~~ 237 (281)
T 1mp8_A 167 EDSTYY--KASKGKLPIKWM---APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---D-VIGRIENGERLP 237 (281)
T ss_dssp --------------CCGGGC---CHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---G-HHHHHHTTCCCC
T ss_pred Cccccc--ccccCCCccccc---ChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---H-HHHHHHcCCCCC
Confidence 432211 122234666776 898754 3688899965 56775 89999752110 0 0011111 1122
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.| ..+++++.+||.+||+.||.+||++.|++++
T Consensus 238 ~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 238 MP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 23 6789999999999999999999999998863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=313.13 Aligned_cols=262 Identities=16% Similarity=0.221 Sum_probs=202.1
Q ss_pred ccccccccccCCCCCCCCeEEEceecccCceEEEEEEEeC------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHh
Q psy622 25 NSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKT------NKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL 98 (473)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~ 98 (473)
.+...+.....-.+..++|++.+.||+|+||+||+|++.. .+++.||||+++... .......+.+|+++++.
T Consensus 19 ~s~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~ 96 (334)
T 2pvf_A 19 VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKM 96 (334)
T ss_dssp ----CCCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHH
T ss_pred cccccCCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHH
Confidence 3444445444455566899999999999999999998752 245789999998653 34456789999999999
Q ss_pred c-CCCCeeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHC
Q psy622 99 T-HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG----------------ALPEDMAAFYAAEVVLALQYLHSH 161 (473)
Q Consensus 99 l-~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~----------------~~~e~~~~~~~~qI~~aL~yLH~~ 161 (473)
+ +||||+++++++.+.+.+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++
T Consensus 97 l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 176 (334)
T 2pvf_A 97 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176 (334)
T ss_dssp HCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9 99999999999999999999999999999999998754 389999999999999999999999
Q ss_pred CeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-cc
Q psy622 162 GIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QD 234 (473)
Q Consensus 162 gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~ 234 (473)
||+||||||+|||++.+ +.+||+|||+++........ .......+|+.|+ |||++. ..|+|++|++ ++
T Consensus 177 ~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~e 251 (334)
T 2pvf_A 177 KCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYY-KKTTNGRLPVKWM---APEALFDRVYTHQSDVWSFGVLMWE 251 (334)
T ss_dssp TEECSCCSGGGEEECTT-CCEEECCCTTCEECTTTSSE-ECCSCCCCCGGGC---CHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred CeeCCCCccceEEEcCC-CCEEEccccccccccccccc-cccCCCCccccee---ChHHhcCCCcChHHHHHHHHHHHHH
Confidence 99999999999999998 99999999999875432211 1122234666676 899653 4688999965 56
Q ss_pred ccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 235 VQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 235 ~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
+++ |..||....... + ...... .....| ..+++++.+||.+||+.||.+||++.|++++
T Consensus 252 llt~g~~p~~~~~~~~---~-~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 252 IFTLGGSPYPGIPVEE---L-FKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHTTSCCSSTTCCHHH---H-HHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCcCcCCHHH---H-HHHHhcCCCCCCC---ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 887 999997521100 0 001111 112223 5789999999999999999999999998864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=307.28 Aligned_cols=246 Identities=19% Similarity=0.287 Sum_probs=197.8
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
.+..++|++.+.||+|+||.||+|+++. +++.||+|+++... ...+.+.+|+++++.++||||+++++++.+...
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGG-GTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccccceeEEeecCCCCceeEEEeEecC-CCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3456789999999999999999999886 57899999998652 345678999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 117 VFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG-GCEEECCCCGGGTSC
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC-CCEEEccCccceecc
Confidence 99999999999999999874 359999999999999999999999999999999999999998 899999999998754
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
.... .......+|+.|+ |||.+. ..|+|++|++ +++++ |..||...... ..............|
T Consensus 163 ~~~~--~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~~~~~~~~~~ 234 (288)
T 3kfa_A 163 GDTY--TAHAGAKFPIKWT---APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEKDYRMERP 234 (288)
T ss_dssp SSSS--EEETTEEECGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHHTTCCCCCC
T ss_pred CCcc--ccccCCccccCcC---ChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhccCCCCCC
Confidence 3221 1122234566666 888754 4678899965 56888 89999752110 000000111122223
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+++++.+||.+||+.||.+||+++|+++
T Consensus 235 ---~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 235 ---EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 678999999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=305.48 Aligned_cols=251 Identities=17% Similarity=0.217 Sum_probs=195.1
Q ss_pred CCCCCCeEEEc-eecccCceEEEEEEEeC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 37 APEISDFEIVK-AISRGAFGKVFLGYKKT-NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 37 ~~~~~~y~i~~-~LG~G~fG~V~~a~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
....++|++.+ .||+|+||.||+|.... .+++.||||+++... ......+.+.+|+++++.++||||+++++++ ..
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 34457899998 99999999999996542 246889999998753 2233466899999999999999999999999 56
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
..+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALR 168 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC-CcEEEccCCcceeec
Confidence 7789999999999999999998889999999999999999999999999999999999999999 999999999998764
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
.............+++.|+ |||.+. ..|.|++|++ +++++ |..||....... + ...+. ....+
T Consensus 169 ~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~-~~~~~--~~~~~ 239 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWY---APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V-TAMLE--KGERM 239 (291)
T ss_dssp TTCSEEEC----CCCGGGC---CHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H-HHHHH--TTCCC
T ss_pred cCCCcccccccCCCCceee---ChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---H-HHHHH--cCCCC
Confidence 3332222222334566676 898753 4688999965 56888 999997521100 0 00111 11122
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+..+++++.++|.+||+.||.+||++.++++
T Consensus 240 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 223678999999999999999999999998874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=309.30 Aligned_cols=249 Identities=17% Similarity=0.243 Sum_probs=198.2
Q ss_pred CCCCCeEEEceecccCceEEEEEEEe----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKK----TNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQ 112 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~----~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~ 112 (473)
...++|++.+.||+|+||.||+|++. ..+++.||+|+++... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 44578999999999999999999863 3356889999998653 234456899999999999 9999999999999
Q ss_pred eCCEEEEEecccCcCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceE
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAANG------------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNML 174 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~~------------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNIL 174 (473)
+.+..|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 9999999999999999999998754 4899999999999999999999999999999999999
Q ss_pred ecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHh
Q psy622 175 ISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSAL 246 (473)
Q Consensus 175 ld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~ 246 (473)
++.+ +.+||+|||+++........ .......+|+.|+ |||.+. ..|+|++|++ +++++ |..||....
T Consensus 178 ~~~~-~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 178 LTHG-RITKICDFGLARDIKNDSNY-VVKGNARLPVKWM---APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EETT-TEEEECCCGGGSCTTSCTTS-EECSSSEECGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EcCC-CCEEEccccccccccccccc-eeccCCCCcceee---ChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9998 99999999999876433221 1222334566666 898653 3678899965 56887 999996421
Q ss_pred hhcCCCCChhh--HhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 247 RVAGSQIPTST--AAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 247 ~~~~~~~~~~~--~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..... ........ ..+..+++++.+||.+||+.||.+||+++|++++
T Consensus 253 ------~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 ------VDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp ------SSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------chhHHHHHhccCCCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 11111 11111111 1125789999999999999999999999998864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=307.42 Aligned_cols=258 Identities=16% Similarity=0.212 Sum_probs=201.7
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~ 116 (473)
+..++|++.+.||+|+||+||+|++.. +++.||||++..... ...+.+|+.+++.+ +|++|+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECC-CCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 345789999999999999999998876 679999999876532 23577899999999 89999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCc-----eeEeecchh
Q psy622 117 VFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH-----CPIVNTLFL 190 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~-----ikL~DFGla 190 (473)
.|+||||+ ||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +. +||+|||++
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP-NSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCS-SSTTTTCEEECCCTTC
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccC-CCCCCCeEEEEECccc
Confidence 99999999 999999999754 69999999999999999999999999999999999999876 55 999999999
Q ss_pred hhhcCCcccc----ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChh---
Q psy622 191 AILQQPIVYL----EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTS--- 256 (473)
Q Consensus 191 ~~~~~~~~~~----~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~--- 256 (473)
+......... .......||+.|+ |||.+. ..|+|++|++ +++++|..||..... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~~~ 231 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYM---SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA----ATNKQKYE 231 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTC---CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS----CCHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccC---CchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc----cccHHHHH
Confidence 8764332211 1123456888888 898754 3578899965 579999999975210 00000
Q ss_pred hHhh--hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc----------CCCCCCCCccc
Q psy622 257 TAAQ--LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR----------LPMFKDYDWDS 310 (473)
Q Consensus 257 ~~~~--~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~----------HPFF~~idw~~ 310 (473)
.+.. .....+.....+++++.+||.+||+.||.+||++++|++ ......+||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 232 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred HHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 0111 111112122468999999999999999999999877653 45566677764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=310.77 Aligned_cols=252 Identities=17% Similarity=0.204 Sum_probs=196.1
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ---- 112 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~---- 112 (473)
.+..++|++++.||+|+||.||+|+++. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLH-DGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETT-TCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecC-CCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence 3445789999999999999999998876 57899999997642 445668899999999999999999999986
Q ss_pred eCCEEEEEecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecc
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
....+|+||||+++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~dfg 179 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVLMDLG 179 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCS
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC-CCEEEEecC
Confidence 34579999999999999999986 4679999999999999999999999999999999999999998 999999999
Q ss_pred hhhhhcCCcccc------ccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCC
Q psy622 189 FLAILQQPIVYL------EISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQ 252 (473)
Q Consensus 189 la~~~~~~~~~~------~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~ 252 (473)
++.......... .......||+.|+ |||.+. ..|+|++|++ +++++|..||....... .
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~ 254 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYR---APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG--D 254 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGC---CGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT--S
T ss_pred cchhcccccccccccccccccccccCCcccC---CHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc--c
Confidence 987642111100 0011234677777 888653 4678899965 57999999997643211 1
Q ss_pred CChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 253 IPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 253 ~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
...........+|. ...+++++.+||.+||+.||.+||+++|+++|
T Consensus 255 -~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 255 -SVALAVQNQLSIPQ-SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -CHHHHHHCC--CCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -hhhHHhhccCCCCc-cccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 11111111222332 25789999999999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=317.46 Aligned_cols=270 Identities=14% Similarity=0.143 Sum_probs=195.6
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCC----CCcEEEEEEeecccccchhH--------HHHHHHHHHHHHhcCCCCee
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTN----KDQLYAIKVMKKDEMINKNM--------VSQVLRERNALALTHSPFCV 105 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~----~~~~vAiK~l~k~~~~~~~~--------~~~~~~E~~iL~~l~hp~Iv 105 (473)
...++|++.+.||+|+||.||+|+++.+ .++.||||++.......... ......|...+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4456899999999999999999988763 25789999998753111111 11234556667778899999
Q ss_pred eEEEEEEeC----CEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec--CC
Q psy622 106 QLFYSLQTS----SCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS--AQ 178 (473)
Q Consensus 106 ~l~~~f~~~----~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld--~~ 178 (473)
++++++... ..+|+||||+ ||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998764 5699999999 99999999876 5899999999999999999999999999999999999999 77
Q ss_pred CCceeEeecchhhhhcCCcccc----ccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCCchhHhh
Q psy622 179 APHCPIVNTLFLAILQQPIVYL----EISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAPFPSALR 247 (473)
Q Consensus 179 ~g~ikL~DFGla~~~~~~~~~~----~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~pf~~~~~ 247 (473)
+.+||+|||+++.+....... ......+||+.|+ |||.+.. .|+|++|++ +++++|..||.....
T Consensus 191 -~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 191 -DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT---SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp -TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTC---CHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred -CeEEEEECCcceecccCCcccccccCcccccCCCCCcc---CHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 899999999998754322111 1113345888888 8997654 478899965 679999999985311
Q ss_pred hcCC------CCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc----------CCCCCCCCcccc
Q psy622 248 VAGS------QIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR----------LPMFKDYDWDSI 311 (473)
Q Consensus 248 ~~~~------~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~----------HPFF~~idw~~l 311 (473)
.... .............++. ..+++++.+||.+||+.||.+||++++|++ .++-..+||...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 344 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPA--ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVV 344 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCT--TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC---
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhccc--ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEec
Confidence 0000 0000000000111121 467899999999999999999999877653 467777888866
Q ss_pred ccC
Q psy622 312 LDQ 314 (473)
Q Consensus 312 ~~~ 314 (473)
.+.
T Consensus 345 ~~~ 347 (364)
T 3op5_A 345 ENG 347 (364)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=306.33 Aligned_cols=252 Identities=19% Similarity=0.301 Sum_probs=191.2
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
....+++|++.+.||+|+||.||+|+++. +++.||+|+++............+.+|+.+++.++||||+++++++.+.+
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLL-DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETT-TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcC-CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34457899999999999999999998876 57899999998765555666778999999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 116 CVFLVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
.+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++.
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGR 184 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCC----
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC-CCEEEEecccee
Confidence 99999999999999999975 4579999999999999999999999999999999999999998 999999999998
Q ss_pred hhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccC
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 264 (473)
....... ......|++.|+ |||.+. ..|.|++|++ +++++|..||..... .............
T Consensus 185 ~~~~~~~---~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~ 254 (310)
T 2wqm_A 185 FFSSKTT---AAHSLVGTPYYM---SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCD 254 (310)
T ss_dssp -----------------CCSSC---CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHHTTC
T ss_pred eecCCCc---cccccCCCeeEe---ChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhhccc
Confidence 7533211 122346777777 888653 3578899965 579999999964210 0000000001112
Q ss_pred CCCc-cccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 265 WPED-EEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 265 ~P~~-~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
++.. ...+++++.+||.+||+.||.+||++.++++
T Consensus 255 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2211 1568999999999999999999999999886
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=303.40 Aligned_cols=250 Identities=19% Similarity=0.225 Sum_probs=197.0
Q ss_pred CCCCCeEEEc-eecccCceEEEEEEEeC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 38 PEISDFEIVK-AISRGAFGKVFLGYKKT-NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 38 ~~~~~y~i~~-~LG~G~fG~V~~a~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
...++|.+.+ .||+|+||.||+|..+. .+++.||+|+++... .....+.+.+|+++++.++||||++++++++ .+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC
Confidence 3456788887 99999999999997642 256789999998752 3455678999999999999999999999994 56
Q ss_pred EEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 116 CVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
.+|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||+++...
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALG 161 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC-CCEEECcccceeeec
Confidence 699999999999999999754 469999999999999999999999999999999999999998 999999999998764
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
.............+|+.|+ |||.+. ..|+|++|++ +++++ |..||...... .....+. ....+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~i~--~~~~~ 232 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWY---APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFIE--QGKRM 232 (287)
T ss_dssp TCSCEECCCCSSCCCGGGC---CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHHHHH--TTCCC
T ss_pred cCcceeecccccccccccc---CHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHh--cCCcC
Confidence 3332222223345677777 898754 4688899965 56887 99999642110 0001111 11112
Q ss_pred CccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..+..+++++.+||.+||+.||.+||++.|+++|
T Consensus 233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 233 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2236899999999999999999999999999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=326.29 Aligned_cols=248 Identities=21% Similarity=0.240 Sum_probs=183.2
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~l 119 (473)
+.|.+.++||+|+||+||.+.. . +|+.||||++.... .+.+.+|+.+|..+ +||||+++++++++.+.+|+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~-~-~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS-F-QGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE-S-SSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEE-E-CCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 4566778999999999987643 3 47899999987642 34678899999876 89999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC------------CC
Q psy622 120 VMEYMIGGDVKSLIAANGAL-------PEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ------------AP 180 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~-------~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~------------~g 180 (473)
||||| +|+|.+++...+.. ++..++.++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 87 v~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 99999 56999999876433 233457799999999999999999999999999999754 14
Q ss_pred ceeEeecchhhhhcCCcccc-ccccccCCCCcccccCCcccccc-------------CCcCCCCcc-ccccC-CCCCchh
Q psy622 181 HCPIVNTLFLAILQQPIVYL-EISDLVNGTPNAFNIRTPGQLLS-------------LKTGTFPTF-QDVQN-SQAPFPS 244 (473)
Q Consensus 181 ~ikL~DFGla~~~~~~~~~~-~~~~~~~gtp~y~~~~ape~i~~-------------~~~~s~g~l-~~~~~-g~~pf~~ 244 (473)
++||+|||+++.+....... ......+||+.|+ |||++.. .|+|++|++ +++++ |..||..
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWR---APELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTS---CHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCcc---CHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 89999999999764432211 1123457898888 8997643 678899965 56887 8999964
Q ss_pred HhhhcCCCCChhhHhhhccCCCCc----cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 245 ALRVAGSQIPTSTAAQLQLEWPED----EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~P~~----~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.... ...+......++.. ...+++++++||.+||+.||.+|||+.|+++||||...
T Consensus 243 ~~~~------~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 243 KYSR------ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp TTTH------HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred chhh------HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 2110 11111112222211 12456889999999999999999999999999999653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=309.78 Aligned_cols=254 Identities=15% Similarity=0.200 Sum_probs=192.2
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNK---DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSL 111 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~---~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 111 (473)
...+..++|++.+.||+|+||.||+|+.+.+. +..||+|+++... .......+.+|+.+++.++||||+++++++
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34566789999999999999999999877532 2469999998653 344456789999999999999999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
.+.+.+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~ 194 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLS 194 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC-
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC-CcEEECCCCcc
Confidence 9999999999999999999999875 579999999999999999999999999999999999999998 99999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhc
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQ 262 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 262 (473)
+................+|+.|+ |||.+. ..|+|++|++ +++++ |..||....... + ...+.. .
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~-~~~~~~-~ 266 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWT---APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---V-MKAIND-G 266 (333)
T ss_dssp ----------------CCCGGGS---CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H-HHHHHT-T
T ss_pred hhhccccccccccCCCCcccccc---CchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---H-HHHHHC-C
Confidence 87643222111112223455666 888754 3678899965 56777 999996421100 0 001111 1
Q ss_pred cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 263 LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 263 ~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
...+ .+..+++++.+||.+||+.||.+||++.|++++
T Consensus 267 ~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 267 FRLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CCCC-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111 225789999999999999999999999988864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=307.41 Aligned_cols=245 Identities=18% Similarity=0.254 Sum_probs=187.6
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCCeeeEEEEEEe--
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL--THSPFCVQLFYSLQT-- 113 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~f~~-- 113 (473)
.-.++|++++.||+|+||+||+|++ +++.||||++.... .....+|.+++.. ++||||+++++++.+
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE---CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 3457899999999999999999976 36889999987642 3456677787776 799999999998654
Q ss_pred --CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCeeecCCCCcceEecCCCCcee
Q psy622 114 --SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH--------SHGIIHRDLKPDNMLISAQAPHCP 183 (473)
Q Consensus 114 --~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH--------~~gIiHRDLKpeNILld~~~g~ik 183 (473)
...+|+||||+++|+|.++++. +.+++..+..++.||+.||+||| ++||+||||||+|||++.+ +.+|
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~-~~~k 153 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCC 153 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT-SCEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC-CCEE
Confidence 3569999999999999999964 57999999999999999999999 9999999999999999998 9999
Q ss_pred EeecchhhhhcCCccccc-cccccCCCCcccccCCccccc------------cCCcCCCCcc-ccccCC----------C
Q psy622 184 IVNTLFLAILQQPIVYLE-ISDLVNGTPNAFNIRTPGQLL------------SLKTGTFPTF-QDVQNS----------Q 239 (473)
Q Consensus 184 L~DFGla~~~~~~~~~~~-~~~~~~gtp~y~~~~ape~i~------------~~~~~s~g~l-~~~~~g----------~ 239 (473)
|+|||+++.......... ......||+.|+ |||.+. ..|+|++|++ +++++| .
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYM---APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGC---CHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EeeCCCeeeccccccccccccccccccccee---ChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 999999986543322211 123347888888 899764 3588999965 579998 7
Q ss_pred CCchhHhhhcCCCCChhhHhh------hccCCCCc--cccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 240 APFPSALRVAGSQIPTSTAAQ------LQLEWPED--EEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 240 ~pf~~~~~~~~~~~~~~~~~~------~~~~~P~~--~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.||...... ......... .....|.. ....++++.+||.+||+.||.+|||++|+++
T Consensus 231 ~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 231 PPFYDVVPN---DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CTTTTTSCS---SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccccCCC---CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 888642110 111111110 11112210 1235578999999999999999999999885
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.46 Aligned_cols=250 Identities=18% Similarity=0.229 Sum_probs=194.8
Q ss_pred cCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEE
Q psy622 34 CLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQL--YAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYS 110 (473)
Q Consensus 34 ~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~--vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 110 (473)
..+....++|++.+.||+|+||.||+|+++. +++. +|+|+++... .....+.+.+|+.+++.+ +||||++++++
T Consensus 18 ~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 94 (327)
T 1fvr_A 18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGA 94 (327)
T ss_dssp CSSBCCGGGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred ccccccHHHccceeeeecCCCceEEEEEEcc-CCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence 3456677899999999999999999999876 4554 4999987542 233455789999999999 99999999999
Q ss_pred EEeCCEEEEEecccCcCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceE
Q psy622 111 LQTSSCVFLVMEYMIGGDVKSLIAANG----------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNML 174 (473)
Q Consensus 111 f~~~~~l~lVmEy~~gg~L~~~L~~~~----------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNIL 174 (473)
+.+.+.+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl 174 (327)
T 1fvr_A 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 174 (327)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEE
Confidence 999999999999999999999998754 6999999999999999999999999999999999999
Q ss_pred ecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHh
Q psy622 175 ISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSAL 246 (473)
Q Consensus 175 ld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~ 246 (473)
++.+ +.+||+|||+++..... .......+++.|+ |||.+. ..|+|++|++ +++++ |..||....
T Consensus 175 ~~~~-~~~kL~Dfg~~~~~~~~----~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 175 VGEN-YVAKIADFGLSRGQEVY----VKKTMGRLPVRWM---AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp ECGG-GCEEECCTTCEESSCEE----CCC----CCTTTC---CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EcCC-CeEEEcccCcCcccccc----ccccCCCCCcccc---ChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 9998 89999999999753211 1112234666676 888653 4688999965 56887 999996521
Q ss_pred hhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 247 RVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
... .............| ..+++++.+||.+||+.||.+||+++|+++|
T Consensus 247 ~~~---~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 247 CAE---LYEKLPQGYRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHH---HHHHGGGTCCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHH---HHHHhhcCCCCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 100 00000000112223 5789999999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=313.96 Aligned_cols=244 Identities=19% Similarity=0.284 Sum_probs=186.0
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc--CCCCeeeEEEEEEeC---
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT--HSPFCVQLFYSLQTS--- 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~~~f~~~--- 114 (473)
.++|++++.||+|+||.||+|+++ ++.||||++.... .....+|.+++... +||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC---CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 478999999999999999999764 5899999987542 23456666776654 899999999999887
Q ss_pred -CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CeeecCCCCcceEecCCCCceeEe
Q psy622 115 -SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH--------GIIHRDLKPDNMLISAQAPHCPIV 185 (473)
Q Consensus 115 -~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~--------gIiHRDLKpeNILld~~~g~ikL~ 185 (473)
..+|+||||++||+|.+++++. .+++..++.++.||+.||+|||++ ||+||||||+|||++.+ +.+||+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kl~ 184 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIA 184 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-SCEEEC
T ss_pred CCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-CCEEEE
Confidence 7899999999999999999765 799999999999999999999999 99999999999999998 999999
Q ss_pred ecchhhhhcCCccccc-cccccCCCCcccccCCcccccc------------CCcCCCCcc-ccccCC----------CCC
Q psy622 186 NTLFLAILQQPIVYLE-ISDLVNGTPNAFNIRTPGQLLS------------LKTGTFPTF-QDVQNS----------QAP 241 (473)
Q Consensus 186 DFGla~~~~~~~~~~~-~~~~~~gtp~y~~~~ape~i~~------------~~~~s~g~l-~~~~~g----------~~p 241 (473)
|||+++.+........ .....+||+.|+ |||++.. .|+|++|++ ++|++| ..|
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYM---PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGC---CHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred eCCCceeeccccccccCCCCCCccCccee---ChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 9999976543222111 122457888888 8997642 589999965 579999 566
Q ss_pred chhHhhhcCCCCChhhHhh------hccCCCCc--cccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 242 FPSALRVAGSQIPTSTAAQ------LQLEWPED--EEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 242 f~~~~~~~~~~~~~~~~~~------~~~~~P~~--~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
|..... .......... ....+|.. ...+++++.+||.+||+.||.+||++.|+++|
T Consensus 262 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 262 YHDLVP---SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTSC---SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhhcC---CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 643211 0000000000 11122210 12456779999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=301.86 Aligned_cols=246 Identities=20% Similarity=0.287 Sum_probs=185.2
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN-KNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
++..++|++.+.||+|+||.||+|++. ++.||+|++++..... ....+.+.+|+++++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET---TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc---CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 456789999999999999999999864 5789999998754322 233567899999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCCcceEecC--------CCCceeE
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG---IIHRDLKPDNMLISA--------QAPHCPI 184 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~g---IiHRDLKpeNILld~--------~~g~ikL 184 (473)
.+|+||||++||+|.+++. .+.+++..++.++.||+.||+|||++| |+||||||+|||++. + +.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~-~~~kl 157 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN-KILKI 157 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS-CCEEE
T ss_pred ceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC-cceEE
Confidence 9999999999999999986 458999999999999999999999999 999999999999986 4 78999
Q ss_pred eecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhh
Q psy622 185 VNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTST 257 (473)
Q Consensus 185 ~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~ 257 (473)
+|||+++....... ....||+.|+ |||.+. ..|.|++|++ +++++|..||....... ....
T Consensus 158 ~Dfg~~~~~~~~~~-----~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~ 225 (271)
T 3dtc_A 158 TDFGLAREWHRTTK-----MSAAGAYAWM---APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA----VAYG 225 (271)
T ss_dssp CCCCC------------------CCGGGS---CHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH----HHHH
T ss_pred ccCCcccccccccc-----cCCCCcccee---CHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHh
Confidence 99999987543221 1346888887 898653 3578899965 57999999997521100 0000
Q ss_pred HhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 258 AAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 258 ~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
....... +..+..+++++.+||.+||+.||.+||++.|+++|
T Consensus 226 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 226 VAMNKLA-LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHTSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcCCCC-CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0111111 11226789999999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.94 Aligned_cols=251 Identities=19% Similarity=0.240 Sum_probs=186.5
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
+....++|++.+.||+|+||.||+|+.+. .+++.||||+++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 45556789999999999999999998762 245679999998653 34456689999999999999999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
...+|+||||++||+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN-LVCKVSDFGLGRV 196 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-----
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC-CCEEECcCccccc
Confidence 999999999999999999998754 79999999999999999999999999999999999999999 9999999999987
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hcc
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQL 263 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~ 263 (473)
...............+++.|+ |||++. ..|+|++|++ +++++ |..||....... + ...+.. ...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~-~~~i~~~~~~ 269 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWT---SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---V-IKAVDEGYRL 269 (373)
T ss_dssp -----------------CTTS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---H-HHHHHTTEEC
T ss_pred cccCCccceeccCCCcCCCcc---ChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---H-HHHHHcCCCC
Confidence 643221111111123455566 898754 3688899965 56676 999996421100 0 001111 112
Q ss_pred CCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+ ..++.++.+||.+||+.||.+||++.|+++
T Consensus 270 ~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 270 PPP---MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CCC---TTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC---ccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 222 578899999999999999999999988875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=302.67 Aligned_cols=243 Identities=15% Similarity=0.223 Sum_probs=197.4
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS- 114 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~- 114 (473)
..+..++|++.+.||+|+||.||+|+++ ++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET---TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC---CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 4567889999999999999999999874 57899999987642 334456799999999999999999999999887
Q ss_pred -CEEEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCCcceEecCCCCceeEeecch
Q psy622 115 -SCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHG--IIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 115 -~~l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~g--IiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
..+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~ 159 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADV 159 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGS
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEeccc
Confidence 78999999999999999999765 4899999999999999999999999 9999999999999998 8999999988
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA 259 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~ 259 (473)
+..... ....||+.|+ |||.+. ..|.|++|++ +++++|..||....... . .....
T Consensus 160 ~~~~~~--------~~~~~t~~y~---aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~-~~~~~ 224 (271)
T 3kmu_A 160 KFSFQS--------PGRMYAPAWV---APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---I-GMKVA 224 (271)
T ss_dssp CCTTSC--------TTCBSCGGGS---CHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---H-HHHHH
T ss_pred eeeecc--------cCccCCcccc---ChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---H-HHHHH
Confidence 765322 1236788877 898754 3688999965 57999999997421100 0 00000
Q ss_pred hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 260 QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 260 ~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.....+..+..+++++.+||.+||+.||.+||+++|+++
T Consensus 225 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 225 -LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011112223679999999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=306.46 Aligned_cols=252 Identities=16% Similarity=0.184 Sum_probs=195.7
Q ss_pred CCeEEEceecccCceEEEEEEEeC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CC
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKT---NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT--SS 115 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~---~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~~ 115 (473)
+.|++++.||+|+||+||+|+.+. .+++.||||++++.. .....+.+.+|+++|+.++||||+++++++.+ ..
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 345999999999999999986432 257899999998753 34456789999999999999999999999987 47
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+||||+++|+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECCT
T ss_pred eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC-CCEEECCccccccccc
Confidence 899999999999999999875 59999999999999999999999999999999999999999 9999999999987654
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhh----cCCCCChh----hHhh
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRV----AGSQIPTS----TAAQ 260 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~----~~~~~~~~----~~~~ 260 (473)
............+|+.|+ |||.+. ..|+|++|++ +++++|..||...... ........ ....
T Consensus 187 ~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWY---APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp TCSEEEC---CCCCGGGC---CHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccCCCCCceee---ChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 333223333445777777 898754 3588999965 5799999998753211 00000000 0000
Q ss_pred -hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 261 -LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 261 -~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.....+..+..+++++.+||.+||+.||.+||+++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111112223678999999999999999999999999884
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=308.78 Aligned_cols=246 Identities=18% Similarity=0.273 Sum_probs=196.5
Q ss_pred CCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQT 113 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~ 113 (473)
..++|++.+.||+|+||.||+|++.. .+++.||||++++.. .......+.+|+.++..+ +||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 35789999999999999999998642 356899999998753 234456789999999999 79999999999876
Q ss_pred CC-EEEEEecccCcCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec
Q psy622 114 SS-CVFLVMEYMIGGDVKSLIAANGA----------------LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS 176 (473)
Q Consensus 114 ~~-~l~lVmEy~~gg~L~~~L~~~~~----------------~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld 176 (473)
.+ .+|+||||++||+|.+++...+. +++..++.++.||+.||+|||++||+||||||+||+++
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 54 59999999999999999987653 89999999999999999999999999999999999999
Q ss_pred CCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhh
Q psy622 177 AQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRV 248 (473)
Q Consensus 177 ~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~ 248 (473)
.+ +.+||+|||+++........ .......||+.|+ |||++. ..|+|++|++ +++++ |..||....
T Consensus 183 ~~-~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-- 255 (316)
T 2xir_A 183 EK-NVVKICDFGLARDIYKDPDY-VRKGDARLPLKWM---APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-- 255 (316)
T ss_dssp GG-GCEEECCCGGGSCTTTCTTS-EEETTEEECGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred CC-CCEEECCCccccccccCccc-eeccCCCcceeec---CchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc--
Confidence 98 99999999999875432221 1122345677777 898653 4688899965 56887 999996421
Q ss_pred cCCCCChhh---Hh-hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 249 AGSQIPTST---AA-QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 249 ~~~~~~~~~---~~-~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..... .. ......| ..+++++.++|.+||+.||.+||++.|+++|
T Consensus 256 ----~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 256 ----IDEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp ----CSHHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----hhHHHHHHhccCccCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11111 11 1122233 5789999999999999999999999999876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=312.07 Aligned_cols=260 Identities=18% Similarity=0.202 Sum_probs=199.1
Q ss_pred ccCCCCCCCCeEEEceecccCceEEEEEEEe----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEE
Q psy622 33 SCLKAPEISDFEIVKAISRGAFGKVFLGYKK----TNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLF 108 (473)
Q Consensus 33 ~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~----~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 108 (473)
+..+.+..++|++++.||+|+||.||+|+.. ..+++.||||++.... .......+.+|+.+++.++||||++++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 22 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp GGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence 4456677789999999999999999999832 1256789999997542 344456889999999999999999999
Q ss_pred EEEEeCCEEEEEecccCcCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC--C
Q psy622 109 YSLQTSSCVFLVMEYMIGGDVKSLIAANG-------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ--A 179 (473)
Q Consensus 109 ~~f~~~~~l~lVmEy~~gg~L~~~L~~~~-------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~--~ 179 (473)
+++.+...+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+ .
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence 99999999999999999999999998753 48999999999999999999999999999999999999954 1
Q ss_pred CceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCC
Q psy622 180 PHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGS 251 (473)
Q Consensus 180 g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~ 251 (473)
..+||+|||+++........ .......||+.|+ |||.+. ..|+|++|++ +++++ |..||.......
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 253 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYY-RKGGCAMLPVKWM---PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-- 253 (327)
T ss_dssp CCEEECCCHHHHHHHC-------CCGGGSCGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred ceEEECcccccccccccccc-ccCCCcCCCccee---CHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--
Confidence 56999999999875432221 1122345677777 888653 4678899965 56887 899996421100
Q ss_pred CCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 252 QIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 252 ~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
+ ...+. ....+..+..+++++.+||.+||+.||.+||++.|+++|.++-
T Consensus 254 -~-~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 254 -V-LEFVT--SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp -H-HHHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -H-HHHHh--cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0 00111 1111222367899999999999999999999999999997763
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=320.33 Aligned_cols=247 Identities=19% Similarity=0.226 Sum_probs=193.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--EE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS--CV 117 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~--~l 117 (473)
.++|++.++||+|+||+||+|+++. +++.||||++++.... ...+.+.+|+++|+.++||||+++++++.... .+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 4679999999999999999999886 6789999999875432 23567789999999999999999999998755 78
Q ss_pred EEEecccCcCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe----cCCCCceeEeecchh
Q psy622 118 FLVMEYMIGGDVKSLIAANG---ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI----SAQAPHCPIVNTLFL 190 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~---~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILl----d~~~g~ikL~DFGla 190 (473)
|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+ +.+ +.+||+|||++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~DFG~a 163 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAA 163 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSC-EEEEECCGGGC
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCc-eeEEEecCCCc
Confidence 99999999999999998643 39999999999999999999999999999999999999 666 78999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc--------------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL--------------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT 255 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~--------------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~ 255 (473)
+....... ....+||+.|+ |||++. ..|+|++|++ +++++|..||...... ....
T Consensus 164 ~~~~~~~~----~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~---~~~~ 233 (396)
T 4eut_A 164 RELEDDEQ----FVSLYGTEEYL---HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP---RRNK 233 (396)
T ss_dssp EECCCGGG----SSCSSSCCTTC---CHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT---TTCH
T ss_pred eEccCCCc----cccccCCcccc---CHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc---cchH
Confidence 87543221 22357888888 899753 3689999965 5799999999631100 0000
Q ss_pred hhHhh------------------hcc----CCC---CccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 256 STAAQ------------------LQL----EWP---EDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 256 ~~~~~------------------~~~----~~P---~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..... ... .+| .....+++.+.+||++||+.||++|++++|++++
T Consensus 234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 00000 000 111 1113456788999999999999999999988653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=330.49 Aligned_cols=244 Identities=19% Similarity=0.298 Sum_probs=196.4
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
..++|++.+.||+|+||.||+|+++. +++.||||+++.... ..+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGG-GTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcC-CCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 44679999999999999999999886 578999999987532 3567899999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 119 LVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+||||++||+|.++|.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-GCEEECCTTCEECCTTC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC-CcEEEeecccceeccCC
Confidence 999999999999999874 359999999999999999999999999999999999999998 99999999999875432
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
.. .......+++.|+ |||.+. ..|+|++|++ +++++ |..||...... .+............|
T Consensus 372 ~~--~~~~~~~~~~~y~---aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~~~~~-- 441 (495)
T 1opk_A 372 TY--TAHAGAKFPIKWT---APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEKDYRMERP-- 441 (495)
T ss_dssp CE--ECCTTCCCCGGGC---CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHHTTCCCCCC--
T ss_pred ce--eecCCCcCCccee---CHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCCCCC--
Confidence 21 1112223455566 999754 4688999976 56887 99999752110 000000111122233
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+++++.+||.+||+.||.+||++.+|++
T Consensus 442 -~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 442 -EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 678999999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=298.66 Aligned_cols=244 Identities=19% Similarity=0.260 Sum_probs=195.0
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+..++|++.+.||+|+||.||+|++.. ++.||+|++++... ..+.+.+|+++++.++||||+++++++.+.+.+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETT--TEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EchhheeeeeEecCCCceeEEEEEecC--CCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 345789999999999999999998763 57899999987643 235788999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+||||++||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG-GCEEECCTTGGGGBCCH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC-CCEEEcccccccccccc
Confidence 9999999999999999875 569999999999999999999999999999999999999998 99999999999875322
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPE 267 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~ 267 (473)
.. .......+++.|+ |||.+. ..|.|++|++ +++++ |..||....... . ...+.. .....|
T Consensus 158 ~~--~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~-~~~i~~~~~~~~~- 227 (267)
T 3t9t_A 158 QY--TSSTGTKFPVKWA---SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---V-VEDISTGFRLYKP- 227 (267)
T ss_dssp HH--HSTTSTTCCGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H-HHHHHTTCCCCCC-
T ss_pred cc--ccccccccccccc---ChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---H-HHHHhcCCcCCCC-
Confidence 11 1112234566666 888754 4678899965 56888 899996421100 0 001111 111222
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..+++++.+||.+||+.||.+||++.|++++
T Consensus 228 --~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 228 --RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --ccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5789999999999999999999999998864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=322.78 Aligned_cols=238 Identities=21% Similarity=0.357 Sum_probs=191.1
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS- 115 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~- 115 (473)
.+..++|++.+.||+|+||.||+|..+ ++.||||+++... ..+.+.+|+.+|+.++||||+++++++....
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~---~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET---TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec---CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 355688999999999999999999764 4789999998653 2457899999999999999999999986654
Q ss_pred EEEEEecccCcCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGA--LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~--~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
.+|+||||++||+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA 339 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-SCEEECCCTTCEEC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC-CCEEEeeCCCcccc
Confidence 79999999999999999987553 7999999999999999999999999999999999999998 99999999999863
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLE 264 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~ 264 (473)
... .....+++.|+ |||.+. ..|+|++|++ +++++ |..||..... ..+ ...+.. ....
T Consensus 340 ~~~------~~~~~~~~~y~---aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~-~~~i~~~~~~~ 406 (450)
T 1k9a_A 340 SST------QDTGKLPVKWT---APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDV-VPRVEKGYKMD 406 (450)
T ss_dssp C------------CCCTTTS---CHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT---TTH-HHHHHTTCCCC
T ss_pred ccc------ccCCCCCccee---CHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHH-HHHHHcCCCCC
Confidence 221 11235666676 898764 4678899965 56887 9999975211 011 111111 1223
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.| ..+++++.+||.+||+.||.+||++.++++
T Consensus 407 ~p---~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 407 AP---DGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 33 679999999999999999999999988764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=307.52 Aligned_cols=248 Identities=16% Similarity=0.212 Sum_probs=187.4
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeCCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQL----YAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSL 111 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~----vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 111 (473)
.....++|++++.||+|+||+||+|+++. +++. ||+|.+.... .....+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECC-TTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred cccCHhHceEEEEeeeCCCeEEEEEEEcC-CCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 34567899999999999999999999876 3454 4666665432 233456889999999999999999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
.+.. .++|+||+.+|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kL~DfG~a 164 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLA 164 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTC-
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC-CCEEEccCcce
Confidence 8765 88999999999999999874 579999999999999999999999999999999999999998 99999999999
Q ss_pred hhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-h
Q psy622 191 AILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-L 261 (473)
Q Consensus 191 ~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~ 261 (473)
+......... ......+|+.|+ |||.+. ..|+|++|++ +++++ |..||....... ....... .
T Consensus 165 ~~~~~~~~~~-~~~~~~~t~~y~---aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~~~~~~ 236 (327)
T 3lzb_A 165 KLLGAEEKEY-HAEGGKVPIKWM---ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGE 236 (327)
T ss_dssp ----------------CCCGGGS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHHTTC
T ss_pred eEccCccccc-cccCCCcccccc---CHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHHHHcCC
Confidence 8764332221 112234566666 898653 4688899965 56888 999997521100 0011111 1
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.... +..++.++.+||.+||+.||.+||++.|+++
T Consensus 237 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 237 RLPQ---PPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp CCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1222 2678999999999999999999999999886
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=305.79 Aligned_cols=253 Identities=19% Similarity=0.211 Sum_probs=188.3
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQ--LYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~--~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
.+..++|++++.||+|+||.||+|++...+++ .||+|+++..........+.+.+|+++++.++||||+++++++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 34457899999999999999999987654433 6899999876554555677899999999999999999999999876
Q ss_pred CEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
. .++||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++...
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRAL 171 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEEC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC-CCEEEccccccccc
Confidence 5 89999999999999999874 579999999999999999999999999999999999999998 99999999999876
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
..............+|+.|+ |||.+. ..|+|++|++ +++++ |..||....... ....+.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~~~~~ 244 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWC---APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGERL 244 (291)
T ss_dssp CC-CCEEEC-----CCGGGC---CHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTSCCCC
T ss_pred cccccchhhhccCCCCceee---CchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH----HHHHHHccCCCC
Confidence 43332222233345666666 898753 4688999965 56888 999996421100 000111111112
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
+ .+..+++++.++|.+||+.||.+||++.++++
T Consensus 245 ~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 245 P-RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 2 22578999999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=301.35 Aligned_cols=260 Identities=15% Similarity=0.207 Sum_probs=195.8
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEE-EEEeCCEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFY-SLQTSSCVF 118 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~f~~~~~l~ 118 (473)
.++|++.+.||+|+||+||+|+++. +++.||||++..... ...+.+|..+++.++|++++..+. ++......|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcC-CCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 3689999999999999999998876 678999999776532 225788999999998777665554 557888999
Q ss_pred EEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe---cCCCCceeEeecchhhhhc
Q psy622 119 LVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI---SAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILl---d~~~g~ikL~DFGla~~~~ 194 (473)
+||||+ +|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.+ +.+||+|||+++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGT-TCEEECCCTTCEECB
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCC-CeEEEecCccceecc
Confidence 999999 9999999985 4579999999999999999999999999999999999999 677 899999999998764
Q ss_pred CCcccc----ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhcc
Q psy622 195 QPIVYL----EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQL 263 (473)
Q Consensus 195 ~~~~~~----~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 263 (473)
...... .......||+.|+ |||.+. ..|+|++|++ +++++|..||.......... ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~ 235 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYA---SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKM 235 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGC---CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-HHHHHHHHHH
T ss_pred CcccCccCCCCcccccCCCcccc---chHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh-hhhhhhcccc
Confidence 332211 1223457888887 898764 3588899965 57999999997521110000 0011111111
Q ss_pred CCC--CccccCChhHHHHHHhccccCCCCCCCHHHHhc----------CCCCCCCCcccc
Q psy622 264 EWP--EDEEALNPSTEETILALLKSDPTQRPSGHQVRR----------LPMFKDYDWDSI 311 (473)
Q Consensus 264 ~~P--~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~----------HPFF~~idw~~l 311 (473)
..| .....+++++.+||.+||+.||++||+++++++ ..+-..+||+.+
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 222 111467899999999999999999999887765 467777888865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=304.59 Aligned_cols=252 Identities=16% Similarity=0.226 Sum_probs=186.7
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTN--KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~--~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
.+..++|++.+.||+|+||.||+|+.... +++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 34457899999999999999999987653 346899999986542 344567899999999999999999999999765
Q ss_pred C-----EEEEEecccCcCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCcee
Q psy622 115 S-----CVFLVMEYMIGGDVKSLIAA------NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCP 183 (473)
Q Consensus 115 ~-----~l~lVmEy~~gg~L~~~L~~------~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ik 183 (473)
. ..|+||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~k 187 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD-MTVC 187 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT-SCEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEE
Confidence 4 35999999999999999953 3569999999999999999999999999999999999999998 9999
Q ss_pred EeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCCh
Q psy622 184 IVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPT 255 (473)
Q Consensus 184 L~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~ 255 (473)
|+|||+++........ .......+++.|+ |||.+. ..|.|++|++ +++++ |..||...... ...
T Consensus 188 l~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~- 259 (313)
T 3brb_A 188 VADFGLSKKIYSGDYY-RQGRIAKMPVKWI---AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMY- 259 (313)
T ss_dssp ECSCSCC-----------------CCGGGS---CHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHH-
T ss_pred EeecCcceeccccccc-CcccccCCCcccc---CchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHH-
Confidence 9999999875432211 1223345677777 888754 3588899965 56888 88898642110 000
Q ss_pred hhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 256 STAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 256 ~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.... ....+..+..+++++.+||.+||+.||.+||++.++++|
T Consensus 260 ~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 260 DYLL--HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHH--TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHH--cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0111 111122236789999999999999999999999998864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=300.19 Aligned_cols=248 Identities=17% Similarity=0.230 Sum_probs=193.6
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNK--DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~--~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
.+..++|++.+.||+|+||+||+|++.... +..||+|++++.. .....+.+.+|+.+++.++||||+++++++.++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 555689999999999999999999876532 3469999998753 234467899999999999999999999998754
Q ss_pred CEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYI 163 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-TEEEECCCCGGGCC
T ss_pred -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC-CcEEeCccCCCccc
Confidence 568999999999999999775 469999999999999999999999999999999999999998 99999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLE 264 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~ 264 (473)
..... .......+++.|+ |||.+. ..|.|++|++ +++++ |..||...... .. ...... ....
T Consensus 164 ~~~~~--~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~-~~~~~~~~~~~ 234 (281)
T 3cc6_A 164 EDEDY--YKASVTRLPIKWM---SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DV-IGVLEKGDRLP 234 (281)
T ss_dssp -----------CCCCCGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GH-HHHHHHTCCCC
T ss_pred ccccc--cccccCCCCccee---CchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HH-HHHHhcCCCCC
Confidence 43221 1122334666676 898653 3688899965 56887 99999642110 00 011111 1222
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.| ..+++.+.+||.+||+.||.+||++.|++++
T Consensus 235 ~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 235 KP---DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 23 5789999999999999999999999998864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=309.51 Aligned_cols=252 Identities=15% Similarity=0.194 Sum_probs=197.0
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCC----CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNK----DQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSL 111 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~----~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 111 (473)
....++|++.+.||+|+||.||+|++.... .+.||+|+++... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 445688999999999999999999876532 2479999998753 234466899999999999 899999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAAN--------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~--------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~ 177 (473)
.+.+.+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 9999999999999999999999753 35899999999999999999999999999999999999999
Q ss_pred CCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhc
Q psy622 178 QAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVA 249 (473)
Q Consensus 178 ~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~ 249 (473)
+ +.+||+|||+++........ .......+|+.|+ |||.+. ..|+|++|++ +++++ |..||......
T Consensus 200 ~-~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~- 273 (333)
T 2i1m_A 200 G-HVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWM---APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN- 273 (333)
T ss_dssp G-GEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGS---CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-
T ss_pred C-CeEEECccccccccccccce-eecCCCCCCcccc---CHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-
Confidence 8 99999999999875432211 1122334566666 898653 4678899965 56887 89999752100
Q ss_pred CCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 250 GSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 250 ~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
............ +..+...++++.+||.+||+.||.+||+++|++++
T Consensus 274 ---~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 274 ---SKFYKLVKDGYQ-MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp ---HHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---HHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 000011111111 11225688999999999999999999999998863
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.95 Aligned_cols=253 Identities=21% Similarity=0.249 Sum_probs=195.6
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
..++|++.+.||+|+||.||+|+.+ +++.||||+++..... .....+.+|+++++.++||||+++++++.+....|
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 3578999999999999999999744 4688999999875422 12236889999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 119 LVMEYMIGGDVKSLIAANG----ALPEDMAAFYAAEVVLALQYLHSH---GIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~----~~~e~~~~~~~~qI~~aL~yLH~~---gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
+||||++||+|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+++
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~~~ 182 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAK 182 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT-CCEEECCCSSCE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC-CCEEeccCcccc
Confidence 9999999999999998643 499999999999999999999999 99999999999999998 999999999998
Q ss_pred hhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh----
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ---- 260 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~---- 260 (473)
....... .......||+.|+ |||.+. ..|+|++|++ +++++|..||..................
T Consensus 183 ~~~~~~~--~~~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 183 LMDYKDT--HVTTAVRGTIGHI---APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp ECCSSSS--CEECCCCSCGGGC---CHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred ccCcccc--cccccccCCcCcc---CHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 7543221 2233446888888 899753 4688999965 5799999999753222111111100000
Q ss_pred -------hccCC-CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCC
Q psy622 261 -------LQLEW-PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLP 301 (473)
Q Consensus 261 -------~~~~~-P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HP 301 (473)
..... +......+.++.+|+.+||+.||.+|||+.||++|-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 00000 111134457899999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=299.56 Aligned_cols=236 Identities=20% Similarity=0.301 Sum_probs=194.3
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-------
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT------- 113 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------- 113 (473)
++|++++.||+|+||.||+|+++. +++.||+|+++... ..+.+|+++++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRI-DGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETT-TCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred cccceeeeeccCCceEEEEEEEcC-CCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 569999999999999999999876 57899999998653 246789999999999999999999865
Q ss_pred ---------CCEEEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCce
Q psy622 114 ---------SSCVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHC 182 (473)
Q Consensus 114 ---------~~~l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~i 182 (473)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~ 161 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQV 161 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC-CCE
Confidence 45689999999999999999764 579999999999999999999999999999999999999998 999
Q ss_pred eEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh
Q psy622 183 PIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT 255 (473)
Q Consensus 183 kL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~ 255 (473)
||+|||+++....... .....||+.|+ |||.+. ..|.|++|++ +++++|..|+.......
T Consensus 162 kl~Dfg~~~~~~~~~~----~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~------ 228 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK----RTRSKGTLRYM---SPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF------ 228 (284)
T ss_dssp EECCCTTCEESSCCSC----CCCCCSCCTTS---CHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHH------
T ss_pred EECcchhheecccccc----ccccCCccccc---ChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHH------
Confidence 9999999987543221 22346888887 888653 3677899965 57999999986532110
Q ss_pred hhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 256 STAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 256 ~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
... ....++ ..+++++++||.+||+.||.+||++.|+++|++.
T Consensus 229 ~~~--~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 229 TDL--RDGIIS---DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp HHH--HTTCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHh--hccccc---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 001 111223 5688999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.23 Aligned_cols=242 Identities=17% Similarity=0.312 Sum_probs=191.9
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
..++|++.+.||+|+||+||+|+.+. ++.||||+++.... ..+.+.+|+.+|+.++||||+++++++. ...+|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK--HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT--TEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred chHHeEEEEEcccCCceEEEEEEECC--ccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 34679999999999999999998764 57899999987532 3568999999999999999999999986 66799
Q ss_pred EEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 119 LVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+||||+++|+|.++|... ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-CCEEECSTTGGGGBCCH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC-CcEEEeeCCCceEcCCC
Confidence 999999999999999854 368999999999999999999999999999999999999998 99999999999875432
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
.. .......+++.|+ |||++. ..|+|++|++ +++++ |..||....... +............|
T Consensus 338 ~~--~~~~~~~~~~~y~---aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~~~~~~~~-- 407 (454)
T 1qcf_A 338 EY--TAREGAKFPIKWT---APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALERGYRMPRP-- 407 (454)
T ss_dssp HH--HTTCSSSSCGGGS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHHTCCCCCC--
T ss_pred ce--eccCCCccccccc---CHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCCCCCC--
Confidence 11 1112223455666 899754 4688999965 56888 999997521100 00000111122223
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+++++.+||.+||+.||++||++++|++
T Consensus 408 -~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 408 -ENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 678999999999999999999999998874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=325.21 Aligned_cols=243 Identities=15% Similarity=0.153 Sum_probs=184.2
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcC---------CCCe
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI-----NKNMVSQVLRERNALALTH---------SPFC 104 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~---------hp~I 104 (473)
..++|++++.||+|+||+||+|++ +++.||||++++.... .....+.+.+|+.+|+.++ ||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred ccccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 357899999999999999999986 4689999999876421 2233467889999998875 7777
Q ss_pred eeEEEEEE------------------------------eCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHH
Q psy622 105 VQLFYSLQ------------------------------TSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLA 154 (473)
Q Consensus 105 v~l~~~f~------------------------------~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~a 154 (473)
+++.+++. +...+|+||||+++|++.+.+.+ +.+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 77776643 27889999999999987777754 579999999999999999
Q ss_pred HHHHH-HCCeeecCCCCcceEecCCCC--------------------ceeEeecchhhhhcCCccccccccccCCCCccc
Q psy622 155 LQYLH-SHGIIHRDLKPDNMLISAQAP--------------------HCPIVNTLFLAILQQPIVYLEISDLVNGTPNAF 213 (473)
Q Consensus 155 L~yLH-~~gIiHRDLKpeNILld~~~g--------------------~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~ 213 (473)
|+||| ++||+||||||+|||++.+ + .+||+|||+|+..... ..+||+.|+
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCCTT
T ss_pred HHHHHHhCCEeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeeccc
Confidence 99999 9999999999999999988 6 8999999999875421 347899988
Q ss_pred ccCCcccccc-----CCcCCCC-c-cccccCCCCCchhHhhhcCCCCChhhHhhh---ccCCCCccccCChhHHHHHHhc
Q psy622 214 NIRTPGQLLS-----LKTGTFP-T-FQDVQNSQAPFPSALRVAGSQIPTSTAAQL---QLEWPEDEEALNPSTEETILAL 283 (473)
Q Consensus 214 ~~~ape~i~~-----~~~~s~g-~-l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~P~~~~~ls~~a~dLI~~L 283 (473)
|||++.+ .|+|+++ + ...++.|..||........ ......... ....+.....+++++++||++|
T Consensus 245 ---aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 245 ---DEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY--LTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp ---CSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH--HHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred ---ChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhH--HHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence 8998753 3556653 3 3457889999975321000 000000000 0011111246889999999999
Q ss_pred cccCCCCCCCHHHHh-cCCCCC
Q psy622 284 LKSDPTQRPSGHQVR-RLPMFK 304 (473)
Q Consensus 284 L~~dP~kRpsa~eil-~HPFF~ 304 (473)
|++| |++|++ +||||+
T Consensus 320 L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 320 LNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp GGSS-----SHHHHHHHCGGGC
T ss_pred hccC-----CHHHHHhcCCCcC
Confidence 9987 999999 999995
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=313.53 Aligned_cols=252 Identities=19% Similarity=0.211 Sum_probs=195.3
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
..++|++.+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHhccCccceeecCCCeeEEEEEEC--CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 4578999999999999999999854 46899999987653 334567899999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 119 LVMEYMIGGDVKSLIAANG----ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~----~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN-FVPKITDFGISKKGT 190 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT-CCEEECCCTTCEECS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC-CCEEEeecccccccc
Confidence 9999999999999997643 58999999999999999999999999999999999999998 999999999998643
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChh---hHhhh---
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTS---TAAQL--- 261 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~---~~~~~--- 261 (473)
..... .......||+.|+ |||.+. ..|+|++|++ +++++|..||.............. .....
T Consensus 191 ~~~~~-~~~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 191 ELDQT-HLSTVVKGTLGYI---DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp SSSCC-CCBCCCEEETTTC---CHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred ccccc-ccccccCCCcccc---CHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 22211 1223345788877 898753 4678899965 579999999964221100000000 00000
Q ss_pred ---ccCC-CCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 262 ---QLEW-PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 262 ---~~~~-P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.... +......+.++.+++.+||+.||++||++.|+++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0000 11113456779999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=305.05 Aligned_cols=243 Identities=20% Similarity=0.222 Sum_probs=179.5
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEE------
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQ------ 112 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~------ 112 (473)
..+|++.++||+|+||.||+|+++. +++.||||++.+.. ......+.+|+.+++.+. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVG-SGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECC-CCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3579999999999999999999876 57899999997653 444567899999999995 999999999994
Q ss_pred --eCCEEEEEecccCcCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCCcceEecCCCCceeEe
Q psy622 113 --TSSCVFLVMEYMIGGDVKSLIAA---NGALPEDMAAFYAAEVVLALQYLHSHG--IIHRDLKPDNMLISAQAPHCPIV 185 (473)
Q Consensus 113 --~~~~l~lVmEy~~gg~L~~~L~~---~~~~~e~~~~~~~~qI~~aL~yLH~~g--IiHRDLKpeNILld~~~g~ikL~ 185 (473)
....+|+||||+ +|+|.+++.. .+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+
T Consensus 103 ~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-SCEEBC
T ss_pred ccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-CCEEEe
Confidence 445699999999 5799998875 467999999999999999999999999 9999999999999998 999999
Q ss_pred ecchhhhhcCCcccc---------ccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHh
Q psy622 186 NTLFLAILQQPIVYL---------EISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSAL 246 (473)
Q Consensus 186 DFGla~~~~~~~~~~---------~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~ 246 (473)
|||+++......... ......+||+.|+ |||++. ..|+|++|++ +++++|..||....
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~---aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYR---TPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp CCTTCBCCSSCC----------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcC---ChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 999998754322110 0111345788877 888762 4688899965 57999999997532
Q ss_pred hhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 247 RVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.. .........+. ....+..+.+||.+||+.||.+||+++|+++|
T Consensus 258 ~~--------~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 258 KL--------RIVNGKYSIPP-HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp ----------------CCCCT-TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HH--------HhhcCcccCCc-ccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11 01111222222 25678889999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=323.46 Aligned_cols=260 Identities=15% Similarity=0.195 Sum_probs=203.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCCEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS-PFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~~~~~l~ 118 (473)
.++|+++++||+|+||.||+|+++. +++.||||+++..... ..+.+|+++++.+.| ++|..+..++......|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETT-TCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECC-CCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 4789999999999999999999876 5789999998865321 247889999999965 66667777778889999
Q ss_pred EEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe---cCCCCceeEeecchhhhhc
Q psy622 119 LVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI---SAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILl---d~~~g~ikL~DFGla~~~~ 194 (473)
|||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||| +.+ +.+||+|||+++.+.
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~-~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGT-TCEEECCCTTCEECB
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCC-CeEEEEeCCcceecc
Confidence 999999 9999999986 4579999999999999999999999999999999999999 566 899999999998764
Q ss_pred CCcccc----ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChh---hHhh
Q psy622 195 QPIVYL----EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTS---TAAQ 260 (473)
Q Consensus 195 ~~~~~~----~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~---~~~~ 260 (473)
...... ......+||+.|+ |||.+. ..|+|++|++ ++|++|..||..... ..... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~---aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~----~~~~~~~~~i~~ 230 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYA---SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA----GTKKQKYEKISE 230 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTC---CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC----SSHHHHHHHHHH
T ss_pred CCccccccccccccccCCCcccc---CHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc----hhHHHHHHHHhh
Confidence 432211 1123567888888 898764 3588999965 579999999975210 00000 0111
Q ss_pred hc--cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHh----------cCCCCCCCCccccccC
Q psy622 261 LQ--LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVR----------RLPMFKDYDWDSILDQ 314 (473)
Q Consensus 261 ~~--~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil----------~HPFF~~idw~~l~~~ 314 (473)
.. ...+.....+++++.+||.+||+.||.+||++++|+ .|+|+..+||+.+..+
T Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~ 296 (483)
T 3sv0_A 231 KKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (483)
T ss_dssp HHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-
T ss_pred ccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccc
Confidence 01 111111246889999999999999999999987654 4899999999988654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=298.86 Aligned_cols=251 Identities=15% Similarity=0.147 Sum_probs=186.5
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
..++.-++|++.+.||+|+||.||+|+.+ ..||+|+++... ......+.+.+|+.+|+.++||||++++++ ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~ 91 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STA 91 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS----SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc----CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccC
Confidence 34556688999999999999999999643 249999998653 234556789999999999999999999995 456
Q ss_pred CEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..+++||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEK 170 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TEEEECCCC-----
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC-CCEEEccceecccc
Confidence 6789999999999999999654 579999999999999999999999999999999999999999 99999999999865
Q ss_pred cCCccccccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhh--
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQL-- 261 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~-- 261 (473)
...... .......||+.|+ |||.+. ..|.|++|++ +++++|..||....... .........
T Consensus 171 ~~~~~~-~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~ 243 (289)
T 3og7_A 171 SRWSGS-HQFEQLSGSILWM---APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGRGSL 243 (289)
T ss_dssp --------------CCCTTC---CHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH---HHHHHHHHTSC
T ss_pred cccccc-ccccccCCCcccc---CchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH---HHHHHhccccc
Confidence 432211 1123346888888 898764 4688899965 57999999996421000 000011111
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
...++.....+++++.+||.+||+.||.+||+++|+++
T Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11122222578899999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=301.48 Aligned_cols=240 Identities=23% Similarity=0.285 Sum_probs=185.5
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
.+..++|++.+.||+|+||+||+|+++ ++.||+|++... ...+.+.+|+++|+.++||||+++++++.+ .
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 73 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR---AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--P 73 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET---TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--T
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC---CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C
Confidence 355789999999999999999999764 478999998753 235678999999999999999999998874 4
Q ss_pred EEEEecccCcCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCCcceEecCCCCc-eeEeecch
Q psy622 117 VFLVMEYMIGGDVKSLIAANG---ALPEDMAAFYAAEVVLALQYLHS---HGIIHRDLKPDNMLISAQAPH-CPIVNTLF 189 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~---~~~e~~~~~~~~qI~~aL~yLH~---~gIiHRDLKpeNILld~~~g~-ikL~DFGl 189 (473)
.|+||||++||+|.+++...+ .+++..+..++.||+.||+|||+ +||+||||||+|||++.+ +. +||+|||+
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~~kl~Dfg~ 152 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAG-GTVLKICDFGT 152 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETT-TTEEEECCCCC
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCC-CCEEEEccccc
Confidence 799999999999999998765 47899999999999999999999 899999999999999988 65 89999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhc
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQ 262 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 262 (473)
+....... ....||+.|+ |||.+. ..|+|++|++ +++++|..||..... ...........
T Consensus 153 ~~~~~~~~------~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~ 219 (307)
T 2eva_A 153 ACDIQTHM------TNNKGSAAWM---APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG----PAFRIMWAVHN 219 (307)
T ss_dssp ------------------CCTTSS---CHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS----SHHHHHHHHHT
T ss_pred cccccccc------ccCCCCCceE---ChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc----cHHHHHHHHhc
Confidence 98653221 1235888887 888754 3577899965 579999999964210 00000000111
Q ss_pred cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 263 LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 263 ~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
...+.....+++.+.+||.+||+.||.+||+++|++++
T Consensus 220 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 12233336789999999999999999999999998863
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=332.21 Aligned_cols=244 Identities=18% Similarity=0.258 Sum_probs=189.5
Q ss_pred eEEE-ceecccCceEEEEEEEeC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 43 FEIV-KAISRGAFGKVFLGYKKT-NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 43 y~i~-~~LG~G~fG~V~~a~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.+. +.||+|+||+||+|.... .+++.||||+++... ......+.+.+|+++|+.++|||||++++++.+ ..+|+|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 4443 489999999999996543 245789999998753 334446789999999999999999999999965 458999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
|||++||+|.++|...+.+++..++.++.||+.||+|||++|||||||||+||||+.+ +.+||+|||+++.+.......
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC-----
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC-CCEEEEEcCCccccccCcccc
Confidence 9999999999999998899999999999999999999999999999999999999999 999999999999865433222
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHh-hhccCCCCcccc
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAA-QLQLEWPEDEEA 271 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~P~~~~~ 271 (473)
.......+|+.|+ |||++. ..|+|++|++ +++++ |..||....... + ...+. ......| ..
T Consensus 527 ~~~~~~~~t~~y~---APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~-~~~i~~~~~~~~p---~~ 596 (635)
T 4fl3_A 527 KAQTHGKWPVKWY---APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V-TAMLEKGERMGCP---AG 596 (635)
T ss_dssp --------CGGGS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H-HHHHHTTCCCCCC---TT
T ss_pred ccccCCCCceeee---ChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H-HHHHHcCCCCCCC---CC
Confidence 2233345667777 899764 3688999966 56887 999997521110 0 01111 1122333 67
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
+++++.+||.+||+.||++||++++|++
T Consensus 597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 597 CPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999999999998874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=297.84 Aligned_cols=251 Identities=18% Similarity=0.192 Sum_probs=190.5
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEE-Ee
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNK--DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSL-QT 113 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~--~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f-~~ 113 (473)
.+...+|++.++||+|+||.||+|+...+. ...||+|++++.. .....+.+.+|+.+++.++||||+++++++ +.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 334567999999999999999999865432 3468999988642 345567899999999999999999999985 56
Q ss_pred CCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
++..|+||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARD 177 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSCGGGCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC-CCEEECccccccc
Confidence 67899999999999999999864 468999999999999999999999999999999999999998 9999999999987
Q ss_pred hcCCcccc-ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhcc
Q psy622 193 LQQPIVYL-EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQL 263 (473)
Q Consensus 193 ~~~~~~~~-~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 263 (473)
........ .......+|+.|+ |||.+. ..|.|++|++ +++++ +.+||..... .. ........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~-~~~~~~~~-- 248 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWM---ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FD-ITVYLLQG-- 248 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---TT-HHHHHHTT--
T ss_pred ccccchhccccccCCCCCcccc---ChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH---HH-HHHHHhcC--
Confidence 54332211 1122334666676 888753 3578899965 56888 5566653210 00 01111111
Q ss_pred CCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+..+..+++++.++|.+||+.||.+||+++|+++
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111222578999999999999999999999998875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=295.67 Aligned_cols=247 Identities=17% Similarity=0.162 Sum_probs=189.5
Q ss_pred CeEEEceecccCceEEEEEEEeCCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE-E
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNK--DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV-F 118 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~--~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l-~ 118 (473)
.|++.++||+|+||.||+|++..+. +..||+|++++.. .....+.+.+|+.+++.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 4778899999999999999876532 2379999997642 345567899999999999999999999999876655 9
Q ss_pred EEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 119 LVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+||||+.+|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES-FTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECCTTSSCTTTTGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEEeCcCCCcccccCCc
Confidence 99999999999999987 4579999999999999999999999999999999999999998 999999999998654322
Q ss_pred cc-cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 198 VY-LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 198 ~~-~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
.. ........+++.|+ |||.+. ..|.|++|++ +++++|..|+..... ......... ....+..+
T Consensus 179 ~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~--~~~~~~~~ 250 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWT---ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID---PFDLTHFLA--QGRRLPQP 250 (298)
T ss_dssp GGCSCCSSCTTCGGGGS---CHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---GGGHHHHHH--TTCCCCCC
T ss_pred ccccccCcCCCCCcccc---ChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC---HHHHHHHhh--cCCCCCCC
Confidence 11 11223345666776 888653 3578899965 568885555432110 000001111 11111223
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+++++.+||.+||+.||.+|||++++++
T Consensus 251 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 678999999999999999999999998875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=329.65 Aligned_cols=246 Identities=20% Similarity=0.267 Sum_probs=189.4
Q ss_pred CCCeEEEc-eecccCceEEEEEEEeCC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 40 ISDFEIVK-AISRGAFGKVFLGYKKTN-KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 40 ~~~y~i~~-~LG~G~fG~V~~a~~~~~-~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
.+++.+.+ .||+|+||+||+|..+.. ++..||||++++.. .....+.+.+|+++|+.++|||||++++++++ +.+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 34567776 899999999999987642 45679999998753 23446789999999999999999999999986 569
Q ss_pred EEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+||||++||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++.+...
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-HYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCSTTTTCC--
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC-CcEEEeeccCcccccCC
Confidence 9999999999999999764 469999999999999999999999999999999999999999 99999999999876433
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPE 267 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~ 267 (473)
...........+++.|+ |||++. ..|+|++|++ +++++ |..||...... .+ ...+.. .....|
T Consensus 490 ~~~~~~~~~~~~~~~y~---APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~-~~~i~~~~~~~~p- 561 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWY---APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EV-MAFIEQGKRMECP- 561 (613)
T ss_dssp ------------CCTTS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HH-HHHHHTTCCCCCC-
T ss_pred CceeeeccCCCCcccee---CHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HH-HHHHHcCCCCCCC-
Confidence 22222222234556777 899764 4688999965 56887 99999752110 00 011111 122334
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+++++.+||.+||+.||.+||++.+|++
T Consensus 562 --~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 562 --PECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp --TTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred --CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 579999999999999999999999988753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=309.50 Aligned_cols=277 Identities=14% Similarity=0.171 Sum_probs=201.3
Q ss_pred CCccchhhHHHHhHhhhcccccccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHH
Q psy622 7 FSGADKENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMV 86 (473)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~ 86 (473)
+...+..++.+.+.....+......+......-.++|++.+.||+|+||.||+|++ +++.||||++++.. .
T Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~------~ 78 (342)
T 1b6c_B 8 PFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE------E 78 (342)
T ss_dssp ------CCHHHHHHHTCCTTCCSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECGGG------H
T ss_pred ccccCCcchhheeeeccccCCCCCCceeecccccccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCchh------H
Confidence 44445566777666655554332222222222246899999999999999999976 36899999997542 3
Q ss_pred HHHHHHHHHHHh--cCCCCeeeEEEEEEeCC----EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-
Q psy622 87 SQVLRERNALAL--THSPFCVQLFYSLQTSS----CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH- 159 (473)
Q Consensus 87 ~~~~~E~~iL~~--l~hp~Iv~l~~~f~~~~----~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH- 159 (473)
..+.+|.+++.. ++||||+++++++.... .+|+||||+++|+|.+++.+. .+++..++.++.||+.||+|||
T Consensus 79 ~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~ 157 (342)
T 1b6c_B 79 RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 157 (342)
T ss_dssp HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHH
Confidence 467889999987 68999999999998876 899999999999999999874 6999999999999999999999
Q ss_pred -------HCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc-cccccCCCCcccccCCccccc---------
Q psy622 160 -------SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE-ISDLVNGTPNAFNIRTPGQLL--------- 222 (473)
Q Consensus 160 -------~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~-~~~~~~gtp~y~~~~ape~i~--------- 222 (473)
++||+||||||+|||++.+ +.+||+|||+++.......... ......||+.|+ |||.+.
T Consensus 158 ~~~~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~ 233 (342)
T 1b6c_B 158 EIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM---APEVLDDSINMKHFE 233 (342)
T ss_dssp CBCSTTCBCEEECSCCSGGGEEECTT-SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGC---CHHHHTSCCCTTCHH
T ss_pred HHhhhcccCCeeeCCCCHHHEEECCC-CCEEEEECCCceeccccccccccccccCCcCcccC---CHhhhcccccccccc
Confidence 8999999999999999999 9999999999987543322111 223456888887 899763
Q ss_pred ---cCCcCCCCcc-ccccCC----------CCCchhHhhhcCCCCChhhHhh------hccCCCCc--cccCChhHHHHH
Q psy622 223 ---SLKTGTFPTF-QDVQNS----------QAPFPSALRVAGSQIPTSTAAQ------LQLEWPED--EEALNPSTEETI 280 (473)
Q Consensus 223 ---~~~~~s~g~l-~~~~~g----------~~pf~~~~~~~~~~~~~~~~~~------~~~~~P~~--~~~ls~~a~dLI 280 (473)
..|+|++|++ +++++| ..||..... .......... ....+|.. ....++.+.+||
T Consensus 234 ~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 310 (342)
T 1b6c_B 234 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP---SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 310 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC---SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHH
T ss_pred cCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc---CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHH
Confidence 3688999965 568888 677754211 0000111110 11112210 013345789999
Q ss_pred HhccccCCCCCCCHHHHhcC
Q psy622 281 LALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 281 ~~LL~~dP~kRpsa~eil~H 300 (473)
.+||+.||.+||+++|+++|
T Consensus 311 ~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 311 RECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHCCSSGGGSCCHHHHHHH
T ss_pred HHHhccChhhCCCHHHHHHH
Confidence 99999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.73 Aligned_cols=251 Identities=20% Similarity=0.240 Sum_probs=182.9
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHH--HhcCCCCeeeEEEEEE
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL--ALTHSPFCVQLFYSLQ 112 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL--~~l~hp~Iv~l~~~f~ 112 (473)
...+.+++|++++.||+|+||.||+|+. +++.||||+++... ...+..|.+++ ..++||||+++++.+.
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE---CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 3456789999999999999999999965 36899999997642 23444455554 4579999999998654
Q ss_pred e-----CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CeeecCCCCcceEecCC
Q psy622 113 T-----SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH---------GIIHRDLKPDNMLISAQ 178 (473)
Q Consensus 113 ~-----~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~---------gIiHRDLKpeNILld~~ 178 (473)
. ...+|+||||++||+|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 2 34789999999999999999875 458999999999999999999999 99999999999999998
Q ss_pred CCceeEeecchhhhhcCCcc-----ccccccccCCCCcccccCCcccccc-------------CCcCCCCcc-ccccCCC
Q psy622 179 APHCPIVNTLFLAILQQPIV-----YLEISDLVNGTPNAFNIRTPGQLLS-------------LKTGTFPTF-QDVQNSQ 239 (473)
Q Consensus 179 ~g~ikL~DFGla~~~~~~~~-----~~~~~~~~~gtp~y~~~~ape~i~~-------------~~~~s~g~l-~~~~~g~ 239 (473)
+.+||+|||+++.+..... ........+||+.|+ |||++.. .|+|++|++ +++++|.
T Consensus 157 -~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 157 -GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYM---APEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp -SCEEECCCTTCEECSSSSCC---------CCTTSCGGGC---CHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred -CcEEEeeccceeecccccccCccccccccccCCCcccee---CchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 9999999999987543211 111122346888888 9998753 588999965 5788987
Q ss_pred CCchhHhhhcCCC---------CC-hhhHh------hhccCCCCc---cccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 240 APFPSALRVAGSQ---------IP-TSTAA------QLQLEWPED---EEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 240 ~pf~~~~~~~~~~---------~~-~~~~~------~~~~~~P~~---~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.||.......... .+ ..... .....+|.. ...+++++.+||.+||+.||++|||++|+++
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 7664321100000 00 00000 011222211 0124457999999999999999999999853
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=303.98 Aligned_cols=257 Identities=16% Similarity=0.198 Sum_probs=197.1
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEe---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKK---TNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ 112 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~---~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 112 (473)
.....++|++++.||+|+||.||+|+.. ..+++.||+|++.... ....+.+.+|+++++.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 4455678999999999999999999842 2357899999998642 445668999999999999999999999986
Q ss_pred eCC--EEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecch
Q psy622 113 TSS--CVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF 189 (473)
Q Consensus 113 ~~~--~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGl 189 (473)
... .+|+||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kL~Dfg~ 191 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGL 191 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTT
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC-CcEEEecCcc
Confidence 543 789999999999999999886 469999999999999999999999999999999999999998 9999999999
Q ss_pred hhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHh----hhcCCCCChh--
Q psy622 190 LAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSAL----RVAGSQIPTS-- 256 (473)
Q Consensus 190 a~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~----~~~~~~~~~~-- 256 (473)
++................+++.|+ |||.+. ..|+|++|++ +++++|..||.... ..........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWY---APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGC---CHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred hhhccccccccccccCCCCceeEE---CchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 987644332222223334555566 898753 4688999965 57999998886421 1111111100
Q ss_pred ---hHhh-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 257 ---TAAQ-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 257 ---~~~~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.... .....+..+..+++++.+||.+||+.||.+||++.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 000111123678999999999999999999999998874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=296.37 Aligned_cols=248 Identities=15% Similarity=0.183 Sum_probs=190.4
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEE-EEEeCCEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFY-SLQTSSCVF 118 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~f~~~~~l~ 118 (473)
.++|++.+.||+|+||.||+|+++. +++.||||++..... ...+.+|+.+++.++|++++..+. ++......|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcC-CCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 4689999999999999999998876 679999999876532 225789999999998777555544 457788999
Q ss_pred EEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec---CCCCceeEeecchhhhhc
Q psy622 119 LVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS---AQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld---~~~g~ikL~DFGla~~~~ 194 (473)
+||||+ +|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++ .+ +.+||+|||+++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~-~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGT-TCEEECCCTTCEECB
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCC-CeEEEeeCCCccccc
Confidence 999999 9999999985 45799999999999999999999999999999999999994 66 899999999998764
Q ss_pred CCcccc----ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhcc
Q psy622 195 QPIVYL----EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQL 263 (473)
Q Consensus 195 ~~~~~~----~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 263 (473)
...... .......||+.|+ |||.+. ..|+|++|++ +++++|..||......... .....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~ 235 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYA---SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKM 235 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTC---CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHHH
T ss_pred ccccccccccccccccccccccC---ChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh-hhhhhhccccc
Confidence 432211 1123457888887 898764 3588899965 5799999999752110000 00011111112
Q ss_pred CCC--CccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 264 EWP--EDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 264 ~~P--~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..| .....+++++.+||.+||+.||.+||+++++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 222 112468899999999999999999999887764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=310.47 Aligned_cols=248 Identities=12% Similarity=0.137 Sum_probs=190.5
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeee---
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTN-------KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQ--- 106 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~-------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~--- 106 (473)
....++|++.+.||+|+||.||+|+++.+ .++.||+|++.+. ..+.+|+++++.++||||++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~ 109 (352)
T 2jii_A 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWK 109 (352)
T ss_dssp CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhh
Confidence 34458899999999999999999998763 3688999999865 25788999999999999887
Q ss_pred ------------EEEEEEe-CCEEEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCc
Q psy622 107 ------------LFYSLQT-SSCVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPD 171 (473)
Q Consensus 107 ------------l~~~f~~-~~~l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpe 171 (473)
+++++.. ...+|+||||+ ||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+
T Consensus 110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~ 188 (352)
T 2jii_A 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE 188 (352)
T ss_dssp HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence 5677765 78999999999 99999999986 68999999999999999999999999999999999
Q ss_pred ceEecCCCC--ceeEeecchhhhhcCCcccc----ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCC
Q psy622 172 NMLISAQAP--HCPIVNTLFLAILQQPIVYL----EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNS 238 (473)
Q Consensus 172 NILld~~~g--~ikL~DFGla~~~~~~~~~~----~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g 238 (473)
|||++.+ + .+||+|||+++.+....... .......||+.|+ |||.+. ..|+|++|++ +++++|
T Consensus 189 NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~il~el~~g 264 (352)
T 2jii_A 189 NIFVDPE-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI---SMDLHKGCGPSRRSDLQSLGYCMLKWLYG 264 (352)
T ss_dssp GEEEETT-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTC---CHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred HEEEcCC-CCceEEEecCcceeeccCCCccccccccccccccCCcccc---CHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 9999988 7 89999999998754322111 1123347888888 898654 4678899965 579999
Q ss_pred CCCchhHhhhcCCCCChhhHh---hhccCCCC---ccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 239 QAPFPSALRVAGSQIPTSTAA---QLQLEWPE---DEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 239 ~~pf~~~~~~~~~~~~~~~~~---~~~~~~P~---~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..||....... ........ .....++. ....+++++.+||.+||+.||.+||+++++++
T Consensus 265 ~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 265 FLPWTNCLPNT--EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp CCTTGGGTTCH--HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCCcccCCcCH--HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 99998632100 00000000 01111110 01357899999999999999999999988764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=309.71 Aligned_cols=256 Identities=15% Similarity=0.145 Sum_probs=189.3
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCC--CCcEEEEEEeecccccch--------hHHHHHHHHHHHHHhcCCCCeee
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTN--KDQLYAIKVMKKDEMINK--------NMVSQVLRERNALALTHSPFCVQ 106 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~--~~~~vAiK~l~k~~~~~~--------~~~~~~~~E~~iL~~l~hp~Iv~ 106 (473)
....++|++.+.||+|+||+||+|+++.. +++.||||++.+...... .....+.+|+.++..++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 34457899999999999999999988751 357899999987532111 11224667888999999999999
Q ss_pred EEEEEEe----CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC--
Q psy622 107 LFYSLQT----SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP-- 180 (473)
Q Consensus 107 l~~~f~~----~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g-- 180 (473)
+++++.+ ...+|+||||+ |++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~ 190 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPD 190 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-STT
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-CCC
Confidence 9999988 78899999999 99999999887799999999999999999999999999999999999999987 6
Q ss_pred ceeEeecchhhhhcCCccc----cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhc
Q psy622 181 HCPIVNTLFLAILQQPIVY----LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVA 249 (473)
Q Consensus 181 ~ikL~DFGla~~~~~~~~~----~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~ 249 (473)
.+||+|||+++.+...... ........||+.|+ |||++. ..|+|++|++ +++++|..||.......
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT---SLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTC---CHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCcccc---CHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 9999999999875332111 11123457888888 898754 4678899965 57999999996421100
Q ss_pred CCCCChhhHhhhccCCCCc------cccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 250 GSQIPTSTAAQLQLEWPED------EEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 250 ~~~~~~~~~~~~~~~~P~~------~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
. .............|.. ...+++++.+||.+||+.||++||++++|++
T Consensus 268 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 268 V--AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp H--HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred H--HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0 0000001111112210 1278899999999999999999999999885
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=295.12 Aligned_cols=241 Identities=18% Similarity=0.325 Sum_probs=190.4
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
..++|++++.||+|+||.||+|+.+ +++.||+|+++.... ..+.+.+|+++++.++||||+++++++.+ +..|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence 3478999999999999999999865 357899999986532 24578899999999999999999999864 5689
Q ss_pred EEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 119 LVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECSSS
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC-CCEEECCCcccccccCc
Confidence 9999999999999997543 69999999999999999999999999999999999999998 99999999999875432
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPE 267 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~ 267 (473)
... ......+++.|+ |||.+. ..|.|++|++ +++++ |..||....... . ...... .....|
T Consensus 163 ~~~--~~~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~-~~~~~~~~~~~~~- 232 (279)
T 1qpc_A 163 EYT--AREGAKFPIKWT---APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---V-IQNLERGYRMVRP- 232 (279)
T ss_dssp CEE--CCTTCCCCTTTS---CHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H-HHHHHTTCCCCCC-
T ss_pred ccc--cccCCCCccCcc---ChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---H-HHHHhcccCCCCc-
Confidence 211 112234556666 898754 4688999965 56887 899996521100 0 001111 112222
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+++++.+||.+||+.||++||+++++++
T Consensus 233 --~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 233 --DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 578999999999999999999999998875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.30 Aligned_cols=237 Identities=13% Similarity=0.073 Sum_probs=186.5
Q ss_pred CCCCeEEEceecccCceEEEEEE-----EeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCCeeeEEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGY-----KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH---SPFCVQLFYS 110 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~-----~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~ 110 (473)
..++|++.+.||+|+||+||+|+ +.. +++.||||++++.. ...+.+|.+++..++ |+||++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAK-NKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC--------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccc-cCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 34679999999999999999994 333 57899999998653 335677888888776 9999999999
Q ss_pred EEeCCEEEEEecccCcCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC--------
Q psy622 111 LQTSSCVFLVMEYMIGGDVKSLIAA-----NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA-------- 177 (473)
Q Consensus 111 f~~~~~l~lVmEy~~gg~L~~~L~~-----~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~-------- 177 (473)
+...+..|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999999984 457999999999999999999999999999999999999988
Q ss_pred ---CCCceeEeecchhhhhcCCccccccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCCchhHhh
Q psy622 178 ---QAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAPFPSALR 247 (473)
Q Consensus 178 ---~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~pf~~~~~ 247 (473)
+ +.+||+|||+++.+...... ......+||+.|+ |||++.. .|+|++|++ ++|++|..||.....
T Consensus 216 ~~~~-~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 216 DDLS-AGLALIDLGQSIDMKLFPKG-TIFTAKCETSGFQ---CVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp ---C-TTEEECCCTTCEEGGGSCTT-EEECCSSCTTSCC---CHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred cccc-CCEEEeeCchhhhhhccCCC-ceeeeecCCCCCC---ChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 6 89999999999765322222 2234467999998 8997643 578899965 679999999964211
Q ss_pred hcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCC-HHHHh
Q psy622 248 VAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPS-GHQVR 298 (473)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps-a~eil 298 (473)
.. .. ....++. ...++...+++.+||+.+|.+|+. ++++.
T Consensus 291 ~~------~~---~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 291 GE------CK---PEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp TE------EE---ECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred Cc------ee---echhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 10 00 0111121 235678999999999999999975 44433
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=294.76 Aligned_cols=238 Identities=21% Similarity=0.353 Sum_probs=184.0
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-C
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS-S 115 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~-~ 115 (473)
.+..++|++.+.||+|+||.||+|+++ ++.||+|+++... ..+.+.+|+++++.++||||+++++++... +
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET---TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc---CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 345789999999999999999999763 5789999998643 345789999999999999999999987544 5
Q ss_pred EEEEEecccCcCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGA--LPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~--~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
.+|+||||++||+|.+++.+.+. +++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++...
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA 167 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC-CcEEEeeccccccc
Confidence 79999999999999999987543 8999999999999999999999999999999999999998 99999999999864
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLE 264 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~ 264 (473)
.... ....+++.|+ |||.+. ..|+|++|++ +++++ |..||...... .. ...+.. ....
T Consensus 168 ~~~~------~~~~~~~~y~---aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~-~~~~~~~~~~~ 234 (278)
T 1byg_A 168 SSTQ------DTGKLPVKWT---APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV-VPRVEKGYKMD 234 (278)
T ss_dssp --------------CCTTTS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GH-HHHHTTTCCCC
T ss_pred cccc------cCCCcccccc---CHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HH-HHHHhcCCCCC
Confidence 3221 1235667776 888753 4688899965 56887 99999642110 00 001111 1122
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.+ ..+++++.++|.+||+.||.+||++.|+++
T Consensus 235 ~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 235 AP---DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc---ccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 23 678999999999999999999999988874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=317.77 Aligned_cols=242 Identities=17% Similarity=0.297 Sum_probs=187.2
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
..++|++.+.||+|+||.||+|+++. ++.||||+++.... ..+.+.+|+++|+.++||||+++++++.+ ..+|
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT--TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC--CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 34679999999999999999998765 36799999987542 23578999999999999999999999876 6789
Q ss_pred EEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 119 LVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC-----
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC-CCEEECCCccceecCCC
Confidence 999999999999999753 469999999999999999999999999999999999999998 99999999999875432
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
... ......+++.|+ |||.+. ..|+|++|++ +++++ |..||....... +............|
T Consensus 334 ~~~--~~~~~~~~~~y~---aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~~~~~~~~-- 403 (452)
T 1fmk_A 334 EYT--ARQGAKFPIKWT---APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVERGYRMPCP-- 403 (452)
T ss_dssp -----------CCGGGS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTCCCCCC--
T ss_pred cee--cccCCccccccc---CHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCCCCCC--
Confidence 211 111223555666 899753 4688999965 56888 899997521100 00000011122223
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+++++.+||.+||+.||++||+++++++
T Consensus 404 -~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 404 -PECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 578999999999999999999999999886
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.93 Aligned_cols=248 Identities=18% Similarity=0.175 Sum_probs=183.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEE-EeCCEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSL-QTSSCV 117 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~--~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f-~~~~~l 117 (473)
..|++.+.||+|+||+||+|+...+.+ ..||+|+++.. ......+.+.+|+.+++.++||||+++++++ +.++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 458899999999999999998764333 46899998763 2345567899999999999999999999986 456689
Q ss_pred EEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC---------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC-CCEEEeecccccccccc
Confidence 99999999999999998754 68999999999999999999999999999999999999998 99999999999875432
Q ss_pred cccc-ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 197 IVYL-EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 197 ~~~~-~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
.... .......+|+.|+ |||.+. ..|+|++|++ +++++ |.+||..... ... ....... ..+.
T Consensus 246 ~~~~~~~~~~~~~~~~y~---aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~---~~~-~~~~~~~--~~~~ 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWM---ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDI-TVYLLQG--RRLL 316 (373)
T ss_dssp ------------CCGGGS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS---SCH-HHHHHTT--CCCC
T ss_pred ccccccccCCCCCccccc---ChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH---HHH-HHHHHcC--CCCC
Confidence 2111 1112234566666 898753 4688999965 56888 6777764210 000 1111111 1122
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.+..+++++.++|.+||+.||.+||++.|++++
T Consensus 317 ~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 225789999999999999999999999998864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=297.13 Aligned_cols=247 Identities=17% Similarity=0.193 Sum_probs=191.8
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccc-cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM-INKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~-~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
|...+.||+|+||.||+|+. .++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE---CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 33458999999999999974 357899999986532 23344668999999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 122 EYMIGGDVKSLIAA---NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 122 Ey~~gg~L~~~L~~---~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++.......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA-FTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCSCSS
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC-CcEEEeecccccccccccc
Confidence 99999999999974 3469999999999999999999999999999999999999998 9999999999987543222
Q ss_pred ccccccccCCCCcccccCCccccc-----cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhH-----------hhh
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL-----SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTA-----------AQL 261 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~-----~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~-----------~~~ 261 (473)
. .......||+.|+ |||.+. ..|+|++|++ +++++|..||...... ....... ...
T Consensus 189 ~-~~~~~~~g~~~y~---aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 261 (307)
T 2nru_A 189 T-VMTSRIVGTTAYM---APEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP---QLLLDIKEEIEDEEKTIEDYI 261 (307)
T ss_dssp C-EECSSCCSCGGGC---CHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSS---SBTTHHHHHHHTTSCCHHHHS
T ss_pred c-ccccccCCCcCcC---ChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcch---HHHHHHHHHhhhhhhhhhhhc
Confidence 1 1223346888887 888643 4688899965 5799999999753210 0000000 000
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
....+..+...+..+.++|.+||+.||.+||++.+++++
T Consensus 262 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 262 DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 111222224556789999999999999999999998864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=294.83 Aligned_cols=227 Identities=11% Similarity=0.073 Sum_probs=180.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++.+.||+|+||.||+|++.. +++.||||+++..........+.+.+|..++..++||||+++++++.+.+.+|+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTA-LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETT-TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecC-CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3679999999999999999999876 579999999998765555667789999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||||++|++|.+++++ + ....++..++.||+.||+|||++||+||||||+|||++.+ |.+||+++|..
T Consensus 109 v~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~-g~~kl~~~~~~--------- 176 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPATM--------- 176 (286)
T ss_dssp EEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT-SCEEECSCCCC---------
T ss_pred EEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC-CCEEEEecccc---------
Confidence 9999999999999964 3 4666788899999999999999999999999999999998 99999854322
Q ss_pred cccccccCCCCcccccCCccccccCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCC-CCccccCChhHH
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLLSLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW-PEDEEALNPSTE 277 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-P~~~~~ls~~a~ 277 (473)
+ ......|+|++|++ ++|++|..||................ ...... ......+++++.
T Consensus 177 -----------------~-~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 177 -----------------P-DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp -----------------T-TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT-TSCBCCHHHHCTTSCHHHH
T ss_pred -----------------C-CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh-ccCCCChhhcccCCCHHHH
Confidence 1 12234688999965 67999999997532110000000000 000100 011247899999
Q ss_pred HHHHhccccCCCCCCCHHHHhc
Q psy622 278 ETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 278 dLI~~LL~~dP~kRpsa~eil~ 299 (473)
+||.+||+.||.+| |+.|+++
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHH
T ss_pred HHHHHHcccCCccC-CHHHHHH
Confidence 99999999999999 9999885
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=336.06 Aligned_cols=265 Identities=22% Similarity=0.285 Sum_probs=198.4
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT--- 113 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--- 113 (473)
...+++|++.+.||+|+||.||+|+++. +++.||||+++... .....+.+.+|+++++.++||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~-tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQD-TGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTT-TTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 3446899999999999999999998776 57899999998652 34456789999999999999999999999765
Q ss_pred ---CCEEEEEecccCcCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCc---eeE
Q psy622 114 ---SSCVFLVMEYMIGGDVKSLIAANG---ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPH---CPI 184 (473)
Q Consensus 114 ---~~~l~lVmEy~~gg~L~~~L~~~~---~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~---ikL 184 (473)
.+..|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +. +||
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~-g~~~~vKL 165 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG-PQRLIHKI 165 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECC-SSSCEEEE
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecC-CCceeEEE
Confidence 677899999999999999998754 69999999999999999999999999999999999999976 44 899
Q ss_pred eecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhh--cCCC---
Q psy622 185 VNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRV--AGSQ--- 252 (473)
Q Consensus 185 ~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~--~~~~--- 252 (473)
+|||+++...... ......||+.|+ |||.+. ..|+|++|++ +++++|..||...... ....
T Consensus 166 ~DFG~a~~~~~~~----~~~~~~gt~~Y~---APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~ 238 (676)
T 3qa8_A 166 IDLGYAKELDQGE----LCTEFVGTLQYL---APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238 (676)
T ss_dssp CSCCCCCBTTSCC----CCCCCCSCCTTC---SSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-
T ss_pred ccccccccccccc----ccccccCCcccC---ChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc
Confidence 9999998754332 123356888887 888764 3577889965 5799999999642100 0000
Q ss_pred -----CChhhHhhhccCC------C-CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccC
Q psy622 253 -----IPTSTAAQLQLEW------P-EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQ 314 (473)
Q Consensus 253 -----~~~~~~~~~~~~~------P-~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~ 314 (473)
............+ | .....+++++.+||.+||+.||++||+++|+++||||+. ++.++++
T Consensus 239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~--l~~iL~~ 310 (676)
T 3qa8_A 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA--LDSILSL 310 (676)
T ss_dssp -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH--HHHHHCC
T ss_pred ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH--HHHHHhc
Confidence 0000000111111 1 112346788999999999999999999999999999986 4455554
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=320.91 Aligned_cols=243 Identities=17% Similarity=0.295 Sum_probs=191.7
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+..++|++.+.||+|+||.||+|+++. ++.||||+++.... ..+.+.+|+++|+.++||||+++++++.+ ..+
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT--TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cchhhhhhheecccCCCeEEEEEEECC--CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 334679999999999999999998765 36799999987542 23578999999999999999999999866 679
Q ss_pred EEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 118 FLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
||||||+.+|+|.++|... ..+++..+..++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++.+..
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIED 415 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCTTSTTTCCC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC-CcEEEcccccceecCC
Confidence 9999999999999999753 469999999999999999999999999999999999999998 8999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
... .......+++.|+ |||++. ..|+|++|++ +++++ |..||....... +............|
T Consensus 416 ~~~--~~~~~~~~~~~y~---aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~~i~~~~~~~~~- 486 (535)
T 2h8h_A 416 NEY--TARQGAKFPIKWT---APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVERGYRMPCP- 486 (535)
T ss_dssp HHH--HTTCSTTSCGGGS---CHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHHHHHTTCCCCCC-
T ss_pred Cce--ecccCCcCccccc---CHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCCCCCC-
Confidence 211 1111223455565 899754 4688999965 56888 899997521100 00000011122223
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+++++.+||.+||+.||++||++++|++
T Consensus 487 --~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 487 --PECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 578999999999999999999999999886
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.57 Aligned_cols=245 Identities=11% Similarity=0.068 Sum_probs=185.0
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CC----------eee-
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS-PF----------CVQ- 106 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~----------Iv~- 106 (473)
....|++.++||+|+||+||+|++.. +++.||||+++..........+.+.+|..+++.+.| ++ ++.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQE-TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CceeEEEecccccCCCEEEEEEEecC-CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34569999999999999999999876 578999999985543334446678999999998876 21 111
Q ss_pred ----------EEEEEEe-----CCEEEEEecccCcCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCee
Q psy622 107 ----------LFYSLQT-----SSCVFLVMEYMIGGDVKSLIAA-------NGALPEDMAAFYAAEVVLALQYLHSHGII 164 (473)
Q Consensus 107 ----------l~~~f~~-----~~~l~lVmEy~~gg~L~~~L~~-------~~~~~e~~~~~~~~qI~~aL~yLH~~gIi 164 (473)
+...+.. ...++++|+++ +|+|.++++. .+.+++..+..++.||+.||+|||++|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 1111211 23578888877 7899999852 23578888999999999999999999999
Q ss_pred ecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc----------------cCCcCC
Q psy622 165 HRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL----------------SLKTGT 228 (473)
Q Consensus 165 HRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~----------------~~~~~s 228 (473)
||||||+|||++.+ +.+||+|||+++..... ....+| +.|+ |||++. ..|+|+
T Consensus 234 HrDiKp~NILl~~~-~~~kL~DFG~a~~~~~~------~~~~~g-~~y~---aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 234 HTYLRPVDIVLDQR-GGVFLTGFEHLVRDGAS------AVSPIG-RGFA---PPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp CSCCCGGGEEECTT-CCEEECCGGGCEETTEE------ECCCCC-TTTC---CHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred cCCcccceEEEecC-CeEEEEeccceeecCCc------cccCCC-Ccee---CchhhhccccccccccCcCCCchhhHHH
Confidence 99999999999999 99999999998874322 234567 7877 999872 568899
Q ss_pred CCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 229 FPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 229 ~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
+|++ +++++|..||....... ... . ..... ..+++++++||.+||+.||++||++.|+++||||+.+.
T Consensus 303 lGvil~elltg~~Pf~~~~~~~---~~~----~-~~~~~---~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALG---GSE----W-IFRSC---KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGS---CSG----G-GGSSC---CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCcchhh---hHH----H-HHhhc---ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence 9965 57999999997532211 110 0 11111 36889999999999999999999999999999998763
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.02 Aligned_cols=246 Identities=19% Similarity=0.263 Sum_probs=192.3
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTN--KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~--~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
+..++|++.+.||+|+||+||+|+++.. .+..||||+++... .....+.+.+|+.+++.++||||+++++++. .+
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 4457899999999999999999987642 34679999987642 3444568999999999999999999999984 56
Q ss_pred EEEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 116 CVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
.+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+++...
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~-~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME 542 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCCCCSCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC-CCEEEEecCCCeecC
Confidence 7899999999999999998754 69999999999999999999999999999999999999998 999999999998754
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEW 265 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~ 265 (473)
.... .......+|+.|+ |||.+. ..|+|++|++ +++++ |..||....... . ...+.. .....
T Consensus 543 ~~~~--~~~~~~~~t~~y~---aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~-~~~i~~~~~~~~ 613 (656)
T 2j0j_A 543 DSTY--YKASKGKLPIKWM---APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V-IGRIENGERLPM 613 (656)
T ss_dssp C------------CCGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H-HHHHHHTCCCCC
T ss_pred CCcc--eeccCCCCCccee---CHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---H-HHHHHcCCCCCC
Confidence 3221 1122335667777 899754 3688999965 56775 999997521100 0 011111 12233
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
| ..+++++.+||.+||+.||.+||++.|+++
T Consensus 614 ~---~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 614 P---PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C---ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3 678999999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=299.93 Aligned_cols=249 Identities=18% Similarity=0.223 Sum_probs=189.7
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
.-.+..++|++.+.||+|+||.||+|+.+. .+|+|+++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~----~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG----EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS----SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC----eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 345667899999999999999999998754 399999986532 222234577899999999999999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..+|+||||++|++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++ + +.+||+|||+++..
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~-~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-N-GKVVITDFGLFSIS 179 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC--
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-C-CCEEEeecCCcccc
Confidence 99999999999999999998755 799999999999999999999999999999999999998 5 79999999998764
Q ss_pred cCCcc--ccccccccCCCCcccccCCccccc---------------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCCh
Q psy622 194 QQPIV--YLEISDLVNGTPNAFNIRTPGQLL---------------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPT 255 (473)
Q Consensus 194 ~~~~~--~~~~~~~~~gtp~y~~~~ape~i~---------------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~ 255 (473)
..... .........|++.|+ |||.+. ..|.|++|++ +++++|..||....... . .
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~---aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~-~ 252 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHL---APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---I-I 252 (319)
T ss_dssp --------CCSCBCCSGGGGTS---CHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH---H-H
T ss_pred ccccccccccccccCCCccccc---ChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H-H
Confidence 32111 111122345777776 888654 3577899965 57999999996421100 0 0
Q ss_pred hhHhhh-ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 256 STAAQL-QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 256 ~~~~~~-~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
...... ....+ ...++.++.+||.+||+.||.+||++.++++
T Consensus 253 ~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 253 WQMGTGMKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHTTCCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHhccCCCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 001111 11111 1368899999999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=322.31 Aligned_cols=236 Identities=21% Similarity=0.301 Sum_probs=191.3
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE---
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC--- 116 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~--- 116 (473)
.++|++.+.||+|+||+||+|+++..+++.||||++.... .......+.+|+.+|+.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 3789999999999999999999875457899999987642 23445678999999999999999999999987655
Q ss_pred --EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 117 --VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 117 --l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
.||||||++|++|.+++.. .+++..++.++.||+.||+|||++|||||||||+|||++. +.+||+|||+++...
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~--~~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE--EQLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS--SCEEECCCTTCEETT
T ss_pred ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC--CcEEEEecccchhcc
Confidence 7999999999999988765 7999999999999999999999999999999999999987 489999999998754
Q ss_pred CCccccccccccCCCCcccccCCccccc-----cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL-----SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~-----~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
.. ...+||+.|+ |||++. ..|+|++|++ +++++|..||..... ..++. ..+
T Consensus 233 ~~-------~~~~gt~~y~---aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---~~~~~--------~~~-- 289 (681)
T 2pzi_A 233 SF-------GYLYGTPGFQ---APEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV---DGLPE--------DDP-- 289 (681)
T ss_dssp CC-------SCCCCCTTTS---CTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC---SSCCT--------TCH--
T ss_pred cC-------CccCCCcccc---CHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc---ccccc--------ccc--
Confidence 32 3357999988 899754 4688999965 568999888865211 11110 001
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
....++.+.+||.+||+.||.+||+..+.+.|+|+.
T Consensus 290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 123568899999999999999999988888888774
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-32 Score=287.32 Aligned_cols=186 Identities=14% Similarity=0.095 Sum_probs=134.7
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI-------NKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~-------~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l 117 (473)
...++.|++|.+..++..- .|+.||+|++.+.... .....+.+.+|+++|+++ .|+||+++++++++++.+
T Consensus 239 ~~~~~~~~~~~h~~~rr~~-fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYF-FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp ECC-C--------CCEEEE-ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred hhccccCCccccccccccc-ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 3446677888777776665 5789999999876322 122345799999999999 799999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
||||||++||+|.++|.+.+.+++. .++.||+.||+|+|++|||||||||+||||+.+ |++||+|||+|+......
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT-SCEEECCCTTEESCC---
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC-CCEEEeecccCeeCCCCC
Confidence 9999999999999999999889865 488999999999999999999999999999999 999999999998754321
Q ss_pred cccccccccCCCCcccccCCcccccc-----CCcCCCCccc-cccCCCCCc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLLS-----LKTGTFPTFQ-DVQNSQAPF 242 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~~-----~~~~s~g~l~-~~~~g~~pf 242 (473)
....+.+|||.|+ |||++.+ .++|+.|+.. .+..+..++
T Consensus 394 ---~~~~t~vGTp~Ym---APE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 ---SWPTNLVQSFFVF---VNELFAENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CCSHHHHHHHHHH---HHHHC-----------------CCCCTTHHHH
T ss_pred ---ccccCceechhhc---cHHHhCCCCCCcccccccccchhhhccccchh
Confidence 2233468999999 8887643 4566666543 354444444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-25 Score=236.82 Aligned_cols=162 Identities=19% Similarity=0.049 Sum_probs=123.2
Q ss_pred EEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch-----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 44 EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK-----NMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 44 ~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~-----~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
...+.||+|+||+||+|.. .++.+|+|+......... ...+++.+|+++|+.++||||+++..++.+....|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY---LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEEC---SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEEE---CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 3456899999999999943 356789998765433222 22456899999999999999996666666777789
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
+||||++||+|.+++.+ ++.++.||+.||+|||++||+||||||+|||++. ++||+|||+++.......
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCccc
Confidence 99999999999999986 6689999999999999999999999999999997 899999999998644322
Q ss_pred cc----ccccccCCCCcccccCCccccc
Q psy622 199 YL----EISDLVNGTPNAFNIRTPGQLL 222 (473)
Q Consensus 199 ~~----~~~~~~~gtp~y~~~~ape~i~ 222 (473)
.. ......+|||.|+ |||++.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~---APEv~~ 509 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEK---FDEIWE 509 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGG---HHHHHH
T ss_pred cccchhhhhhhhcCCCCcC---CHHHHH
Confidence 11 1223568999998 898764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.6e-24 Score=208.99 Aligned_cols=132 Identities=17% Similarity=0.108 Sum_probs=107.5
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccch---------------hHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK---------------NMVSQVLRERNALALTHSPFCVQLFYSL 111 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~---------------~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 111 (473)
+.||+|+||.||+|++ . +++.||||+++....... .....+.+|+.+|+.++ | ++++.++
T Consensus 96 ~~iG~G~~g~Vy~~~~-~-~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 96 KLMGEGKESAVFNCYS-E-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEECSSEEEEEEEE-T-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred CEeccCCCceEEEEEe-C-CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 9999999999999988 4 578999999975432111 23567899999999998 4 5666655
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
.. +..|+||||++||+|.+ +. ...+..++.||+.||+|||++||+||||||+|||++ + +++||+|||+|+
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vkl~DFG~a~ 240 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWIIDFPQSV 240 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEECCCTTCE
T ss_pred ec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEEEEECCCCe
Confidence 44 45699999999999988 42 134567999999999999999999999999999999 7 999999999997
Q ss_pred hh
Q psy622 192 IL 193 (473)
Q Consensus 192 ~~ 193 (473)
..
T Consensus 241 ~~ 242 (282)
T 1zar_A 241 EV 242 (282)
T ss_dssp ET
T ss_pred EC
Confidence 53
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-21 Score=188.87 Aligned_cols=140 Identities=17% Similarity=0.105 Sum_probs=108.3
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcE--EEEEEeecccccc---------------------hhHHHHHHHHHHHHHhc
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQL--YAIKVMKKDEMIN---------------------KNMVSQVLRERNALALT 99 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~--vAiK~l~k~~~~~---------------------~~~~~~~~~E~~iL~~l 99 (473)
|++.+.||+|+||.||+|++.. +|+. ||||+++...... ......+.+|..+|..+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~-~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF-DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE-TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC-CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 7899999999999999998854 4678 9999976542110 11124688999999999
Q ss_pred CCCCe--eeEEEEEEeCCEEEEEecccCc-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCCc
Q psy622 100 HSPFC--VQLFYSLQTSSCVFLVMEYMIG-G----DVKSLIAANGALPEDMAAFYAAEVVLALQYLH-SHGIIHRDLKPD 171 (473)
Q Consensus 100 ~hp~I--v~l~~~f~~~~~l~lVmEy~~g-g----~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH-~~gIiHRDLKpe 171 (473)
.|++| ..++.. ...||||||+.+ | +|.+++.. .++..+..++.||+.||.||| +.|||||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 77754 333332 356899999942 3 67666432 345678899999999999999 999999999999
Q ss_pred ceEecCCCCceeEeecchhhhh
Q psy622 172 NMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 172 NILld~~~g~ikL~DFGla~~~ 193 (473)
|||++. .++|+|||+|...
T Consensus 201 NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS---SEEECCCTTCEET
T ss_pred HEEEcC---cEEEEECcccccC
Confidence 999987 7999999999874
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-18 Score=175.71 Aligned_cols=141 Identities=14% Similarity=0.125 Sum_probs=102.3
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc-----------ch----hH----HHHHHHHHHHHHhcCCCC
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI-----------NK----NM----VSQVLRERNALALTHSPF 103 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~-----------~~----~~----~~~~~~E~~iL~~l~hp~ 103 (473)
|++.+.||+|+||.||+|++. .|+.||||+++..... .. .. .....+|...|..+.+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 889999999999999999764 4789999998643211 00 00 112346777777775444
Q ss_pred eeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC---
Q psy622 104 CVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP--- 180 (473)
Q Consensus 104 Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g--- 180 (473)
+....-+.... .+|||||++|++|..+. ....++.++.||+.+|.+||++|||||||||.|||++.+ |
T Consensus 175 v~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d-gd~~ 245 (397)
T 4gyi_A 175 FPVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE-KDAE 245 (397)
T ss_dssp CSCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE-ECSS
T ss_pred CCCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC-CCcc
Confidence 32222111222 37999999999986543 223466788999999999999999999999999999987 5
Q ss_pred -------ceeEeecchhhhhc
Q psy622 181 -------HCPIVNTLFLAILQ 194 (473)
Q Consensus 181 -------~ikL~DFGla~~~~ 194 (473)
.+.|+||+-+....
T Consensus 246 d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CTTSEEEEEEECCCTTCEETT
T ss_pred cccccccceEEEEeCCcccCC
Confidence 38899999887643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=8.9e-13 Score=126.12 Aligned_cols=141 Identities=13% Similarity=0.044 Sum_probs=112.4
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~ 118 (473)
++.|++...++.|+.+.||++.. .++.+++|+....... ....+.+|..+|+.+ .+..+.+++++..+.+..|
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC---SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC---CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 45799999999999999999853 2468999998764211 123578899999988 4677888999999999999
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS-------------------------------------- 160 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~-------------------------------------- 160 (473)
+||||++|.+|.+.+. +......++.++..+|..||+
T Consensus 87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999999977531 223345778899999999998
Q ss_pred ---------------------CCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 161 ---------------------HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 161 ---------------------~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
..++|+|++|.|||++.+ +.+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhccc
Confidence 458999999999999865 5567999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-11 Score=116.56 Aligned_cols=136 Identities=13% Similarity=0.157 Sum_probs=100.8
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCC--eeeEEEEEEeCCEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPF--CVQLFYSLQTSSCV 117 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~f~~~~~l 117 (473)
+.++.+..+.+.|..+.||++... +|+.+++|+..... ...+.+|..+++.+.+.. +.+++++..+.+..
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~--~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECT--TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred cCCCceEecccCCCCceEEEEecC--CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 456777666667777999998532 35679999976531 135678899998884333 56688888888889
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG----------------------------------- 162 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~g----------------------------------- 162 (473)
|+||||++|.+|. .. ... ...++.+++.+|..||+..
T Consensus 91 ~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999999999883 11 122 2356677777788887643
Q ss_pred -----------------------eeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 163 -----------------------IIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 163 -----------------------IiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
++|+|++|.|||++.+ +.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhccc
Confidence 9999999999999875 5667999999765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.6e-10 Score=115.79 Aligned_cols=141 Identities=14% Similarity=0.240 Sum_probs=104.9
Q ss_pred EEceecccCceEEEEEEEeCCCCcEEEEEEee--cccccchhHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeC---CEE
Q psy622 45 IVKAISRGAFGKVFLGYKKTNKDQLYAIKVMK--KDEMINKNMVSQVLRERNALALTH--SPFCVQLFYSLQTS---SCV 117 (473)
Q Consensus 45 i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~--k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~f~~~---~~l 117 (473)
-++.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+++.+. +..+.+++..+.+. +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~---~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP---GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECS---SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEEC---CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 4678899999999998643 3578888876 43211 12346788999999885 45578888888776 458
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS------------------------------------- 160 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~------------------------------------- 160 (473)
|+||||++|..+.+. ....+++.....++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999999999877431 12346788889999999999999997
Q ss_pred ---------------------CCeeecCCCCcceEecCCCCc-eeEeecchhhh
Q psy622 161 ---------------------HGIIHRDLKPDNMLISAQAPH-CPIVNTLFLAI 192 (473)
Q Consensus 161 ---------------------~gIiHRDLKpeNILld~~~g~-ikL~DFGla~~ 192 (473)
.+++|+|++|.|||++.+++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 359999999999999977323 58999998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.55 E-value=1.4e-07 Score=91.88 Aligned_cols=133 Identities=20% Similarity=0.219 Sum_probs=97.8
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCC--eeeEEEEEEeCC---EEEEE
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPF--CVQLFYSLQTSS---CVFLV 120 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~--Iv~l~~~f~~~~---~l~lV 120 (473)
+.++.|....||++. ..+++|+.... .....+.+|..+|+.+ .+.. +.+++....... ..|+|
T Consensus 26 ~~~~~G~~n~v~~v~------~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN------RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST------TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC------CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 458999999999862 34889986532 2355788999999887 3332 334444433332 35899
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS---------------------------------------- 160 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~---------------------------------------- 160 (473)
|++++|.+|..... ..++..+...++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999998875433 246788888888888888888886
Q ss_pred ------------------CCeeecCCCCcceEecCC-CCceeEeecchhhh
Q psy622 161 ------------------HGIIHRDLKPDNMLISAQ-APHCPIVNTLFLAI 192 (473)
Q Consensus 161 ------------------~gIiHRDLKpeNILld~~-~g~ikL~DFGla~~ 192 (473)
..++|+|++|.||+++.+ ++.+.|+||+.+..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 137999999999999983 26788999998865
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=1.6e-06 Score=84.69 Aligned_cols=133 Identities=20% Similarity=0.209 Sum_probs=90.4
Q ss_pred ceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC---CeeeEEEEEE-eCCEEEEEec
Q psy622 47 KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP---FCVQLFYSLQ-TSSCVFLVME 122 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp---~Iv~l~~~f~-~~~~l~lVmE 122 (473)
+.++.|....||+. ++.+++|+-.. ......+.+|..+|..+.+. .+.+++.+.. ..+..|+|||
T Consensus 25 ~~l~~G~~n~v~~v------g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 25 ESLGEGFRNYAILV------NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEECSSEEEEEE------TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eecCCCcceeEEEE------CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 45788998999987 24588888432 23356789999999998542 2445555553 4456789999
Q ss_pred ccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q psy622 123 YMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH----------------------------------------- 161 (473)
Q Consensus 123 y~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~----------------------------------------- 161 (473)
+++|..|....- ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988876322 1234444455555555555555532
Q ss_pred -------------------CeeecCCCCcceEecC---CCCceeEeecchhhh
Q psy622 162 -------------------GIIHRDLKPDNMLISA---QAPHCPIVNTLFLAI 192 (473)
Q Consensus 162 -------------------gIiHRDLKpeNILld~---~~g~ikL~DFGla~~ 192 (473)
.++|+|++|.|||++. ++..+.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3699999999999997 313458999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.9e-06 Score=82.15 Aligned_cols=138 Identities=15% Similarity=0.145 Sum_probs=96.0
Q ss_pred CeEEEceecccCc-eEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEE
Q psy622 42 DFEIVKAISRGAF-GKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 42 ~y~i~~~LG~G~f-G~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~l 119 (473)
.|+...+ ..|.. ..||+..... .+..+.+|+-... ....+.+|..+|+.+. +--+.+++.+..+.+..|+
T Consensus 26 g~~~~~~-~~G~S~~~v~rl~~~~-~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~l 97 (272)
T 4gkh_A 26 GYRWARD-NVGQSGATIYRLYGKP-NAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWL 97 (272)
T ss_dssp TCEEEEE-ECSSSSCEEEEEECCT-TCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred CCeEEEc-cCCCcCCeEEEEEecC-CCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEE
Confidence 3454433 33444 4788875544 3567899986543 2456788999998773 3236678888899999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH-------------------------------------- 161 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~-------------------------------------- 161 (473)
|||+++|.++.+..... ......+..++...|.-||+.
T Consensus 98 vme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 98 LTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp EEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred EEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 99999998887765542 122334555666666666631
Q ss_pred --------------------CeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 162 --------------------GIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 162 --------------------gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
.++|+|+.|.|||++.+ +.+-|+||+.+..
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~~ 223 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVGI 223 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence 27999999999999976 6667999998865
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=3.6e-06 Score=85.16 Aligned_cols=79 Identities=23% Similarity=0.282 Sum_probs=49.2
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeecccc-cch---hHHHHHHHHHHHHHhcC-C-CC-eeeEEEEEEeCCEEE
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEM-INK---NMVSQVLRERNALALTH-S-PF-CVQLFYSLQTSSCVF 118 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~-~~~---~~~~~~~~E~~iL~~l~-h-p~-Iv~l~~~f~~~~~l~ 118 (473)
++.||.|..+.||++.... +++.|++|......- ... ....++..|.++|+.+. + |. +.+++.+ +....+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~-~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEECCSSSSEEEEEEEC-----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEECCCCceEEEEEEEECC-CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 5688999999999996543 356799998654211 000 12345678999988773 2 33 3445543 445568
Q ss_pred EEecccCcC
Q psy622 119 LVMEYMIGG 127 (473)
Q Consensus 119 lVmEy~~gg 127 (473)
+|||+++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=3.6e-05 Score=75.48 Aligned_cols=136 Identities=12% Similarity=0.111 Sum_probs=77.8
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-----CCCCeeeEE-E--EEEeCCEE
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-----HSPFCVQLF-Y--SLQTSSCV 117 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~-~--~f~~~~~l 117 (473)
++.|+.|..+.||++... . ..+++|+.... . ..+..|..+++.+ ..|.++... + +....+..
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~-~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--S-GAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEECC----CEEEEEEET--T-EEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred eeeccccccCcEEEEEeC--C-CCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 345677788999998643 2 35899998763 1 2233445555443 234444310 0 12457789
Q ss_pred EEEecccCcCCHH--------------HHHHhC-CCC--C-----------HH--------H------------------
Q psy622 118 FLVMEYMIGGDVK--------------SLIAAN-GAL--P-----------ED--------M------------------ 143 (473)
Q Consensus 118 ~lVmEy~~gg~L~--------------~~L~~~-~~~--~-----------e~--------~------------------ 143 (473)
|+||+|++|..+. ..++.. ..+ + .. .
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986531 111210 111 1 00 0
Q ss_pred -----HHHHHHHHHHHHHHHHH-------------CCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 144 -----AAFYAAEVVLALQYLHS-------------HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 144 -----~~~~~~qI~~aL~yLH~-------------~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
...+..++..++++|++ .+++|+|+++.|||++.+ +.+.|+||+.+..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~~ 252 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGEN-EQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGG-GCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCC-CcEEEEehhhccc
Confidence 11122234445666652 579999999999999877 7899999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=4.4e-05 Score=75.72 Aligned_cols=84 Identities=13% Similarity=0.146 Sum_probs=54.5
Q ss_pred eEEEcee-cccCceEEEEEEEe---CC--CCcEEEEEEeeccc---ccchhHHHHHHHHHHHHHhcC-C--CCeeeEEEE
Q psy622 43 FEIVKAI-SRGAFGKVFLGYKK---TN--KDQLYAIKVMKKDE---MINKNMVSQVLRERNALALTH-S--PFCVQLFYS 110 (473)
Q Consensus 43 y~i~~~L-G~G~fG~V~~a~~~---~~--~~~~vAiK~l~k~~---~~~~~~~~~~~~E~~iL~~l~-h--p~Iv~l~~~ 110 (473)
...++.| +.|..+.+|++... .+ .++.+++|+..... ... ...+.+|..+|+.+. + -.+.+++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 3445778 88999999988643 00 14578889866532 111 124667888887773 2 346677777
Q ss_pred EEeC---CEEEEEecccCcCCH
Q psy622 111 LQTS---SCVFLVMEYMIGGDV 129 (473)
Q Consensus 111 f~~~---~~l~lVmEy~~gg~L 129 (473)
..+. +..|+|||+++|..+
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCC
T ss_pred ccCCCccCCceEEEEecCCCCh
Confidence 6654 357899999988654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00022 Score=72.52 Aligned_cols=32 Identities=16% Similarity=0.445 Sum_probs=27.8
Q ss_pred HHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 159 HSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 159 H~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
+...++|+|++|.|||++.+ + ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQD-S-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSS-C-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCC-C-CEEEeCccccc
Confidence 45679999999999999987 5 99999988765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.0006 Score=66.58 Aligned_cols=75 Identities=17% Similarity=0.168 Sum_probs=58.1
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCEEEEEec
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH---SPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
++.|+.|....+|+... .++.|++|+-... ....+..|...|+.+. ...+.+++......+..|+|||
T Consensus 41 ~~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND---EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEECCSSSSEEEEEES---SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eEEeCCccceeeeEEEE---CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 56789999999999853 3467888987643 2456788988888772 3567888888888889999999
Q ss_pred ccCcCCH
Q psy622 123 YMIGGDV 129 (473)
Q Consensus 123 y~~gg~L 129 (473)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00037 Score=67.39 Aligned_cols=132 Identities=14% Similarity=0.061 Sum_probs=72.5
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEeccc
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCVFLVMEYM 124 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lVmEy~ 124 (473)
++.|+.|....+|++ +.|++|+....... .....+|..+++.+. +....++++.. ...-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~-------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE-------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECC
T ss_pred eeEcCCcccccccee-------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeec
Confidence 678888999999998 23888887653110 011245777776652 22224555543 33347899999
Q ss_pred -CcCCHHH---------------HH---HhCC-CC----C-HHHHHHHHHH--------------HHHHHHHHH----H-
Q psy622 125 -IGGDVKS---------------LI---AANG-AL----P-EDMAAFYAAE--------------VVLALQYLH----S- 160 (473)
Q Consensus 125 -~gg~L~~---------------~L---~~~~-~~----~-e~~~~~~~~q--------------I~~aL~yLH----~- 160 (473)
+|.+|.. .| +..+ .+ . ......+... +...+..+. .
T Consensus 90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~ 169 (301)
T 3dxq_A 90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH 169 (301)
T ss_dssp TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence 6654421 01 1111 11 1 1112222111 111122111 1
Q ss_pred ---CCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 161 ---HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 161 ---~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
..++|+|+.|.||| ..+ +.+.|+||..+..
T Consensus 170 ~~~~~l~HgDl~~~Nil-~~~-~~~~lID~e~a~~ 202 (301)
T 3dxq_A 170 PLPLAACHCDPLCENFL-DTG-ERMWIVDWEYSGM 202 (301)
T ss_dssp CCCCEEECSCCCGGGEE-ECS-SCEEECCCTTCEE
T ss_pred CCCceeeccCCCcCCEE-ECC-CCEEEEecccccC
Confidence 23899999999999 445 6789999988764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0023 Score=62.27 Aligned_cols=103 Identities=13% Similarity=0.149 Sum_probs=60.9
Q ss_pred CCCCCCccchhhHHHHhHhhhcccccccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccc
Q psy622 3 SSGLFSGADKENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN 82 (473)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~ 82 (473)
+.+.|+..+.+.+.+.+... .+.. . ... ..|+ |.-..||++... .|+.+++|+......
T Consensus 4 ~~~~~~~l~~~~i~~~l~~~------g~~~------~-~~~---~~l~-g~~n~~y~v~~~--~g~~~vlK~~~~~~~-- 62 (328)
T 1zyl_A 4 SAFTFQTLHPDTIMDALFEH------GIRV------D-SGL---TPLN-SYENRVYQFQDE--DRRRFVVKFYRPERW-- 62 (328)
T ss_dssp CCCCCCCCCHHHHHHHHHHT------TCCC------C-SCC---EEEC-CSSSEEEEECCT--TCCCEEEEEECTTTS--
T ss_pred CCCCCCCCCHHHHHHHHHHc------CCCC------C-ceE---Eeec-CcccceEEEEcC--CCCEEEEEEcCCCCC--
Confidence 55668888888888877432 1100 0 122 3455 777899987432 345789999874321
Q ss_pred hhHHHHHHHHHHHHHhcC-CC-CeeeEEEE-----EEeCCEEEEEecccCcCC
Q psy622 83 KNMVSQVLRERNALALTH-SP-FCVQLFYS-----LQTSSCVFLVMEYMIGGD 128 (473)
Q Consensus 83 ~~~~~~~~~E~~iL~~l~-hp-~Iv~l~~~-----f~~~~~l~lVmEy~~gg~ 128 (473)
....+..|..++..+. +. .+.+++.. ....+..++||++++|..
T Consensus 63 --~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~ 113 (328)
T 1zyl_A 63 --TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 113 (328)
T ss_dssp --CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred --CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCC
Confidence 1235666777777662 11 13334332 233567789999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0018 Score=62.91 Aligned_cols=162 Identities=14% Similarity=0.181 Sum_probs=87.6
Q ss_pred CCCccchhhHHHHhHhhhcccccccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhH
Q psy622 6 LFSGADKENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNM 85 (473)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~ 85 (473)
-|+..+.+.+....... .+....-++.|+.|....+|++.... + .+++|+..... .
T Consensus 3 v~~~~~~~~l~~~l~~~----------------~~~~~~~~~~i~~G~~n~~~~v~~~~--g-~~vlk~~~~~~--~--- 58 (322)
T 2ppq_A 3 VYTDITEDELRNFLTQY----------------DVGSLTSYKGIAEGVENSNFLLHTTK--D-PLILTLYEKRV--E--- 58 (322)
T ss_dssp --CCCCHHHHHHHHTTB----------------CCCCEEEEEEECC---EEEEEEEESS--C-CEEEEEECC--------
T ss_pred ccccCCHHHHHHHHHhC----------------CCCcceEeeccCCCcccceEEEEeCC--c-cEEEEEeCCCC--C---
Confidence 35666666666655311 12334456778888889999986432 3 58899987631 1
Q ss_pred HHHHHHHHHHHHhcC-----CCCeeeEE-E--EEEeCCEEEEEecccCcCCHH-----------H---HHHhC-CCC---
Q psy622 86 VSQVLRERNALALTH-----SPFCVQLF-Y--SLQTSSCVFLVMEYMIGGDVK-----------S---LIAAN-GAL--- 139 (473)
Q Consensus 86 ~~~~~~E~~iL~~l~-----hp~Iv~l~-~--~f~~~~~l~lVmEy~~gg~L~-----------~---~L~~~-~~~--- 139 (473)
...+..|..++..+. -|.++... + +....+..++||+|++|..+. . .++.. ..+
T Consensus 59 ~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~ 138 (322)
T 2ppq_A 59 KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIK 138 (322)
T ss_dssp CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCC
T ss_pred HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCc
Confidence 123456777776552 23333210 0 122356789999999886431 1 11211 111
Q ss_pred -----CHHHHHH---------------HHHHHHHHHHHHHH-------CCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 140 -----PEDMAAF---------------YAAEVVLALQYLHS-------HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 140 -----~e~~~~~---------------~~~qI~~aL~yLH~-------~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
....-.. +...+...++.++. .+++|+|+++.|||++.+ +.+.|+||+.+..
T Consensus 139 ~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 139 RPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACN 217 (322)
T ss_dssp CBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred ccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence 1000000 01123444555553 369999999999999876 5558999988764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.019 Score=54.77 Aligned_cols=78 Identities=13% Similarity=-0.040 Sum_probs=52.3
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-C--CCeeeEEEEEEeCCEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-S--PFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-h--p~Iv~l~~~f~~~~~l~ 118 (473)
...-++.+|.|..+.||++... .|+.|.+|+-....... ...+.+|...|+.+. . -.+.+++.. +. -+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA--DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET--TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TE
T ss_pred CeEEEEecCCCCCeEEEEEEEC--CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ce
Confidence 4566788999999999999654 36789999866442211 224678998888773 2 123444443 22 36
Q ss_pred EEecccCcCC
Q psy622 119 LVMEYMIGGD 128 (473)
Q Consensus 119 lVmEy~~gg~ 128 (473)
+||||+.++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0035 Score=63.95 Aligned_cols=75 Identities=16% Similarity=0.143 Sum_probs=49.1
Q ss_pred EEceecccCceEEEEEEEeCC------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEE
Q psy622 45 IVKAISRGAFGKVFLGYKKTN------KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 45 i~~~LG~G~fG~V~~a~~~~~------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l 117 (473)
-++.|+.|.-..||++..... .++.|++|+..... . ...+.+|..+++.+. +....++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 346778888899999975421 24678999874321 1 134557888888773 4344667776643
Q ss_pred EEEecccCcCC
Q psy622 118 FLVMEYMIGGD 128 (473)
Q Consensus 118 ~lVmEy~~gg~ 128 (473)
.+|+||++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 28999998743
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0052 Score=60.01 Aligned_cols=32 Identities=16% Similarity=0.281 Sum_probs=26.8
Q ss_pred CCeeecCCCCcceEecCC---CCceeEeecchhhh
Q psy622 161 HGIIHRDLKPDNMLISAQ---APHCPIVNTLFLAI 192 (473)
Q Consensus 161 ~gIiHRDLKpeNILld~~---~g~ikL~DFGla~~ 192 (473)
..++|+|+.+.|||++.+ .+.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999863 15689999998875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=96.63 E-value=0.00017 Score=70.35 Aligned_cols=68 Identities=12% Similarity=0.131 Sum_probs=56.5
Q ss_pred CccCCCCceeecCCCCCCCCCcccc---ccc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPE---DEE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|....++.+..+...||+ ++. ...-.+|+.||+.+. |||||.+.|+|.+...+|+|++.+.
T Consensus 38 ~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yivmEy~~ 115 (311)
T 4aw0_A 38 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAK 115 (311)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEEEecCC
Confidence 4579999998888887778889999 221 113467999999995 9999999999999999999999886
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.00036 Score=69.17 Aligned_cols=68 Identities=7% Similarity=-0.126 Sum_probs=55.1
Q ss_pred CccCCCCceeecCCCCCCCCCccccc---cc----ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPED---EE----ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-++....+...|||+ .+ ...-.+|+.||+.+ .|||||.+.|+|.+...+|+|++.|.
T Consensus 80 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 80 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 34788999877777776677789992 11 12345899999999 59999999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=96.59 E-value=0.00043 Score=68.35 Aligned_cols=69 Identities=17% Similarity=0.269 Sum_probs=59.4
Q ss_pred ccCCCCceeecCCCCCCCCCcccc---cccccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPE---DEEALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|..+-++....+...||+ ++...+..+|+++|+.+.+|||||.+.++|.+...+|++++.|.-
T Consensus 29 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 478888887777777777779999 444567889999999999999999999999999999999999853
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0051 Score=61.63 Aligned_cols=138 Identities=14% Similarity=0.133 Sum_probs=81.0
Q ss_pred ceecccCceEEEEEEEeC------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEE
Q psy622 47 KAISRGAFGKVFLGYKKT------NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~l 119 (473)
+.|..|--..+|++.... +.++.|++|+.... ........+|..+++.+ .+....++++.+.+. +
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----R 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----c
Confidence 456667788899986532 12367899986332 11234556899999877 344446677776542 9
Q ss_pred EecccCcCCHH--------------HHH---HhC----C-CC--CHHHHHHHHHHHHH-------------------HHH
Q psy622 120 VMEYMIGGDVK--------------SLI---AAN----G-AL--PEDMAAFYAAEVVL-------------------ALQ 156 (473)
Q Consensus 120 VmEy~~gg~L~--------------~~L---~~~----~-~~--~e~~~~~~~~qI~~-------------------aL~ 156 (473)
||||++|..|. ..| +.. + .. -..++..|..++-. .++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999885542 111 111 1 11 13455556554422 233
Q ss_pred HHH----H----CCeeecCCCCcceEecCC---CCceeEeecchhhh
Q psy622 157 YLH----S----HGIIHRDLKPDNMLISAQ---APHCPIVNTLFLAI 192 (473)
Q Consensus 157 yLH----~----~gIiHRDLKpeNILld~~---~g~ikL~DFGla~~ 192 (473)
.|. . ..++|+|+.+.|||++.+ .+.+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 333 2 259999999999999865 25899999988865
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.011 Score=58.05 Aligned_cols=31 Identities=16% Similarity=0.191 Sum_probs=27.2
Q ss_pred CCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 161 HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 161 ~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
..++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNE-ESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGG-GCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCC-CeEEEEECCCCee
Confidence 369999999999999977 7899999987765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0032 Score=62.59 Aligned_cols=75 Identities=16% Similarity=0.151 Sum_probs=42.6
Q ss_pred EceecccCceEEEEEEEeCC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEE
Q psy622 46 VKAISRGAFGKVFLGYKKTN-------KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~-------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l 117 (473)
++.|+.|....+|++..... .++.|++|+..... . .......|..+++.+. +..+.++++.+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---D-ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---G-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---c-ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 45677788889999865320 12578888876431 1 1112356777887763 33344666654 22
Q ss_pred EEEecccCcCC
Q psy622 118 FLVMEYMIGGD 128 (473)
Q Consensus 118 ~lVmEy~~gg~ 128 (473)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=96.43 E-value=0.00039 Score=66.67 Aligned_cols=68 Identities=15% Similarity=0.105 Sum_probs=51.8
Q ss_pred CccCCCCceeecCCCCCCCCCcccc---cccc-------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPE---DEEA-------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-++.+..+...||+ ++.. ..-.+|+.||+.+. |||||.+.|+|.+...+|+|++.|.
T Consensus 19 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~ivmEy~~ 96 (275)
T 3hyh_A 19 KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMVIEYAG 96 (275)
T ss_dssp EEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEEEeCCC
Confidence 4478899997777777777778999 2221 12357999999995 9999999999999999999999983
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.00033 Score=69.52 Aligned_cols=68 Identities=13% Similarity=0.160 Sum_probs=49.4
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---cc------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---EA------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-++.+......|||+. .. ..-.+|+.||+.+. |||||.+.|+|.+...+|+|++.|.
T Consensus 30 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiVmEy~~ 106 (350)
T 4b9d_A 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIVMDYCE 106 (350)
T ss_dssp EEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEEEeCCC
Confidence 448889998777776666677899922 11 12357999999995 9999999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.29 E-value=0.00064 Score=69.19 Aligned_cols=68 Identities=7% Similarity=-0.119 Sum_probs=55.2
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-++....+...|||+.- ...-.+|+.||+.+ .|||||.+.|+|.+...+|+|++.|.
T Consensus 157 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEEEEeCCC
Confidence 4578899987777777777778999221 11234799999999 59999999999999999999999996
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=96.29 E-value=0.00046 Score=68.14 Aligned_cols=67 Identities=12% Similarity=0.014 Sum_probs=55.9
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc--ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE--ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..|.+.|...-+..+......+||+.- +..-.+|+.||+.+ .|||||.+.++|.+...+|+|++.|.
T Consensus 65 ~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGL-SSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTC-CCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccC
Confidence 378999998877777777778999332 33446899999998 59999999999999999999999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=96.16 E-value=0.00076 Score=65.92 Aligned_cols=69 Identities=14% Similarity=0.185 Sum_probs=57.6
Q ss_pred ccCCCCceeecCCCCCCCCCcccc---ccc-ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPE---DEE-ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|..+-++....+...+|| +++ ..+.++|+.+|+.+.+|||||.+.++|.+...+|++++.|..
T Consensus 18 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 477888887777666666778998 332 457789999999999999999999999999999999999864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.97 E-value=0.014 Score=59.88 Aligned_cols=76 Identities=13% Similarity=0.183 Sum_probs=46.4
Q ss_pred EEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEecc
Q psy622 45 IVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCVFLVMEY 123 (473)
Q Consensus 45 i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lVmEy 123 (473)
-++.|+.|--..+|++.... .++.|++|+..... ...+ ...+|..+|+.+. +....++++.+. + .+||||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMS-KQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETT-TTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECC-CCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEe
Confidence 34577888889999986543 23678899875431 0001 1247888888884 333466777763 2 259999
Q ss_pred cCcCCH
Q psy622 124 MIGGDV 129 (473)
Q Consensus 124 ~~gg~L 129 (473)
++|-+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=95.94 E-value=0.0013 Score=63.47 Aligned_cols=67 Identities=19% Similarity=0.226 Sum_probs=52.1
Q ss_pred cCCCCceeecCCCCCCCCCccccc---ccccC------cchHHHHHHhhcCCCcEEeccccccc----ccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPED---EEALN------PSTEETILALLKSDPIVFMGDDTWSS----FSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 460 (473)
.|.+.|...-+.........+|+. +...+ -.+|+.||+.+ .|||||.+.|+|.+ ...+|+|++.|.
T Consensus 34 iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~ 112 (290)
T 3fpq_A 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMT 112 (290)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEEEEEeCCC
Confidence 788999977777766677789982 22112 24799999999 59999999999865 567999999997
Q ss_pred C
Q psy622 461 P 461 (473)
Q Consensus 461 ~ 461 (473)
-
T Consensus 113 g 113 (290)
T 3fpq_A 113 S 113 (290)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.80 E-value=0.0018 Score=65.37 Aligned_cols=68 Identities=13% Similarity=0.130 Sum_probs=52.9
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---ccc------CcchHHHHHHhhcCCCcEEeccccc------ccccceehhh
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---EAL------NPSTEETILALLKSDPIVFMGDDTW------SSFSAIFNTL 456 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~ 456 (473)
...|.|.|..+-++.+..+...+||+. ... ...+|+.||+.+ .|||||.+.|+| .++..+|+|+
T Consensus 60 ~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~~~~ivm 138 (398)
T 4b99_A 60 ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEFKSVYVVL 138 (398)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTCCCEEEEE
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccCCEEEEEE
Confidence 458899999888777777777899932 111 123699999999 499999999885 4567899999
Q ss_pred cccC
Q psy622 457 DAMS 460 (473)
Q Consensus 457 ~~~~ 460 (473)
++|.
T Consensus 139 E~~~ 142 (398)
T 4b99_A 139 DLME 142 (398)
T ss_dssp ECCS
T ss_pred eCCC
Confidence 9995
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=95.74 E-value=0.0011 Score=65.96 Aligned_cols=69 Identities=9% Similarity=0.032 Sum_probs=52.7
Q ss_pred CccCCCCceeecCCCCC--CC-CCccccccc-----ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPD--NS-ELEWPEDEE-----ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-++..+ .+ ...+|++.- ...-.+|+.+|+.+.+|||||.+.++|.+..++|+|++.|.
T Consensus 27 ~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~ 103 (361)
T 4f9c_A 27 DKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLE 103 (361)
T ss_dssp EEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCC
T ss_pred EEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCC
Confidence 45788899866554332 22 336888321 22345799999999999999999999999999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=95.66 E-value=0.0012 Score=69.99 Aligned_cols=68 Identities=13% Similarity=0.158 Sum_probs=56.1
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|....++.+..+...||++.- ...-.+|+.||+.+. |||||.+.|+|.+...+|++++.|.
T Consensus 163 ~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEEEEeecC
Confidence 3478899998888888777788998211 123457999999995 9999999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=95.29 E-value=0.0022 Score=62.35 Aligned_cols=69 Identities=12% Similarity=0.176 Sum_probs=46.7
Q ss_pred CccCCCCceeecCC---CCCCCCCcccc---ccc------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhccc
Q psy622 392 NLSGVSPFLAMDRS---PPDNSELEWPE---DEE------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAM 459 (473)
Q Consensus 392 ~~~~~~~~~~~~~~---~~~~~~~~~~~---~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (473)
...|.+.|...-+. ........||+ ++. ...-.+|+.||+.+ .|||||.+.++|.+...+|+|++.|
T Consensus 30 ~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy~ 108 (304)
T 3ubd_A 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKLYLILDFL 108 (304)
T ss_dssp EEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTEEEEEECCC
T ss_pred EEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEEcC
Confidence 44788888855432 22334457898 111 22456799999988 5999999999999999999999998
Q ss_pred CC
Q psy622 460 SP 461 (473)
Q Consensus 460 ~~ 461 (473)
.-
T Consensus 109 ~g 110 (304)
T 3ubd_A 109 RG 110 (304)
T ss_dssp TT
T ss_pred CC
Confidence 63
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.24 E-value=0.021 Score=57.96 Aligned_cols=76 Identities=12% Similarity=0.093 Sum_probs=46.5
Q ss_pred EEceecccCceEEEEEEEeCCC------CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q psy622 45 IVKAISRGAFGKVFLGYKKTNK------DQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 45 i~~~LG~G~fG~V~~a~~~~~~------~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l 117 (473)
-++.|..|--..+|++...... ++.|++|+..... . ..-...+|..+++.+ .+....++++.+. +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---G-KFYDSKVELDVFRYLSNINIAPNIIADFP--E-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--
Confidence 3455666888899998754211 4678999865431 1 011234677777776 3344456666443 2
Q ss_pred EEEecccCcCC
Q psy622 118 FLVMEYMIGGD 128 (473)
Q Consensus 118 ~lVmEy~~gg~ 128 (473)
++||||++|..
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 68999999865
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.87 E-value=0.005 Score=60.47 Aligned_cols=67 Identities=10% Similarity=0.064 Sum_probs=48.6
Q ss_pred ccCCCCceeecCC-----CCCCCCCccccccc-cc------CcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 393 LSGVSPFLAMDRS-----PPDNSELEWPEDEE-AL------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..|.+.|...-+. .+......+||+.- .. +-.+|++||+.+ .|||||.+.+++.+...+|+|++.|.
T Consensus 48 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey~~ 126 (329)
T 4aoj_A 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTEGRPLLMVFEYMR 126 (329)
T ss_dssp EEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred EEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 3788888844332 23334457888332 11 234799999999 69999999999999999999999996
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=94.78 E-value=0.0026 Score=61.60 Aligned_cols=68 Identities=12% Similarity=0.075 Sum_probs=49.4
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc--------ccCcchHHHHHHhhcCCCcEEeccccccc------------ccce
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE--------ALNPSTEETILALLKSDPIVFMGDDTWSS------------FSAI 452 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~ 452 (473)
..|.+.|...-++....+...|||+.- ...-.+|+.||+.+ .|||||.+.++|-+ ..++
T Consensus 12 ~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l 90 (299)
T 4g31_A 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQPSSPKVYL 90 (299)
T ss_dssp EEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC----------CEEE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccccCCCcEE
Confidence 478889987777777777778999321 11234799999999 59999999999853 3368
Q ss_pred ehhhcccCC
Q psy622 453 FNTLDAMSP 461 (473)
Q Consensus 453 ~~~~~~~~~ 461 (473)
|++++.|.-
T Consensus 91 ~ivmE~~~g 99 (299)
T 4g31_A 91 YIQMQLCRK 99 (299)
T ss_dssp EEEEECCCS
T ss_pred EEEEecCCC
Confidence 999998863
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=93.98 E-value=0.0087 Score=64.26 Aligned_cols=70 Identities=13% Similarity=0.147 Sum_probs=55.6
Q ss_pred CccCCCCceeecCCCCCCCCCccccc---cc-------ccCcchHHHHHHhhc--CCCcEEecccccccccceehhhccc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPED---EE-------ALNPSTEETILALLK--SDPIVFMGDDTWSSFSAIFNTLDAM 459 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (473)
...|.|.|..+-++.+..+...||++ +. +....+|..+|.++. .|||||.+.++|.+...+|+|++.|
T Consensus 195 k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~ 274 (689)
T 3v5w_A 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 274 (689)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecC
Confidence 44899999988877777788899992 11 122346777777776 6999999999999999999999998
Q ss_pred CC
Q psy622 460 SP 461 (473)
Q Consensus 460 ~~ 461 (473)
.-
T Consensus 275 ~G 276 (689)
T 3v5w_A 275 NG 276 (689)
T ss_dssp CS
T ss_pred CC
Confidence 73
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=93.97 E-value=0.012 Score=57.47 Aligned_cols=69 Identities=16% Similarity=0.152 Sum_probs=54.6
Q ss_pred CccCCCCceeecCCCCCCCCCccccc---ccccCc------chHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPED---EEALNP------STEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|....+..+..+...+|++ +...++ .+|+.+|+.+. ||||+.+.++|.+...+|++++.|..
T Consensus 21 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~ 98 (328)
T 3fe3_A 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLYLIMEYASG 98 (328)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEEEEECCCC
Confidence 45788888877777766677788983 222232 37999999995 99999999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=93.86 E-value=0.012 Score=56.44 Aligned_cols=68 Identities=9% Similarity=-0.007 Sum_probs=53.2
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..|.+.|...-++....+...+||+.- ...-.+|+++|+.+..||||+.+.++|.+...+|++++.|.
T Consensus 20 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (316)
T 2ac3_A 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94 (316)
T ss_dssp CCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCC
Confidence 367888886666655556668888322 11234799999999999999999999999999999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=93.76 E-value=0.012 Score=58.50 Aligned_cols=68 Identities=16% Similarity=0.260 Sum_probs=53.3
Q ss_pred CccCCCCceeecCCCCCCCCCcccc---ccccc----------CcchHHHHHHhhcCCCcEEecccccccccceehhhcc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPE---DEEAL----------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDA 458 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (473)
...|.+.|....++....+...||+ .+... .-.+|+.+|+.+. |||||.+.++|.+...+|++++.
T Consensus 18 ~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~e~ 96 (361)
T 2yab_A 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYENRTDVVLILEL 96 (361)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEEeCCEEEEEEEc
Confidence 3477888887777766666778998 22211 1247999999996 99999999999999999999999
Q ss_pred cC
Q psy622 459 MS 460 (473)
Q Consensus 459 ~~ 460 (473)
|.
T Consensus 97 ~~ 98 (361)
T 2yab_A 97 VS 98 (361)
T ss_dssp CC
T ss_pred CC
Confidence 85
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=93.57 E-value=0.013 Score=58.24 Aligned_cols=70 Identities=13% Similarity=0.059 Sum_probs=50.9
Q ss_pred CccCCCCceeecCCCCCCCCCccccc---ccccCcchHHHHHHhhcCCCcEEeccccc----------------------
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPED---EEALNPSTEETILALLKSDPIVFMGDDTW---------------------- 446 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------- 446 (473)
...|.+.|...-+.....+...+|++ +......+|+.+|+.+ .|||||.+.++|
T Consensus 13 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (383)
T 3eb0_A 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGG 91 (383)
T ss_dssp EEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTC-CCTTBCCEEEEEEEC-------------------
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHc-CCCCccchhheeeecCcccccccccccccccccc
Confidence 34677788766555555556688983 2234567999999999 699999999999
Q ss_pred ----------------ccccceehhhcccCCC
Q psy622 447 ----------------SSFSAIFNTLDAMSPT 462 (473)
Q Consensus 447 ----------------~~~~~~~~~~~~~~~~ 462 (473)
.+..++|++++.|..+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 123 (383)
T 3eb0_A 92 KNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123 (383)
T ss_dssp ------------------CCEEEEEECCCSEE
T ss_pred cccccccccccccccCCCceEEEEEEecCCcc
Confidence 6677899999999753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=92.99 E-value=0.021 Score=55.09 Aligned_cols=67 Identities=10% Similarity=0.026 Sum_probs=44.8
Q ss_pred cCCCCceeecCC-----CCCCCCCccccccc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRS-----PPDNSELEWPEDEE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|...-+. ........+||+.- ..+-.+|++||+.+ .|||||.+.+++.+...+|+|++.|.-
T Consensus 21 lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey~~~ 99 (299)
T 4asz_A 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEYMKH 99 (299)
T ss_dssp EEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred EeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEcCCC
Confidence 577777643322 12223336788322 11234799999999 599999999999999999999999963
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.83 E-value=0.01 Score=60.74 Aligned_cols=68 Identities=18% Similarity=0.114 Sum_probs=52.4
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc---------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE---------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|....++........||+..- ...-.+|+.+|+.+ .|||||.+.++|.+...+|++++.|..
T Consensus 18 ~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (444)
T 3soa_A 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTG 94 (444)
T ss_dssp EEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSSEEEEEECCCBC
T ss_pred EeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECCEEEEEEEeCCC
Confidence 467888887777777777778888211 11235899999999 699999999999999999999999853
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=92.72 E-value=0.018 Score=57.91 Aligned_cols=70 Identities=10% Similarity=0.125 Sum_probs=54.6
Q ss_pred CccCCCCceeecCCCCCCCCCcccc---cccc-------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPE---DEEA-------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-+.....+...||+ .+.. ....+|+.+|+.+..|||||.+.++|.+...+|+|++.|.-
T Consensus 58 ~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~g 137 (396)
T 4dc2_A 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 137 (396)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCC
Confidence 4578888886666655556667888 2211 12457999999999999999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=92.64 E-value=0.015 Score=57.89 Aligned_cols=68 Identities=13% Similarity=0.003 Sum_probs=45.0
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc---------ccCcchHHHHHHhhcCCCcEEecccccc--cccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE---------ALNPSTEETILALLKSDPIVFMGDDTWS--SFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 460 (473)
..|.+.|...-+.....+...+|+++- .....+|+.+|+.+.+|||||.+.++|. ++..+|+|++.|.
T Consensus 16 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 94 (388)
T 3oz6_A 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME 94 (388)
T ss_dssp C-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS
T ss_pred EeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC
Confidence 366777775555544455567887321 1223479999999999999999999995 5668999999997
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=92.59 E-value=0.03 Score=56.63 Aligned_cols=69 Identities=12% Similarity=-0.030 Sum_probs=51.8
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---cccCcchHHHHHHhhcCCCcEEeccccc------ccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---EALNPSTEETILALLKSDPIVFMGDDTW------SSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 461 (473)
...|.+.|..+-+.....+...+||++ ......+|+.+|+.+ .|||||.+.++| .+..++|++++.|..
T Consensus 60 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~ 137 (420)
T 1j1b_A 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 137 (420)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE
T ss_pred eEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEeehhcccc
Confidence 457888888666665555566888832 234556899999999 599999999998 345678899998874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=92.57 E-value=0.024 Score=53.87 Aligned_cols=70 Identities=17% Similarity=0.150 Sum_probs=51.8
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc----------------ccCcchHHHHHHhhcCCCcEEecccccccccceehh
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE----------------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNT 455 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 455 (473)
...|.+.|...-++....+...+||+.- .....+|+.+|+.+.+||||+.+.++|.+...+|++
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (298)
T 1phk_A 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102 (298)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred eeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEE
Confidence 3456666765555555555557777321 112347999999999999999999999999999999
Q ss_pred hcccCC
Q psy622 456 LDAMSP 461 (473)
Q Consensus 456 ~~~~~~ 461 (473)
++.|..
T Consensus 103 ~e~~~~ 108 (298)
T 1phk_A 103 FDLMKK 108 (298)
T ss_dssp EECCTT
T ss_pred EeccCC
Confidence 999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.56 E-value=0.035 Score=53.87 Aligned_cols=68 Identities=13% Similarity=0.259 Sum_probs=51.8
Q ss_pred ccCCCCceeecCCCCCCCCCccccc---cccc----------CcchHHHHHHhhcCCCcEEecccccccccceehhhccc
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPED---EEAL----------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAM 459 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (473)
..|.+.|...-++....+...+|++ +... .-.+|+.+|+.+. ||||+.+.++|.+...+|++++.|
T Consensus 18 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~ 96 (326)
T 2y0a_A 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELV 96 (326)
T ss_dssp EEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEEEEEcC
Confidence 3677888866666666666788882 1111 1247999999995 999999999999999999999988
Q ss_pred CC
Q psy622 460 SP 461 (473)
Q Consensus 460 ~~ 461 (473)
.-
T Consensus 97 ~~ 98 (326)
T 2y0a_A 97 AG 98 (326)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=92.53 E-value=0.023 Score=56.18 Aligned_cols=69 Identities=19% Similarity=0.185 Sum_probs=53.9
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc---cc------CcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE---AL------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-++....+...+|++.- .. .-.+|+.+|+.+ .|||||.+.++|.+...+|++++.|.-
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g 112 (362)
T 2bdw_A 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG 112 (362)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 3477888887777776667778998221 11 223699999999 599999999999999999999998863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.49 E-value=0.016 Score=57.19 Aligned_cols=70 Identities=13% Similarity=0.099 Sum_probs=54.4
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc----------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE----------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-+.....+...||++.- .....+|+.+|+++..|||||.+.++|.+...+|+|++.|.-
T Consensus 29 ~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g 108 (353)
T 3txo_A 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNG 108 (353)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCC
Confidence 4478888886666655556668898211 112457899999999999999999999999999999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=92.34 E-value=0.027 Score=54.56 Aligned_cols=69 Identities=12% Similarity=-0.139 Sum_probs=50.8
Q ss_pred ccCCCCceeecCCCCCCCCCcccccc-----cccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDE-----EALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|...-+.....+...+||+. ....-.+|+.+|+.+..||||+.+.+++.+...+|++++.|..
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (330)
T 2izr_A 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGP 89 (330)
T ss_dssp ECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCCC
T ss_pred EeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCCC
Confidence 35666666444444444455788821 1234568999999999999999999999999999999999844
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=92.34 E-value=0.016 Score=56.32 Aligned_cols=68 Identities=13% Similarity=0.129 Sum_probs=51.8
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|...-++....+...+|+..- ...-.+|+.+|+.+ .||||+.+.++|.+...+|++++.|.-
T Consensus 12 ~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 367777876666666666667887211 22345799999988 499999999999999999999998863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=92.21 E-value=0.019 Score=56.42 Aligned_cols=68 Identities=18% Similarity=0.259 Sum_probs=53.5
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc------------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhccc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE------------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAM 459 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (473)
...|.+.|...-++....+...+||+.- ...-.+|+.+|+.+ .|||||.+.++|.+...+|++++.|
T Consensus 30 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~ 108 (351)
T 3c0i_A 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFEFM 108 (351)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEeCC
Confidence 4477888887777666666778998211 11235899999999 5999999999999999999999998
Q ss_pred C
Q psy622 460 S 460 (473)
Q Consensus 460 ~ 460 (473)
.
T Consensus 109 ~ 109 (351)
T 3c0i_A 109 D 109 (351)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=91.97 E-value=0.035 Score=54.51 Aligned_cols=70 Identities=10% Similarity=0.153 Sum_probs=53.2
Q ss_pred CccCCCCceeecCCCCCCCCCccccc---cccc-------CcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPED---EEAL-------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-+.....+...||++ +... .-.+|+.+|+.+..|||||.+.++|.+...+|++++.|.-
T Consensus 15 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~g 94 (345)
T 3a8x_A 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 94 (345)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCC
Confidence 34677888766655555566688882 2111 1357899999999999999999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=91.88 E-value=0.022 Score=57.27 Aligned_cols=68 Identities=6% Similarity=-0.000 Sum_probs=53.7
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc--ccCcchHHHHHHhhcCCCcEEeccccccc----ccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE--ALNPSTEETILALLKSDPIVFMGDDTWSS----FSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 460 (473)
..|.+.|..+-++....+...+|++.- .....+|+.+|.++..|||||.+.++|.. ...+|+|++.|.
T Consensus 69 ~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred eeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 468888887766666666668999322 23567899999999999999999998865 778999999886
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=91.74 E-value=0.029 Score=55.45 Aligned_cols=68 Identities=10% Similarity=-0.087 Sum_probs=51.1
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-+.....+...+||+.- ..+-.+|+.+|+.++ |||||.+.++|.+...+|++++.|.
T Consensus 26 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp EEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 3467777775555555555667888221 223458999999985 9999999999999999999999985
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=91.73 E-value=0.046 Score=52.99 Aligned_cols=37 Identities=16% Similarity=-0.000 Sum_probs=33.6
Q ss_pred chHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 424 STEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.+|+.+|+.+ .|||||.+.+++.+...+|+|++.|+-
T Consensus 77 ~~E~~il~~l-~HpNIV~l~g~~~~~~~~~lV~Ey~~~ 113 (308)
T 4gt4_A 77 RHEAMLRARL-QHPNVVCLLGVVTKDQPLSMIFSYCSH 113 (308)
T ss_dssp HHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCSS
T ss_pred HHHHHHHHhC-CCCCCCCcceEEEECCEEEEEEEcCCC
Confidence 4699999998 699999999999999999999999873
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=91.66 E-value=0.038 Score=53.55 Aligned_cols=68 Identities=19% Similarity=0.214 Sum_probs=52.0
Q ss_pred cCCCCceeecCCCCCCCCCccccc---ccc------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPED---EEA------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|...-++........+|++ +.. ..-.+|+.+|+.+.+||||+.+.++|.+...+|++++.|.-
T Consensus 37 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (327)
T 3lm5_A 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113 (327)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence 677777766555555556688882 111 12347999999999999999999999999999999998864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=91.64 E-value=0.039 Score=55.72 Aligned_cols=68 Identities=12% Similarity=0.094 Sum_probs=53.1
Q ss_pred CccCCCCceeecCCCCCCCCCccccc---cc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPED---EE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-+.....+...||++ +. ...-.+|+.+|+++ .|||||.+.++|.+...+|+|++.|.
T Consensus 75 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 45788888866666666666788982 11 12244899999887 69999999999999999999999885
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=91.52 E-value=0.03 Score=54.05 Aligned_cols=70 Identities=10% Similarity=-0.007 Sum_probs=52.7
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc----cccCcchHHHHHHhhcCCCcEEeccccccc--ccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE----EALNPSTEETILALLKSDPIVFMGDDTWSS--FSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 461 (473)
...|.+.|...-+.....+...+||+. ....-.+|+.+|+.+.+||||+.+.++|.+ ...+|++++.|.-
T Consensus 42 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 346777777655554445556788822 123456899999999999999999999988 7888999988864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=91.39 E-value=0.042 Score=56.84 Aligned_cols=69 Identities=12% Similarity=0.028 Sum_probs=51.2
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---cc-----------------cCcchHHHHHHhhcCCCcEEecccccccccc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---EA-----------------LNPSTEETILALLKSDPIVFMGDDTWSSFSA 451 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (473)
...|.+.|..+-++....+...+|+.. .. ..-.+|+.+|+.+ .|||||.+.++|.+..+
T Consensus 42 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 120 (504)
T 3q5i_A 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKY 120 (504)
T ss_dssp EEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred eEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCE
Confidence 447788888777666666667788821 11 1123699999999 59999999999999999
Q ss_pred eehhhcccCC
Q psy622 452 IFNTLDAMSP 461 (473)
Q Consensus 452 ~~~~~~~~~~ 461 (473)
+|+|++.|..
T Consensus 121 ~~lv~e~~~g 130 (504)
T 3q5i_A 121 FYLVTEFYEG 130 (504)
T ss_dssp EEEEEECCTT
T ss_pred EEEEEecCCC
Confidence 9999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=91.22 E-value=0.049 Score=51.93 Aligned_cols=70 Identities=7% Similarity=-0.052 Sum_probs=48.9
Q ss_pred CccCCCCceeecCCC-----CCCCCCcccccccc--------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcc
Q psy622 392 NLSGVSPFLAMDRSP-----PDNSELEWPEDEEA--------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDA 458 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (473)
...|.+.|..+-+.. ...+...+||+... ..-.+|+.+|+.++.||||+.+.++|.+...+|++++.
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 108 (313)
T 1t46_A 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 108 (313)
T ss_dssp EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEec
Confidence 345666776433221 23344467773221 12347999999999999999999999999999999998
Q ss_pred cCC
Q psy622 459 MSP 461 (473)
Q Consensus 459 ~~~ 461 (473)
|.-
T Consensus 109 ~~~ 111 (313)
T 1t46_A 109 CCY 111 (313)
T ss_dssp CTT
T ss_pred CCC
Confidence 743
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=91.18 E-value=0.039 Score=52.34 Aligned_cols=67 Identities=10% Similarity=-0.008 Sum_probs=48.7
Q ss_pred cCCCCceeecCCCCCCCCCccccccc---c------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE---A------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|...-+.....+...+|++.- . ..-.+|+.+|+.++ |||||.+.++|.+...+|++++.|..
T Consensus 10 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 85 (292)
T 3o0g_A 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred ecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEEEecCCC
Confidence 56666665554444445556887221 1 12237999999985 99999999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=91.07 E-value=0.079 Score=51.13 Aligned_cols=37 Identities=8% Similarity=-0.024 Sum_probs=34.5
Q ss_pred chHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 424 STEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.+|+.+|+.+..||||+.+.++|.+...+|++++.|.
T Consensus 97 ~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 133 (333)
T 2i1m_A 97 MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133 (333)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCC
Confidence 4799999999999999999999999999999999885
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.05 E-value=0.052 Score=54.32 Aligned_cols=68 Identities=12% Similarity=0.179 Sum_probs=45.5
Q ss_pred ccCCCCceeecCCCCC--CCCCccccccc-----ccCcchHHHHHHhhcCCCcEEeccccc--ccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPD--NSELEWPEDEE-----ALNPSTEETILALLKSDPIVFMGDDTW--SSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 461 (473)
..|.+.|..+-++... .....+|++.- ...-.+|+.+|+.++ |||||.+.++| .+...+|++++.|..
T Consensus 28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~lv~e~~~~ 104 (405)
T 3rgf_A 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEH 104 (405)
T ss_dssp CCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCC-CTTBCCCCEEEEETTTTEEEEEEECCSE
T ss_pred EeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcC-CCCeeeEeeEEecCCCCeEEEEEeCCCC
Confidence 3678888855544422 34457888322 123458999999996 99999999999 668899999998864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=90.97 E-value=0.036 Score=57.04 Aligned_cols=69 Identities=13% Similarity=0.090 Sum_probs=53.6
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---c-c-----cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---E-A-----LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-++....+...+||+. . . ..-.+|+.+|+.+ .|||||.+.++|.+...+|++++.|..
T Consensus 28 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 105 (486)
T 3mwu_A 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTG 105 (486)
T ss_dssp EEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEEEEEEEcCCC
Confidence 346778888776666666677899822 1 1 1224799999999 699999999999999999999998864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=90.70 E-value=0.031 Score=56.96 Aligned_cols=69 Identities=14% Similarity=0.073 Sum_probs=43.8
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc---------ccCcchHHHHHHhhcCCCcEEeccccc-----ccccceehhhc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE---------ALNPSTEETILALLKSDPIVFMGDDTW-----SSFSAIFNTLD 457 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 457 (473)
...|.+.|..+-+.....+...+|+++- .....+|+.+|+.+ .|||||.+.++| .++..+|+|++
T Consensus 59 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e 137 (458)
T 3rp9_A 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLE 137 (458)
T ss_dssp CC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred eEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCceEEEEEe
Confidence 4577788875555555555667888322 11234799999999 699999999999 66678999999
Q ss_pred ccCC
Q psy622 458 AMSP 461 (473)
Q Consensus 458 ~~~~ 461 (473)
.|..
T Consensus 138 ~~~~ 141 (458)
T 3rp9_A 138 IADS 141 (458)
T ss_dssp CCSE
T ss_pred cccc
Confidence 8863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=90.67 E-value=0.065 Score=52.92 Aligned_cols=69 Identities=19% Similarity=0.171 Sum_probs=52.0
Q ss_pred ccCCCCceeecCCCCCCCCCcccccccc---------------cCcchHHHHHHhhcCCCcEEecccccccccceehhhc
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEEA---------------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLD 457 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (473)
..|.++|..+-++....+...+||+... ..-.+|+.+|+.+..||||+.+.++|.....+|+|++
T Consensus 101 ~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 180 (365)
T 2y7j_A 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180 (365)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEEC
T ss_pred EEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEE
Confidence 3666777766555544455678883211 1224799999999999999999999999999999999
Q ss_pred ccCC
Q psy622 458 AMSP 461 (473)
Q Consensus 458 ~~~~ 461 (473)
.|.-
T Consensus 181 ~~~g 184 (365)
T 2y7j_A 181 LMRK 184 (365)
T ss_dssp CCTT
T ss_pred eCCC
Confidence 9864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=90.45 E-value=0.037 Score=54.38 Aligned_cols=70 Identities=11% Similarity=0.085 Sum_probs=53.3
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc----------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE----------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-+.....+...||++.- .....+|+.+|+.+..||||+.+.++|.+...+|++++.|.-
T Consensus 23 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g 102 (345)
T 1xjd_A 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG 102 (345)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCC
Confidence 4467778876655555555667888211 112457899999999999999999999999999999998853
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.44 E-value=0.98 Score=45.07 Aligned_cols=30 Identities=13% Similarity=0.288 Sum_probs=24.4
Q ss_pred eeecCCCCcceEecC-----CCCceeEeecchhhh
Q psy622 163 IIHRDLKPDNMLISA-----QAPHCPIVNTLFLAI 192 (473)
Q Consensus 163 IiHRDLKpeNILld~-----~~g~ikL~DFGla~~ 192 (473)
++|.|+.+.|||+.. +.+.+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 689999999999932 227799999988765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=90.38 E-value=0.079 Score=52.34 Aligned_cols=37 Identities=11% Similarity=-0.033 Sum_probs=32.5
Q ss_pred chHHHHHHhhcCCCcEEecccccc-cccceehhhcccC
Q psy622 424 STEETILALLKSDPIVFMGDDTWS-SFSAIFNTLDAMS 460 (473)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 460 (473)
.+|+.||+.+.+|||||.+.+++. ++..+|+|++.|.
T Consensus 115 ~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~ 152 (353)
T 4ase_A 115 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 152 (353)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCT
T ss_pred HHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCC
Confidence 469999999999999999999875 4678999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=90.34 E-value=0.069 Score=51.43 Aligned_cols=69 Identities=9% Similarity=0.024 Sum_probs=45.6
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc-----c---cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE-----A---LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-+.....+...+|++.- + ..-.+|+.+|+.+ .|||||.+.++|.+...+|++++.|..
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 87 (317)
T 2pmi_A 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLVFEFMDN 87 (317)
T ss_dssp --------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEEEECCCC
T ss_pred eEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEEEEecCC
Confidence 3467777775555554555567787221 1 1224799999999 599999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=90.29 E-value=0.028 Score=54.73 Aligned_cols=99 Identities=13% Similarity=0.039 Sum_probs=51.2
Q ss_pred CCCCCccccCchhhhccccccCCCCCCccCCccCCCCceeecCCCCCCCCC----cccccccc--------cCcchHHHH
Q psy622 362 HTASGMDVDSPSALYSKLSTMDCMSPPNAHNLSGVSPFLAMDRSPPDNSEL----EWPEDEEA--------LNPSTEETI 429 (473)
Q Consensus 362 ~~f~g~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~--------~~~~~~~~~ 429 (473)
..|+++.+..|......+..+............|.+.|..+-+.....+.+ .+||+... .+-.+|+.+
T Consensus 20 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~ 99 (333)
T 1mqb_A 20 LYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99 (333)
T ss_dssp ------------------CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHH
T ss_pred ccccccccCChhhhhhhccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHH
Confidence 345555555555444444443333333334557777777444333222222 37773221 123368899
Q ss_pred HHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 430 LALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
|+.+ .||||+.+.+++.+...+|++++.|.-
T Consensus 100 l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 130 (333)
T 1mqb_A 100 MGQF-SHHNIIRLEGVISKYKPMMIITEYMEN 130 (333)
T ss_dssp HHTC-CCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred HHhC-CCCCCCcEEEEEecCCCcEEEEeCCCC
Confidence 9988 699999999999999999999998864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=90.03 E-value=0.033 Score=54.53 Aligned_cols=68 Identities=13% Similarity=0.147 Sum_probs=53.0
Q ss_pred CccCCCCceeecCCCCCCCCCccccc---cc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPED---EE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|....+..+..+...+|++ +. ...-.+|+.+|+.+. |||||.+.++|.+...+|++++.|.
T Consensus 15 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~ 92 (336)
T 3h4j_B 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIVMVIEYAG 92 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEEEECCC
Confidence 44677888877777666677788882 11 112357999999885 9999999999999999999999884
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=89.97 E-value=0.042 Score=52.36 Aligned_cols=68 Identities=6% Similarity=0.010 Sum_probs=51.1
Q ss_pred cCCCCceeecCCCCCCCCCcccccc--cccCcchHHHHHHhhcCCCcEEeccccccc----ccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDE--EALNPSTEETILALLKSDPIVFMGDDTWSS----FSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 461 (473)
.|.+.|...-+.........+|++. ......+|+++|....+||||+.+.++|.+ ...+|++++.|.-
T Consensus 26 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 5667776554444444556788832 233567899999999999999999999877 7889999998864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.78 E-value=0.06 Score=52.80 Aligned_cols=68 Identities=13% Similarity=0.111 Sum_probs=46.8
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc-----cccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE-----EALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-++....+...+||+. ....-.+|+.+|+.+. ||||+.+.++|.+...+|++++.|.
T Consensus 59 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCC-CCCCcceeeeEecCCeEEEEEEeCC
Confidence 346777777555554444555788822 1224557999999995 9999999999999999999999885
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=89.72 E-value=0.06 Score=52.15 Aligned_cols=68 Identities=13% Similarity=-0.050 Sum_probs=50.6
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc--------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE--------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-+.....+...+||+.- ...-.+|+.+|+.+ .|||||.+.+++.+...+|++++.|.
T Consensus 13 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 3467777776555555555667888221 12346899999998 59999999999999999999999885
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.46 E-value=0.087 Score=53.43 Aligned_cols=50 Identities=10% Similarity=-0.081 Sum_probs=41.9
Q ss_pred CCccccccc----ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 411 ELEWPEDEE----ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 411 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...+||++- .....+|+.+|+.+..|||||.+.+++.+...+|++++.|.
T Consensus 48 ~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 48 NRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp SSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 456787321 23467999999999999999999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=89.42 E-value=0.07 Score=54.76 Aligned_cols=69 Identities=10% Similarity=0.031 Sum_probs=53.0
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---cc-------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---EA-------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-++....+...+||+. .. ..-.+|+.+|+.+ .|||||.+.++|.+..++|++++.+..
T Consensus 32 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 110 (484)
T 3nyv_A 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTG 110 (484)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 346788888776666666677899822 11 1124799999999 699999999999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.40 E-value=0.058 Score=52.16 Aligned_cols=68 Identities=10% Similarity=0.051 Sum_probs=50.0
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc--------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE--------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|...-+.....+...+|++.- ...-.+|+.+|+.++ ||||+.+.++|.+...+|++++.|..
T Consensus 9 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (324)
T 3mtl_A 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLDK 84 (324)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred EEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEEeccccc
Confidence 356667765555444445556777211 123457999999995 99999999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.39 E-value=0.053 Score=54.24 Aligned_cols=68 Identities=13% Similarity=0.092 Sum_probs=50.4
Q ss_pred ccCCCCceeecCCCCCCCCCcccccc---c-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDE---E-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|...-+.....+...||++. . ..+-.+|+.+|+.+ .|||||.+.++|.+...+|++++.|.-
T Consensus 22 ~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~g 99 (384)
T 4fr4_A 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFMVVDLLLG 99 (384)
T ss_dssp EEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 36777777555554455566788821 1 11334799999998 699999999999999999999998853
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=89.33 E-value=0.1 Score=50.19 Aligned_cols=68 Identities=16% Similarity=0.207 Sum_probs=49.7
Q ss_pred ccCCCCceeecCCCCCCCCCccccc---cccc----------CcchHHHHHHhhcCCCcEEecccccccccceehhhccc
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPED---EEAL----------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAM 459 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (473)
..|.+.|...-++....+...+|++ .... .-.+|+.+|+.+. ||||+.+.++|.+...+|++++.|
T Consensus 19 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 97 (321)
T 2a2a_A 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYENRTDVVLILELV 97 (321)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCC
T ss_pred EeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEEEEEEEcC
Confidence 4667777755555555555678872 1111 1247999999995 999999999999999999999988
Q ss_pred CC
Q psy622 460 SP 461 (473)
Q Consensus 460 ~~ 461 (473)
.-
T Consensus 98 ~~ 99 (321)
T 2a2a_A 98 SG 99 (321)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=89.17 E-value=0.052 Score=55.69 Aligned_cols=69 Identities=7% Similarity=0.039 Sum_probs=49.4
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc---------ccCcchHHHHHHhhcCCCcEEeccccccc------ccceehhh
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE---------ALNPSTEETILALLKSDPIVFMGDDTWSS------FSAIFNTL 456 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 456 (473)
...|.+.|...-+.........+|++.- .....+|+.+|+.+ .|||||.+.++|.+ +..+|+|+
T Consensus 68 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 146 (464)
T 3ttj_A 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVM 146 (464)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccCCeEEEEE
Confidence 4467788876655555555567888321 12334799999998 69999999999954 45679999
Q ss_pred cccCC
Q psy622 457 DAMSP 461 (473)
Q Consensus 457 ~~~~~ 461 (473)
+.|..
T Consensus 147 E~~~~ 151 (464)
T 3ttj_A 147 ELMDA 151 (464)
T ss_dssp ECCSE
T ss_pred eCCCC
Confidence 99974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=89.13 E-value=0.08 Score=53.89 Aligned_cols=69 Identities=9% Similarity=0.049 Sum_probs=52.3
Q ss_pred CccCCCCceeecCCCCCCCCCccccc---c------c-ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPED---E------E-ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-+.....+...||++ + . ...-.+|+.+|+.+ .|||||.+.++|.+...+|+|++.|.-
T Consensus 80 ~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 34778888866655555566678882 1 1 22356789999887 799999999999999999999999853
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=89.04 E-value=0.052 Score=56.01 Aligned_cols=69 Identities=12% Similarity=0.097 Sum_probs=50.2
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---cc------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---EA------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-++....+...+|+.. .. ..-.+|+.+|+.+ .|||||.+.++|.+...+|+|++.|..
T Consensus 43 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 120 (494)
T 3lij_A 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKG 120 (494)
T ss_dssp EEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 457888888766666666667788821 11 1124699999998 599999999999999999999998864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=89.01 E-value=0.098 Score=51.01 Aligned_cols=69 Identities=19% Similarity=0.149 Sum_probs=50.1
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc------c------cCcchHHHHHHhhcCCCcEEecccccccccceehhhccc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE------A------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAM 459 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (473)
...|.+.|..+-++....+...+||+.- + ..-.+|+.+|+.+ .||||+.+.++|.+...+|++++.|
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 94 (346)
T 1ua2_A 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDFM 94 (346)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEECC
T ss_pred eEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCceEEEEEcC
Confidence 3466677775555555555567787221 1 1123799999999 5999999999999999999999998
Q ss_pred CC
Q psy622 460 SP 461 (473)
Q Consensus 460 ~~ 461 (473)
..
T Consensus 95 ~~ 96 (346)
T 1ua2_A 95 ET 96 (346)
T ss_dssp SE
T ss_pred CC
Confidence 74
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=88.83 E-value=0.045 Score=54.36 Aligned_cols=66 Identities=11% Similarity=0.038 Sum_probs=47.7
Q ss_pred cCCC--CceeecCCCCCCCCCccccccc---c------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 394 SGVS--PFLAMDRSPPDNSELEWPEDEE---A------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~--~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.|.+ .|...-++....+...+||+.- . ..-.+|+.+|+.++ |||||.+.++|.+...+|++++.|.
T Consensus 33 lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 109 (389)
T 3gni_B 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTSFMA 109 (389)
T ss_dssp EEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECCEEEEEEEccC
Confidence 4555 6664444444445567888221 1 12235999999995 9999999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=88.59 E-value=0.052 Score=53.14 Aligned_cols=70 Identities=9% Similarity=0.110 Sum_probs=53.0
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc------ccCcchHHHHHHhhc----CCCcEEecccccccccceehhhcccCCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE------ALNPSTEETILALLK----SDPIVFMGDDTWSSFSAIFNTLDAMSPT 462 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (473)
..|.+.|...-++....+...+||+.- .....+|+.+|+.+. .|||||.+.++|.+...+|++++.|..+
T Consensus 42 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 121 (360)
T 3llt_A 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPS 121 (360)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCCCCB
T ss_pred EEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCCCCC
Confidence 367777876655555555567888221 234567999999998 6999999999999999999999988443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=88.58 E-value=0.087 Score=52.61 Aligned_cols=69 Identities=13% Similarity=0.049 Sum_probs=48.1
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---cccCcchHHHHHHhhcCCCcEEeccccc------ccccceehhhcccCCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---EALNPSTEETILALLKSDPIVFMGDDTW------SSFSAIFNTLDAMSPT 462 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~ 462 (473)
...|.+.|...-+.... ..+++|+.+ ......+|+.+|+.+ .|||||.+.++| .+..++|++++.|..+
T Consensus 46 ~~lG~G~~g~V~~a~~~-~~~~~aikk~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~ 123 (394)
T 4e7w_A 46 KVIGNGSFGVVFQAKLV-ESDEVAIKKVLQDKRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET 123 (394)
T ss_dssp EEEEEETTEEEEEEEET-TTEEEEEEEEECCTTSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE
T ss_pred EEEeeCCCeEEEEEEEC-CCCeEEEEEEecCcchHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEEEeeccCcc
Confidence 34677777744443322 234577722 233456899999999 599999999999 5566799999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.50 E-value=0.08 Score=51.23 Aligned_cols=69 Identities=7% Similarity=-0.018 Sum_probs=46.9
Q ss_pred CccCCCCceeecCCCCCCC---CCcccccccc--------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNS---ELEWPEDEEA--------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-+...... ...+||.... ..-.+|+.+|+.+ .|||||.+.++|.+...+|+|++.|.
T Consensus 55 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 133 (325)
T 3kul_A 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYME 133 (325)
T ss_dssp EEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred eEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCccEEEeeCCC
Confidence 4467777774432222211 1247773221 1234699999999 59999999999999999999999985
Q ss_pred C
Q psy622 461 P 461 (473)
Q Consensus 461 ~ 461 (473)
-
T Consensus 134 ~ 134 (325)
T 3kul_A 134 N 134 (325)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=88.44 E-value=0.057 Score=52.29 Aligned_cols=68 Identities=15% Similarity=0.208 Sum_probs=49.5
Q ss_pred ccCCCCceeecCCCCCCCCCcccccc---c-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDE---E-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|...-+.....+...||++. . .....+|+.+|+.+ .|||||.+.++|.+...+|++++.|.-
T Consensus 13 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~g 90 (318)
T 1fot_A 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIEG 90 (318)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence 35677777555544445556788821 1 11234688899887 799999999999999999999998863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=88.31 E-value=0.065 Score=51.89 Aligned_cols=68 Identities=6% Similarity=-0.056 Sum_probs=49.6
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc---------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE---------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-+.....+...+||+.- ...-.+|+.+|+.+ .|||||.+.++|.+...+|++++.|.
T Consensus 40 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 116 (329)
T 3gbz_A 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHRLHLIFEYAE 116 (329)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCEEEEEEecCC
Confidence 4466677775555544455557777211 11234799999999 69999999999999999999999886
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.23 E-value=0.08 Score=50.50 Aligned_cols=70 Identities=13% Similarity=0.091 Sum_probs=50.6
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc------------ccCcchHHHHHHhhc--CCCcEEeccccccccc-----ce
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE------------ALNPSTEETILALLK--SDPIVFMGDDTWSSFS-----AI 452 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-----~~ 452 (473)
...|.+.|...-+.....+...+|++.- .....+|+++|+.++ .||||+.+.++|.+.. .+
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~ 94 (308)
T 3g33_A 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKV 94 (308)
T ss_dssp EEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeE
Confidence 3467777776665555555667888321 113458999999998 4999999999987655 68
Q ss_pred ehhhcccCC
Q psy622 453 FNTLDAMSP 461 (473)
Q Consensus 453 ~~~~~~~~~ 461 (473)
|++++.|..
T Consensus 95 ~lv~e~~~~ 103 (308)
T 3g33_A 95 TLVFEHVDQ 103 (308)
T ss_dssp EEEEECCCC
T ss_pred EEEehhhhc
Confidence 999988864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=88.22 E-value=0.094 Score=49.49 Aligned_cols=68 Identities=13% Similarity=0.139 Sum_probs=48.5
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc---c-----cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE---A-----LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|...-+.....+...+|+..- . ..-.+|+.+|+.+ .||||+.+.++|.+...+|++++.|..
T Consensus 29 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 104 (285)
T 3is5_A 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEG 104 (285)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCSC
T ss_pred eeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeEEEEEEeCCC
Confidence 356666665544444444556777221 1 1225799999999 599999999999999999999998864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=88.06 E-value=0.06 Score=50.40 Aligned_cols=67 Identities=12% Similarity=0.039 Sum_probs=48.7
Q ss_pred cCCCCceeecCCCCCCCCCccccccc---------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE---------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.|.+.|...-+.........+|++.- ..+-.+|+.+|+.+..||||+.+.++|.+...+|++++.|.
T Consensus 19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 94 (289)
T 1x8b_A 19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94 (289)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecC
Confidence 55666665544444445557777221 22344688888888899999999999999999999999885
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.80 E-value=0.11 Score=49.60 Aligned_cols=67 Identities=9% Similarity=0.009 Sum_probs=48.6
Q ss_pred cCCCCceeecCCCCCCCCCccccccc---ccC------cchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE---ALN------PSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|...-++....+...+|+..- ..+ -.+|+.+|+.+. ||||+.+.++|.+...+|++++.|..
T Consensus 11 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (311)
T 4agu_A 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHLVFEYCDH 86 (311)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEEEEEeCCC
Confidence 56666765554444445557887322 111 236999999996 99999999999999999999998874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=87.77 E-value=0.11 Score=48.65 Aligned_cols=68 Identities=19% Similarity=0.184 Sum_probs=50.1
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc---cc------CcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE---AL------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|...-++........+|++.- .. .-.+|+.+|+.+ .||||+.+.++|.+....|++++.|..
T Consensus 13 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 89 (284)
T 3kk8_A 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG 89 (284)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred hhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCEEEEEEecCCC
Confidence 356677776655555555667888221 11 123699999999 599999999999999999999998864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=87.76 E-value=0.065 Score=55.24 Aligned_cols=68 Identities=18% Similarity=0.136 Sum_probs=52.5
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---c-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---E-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|....+..+..+...+||+. . ...-.+|+.+|+.+. ||||+.+.++|.+...+|++++.|.
T Consensus 22 ~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~ 99 (476)
T 2y94_A 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIFMVMEYVS 99 (476)
T ss_dssp EEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEeCCC
Confidence 446778888776666666667888821 1 112358999999885 9999999999999999999999885
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=87.69 E-value=0.075 Score=51.54 Aligned_cols=67 Identities=9% Similarity=0.015 Sum_probs=48.3
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc------------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE------------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..|.+.|...-+.........+|++.- ...-.+|+.+|+.++ |||||.+.++|.+...+|+|++.|.
T Consensus 33 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~ 111 (345)
T 3hko_A 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCH 111 (345)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhccCCeEEEEEeCCC
Confidence 356666665544444445556777211 112346999999995 9999999999999999999999885
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=87.67 E-value=0.15 Score=47.69 Aligned_cols=67 Identities=15% Similarity=0.211 Sum_probs=47.6
Q ss_pred cCCCCceeecCCCCCCCCCcccccc---cc----------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDE---EA----------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.|.+.|...-+.....+...+|++. .. ..-.+|+.+|+.++ ||||+.+.++|.+...+|++++.|.
T Consensus 13 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 91 (283)
T 3bhy_A 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKTDVVLILELVS 91 (283)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCC
T ss_pred hcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCCeEEEEEeecC
Confidence 4566666544444444455777721 11 11247999999996 9999999999999999999999885
Q ss_pred C
Q psy622 461 P 461 (473)
Q Consensus 461 ~ 461 (473)
.
T Consensus 92 ~ 92 (283)
T 3bhy_A 92 G 92 (283)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=87.57 E-value=0.071 Score=49.90 Aligned_cols=67 Identities=10% Similarity=0.127 Sum_probs=47.9
Q ss_pred cCCCCceeecCCCCCCCCCccccccc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|...-+.........+|+.+- ...-.+|+.+|+.+ .||||+.+.++|.+...+|++++.|..
T Consensus 17 lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEEEEEeccCC
Confidence 55666665544444444456677221 11234799999999 799999999999999999999998853
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=87.51 E-value=0.053 Score=54.25 Aligned_cols=68 Identities=15% Similarity=0.124 Sum_probs=50.9
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|..+-++....+...+|+..- ...-.+|+.+|+.+ .|||||.+.++|.+...+|++++.|.-
T Consensus 58 ~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred EEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 367777776665555555567777221 11345799999988 599999999999999999999998863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.46 E-value=0.14 Score=49.90 Aligned_cols=67 Identities=10% Similarity=-0.035 Sum_probs=47.7
Q ss_pred cCCCCceeecCCCCCCCCCccccccc---------------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcc
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE---------------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDA 458 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (473)
.|.+.|...-+.........+||+.- ...-.+|+.+|+.+ .||||+.+.++|.+...+|++++.
T Consensus 32 lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~ 110 (335)
T 3dls_A 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQGFFQLVMEK 110 (335)
T ss_dssp CSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEeeCCEEEEEEEe
Confidence 56666664444444444456776211 11335699999999 699999999999999999999997
Q ss_pred cCC
Q psy622 459 MSP 461 (473)
Q Consensus 459 ~~~ 461 (473)
|..
T Consensus 111 ~~~ 113 (335)
T 3dls_A 111 HGS 113 (335)
T ss_dssp CTT
T ss_pred CCC
Confidence 754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=87.45 E-value=0.079 Score=51.82 Aligned_cols=68 Identities=10% Similarity=0.059 Sum_probs=50.8
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc----------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE----------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|...-+.....+...||++.- .....+|+.+|+.+ .||||+.+.++|.+...+|++++.|.-
T Consensus 12 ~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~E~~~g 89 (337)
T 1o6l_A 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 467777776555555555667888211 12345789999988 599999999999999999999998863
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=87.44 E-value=0.18 Score=48.73 Aligned_cols=67 Identities=13% Similarity=0.163 Sum_probs=44.4
Q ss_pred ccCCCCceeec---CCCCCCCCCcccccc-----------cccCcchHHHHHHhhcCCCcEEecccccccccceehhhcc
Q psy622 393 LSGVSPFLAMD---RSPPDNSELEWPEDE-----------EALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDA 458 (473)
Q Consensus 393 ~~~~~~~~~~~---~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (473)
..|.+.|...- ..........+|++. ....-.+|+.+|+.++ ||||+.+.++|.+...+|++++.
T Consensus 24 ~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3a62_A 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGGKLYLILEY 102 (327)
T ss_dssp EEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECSSCEEEEEEC
T ss_pred EEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcCCEEEEEEeC
Confidence 35666666332 222234455677721 1123457999999995 99999999999999999999998
Q ss_pred cC
Q psy622 459 MS 460 (473)
Q Consensus 459 ~~ 460 (473)
|.
T Consensus 103 ~~ 104 (327)
T 3a62_A 103 LS 104 (327)
T ss_dssp CT
T ss_pred CC
Confidence 85
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=87.39 E-value=0.21 Score=48.96 Aligned_cols=70 Identities=10% Similarity=0.147 Sum_probs=50.9
Q ss_pred CccCCCCceeecCC---CCCCCCCcccccc-----------cccCcchHHHHHHhhcCCCcEEecccccccccceehhhc
Q psy622 392 NLSGVSPFLAMDRS---PPDNSELEWPEDE-----------EALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLD 457 (473)
Q Consensus 392 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (473)
...|.+.|...-+. ........+||+. ......+|+.+|+.+.+||||+.+.++|.+...+|++++
T Consensus 60 ~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 139 (355)
T 1vzo_A 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILD 139 (355)
T ss_dssp EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEEC
T ss_pred EEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEee
Confidence 44677777733322 2223445788721 123466899999999999999999999999999999999
Q ss_pred ccCC
Q psy622 458 AMSP 461 (473)
Q Consensus 458 ~~~~ 461 (473)
.|.-
T Consensus 140 ~~~~ 143 (355)
T 1vzo_A 140 YING 143 (355)
T ss_dssp CCCS
T ss_pred cCCC
Confidence 9863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=87.31 E-value=0.083 Score=55.79 Aligned_cols=68 Identities=13% Similarity=0.078 Sum_probs=53.3
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc----------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE----------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-++........||++.- .....+|+.||+.+ .|||||.+.++|.+...+|+|++.|.
T Consensus 190 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~ 267 (576)
T 2acx_A 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMN 267 (576)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence 4578888886666665566678998211 12245799999998 69999999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=87.20 E-value=0.16 Score=49.41 Aligned_cols=69 Identities=16% Similarity=0.068 Sum_probs=46.5
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc---ccC------cchHHHHHHhhcCCCcEEeccccccc--------ccceeh
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE---ALN------PSTEETILALLKSDPIVFMGDDTWSS--------FSAIFN 454 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 454 (473)
...|.+.|...-+.....+...+|++.- ..+ -.+|+.+|+.++ ||||+.+.++|.+ ...+|+
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~l 101 (351)
T 3mi9_A 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYL 101 (351)
T ss_dssp EECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC--------CEEEE
T ss_pred EEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCcccHhheeeccccccccCCceEEE
Confidence 3356666665444444445557777321 111 127999999996 9999999999877 446899
Q ss_pred hhcccCC
Q psy622 455 TLDAMSP 461 (473)
Q Consensus 455 ~~~~~~~ 461 (473)
|++.|..
T Consensus 102 v~e~~~~ 108 (351)
T 3mi9_A 102 VFDFCEH 108 (351)
T ss_dssp EEECCSE
T ss_pred EEeccCC
Confidence 9998874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=87.17 E-value=0.072 Score=52.37 Aligned_cols=68 Identities=12% Similarity=0.135 Sum_probs=51.1
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---c-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---E-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-+.....+...||++. . .....+|+.+|+.+ .||||+.+.++|.+...+|++++.|.
T Consensus 47 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 124 (350)
T 1rdq_E 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 456777777655555555566888821 1 11234689999988 79999999999999999999999885
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.96 E-value=0.14 Score=51.66 Aligned_cols=68 Identities=7% Similarity=0.003 Sum_probs=52.0
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc----------cccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE----------EALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-+.....+...||++. ....-.+|+.+|+.+ .|||||.+.++|.+..++|+|++.|.
T Consensus 67 ~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lVmE~~~ 144 (412)
T 2vd5_A 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYLVMEYYV 144 (412)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence 447778887665555555666889821 122356789999876 79999999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.92 E-value=0.081 Score=50.77 Aligned_cols=71 Identities=7% Similarity=0.099 Sum_probs=50.5
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc---------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE---------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSPT 462 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (473)
...|.+.|...-+.....+...+||++. ...--+|+..+..+..|||||.+.++|.+...+|++++.|..+
T Consensus 63 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 142 (311)
T 3p1a_A 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPS 142 (311)
T ss_dssp EEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCCCB
T ss_pred heeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEeccCCC
Confidence 3467777775555444445567888322 1122345666777779999999999999999999999999654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=86.90 E-value=0.05 Score=53.68 Aligned_cols=70 Identities=11% Similarity=0.130 Sum_probs=52.3
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc----------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE----------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-+.....+...||++.- .....+|+.+|+.+..||||+.+.++|.+...+|++++.|.-
T Consensus 26 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g 105 (353)
T 2i0e_A 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 105 (353)
T ss_dssp EEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCC
Confidence 3467777775555555555557888211 112347888999999999999999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.84 E-value=0.13 Score=48.78 Aligned_cols=36 Identities=17% Similarity=0.188 Sum_probs=31.7
Q ss_pred chHHHHHHhhcCCCcEEeccccccc--ccceehhhcccC
Q psy622 424 STEETILALLKSDPIVFMGDDTWSS--FSAIFNTLDAMS 460 (473)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 460 (473)
.+|+.+|+.+ .||||+.+.++|.+ ...+|++++.|.
T Consensus 84 ~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 121 (298)
T 2zv2_A 84 YQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVN 121 (298)
T ss_dssp HHHHHHHHTC-CCTTBCCEEEEEECSSSSEEEEEEECCT
T ss_pred HHHHHHHHhC-CCCCCCeEEEEEEcCCCCEEEEEEecCC
Confidence 4799999999 59999999999986 678999998875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.69 E-value=0.071 Score=52.91 Aligned_cols=67 Identities=12% Similarity=0.105 Sum_probs=45.6
Q ss_pred cCCCCceeecCCCCCCCCCccccccc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|...-++....+...+|++.- ...-.+|+.+|+.+ .|||||.+.++|.+...+|+|++.|.-
T Consensus 97 lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp CC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 56667765554444444556777221 12335799999999 699999999999999999999999853
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=86.44 E-value=0.1 Score=49.21 Aligned_cols=66 Identities=11% Similarity=0.059 Sum_probs=46.0
Q ss_pred cCCCCceeecCCCCCCCCCccccccc---c------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE---A------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|...-+... .....+|+.+- . ..-.+|+.+|+.+ .||||+.+.++|.+...+|++++.|..
T Consensus 10 lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (288)
T 1ob3_A 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (288)
T ss_dssp EEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred cccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEEEEecCC
Confidence 45666664443332 23456777221 1 1123799999999 499999999999999999999998874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=86.33 E-value=0.099 Score=49.80 Aligned_cols=68 Identities=7% Similarity=-0.041 Sum_probs=49.9
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc--cc-----CcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE--AL-----NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-+.....+...+||..- .. .-.+|+.+|+.+ .|||||.+.++|.+...+|++++.|.
T Consensus 26 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp EEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEEEEEECCC
Confidence 4467788876655555555667888221 11 124688888887 69999999999999999999999885
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=86.29 E-value=0.16 Score=53.47 Aligned_cols=38 Identities=5% Similarity=-0.156 Sum_probs=35.6
Q ss_pred cchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 423 PSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
=.+|+++|+.+.+||||+.+.+.|.+...+|+|+.++.
T Consensus 288 ~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~ 325 (569)
T 4azs_A 288 LHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLP 325 (569)
T ss_dssp HHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCC
T ss_pred HHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCC
Confidence 56799999999999999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=86.23 E-value=0.26 Score=47.29 Aligned_cols=68 Identities=10% Similarity=-0.025 Sum_probs=46.9
Q ss_pred CccCCCCceee----cCCCCCCCCCcccccccc--c------CcchHHHHHHhhcCCCcEEeccccccc--ccceehhhc
Q psy622 392 NLSGVSPFLAM----DRSPPDNSELEWPEDEEA--L------NPSTEETILALLKSDPIVFMGDDTWSS--FSAIFNTLD 457 (473)
Q Consensus 392 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~--~------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 457 (473)
...|.+.|... -+.........+||+.-. . .-.+|+.+|+.+. ||||+.+.++|.+ ...+|++++
T Consensus 37 ~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e 115 (318)
T 3lxp_A 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLVME 115 (318)
T ss_dssp EEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTTTEEEEEEC
T ss_pred heecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC-CcchhhEEEEEecCCCceEEEEEe
Confidence 34677777754 233444455578883321 1 1257999999997 9999999999976 578899998
Q ss_pred ccC
Q psy622 458 AMS 460 (473)
Q Consensus 458 ~~~ 460 (473)
.|.
T Consensus 116 ~~~ 118 (318)
T 3lxp_A 116 YVP 118 (318)
T ss_dssp CCT
T ss_pred ccc
Confidence 874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=86.23 E-value=0.12 Score=49.07 Aligned_cols=66 Identities=11% Similarity=0.059 Sum_probs=47.5
Q ss_pred cCCCCceeecCCCCCCCCCccccccc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.|.+.|...-+.....+...+|++.- ...-.+|+.+|+.+ .||||+.+.++|.+...+|++++.|.
T Consensus 17 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred ccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhcccCCEEEEEEEcCC
Confidence 56666665444444444556777221 11234799999999 59999999999999999999999885
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=86.22 E-value=0.11 Score=48.64 Aligned_cols=67 Identities=10% Similarity=-0.003 Sum_probs=45.7
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-+.... +...+|++.- +.+-.+|+.+|+.+. ||||+.+.++|.+...+|++++.|.
T Consensus 30 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 30 KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp EECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEECCCT
T ss_pred hhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCCeEEEEeccC
Confidence 33566777655443222 3446777221 123357999999996 9999999999999999999999885
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.21 E-value=0.079 Score=50.61 Aligned_cols=68 Identities=10% Similarity=-0.055 Sum_probs=49.2
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-+.....+...+|++.- ...-.+|+.+|+.++ ||||+.+.++|.+...+|++++.|.
T Consensus 16 ~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp EEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEEEEEecC
Confidence 3466777775554444444556777321 112347999999995 9999999999999999999999885
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=86.20 E-value=0.1 Score=50.86 Aligned_cols=68 Identities=9% Similarity=-0.099 Sum_probs=47.2
Q ss_pred ccCCCCceeecCCC-----CCCCCCcccccccc--------cCcchHHHHHHhhcCCCcEEeccccccc-ccceehhhcc
Q psy622 393 LSGVSPFLAMDRSP-----PDNSELEWPEDEEA--------LNPSTEETILALLKSDPIVFMGDDTWSS-FSAIFNTLDA 458 (473)
Q Consensus 393 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 458 (473)
..|.+.|..+-+.. +......+||+... ..-.+|+.+|+.+.+|||||.+.++|.+ ...+|++++.
T Consensus 29 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~ 108 (359)
T 3vhe_A 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 108 (359)
T ss_dssp EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEEC
T ss_pred eecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEe
Confidence 36677777443322 34445578883321 1235799999999999999999999876 4558888887
Q ss_pred cC
Q psy622 459 MS 460 (473)
Q Consensus 459 ~~ 460 (473)
|.
T Consensus 109 ~~ 110 (359)
T 3vhe_A 109 CK 110 (359)
T ss_dssp CT
T ss_pred cC
Confidence 75
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=86.20 E-value=0.21 Score=49.31 Aligned_cols=38 Identities=5% Similarity=0.072 Sum_probs=34.9
Q ss_pred chHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 424 STEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.+|+.+|+.+..|||||.+.++|.+...+|++++.|.-
T Consensus 134 ~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~ 171 (370)
T 2psq_A 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 171 (370)
T ss_dssp HHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCC
Confidence 47999999999999999999999999999999998854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=86.16 E-value=0.097 Score=48.78 Aligned_cols=66 Identities=11% Similarity=-0.040 Sum_probs=46.4
Q ss_pred cCCCCceeecCCCCCCCCCccccccc------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|...-+.... ....+|++.- ..+-.+|+.+|+.++ ||||+.+.++|.+...+|++++.|.-
T Consensus 18 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 18 IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp EEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred ecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEEEEEeCCC
Confidence 556666643333222 3446777221 112357999999996 99999999999999999999998864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=86.13 E-value=0.14 Score=48.11 Aligned_cols=66 Identities=9% Similarity=-0.002 Sum_probs=46.1
Q ss_pred cCCCCceeecCCCCCCCCCcccccccc------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEEA------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.|.+.|..+-+.....+...+|+..-. ..-.+|+.+|+.++ ||||+.+.++|.+...+|++++.|.
T Consensus 21 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~ 92 (288)
T 3kfa_A 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMT 92 (288)
T ss_dssp SGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEEEEEECCT
T ss_pred cCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCEEEEEEcCC
Confidence 455555533333333334456762221 12347999999996 9999999999999999999999886
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=86.01 E-value=0.13 Score=55.49 Aligned_cols=69 Identities=12% Similarity=0.140 Sum_probs=52.9
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc----------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE----------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-+.....+...|||+.- .....+|+.+|+++..||||+.+.++|.+...+|+|++.|.
T Consensus 347 ~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 4578888885555544445556898221 11245688999999999999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=85.94 E-value=0.16 Score=47.90 Aligned_cols=69 Identities=12% Similarity=-0.115 Sum_probs=51.5
Q ss_pred ccCCCCceeecCCCCCCCCCcccccc-----cccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDE-----EALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|...-+.....+...+||+. ....-.+|+.+|+.+.+||||+.+.+++.+...+|++++.|..
T Consensus 17 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (298)
T 1csn_A 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP 90 (298)
T ss_dssp EEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCC
T ss_pred EEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEecCC
Confidence 35666666555544444556788821 1234568999999999999999999999999999999998843
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=85.85 E-value=0.22 Score=47.66 Aligned_cols=68 Identities=13% Similarity=0.032 Sum_probs=47.3
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc---c------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE---A------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-+.... ....+|++.- . ..-.+|+.+|+.+ .|||||.+.++|.+...+|++++.|..
T Consensus 27 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 103 (311)
T 3niz_A 27 EKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSERCLTLVFEFMEK 103 (311)
T ss_dssp EEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCSSCEEEEEECCSE
T ss_pred hhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccCCEEEEEEcCCCC
Confidence 33566666644333222 2346777221 1 1234799999999 599999999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=85.85 E-value=0.17 Score=48.04 Aligned_cols=66 Identities=11% Similarity=-0.049 Sum_probs=46.9
Q ss_pred cCCCCceeecCCCCCCCCCccccccc---c-------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE---A-------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.|.+.|...-++........+|++.- . ..-.+|+.+|+.+ .||||+.+.++|.+...+|+|++.|.
T Consensus 39 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 114 (286)
T 3uqc_A 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGGLVVAEWIR 114 (286)
T ss_dssp EEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcEEEEEEecC
Confidence 56666665544444444557777221 1 1235788888777 79999999999999999999999885
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=85.82 E-value=1.6 Score=39.88 Aligned_cols=60 Identities=8% Similarity=0.027 Sum_probs=44.9
Q ss_pred cCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHH-HHCCeeecCCCCcceEecCCCCceeEee
Q psy622 126 GGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYL-HSHGIIHRDLKPDNMLISAQAPHCPIVN 186 (473)
Q Consensus 126 gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yL-H~~gIiHRDLKpeNILld~~~g~ikL~D 186 (473)
.-+|.+.|+.. .+++|++++.++.|.+.+|.-+ +++.-..+=+-|..|+|..+ |.|-..+
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d-G~V~f~~ 93 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD-GAVTLAP 93 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT-SCEEECC
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC-Cceeccc
Confidence 34799999864 5899999999999999998776 22222234455799999998 8877653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=85.81 E-value=0.13 Score=50.98 Aligned_cols=67 Identities=12% Similarity=0.009 Sum_probs=47.0
Q ss_pred cCCCCceeecCCCCCCCCCccccccc--------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE--------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|...-+.....+...+||+.- ...-.+|+.+|+.+ .|||||.+.+++.+...+|++++.|.-
T Consensus 122 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 196 (377)
T 3cbl_A 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQG 196 (377)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence 45555654433333333446676211 12456799999998 699999999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=85.79 E-value=0.18 Score=50.80 Aligned_cols=68 Identities=18% Similarity=0.127 Sum_probs=48.5
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---c------------ccCcchHHHHHHhhcCCCcEEecccccccccceehhh
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---E------------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTL 456 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (473)
...|.+.|...-+.....+...+||+. . ..+-.+|+.+|+.+ .|||||.+.++|.... +|+++
T Consensus 141 ~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~-~~lv~ 218 (419)
T 3i6u_A 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED-YYIVL 218 (419)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEESSE-EEEEE
T ss_pred eEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEecCc-eEEEE
Confidence 346777777665555555566788721 1 11235799999999 7999999999997665 68899
Q ss_pred cccCC
Q psy622 457 DAMSP 461 (473)
Q Consensus 457 ~~~~~ 461 (473)
+.|..
T Consensus 219 e~~~~ 223 (419)
T 3i6u_A 219 ELMEG 223 (419)
T ss_dssp ECCTT
T ss_pred EcCCC
Confidence 88853
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=85.77 E-value=0.076 Score=51.15 Aligned_cols=65 Identities=11% Similarity=-0.114 Sum_probs=42.8
Q ss_pred cCCCCceeecCCCCCCCCCcccccc---c-ccCcchHHHHHHhhc-CCCcEEecccccccc----cceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDE---E-ALNPSTEETILALLK-SDPIVFMGDDTWSSF----SAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~~~~ 460 (473)
.|.+.|...-|... ....+||+. + ..+-.+|.+|+.+.+ .|||||.+.+++.+. ..+|+|++.|.
T Consensus 11 iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 56777774444322 234788822 1 223345667776554 799999999998654 46899999996
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=85.66 E-value=0.1 Score=48.52 Aligned_cols=66 Identities=12% Similarity=-0.001 Sum_probs=46.9
Q ss_pred cCCCCceeecCCCCCCCCCccccccc------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|...-+... .+..++||+.- ..+-.+|+.+|+.+. ||||+.+.++|.+...+|++++.|..
T Consensus 16 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 16 LGSGQFGVVKLGKW-KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp EEEETTEEEEEEEE-TTTEEEEEEEECBTTBCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred eccCCCceEEEEEe-cCceeEEEEEeccCCCcHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCceEEEEEccCC
Confidence 56666664443322 23446887221 122357999999996 99999999999999999999998853
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=85.66 E-value=0.19 Score=50.79 Aligned_cols=69 Identities=17% Similarity=0.079 Sum_probs=49.3
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc---------ccCcchHHHHHHhhcCCCcEEecccccccc-----cceehhhc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE---------ALNPSTEETILALLKSDPIVFMGDDTWSSF-----SAIFNTLD 457 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 457 (473)
...|.+.|...-+.....+...+|+++- .....+|+.+|+.+. |||||.+.++|-.. ..+|+|++
T Consensus 32 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~e 110 (432)
T 3n9x_A 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLE 110 (432)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred EEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCCCcCCeEEEEEe
Confidence 3466777775555554555557888322 113348999999995 99999999998665 67999999
Q ss_pred ccCC
Q psy622 458 AMSP 461 (473)
Q Consensus 458 ~~~~ 461 (473)
.|..
T Consensus 111 ~~~~ 114 (432)
T 3n9x_A 111 IADS 114 (432)
T ss_dssp CCSE
T ss_pred cCCc
Confidence 8863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=85.58 E-value=0.19 Score=49.22 Aligned_cols=68 Identities=10% Similarity=-0.027 Sum_probs=50.3
Q ss_pred CccCCCCceeecCCCCCCCCCcccccccc----------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEEA----------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-+.....+...+||+.-. ..-.+|+.+|+.+ .|||||.+.++|.+...+|+|++.|.
T Consensus 60 ~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeEEEEEecCC
Confidence 34677888755555444455678883221 1123799999998 59999999999999999999999985
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.51 E-value=0.18 Score=48.69 Aligned_cols=36 Identities=6% Similarity=-0.123 Sum_probs=30.6
Q ss_pred chHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 424 STEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.+|+.+|+.+ .|||||.+.+++.+. .+|+|++.|.-
T Consensus 80 ~~E~~il~~l-~HpNIV~l~g~~~~~-~~~iVmEy~~g 115 (307)
T 3omv_A 80 RNEVAVLRKT-RHVNILLFMGYMTKD-NLAIVTQWCEG 115 (307)
T ss_dssp HHHHHHHTTC-CCTTBCCEEEEECSS-SCEEEEECCSS
T ss_pred HHHHHHHHhC-CCCCEeeEEEEEECC-eEEEEEEcCCC
Confidence 4699999999 599999999988765 57999998863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=85.31 E-value=0.13 Score=50.92 Aligned_cols=68 Identities=10% Similarity=0.105 Sum_probs=47.6
Q ss_pred CccCCCCceeecCCCCC---CCCCcccccccc--------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPD---NSELEWPEDEEA--------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-+.... .....+||+... ..-.+|+.+|+.+ .|||||.+.+++.+...+|++++.|.
T Consensus 51 ~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 129 (373)
T 2qol_A 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYME 129 (373)
T ss_dssp EEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCceEEEEeCCC
Confidence 34677777755443332 233457773221 1234689999998 69999999999999999999999885
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=85.16 E-value=0.2 Score=48.27 Aligned_cols=68 Identities=7% Similarity=-0.004 Sum_probs=47.9
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc---ccC------cchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE---ALN------PSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|..+-++........+||+.- ..+ -.+|+.+|+.+. ||||+.+.++|.+...+|++++.+..
T Consensus 32 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWYLVFEFVDH 108 (331)
T ss_dssp EGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEEEEEEecCCc
Confidence 355666664444444444556777321 111 236999999996 99999999999999999999998864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=85.10 E-value=0.27 Score=47.56 Aligned_cols=37 Identities=11% Similarity=0.041 Sum_probs=34.5
Q ss_pred chHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 424 STEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.+|+.+|+.+..||||+.+.++|.+...+|++++.|.
T Consensus 96 ~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 132 (344)
T 1rjb_A 96 MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 132 (344)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCC
Confidence 4799999999999999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=85.01 E-value=0.16 Score=52.34 Aligned_cols=67 Identities=7% Similarity=-0.033 Sum_probs=45.9
Q ss_pred cCCCCceeecCCCCCCCCCcccccccc------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEEA------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|..+-+.........+||+... ..-.+|+.+|+.+ .|||||.+.+++.+...+|++++.|.-
T Consensus 228 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~E~~~~ 300 (495)
T 1opk_A 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTY 300 (495)
T ss_dssp SGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred ecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEEEEEEccCC
Confidence 455555533333333333466772221 1224799999999 599999999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=85.01 E-value=0.22 Score=46.79 Aligned_cols=66 Identities=12% Similarity=0.096 Sum_probs=47.2
Q ss_pred cCCCCceeecCCCCCCCCCcccccc---cccC------cchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDE---EALN------PSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.|.+.|...-++........+|++. ...+ -.+|+.+|+.+ .||||+.+.+++.+...+|++++.|.
T Consensus 30 lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (287)
T 2wei_A 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYT 104 (287)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCeEEEEEEccC
Confidence 5566666444444444556788722 1111 23799999999 79999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.85 E-value=0.28 Score=48.55 Aligned_cols=39 Identities=5% Similarity=0.043 Sum_probs=35.6
Q ss_pred cchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 423 PSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
-.+|+++|+.+..|||||.+.++|.+...+|++++.|.-
T Consensus 121 ~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~ 159 (382)
T 3tt0_A 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 159 (382)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCC
Confidence 448999999999999999999999999999999998853
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=84.84 E-value=0.11 Score=49.83 Aligned_cols=55 Identities=15% Similarity=0.102 Sum_probs=36.5
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc---c-----cCcchHHHHHHhhcCCCcEEeccccccc
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE---A-----LNPSTEETILALLKSDPIVFMGDDTWSS 448 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (473)
..|.+.|...-+.....+...+||+.- . ..-.+|+.+|+.+ .|||||.+.++|-+
T Consensus 13 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 75 (332)
T 3qd2_B 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLE 75 (332)
T ss_dssp EEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEE
T ss_pred EecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE
Confidence 356677775555555555667888322 1 1234799999999 59999999998733
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=84.76 E-value=0.26 Score=48.67 Aligned_cols=67 Identities=13% Similarity=0.131 Sum_probs=42.3
Q ss_pred cCCCCceeecCCCCCCCCCcccccccc---------cCcchHHHHHHhhcCCCcEEeccccccc------ccceehhhcc
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEEA---------LNPSTEETILALLKSDPIVFMGDDTWSS------FSAIFNTLDA 458 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~ 458 (473)
.|.+.|...-+.....+...+|+++-. ....+|+.+|+.++ ||||+.+.++|.. +..+|++++.
T Consensus 37 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~~lv~e~ 115 (367)
T 2fst_X 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHL 115 (367)
T ss_dssp CC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGGGCCCCEEEEEC
T ss_pred EeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCccccCCeEEEEecc
Confidence 566666644433333344567773321 12237999999996 9999999999865 3678999998
Q ss_pred cCC
Q psy622 459 MSP 461 (473)
Q Consensus 459 ~~~ 461 (473)
|..
T Consensus 116 ~~~ 118 (367)
T 2fst_X 116 MGA 118 (367)
T ss_dssp CCE
T ss_pred cCC
Confidence 854
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=84.36 E-value=0.25 Score=48.65 Aligned_cols=67 Identities=12% Similarity=0.059 Sum_probs=41.4
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc---------ccCcchHHHHHHhhcCCCcEEecccccccc------cceehhhc
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE---------ALNPSTEETILALLKSDPIVFMGDDTWSSF------SAIFNTLD 457 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 457 (473)
..|.+.|...-+.........+|+++- .....+|+.+|+.++ |||||.+.++|... ..+|++++
T Consensus 32 ~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~~~~~lv~e 110 (367)
T 1cm8_A 32 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMP 110 (367)
T ss_dssp EC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCccccCceEEEEEe
Confidence 356666664444433444556777322 112347999999996 99999999998765 45699999
Q ss_pred ccC
Q psy622 458 AMS 460 (473)
Q Consensus 458 ~~~ 460 (473)
.|.
T Consensus 111 ~~~ 113 (367)
T 1cm8_A 111 FMG 113 (367)
T ss_dssp CCS
T ss_pred cCC
Confidence 884
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.26 E-value=0.16 Score=48.70 Aligned_cols=67 Identities=7% Similarity=-0.112 Sum_probs=46.6
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc---c-----cCcchHHHHHHhhcCCCcEEeccccccccc--ceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE---A-----LNPSTEETILALLKSDPIVFMGDDTWSSFS--AIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 460 (473)
..|.+.|...-+.........+||+.- . ..-.+|+.+|+.++ ||||+.+.++|.+.. .+|++++.|.
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (319)
T 4euu_A 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCP 92 (319)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEEEEEECCT
T ss_pred EecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCceEEEEEeCCC
Confidence 356677775554444445557888221 0 11238999999996 999999999987544 8899998885
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=84.15 E-value=0.22 Score=46.50 Aligned_cols=67 Identities=12% Similarity=0.116 Sum_probs=45.8
Q ss_pred cCCCCceeecCCCCCCCCCccccc---ccccCcchHHHHHHhhcCCCcEEeccccccc----------------ccceeh
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPED---EEALNPSTEETILALLKSDPIVFMGDDTWSS----------------FSAIFN 454 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~ 454 (473)
.|.+.|..+-+.....+...+|++ .....-.+|+.+|+.+ .||||+.+.++|.+ ...+|+
T Consensus 19 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 97 (284)
T 2a19_B 19 IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFI 97 (284)
T ss_dssp EECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC---------CCEEEEEEE
T ss_pred eccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccccccccCcceEEE
Confidence 455566544333333345577872 2233567899999999 59999999998865 455888
Q ss_pred hhcccCC
Q psy622 455 TLDAMSP 461 (473)
Q Consensus 455 ~~~~~~~ 461 (473)
+++.|.-
T Consensus 98 v~e~~~~ 104 (284)
T 2a19_B 98 QMEFCDK 104 (284)
T ss_dssp EECCCCS
T ss_pred EEeccCC
Confidence 8888764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=84.15 E-value=0.16 Score=53.29 Aligned_cols=68 Identities=10% Similarity=0.059 Sum_probs=52.1
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc----------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE----------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-++....+...||++.- .....+|+.+|+.+ .|||||.+.++|.+...+|+|++.|.
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 3477888886666555556668888211 11234699999998 69999999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=84.00 E-value=0.22 Score=49.00 Aligned_cols=69 Identities=6% Similarity=-0.038 Sum_probs=48.8
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc---c------cCcchHHHHHHhhcCCCcEEeccccccccc------ceehhh
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE---A------LNPSTEETILALLKSDPIVFMGDDTWSSFS------AIFNTL 456 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 456 (473)
...|.+.|...-++........+||+.- . ..-.+|+.+|+.+ .||||+.+.++|.+.. .+|+++
T Consensus 31 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~lv~ 109 (371)
T 2xrw_A 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVM 109 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred eeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccccceEEEE
Confidence 4467777776555544455567888322 1 1234789999988 5999999999987654 789999
Q ss_pred cccCC
Q psy622 457 DAMSP 461 (473)
Q Consensus 457 ~~~~~ 461 (473)
+.|..
T Consensus 110 e~~~~ 114 (371)
T 2xrw_A 110 ELMDA 114 (371)
T ss_dssp ECCSE
T ss_pred EcCCC
Confidence 99864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.92 E-value=0.16 Score=50.15 Aligned_cols=68 Identities=16% Similarity=0.044 Sum_probs=45.6
Q ss_pred ccCCCCceeecCCC-----CCCCCCccccccc--------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhccc
Q psy622 393 LSGVSPFLAMDRSP-----PDNSELEWPEDEE--------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAM 459 (473)
Q Consensus 393 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (473)
..|.+.|...-+.. .......+||+.- ...-.+|+.+|+.+ .|||||.+.++|.+...+|+|++.|
T Consensus 78 ~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~ 156 (367)
T 3l9p_A 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELM 156 (367)
T ss_dssp ECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCEEEEEeC
Confidence 35666666332211 2333446787332 11234688899988 6999999999999999999999988
Q ss_pred CC
Q psy622 460 SP 461 (473)
Q Consensus 460 ~~ 461 (473)
..
T Consensus 157 ~~ 158 (367)
T 3l9p_A 157 AG 158 (367)
T ss_dssp TT
T ss_pred CC
Confidence 53
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=83.77 E-value=0.2 Score=48.49 Aligned_cols=69 Identities=13% Similarity=0.044 Sum_probs=50.0
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---c-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---E-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|..+-+.....+...||+.. . ...-.+|+.+|+.+ .||||+.+.++|.+...+|++++.|.-
T Consensus 47 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 125 (335)
T 2owb_A 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCRR 125 (335)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEecCCC
Confidence 446677777555554455556777722 1 11224689999988 699999999999999999999998863
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=83.70 E-value=0.19 Score=47.46 Aligned_cols=66 Identities=9% Similarity=0.052 Sum_probs=45.7
Q ss_pred cCCCCceeecCCCCCCCCCccccccc---c------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE---A------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.|.+.|...-+.....+...+||+.- . ..-.+|+.+|+.+ .||||+.+.++|.+...+|++++.+.
T Consensus 11 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (299)
T 2r3i_A 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLH 85 (299)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred hccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHc-CCCCeeeEEEEEecCCceEEEEEccc
Confidence 45555554443333334456777221 1 1234799999998 69999999999999999999999886
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=83.62 E-value=0.46 Score=45.45 Aligned_cols=68 Identities=12% Similarity=-0.001 Sum_probs=47.9
Q ss_pred CccCCCCceeecCCCCCCCCCcccccccc-c------CcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEEA-L------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-+.... +...+||+... . .-.+|+.+|+.+. ||||+.+.++|.+...+|++++.|..
T Consensus 45 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 119 (321)
T 2qkw_B 45 FLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCR-HPHLVSLIGFCDERNEMILIYKYMEN 119 (321)
T ss_dssp CCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred ceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence 45677777744433322 34577873321 1 1247889998885 99999999999999999999998863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=83.36 E-value=0.14 Score=48.03 Aligned_cols=67 Identities=12% Similarity=0.064 Sum_probs=48.5
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc----------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE----------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..|.+.|...-+.....+...+||..- ...-.+|+.+|+.++ ||||+.+.++|.+...+|++++.|.
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (279)
T 3fdn_A 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLILEYAP 92 (279)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEEEEEecCC
Confidence 356666765555544555557787211 112346889998886 9999999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.21 E-value=0.21 Score=47.32 Aligned_cols=67 Identities=7% Similarity=-0.095 Sum_probs=47.9
Q ss_pred cCCCCceeecCCCCCCCCCccccccc---c-------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE---A-------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|...-+.........+|++.- . ..-.+|+.+|+.+ .||||+.+.+++.+...+|++++.|.-
T Consensus 19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g 95 (294)
T 4eqm_A 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEEDDCYYLVMEYIEG 95 (294)
T ss_dssp EEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeCCeEEEEEeCCCC
Confidence 56666665555444455556777321 1 1224688888888 599999999999999999999998863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.20 E-value=0.19 Score=48.24 Aligned_cols=69 Identities=9% Similarity=-0.021 Sum_probs=49.1
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc-------ccCcchHHHHHHhhcCCCcEEeccccc--------ccccceehhh
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE-------ALNPSTEETILALLKSDPIVFMGDDTW--------SSFSAIFNTL 456 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 456 (473)
...|.+.|...-+.........+||+.- ...-.+|+.+|+.+..||||+.+.++| .....+|+++
T Consensus 34 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~ 113 (337)
T 3ll6_A 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLT 113 (337)
T ss_dssp EEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEE
T ss_pred EEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEE
Confidence 3466777775555544445567888322 112357899999999999999998887 5666788998
Q ss_pred cccC
Q psy622 457 DAMS 460 (473)
Q Consensus 457 ~~~~ 460 (473)
+.|.
T Consensus 114 e~~~ 117 (337)
T 3ll6_A 114 ELCK 117 (337)
T ss_dssp ECCS
T ss_pred EecC
Confidence 8885
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=83.15 E-value=0.26 Score=47.37 Aligned_cols=38 Identities=11% Similarity=0.064 Sum_probs=34.6
Q ss_pred cchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 423 PSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
-.+|+.+|+.+..||||+.+.++|.+...+|++++.|.
T Consensus 72 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 72 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp HHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred HHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 34699999999999999999999999999999998874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=83.06 E-value=0.37 Score=46.47 Aligned_cols=38 Identities=5% Similarity=0.072 Sum_probs=34.7
Q ss_pred chHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 424 STEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.+|+.+|+.+..||||+.+.++|.+...+|++++.+.-
T Consensus 88 ~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 125 (334)
T 2pvf_A 88 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125 (334)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTT
T ss_pred HHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCC
Confidence 47999999999999999999999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=83.04 E-value=0.24 Score=46.72 Aligned_cols=67 Identities=13% Similarity=0.034 Sum_probs=45.6
Q ss_pred ccCCCCceeecCCC----CCCCCCcccccccc-------cCcchHHHHHHhhcCCCcEEeccccccc--ccceehhhccc
Q psy622 393 LSGVSPFLAMDRSP----PDNSELEWPEDEEA-------LNPSTEETILALLKSDPIVFMGDDTWSS--FSAIFNTLDAM 459 (473)
Q Consensus 393 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 459 (473)
..|.+.|...-++. .......+||+.-. ..-.+|+.+|+.++ ||||+.+.++|.+ ...+|++++.|
T Consensus 17 ~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~ 95 (295)
T 3ugc_A 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYL 95 (295)
T ss_dssp EEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHHHHTSCEEEEECC
T ss_pred eeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCCceEEEEEeC
Confidence 36677777443332 34445578883321 12347999999995 9999999998843 46689999887
Q ss_pred C
Q psy622 460 S 460 (473)
Q Consensus 460 ~ 460 (473)
.
T Consensus 96 ~ 96 (295)
T 3ugc_A 96 P 96 (295)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=83.02 E-value=0.11 Score=51.54 Aligned_cols=70 Identities=11% Similarity=0.133 Sum_probs=46.4
Q ss_pred CccCCCCceeecCCCCCCCCCccccc---cc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPED---EE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|..+-+.....+...||++ +. ...-.+|+.+|...-.|||||.+.++|.+...+|++++.|.-
T Consensus 44 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g 123 (373)
T 2r5t_A 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 123 (373)
T ss_dssp EEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCC
Confidence 44677888766655555566678882 11 122344555555556899999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=82.95 E-value=0.32 Score=48.38 Aligned_cols=65 Identities=9% Similarity=-0.045 Sum_probs=46.9
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc---cc------CcchHHHHHHhhcC-CCcEEecccccccccceehhhcc
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE---AL------NPSTEETILALLKS-DPIVFMGDDTWSSFSAIFNTLDA 458 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 458 (473)
..|.+.|...-+..... ...+||+.- .. .-.+|+.+|+.+.+ |||||.+.+++.....+|++++.
T Consensus 63 ~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~ 137 (390)
T 2zmd_A 63 QIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137 (390)
T ss_dssp EEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec
Confidence 46777777544433332 456888321 11 22579999999986 89999999999999999999884
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=82.95 E-value=0.35 Score=47.60 Aligned_cols=69 Identities=12% Similarity=0.061 Sum_probs=49.7
Q ss_pred CccCCCCceeecCCCCCCCCCcccccccc---------cCcchHHHHHHhhcCCCcEEecccccccccce------ehhh
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEEA---------LNPSTEETILALLKSDPIVFMGDDTWSSFSAI------FNTL 456 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 456 (473)
...|.+.|...-++....+...+|++.-. ..-.+|+.+|+.++ ||||+.+.++|.+...+ |+++
T Consensus 48 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv~ 126 (371)
T 4exu_A 48 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVM 126 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCCcccceeEEEEE
Confidence 44677888766555555555678883221 12347999999996 99999999999887766 8888
Q ss_pred cccCC
Q psy622 457 DAMSP 461 (473)
Q Consensus 457 ~~~~~ 461 (473)
+.|..
T Consensus 127 e~~~~ 131 (371)
T 4exu_A 127 PFMQT 131 (371)
T ss_dssp ECCCE
T ss_pred ccccc
Confidence 88863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=82.77 E-value=0.36 Score=48.73 Aligned_cols=66 Identities=9% Similarity=-0.105 Sum_probs=47.0
Q ss_pred cCCCCceeecCCCCCCCCCccccccc----ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE----ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.|.+.|...-.. .......+||++. .....+|+.+|+.+..|||||.+.+++.+...+|++++.|.
T Consensus 23 LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 23 LGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred EeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 556666532111 1223457888432 11346899999999899999999999999999999999984
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=82.54 E-value=0.31 Score=47.38 Aligned_cols=71 Identities=10% Similarity=0.131 Sum_probs=41.9
Q ss_pred CccCCCCceeecCCCCCCCCCccccc---ccccCcchHHHHHHhhc--CCCcEEecccccccc-------cceehhhccc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPED---EEALNPSTEETILALLK--SDPIVFMGDDTWSSF-------SAIFNTLDAM 459 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-------~~~~~~~~~~ 459 (473)
...|.+.|...-+.....+...+||+ +......+|+.+++.+. .|||||.+.++|.+. .++|++++.|
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~ 108 (360)
T 3e3p_A 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV 108 (360)
T ss_dssp ----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecc
Confidence 45677777755554444455678883 22334567777776665 799999999998543 3488999998
Q ss_pred CCC
Q psy622 460 SPT 462 (473)
Q Consensus 460 ~~~ 462 (473)
..+
T Consensus 109 ~~~ 111 (360)
T 3e3p_A 109 PDT 111 (360)
T ss_dssp SCB
T ss_pred ccc
Confidence 754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=82.30 E-value=0.16 Score=49.52 Aligned_cols=69 Identities=13% Similarity=-0.042 Sum_probs=49.7
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc--c------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE--A------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-+.....+...+|+... . ..-.+|+.+|+.+ .||||+.+.++|.+...+|++++.|.-
T Consensus 39 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 115 (360)
T 3eqc_A 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDG 115 (360)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCEEEEEEECCCC
Confidence 3466677765554444445567777221 1 1235788999988 699999999999999999999998863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.24 E-value=0.2 Score=48.02 Aligned_cols=69 Identities=6% Similarity=-0.051 Sum_probs=46.6
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc------ccCcchHHHHHHhhcCCCcEEeccccccc------ccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE------ALNPSTEETILALLKSDPIVFMGDDTWSS------FSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~ 460 (473)
..|.+.|...-+.....+...+|++.- ...-.+|+.+|+.+..||||+.+.++|.. ...+|++++.|.
T Consensus 31 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~ 110 (326)
T 2x7f_A 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 110 (326)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCT
T ss_pred EeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCC
Confidence 355556654443333334446666221 22345899999999999999999999966 567899998876
Q ss_pred C
Q psy622 461 P 461 (473)
Q Consensus 461 ~ 461 (473)
.
T Consensus 111 ~ 111 (326)
T 2x7f_A 111 A 111 (326)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=82.16 E-value=0.26 Score=47.18 Aligned_cols=65 Identities=18% Similarity=0.131 Sum_probs=45.5
Q ss_pred cCCCCceeecCCCCCCCCCccccccc---------------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcc
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE---------------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDA 458 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (473)
.|.+.|...-+.....+...+||+.- ..+-.+|+.+|+.+ .||||+.+.++|.+.. +|++++.
T Consensus 18 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~lv~e~ 95 (322)
T 2ycf_A 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED-YYIVLEL 95 (322)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESSS-EEEEEEC
T ss_pred EecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCCc-eEEEEec
Confidence 56666765554444445557777211 11335799999999 7999999999998776 7888888
Q ss_pred cC
Q psy622 459 MS 460 (473)
Q Consensus 459 ~~ 460 (473)
|.
T Consensus 96 ~~ 97 (322)
T 2ycf_A 96 ME 97 (322)
T ss_dssp CT
T ss_pred CC
Confidence 75
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=82.14 E-value=0.17 Score=47.06 Aligned_cols=66 Identities=14% Similarity=-0.053 Sum_probs=46.7
Q ss_pred cCCCCceeecCCCCCCCCCccccccc---c-----cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE---A-----LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.|.+.|...-+.....+...+||..- . ..-.+|+.+|+.+ .||||+.+.+++.+...+|++++.+.
T Consensus 15 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (276)
T 2yex_A 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCS 88 (276)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEEEEEEecC
Confidence 45566664444444444557777221 1 1234789999988 69999999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=81.95 E-value=0.22 Score=47.10 Aligned_cols=67 Identities=10% Similarity=0.010 Sum_probs=44.9
Q ss_pred cCCCCceeecCCCCCCCCCccccccc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|...-+.....+...+|+..- ...-.+|+.+|+.+ .||||+.+.++|.+...+|++++.|.-
T Consensus 27 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred eccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 45555654443333334456666221 11223689999998 699999999999999999999998853
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=81.94 E-value=0.16 Score=48.03 Aligned_cols=69 Identities=13% Similarity=0.044 Sum_probs=48.6
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---c-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---E-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|..+-+.....+...+|+.. . ...-.+|+.+|+.+ .||||+.+.++|.+...+|++++.|..
T Consensus 21 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 345666666544444444455677621 1 11224689999988 799999999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.86 E-value=0.19 Score=47.23 Aligned_cols=67 Identities=9% Similarity=-0.008 Sum_probs=46.5
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..|.+.|...-+.....+...+|+..- ...-.+|+.+|+.+ .||||+.+.++|.+...+|++++.|.
T Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 356666664444433334456777321 11234789999988 69999999999999999999998874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=81.74 E-value=0.41 Score=45.80 Aligned_cols=65 Identities=12% Similarity=0.058 Sum_probs=45.4
Q ss_pred cCCCCceeecCCCCCCCCCccccccc---cc------CcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE---AL------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|...-+... ....+||+.- .. .-.+|+.+|+.++ |||||.+.++|.+...+|++++.|.-
T Consensus 45 lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 3p86_A 45 IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSR 118 (309)
T ss_dssp EEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred eecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCceEEEEecCCC
Confidence 56666664433321 2345777221 11 1236999999995 99999999999999999999998853
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=81.67 E-value=0.21 Score=49.15 Aligned_cols=69 Identities=12% Similarity=-0.019 Sum_probs=50.9
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc------ccCcchHHHHHHhhcC-------CCcEEecccccc----cccceehh
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE------ALNPSTEETILALLKS-------DPIVFMGDDTWS----SFSAIFNT 455 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~----~~~~~~~~ 455 (473)
..|.+.|...-+.....+...+||+.- ...-.+|+.+|+.+.+ ||||+.+.++|. ++..+|++
T Consensus 44 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv 123 (397)
T 1wak_A 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMV 123 (397)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEE
Confidence 366777775555544455567888322 1234589999999974 999999999997 78899999
Q ss_pred hcccCC
Q psy622 456 LDAMSP 461 (473)
Q Consensus 456 ~~~~~~ 461 (473)
++.|..
T Consensus 124 ~e~~~~ 129 (397)
T 1wak_A 124 FEVLGH 129 (397)
T ss_dssp ECCCCC
T ss_pred EeccCc
Confidence 998854
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=81.19 E-value=0.11 Score=52.79 Aligned_cols=69 Identities=10% Similarity=0.076 Sum_probs=45.5
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc----------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE----------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-+.........+||+.- .....+|+.+|+.+. ||||+.+.++|.+...+|+|++.|..
T Consensus 154 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~ 232 (446)
T 4ejn_A 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG 232 (446)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEEEEECCCSS
T ss_pred EEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEEEEEeeCCC
Confidence 3467777775555544555567888211 123456888888775 99999999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=81.18 E-value=0.87 Score=48.81 Aligned_cols=68 Identities=13% Similarity=0.026 Sum_probs=49.4
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc--cc------CcchHHHHHHhhcCCCcEEeccccccc------ccceehhhc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE--AL------NPSTEETILALLKSDPIVFMGDDTWSS------FSAIFNTLD 457 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~ 457 (473)
...|.+.|...-+.....+...+||+.- .. .-.+|+.+|+.+ .|||||.+.+++.+ ....|++++
T Consensus 20 ~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~~~~LVmE 98 (676)
T 3qa8_A 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDLPLLAME 98 (676)
T ss_dssp CCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTSSCCCEEE
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCCeEEEEEE
Confidence 3467777776666666566667888322 11 234599999999 69999999888766 778899999
Q ss_pred ccC
Q psy622 458 AMS 460 (473)
Q Consensus 458 ~~~ 460 (473)
.|.
T Consensus 99 y~~ 101 (676)
T 3qa8_A 99 YCE 101 (676)
T ss_dssp CCS
T ss_pred eCC
Confidence 885
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=81.13 E-value=0.3 Score=46.78 Aligned_cols=68 Identities=10% Similarity=-0.016 Sum_probs=47.8
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc-----c---cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE-----A---LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-+... .+...+||+.- . ..-.+|+.+|+.+. ||||+.+.++|.+....|++++.|.-
T Consensus 36 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 111 (326)
T 3uim_A 36 NILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMAN 111 (326)
T ss_dssp TEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCC-CTTBCCCCEEECCSSCCEEEEECCTT
T ss_pred eeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhcc-CCCccceEEEEecCCceEEEEEeccC
Confidence 3466777775544432 23457787221 1 12257899998886 99999999999999999999998854
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.71 E-value=0.21 Score=46.67 Aligned_cols=68 Identities=16% Similarity=0.155 Sum_probs=47.9
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc----------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE----------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|...-+.....+...+|++.- ...-.+|+.+|+.+ .||||+.+.++|.+...+|++++.|..
T Consensus 18 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (278)
T 3cok_A 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLVLEMCHN 95 (278)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEEEecCCC
Confidence 356666664444433344556787211 12345789999888 599999999999999999999998854
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.46 E-value=0.28 Score=48.83 Aligned_cols=67 Identities=7% Similarity=-0.117 Sum_probs=46.3
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc--------ccCcchHHHHHHhhcCCCcEEeccccccccc--ceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE--------ALNPSTEETILALLKSDPIVFMGDDTWSSFS--AIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 460 (473)
..|.+.|...-+.........+||+.- ...-.+|+++|+.++ |||||.+.++|.+.. .+|++++.|.
T Consensus 16 ~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~lv~e~~~ 92 (396)
T 4eut_A 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCP 92 (396)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred EEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCCeeEEEEecCC
Confidence 356677775554444445557888221 111238999999995 999999999987644 7899988875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=80.43 E-value=0.31 Score=45.79 Aligned_cols=67 Identities=21% Similarity=0.230 Sum_probs=45.2
Q ss_pred cCCCCceeecCCCCCCCCCcccccc---cccC------cchHHHHHHhhcCCCcEEeccccccc----ccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDE---EALN------PSTEETILALLKSDPIVFMGDDTWSS----FSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 460 (473)
.|.+.|...-+.....+...+|+.. ...+ -.+|+.+|+.+ .||||+.+.++|.+ ...+|++++.|.
T Consensus 34 lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 112 (290)
T 1t4h_A 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMT 112 (290)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEECCC
T ss_pred ccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCceEEEEEEecC
Confidence 5666666444444444455677621 1112 24689999988 69999999998765 577999999886
Q ss_pred C
Q psy622 461 P 461 (473)
Q Consensus 461 ~ 461 (473)
.
T Consensus 113 ~ 113 (290)
T 1t4h_A 113 S 113 (290)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.38 E-value=0.21 Score=47.26 Aligned_cols=70 Identities=11% Similarity=0.042 Sum_probs=46.9
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc-----------ccCcchHHHHHHhhcCCCcEEeccccc--ccccceehhhcc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE-----------ALNPSTEETILALLKSDPIVFMGDDTW--SSFSAIFNTLDA 458 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 458 (473)
...|.+.|...-+.....+...+|++.- ...-.+|+.+|+.++ ||||+.+.+++ .+...+|++++.
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---CEEEEEEC
T ss_pred eEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCCeEEEEehh
Confidence 3456677765554444445557777211 123458999999995 99999999998 667789999998
Q ss_pred cCCC
Q psy622 459 MSPT 462 (473)
Q Consensus 459 ~~~~ 462 (473)
|..+
T Consensus 90 ~~~~ 93 (305)
T 2wtk_C 90 CVCG 93 (305)
T ss_dssp CSEE
T ss_pred ccCC
Confidence 8743
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=80.20 E-value=0.19 Score=48.42 Aligned_cols=68 Identities=7% Similarity=-0.130 Sum_probs=48.7
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc---c----cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE---A----LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|...-+.....+...+||+.- . ..-.+|+.+|+.+ .|||||.+.++|.....+|++++.|.-
T Consensus 52 ~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred EeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEecCCC
Confidence 367777775544444444557888322 1 1123789999988 699999999999999999999998853
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=80.17 E-value=0.22 Score=50.22 Aligned_cols=70 Identities=14% Similarity=0.070 Sum_probs=53.2
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc------ccCcchHHHHHHhhc-----CCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE------ALNPSTEETILALLK-----SDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-++....+...+||+.- ..+..+|+.+|+.+. .||||+.+.++|.....+|++++.|.
T Consensus 103 ~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 182 (429)
T 3kvw_A 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS 182 (429)
T ss_dssp EEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC
T ss_pred EEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC
Confidence 3467788886665555555667888321 234567999999886 78999999999999999999999986
Q ss_pred C
Q psy622 461 P 461 (473)
Q Consensus 461 ~ 461 (473)
.
T Consensus 183 ~ 183 (429)
T 3kvw_A 183 M 183 (429)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=80.09 E-value=0.34 Score=46.32 Aligned_cols=69 Identities=13% Similarity=0.036 Sum_probs=47.2
Q ss_pred ccCCCCceeecCCCCC-CCCCccccccc---------ccCcchHHHHHHhhc--CCCcEEecccccc-----cccceehh
Q psy622 393 LSGVSPFLAMDRSPPD-NSELEWPEDEE---------ALNPSTEETILALLK--SDPIVFMGDDTWS-----SFSAIFNT 455 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-----~~~~~~~~ 455 (473)
..|.+.|...-+.... .+...+|++.- ...-.+|+.+|+.++ .||||+.+.++|. ....+|++
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 97 (326)
T 1blx_A 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV 97 (326)
T ss_dssp EEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEE
T ss_pred eecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEE
Confidence 3566667654444332 23335676211 113347999999998 8999999999986 77889999
Q ss_pred hcccCC
Q psy622 456 LDAMSP 461 (473)
Q Consensus 456 ~~~~~~ 461 (473)
++.|..
T Consensus 98 ~e~~~~ 103 (326)
T 1blx_A 98 FEHVDQ 103 (326)
T ss_dssp EECCSC
T ss_pred EecCCC
Confidence 998874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=80.04 E-value=0.22 Score=46.69 Aligned_cols=70 Identities=9% Similarity=-0.036 Sum_probs=48.7
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc--ccC------cchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE--ALN------PSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.+.|...-+.........+|++.- ..+ -..|+.++.....||||+.+.++|.+...+|++++.|..
T Consensus 13 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 90 (290)
T 3fme_A 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT 90 (290)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE
T ss_pred HhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc
Confidence 3467777776555555555667888322 111 123455556677999999999999999999999999863
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 473 | ||||
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-49 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-46 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-43 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-36 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-36 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-34 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-34 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-33 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-32 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-31 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-31 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-31 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-29 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-25 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-25 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-17 |
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (456), Expect = 5e-53
Identities = 85/338 (25%), Positives = 149/338 (44%), Gaps = 32/338 (9%)
Query: 8 SGADKENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKD 67
G+++E++ E KA E+ L ++ F+ +K + G+FG+V L K +
Sbjct: 8 KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG- 66
Query: 68 QLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGG 127
YA+K++ K +++ + L E+ L + PF V+L +S + +S +++VMEY+ GG
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 128 DVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNT 187
++ S + G E A FYAA++VL +YLHS +I+RDLKP+N+LI Q
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-------GY 179
Query: 188 LFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLSLKTGT-------FPTFQDVQNSQA 240
+ + + + GTP A P +LS ++
Sbjct: 180 IQVTDFGFAKRVKGRTWTLCGTPEA---LAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 241 PFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQR-----PSGH 295
PF + P ++ + ++ + LL+ D T+R +
Sbjct: 237 PFF-------ADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVN 289
Query: 296 QVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYF 331
++ F DW +I + E PF+P+ DTS F
Sbjct: 290 DIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNF 327
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 8e-51
Identities = 91/331 (27%), Positives = 151/331 (45%), Gaps = 31/331 (9%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
I DF + K + +G+FGKVFL K +Q +AIK +KKD ++ + V + E+ L+L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKT-NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 59
Query: 100 -HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
PF +F + QT +F VMEY+ GGD+ I + A FYAAE++L LQ+L
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 159 HSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTP 218
HS GI++RDLK DN+L+ + ++ ++ ++ GT + P
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIAD----FGMCKENMLGDAKTNTFCGT---PDYIAP 172
Query: 219 GQLLSLKTGT-------FPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271
LL K ++ Q+PF Q ++++ P
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH-------GQDEEELFHSIRMDNPFYPRW 225
Query: 272 LNPSTEETILALLKSDPTQRPSGH-QVRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDT 328
L ++ ++ L +P +R +R+ P+F++ +W+ + +E PPF P+ FD
Sbjct: 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDC 285
Query: 329 SYFHADKTN-----SYMDSTLSTTHGNGSFV 354
S F + N S+ D L + F
Sbjct: 286 SNFDKEFLNEKPRLSFADRALINSMDQNMFR 316
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-50
Identities = 81/300 (27%), Positives = 131/300 (43%), Gaps = 32/300 (10%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNA 95
K PE DF+ K + G+F V L + + YAIK+++K +I +N V V RER+
Sbjct: 5 KRPE--DFKFGKILGEGSFSTVVLARELATS-REYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
++ PF V+L+++ Q ++ + Y G++ I G+ E FY AE+V AL
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLEISDLVNGTPNAFN 214
+YLH GIIHRDLKP+N+L++ I T F A + P ++ GT
Sbjct: 122 EYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTA---Q 175
Query: 215 IRTPGQLLSLKTGTFP-------TFQDVQNSQAPFPSALRVAGSQIPTSTA-AQLQLEWP 266
+P L + PF AG++ +L+ ++P
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKIIKLEYDFP 230
Query: 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRL------PMFKDYDWDSILDQEPPFVP 320
E P + + LL D T+R ++ P F+ W+++ Q PP +
Sbjct: 231 EK---FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 171 bits (434), Expect = 1e-49
Identities = 71/307 (23%), Positives = 127/307 (41%), Gaps = 26/307 (8%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
++DF + + I RG FG+V+ K ++YA+K + K + K + L ER L+L
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTG-KMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 100 HS---PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQ 156
+ PF V + Y+ T + +++ M GGD+ ++ +G E FYAAE++L L+
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 157 YLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTP--NAFN 214
++H+ +++RDLKP N+L+ H I + + + GT A
Sbjct: 122 HMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSK-----KKPHASVGTHGYMAPE 175
Query: 215 IRTPGQLLSLKTGTFP---TFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271
+ G F + +PF ++ E ++
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ----HKTKDKHEIDRMTLTMAVELPDS 231
Query: 272 LNPSTEETILALLKSDPTQRPSG-----HQVRRLPMFKDYDWDSILDQE--PPFVPQPDD 324
+P + LL+ D +R +V+ P F+ DW + Q+ PP +P +
Sbjct: 232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGE 291
Query: 325 VFDTSYF 331
V F
Sbjct: 292 VNAADAF 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 7e-48
Identities = 82/315 (26%), Positives = 137/315 (43%), Gaps = 23/315 (7%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
++DF+ +K + +G FGKV L +K + YA+K+++K+ +I K+ V+ + E L T
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATG-RYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
PF L Y+ QT + VMEY GG++ ++ E+ A FY AE+V AL+YLH
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 160 SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPN-AFNIRTP 218
S +++RD+K +N+++ H I + ++ GTP
Sbjct: 123 SRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKT---FCGTPEYLAPEVLE 178
Query: 219 GQLLSLKTGTF---PTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPS 275
+ ++ + PF +Q + +E L+P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFY-------NQDHERLFELILMEEIRFPRTLSPE 231
Query: 276 TEETILALLKSDPTQRPSG-----HQVRRLPMFKDYDWDSILDQE--PPFVPQPDDVFDT 328
+ + LLK DP QR G +V F +W ++ ++ PPF PQ DT
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDT 291
Query: 329 SYFHADKTNSYMDST 343
YF + T + T
Sbjct: 292 RYFDDEFTAQSITIT 306
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (406), Expect = 4e-46
Identities = 79/310 (25%), Positives = 139/310 (44%), Gaps = 39/310 (12%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
+ DF+I++ + G+FG+V L + N + YA+KV+KK+ ++ V ER L++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNG-RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLH 159
PF ++++ + Q + +F++M+Y+ GG++ SL+ + P +A FYAAEV LAL+YLH
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 160 SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPG 219
S II+RDLKP+N+L+ + + +++ + GTP+
Sbjct: 122 SKDIIYRDLKPENILLDKN-------GHIKITDFGFAKYVPDVTYTLCGTPDYIAPEV-- 172
Query: 220 QLLSLKTGTFPTFQDVQNS----------QAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269
+ T + D + PF T ++
Sbjct: 173 ----VSTKPYNKSIDWWSFGILIYEMLAGYTPFY-------DSNTMKTYEKILNAELRFP 221
Query: 270 EALNPSTEETILALLKSDPTQR-----PSGHQVRRLPMFKDYDWDSILDQ--EPPFVPQP 322
N ++ + L+ D +QR V+ P FK+ W+ +L + E P+ P
Sbjct: 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPI 281
Query: 323 -DDVFDTSYF 331
DTS F
Sbjct: 282 QQGQGDTSQF 291
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-46
Identities = 72/302 (23%), Positives = 130/302 (43%), Gaps = 17/302 (5%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINK-NMVSQVLRERNAL 96
I +FE++K + GA+GKVFL K + D +LYA+KV+KK ++ K ER L
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 97 A-LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
+ SPF V L Y+ QT + + L+++Y+ GG++ + ++ E Y E+VLAL
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNI 215
++LH GII+RD+K +N+L+ + L + +
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 216 RTPGQLLSLKTGTF---PTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEAL 272
R + ++ +PF + + + +P++ +
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE---M 259
Query: 273 NPSTEETILALLKSDPTQRPSG-----HQVRRLPMFKDYDWDSILDQE--PPFVPQPDDV 325
+ ++ I LL DP +R +++ F+ +WD + ++ PF P D
Sbjct: 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDE 319
Query: 326 FD 327
D
Sbjct: 320 LD 321
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 7e-45
Identities = 49/273 (17%), Positives = 114/273 (41%), Gaps = 16/273 (5%)
Query: 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
P + D+++V+ + GA+G+V L + + + A+K++ ++ + +E
Sbjct: 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD--CPENIKKEICINK 58
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
+ + V+ + + + +L +EY GG++ I + +PE A + +++ + Y
Sbjct: 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 158 LHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRT 217
LH GI HRD+KP+N+L+ + ++ LA + + + + + GT
Sbjct: 119 LHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTL---PYVA 173
Query: 218 PGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW------PEDEEA 271
P L + P DV + + L S + Q +W +
Sbjct: 174 PELLKRREFHAEPV--DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 231
Query: 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304
++ + + +L +P+ R + +++ +
Sbjct: 232 IDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 5e-43
Identities = 60/274 (21%), Positives = 107/274 (39%), Gaps = 26/274 (9%)
Query: 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALAL 98
+ DFEI + + +G FG V+L +K +K + A+KV+ K ++ + Q+ RE +
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
P ++L+ ++ V+L++EY G V + E A Y E+ AL Y
Sbjct: 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122
Query: 159 HSHGIIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLEISDLVNGTPNAFNIRT 217
HS +IHRD+KP+N+L+ + F ++ + GT +
Sbjct: 123 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPS----SRRTTLCGTL---DYLP 172
Query: 218 PGQLLSLKTGT-------FPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270
P + + + PF + T ++ +
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------ANTYQETYKRISRVEFTFPD 225
Query: 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304
+ + I LLK +P+QRP +V P
Sbjct: 226 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 6e-43
Identities = 50/306 (16%), Positives = 109/306 (35%), Gaps = 39/306 (12%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
DFE + + G G VF K + + A K++ + I + +Q++RE L +S
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSG-LVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS- 160
P+ V + + + + + ME+M GG + ++ G +PE + + V+ L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 161 HGIIHRDLKPDNMLISAQ-----------------APHCPIVNTLFLA---ILQQP---- 196
H I+HRD+KP N+L++++ + + +++ +
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 183
Query: 197 -------IVYLEI----SDLVNGTPNAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSA 245
+ +E+ + + Q+ T P + + +
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 246 LRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305
R + + + ++ + L +P +R Q+ K
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
Query: 306 YDWDSI 311
D + +
Sbjct: 304 SDAEEV 309
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 153 bits (387), Expect = 6e-43
Identities = 60/295 (20%), Positives = 119/295 (40%), Gaps = 29/295 (9%)
Query: 35 LKAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRER 93
+K + D ++I++ + GAFG V +K +++ K + ++K V E
Sbjct: 22 VKQGSVYDYYDILEELGSGAFGVVHRCVEKATG-RVFVAKFINTPYPLDKY---TVKNEI 77
Query: 94 NALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVV 152
+ + H P + L + + + L++E++ GG++ IAA + E Y +
Sbjct: 78 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137
Query: 153 LALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNA 212
L+++H H I+H D+KP+N++ + + LA P EI + T
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATA-- 192
Query: 213 FNIRTPGQLLSLKTGTFP-------TFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265
P + G + + + +PF G + + +W
Sbjct: 193 -EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA------GEDDLETLQNVKRCDW 245
Query: 266 PEDEEA---LNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPP 317
DE+A ++P ++ I LL+ +P +R + H P K D ++ + P
Sbjct: 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG-DHSNLTSRIPS 299
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 151 bits (383), Expect = 2e-42
Identities = 57/305 (18%), Positives = 109/305 (35%), Gaps = 27/305 (8%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
+ ++I + + GAFG V ++ +A K + +K V +E +++
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATG-NNFAAKFVMTPHESDKE---TVRKEIQTMSVL 80
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIA-ANGALPEDMAAFYAAEVVLALQYL 158
P V L + + + + ++ E+M GG++ +A + + ED A Y +V L ++
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 159 HSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTP 218
H + +H DLKP+N++ + + + + L P V T P
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP------KQSVKVTTGTAEFAAP 194
Query: 219 GQLLSLKTGT-------FPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271
G + + +PF G + +W D+ A
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG------GENDDETLRNVKSCDWNMDDSA 248
Query: 272 LNPSTEET---ILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDT 328
+ +E+ I LL +DP R + HQ P + Q P
Sbjct: 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIK 308
Query: 329 SYFHA 333
+ + A
Sbjct: 309 TKYDA 313
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 148 bits (375), Expect = 5e-42
Identities = 53/282 (18%), Positives = 105/282 (37%), Gaps = 26/282 (9%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN------KNMVSQVLRERNA 95
++E + + RG V K + YA+K++ + + + L+E +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTC-KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 96 LA-LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLA 154
L ++ P +QL + +T++ FLV + M G++ + L E ++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 155 LQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPN--A 212
+ LH I+HRDLKP+N+L+ + + + F L E V GTP+ A
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPG----EKLREVCGTPSYLA 177
Query: 213 FNIRTPGQLLSLKTGTFP--------TFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264
I + + PF ++ + + Q
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--MLRMIMSGNYQFG 235
Query: 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306
PE ++ + + ++ + L P +R + + P F+ Y
Sbjct: 236 SPEWDD-YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (373), Expect = 2e-41
Identities = 58/281 (20%), Positives = 99/281 (35%), Gaps = 29/281 (10%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
F ++ I G+FG V+ N ++ AIK M + +++E L P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
+Q +LVMEY +G L L E A + L YLHSH
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 163 IIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL 222
+IHRD+K N+L+S P + A + P ++ GTP P +L
Sbjct: 136 MIHRDVKAGNILLS--EPGLVKLGDFGSASIMAP------ANSFVGTP---YWMAPEVIL 184
Query: 223 SLKTGTFPTFQDVQN----------SQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA- 271
++ G + DV + + P ++ Q E P +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLF------NMNAMSALYHIAQNESPALQSGH 238
Query: 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSIL 312
+ + + L+ P RP+ + + +++
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 279
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 1e-40
Identities = 68/305 (22%), Positives = 124/305 (40%), Gaps = 20/305 (6%)
Query: 36 KAPEISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
+A +I D ++ + GAF +V L K + +L AIK + K + + + E
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCIAKKAL--EGKEGSMENEIA 59
Query: 95 ALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLA 154
L P V L ++ ++L+M+ + GG++ I G E A+ +V+ A
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119
Query: 155 LQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLEISDLVNGTPN-A 212
++YLH GI+HRDLKP+N+L + I+ + F L+ ++ P + GTP
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYV 176
Query: 213 FNIRTPGQLLSLKTGTF---PTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269
+ S + + PF A+ + + P +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFEQILKAEYEFDSPYWD 234
Query: 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFD 327
+ ++ S ++ I L++ DP +R + Q + P D+ LD+ Q F
Sbjct: 235 D-ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA---GDTALDKNIHQSVSEQIKKNFA 290
Query: 328 TSYFH 332
S +
Sbjct: 291 KSKWK 295
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 143 bits (361), Expect = 4e-40
Identities = 52/266 (19%), Positives = 102/266 (38%), Gaps = 25/266 (9%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
+E+ + + G +V L + A+KV++ D + + + RE A +
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLH-RDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 102 PFCVQLFYSLQTSS----CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
P V ++ + + + ++VMEY+ G ++ ++ G + A A+ AL +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 158 LHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRT 217
H +GIIHRD+KP N++ISA +++ + + + V GT +
Sbjct: 127 SHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTA---QYLS 182
Query: 218 PGQLLSLKTGTFPTFQDVQN----------SQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267
P Q + + DV + + PF V + + +
Sbjct: 183 PEQ---ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVAYQHVREDPIPPSA 236
Query: 268 DEEALNPSTEETILALLKSDPTQRPS 293
E L+ + +L L +P R
Sbjct: 237 RHEGLSADLDAVVLKALAKNPENRYQ 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 8e-40
Identities = 60/289 (20%), Positives = 113/289 (39%), Gaps = 35/289 (12%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
+EI+ + GAFGKV+ K L A KV+ ++ + + E + LA
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETS-VLAAAKVIDTK---SEEELEDYMVEIDILASCDH 68
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIA-ANGALPEDMAAFYAAEVVLALQYLHS 160
P V+L + + +++++E+ GG V +++ L E + + AL YLH
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 161 HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPN------AFN 214
+ IIHRDLK N+L + + + A + I + D GTP
Sbjct: 129 NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTI---QRRDSFIGTPYWMAPEVVMC 184
Query: 215 IRTPGQLLSLKTGTFP---TFQDVQNSQAPFPS------ALRVAGSQIPTSTAAQLQLEW 265
+ + K + T ++ + P L++A S+ PT L
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-------LAQ 237
Query: 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQ 314
P + + ++ + L+ + R + Q+ + P D + + +
Sbjct: 238 PSR---WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV-DSNKPIRE 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-39
Identities = 65/301 (21%), Positives = 113/301 (37%), Gaps = 30/301 (9%)
Query: 40 ISDFEIV-KAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA- 97
I D+++ + + G GKV + K + + +A+K+++ RE
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQ-EKFALKMLQDCPKA--------RREVELHWR 60
Query: 98 LTHSPFCVQLFYSLQTSS----CVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEV 151
+ P V++ + C+ +VME + GG++ S I G A E A+ +
Sbjct: 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 120
Query: 152 VLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPN 211
A+QYLHS I HRD+KP+N+L +++ P+ + T F + +
Sbjct: 121 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF-----GFAKETTSHNSLTTPCY 175
Query: 212 AFNIRTPGQLLSLKTGT-------FPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264
P L K + PF S +A S + Q E
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 265 WPEDEEA-LNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVPQPD 323
+P E + ++ + I LLK++PTQR + + P V + D
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 295
Query: 324 D 324
Sbjct: 296 K 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 6e-38
Identities = 56/289 (19%), Positives = 102/289 (35%), Gaps = 34/289 (11%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+ + I +GA G V+ Q AI+ M + K ++ E + +P
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATG-QEVAIRQMNLQQQPKKE---LIINEILVMRENKNP 77
Query: 103 FCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG 162
V S +++VMEY+ GG + ++ + E A E + AL++LHS+
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 163 IIHRDLKPDNMLISAQA-PHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQ- 220
+IHRD+K DN+L+ +Q + P + G
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 221 ---------LLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271
+ + G P + + +A +A + P +L+ PE
Sbjct: 197 VDIWSLGIMAIEMIEGEPP-YLNENPLRA----LYLIATNGTP-------ELQNPEK--- 241
Query: 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVP 320
L+ + + L D +R S ++ + K S L P +
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSL---TPLIA 287
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 7e-38
Identities = 56/291 (19%), Positives = 115/291 (39%), Gaps = 40/291 (13%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMV---SQVLRERNALA 97
S +++ + G FG V+ G + ++ AIK ++KD + + + ++V E L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDN-LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 98 LTHS--PFCVQLFYSLQTSSCVFLVMEYMIGG-DVKSLIAANGALPEDMAAFYAAEVVLA 154
S ++L + L++E D+ I GAL E++A + +V+ A
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 155 LQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFN 214
+++ H+ G++HRD+K +N+LI +++ L + VY + +GT
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLID-FGSGALLKDTVYTD----FDGTR---V 174
Query: 215 IRTPGQLLSLKTGTFP--------TFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266
P + + D+ PF + + Q+ +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFR 224
Query: 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPP 317
+ ++ + I L P+ RP+ +++ P +D +L QE
Sbjct: 225 QR---VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV----LLPQETA 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 5e-37
Identities = 53/283 (18%), Positives = 106/283 (37%), Gaps = 44/283 (15%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+ I RG+F V+ G A ++ ++ K+ + E L P
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETT-VEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHP 68
Query: 103 FCVQLFYSLQTSS----CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
V+ + S +++ C+ LV E M G +K+ + + + + +++ LQ+L
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 159 HSHG--IIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLEISDLVNGTPN---- 211
H+ IIHRDLK DN+ I+ I + LA L++ + V GTP
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGD--LGLATLKRA----SFAKAVIGTPEFMAP 182
Query: 212 ---------AFNIRTPGQLL-SLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQL 261
+ ++ G + + T +P + + QN+ +
Sbjct: 183 EMYEEKYDESVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRRVTS-------------- 227
Query: 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304
++ ++ P +E I ++ + +R S + F+
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-36
Identities = 56/275 (20%), Positives = 95/275 (34%), Gaps = 33/275 (12%)
Query: 39 EISDFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
I+D E+ G FG V G Y+ K AIKV+K+ K +++RE +
Sbjct: 11 LIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMH 64
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKS-LIAANGALPEDMAAFYAAEVVLALQ 156
+P+ V+L Q + + LVME GG + L+ +P A +V + ++
Sbjct: 65 QLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 123
Query: 157 YLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIR 216
YL +HRDL N+L+ + + I + L Y +
Sbjct: 124 YLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA-- 180
Query: 217 TPGQLLSLKTGTFPTFQDV-----------QNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265
P + F + DV Q P+ + G ++ ++E
Sbjct: 181 -PEC---INFRKFSSRSDVWSYGVTMWEALSYGQKPYKK---MKGPEVMAFIEQGKRMEC 233
Query: 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300
P + P + RP V +
Sbjct: 234 PPE---CPPELYALMSDCWIYKWEDRPDFLTVEQR 265
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-36
Identities = 53/293 (18%), Positives = 109/293 (37%), Gaps = 22/293 (7%)
Query: 40 ISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN---MVSQVLRERNA 95
+ D ++ + + G F V +K+ YA K +KK + + RE +
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTG-LQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 96 LALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLAL 155
L P + L + + V L++E + GG++ +A +L E+ A + +++ +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNI 215
YLHS I H DLKP+N+++ + P + + + + ++ +
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK----IDFGNEFKNIFGTPEF 182
Query: 216 RTPGQLLSLKTGTFP-------TFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268
P + G + + +PF + ++ + + E+ +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQE---PPF 318
+ ++ I LL DP +R + + P K D L P F
Sbjct: 243 ---TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 3e-36
Identities = 50/283 (17%), Positives = 97/283 (34%), Gaps = 43/283 (15%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
EI + + I G+FG V+ G + A+K++ + E L
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAP-TPQQLQAFKNEVGVL 58
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI-AANGALPEDMAAFYAAEVVLAL 155
T + LF T+ + +V ++ G + + A + +
Sbjct: 59 RKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLF-LAILQQPIVYLEISDLVNGT----- 209
YLH+ IIHRDLK +N+ + I + F LA ++ + ++G+
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDL-TVKIGD--FGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 210 PNAFNIRTPGQ-------------LLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTS 256
P ++ L L TG P + ++ N + + G +
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQ----IIFMVGRGYLSP 229
Query: 257 TAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299
++++ P+ + L + LK +RP Q+
Sbjct: 230 DLSKVRSNCPKAMKRL-------MAECLKKKRDERPLFPQILA 265
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 132 bits (333), Expect = 4e-36
Identities = 53/287 (18%), Positives = 104/287 (36%), Gaps = 26/287 (9%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
+ ++ I G +G V+ + +A+K ++ ++ ++ + S +RE + L
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYG--ETFALKKIRLEKE-DEGIPSTTIREISILKELKH 59
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
V+L+ + T + LV E++ K L G L A + +++ + Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 162 GIIHRDLKPDNMLISAQAPHCPI---------VNTLFLAILQQPIVYLEISDLVNGTPN- 211
++HRDLKP N+LI+ + + + Y L+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 212 -AFNIRTPGQL-LSLKTGTFP--------TFQDVQNSQAPFPSALRVAGSQIPTSTAAQL 261
+I + G + + GT + S +++P
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 262 QLE---WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305
E W + L+ S + + +LK DP QR + Q FK+
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 6e-36
Identities = 54/315 (17%), Positives = 104/315 (33%), Gaps = 36/315 (11%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
+ + ++ + GA+G V AIK + + ++ + RE L
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTG-AKVAIKKLYRP-FQSELFAKRAYRELRLLKHMR 75
Query: 101 SPFCVQLFY------SLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLA 154
+ L +L + +LVM +M G + + L ED F +++
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKG 133
Query: 155 LQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL---------EISDL 205
L+Y+H+ GIIHRDLKP N+ ++ + L + Y+ I +
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNW 193
Query: 206 VNGTPNAFNIRTPGQLLSLKTGTFP--------TFQDVQNSQAPFPSAL-----RVAGSQ 252
+ T + + TG +++ P+
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253
Query: 253 IPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSIL 312
+ ++ +P + +L D QR + + P F+
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD---- 309
Query: 313 DQEPPFVPQPDDVFD 327
++ P V + DD FD
Sbjct: 310 TEDEPQVQKYDDSFD 324
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 8e-36
Identities = 51/281 (18%), Positives = 102/281 (36%), Gaps = 39/281 (13%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
D+E++ I G++G+ +K++ ++ K + M + ++ E N L
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDG-KILVWKELDYGSM-TEAEKQMLVSEVNLLRELKH 62
Query: 102 PFCVQLFYSL--QTSSCVFLVMEYMIGGDVKSLIAAN----GALPEDMAAFYAAEVVLAL 155
P V+ + + +T++ +++VMEY GGD+ S+I L E+ ++ LAL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 156 QYLH-----SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTP 210
+ H H ++HRDLKP N+ + + + + + IL +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHD------TSFAKAFV 175
Query: 211 NAFNIRTPGQLLSLKTGTFPTFQDV----------QNSQAPFPSALRVAGSQIPTSTAAQ 260
+P Q + ++ D+ PF
Sbjct: 176 GTPYYMSPEQ---MNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKI 226
Query: 261 LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLP 301
+ ++ + E I +L RPS ++ P
Sbjct: 227 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-35
Identities = 52/270 (19%), Positives = 102/270 (37%), Gaps = 33/270 (12%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
+ + ++++ I +G FG V LG + A+K +K D L E + +
Sbjct: 6 MKELKLLQTIGKGEFGDVMLG---DYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQL 57
Query: 100 HSPFCVQLF-YSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQ 156
VQL ++ +++V EYM G + + + G L D ++ +V A++
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 157 YLHSHGIIHRDLKPDNMLISAQAPHCPI------VNTLFLAILQQPIVYLEISDLVNGTP 210
YL + +HRDL N+L+S + + P+ + L
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKF 177
Query: 211 N-AFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269
+ ++ + G LL ++ + P+P R+ + +++ P+
Sbjct: 178 STKSDVWSFGILL---------WEIYSFGRVPYP---RIPLKDVVPRVEKGYKMDAPDG- 224
Query: 270 EALNPSTEETILALLKSDPTQRPSGHQVRR 299
P+ E + D RPS Q+R
Sbjct: 225 --CPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-35
Identities = 50/291 (17%), Positives = 103/291 (35%), Gaps = 55/291 (18%)
Query: 39 EISD-FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
E+ + + I + + RG FG V + ++K + Y K +K V +E + L
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSK-KTYMAKFVKVK----GTDQVLVKKEISILN 56
Query: 98 LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQ 156
+ + L S ++ + ++ E++ G D+ I + L E Y +V ALQ
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 157 YLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIR 216
+LHSH I H D++P+N++ + + A + + + L+ P +
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPE 173
Query: 217 TPGQ---------------LLSLKTGTFP--------TFQDVQNSQAPFPSALRVAGSQI 253
+ L +G P +++ N++ F
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------- 226
Query: 254 PTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304
+ E ++ + + LL + R + + + P K
Sbjct: 227 -----------FKE----ISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-35
Identities = 50/285 (17%), Positives = 97/285 (34%), Gaps = 25/285 (8%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
EI E+ + I G FG V G + ++ A+ + + ++ + L+E +
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLAL 155
P V+L + T + V+++ME G+++S + +L YA ++ AL
Sbjct: 63 RQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 156 QYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNI 215
YL S +HRD+ N+L+S+ + + F +
Sbjct: 122 AYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 216 RTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQL-----QLEWPEDEE 270
S+ F + DV L + E
Sbjct: 179 E------SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 232
Query: 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQE 315
P+ + DP++RP +++ +IL++E
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKA-------QLSTILEEE 270
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-34
Identities = 52/274 (18%), Positives = 95/274 (34%), Gaps = 17/274 (6%)
Query: 33 SCLKAPEISDFEIVKAISRGAFGKVFLGY--KKTNKDQLYAIKVMKKDEMINKNMVSQVL 90
+CL + D +++ + G+FG V G + K A+K +K D + + +
Sbjct: 2 TCLIGEK--DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 59
Query: 91 RERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAA 149
RE NA+ ++L Y + + + +V E G + + + G + YA
Sbjct: 60 REVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 118
Query: 150 EVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGT 209
+V + YL S IHRDL N+L++ + L L Q + + +
Sbjct: 119 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM-RALPQNDDHYVMQEHRKVP 177
Query: 210 -----PNAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLE 264
P + RT ++ Q P+ + +L
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDKEGERLP 235
Query: 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVR 298
PED ++ P RP+ +R
Sbjct: 236 RPED---CPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-34
Identities = 57/289 (19%), Positives = 109/289 (37%), Gaps = 26/289 (8%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
+E ++ I G +G VF + ++ A+K ++ D+ ++ + S LRE L
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETH-EIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
V+L L + + LV E+ K + NG L ++ + +++ L + HS
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 162 GIIHRDLKPDNMLISAQ------------------APHCPIVNTLFLA---ILQQPIVYL 200
++HRDLKP N+LI+ + V TL+ +L +Y
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 201 EISDLVNGTPNAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQ 260
D+ + + G+ L + + + +++P
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 261 L---QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306
+ LN + + + LLK +P QR S + + P F D+
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-34
Identities = 54/297 (18%), Positives = 99/297 (33%), Gaps = 29/297 (9%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN---AL 96
+E V I GA+GKVF N + A+K ++ + M +RE L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHL 64
Query: 97 ALTHSPFCVQLFYSLQTSS-----CVFLVMEYMIGGDVKSL-IAANGALPEDMAAFYAAE 150
P V+LF S + LV E++ L +P + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 151 VVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV------------ 198
++ L +LHSH ++HRDLKP N+L+++ L Q +
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 199 -------YLEISDLVNGTPNAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGS 251
Y DL + + L + + + P +
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 252 QIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDW 308
+ ++ + ++ ++ +L L +P +R S + P F+D +
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-34
Identities = 50/273 (18%), Positives = 93/273 (34%), Gaps = 29/273 (10%)
Query: 47 KAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCV 105
K + G FG V G Y+ + A+K++K E + + ++L E N + +P+ V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIV 71
Query: 106 QLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIH 165
++ + S LVME G + + N + + +V + ++YL +H
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 166 RDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLSLK 225
RDL N+L+ Q + I + L+ Y + + P +
Sbjct: 131 RDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APEC---IN 183
Query: 226 TGTFPTFQDV-----------QNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNP 274
F + DV Q P+ + GS++ ++ P
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRG---MKGSEVTAMLEKGERMGCPAG---CPR 237
Query: 275 STEETILALLKSDPTQRPSGHQVRRL--PMFKD 305
+ + D RP V + D
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-34
Identities = 45/293 (15%), Positives = 83/293 (28%), Gaps = 48/293 (16%)
Query: 41 SDFEIVKAISRGAFGKVFLGY----KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
+ E K + GAFGKV KT A+K++K+ + + ++ E +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMM 94
Query: 97 A-LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI---------------------- 133
L V L + S ++L+ EY GD+ + +
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 134 -AANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192
L + +A +V +++L +HRDL N+L++ + LA
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLAR 212
Query: 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLLSLKTGTFPTFQD--------VQNSQAPFPS 244
+ P L P+P
Sbjct: 213 DIMSDSNYVVRGNARLPV---KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 245 ALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQV 297
A +++ P + + D +RPS +
Sbjct: 270 IPVDA--NFYKLIQNGFKMDQPFY---ATEEIYIIMQSCWAFDSRKRPSFPNL 317
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 5e-34
Identities = 49/282 (17%), Positives = 99/282 (35%), Gaps = 37/282 (13%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
E+ ++V+ + G FG+V++GY + A+K +K+ M L E N +
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGH--TKVAVKSLKQGSMSPD----AFLAEANLM 62
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGA--LPEDMAAFYAAEVVLA 154
V+L Y++ T ++++ EYM G + + L + AA++
Sbjct: 63 KQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 155 LQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFN 214
+ ++ IHRDL+ N+L+S I ++ L+
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCK--------------IADFGLARLIEDNEYTAR 167
Query: 215 IRTPGQL-----LSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQL-----QLE 264
+ ++ GTF DV + + P T ++ +
Sbjct: 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 227
Query: 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306
+ + + K P RP+ +R + +D+
Sbjct: 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS--VLEDF 267
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 7e-34
Identities = 52/304 (17%), Positives = 90/304 (29%), Gaps = 31/304 (10%)
Query: 44 EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN--MVSQVLRERNALALTHS 101
E + + G F V+ K Q+ AIK +K + LRE L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTN-QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 59
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
P + L + S + LV ++M + + L Y + L+YLH H
Sbjct: 60 PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 162 GIIHRDLKPDNMLI------------------SAQAPHCPIVNTLFLA---ILQQPIVYL 200
I+HRDLKP+N+L+ S + V T + +L +Y
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 201 EISDLVNGTPNAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQ 260
D+ + + + +P +
Sbjct: 180 VGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 261 L--QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPF 318
+ A + I L +P R + Q ++ F +
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR----PGPTPGCQ 294
Query: 319 VPQP 322
+P+P
Sbjct: 295 LPRP 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (321), Expect = 7e-34
Identities = 58/303 (19%), Positives = 106/303 (34%), Gaps = 45/303 (14%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LTH 100
D+++V+ + RG + +VF TN + +K++K + ++ RE L L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNN-EKVVVKILKPVKK------KKIKREIKILENLRG 88
Query: 101 SPFCVQL--FYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
P + L S LV E++ D K L L + FY E++ AL Y
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 145
Query: 159 HSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ---------PIVYL--EISDLVN 207
HS GI+HRD+KP N++I + +++ + E+
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 208 GTPNAFNIRTPGQLLS-LKTGTFPTFQDVQN--------------------SQAPFPSAL 246
+ ++ + G +L+ + P F N +
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 247 RVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306
R S + E++ ++P + + LL+ D R + + P F
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325
Query: 307 DWD 309
D
Sbjct: 326 VKD 328
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-33
Identities = 60/324 (18%), Positives = 108/324 (33%), Gaps = 43/324 (13%)
Query: 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
P+ + K I G+FG V+ + +L AIK + +D+ RE +
Sbjct: 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSG-ELVAIKKVLQDKR-------FKNRELQIMR 68
Query: 98 LTHSPFCVQLFYSLQTSS------CVFLVMEYMIGG---DVKSLIAANGALPEDMAAFYA 148
V+L Y +S + LV++Y+ + A LP Y
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 149 AEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ---------PIVY 199
++ +L Y+HS GI HRD+KP N+L+ + + L + Y
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 200 LEISDLVNGTPNAF--NIRTPGQLLS-LKTGT--FPTFQDVQNSQAPFPSALRVAGSQIP 254
+ T ++ + G +L+ L G FP V QI
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 255 TSTAAQLQLEWPEDEE---------ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305
+ ++P+ + P LL+ PT R + + F +
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308
Query: 306 YDWDSILDQEPPFVPQPDDVFDTS 329
++ + P +F+ +
Sbjct: 309 LRDPNV---KLPNGRDTPALFNFT 329
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-33
Identities = 60/309 (19%), Positives = 112/309 (36%), Gaps = 37/309 (11%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSP 102
+ + I GA+G V Y NK AIK + E ++ + LRE L
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNK-VRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 66
Query: 103 FCVQLFYSLQTSSCV----FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
+ + ++ + ++ +++G D+ L+ L D ++ +++ L+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 159 HSHGIIHRDLKPDNMLIS------------AQAPHCPIVNTLFLAILQQPIVYL--EISD 204
HS ++HRDLKP N+L++ A+ +T FL Y EI
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 205 LVNGTPNAFNIRTPGQLL-SLKTGTFP----TFQDVQN---------SQAPFPSALRVAG 250
G + +I + G +L + + + D N SQ + +
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 251 SQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY-DWD 309
S + ++ W + + + +L +P +R Q P + Y D
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305
Query: 310 SILDQEPPF 318
E PF
Sbjct: 306 DEPIAEAPF 314
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-32
Identities = 59/307 (19%), Positives = 103/307 (33%), Gaps = 43/307 (14%)
Query: 39 EISDFEIVKAISRGAFGKVFLG-YKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA 97
+ +D + I G FG+V KK AIK MK+ +K+ E L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLC 65
Query: 98 -LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI----------------AANGALP 140
L H P + L + + ++L +EY G++ + + L
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 141 EDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200
+AA+V + YL IHRDL N+L+ + + L+ Q+ V
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVK- 182
Query: 201 EISDLVNGTPNAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQ 260
+ I SL + T DV + + + G+ T A+
Sbjct: 183 --KTMGRLPVRWMAIE------SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234
Query: 261 L-----QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQE 315
L Q E + + + + P +RPS Q+ + +L++
Sbjct: 235 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV-------SLNRMLEER 287
Query: 316 PPFVPQP 322
+V
Sbjct: 288 KTYVNTT 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-32
Identities = 48/287 (16%), Positives = 94/287 (32%), Gaps = 38/287 (13%)
Query: 41 SDFEIVKAISRGAFGKVFLGY------KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERN 94
+ K + GAFG+V L K N+ A+K++K D + +S ++ E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEME 70
Query: 95 ALA-LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI----------------AANG 137
+ + + L + +++++EY G+++ +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 138 ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197
L A +V ++YL S IHRDL N+L++ + + LA I
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED--NVMKIADFGLARDIHHI 188
Query: 198 VYLEISDLVNGTPNAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTST 257
Y + + +L + DV + + GS P
Sbjct: 189 DYYKKTTNGRLPVKWMAPE------ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242
Query: 258 AAQL-----QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299
+L + + + + P+QRP+ Q+
Sbjct: 243 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (308), Expect = 2e-32
Identities = 51/278 (18%), Positives = 96/278 (34%), Gaps = 27/278 (9%)
Query: 36 KAPEISDFEIVKAISRGAFGKVFLGYKKTN--KDQLYAIKVMKKDEMINKNMVSQVLRER 93
K +IS +I + I G FG+V G+ K ++ AIK +K + L E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEA 78
Query: 94 NALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVV 152
+ + P + L + S+ V ++ E+M G + S + N G +
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138
Query: 153 LALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNA 212
++YL +HRDL N+L+++ V+ L+ + G
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 213 FNIRTPGQLLSLKTGTFPTFQDVQN-----------SQAPFPSALRVAGSQIPTSTAAQL 261
P ++ F + DV + + P+ + + +
Sbjct: 197 IRWTAPEA---IQYRKFTSASDVWSYGIVMWEVMSYGERPYWD---MTNQDVINAIEQDY 250
Query: 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299
+L P D + + +L + D RP Q+
Sbjct: 251 RLPPPMD---CPSALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-32
Identities = 45/289 (15%), Positives = 87/289 (30%), Gaps = 39/289 (13%)
Query: 41 SDFEIVKAISRGAFGKVFLGY----KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
+ K + GAFGKV K++ A+K++K + ++ E L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVL 80
Query: 97 A-LTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLI------------------AANG 137
+ L + V L + ++ EY GD+ + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 138 ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197
AL + ++ +V + +L S IHRDL N+L+ + LA +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIKND 198
Query: 198 VYLEISDLVNGTPNAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTST 257
+ + + + DV + + S P
Sbjct: 199 SNYVVKGNARLPVKWMAPES------IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 258 AAQLQLEW------PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300
+ E + + +DP +RP+ Q+ +L
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (306), Expect = 4e-32
Identities = 44/295 (14%), Positives = 86/295 (29%), Gaps = 36/295 (12%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LTHS 101
+ + + I G+FG ++LG + AIK+ K Q+ E +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAG-EEVAIKLECV-----KTKHPQLHIESKIYKMMQGG 62
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
+ + +VME + + A +++ ++Y+HS
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 162 GIIHRDLKPDNMLISAQAPHCPIVNTLF-------LAILQQPIVYLEISDLVNGTPNAFN 214
IHRD+KPDN L+ + F A Q I Y E +L GT
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT-GTA---R 178
Query: 215 IRTPGQLLSLKTGT--------FPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266
+ L ++ + S + + ++
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRL---PMFKD-------YDWDSI 311
+ + +P +R+L + +DW+ +
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-32
Identities = 57/291 (19%), Positives = 113/291 (38%), Gaps = 26/291 (8%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
+ +F+ V+ I G +G V+ K ++ A+K ++ D + + S +RE + L
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTG-EVVALKKIRLDTE-TEGVPSTAIREISLLKEL 58
Query: 100 HSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSL-IAANGALPEDMAAFYAAEVVLALQYL 158
+ P V+L + T + ++LV E++ K + +A +P + Y +++ L +
Sbjct: 59 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 159 HSHGIIHRDLKPDNMLISAQAPHCPI---------VNTLFLAILQQPIVYL--EISDLVN 207
HSH ++HRDLKP N+LI+ + V + Y EI
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 208 GTPNAFNIRTPGQLL-SLKTGTFP--------TFQDVQNSQAPFPSALRVAGSQIPTSTA 258
A +I + G + + T + + + + +P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 259 AQLQLEWPEDEEALNPSTEET---ILALLKSDPTQRPSGHQVRRLPMFKDY 306
+ + + + + P E+ + +L DP +R S P F+D
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 1e-31
Identities = 46/315 (14%), Positives = 94/315 (29%), Gaps = 22/315 (6%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKK--DEMINKNMVSQVLRERNALAL 98
++F+ +K + GAFG V+ G + I V K E + ++L E +A
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPE-GEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 99 THSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYL 158
+P +L TS+ + G + + + + ++ + YL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 159 HSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTP 218
++HRDL N+L+ + LA L ++
Sbjct: 128 EDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM---AL 182
Query: 219 GQLLSLKTGTFPT--------FQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEE 270
+L ++ + P+ + S+I + +L P
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---IPASEISSILEKGERLPQPPI-- 237
Query: 271 ALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDTSY 330
++ D RP ++ D L + D+++
Sbjct: 238 -CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNF 296
Query: 331 FHADKTNSYMDSTLS 345
+ A MD +
Sbjct: 297 YRALMDEEDMDDVVD 311
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (300), Expect = 3e-31
Identities = 52/291 (17%), Positives = 102/291 (35%), Gaps = 37/291 (12%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
+D + + G +G+V+ G K A+K +K+D M V + L+E +
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK 71
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYL 158
P VQL +++ E+M G++ + + + + A ++ A++YL
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 159 HSHGIIHRDLKPDNMLIS----------AQAPHCPIVNTLFLAILQQPIVYLEISDLVNG 208
IHRDL N L+ + A + PI + L
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 209 --TPNAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266
+ + L + T + + SQ+ ++E P
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------------SQVYELLEKDYRMERP 238
Query: 267 EDEEALNPSTEETILALLKSDPTQRPSGHQVRRL--PMFKDYDWDSILDQE 315
E E + A + +P+ RPS ++ + MF++ +++E
Sbjct: 239 EG---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 286
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-31
Identities = 43/268 (16%), Positives = 82/268 (30%), Gaps = 31/268 (11%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
D +K + G FG V G + D AIK++K+ M + + E +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSED----EFIEEAKVMMNLS 57
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIA-ANGALPEDMAAFYAAEVVLALQYLH 159
VQL+ +F++ EYM G + + + +V A++YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 160 SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPG 219
S +HRDL N L++ Q + +S V ++ +
Sbjct: 118 SKQFLHRDLAARNCLVNDQ--------------GVVKVSDFGLSRYVLDDEYTSSVGSKF 163
Query: 220 QLL-----SLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQL-----QLEWPEDE 269
+ L F + D+ + T ++ Q
Sbjct: 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 223
Query: 270 EALNPSTEETILALLKSDPTQRPSGHQV 297
+ + + +RP+ +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKIL 251
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (298), Expect = 6e-31
Identities = 50/295 (16%), Positives = 86/295 (29%), Gaps = 47/295 (15%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKD----QLYAIKVMKKDEMINKNMVSQVLRERNAL 96
++ E V+ I GAFG+VF + A+K++K++ + +M + RE +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 70
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG------------------- 137
A +P V+L + L+ EYM GD+ + +
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 138 -----ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192
L A +V + YL +HRDL N L+ + L+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSR 188
Query: 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQ 252
Y + S+ + T DV +
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPE------SIFYNRYTTESDVWAYGVVLWEIF--SYGL 240
Query: 253 IPTSTAAQLQL-------EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300
P A ++ E + P RPS + R+
Sbjct: 241 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 8e-31
Identities = 53/323 (16%), Positives = 109/323 (33%), Gaps = 32/323 (9%)
Query: 29 DVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ 88
+++K+ + PE ++ + + GA+G V + A+K + + + +
Sbjct: 8 ELNKTIWEVPE--RYQNLSPVGSGAYGSVCAAFDTKTG-LRVAVKKLSRPFQ-SIIHAKR 63
Query: 89 VLRERNALALTHSPFCVQLFYSLQTSSCV-----FLVMEYMIGGDVKSLIAANGALPEDM 143
RE L + L + + ++ +++G D+ +++ L +D
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDH 122
Query: 144 AAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI------LQQPI 197
F +++ L+Y+HS IIHRDLKP N+ ++ + L
Sbjct: 123 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182
Query: 198 VYLEISDLVNGTPNAF--NIRTPGQLL-SLKTGTFP--------TFQDVQNSQAPFPSAL 246
Y ++N +I + G ++ L TG + + + L
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 247 RVAGSQIPTSTAAQLQLEWPEDEEA-----LNPSTEETILALLKSDPTQRPSGHQVRRLP 301
S Q + P+ A NP + + +L D +R + Q
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302
Query: 302 MFKDYDWDSILDQEPPFVPQPDD 324
F Y P+ +
Sbjct: 303 YFAQYHDPDDEPVADPYDQSFES 325
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-30
Identities = 43/267 (16%), Positives = 79/267 (29%), Gaps = 25/267 (9%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH 100
S+ V+ I G FG V LGY AIK +++ M + + E +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNK--DKVAIKTIREGAMSEE----DFIEEAEVMMKLS 58
Query: 101 SPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGAL-PEDMAAFYAAEVVLALQYLH 159
P VQL+ + + LV E+M G + + L + +V + YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 160 SHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPG 219
+IHRDL N L+ + + + T +
Sbjct: 119 EACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDD----------QYTSSTGTKFPVK 167
Query: 220 QLL--SLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQL-----QLEWPEDEEAL 272
+ + DV + + +++
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 227
Query: 273 NPSTEETILALLKSDPTQRPSGHQVRR 299
+ + + K P RP+ ++ R
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-29
Identities = 60/329 (18%), Positives = 96/329 (29%), Gaps = 65/329 (19%)
Query: 24 ENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK 83
E CD E+S +E + I +G FG+VF + Q A+K + + +
Sbjct: 2 ECPFCD---------EVSKYEKLAKIGQGTFGEVFKARHRKTG-QKVALKKVLMENE-KE 50
Query: 84 NMVSQVLRERNALALTHSPFCVQLFYSLQTSS--------CVFLVMEYMIGGDVKSLIAA 135
LRE L L V L +T + ++LV ++ L
Sbjct: 51 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV 110
Query: 136 NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI-------------------- 175
++ L Y+H + I+HRD+K N+LI
Sbjct: 111 LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 170
Query: 176 --SAQAPHCPIVNTLFLA---ILQQPIVYLEISD----------LVNGTPNAFNIRTPGQ 220
S + V TL+ +L Y D + +P T
Sbjct: 171 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP-IMQGNTEQH 229
Query: 221 LLSL---KTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTE 277
L+L G+ L + Q +++ +P
Sbjct: 230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKR-------KVKDRLKAYVRDPYAL 282
Query: 278 ETILALLKSDPTQRPSGHQVRRLPMFKDY 306
+ I LL DP QR F
Sbjct: 283 DLIDKLLVLDPAQRIDSDDALNHDFFWSD 311
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 114 bits (286), Expect = 2e-29
Identities = 52/306 (16%), Positives = 102/306 (33%), Gaps = 56/306 (18%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LTHS 101
+++ + I G+FG +F G N +Q AIK + ++ Q+ E L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLN-NQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 60
Query: 102 PFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSH 161
++Y Q LV++ + L A A +++ +Q +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 162 GIIHRDLKPDNMLISAQAPHCPIVNTLFLA-----------ILQQPIVYLEISDLVNGT- 209
+++RD+KPDN LI P+ N +++ + +Q I Y E +L GT
Sbjct: 121 SLVYRDIKPDNFLIG--RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS-GTA 177
Query: 210 ----PNAFNIRTPGQ----------LLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPT 255
N R + + G+ P + G + +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK---QKYERIGEKKQS 234
Query: 256 STAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL----------PMFKD 305
+ +L +PE+ + P ++ L ++
Sbjct: 235 TPLRELCAGFPEEFYKY-------MHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN 287
Query: 306 YDWDSI 311
+DW+ +
Sbjct: 288 FDWNLL 293
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 2e-29
Identities = 57/328 (17%), Positives = 110/328 (33%), Gaps = 47/328 (14%)
Query: 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT 99
+ ++ +K I GA G V Y D+ AIK + + N+ + RE +
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCV 73
Query: 100 HSPFCVQLFY------SLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVL 153
+ + L +L+ V+LVME M + + L + ++ +++
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLC 130
Query: 154 ALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPN-- 211
+++LHS GIIHRDLKP N+++ + + L ++ + P
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 212 -------AFNIRTPGQL-LSLKTGTFPTFQD---------VQNSQAPFPSAL-------- 246
+I + G + + ++ P P +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 247 -------RVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299
+ AG P L E + + + +L DP +R S +
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
Query: 300 LPMFKDYDWDSILDQEPPFVPQPDDVFD 327
P + + ++ PP + D D
Sbjct: 311 HPYINVWYDPAEVEAPPPQI--YDKQLD 336
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 8e-29
Identities = 51/300 (17%), Positives = 101/300 (33%), Gaps = 43/300 (14%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
EI + + +G FG+V++G AIK +K M + L+E +
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGT--TRVAIKTLKPGTMSPE----AFLQEAQVM 66
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALP--EDMAAFYAAEVVLA 154
VQL Y++ + +++V EYM G + + AA++
Sbjct: 67 KKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 155 LQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFN 214
+ Y+ +HRDL+ N+L+ C + + +++
Sbjct: 126 MAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQG--AKFPIKW-- 180
Query: 215 IRTPGQLLSLKTGTFPTFQDV-----------QNSQAPFPSALRVAGSQIPTSTAAQLQL 263
P L G F DV + P+P + ++ ++
Sbjct: 181 -TAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM 233
Query: 264 EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVPQPD 323
P + S + + + +P +RP+ ++ +DY EP + P +
Sbjct: 234 PCPPE---CPESLHDLMCQCWRKEPEERPTFEYLQA--FLEDY----FTSTEPQYQPGEN 284
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-27
Identities = 41/286 (14%), Positives = 91/286 (31%), Gaps = 49/286 (17%)
Query: 41 SDFEIVKAISRGAFGKVFLGY----KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL 96
+ + + +G+FG V+ G K + AIK + + + + + + L E + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVM 77
Query: 97 ALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANG----------ALPEDMAAF 146
+ V+L + ++ME M GD+KS + +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 147 YAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLV 206
A E+ + YL+++ +HRDL N +++ + + Y
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 207 NGTPN--------------AFNIRTPGQLL-SLKTGTFPTFQDVQNSQAPFPSALRVAGS 251
++ + G +L + T +Q + N Q
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----------- 244
Query: 252 QIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQV 297
++ + + E + + +P RPS ++
Sbjct: 245 -----LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-27
Identities = 42/286 (14%), Positives = 91/286 (31%), Gaps = 36/286 (12%)
Query: 41 SDFEIVKAISRGAFGKVFLGYKKTNKD----QLYAIKVMKKDEMINKNMVSQVLRERNAL 96
++ K + RGAFG+V + A+K++K+ + + + + +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILI 71
Query: 97 ALTHSPFCVQLF-YSLQTSSCVFLVMEYMIGGDVKSLI----------------AANGAL 139
+ H V L + + +++E+ G++ + + L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 140 PEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199
+ Y+ +V +++L S IHRDL N+L+S + + + LA
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDPD 189
Query: 200 LEISDLVNGTPNAFNIRTPGQLLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAA 259
T + + DV + + S P
Sbjct: 190 YVRKGDARLPLKWMAPET------IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 260 QLQLEW------PEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299
+ + P +T+L +P+QRP+ ++
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-25
Identities = 43/276 (15%), Positives = 90/276 (32%), Gaps = 26/276 (9%)
Query: 39 EI--SDFEIVKAISRGAFGKVFLGYKKTN---KDQLYAIKVMKKDEMINKNMVSQVLRER 93
EI S K I G FG+V+ G KT+ K+ AIK +K + L E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEA 60
Query: 94 NALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSL-IAANGALPEDMAAFYAAEVV 152
+ ++L + + ++ EYM G + +G +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 153 LALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNA 212
++YL + +HRDL N+L+++ C + + +L+ +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 213 FNIRTPGQLLSLKTGTFPTFQDVQNSQA--------PFPSALRVAGSQIPTSTAAQLQLE 264
+ F + DV + ++ ++ + +L
Sbjct: 180 TAPEA------ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 233
Query: 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300
P D + + ++ + + +RP + +
Sbjct: 234 TPMDC---PSAIYQLMMQCWQQERARRPKFADIVSI 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 4e-25
Identities = 53/292 (18%), Positives = 90/292 (30%), Gaps = 39/292 (13%)
Query: 49 ISRGAFGKVFLGY--KKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQ 106
I RG FG V+ G K A+K + + + VSQ L E + P +
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 107 LF-YSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAF-YAAEVVLALQYLHSHGII 164
L L++ +V+ YM GD+++ I P + +V +++L S +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 165 HRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPN--AFNIRTPGQ-- 220
HRDL N ++ + L + + + A +
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 221 -----------LLSLKTGTFPTFQDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269
L L T P + DV T LQ
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLLQGRRLLQP 256
Query: 270 EALNPSTEETILALLKSDPTQRPSGHQV-RRL-PMFKDYDWDSILDQEPPFV 319
E E +L RPS ++ R+ +F + + + +V
Sbjct: 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYV 308
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 3e-22
Identities = 26/149 (17%), Positives = 55/149 (36%), Gaps = 20/149 (13%)
Query: 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHS 101
+ ++I +G FG+V+ G + + A+K+ E + +++ + +
Sbjct: 4 TIVLQESIGKGRFGEVWRG---KWRGEEVAVKIFSSREERSWFREAEIYQ----TVMLRH 56
Query: 102 PFCVQLFYSLQ----TSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQY 157
+ + T + ++LV +Y G + + + + A L +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAH 115
Query: 158 LHSH--------GIIHRDLKPDNMLISAQ 178
LH I HRDLK N+L+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKN 144
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 88.9 bits (219), Expect = 6e-20
Identities = 50/342 (14%), Positives = 115/342 (33%), Gaps = 61/342 (17%)
Query: 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQV-----LRERNALA 97
+ +V+ + G F V+L N A+K+++ D++ + ++ + + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNN-THVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 98 LTH--SPFCVQL--FYSLQTSSCVFLVMEYMIGGDVKSLI---AANGALPEDMAAFYAAE 150
+ ++L ++ + + V +VM + + G+ + + +P + +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 151 VVLALQYL-HSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGT 209
++L L Y+ GIIH D+KP+N+L+ + + +A L Y E T
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 210 PN--AFNIRTPGQ-------------LLSLKTGTFP------------------------ 230
+ + + L TG F
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 231 -----TFQDVQNSQAPFPS-ALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALL 284
++ + ++ F S L S++ + E + + + + +L
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
Query: 285 KSDPTQRPSGHQVRRLPMFKD-YDWDSILDQEPPFVPQPDDV 325
+ DP +R + P KD + I + D+
Sbjct: 313 QLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDI 354
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.0 bits (186), Expect = 9e-17
Identities = 23/148 (15%), Positives = 49/148 (33%), Gaps = 20/148 (13%)
Query: 44 EIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ---VLRERNALALTH 100
I K + G VF Y + + +K K K + + + LA+
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGE--CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 101 SPFCVQLFYSLQTSSCV--------FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVV 152
+ + LQ + ++ME + ++ + + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-------RVENPDEVLDMIL 113
Query: 153 LALQYLHSHGIIHRDLKPDNMLISAQAP 180
+ + GI+H DL N+L+S +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEGI 141
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 473 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.47 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.84 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.76 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.09 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.58 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 96.52 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 96.42 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 96.41 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 96.34 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 96.23 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 96.09 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 95.87 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 95.78 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 95.61 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 95.57 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 95.56 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 95.5 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 95.49 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 95.48 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 95.41 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 95.36 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 95.33 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.3 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 95.16 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 95.14 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 95.12 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 95.09 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 95.06 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 95.02 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 94.75 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 94.62 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 94.58 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 94.32 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 94.2 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 93.62 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 93.54 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 93.24 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 93.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 92.87 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 92.87 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 92.84 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 92.35 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 92.33 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 92.21 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 91.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 91.96 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 90.85 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 90.12 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 89.9 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 89.56 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 89.18 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 88.77 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 88.57 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 88.2 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 87.5 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 87.37 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 86.82 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 86.81 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 86.53 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 85.49 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 82.87 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-64 Score=500.26 Aligned_cols=320 Identities=26% Similarity=0.412 Sum_probs=262.1
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
++++++|++++.||+|+||+||+|+++. +++.||||++++.........+++.+|+.+|+.++||||++++++|++.+.
T Consensus 1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 79 (337)
T d1o6la_ 1 KVTMNDFDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE
T ss_pred CCchHhcEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccc
Confidence 3678999999999999999999999887 689999999998866666667889999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+|||||+||+|..++.+.+.++|..++.|++||+.||+|||++|||||||||+|||++.+ |++||+|||+|+.....
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC-CCEEEeecccccccccC
Confidence 99999999999999999999999999999999999999999999999999999999999999 99999999999875332
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
. ......+|||.|+ |||++. ..|+|++|++ ++|++|..||.+.... .....+......+|
T Consensus 159 ~---~~~~~~~GT~~Y~---aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~----~~~~~i~~~~~~~p--- 225 (337)
T d1o6la_ 159 G---ATMKTFCGTPEYL---APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEEIRFP--- 225 (337)
T ss_dssp T---CCBCCCEECGGGC---CGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCC---
T ss_pred C---cccccceeCHHHh---hhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH----HHHHHHhcCCCCCC---
Confidence 2 2234568999999 999864 4788899965 5799999999753211 01123333455666
Q ss_pred ccCChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDS 342 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~ 342 (473)
..+|+++++||++||++||.+|++ ++|+++||||++++|+.+.++ .|||+|.+.++.|+++|+.+++++....
T Consensus 226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~~~~f~~~~~~~~~~~ 305 (337)
T d1o6la_ 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITI 305 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC-
T ss_pred ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhhhhhcCchhhhccCCC
Confidence 689999999999999999999995 899999999999999999876 7999999999999999999888765544
Q ss_pred CCCccCCCC-CceecccCCCCCCCCccccC
Q psy622 343 TLSTTHGNG-SFVCCSNLNSHTASGMDVDS 371 (473)
Q Consensus 343 ~~~~~~~~~-~~~~~~~~~~~~f~g~~~~~ 371 (473)
+..+..... .........+..|.||+|++
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~f~~f~~v~ 335 (337)
T d1o6la_ 306 TPPDRYDSLGLLELDQREEQEMFEDFDYIA 335 (337)
T ss_dssp -------------------CCTTTTCCEEC
T ss_pred CCCccccccccccccchhhhhccCCCEeeC
Confidence 433322211 11111223567899999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-61 Score=477.28 Aligned_cols=309 Identities=28% Similarity=0.471 Sum_probs=231.0
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hcCCCCeeeEEEEEEeCCEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALA-LTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
+++|+++++||+|+||+||+|+++. +++.||||++++.........+.+.+|..++. .++|||||++++++++++.+|
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~-t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECC-CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 5799999999999999999999887 68999999999876555556677888888776 679999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++|||||||||+|||++.+ |++||+|||+++......
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTT-
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC-Cceeccccchhhhccccc-
Confidence 999999999999999998899999999999999999999999999999999999999999 999999999998754322
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcccc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ 271 (473)
......+||+.|+ |||++. ..|+|++|++ ++|++|..||.+.... .....+......+| ..
T Consensus 158 --~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~~~~~~~p---~~ 225 (320)
T d1xjda_ 158 --AKTNTFCGTPDYI---APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIRMDNPFYP---RW 225 (320)
T ss_dssp --CCBCCCCSCGGGC---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCC---TT
T ss_pred --ccccccCCCCCcC---CHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCC---cc
Confidence 2234468999988 899764 3678999976 6799999999742110 00112233344445 68
Q ss_pred CChhHHHHHHhccccCCCCCCCHH-HHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCccC
Q psy622 272 LNPSTEETILALLKSDPTQRPSGH-QVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTSYFHADKTNSYMDSTLSTTH 348 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~-eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s~Fd~~~t~~~~~~~~~~~~ 348 (473)
+|+++++||++||++||.+|||++ |+++||||++++|+.+.++ .||++|.+.++.|++|||.+++++.+..+..+..
T Consensus 226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~ 305 (320)
T d1xjda_ 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRA 305 (320)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC--------------------------------
T ss_pred CCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhhcChHhhhCCccCCCCccc
Confidence 999999999999999999999995 8999999999999998766 7999999999999999999988765554444443
Q ss_pred CCCCceecccCCCCCCCCccc
Q psy622 349 GNGSFVCCSNLNSHTASGMDV 369 (473)
Q Consensus 349 ~~~~~~~~~~~~~~~f~g~~~ 369 (473)
.. ...++..|.||+|
T Consensus 306 ~~------~~~~~~~f~~f~~ 320 (320)
T d1xjda_ 306 LI------NSMDQNMFRNFSF 320 (320)
T ss_dssp ------------CCTTTTCCC
T ss_pred cc------CchhhcccCcCcC
Confidence 32 4557889999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-59 Score=467.83 Aligned_cols=309 Identities=28% Similarity=0.481 Sum_probs=257.8
Q ss_pred ccchhhHHHHhHhhhcccccccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHH
Q psy622 9 GADKENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQ 88 (473)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~ 88 (473)
+...+.+.+.+.++.+.............+.+++|++++.||+|+||+||+|+++. +|+.||||++++.........++
T Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~-~g~~~AvK~i~~~~~~~~~~~~~ 87 (350)
T d1rdqe_ 9 GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQIEH 87 (350)
T ss_dssp -----CHHHHHHHHHHHHHHHHHSCCCCCCCGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHH
T ss_pred CccHHHHHHHHHHHHHHHHhhccccccCCCCccCeEEEEEeecCcCcEEEEEEECC-CCCEEEEEEEchHHccCHHHHHH
Confidence 34445666666666555555555555666778999999999999999999999886 68999999999876555566778
Q ss_pred HHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Q psy622 89 VLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDL 168 (473)
Q Consensus 89 ~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDL 168 (473)
+.+|+++|+.++|||||+++++|++...+|+||||+.||+|..++.+.+.+++..++.|+.||+.||+|||++|||||||
T Consensus 88 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDI 167 (350)
T d1rdqe_ 88 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167 (350)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcC
Confidence 99999999999999999999999999999999999999999999999889999999999999999999999999999999
Q ss_pred CCcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCC
Q psy622 169 KPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAP 241 (473)
Q Consensus 169 KpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~p 241 (473)
||+||||+.+ |++||+|||+|+.+... ....+|||.|+ |||++.. .|+|++|++ ++|++|..|
T Consensus 168 KP~NILl~~~-g~ikL~DFG~a~~~~~~------~~~~~Gt~~Y~---APE~~~~~~~~~~~DiwSlGvilyemltG~~P 237 (350)
T d1rdqe_ 168 KPENLLIDQQ-GYIQVTDFGFAKRVKGR------TWTLCGTPEAL---APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237 (350)
T ss_dssp SGGGEEECTT-SCEEECCCTTCEECSSC------BCCCEECGGGC---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CHHHcccCCC-CCEEeeeceeeeecccc------cccccCccccC---CHHHHcCCCCCccccccchhHHHHHHHhCCCC
Confidence 9999999999 99999999999976432 23467999998 9997643 588999965 579999999
Q ss_pred chhHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--
Q psy622 242 FPSALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ-- 314 (473)
Q Consensus 242 f~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~-- 314 (473)
|.+.... .....+......+| ..+++++.+||++||++||.+|+ +++|+++||||+++||+.+.++
T Consensus 238 f~~~~~~----~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~ 310 (350)
T d1rdqe_ 238 FFADQPI----QIYEKIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV 310 (350)
T ss_dssp SCCSSHH----HHHHHHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCS
T ss_pred CCCcCHH----HHHHHHhcCCCCCC---ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCC
Confidence 9752110 00122223344444 68999999999999999999995 8999999999999999999876
Q ss_pred CCCCcCCCCCCCCCCCCCCCC
Q psy622 315 EPPFVPQPDDVFDTSYFHADK 335 (473)
Q Consensus 315 ~pPf~P~~~~~~D~s~Fd~~~ 335 (473)
+|||+|.+.++.|++|||...
T Consensus 311 ~~p~~p~~~~~~d~s~~~~~~ 331 (350)
T d1rdqe_ 311 EAPFIPKFKGPGDTSNFDDYE 331 (350)
T ss_dssp CCSCCCCCCSTTCCTTSCCCC
T ss_pred CcCccCCCCCcchhhhcCCCC
Confidence 799999999999999998643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-58 Score=458.49 Aligned_cols=278 Identities=30% Similarity=0.542 Sum_probs=231.2
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
++++|++++.||+|+||+||+|+++. +|+.||||++++.........+++.+|+.+|+.++|||||++++++++++.+|
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 80 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 80 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECC-CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence 47899999999999999999999886 68999999999876555566788999999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcc
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIV 198 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~ 198 (473)
+|||||+||+|..++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+ |++||+|||+|+.....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSSC--
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC-CCEEEecCccceEeccc--
Confidence 999999999999999999999999999999999999999999999999999999999999 99999999999875432
Q ss_pred ccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcccc
Q psy622 199 YLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271 (473)
Q Consensus 199 ~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ 271 (473)
....+|||.|+ |||++. ..|+|++|++ ++|++|..||.+.... .....+......+| ..
T Consensus 158 ----~~~~~Gt~~Y~---APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i~~~~~~~p---~~ 223 (316)
T d1fota_ 158 ----TYTLCGTPDYI---APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----KTYEKILNAELRFP---PF 223 (316)
T ss_dssp ----BCCCCSCTTTC---CHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHCCCCCC---TT
T ss_pred ----cccccCccccc---CHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH----HHHHHHHcCCCCCC---CC
Confidence 23468999999 999764 4678899965 5699999999752110 00122233445555 68
Q ss_pred CChhHHHHHHhccccCCCCCC-----CHHHHhcCCCCCCCCccccccC--CCCCcCCCC-CCCCCCCCCCC
Q psy622 272 LNPSTEETILALLKSDPTQRP-----SGHQVRRLPMFKDYDWDSILDQ--EPPFVPQPD-DVFDTSYFHAD 334 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRp-----sa~eil~HPFF~~idw~~l~~~--~pPf~P~~~-~~~D~s~Fd~~ 334 (473)
++++++++|.+||++||.+|+ |++|+++||||++++|+.+.++ +|||+|.+. ...|+++||..
T Consensus 224 ~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~~d~~~f~~~ 294 (316)
T d1fota_ 224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKY 294 (316)
T ss_dssp SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-------------
T ss_pred CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCCCcchhhhcCCC
Confidence 999999999999999999997 8999999999999999999876 899999865 55799999853
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-58 Score=450.04 Aligned_cols=271 Identities=28% Similarity=0.494 Sum_probs=228.1
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
....++|++++.||+|+||+||+|+++. +++.||||++++.........+.+.+|+++|+.++||||++++++|++++.
T Consensus 4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 82 (288)
T d1uu3a_ 4 KKRPEDFKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 82 (288)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE
T ss_pred CCCCCCCEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE
Confidence 3345789999999999999999999886 578999999998765555667789999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.+ |++||+|||+|+.+...
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECC--
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC-ceEEecccccceecccC
Confidence 99999999999999999998999999999999999999999999999999999999999999 99999999999876432
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
... ......+|||.|+ |||++. ..|+||+|++ ++|++|..||...... .....+......+|
T Consensus 162 ~~~-~~~~~~~GT~~Y~---APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i~~~~~~~p--- 230 (288)
T d1uu3a_ 162 SKQ-ARANSFVGTAQYV---SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY----LIFQKIIKLEYDFP--- 230 (288)
T ss_dssp ---------CCCCGGGC---CHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHTTCCCCC---
T ss_pred Ccc-cccccccCCcccc---CceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH----HHHHHHHcCCCCCC---
Confidence 222 2233468999999 999864 3688999965 5799999999742110 00122333455566
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHH------HhcCCCCCCCCccccccCCCCCcC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQ------VRRLPMFKDYDWDSILDQEPPFVP 320 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~e------il~HPFF~~idw~~l~~~~pPf~P 320 (473)
..+++++++||++||+.||++|||++| +++||||+++||+.|.++.||-.|
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 579999999999999999999999887 689999999999999999888655
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-57 Score=458.97 Aligned_cols=310 Identities=22% Similarity=0.383 Sum_probs=235.7
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHH---HHHHHhcCCCCeeeEEEEEEeC
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRE---RNALALTHSPFCVQLFYSLQTS 114 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E---~~iL~~l~hp~Iv~l~~~f~~~ 114 (473)
.++++|+++++||+|+||+||+|+++. +|+.||||++.+...........+.+| +.+++.++|||||+++++|++.
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~-t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECC-CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 368999999999999999999999887 689999999987655444334445555 5566677899999999999999
Q ss_pred CEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 115 SCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 115 ~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
+.+|+|||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+ |++||+|||+|+.+.
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS 158 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-SCEEECCCTTCEECS
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC-CcEEEeeeceeeecC
Confidence 9999999999999999999998899999999999999999999999999999999999999999 999999999998754
Q ss_pred CCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
... ....+|||.|+ |||++. ..|+|++|++ ++|++|..||.... ...............+
T Consensus 159 ~~~-----~~~~~GT~~y~---APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~~~~~~~~~~ 226 (364)
T d1omwa3 159 KKK-----PHASVGTHGYM---APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK----TKDKHEIDRMTLTMAV 226 (364)
T ss_dssp SSC-----CCSCCSCGGGC---CHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC----SSCHHHHHHHSSSCCC
T ss_pred CCc-----ccccccccccc---hhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcccCCC
Confidence 322 23457999998 898764 2577899965 57999999997421 1111111111111112
Q ss_pred CccccCChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCCC-----CCCCC
Q psy622 267 EDEEALNPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDTS-----YFHAD 334 (473)
Q Consensus 267 ~~~~~ls~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~s-----~Fd~~ 334 (473)
..+..+|+++++||.+||++||++||| |+|+++||||++++|+.+..+ +|||+|......+.+ +|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~~~~~~~~~d~~~~~~~ 306 (364)
T d1omwa3 227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEE 306 (364)
T ss_dssp CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC----------------
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCCCCCcCCccccccCChh
Confidence 223689999999999999999999998 799999999999999999876 799999776554444 44443
Q ss_pred CCCCCCCCCCCccCCCCCceecccCCCCCCCCccccCchhhh
Q psy622 335 KTNSYMDSTLSTTHGNGSFVCCSNLNSHTASGMDVDSPSALY 376 (473)
Q Consensus 335 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~p~~~~ 376 (473)
.+... .. ...++..|.+|+...+....
T Consensus 307 ~~~~~------~~---------~~~~~~~~~~~~~~~~~~~~ 333 (364)
T d1omwa3 307 DTKGI------KL---------LDSDQELYRNFPLTISERWQ 333 (364)
T ss_dssp ----C------CC---------CSSSSGGGTTCCEECHHHHH
T ss_pred hccCC------CC---------CChHHHHHhcCCccCchHHH
Confidence 33211 00 12245667788777665443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-55 Score=421.74 Aligned_cols=256 Identities=16% Similarity=0.307 Sum_probs=210.0
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
|-+++|++++.||+|+||+||+|+++. +++.||||++++... ....+.+.+|+++|+.++|||||++++++++++.+
T Consensus 2 Pf~~dy~~~~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~ 78 (271)
T d1nvra_ 2 PFVEDWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78 (271)
T ss_dssp TTTTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred CCCcceEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence 457899999999999999999999887 689999999987643 22345789999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
|+|||||+||+|.++|.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+|+.+....
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECEETT
T ss_pred EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC-CCEEEccchhheeeccCC
Confidence 9999999999999999888899999999999999999999999999999999999999999 999999999999764332
Q ss_pred cccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
.. ......+|||.|+ |||++. ..|+|++|++ ++|++|..||.... ...............+...
T Consensus 158 ~~-~~~~~~~GT~~Y~---APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~----~~~~~~~~~~~~~~~~~~~ 229 (271)
T d1nvra_ 158 RE-RLLNKMCGTLPYV---APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS----DSCQEYSDWKEKKTYLNPW 229 (271)
T ss_dssp EE-CCBCCCCSCGGGS---CTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS----TTSHHHHHHHTTCTTSTTG
T ss_pred cc-ccccceeeCcCcc---CHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCCCCcc
Confidence 22 2344568999999 999753 3688999965 57999999996421 1111111111122222223
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
..+|+++++||.+||+.||++|||++|+++||||+.
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 578999999999999999999999999999999973
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-55 Score=420.38 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=216.0
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
+.++++|++++.||+|+||+||+|+++. +++.||||++.+.........+.+.+|+++|+.++|||||++++++++++.
T Consensus 2 ~~~l~dy~i~~~iG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 80 (263)
T d2j4za1 2 QWALEDFEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 80 (263)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcchhHeEEEEEEecCCCcEEEEEEECC-CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCE
Confidence 4568899999999999999999999887 689999999998765555567789999999999999999999999999999
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.+ +++||+|||+|+.....
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCSCSCCCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC-CCEeecccceeeecCCC
Confidence 99999999999999999998899999999999999999999999999999999999999999 99999999999875432
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDE 269 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~ 269 (473)
. ....+|||.|+ |||++. ..|+|++|++ ++|++|..||...... .....+......+|
T Consensus 160 ~-----~~~~~Gt~~Y~---APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~p--- 224 (263)
T d2j4za1 160 R-----RTTLCGTLDYL---PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISRVEFTFP--- 224 (263)
T ss_dssp C-----CEETTEEGGGC---CHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHTTCCCCC---
T ss_pred c-----ccccCCCCccc---CHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCC---
Confidence 2 23457999998 898764 4678899965 5799999999742110 00122233444555
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
..+|+++++||.+||+.||++|||++|+++||||+.
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 579999999999999999999999999999999963
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=410.91 Aligned_cols=261 Identities=20% Similarity=0.275 Sum_probs=209.8
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK---NMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
++|++++.||+|+||+||+|+++. +|+.||||++++...... ...+.+.+|+.+|+.++|||||+++++|++++.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 469999999999999999999876 689999999987654322 2356899999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCC----ceeEeecchhhhh
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAP----HCPIVNTLFLAIL 193 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g----~ikL~DFGla~~~ 193 (473)
|||||||+||+|.++|.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ + ++||+|||+++..
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~-~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR-NVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS-SSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecC-CCcccceEecchhhhhhc
Confidence 9999999999999999988899999999999999999999999999999999999999877 4 5999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP 266 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P 266 (473)
..... ....+||+.|+ |||++. ..|+|++|++ ++|++|..||.+..... ....+......++
T Consensus 168 ~~~~~----~~~~~~t~~y~---APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~~~~~~ 236 (293)
T d1jksa_ 168 DFGNE----FKNIFGTPEFV---APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANVSAVNYEFE 236 (293)
T ss_dssp TTSCB----CSCCCCCGGGC---CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHTTCCCCC
T ss_pred CCCcc----ccccCCCCccc---CHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH----HHHHHHhcCCCCC
Confidence 43322 23457888888 899764 4678899965 67999999997421100 0012222233333
Q ss_pred C-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccC
Q psy622 267 E-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQ 314 (473)
Q Consensus 267 ~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~ 314 (473)
. .+..+|+++++||++||+.||++|||++|+++||||++++|+..+..
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~l~~ 285 (293)
T d1jksa_ 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSS 285 (293)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---------
T ss_pred chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHhhcc
Confidence 2 22578999999999999999999999999999999999999987654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=408.86 Aligned_cols=249 Identities=20% Similarity=0.298 Sum_probs=206.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
++|++++.||+|+||+||+|+++. +|+.||||++++.... ..+.+.+|+++|+.++|||||+++++|++++.+|+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTT-TCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECC-CCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 579999999999999999999876 6899999999876432 245789999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYL 200 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~ 200 (473)
||||+||+|.+++.+ +.+++.+++.|+.||+.||+|||++|||||||||+|||++.+ |++||+|||+|+.+....
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~~--- 170 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ--- 170 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTT---
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC-CcEeeccchhheeecccc---
Confidence 999999999998876 479999999999999999999999999999999999999998 999999999998754322
Q ss_pred ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCccccCC
Q psy622 201 EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEALN 273 (473)
Q Consensus 201 ~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls 273 (473)
......+|||.|+ |||++. ..|+|++|++ ++|++|..||.+..... ............+ ..+..+|
T Consensus 171 ~~~~~~~gt~~Y~---aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~~~~~~~~-~~~~~~s 243 (293)
T d1yhwa1 171 SKRSTMVGTPYWM---APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLIATNGTPEL-QNPEKLS 243 (293)
T ss_dssp CCBCCCCSCGGGC---CHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHHCSCCC-SSGGGSC
T ss_pred ccccccccCCCcc---ChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH---HHHHHHhCCCCCC-CCcccCC
Confidence 2234468999998 999764 4678899965 57999999997521100 0000111111112 2236799
Q ss_pred hhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 274 PSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 274 ~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
+++++||.+||+.||++|||++|+++||||+.
T Consensus 244 ~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=416.20 Aligned_cols=283 Identities=25% Similarity=0.453 Sum_probs=231.5
Q ss_pred CCCCCCCeEEEceecccCceEEEEEEEeC--CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcCC-CCeeeEEEEE
Q psy622 36 KAPEISDFEIVKAISRGAFGKVFLGYKKT--NKDQLYAIKVMKKDEMIN-KNMVSQVLRERNALALTHS-PFCVQLFYSL 111 (473)
Q Consensus 36 ~~~~~~~y~i~~~LG~G~fG~V~~a~~~~--~~~~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f 111 (473)
..+.+++|++++.||+|+||+||+|++.. .+|+.||||++++..... ....+++.+|+++|++++| |||+++++++
T Consensus 19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 44678999999999999999999998743 257899999998765432 2334578899999999965 8999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
++...+|+||||+.||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+||||+.+ |.+||+|||+++
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSK 177 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC-CCEEEeeccchh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999 999999999998
Q ss_pred hhcCCccccccccccCCCCcccccCCccccc--------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-h
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQLL--------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-L 261 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~--------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~ 261 (473)
.+..... .......|++.|+ +||.+. ..|+||+|++ ++|++|..||..... ......+.. .
T Consensus 178 ~~~~~~~--~~~~~~~g~~~~~---~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~----~~~~~~i~~~~ 248 (322)
T d1vzoa_ 178 EFVADET--ERAYDFCGTIEYM---APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE----KNSQAEISRRI 248 (322)
T ss_dssp ECCGGGG--GGGCGGGSCCTTC---CHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS----CCCHHHHHHHH
T ss_pred hhccccc--ccccccccccccc---hhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhc
Confidence 7543222 2233457888887 787652 3588999965 679999999975311 111111211 1
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCC-----HHHHhcCCCCCCCCccccccC--CCCCcCCCCCCCCC
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPS-----GHQVRRLPMFKDYDWDSILDQ--EPPFVPQPDDVFDT 328 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRps-----a~eil~HPFF~~idw~~l~~~--~pPf~P~~~~~~D~ 328 (473)
....+..+..+|+++++||.+||+.||++||| ++|+++||||++++|+.+..+ +|||+|.++++.|+
T Consensus 249 ~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~~~~~ 322 (322)
T d1vzoa_ 249 LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDV 322 (322)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CCC
T ss_pred ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCCCCCC
Confidence 11112223679999999999999999999994 899999999999999999887 89999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=407.49 Aligned_cols=250 Identities=20% Similarity=0.291 Sum_probs=207.0
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.|++++.||+|+||+||+|+++. +++.||||++++.. ....+.+.+|+++|+.++|||||++++++.+++.+|+|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE-TSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC-CCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 469999999999999999999887 67899999998753 33456789999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+.....
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~~~~--- 163 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRT--- 163 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECHHH---
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC-CCEEEEechhhhccCCC---
Confidence 999999999999765 4579999999999999999999999999999999999999999 99999999999764321
Q ss_pred cccccccCCCCcccccCCccccc-----------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-----------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-----------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
.......+|||.|+ |||++. ..|+|++|++ ++|++|..||.+.... . ....+.........
T Consensus 164 ~~~~~~~~Gt~~y~---APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~-~~~~i~~~~~~~~~ 236 (288)
T d2jfla1 164 IQRRDSFIGTPYWM---APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---R-VLLKIAKSEPPTLA 236 (288)
T ss_dssp HHHHTCCCSCCTTC---CHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---G-HHHHHHHSCCCCCS
T ss_pred cccccccccccccC---CHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---H-HHHHHHcCCCCCCC
Confidence 12233568999998 999762 3588999965 6799999999752110 0 00111122222222
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.+..+|+++++||.+||+.||++|||++|+++||||+.
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 23689999999999999999999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=422.16 Aligned_cols=260 Identities=21% Similarity=0.331 Sum_probs=211.2
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+..++|++++.||+|+||+||+|+++. +++.||||++++.. .....+++.+|+.+|+.++|||||+++++|+++.++
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETT-TTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 445789999999999999999999887 68999999998753 234456899999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+||||+.+ |++||+|||+|+.+...
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC-CCEEEeeCCCccccCCC
Confidence 9999999999999999998899999999999999999999997 599999999999999999 99999999999975421
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhh----------cCC--CCC---
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRV----------AGS--QIP--- 254 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~----------~~~--~~~--- 254 (473)
.....+||+.|+ |||++. ..|+|++|++ ++|++|+.||...... .+. ..+
T Consensus 159 -----~~~~~~GT~~Y~---APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 159 -----MANSFVGTRSYM---SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp -----TC---CCSSCCC---CHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred -----ccccccCCcccc---CchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 223468999998 999864 4677899965 6799999999641100 000 000
Q ss_pred ----------------h----hhHhh----hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccc
Q psy622 255 ----------------T----STAAQ----LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDS 310 (473)
Q Consensus 255 ----------------~----~~~~~----~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~ 310 (473)
. ..... .....|. ..+|+++++||.+||+.||++|||++|+++||||+..+|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 308 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCB--TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCcc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCccc
Confidence 0 00000 0111121 35789999999999999999999999999999999888875
Q ss_pred c
Q psy622 311 I 311 (473)
Q Consensus 311 l 311 (473)
+
T Consensus 309 ~ 309 (322)
T d1s9ja_ 309 V 309 (322)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-51 Score=412.87 Aligned_cols=260 Identities=18% Similarity=0.266 Sum_probs=214.6
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+++|++++.||+|+||+||+|+++. +|+.||||++.+.. ....+.+.+|+++|+.++|||||+++++|++++.+|+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~-~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 5789999999999999999999887 68999999998754 3345688999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC-CCceeEeecchhhhhcCCc
Q psy622 120 VMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ-APHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~-~g~ikL~DFGla~~~~~~~ 197 (473)
|||||+||+|.++|.+ .+.+++..++.|+.||+.||+|||++|||||||||+|||++.+ .+.+||+|||+|+.+....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999999999964 4679999999999999999999999999999999999999642 2789999999998764332
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC-cc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE-DE 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~-~~ 269 (473)
...+.+|||.|+ |||++. ..|+|++|++ ++|++|..||.+.... .....+......++. ..
T Consensus 181 ----~~~~~~gT~~Y~---aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~ 249 (350)
T d1koaa2 181 ----SVKVTTGTAEFA---APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----ETLRNVKSCDWNMDDSAF 249 (350)
T ss_dssp ----CEEEECSCTTTC---CHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCSCCGGG
T ss_pred ----ccceecCccccc---CHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCcccc
Confidence 223468999998 999764 4788899975 5799999999642110 000122222333322 22
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCccccccC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSILDQ 314 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l~~~ 314 (473)
..+|+++++||.+||+.||++|||++|+++||||+..+|.....+
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~ 294 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 294 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCC
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhh
Confidence 578999999999999999999999999999999999988755443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-52 Score=410.06 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=192.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLV 120 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 120 (473)
+.|++++.||+|+||+||+|+++. +++.||||++.+..... ..+.+.+|+++|+.++|||||+++++|++++.+|+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKR-TQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETT-TCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECC-CCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 459999999999999999999886 68899999998865432 245788999999999999999999999999999999
Q ss_pred ecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC---CCCceeEeecchhhhhcCCc
Q psy622 121 MEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA---QAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~---~~g~ikL~DFGla~~~~~~~ 197 (473)
||||+||+|.++|.+.+.+++.+++.++.||+.||+|||++|||||||||+|||+.. + +++||+|||+|+......
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~-~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDED-SKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTT-CCEEECCC----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCC-ceEEEeccceeEEccCCC
Confidence 999999999999999889999999999999999999999999999999999999953 5 899999999998754322
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC-Ccc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP-EDE 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P-~~~ 269 (473)
.....+|||.|+ |||++. ..|+|++|++ ++|++|..||.+..... ....+......++ ...
T Consensus 165 ----~~~~~~GT~~y~---APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~ 233 (307)
T d1a06a_ 165 ----VLSTACGTPGYV---APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK----LFEQILKAEYEFDSPYW 233 (307)
T ss_dssp ------------CTTS---CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHTTCCCCCTTTT
T ss_pred ----eeeeeeeCcccc---CcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHhccCCCCCCccc
Confidence 223468999999 999764 4678899965 57999999997421100 0011222222222 122
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
..+|+++++||.+||++||++|||++|+++||||++-
T Consensus 234 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred cCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 5799999999999999999999999999999999853
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.9e-51 Score=396.86 Aligned_cols=254 Identities=19% Similarity=0.274 Sum_probs=211.0
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccc------hhHHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN------KNMVSQVLRERNALALTH-SPFCVQLFYSLQ 112 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~------~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~ 112 (473)
.++|++++.||+|+||+||+|+++. +++.||||++++..... +...+.+++|+.+|+.++ ||||++++++|+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~-~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred cccCEEceEEecCcCeEEEEEEECC-CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 3789999999999999999999876 68999999998764332 223457899999999996 999999999999
Q ss_pred eCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
+++++|||||||+||+|.++|...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~ 159 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQ 159 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC-CCeEEccchheeE
Confidence 999999999999999999999998999999999999999999999999999999999999999998 9999999999987
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA 259 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~ 259 (473)
+..... ....+||+.|+ +||.+. ..|+|++|++ ++|++|..||.+..... ....+.
T Consensus 160 ~~~~~~----~~~~~gt~~y~---~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~----~~~~i~ 228 (277)
T d1phka_ 160 LDPGEK----LREVCGTPSYL---APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----MLRMIM 228 (277)
T ss_dssp CCTTCC----BCCCCSCGGGC---CHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHH
T ss_pred ccCCCc----eeeeeccCCCC---CHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH----HHHHHH
Confidence 643221 23357888887 888653 3689999965 57999999997531100 011222
Q ss_pred hhccCCCC-ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 260 QLQLEWPE-DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 260 ~~~~~~P~-~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.....++. ....+|+++++||.+||+.||++|||++||++||||+..
T Consensus 229 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 229 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp HTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred hCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 22333332 224799999999999999999999999999999999853
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-51 Score=393.25 Aligned_cols=246 Identities=20% Similarity=0.320 Sum_probs=202.2
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCEEE
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT----SSCVF 118 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~----~~~l~ 118 (473)
|++.++||+|+||+||+|+++. +++.||+|++.+... .....+.+.+|+++|+.++|||||+++++|++ ...+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~-~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECC-CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 4788899999999999999876 678999999987654 34456789999999999999999999999975 45799
Q ss_pred EEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 119 LVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHG--IIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~g--IiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| ||||||||+||||+.+.+.+||+|||+|+.....
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999999999889999999999999999999999999 9999999999999753389999999999864321
Q ss_pred ccccccccccCCCCcccccCCccccc-----cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhh--ccCCCCc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL-----SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQL--QLEWPED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~-----~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~P~~ 268 (473)
.....+|||.|+ |||++. ..|+|++|++ ++|++|..||.+.. ......... ....+..
T Consensus 169 -----~~~~~~GT~~Y~---aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~------~~~~~~~~i~~~~~~~~~ 234 (270)
T d1t4ha_ 169 -----FAKAVIGTPEFM---APEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVTSGVKPASF 234 (270)
T ss_dssp -----SBEESCSSCCCC---CGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHHHTTTCCCGGG
T ss_pred -----ccCCcccCcccc---CHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcc------cHHHHHHHHHcCCCCccc
Confidence 223468999999 999764 3688899965 67999999996421 000111110 1111122
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFK 304 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~ 304 (473)
+...++++++||.+||+.||++|||++|+++||||+
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 356889999999999999999999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-51 Score=406.28 Aligned_cols=247 Identities=21% Similarity=0.265 Sum_probs=208.4
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEe
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVM 121 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 121 (473)
.|++++.||+|+||+||+|+++. +++.||||++++.........+.+.+|+++|+.++|||||++++++.+++.+|+||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECC-CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 49999999999999999999887 68999999999876666666778999999999999999999999999999999999
Q ss_pred cccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccc
Q psy622 122 EYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLE 201 (473)
Q Consensus 122 Ey~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~ 201 (473)
|||.||+|..++...+.+++..++.++.||+.||+|||++|||||||||+||||+.+ +++||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~~----- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA----- 168 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSSB-----
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC-CCEEEeecccccccCCC-----
Confidence 999999998888888899999999999999999999999999999999999999998 99999999999874321
Q ss_pred cccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcccc
Q psy622 202 ISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271 (473)
Q Consensus 202 ~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ 271 (473)
...+|||.|+ |||++. ..|+|++|++ ++|++|..||.+..... . ...+.......+ ....
T Consensus 169 --~~~~GT~~Y~---APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~---~-~~~i~~~~~~~~-~~~~ 238 (309)
T d1u5ra_ 169 --NSFVGTPYWM---APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---A-LYHIAQNESPAL-QSGH 238 (309)
T ss_dssp --CCCCSCGGGC---CHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H-HHHHHHSCCCCC-SCTT
T ss_pred --CccccCcccc---CHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH---H-HHHHHhCCCCCC-CCCC
Confidence 2357999998 999763 3688999965 57999999997521100 0 001111111111 1256
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
+|+++++||.+||+.||.+|||++|+++||||..
T Consensus 239 ~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 8999999999999999999999999999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-51 Score=394.21 Aligned_cols=249 Identities=20% Similarity=0.333 Sum_probs=195.6
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT--SSCV 117 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~~~l 117 (473)
.++|++++.||+|+||+||+|+++. +|+.||||++++... .+...+.+.+|+++|+.++|||||++++++.+ .+.+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred chhCEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 4789999999999999999999887 689999999988754 34556789999999999999999999999964 5679
Q ss_pred EEEecccCcCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCCcceEecCCCCceeEeecc
Q psy622 118 FLVMEYMIGGDVKSLIAA----NGALPEDMAAFYAAEVVLALQYLHSHG-----IIHRDLKPDNMLISAQAPHCPIVNTL 188 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~----~~~~~e~~~~~~~~qI~~aL~yLH~~g-----IiHRDLKpeNILld~~~g~ikL~DFG 188 (473)
|+|||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++| ||||||||+||||+.+ +.+||+|||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG 159 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFG 159 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeecc
Confidence 999999999999999864 457999999999999999999999976 9999999999999999 999999999
Q ss_pred hhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhh
Q psy622 189 FLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQL 261 (473)
Q Consensus 189 la~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~ 261 (473)
+|+.+.... ......+|||.|+ |||++. ..|+|++|++ ++|++|..||....... ....+.
T Consensus 160 ~a~~~~~~~---~~~~~~~gt~~Y~---APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~----~~~~i~-- 227 (269)
T d2java1 160 LARILNHDT---SFAKAFVGTPYYM---SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIR-- 227 (269)
T ss_dssp HHHHC--------------CCCSCC---CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHH--
T ss_pred ceeecccCC---CccccCCCCcccC---CHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH----HHHHHH--
Confidence 999864322 2234568999998 999764 3678899965 67999999996421100 001111
Q ss_pred ccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCC
Q psy622 262 QLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMF 303 (473)
Q Consensus 262 ~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF 303 (473)
...++..+..+|+++++||.+||+.||++|||++|+++|||.
T Consensus 228 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 228 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 122333336899999999999999999999999999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.8e-51 Score=407.03 Aligned_cols=251 Identities=20% Similarity=0.313 Sum_probs=208.4
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++++.||+|+||+||+|+++. +|+.||||++++.. ......+.+|+.+|+.++|||||+++++|++++.+|+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4679999999999999999999887 68999999998764 2334578899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEec--CCCCceeEeecchhhhhcCC
Q psy622 120 VMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLIS--AQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld--~~~g~ikL~DFGla~~~~~~ 196 (473)
|||||+||+|.+++.+.+ .+++.+++.++.||+.||+|||++|||||||||+||||+ .+ +++||+|||+|+.+...
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~-~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA-SSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTC-CCEEECCCTTCEECCTT
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCC-CeEEEeecccceecCCC
Confidence 999999999999887654 699999999999999999999999999999999999998 44 89999999999886432
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCC-c
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPE-D 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~-~ 268 (473)
. ...+.+||+.|+ |||++. ..|+|++|++ ++|++|..||.+..... ....+......+|. .
T Consensus 183 ~----~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~~~~~~~~ 251 (352)
T d1koba_ 183 E----IVKVTTATAEFA---APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQNVKRCDWEFDEDA 251 (352)
T ss_dssp S----CEEEECSSGGGC---CHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHHCCCCCCSST
T ss_pred C----ceeeccCccccc---CHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCccc
Confidence 2 233467899888 898764 3678899965 56999999997521100 00122223333332 2
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
...+|+++++||.+||++||.+|||++|+++||||++.
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 25799999999999999999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=388.56 Aligned_cols=246 Identities=21% Similarity=0.284 Sum_probs=208.3
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchh---HHHHHHHHHHHHHhcC--CCCeeeEEEEEEeC
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKN---MVSQVLRERNALALTH--SPFCVQLFYSLQTS 114 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~---~~~~~~~E~~iL~~l~--hp~Iv~l~~~f~~~ 114 (473)
.++|++.+.||+|+||+||+|+++. +++.||||++++....... ...++.+|+.+|++++ |||||+++++|++.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECC-CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4689999999999999999999887 5799999999876543221 1234678999999986 89999999999999
Q ss_pred CEEEEEecccCc-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 115 SCVFLVMEYMIG-GDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 115 ~~l~lVmEy~~g-g~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
+.+|+||||+.+ +++.+++.+.+.+++.+++.++.||+.||+|||++|||||||||+|||++.+.+.+||+|||+|+..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999975 6889999888899999999999999999999999999999999999999965479999999999864
Q ss_pred cCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
... ..+..+||+.|+ |||++. ..|+|++|++ ++|++|..||.... .+......+
T Consensus 162 ~~~-----~~~~~~GT~~y~---aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~~~~~ 223 (273)
T d1xwsa_ 162 KDT-----VYTDFDGTRVYS---PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFF 223 (273)
T ss_dssp CSS-----CBCCCCSCGGGS---CHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCC
T ss_pred ccc-----cccccccCCCcC---CHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HHhhcccCC
Confidence 322 223467999988 898653 3688999965 57999999997532 223334455
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYD 307 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~id 307 (473)
+ ..+|+++++||++||+.||++|||++|+++||||+++-
T Consensus 224 ~---~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 224 R---QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp S---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred C---CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 5 57999999999999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=394.17 Aligned_cols=250 Identities=19% Similarity=0.268 Sum_probs=207.0
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
.++|++++.||+|+||+||+|+++. +++.||||++++.. .....+.+|+++|+.++|||||+++++|++++++||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~-~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 5789999999999999999999887 68999999998763 234568899999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC-CCceeEeecchhhhhcCCc
Q psy622 120 VMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ-APHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~-~g~ikL~DFGla~~~~~~~ 197 (473)
|||||+||+|.++|.+.+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++......
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999999999998765 79999999999999999999999999999999999999864 2589999999998754322
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc-c
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED-E 269 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~-~ 269 (473)
...+.+|||.|+ +||... ..|+|++|++ ++|++|..||...... .....+......+|.. .
T Consensus 159 ----~~~~~~~t~~y~---ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~ 227 (321)
T d1tkia_ 159 ----NFRLLFTAPEYY---APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----QIIENIMNAEYTFDEEAF 227 (321)
T ss_dssp ----EEEEEESCGGGS---CHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHTCCCCCHHHH
T ss_pred ----cccccccccccc---cchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCChhhc
Confidence 223457899988 888643 4689999965 5699999999752110 0012222333444321 1
Q ss_pred ccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 270 EALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 270 ~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
..+|+++++||.+||++||.+|||++|+++||||+.
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 368999999999999999999999999999999964
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=389.14 Aligned_cols=257 Identities=23% Similarity=0.372 Sum_probs=199.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+++|++++.||+|+||+||+|+++. +++.||||++++.. ......+++.+|+++|++++|||||+++++|+++.++|+
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i 78 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 78 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECC-CCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence 5799999999999999999999887 67899999997653 223345689999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHH-h-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 120 VMEYMIGGDVKSLIA-A-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 120 VmEy~~gg~L~~~L~-~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
||||+.| ++..++. . .+.+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+......
T Consensus 79 v~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 79 VFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTHHHHHCCCS
T ss_pred EEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc-CcceeccCCcceeccCCc
Confidence 9999955 5555543 3 3579999999999999999999999999999999999999999 899999999999864322
Q ss_pred cccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHh---------hhcCCCC--ChhhH
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQI--PTSTA 258 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~--~~~~~ 258 (473)
.......||+.|+ |||.+. ..|.|++|++ ++|++|..||.+.. ...+... .....
T Consensus 157 ---~~~~~~~gt~~y~---apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 157 ---RTYTHEVVTLWYR---APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp ---BCTTCCBCCCTTC---CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ---ccceeecccceee---ehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 2233457888888 888643 4677899965 57999999996421 1111100 00000
Q ss_pred h---hhccCCC--------CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 259 A---QLQLEWP--------EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 259 ~---~~~~~~P--------~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
. .....++ .....+|+++++||++||+.||++|||++|+++||||+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0 0001111 0123678999999999999999999999999999999877
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=389.15 Aligned_cols=256 Identities=19% Similarity=0.214 Sum_probs=198.2
Q ss_pred EEceecccCceEEEEEEEeCCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEec
Q psy622 45 IVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINK--NMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVME 122 (473)
Q Consensus 45 i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~--~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 122 (473)
.+++||+|+||+||+|+++. +|+.||||++++...... ...+.+.+|+.+|+.++|||||+++++|++++++|+|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS-CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECC-CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 57899999999999999876 689999999987643222 223478999999999999999999999999999999999
Q ss_pred ccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCcccccc
Q psy622 123 YMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEI 202 (473)
Q Consensus 123 y~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~ 202 (473)
|+.|+++..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... ..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~---~~ 156 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPN---RA 156 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCC---CC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC-CccccccCccccccCCCc---cc
Confidence 99998888777777789999999999999999999999999999999999999999 999999999998754332 22
Q ss_pred ccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCChhhHh----h-
Q psy622 203 SDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPTSTAA----Q- 260 (473)
Q Consensus 203 ~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~~~~~----~- 260 (473)
....+||+.|+ |||++. ..|+|++|++ ++|++|.+||.... ...+......... .
T Consensus 157 ~~~~~gt~~y~---aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 YTHQVVTRWYR---APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCSCCCCTTC---CHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred ccceecChhhc---cHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 23457899988 899764 3578999965 57999999996421 1111110000000 0
Q ss_pred --hccCCCC-----ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCc
Q psy622 261 --LQLEWPE-----DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDW 308 (473)
Q Consensus 261 --~~~~~P~-----~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw 308 (473)
....++. ....+++++++||.+||+.||++|||++|+++||||++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 0001111 11367899999999999999999999999999999987543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=394.62 Aligned_cols=252 Identities=24% Similarity=0.290 Sum_probs=200.9
Q ss_pred CCCCCeEEEc-eecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe--
Q psy622 38 PEISDFEIVK-AISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQT-- 113 (473)
Q Consensus 38 ~~~~~y~i~~-~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~-- 113 (473)
.-+++|++++ +||+|+||+||+|+++. +++.||||++++. ..+.+|+.++.++ +|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECC-CCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 3368999985 69999999999999887 6799999999764 2567899987654 89999999999986
Q ss_pred --CCEEEEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC--CCceeEeec
Q psy622 114 --SSCVFLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ--APHCPIVNT 187 (473)
Q Consensus 114 --~~~l~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~--~g~ikL~DF 187 (473)
...+|+|||||+||+|.++|.+. ..|++.+++.|+.||+.||+|||++||+||||||+|||++.+ .+++||+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence 46799999999999999999875 369999999999999999999999999999999999999863 268999999
Q ss_pred chhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh
Q psy622 188 LFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ 260 (473)
Q Consensus 188 Gla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~ 260 (473)
|+|+...... .....+|||.|+ |||++. ..|+|++|++ ++|++|..||.+.............+..
T Consensus 159 G~a~~~~~~~----~~~~~~gt~~y~---aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~ 231 (335)
T d2ozaa1 159 GFAKETTSHN----SLTTPCYTPYYV---APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 231 (335)
T ss_dssp TTCEECCCCC----CCCCCSCCCSSC---CCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS
T ss_pred ceeeeccCCC----ccccccCCcccC---CcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc
Confidence 9998754322 233468999999 899864 3688999965 5699999999763211100001111222
Q ss_pred hccCCCCc-cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 261 LQLEWPED-EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 261 ~~~~~P~~-~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
....+|.. ...+|+++++||++||+.||++|||++|+++||||.+
T Consensus 232 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 23334421 2468999999999999999999999999999999964
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-48 Score=379.53 Aligned_cols=256 Identities=21% Similarity=0.319 Sum_probs=202.2
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+++|+++++||+|+||+||+|+++ +++.||||++++... .....+++.+|+.+|+.++|||||+++++|.+++.+|+
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence 579999999999999999999875 468999999987643 33446789999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
+|||+.++.+..+.+..+.+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|........
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC-CCEEecccccceecccCcc-
Confidence 99999888887777778899999999999999999999999999999999999999999 9999999999998644322
Q ss_pred cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhH---------hhhcCCCCChhh-----
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSA---------LRVAGSQIPTST----- 257 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~---------~~~~~~~~~~~~----- 257 (473)
......|++.|+ +||.+. ..|.|++|++ ++|++|..||... ....+.......
T Consensus 156 --~~~~~~~~~~y~---~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 --KYTHEIVTLWYR---APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTC---CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceecccchhh---hHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 122345778777 888653 3577899965 5799999999642 111111100000
Q ss_pred Hh--------hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 258 AA--------QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 258 ~~--------~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
.. .....++.....++++++|||++||+.||++|||++|+++||||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 00 0011112223578999999999999999999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-47 Score=381.11 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=200.3
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe--CC
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQT--SS 115 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~--~~ 115 (473)
+.++|+++++||+|+||+||+|+++. +++.||||++++.. .+++.+|+++|+.+ .||||++++++|.. ..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 45789999999999999999999887 68999999997642 35788999999999 59999999999985 45
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
.+|+|||||.+|+|..+. +.+++..++.++.||+.||+|||++|||||||||+|||++.+++.+||+|||+|+....
T Consensus 106 ~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp SEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 799999999999997663 47999999999999999999999999999999999999997746799999999987543
Q ss_pred CccccccccccCCCCcccccCCcccccc-------CCcCCCCcc-ccccCCCCCchhHhh----------hcC-------
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLLS-------LKTGTFPTF-QDVQNSQAPFPSALR----------VAG------- 250 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~~-------~~~~s~g~l-~~~~~g~~pf~~~~~----------~~~------- 250 (473)
... ....+||+.|+ |||.+.. .|.|++|++ +++++|..||..... ..+
T Consensus 183 ~~~----~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 183 GQE----YNVRVASRYFK---GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp TCC----CCSCCSCGGGC---CHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred CCc----ccccccCcccc---CcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 322 23457888887 8987543 467888865 579999999853100 000
Q ss_pred -----CCCChhhHh---------hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 251 -----SQIPTSTAA---------QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 251 -----~~~~~~~~~---------~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
......... ............++++++|||++||+.||++|||++|+++||||+++.|+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 328 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCCC
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 000000000 00011111225689999999999999999999999999999999999996
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=378.04 Aligned_cols=260 Identities=21% Similarity=0.250 Sum_probs=200.2
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCCeeeEEEEEEe----
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT---HSPFCVQLFYSLQT---- 113 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~~---- 113 (473)
++|++++.||+|+||+||+|+++.++++.||||++++.... ......+.+|+++|+.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 68999999999999999999987656788999999875422 22233566777777655 89999999999863
Q ss_pred -CCEEEEEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhh
Q psy622 114 -SSCVFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLA 191 (473)
Q Consensus 114 -~~~l~lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~ 191 (473)
...+|++|||+.||++...... ...+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~-~~~kl~dfg~~~ 164 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLAR 164 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCCSCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC-CCeeecchhhhh
Confidence 3579999999988777655443 3579999999999999999999999999999999999999999 999999999998
Q ss_pred hhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCCh
Q psy622 192 ILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPT 255 (473)
Q Consensus 192 ~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~ 255 (473)
..... ......+||+.|+ |||++. ..|+||+|++ ++|++|..||.... ...+.....
T Consensus 165 ~~~~~----~~~~~~~gT~~Y~---APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 165 IYSFQ----MALTSVVVTLWYR---APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCCGG----GGGCCCCCCCTTC---CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhccc----ccCCCcccChhhc---CcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 64322 2234568999998 999764 4678899965 57999999996421 111110000
Q ss_pred ----------hhHh-hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 256 ----------STAA-QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 256 ----------~~~~-~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
.... ......+.....+++++++||.+||+.||++|||++|+++||||+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence 0000 00001111235789999999999999999999999999999999999763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=368.03 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=204.6
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 119 (473)
+++|++++.||+|+||+||+|+++. +++.||||++++.. .......++++|+.+|+.++||||+++++++.+...+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~-~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i 78 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECC-CCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence 4789999999999999999999887 67999999998764 344567789999999999999999999999999999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
|++++.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+|||++.+ +.+||+|||.|+........
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSCCSC
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC-CceeeeecchhhcccCCCcc
Confidence 99999999999999988899999999999999999999999999999999999999998 99999999999875432211
Q ss_pred cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhH----------hhhcCCCCChh----h
Q psy622 200 LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSA----------LRVAGSQIPTS----T 257 (473)
Q Consensus 200 ~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~----------~~~~~~~~~~~----~ 257 (473)
.....+++.|. +||.+. ..|.|++|++ ++|++|..||... ........... .
T Consensus 158 ---~~~~~~~~~~~---~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 158 ---YSAEVVTLWYR---PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp ---CCSCCSCGGGC---CHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred ---ceeeccccchh---hhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 11223444444 666542 3678899965 5799999987320 00000000000 0
Q ss_pred H---------hhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 258 A---------AQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 258 ~---------~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
. .............+++++++||++||+.||++||||+|+++||||+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 0 000111122235789999999999999999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=378.78 Aligned_cols=256 Identities=19% Similarity=0.252 Sum_probs=198.6
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS---- 115 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~---- 115 (473)
-++|++++.||+|+||+||+|+++. +|+.||||++++.. ......+++.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETT-TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 4689999999999999999999887 68999999998753 34556778999999999999999999999998654
Q ss_pred --EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 116 --CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 116 --~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
++|+||||+ |++|..+++. +.+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQA 171 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred cceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc-cccccccccceecc
Confidence 589999999 7788887765 579999999999999999999999999999999999999999 99999999999875
Q ss_pred cCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhhh--------cCCCCChhh
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALRV--------AGSQIPTST 257 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~~--------~~~~~~~~~ 257 (473)
... .+...||+.|+ |||++. ..|+|++|++ ++|++|..||...... .....+...
T Consensus 172 ~~~------~~~~~~t~~y~---aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 172 DSE------MTGYVVTRWYR---APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CSS------CCSSCSCGGGC---CTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCc------ccccccccccc---CHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 432 12357888887 898753 4677899965 5799999999642100 000011100
Q ss_pred Hh-----------h-----hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcc
Q psy622 258 AA-----------Q-----LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWD 309 (473)
Q Consensus 258 ~~-----------~-----~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~ 309 (473)
.. . ....++.....+++++++||.+||+.||.+|||++|+++||||+++.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 00 0 0111222235789999999999999999999999999999999988754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-47 Score=370.71 Aligned_cols=252 Identities=21% Similarity=0.324 Sum_probs=195.5
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----E
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS----C 116 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----~ 116 (473)
++|++.+.||+|+||+||+|+++. +++.||||++++.........+++.+|+++|+.++||||+++++++.+.. .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLR-LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECC-CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 569999999999999999999887 68999999999876666666778999999999999999999999997653 4
Q ss_pred EEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 117 VFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|+|||||+||+|..++...+.+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.++|+|||.++.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-SCEEECCCTTCEECC--
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcc-ccceeehhhhhhhhccc
Confidence 89999999999999999998999999999999999999999999999999999999999999 99999999998865443
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCC-Cc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWP-ED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P-~~ 268 (473)
..........+|||.|+ |||++. ..|.|++|++ ++|++|..||....... .. ..........| ..
T Consensus 165 ~~~~~~~~~~~Gt~~Y~---aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~-~~~~~~~~~~~~~~ 237 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYL---SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---VA-YQHVREDPIPPSAR 237 (277)
T ss_dssp --------------TTC---CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH-HHHHHCCCCCGGGT
T ss_pred cccccccccccCccccc---CHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH---HH-HHHHhcCCCCCchh
Confidence 33333345568999999 899764 4678899965 67999999997421100 00 00111111111 11
Q ss_pred cccCChhHHHHHHhccccCCCCCC-CHHHHhcCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRP-SGHQVRRLPM 302 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRp-sa~eil~HPF 302 (473)
...+|+++++||.+||++||.+|| ++++++ |+|
T Consensus 238 ~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l 271 (277)
T d1o6ya_ 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMR-ADL 271 (277)
T ss_dssp SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHH
T ss_pred ccCCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHH
Confidence 257899999999999999999999 566665 443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=368.12 Aligned_cols=247 Identities=18% Similarity=0.254 Sum_probs=195.1
Q ss_pred ceecccCceEEEEEEEeC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEecccC
Q psy622 47 KAISRGAFGKVFLGYKKT-NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVFLVMEYMI 125 (473)
Q Consensus 47 ~~LG~G~fG~V~~a~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 125 (473)
++||+|+||+||+|..+. .+++.||||+++... ......+.+++|+++|++++|||||+++++++++ ..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 479999999999998654 345789999997654 3344567899999999999999999999999754 5789999999
Q ss_pred cCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccccccccc
Q psy622 126 GGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDL 205 (473)
Q Consensus 126 gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~ 205 (473)
||+|.+++.+.+.+++..+..++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++.+............
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc-Ccccccchhhhhhccccccccccccc
Confidence 99999999998899999999999999999999999999999999999999999 99999999999876544333333445
Q ss_pred cCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCCccccCChhH
Q psy622 206 VNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPEDEEALNPST 276 (473)
Q Consensus 206 ~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~~~~ls~~a 276 (473)
..||+.|+ |||.+. ..|+|++|++ +++++ |..||.+..... + ...+.. .....| ..+++++
T Consensus 170 ~~gt~~y~---APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~-~~~i~~~~~~~~p---~~~~~~~ 239 (277)
T d1xbba_ 170 GKWPVKWY---APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V-TAMLEKGERMGCP---AGCPREM 239 (277)
T ss_dssp -CCCGGGC---CHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H-HHHHHTTCCCCCC---TTCCHHH
T ss_pred cCCCceec---CchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---H-HHHHHcCCCCCCC---cccCHHH
Confidence 57888888 999763 5788999975 56776 899997521100 0 011111 223334 6899999
Q ss_pred HHHHHhccccCCCCCCCHHHH---hcCCCCCCC
Q psy622 277 EETILALLKSDPTQRPSGHQV---RRLPMFKDY 306 (473)
Q Consensus 277 ~dLI~~LL~~dP~kRpsa~ei---l~HPFF~~i 306 (473)
++||.+||+.||++|||+++| ++|+|+.-+
T Consensus 240 ~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 999999999999999999887 467766433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=373.40 Aligned_cols=257 Identities=20% Similarity=0.306 Sum_probs=198.1
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS----- 115 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----- 115 (473)
++|++++.||+|+||+||+|+++. +++.||||++++.. .....+++++|+.+|+.++||||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETT-TCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECC-CCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 469999999999999999999886 68999999998753 3455678999999999999999999999997543
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
++|++++ +.||+|.+++... .+++..++.++.||+.||+|||++|||||||||+||||+.+ +++||+|||+++....
T Consensus 85 ~~~l~~~-~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 85 DVYLVTH-LMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADP 161 (345)
T ss_dssp CEEEEEE-CCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCG
T ss_pred eEEEEEe-ecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC-CCEEEcccCceeeccC
Confidence 4566655 5599999999864 79999999999999999999999999999999999999998 9999999999987644
Q ss_pred CccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHhh---------hcCCCCChh--
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSALR---------VAGSQIPTS-- 256 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~~---------~~~~~~~~~-- 256 (473)
...........+||+.|+ |||++. ..|.|++|++ ++|++|..||..... .........
T Consensus 162 ~~~~~~~~~~~~gt~~y~---aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYR---APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp GGCBCCTTCCCCSCGGGC---CGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred CCccceeeccccccceec---hHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 333333344567888888 898753 3578899965 579999999964210 000000000
Q ss_pred -----hHhh--------hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 257 -----TAAQ--------LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 257 -----~~~~--------~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.... ....+......+|+++++||.+||+.||.+|||++|+++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0000 0011111124688999999999999999999999999999999854
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=363.51 Aligned_cols=251 Identities=20% Similarity=0.266 Sum_probs=201.1
Q ss_pred CCCeEEEce-ecccCceEEEEEEEeCC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 40 ISDFEIVKA-ISRGAFGKVFLGYKKTN-KDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 40 ~~~y~i~~~-LG~G~fG~V~~a~~~~~-~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
.++|.+.+. ||+|+||+||+|.++.. ++..||||++++.. .+...+.+++|+++|++++|||||+++++++++ .+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-AL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eE
Confidence 467888885 99999999999977542 34579999998653 345567899999999999999999999999754 58
Q ss_pred EEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+.+ +.+||+|||+++.+...
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC-Cceeeccchhhhccccc
Confidence 9999999999999998654 579999999999999999999999999999999999999999 99999999999987554
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPE 267 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~ 267 (473)
..........+||+.|+ |||++. ..|+|++|++ +++++ |..||.+.... .+ ...+.. .....|
T Consensus 163 ~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~-~~~i~~~~~~~~p- 234 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWY---APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EV-MAFIEQGKRMECP- 234 (285)
T ss_dssp SCEECCCCSSCCCGGGC---CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HH-HHHHHTTCCCCCC-
T ss_pred ccccccccccccCcccc---ChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HH-HHHHHcCCCCCCC-
Confidence 44334444567888888 999764 4688999975 56776 89999752110 00 011111 122333
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHH---hcCCCCC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQV---RRLPMFK 304 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~ei---l~HPFF~ 304 (473)
..+++++.+||.+||+.||++||++.+| ++|+|++
T Consensus 235 --~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 235 --PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp --TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 6899999999999999999999998776 5677763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-46 Score=366.70 Aligned_cols=245 Identities=18% Similarity=0.262 Sum_probs=196.4
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+..++|++.+.||+|+||+||+|+++. +++.||||++++... ..+++++|+++|+.++|||||++++++.+++.+
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGG-GTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECC-CCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 445789999999999999999999886 578999999987532 345789999999999999999999999999999
Q ss_pred EEEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 118 FLVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
|+|||||++|+|..+|.+. ..+++..++.++.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+....
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTG 167 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCCTTTCCS
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC-CcEEEccccceeecCC
Confidence 9999999999999999864 478999999999999999999999999999999999999999 9999999999997543
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHh-hhccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAA-QLQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~P~ 267 (473)
.... ......|++.|+ |||++. ..|+|++|++ ++|++|..||....... .....+. ......|
T Consensus 168 ~~~~--~~~~~~g~~~y~---aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~---~~~~~i~~~~~~~~~- 238 (287)
T d1opja_ 168 DTYT--AHAGAKFPIKWT---APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEKDYRMERP- 238 (287)
T ss_dssp SSSE--EETTEEECGGGC---CHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHTTCCCCCC-
T ss_pred CCce--eecccccccccc---ChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH---HHHHHHhcCCCCCCC-
Confidence 2221 112223555555 999764 4788999965 56888766654311000 0001111 1122333
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..+++++++||.+||+.||++|||++||++
T Consensus 239 --~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 239 --EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --ccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 689999999999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=370.64 Aligned_cols=247 Identities=17% Similarity=0.238 Sum_probs=197.4
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKD----QLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQ 112 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~----~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~ 112 (473)
+..++|++.++||+|+||+||+|+++.... ..||+|++.+.. .......+.+|+.+|.++ +|||||++++++.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 345789999999999999999999876322 369999987653 233355789999999998 8999999999999
Q ss_pred eCCEEEEEecccCcCCHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAAN-----------------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLK 169 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~-----------------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLK 169 (473)
+.+.+|+|||||+||+|.++|++. +.+++..++.|+.||+.||+|||++||||||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 999999999999999999999764 248999999999999999999999999999999
Q ss_pred CcceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCC
Q psy622 170 PDNMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAP 241 (473)
Q Consensus 170 peNILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~p 241 (473)
|+|||++.+ +++||+|||+|+........ .......||+.|+ |||++. ..|+|++|++ ++|++ |..|
T Consensus 192 p~Nill~~~-~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~---aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 192 ARNVLVTHG-KVVKICDFGLARDIMSDSNY-VVRGNARLPVKWM---APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp GGGEEEETT-TEEEECCCGGGSCGGGCTTS-EEETTEEECGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred hhccccccC-CeEEEeeccccccccCCCce-eeeccccCCCccC---ChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 999999999 99999999999875443222 2233456888888 999764 3688999976 56886 8999
Q ss_pred chhHhhhcCCCCChh--hHhh--hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 242 FPSALRVAGSQIPTS--TAAQ--LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 242 f~~~~~~~~~~~~~~--~~~~--~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
|.+.. .... .+.. ..+..| ..+++++++||.+||+.||++|||++||++|
T Consensus 267 f~~~~------~~~~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 267 YPGIP------VDANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp STTCC------CSHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCC------HHHHHHHHHhcCCCCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 97521 1111 1111 122333 6899999999999999999999999999876
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=374.48 Aligned_cols=254 Identities=21% Similarity=0.264 Sum_probs=194.5
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT--- 113 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--- 113 (473)
.+...+|+.+++||+|+||+||+|+++. +++.||||++++... ...+|+++|+.++||||++++++|..
T Consensus 16 ~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp CCEEEEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcccCCcEeeeEEeeCcCeEEEEEEECC-CCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 3434479999999999999999999887 689999999987642 22469999999999999999999853
Q ss_pred ---CCEEEEEecccCcCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeec
Q psy622 114 ---SSCVFLVMEYMIGGDVKSLI---AANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNT 187 (473)
Q Consensus 114 ---~~~l~lVmEy~~gg~L~~~L---~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DF 187 (473)
..++|+|||||++|.+..+. .....+++.+++.++.||+.||+|||++||+||||||+|||++.++..+||+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DF 167 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 167 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecc
Confidence 34689999999766443333 345579999999999999999999999999999999999999987458999999
Q ss_pred chhhhhcCCccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHh---------hhcC
Q psy622 188 LFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSAL---------RVAG 250 (473)
Q Consensus 188 Gla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~ 250 (473)
|+++.+.... .....+||+.|+ |||.+. ..|+|++|++ ++|++|..||.... +..+
T Consensus 168 G~a~~~~~~~----~~~~~~gt~~y~---aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g 240 (350)
T d1q5ka_ 168 GSAKQLVRGE----PNVSYICSRYYR---APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240 (350)
T ss_dssp TTCEECCTTS----CCCSCCSCTTSC---CHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred cchhhccCCc----cccccccccccc---ChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9998754322 123357888887 888654 3577899965 57999999996421 1111
Q ss_pred CCCChhhHhh-----hccCCCC---------ccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 251 SQIPTSTAAQ-----LQLEWPE---------DEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 251 ~~~~~~~~~~-----~~~~~P~---------~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
... ...... ....++. ....+++++.+||.+||+.||++|||++|+++||||+++
T Consensus 241 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 241 TPT-REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CCC-HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred CCh-HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 111 111100 0111110 113689999999999999999999999999999999866
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=370.07 Aligned_cols=261 Identities=20% Similarity=0.200 Sum_probs=196.7
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT----- 113 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~----- 113 (473)
.+++|++++.||+|+||+||+|+++. +|+.||||++.+... ......++.+|+++|+.++||||+++++++.+
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRK-TGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 37899999999999999999999886 689999999987643 23345678999999999999999999999865
Q ss_pred ---CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchh
Q psy622 114 ---SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFL 190 (473)
Q Consensus 114 ---~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla 190 (473)
+.++|+||||+.++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~-~~~kl~dfg~~ 164 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLA 164 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTC
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC-CcEEeeeccee
Confidence 45689999999888777666667789999999999999999999999999999999999999999 99999999999
Q ss_pred hhhcCCccc-cccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHh---------hhcCCC
Q psy622 191 AILQQPIVY-LEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQ 252 (473)
Q Consensus 191 ~~~~~~~~~-~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~ 252 (473)
+........ .......+||+.|+ |||++. ..|+|++|++ ++|++|+.||.+.. ...+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~---aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYR---PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGC---CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eecccccccccccccceecCHHHh---hHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 865432221 12233457888887 899754 3578899965 57999999996411 111110
Q ss_pred CChhh------HhhhccCCCCc----------cccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCC
Q psy622 253 IPTST------AAQLQLEWPED----------EEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKD 305 (473)
Q Consensus 253 ~~~~~------~~~~~~~~P~~----------~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~ 305 (473)
..... ........... ....+++++|||.+||+.||++|||++|+++||||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 00000 00000000000 0124788999999999999999999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=360.96 Aligned_cols=249 Identities=15% Similarity=0.138 Sum_probs=193.4
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+..++|++.+.||+|+||+||+|+.+ ..||||+++.... .....+.+.+|+.+|+.++|||||++++++ +...+
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~~~~ 78 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 78 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS----SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC----CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEE-eccEE
Confidence 34678999999999999999999643 3599999987643 344567899999999999999999999876 45678
Q ss_pred EEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+|||||+||+|.++|... +.+++..+..++.||+.||+|||++|||||||||+||||+.+ +++||+|||+|+.....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-SSEEECCCCCSCC----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC-CCEEEccccceeecccc
Confidence 9999999999999999865 579999999999999999999999999999999999999999 99999999999875433
Q ss_pred ccccccccccCCCCcccccCCccccc---------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhh--ccC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL---------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQL--QLE 264 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~---------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~ 264 (473)
... .......|||.|+ |||++. ..|+||+|++ ++|++|..||.+..... ......... ...
T Consensus 158 ~~~-~~~~~~~gt~~y~---APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 158 SGS-HQFEQLSGSILWM---APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFMVGRGYLSPD 230 (276)
T ss_dssp ---------CCCCGGGC---CHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHHTSCCCC
T ss_pred CCc-ccccccccCcccC---CHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHHHHHhcCCCCCc
Confidence 222 2233457999998 899763 2478899965 67999999997521000 000011111 111
Q ss_pred CCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 265 WPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 265 ~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.+..+..+++++++||.+||+.||++|||++||++|
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 122235789999999999999999999999999876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-46 Score=364.25 Aligned_cols=250 Identities=19% Similarity=0.236 Sum_probs=188.6
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~--~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
+..++|++.++||+|+||+||+|+++.+.+ ..||||++.... .....+.+.+|+++|++++|||||++++++.+++
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 456889999999999999999998876322 368899887653 3445678999999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 116 CVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
.+|+|||||+||+|.+++... +.+++.++..++.||+.||+|||++|||||||||+||||+.+ +++||+|||+++.+.
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLE 179 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC-CcEEECCcccceEcc
Confidence 999999999999999998874 579999999999999999999999999999999999999999 999999999999764
Q ss_pred CCcccccc--ccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hcc
Q psy622 195 QPIVYLEI--SDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQL 263 (473)
Q Consensus 195 ~~~~~~~~--~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~ 263 (473)
........ .....||+.|+ |||.+. ..|+|++|++ +++++ |..||....... +. ..+.. ...
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~---aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~-~~i~~~~~~ 252 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWT---APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VI-NAIEQDYRL 252 (299)
T ss_dssp ----------------CGGGS---CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH-HHHHTTCCC
T ss_pred CCCCcceeeecccccCCcccc---CHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HH-HHHHcCCCC
Confidence 43222111 11235677887 898754 3688999966 56886 899997521100 00 11111 122
Q ss_pred CCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..| ..+++++.+||.+||+.||++|||+.||+++
T Consensus 253 ~~~---~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 253 PPP---MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCC---ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 223 6799999999999999999999999887753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=354.68 Aligned_cols=243 Identities=19% Similarity=0.262 Sum_probs=187.0
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
+.++|++++.||+|+||+||+|+++. ++.||||++++... ..+.+.+|+++++.++|||||++++++.+++.+|
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~--~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETT--TEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECC--CCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 46789999999999999999998764 47899999987532 2347899999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 119 LVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+++......
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG-GCEEECSCC---------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC-CCeEecccchheeccCCC
Confidence 999999999999998765 468999999999999999999999999999999999999999 999999999998764332
Q ss_pred cccccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCC-CCCchhHhhhcCCCCChhhHhh-hccCCCCc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNS-QAPFPSALRVAGSQIPTSTAAQ-LQLEWPED 268 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g-~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~ 268 (473)
.. ......||+.|+ |||++.. .|+|++|++ ++++++ .+||...... .+. ..+.. .....|
T Consensus 156 ~~--~~~~~~gt~~y~---aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~-~~i~~~~~~~~p-- 224 (263)
T d1sm2a_ 156 YT--SSTGTKFPVKWA---SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVV-EDISTGFRLYKP-- 224 (263)
T ss_dssp -----------CTTSC---CHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHH-HHHHHTCCCCCC--
T ss_pred ce--eecceecCcccC---ChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHH-HHHHhcCCCCCc--
Confidence 21 122346788887 8997653 688999966 568875 5555421000 000 11111 122233
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..+++++.+||.+||+.||++|||++||++|
T Consensus 225 -~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 225 -RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -cccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 6789999999999999999999999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=357.85 Aligned_cols=247 Identities=17% Similarity=0.247 Sum_probs=195.3
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
..++|++++.||+|+||+||+|+++. ++.||||++++... ..+.+.+|+++|++++|||||++++++. ++.+|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~--~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~ 83 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNG--HTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT--TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECC--CCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeE
Confidence 34789999999999999999998763 57899999987532 2357899999999999999999999875 45679
Q ss_pred EEecccCcCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 119 LVMEYMIGGDVKSLIAAN--GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~--~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
+|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.+ +++||+|||+|+.+...
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDN 162 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECSSS
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc-cceeeccccceEEccCC
Confidence 999999999999977543 369999999999999999999999999999999999999999 99999999999976433
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhh-hccCCCCc
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQ-LQLEWPED 268 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~ 268 (473)
.. .......||+.|+ |||++. ..|+|++|++ ++|++|..|+.... ........ .....+..
T Consensus 163 ~~--~~~~~~~gt~~y~---APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~------~~~~~~~~i~~~~~~~~ 231 (272)
T d1qpca_ 163 EY--TAREGAKFPIKWT---APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVR 231 (272)
T ss_dssp CE--ECCTTCCCCTTTS---CHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHHHHTTCCCCC
T ss_pred cc--ccccccCCccccc---ChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC------CHHHHHHHHHhcCCCCC
Confidence 22 2223346788877 999764 3688999965 56888655543210 00011111 01111222
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhc--CCCCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRR--LPMFK 304 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~--HPFF~ 304 (473)
+..+++++.+||.+||+.||++|||++||++ |+||.
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 3689999999999999999999999999988 78875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=369.90 Aligned_cols=268 Identities=21% Similarity=0.287 Sum_probs=193.4
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe------
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT------ 113 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------ 113 (473)
+++|+++++||+|+||+||+|+++. +|+.||||++++.. .......++.+|+.+|+.++|||||+++++|..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~-t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETT-TTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCcCeEEEEEEECC-CCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 4789999999999999999999887 68999999998764 345556789999999999999999999999963
Q ss_pred CCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAIL 193 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~ 193 (473)
..++|+|||||.| ++.+.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+|++|||+++..
T Consensus 94 ~~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~-~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 94 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTA 169 (355)
T ss_dssp CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC----
T ss_pred CceeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc-cceeeechhhhhcc
Confidence 4789999999965 4555553 579999999999999999999999999999999999999999 99999999998875
Q ss_pred cCCccccccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCCh--
Q psy622 194 QQPIVYLEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPT-- 255 (473)
Q Consensus 194 ~~~~~~~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~-- 255 (473)
.... .....+||+.|+ |||++.+ .|.|++|++ +++++|.+||.+.. .......+.
T Consensus 170 ~~~~----~~~~~~~t~~y~---aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 170 GTSF----MMTPYVVTRYYR---APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ---------------CCTTC---CHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccc----cccccccccccc---ChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 4322 223457888887 9998653 577888965 57999999995311 001110000
Q ss_pred ----hhH---hhhcc--------------CCC---CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCCCcccc
Q psy622 256 ----STA---AQLQL--------------EWP---EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDYDWDSI 311 (473)
Q Consensus 256 ----~~~---~~~~~--------------~~P---~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~idw~~l 311 (473)
... ..... ..+ ......++++++||++||+.||++||||+||++||||+..-|...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~ 322 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAE 322 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHH
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCccc
Confidence 000 00000 000 001235788999999999999999999999999999997544433
Q ss_pred ccCCCCCcC
Q psy622 312 LDQEPPFVP 320 (473)
Q Consensus 312 ~~~~pPf~P 320 (473)
....||..+
T Consensus 323 ~~~~~~~~~ 331 (355)
T d2b1pa1 323 VEAPPPQIY 331 (355)
T ss_dssp HTCCCC---
T ss_pred ccCCCCCCC
Confidence 333455433
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=350.72 Aligned_cols=243 Identities=19% Similarity=0.218 Sum_probs=199.1
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 118 (473)
+.++|+++++||+|+||+||+|+.+ +++.||||++++.... .+.+++|+.+++.++||||+++++++.+++.+|
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~ 75 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET--TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence 4679999999999999999999975 4678999999986432 347899999999999999999999999999999
Q ss_pred EEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCc
Q psy622 119 LVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPI 197 (473)
Q Consensus 119 lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~ 197 (473)
+||||+++|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+++.+....
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT-CCEEECCCSSCCBCSSSS
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC-CcEEECcchhheeccCCC
Confidence 999999999999997754 579999999999999999999999999999999999999998 999999999998754432
Q ss_pred cccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCCc
Q psy622 198 VYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPED 268 (473)
Q Consensus 198 ~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~~ 268 (473)
.. ......||+.|+ |||.+. ..|+|++|++ ++|++ |..||....... + ...+.. .....|
T Consensus 155 ~~--~~~~~~~t~~y~---aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~-~~~i~~~~~~~~p-- 223 (258)
T d1k2pa_ 155 YT--SSVGSKFPVRWS---PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---T-AEHIAQGLRLYRP-- 223 (258)
T ss_dssp CC--CCCCSCCCGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---H-HHHHHTTCCCCCC--
T ss_pred ce--eecccCCCCCcC---CcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---H-HHHHHhCCCCCCc--
Confidence 22 122346777777 899764 4688999976 56876 899997532110 0 011111 122233
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..+++++++||.+||+.||++|||++||++|
T Consensus 224 -~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 224 -HLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -ccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 6889999999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=367.27 Aligned_cols=252 Identities=19% Similarity=0.274 Sum_probs=193.6
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----C
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTS-----S 115 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~-----~ 115 (473)
++|++++.||+|+||+||+|+++. +|+.||||++++.. ......+++.+|+++|+.++|||||+++++|... .
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETT-TTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCeEEEEEEecCCCeEEEEEEECC-CCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 679999999999999999999887 68999999998764 3344566899999999999999999999999643 2
Q ss_pred EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 116 CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
..++||+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+ |.+|++|||++.....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~-~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTDD 173 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCC----CCTG
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc-ccccccccchhcccCc
Confidence 34556667779999999865 579999999999999999999999999999999999999999 9999999999986432
Q ss_pred CccccccccccCCCCcccccCCccccc-------cCCcCCCCcc-ccccCCCCCchhHh---------hhcCCCCChhh-
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL-------SLKTGTFPTF-QDVQNSQAPFPSAL---------RVAGSQIPTST- 257 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~-------~~~~~s~g~l-~~~~~g~~pf~~~~---------~~~~~~~~~~~- 257 (473)
. .....||+.|+ |||+.. ..|.|++|++ ++|++|..||.+.. ..... .....
T Consensus 174 ~------~~~~~g~~~y~---apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~-~~~~~~ 243 (348)
T d2gfsa1 174 E------MTGYVATRWYR---APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT-PGAELL 243 (348)
T ss_dssp G------GSSSCHHHHTS---CHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCHHHH
T ss_pred c------ccccccccccc---CchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC-CChHHh
Confidence 1 22346777776 787643 4678899965 56999999996411 11110 00000
Q ss_pred -------Hh---hhccCCC-----CccccCChhHHHHHHhccccCCCCCCCHHHHhcCCCCCCC
Q psy622 258 -------AA---QLQLEWP-----EDEEALNPSTEETILALLKSDPTQRPSGHQVRRLPMFKDY 306 (473)
Q Consensus 258 -------~~---~~~~~~P-----~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~HPFF~~i 306 (473)
.. ......+ .....+++++++||++||+.||++|||++|+++||||+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00 0000111 1124689999999999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=352.59 Aligned_cols=252 Identities=16% Similarity=0.176 Sum_probs=190.4
Q ss_pred CCCCCCeEEEceecccCceEEEEEEEeCCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 37 APEISDFEIVKAISRGAFGKVFLGYKKTNKD---QLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 37 ~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~---~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
++..++|++.++||+|+||+||+|+.+.+.+ ..||||+++... .......+++|+++|+.++|||||++++++.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 3456789999999999999999998876432 479999997653 34445678999999999999999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
...+++|||||.+|++.+++... +.+++..+..++.||+.||+|||++|||||||||+||||+.+ +.+||+|||+++.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRV 159 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC---
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC-CeEEEcccchhhc
Confidence 99999999999999999988765 579999999999999999999999999999999999999999 9999999999998
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCC
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEW 265 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (473)
+..............||+.|+ |||++. ..|+|++|++ ++|+++..|+...... ..+............
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~---APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~~~~~~~ 234 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWT---APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAINDGFRLPT 234 (283)
T ss_dssp --------------CCCGGGS---CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCCCCC
T ss_pred ccCCCccceEeccCCCCcccc---CHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHHhccCCCCC
Confidence 654332222233346788888 999754 3688999965 5688865555431100 000000111112233
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
| ..+++++.+||.+||+.||++||++.||++
T Consensus 235 ~---~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 235 P---MDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp C---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred c---hhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 3 678999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-45 Score=353.07 Aligned_cols=258 Identities=17% Similarity=0.267 Sum_probs=196.9
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
+..++|++.+.||+|+||+||+|+++. ++.||||++++... ..+.+.+|+.++++++|||||++++++.+ +.+
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~--~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~ 86 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 86 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT--TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECC--CCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCe
Confidence 445899999999999999999998865 35799999986542 23578999999999999999999999854 568
Q ss_pred EEEecccCcCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 118 FLVMEYMIGGDVKSLIAA--NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~--~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
|+|||||++|+|..++.. .+.+++.++..++.||+.||+|||++||+||||||+||||+.+ +++||+|||+++....
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIED 165 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC-CcEEEcccchhhhccC
Confidence 999999999999988864 3579999999999999999999999999999999999999999 9999999999987543
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCc
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPED 268 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~ 268 (473)
... .......||+.|+ |||++. ..|+|++|++ +++++|..|+...... ..+............|
T Consensus 166 ~~~--~~~~~~~gt~~y~---aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~~~~~~~~-- 236 (285)
T d1fmka3 166 NEY--TARQGAKFPIKWT---APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYRMPCP-- 236 (285)
T ss_dssp ------------CCGGGS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCCCC--
T ss_pred CCc--eeecccccccccc---ChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHhcCCCCCC--
Confidence 222 1223356888888 898764 4678999965 5688865555431100 0000000011122233
Q ss_pred cccCChhHHHHHHhccccCCCCCCCHHHHhc--CCCCCCCCccccccCCCCCcCC
Q psy622 269 EEALNPSTEETILALLKSDPTQRPSGHQVRR--LPMFKDYDWDSILDQEPPFVPQ 321 (473)
Q Consensus 269 ~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~--HPFF~~idw~~l~~~~pPf~P~ 321 (473)
..+++++++||.+||+.||++||++++|++ |+||+.. .|++.|.
T Consensus 237 -~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~--------~p~~~p~ 282 (285)
T d1fmka3 237 -PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST--------EPQYQPG 282 (285)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS--------CCCCCCS
T ss_pred -cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC--------CCCCCCC
Confidence 689999999999999999999999999988 8899753 4666664
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=352.33 Aligned_cols=251 Identities=19% Similarity=0.199 Sum_probs=188.7
Q ss_pred CCCCeEEEceecccCceEEEEEEEeCCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q psy622 39 EISDFEIVKAISRGAFGKVFLGYKKTNKDQ--LYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSC 116 (473)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~--~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 116 (473)
+.++|++++.||+|+||+||+|+.+..+++ .||||++++.........+.+.+|+.+|++++|||||++++++.+ ..
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 457899999999999999999987754443 689999998766566667789999999999999999999999976 46
Q ss_pred EEEEecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcC
Q psy622 117 VFLVMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQ 195 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~ 195 (473)
+|+|||||++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++.+..
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~-~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQ 163 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEECCC
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc-cceeeccchhhhhccc
Confidence 7899999999999988765 4579999999999999999999999999999999999999999 9999999999998654
Q ss_pred CccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhhhccCCCC
Q psy622 196 PIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQLQLEWPE 267 (473)
Q Consensus 196 ~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~ 267 (473)
............|++.|+ |||.+. ..|+|++|++ ++|++ |..||.+..... ....+...... +.
T Consensus 164 ~~~~~~~~~~~~~~~~~~---aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~----~~~~i~~~~~~-~~ 235 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWC---APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGER-LP 235 (273)
T ss_dssp -CCEEEC-----CCGGGC---CHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTSCCC-CC
T ss_pred CCCcceecCccccCcccC---CHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH----HHHHHHhCCCC-CC
Confidence 433333344455666776 898753 4789999965 67887 899997521110 00111111112 22
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
.+..+++++++||.+||+.||++|||++||++
T Consensus 236 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 23678999999999999999999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=349.54 Aligned_cols=245 Identities=19% Similarity=0.259 Sum_probs=186.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTNK--DQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSSCV 117 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~~--~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 117 (473)
.++|++.+.||+|+||+||+|+++.+. +..||||+++... .....+.+.+|+.+|+.++|||||++++++. .+.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 468999999999999999999876532 3568888886542 3455678999999999999999999999995 5679
Q ss_pred EEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCC
Q psy622 118 FLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQP 196 (473)
Q Consensus 118 ~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~ 196 (473)
|+||||+++|+|..++... +.+++..++.++.||+.||+|||++|||||||||+||+++.+ +.+||+|||+|+.+...
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC-CcEEEccchhheeccCC
Confidence 9999999999999987764 579999999999999999999999999999999999999999 99999999999875432
Q ss_pred ccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hccCCCC
Q psy622 197 IVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQLEWPE 267 (473)
Q Consensus 197 ~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~P~ 267 (473)
.. .......||+.|+ |||++. ..|.|++|++ ++|++ |.+||...... .+. ..+.. .....|
T Consensus 162 ~~--~~~~~~~gt~~y~---apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~-~~i~~~~~~~~~- 231 (273)
T d1mp8a_ 162 TY--YKASKGKLPIKWM---APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI-GRIENGERLPMP- 231 (273)
T ss_dssp -----------CCGGGC---CHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHH-HHHHTTCCCCCC-
T ss_pred cc--eeccceecCcccc---hhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHH-HHHHcCCCCCCC-
Confidence 22 2233456888888 898764 4688999965 56776 89998752110 000 11111 122333
Q ss_pred ccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 268 DEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 268 ~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..+++++++||.+||+.||++|||++||++|
T Consensus 232 --~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 232 --PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 6899999999999999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=352.71 Aligned_cols=247 Identities=17% Similarity=0.227 Sum_probs=191.5
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQ----LYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~----~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
++.++|+++++||+|+||+||+|+++. +|+ .||+|+++... .....+.+++|+++|++++|||||++++++.+
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~-~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 82 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcC-CCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 445789999999999999999998876 343 58888887542 23346689999999999999999999999986
Q ss_pred CCEEEEEecccCcCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN-GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~-~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
+ ..+++|||+.+|+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +++||+|||+++.
T Consensus 83 ~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~-~~~kl~DFGla~~ 160 (317)
T d1xkka_ 83 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKL 160 (317)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCCSHHHH
T ss_pred C-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC-CCeEeecccccee
Confidence 5 567888899999999888764 579999999999999999999999999999999999999999 9999999999998
Q ss_pred hcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHhh-hcc
Q psy622 193 LQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAAQ-LQL 263 (473)
Q Consensus 193 ~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~ 263 (473)
+...... .......||+.|+ |||++. ..|+|++|++ ++|++ |..||.+.... .+ ...+.. ..+
T Consensus 161 ~~~~~~~-~~~~~~~gt~~y~---APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~-~~~i~~~~~~ 232 (317)
T d1xkka_ 161 LGAEEKE-YHAEGGKVPIKWM---ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI-SSILEKGERL 232 (317)
T ss_dssp TTTTCC---------CCTTTS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GH-HHHHHHTCCC
T ss_pred ccccccc-ccccccccCcccc---ChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HH-HHHHHcCCCC
Confidence 6543322 1222345788888 999753 4688999976 56887 78888642110 00 111111 223
Q ss_pred CCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
..| ..+++++.+||.+||+.||.+|||+.||++|
T Consensus 233 ~~p---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 PQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC---cccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 333 6899999999999999999999999999988
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-43 Score=348.49 Aligned_cols=247 Identities=19% Similarity=0.226 Sum_probs=197.4
Q ss_pred CCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQTSS 115 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 115 (473)
.++|++++.||+|+||+||+|+.+. .+++.||||++++.. .....+++.+|+++|+.++||||+++++++.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 4689999999999999999998874 245789999998653 3445678999999999999999999999999999
Q ss_pred EEEEEecccCcCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCc
Q psy622 116 CVFLVMEYMIGGDVKSLIAANG------------------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPD 171 (473)
Q Consensus 116 ~l~lVmEy~~gg~L~~~L~~~~------------------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpe 171 (473)
.+++||||+++|+|.++|...+ .+++..+..++.||+.||+|||++|||||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999997532 3889999999999999999999999999999999
Q ss_pred ceEecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCC-CCch
Q psy622 172 NMLISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQ-APFP 243 (473)
Q Consensus 172 NILld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~-~pf~ 243 (473)
|||+|.+ +++||+|||+|+.+...... ......+||+.|+ |||.+. ..|+|++|++ ++|+++. +||.
T Consensus 170 NILld~~-~~~Kl~DFGls~~~~~~~~~-~~~~~~~~~~~y~---aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 170 NCLVGEN-MVVKIADFGLSRNIYSADYY-KADGNDAIPIRWM---PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp GEEECGG-GCEEECCCSCHHHHTGGGCB-C----CCBCGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ceEECCC-CcEEEccchhheeccCCccc-cccCCCCcCcCcC---CHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 9999999 99999999999876443222 2233456778877 898754 4688999965 5687775 6776
Q ss_pred hHhhhcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 244 SALRVAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
...... +. ..+. ....+..+..+++++.+||.+||+.||++|||+.||++
T Consensus 245 ~~~~~e---~~-~~v~--~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 245 GMAHEE---VI-YYVR--DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TSCHHH---HH-HHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHH---HH-HHHH--cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 421100 00 1111 12233334689999999999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-44 Score=348.82 Aligned_cols=248 Identities=18% Similarity=0.252 Sum_probs=186.9
Q ss_pred CCCeEEEceecccCceEEEEEEEeCC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe-
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTN----KDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQT- 113 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~- 113 (473)
.++|++.+.||+|+||+||+|+++.. +++.||||++++.. .....+.+.+|..++.++ +||||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 47899999999999999999987642 34689999998653 234456788888888777 79999999998865
Q ss_pred CCEEEEEecccCcCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecC
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN----------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISA 177 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~----------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~ 177 (473)
+..+|+|||||+||+|.++|... ..+++.+++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 45799999999999999999753 24899999999999999999999999999999999999999
Q ss_pred CCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCC-CCCchhHhhhc
Q psy622 178 QAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNS-QAPFPSALRVA 249 (473)
Q Consensus 178 ~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g-~~pf~~~~~~~ 249 (473)
+ +++||+|||+|+........ .......||+.|+ |||++. ..|+|++|++ ++|+++ .+||...
T Consensus 170 ~-~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~---APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~---- 240 (299)
T d1ywna1 170 K-NVVKICDFGLARDIYKDPDY-VRKGDARLPLKWM---APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV---- 240 (299)
T ss_dssp G-GCEEECC------CCSCTTS-CCTTSCCCGGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----
T ss_pred C-CcEEEccCcchhhccccccc-cccCceeeCcccc---chhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC----
Confidence 9 99999999999875433222 2233457899988 999763 4688999976 568876 5677542
Q ss_pred CCCCChhhHhh-hccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 250 GSQIPTSTAAQ-LQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 250 ~~~~~~~~~~~-~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
......... .....+..+..+++++++||.+||+.||++|||++||++|
T Consensus 241 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 241 --KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp --CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 111111110 1111222336899999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=348.25 Aligned_cols=249 Identities=18% Similarity=0.214 Sum_probs=194.4
Q ss_pred CCCCCCCCeEEEceecccCceEEEEEEEeCCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q psy622 35 LKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQ--LYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSL 111 (473)
Q Consensus 35 ~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~--~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 111 (473)
.+.++.++|++.++||+|+||+||+|+++. ++. .||||++++.. .....+.+.+|+++|+.+ +|||||++++++
T Consensus 4 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 4 YPVLDWNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred CCccCHHHcEEEEEEeeCCCcEEEEEEECC-CCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 345677899999999999999999999886 444 47788876542 234456799999999998 799999999999
Q ss_pred EeCCEEEEEecccCcCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEe
Q psy622 112 QTSSCVFLVMEYMIGGDVKSLIAAN----------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLI 175 (473)
Q Consensus 112 ~~~~~l~lVmEy~~gg~L~~~L~~~----------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILl 175 (473)
.+++.+|+||||++||+|.++|++. ..+++..+..++.||+.||.|||++|||||||||+|||+
T Consensus 81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~ 160 (309)
T d1fvra_ 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 160 (309)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE
Confidence 9999999999999999999999754 579999999999999999999999999999999999999
Q ss_pred cCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCC-CCchhHhh
Q psy622 176 SAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQ-APFPSALR 247 (473)
Q Consensus 176 d~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~-~pf~~~~~ 247 (473)
+.+ +.+||+|||+++....... .....||+.|+ |||.+. ..|+|+||++ ++|++|. +||.....
T Consensus 161 ~~~-~~~kl~DfG~a~~~~~~~~----~~~~~gt~~y~---aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~ 232 (309)
T d1fvra_ 161 GEN-YVAKIADFGLSRGQEVYVK----KTMGRLPVRWM---AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232 (309)
T ss_dssp CGG-GCEEECCTTCEESSCEECC----C----CCTTTC---CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cCC-CceEEcccccccccccccc----ccceecCCccc---chHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence 999 9999999999986432211 22346788877 888753 5789999965 5688865 56653211
Q ss_pred hcCCCCChhhHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 248 VAGSQIPTSTAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
.. + ...+.+ ...+..+..+++++++||.+||+.||++|||++||++|
T Consensus 233 ~~---~-~~~i~~--~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 233 AE---L-YEKLPQ--GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HH---H-HHHGGG--TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HH---H-HHHHHh--cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 00 0 011111 11223336899999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=347.32 Aligned_cols=256 Identities=16% Similarity=0.211 Sum_probs=204.1
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT 113 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 113 (473)
+..++|++.+.||+|+||.||+|.++. .+++.||||++++.. .......+++|++++++++|||||++++++..
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 445899999999999999999998753 134689999998653 34456689999999999999999999999999
Q ss_pred CCEEEEEecccCcCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCcee
Q psy622 114 SSCVFLVMEYMIGGDVKSLIAAN----------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCP 183 (473)
Q Consensus 114 ~~~l~lVmEy~~gg~L~~~L~~~----------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ik 183 (473)
+..+++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.+ +++|
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~-~~~K 173 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK 173 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC-ceEE
Confidence 99999999999999999998642 247899999999999999999999999999999999999999 9999
Q ss_pred EeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCC-CCCchhHhhhcCCCCCh
Q psy622 184 IVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNS-QAPFPSALRVAGSQIPT 255 (473)
Q Consensus 184 L~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g-~~pf~~~~~~~~~~~~~ 255 (473)
|+|||+++.+...... ......+|||.|+ +||.+. ..++|++|++ ++|++| .+||..... .
T Consensus 174 l~DFGla~~~~~~~~~-~~~~~~~~t~~y~---aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-------~ 242 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYY-RKGGKGLLPVRWM---SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------E 242 (308)
T ss_dssp ECCTTCCCGGGGGGCE-EGGGSSEECGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------H
T ss_pred EeecccceeccCCcce-eeccceecccccC---CHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-------H
Confidence 9999999876543322 2233456889988 888754 4588899955 678877 567754211 0
Q ss_pred hhHh-hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc------CCCCCCCC
Q psy622 256 STAA-QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR------LPMFKDYD 307 (473)
Q Consensus 256 ~~~~-~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~------HPFF~~id 307 (473)
+... ......+..+..+++++.+||.+||+.||.+|||++||++ +|+|+.++
T Consensus 243 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301 (308)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred HHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCC
Confidence 1111 0122233334689999999999999999999999999987 66666544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-44 Score=342.05 Aligned_cols=238 Identities=21% Similarity=0.347 Sum_probs=185.0
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCCE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQ-TSSC 116 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-~~~~ 116 (473)
++.++|+++++||+|+||.||+|+.+ ++.||||++++.. ..+.+++|+++|++++||||+++++++. +.+.
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 75 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET---TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEEC---CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence 56789999999999999999999874 4689999997643 3457899999999999999999999884 4567
Q ss_pred EEEEecccCcCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhc
Q psy622 117 VFLVMEYMIGGDVKSLIAANG--ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQ 194 (473)
Q Consensus 117 l~lVmEy~~gg~L~~~L~~~~--~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~ 194 (473)
+|+||||+++|+|.++|.+.+ .+++..++.++.||+.||+|||+++|+||||||+|||++.+ +++||+|||+++...
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEAS 154 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC-----
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC-CCEeecccccceecC
Confidence 999999999999999997643 59999999999999999999999999999999999999999 999999999998754
Q ss_pred CCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHhhhcCCCCChhhHh-hhccCC
Q psy622 195 QPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSALRVAGSQIPTSTAA-QLQLEW 265 (473)
Q Consensus 195 ~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 265 (473)
... ....+++.|+ |||++. ..|+|+||++ ++|++ |.+||..... ..+ ...+. .....+
T Consensus 155 ~~~------~~~~~~~~y~---aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~-~~~i~~~~~~~~ 221 (262)
T d1byga_ 155 STQ------DTGKLPVKWT---APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDV-VPRVEKGYKMDA 221 (262)
T ss_dssp -------------CCTTTS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGH-HHHHTTTCCCCC
T ss_pred CCC------ccccccccCC---ChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHH-HHHHHcCCCCCC
Confidence 321 2345677776 888753 4688999974 67877 6887764211 000 01111 122333
Q ss_pred CCccccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 266 PEDEEALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 266 P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
| ..+++++++||.+||..||++|||+.|++++
T Consensus 222 ~---~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 222 P---DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---ccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 3 6899999999999999999999999888764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=340.59 Aligned_cols=248 Identities=17% Similarity=0.236 Sum_probs=199.0
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKT----NKDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQ 112 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~ 112 (473)
+..++|++.++||+|+||.||+|+.+. .+++.||||++++.. .......+.+|..+++.+ +|||||+++++++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 445799999999999999999998753 356789999998754 344566899999999998 7999999999999
Q ss_pred eCCEEEEEecccCcCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceE
Q psy622 113 TSSCVFLVMEYMIGGDVKSLIAANG------------------ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNML 174 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L~~~L~~~~------------------~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNIL 174 (473)
+...+|+|||||+||+|.++|.+.. .+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 9999999999999999999998643 5899999999999999999999999999999999999
Q ss_pred ecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHh
Q psy622 175 ISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSAL 246 (473)
Q Consensus 175 ld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~ 246 (473)
++.+ +.+||+|||+++........ ......+|||.|+ |||.+. ..|+|++|++ ++|++ |.+||...
T Consensus 178 ~~~~-~~~ki~DfG~~~~~~~~~~~-~~~~~~~gt~~y~---aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~- 251 (311)
T d1t46a_ 178 LTHG-RITKICDFGLARDIKNDSNY-VVKGNARLPVKWM---APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM- 251 (311)
T ss_dssp EETT-TEEEECCCGGGSCTTSCTTS-EECSSSEECGGGC---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-
T ss_pred cccc-CcccccccchheeccCCCcc-eEeeecccChHHc---CHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-
Confidence 9998 99999999999986543322 2334467899888 898654 4688899965 56887 55555431
Q ss_pred hhcCCCCChh--hHhhhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 247 RVAGSQIPTS--TAAQLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 247 ~~~~~~~~~~--~~~~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
..... .+..... .+..+..+++++.+||.+||+.||++|||++||++
T Consensus 252 -----~~~~~~~~~i~~~~-~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 252 -----PVDSKFYKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp -----CSSHHHHHHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CHHHHHHHHHhcCC-CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11111 1111111 12223578999999999999999999999999885
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=339.80 Aligned_cols=248 Identities=18% Similarity=0.249 Sum_probs=194.4
Q ss_pred CCCCCeEEEceecccCceEEEEEEEeCCC------CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEE
Q psy622 38 PEISDFEIVKAISRGAFGKVFLGYKKTNK------DQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYS 110 (473)
Q Consensus 38 ~~~~~y~i~~~LG~G~fG~V~~a~~~~~~------~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 110 (473)
+..++|++++.||+|+||.||+|+..... +..||||++++.. .......+.+|..++..+ +|||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 34589999999999999999999876521 2479999998763 344467889999999888 89999999999
Q ss_pred EEeCCEEEEEecccCcCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceE
Q psy622 111 LQTSSCVFLVMEYMIGGDVKSLIAAN----------------GALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNML 174 (473)
Q Consensus 111 f~~~~~l~lVmEy~~gg~L~~~L~~~----------------~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNIL 174 (473)
+.+++.+|+|||||++|+|.++|... ..+++.+++.++.||+.||+|||++|||||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 99999999999999999999999754 35899999999999999999999999999999999999
Q ss_pred ecCCCCceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccC-CCCCchhHh
Q psy622 175 ISAQAPHCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQN-SQAPFPSAL 246 (473)
Q Consensus 175 ld~~~g~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~-g~~pf~~~~ 246 (473)
++.+ +.+||+|||+++........ .......||+.|+ |||.+. ..|.|++|+. ++|++ |.+||....
T Consensus 168 l~~~-~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~---aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 168 VTED-NVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWM---APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp ECTT-CCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ecCC-CCeEeccchhhccccccccc-cccccCCCChhhh---hhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 9999 99999999999976543322 2233456888887 898764 4688999964 67886 788886421
Q ss_pred hhcCCCCChhhHh-hhccCCCCccccCChhHHHHHHhccccCCCCCCCHHHHhc
Q psy622 247 RVAGSQIPTSTAA-QLQLEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVRR 299 (473)
Q Consensus 247 ~~~~~~~~~~~~~-~~~~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil~ 299 (473)
... + ...+. ...+..| ..+++++++||.+||+.||.+|||+.||++
T Consensus 243 ~~~---~-~~~i~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEE---L-FKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHH---H-HHHHHTTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH---H-HHHHHcCCCCCCC---ccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 100 0 01111 1223333 689999999999999999999999999885
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=335.19 Aligned_cols=246 Identities=17% Similarity=0.158 Sum_probs=191.0
Q ss_pred EEEceecccCceEEEEEEEeCCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCEEEEE
Q psy622 44 EIVKAISRGAFGKVFLGYKKTNKD--QLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPFCVQLFYSLQT-SSCVFLV 120 (473)
Q Consensus 44 ~i~~~LG~G~fG~V~~a~~~~~~~--~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-~~~l~lV 120 (473)
.+.++||+|+||+||+|++..+.+ ..||||++++. ......+++.+|+++|++++||||+++++++.+ ++.+|+|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 346789999999999998765432 36899999753 345567889999999999999999999998765 5789999
Q ss_pred ecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeecchhhhhcCCccc
Q psy622 121 MEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNTLFLAILQQPIVY 199 (473)
Q Consensus 121 mEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DFGla~~~~~~~~~ 199 (473)
||||++|+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||||+++ +.+||+|||+++........
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTTCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-CCEEEecccchhhccccccc
Confidence 99999999999998654 67888999999999999999999999999999999999998 99999999999976433222
Q ss_pred c-ccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhccCCCCcccc
Q psy622 200 L-EISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQLEWPEDEEA 271 (473)
Q Consensus 200 ~-~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ 271 (473)
. .......||+.|+ |||.+. ..|.|+||++ +++++|..||...... ..+......... +..+..
T Consensus 187 ~~~~~~~~~gt~~y~---aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~~g~~---~~~p~~ 258 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWM---ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGRR---LLQPEY 258 (311)
T ss_dssp CTTCTTCSSCCGGGS---CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCC---CCCCTT
T ss_pred cceeccccccccccc---ChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCC---CCCccc
Confidence 1 1122235677776 898754 4578999965 6788887777642211 111111111122 233368
Q ss_pred CChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 272 LNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 272 ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
+++++.+||.+||+.||++||++.||++|
T Consensus 259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.6e-40 Score=329.45 Aligned_cols=272 Identities=18% Similarity=0.242 Sum_probs=197.4
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----------CCCeeeEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-----------SPFCVQLFY 109 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----------hp~Iv~l~~ 109 (473)
++|+++++||+|+||+||+|+++. +|+.||||++++.. ...+.+.+|+++|+.++ |+||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~-~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 469999999999999999999887 68999999998763 23456778888887764 588999998
Q ss_pred EEE--eCCEEEEEecccCcCCHH-HHHHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCCcceEecCCCC---
Q psy622 110 SLQ--TSSCVFLVMEYMIGGDVK-SLIAA--NGALPEDMAAFYAAEVVLALQYLHS-HGIIHRDLKPDNMLISAQAP--- 180 (473)
Q Consensus 110 ~f~--~~~~l~lVmEy~~gg~L~-~~L~~--~~~~~e~~~~~~~~qI~~aL~yLH~-~gIiHRDLKpeNILld~~~g--- 180 (473)
++. .....+++|+++..+... ..... ...+++..++.++.||+.||+|||+ +||+||||||+||||+.+ +
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~-~~~~ 166 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPE 166 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE-ETTT
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc-Cccc
Confidence 875 456677777665544433 33332 3579999999999999999999998 899999999999999876 4
Q ss_pred ---ceeEeecchhhhhcCCccccccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcC
Q psy622 181 ---HCPIVNTLFLAILQQPIVYLEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAG 250 (473)
Q Consensus 181 ---~ikL~DFGla~~~~~~~~~~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~ 250 (473)
.++|+|||.++..... ....+||+.|+ |||++. ..|.|++|+. ++|++|..||........
T Consensus 167 ~~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH------YTNSIQTREYR---SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp TEEEEEECCCTTCEETTBC------CCSCCSCGGGC---CHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccceeeEeecccccccccc------ccccccccccc---ChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 3899999999864322 23457899888 899754 3677889965 579999999964211000
Q ss_pred --------------CCCChhhHh------------------------------hhccCCCCccccCChhHHHHHHhcccc
Q psy622 251 --------------SQIPTSTAA------------------------------QLQLEWPEDEEALNPSTEETILALLKS 286 (473)
Q Consensus 251 --------------~~~~~~~~~------------------------------~~~~~~P~~~~~ls~~a~dLI~~LL~~ 286 (473)
...+..... .....+ ....++++++||.+||+.
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF---SKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCC---CHHHHHHHHHHHGGGGCS
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhccccccc---CcccCHHHHHHHHHHCCC
Confidence 001111000 001111 134678899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCCccccccCCCCCcCCCCCCCCCC-CCC
Q psy622 287 DPTQRPSGHQVRRLPMFKDYDWDSILDQEPPFVPQPDDVFDTS-YFH 332 (473)
Q Consensus 287 dP~kRpsa~eil~HPFF~~idw~~l~~~~pPf~P~~~~~~D~s-~Fd 332 (473)
||.+|||++|+++||||+++.+. .+...|..|...+..|.. +|+
T Consensus 315 dP~~Rpta~e~L~Hp~f~~~~~~--~~~~~p~~~~~~~~~~~~~~~~ 359 (362)
T d1q8ya_ 315 DPRKRADAGGLVNHPWLKDTLGM--EEIRVPDRELYGSGSDIPGWFE 359 (362)
T ss_dssp STTTCBCHHHHHTCGGGTTCTTC--TTCCCTTSCTTCBSTTSTTSSS
T ss_pred ChhHCcCHHHHhcCcccCCCCCc--ccCCCCCcccCCCCCCCCchhh
Confidence 99999999999999999976644 223567777776665643 443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-40 Score=321.62 Aligned_cols=252 Identities=15% Similarity=0.175 Sum_probs=189.1
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCCEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTHSPF-CVQLFYSLQTSSCVFL 119 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~~~~~l~l 119 (473)
++|++.+.||+|+||+||+|+++. +++.||||++..... ..++.+|.++++.++|++ |+.+.+++.+....++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECC-CCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 469999999999999999999876 579999999887532 125778999999997655 5666677788999999
Q ss_pred EecccCcCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC--CCceeEeecchhhhhcCC
Q psy622 120 VMEYMIGGDVKSLIAA-NGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ--APHCPIVNTLFLAILQQP 196 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~-~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~--~g~ikL~DFGla~~~~~~ 196 (473)
||||+ +|+|...+.. .+.+++..++.++.||+.||+|||++|||||||||+|||++.. +..+||+|||+|+.+...
T Consensus 81 vme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99999 6666666654 5689999999999999999999999999999999999998643 257999999999986443
Q ss_pred ccc----cccccccCCCCcccccCCccccc------cCCcCCCCcc-ccccCCCCCchhHhhhcCCCCChhhHhhhc--c
Q psy622 197 IVY----LEISDLVNGTPNAFNIRTPGQLL------SLKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTSTAAQLQ--L 263 (473)
Q Consensus 197 ~~~----~~~~~~~~gtp~y~~~~ape~i~------~~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~--~ 263 (473)
... ........||+.|+ |||.+. ..|.|++|++ ++|++|..||........... ........ .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-~~~~~~~~~~~ 235 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYA---SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMST 235 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSC---CHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHHS
T ss_pred ccccceeccccCCcCCCcccc---CHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-HHHhhcccCCC
Confidence 221 12234567999998 898754 3577899965 679999999975321110000 00111111 1
Q ss_pred CCCCccccCChhHHHHHHhccccCCCCCCCHH---HHhcCCCC
Q psy622 264 EWPEDEEALNPSTEETILALLKSDPTQRPSGH---QVRRLPMF 303 (473)
Q Consensus 264 ~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~---eil~HPFF 303 (473)
..+.....+|+++.+||.+||+.||++||+++ ++++|+|.
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 11122257899999999999999999999976 45667654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-40 Score=320.53 Aligned_cols=246 Identities=15% Similarity=0.169 Sum_probs=181.7
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHH--HhcCCCCeeeEEEEEEeCC---
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNAL--ALTHSPFCVQLFYSLQTSS--- 115 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL--~~l~hp~Iv~l~~~f~~~~--- 115 (473)
.+|.+.+.||+|+||.||+|+. +|+.||||+++... .....+|.+++ ..++|||||++++++.+..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE---TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 4789999999999999999975 35899999987542 23444455544 5679999999999997643
Q ss_pred -EEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCeeecCCCCcceEecCCCCceeEee
Q psy622 116 -CVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS--------HGIIHRDLKPDNMLISAQAPHCPIVN 186 (473)
Q Consensus 116 -~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~--------~gIiHRDLKpeNILld~~~g~ikL~D 186 (473)
.+|+|||||++|+|..+|++. .+++.....++.|++.||+|||+ +|||||||||+||||+.+ +++||+|
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~D 151 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIAD 151 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECC
T ss_pred eEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEe
Confidence 699999999999999999875 68999999999999999999996 599999999999999999 9999999
Q ss_pred cchhhhhcCCccccc-cccccCCCCcccccCCccccc------------cCCcCCCCcc-ccccCCCCCchhHhhhc---
Q psy622 187 TLFLAILQQPIVYLE-ISDLVNGTPNAFNIRTPGQLL------------SLKTGTFPTF-QDVQNSQAPFPSALRVA--- 249 (473)
Q Consensus 187 FGla~~~~~~~~~~~-~~~~~~gtp~y~~~~ape~i~------------~~~~~s~g~l-~~~~~g~~pf~~~~~~~--- 249 (473)
||+++.......... ......||+.|+ |||++. ..|.|++|+. +++++|..||.......
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~---aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYM---APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGC---CHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred cCccccccCCCcceeccccceecccCcC---ChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 999997644332222 233467999988 899754 2588999965 67899887764311000
Q ss_pred ----CCCCChhhHhh------hccCCCCcc--ccCChhHHHHHHhccccCCCCCCCHHHHhcC
Q psy622 250 ----GSQIPTSTAAQ------LQLEWPEDE--EALNPSTEETILALLKSDPTQRPSGHQVRRL 300 (473)
Q Consensus 250 ----~~~~~~~~~~~------~~~~~P~~~--~~ls~~a~dLI~~LL~~dP~kRpsa~eil~H 300 (473)
........... ....+|... ......+.+|+.+||+.||++|||+.||+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00000011111 111222211 1122458999999999999999999998763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.1e-39 Score=316.61 Aligned_cols=244 Identities=17% Similarity=0.216 Sum_probs=190.6
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~l 119 (473)
++|++++.||+|+||+||+|+++. +++.||||++++... ...+.+|.++++.+. |++|+.+++++......|+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 579999999999999999999887 589999999876532 224678889999885 5899999999999999999
Q ss_pred EecccCcCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCC----CCceeEeecchhhhhc
Q psy622 120 VMEYMIGGDVKSLIAANG-ALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQ----APHCPIVNTLFLAILQ 194 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~-~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~----~g~ikL~DFGla~~~~ 194 (473)
||||+ ||+|.+++...+ .+++..+..++.|++.||+|||++|||||||||+|||++.. .+.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 899999998754 79999999999999999999999999999999999999742 2789999999998764
Q ss_pred CCccc----cccccccCCCCcccccCCcccccc------CCcCCCCcc-ccccCCCCCchhHhhhcCCCCChh---hHhh
Q psy622 195 QPIVY----LEISDLVNGTPNAFNIRTPGQLLS------LKTGTFPTF-QDVQNSQAPFPSALRVAGSQIPTS---TAAQ 260 (473)
Q Consensus 195 ~~~~~----~~~~~~~~gtp~y~~~~ape~i~~------~~~~s~g~l-~~~~~g~~pf~~~~~~~~~~~~~~---~~~~ 260 (473)
..... .......+|||.|+ |||++.. .|.|++|+. ++|++|..||..... ..... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~---aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~----~~~~~~~~~i~~ 230 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYM---SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA----ATNKQKYERIGE 230 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTC---CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS----CCHHHHHHHHHH
T ss_pred cCccccceeecccCceEEchhhc---CHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc----hhHHHHHHHHHh
Confidence 32211 12234568999999 8997643 578899965 679999999964210 00000 1111
Q ss_pred hc--cCCCCccccCChhHHHHHHhccccCCCCCCCHHHHh
Q psy622 261 LQ--LEWPEDEEALNPSTEETILALLKSDPTQRPSGHQVR 298 (473)
Q Consensus 261 ~~--~~~P~~~~~ls~~a~dLI~~LL~~dP~kRpsa~eil 298 (473)
.. ...+.....+++++.+++..|++.+|.+||+.+.+.
T Consensus 231 ~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred ccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 11 111111246889999999999999999999865443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=5.7e-24 Score=193.26 Aligned_cols=137 Identities=17% Similarity=0.108 Sum_probs=108.3
Q ss_pred eEEEceecccCceEEEEEEEeCCCCcEEEEEEeeccccc---------------chhHHHHHHHHHHHHHhcCCCCeeeE
Q psy622 43 FEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMI---------------NKNMVSQVLRERNALALTHSPFCVQL 107 (473)
Q Consensus 43 y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~---------------~~~~~~~~~~E~~iL~~l~hp~Iv~l 107 (473)
+.+.++||+|+||+||+|++. +|+.||||+++..... .........+|...+..+.|++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence 357899999999999999875 4689999997643110 01112345678899999999999988
Q ss_pred EEEEEeCCEEEEEecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCCcceEecCCCCceeEeec
Q psy622 108 FYSLQTSSCVFLVMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHSHGIIHRDLKPDNMLISAQAPHCPIVNT 187 (473)
Q Consensus 108 ~~~f~~~~~l~lVmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~~gIiHRDLKpeNILld~~~g~ikL~DF 187 (473)
+++.. .++||||++++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.+ .++|+||
T Consensus 80 ~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDF 146 (191)
T d1zara2 80 YAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDF 146 (191)
T ss_dssp EEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCC
T ss_pred EEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEEC
Confidence 76632 27999999876653 35666788899999999999999999999999999999965 5899999
Q ss_pred chhhhhc
Q psy622 188 LFLAILQ 194 (473)
Q Consensus 188 Gla~~~~ 194 (473)
|+|+...
T Consensus 147 G~a~~~~ 153 (191)
T d1zara2 147 PQSVEVG 153 (191)
T ss_dssp TTCEETT
T ss_pred CCcccCC
Confidence 9997743
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.47 E-value=2.5e-07 Score=85.53 Aligned_cols=140 Identities=12% Similarity=0.039 Sum_probs=94.0
Q ss_pred CCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEE
Q psy622 41 SDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH-SPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 41 ~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~l 119 (473)
+.|++.+..+.++.+.||+.. . .++.+.+|+....... ....+.+|...|..+. +--+.+++++..+++..|+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~-~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--G-ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--C-SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--e-CCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 567888877666778999874 2 3456788887654321 1234677888887663 3335677888888999999
Q ss_pred EecccCcCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q psy622 120 VMEYMIGGDVKSLIAANGALPEDMAAFYAAEVVLALQYLHS--------------------------------------- 160 (473)
Q Consensus 120 VmEy~~gg~L~~~L~~~~~~~e~~~~~~~~qI~~aL~yLH~--------------------------------------- 160 (473)
||++++|.++....... .....++.++...+..||+
T Consensus 88 v~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99999998876543211 1112233334444444442
Q ss_pred --------------C------CeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 161 --------------H------GIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 161 --------------~------gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
. .++|+|+.|.|||++.+ +.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhccc
Confidence 1 37999999999999876 5567999988765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.84 E-value=1.3e-05 Score=73.11 Aligned_cols=80 Identities=11% Similarity=0.143 Sum_probs=52.1
Q ss_pred CeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeCCEEEE
Q psy622 42 DFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMINKNMVSQVLRERNALALTH--SPFCVQLFYSLQTSSCVFL 119 (473)
Q Consensus 42 ~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~f~~~~~l~l 119 (473)
.+++..+-+..+-..||+.... .+..+.+|.-.... ...+.+|...|+.+. .-.+.+++.+..+++..++
T Consensus 12 g~~~~~~~~G~s~~~v~r~~~~--~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 12 GYDWAQQTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp TCEEEECSCTTSSCEEEEEECT--TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCceEEcCCcccCCeEEEEEeC--CCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence 3455444333334688988543 35668888765442 123566777777662 2235667888888889999
Q ss_pred EecccCcCCH
Q psy622 120 VMEYMIGGDV 129 (473)
Q Consensus 120 VmEy~~gg~L 129 (473)
||++++|-++
T Consensus 84 v~~~i~G~~~ 93 (255)
T d1nd4a_ 84 LLGEVPGQDL 93 (255)
T ss_dssp EEECCSSEET
T ss_pred EEEeeecccc
Confidence 9999988665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.76 E-value=3.5e-05 Score=75.47 Aligned_cols=81 Identities=21% Similarity=0.275 Sum_probs=48.5
Q ss_pred EceecccCceEEEEEEEeCCCCcEEEEEEeeccc-ccc---hhHHHHHHHHHHHHHhc-CC--CCeeeEEEEEEeCCEEE
Q psy622 46 VKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDE-MIN---KNMVSQVLRERNALALT-HS--PFCVQLFYSLQTSSCVF 118 (473)
Q Consensus 46 ~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~-~~~---~~~~~~~~~E~~iL~~l-~h--p~Iv~l~~~f~~~~~l~ 118 (473)
.+.||.|....||++.... +++.+++|.-.... ... .....+...|...|+.+ .+ ..+.+++.+ ++...+
T Consensus 31 ~~eig~G~~N~vfrV~~~~-~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEeCCCceEeEEEEEeCC-CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence 4568999999999997554 45778888754311 000 11234566788888766 22 344555543 445567
Q ss_pred EEecccCcCCH
Q psy622 119 LVMEYMIGGDV 129 (473)
Q Consensus 119 lVmEy~~gg~L 129 (473)
+|||++.+..+
T Consensus 108 lvmE~L~~~~~ 118 (392)
T d2pula1 108 TVMEDLSHLKI 118 (392)
T ss_dssp EEECCCTTSEE
T ss_pred EEEeccCCccc
Confidence 89999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.09 E-value=0.00097 Score=62.99 Aligned_cols=164 Identities=13% Similarity=0.127 Sum_probs=89.6
Q ss_pred CCCCCCccchhhHHHHhHhhhcccccccccccCCCCCCCCeEEEceecccCceEEEEEEEeCCCCcEEEEEEeecccccc
Q psy622 3 SSGLFSGADKENILEITNKASENSLCDVSKSCLKAPEISDFEIVKAISRGAFGKVFLGYKKTNKDQLYAIKVMKKDEMIN 82 (473)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~V~~a~~~~~~~~~vAiK~l~k~~~~~ 82 (473)
|+.+|.+...+-+.+++...- +.. + ... ..|+ +.--.||++... .|+.|++|+.+....
T Consensus 1 ~~~~f~~L~pd~i~~al~~~g------~~~------~-~~~---~~L~-s~EN~vy~v~~~--dg~~~VlK~~rp~~~-- 59 (325)
T d1zyla1 1 SAFTFQTLHPDTIMDALFEHG------IRV------D-SGL---TPLN-SYENRVYQFQDE--DRRRFVVKFYRPERW-- 59 (325)
T ss_dssp CCCCCCCCCHHHHHHHHHHTT------CCC------C-SCC---EEEC-CSSSEEEEECCT--TCCCEEEEEECTTTS--
T ss_pred CCCCccccCHHHHHHHHHHcC------CCC------C-cCc---cccc-cccceeEEEEcC--CCCEEEEEEeCCCCC--
Confidence 566788888888887764321 100 0 001 1222 223689998654 367899999876421
Q ss_pred hhHHHHHHHHHHHHHhcCC-----CCeeeE--EEEEEeCCEEEEEecccCcCCHH-----------HHH---Hh----C-
Q psy622 83 KNMVSQVLRERNALALTHS-----PFCVQL--FYSLQTSSCVFLVMEYMIGGDVK-----------SLI---AA----N- 136 (473)
Q Consensus 83 ~~~~~~~~~E~~iL~~l~h-----p~Iv~l--~~~f~~~~~l~lVmEy~~gg~L~-----------~~L---~~----~- 136 (473)
..+++..|...+..+.. +..+.. -..+...+..+.|+++++|..+. ..+ +. .
T Consensus 60 --s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~ 137 (325)
T d1zyla1 60 --TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQL 137 (325)
T ss_dssp --CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSC
T ss_pred --CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCC
Confidence 23456678777766521 111111 12234567889999999764321 011 11 0
Q ss_pred -----------------------CCCCHHHHHHHHHHHHHHHHHHHH-------CCeeecCCCCcceEecCCCCceeEee
Q psy622 137 -----------------------GALPEDMAAFYAAEVVLALQYLHS-------HGIIHRDLKPDNMLISAQAPHCPIVN 186 (473)
Q Consensus 137 -----------------------~~~~e~~~~~~~~qI~~aL~yLH~-------~gIiHRDLKpeNILld~~~g~ikL~D 186 (473)
..++......+...+-..++.+.. .++||+|+.|.|||++. + ..++|
T Consensus 138 ~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~--~-~~~ID 214 (325)
T d1zyla1 138 FIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRD--G-PMFVD 214 (325)
T ss_dssp CSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESS--S-EEECC
T ss_pred ccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeC--C-ceEEe
Confidence 011111112222222333333332 36999999999999974 3 34789
Q ss_pred cchhhh
Q psy622 187 TLFLAI 192 (473)
Q Consensus 187 FGla~~ 192 (473)
|+-|..
T Consensus 215 Fdd~~~ 220 (325)
T d1zyla1 215 LDDARN 220 (325)
T ss_dssp CTTCCE
T ss_pred chhccc
Confidence 998875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.58 E-value=0.005 Score=59.47 Aligned_cols=80 Identities=16% Similarity=0.182 Sum_probs=52.1
Q ss_pred CCCeEEEceecccCceEEEEEEEeCC------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q psy622 40 ISDFEIVKAISRGAFGKVFLGYKKTN------KDQLYAIKVMKKDEMINKNMVSQVLRERNALALT-HSPFCVQLFYSLQ 112 (473)
Q Consensus 40 ~~~y~i~~~LG~G~fG~V~~a~~~~~------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~ 112 (473)
.+++++ +.|+.|---.+|++..... ..+.|.+++.-... . .....+|..+++.+ .+....++++++.
T Consensus 42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~ 115 (395)
T d1nw1a_ 42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFS 115 (395)
T ss_dssp GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence 455655 4677788889999876532 23456777655321 1 22345788888877 4555567888775
Q ss_pred eCCEEEEEecccCcCCH
Q psy622 113 TSSCVFLVMEYMIGGDV 129 (473)
Q Consensus 113 ~~~~l~lVmEy~~gg~L 129 (473)
+ .+|+||++|-.|
T Consensus 116 ~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 116 G----GRLEEYIPSRPL 128 (395)
T ss_dssp T----EEEECCCCEEEC
T ss_pred C----ceEEEEeccccC
Confidence 4 589999987544
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.52 E-value=0.00012 Score=69.49 Aligned_cols=68 Identities=13% Similarity=0.168 Sum_probs=56.2
Q ss_pred ccCCCCceeecCCCCCCCCCccccc---cc---ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPED---EE---ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.|.|...-++....+...|||+ +. ...-.+|++||+.++ |||||.+.++|.+...+|+|++.|.-
T Consensus 12 ~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEEEEecCCC
Confidence 4788999988888887777899992 11 122458999999996 99999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=96.42 E-value=0.00026 Score=65.64 Aligned_cols=68 Identities=18% Similarity=0.171 Sum_probs=55.7
Q ss_pred ccCCCCceeecCCCCCCCCCcccccc---cc-------------cCcchHHHHHHhhcCCCcEEecccccccccceehhh
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDE---EA-------------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTL 456 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (473)
..|.|.|...-++.+..+...|||+. .. ....+|+.+|+.++.|||||.+.++|.+..++|+++
T Consensus 10 ~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivm 89 (277)
T d1phka_ 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 89 (277)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEE
Confidence 46788888777777777777999922 11 124579999999999999999999999999999999
Q ss_pred cccC
Q psy622 457 DAMS 460 (473)
Q Consensus 457 ~~~~ 460 (473)
+.|.
T Consensus 90 E~~~ 93 (277)
T d1phka_ 90 DLMK 93 (277)
T ss_dssp ECCT
T ss_pred EcCC
Confidence 9985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.41 E-value=0.00035 Score=65.17 Aligned_cols=69 Identities=13% Similarity=0.253 Sum_probs=54.0
Q ss_pred CccCCCCceeecCCCCCCCCCccccc---cccc----------CcchHHHHHHhhcCCCcEEecccccccccceehhhcc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPED---EEAL----------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDA 458 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (473)
...|.|.|...-++....++..|||+ +... .-.+|+.||+.+ .|||||.+.++|.+...+|++++.
T Consensus 16 ~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~ 94 (293)
T d1jksa_ 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVILILEL 94 (293)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEc
Confidence 34788899877776666666789992 2111 124699999999 499999999999999999999999
Q ss_pred cCC
Q psy622 459 MSP 461 (473)
Q Consensus 459 ~~~ 461 (473)
|.-
T Consensus 95 ~~g 97 (293)
T d1jksa_ 95 VAG 97 (293)
T ss_dssp CCS
T ss_pred CCC
Confidence 863
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.34 E-value=0.00033 Score=65.92 Aligned_cols=67 Identities=13% Similarity=0.158 Sum_probs=51.6
Q ss_pred ccCCCCceeecCCCCCCCCCccccc---cc-----ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPED---EE-----ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..|.|.|...-++....+...|||+ +. ...-.+|+.||+.+ .|||||.+.++|.+...+|++++.|.
T Consensus 16 ~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp ESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccC
Confidence 4788888866666655556678982 11 22346899999999 59999999999999999999999996
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.23 E-value=0.00029 Score=65.03 Aligned_cols=68 Identities=13% Similarity=-0.031 Sum_probs=54.0
Q ss_pred CccCCCCceeecCCCCCCCCCccccc---cc-----ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPED---EE-----ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.+.|...-++.+..+...|||+ .. ..+-.+|+++|+.+ .|||||.+.++|.+...+|+|++.+.
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEEEEeccC
Confidence 34688888877777776677789992 11 12346899999999 59999999999999999999999885
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.09 E-value=0.00046 Score=64.23 Aligned_cols=68 Identities=12% Similarity=0.051 Sum_probs=54.1
Q ss_pred ccCCCCceeecCCCCCCCCCccccc---cc----ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPED---EE----ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.+.|...-++....++..+||+ +. ..+-.+|+.+|+.+. |||||.+.++|.+...+|+|++.|.-
T Consensus 19 ~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 4788899877777666666688982 11 124457999999985 99999999999999999999999863
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.87 E-value=0.00051 Score=65.40 Aligned_cols=67 Identities=6% Similarity=0.018 Sum_probs=54.2
Q ss_pred cCCCCceeecCCCCCCCCCcccccc--cccCcchHHHHHHhhcCCCcEEeccccccc----ccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDE--EALNPSTEETILALLKSDPIVFMGDDTWSS----FSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 460 (473)
.|.|.|...-++....+...|||+. ......+|+++++++..|||||.+.++|.+ ..++|++++.|.
T Consensus 20 lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred eeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 6889999777776666777999922 123567899999999999999999999965 578999999886
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.78 E-value=0.00054 Score=63.71 Aligned_cols=69 Identities=7% Similarity=-0.034 Sum_probs=53.2
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.|.|..+-++....+...+||+.- ..+-.+|+.+|+.+ .|||||.+.++|.+...+|+++..|.-
T Consensus 23 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~~ 97 (287)
T d1opja_ 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTY 97 (287)
T ss_dssp EETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEEEeecccC
Confidence 3478888887766665555667998221 11235799999999 599999999999999999999998863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.61 E-value=0.00094 Score=62.24 Aligned_cols=69 Identities=7% Similarity=-0.026 Sum_probs=54.2
Q ss_pred CCccCCCCceeecCCCCCCCCCcccccc---cc-c---CcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 391 HNLSGVSPFLAMDRSPPDNSELEWPEDE---EA-L---NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
....|.|.|...-++.....+..|||+. .. . .-.+|+.+|+.+ .|||||.+.++|.+...+|+|++.|.
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEEEEEecC
Confidence 4558999999777666656666899922 11 1 134799999998 59999999999999999999999885
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.57 E-value=0.0013 Score=61.25 Aligned_cols=69 Identities=17% Similarity=0.153 Sum_probs=53.4
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---c---cc------CcchHHHHHHhhcCCCcEEecccccccccceehhhccc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---E---AL------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAM 459 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~---~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (473)
...|.|.|...-++....++..+||+. . .. .-.+|+.||+.+. |||||.+.++|.+...+|+|++.|
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhhhh
Confidence 346888898777777666777899822 1 11 1237999999984 999999999999999999999988
Q ss_pred CC
Q psy622 460 SP 461 (473)
Q Consensus 460 ~~ 461 (473)
..
T Consensus 83 ~~ 84 (299)
T d1ua2a_ 83 ET 84 (299)
T ss_dssp SE
T ss_pred cc
Confidence 53
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.56 E-value=0.0013 Score=62.69 Aligned_cols=69 Identities=12% Similarity=-0.049 Sum_probs=54.5
Q ss_pred CccCCCCceeecCCCCCCCCCcccc---cccccCcchHHHHHHhhcCCCcEEeccccc------ccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPE---DEEALNPSTEETILALLKSDPIVFMGDDTW------SSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 461 (473)
...|.|.|..+-++....+...||| .+.+....+|+.||+.+ .|||||.+.++| .+..++|+|++.|..
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~ 103 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 103 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEEECCSE
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEEeccCC
Confidence 4488888987777666666778999 33344667899999998 699999999998 355679999999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=95.50 E-value=0.00052 Score=65.81 Aligned_cols=68 Identities=15% Similarity=0.124 Sum_probs=54.0
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.|.|...-++....+...+||+.- ...-.+|+.+|+.+ .|||||.+.|+|.+...+|+|++.|.-
T Consensus 36 ~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 478888887777766666668999221 12335799999999 699999999999999999999998863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.49 E-value=0.00083 Score=61.56 Aligned_cols=67 Identities=12% Similarity=0.063 Sum_probs=53.2
Q ss_pred ccCCCCceeecCCCCCCCCCcccccc---c-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDE---E-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..|.+.|..+-++....+...||++. . ...-.+|+.+|+.+ .|||||.+.++|.+...+|+|++.|.
T Consensus 13 ~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ivmEy~~ 89 (263)
T d2j4za1 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAP 89 (263)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEEEeecC
Confidence 36888898777776666667899821 1 11235799999998 69999999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.48 E-value=0.0008 Score=64.06 Aligned_cols=68 Identities=12% Similarity=0.119 Sum_probs=54.8
Q ss_pred ccCCCCceeecCCCCCCCCCcccc---ccc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPE---DEE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.|.|...-++....+...||+ ++. ...-.+|+.||+.+. |||||.+.++|.+...+|+|++.|.-
T Consensus 12 ~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv~ey~~g 89 (337)
T d1o6la_ 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccceeccCC
Confidence 468888987777766667779999 221 122457999999996 99999999999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.41 E-value=0.00047 Score=65.20 Aligned_cols=67 Identities=13% Similarity=-0.040 Sum_probs=52.2
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc--c------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE--A------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..|.|.|...-++....+...+|++.- . ..-.+|+.||+.+ .|||||.+.|+|.+...+|+|++.|.
T Consensus 13 ~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp EEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 468888886666666556667888221 1 1234799999998 59999999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=95.36 E-value=0.0011 Score=62.51 Aligned_cols=71 Identities=11% Similarity=-0.017 Sum_probs=55.5
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---c-ccCcchHHHHHHhhcCCCcEEecccccc--cccceehhhcccCCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---E-ALNPSTEETILALLKSDPIVFMGDDTWS--SFSAIFNTLDAMSPT 462 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 462 (473)
...|.|.|...-++....+...+|++. . ...-.+|+.||+.+++|||||.+.++|. ....+|.+++.|...
T Consensus 41 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~ 117 (328)
T d3bqca1 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117 (328)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence 347888999777776666677899832 2 2345689999999999999999999986 456799999988754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.33 E-value=0.001 Score=61.78 Aligned_cols=68 Identities=12% Similarity=0.118 Sum_probs=53.6
Q ss_pred CccCCCCceeecCCCCCCCCCccccc---cc---c----cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPED---EE---A----LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~---~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.|.|...-++....++..|||+ +. . ..-.+|++||+.+ .|||||.+.++|.+...+|++++.|.
T Consensus 14 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEEEEccC
Confidence 34688888877776666666789992 11 1 1235799999998 59999999999999999999999985
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.30 E-value=0.069 Score=49.05 Aligned_cols=31 Identities=26% Similarity=0.446 Sum_probs=27.2
Q ss_pred CCeeecCCCCcceEecCCCCceeEeecchhhh
Q psy622 161 HGIIHRDLKPDNMLISAQAPHCPIVNTLFLAI 192 (473)
Q Consensus 161 ~gIiHRDLKpeNILld~~~g~ikL~DFGla~~ 192 (473)
.|+||+|+.+.||+++.+ ...-++||+.|..
T Consensus 183 ~giIHgDl~~dNvl~~~~-~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGD-ELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccc-cceeEeccccccc
Confidence 379999999999999987 6678999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=95.16 E-value=0.0009 Score=64.02 Aligned_cols=69 Identities=13% Similarity=0.150 Sum_probs=54.3
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc----c---cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE----A---LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.|.|...-++....+...+||+.- . ..-.+|+.||+.++ |||||.+.++|.+...+|+|++.|.-
T Consensus 32 ~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 3478888987777766666778999321 1 11247999999995 99999999999999999999999863
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=95.14 E-value=0.0011 Score=62.46 Aligned_cols=68 Identities=15% Similarity=0.201 Sum_probs=53.5
Q ss_pred ccCCCCceeecCCCCCCCCCcccccc---c----c---cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDE---E----A---LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~----~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.|.|...-++.+..+...|||+. . . ..-.+|+.+|+.+ .|||||.+.++|.+...+|+|++.|..
T Consensus 11 ~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~g 88 (316)
T d1fota_ 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIEG 88 (316)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeEeeecCC
Confidence 36788888777766666667899921 1 1 1234799999998 699999999999999999999999964
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.12 E-value=0.0016 Score=59.86 Aligned_cols=67 Identities=21% Similarity=0.221 Sum_probs=50.5
Q ss_pred ccCCCCceeecCCCCCCCCCcccccc---cccC------cchHHHHHHhhcCCCcEEeccccccc----ccceehhhccc
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDE---EALN------PSTEETILALLKSDPIVFMGDDTWSS----FSAIFNTLDAM 459 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 459 (473)
..|.+.|...-++.......++|+.. ...+ -.+|++||+.++ |||||.+.++|.+ ...+|++++.|
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 37889999777666666666888822 2112 247999999996 9999999999864 56789999988
Q ss_pred C
Q psy622 460 S 460 (473)
Q Consensus 460 ~ 460 (473)
.
T Consensus 95 ~ 95 (270)
T d1t4ha_ 95 T 95 (270)
T ss_dssp C
T ss_pred C
Confidence 6
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.09 E-value=0.00066 Score=63.44 Aligned_cols=70 Identities=10% Similarity=0.037 Sum_probs=49.5
Q ss_pred CCccCCCCceeecCCCCCCCCC---ccccccc--c------cCcchHHHHHHhhcCCCcEEecccccccccceehhhccc
Q psy622 391 HNLSGVSPFLAMDRSPPDNSEL---EWPEDEE--A------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAM 459 (473)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (473)
....|.|.|...-+.......+ ..||... . .+-.+|+.+|+.+ .|||||.+.+++.+...+|++++.|
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~iv~Ey~ 109 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFM 109 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEec
Confidence 3568899998666554433333 2455221 1 1234699999999 6999999999999999999999988
Q ss_pred CC
Q psy622 460 SP 461 (473)
Q Consensus 460 ~~ 461 (473)
.-
T Consensus 110 ~~ 111 (299)
T d1jpaa_ 110 EN 111 (299)
T ss_dssp TT
T ss_pred CC
Confidence 63
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=95.06 E-value=0.00079 Score=63.26 Aligned_cols=68 Identities=10% Similarity=-0.005 Sum_probs=53.4
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---cc-------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---EA-------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
...|.|.|...-++....+...+||+. .. .+-.+|+.||+.+. |||||.+.++|.+...+|++++.|.
T Consensus 21 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv~E~~~ 98 (309)
T d1u5ra_ 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCL 98 (309)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEEEEEEecC
Confidence 347889998777766666666899822 11 12346999999995 9999999999999999999999985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.02 E-value=0.0011 Score=61.67 Aligned_cols=68 Identities=9% Similarity=0.064 Sum_probs=52.8
Q ss_pred ccCCCCceeecCCCCCCCCCcccccc---c------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDE---E------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.|.|...-++....+...+||+. . ..+-.+|+.||+.+. |||||.+.++|.+...+|+|++.|..
T Consensus 9 ~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv~e~~~~ 85 (298)
T d1gz8a_ 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFLHQ 85 (298)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEEEeecCC
Confidence 46778888777666666666899821 1 123457999999985 99999999999999999999998853
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.75 E-value=0.0035 Score=57.35 Aligned_cols=70 Identities=14% Similarity=0.041 Sum_probs=53.1
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---cc----------cCcchHHHHHHhhc-CCCcEEecccccccccceehhhc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---EA----------LNPSTEETILALLK-SDPIVFMGDDTWSSFSAIFNTLD 457 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~----------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 457 (473)
...|.|.|...-++....++..+||+. .. ..-.+|+.+|+.+. .|||||.+.++|.+...+|++++
T Consensus 10 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e 89 (273)
T d1xwsa_ 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 89 (273)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEE
Confidence 346778888666555555666888821 10 11358999999997 49999999999999999999998
Q ss_pred ccCC
Q psy622 458 AMSP 461 (473)
Q Consensus 458 ~~~~ 461 (473)
.+.+
T Consensus 90 ~~~~ 93 (273)
T d1xwsa_ 90 RPEP 93 (273)
T ss_dssp CCSS
T ss_pred eccC
Confidence 8765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.62 E-value=0.0028 Score=59.30 Aligned_cols=69 Identities=7% Similarity=-0.042 Sum_probs=50.9
Q ss_pred CccCCCCceeecCC----C-CCCCCCcccccccc--c------CcchHHHHHHhhcCCCcEEecccccccccceehhhcc
Q psy622 392 NLSGVSPFLAMDRS----P-PDNSELEWPEDEEA--L------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDA 458 (473)
Q Consensus 392 ~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~--~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 458 (473)
...|.+.|...-+. . .......+||++.. . .-.+|+.+++.+++|||||.+.+++.+...+|+++..
T Consensus 29 ~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~ 108 (311)
T d1t46a_ 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 108 (311)
T ss_dssp EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEc
Confidence 35789999854332 2 23334478883321 1 1246889999999999999999999999999999998
Q ss_pred cC
Q psy622 459 MS 460 (473)
Q Consensus 459 ~~ 460 (473)
|.
T Consensus 109 ~~ 110 (311)
T d1t46a_ 109 CC 110 (311)
T ss_dssp CT
T ss_pred CC
Confidence 86
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.58 E-value=0.0021 Score=60.47 Aligned_cols=68 Identities=12% Similarity=0.122 Sum_probs=54.1
Q ss_pred ccCCCCceeecCCCCCCCCCcccc---ccc----c---cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPE---DEE----A---LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~----~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..|.|.|...-++.+..++..||| ++. + .....|+.+|.+.-.|||||.+.++|.+...+|+|++.|.
T Consensus 9 ~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 367888887777777777789999 221 1 1235678888888899999999999999999999999996
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.32 E-value=0.0049 Score=58.65 Aligned_cols=68 Identities=6% Similarity=0.016 Sum_probs=50.6
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc---cc------CcchHHHHHHhhcCCCcEEecccccc------cccceehhh
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE---AL------NPSTEETILALLKSDPIVFMGDDTWS------SFSAIFNTL 456 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~ 456 (473)
...|+|.|+..-++....++..|||+.- .. .-.+|+.||+.+ +|||||.+.++|. +...+|+|+
T Consensus 23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCceeEEEE
Confidence 4588899987777776666778999321 11 234899999999 5999999999995 457899999
Q ss_pred cccC
Q psy622 457 DAMS 460 (473)
Q Consensus 457 ~~~~ 460 (473)
..|.
T Consensus 102 Ey~~ 105 (355)
T d2b1pa1 102 ELMD 105 (355)
T ss_dssp ECCS
T ss_pred eccc
Confidence 9884
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.20 E-value=0.0027 Score=57.73 Aligned_cols=66 Identities=12% Similarity=0.004 Sum_probs=51.7
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..|.|.|.+.-++... +..++||+.- +.+-.+|+.+|+.+ .|||||.+-++|.+...+|.|++.|+
T Consensus 11 ~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 11 ELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred EEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEccC
Confidence 4788999876655543 5558999322 22335799999999 59999999999999999999999886
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.62 E-value=0.0044 Score=56.68 Aligned_cols=68 Identities=10% Similarity=0.077 Sum_probs=49.1
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---cccC------cchHHHHHHhhcCCCcEEeccccccc--ccceehhhcccC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---EALN------PSTEETILALLKSDPIVFMGDDTWSS--FSAIFNTLDAMS 460 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 460 (473)
...|.+.|...-++....+...+||+. ...+ -.+|+.+|+.+ .|||||.+.++|-+ ...+|++++.|.
T Consensus 10 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ivmEy~~ 88 (269)
T d2java1 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCE 88 (269)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence 346888898777776666666899932 1111 23688999888 59999999999954 667999999885
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.54 E-value=0.0028 Score=59.23 Aligned_cols=68 Identities=10% Similarity=0.068 Sum_probs=51.2
Q ss_pred ccCCCCceeecCCCCCCCCCcccc--ccc--------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPE--DEE--------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..|.|.|..+-++....+...++| .+. ...-.+|+.+|..+..|||||.+-++|.+...+|.|+..|.
T Consensus 17 ~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 378888887766655555554444 221 11235899999999999999999999999999999998875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.24 E-value=0.0077 Score=55.68 Aligned_cols=70 Identities=11% Similarity=0.049 Sum_probs=50.5
Q ss_pred CccCCCCceeecCCCCCCCCCc-ccccc---c------ccCcchHHHHHHhhc--CCCcEEecccccc-----cccceeh
Q psy622 392 NLSGVSPFLAMDRSPPDNSELE-WPEDE---E------ALNPSTEETILALLK--SDPIVFMGDDTWS-----SFSAIFN 454 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-----~~~~~~~ 454 (473)
...|.+.|...-++......++ +||+. . .....+|+.+|+.++ .|||||.+.++|. ...++|+
T Consensus 13 ~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~ 92 (305)
T d1blxa_ 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 92 (305)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred EEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEE
Confidence 3478889997777766555554 68821 1 123347999999887 6999999999984 4567888
Q ss_pred hhcccCC
Q psy622 455 TLDAMSP 461 (473)
Q Consensus 455 ~~~~~~~ 461 (473)
+...|..
T Consensus 93 ~~e~~~~ 99 (305)
T d1blxa_ 93 VFEHVDQ 99 (305)
T ss_dssp EEECCSC
T ss_pred EEEeccC
Confidence 8887764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.00 E-value=0.0059 Score=55.45 Aligned_cols=66 Identities=12% Similarity=-0.030 Sum_probs=48.2
Q ss_pred cCCCCceeecCCCCCCCCCccccccc------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.|.+.|...-+.... +...+||++- ..+-.+|+.+|+.+ .|||||.+.+++.+...+|++++.|.-
T Consensus 13 iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 13 IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp EECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEEEEecCC
Confidence 677777744443322 3346888322 11235799999999 599999999999999999999999863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.87 E-value=0.0055 Score=58.28 Aligned_cols=70 Identities=13% Similarity=0.166 Sum_probs=55.2
Q ss_pred CCccCCCCceeecCCCCCCCCCccccc---cc---cc----CcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 391 HNLSGVSPFLAMDRSPPDNSELEWPED---EE---AL----NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~---~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
....|.|.|...-++.+..+...|||+ +. .. .-.+|+.||+.+ .|||||.+.++|.+...+|.+++.|.
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v~e~~~ 124 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccccccccccccccc
Confidence 356889999977777766667789992 21 11 124799999998 69999999999999999999999886
Q ss_pred C
Q psy622 461 P 461 (473)
Q Consensus 461 ~ 461 (473)
.
T Consensus 125 ~ 125 (350)
T d1rdqe_ 125 G 125 (350)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.87 E-value=0.017 Score=54.04 Aligned_cols=69 Identities=10% Similarity=0.161 Sum_probs=52.2
Q ss_pred CccCCCCceeecCCC--C-CCCCCcccccc---c--------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhc
Q psy622 392 NLSGVSPFLAMDRSP--P-DNSELEWPEDE---E--------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLD 457 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~--~-~~~~~~~~~~~---~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (473)
...|.|.|...-+.. . ....-++||+. . ...-.+|+.+|+.+.+||||+.+.++|.+...+|.+++
T Consensus 30 ~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e 109 (322)
T d1vzoa_ 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILD 109 (322)
T ss_dssp EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEEC
T ss_pred EEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeee
Confidence 347889998654332 2 33445799821 1 12355899999999999999999999999999999998
Q ss_pred ccC
Q psy622 458 AMS 460 (473)
Q Consensus 458 ~~~ 460 (473)
.|.
T Consensus 110 ~~~ 112 (322)
T d1vzoa_ 110 YIN 112 (322)
T ss_dssp CCC
T ss_pred ccc
Confidence 884
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=92.84 E-value=0.0072 Score=57.74 Aligned_cols=70 Identities=13% Similarity=0.127 Sum_probs=52.6
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---c-------ccCcchHHHHHHhhc--CCCcEEecccccccccceehhhccc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---E-------ALNPSTEETILALLK--SDPIVFMGDDTWSSFSAIFNTLDAM 459 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (473)
...|.|.|...-++........|||+. . +....+|+.++++++ .|||||.+.++|.+...+|+|++.|
T Consensus 10 ~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~ 89 (364)
T d1omwa3 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 89 (364)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEec
Confidence 347888888776666666667899821 1 122346667777776 5999999999999999999999998
Q ss_pred CC
Q psy622 460 SP 461 (473)
Q Consensus 460 ~~ 461 (473)
.-
T Consensus 90 ~g 91 (364)
T d1omwa3 90 NG 91 (364)
T ss_dssp CS
T ss_pred CC
Confidence 63
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.35 E-value=0.011 Score=54.10 Aligned_cols=69 Identities=9% Similarity=-0.016 Sum_probs=53.9
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---ccc------CcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---EAL------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
...|.|.|+..-++....+...+||+. ... .-.+|+.||+.+ .|||||.+.++|.+...+|.++..+..
T Consensus 8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEEeeeccc
Confidence 346888898777777777777899932 211 225899999887 599999999999999999999887753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.33 E-value=0.018 Score=53.82 Aligned_cols=69 Identities=9% Similarity=0.020 Sum_probs=48.6
Q ss_pred ccCCCCceeecCCCC----CCCC-Cccccccc--ccC------cchHHHHHHhhcCCCcEEecccccccccceehhhccc
Q psy622 393 LSGVSPFLAMDRSPP----DNSE-LEWPEDEE--ALN------PSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAM 459 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~----~~~~-~~~~~~~~--~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (473)
..|.+.|...-+... +.+. -.+||... ..+ -.+|+.+|+.+.+|||||.+.++|.+...+|++++.|
T Consensus 44 ~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~ 123 (325)
T d1rjba_ 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYC 123 (325)
T ss_dssp EEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcC
Confidence 468888885443322 2222 25777221 111 2369999999999999999999999999999999988
Q ss_pred CC
Q psy622 460 SP 461 (473)
Q Consensus 460 ~~ 461 (473)
.-
T Consensus 124 ~~ 125 (325)
T d1rjba_ 124 CY 125 (325)
T ss_dssp TT
T ss_pred CC
Confidence 63
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.21 E-value=0.0088 Score=56.47 Aligned_cols=68 Identities=10% Similarity=0.032 Sum_probs=44.3
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---ccc------CcchHHHHHHhhcCCCcEEeccccccccc------ceehhh
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---EAL------NPSTEETILALLKSDPIVFMGDDTWSSFS------AIFNTL 456 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 456 (473)
...|.|.|...-++........+||+. ... ...+|+.||+.+ .|||||.+.++|.+.. .+|+++
T Consensus 24 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~ 102 (346)
T d1cm8a_ 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVM 102 (346)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccccceEEEEE
Confidence 347889998777666555556789832 111 234799999999 5999999999987554 578999
Q ss_pred cccC
Q psy622 457 DAMS 460 (473)
Q Consensus 457 ~~~~ 460 (473)
+.|.
T Consensus 103 e~~~ 106 (346)
T d1cm8a_ 103 PFMG 106 (346)
T ss_dssp ECCS
T ss_pred eccc
Confidence 8873
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.97 E-value=0.007 Score=55.57 Aligned_cols=72 Identities=11% Similarity=0.069 Sum_probs=49.8
Q ss_pred ccCCccCCCCceeecCCCCCCCCC----ccccccc--cc------CcchHHHHHHhhcCCCcEEecccccccccceehhh
Q psy622 389 NAHNLSGVSPFLAMDRSPPDNSEL----EWPEDEE--AL------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTL 456 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~--~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (473)
...+..|.|.|..+-+.....+.+ .+||++. .. .=.+|+.+|+.+ .|||||.+.+++.+...+|.++
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCceEEEE
Confidence 345668888888554443332222 5777322 11 123789999999 5999999999999999999999
Q ss_pred cccCC
Q psy622 457 DAMSP 461 (473)
Q Consensus 457 ~~~~~ 461 (473)
+.|.-
T Consensus 89 e~~~~ 93 (283)
T d1mqba_ 89 EYMEN 93 (283)
T ss_dssp ECCTT
T ss_pred Eeccc
Confidence 88854
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=91.96 E-value=0.0055 Score=56.25 Aligned_cols=69 Identities=10% Similarity=0.060 Sum_probs=51.0
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc------c---cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCCC
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE------A---LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSPT 462 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (473)
...|.|.|..+-++... +...|||+.- + .+-.+|+.||+.+. |||||.+.++|.+...+|.++..+...
T Consensus 8 ~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~~e~~~~~ 85 (286)
T d1ob3a_ 8 EKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQD 85 (286)
T ss_dssp EEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred cEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEEEEeehhh
Confidence 34678888866665443 3457999221 1 12347999999995 999999999999999999998877643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=90.85 E-value=0.02 Score=52.13 Aligned_cols=67 Identities=12% Similarity=0.060 Sum_probs=49.6
Q ss_pred ccCCCCceeecCCCCCCCCCccccc---cc-ccC------cchHHHHHHhhcCCCcEEecccccccc----cceehhhcc
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPED---EE-ALN------PSTEETILALLKSDPIVFMGDDTWSSF----SAIFNTLDA 458 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 458 (473)
..|.+.|...-++........+||+ +. ..+ -.+|+.+|+.+ .|||||.+.++|.+. ..+|+|++.
T Consensus 14 ~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~~~~lvmE~ 92 (277)
T d1o6ya_ 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEY 92 (277)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCceEEEEEEC
Confidence 4688888877777666666789992 22 112 24689999876 799999999998653 358999998
Q ss_pred cC
Q psy622 459 MS 460 (473)
Q Consensus 459 ~~ 460 (473)
|.
T Consensus 93 ~~ 94 (277)
T d1o6ya_ 93 VD 94 (277)
T ss_dssp CC
T ss_pred CC
Confidence 87
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.12 E-value=0.033 Score=51.49 Aligned_cols=70 Identities=16% Similarity=0.082 Sum_probs=48.6
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---cccC------cchHHHHHHhhcCCCcEEeccccccccc--------ceeh
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---EALN------PSTEETILALLKSDPIVFMGDDTWSSFS--------AIFN 454 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 454 (473)
...|.|.|...-++....+...|||+. +... ..+|+.||+.+ +||||+.+.++|.+.. .+|+
T Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~~~~~~~i 94 (318)
T d3blha1 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIYL 94 (318)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC----------CEEE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccccCceEEE
Confidence 457888888766666555566899932 2111 23899999999 5999999999986644 4677
Q ss_pred hhcccCCC
Q psy622 455 TLDAMSPT 462 (473)
Q Consensus 455 ~~~~~~~~ 462 (473)
++..|...
T Consensus 95 v~e~~~~~ 102 (318)
T d3blha1 95 VFDFCEHD 102 (318)
T ss_dssp EEECCCEE
T ss_pred EEeccCCC
Confidence 77777643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.90 E-value=0.047 Score=49.85 Aligned_cols=65 Identities=11% Similarity=0.102 Sum_probs=44.6
Q ss_pred cCCCCceeecCCCCC-CCC-Cccccccc--cc------CcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPD-NSE-LEWPEDEE--AL------NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~-~~~-~~~~~~~~--~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.|.+.|...-+.... .+. -.+||+.. .. .-.+|+.+|+.+ .|||||.+.+++.+. .+|+|++.|.
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~-~~~lvmE~~~ 91 (285)
T d1u59a_ 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAE-ALMLVMEMAG 91 (285)
T ss_dssp EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeeccC-eEEEEEEeCC
Confidence 688888865554322 222 26787221 11 123699999999 599999999999764 5789999886
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.56 E-value=0.019 Score=52.14 Aligned_cols=64 Identities=11% Similarity=0.004 Sum_probs=46.1
Q ss_pred cCCCCceeecCCCCCCCCCccccccc---cc---CcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPEDEE---AL---NPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.|.|.|...-+... .+...+||+.- .. .-.+|+.+|+.+ .|||||.+.+++.+.. +|++++.|.
T Consensus 21 iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~-~~iv~Ey~~ 90 (272)
T d1qpca_ 21 LGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQEP-IYIITEYME 90 (272)
T ss_dssp EEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-CEEEEECCT
T ss_pred EecCCCcEEEEEEE-CCCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeeccCC-eEEEEEeCC
Confidence 67888885554443 24557898322 11 124899999999 7999999999987754 688988875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.18 E-value=0.038 Score=51.75 Aligned_cols=66 Identities=11% Similarity=0.085 Sum_probs=46.4
Q ss_pred CccCCCCceeecCCCCCCCCCcccccc---cccC------cchHHHHHHhhcCCCcEEecccccc------cccceehhh
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDE---EALN------PSTEETILALLKSDPIVFMGDDTWS------SFSAIFNTL 456 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~ 456 (473)
...|.|.|...-++........+||+. ...+ ..+|+.||+.+ .|||||.+.++|. +...+|.+.
T Consensus 24 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~~~~~i~~ 102 (348)
T d2gfsa1 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVT 102 (348)
T ss_dssp EECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccCceEEEEE
Confidence 347888998777776666667899932 2112 24799999999 5999999999984 344566555
Q ss_pred cc
Q psy622 457 DA 458 (473)
Q Consensus 457 ~~ 458 (473)
.+
T Consensus 103 ~~ 104 (348)
T d2gfsa1 103 HL 104 (348)
T ss_dssp EC
T ss_pred ee
Confidence 44
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=88.77 E-value=0.041 Score=50.42 Aligned_cols=70 Identities=11% Similarity=-0.087 Sum_probs=55.2
Q ss_pred cCCCCceeecCCCCCCCCCccccc---cc--ccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCCCc
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPED---EE--ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSPTY 463 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (473)
.|.+.|...-+......+..+||+ ++ ...-.+|+++|+.+++||||+.+.+.+......|.|+++|.++.
T Consensus 13 iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~~~l 87 (293)
T d1csna_ 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSL 87 (293)
T ss_dssp EEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBH
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecCCCH
Confidence 677888866666655556689992 22 22336899999999999999999999999999999999986543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=88.57 E-value=0.04 Score=50.45 Aligned_cols=70 Identities=9% Similarity=-0.048 Sum_probs=54.6
Q ss_pred ccCCCCceeecCCCCCCCCCccccc-----ccccCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCCC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPED-----EEALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSPT 462 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (473)
..|.+.|...-+.....++.++||+ .....-.+|+++|+.+.+|+||+.+.+.+.+....|.|+.+|...
T Consensus 14 ~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~~ 88 (299)
T d1ckia_ 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPS 88 (299)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCCB
T ss_pred EEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCCc
Confidence 3688888866655555556689992 223345579999999999999999999999999999999998543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.20 E-value=0.069 Score=48.93 Aligned_cols=38 Identities=5% Similarity=0.065 Sum_probs=34.3
Q ss_pred chHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 424 STEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
.+|+.+|..+.+|||||.+.++|.+...+|.+++.|.-
T Consensus 66 ~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~ 103 (299)
T d1fgka_ 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 103 (299)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred HHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCC
Confidence 45889999999999999999999999999999998863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.50 E-value=0.061 Score=48.79 Aligned_cols=63 Identities=10% Similarity=-0.033 Sum_probs=43.3
Q ss_pred ccCCCCceeecCCCCCCCCCcccccc---cccCc------chHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDE---EALNP------STEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..|.+.|..+-+... .+++||+. ...++ .+|+.+|+.+ .|||||.+.++..+ ..+|++++.|.
T Consensus 15 ~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~-~~~~lv~Ey~~ 86 (276)
T d1uwha_ 15 RIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA-PQLAIVTQWCE 86 (276)
T ss_dssp EEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred EEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec-cEEEEEEecCC
Confidence 367778875554432 24588822 11122 2699999999 69999999987655 46789998886
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.37 E-value=0.032 Score=50.66 Aligned_cols=66 Identities=8% Similarity=-0.091 Sum_probs=41.4
Q ss_pred ccCCCCceeecCCCC--CCCCC-ccccc---cc-------ccCcchHHHHHHhhcCCCcEEecccccccccceehhhccc
Q psy622 393 LSGVSPFLAMDRSPP--DNSEL-EWPED---EE-------ALNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAM 459 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~--~~~~~-~~~~~---~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (473)
..|.|.|...-|... ..+.+ ++||. +. ..+-.+|+.+|+.+ .|||||.+-+++.+. .+|++++.|
T Consensus 15 ~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~~-~~~lv~e~~ 92 (273)
T d1u46a_ 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP-PMKMVTELA 92 (273)
T ss_dssp ECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS-SCEEEEECC
T ss_pred EEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeec-chheeeeee
Confidence 367778875544332 22222 57771 11 12346899999999 699999999999886 567888887
Q ss_pred C
Q psy622 460 S 460 (473)
Q Consensus 460 ~ 460 (473)
.
T Consensus 93 ~ 93 (273)
T d1u46a_ 93 P 93 (273)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.82 E-value=0.073 Score=48.55 Aligned_cols=65 Identities=12% Similarity=-0.055 Sum_probs=46.0
Q ss_pred ccCCCCceeecCCCCCCCCCccccccc---c---cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 393 LSGVSPFLAMDRSPPDNSELEWPEDEE---A---LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
..|.+.|..+-+.....+ ..+||+.- . .+-.+|+.+|+.+ .|||||.+-++|.+.. +|+++..|.
T Consensus 24 ~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~-~~lv~Ey~~ 94 (285)
T d1fmka3 24 KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSEEP-IYIVTEYMS 94 (285)
T ss_dssp EEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-CEEEECCCT
T ss_pred EEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEecCC-eEEEEEecC
Confidence 367788885555543333 46888222 1 2234899999998 5999999999998764 788988886
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.81 E-value=0.03 Score=50.60 Aligned_cols=64 Identities=11% Similarity=0.004 Sum_probs=41.8
Q ss_pred cCCCCceeecCCCCCCCCCcccc-----cccccCcchHHHHHHhhcCCCcEEecccccc-cccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPPDNSELEWPE-----DEEALNPSTEETILALLKSDPIVFMGDDTWS-SFSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 460 (473)
.|.+.|...-+... ...++|| ++....-.+|+++|+.| .|||||.+-+++- +-..+|++++.++
T Consensus 15 lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 15 IGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp EEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred EecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 56677774433222 1236888 11123456899999999 5999999999874 4456789988775
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.53 E-value=0.084 Score=47.58 Aligned_cols=67 Identities=7% Similarity=-0.011 Sum_probs=44.7
Q ss_pred ccCCCCceeecCCCCCCCCC---ccccccc--c------cCcchHHHHHHhhcCCCcEEecccccccccceehhhcccCC
Q psy622 393 LSGVSPFLAMDRSPPDNSEL---EWPEDEE--A------LNPSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMSP 461 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~--~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (473)
..|.|.|...-++......+ ..||... . ..-.+|+.+|+.+ .|||||.+.++|.+ ..+|+|++.|+-
T Consensus 14 ~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~-~~~~iv~E~~~~ 91 (273)
T d1mp8a_ 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE-NPVWIIMELCTL 91 (273)
T ss_dssp EEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred EEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec-CeEEEEEEeccC
Confidence 36778888665554433222 4555211 1 1223699999998 69999999999976 468999988863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.49 E-value=0.096 Score=47.40 Aligned_cols=65 Identities=12% Similarity=0.062 Sum_probs=43.4
Q ss_pred cCCCCceeecCCCC--CCCCCcccccc---cccC------cchHHHHHHhhcCCCcEEecccccccccceehhhcccC
Q psy622 394 SGVSPFLAMDRSPP--DNSELEWPEDE---EALN------PSTEETILALLKSDPIVFMGDDTWSSFSAIFNTLDAMS 460 (473)
Q Consensus 394 ~~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (473)
.|.+.|...-+... ......+||+. ...+ -.+|+.+|+.+ .|||||.+.+++.+.. .|+|++.|.
T Consensus 15 iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~~~-~~lvmE~~~ 90 (277)
T d1xbba_ 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAES-WMLVMEMAE 90 (277)
T ss_dssp EEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESSS-EEEEEECCT
T ss_pred cccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEeccCC-EEEEEEcCC
Confidence 67788875554432 11223678822 1222 23699999999 6999999999997765 578888886
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.87 E-value=0.095 Score=48.99 Aligned_cols=67 Identities=9% Similarity=0.023 Sum_probs=44.4
Q ss_pred CccCCCCceeecCCCCCCCCCccccccc---c-----cCcchHHHHHHhhcCCCcEEecccccccc-----cceehhhcc
Q psy622 392 NLSGVSPFLAMDRSPPDNSELEWPEDEE---A-----LNPSTEETILALLKSDPIVFMGDDTWSSF-----SAIFNTLDA 458 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 458 (473)
...|.|.|...-++....+...+||+.- . ....+|+.||+.+ +|||||.+.++|-+- .++|++..+
T Consensus 14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~~~l~~~~ 92 (345)
T d1pmea_ 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYLVTHL 92 (345)
T ss_dssp EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccceEEEEEee
Confidence 4578888887766666666668999321 1 1234799999999 799999999887543 456776554
Q ss_pred c
Q psy622 459 M 459 (473)
Q Consensus 459 ~ 459 (473)
+
T Consensus 93 ~ 93 (345)
T d1pmea_ 93 M 93 (345)
T ss_dssp C
T ss_pred c
Confidence 4
|